Citrus Sinensis ID: 037275
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 992 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGP4 | 1010 | Probable LRR receptor-lik | yes | no | 0.977 | 0.960 | 0.453 | 0.0 | |
| C0LGT6 | 1031 | LRR receptor-like serine/ | no | no | 0.964 | 0.928 | 0.442 | 0.0 | |
| Q9SD62 | 1025 | Putative receptor-like pr | no | no | 0.975 | 0.944 | 0.455 | 0.0 | |
| Q9ZUI0 | 980 | Putative leucine-rich rep | no | no | 0.896 | 0.907 | 0.359 | 1e-140 | |
| Q9FL28 | 1173 | LRR receptor-like serine/ | no | no | 0.950 | 0.803 | 0.323 | 1e-138 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.901 | 0.715 | 0.332 | 1e-125 | |
| Q8VZG8 | 1045 | Probable LRR receptor-lik | no | no | 0.877 | 0.832 | 0.324 | 1e-124 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.931 | 0.839 | 0.321 | 1e-122 | |
| Q9M2Z1 | 1002 | Leucine-rich repeat recep | no | no | 0.931 | 0.922 | 0.334 | 1e-122 | |
| O49318 | 1124 | Probable leucine-rich rep | no | no | 0.948 | 0.837 | 0.309 | 1e-121 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 831 bits (2147), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 455/1003 (45%), Positives = 652/1003 (65%), Gaps = 33/1003 (3%)
Query: 5 SNETDRLALLAIGSQLEDDPLGVTSSWNNSTNLCQWTGVTCGHRHQRVTKLDLSNRTIGG 64
++ETDR ALL SQ+ +D V SSWN+S LC W GVTCG +++RVT L+L +GG
Sbjct: 21 TDETDRQALLQFKSQVSEDKRVVLSSWNHSFPLCNWKGVTCGRKNKRVTHLELGRLQLGG 80
Query: 65 TLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNL 124
+SP +GNLSFL L+L +N F G IP ++G+L RLE L + N G IP L CS L
Sbjct: 81 VISPSIGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGINYLRGPIPLGLYNCSRL 140
Query: 125 ISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLW 184
++ N L G +P+ELG + L L + N++ G P S+GNL+ LE++ + N L
Sbjct: 141 LNLRLDSNRLGGSVPSELG-SLTNLVQLNLYGNNMRGKLPTSLGNLTLLEQLALSHNNLE 199
Query: 185 GRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLP 244
G IP+++ L + L L N FSG+ PP+++N+SSL+ + + N F+G L D+G+ LP
Sbjct: 200 GEIPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGILLP 259
Query: 245 KLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNL 304
LL F + N F GSIP +LSN S L L + +N G + F ++ NL+ L L +N+L
Sbjct: 260 NLLSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIPT-FGNVPNLKLLFLHTNSL 318
Query: 305 GTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIP 364
G+ + DL+FLT LTNCT+L +G+ NR GG LP SIANLS+ + + + G ISG IP
Sbjct: 319 GSDSSRDLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLISGSIP 378
Query: 365 TGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNL 424
I NL+NL +L +D N L+G +P ++G+L NL+ L L SN L+GGIP +GN+T+L L
Sbjct: 379 YDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETL 438
Query: 425 ALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTL 484
LS+N +G +P SLGNC +L+EL + D +L G +P +I+ I L L LD+S N L G+L
Sbjct: 439 DLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQL-LRLDMSGNSLIGSL 497
Query: 485 PLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKE 544
P ++G L+NL ++ N+ SG++P TL C +++ L+L+GN F G IP L L +KE
Sbjct: 498 PQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIP-DLKGLVGVKE 556
Query: 545 LDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNKTGISLSGNGKVCGGL 604
+D+S+N+LSG IPEY + S LEYLNLS+N+ EG+VP KG+F N T +S+ GN +CGG+
Sbjct: 557 VDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGI 616
Query: 605 DELNLPPCPSRG---LKKRTDFLLKVVVPVTVSGVILSLCLVLFLAR------RRRSAHK 655
L PC S+ +KK + L KVV+ V+V ++L L+LF+A R+R +K
Sbjct: 617 MGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVG---ITLLLLLFMASVTLIWLRKRKKNK 673
Query: 656 SS---VSQLMDQQFPMISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVI 712
+ ++ ISY +L ATN FSSSNM+G GSFG VYK L +VAVKV+
Sbjct: 674 ETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVL 733
Query: 713 NLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWL 772
N++++GA F+AEC++L++IRHRNL+K++T CSSIDF+G +F+A++YE+M NGSL+ WL
Sbjct: 734 NMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWL 793
Query: 773 HQSEDQQ---EARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVA 829
H E ++ +R+LTL++R+NI IDVAS ++Y+H HC P+ H DLKPSNVLLD DL A
Sbjct: 794 HPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTA 853
Query: 830 HLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLL 889
H+ DFGLA+ L ++ SS+ G++GT+GY APEYG+GG+ S+ GDVYSFGILLL
Sbjct: 854 HVSDFGLARLLLKFDEESFFNQLSSA-GVRGTIGYAAPEYGVGGQPSINGDVYSFGILLL 912
Query: 890 EMFTRRRPTDGMFNQGLTLHEFARTALPDKVMEIVD-SVLLLEVQASNSRSCGDERLRTE 948
EMFT +RPT+ +F TL+ + ++ALP+++++IVD S+L + ++
Sbjct: 913 EMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESILHIGLRVG---------FPVV 963
Query: 949 ERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTFLGRMR 991
E L V E G+ C ESP R+ VV +L R+ F R
Sbjct: 964 ECLTMVFEVGLRCCEESPMNRLATSIVVKELISIRERFFKASR 1006
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 780 bits (2015), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 443/1001 (44%), Positives = 630/1001 (62%), Gaps = 44/1001 (4%)
Query: 5 SNETDRLALLAIGSQL-EDDPLGVTSSWNNSTNLCQWTGVTCGHRHQRVTKLDLSNRTIG 63
SNETD ALL SQ+ E++ V +SWN+S+ C W GVTCG R +RV L+L +
Sbjct: 27 SNETDMQALLEFKSQVSENNKREVLASWNHSSPFCNWIGVTCGRRRERVISLNLGGFKLT 86
Query: 64 GTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSN 123
G +SP +GNLSFLR LNLADN+F IP ++GRL RL+ L ++ N G+IP++LS CS
Sbjct: 87 GVISPSIGNLSFLRLLNLADNSFGSTIPQKVGRLFRLQYLNMSYNLLEGRIPSSLSNCSR 146
Query: 124 LISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGL 183
L + + N+L +P+ELG + KL L ++ N+LTG+FPAS+GNL++L++++ N +
Sbjct: 147 LSTVDLSSNHLGHGVPSELG-SLSKLAILDLSKNNLTGNFPASLGNLTSLQKLDFAYNQM 205
Query: 184 WGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSL 243
G IP+ + L ++ + N FSG PP+++NISSLE++ L N F+G+L D G L
Sbjct: 206 RGEIPDEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNSFSGNLRADFGYLL 265
Query: 244 PKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNN 303
P L ++ N F G+IP++L+N S+L + N G + + F L+NL WL + +N+
Sbjct: 266 PNLRRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNS 325
Query: 304 LGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGII 363
LG ++ L+F+ + NCT+L + + NR GG LP SIANLS+T+T + + N ISG I
Sbjct: 326 LGNNSSSGLEFIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLGQNLISGTI 385
Query: 364 PTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTN 423
P I NLV+L EL ++ N L+G +P + G+L NLQ++ L SN ++G IP+ GN+T L
Sbjct: 386 PHDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQK 445
Query: 424 LALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGT 483
L L+SN G IP SLG C+ L++L M L G +P +IL I +L+ +DLS N L+G
Sbjct: 446 LHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAY-IDLSNNFLTGH 504
Query: 484 LPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIK 543
P EVG L+ LV S N+ SG++P + C S++ L++QGNSF G+IP +S L S+K
Sbjct: 505 FPEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIP-DISRLVSLK 563
Query: 544 ELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNKTGISLSGNGKVCGG 603
+D S+NNLSG+IP YL +L L LNLS N FEG VPT GVF N T +S+ GN +CGG
Sbjct: 564 NVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGG 623
Query: 604 LDELNLPPCPSRGLKKRTDFLLKVVVPVTVSGV---ILSLCLVL-------FLARRRR-- 651
+ E+ L PC + ++ L V VSG+ I SL L++ F+ R+++
Sbjct: 624 VREMQLKPCIVQASPRKRKPL--SVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKNN 681
Query: 652 -SAHKSSVSQLMDQQFPMISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVK 710
S S S + +SY EL AT+ FSS+N+IG G+FG V+KG LG +VAVK
Sbjct: 682 ASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVK 741
Query: 711 VINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLED 770
V+NL + GA+ F+AEC+ + IRHRNL+K+IT+CSS+D +G DF+A+VYE+M GSL+
Sbjct: 742 VLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDM 801
Query: 771 WLHQSEDQQ----EARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQD 826
WL Q ED + +RSLT +++NI IDVASA+EY+H HC PV H D+KPSN+LLD D
Sbjct: 802 WL-QLEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDD 860
Query: 827 LVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGI 886
L AH+ DFGLA+ L ++ + SS+ G++GT+GY APEYGMGG+ S+ GDVYSFGI
Sbjct: 861 LTAHVSDFGLAQLLYKYDRESFLNQFSSA-GVRGTIGYAAPEYGMGGQPSIQGDVYSFGI 919
Query: 887 LLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLR 946
LLLEMF+ ++PTD F LH + ++ L +S + DE LR
Sbjct: 920 LLLEMFSGKKPTDESFAGDYNLHSYTKSILSG-------------CTSSGGSNAIDEGLR 966
Query: 947 TEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTFL 987
V++ G+ CS E P +RM + V +L R F
Sbjct: 967 L------VLQVGIKCSEEYPRDRMRTDEAVRELISIRSKFF 1001
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 773 bits (1997), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 455/1000 (45%), Positives = 645/1000 (64%), Gaps = 32/1000 (3%)
Query: 5 SNETDRLALLAIGSQLEDDPLGVTSSWNNSTNLCQWTGVTCGHRHQRVTKLDLSNRTIGG 64
+ ETD+ ALL SQ+ + V SWN+S LC WTGV CG +H+RVT +DL + G
Sbjct: 36 TEETDKQALLEFKSQVSETSRVVLGSWNDSLPLCSWTGVKCGLKHRRVTGVDLGGLKLTG 95
Query: 65 TLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNL 124
+SP+VGNLSFLR LNLADN FHG IP ++G L RL+ L ++NN F G IP LS CS+L
Sbjct: 96 VVSPFVGNLSFLRSLNLADNFFHGAIPSEVGNLFRLQYLNMSNNLFGGVIPVVLSNCSSL 155
Query: 125 ISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLW 184
+ + N+L +P E G KL L++ N+LTG FPAS+GNL++L+ ++ + N +
Sbjct: 156 STLDLSSNHLEQGVPLEFGSL-SKLVLLSLGRNNLTGKFPASLGNLTSLQMLDFIYNQIE 214
Query: 185 GRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLP 244
G IP ++ L+ +I + N+F+G+ PP I+N+SSL + + N F+G+L D G LP
Sbjct: 215 GEIPGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGSLLP 274
Query: 245 KLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNL 304
L + N+F G+IPE+LSN S+L +L + N GK+ + F L+NL L L +N+L
Sbjct: 275 NLQILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSL 334
Query: 305 GTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIP 364
G + DLDFL LTNC++L + + N+ GG LP IANLS+ +T++ + GN ISG IP
Sbjct: 335 GNYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGNLISGSIP 394
Query: 365 TGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNL 424
GI NLV+L L + +N LTG +P ++GEL L+ + L SN L+G IP+SLGN++ LT L
Sbjct: 395 HGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYL 454
Query: 425 ALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTL 484
L +N +GSIP SLG+C L++L++ +L G++P +++ + +L + L++S+NLL G L
Sbjct: 455 YLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSL-VVLNVSFNLLVGPL 513
Query: 485 PLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKE 544
++G LK L+ ++S N+ SG+IP TL+ C SL+ L LQGNSF G IP + L ++
Sbjct: 514 RQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIP-DIRGLTGLRF 572
Query: 545 LDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNKTGISLSGNGKVCGGL 604
LD+S NNLSG IPEY+ N S L+ LNLS N+F+G VPT+GVF N + +S+ GN +CGG+
Sbjct: 573 LDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGI 632
Query: 605 DELNLPPCPSRGLKKRTDFLLKVVVPVTVSGVILSLC-------------LVLFLARRRR 651
L L PC S L +R + K++ + VS V+ +L L + R
Sbjct: 633 PSLQLQPC-SVELPRRHSSVRKIIT-ICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANN 690
Query: 652 SAHKSSVSQLMDQQFPMISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKV 711
+ + S S + + ISY EL K T FSSSN+IG G+FG V+KG LG VA+KV
Sbjct: 691 NENDRSFSP-VKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKV 749
Query: 712 INLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDW 771
+NL ++GA+ F+AEC+AL IRHRNL+K++TICSS DF+G DF+A+VYE+M NG+L+ W
Sbjct: 750 LNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMW 809
Query: 772 LHQSEDQQE---ARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLV 828
LH E ++ +R+L L R+NI IDVASA+ Y+H +C P+ H D+KPSN+LLD+DL
Sbjct: 810 LHPDEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLT 869
Query: 829 AHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILL 888
AH+ DFGLA+ L DT SS G++GT+GY APEYGMGG S+ GDVYSFGI+L
Sbjct: 870 AHVSDFGLAQLLLKFDRDT-FHIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVL 928
Query: 889 LEMFTRRRPTDGMFNQGLTLHEFARTALPDK-VMEIVDSVLLLEVQASNSRSCGDERLRT 947
LE+FT +RPT+ +F GLTLH F ++AL + ++I D +L R +
Sbjct: 929 LEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETIL--------RGAYAQHFNM 980
Query: 948 EERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTFL 987
E L V GV CS ESP R+ M + ++KL R++F
Sbjct: 981 VECLTLVFRVGVSCSEESPVNRISMAEAISKLVSIRESFF 1020
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 499 bits (1286), Expect = e-140, Method: Compositional matrix adjust.
Identities = 351/977 (35%), Positives = 520/977 (53%), Gaps = 88/977 (9%)
Query: 35 TNLCQWTGVTCGHRHQRVTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQI 94
++C W+GV C +V +LD+S R +GG +SP + NL+ L L+L+ N F G+IP +I
Sbjct: 51 VDVCNWSGVKCNKESTQVIELDISGRDLGGEISPSIANLTGLTVLDLSRNFFVGKIPPEI 110
Query: 95 GRLVR-LEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLT 153
G L L+ L L+ N G IP L + L+ + N L G IP +L N
Sbjct: 111 GSLHETLKQLSLSENLLHGNIPQELGLLNRLVYLDLGSNRLNGSIPVQLFCN-------- 162
Query: 154 IADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLG-NLRNLILLNLGENRFSGIVP 212
G+ S+L+ I++ N L G IP N +L+ L L L N+ +G VP
Sbjct: 163 --------------GSSSSLQYIDLSNNSLTGEIPLNYHCHLKELRFLLLWSNKLTGTVP 208
Query: 213 PSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVE 272
S+ N ++L+ + L +N +G LP + +P+L ++ N+F S +N +NL
Sbjct: 209 SSLSNSTNLKWMDLESNMLSGELPSQVISKMPQLQFLYLSYNHFV-----SHNNNTNL-- 261
Query: 273 LTLFDNQFRGKVSIYFRSLKN---LEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGL 329
+F SL N L+ L L N+LG + + L++ L I L
Sbjct: 262 ------------EPFFASLANSSDLQELELAGNSLGGEITSSVRHLSV-----NLVQIHL 304
Query: 330 DDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPH 389
D NR G +P I+NL + + + N +SG IP + L L + + +N LTG IP
Sbjct: 305 DQNRIHGSIPPEISNLLNLTLLNLSS-NLLSGPIPRELCKLSKLERVYLSNNHLTGEIPM 363
Query: 390 AIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELH 449
+G++ L LL + N L+G IP S GNL+ L L L N L G++P SLG C NL L
Sbjct: 364 ELGDIPRLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINLEILD 423
Query: 450 MADIELTGALPPQILS-ISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEI 508
++ LTG +P +++S + L L L+LS N LSG +PLE+ + ++ ++S N SG+I
Sbjct: 424 LSHNNLTGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGKI 483
Query: 509 PVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEY 568
P L +C +L+ L L N FS ++PSSL L +KELD+S N L+G IP + S L++
Sbjct: 484 PPQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKH 543
Query: 569 LNLSYNHFEGEVPTKGVFSNKTGISLSGNGKVCGGLDELNLPPCPSRGLKKRTDFLLKVV 628
LN S+N G V KG FS T S G+ +CG + + + KK+ + ++
Sbjct: 544 LNFSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIKGM-------QACKKKHKYPSVLL 596
Query: 629 VPVTVSGVILSLCLVLF-LARRRRSAHKSSV-----------SQLMDQQFPMISYAELSK 676
+ LC+ + L +R R +V D ++P ISY +L
Sbjct: 597 PVLLSLIATPVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQNDPKYPRISYQQLIA 656
Query: 677 ATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNG-FVAECQALRNIRH 735
AT F++S++IG G FG VYKG L N VAVKV++ K +G F ECQ L+ RH
Sbjct: 657 ATGGFNASSLIGSGRFGHVYKGVL-RNNTKVAVKVLDPKTALEFSGSFKRECQILKRTRH 715
Query: 736 RNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIID 795
RNLI+IIT CS F A+V M NGSLE L+ E +++L LIQ +NI D
Sbjct: 716 RNLIRIITTCSK-----PGFNALVLPLMPNGSLERHLYPGE--YSSKNLDLIQLVNICSD 768
Query: 796 VASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLS----SSPLDTAVET 851
VA I Y+HH+ VVH DLKPSN+LLD ++ A + DFG+++ + + D +V
Sbjct: 769 VAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVSF 828
Query: 852 PSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEF 911
S+ + G+VGYIAPEYGMG AS GDVYSFG+LLLE+ + RRPTD + N+G +LHEF
Sbjct: 829 GSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLHEF 888
Query: 912 ARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERME 971
++ PD + I++ L C E+L E ++ ++E G+VC+ +P+ R +
Sbjct: 889 MKSHYPDSLEGIIEQALSRWKPQGKPEKC--EKL-WREVILEMIELGLVCTQYNPSTRPD 945
Query: 972 MRDVVAKLCRARDTFLG 988
M DV ++ R ++
Sbjct: 946 MLDVAHEMGRLKEYLFA 962
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 493 bits (1269), Expect = e-138, Method: Compositional matrix adjust.
Identities = 373/1154 (32%), Positives = 557/1154 (48%), Gaps = 211/1154 (18%)
Query: 12 ALLAIGSQLEDDPLGVTSSWN--NSTNLCQWTGVTC---GHRHQRVTKLDLSNRTIGGTL 66
AL + + + +DPLGV S W S C WTG+TC GH V + L + + G L
Sbjct: 33 ALKSFKNGISNDPLGVLSDWTIIGSLRHCNWTGITCDSTGH----VVSVSLLEKQLEGVL 88
Query: 67 SPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLIS 126
SP + NL++L+ L+L N+F G+IP +IG+L L L+L N FSG IP+ + N+
Sbjct: 89 SPAIANLTYLQVLDLTSNSFTGKIPAEIGKLTELNQLILYLNYFSGSIPSGIWELKNIFY 148
Query: 127 FNARRNNLVGEIPAEL---------GYNW--------------LKLENLTIADNHLTGHF 163
+ R N L G++P E+ G+++ + L+ A NHLTG
Sbjct: 149 LDLRNNLLSGDVPEEICKTSSLVLIGFDYNNLTGKIPECLGDLVHLQMFVAAGNHLTGSI 208
Query: 164 PASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLEN 223
P SIG L+ L +++ GN L G+IP + GNL NL L L EN G +P I N SSL
Sbjct: 209 PVSIGTLANLTDLDLSGNQLTGKIPRDFGNLLNLQSLVLTENLLEGDIPAEIGNCSSLVQ 268
Query: 224 VFLPTNRFNGSLPLDIG-----------------------VSLPKLLGFIVAENNFAGSI 260
+ L N+ G +P ++G L +L ++EN+ G I
Sbjct: 269 LELYDNQLTGKIPAELGNLVQLQALRIYKNKLTSSIPSSLFRLTQLTHLGLSENHLVGPI 328
Query: 261 PESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLT---- 316
E + +L LTL N F G+ +L+NL L +G NN+ DL LT
Sbjct: 329 SEEIGFLESLEVLTLHSNNFTGEFPQSITNLRNLTVLTVGFNNISGELPADLGLLTNLRN 388
Query: 317 ------LLT--------NCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGI 362
LLT NCT L + L N+ G +P ++ +T I I N +G
Sbjct: 389 LSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPRGFGRMN--LTFISIGRNHFTGE 446
Query: 363 IPTGIRNLVNLVELCMDDNKLTGT------------------------IPHAIGELKNLQ 398
IP I N NL L + DN LTGT IP IG LK+L
Sbjct: 447 IPDDIFNCSNLETLSVADNNLTGTLKPLIGKLQKLRILQVSYNSLTGPIPREIGNLKDLN 506
Query: 399 LLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQG------------------------- 433
+LYL SN G IP + NLTLL L + SNDL+G
Sbjct: 507 ILYLHSNGFTGRIPREMSNLTLLQGLRMYSNDLEGPIPEEMFDMKLLSVLDLSNNKFSGQ 566
Query: 434 -----------------------SIPPSLGNCKNLIELHMADIELTGALPPQIL-SISTL 469
SIP SL + L ++D LTG +P ++L S+ +
Sbjct: 567 IPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTGTIPGELLASLKNM 626
Query: 470 SLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQL-------- 521
L L+ S NLL+GT+P E+G L+ + ++S N FSG IP +L AC ++ L
Sbjct: 627 QLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACKNVFTLDFSQNNLS 686
Query: 522 ------YLQG-----------NSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLS 564
QG NSFSG IP S ++ + LD+SSNNL+G+IPE L NLS
Sbjct: 687 GHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLS 746
Query: 565 FLEYLNLSYNHFEGEVPTKGVFSNKTGISLSGNGKVCGGLDELNLPPC----PSRGLKKR 620
L++L L+ N+ +G VP GVF N L GN +CG L PC S KR
Sbjct: 747 TLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSKKPLK--PCTIKQKSSHFSKR 804
Query: 621 TDFLLKVV-----VPVTVSGVILSLCLVLFLARRRRSAHKSSVSQLMDQQFPMISYAELS 675
T +L ++ + + + V++ C + S+ S + EL
Sbjct: 805 TRVILIILGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPDLDSALKLKRFEPKELE 864
Query: 676 KATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNG--FVAECQALRNI 733
+AT+ F+S+N+IG S VYKG L E+G ++AVKV+NLK+ A + F E + L +
Sbjct: 865 QATDSFNSANIIGSSSLSTVYKGQL-EDGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQL 923
Query: 734 RHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINII 793
+HRNL+KI+ ++ +A+V +M+NG+LED +H S A +L+++I++
Sbjct: 924 KHRNLVKILGFA----WESGKTKALVLPFMENGNLEDTIHGS----AAPIGSLLEKIDLC 975
Query: 794 IDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPS 853
+ +AS I+Y+H P+VH DLKP+N+LLD D VAH+ DFG A+ L T +
Sbjct: 976 VHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILG---FREDGSTTA 1032
Query: 854 SSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPT--DGMFNQGLTLHEF 911
S+ +GT+GY+APE+ + + DV+SFGI+++E+ T++RPT + +Q +TL +
Sbjct: 1033 STSAFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDSQDMTLRQL 1092
Query: 912 ARTALPDKVMEIVDSVLLLEVQASNSRSCGDE--RLRTEERLVAVVETGVVCSMESPTER 969
++ + +V VL +E+ GD L+ EE + ++ + C+ P +R
Sbjct: 1093 VEKSIGNGRKGMV-RVLDMEL--------GDSIVSLKQEEAIEDFLKLCLFCTSSRPEDR 1143
Query: 970 MEMRDVVAKLCRAR 983
+M +++ L + R
Sbjct: 1144 PDMNEILTHLMKLR 1157
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 449 bits (1156), Expect = e-125, Method: Compositional matrix adjust.
Identities = 345/1037 (33%), Positives = 505/1037 (48%), Gaps = 143/1037 (13%)
Query: 48 RHQRVTKLDLSNRTIGGTLSPYVGNLSFLRY------------------------LNLAD 83
R + + L+L+N ++ G + +G +S L+Y L+L+
Sbjct: 237 RLENLEILNLANNSLTGEIPSQLGEMSQLQYLSLMANQLQGLIPKSLADLGNLQTLDLSA 296
Query: 84 NNFHGEIPHQIGRLVRLEALVLANN-------------------------SFSGKIPTNL 118
NN GEIP + + +L LVLANN SG+IP L
Sbjct: 297 NNLTGEIPEEFWNMSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVEL 356
Query: 119 SRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINV 178
S+C +L + N+L G IP L + ++L +L + +N L G SI NL+ L+ + +
Sbjct: 357 SKCQSLKQLDLSNNSLAGSIPEAL-FELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVL 415
Query: 179 LGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLD 238
N L G++P + LR L +L L ENRFSG +P I N +SL+ + + N F G +P
Sbjct: 416 YHNNLEGKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPS 475
Query: 239 IGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLN 298
IG L +L + +N G +P SL N L L L DNQ G + F LK LE L
Sbjct: 476 IG-RLKELNLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLM 534
Query: 299 LGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQ 358
L +N+L + N D L L N LT I L NR G + H + SS ++ + N
Sbjct: 535 LYNNSL---QGNLPDSLISLRN---LTRINLSHNRLNGTI-HPLCGSSSYLS-FDVTNNG 586
Query: 359 ISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNL 418
IP + N NL L + N+LTG IP +G+++ L LL + SN L G IP L
Sbjct: 587 FEDEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLC 646
Query: 419 TLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYN 478
LT++ L++N L G IPP LG L EL ++ + +LP ++ + + L L L L N
Sbjct: 647 KKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKL-LVLSLDGN 705
Query: 479 LLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSS 538
L+G++P E+GNL L N+ N+FSG +P + + L +L L NS +G IP +
Sbjct: 706 SLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQ 765
Query: 539 LKSIKE-LDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVP---------------- 581
L+ ++ LD+S NN +G IP + LS LE L+LS+N GEVP
Sbjct: 766 LQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSF 825
Query: 582 ------TKGVFSNKTGISLSGNGKVCGGLDELNLPPC-------PSRGLKKRTDFLLKVV 628
K FS S GN +CG L C +GL R+ ++ +
Sbjct: 826 NNLGGKLKKQFSRWPADSFLGNTGLCGS----PLSRCNRVRSNNKQQGLSARSVVIISAI 881
Query: 629 VPVTVSGVILSLCLVLFLARR----RRSAHKSSV-----SQLMDQQFPM---------IS 670
+T G+++ L + LF +R ++ H S+ S P+ I
Sbjct: 882 SALTAIGLMI-LVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIR 940
Query: 671 YAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASN-GFVAECQA 729
+ ++ +AT++ S MIG G G VYK L ENG VAVK I K SN F E +
Sbjct: 941 WEDIMEATHNLSEEFMIGSGGSGKVYKAEL-ENGETVAVKKILWKDDLMSNKSFSREVKT 999
Query: 730 LRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSED--QQEARSLTLI 787
L IRHR+L+K++ CSS K ++YEYM+NGS+ DWLH+ + +++ + L
Sbjct: 1000 LGRIRHRHLVKLMGYCSS---KSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWE 1056
Query: 788 QRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDT 847
R+ I + +A +EY+HH C PP+VH D+K SNVLLD ++ AHLGDFGLAK L+ + DT
Sbjct: 1057 ARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTEN-CDT 1115
Query: 848 AVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLT 907
+ S+ + GYIAPEY +A+ DVYS GI+L+E+ T + PTD +F +
Sbjct: 1116 NTD---SNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMD 1172
Query: 908 LHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLR-----TEERLVAVVETGVVCS 962
+ + T LEV S D +L+ E+ V+E + C+
Sbjct: 1173 MVRWVETH--------------LEVAGSARDKLIDPKLKPLLPFEEDAACQVLEIALQCT 1218
Query: 963 MESPTERMEMRDVVAKL 979
SP ER R L
Sbjct: 1219 KTSPQERPSSRQACDSL 1235
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 448 bits (1152), Expect = e-124, Method: Compositional matrix adjust.
Identities = 317/977 (32%), Positives = 478/977 (48%), Gaps = 107/977 (10%)
Query: 29 SSW--NNSTNLC-QWTGVTCG-----------------------HRHQRVTKLDLSNRTI 62
SSW N+++ C W GV C +T +DLS
Sbjct: 71 SSWVNPNTSSFCTSWYGVACSLGSIIRLNLTNTGIEGTFEDFPFSSLPNLTFVDLSMNRF 130
Query: 63 GGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCS 122
GT+SP G S L Y +L+ N GEIP ++G L L+ L L N +G IP+ + R +
Sbjct: 131 SGTISPLWGRFSKLEYFDLSINQLVGEIPPELGDLSNLDTLHLVENKLNGSIPSEIGRLT 190
Query: 123 NLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNG 182
+ N L G IP+ G N KL NL + N L+G P+ IGNL L + + N
Sbjct: 191 KVTEIAIYDNLLTGPIPSSFG-NLTKLVNLYLFINSLSGSIPSEIGNLPNLRELCLDRNN 249
Query: 183 LWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVS 242
L G+IP++ GNL+N+ LLN+ EN+ SG +PP I N+++L+ + L TN+ G +P +G +
Sbjct: 250 LTGKIPSSFGNLKNVTLLNMFENQLSGEIPPEIGNMTALDTLSLHTNKLTGPIPSTLG-N 308
Query: 243 LPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSN 302
+ L + N GSIP L ++++L + +N+ G V F L LEWL L N
Sbjct: 309 IKTLAVLHLYLNQLNGSIPPELGEMESMIDLEISENKLTGPVPDSFGKLTALEWLFLRDN 368
Query: 303 NLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGI 362
L + N TELT + LD N F G LP +I + ++ + N G
Sbjct: 369 QLSG------PIPPGIANSTELTVLQLDTNNFTGFLPDTICR-GGKLENLTLDDNHFEGP 421
Query: 363 IPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLT 422
+P +R+ +L+ + N +G I A G L + L +N G + + L
Sbjct: 422 VPKSLRDCKSLIRVRFKGNSFSGDISEAFGVYPTLNFIDLSNNNFHGQLSANWEQSQKLV 481
Query: 423 NLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSG 482
LS+N + G+IPP + N L +L ++ +TG LP I +I+ +S L L+ N LSG
Sbjct: 482 AFILSNNSITGAIPPEIWNMTQLSQLDLSSNRITGELPESISNINRIS-KLQLNGNRLSG 540
Query: 483 TLPLEVGNLKNLVYFNISVNRFSGEIPVTL------------------------SACTSL 518
+P + L NL Y ++S NRFS EIP TL + + L
Sbjct: 541 KIPSGIRLLTNLEYLDLSSNRFSSEIPPTLNNLPRLYYMNLSRNDLDQTIPEGLTKLSQL 600
Query: 519 QQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEG 578
Q L L N G I S SL++++ LD+S NNLSGQIP +++ L ++++S+N+ +G
Sbjct: 601 QMLDLSYNQLDGEISSQFRSLQNLERLDLSHNNLSGQIPPSFKDMLALTHVDVSHNNLQG 660
Query: 579 EVPTKGVFSNKTGISLSGNGKVCGGLDELN-LPPC---PSRGLKKRTDFLLKVVVPVTVS 634
+P F N + GN +CG ++ L PC S+ K + ++ ++VP+ +
Sbjct: 661 PIPDNAAFRNAPPDAFEGNKDLCGSVNTTQGLKPCSITSSKKSHKDRNLIIYILVPIIGA 720
Query: 635 GVILSLCLVLFLARRRRSAH--KSSVSQLMDQQFPMIS------YAELSKATNDFSSSNM 686
+ILS+C +F+ R+R+ + + S+ + + S Y E+ KAT +F +
Sbjct: 721 IIILSVCAGIFICFRKRTKQIEEHTDSESGGETLSIFSFDGKVRYQEIIKATGEFDPKYL 780
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVIN------LKQKGASNGFVAECQALRNIRHRNLIK 740
IG G G VYK L N +M AVK +N + F+ E +AL IRHRN++K
Sbjct: 781 IGTGGHGKVYKAKL-PNAIM-AVKKLNETTDSSISNPSTKQEFLNEIRALTEIRHRNVVK 838
Query: 741 IITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAI 800
+ CS + F +VYEYM+ GSL L E+ EA+ L +RIN++ VA A+
Sbjct: 839 LFGFCS---HRRNTF--LVYEYMERGSLRKVL---ENDDEAKKLDWGKRINVVKGVAHAL 890
Query: 801 EYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSS--KGI 858
Y+HH P +VH D+ N+LL +D A + DFG AK L P SS +
Sbjct: 891 SYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAKLLK----------PDSSNWSAV 940
Query: 859 KGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMF-------NQGLTLHEF 911
GT GY+APE + + DVYSFG+L LE+ P D + + L+L
Sbjct: 941 AGTYGYVAPELAYAMKVTEKCDVYSFGVLTLEVIKGEHPGDLVSTLSSSPPDATLSLKSI 1000
Query: 912 ARTALPDKVMEIVDSVL 928
+ LP+ EI + VL
Sbjct: 1001 SDHRLPEPTPEIKEEVL 1017
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 440 bits (1131), Expect = e-122, Method: Compositional matrix adjust.
Identities = 346/1076 (32%), Positives = 510/1076 (47%), Gaps = 152/1076 (14%)
Query: 22 DDPLGVTSSWNN-STNLCQWTGVTCGHRHQRVTKLDLSNRTIGGTLSPYVGNLSFLRYLN 80
+D G +SWN +N C WTG+ C H + VT +DL+ + GTLSP + L LR LN
Sbjct: 39 NDSNGYLASWNQLDSNPCNWTGIACTHL-RTVTSVDLNGMNLSGTLSPLICKLHGLRKLN 97
Query: 81 LADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPA 140
++ N G IP + LE L L N F G IP L+ L N L G IP
Sbjct: 98 VSTNFISGPIPQDLSLCRSLEVLDLCTNRFHGVIPIQLTMIITLKKLYLCENYLFGSIPR 157
Query: 141 ELGYNWLKLENLTIADNHLTGHFPASIGNLSTL---------------------ERINVL 179
++G N L+ L I N+LTG P S+ L L E + VL
Sbjct: 158 QIG-NLSSLQELVIYSNNLTGVIPPSMAKLRQLRIIRAGRNGFSGVIPSEISGCESLKVL 216
Query: 180 G---NGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLP 236
G N L G +P L L+NL L L +NR SG +PPS+ NIS LE + L N F GS+P
Sbjct: 217 GLAENLLEGSLPKQLEKLQNLTDLILWQNRLSGEIPPSVGNISRLEVLALHENYFTGSIP 276
Query: 237 LDIGV----------------SLPKLLGFIV-------AENNFAGSIPESLSNASNLVEL 273
+IG +P+ +G ++ +EN G IP+ + NL L
Sbjct: 277 REIGKLTKMKRLYLYTNQLTGEIPREIGNLIDAAEIDFSENQLTGFIPKEFGHILNLKLL 336
Query: 274 TLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNR 333
LF+N G + L LE L+L N L +L FL L + + L DN+
Sbjct: 337 HLFENILLGPIPRELGELTLLEKLDLSINRLNGTIPQELQFLPYLVD------LQLFDNQ 390
Query: 334 FGGVLP--------HSIANLSS---------------TMTDIVIAGNQISGIIPTGIRNL 370
G +P S+ ++S+ T+ + + N++SG IP ++
Sbjct: 391 LEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRFQTLILLSLGSNKLSGNIPRDLKTC 450
Query: 371 VNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSND 430
+L +L + DN+LTG++P + L+NL L L N+L+G I LG L L L L++N+
Sbjct: 451 KSLTKLMLGDNQLTGSLPIELFNLQNLTALELHQNWLSGNISADLGKLKNLERLRLANNN 510
Query: 431 LQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGN 490
G IPP +GN ++ +++ +LTG +P ++ S T+ LDLS N SG + E+G
Sbjct: 511 FTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSCVTIQ-RLDLSGNKFSGYIAQELGQ 569
Query: 491 LKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIK-ELDMSS 549
L L +S NR +GEIP + T L +L L GN S +IP L L S++ L++S
Sbjct: 570 LVYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLTSLQISLNISH 629
Query: 550 NNLSGQIPEYLENLSFLEYL------------------------NLSYNHFEGEVPTKGV 585
NNLSG IP+ L NL LE L N+S N+ G VP V
Sbjct: 630 NNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLVGTVPDTAV 689
Query: 586 FSNKTGISLSGNGKVCGGLDELNLPPCPSRGLK-------KRTDFLLKVVVPVTVSGVIL 638
F + +GN +C P P K + +L + V S ++
Sbjct: 690 FQRMDSSNFAGNHGLCNSQRSHCQPLVPHSDSKLNWLINGSQRQKILTITCIVIGSVFLI 749
Query: 639 SLCLVLFLARRRRSAHKSSVSQ----LMDQQ-FPM--ISYAELSKATNDFSSSNMIGQGS 691
+ + + +RR A + Q +MD FP +Y L AT +FS ++G+G+
Sbjct: 750 TFLGLCWTIKRREPAFVALEDQTKPDVMDSYYFPKKGFTYQGLVDATRNFSEDVVLGRGA 809
Query: 692 FGFVYKGNLGENGMMVAVKVINLKQKGAS--NGFVAECQALRNIRHRNLIKIITICSSID 749
G VYK + G ++AVK +N + +GAS N F AE L IRHRN++K+ C
Sbjct: 810 CGTVYKAEM-SGGEVIAVKKLNSRGEGASSDNSFRAEISTLGKIRHRNIVKLYGFCYH-- 866
Query: 750 FKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQP 809
+ ++YEYM GSL + L + E L R I + A + Y+HH C+P
Sbjct: 867 ---QNSNLLLYEYMSKGSLGEQLQRGEKNC---LLDWNARYRIALGAAEGLCYLHHDCRP 920
Query: 810 PVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEY 869
+VH D+K +N+LLD+ AH+GDFGLAK + S S + G+ GYIAPEY
Sbjct: 921 QIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLS-------YSKSMSAVAGSYGYIAPEY 973
Query: 870 GMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKV--MEIVDSV 927
+ + D+YSFG++LLE+ T + P + QG L + R ++ + + +E+ D+
Sbjct: 974 AYTMKVTEKCDIYSFGVVLLELITGKPPVQPL-EQGGDLVNWVRRSIRNMIPTIEMFDAR 1032
Query: 928 LLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRAR 983
L +N + RT + V++ + C+ SP R MR+VVA + AR
Sbjct: 1033 L-----DTNDK-------RTVHEMSLVLKIALFCTSNSPASRPTMREVVAMITEAR 1076
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 438 bits (1127), Expect = e-122, Method: Compositional matrix adjust.
Identities = 334/998 (33%), Positives = 498/998 (49%), Gaps = 74/998 (7%)
Query: 1 FSVPSNETDRLALLAIGSQLE-DDPLGVTSSWNNSTNLCQWTGVTCGHRHQRVTKLDLSN 59
F+V T+ ALL++ S D+ + +SWN ST C WTGVTC + VT LDLS
Sbjct: 19 FTVAKPITELHALLSLKSSFTIDEHSPLLTSWNLSTTFCSWTGVTCDVSLRHVTSLDLSG 78
Query: 60 RTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLS 119
+ GTLS V +L L+ L+LA N G IP QI L L L L+NN F+G P LS
Sbjct: 79 LNLSGTLSSDVAHLPLLQNLSLAANQISGPIPPQISNLYELRHLNLSNNVFNGSFPDELS 138
Query: 120 R-CSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINV 178
NL + NNL G++P L N +L +L + N+ +G PA+ G LE + V
Sbjct: 139 SGLVNLRVLDLYNNNLTGDLPVSL-TNLTQLRHLHLGGNYFSGKIPATYGTWPVLEYLAV 197
Query: 179 LGNGLWGRIPNNLGNLRNLILLNLGE-NRFSGIVPPSIFNISSLENVFLPTNRFNGSLPL 237
GN L G+IP +GNL L L +G N F +PP I N+S L G +P
Sbjct: 198 SGNELTGKIPPEIGNLTTLRELYIGYYNAFENGLPPEIGNLSELVRFDAANCGLTGEIPP 257
Query: 238 DIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWL 297
+IG L KL + N F G+I + L S+L + L +N F G++ F LKNL L
Sbjct: 258 EIG-KLQKLDTLFLQVNAFTGTITQELGLISSLKSMDLSNNMFTGEIPTSFSQLKNLTLL 316
Query: 298 NLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGN 357
NL N L + EL + L +N F G +P + + + + ++ N
Sbjct: 317 NLFRNKLYGA------IPEFIGEMPELEVLQLWENNFTGSIPQKLGE-NGRLVILDLSSN 369
Query: 358 QISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGN 417
+++G +P + + L+ L N L G+IP ++G+ ++L + + NFL G IP L
Sbjct: 370 KLTGTLPPNMCSGNRLMTLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKELFG 429
Query: 418 LTLLTNLALSSNDLQGSIPPSLGNCK-NLIELHMADIELTGALPPQILSISTLSLSLDLS 476
L L+ + L N L G +P S G +L ++ +++ +L+G+LP I ++S + L L
Sbjct: 430 LPKLSQVELQDNYLTGELPISGGGVSGDLGQISLSNNQLSGSLPAAIGNLSGVQ-KLLLD 488
Query: 477 YNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSL 536
N SG++P E+G L+ L + S N FSG I +S C L + L N SG IP+ L
Sbjct: 489 GNKFSGSIPPEIGRLQQLSKLDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGDIPNEL 548
Query: 537 SSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNKTGISLSG 596
+ +K + L++S N+L G IP + ++ L ++ SYN+ G VP+ G FS S G
Sbjct: 549 TGMKILNYLNLSRNHLVGSIPVTIASMQSLTSVDFSYNNLSGLVPSTGQFSYFNYTSFVG 608
Query: 597 NGKVCGGLDELNLPPCPSRGLKKRTDFLLKVVVPVTVSGVILSLCLVLFL------ARRR 650
N +CG L PC +G + L + + + L C ++F AR
Sbjct: 609 NSHLCGPY----LGPC-GKGTHQSHVKPLSATTKLLLV-LGLLFCSMVFAIVAIIKARSL 662
Query: 651 RSAHKSSVSQLMDQQFPMISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVK 710
R+A ++ +L F + + + N+IG+G G VYKG + G +VAVK
Sbjct: 663 RNASEAKAWRL--TAFQRLDFT-CDDVLDSLKEDNIIGKGGAGIVYKGTM-PKGDLVAVK 718
Query: 711 VINLKQKGAS--NGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSL 768
+ G+S +GF AE Q L IRHR++++++ CS+ + +VYEYM NGSL
Sbjct: 719 RLATMSHGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSN-----HETNLLVYEYMPNGSL 773
Query: 769 EDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLV 828
+ LH ++ L R I ++ A + Y+HH C P +VH D+K +N+LLD +
Sbjct: 774 GEVLH----GKKGGHLHWNTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFE 829
Query: 829 AHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILL 888
AH+ DFGLAKFL S T I G+ GYIAPEY + DVYSFG++L
Sbjct: 830 AHVADFGLAKFLQDS------GTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVL 883
Query: 889 LEMFTRRRPTDGMFNQGLTLHEFARTAL---PDKVMEIVD----SVLLLEVQASNSRSCG 941
LE+ T ++P G F G+ + ++ R+ D V++++D SV + EV
Sbjct: 884 LELITGKKPV-GEFGDGVDIVQWVRSMTDSNKDCVLKVIDLRLSSVPVHEV--------- 933
Query: 942 DERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKL 979
V ++C E ER MR+VV L
Sbjct: 934 ----------THVFYVALLCVEEQAVERPTMREVVQIL 961
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 436 bits (1122), Expect = e-121, Method: Compositional matrix adjust.
Identities = 341/1102 (30%), Positives = 514/1102 (46%), Gaps = 161/1102 (14%)
Query: 8 TDRLALLAIGSQLEDDPLGVTSSWNN-STNLCQWTGVTCGHRHQR-------VTKLDLSN 59
+D LL + ++ D L +WN C W GV C + VT LDLS+
Sbjct: 35 SDGQFLLELKNRGFQDSLNRLHNWNGIDETPCNWIGVNCSSQGSSSSSNSLVVTSLDLSS 94
Query: 60 RTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLS 119
+ G +SP +G L L YLNLA N G+IP +IG +LE + L NN F G IP ++
Sbjct: 95 MNLSGIVSPSIGGLVNLVYLNLAYNALTGDIPREIGNCSKLEVMFLNNNQFGGSIPVEIN 154
Query: 120 RCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVL 179
+ S L SFN N L G +P E+G + LE L N+LTG P S+GNL+ L
Sbjct: 155 KLSQLRSFNICNNKLSGPLPEEIG-DLYNLEELVAYTNNLTGPLPRSLGNLNKLTTFRAG 213
Query: 180 GNGLWGRIPNNLGNLRNLILLNLGEN------------------------RFSGIVPPSI 215
N G IP +G NL LL L +N +FSG +P I
Sbjct: 214 QNDFSGNIPTEIGKCLNLKLLGLAQNFISGELPKEIGMLVKLQEVILWQNKFSGFIPKDI 273
Query: 216 FNISSLE------------------------NVFLPTNRFNGSLPLDIGVSLPKLLGFIV 251
N++SLE ++L N+ NG++P ++G L K++
Sbjct: 274 GNLTSLETLALYGNSLVGPIPSEIGNMKSLKKLYLYQNQLNGTIPKELG-KLSKVMEIDF 332
Query: 252 AENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNL------G 305
+EN +G IP LS S L L LF N+ G + L+NL L+L N+L G
Sbjct: 333 SENLLSGEIPVELSKISELRLLYLFQNKLTGIIPNELSKLRNLAKLDLSINSLTGPIPPG 392
Query: 306 TGEANDLDFLTLLTNC------------TELTAIGLDDNRFGGVLPHSIANLSS------ 347
+ L L N + L + +N+ G +P I S+
Sbjct: 393 FQNLTSMRQLQLFHNSLSGVIPQGLGLYSPLWVVDFSENQLSGKIPPFICQQSNLILLNL 452
Query: 348 -----------------TMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHA 390
++ + + GN+++G PT + LVNL + +D N+ +G +P
Sbjct: 453 GSNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPTELCKLVNLSAIELDQNRFSGPLPPE 512
Query: 391 IGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHM 450
IG + LQ L+L +N + +P + L+ L +SSN L G IP + NCK L L +
Sbjct: 513 IGTCQKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSSNSLTGPIPSEIANCKMLQRLDL 572
Query: 451 ADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPV 510
+ G+LPP++ S+ L + L LS N SG +P +GNL +L + N FSG IP
Sbjct: 573 SRNSFIGSLPPELGSLHQLEI-LRLSENRFSGNIPFTIGNLTHLTELQMGGNLFSGSIPP 631
Query: 511 TLSACTSLQ-QLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYL 569
L +SLQ + L N FSG IP + +L + L +++N+LSG+IP ENLS L
Sbjct: 632 QLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLSLNNNHLSGEIPTTFENLSSLLGC 691
Query: 570 NLSYNHFEGEVPTKGVFSNKTGISLSGNGKVCGGLDELNLPPC-PSR-----------GL 617
N SYN+ G++P +F N T S GN +CGG +L C PS G
Sbjct: 692 NFSYNNLTGQLPHTQIFQNMTLTSFLGNKGLCGG----HLRSCDPSHSSWPHISSLKAGS 747
Query: 618 KKRTDFLLKVVVPVTVSGVILSLCLVLFLARRRRSA-----HKSSVSQLMDQQF---PMI 669
+R ++ V + ++L +V FL K Q D F
Sbjct: 748 ARRGRIIIIVSSVIGGISLLLIAIVVHFLRNPVEPTAPYVHDKEPFFQESDIYFVPKERF 807
Query: 670 SYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVIN-------LKQKGASNG 722
+ ++ +AT F S ++G+G+ G VYK + +G +AVK + N
Sbjct: 808 TVKDILEATKGFHDSYIVGRGACGTVYKAVM-PSGKTIAVKKLESNREGNNNNSNNTDNS 866
Query: 723 FVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEAR 782
F AE L IRHRN++++ + C +G + ++YEYM GSL + LH ++
Sbjct: 867 FRAEILTLGKIRHRNIVRLYSFCYH---QGSNSNLLLYEYMSRGSLGELLHGG----KSH 919
Query: 783 SLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSS 842
S+ R I + A + Y+HH C+P ++H D+K +N+L+D++ AH+GDFGLAK +
Sbjct: 920 SMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVI-D 978
Query: 843 SPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMF 902
PL +V + G+ GYIAPEY + + D+YSFG++LLE+ T + P +
Sbjct: 979 MPLSKSVS------AVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPVQPL- 1031
Query: 903 NQGLTLHEFARTALPDKVM--EIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVV 960
QG L + R + D + EI+D L ++ D L ++ V + V+
Sbjct: 1032 EQGGDLATWTRNHIRDHSLTSEILDPYL--------TKVEDDVILN---HMITVTKIAVL 1080
Query: 961 CSMESPTERMEMRDVVAKLCRA 982
C+ SP++R MR+VV L +
Sbjct: 1081 CTKSSPSDRPTMREVVLMLIES 1102
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 992 | ||||||
| 224127492 | 1022 | predicted protein [Populus trichocarpa] | 0.985 | 0.956 | 0.5 | 0.0 | |
| 359482058 | 1040 | PREDICTED: probable LRR receptor-like se | 0.981 | 0.936 | 0.500 | 0.0 | |
| 147853780 | 1904 | hypothetical protein VITISV_030954 [Viti | 0.981 | 0.511 | 0.500 | 0.0 | |
| 224097752 | 1025 | predicted protein [Populus trichocarpa] | 0.987 | 0.956 | 0.496 | 0.0 | |
| 255577438 | 1028 | receptor-kinase, putative [Ricinus commu | 0.987 | 0.953 | 0.495 | 0.0 | |
| 224119022 | 1021 | predicted protein [Populus trichocarpa] | 0.979 | 0.952 | 0.509 | 0.0 | |
| 224081190 | 1011 | predicted protein [Populus trichocarpa] | 0.981 | 0.963 | 0.495 | 0.0 | |
| 224141953 | 1026 | predicted protein [Populus trichocarpa] | 0.983 | 0.951 | 0.497 | 0.0 | |
| 224119102 | 1007 | predicted protein [Populus trichocarpa] | 0.981 | 0.967 | 0.503 | 0.0 | |
| 224113117 | 1006 | predicted protein [Populus trichocarpa] | 0.988 | 0.975 | 0.499 | 0.0 |
| >gi|224127492|ref|XP_002329291.1| predicted protein [Populus trichocarpa] gi|222870745|gb|EEF07876.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 954 bits (2465), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 499/998 (50%), Positives = 686/998 (68%), Gaps = 20/998 (2%)
Query: 6 NETDRLALLAIGSQLEDDPLGVTSSWNNSTNLCQWTGVTCGHRHQRVTKLDLSNRTIGGT 65
NETD+L+LL +Q+ DPLG SSWN S+ CQW+GVTCG RHQRV +LDL + + G+
Sbjct: 32 NETDKLSLLTFKAQITGDPLGKLSSWNESSQFCQWSGVTCGRRHQRVVELDLHSYQLVGS 91
Query: 66 LSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLI 125
LSP++GNLSFLR LNLA+N+ IP ++GRL RLE LVL NN+F G IP N+SRC+NL
Sbjct: 92 LSPHIGNLSFLRILNLANNSLSLYIPQELGRLFRLEELVLRNNTFDGGIPANISRCANLR 151
Query: 126 SFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWG 185
+ R NL G++PAELG KL+ LTI N+ G P S GNLS + I N L G
Sbjct: 152 ILDFSRGNLTGKLPAELGL-LSKLQVLTIELNNFVGEIPYSFGNLSAINAIYGSINNLEG 210
Query: 186 RIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPK 245
IPN G L+ L +L+LG N SG++PPSIFN+SSL + P N+ GSLP +G++LP
Sbjct: 211 SIPNVFGQLKRLKILSLGANNLSGMIPPSIFNLSSLTLLSFPVNQLYGSLPHTLGLTLPN 270
Query: 246 LLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLG 305
L F + N F G IP + SNASNL+ + N F GKV S +L+ L +G NNLG
Sbjct: 271 LQVFNIHTNQFGGLIPATFSNASNLLSFQIGSNNFNGKVP-PLSSSHDLQVLGVGDNNLG 329
Query: 306 TGEANDLDFL-TLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIP 364
GE NDL+F+ L N T L A+ DN FGGVLP ++N S+ + + A NQI G IP
Sbjct: 330 KGENNDLNFVYPLANNMTSLEALDTSDNNFGGVLPEIVSNFSTKLMKMTFARNQIRGSIP 389
Query: 365 TGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNL 424
T I NL+NL L ++ N+LTG IP ++G+L+ L L+L+ N ++G IP+S+GN+T L +
Sbjct: 390 TQIGNLINLEALGLETNQLTGMIPSSMGKLQKLSDLFLNGNKISGMIPSSMGNMTSLGRV 449
Query: 425 ALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTL 484
+ N+L+GSIPPSLGN + L+ L ++ L+G +P +++SI +LS+ L LS N L+G+L
Sbjct: 450 NMRLNNLEGSIPPSLGNWQKLLSLALSQNNLSGPIPKELVSIPSLSMYLVLSENELTGSL 509
Query: 485 PLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKE 544
P+E+ L NL Y ++S NRFSGEIP +L +C SL+ L+L+ N G IP +LSSL++I+E
Sbjct: 510 PIEMEKLVNLGYLDVSKNRFSGEIPKSLGSCVSLESLHLEENFLQGPIPITLSSLRAIQE 569
Query: 545 LDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNKTGISLSGNGKVCGGL 604
L++S NNL+GQIPE+LE+ LE LNLS+N FEGEVP +G F N + IS+ GN K+CGG+
Sbjct: 570 LNLSYNNLTGQIPEFLEDFKLLESLNLSFNDFEGEVPVQGAFQNTSAISIFGNKKLCGGI 629
Query: 605 DELNLPPCPSR---GLKKRTDFLLKVVVPVTVSGVILSLCLVLFLARRRRSAHKSSVSQL 661
+LNL CPS K T + + GVIL + +LF R++ ++
Sbjct: 630 PQLNLTRCPSSEPTNSKSPTKLIWIIGSVCGFLGVILIISFLLFYCFRKKKDKPAASQPS 689
Query: 662 MDQQFPMISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASN 721
++ FP ++Y +L AT+ FSS+N+IG+GSFG V+KG LG + ++VAVKV+NL +KGAS
Sbjct: 690 LETSFPRVAYEDLLGATDGFSSANLIGEGSFGSVFKGILGPDKIVVAVKVLNLLRKGASK 749
Query: 722 GFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEA 781
F+AEC+AL++IRHRNL+K++T CSSIDF+G DF+A+VYE+M NG+LE+WLH + EA
Sbjct: 750 SFMAECEALKSIRHRNLVKLLTTCSSIDFQGNDFKALVYEFMVNGNLEEWLHPVQTSDEA 809
Query: 782 ---RSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAK 838
++L L+ R+NI I +ASA+ Y+HH CQ P++H DLKPSN+LLD ++ AH+GDFGLA+
Sbjct: 810 NGPKALDLMHRLNIAIHMASALNYLHHDCQMPIIHCDLKPSNILLDTNMTAHVGDFGLAR 869
Query: 839 FLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPT 898
F S + T SS G+KGT+GY APEYG+GG+ S GDVYS+GILLLEMFT +RP
Sbjct: 870 FHSEASNQT------SSVGLKGTIGYAAPEYGIGGKVSTYGDVYSYGILLLEMFTGKRPV 923
Query: 899 DGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSR-SCGDERLRTEER---LVAV 954
DGMF GL LH +A+ ALPD+++E+VD +L+ E+++ NS G + E L+ +
Sbjct: 924 DGMFKDGLNLHSYAKMALPDRIVEVVDPLLVREIRSVNSSDEMGMYHIGPHEISACLMTI 983
Query: 955 VETGVVCSMESPTERMEMRDVVAKLCRARDTFLG-RMR 991
++ GV CS+E P ERM++ DVV +L R +DT LG RMR
Sbjct: 984 IKMGVACSVELPRERMDIGDVVTELNRIKDTLLGTRMR 1021
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359482058|ref|XP_002274540.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 942 bits (2436), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 502/1003 (50%), Positives = 676/1003 (67%), Gaps = 29/1003 (2%)
Query: 6 NETDRLALLAIGSQLEDDPLGVTSSWNNSTNLCQWTGVTCGHRHQRVTKLDLSNRTIGGT 65
NETDRLALLAI +Q+ DPLG+T+SWN+S + C WTGVTCGHRHQRV L+L++ + G+
Sbjct: 37 NETDRLALLAIKAQITQDPLGITTSWNDSVHFCNWTGVTCGHRHQRVNTLNLNSLHLVGS 96
Query: 66 LSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLI 125
LSP +GNL+FL LNL NNFHG+IP ++GRL RL AL L NNSFSG+IP NLSRCSNL+
Sbjct: 97 LSPSIGNLTFLTGLNLELNNFHGQIPQELGRLSRLRALNLTNNSFSGEIPANLSRCSNLV 156
Query: 126 SFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWG 185
F NNL+G IP+ LG ++ K+ + + N+LTG P S+GNL++++ ++ N L G
Sbjct: 157 YFRLGFNNLIGRIPSWLG-SYPKVVRMQLHYNNLTGPVPDSLGNLTSIKSLSFAVNHLEG 215
Query: 186 RIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPK 245
IP LG L+ L + LG N FSGI+P S++N+SSLE LP N+ GSLP D+ +LP
Sbjct: 216 SIPQALGQLQTLEFMGLGMNGFSGIIPSSVYNMSSLEVFSLPYNKLYGSLPWDLAFTLPN 275
Query: 246 LLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLG 305
L + N+F GS+P SLSNASNL+E + + F GKVSI F + NL L L SN LG
Sbjct: 276 LQVLNIGNNDFTGSLPSSLSNASNLLEFDITMSNFTGKVSIDFGGMPNLWGLFLASNPLG 335
Query: 306 TGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPT 365
GEA+DL FL L C L + L ++FGGVLP+SIANLS+ + + + NQ+SG IP
Sbjct: 336 KGEADDLSFLNSLMKCRALKVLDLSGSQFGGVLPNSIANLSTQLMKLKLDNNQLSGTIPP 395
Query: 366 GIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLA 425
GI NLVNL +L + +N TG+IP IG L+ L + L N L+G IP+SLGN+T L +L
Sbjct: 396 GIGNLVNLTDLILANNDFTGSIPVLIGNLQMLGRIDLSRNQLSGHIPSSLGNITRLYSLH 455
Query: 426 LSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLP 485
L +N L G IP S GN L EL ++ L G +P +++ + +L++SL+L+ N L+G LP
Sbjct: 456 LQNNHLSGKIPSSFGNLLYLQELDLSYNSLNGTIPEKVMDLVSLTISLNLARNQLTGLLP 515
Query: 486 LEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKEL 545
EV LKNL + ++S N+ SGEIP L +C +L+ L+++GN F GSIP S SL+ + +L
Sbjct: 516 SEVRKLKNLGHLDVSENKLSGEIPDGLGSCLTLEHLHMEGNFFKGSIPPSFISLRGLLDL 575
Query: 546 DMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNKTGISLSGNGKVCGGLD 605
D+S NNLSGQIPE+L+ LS L LNLS+N+FEG++PTKGVF+N T S++GN K+CGG+
Sbjct: 576 DLSRNNLSGQIPEFLQQLS-LSNLNLSFNNFEGQLPTKGVFNNATSTSVAGNNKLCGGIP 634
Query: 606 ELNLPPCP---------SRGLKKRTDFLLKVVVPVTVSGVILSLCLVLFLARRRRSAHKS 656
EL+LP CP RGLK L + V +I+SL ++ L R +R ++
Sbjct: 635 ELHLPACPVTKPKTGESKRGLKLMIGLLTGFLGLV----LIMSLLVINRLRRVKREPSQT 690
Query: 657 SVSQLMDQQFPMISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ 716
S S +SY L KAT FSS+N+IG G FG VYKG LG++ +VAVKVI L Q
Sbjct: 691 SASS--KDLILNVSYDGLFKATGGFSSANLIGTGGFGSVYKGILGQDETVVAVKVIQLHQ 748
Query: 717 KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSE 776
+GA F AEC+ALRNIRHRNL+K++T CSS+D++G DF+A+VYE+M NGSLE+WLH
Sbjct: 749 RGAVKSFKAECEALRNIRHRNLVKVLTTCSSVDYQGNDFKALVYEFMPNGSLENWLHPVP 808
Query: 777 DQQEA----RSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLG 832
E R L+L QR+NI IDVASA++Y+HHHC P+VH DLKPSN+LLD D+ AH+G
Sbjct: 809 TPDEINDVLRILSLPQRLNIAIDVASALDYLHHHCHKPIVHCDLKPSNILLDNDMTAHVG 868
Query: 833 DFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMF 892
DFGLA+F+ + + + SSS G+KGT+GY APEYGMG + S GD YS+GILLLEMF
Sbjct: 869 DFGLARFIPEAA-GRSHPSQSSSIGLKGTIGYAAPEYGMGTKVSALGDTYSYGILLLEMF 927
Query: 893 TRRRPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGD-------ERL 945
T +RPT+ MF+ L LH F + ALP+++ +I+D L + D +R
Sbjct: 928 TGKRPTESMFSDQLNLHNFVKMALPERIADIIDPFFLSSEAKEEETTAADSSNLAHMKRE 987
Query: 946 RTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTFLG 988
+ E L++++ GV CS+ESP ERM + + + +L R LG
Sbjct: 988 KMHECLISILRIGVSCSLESPRERMAITEAIKELQLIRKILLG 1030
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147853780|emb|CAN83822.1| hypothetical protein VITISV_030954 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 942 bits (2434), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 502/1003 (50%), Positives = 675/1003 (67%), Gaps = 29/1003 (2%)
Query: 6 NETDRLALLAIGSQLEDDPLGVTSSWNNSTNLCQWTGVTCGHRHQRVTKLDLSNRTIGGT 65
NETDRLALLAI +Q+ DPLG+T+SWN+S + C WTGVTCGHRHQRV L+LS+ + G+
Sbjct: 68 NETDRLALLAIKAQITQDPLGITTSWNDSVHFCNWTGVTCGHRHQRVNTLNLSSLHLVGS 127
Query: 66 LSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLI 125
LSP +GNL+FL LNL NNFHG+IP ++GRL RL AL L NNSFSG+IP NLSRCSNL+
Sbjct: 128 LSPSIGNLTFLTGLNLELNNFHGQIPQELGRLSRLRALNLTNNSFSGEIPANLSRCSNLV 187
Query: 126 SFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWG 185
F NNL+G IP+ LG ++ K+ + + N+LTG P S+GNL++++ ++ N L G
Sbjct: 188 YFRLGFNNLIGRIPSWLG-SYPKVVRMQLHYNNLTGPVPDSLGNLTSIKSLSFAVNHLEG 246
Query: 186 RIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPK 245
IP LG L+ L + LG N FSGI+P S++N+SSLE LP N+ GSLP D+ +LP
Sbjct: 247 SIPQALGQLQTLEFMGLGMNGFSGIIPSSVYNMSSLEVFSLPYNKLYGSLPWDLAFTLPN 306
Query: 246 LLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLG 305
L + N+F G +P SLSNASNL+E + + F GKVSI F + NL L L SN LG
Sbjct: 307 LQVLNIGNNDFTGPLPSSLSNASNLLEFDITMSNFTGKVSIDFGGMPNLWGLFLASNPLG 366
Query: 306 TGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPT 365
GEA+DL FL L C L + L ++FGGVLP+SIANLS+ + + + NQ+SG IP
Sbjct: 367 KGEADDLSFLNSLMKCRALKVLDLSGSQFGGVLPNSIANLSTQLMKLKLDNNQLSGTIPP 426
Query: 366 GIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLA 425
GI NLVNL +L + +N TG+IP IG L+ L + L N L+G IP+SLGN+T L +L
Sbjct: 427 GIGNLVNLTDLILANNDFTGSIPVLIGNLQMLGRIDLSRNQLSGHIPSSLGNITRLYSLH 486
Query: 426 LSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLP 485
L +N L G IP S GN L EL ++ L G +P +++ + +L++SL+L+ N L+G LP
Sbjct: 487 LQNNHLSGKIPSSFGNLLYLQELDLSYNSLNGTIPEKVMDLVSLTISLNLARNQLTGLLP 546
Query: 486 LEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKEL 545
EV LKNL + ++S N+ SGEIP L +C +L+ L+++GN F GSIP S SL+ + +L
Sbjct: 547 SEVRKLKNLGHLDVSENKLSGEIPDGLGSCLTLEHLHMEGNFFKGSIPPSFISLRGLLDL 606
Query: 546 DMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNKTGISLSGNGKVCGGLD 605
D+S NNLSGQIPE+L+ LS L LNLS+N+FEG++PTKGVF+N T S++GN K+CGG+
Sbjct: 607 DLSRNNLSGQIPEFLQQLS-LSNLNLSFNNFEGQLPTKGVFNNATSTSVAGNNKLCGGIP 665
Query: 606 ELNLPPCP---------SRGLKKRTDFLLKVVVPVTVSGVILSLCLVLFLARRRRSAHKS 656
EL+LP CP RGLK L + V +I+SL ++ L R +R ++
Sbjct: 666 ELHLPACPVTKPKTGESKRGLKLMIGLLTGFLGLV----LIMSLLVINRLRRVKREPSQT 721
Query: 657 SVSQLMDQQFPMISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ 716
S S +SY L KAT FSS+N+IG G FG VYKG LG++ +VAVKVI L Q
Sbjct: 722 SASS--KDLILNVSYDGLFKATGGFSSANLIGTGGFGSVYKGXLGQDETVVAVKVIQLHQ 779
Query: 717 KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSE 776
+GA F AEC+ALRNIRHRNL+K++T CSS+D++G DF+A+VYE+M NGSLE+WLH
Sbjct: 780 RGAVKSFKAECEALRNIRHRNLVKVLTTCSSVDYQGNDFKALVYEFMPNGSLENWLHPVP 839
Query: 777 DQQEA----RSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLG 832
E R L+L QR+NI IDVASA++Y+HHHC P+VH DLKPSN+LLD D+ AH+G
Sbjct: 840 TPDEINDVLRILSLPQRLNIAIDVASALDYLHHHCHKPIVHCDLKPSNILLDNDMTAHVG 899
Query: 833 DFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMF 892
DFGLA+F+ + + + SSS G+KGT+GY APEYGMG + S GD YS+GILLLEMF
Sbjct: 900 DFGLARFIPEAA-GRSHPSQSSSIGLKGTIGYAAPEYGMGTKVSALGDTYSYGILLLEMF 958
Query: 893 TRRRPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGD-------ERL 945
T +RPT+ MF+ L LH F + ALP+++ +I+D L + D +R
Sbjct: 959 TGKRPTESMFSDQLNLHNFVKMALPERIADIIDPFFLSSEAKEEETTAADSSNLAHMKRE 1018
Query: 946 RTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTFLG 988
+ E L++++ GV CS+ESP ERM + + + +L R LG
Sbjct: 1019 KMHECLISILRIGVSCSLESPRERMAITEAIKELQLIRKILLG 1061
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224097752|ref|XP_002311067.1| predicted protein [Populus trichocarpa] gi|222850887|gb|EEE88434.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 932 bits (2408), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 497/1002 (49%), Positives = 679/1002 (67%), Gaps = 22/1002 (2%)
Query: 1 FSVPS--NETDRLALLAIGSQLEDDPLGVTSSWNNSTNLCQWTGVTCGHRHQRVTKLDLS 58
FS+P+ NETDRL+LLA+ SQ+ +DP G+ SSWN S + C W+GV CG RH+RV ++DL
Sbjct: 25 FSLPTGGNETDRLSLLALKSQITNDPFGMLSSWNESLHFCDWSGVICGKRHRRVVEIDLH 84
Query: 59 NRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNL 118
+ + G+LSP++GNLSFLR L L +N F IP ++G L RL L L NN+F GKIP N+
Sbjct: 85 SAQLVGSLSPHIGNLSFLRILKLENNRFSHNIPQELGHLFRLRMLSLENNTFDGKIPVNI 144
Query: 119 SRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINV 178
S CSNL+ + NNL G++P ELG + KL+ N+L G P+S GNLS + +I
Sbjct: 145 SHCSNLLILSLSGNNLTGKLPIELG-SLSKLQVFFFQFNYLVGGIPSSFGNLSAIIQIFG 203
Query: 179 LGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLD 238
GN L G IPN++G L++L + G N +G++PPSI+N+SSL +P N+ +G+LP D
Sbjct: 204 AGNYLQGGIPNSIGQLKSLKSFSFGRNNMTGMIPPSIYNLSSLMRFAVPVNQLHGNLPPD 263
Query: 239 IGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLN 298
+G++LP L +++ N F+GSIP + SNAS + + L +N G+V SL L WL
Sbjct: 264 LGLTLPNLEILLMSFNRFSGSIPPTFSNASTIAVIELSNNNLTGRVP-DLSSLSKLRWLI 322
Query: 299 LGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQ 358
+ N LG G +DL FL L N T L + ++DN FGG+LP I+N S + + NQ
Sbjct: 323 VDVNYLGNGNDDDLSFLPPLANKTSLEELSINDNNFGGLLPKIISNFSENLKRMTFGRNQ 382
Query: 359 ISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNL 418
I G IP+GI NL+ L L ++ N+LTG IP++IG+L+NL +L L N ++G IP+S+GN+
Sbjct: 383 IRGSIPSGIGNLIGLDTLGLEMNQLTGVIPNSIGKLQNLGVLALGGNKISGNIPSSMGNI 442
Query: 419 TLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYN 478
T L + LS+N+LQG IP SLGNC+NL+ LH+ L+G++P +++SI + S L LS N
Sbjct: 443 TSLLEVYLSANNLQGRIPSSLGNCQNLLILHLDQNNLSGSIPKEVISIPSSSRILVLSEN 502
Query: 479 LLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSS 538
L+G+LPLEVG L NL YFN+S NR SGEIP TL +C SL+ LY++GN F G IP SLSS
Sbjct: 503 QLTGSLPLEVGKLANLGYFNLSHNRLSGEIPRTLGSCVSLEFLYMEGNLFQGPIPESLSS 562
Query: 539 LKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNKTGISLSGNG 598
L++++ L++S NNLSG+IP++L L L L+LS+N+ EGEVP +G+F+ +G S+ GN
Sbjct: 563 LRALQILNLSHNNLSGEIPKFLAELKLLTSLDLSFNNLEGEVPVQGIFARASGFSMLGNK 622
Query: 599 KVCGGLDELNLPPC---PSRGLKKRTDFLLKVVVPVTVSGVILSLCLVLFLARRRRSAHK 655
K+CGG+ +LNL C SR LK T L + +P G+IL + +LF + + +
Sbjct: 623 KLCGGMPQLNLSRCTSKKSRKLKSSTKLKLIIAIPCGFVGIILVVSYMLFFFLKEKKSRP 682
Query: 656 SSVSQLMDQQFPMISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK 715
+S S + F ++Y +L +ATN FS +N+IG GSFG VYKG L +G VAVKV NL
Sbjct: 683 ASGSP-WESTFQRVAYEDLLQATNGFSPANLIGAGSFGSVYKGILRSDGAAVAVKVFNLL 741
Query: 716 QKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQS 775
++GAS F+AEC AL NIRHRNL+K++T CS IDF+G DF+A+VYE+M NGSLE+WLH +
Sbjct: 742 REGASKSFMAECAALINIRHRNLVKVLTACSGIDFQGNDFKALVYEFMVNGSLEEWLHPA 801
Query: 776 EDQQEA---RSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLG 832
+ EA R L+L+QR+NI IDVASA++Y+H+HCQ +VH DLKPSNVLLD DL AH+G
Sbjct: 802 QISDEAHRRRDLSLLQRLNIAIDVASALDYLHNHCQIAIVHCDLKPSNVLLDGDLTAHVG 861
Query: 833 DFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMF 892
DFGLA+ L + ++ +SS G+KGT+GY APEYG+G E S GDVYS+GILLLE+F
Sbjct: 862 DFGLARLLPQASHQLCLDQ-TSSIGLKGTIGYAAPEYGLGSEVSPYGDVYSYGILLLEVF 920
Query: 893 TRRRPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTE---- 948
T RRPTDG+F GL LH FA+TALP V E++D VL+ E + + GD R
Sbjct: 921 TGRRPTDGLFKDGLNLHNFAKTALPISVAEVLDPVLVTEAE----ETSGDASRRMSHIGN 976
Query: 949 --ERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTFLG 988
E L A+V+ GV CS E P ERME+ V +L R R LG
Sbjct: 977 HMECLAAIVKVGVACSAEFPRERMEISSVAVELRRIRHILLG 1018
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255577438|ref|XP_002529598.1| receptor-kinase, putative [Ricinus communis] gi|223530931|gb|EEF32790.1| receptor-kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 931 bits (2406), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 497/1003 (49%), Positives = 687/1003 (68%), Gaps = 23/1003 (2%)
Query: 6 NETDRLALLAIGSQLEDDPLGVTSSWNNSTNLCQWTGVTCGHRHQRVTKLDLSNRTIGGT 65
NETDRL+LLA + + DDPL + SSWN S + C+W+G+TCG RHQRV ++DL + + G+
Sbjct: 32 NETDRLSLLAFKAHITDDPLHILSSWNESLHFCKWSGITCGSRHQRVIEIDLESSRLSGS 91
Query: 66 LSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLI 125
L+ ++GNLSFLR LNL +N+ IP +IGRL RL L+L NSFSG+IP N+S CSNL+
Sbjct: 92 LTAFIGNLSFLRVLNLQNNSLSHYIPQEIGRLFRLRTLILRRNSFSGEIPVNISYCSNLL 151
Query: 126 SFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWG 185
+ RNNL G++PAEL + KL+ N+LTG S NLS+LE I N G
Sbjct: 152 TLRLGRNNLTGKLPAELK-SLSKLQMFEFEINYLTGEISPSFSNLSSLEIIYGTRNNFHG 210
Query: 186 RIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPK 245
IPN++G L++L +LG + FSG++PPSIFN+SSL + +P N+ +G+LP D+G SLPK
Sbjct: 211 EIPNSIGQLKSLQTFSLGGSNFSGVIPPSIFNLSSLTILSVPINQLHGNLPPDLGQSLPK 270
Query: 246 LLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLG 305
L + N F+GSIP ++SNASNLV L + N F GKV R L NL ++ + NNLG
Sbjct: 271 LEVLRLYANKFSGSIPPTISNASNLVALDVSQNNFTGKVPSLAR-LHNLSYIGIHKNNLG 329
Query: 306 TGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPT 365
GE +DL FL L N T L + + +N GGVLP ++N S+ + + N+I G IP+
Sbjct: 330 NGEDDDLSFLYTLANNTNLEILAITENNLGGVLPEMLSNFSTKLVHMAFGRNKIRGRIPS 389
Query: 366 GIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLA 425
I NL+ L L + N+LTG+IP ++G+LKNL LYL+ N ++G IP+SLGN+T L+ ++
Sbjct: 390 EIDNLIRLEALGFERNELTGSIPSSLGKLKNLIKLYLNDNNISGSIPSSLGNITSLSTIS 449
Query: 426 LSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLP 485
L N+L+GSIP SLGNC+ ++ + ++ L+G +P +++SI +LS+SLDLS N +G+LP
Sbjct: 450 LKVNNLEGSIPSSLGNCQQMLLMDLSRNNLSGTIPKELISIPSLSISLDLSENQFTGSLP 509
Query: 486 LEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKEL 545
+EVG L NL Y ++S N+ SGEIP +L +CT L+ LYLQGN+F G+IP SLSSL+ I +L
Sbjct: 510 MEVGGLVNLGYLDVSKNKLSGEIPKSLGSCTRLETLYLQGNAFQGTIPVSLSSLRGINDL 569
Query: 546 DMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNKTGISLSGNGKVCGGLD 605
++S NNL+GQIP + LE L+LSYN FEGEVP +GVF N + S+SGN +CGG+
Sbjct: 570 NLSHNNLTGQIPNFFAEFKSLEKLDLSYNDFEGEVPAEGVFKNASAFSISGNKNLCGGIP 629
Query: 606 ELNLPPCP-SRGLKKRTDFLLKVVVPVTVSGVILSLCL---VLFLARRRRSAHKSSVSQL 661
E+NLP C ++ +K +T L++++ V GV+ L L +LF + R ++S S L
Sbjct: 630 EINLPRCTLNKSMKPKTSHKLRLIIVVACCGVVGVLLLTSALLFCCLKMRKNKEASGSSL 689
Query: 662 MDQQFPMISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASN 721
D F +SY L KAT+ FSS+N+IG GSFG VYKG L + ++AVKV+NL+ KGAS
Sbjct: 690 -DIFFQKVSYQNLLKATDGFSSANLIGAGSFGSVYKGILAPDETIIAVKVLNLQHKGASR 748
Query: 722 GFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLH--QSEDQ- 778
F+ ECQAL N+RHRNL+K++T CSS DF+ DF+A+VYEYM NGSLE+WLH Q+ DQ
Sbjct: 749 SFMTECQALANVRHRNLVKVLTACSSSDFEENDFKALVYEYMVNGSLEEWLHPTQNPDQD 808
Query: 779 QEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAK 838
Q R L+LI+R++I IDVASA++Y+H+ CQ PVVH DLKPSN+LLD D+ AH+GDFGLA+
Sbjct: 809 QPPRILSLIERLSISIDVASALDYLHNQCQVPVVHCDLKPSNILLDSDMTAHVGDFGLAR 868
Query: 839 FLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPT 898
FL ++ +PSSS GI+GTVGY APEYGMG + S GDVY++GILLLE+FT ++PT
Sbjct: 869 FLIAA---PHHSSPSSSIGIRGTVGYAAPEYGMGSDVSTYGDVYTYGILLLELFTGKKPT 925
Query: 899 DGMFNQGLTLHEFARTALPDKVMEIVDSVLLL--EVQASNSRSCGDERLRTEER------ 950
D MF GL LH A+ A+PD++ D LL+ + S S + R+ R
Sbjct: 926 DAMFKDGLNLHILAKMAMPDRLALAADPFLLITEDEGTSASATSASHRITCIARDKVLGC 985
Query: 951 LVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTFL--GRMR 991
L ++++ GV CS ESP +RM++ DV +L R R+ L G+ R
Sbjct: 986 LNSILKIGVDCSAESPRDRMDISDVANELVRIRNILLETGKHR 1028
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224119022|ref|XP_002331306.1| predicted protein [Populus trichocarpa] gi|222873889|gb|EEF11020.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 931 bits (2405), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 503/988 (50%), Positives = 668/988 (67%), Gaps = 16/988 (1%)
Query: 5 SNETDRLALLAIGSQLEDDPLGVTSSWNNSTNLCQWTGVTCGHRHQRVTKLDLSNRTIGG 64
+NETD LAL+ +++ DDPLG+ SSWN++ + CQW GV+CG RHQRV L L + + G
Sbjct: 26 TNETDLLALIQFKNKIVDDPLGIMSSWNSTIHFCQWHGVSCGRRHQRVRVLALQSLKLSG 85
Query: 65 TLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNL 124
T+SP++GNLSFLR L+L +N+F EIP Q+GRL L+ L NNS SG+IP ++S CSNL
Sbjct: 86 TISPHIGNLSFLRELHLQNNSFFHEIPPQVGRLRSLQIFSLHNNSISGQIPPSISDCSNL 145
Query: 125 ISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNG-L 183
IS NNL GEIP ELG + LKL+NLT+ N LTG P S+GNLS+LE + + N L
Sbjct: 146 ISIKIEFNNLTGEIPMELG-SLLKLKNLTLEVNGLTGTIPPSLGNLSSLEILRLEKNKIL 204
Query: 184 WGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSL 243
+G +P+ LG L+NL +LNL +NR SG++PPSIFN+SSL + + N F+G+LP DIG+SL
Sbjct: 205 FGNVPSTLGKLKNLRILNLMDNRLSGVIPPSIFNLSSLTALDIGFNLFHGNLPSDIGISL 264
Query: 244 PKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNN 303
P L F +A N F GSIP S+SNASN+ L + N G+V L L + L SN+
Sbjct: 265 PNLEFFSIASNQFTGSIPVSISNASNIELLQVSLNNLTGEVPT-LEKLHRLNFFTLFSNH 323
Query: 304 LGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGII 363
LG+G+ANDL FL+ LTN T L + + N FGG LP I+NLS+ + I + N I G I
Sbjct: 324 LGSGQANDLSFLSSLTNATTLEYLSIKRNNFGGELPKQISNLSTMLGVISLPENNILGSI 383
Query: 364 PTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTN 423
P GI LVNL + +NK++G IP +IGEL+NL+ L LD N L+G IP+S+GNLT L
Sbjct: 384 PAGIEKLVNLKVFDVGNNKISGIIPSSIGELQNLEGLVLDYNNLSGRIPSSVGNLTKLMA 443
Query: 424 LALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGT 483
L L N L+GSIP SLGNCK L+ L + L+G +PP + I +L L + S N SG+
Sbjct: 444 LYLGDNSLEGSIPSSLGNCKKLLVLTLCGNNLSGDIPPGLFGIFSL-LYICFSKNHFSGS 502
Query: 484 LPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIK 543
LP+E+G L NL + ++S N SGEIP +L C SL+ LY+ N F GSIPS+LSSL+ +
Sbjct: 503 LPIEIGKLINLEFLDVSGNMLSGEIPSSLGGCISLEDLYMNSNFFHGSIPSALSSLRGVL 562
Query: 544 ELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNKTGISLSGNGKVCGG 603
+ + S NNLSG+IPE+ + + LE L+LSYN+FEG +P +G+F N T +S+ GN ++CGG
Sbjct: 563 QFNFSHNNLSGKIPEFFQGFNSLEMLDLSYNNFEGMIPDEGIFKNSTAVSVIGNSQLCGG 622
Query: 604 LDELNLPPCPSRGLKKRTDFLLKVVVPVTVSGVILSLCLV---LFLARRRRSAHKSSVSQ 660
EL LP C K+ LK+ + + V+L+L LV LFL RR + +S
Sbjct: 623 NTELGLPRCKVHQPKRLK---LKLKIAIFAITVLLALALVVTCLFLCSSRRKRREIKLSS 679
Query: 661 LMDQQFPMISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGAS 720
M + +SY L KATN FSSSN++G GSFG VYKG L +NGM++AVKV+NL ++GAS
Sbjct: 680 -MRNELLEVSYQILLKATNGFSSSNLVGIGSFGSVYKGMLDQNGMVIAVKVLNLMRQGAS 738
Query: 721 NGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLH-QSEDQQ 779
F+AEC+ALRNIRHRNL+K++T CSSID+ G DF+AIVYE+M NGSLEDWLH
Sbjct: 739 RSFIAECEALRNIRHRNLVKVLTACSSIDYHGNDFKAIVYEFMANGSLEDWLHPTGTGGG 798
Query: 780 EARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKF 839
+L L+QR+NI IDVA A+EY+HHHC+ P+ H DLKPSNVLLD +L H+GDFGLAKF
Sbjct: 799 TTLTLNLLQRLNIAIDVACALEYLHHHCEMPIAHCDLKPSNVLLDDELTGHVGDFGLAKF 858
Query: 840 LSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTD 899
LS + LD S+S G++GT+GY PEYG+GGE S GD YS+GILLLEMFT +RPTD
Sbjct: 859 LSGASLDYPTNE-STSIGVRGTIGYAPPEYGVGGEVSAYGDTYSYGILLLEMFTGKRPTD 917
Query: 900 GMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTE---ERLVAVVE 956
MF +G LH F + A+P++V +I D LL E + +R E L +++
Sbjct: 918 EMFREGSNLHNFVKRAVPEQVKQITDPTLLQEEPTGDDDKHEISSMRNSRPLECLNSILR 977
Query: 957 TGVVCSMESPTERMEMRDVVAKLCRARD 984
G+ CS+E P ERM++ D VA+L R+
Sbjct: 978 IGISCSVEFPRERMKISDAVAQLHSVRN 1005
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224081190|ref|XP_002306327.1| predicted protein [Populus trichocarpa] gi|222855776|gb|EEE93323.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 922 bits (2384), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 492/993 (49%), Positives = 669/993 (67%), Gaps = 19/993 (1%)
Query: 6 NETDRLALLAIGSQLEDDPLGVTSSWNNSTNLCQWTGVTCGHRHQRVTKLDLSNRTIGGT 65
NETDRL+LLA +Q+ D PL SSWN ST+ C+W+GV CGHRHQR+ +L+L + + G
Sbjct: 31 NETDRLSLLAFKAQITD-PLDALSSWNASTHFCKWSGVICGHRHQRIVELNLQSSQLTGN 89
Query: 66 LSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLI 125
LSP++GNLSFLR LNL N F +IP ++GRL RL+ LVL NN+FSG+IP N+S CSNL+
Sbjct: 90 LSPHIGNLSFLRVLNLEGNYFSRDIPQELGRLFRLQRLVLGNNTFSGEIPVNISSCSNLL 149
Query: 126 SFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWG 185
+ NNL G+IPA+LG + KL + N+L G P+S GNLS+++ N L G
Sbjct: 150 VLHLGSNNLTGKIPAQLG-SLSKLGAFVLQGNNLVGDIPSSFGNLSSVQNFFWTKNYLRG 208
Query: 186 RIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPK 245
IP +LGNL+ L + EN SG +P SI NISSL V L N+ +GSLP D+G++LP
Sbjct: 209 GIPESLGNLKRLKYFAVAENDLSGTIPSSICNISSLAYVSLGQNQLHGSLPPDLGLNLPN 268
Query: 246 LLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLG 305
L ++ N+ G IP +LSNAS + + L N GK+ SL +L+ L + N+LG
Sbjct: 269 LAYLVINFNHLNGPIPATLSNASKIFLVDLSYNNLTGKIP-DLASLPDLQKLLVHHNDLG 327
Query: 306 TGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPT 365
GE +DL FL L N T L ++G++DN FGGVLP ++N S+ + I NQI G IPT
Sbjct: 328 NGEEDDLSFLYTLANSTNLESLGINDNNFGGVLPEIVSNFSTNLKGITFGRNQIHGSIPT 387
Query: 366 GIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLA 425
I NL++L L ++ N+L G IP +IG+L+NL LYL+ N ++G IP+SLGN+T L ++
Sbjct: 388 EIGNLISLDTLSLETNQLHGIIPSSIGKLQNLAALYLNENKISGSIPSSLGNITSLVEVS 447
Query: 426 LSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLP 485
+ N+LQG+IP SLGN L+ L ++ L+G +P ++L IS+LS+ L L N L+G+LP
Sbjct: 448 FAQNNLQGTIPASLGNWHKLLILDLSQNNLSGPIPKEVLGISSLSVLLYLHDNQLTGSLP 507
Query: 486 LEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKEL 545
EVG L NL + +S NR SGEIP +L +C SL+ L L GN F G +P LSSL++++ L
Sbjct: 508 SEVGQLVNLGFLRVSKNRLSGEIPKSLDSCKSLEGLDLGGNFFEGPVP-DLSSLRALQML 566
Query: 546 DMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNKTGISLSGNGKVCGGLD 605
+S NNLSGQIP++L++ LE L+LSYN FEGEVP +GVF N + IS+ GN K+CGG+
Sbjct: 567 LLSYNNLSGQIPQFLKDFKLLETLDLSYNDFEGEVPEQGVFENTSRISVQGNKKLCGGIP 626
Query: 606 ELNLPPC----PSRGLKKRTDFLLKVVVPVTVSGVILSLCLVLFLARRRRSAHKSSVSQL 661
+L+LP C P+R K T +L + +P G++L +LF +R+ + S S
Sbjct: 627 QLDLPKCTSNEPARP-KSHTKLILIIAIPCGFLGIVLMTSFLLFYSRKTKDEPASGPS-- 683
Query: 662 MDQQFPMISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASN 721
+ F ++Y +L +AT+ FSSSN++G G+FG VY+G L +G +VAVKV+NL +KGAS
Sbjct: 684 WESSFQRLTYQDLLQATDGFSSSNLVGAGAFGSVYRGTLTSDGAVVAVKVLNLLRKGASK 743
Query: 722 GFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQ---SEDQ 778
F+AEC AL NIRHRNL+K+IT CSS DF+G DF+A+VYE+M NGSLE+WLH S+
Sbjct: 744 SFMAECAALINIRHRNLVKVITACSSNDFQGNDFKALVYEFMVNGSLEEWLHPVHISDVT 803
Query: 779 QEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAK 838
E R+L L+QR+NI IDVASA++Y+H+HCQ PVVH DLKPSNVLL D+ A +GDFGLA+
Sbjct: 804 PETRNLDLVQRLNIAIDVASALDYLHNHCQVPVVHCDLKPSNVLLGDDMTACVGDFGLAR 863
Query: 839 FLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPT 898
FL + + SSS G+KGT+GY APEYGMG E S GDVYS+GILLLEMFT RRPT
Sbjct: 864 FLPEASNQLPADE-SSSVGLKGTIGYAAPEYGMGSEVSTYGDVYSYGILLLEMFTGRRPT 922
Query: 899 DGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETG 958
DGMF G LH +A+ LPD V+E VD L + + D+ + E +V++++ G
Sbjct: 923 DGMFKDGHNLHNYAKMVLPDNVLEFVDPTL----REHEEMNHNDDSHKVMECMVSIIKVG 978
Query: 959 VVCSMESPTERMEMRDVVAKLCRARDTFLGRMR 991
+ CS E P ERM + +VV +L R R+ GR R
Sbjct: 979 LACSAELPGERMGIANVVVELHRIREMLDGRKR 1011
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224141953|ref|XP_002324325.1| predicted protein [Populus trichocarpa] gi|222865759|gb|EEF02890.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 918 bits (2373), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 497/1000 (49%), Positives = 672/1000 (67%), Gaps = 24/1000 (2%)
Query: 2 SVPSNETDRLALLAIGSQLEDDPLGVTSSWNNSTNLCQWTGVTCGHRHQRVTKLDLSNRT 61
S NETD ALLA ++++D SSWN+S + C W G+TCG RH RV ++L ++
Sbjct: 26 SFGGNETDYEALLAFKAKIQDPHSNTLSSWNDSLDFCNWPGITCGRRHGRVRIINLVDQK 85
Query: 62 IGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRC 121
+ GTLSPYVGN+SFLR + LA+N HGEIP ++GRL+RL L+L NNS GKIP NLS C
Sbjct: 86 LAGTLSPYVGNISFLREIRLANNTIHGEIPPEVGRLLRLRVLMLTNNSIEGKIPANLSGC 145
Query: 122 SNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGN 181
S+L RN L GEIP ELG+ KL L+ N+L G P SIGNL++LE +++ N
Sbjct: 146 SSLAELYIDRNKLGGEIPTELGF-LSKLTILSFRQNNLLGKIPHSIGNLTSLESLSLKRN 204
Query: 182 GLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGV 241
L G IP++LG L+ L L LGEN+ SG +PPS++N+S + +L N F GSLP ++G+
Sbjct: 205 VLEGTIPDSLGRLKRLTSLLLGENKLSGFIPPSLYNLSLITTFYLGGNGFRGSLPSNLGL 264
Query: 242 SLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGS 301
S P L + +N F+G IP SL+NAS L ++ N GK+ F L +L L+ GS
Sbjct: 265 SFPHLQWLALWQNQFSGPIPGSLTNASELQIVSFTYNSLTGKIPDIFGKLHHLSGLHFGS 324
Query: 302 NNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISG 361
NNLGTG +++ FL LTNC+ L + +++NR G LP ++ NLS+ M ++GN I G
Sbjct: 325 NNLGTGGDDEMAFLASLTNCSMLKVVSINNNRLEGSLPITVGNLSTYMVYFGLSGNHIVG 384
Query: 362 IIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLL 421
IP+GI NLVNL L MD N TG IP + G L+ L+ L SN L+G IP+SLGNL+LL
Sbjct: 385 RIPSGIGNLVNLTFLYMDRNHFTGEIPTSFGNLRKLEQFSLFSNRLSGKIPSSLGNLSLL 444
Query: 422 TNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLS 481
+ L L N L+ +IP SLG CKNL+ L ++ L G++P Q+ S++ SL+LS+N +
Sbjct: 445 SVLYLDDNKLKDTIPASLGGCKNLVSLGLSRKNLNGSIPEQLFGTSSVLFSLNLSHNQFT 504
Query: 482 GTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKS 541
G+LP +G+LK L ++S N SGEIP + CTSL+ L+++ N F GSIPSS SSL+
Sbjct: 505 GSLPSTIGSLKGLSELDVSWNMLSGEIPTSFGGCTSLEVLHMEDNFFQGSIPSSFSSLRG 564
Query: 542 IKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNKTGISLSGNGKVC 601
I+ LD+S NNLSGQ+P +L + F+ LNLSYN+FEGEVP KGVF+N++ +S+ GN K+C
Sbjct: 565 IQFLDLSCNNLSGQLPNFLVTIPFIS-LNLSYNNFEGEVPRKGVFTNESAVSVVGNDKLC 623
Query: 602 GGLDELNLPPCPSRGLKK----RTDFLLKVVVPVTVSGVILSLCLVLFLARRRRSAHKSS 657
GG+ EL+LP CP++ KK +LL + +P + G I + +++R H S
Sbjct: 624 GGILELHLPECPNKEPKKTKMSHLQYLLAITIPCALVGAITVSSFLFCWFKKKRKEHSSD 683
Query: 658 VSQLMDQQFPMISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK 717
L+ + FP ISY L KAT+ FS++N+IG GSF VYKG + E+G +VA+KV+NL+++
Sbjct: 684 T--LLKESFPQISYERLFKATDGFSTTNLIGVGSFSSVYKGRIDEDGTLVAIKVLNLQRR 741
Query: 718 GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSE- 776
GAS F EC+ALRNIRHRNL+KIIT CSSIDF+G +F+A+VYEYM GSLE WLH ++
Sbjct: 742 GASKSFKDECEALRNIRHRNLVKIITSCSSIDFQGNNFKALVYEYMPKGSLEKWLHPTQE 801
Query: 777 ---DQQ--EARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHL 831
DQQ + + L++RINI IDVA+A++Y+HHHC P++H D+KPSN+LLD+D++ HL
Sbjct: 802 THDDQQINQVQRPNLLERINIAIDVAAALDYLHHHCHSPIIHCDVKPSNILLDKDMIGHL 861
Query: 832 GDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEM 891
GDFGLA+ + ++E SSS GIKGT GY APEYG G E S+ GDVYS+GILLLEM
Sbjct: 862 GDFGLARIFQEFS-EPSLE--SSSAGIKGTTGYAAPEYGQGREVSIDGDVYSYGILLLEM 918
Query: 892 FTRRRPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERL 951
T +RP D F +GL LH FA+ ALPD V+EI D VLL E N+ S EE L
Sbjct: 919 MTGKRPIDDTFEKGLNLHMFAKMALPDHVIEITDPVLLSERHLENAAS-------MEECL 971
Query: 952 VAVVETGVVCSMESPTERMEMRDVVAKLCRARDTFLGRMR 991
++V+ GV CSM+SP +RM+M VV +L RDTF G R
Sbjct: 972 TSLVKIGVACSMDSPRDRMDMSRVVRELLMVRDTFQGTAR 1011
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224119102|ref|XP_002331325.1| predicted protein [Populus trichocarpa] gi|222873908|gb|EEF11039.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 918 bits (2373), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 499/992 (50%), Positives = 662/992 (66%), Gaps = 18/992 (1%)
Query: 2 SVPSNETDRLALLAIGSQLEDDPLGVTSSWNNSTNLCQWTGVTCGHRHQRVTKLDLSNRT 61
S+ NETDRLALL S++ DPLG+ WN+S + C W GVTC +HQRV LDL +
Sbjct: 28 SIGRNETDRLALLDFKSKITHDPLGIMRLWNSSIHFCHWFGVTCSQKHQRVAVLDLQSLK 87
Query: 62 IGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRC 121
+ G++SPY+GNLSFLR L L N+F EIP QIG L RL+ L L NNSF+G+IP ++S
Sbjct: 88 LSGSVSPYIGNLSFLRNLYLQHNSFSHEIPAQIGHLHRLQILALHNNSFTGEIPASMSSS 147
Query: 122 SNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGN 181
NL+S N L GEIP E G ++LKL +L I DN+L G P S+GN+S+L+ + + N
Sbjct: 148 YNLVSLILDNNKLTGEIPKEFG-SFLKLTDLYIDDNNLVGTIPPSLGNISSLQELWLDDN 206
Query: 182 GLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGV 241
L+G +P L L NL +L+L NRFSG +PPS+ N+SSL + N F G+LP D+G+
Sbjct: 207 NLFGNLPATLSKLVNLRVLSLFNNRFSGTIPPSMLNLSSLRTFQVGLNHFQGNLPPDLGI 266
Query: 242 SLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGS 301
SLP L F + N F GS+P S+SN SNL L L N+ RGK+ L+ L + + S
Sbjct: 267 SLPNLEFFSIYSNQFTGSVPVSISNLSNLEMLELNLNKLRGKMP-SLEKLQRLLSITIAS 325
Query: 302 NNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISG 361
NNLG+GEANDL FL+ LTN T L + + N F G LP I+NLS+T+ + + N + G
Sbjct: 326 NNLGSGEANDLSFLSSLTNATNLEELIITQNNFQGQLPPQISNLSTTLEIMGLDSNLLFG 385
Query: 362 IIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLL 421
IP GI NL++L + + +N L+G IP IG+L+NL++L L N +G IP+SLGNLT L
Sbjct: 386 SIPDGIENLISLNDFEVQNNHLSGIIPSTIGKLQNLEILGLALNNFSGDIPSSLGNLTNL 445
Query: 422 TNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLS 481
L L+ ++QGSIP SL NC L+EL ++ +TG++PP I +S+LS++LDLS N LS
Sbjct: 446 IGLYLNDINVQGSIPSSLANCNKLLELDLSGNYITGSIPPGIFGLSSLSINLDLSRNHLS 505
Query: 482 GTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKS 541
G+LP EVGNL+NL F IS N SG+IP +L+ C SLQ LYL N F GS+PSSLS+L+
Sbjct: 506 GSLPKEVGNLENLEIFAISGNMISGKIPSSLAQCISLQFLYLDANFFEGSVPSSLSTLRG 565
Query: 542 IKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNKTGISLSGNGKVC 601
I+E + S NNLSG+I E+ ++ LE L+LSYN+FEG VP +G+F N T S+ GN K+C
Sbjct: 566 IQEFNFSHNNLSGKIHEFFQDFRSLEILDLSYNNFEGMVPFRGIFKNATATSVIGNSKLC 625
Query: 602 GGLDELNLPPCPSRGLKKRTDFLLKV---VVPVTVSGVILSLCLVLFLAR-RRRSAHKSS 657
GG + LPPC + KR +K+ V+ + ++ +L L LF +R +RR SS
Sbjct: 626 GGTPDFELPPCNFKH-PKRLSLKMKITIFVISLLLAVAVLITGLFLFWSRKKRREFTPSS 684
Query: 658 VSQLMDQQFPMISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK 717
++ + +SY L KATN FSS N+IG GSFG VYKG L NG VAVKV+NL+++
Sbjct: 685 DGNVLLK----VSYQSLLKATNGFSSINLIGTGSFGSVYKGILDHNGTAVAVKVLNLRRQ 740
Query: 718 GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSED 777
GAS F+AEC+AL N+RHRNL+K++T CS +D+ G DF+A+VYE+M NGSLE WLH S
Sbjct: 741 GASKSFMAECEALPNVRHRNLVKVVTACSGVDYHGNDFKALVYEFMVNGSLETWLHPSRA 800
Query: 778 QQEARS-LTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836
E R L L QR++I IDVA A++Y HH C+ +VH DLKP NVLLD ++V H+GDFGL
Sbjct: 801 TDEVRGILDLTQRLSIAIDVAHALDYFHHQCEKQIVHCDLKPGNVLLDDEMVGHVGDFGL 860
Query: 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRR 896
AKFL L + PSSS GI+GT+GY PEYG G E S GDVYS+GILLLEMFT +R
Sbjct: 861 AKFLLEDTLHHST-NPSSSIGIRGTIGYTPPEYGAGNEVSAYGDVYSYGILLLEMFTGKR 919
Query: 897 PTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVE 956
PTD +FN GL LH + +T LP+KV++I D L N E+ R + LV+V
Sbjct: 920 PTDDLFN-GLNLHSYVKTFLPEKVLQIADPTL----PQINFEGNSIEQNRVLQCLVSVFT 974
Query: 957 TGVVCSMESPTERMEMRDVVAKLCRARDTFLG 988
TG+ CS+ESP ERM + DV+A+L AR+ LG
Sbjct: 975 TGISCSVESPQERMGIADVIAQLFSARNELLG 1006
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113117|ref|XP_002316396.1| predicted protein [Populus trichocarpa] gi|222865436|gb|EEF02567.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 912 bits (2356), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 496/993 (49%), Positives = 679/993 (68%), Gaps = 12/993 (1%)
Query: 8 TDRLALLAIGSQLEDDPLGVTSSWNNSTNLCQWTGVTCGHRHQRVTKLDLSNRTIGGTLS 67
TDRL+LLA +Q+ DDPLG SSWN S + C+W+G CG RHQRV +LDL + + G+LS
Sbjct: 15 TDRLSLLAFKAQITDDPLGALSSWNESLHFCEWSGAKCGRRHQRVVELDLHSCKLAGSLS 74
Query: 68 PYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISF 127
P++GNLSFLR L+L++N+F IP ++GRL+RL+ L L NN+FSG+IP N+S CSNL
Sbjct: 75 PHIGNLSFLRILDLSNNSFSQNIPQELGRLLRLQQLNLENNTFSGEIPANISNCSNLQLI 134
Query: 128 NARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRI 187
+ + NNL+G+IPAELG + L L+ + NHL G P S NLS++E I V N L G I
Sbjct: 135 DLKGNNLIGKIPAELG-SLLNLQACLLVTNHLVGEIPLSFENLSSVEIIGVGDNHLQGSI 193
Query: 188 PNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLL 247
P +G L+ L L++ N SG +PPSI+N+SSL + N+F+GSLP D+G LP L
Sbjct: 194 PYGIGKLKRLRKLSVPLNNLSGTIPPSIYNLSSLTLFSVAINQFHGSLPSDLGQKLPSLE 253
Query: 248 GFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTG 307
+ N F G IP ++SNAS L + +N F GKV F +L NL++L + SN LG G
Sbjct: 254 VLVFYANRFNGPIPVTISNASTLSVIDFGNNSFTGKVPP-FANLPNLQYLGIDSNELGNG 312
Query: 308 EANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGI 367
E DL FL L N T L +G+ DN GG+ P I+N SS T + + NQ+ G IP I
Sbjct: 313 EEGDLSFLQSLANYTNLEELGMSDNNLGGMFPEIISNFSSQFTTLSMGRNQVRGSIPVDI 372
Query: 368 RNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALS 427
NL++L L ++ N+LTG IP +IG+LKNL L L N ++G IP+SLGN+T L L LS
Sbjct: 373 GNLISLDTLMLETNQLTGVIPTSIGKLKNLHGLTLVENKISGNIPSSLGNVTSLVELYLS 432
Query: 428 SNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLE 487
+N+LQG IP SL NC+NL+ L +A L+G L Q++ +++LS+SLDLS+N L G LP E
Sbjct: 433 ANNLQGGIPSSLANCQNLMSLKLAQNNLSGPLTKQVIGMASLSVSLDLSHNQLIGPLPSE 492
Query: 488 VGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDM 547
VG L NL Y ++S NR SGEIP +L +C L+ L+L+GN GSIP LSSL++++ L++
Sbjct: 493 VGRLVNLGYLDVSHNRLSGEIPGSLGSCIMLEYLHLEGNFLQGSIPELLSSLRALQYLNL 552
Query: 548 SSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNKTGISLSGNGKVCGGLDEL 607
S NNL+GQIP +L + L+ L+LS+NH EGE+PT+ VF N + +S+ GN K+CGG+ +L
Sbjct: 553 SYNNLTGQIPRFLADFQLLQRLDLSFNHLEGEMPTQRVFGNVSAVSVLGNDKLCGGISQL 612
Query: 608 NLPPCPSRGLKK-RTDFLLKVVVPVTVSGVILSLCLVLFLARR-RRSAHKSSVSQLMDQQ 665
NL C S L+K + LK+V+ + +I L + L R++ ++ + +
Sbjct: 613 NLSRCTSNELRKPKFSTKLKLVISIPCGFIIALLLISSLLIHSWRKTKNEPASGASWEVS 672
Query: 666 FPMISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVA 725
F ++Y EL +AT FSSSN IG GSFG VYK L +GM+VAVKV NL +KGAS ++A
Sbjct: 673 FRRVTYEELYQATGGFSSSNFIGGGSFGSVYKAILAPDGMIVAVKVFNLLRKGASKSYMA 732
Query: 726 ECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWL---HQSEDQQEAR 782
EC AL NIRHRNL+KI+T CSS+DF+G DF+A+VYE+M NGSLE+WL H S++++E
Sbjct: 733 ECAALINIRHRNLVKILTACSSLDFRGNDFKALVYEFMVNGSLEEWLHPVHTSDEEREQG 792
Query: 783 SLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSS 842
+L LIQR+N+ IDVASA++Y+H+HCQ VVH DLKPSNVLLD D+ AH+GDFGLA+F
Sbjct: 793 NLNLIQRLNVAIDVASALDYLHYHCQMAVVHCDLKPSNVLLDGDMTAHVGDFGLARFRPE 852
Query: 843 SPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMF 902
+ + + +SS G+KGTVGY APEYG+G E S GDVYS+GILLLE+ T + PTDG F
Sbjct: 853 ASVQLS-SNQNSSIGLKGTVGYAAPEYGIGNEVSTYGDVYSYGILLLEILTGKTPTDGSF 911
Query: 903 NQGLTLHEFARTALPDKVMEIVDSVLLLEV-QASNSRSCGDERL---RTEERLVAVVETG 958
+GL LH++ + ALPD+V+E+VD +LL E+ Q S + S G +R+ + E LV+++E G
Sbjct: 912 KEGLNLHKYVKMALPDRVVEVVDPILLREIEQTSANASDGMKRIGNDKVLECLVSIMEVG 971
Query: 959 VVCSMESPTERMEMRDVVAKLCRARDTFLGRMR 991
V CS++ P ER + +VVA+L R R LG R
Sbjct: 972 VSCSVDLPRERTNISNVVAELHRIRGILLGTRR 1004
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 992 | ||||||
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.977 | 0.960 | 0.423 | 2.9e-206 | |
| TAIR|locus:2075661 | 1025 | AT3G47110 [Arabidopsis thalian | 0.974 | 0.943 | 0.433 | 1.1e-204 | |
| TAIR|locus:2079157 | 1011 | AT3G47580 [Arabidopsis thalian | 0.981 | 0.963 | 0.412 | 4.1e-200 | |
| TAIR|locus:2075631 | 1009 | AT3G47090 [Arabidopsis thalian | 0.982 | 0.966 | 0.408 | 1.1e-195 | |
| TAIR|locus:2149922 | 1031 | EFR "EF-TU receptor" [Arabidop | 0.962 | 0.926 | 0.413 | 2.5e-193 | |
| UNIPROTKB|Q40640 | 1025 | Xa21 "Receptor kinase-like pro | 0.980 | 0.949 | 0.400 | 4.1e-184 | |
| UNIPROTKB|O24435 | 813 | O24435 "Receptor kinase-like p | 0.715 | 0.873 | 0.402 | 6.6e-129 | |
| TAIR|locus:2005540 | 999 | HAE "HAESA" [Arabidopsis thali | 0.889 | 0.882 | 0.313 | 2.1e-113 | |
| TAIR|locus:2120412 | 992 | BAM3 "BARELY ANY MERISTEM 3" [ | 0.859 | 0.859 | 0.298 | 1.7e-109 | |
| TAIR|locus:2032553 | 996 | HSL1 "HAESA-like 1" [Arabidops | 0.877 | 0.873 | 0.302 | 3.9e-108 |
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1995 (707.3 bits), Expect = 2.9e-206, P = 2.9e-206
Identities = 425/1003 (42%), Positives = 611/1003 (60%)
Query: 5 SNETDRLALLAIGSQLEDDPLGVTSSWNNSTNLCQWTGVTCGHRHQRVTKLDLSNRTIGG 64
++ETDR ALL SQ+ +D V SSWN+S LC W GVTCG +++RVT L+L +GG
Sbjct: 21 TDETDRQALLQFKSQVSEDKRVVLSSWNHSFPLCNWKGVTCGRKNKRVTHLELGRLQLGG 80
Query: 65 TLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNL 124
+SP +GNLSFL L+L +N F G IP ++G+L RLE L + N G IP L CS L
Sbjct: 81 VISPSIGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGINYLRGPIPLGLYNCSRL 140
Query: 125 ISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLW 184
++ N L G +P+ELG + L L + N++ G P S+GNL+ LE++ + N L
Sbjct: 141 LNLRLDSNRLGGSVPSELG-SLTNLVQLNLYGNNMRGKLPTSLGNLTLLEQLALSHNNLE 199
Query: 185 XXXXXXXXXXXXXXXXXXXXXXFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLP 244
FSG+ PP+++N+SSL+ + + N F+G L D+G+ LP
Sbjct: 200 GEIPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGILLP 259
Query: 245 KLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNL 304
LL F + N F GSIP +LSN S L L + +N G + F ++ NL+ L L +N+L
Sbjct: 260 NLLSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIPT-FGNVPNLKLLFLHTNSL 318
Query: 305 GTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIP 364
G+ + DL+FLT LTNCT+L +G+ NR GG LP SIANLS+ + + + G ISG IP
Sbjct: 319 GSDSSRDLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLISGSIP 378
Query: 365 TGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPXXXXXXXXXXXX 424
I NL+NL +L +D N L+G +P ++G+L NL+ L L SN L+GGIP
Sbjct: 379 YDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETL 438
Query: 425 XXXXXXXQGSIPPSLGNCKNLIELHMADIELTGALPPQIXXXXXXXXXXXXXXXXXXGTL 484
+G +P SLGNC +L+EL + D +L G +P +I G+L
Sbjct: 439 DLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLI-GSL 497
Query: 485 PLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNXXXXXXXXXXXXXXXXXE 544
P ++G L+NL ++ N+ SG++P TL C +++ L+L+GN E
Sbjct: 498 PQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPDLKGLVGVK-E 556
Query: 545 LDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNKTGISLSGNGKVCGGL 604
+D+S+N+LSG IPEY + S LEYLNLS+N+ EG+VP KG+F N T +S+ GN +CGG+
Sbjct: 557 VDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGI 616
Query: 605 DELNLPPCPSRG---LKKRTDFLLKVVVPVTVSGVILSLCLVLFLAR------RRRSAHK 655
L PC S+ +KK + L KVV+ V+V ++L L+LF+A R+R +K
Sbjct: 617 MGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVG---ITLLLLLFMASVTLIWLRKRKKNK 673
Query: 656 SS---VSQLMDQQFPMISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVI 712
+ ++ ISY +L ATN FSSSNM+G GSFG VYK L +VAVKV+
Sbjct: 674 ETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVL 733
Query: 713 NLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWL 772
N++++GA F+AEC++L++IRHRNL+K++T CSSIDF+G +F+A++YE+M NGSL+ WL
Sbjct: 734 NMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWL 793
Query: 773 HQSEDQQ---EARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVA 829
H E ++ +R+LTL++R+NI IDVAS ++Y+H HC P+ H DLKPSNVLLD DL A
Sbjct: 794 HPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTA 853
Query: 830 HLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLL 889
H+ DFGLA+ L ++ SS+ G++GT+GY APEYG+GG+ S+ GDVYSFGILLL
Sbjct: 854 HVSDFGLARLLLKFDEESFFNQLSSA-GVRGTIGYAAPEYGVGGQPSINGDVYSFGILLL 912
Query: 890 EMFTRRRPTDGMFNQGLTLHEFARTALPDKVMEIVD-SVLLLEVQASNSRSCGDERLRTE 948
EMFT +RPT+ +F TL+ + ++ALP+++++IVD S+L + ++
Sbjct: 913 EMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESILHIGLRVG---------FPVV 963
Query: 949 ERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTFLGRMR 991
E L V E G+ C ESP R+ VV +L R+ F R
Sbjct: 964 ECLTMVFEVGLRCCEESPMNRLATSIVVKELISIRERFFKASR 1006
|
|
| TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1980 (702.1 bits), Expect = 1.1e-204, P = 1.1e-204
Identities = 433/999 (43%), Positives = 609/999 (60%)
Query: 5 SNETDRLALLAIGSQLEDDPLGVTSSWNNSTNLCQWTGVTCGHRHQRVTKLDLSNRTIGG 64
+ ETD+ ALL SQ+ + V SWN+S LC WTGV CG +H+RVT +DL + G
Sbjct: 36 TEETDKQALLEFKSQVSETSRVVLGSWNDSLPLCSWTGVKCGLKHRRVTGVDLGGLKLTG 95
Query: 65 TLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNL 124
+SP+VGNLSFLR LNLADN FHG IP ++G L RL+ L ++NN F G IP LS CS+L
Sbjct: 96 VVSPFVGNLSFLRSLNLADNFFHGAIPSEVGNLFRLQYLNMSNNLFGGVIPVVLSNCSSL 155
Query: 125 ISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLW 184
+ + N+L +P E G + KL L++ N+LTG FPAS+GNL++L+ ++ + N +
Sbjct: 156 STLDLSSNHLEQGVPLEFG-SLSKLVLLSLGRNNLTGKFPASLGNLTSLQMLDFIYNQIE 214
Query: 185 XXXXXXXXXXXXXXXXXXXXXXFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLP 244
F+G+ PP I+N+SSL + + N F+G+L D G LP
Sbjct: 215 GEIPGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGSLLP 274
Query: 245 KLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNL 304
L + N+F G+IPE+LSN S+L +L + N GK+ + F L+NL L L +N+L
Sbjct: 275 NLQILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSL 334
Query: 305 GTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIP 364
G + DLDFL LTNC++L + + N+ GG LP IANLS+ +T++ + GN ISG IP
Sbjct: 335 GNYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGNLISGSIP 394
Query: 365 TGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPXXXXXXXXXXXX 424
GI NLV+L L + +N LTG +P ++GEL L+ + L SN L+G IP
Sbjct: 395 HGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYL 454
Query: 425 XXXXXXXQGSIPPSLGNCKNLIELHMADIELTGALPPQIXXXXXXXXXXXXXXXXXXGTL 484
+GSIP SLG+C L++L++ +L G++P ++ G L
Sbjct: 455 YLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNLLV-GPL 513
Query: 485 PLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNXXXXXXXXXXXXXXXXXE 544
++G LK L+ ++S N+ SG+IP TL+ C SL+ L LQGN
Sbjct: 514 RQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPDIRGLTGLRF- 572
Query: 545 LDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNKTGISLSGNGKVCGGL 604
LD+S NNLSG IPEY+ N S L+ LNLS N+F+G VPT+GVF N + +S+ GN +CGG+
Sbjct: 573 LDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGI 632
Query: 605 DELNLPPCPSRGLKKRTDFLLKVVVPVTVSGV---ILSLCL-VLFLA--RRRRSAHKSSV 658
L L PC S L +R + K++ + VS V +L LCL V++L + R + +++
Sbjct: 633 PSLQLQPC-SVELPRRHSSVRKIIT-ICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANN 690
Query: 659 SQLMDQQF-PM------ISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKV 711
++ D+ F P+ ISY EL K T FSSSN+IG G+FG V+KG LG VA+KV
Sbjct: 691 NE-NDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKV 749
Query: 712 INLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDW 771
+NL ++GA+ F+AEC+AL IRHRNL+K++TICSS DF+G DF+A+VYE+M NG+L+ W
Sbjct: 750 LNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMW 809
Query: 772 LHQSEDQQE---ARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLV 828
LH E ++ +R+L L R+NI IDVASA+ Y+H +C P+ H D+KPSN+LLD+DL
Sbjct: 810 LHPDEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLT 869
Query: 829 AHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILL 888
AH+ DFGLA+ L DT SS G++GT+GY APEYGMGG S+ GDVYSFGI+L
Sbjct: 870 AHVSDFGLAQLLLKFDRDT-FHIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVL 928
Query: 889 LEMFTRRRPTDGMFNQGLTLHEFARTALPDK-VMEIVDSVLLLEVQASNSRSCGDERLRT 947
LE+FT +RPT+ +F GLTLH F ++AL + ++I D +L R +
Sbjct: 929 LEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETIL--------RGAYAQHFNM 980
Query: 948 EERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTF 986
E L V GV CS ESP R+ M + ++KL R++F
Sbjct: 981 VECLTLVFRVGVSCSEESPVNRISMAEAISKLVSIRESF 1019
|
|
| TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1937 (686.9 bits), Expect = 4.1e-200, P = 4.1e-200
Identities = 412/1000 (41%), Positives = 591/1000 (59%)
Query: 5 SNETDRLALLAIGSQLEDDPLGVTSSWNNSTNLCQWTGVTCGHRHQRVTKLDLSNRTIGG 64
++ETDR ALL SQ+ + V SSWNNS LC W VTCG +H+RVT L+L +GG
Sbjct: 21 TDETDRQALLEFKSQVSEGKRDVLSSWNNSFPLCNWKWVTCGRKHKRVTHLNLGGLQLGG 80
Query: 65 TLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNL 124
+SP +GN+SFL L+L+DN F G IP ++G L RLE L +A NS G IP LS CS L
Sbjct: 81 IVSPSIGNVSFLISLDLSDNAFGGIIPREVGNLFRLEHLYMAFNSLEGGIPATLSNCSRL 140
Query: 125 ISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLW 184
++ + N L +P+ELG + KL L + N+L G P S+GNL++L+ + N +
Sbjct: 141 LNLDLYSNPLRQGVPSELG-SLTKLVILDLGRNNLKGKLPRSLGNLTSLKSLGFTDNNIE 199
Query: 185 XXXXXXXXXXXXXXXXXXXXXXFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLP 244
F G+ PP+I+N+S+LE++FL + F+GSL D G LP
Sbjct: 200 GEVPDELARLSQMVGLGLSMNKFFGVFPPAIYNLSALEDLFLFGSGFSGSLKPDFGNLLP 259
Query: 245 KLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNL 304
+ + EN+ G+IP +LSN S L + + N G + F + +L++L+L N L
Sbjct: 260 NIRELNLGENDLVGAIPTTLSNISTLQKFGINKNMMTGGIYPNFGKVPSLQYLDLSENPL 319
Query: 305 GTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIP 364
G+ DL+F+ LTNCT L + + R GG LP SIAN+S+ + + + GN G IP
Sbjct: 320 GSYTFGDLEFIDSLTNCTHLQLLSVGYTRLGGALPTSIANMSTELISLNLIGNHFFGSIP 379
Query: 365 TGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPXXXXXXXXXXXX 424
I NL+ L L + N LTG +P ++G+L L LL L SN ++G IP
Sbjct: 380 QDIGNLIGLQRLQLGKNMLTGPLPTSLGKLLRLGLLSLYSNRMSGEIPSFIGNLTQLEIL 439
Query: 425 XXXXXXXQGSIPPSLGNCKNLIELHMADIELTGALPPQIXXXXXXXXXXXXXXXXXXGTL 484
+G +PPSLG C ++++L + +L G +P +I G+L
Sbjct: 440 YLSNNSFEGIVPPSLGKCSHMLDLRIGYNKLNGTIPKEIMQIPTLVNLSMEGNSLS-GSL 498
Query: 485 PLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNXXXXXXXXXXXXXXXXXE 544
P ++G+L+NLV ++ N+FSG +P TL C +++QL+LQGN
Sbjct: 499 PNDIGSLQNLVKLSLENNKFSGHLPQTLGNCLAMEQLFLQGNSFDGAIPNIRGLMGVR-R 557
Query: 545 LDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNKTGISLSGNGKVCGGL 604
+D+S+N+LSG IPEY N S LEYLNLS N+F G+VP+KG F N T + + GN +CGG+
Sbjct: 558 VDLSNNDLSGSIPEYFANFSKLEYLNLSINNFTGKVPSKGNFQNSTIVFVFGNKNLCGGI 617
Query: 605 DELNLPPCPSRGLK---KRTDFLLKVVVPVTVSGVILSLCLVL-------FLARRRRSAH 654
+L L PC ++ K + L KV + V++ G+ L L LV+ F RR+
Sbjct: 618 KDLKLKPCLAQEPPVETKHSSHLKKVAILVSI-GIALLLLLVIASMVLCWFRKRRKNQQT 676
Query: 655 KSSVSQLMDQQFPMISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINL 714
+ V ++ ISY +L ATN FSSSNM+G GSFG V+K L +VAVKV+N+
Sbjct: 677 NNLVPSKLEIFHEKISYGDLRNATNGFSSSNMVGSGSFGTVFKALLPTESKIVAVKVLNM 736
Query: 715 KQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQ 774
+++GA F+AEC++L++ RHRNL+K++T C+S DF+G +F+A++YEY+ NGS++ WLH
Sbjct: 737 QRRGAMKSFMAECESLKDTRHRNLVKLLTACASTDFQGNEFRALIYEYLPNGSVDMWLHP 796
Query: 775 SEDQQ---EARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHL 831
E ++ R+LTL++R+NI+IDVAS ++Y+H HC P+ H DLKPSNVLL+ DL AH+
Sbjct: 797 EEVEEIRRPPRTLTLLERLNIVIDVASVLDYLHVHCHEPIAHCDLKPSNVLLEDDLTAHV 856
Query: 832 GDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEM 891
DFGLA+ L ++ + SS+ G++GT+GY APEYGMGG+ S+ GDVYSFG+LLLEM
Sbjct: 857 SDFGLARLLLKFDKESFLNQLSSA-GVRGTIGYAAPEYGMGGQPSIHGDVYSFGVLLLEM 915
Query: 892 FTRRRPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERL 951
FT +RPTD +F LTLH + + ALP+KV EI D +L G RT E L
Sbjct: 916 FTGKRPTDELFGGNLTLHSYTKLALPEKVFEIADKAIL-----HIGLRVG---FRTAECL 967
Query: 952 VAVVETGVVCSMESPTERMEMRDVVAKLCRARDTFLGRMR 991
V+E G+ C E PT R+ +V +L R+ F R
Sbjct: 968 TLVLEVGLRCCEEYPTNRLATSEVAKELISIRERFFKTRR 1007
|
|
| TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1895 (672.1 bits), Expect = 1.1e-195, P = 1.1e-195
Identities = 407/997 (40%), Positives = 592/997 (59%)
Query: 5 SNETDRLALLAIGSQLEDDPLGVTSSWNNSTNLCQWTGVTCGHRHQRVTKLDLSNRTIGG 64
++E+DR ALL I SQ+ + S+WNNS LC W V CG +H+RVT+LDL +GG
Sbjct: 21 TDESDRQALLEIKSQVSESKRDALSAWNNSFPLCSWKWVRCGRKHKRVTRLDLGGLQLGG 80
Query: 65 TLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNL 124
+SP +GNLSFL YL+L++N+F G IP ++G L RL+ L + N G+IP +LS CS L
Sbjct: 81 VISPSIGNLSFLIYLDLSNNSFGGTIPQEMGNLFRLKYLAVGFNYLEGEIPASLSNCSRL 140
Query: 125 ISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLW 184
+ + NNL +P+ELG + KL L + N L G FP I NL++L +N+ N L
Sbjct: 141 LYLDLFSNNLGDGVPSELG-SLRKLLYLYLGLNDLKGKFPVFIRNLTSLIVLNLGYNHLE 199
Query: 185 XXXXXXXXXXXXXXXXXXXXXXFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLP 244
FSG+ PP+ +N+SSLEN++L N F+G+L D G LP
Sbjct: 200 GEIPDDIAMLSQMVSLTLTMNNFSGVFPPAFYNLSSLENLYLLGNGFSGNLKPDFGNLLP 259
Query: 245 KLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNL 304
+ + N G+IP +L+N S L + N+ G +S F L+NL +L L +N+L
Sbjct: 260 NIHELSLHGNFLTGAIPTTLANISTLEMFGIGKNRMTGSISPNFGKLENLHYLELANNSL 319
Query: 305 GTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIP 364
G+ DL FL LTNC+ L + + NR GG LP SI N+S+ +T + + GN I G IP
Sbjct: 320 GSYSFGDLAFLDALTNCSHLHGLSVSYNRLGGALPTSIVNMSTELTVLNLKGNLIYGSIP 379
Query: 365 TGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPXXXXXXXXXXXX 424
I NL+ L L + DN LTG +P ++G L L L L SN +G IP
Sbjct: 380 HDIGNLIGLQSLLLADNLLTGPLPTSLGNLVGLGELILFSNRFSGEIPSFIGNLTQLVKL 439
Query: 425 XXXXXXXQGSIPPSLGNCKNLIELHMADIELTGALPPQIXXXXXXXXXXXXXXXXXXGTL 484
+G +PPSLG+C ++++L + +L G +P +I G+L
Sbjct: 440 YLSNNSFEGIVPPSLGDCSHMLDLQIGYNKLNGTIPKEIMQIPTLVHLNMESNSLS-GSL 498
Query: 485 PLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNXXXXXXXXXXXXXXXXXE 544
P ++G L+NLV + N SG +P TL C S++ +YLQ N
Sbjct: 499 PNDIGRLQNLVELLLGNNNLSGHLPQTLGKCLSMEVIYLQENHFDGTIPDIKGLMGVK-N 557
Query: 545 LDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNKTGISLSGNGKVCGGL 604
+D+S+NNLSG I EY EN S LEYLNLS N+FEG VPT+G+F N T +S+ GN +CG +
Sbjct: 558 VDLSNNNLSGSISEYFENFSKLEYLNLSDNNFEGRVPTEGIFQNATLVSVFGNKNLCGSI 617
Query: 605 DELNLPPCPSRG--LKKRTDFLLK-VVVPVTVSGVILSLCLVLFLA--RRRRSAHK--SS 657
EL L PC ++ ++ R LLK V + V+V +L L ++ L+ ++R++ K +S
Sbjct: 618 KELKLKPCIAQAPPVETRHPSLLKKVAIGVSVGIALLLLLFIVSLSWFKKRKNNQKINNS 677
Query: 658 VSQLMDQQFPMISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK 717
++ +SY +L AT+ FSSSN++G GSFG V+K L +VAVKV+N++++
Sbjct: 678 APFTLEIFHEKLSYGDLRNATDGFSSSNIVGSGSFGTVFKALLQTENKIVAVKVLNMQRR 737
Query: 718 GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSED 777
GA F+AEC++L++IRHRNL+K++T C+SIDF+G +F+A++YE+M NGSL+ WLH E
Sbjct: 738 GAMKSFMAECESLKDIRHRNLVKLLTACASIDFQGNEFRALIYEFMPNGSLDKWLHPEEV 797
Query: 778 QQ---EARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834
++ +R+LTL++R+NI IDVAS ++Y+H HC P+ H DLKPSN+LLD DL AH+ DF
Sbjct: 798 EEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNILLDDDLTAHVSDF 857
Query: 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTR 894
GLA+ L ++ SS+ G++GT+GY APEYGMGG+ S+ GDVYSFG+L+LEMFT
Sbjct: 858 GLARLLLKFDQESFFNQLSSA-GVRGTIGYAAPEYGMGGQPSIHGDVYSFGVLVLEMFTG 916
Query: 895 RRPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAV 954
+RPT+ +F TL+ + + ALP++V++I D +L S R G L E L +
Sbjct: 917 KRPTNELFGGNFTLNSYTKAALPERVLDIADKSIL----HSGLR-VGFPVL---ECLKGI 968
Query: 955 VETGVVCSMESPTERMEMRDVVAKLCRARDTFLGRMR 991
++ G+ C ESP R+ + +L R+ F R
Sbjct: 969 LDVGLRCCEESPLNRLATSEAAKELISIRERFFKTRR 1005
|
|
| TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1873 (664.4 bits), Expect = 2.5e-193, P = 2.5e-193
Identities = 414/1001 (41%), Positives = 589/1001 (58%)
Query: 5 SNETDRLALLAIGSQL-EDDPLGVTSSWNNSTNLCQWTGVTCGHRHQRVTKLDLSNRTIG 63
SNETD ALL SQ+ E++ V +SWN+S+ C W GVTCG R +RV L+L +
Sbjct: 27 SNETDMQALLEFKSQVSENNKREVLASWNHSSPFCNWIGVTCGRRRERVISLNLGGFKLT 86
Query: 64 GTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSN 123
G +SP +GNLSFLR LNLADN+F IP ++GRL RL+ L ++ N G+IP++LS CS
Sbjct: 87 GVISPSIGNLSFLRLLNLADNSFGSTIPQKVGRLFRLQYLNMSYNLLEGRIPSSLSNCSR 146
Query: 124 LISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGL 183
L + + N+L +P+ELG + KL L ++ N+LTG+FPAS+GNL++L++++ N +
Sbjct: 147 LSTVDLSSNHLGHGVPSELG-SLSKLAILDLSKNNLTGNFPASLGNLTSLQKLDFAYNQM 205
Query: 184 WXXXXXXXXXXXXXXXXXXXXXXFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSL 243
FSG PP+++NISSLE++ L N F+G+L D G L
Sbjct: 206 RGEIPDEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNSFSGNLRADFGYLL 265
Query: 244 PKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNN 303
P L ++ N F G+IP++L+N S+L + N G + + F L+NL WL + +N+
Sbjct: 266 PNLRRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNS 325
Query: 304 LGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGII 363
LG ++ L+F+ + NCT+L + + NR GG LP SIANLS+T+T + + N ISG I
Sbjct: 326 LGNNSSSGLEFIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLGQNLISGTI 385
Query: 364 PTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPXXXXXXXXXXX 423
P I NLV+L EL ++ N L+G +P + G+L NLQ++ L SN ++G IP
Sbjct: 386 PHDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQK 445
Query: 424 XXXXXXXXQGSIPPSLGNCKNLIELHMADIELTGALPPQIXXXXXXXXXXXXXXXXXXGT 483
G IP SLG C+ L++L M L G +P +I G
Sbjct: 446 LHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLT-GH 504
Query: 484 LPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNXXXXXXXXXXXXXXXXX 543
P EVG L+ LV S N+ SG++P + C S++ L++QGN
Sbjct: 505 FPEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPDISRLVSLK- 563
Query: 544 ELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNKTGISLSGNGKVCGG 603
+D S+NNLSG+IP YL +L L LNLS N FEG VPT GVF N T +S+ GN +CGG
Sbjct: 564 NVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGG 623
Query: 604 LDELNLPPCPSRGL-KKRTDFLLKVVVPVTVSGV---ILSLCLVLFLA------RRRRSA 653
+ E+ L PC + +KR ++ V VSG+ I SL L++ +A +R++
Sbjct: 624 VREMQLKPCIVQASPRKRKPLSVRKKV---VSGICIGIASLLLIIIVASLCWFMKRKKKN 680
Query: 654 HKS----SVSQLMDQQFPMISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAV 709
+ S S S + +SY EL AT+ FSS+N+IG G+FG V+KG LG +VAV
Sbjct: 681 NASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAV 740
Query: 710 KVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLE 769
KV+NL + GA+ F+AEC+ + IRHRNL+K+IT+CSS+D +G DF+A+VYE+M GSL+
Sbjct: 741 KVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLD 800
Query: 770 DWLHQSEDQQE----ARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQ 825
WL Q ED + +RSLT +++NI IDVASA+EY+H HC PV H D+KPSN+LLD
Sbjct: 801 MWL-QLEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDD 859
Query: 826 DLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFG 885
DL AH+ DFGLA+ L ++ + SS+ G++GT+GY APEYGMGG+ S+ GDVYSFG
Sbjct: 860 DLTAHVSDFGLAQLLYKYDRESFLNQFSSA-GVRGTIGYAAPEYGMGGQPSIQGDVYSFG 918
Query: 886 ILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERL 945
ILLLEMF+ ++PTD F LH + ++ +L +S + DE L
Sbjct: 919 ILLLEMFSGKKPTDESFAGDYNLHSYTKS-------------ILSGCTSSGGSNAIDEGL 965
Query: 946 RTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTF 986
R V++ G+ CS E P +RM + V +L R F
Sbjct: 966 RL------VLQVGIKCSEEYPRDRMRTDEAVRELISIRSKF 1000
|
|
| UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 1786 (633.8 bits), Expect = 4.1e-184, P = 4.1e-184
Identities = 396/989 (40%), Positives = 572/989 (57%)
Query: 9 DRLALLAIGSQLEDDPLGVTSSWNNSTN--LCQWTGVTCGHRHQR----VTKLDLSNRTI 62
D LALL+ S L +SWN S + C W GV CG R +R V KL L + +
Sbjct: 32 DELALLSFKSSLLYQGGQSLASWNTSGHGQHCTWVGVVCGRRRRRHPHRVVKLLLRSSNL 91
Query: 63 GGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCS 122
G +SP +GNLSFLR L+L DN GEIP ++ RL RL+ L L++NS G IP + C+
Sbjct: 92 SGIISPSLGNLSFLRELDLGDNYLSGEIPPELSRLSRLQLLELSDNSIQGSIPAAIGACT 151
Query: 123 NLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNG 182
L S + N L G IP E+G + L NL + N L+G P+++GNL++L+ ++ N
Sbjct: 152 KLTSLDLSHNQLRGMIPREIGASLKHLSNLYLYKNGLSGEIPSALGNLTSLQEFDLSFNR 211
Query: 183 LWXXXXXXXXXXXXXXXXXXXXXXFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVS 242
L SG++P SI+N+SSL + N+ G +P + +
Sbjct: 212 LSGAIPSSLGQLSSLLTMNLGQNNLSGMIPNSIWNLSSLRAFSVRENKLGGMIPTNAFKT 271
Query: 243 LPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSN 302
L L + N F G IP S++NAS+L + ++ N F G ++ F L+NL L L N
Sbjct: 272 LHLLEVIDMGTNRFHGKIPASVANASHLTVIQIYGNLFSGIITSGFGRLRNLTELYLWRN 331
Query: 303 NLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGI 362
T E +D F++ LTNC++L + L +N GGVLP+S +NLS++++ + + N+I+G
Sbjct: 332 LFQTREQDDWGFISDLTNCSKLQTLNLGENNLGGVLPNSFSNLSTSLSFLALELNKITGS 391
Query: 363 IPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPXXXXXXXXXX 422
IP I NL+ L L + +N G++P ++G LKNL +L N L+G IP
Sbjct: 392 IPKDIGNLIGLQHLYLCNNNFRGSLPSSLGRLKNLGILLAYENNLSGSIPLAIGNLTELN 451
Query: 423 XXXXXXXXXQGSIPPSLGNCKNLIELHMADIELTGALPPQIXXXXXXXXXXXXXXXXXXG 482
G IP +L N NL+ L ++ L+G +P ++ G
Sbjct: 452 ILLLGTNKFSGWIPYTLSNLTNLLSLGLSTNNLSGPIPSELFNIQTLSIMINVSKNNLEG 511
Query: 483 TLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNXXXXXXXXXXXXXXXX 542
++P E+G+LKNLV F+ NR SG+IP TL C L+ LYLQ N
Sbjct: 512 SIPQEIGHLKNLVEFHAESNRLSGKIPNTLGDCQLLRYLYLQNNLLSGSIPSALGQLKGL 571
Query: 543 XELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNKTGISLSGNGKVCG 602
LD+SSNNLSGQIP L +++ L LNLS+N F GEVPT G F+ +GIS+ GN K+CG
Sbjct: 572 ETLDLSSNNLSGQIPTSLADITMLHSLNLSFNSFVGEVPTIGAFAAASGISIQGNAKLCG 631
Query: 603 GLDELNLPPCPSRGLKKRTDF-LLKVVVPVTVSGVILSLCLVLFLARRRRSAHKSSVSQL 661
G+ +L+LP C L+ R F +L + V + + ILS L L + +R+ K + S+
Sbjct: 632 GIPDLHLPRCCPL-LENRKHFPVLPISVSLAAALAILS-SLYLLITWHKRTK-KGAPSRT 688
Query: 662 MDQQFPMISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASN 721
+ P++SY++L KAT+ F+ +N++G GSFG VYKG L VAVKV+ L+ A
Sbjct: 689 SMKGHPLVSYSQLVKATDGFAPTNLLGSGSFGSVYKGKLNIQDH-VAVKVLKLENPKALK 747
Query: 722 GFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLH-QSEDQQE 780
F AEC+ALRN+RHRNL+KI+TICSSID +G DF+AIVY++M NGSLEDW+H ++ DQ +
Sbjct: 748 SFTAECEALRNMRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWIHPETNDQAD 807
Query: 781 ARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFL 840
R L L +R+ I++DVA A++Y+H H PVVH D+K SNVLLD D+VAH+GDFGLA+ L
Sbjct: 808 QRHLNLHRRVTILLDVACALDYLHRHGPEPVVHCDIKSSNVLLDSDMVAHVGDFGLARIL 867
Query: 841 SSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDG 900
+ ++ +SS G GT+GY APEYG+G AS GD+YS+GIL+LE+ T +RPTD
Sbjct: 868 VDGT--SLIQQSTSSMGFIGTIGYAAPEYGVGLIASTHGDIYSYGILVLEIVTGKRPTDS 925
Query: 901 MFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQA-SNSRSCGDERLRTEERLVAVVETGV 959
F L L ++ L +V ++VD+ L+L+ + NS + R R E +V ++ G+
Sbjct: 926 TFRPDLGLRQYVELGLHGRVTDVVDTKLILDSENWLNSTNNSPCR-RITECIVWLLRLGL 984
Query: 960 VCSMESPTERMEMRDVVAKLCRARDTFLG 988
CS E P+ R D++ +L + G
Sbjct: 985 SCSQELPSSRTPTGDIIDELNAIKQNLSG 1013
|
|
| UNIPROTKB|O24435 O24435 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 1265 (450.4 bits), Expect = 6.6e-129, P = 6.6e-129
Identities = 290/720 (40%), Positives = 396/720 (55%)
Query: 79 LNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEI 138
L L +N G I +G L L L L++N SGKIP LSR S L N+L GEI
Sbjct: 83 LRLRSSNLAGIISPSLGNLSFLRTLQLSDNHLSGKIPQELSRLSRLQQLVLNFNSLSGEI 142
Query: 139 PAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWXXXXXXXXXXXXXX 198
PA LG N L L + +N L+G P+S+G L+ L + + N L
Sbjct: 143 PAALG-NLTSLSVLELTNNTLSGAIPSSLGKLTGLTDLALAENTLSGSIPSSFGQLRRLS 201
Query: 199 XXXXXXXXFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAG 258
SG +P I+NISSL + +N+ +G+LP + +LP L + N F G
Sbjct: 202 FLSLAFNNLSGAIPDPIWNISSLTIFEVISNKLSGTLPTNAFSNLPSLQEVYMYYNQFHG 261
Query: 259 SIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLL 318
IP S+ NASN+ T+ N F G V ++NL+ L L E ND F+T L
Sbjct: 262 RIPASIGNASNISIFTIGLNSFSGVVPPEIGRMRNLQRLELPETLSEAEETNDWKFMTAL 321
Query: 319 TNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCM 378
TNC+ L + L +FGGVLP S++NLSS++ + I N+ISG +P I NLVNL L +
Sbjct: 322 TNCSNLQEVELGGCKFGGVLPDSVSNLSSSLVSLSIRDNKISGSLPRDIGNLVNLQYLSL 381
Query: 379 DDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPXXXXXXXXXXXXXXXXXXXQGSIPPS 438
+N LTG++P + +LKNL+ L +D+N L G +P G+IP +
Sbjct: 382 ANNSLTGSLPSSFSKLKNLRRLTVDNNKLIGSLPLTIGNLTQLTNMEVQFNAFGGTIPST 441
Query: 439 LGNCKNLIELHMADIELTGALPPQIXXXXXXXXXXXXXXXXXXGTLPLEVGNLKNLVYFN 498
LGN L ++++ G +P +I G++P E+G LKN+V F+
Sbjct: 442 LGNLTKLFQINLGHNNFIGQIPIEIFSIPALSEILDVSHNNLEGSIPKEIGKLKNIVEFH 501
Query: 499 ISVNRFSGEIPVTLSACTSLQQLYLQGNXXXXXXXXXXXXXXXXXELDMSSNNLSGQIPE 558
N+ SGE P T+ C LQ L+LQ N LD+S NNLSGQIP
Sbjct: 502 ADSNKLSGENPSTIGECQLLQHLFLQNNFLNGSIPIALTQLKGLDTLDLSGNNLSGQIPM 561
Query: 559 YLENLSFLEYLNLSYNHFEGEVPTKGVFSNKTGISLSGNGKVCGGLDELNLPPCPSRGLK 618
L ++ L LNLS+N F GEVPT GVF+N + I + GN +CGG+ EL+LP C + K
Sbjct: 562 SLGDMPLLHSLNLSFNSFHGEVPTNGVFANASEIYIQGNAHICGGIPELHLPTCSLKSRK 621
Query: 619 KRT-DFLLKVVVPVTVSGV-ILSLCLVLFLARRRRSAHKSSVSQLMDQQFPMISYAELSK 676
K+ LL VVV VS + + SL +L +RR + + + Q PMI+Y +L K
Sbjct: 622 KKKHQILLLVVVICLVSTLAVFSLLYMLLTCHKRRKKEVPATTSM--QGHPMITYKQLVK 679
Query: 677 ATNDFSSSNMIGQGSFGFVYKGNL----GENGMMVAVKVINLKQKGASNGFVAECQALRN 732
AT+ FSSS+++G GSFG VYKG GE +VAV+V+ L+ A F AEC+ LRN
Sbjct: 680 ATDGFSSSHLLGSGSFGSVYKGEFDSQDGEITSLVAVRVLKLETPKALKSFTAECETLRN 739
Query: 733 IRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLH-QSEDQQEARSLTLIQRIN 791
RHRNL+KI+TICSSID +G DF+AIVY++M NGSLEDWLH ++ DQ E R LTL QR++
Sbjct: 740 TRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWLHPETNDQAEQRHLTLHQRVS 799
|
|
| TAIR|locus:2005540 HAE "HAESA" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 989 (353.2 bits), Expect = 2.1e-113, Sum P(2) = 2.1e-113
Identities = 293/936 (31%), Positives = 450/936 (48%)
Query: 23 DPLGVTSSW--NNSTNLCQWTGVTCGHRHQRVTKLDLSNRTIGGTLSPYVGNLSFLRYLN 80
DP SSW NN C+W GV+C V +DLS+ + G + +L L L+
Sbjct: 37 DPAQSLSSWSDNNDVTPCKWLGVSCDAT-SNVVSVDLSSFMLVGPFPSILCHLPSLHSLS 95
Query: 81 LADNNFHGEIP-HQIGRLVRLEALVLANNSFSGKIPTNLS-RCSNLISFNARRNNLVGEI 138
L +N+ +G + L +L L+ N G IP +L NL NNL I
Sbjct: 96 LYNNSINGSLSADDFDTCHNLISLDLSENLLVGSIPKSLPFNLPNLKFLEISGNNLSDTI 155
Query: 139 PAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWXXXXXXXXXXXXXX 198
P+ G + KLE+L +A N L+G PAS+GN++TL+ + + N L+
Sbjct: 156 PSSFG-EFRKLESLNLAGNFLSGTIPASLGNVTTLKELKLAYN-LFSPSQIPSQLGNLTE 213
Query: 199 XXXXXXXXFS--GIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNF 256
+ G +PPS+ ++SL N+ L N+ GS+P I L + + N+F
Sbjct: 214 LQVLWLAGCNLVGPIPPSLSRLTSLVNLDLTFNQLTGSIPSWI-TQLKTVEQIELFNNSF 272
Query: 257 AGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLT 316
+G +PES+ N + L N+ GK+ +L NLE LNL N L G +
Sbjct: 273 SGELPESMGNMTTLKRFDASMNKLTGKIPDNL-NLLNLESLNLFENML-EGPLPES---- 326
Query: 317 LLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVEL 376
+T L+ + L +NR GVLP + +S + + ++ N+ SG IP + L L
Sbjct: 327 -ITRSKTLSELKLFNNRLTGVLPSQLG-ANSPLQYVDLSYNRFSGEIPANVCGEGKLEYL 384
Query: 377 CMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPXXXXXXXXXXXXXXXXXXXQGSIP 436
+ DN +G I + +G+ K+L + L +N L+G IP GSIP
Sbjct: 385 ILIDNSFSGEISNNLGKCKSLTRVRLSNNKLSGQIPHGFWGLPRLSLLELSDNSFTGSIP 444
Query: 437 PSLGNCKNLIELHMADIELTGALPPQIXXXXXXXXXXXXXXXXXXGTLPLEVGNLKNLVY 496
++ KNL L ++ +G++P +I G +P + LK L
Sbjct: 445 KTIIGAKNLSNLRISKNRFSGSIPNEIGSLNGIIEISGAENDFS-GEIPESLVKLKQLSR 503
Query: 497 FNISVNRFSGEIPVTLSACTSLQQLYLQGNXXXXXXXXXXXXXXXXXELDMSSNNLSGQI 556
++S N+ SGEIP L +L +L L N LD+SSN SG+I
Sbjct: 504 LDLSKNQLSGEIPRELRGWKNLNELNLANNHLSGEIPKEVGILPVLNYLDLSSNQFSGEI 563
Query: 557 PEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNKT-GISLSGNGKVCGGLDELNLPPCPSR 615
P L+NL L LNLSYNH G++P +++NK GN +C LD L C
Sbjct: 564 PLELQNLK-LNVLNLSYNHLSGKIPP--LYANKIYAHDFIGNPGLCVDLDGL----CRKI 616
Query: 616 GLKKRTDFLLKVVVPVTVSGVILSLCLVLFLA--RRRRSAHKSSVSQLMDQQFPMISYAE 673
K ++ ++ ++G++ + +V+F+A R+ R+ S+++ + F + ++E
Sbjct: 617 TRSKNIGYVWILLTIFLLAGLVFVVGIVMFIAKCRKLRALKSSTLAASKWRSFHKLHFSE 676
Query: 674 LSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNG----------F 723
+ + N+IG GS G VYK L G +VAVK +N KG + F
Sbjct: 677 -HEIADCLDEKNVIGFGSSGKVYKVEL-RGGEVVAVKKLNKSVKGGDDEYSSDSLNRDVF 734
Query: 724 VAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARS 783
AE + L IRH++++++ CSS D K +VYEYM NGSL D LH D++
Sbjct: 735 AAEVETLGTIRHKSIVRLWCCCSSGDCK-----LLVYEYMPNGSLADVLHG--DRKGGVV 787
Query: 784 LTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSS 843
L +R+ I +D A + Y+HH C PP+VH D+K SN+LLD D A + DFG+AK S
Sbjct: 788 LGWPERLRIALDAAEGLSYLHHDCVPPIVHRDVKSSNILLDSDYGAKVADFGIAKVGQMS 847
Query: 844 PLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFN 903
+TP + GI G+ GYIAPEY + D+YSFG++LLE+ T ++PTD
Sbjct: 848 ----GSKTPEAMSGIAGSCGYIAPEYVYTLRVNEKSDIYSFGVVLLELVTGKQPTDSELG 903
Query: 904 QGLTLHEFARTALPDKVME-IVDSVLLLEVQASNSR 938
+ ++ TAL +E ++D L L+ + S+
Sbjct: 904 DK-DMAKWVCTALDKCGLEPVIDPKLDLKFKEEISK 938
|
|
| TAIR|locus:2120412 BAM3 "BARELY ANY MERISTEM 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 970 (346.5 bits), Expect = 1.7e-109, Sum P(2) = 1.7e-109
Identities = 271/907 (29%), Positives = 436/907 (48%)
Query: 30 SWN--NSTNLCQWTGVTCGHRHQRVTKLDLSNRTIGGTLSPYVGNLS-FLRYLNLADNNF 86
SWN N +LC WTGV+C + +Q +T+LDLSN I GT+SP + LS L +L+++ N+F
Sbjct: 54 SWNIPNFNSLCSWTGVSCDNLNQSITRLDLSNLNISGTISPEISRLSPSLVFLDISSNSF 113
Query: 87 HGEIPHQIGRLVRLEALVLANNSFSGKIPTN-LSRCSNLISFNARRNNLVGEIPAELGYN 145
GE+P +I L LE L +++N F G++ T S+ + L++ +A N+ G +P L
Sbjct: 114 SGELPKEIYELSGLEVLNISSNVFEGELETRGFSQMTQLVTLDAYDNSFNGSLPLSLT-T 172
Query: 146 WLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWXXX-XXXXXXXXXXXXXXXXX 204
+LE+L + N+ G P S G+ +L+ +++ GN L
Sbjct: 173 LTRLEHLDLGGNYFDGEIPRSYGSFLSLKFLSLSGNDLRGRIPNELANITTLVQLYLGYY 232
Query: 205 XXFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESL 264
+ G +P + +L ++ L GS+P ++G +L L + N GS+P L
Sbjct: 233 NDYRGGIPADFGRLINLVHLDLANCSLKGSIPAELG-NLKNLEVLFLQTNELTGSVPREL 291
Query: 265 SNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTEL 324
N ++L L L +N G++ + L+ L+ NL N L GE + F++ L +L
Sbjct: 292 GNMTSLKTLDLSNNFLEGEIPLELSGLQKLQLFNLFFNRLH-GEIPE--FVSELP---DL 345
Query: 325 TAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLT 384
+ L N F G +P + + + + +I ++ N+++G+IP + L L + +N L
Sbjct: 346 QILKLWHNNFTGKIPSKLGS-NGNLIEIDLSTNKLTGLIPESLCFGRRLKILILFNNFLF 404
Query: 385 GTIPHAIGELKNLQLLYLDSNFLAGGIPXXXXXXXXXXXXXXXXXXXQGSIPPS-LGNCK 443
G +P +G+ + L L NFL +P G IP GN +
Sbjct: 405 GPLPEDLGQCEPLWRFRLGQNFLTSKLPKGLIYLPNLSLLELQNNFLTGEIPEEEAGNAQ 464
Query: 444 --NLIELHMADIELTGALPPQIXXXXXXXXXXXXXXXXXXGTLPLEVGNLKNLVYFNISV 501
+L ++++++ L+G +P I G +P E+G+LK+L+ ++S
Sbjct: 465 FSSLTQINLSNNRLSGPIPGSIRNLRSLQILLLGANRLS-GQIPGEIGSLKSLLKIDMSR 523
Query: 502 NRFSGEIPVTLSACTSLQQLYLQGNXXXXXXXXXXXXXXXXXELDMSSNNLSGQIPEYLE 561
N FSG+ P C SL L L N L++S N+ + +P L
Sbjct: 524 NNFSGKFPPEFGDCMSLTYLDLSHNQISGQIPVQISQIRILNYLNVSWNSFNQSLPNELG 583
Query: 562 NLSFLEYLNLSYNHFEGEVPTKGVFSNKTGISLSGNGKVCG-------GLDE------LN 608
+ L + S+N+F G VPT G FS S GN +CG G LN
Sbjct: 584 YMKSLTSADFSHNNFSGSVPTSGQFSYFNNTSFLGNPFLCGFSSNPCNGSQNQSQSQLLN 643
Query: 609 LPPCPSRGLKKRTDFLLKVVVPVTVSGVILSLCLVLFLARRRRSAHKSSVSQLMDQQFPM 668
SRG K+ + + G L ++ + RR + ++ +L+ F
Sbjct: 644 QNNARSRG---EISAKFKLFFGLGLLGFFLVFVVLAVVKNRRMRKNNPNLWKLIG--FQK 698
Query: 669 ISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGAS--NGFVAE 726
+ + +++IG+G G VYKG + NG VAVK + KG+S NG AE
Sbjct: 699 LGFRS-EHILECVKENHVIGKGGRGIVYKGVM-PNGEEVAVKKLLTITKGSSHDNGLAAE 756
Query: 727 CQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTL 786
Q L IRHRN+++++ CS+ D +VYEYM NGSL + LH + L
Sbjct: 757 IQTLGRIRHRNIVRLLAFCSN-----KDVNLLVYEYMPNGSLGEVLHG----KAGVFLKW 807
Query: 787 IQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLD 846
R+ I ++ A + Y+HH C P ++H D+K +N+LL + AH+ DFGLAKF+ +
Sbjct: 808 ETRLQIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLGPEFEAHVADFGLAKFMMQD--N 865
Query: 847 TAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGL 906
A E SS I G+ GYIAPEY DVYSFG++LLE+ T R+P D +G+
Sbjct: 866 GASECMSS---IAGSYGYIAPEYAYTLRIDEKSDVYSFGVVLLELITGRKPVDNFGEEGI 922
Query: 907 TLHEFAR 913
+ ++++
Sbjct: 923 DIVQWSK 929
|
|
| TAIR|locus:2032553 HSL1 "HAESA-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 930 (332.4 bits), Expect = 3.9e-108, Sum P(2) = 3.9e-108
Identities = 281/930 (30%), Positives = 428/930 (46%)
Query: 22 DDPLGVTSSWN-NSTNLCQWTGVTCGHRHQRVTKLDLSNRTIGGTLSPYVGNLSFLRYLN 80
DDP SSWN N + C+W+GV+C VT +DLS+ + G + LS L +L+
Sbjct: 31 DDPDSYLSSWNSNDASPCRWSGVSCAGDFSSVTSVDLSSANLAGPFPSVICRLSNLAHLS 90
Query: 81 LADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPA 140
L +N+ + +P I L+ L L+ N +G++P L+ L+ + NN G+IPA
Sbjct: 91 LYNNSINSTLPLNIAACKSLQTLDLSQNLLTGELPQTLADIPTLVHLDLTGNNFSGDIPA 150
Query: 141 ELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWXXXXXXXXXXXXXXXX 200
G + LE L++ N L G P +GN+STL+ +N+ N
Sbjct: 151 SFG-KFENLEVLSLVYNLLDGTIPPFLGNISTLKMLNLSYNPFSPSRIPPEFGNLTNLEV 209
Query: 201 XXXXX-XFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGS 259
G +P S+ +S L ++ L N G +P +G L ++ + N+ G
Sbjct: 210 MWLTECHLVGQIPDSLGQLSKLVDLDLALNDLVGHIPPSLG-GLTNVVQIELYNNSLTGE 268
Query: 260 IPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLT 319
IP L N +L L NQ GK+ + LE LNL NNL GE + L
Sbjct: 269 IPPELGNLKSLRLLDASMNQLTGKIPDELCRVP-LESLNLYENNL-EGELPAS--IALSP 324
Query: 320 NCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMD 379
N E+ G NR G LP + L+S + + ++ N+ SG +P + L EL +
Sbjct: 325 NLYEIRIFG---NRLTGGLPKDLG-LNSPLRWLDVSENEFSGDLPADLCAKGELEELLII 380
Query: 380 DNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPXXXXXXXXXXXXXXXXXXXQGSIPPSL 439
N +G IP ++ + ++L + L N +G +P G I S+
Sbjct: 381 HNSFSGVIPESLADCRSLTRIRLAYNRFSGSVPTGFWGLPHVNLLELVNNSFSGEISKSI 440
Query: 440 GNCKNLIELHMADIELTGALPPQIXXXXXXXXXXXXXXXXXXGTLPLEVGNLKNLVYFNI 499
G NL L +++ E TG+LP +I G+LP + +L L ++
Sbjct: 441 GGASNLSLLILSNNEFTGSLPEEIGSLDNLNQLSASGNKFS-GSLPDSLMSLGELGTLDL 499
Query: 500 SVNRFSGEIPVTLSACTSLQQLYLQGNXXXXXXXXXXXXXXXXXELDMSSNNLSGQIPEY 559
N+FSGE+ + + L +L L N LD+S N SG+IP
Sbjct: 500 HGNQFSGELTSGIKSWKKLNELNLADNEFTGKIPDEIGSLSVLNYLDLSGNMFSGKIPVS 559
Query: 560 LENLSFLEYLNLSYNHFEGEVP---TKGVFSNKTGISLSGNGKVCGGLDELNLPPCPSRG 616
L++L L LNLSYN G++P K ++ N S GN +CG + L C S
Sbjct: 560 LQSLK-LNQLNLSYNRLSGDLPPSLAKDMYKN----SFIGNPGLCGDIKGL----CGSEN 610
Query: 617 LKKRTDF--LLKVVVPVTVSGVILSLCLVLFLARRRRSAHKSSVSQLMDQQFPMISYAEL 674
K+ + LL+ + + ++ + F R + A S+ F + ++E
Sbjct: 611 EAKKRGYVWLLRSIFVLAAMVLLAGVAWFYFKYRTFKKARAMERSKWTLMSFHKLGFSE- 669
Query: 675 SKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVI---NLKQ-------KGASNG-- 722
+ N+IG G+ G VYK L NG VAVK + ++K+ KG G
Sbjct: 670 HEILESLDEDNVIGAGASGKVYKVVL-TNGETVAVKRLWTGSVKETGDCDPEKGYKPGVQ 728
Query: 723 ---FVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQ 779
F AE + L IRH+N++K+ CS+ D K +VYEYM NGSL D LH S+
Sbjct: 729 DEAFEAEVETLGKIRHKNIVKLWCCCSTRDCK-----LLVYEYMPNGSLGDLLHSSKGGM 783
Query: 780 EARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKF 839
L R II+D A + Y+HH PP+VH D+K +N+L+D D A + DFG+AK
Sbjct: 784 ----LGWQTRFKIILDAAEGLSYLHHDSVPPIVHRDIKSNNILIDGDYGARVADFGVAK- 838
Query: 840 LSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTD 899
+D + P S I G+ GYIAPEY + D+YSFG+++LE+ TR+RP D
Sbjct: 839 ----AVDLTGKAPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILEIVTRKRPVD 894
Query: 900 GMFNQGLTLHEFARTALPDKVME-IVDSVL 928
+ L ++ + L K +E ++D L
Sbjct: 895 PELGEK-DLVKWVCSTLDQKGIEHVIDPKL 923
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| C0LGP4 | Y3475_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.4536 | 0.9778 | 0.9603 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 992 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-125 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 8e-46 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-42 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-38 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-38 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-38 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-36 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-35 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-35 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-33 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-31 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 8e-30 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-28 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-28 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-27 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 8e-27 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-26 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-26 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 8e-26 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-25 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-25 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-24 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-24 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-24 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-24 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-24 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-23 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-23 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 8e-23 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-22 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-22 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-21 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-21 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-21 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 9e-21 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-20 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-20 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-20 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 8e-20 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-19 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-19 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-19 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-19 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 7e-19 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-18 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-18 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-18 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-18 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 9e-18 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-17 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-17 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-17 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-17 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-16 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-16 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-16 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-16 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-16 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-16 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-16 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 9e-16 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-15 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-15 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-15 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-15 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-15 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-14 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-14 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-14 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-14 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-14 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-14 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-14 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-14 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 9e-14 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-13 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-13 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-13 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-13 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 6e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-13 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 9e-13 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 9e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-12 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-12 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-12 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-12 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-12 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-12 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 4e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-12 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-12 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 7e-12 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 8e-12 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-12 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 9e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 9e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-11 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-11 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-11 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 7e-11 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-11 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 8e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-10 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-10 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-10 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-10 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-10 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-10 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-10 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-10 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 5e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 8e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 8e-10 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-10 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 9e-10 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 9e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-09 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 1e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-09 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-09 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-09 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 7e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 8e-09 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 8e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 9e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 9e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 9e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 9e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 9e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-08 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-08 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-08 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 6e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-08 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-08 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-07 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-07 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-07 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 8e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 9e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-06 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 4e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-06 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 9e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-05 | |
| PRK15370 | 754 | PRK15370, PRK15370, E3 ubiquitin-protein ligase Sl | 1e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-05 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-05 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 6e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 9e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-04 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 6e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 8e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.001 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.002 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.002 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.002 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 0.002 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 405 bits (1042), Expect = e-125
Identities = 310/1000 (31%), Positives = 483/1000 (48%), Gaps = 118/1000 (11%)
Query: 13 LLAIGSQLEDDPLGVTSSWNNSTNLCQWTGVTCGHRHQRVTKLDLSNRTIGGTLS----- 67
LL+ S + +DPL S+WN+S ++C W G+TC + RV +DLS + I G +S
Sbjct: 34 LLSFKSSI-NDPLKYLSNWNSSADVCLWQGITCNN-SSRVVSIDLSGKNISGKISSAIFR 91
Query: 68 -PYV-------GNLSF------------LRYLNLADNNFHGEIPHQIGRLVRLEALVLAN 107
PY+ LS LRYLNL++NNF G IP G + LE L L+N
Sbjct: 92 LPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSN 149
Query: 108 NSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASI 167
N SG+IP ++ S+L + N LVG+IP L N LE LT+A N L G P +
Sbjct: 150 NMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLT-NLTSLEFLTLASNQLVGQIPREL 208
Query: 168 GNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLP 227
G + +L+ I + N L G IP +G L +L L+L N +G +P S+ N+ +L+ +FL
Sbjct: 209 GQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLY 268
Query: 228 TNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIY 287
N+ +G +P I SL KL+ +++N+ +G IPE + NL L LF N F GK+ +
Sbjct: 269 QNKLSGPIPPSI-FSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVA 327
Query: 288 FRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSS 347
SL L+ L L SN +L LT + +LS+
Sbjct: 328 LTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLT----------------------VLDLST 365
Query: 348 TMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFL 407
N ++G IP G+ + NL +L + N L G IP ++G ++L+ + L N
Sbjct: 366 ---------NNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSF 416
Query: 408 AGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSIS 467
+G +P+ L L+ L +S+N+LQG I + +L L +A + G LP S
Sbjct: 417 SGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPD--SFGS 474
Query: 468 TLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNS 527
+LDLS N SG +P ++G+L L+ +S N+ SGEIP LS+C L L L N
Sbjct: 475 KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQ 534
Query: 528 FSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFS 587
SG IP+S S + + +LD+S N LSG+IP+ L N+ L +N+S+NH G +P+ G F
Sbjct: 535 LSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFL 594
Query: 588 NKTGISLSGNGKVCGGLDELNLPPCPSRGLKKRTDFLLKVVVPVTVSGVILSLCLVLFLA 647
+++GN +CGG LPPC + ++K + + + V+ +
Sbjct: 595 AINASAVAGNIDLCGGDTTSGLPPC--KRVRKTPSWWFYITCTLGAFLVLALVAFGFVFI 652
Query: 648 RRRRSAHKSSVSQ---LMDQQFPMISYAELSKATNDFSSS----NMIGQGSFGFVYKGNL 700
R R + V + QF S S ND SS N+I +G G YKG
Sbjct: 653 RGRNNLELKRVENEDGTWELQF-FDSKVSKSITINDILSSLKEENVISRGKKGASYKGKS 711
Query: 701 GENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVY 760
+NGM VK IN + +A+ + ++H N++K+I +C S KG +++
Sbjct: 712 IKNGMQFVVKEIN-DVNSIPSSEIAD---MGKLQHPNIVKLIGLCRS--EKGA---YLIH 762
Query: 761 EYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSN 820
EY++ +L + L R+L+ +R I I +A A+ ++H C P VV G+L P
Sbjct: 763 EYIEGKNLSEVL---------RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEK 813
Query: 821 VLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGD 880
+++D HL + L T + SS Y+APE + + D
Sbjct: 814 IIIDGKDEPHL------RLSLPGLLCTDTKCFISS-------AYVAPETRETKDITEKSD 860
Query: 881 VYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKVMEI-VDSVLLLEVQASNSRS 939
+Y FG++L+E+ T + P D F ++ E+AR D +++ +D + +V +
Sbjct: 861 IYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVN---- 916
Query: 940 CGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKL 979
+ +V V+ + C+ PT R DV+ L
Sbjct: 917 --------QNEIVEVMNLALHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 8e-46
Identities = 64/208 (30%), Positives = 105/208 (50%), Gaps = 24/208 (11%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKG-ASNGFVAECQALRNIRHRNLIKIITIC 745
+G+G FG VY + G VA+K+I + + E + L+ + H N++K+ +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 746 SSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHH 805
+ +V EY + GSL+D L ++ L+ + + I++ + +EY+H
Sbjct: 61 EDENHLY-----LVMEYCEGGSLKDLL-----KENEGKLSEDEILRILLQILEGLEYLHS 110
Query: 806 HCQPPVVHGDLKPSNVLLDQD-LVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGY 864
+ ++H DLKP N+LLD D L DFGL+K L+S S K I GT Y
Sbjct: 111 N---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD--------KSLLKTIVGTPAY 159
Query: 865 IAPEYGMG-GEASMTGDVYSFGILLLEM 891
+APE +G G S D++S G++L E+
Sbjct: 160 MAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 7e-42
Identities = 67/224 (29%), Positives = 104/224 (46%), Gaps = 24/224 (10%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINL-KQKGASNGFVAECQALRNIRHRNLIKIITIC 745
+G+GSFG VY + G +VA+KVI K K + E + L+ ++H N++++ +
Sbjct: 7 LGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV- 65
Query: 746 SSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHH 805
F+ D +V EY + G L D L + L+ + + + SA+EY+H
Sbjct: 66 ----FEDEDKLYLVMEYCEGGDLFDLLKKR------GRLSEDEARFYLRQILSALEYLHS 115
Query: 806 HCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYI 865
+VH DLKP N+LLD+D L DFGLA+ L GT Y+
Sbjct: 116 KG---IVHRDLKPENILLDEDGHVKLADFGLARQLDP---------GEKLTTFVGTPEYM 163
Query: 866 APEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLH 909
APE +G D++S G++L E+ T + P G
Sbjct: 164 APEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFK 207
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 2e-38
Identities = 68/214 (31%), Positives = 103/214 (48%), Gaps = 25/214 (11%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHRNLIKIITI 744
+G GSFG VYK G +VAVK++ + E + LR + H N++++I
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 745 CSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIH 804
F+ D +V EY + G L D+L + L+ + I + + +EY+H
Sbjct: 67 -----FEDKDHLYLVMEYCEGGDLFDYLSRG------GPLSEDEAKKIALQILRGLEYLH 115
Query: 805 HHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGY 864
+ ++H DLKP N+LLD++ V + DFGLAK L S SS GT Y
Sbjct: 116 SN---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKS--------SSSLTTFVGTPWY 164
Query: 865 IAPE-YGMGGEASMTGDVYSFGILLLEMFTRRRP 897
+APE G DV+S G++L E+ T + P
Sbjct: 165 MAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 2e-38
Identities = 66/228 (28%), Positives = 112/228 (49%), Gaps = 32/228 (14%)
Query: 686 MIGQGSFGFVYKG----NLGENGMMVAVKVINL-KQKGASNGFVAECQALRNIRHRNLIK 740
+G+G+FG VYKG G+ + VAVK + + F+ E + +R + H N++K
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 741 IITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAI 800
++ +C+ + IV EYM+ G L +L ++ + L+L ++ + +A +
Sbjct: 66 LLGVCTE-----EEPLYIVMEYMEGGDLLSYLRKNRPK-----LSLSDLLSFALQIARGM 115
Query: 801 EYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKG 860
EY+ +H DL N L+ ++LV + DFGL++ L +G K
Sbjct: 116 EYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY-------RKRGGKL 165
Query: 861 TVGYIAPE---YGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFNQ 904
+ ++APE G S DV+SFG+LL E+FT +P GM N+
Sbjct: 166 PIRWMAPESLKEGKFTSKS---DVWSFGVLLWEIFTLGEQPYPGMSNE 210
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 6e-38
Identities = 67/228 (29%), Positives = 108/228 (47%), Gaps = 31/228 (13%)
Query: 686 MIGQGSFGFVYKG----NLGENGMMVAVKVINL-KQKGASNGFVAECQALRNIRHRNLIK 740
+G+G+FG VYKG + VAVK + + F+ E + +R + H N++K
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 741 IITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAI 800
++ +C+ + IV EYM G L D+L ++ + L+L ++ + +A +
Sbjct: 66 LLGVCTE-----EEPLMIVMEYMPGGDLLDYLRKNRP----KELSLSDLLSFALQIARGM 116
Query: 801 EYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKG 860
EY+ +H DL N L+ ++LV + DFGL++ L KG K
Sbjct: 117 EYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKV-------KGGKL 166
Query: 861 TVGYIAPE---YGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFNQ 904
+ ++APE G S DV+SFG+LL E+FT P GM N
Sbjct: 167 PIRWMAPESLKEGKFTSKS---DVWSFGVLLWEIFTLGEEPYPGMSNA 211
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 59/222 (26%), Positives = 102/222 (45%), Gaps = 24/222 (10%)
Query: 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGA--SNGFVAECQALRNIRHRN 737
+++ ++G+GSFG VY + G ++AVK + L E + L +++H N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 738 LIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQ--SEDQQEARSLTLIQRINIIID 795
+++ + ++ I EY+ GSL L + + R T
Sbjct: 61 IVRYYGSERDEEKNTLN---IFLEYVSGGSLSSLLKKFGKLPEPVIRKYT--------RQ 109
Query: 796 VASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSS 855
+ + Y+H + +VH D+K +N+L+D D V L DFG AK L +ET +
Sbjct: 110 ILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGD------IETGEGT 160
Query: 856 KGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897
++GT ++APE G E D++S G ++EM T + P
Sbjct: 161 GSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 1e-35
Identities = 69/230 (30%), Positives = 110/230 (47%), Gaps = 37/230 (16%)
Query: 687 IGQGSFGFVYKGNL----GENGMMVAVKVINLKQKGASNG---FVAECQALRNIRHRNLI 739
+G+G+FG VYKG L VAVK LK+ + F+ E ++ + H N++
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKT--LKEGASEEEREEFLEEASIMKKLSHPNIV 64
Query: 740 KIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASA 799
+++ +C+ +G IV EYM G L D+L + LTL + + + +A
Sbjct: 65 RLLGVCT----QGEPLY-IVTEYMPGGDLLDFLRKHG-----EKLTLKDLLQMALQIAKG 114
Query: 800 IEYIH-HHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGI 858
+EY+ + VH DL N L+ ++LV + DFGL++ + G
Sbjct: 115 MEYLESKNF----VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYR------KRGGG 164
Query: 859 KGTVGYIAPE---YGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFNQ 904
K + ++APE G S DV+SFG+LL E+FT +P GM N+
Sbjct: 165 KLPIKWMAPESLKDGKFTSKS---DVWSFGVLLWEIFTLGEQPYPGMSNE 211
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 7e-35
Identities = 68/238 (28%), Positives = 115/238 (48%), Gaps = 38/238 (15%)
Query: 685 NMIGQGSFGFVYKGNL---GENGMMVAVKVINLKQKGASNG----FVAECQALRNIRHRN 737
+G+G+FG VYKG L VAVK + ++ AS F+ E + ++ + H N
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTL---KEDASEEERKDFLKEARVMKKLGHPN 57
Query: 738 LIKIITICSSIDFKGVDFQA--IVYEYMQNGSLEDWLHQS---EDQQEARSLTLIQRINI 792
+++++ +C + + +V EYM+ G L D+L +S E +L+L ++
Sbjct: 58 VVRLLGVC-------TEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSF 110
Query: 793 IIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETP 852
I +A +EY+ VH DL N L+ +DLV + DFGL++ +
Sbjct: 111 AIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYR----- 162
Query: 853 SSSKG---IKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFNQGL 906
+ G I+ ++APE G + DV+SFG+LL E+FT P G+ N+ +
Sbjct: 163 KKTGGKLPIR----WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV 216
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 7e-33
Identities = 66/218 (30%), Positives = 101/218 (46%), Gaps = 22/218 (10%)
Query: 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLI 739
F IG+G FG VYK G VA+KVI L+ K + E Q L+ +H N++
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60
Query: 740 KIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASA 799
K S K D IV E+ GSL+D L + ++LT Q + ++
Sbjct: 61 KYYG---SYLKK--DELWIVMEFCSGGSLKDLLKST-----NQTLTESQIAYVCKELLKG 110
Query: 800 IEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIK 859
+EY+H + ++H D+K +N+LL D L DFGL+ LS + + +
Sbjct: 111 LEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK---------ARNTMV 158
Query: 860 GTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897
GT ++APE G D++S GI +E+ + P
Sbjct: 159 GTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 74/226 (32%), Positives = 110/226 (48%), Gaps = 22/226 (9%)
Query: 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLI 739
+F+ +G G FG V++G L +N + VA+K++ F E QAL+ +RH++LI
Sbjct: 7 EFTLERKLGSGYFGEVWEG-LWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65
Query: 740 KIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASA 799
+ +CS + I+ E M+ GSL +L E + L + I++ VA
Sbjct: 66 SLFAVCS-----VGEPVYIITELMEKGSLLAFLRSP----EGQVLPVASLIDMACQVAEG 116
Query: 800 IEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIK 859
+ Y+ +H DL N+L+ +DLV + DFGLA+ + V S K I
Sbjct: 117 MAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKED-----VYLSSDKK-IP 167
Query: 860 GTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRR-PTDGMFNQ 904
+ APE G S DV+SFGILL EMFT + P GM N
Sbjct: 168 --YKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH 211
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 8e-30
Identities = 70/219 (31%), Positives = 107/219 (48%), Gaps = 24/219 (10%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGAS-NGFVAECQALRNIRHRNLIKIITIC 745
+G G FG V+ G VAVK LK S F+ E Q ++ +RH L+++ +C
Sbjct: 14 LGAGQFGEVWMG-TWNGTTKVAVKT--LKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC 70
Query: 746 SSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHH 805
S + IV EYM GSL D+L E + L L Q +++ +A + Y+
Sbjct: 71 S-----EEEPIYIVTEYMSKGSLLDFLKSGE----GKKLRLPQLVDMAAQIAEGMAYLE- 120
Query: 806 HCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYI 865
+H DL N+L+ ++LV + DFGLA+ + + ++ +G K + +
Sbjct: 121 --SRNYIHRDLAARNILVGENLVCKIADFGLARLI-------EDDEYTAREGAKFPIKWT 171
Query: 866 APEYGMGGEASMTGDVYSFGILLLEMFTRRR-PTDGMFN 903
APE G ++ DV+SFGILL E+ T R P GM N
Sbjct: 172 APEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN 210
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 71/215 (33%), Positives = 104/215 (48%), Gaps = 26/215 (12%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNL 738
+ IG+G FG V G+ G VAVK + A F+AE + +RH NL
Sbjct: 6 KELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAA-QAFLAEASVMTTLRHPNL 62
Query: 739 IKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVAS 798
++++ + + + IV EYM GSL D+L +TL Q++ +DV
Sbjct: 63 VQLLGVV--LQGNPL---YIVTEYMAKGSLVDYLRSRGRA----VITLAQQLGFALDVCE 113
Query: 799 AIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGI 858
+EY+ + VH DL NVL+ +DLVA + DFGLAK +S D+
Sbjct: 114 GMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK-EASQGQDSG---------- 159
Query: 859 KGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT 893
K V + APE + S DV+SFGILL E+++
Sbjct: 160 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 6e-28
Identities = 63/220 (28%), Positives = 102/220 (46%), Gaps = 21/220 (9%)
Query: 684 SNMIGQGSFGFVYKG---NLGEN-GMMVAVKVINLKQKGAS-NGFVAECQALRNIRHRNL 738
+G+G FG V LG+N G VAVK +N + + F E + LR + H N+
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 739 IKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVAS 798
+K +C + + ++ EY+ +GSL D+L + DQ + L L +
Sbjct: 69 VKYKGVCEKPGGRSL---RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFS-----SQICK 120
Query: 799 AIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGI 858
++Y+ +H DL N+L++ + + + DFGLAK L V+ P S
Sbjct: 121 GMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESP-- 175
Query: 859 KGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPT 898
+ + APE + S DV+SFG+ L E+FT P+
Sbjct: 176 ---IFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPS 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 3e-27
Identities = 74/222 (33%), Positives = 114/222 (51%), Gaps = 24/222 (10%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLK---QKGASNGFVAECQALRNIRH-RNLIKII 742
+G+GSFG VY L + +VA+KV+ K + F+ E Q L ++ H N++K+
Sbjct: 8 LGEGSFGEVY---LARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 743 TICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEY 802
+V EY+ GSLED L + + L+ + + I+ + SA+EY
Sbjct: 65 DFFQDEGSL-----YLVMEYVDGGSLEDLLKKIGRK---GPLSESEALFILAQILSALEY 116
Query: 803 IHHHCQPPVVHGDLKPSNVLLDQDL-VAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGT 861
+H ++H D+KP N+LLD+D V L DFGLAK L +++ S+ GT
Sbjct: 117 LHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPST--SVGT 171
Query: 862 VGYIAPEYGMG---GEASMTGDVYSFGILLLEMFTRRRPTDG 900
GY+APE +G AS + D++S GI L E+ T P +G
Sbjct: 172 PGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEG 213
|
Length = 384 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 8e-27
Identities = 72/219 (32%), Positives = 109/219 (49%), Gaps = 24/219 (10%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGAS-NGFVAECQALRNIRHRNLIKIITIC 745
+G G FG V++G L N VAVK LK F+AE Q ++ +RH LI++ +C
Sbjct: 14 LGAGQFGEVWEG-LWNNTTPVAVK--TLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC 70
Query: 746 SSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHH 805
+ + IV E M+ GSL ++L R+L L Q I++ VAS + Y+
Sbjct: 71 TL-----EEPIYIVTELMKYGSLLEYLQGGA----GRALKLPQLIDMAAQVASGMAYLEA 121
Query: 806 HCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYI 865
+H DL NVL+ ++ + + DFGLA+ + + + +G K + +
Sbjct: 122 Q---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE-------AREGAKFPIKWT 171
Query: 866 APEYGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFN 903
APE + S+ DV+SFGILL E+ T R P GM N
Sbjct: 172 APEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN 210
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 109 bits (276), Expect = 1e-26
Identities = 64/231 (27%), Positives = 108/231 (46%), Gaps = 46/231 (19%)
Query: 685 NMIGQGSFGFVYKGNLGENGMMVAVKVINL-----KQKGASNGFVAECQALRNIRHRNLI 739
IG+GSFG VY +G + +K I+L K++ + + E + L+ + H N+I
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDA---LNEVKILKKLNHPNII 62
Query: 740 KIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASA 799
K F+ IV EY G L + + ++E + Q ++ + + A
Sbjct: 63 KYYE-----SFEEKGKLCIVMEYADGGDLSQKIKKQ--KKEGKPFPEEQILDWFVQLCLA 115
Query: 800 IEYIH-HHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLD---TAVETPSSS 855
++Y+H ++H D+KP N+ L + + LGDFG++K LSS+ +D T V TP
Sbjct: 116 LKYLHSRK----ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST-VDLAKTVVGTPY-- 168
Query: 856 KGIKGTVGYIAPE------YGMGGEASMTGDVYSFGILLLEMFTRRRPTDG 900
Y++PE Y S D++S G +L E+ T + P +G
Sbjct: 169 --------YLSPELCQNKPY---NYKS---DIWSLGCVLYELCTLKHPFEG 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 73/231 (31%), Positives = 107/231 (46%), Gaps = 35/231 (15%)
Query: 684 SNMIGQGSFGFVYKG-NLGENGMMVAVKVINLKQKGASNGFVA---ECQALRNIRHRNLI 739
N IG G+FG VY NL +M AVK I + Q E + L ++H NL+
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELM-AVKEIRI-QDNDPKTIKEIADEMKVLELLKHPNLV 62
Query: 740 KIITICSSIDFKGVDFQ----AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIID 795
K + GV+ I EY G+LE+ L E +I+ + +
Sbjct: 63 K---------YYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEH----VIRVYTLQL- 108
Query: 796 VASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSS 855
+ Y+H H +VH D+KP+N+ LD + V LGDFG A L ++ T E
Sbjct: 109 -LEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT-TTMGE---EV 160
Query: 856 KGIKGTVGYIAPEYGMGGEASMTG---DVYSFGILLLEMFTRRRPTDGMFN 903
+ + GT Y+APE GG+ G D++S G ++LEM T +RP + N
Sbjct: 161 QSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 66/220 (30%), Positives = 108/220 (49%), Gaps = 24/220 (10%)
Query: 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINL--KQKGASNGFVAECQALRNIRHRN 737
++ ++IG+G+FG VYKG E G VA+K I+L ++ A + E L+N++H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 738 LIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVA 797
++K I + D I+ EY +NGSL + + E +L+ + V
Sbjct: 61 IVKYIGS-----IETSDSLYIILEYAENGSLRQIIKKFGPFPE----SLV--AVYVYQVL 109
Query: 798 SAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKG 857
+ Y+H + V+H D+K +N+L +D V L DFG+A L+ D A
Sbjct: 110 QGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDA--------S 158
Query: 858 IKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897
+ GT ++APE AS D++S G ++E+ T P
Sbjct: 159 VVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 66/219 (30%), Positives = 96/219 (43%), Gaps = 35/219 (15%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVIN---LKQKGASNGFVAECQALRNIRHRNLIKIIT 743
+G+GSFG V + G + A+KV+ + ++ + E L I H ++K
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK--L 58
Query: 744 ICSSIDFKGVDFQA-----IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVAS 798
+ FQ +V EY G L L + E R+ R ++
Sbjct: 59 HYA--------FQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERA-----RF-YAAEIVL 104
Query: 799 AIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGI 858
A+EY+H +++ DLKP N+LLD D L DFGLAK LSS S +
Sbjct: 105 ALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSS--------EGSRTNTF 153
Query: 859 KGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897
GT Y+APE +G D +S G+LL EM T + P
Sbjct: 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 70/230 (30%), Positives = 112/230 (48%), Gaps = 34/230 (14%)
Query: 685 NMIGQGSFGFVYKGNLGENG---MMVAVKVINLK---QKGASNGFVAECQALRNIRHRNL 738
+IG G FG V +G L G + VA+K LK F+ E + H N+
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKT--LKAGSSDKQRLDFLTEASIMGQFDHPNI 67
Query: 739 IKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVAS 798
I++ + + K I+ EYM+NGSL+ +L +++ + T+ Q + ++ +AS
Sbjct: 68 IRLEGVVT----KSRPVM-IITEYMENGSLDKFLRENDGK-----FTVGQLVGMLRGIAS 117
Query: 799 AIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGI 858
++Y+ VH DL N+L++ +LV + DFGL++ L S + T KG
Sbjct: 118 GMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS--EATYTT----KGG 168
Query: 859 KGTVGYIAPE---YGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFNQ 904
K + + APE Y AS DV+SFGI++ E+ + RP M NQ
Sbjct: 169 KIPIRWTAPEAIAYRKFTSAS---DVWSFGIVMWEVMSYGERPYWDMSNQ 215
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 72/221 (32%), Positives = 115/221 (52%), Gaps = 27/221 (12%)
Query: 687 IGQGSFGFVYKGNLGENGMM-VAVKVINLKQKGAS-NGFVAECQALRNIRHRNLIKIITI 744
+GQG FG V+ G NG VA+K LK S F+ E Q ++ +RH L+++ +
Sbjct: 14 LGQGCFGEVWMGTW--NGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 69
Query: 745 CSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIH 804
S IV EYM GSL D+L + + L L Q +++ +AS + Y+
Sbjct: 70 VSEEPI------YIVTEYMSKGSLLDFL----KGEMGKYLRLPQLVDMAAQIASGMAYVE 119
Query: 805 HHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGY 864
+ VH DL+ +N+L+ ++LV + DFGLA+ + + ++ +G K + +
Sbjct: 120 ---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIKW 169
Query: 865 IAPEYGMGGEASMTGDVYSFGILLLEMFTRRR-PTDGMFNQ 904
APE + G ++ DV+SFGILL E+ T+ R P GM N+
Sbjct: 170 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 210
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 58/218 (26%), Positives = 106/218 (48%), Gaps = 34/218 (15%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGF----VAECQALRNIRHRNLIKII 742
IG+G++G VYK + G +VA+K I ++ + GF + E + L+ +RH N++++
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENE--KEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 743 TICSSIDFKGVDFQAIVYEYMQ---NGSLEDWLHQ-SEDQQEARSLTLIQRINIIIDVAS 798
I +S + +V+EYM G L+ + +E Q + Q +
Sbjct: 65 EIVTSKGKGSI---YMVFEYMDHDLTGLLDSPEVKFTESQ--IKCYMK-Q-------LLE 111
Query: 799 AIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGI 858
++Y+H + ++H D+K SN+L++ D V L DFGLA+ + +++ I
Sbjct: 112 GLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRN-----SADYTNRVI 163
Query: 859 KGTVGYIAPEYGMGGEASMTG-DVYSFGILLLEMFTRR 895
T+ Y PE +G D++S G +L E+F +
Sbjct: 164 --TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 72/280 (25%), Positives = 123/280 (43%), Gaps = 43/280 (15%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVIN---LKQKGASNGFVAECQAL-RNIR 734
+DF +IG+GSF V E A+K+++ L ++ E + L R
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 735 HRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQ--SEDQQEARSLTLIQRINI 792
H +IK+ + D + + F V EY NG L ++ + S D++ R
Sbjct: 61 HPGIIKLY--YTFQDEENLYF---VLEYAPNGELLQYIRKYGSLDEKCTR--------FY 107
Query: 793 IIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTA---V 849
++ A+EY+H ++H DLKP N+LLD+D+ + DFG AK L + +
Sbjct: 108 AAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGD 164
Query: 850 ETPSSSKGIK---------GTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDG 900
T S+ K GT Y++PE A + D+++ G ++ +M T + P G
Sbjct: 165 ATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRG 224
Query: 901 MFNQGLTLH-------EFARTALPDKVMEIVDSVLLLEVQ 933
N+ LT F P ++++ +L+L+ Q
Sbjct: 225 S-NEYLTFQKILKLEYSFPPN-FPPDAKDLIEKLLVLDPQ 262
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 7e-24
Identities = 72/220 (32%), Positives = 111/220 (50%), Gaps = 25/220 (11%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGAS-NGFVAECQALRNIRHRNLIKIITIC 745
+G G FG V+ G N VAVK LK S F+ E Q ++ +RH L+++ +
Sbjct: 14 LGNGQFGEVWMGTWNGN-TKVAVK--TLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVV 70
Query: 746 SSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHH 805
S IV EYM GSL D+L E R+L L +++ VA+ + YI
Sbjct: 71 SEEPI------YIVTEYMSKGSLLDFLKDGE----GRALKLPNLVDMAAQVAAGMAYIE- 119
Query: 806 HCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYI 865
+ +H DL+ +N+L+ LV + DFGLA+ + + ++ +G K + +
Sbjct: 120 --RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-------TARQGAKFPIKWT 170
Query: 866 APEYGMGGEASMTGDVYSFGILLLEMFTRRR-PTDGMFNQ 904
APE + G ++ DV+SFGILL E+ T+ R P GM N+
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR 210
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 73/230 (31%), Positives = 111/230 (48%), Gaps = 42/230 (18%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVK------VINLKQKGASNGFVAECQALRNIRHRNLIK 740
IG+G+FG VYKG L + VAVK +LK+K F+ E + L+ H N++K
Sbjct: 3 IGKGNFGDVYKGVL-KGNTEVAVKTCRSTLPPDLKRK-----FLQEAEILKQYDHPNIVK 56
Query: 741 IITICSSIDFKGVDFQA--IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVAS 798
+I +C V Q IV E + GSL +L + +++ LT+ + + + +D A+
Sbjct: 57 LIGVC-------VQKQPIYIVMELVPGGSLLTFLRKKKNR-----LTVKKLLQMSLDAAA 104
Query: 799 AIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKG- 857
+EY+ +H DL N L+ ++ V + DFG+ S + + T S
Sbjct: 105 GMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGM-----SREEEGGIYTVSDGLKQ 156
Query: 858 --IKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFNQ 904
IK T APE G + DV+S+GILL E F+ P GM NQ
Sbjct: 157 IPIKWT----APEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ 202
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 99.2 bits (248), Expect = 5e-23
Identities = 63/226 (27%), Positives = 98/226 (43%), Gaps = 50/226 (22%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLI----KII 742
+GQGS G VYK G + A+K I++ + R + K +
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVD---------------GDEEFRKQLLRELKTL 53
Query: 743 TICSS---IDFKGVDFQ----AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIID 795
C S + G ++ +IV EYM GSL D L + E L I R
Sbjct: 54 RSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPE-PVLAYIAR-----Q 107
Query: 796 VASAIEYIH--HHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSS--PLDTAVET 851
+ ++Y+H H ++H D+KPSN+L++ + DFG++K L ++ +T V
Sbjct: 108 ILKGLDYLHTKRH----IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-- 161
Query: 852 PSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897
GTV Y++PE G S D++S G+ LLE + P
Sbjct: 162 --------GTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 7e-23
Identities = 67/220 (30%), Positives = 111/220 (50%), Gaps = 25/220 (11%)
Query: 687 IGQGSFGFVYKGNLGENGMM-VAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITIC 745
+GQG FG V+ G NG VA+K + F+ E Q ++ +RH L+ + +
Sbjct: 14 LGQGCFGEVWMGTW--NGTTKVAIKTLK-PGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV 70
Query: 746 SSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHH 805
S IV E+M GSL D+L + + + L L Q +++ +A + YI
Sbjct: 71 SEEPI------YIVTEFMGKGSLLDFLKEGD----GKYLKLPQLVDMAAQIADGMAYIE- 119
Query: 806 HCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYI 865
+ +H DL+ +N+L+ +LV + DFGLA+ + + ++ +G K + +
Sbjct: 120 --RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-------TARQGAKFPIKWT 170
Query: 866 APEYGMGGEASMTGDVYSFGILLLEMFTRRR-PTDGMFNQ 904
APE + G ++ DV+SFGILL E+ T+ R P GM N+
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR 210
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 8e-23
Identities = 75/218 (34%), Positives = 108/218 (49%), Gaps = 28/218 (12%)
Query: 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLI 739
+ IG+G FG V G+ G VAVK I K + F+AE + +RH NL+
Sbjct: 7 ELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 62
Query: 740 KIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQR-INIIIDVAS 798
+++ + ++ KG + IV EYM GSL D+L + RS+ + +DV
Sbjct: 63 QLLGVI--VEEKGGLY--IVTEYMAKGSLVDYL-----RSRGRSVLGGDCLLKFSLDVCE 113
Query: 799 AIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGI 858
A+EY+ + VH DL NVL+ +D VA + DFGL K SS+ DT
Sbjct: 114 AMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DTG---------- 159
Query: 859 KGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRR 896
K V + APE + S DV+SFGILL E+++ R
Sbjct: 160 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 2e-22
Identities = 69/219 (31%), Positives = 111/219 (50%), Gaps = 25/219 (11%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGAS-NGFVAECQALRNIRHRNLIKIITIC 745
+G G FG V+ G VA+K +LKQ S F+AE ++ ++H L+++ +
Sbjct: 14 LGAGQFGEVWMG-YYNGHTKVAIK--SLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVV 70
Query: 746 SSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHH 805
+ I+ EYM+NGSL D+L E + LT+ + I++ +A + +I
Sbjct: 71 TQEPI------YIITEYMENGSLVDFLKTPEGIK----LTINKLIDMAAQIAEGMAFIE- 119
Query: 806 HCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYI 865
+ +H DL+ +N+L+ + L + DFGLA+ + + TA E G K + +
Sbjct: 120 --RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-TARE------GAKFPIKWT 170
Query: 866 APEYGMGGEASMTGDVYSFGILLLEMFTRRR-PTDGMFN 903
APE G ++ DV+SFGILL E+ T R P GM N
Sbjct: 171 APEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN 209
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 4e-22
Identities = 68/211 (32%), Positives = 109/211 (51%), Gaps = 30/211 (14%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICS 746
IG+G FG V +G G VAVK N+K + F+ E + + H+NL++++ +
Sbjct: 14 IGEGEFGAVLQGEY--TGQKVAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGV-- 67
Query: 747 SIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSL-TLIQRINIIIDVASAIEYIHH 805
I G+ IV E M G+L ++L + R+L ++IQ + +DVA +EY+
Sbjct: 68 -ILHNGL---YIVMELMSKGNLVNFL-----RTRGRALVSVIQLLQFSLDVAEGMEYLE- 117
Query: 806 HCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYI 865
+VH DL N+L+ +D VA + DFGLA+ + S +D + K V +
Sbjct: 118 --SKKLVHRDLAARNILVSEDGVAKVSDFGLAR-VGSMGVDNS----------KLPVKWT 164
Query: 866 APEYGMGGEASMTGDVYSFGILLLEMFTRRR 896
APE + S DV+S+G+LL E+F+ R
Sbjct: 165 APEALKHKKFSSKSDVWSYGVLLWEVFSYGR 195
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 96.1 bits (240), Expect = 1e-21
Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 30/215 (13%)
Query: 681 FSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIK 740
+ + IG+G+ G VYK G VA+K + L+++ + E +++ +H N++
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVD 79
Query: 741 IITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSE----DQQEARSLTLIQRINIIIDV 796
S + +V EYM GSL D + Q+ + Q A + +V
Sbjct: 80 YY---DSYLVGDELW--VVMEYMDGGSLTDIITQNFVRMNEPQIAY---------VCREV 125
Query: 797 ASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSK 856
+EY+H V+H D+K N+LL +D L DFG A L+ S
Sbjct: 126 LQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE--------KSKRN 174
Query: 857 GIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEM 891
+ GT ++APE + D++S GI+ +EM
Sbjct: 175 SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEM 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 61/224 (27%), Positives = 99/224 (44%), Gaps = 28/224 (12%)
Query: 681 FSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK----GASNGFVAECQALRNIRHR 736
F +IG+G+FG V + M A+K +N KQK G+ + E + L+ + H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMN-KQKCVEKGSVRNVLNERRILQELNHP 60
Query: 737 NLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDV 796
L+ + S F+ + +V + + G L L Q E + + I ++
Sbjct: 61 FLVNL---WYS--FQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQV-----KF-WICEI 109
Query: 797 ASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSK 856
A+EY+H ++H D+KP N+LLD+ H+ DF +A T V + +
Sbjct: 110 VLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIA---------TKVTPDTLTT 157
Query: 857 GIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDG 900
GT GY+APE S+ D +S G+ E +RP G
Sbjct: 158 STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRG 201
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 64/212 (30%), Positives = 107/212 (50%), Gaps = 32/212 (15%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASN--GFVAECQALRNIRHRNLIKIITI 744
+G G FG V+ G + VA+K+I +GA + F+ E + + + H NL+++ +
Sbjct: 12 LGSGQFGVVHLGKW-RGKIDVAIKMIR---EGAMSEDDFIEEAKVMMKLSHPNLVQLYGV 67
Query: 745 CSSIDFKGVDFQA---IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIE 801
C+ Q IV EYM NG L ++L + + + L +++ DV A+E
Sbjct: 68 CTK--------QRPIFIVTEYMANGCLLNYLRERKGKLGTEWL-----LDMCSDVCEAME 114
Query: 802 YIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGT 861
Y+ + +H DL N L+ +D V + DFGLA+++ LD + +SS+G K
Sbjct: 115 YLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYV----LD---DQYTSSQGTKFP 164
Query: 862 VGYIAPEYGMGGEASMTGDVYSFGILLLEMFT 893
V + PE S DV+SFG+L+ E+F+
Sbjct: 165 VKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 6e-21
Identities = 59/215 (27%), Positives = 114/215 (53%), Gaps = 22/215 (10%)
Query: 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKG-ASNGFVAECQALRNIRHRNL 738
D + + +G G +G VY+G + + VAVK LK+ F+ E ++ I+H NL
Sbjct: 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEVEEFLKEAAVMKEIKHPNL 64
Query: 739 IKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVAS 798
++++ +C+ + F I+ E+M G+L D+L + ++QE ++ L+ + ++S
Sbjct: 65 VQLLGVCT----REPPFY-IITEFMTYGNLLDYL-RECNRQEVNAVVLLY---MATQISS 115
Query: 799 AIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGI 858
A+EY+ +H DL N L+ ++ + + DFGL++ ++ +T ++ G
Sbjct: 116 AMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-------DTYTAHAGA 165
Query: 859 KGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT 893
K + + APE + S+ DV++FG+LL E+ T
Sbjct: 166 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 9e-21
Identities = 84/317 (26%), Positives = 141/317 (44%), Gaps = 75/317 (23%)
Query: 687 IGQGSFGFVYKGNL-----GENGMMVAVKVINLKQ---KGASNGFVAECQALRNIRHRNL 738
+G+G+FG V+ G + +VAVK LK+ A F E + L N +H N+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKT--LKETASNDARKDFEREAELLTNFQHENI 70
Query: 739 IKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLH---------QSEDQQEARSLTLIQR 789
+K +C+ D +V+EYM++G L +L +S D LTL Q
Sbjct: 71 VKFYGVCTE-----GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGE-LTLSQL 124
Query: 790 INIIIDVASAIEYI--HHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDT 847
+ I + +AS + Y+ H VH DL N L+ DLV +GDFG+++
Sbjct: 125 LQIAVQIASGMVYLASQH-----FVHRDLATRNCLVGYDLVVKIGDFGMSR--------- 170
Query: 848 AVETPSSSKGIKGT----VGYIAPEYGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMF 902
V T + + G + ++ PE M + + DV+SFG++L E+FT ++P G+
Sbjct: 171 DVYTTDYYR-VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS 229
Query: 903 NQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCS 962
N+ +V+E + LL+ R+C E V + + C
Sbjct: 230 NE--------------EVIECITQGRLLQ----RPRTCPSE----------VYDIMLGCW 261
Query: 963 MESPTERMEMRDVVAKL 979
P +R+ ++D+ +L
Sbjct: 262 KRDPQQRINIKDIHERL 278
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 2e-20
Identities = 70/231 (30%), Positives = 119/231 (51%), Gaps = 35/231 (15%)
Query: 686 MIGQGSFGFVYKGNL---GENGMMVAVKVINL----KQKGASNGFVAECQALRNIRHRNL 738
+IG G FG V +G L G+ + VA+K + KQ+ F++E + H N+
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQR---RDFLSEASIMGQFDHPNI 67
Query: 739 IKIITICSSIDFKGVDFQA----IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIII 794
I + +GV ++ I+ E+M+NG+L+ +L Q++ Q T+IQ + ++
Sbjct: 68 IHL---------EGVVTKSRPVMIITEFMENGALDSFLRQNDGQ-----FTVIQLVGMLR 113
Query: 795 DVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSS 854
+A+ ++Y+ + VH DL N+L++ +LV + DFGL++FL D T +S
Sbjct: 114 GIAAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP---TYTS 167
Query: 855 SKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLE-MFTRRRPTDGMFNQ 904
S G K + + APE + + DV+S+GI++ E M RP M NQ
Sbjct: 168 SLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ 218
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 62/213 (29%), Positives = 96/213 (45%), Gaps = 23/213 (10%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVIN---LKQKGASNGFVAECQALRNIRHRNL-IKII 742
I +G++G V+ G + A+KVI + +K + + E R+I + ++
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTE----RDILSQAQSPYVV 56
Query: 743 TICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQ--SEDQQEARSLTLIQRINIIIDVASAI 800
+ S F+G +V EY+ G L L S D+ AR I ++ A+
Sbjct: 57 KLYYS--FQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVAR--------IYIAEIVLAL 106
Query: 801 EYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKG 860
EY+H + ++H DLKP N+L+D + L DFGL+K + K I G
Sbjct: 107 EYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVG 163
Query: 861 TVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT 893
T YIAPE +G S T D +S G +L E
Sbjct: 164 TPDYIAPEVILGQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 3e-20
Identities = 65/222 (29%), Positives = 97/222 (43%), Gaps = 31/222 (13%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVI---NLKQKGASNGFVAECQALRNIRHRNLIKIIT 743
IG+GSFG V K +G ++ K I N+ +K V+E LR ++H N I+
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEK-EKQQLVSEVNILRELKHPN---IVR 63
Query: 744 ICSSIDFKGVDFQA----IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASA 799
I +D IV EY + G L + + ++E + + I+ + A
Sbjct: 64 YYDRI----IDRSNQTLYIVMEYCEGGDLAQLIQKC--KKERKYIEEEFIWRILTQLLLA 117
Query: 800 IEYIHH--HCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFL--SSSPLDTAVETPSSS 855
+ H+ V+H DLKP+N+ LD + LGDFGLAK L SS T V TP
Sbjct: 118 LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPY-- 175
Query: 856 KGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897
Y++PE D++S G L+ E+ P
Sbjct: 176 --------YMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 8e-20
Identities = 59/228 (25%), Positives = 102/228 (44%), Gaps = 31/228 (13%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGAS-NGFVAECQALRNIRHRNLIKIITIC 745
+G G FG V G VA+K+I K+ S + F+ E + + + H L+++ +C
Sbjct: 12 LGTGQFGVVKYGKW-RGQYDVAIKMI--KEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 746 SSIDFKGVDFQA---IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEY 802
+ Q IV EYM NG L ++L + + Q + + DV + Y
Sbjct: 69 TK--------QRPIYIVTEYMSNGCLLNYLREHG-----KRFQPSQLLEMCKDVCEGMAY 115
Query: 803 IHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTV 862
+ +H DL N L+D + DFGL++++ LD + +SS G K V
Sbjct: 116 LESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYV----LD---DEYTSSVGSKFPV 165
Query: 863 GYIAPEYGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFNQGLTLH 909
+ PE + + S DV++FG+L+ E+++ + P + N
Sbjct: 166 RWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEK 213
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-19
Identities = 68/240 (28%), Positives = 104/240 (43%), Gaps = 23/240 (9%)
Query: 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGAS--NGFVAECQALRNIRHRN 737
DF N IG+GSFG V+K + + A+K I+L + + E + L +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 738 LIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVA 797
+I+ S +D KG IV EY +NG L L Q R L Q I +
Sbjct: 61 IIRYYE--SFLD-KGK--LNIVMEYAENGDLHKLLKM----QRGRPLPEDQVWRFFIQIL 111
Query: 798 SAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKG 857
+ ++H ++H D+K N+ LD +GD G+AK LS + +
Sbjct: 112 LGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN--------FANT 160
Query: 858 IKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALP 917
I GT Y++PE + DV++ G++L E T + P D NQG + + R P
Sbjct: 161 IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN-NQGALILKIIRGVFP 219
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 1e-19
Identities = 63/223 (28%), Positives = 107/223 (47%), Gaps = 33/223 (14%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGA--SNGFVAECQALRNIRHRNLIKIITI 744
IG G FG V+ G VA+K I ++GA F+ E Q + + H L+++ +
Sbjct: 12 IGSGQFGLVWLGYW-LEKRKVAIKTI---REGAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 745 C---SSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIE 801
C S I +V+E+M++G L D+L + +L + + +DV +
Sbjct: 68 CTERSPI--------CLVFEFMEHGCLSDYLRAQRGKFSQETL-----LGMCLDVCEGMA 114
Query: 802 YIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGT 861
Y+ V+H DL N L+ ++ V + DFG+ +F+ LD + +SS G K
Sbjct: 115 YLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFV----LD---DQYTSSTGTKFP 164
Query: 862 VGYIAPEYGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFN 903
V + +PE + S DV+SFG+L+ E+F+ + P + N
Sbjct: 165 VKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN 207
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 63/222 (28%), Positives = 103/222 (46%), Gaps = 34/222 (15%)
Query: 687 IGQGSFGFVYKGNL-----GENGMMVAVKVINLKQKGAS----NGFVAECQALRNIRHRN 737
+GQGSFG VY+G GE VA+K +N + AS F+ E ++ +
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN---ENASMRERIEFLNEASVMKEFNCHH 70
Query: 738 LIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWL--HQSEDQQEAR--SLTLIQRINII 793
+++++ + S+ +V E M G L+ +L + E + TL + I +
Sbjct: 71 VVRLLGVVST-----GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMA 125
Query: 794 IDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPS 853
++A + Y+ VH DL N ++ +DL +GDFG+ + + ET
Sbjct: 126 AEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIY--------ETDY 174
Query: 854 SSKGIKGT--VGYIAPEYGMGGEASMTGDVYSFGILLLEMFT 893
KG KG V ++APE G + DV+SFG++L EM T
Sbjct: 175 YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 2e-19
Identities = 69/230 (30%), Positives = 113/230 (49%), Gaps = 35/230 (15%)
Query: 686 MIGQGSFGFVYKGNL---GENGMMVAVKVINL----KQKGASNGFVAECQALRNIRHRNL 738
+IG G FG V G L G+ + VA+K + KQ+ F++E + H N+
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR---RDFLSEASIMGQFDHPNI 67
Query: 739 IK---IITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIID 795
I ++T + IV EYM+NGSL+ +L + + Q T+IQ + ++
Sbjct: 68 IHLEGVVTKSKPV--------MIVTEYMENGSLDAFLRKHDGQ-----FTVIQLVGMLRG 114
Query: 796 VASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSS 855
+AS ++Y+ VH DL N+L++ +LV + DFGL++ L P E ++
Sbjct: 115 IASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-----EAAYTT 166
Query: 856 KGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLE-MFTRRRPTDGMFNQ 904
+G K + + APE + + DV+S+GI++ E M RP M NQ
Sbjct: 167 RGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ 216
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 63/217 (29%), Positives = 101/217 (46%), Gaps = 35/217 (16%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIR------HRNLIK 740
IG+G++G VYK G +VA+K I K + S G ALR I+ H N+IK
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKI--KLRFESEGI--PKTALREIKLLKELNHPNIIK 62
Query: 741 IITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAI 800
++ + F+ +V+E+M D +D+Q +LI+ + + + +
Sbjct: 63 LLDV-----FRHKGDLYLVFEFM----DTDLYKLIKDRQRGLPESLIK--SYLYQLLQGL 111
Query: 801 EYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKG 860
+ H H ++H DLKP N+L++ + V L DFGLA+ S T
Sbjct: 112 AFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV---RPYTHYVV----- 160
Query: 861 TVGYIAPE--YGMGGEASMTGDVYSFGILLLEMFTRR 895
T Y APE G G ++ D++S G + E+ +RR
Sbjct: 161 TRWYRAPELLLGDKGYSTPV-DIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 63/227 (27%), Positives = 101/227 (44%), Gaps = 29/227 (12%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVA-ECQALRNIRHRN 737
+D+ +IG G+ VY N VA+K I+L++ S + E QA+ H N
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60
Query: 738 LIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQS--EDQQEARSLTLIQRINIIID 795
++K S F D +V Y+ GSL D + S + + + + +
Sbjct: 61 VVK--YYTS---FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLK-----E 110
Query: 796 VASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSS 855
V +EY+H + Q +H D+K N+LL +D + DFG++ L D T
Sbjct: 111 VLKGLEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASL----ADGGDRTRKVR 163
Query: 856 KGIKGTVGYIAPE-----YGMGGEASMTGDVYSFGILLLEMFTRRRP 897
K GT ++APE +G +A D++SFGI +E+ T P
Sbjct: 164 KTFVGTPCWMAPEVMEQVHGYDFKA----DIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 4e-19
Identities = 62/234 (26%), Positives = 113/234 (48%), Gaps = 29/234 (12%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNL---GENGMMVAVKVINL----KQKGASNGFVAECQALR 731
+ + +IG G FG V++G L G + VA+K + KQ+ F++E +
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQR---QDFLSEASIMG 61
Query: 732 NIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRIN 791
H N+I++ + + FK I+ EYM+NG+L+ +L + + + Q +
Sbjct: 62 QFSHHNIIRLEGVVTK--FKPA---MIITEYMENGALDKYLRDHDGE-----FSSYQLVG 111
Query: 792 IIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVET 851
++ +A+ ++Y+ VH DL N+L++ +L + DFGL++ L P E
Sbjct: 112 MLRGIAAGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP-----EG 163
Query: 852 PSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFNQ 904
++ G K + + APE + + DV+SFGI++ E+ + RP M N
Sbjct: 164 TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH 217
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 88.0 bits (219), Expect = 7e-19
Identities = 63/225 (28%), Positives = 106/225 (47%), Gaps = 48/225 (21%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINL-KQKGASNG--FVA--ECQALRNIRHRNLIKI 741
+G+G++ VYK E G +VA+K I L ++K A +G F A E + L+ ++H N+I +
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 742 ITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIII---DVAS 798
+ + F +V+E+M+ LE +I+ +I++ D+ S
Sbjct: 68 LDV-----FGHKSNINLVFEFME-TDLE---------------KVIKDKSIVLTPADIKS 106
Query: 799 -------AIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVET 851
+EY+H + ++H DLKP+N+L+ D V L DFGLA+ S
Sbjct: 107 YMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN------R 157
Query: 852 PSSSKGIKGTVGYIAPEYGMGGEASMTG-DVYSFGILLLEMFTRR 895
+ + + T Y APE G G D++S G + E+ R
Sbjct: 158 KMTHQVV--TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (215), Expect = 2e-18
Identities = 49/165 (29%), Positives = 78/165 (47%), Gaps = 25/165 (15%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIR-------HRNLI 739
+G G+FG VY E G +VA+K +K+K S EC LR ++ H N++
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKK--MKKKFYS---WEECMNLREVKSLRKLNEHPNIV 61
Query: 740 KIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASA 799
K+ + F+ D V+EYM+ L+Q ++ + + +II +
Sbjct: 62 KLKEV-----FRENDELYFVFEYMEGN-----LYQLMKDRKGKPFSESVIRSIIYQILQG 111
Query: 800 IEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSP 844
+ +IH H H DLKP N+L+ V + DFGLA+ + S P
Sbjct: 112 LAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP 153
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 2e-18
Identities = 62/247 (25%), Positives = 112/247 (45%), Gaps = 52/247 (21%)
Query: 673 ELSKATNDFSSSNMIGQGSFGFVYKGNL---GENGMMVAVKVINLKQKGA---SNGFVAE 726
E+ + F +G+G+FG VYKG L E +V + LK+ F E
Sbjct: 1 EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58
Query: 727 CQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWL----------HQSE 776
+ + +++H N++ ++ +C+ K +++EY+ +G L ++L +S
Sbjct: 59 AELMSDLQHPNIVCLLGVCT----KEQPT-CMLFEYLAHGDLHEFLVRNSPHSDVGAESG 113
Query: 777 DQQEARSLTLIQRINIIIDVASAIEYIH-HHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835
D+ SL ++I I +A+ +EY+ HH VH DL N L+ + L + DFG
Sbjct: 114 DETVKSSLDCSDFLHIAIQIAAGMEYLSSHH----FVHRDLAARNCLVGEGLTVKISDFG 169
Query: 836 LA---------KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGI 886
L+ + S S L V ++ PE + G+ + D++SFG+
Sbjct: 170 LSRDIYSADYYRVQSKSLL---------------PVRWMPPEAILYGKFTTESDIWSFGV 214
Query: 887 LLLEMFT 893
+L E+F+
Sbjct: 215 VLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 63/229 (27%), Positives = 104/229 (45%), Gaps = 23/229 (10%)
Query: 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVI---NLKQKGASNGFVAECQALRNIR 734
+F IG+G F VYK +G +VA+K + + A + E L+ +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 735 HRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIII 794
H N+IK + S I+ ++ IV E G L + + Q+ R + +
Sbjct: 61 HPNVIKYLA--SFIENNELN---IVLELADAGDLSRMIKHFKKQK--RLIPERTIWKYFV 113
Query: 795 DVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSS 854
+ SA+E++H ++H D+KP+NV + V LGD GL +F SS +T ++
Sbjct: 114 QLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS-------KT-TA 162
Query: 855 SKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP--TDGM 901
+ + GT Y++PE + D++S G LL EM + P D M
Sbjct: 163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 3e-18
Identities = 65/219 (29%), Positives = 106/219 (48%), Gaps = 24/219 (10%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGAS-NGFVAECQALRNIRHRNLIKIITIC 745
+G G FG V+ G N VAVK LK S F+ E ++ ++H L+++ +
Sbjct: 14 LGAGQFGEVWMG-YYNNSTKVAVK--TLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 746 SSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHH 805
+ + I+ EYM GSL D+L E + L + I+ +A + YI
Sbjct: 71 TK-----EEPIYIITEYMAKGSLLDFL----KSDEGGKVLLPKLIDFSAQIAEGMAYIE- 120
Query: 806 HCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYI 865
+ +H DL+ +NVL+ + L+ + DFGLA+ + + ++ +G K + +
Sbjct: 121 --RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-------TAREGAKFPIKWT 171
Query: 866 APEYGMGGEASMTGDVYSFGILLLEMFTRRR-PTDGMFN 903
APE G ++ DV+SFGILL E+ T + P GM N
Sbjct: 172 APEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN 210
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 4e-18
Identities = 68/225 (30%), Positives = 110/225 (48%), Gaps = 33/225 (14%)
Query: 685 NMIGQGSFGFVYKGNL------GENGMMVAVKVINLKQKGASNG----FVAECQALRNIR 734
N +G G+FG VY+G G + VAVK + +KGA++ F+ E + N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTL---RKGATDQEKKEFLKEAHLMSNFN 57
Query: 735 HRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARS-LTLIQRINII 793
H N++K++ +C + Q I+ E M+ G L +L + ++ LTL + ++I
Sbjct: 58 HPNIVKLLGVCLL-----NEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDIC 112
Query: 794 IDVASAIEYIHHHCQPPVVHGDLKPSNVLL-----DQDLVAHLGDFGLAKFLSSSPLDTA 848
+DVA Y+ Q +H DL N L+ D D V +GDFGLA+ + S
Sbjct: 113 LDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDY--- 166
Query: 849 VETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT 893
+G V ++APE + G+ + DV+SFG+L+ E+ T
Sbjct: 167 --YRKEGEG-LLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 5e-18
Identities = 67/216 (31%), Positives = 97/216 (44%), Gaps = 29/216 (13%)
Query: 687 IGQGSFGFV----YKGNLGENGMMVAVKVINLKQKGASN--GFVAECQALRNIRHRNLIK 740
+G+G FG V Y G MVAVK + ++ G N G+ E L+ + H N++K
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLK-RECGQQNTSGWKKEINILKTLYHENIVK 70
Query: 741 IITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAI 800
CS KG+ ++ EY+ GSL D+L + L L Q + + +
Sbjct: 71 YKGCCSEQGGKGL---QLIMEYVPLGSLRDYLPKH-------KLNLAQLLLFAQQICEGM 120
Query: 801 EYIH--HHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGI 858
Y+H H+ +H DL NVLLD D + +GDFGLAK + V S
Sbjct: 121 AYLHSQHY-----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP-- 173
Query: 859 KGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTR 894
V + A E + S DV+SFG+ L E+ T
Sbjct: 174 ---VFWYAVECLKENKFSYASDVWSFGVTLYELLTH 206
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 9e-18
Identities = 62/224 (27%), Positives = 98/224 (43%), Gaps = 31/224 (13%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGA-SNGFVAECQALRNIRHRN 737
+D +G G+ G V K G ++AVK I L+ A + E L
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY 60
Query: 738 LIKIITICSSIDFKGVDFQ----AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINII 793
++ F G + +I EYM GSL+ L + + + R L I
Sbjct: 61 IV---------GFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIA 106
Query: 794 IDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPS 853
+ V + Y+H + ++H D+KPSN+L++ L DFG++ L +S T V
Sbjct: 107 VAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV---- 160
Query: 854 SSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897
GT Y+APE G + S+ D++S G+ L+E+ T R P
Sbjct: 161 ------GTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (210), Expect = 1e-17
Identities = 61/214 (28%), Positives = 105/214 (49%), Gaps = 29/214 (13%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGF----VAECQALRNIRHRNLIKII 742
+G+G++G VYK + G +VA+K I L + G + E L+ ++H N++K++
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNE--EEGIPSTALREISLLKELKHPNIVKLL 64
Query: 743 TICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEY 802
+ + +V+EY L+ +L + + S LI+ I + + + Y
Sbjct: 65 DVIHTERK-----LYLVFEYCDM-DLKKYLDK---RPGPLSPNLIKSI--MYQLLRGLAY 113
Query: 803 IHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTV 862
H H ++H DLKP N+L+++D V L DFGLA+ PL T + + T+
Sbjct: 114 CHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAF-GIPLRT------YTHEVV-TL 162
Query: 863 GYIAPEYGMGGEASMTG-DVYSFGILLLEMFTRR 895
Y APE +G + T D++S G + EM T +
Sbjct: 163 WYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 56/221 (25%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 686 MIGQGSFGFVYKGN---LGENGMM-VAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIK 740
++G G+FG VYKG GE + VA+KV+ + A+ + E + ++ H ++++
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 741 IITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAI 800
++ IC S ++ + M G L D++ +D ++ L +N + +A +
Sbjct: 74 LLGICLS------SQVQLITQLMPLGCLLDYVRNHKDNIGSQYL-----LNWCVQIAKGM 122
Query: 801 EYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKG 860
Y+ +VH DL NVL+ + DFGLAK L E ++G K
Sbjct: 123 SYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD------EKEYHAEGGKV 173
Query: 861 TVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDG 900
+ ++A E + + DV+S+G+ + E+ T +P +G
Sbjct: 174 PIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG 214
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 2e-17
Identities = 60/219 (27%), Positives = 109/219 (49%), Gaps = 26/219 (11%)
Query: 686 MIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHRNLIKIIT 743
++G+G+FG V+ + +V +K I ++Q K ECQ L+ + H N+I+
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 744 ICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRI-NIIIDVASAIEY 802
+ ++ K + IV EY G+L +++ Q+ SL I + + + A+ +
Sbjct: 67 --NFLEDKAL---MIVMEYAPGGTLAEYI-----QKRCNSLLDEDTILHFFVQILLALHH 116
Query: 803 IHHHCQPPVVHGDLKPSNVLLDQ-DLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGT 861
+H ++H DLK N+LLD+ +V +GDFG++K LSS S + + GT
Sbjct: 117 VHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK---------SKAYTVVGT 164
Query: 862 VGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDG 900
YI+PE G + D+++ G +L E+ + +R +
Sbjct: 165 PCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEA 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 62/278 (22%), Positives = 125/278 (44%), Gaps = 22/278 (7%)
Query: 681 FSSSNMIGQGSFGFVYKGNLG-ENGMMVAVKVINLKQKGASN----GFVAECQALRNIRH 735
++G+G FG V +G L ++G + V V +K + F++E +++ H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 736 RNLIKIITIC-SSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIII 794
N++K+I +C + + + ++ +M++G L +L S L L + ++
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 795 DVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSS 854
D+A +EY+ + +H DL N +L +D+ + DFGL+K + S D + +
Sbjct: 121 DIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSG--DYYRQGRIA 175
Query: 855 SKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFNQGLTLHEFAR 913
K V +IA E + DV++FG+ + E+ TR + P G+ N + +
Sbjct: 176 ----KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHG 231
Query: 914 TAL------PDKVMEIVDSVLLLEVQASNSRSCGDERL 945
L D++ +++ S + + + + E L
Sbjct: 232 NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVL 269
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 60/218 (27%), Positives = 91/218 (41%), Gaps = 32/218 (14%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVIN---LKQKGASNGFVAECQALRNIRHRNLIKIIT 743
+G+G FG V + G M A K ++ LK++ + E + L + R
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSR-----FI 55
Query: 744 ICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQ--QEARSLTLIQRINIIIDVASAIE 801
+ + F+ D +V M G L+ ++ + EAR++ +I +E
Sbjct: 56 VSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQI------ICGLE 109
Query: 802 YIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSK--GIK 859
++H Q +V+ DLKP NVLLD + D GLA VE K G
Sbjct: 110 HLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLA-----------VELKGGKKIKGRA 155
Query: 860 GTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897
GT GY+APE G + D ++ G L EM R P
Sbjct: 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 30/211 (14%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQK--GASNGFVAECQALRNIRHRNLIKIITI 744
IG+G+ G V+K E G VA+K + L++ G N + E +AL+ +H ++K++ +
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 745 CSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSED---QQEARSLTLIQRINIIIDVASAIE 801
G F +V EYM L + L E + + +S + + +
Sbjct: 68 FP----HGSGF-VLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRM--------LLKGVA 113
Query: 802 YIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGT 861
Y+H ++H DLKP+N+L+ D V + DFGLA+ S E P T
Sbjct: 114 YMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSE-------EEPRLYSHQVAT 163
Query: 862 VGYIAPEYGMGGEASMTG-DVYSFGILLLEM 891
Y APE G G D+++ G + E+
Sbjct: 164 RWYRAPELLYGARKYDPGVDLWAVGCIFAEL 194
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 3e-17
Identities = 61/219 (27%), Positives = 96/219 (43%), Gaps = 31/219 (14%)
Query: 686 MIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVA-----ECQALRNIRHRNLIK 740
++G GSFG VY+G ++G AVK ++L G + E L ++H N+++
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 741 II-TICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASA 799
+ T D I E + GSL L ++ S +
Sbjct: 67 YLGTEREE------DNLYIFLELVPGGSLAKLL------KKYGSFPEPVIRLYTRQILLG 114
Query: 800 IEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIK 859
+EY+H VH D+K +N+L+D + V L DFG+AK V S +K K
Sbjct: 115 LEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAK---------QVVEFSFAKSFK 162
Query: 860 GTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRRRP 897
G+ ++APE G + D++S G +LEM T + P
Sbjct: 163 GSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 3e-17
Identities = 66/242 (27%), Positives = 116/242 (47%), Gaps = 26/242 (10%)
Query: 686 MIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASN---------GFVAECQALRNIRHR 736
+IG GSFG VY G +G ++AVK + L AS+ E L+ ++H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 737 NLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDV 796
N+++ + SS+D D I EY+ GS+ L+ +E TL++ N + +
Sbjct: 67 NIVQYLG--SSLD---ADHLNIFLEYVPGGSVAALLNNYGAFEE----TLVR--NFVRQI 115
Query: 797 ASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSK 856
+ Y+H+ ++H D+K +N+L+D + DFG++K L ++ L T S
Sbjct: 116 LKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS- 171
Query: 857 GIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTAL 916
++G+V ++APE + D++S G L++EM T + P Q + + A
Sbjct: 172 -LQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC-TQLQAIFKIGENAS 229
Query: 917 PD 918
P+
Sbjct: 230 PE 231
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 5e-17
Identities = 66/226 (29%), Positives = 107/226 (47%), Gaps = 33/226 (14%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVI------NLKQKGASNGFVAECQALRNIRHRNLIK 740
IG+G+FG V+ G L + VAVK +LK K F+ E + L+ H N+++
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAK-----FLQEARILKQYSHPNIVR 57
Query: 741 IITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAI 800
+I +C+ K + IV E +Q G +L + E L + + I ++ + A+ +
Sbjct: 58 LIGVCTQ---KQPIY--IVMELVQGGDFLTFL-----RTEGPRLKVKELIQMVENAAAGM 107
Query: 801 EYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKG 860
EY+ +H DL N L+ + V + DFG+++ + +S+ G+K
Sbjct: 108 EYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSR-------EEEDGVYASTGGMKQ 157
Query: 861 T-VGYIAPEYGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFNQ 904
V + APE G S DV+SFGILL E F+ P + NQ
Sbjct: 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ 203
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 23/218 (10%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICS 746
+G G FG V+ ++ VAVK + F+AE ++ ++H L+K+ + +
Sbjct: 14 LGAGQFGEVWMATYNKH-TKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAVVT 71
Query: 747 SIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHH 806
I+ E+M GSL D+L E ++ L + I+ +A + +I
Sbjct: 72 KEPI------YIITEFMAKGSLLDFLKSDEGSKQP----LPKLIDFSAQIAEGMAFIE-- 119
Query: 807 CQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIA 866
Q +H DL+ +N+L+ LV + DFGLA+ + + ++ +G K + + A
Sbjct: 120 -QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-------TAREGAKFPIKWTA 171
Query: 867 PEYGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFN 903
PE G ++ DV+SFGILL+E+ T R P GM N
Sbjct: 172 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 209
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 56/221 (25%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 684 SNMIGQGSFGFVYKGNLGENGMMVAVK--VINLKQKGASNGFVAECQALRNIR---HRNL 738
IG+G++G VYK G VA+K + L ++G + E L+ + H N+
Sbjct: 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNI 63
Query: 739 IKIITICSSIDFKGVDFQAIVYEYMQNGSLEDW-LHQSEDQQEARSLTLIQRINIIIDVA 797
++++ +C +V+E++ D L + L +++ +
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHV------DQDLATYLSKCPKPGLPPETIKDLMRQLL 117
Query: 798 SAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSS-SPLDTAVETPSSSK 856
++++H H +VH DLKP N+L+ D + DFGLA+ S L + V
Sbjct: 118 RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV------ 168
Query: 857 GIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897
T+ Y APE + + D++S G + E+F RRRP
Sbjct: 169 ----TLWYRAPEVLLQSSYATPVDMWSVGCIFAELF-RRRP 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 2e-16
Identities = 63/225 (28%), Positives = 96/225 (42%), Gaps = 46/225 (20%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVIN----LKQKGASNGFVAECQALRNIR 734
+DF +G GSFG V +G A+K+++ +K K + + E + L++IR
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEH-VLNEKRILQSIR 59
Query: 735 HRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSE--DQQEARSLTLIQRINI 792
H L+ + F+ +V EY+ G L L +S + AR
Sbjct: 60 HPFLVNLYG-----SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYA------- 107
Query: 793 IIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETP 852
V A+EY+H +V+ DLKP N+LLD D + DFG AK +
Sbjct: 108 -AQVVLALEYLHS-LD--IVYRDLKPENLLLDSDGYIKITDFGFAKRV-----------K 152
Query: 853 SSSKGIKGTVGYIAPE------YGMGGEASMTGDVYSFGILLLEM 891
+ + GT Y+APE YG D ++ GIL+ EM
Sbjct: 153 GRTYTLCGTPEYLAPEIILSKGYG------KAVDWWALGILIYEM 191
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 62/228 (27%), Positives = 108/228 (47%), Gaps = 40/228 (17%)
Query: 686 MIGQGSFGFVYKGNLGENGMMVAVKVINL----------KQKGASNGFVAECQALRNIRH 735
+IG+G++G VY G M+AVK + L +QK +E + L+++ H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 736 RNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWL--HQSEDQQEARSLTLIQRINII 793
N+++ + ++ +I EY+ GS+ L + ++Q R T
Sbjct: 68 LNIVQYLGF-----ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTE------- 115
Query: 794 IDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPS 853
V + Y+H ++H DLK N+L+D D + + DFG++K S + + S
Sbjct: 116 -QVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISK--KSDDIYDNDQNMS 169
Query: 854 SSKGIKGTVGYIAPE----YGMGGEASMTGDVYSFGILLLEMFTRRRP 897
++G+V ++APE Y G A + D++S G ++LEMF RRP
Sbjct: 170 ----MQGSVFWMAPEVIHSYSQGYSAKV--DIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 67/224 (29%), Positives = 108/224 (48%), Gaps = 44/224 (19%)
Query: 686 MIGQGSFGFVYKGN---LGEN-GMMVAVKVINLKQKGASN--GFVAECQALRNIRHRNLI 739
+G+G+FG V L +N G +VAVK L+ A + F E + L++++H N++
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVK--KLQHSTAEHLRDFEREIEILKSLQHDNIV 68
Query: 740 KIITICSSIDFKGVDFQA------IVYEYMQNGSLEDWLHQSEDQQEARSLTLI-QRINI 792
K +KGV + A +V EY+ GSL D+L + ++ + R L L +I
Sbjct: 69 K---------YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICK 119
Query: 793 IIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDT---AV 849
++ + Y+H DL N+L++ + +GDFGL K L P D V
Sbjct: 120 GMEYLGSKRYVHR---------DLATRNILVESENRVKIGDFGLTKVL---PQDKEYYKV 167
Query: 850 ETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT 893
P S + + APE + S+ DV+SFG++L E+FT
Sbjct: 168 REPGESP-----IFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 3e-16
Identities = 63/232 (27%), Positives = 109/232 (46%), Gaps = 32/232 (13%)
Query: 681 FSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINL--KQKGASNGFVAECQALRNIRHRNL 738
F IG+G++G VYK G +VA+K I L + +G + + E L+ + H N+
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 739 IKIITICSSIDFKGVDFQA---IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIID 795
+K++ + + + +V+E++ + L+ ++ S L LI+ + +
Sbjct: 62 VKLLDVIHT--------ENKLYLVFEFL-HQDLKKFMDAS--PLSGIPLPLIK--SYLFQ 108
Query: 796 VASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSS 855
+ + + H H V+H DLKP N+L++ + L DFGLA+ P+ T
Sbjct: 109 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-- 162
Query: 856 KGIKGTVGYIAPEYGMGGEASMTG-DVYSFGILLLEMFTRRR--PTDGMFNQ 904
T+ Y APE +G + T D++S G + EM TRR P D +Q
Sbjct: 163 -----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 3e-16
Identities = 61/222 (27%), Positives = 109/222 (49%), Gaps = 30/222 (13%)
Query: 687 IGQGSFGFVYKG---NL--GENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKI 741
+G+G+FG V+ NL ++ M+VAVK + + A F E + L ++H+++++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 742 ITICSSIDFKGVDFQAIVYEYMQNGSLEDWLH----------QSEDQQEARSLTLIQRIN 791
+C+ +V+EYM++G L +L ED + LTL Q +
Sbjct: 73 YGVCTE-----GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQ-LTLGQMLA 126
Query: 792 IIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVET 851
I +AS + Y+ VH DL N L+ Q LV +GDFG+++ + S+ D
Sbjct: 127 IASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST--DYYRVG 181
Query: 852 PSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT 893
+ I+ ++ PE + + + D++SFG++L E+FT
Sbjct: 182 GRTMLPIR----WMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 3e-16
Identities = 74/230 (32%), Positives = 115/230 (50%), Gaps = 38/230 (16%)
Query: 681 FSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGF----VAECQALRNIRHR 736
F IG+G++G VYK + G +VA+K + L + GF + E + LR + HR
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE--KEGFPITAIREIKILRQLNHR 66
Query: 737 NLIKIITICS----SIDFKGVDFQA--IVYEYMQN---GSLEDWL-HQSEDQQEARSLTL 786
N++ + I + ++DFK D A +V+EYM + G LE L H SED ++ L
Sbjct: 67 NIVNLKEIVTDKQDALDFKK-DKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL 125
Query: 787 IQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLD 846
++ +N Y H + +H D+K SN+LL+ L DFGLA+ +S
Sbjct: 126 LEGLN----------YCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEE-- 170
Query: 847 TAVETPSSSKGIKGTVGYIAPEYGMGGEA-SMTGDVYSFGILLLEMFTRR 895
P ++K I T+ Y PE +G E DV+S G +L E+FT++
Sbjct: 171 ---SRPYTNKVI--TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 4e-16
Identities = 57/223 (25%), Positives = 93/223 (41%), Gaps = 40/223 (17%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGF---------VAECQALRNIRHRN 737
IG G++G V G VA+K I+ N F + E + LR++RH N
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKIS-------NVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 738 LIKIITICSSIDFKGVDFQA--IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIID 795
+I ++ I DF IV E M+ L + + + IQ +
Sbjct: 61 IIGLLDI--LRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDH----IQYF--LYQ 111
Query: 796 VASAIEYIH--HHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPS 853
+ ++Y+H + V+H DLKPSN+L++ + + DFGLA+ + + T
Sbjct: 112 ILRGLKYLHSAN-----VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEY 166
Query: 854 SSKGIKGTVGYIAPEYGMGGEASMTG-DVYSFGILLLEMFTRR 895
T Y APE + D++S G + E+ TR+
Sbjct: 167 VV-----TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-16
Identities = 68/227 (29%), Positives = 108/227 (47%), Gaps = 35/227 (15%)
Query: 686 MIGQGSFGFVYKGNLGENGMMVAVKVI------NLKQKGASNGFVAECQALRNIRHRNLI 739
++G+G+FG V+KG L ++ VAVK LK K F++E + L+ H N++
Sbjct: 2 LLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIK-----FLSEARILKQYDHPNIV 55
Query: 740 KIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASA 799
K+I +C+ IV E + G +L + +D+ L Q + +D A+
Sbjct: 56 KLIGVCTQ-----RQPIYIVMELVPGGDFLSFLRKKKDE-----LKTKQLVKFALDAAAG 105
Query: 800 IEYIH-HHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGI 858
+ Y+ +C +H DL N L+ ++ V + DFG+ S D + + S K I
Sbjct: 106 MAYLESKNC----IHRDLAARNCLVGENNVLKISDFGM-----SRQEDDGIYSSSGLKQI 156
Query: 859 KGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRR-PTDGMFNQ 904
+ + APE G S DV+S+GILL E F+ P GM NQ
Sbjct: 157 P--IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ 201
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 5e-16
Identities = 56/221 (25%), Positives = 109/221 (49%), Gaps = 22/221 (9%)
Query: 681 FSSSNMIGQGSFGFVYKGNLGE--NGMMVAVKVINLKQKGAS----NGFVAECQALRNIR 734
+ S+++ +G+FG ++ G L + G V V +K AS + E L +
Sbjct: 8 VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD-HASEIQVTLLLQESCLLYGLS 66
Query: 735 HRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSE--DQQEARSLTLIQRINI 792
H+N++ I+ +C + ++Y YM G+L+ +L Q + ++L+ Q +++
Sbjct: 67 HQNILPILHVCIE----DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHM 122
Query: 793 IIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETP 852
I +A + Y+H V+H D+ N ++D++L + D L++ L P+D
Sbjct: 123 AIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLF--PMDYHCLGD 177
Query: 853 SSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT 893
+ ++ +K ++A E + E S DV+SFG+LL E+ T
Sbjct: 178 NENRPVK----WMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 6e-16
Identities = 58/229 (25%), Positives = 94/229 (41%), Gaps = 50/229 (21%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNL 738
F+ IG+GSFG VYK +VA+KVI+L++ + + + +
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE---AEDEIED-----------I 46
Query: 739 IKIITICSSID-----------FKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLI 787
+ I S KG I+ EY GS D L + +
Sbjct: 47 QQEIQFLSQCRSPYITKYYGSFLKGSKL-WIIMEYCGGGSCLDLLKPGKLDETY------ 99
Query: 788 QRINIII-DVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSS--SP 844
I I+ +V +EY+H + +H D+K +N+LL ++ L DFG++ L+S S
Sbjct: 100 --IAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK 154
Query: 845 LDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT 893
+T V TP ++APE D++S GI +E+
Sbjct: 155 RNTFVGTPF----------WMAPEVIKQSGYDEKADIWSLGITAIELAK 193
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 8e-16
Identities = 62/222 (27%), Positives = 108/222 (48%), Gaps = 29/222 (13%)
Query: 687 IGQGSFGFVYKG---NLG--ENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKI 741
+G+G+FG V+ NL ++ M+VAVK + A F E + L N++H +++K
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 742 ITICSSIDFKGVDFQAIVYEYMQNGSLEDWLH----------QSEDQQEARSLTLIQRIN 791
+C D +V+EYM++G L +L + +Q L L Q ++
Sbjct: 73 YGVCGD-----GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 792 IIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVET 851
I +AS + Y+ VH DL N L+ +L+ +GDFG+++ + S+ D
Sbjct: 128 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYST--DYYRVG 182
Query: 852 PSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT 893
+ I+ ++ PE M + + DV+SFG++L E+FT
Sbjct: 183 GHTMLPIR----WMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 8e-16
Identities = 67/230 (29%), Positives = 98/230 (42%), Gaps = 54/230 (23%)
Query: 686 MIGQGSFGFVYKGNLGENGMMVAVKVINLK---------QKGASNGFVAECQALRNIRHR 736
+IG+G++G VY+G G +VA+K+INL Q+ E L +R
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQR--------EVALLSQLRQS 59
Query: 737 NLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRIN----- 791
I S KG I+ EY + GS+ R+L I
Sbjct: 60 QPPNITKYYGSY-LKGPRL-WIIMEYAEGGSV-------------RTLMKAGPIAEKYIS 104
Query: 792 -IIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVE 850
II +V A++YIH V+H D+K +N+L+ L DFG+A L+
Sbjct: 105 VIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ-------- 153
Query: 851 TPSSSKGIK--GTVGYIAPEYGMGGEASMT-GDVYSFGILLLEMFTRRRP 897
+SSK GT ++APE G+ T D++S GI + EM T P
Sbjct: 154 --NSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 9e-16
Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 26/209 (12%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGA--SNGFVAECQALRNIRHRNLIKIITI 744
+G G FG V+ G + VA+K IN +GA F+ E + + + H L+++ +
Sbjct: 12 LGSGQFGVVHLGKW-RAQIKVAIKAIN---EGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67
Query: 745 CSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIH 804
C K + IV E+M+NG L ++L Q + + L +++ DV +EY+
Sbjct: 68 C--TQQKPL---YIVTEFMENGCLLNYLRQRQGKLSKDML-----LSMCQDVCEGMEYLE 117
Query: 805 HHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGY 864
+ +H DL N L+ V + DFG+ +++ LD + +SS G K V +
Sbjct: 118 ---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYV----LD---DEYTSSSGAKFPVKW 167
Query: 865 IAPEYGMGGEASMTGDVYSFGILLLEMFT 893
PE + S DV+SFG+L+ E+FT
Sbjct: 168 SPPEVFNFSKYSSKSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 61/217 (28%), Positives = 104/217 (47%), Gaps = 20/217 (9%)
Query: 685 NMIGQGSFGFVYKGNLGENG---MMVAVKVIN-LKQKGASNGFVAECQALRNIRHRNLIK 740
+IG+G FG VY G L ++ + AVK +N + F+ E +++ H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 741 IITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAI 800
++ IC + +G +V YM++G L +++ + E + T+ I + VA +
Sbjct: 61 LLGIC--LPSEGSPL--VVLPYMKHGDLRNFI-----RSETHNPTVKDLIGFGLQVAKGM 111
Query: 801 EYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKG 860
EY+ VH DL N +LD+ + DFGLA+ + D + + G K
Sbjct: 112 EYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDI----YDKEYYSVHNHTGAKL 164
Query: 861 TVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897
V ++A E + + DV+SFG+LL E+ TR P
Sbjct: 165 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 201
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 61/217 (28%), Positives = 97/217 (44%), Gaps = 24/217 (11%)
Query: 686 MIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGAS-----NGFVAECQALRNIRHRNLIK 740
++GQG+FG VY + G +AVK + N E Q L+N++H +++
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 741 IITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAI 800
C D +I EYM GS++D L E + ++I +
Sbjct: 69 YYG-CLRDDET----LSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQI------LEGV 117
Query: 801 EYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKG 860
EY+H + +VH D+K +N+L D LGDFG +S L T + + K + G
Sbjct: 118 EYLHSN---MIVHRDIKGANILRDSAGNVKLGDFG-----ASKRLQTICSSGTGMKSVTG 169
Query: 861 TVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897
T +++PE G DV+S G ++EM T + P
Sbjct: 170 TPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 58/225 (25%), Positives = 99/225 (44%), Gaps = 35/225 (15%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNL 738
F +G+GS+G VYK E G +VA+KV+ + + + E L+ +
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYI 60
Query: 739 IKIITICSSIDFKGVDFQA----IVYEYMQNGSLEDWLHQSEDQQEARSLTLI-QRINII 793
+K + G F+ IV EY GS+ D + + + TL + I I
Sbjct: 61 VK---------YYGSYFKNTDLWIVMEYCGAGSVSDIM-------KITNKTLTEEEIAAI 104
Query: 794 I-DVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETP 852
+ +EY+H + +H D+K N+LL+++ A L DFG++ L +T
Sbjct: 105 LYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQL--------TDTM 153
Query: 853 SSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897
+ + GT ++APE + D++S GI +EM + P
Sbjct: 154 AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 63/227 (27%), Positives = 104/227 (45%), Gaps = 30/227 (13%)
Query: 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINL-----KQKGASNGFVAECQALRNIR 734
DF +G+GS+G VYK + A+K ++L K++ + V E + L ++
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDA---VNEIRILASVN 57
Query: 735 HRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRI-NII 793
H N+I + +D + IV EY G L + + +++ R L Q I I
Sbjct: 58 HPNIISYKE--AFLDGNKL---CIVMEYAPFGDLSKAISK---RKKKRKLIPEQEIWRIF 109
Query: 794 IDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPS 853
I + ++ +H ++H DLK +N+LL + + +GD G++K L + T + TP
Sbjct: 110 IQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPH 166
Query: 854 SSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDG 900
Y+APE G S D++S G LL EM T P +
Sbjct: 167 ----------YMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEA 203
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 59/222 (26%), Positives = 96/222 (43%), Gaps = 42/222 (18%)
Query: 686 MIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGAS------NGFVAECQALRNIRHRNLI 739
++G+G++G V K G +VA+K K K + + E + LR +RH N++
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIK----KFKESEDDEDVKKTALREVKVLRQLRHENIV 63
Query: 740 KIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASA 799
+ KG + +V+EY++ LE E ++ I + A
Sbjct: 64 NLKEAFRR---KGRLY--LVFEYVERTLLE----LLEASPGGLPPDAVRSY--IWQLLQA 112
Query: 800 IEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFL---SSSPLDTAVETPSSSK 856
I Y H H ++H D+KP N+L+ + V L DFG A+ L +SPL V
Sbjct: 113 IAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV------- 162
Query: 857 GIKGTVGYIAPEYGMGGEASMTG---DVYSFGILLLEMFTRR 895
T Y APE +G + G DV++ G ++ E+
Sbjct: 163 ---ATRWYRAPELLVG--DTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 4e-15
Identities = 65/235 (27%), Positives = 103/235 (43%), Gaps = 47/235 (20%)
Query: 681 FSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGAS---NGFVAECQALRNIRHRN 737
F+ IG GSFG VY +VA+K ++ K ++ + E + L+ +RH N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 738 LIKIITICSSIDFKGVDFQA----IVYEYMQNGSLEDWL--HQSEDQQEARSLTLIQRIN 791
+I++KG + +V EY GS D L H+ Q+ ++
Sbjct: 77 ---------TIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQE-------VEIAA 119
Query: 792 IIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVET 851
I + Y+H H + +H D+K N+LL + L DFG A + SP ++ V T
Sbjct: 120 ICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLV--SPANSFVGT 174
Query: 852 PSSSKGIKGTVGYIAPEYGMG-GEASMTG--DVYSFGILLLEMFTRRRPTDGMFN 903
P ++APE + E G DV+S GI +E+ R+ P +FN
Sbjct: 175 PY----------WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP---LFN 216
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 4e-15
Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 21/212 (9%)
Query: 687 IGQGSFGFV----YKGNLGENGMMVAVKVINLKQKGA-SNGFVAECQALRNIRHRNLIKI 741
+G+G FG V Y G VAVK + + G E + LRN+ H N++K
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 742 ITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIE 801
IC+ G+ ++ E++ +GSL+++L +++++ + L Q++ + + ++
Sbjct: 72 KGICTEDGGNGIK---LIMEFLPSGSLKEYLPRNKNK-----INLKQQLKYAVQICKGMD 123
Query: 802 YIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGT 861
Y+ VH DL NVL++ + +GDFGL K ++T E + +
Sbjct: 124 YLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK-----AIETDKEYYTVKDDLDSP 175
Query: 862 VGYIAPEYGMGGEASMTGDVYSFGILLLEMFT 893
V + APE + + + DV+SFG+ L E+ T
Sbjct: 176 VFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 5e-15
Identities = 61/247 (24%), Positives = 102/247 (41%), Gaps = 28/247 (11%)
Query: 680 DFSSSNMIGQGSFGFVYKG---NLGENGMMVAVKVINLKQKGA-SNGFVAECQALRNIRH 735
D + IG+G FG VY+G + + VAVK + F+ E +R H
Sbjct: 7 DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDH 66
Query: 736 RNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIID 795
+++K+I + + + IV E G L +L ++ + SL L
Sbjct: 67 PHIVKLIGVIT------ENPVWIVMELAPLGELRSYLQVNKYSLDLASLIL-----YSYQ 115
Query: 796 VASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSS 855
+++A+ Y+ VH D+ NVL+ LGDFGL+++L A S
Sbjct: 116 LSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKA------S 166
Query: 856 KGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFNQGLTLH--EFA 912
KG K + ++APE + DV+ FG+ + E+ +P G+ N +
Sbjct: 167 KG-KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE 225
Query: 913 RTALPDK 919
R +P
Sbjct: 226 RLPMPPN 232
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 1e-14
Identities = 64/222 (28%), Positives = 100/222 (45%), Gaps = 38/222 (17%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVA---------ECQALRNIRHRN 737
IG G++G V +G VA+K I + F E + LR+ +H N
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKI-------PHAFDVPTLAKRTLRELKILRHFKHDN 65
Query: 738 LIKIITICSSIDFKGVDFQAI--VYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIID 795
+I I I G DF+ + V + M++ LH + + I+ +
Sbjct: 66 IIAIRDILRP---PGADFKDVYVVMDLMESD-----LHHIIHSDQPLTEEHIRYF--LYQ 115
Query: 796 VASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLD-TAVETPSS 854
+ ++YIH V+H DLKPSN+L+++D +GDFG+A+ LSSSP + T
Sbjct: 116 LLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172
Query: 855 SKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRR 895
+ T Y APE + E + D++S G + EM RR
Sbjct: 173 A-----TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRR 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 63/227 (27%), Positives = 102/227 (44%), Gaps = 27/227 (11%)
Query: 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVK---VINLKQKGASNGFVAECQALRNIRHR 736
+F IG+G F VY+ +G+ VA+K + +L A + E L+ + H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 737 NLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINI---I 793
N+IK S I+ ++ IV E G L + + Q+ LI +
Sbjct: 63 NVIKYYA--SFIEDNELN---IVLELADAGDLSRMIKHFKKQKR-----LIPEKTVWKYF 112
Query: 794 IDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPS 853
+ + SA+E++H V+H D+KP+NV + V LGD GL +F SS +
Sbjct: 113 VQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--------TT 161
Query: 854 SSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDG 900
++ + GT Y++PE + D++S G LL EM + P G
Sbjct: 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 57/223 (25%), Positives = 96/223 (43%), Gaps = 25/223 (11%)
Query: 687 IGQGSFGFVYKG-NLGENGMMVAVKVINLKQKGASNG---FVAECQALRNIRHRNLIKII 742
+G G+FG V KG L ++G V V V LKQ+ + G F+ E + + H ++++I
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 743 TICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEY 802
+C +V E G L +L ++ R + + + VA + Y
Sbjct: 63 GVCKGEPL------MLVMELAPLGPLLKYL------KKRREIPVSDLKELAHQVAMGMAY 110
Query: 803 IHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTV 862
+ VH DL NVLL A + DFG+++ L + ++ + +
Sbjct: 111 LE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSR-----ALGAGSDYYRATTAGRWPL 162
Query: 863 GYIAPEYGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFNQ 904
+ APE G+ S DV+S+G+ L E F+ +P M
Sbjct: 163 KWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA 205
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 60/231 (25%), Positives = 100/231 (43%), Gaps = 47/231 (20%)
Query: 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK--QKGASNGFVAECQALRNIRHRN 737
D++ IG+G++G VYKG + G +VA+K I L+ ++G + + E L+ ++H N
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60
Query: 738 LIKIITICS------------SIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLT 785
++ + + S+D K +YM ++ +L+Q
Sbjct: 61 IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQ----------- 109
Query: 786 LIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPL 845
+ I + H V+H DLKP N+L+D V L DFGLA+ +
Sbjct: 110 ----------ILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFG---I 153
Query: 846 DTAVETPSSSKGIKGTVGYIAPEYGMGGEA-SMTGDVYSFGILLLEMFTRR 895
V T T+ Y APE +G S D++S G + EM T++
Sbjct: 154 PVRVYTHEVV-----TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 29/218 (13%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVIN---LKQKGASNGFVAECQALRNIRHRNLIKIIT 743
+G+G FG V + G + A K +N LK++ G + E + L + R ++ +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-- 58
Query: 744 ICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQ----QEARSLTLIQRINIIIDVASA 799
+ F+ +V M G L ++ +++ E R+ +I S
Sbjct: 59 ---AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQI------ISG 109
Query: 800 IEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIK 859
+E++H +++ DLKP NVLLD D + D GLA L + S +KG
Sbjct: 110 LEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELK--------DGQSKTKGYA 158
Query: 860 GTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897
GT G++APE G E + D ++ G+ L EM R P
Sbjct: 159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 65/234 (27%), Positives = 114/234 (48%), Gaps = 35/234 (14%)
Query: 687 IGQGSFGFVYKGNL-----GENGMMVAVKVIN----LKQKGASNGFVAECQALRNIRHRN 737
+GQGSFG VY+GN GE VAVK +N L+++ F+ E ++ +
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE---FLNEASVMKGFTCHH 70
Query: 738 LIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLH----QSEDQQEARSLTLIQRINII 793
+++++ + S KG +V E M +G L+ +L ++E+ TL + I +
Sbjct: 71 VVRLLGVVS----KGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 125
Query: 794 IDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPS 853
++A + Y++ VH DL N ++ D +GDFG+ + + ET
Sbjct: 126 AEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI--------YETDY 174
Query: 854 SSKGIKG--TVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQ 904
KG KG V ++APE G + + D++SFG++L E+ + +P G+ N+
Sbjct: 175 YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE 228
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 55/210 (26%), Positives = 89/210 (42%), Gaps = 28/210 (13%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICS 746
IG G++G VYK G +VA+KVI L+ E L+ RH N++
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFG--- 67
Query: 747 SIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHH 806
+ D IV EY GSL+D + + + R + + Y+H
Sbjct: 68 --SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCR-----ETLKGLAYLHET 120
Query: 807 CQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIA 866
+H D+K +N+LL +D L DFG++ L++ T + K GT ++A
Sbjct: 121 ---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTA--------TIAKRKSFIGTPYWMA 169
Query: 867 PEYGMGGEASMTG-----DVYSFGILLLEM 891
PE + G D+++ GI +E+
Sbjct: 170 PE--VAAVERKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 58/212 (27%), Positives = 91/212 (42%), Gaps = 24/212 (11%)
Query: 687 IGQGSFGFVYKG---NLGENGMMVAVKVI-NLKQKGASNGFVAECQALRNIRHRNLIKII 742
+G GSFG V +G G + VAVK + + K + F+ E + ++ H NLI++
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 743 TICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRI-NIIIDVASAIE 801
+ + +V E GSL D L + +A LI + + + +A+ +
Sbjct: 63 GVVLTHPLM------MVTELAPLGSLLDRLRK-----DALGHFLISTLCDYAVQIANGMR 111
Query: 802 YIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGT 861
Y+ +H DL N+LL D +GDFGL L + + +K
Sbjct: 112 YLE---SKRFIHRDLAARNILLASDDKVKIGDFGL-----MRALPQNEDHYVMEEHLKVP 163
Query: 862 VGYIAPEYGMGGEASMTGDVYSFGILLLEMFT 893
+ APE S DV+ FG+ L EMFT
Sbjct: 164 FAWCAPESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 26/218 (11%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVA--ECQALRNIRHRNLIKIITI 744
+G+G+FG E+ +V K +NL + A E L ++H N II
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPN---IIAY 64
Query: 745 CSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQ--QEARSLTLIQRINIIIDVASAIEY 802
+ I EY G+L D + + + Q +E + + + SA+ Y
Sbjct: 65 YNHFMDDNTLL--IEMEYANGGTLYDKIVRQKGQLFEEE------MVLWYLFQIVSAVSY 116
Query: 803 IHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTV 862
IH + ++H D+K N+ L + + LGDFG++K L S E S ++ + GT
Sbjct: 117 IH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGS-------EY-SMAETVVGTP 165
Query: 863 GYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDG 900
Y++PE G + + D+++ G +L E+ T +R D
Sbjct: 166 YYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 3e-14
Identities = 69/254 (27%), Positives = 115/254 (45%), Gaps = 43/254 (16%)
Query: 652 SAHKSSVSQLMDQQFPMISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKV 711
S+ SS S S +EL + N IG G+ G VYK G + A+KV
Sbjct: 54 SSSSSSSSASGSAPSAAKSLSELERV-------NRIGSGAGGTVYKVIHRPTGRLYALKV 106
Query: 712 INLKQKGA-SNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLED 770
I + E + LR++ H N++K C + + Q ++ E+M GSLE
Sbjct: 107 IYGNHEDTVRRQICREIEILRDVNHPNVVK----CHDMFDHNGEIQ-VLLEFMDGGSLEG 161
Query: 771 WLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAH 830
H +++Q A ++ + S I Y+H +VH D+KPSN+L++
Sbjct: 162 -THIADEQFLA---------DVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVK 208
Query: 831 LGDFGLAKFLSSS--PLDTAVETPSSSKGIKGTVGYIAPE-----YGMGGEASMTGDVYS 883
+ DFG+++ L+ + P +++V GT+ Y++PE G GD++S
Sbjct: 209 IADFGVSRILAQTMDPCNSSV----------GTIAYMSPERINTDLNHGAYDGYAGDIWS 258
Query: 884 FGILLLEMFTRRRP 897
G+ +LE + R P
Sbjct: 259 LGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 55/211 (26%), Positives = 104/211 (49%), Gaps = 22/211 (10%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINL-KQKGASNGFVAECQALRNIRHRNLIKIITIC 745
+G+G++ VYKG G +VA+K I+L ++G + + E ++ ++H N++++ +
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 746 SSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHH 805
+ + K + +V+EYM D + +L + + I + H
Sbjct: 68 HTEN-KLM----LVFEYMDK----DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 806 HCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYI 865
+ V+H DLKP N+L+++ L DFGLA+ P++T S++ + T+ Y
Sbjct: 119 N---RVLHRDLKPQNLLINKRGELKLADFGLARAF-GIPVNTF-----SNEVV--TLWYR 167
Query: 866 APEYGMGGEASMTG-DVYSFGILLLEMFTRR 895
AP+ +G T D++S G ++ EM T R
Sbjct: 168 APDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 60/225 (26%), Positives = 102/225 (45%), Gaps = 36/225 (16%)
Query: 685 NMIGQGSFGFVYKGN-LGENG----MMVAVKVINLKQKGASN-GFVAECQALRNIRHRNL 738
+G G+FG VY+G G +G + VAVK + F+ E + H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 739 IKIITICSSIDFKGVDFQA----IVYEYMQNGSLEDWLHQSEDQQEARS-LTLIQRINII 793
+++I GV F+ I+ E M G L+ +L ++ + E S LT+ +
Sbjct: 72 VRLI---------GVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCA 122
Query: 794 IDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQ---DLVAHLGDFGLAKFLSSSPLDTAVE 850
DVA +Y+ + +H D+ N LL VA + DFG+A+ + +
Sbjct: 123 RDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASY----- 174
Query: 851 TPSSSKGIKGT--VGYIAPEYGMGGEASMTGDVYSFGILLLEMFT 893
KG + + ++ PE + G + DV+SFG+LL E+F+
Sbjct: 175 ---YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 60/229 (26%), Positives = 97/229 (42%), Gaps = 49/229 (21%)
Query: 685 NMIGQGSFGFVYKGNLGENGMMVAVKVINL-------KQKGASNGFVAECQALRNIRHRN 737
+ +G+G+ G V K L GM+ A+K I KQ + E + ++ +
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQ------ILRELEINKSCKSPY 60
Query: 738 LIKIITIC-----SSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINI 792
++K SSI I EY + GSL+ ++ + +
Sbjct: 61 IVKYYGAFLDESSSSI--------GIAMEYCEGGSLDSIY------KKVKKRGGRIGEKV 106
Query: 793 IIDVASAI----EYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTA 848
+ +A ++ Y+H ++H D+KPSN+LL + L DFG++ L +S T
Sbjct: 107 LGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTF 163
Query: 849 VETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897
GT Y+APE G S+T DV+S G+ LLE+ R P
Sbjct: 164 T----------GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 4e-14
Identities = 64/234 (27%), Positives = 103/234 (44%), Gaps = 34/234 (14%)
Query: 686 MIGQGSFGFVYKGNLGENGMMVAVKVIN---LKQKGASNGFVAECQALRNIRHRNLIKII 742
+IG+G G VY VA+K I + F+ E + ++ H ++ +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 743 TICSSIDFKGVDFQAIVY---EYMQNGSLEDWLHQSEDQQEARSLTLIQR------INII 793
+ICS D VY Y++ +L+ L +S Q+E+ S L ++ ++I
Sbjct: 69 SICSDGD--------PVYYTMPYIEGYTLKSLL-KSVWQKESLSKELAEKTSVGAFLSIF 119
Query: 794 IDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSS-----SPLDTA 848
+ + IEY+H V+H DLKP N+LL + D+G A F +D
Sbjct: 120 HKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVD 176
Query: 849 VETPSSSK-----GIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897
S I GT Y+APE +G AS + D+Y+ G++L +M T P
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 56/230 (24%), Positives = 103/230 (44%), Gaps = 35/230 (15%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGF----VAECQALRNIR 734
+ + IGQG+FG V+K + +VA+K + ++ GF + E + L+ ++
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMEN--EKEGFPITALREIKILQLLK 69
Query: 735 HRNLIKIITICSSIDFKGVDFQAIVY------EYMQNGSLEDWLHQSEDQQEARSLTLIQ 788
H N++ +I IC + ++ Y E+ G L + TL +
Sbjct: 70 HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLL---------SNKNVKFTLSE 120
Query: 789 RINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTA 848
++ + + + YIH + ++H D+K +N+L+ +D + L DFGLA+ S S
Sbjct: 121 IKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNS-- 175
Query: 849 VETPSSSKGIKGTVGYIAPEYGMG----GEASMTGDVYSFGILLLEMFTR 894
P+ T+ Y PE +G G D++ G ++ EM+TR
Sbjct: 176 --KPNRYTNRVVTLWYRPPELLLGERDYGPPI---DMWGAGCIMAEMWTR 220
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 6e-14
Identities = 61/234 (26%), Positives = 111/234 (47%), Gaps = 43/234 (18%)
Query: 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNG---FVAECQALRNI-RH 735
D ++IG+G+FG V + + ++G+ + + LK+ + N F E + L + H
Sbjct: 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHH 62
Query: 736 RNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQS----------EDQQEARSLT 785
N+I ++ C + +G + AI EY G+L D+L +S ++ A +LT
Sbjct: 63 PNIINLLGACEN---RGYLYIAI--EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLT 117
Query: 786 LIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPL 845
Q + DVA+ ++Y+ + +H DL NVL+ ++L + + DFGL++
Sbjct: 118 SQQLLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR------- 167
Query: 846 DTAVETPSSSKGIKGTVGYIAPEYGMGGEA------SMTGDVYSFGILLLEMFT 893
+K T+G + P M E+ + DV+SFG+LL E+ +
Sbjct: 168 -------GEEVYVKKTMGRL-PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 7e-14
Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 31/214 (14%)
Query: 686 MIGQGSFGFVYKGNLGENGMMVAVKVI--NLKQKGASNGFVAECQALRNIRHRNLIKIIT 743
++G+GS+G V K E G +VA+K + K + E + L+ +RH NL+ +I
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 744 ICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYI 803
+ F+ +V+E++ + L+D E+R + + IE+
Sbjct: 68 V-----FRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVR------KYLFQILRGIEFC 116
Query: 804 HHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVG 863
H H ++H D+KP N+L+ Q V L DFG A+ L ++P + + + T
Sbjct: 117 HSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYTDYVA-------TRW 165
Query: 864 YIAPEYGMG----GEASMTGDVYSFGILLLEMFT 893
Y APE +G G A D+++ G L+ EM T
Sbjct: 166 YRAPELLVGDTKYGRAV---DIWAVGCLVTEMLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 9e-14
Identities = 65/230 (28%), Positives = 115/230 (50%), Gaps = 16/230 (6%)
Query: 681 FSSSNMIGQGSFGFVYKGNLG-ENGMM--VAVKVINLKQKGASN--GFVAECQALRNIRH 735
F+ M+G+G FG V + L E+G VAVK++ +S+ F+ E ++ H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 736 RNLIKIITICSSIDFKG-VDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIII 794
N+IK+I + KG + ++ +M++G L +L S +E +L L + +I
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 795 DVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSS 854
D+AS +EY+ +H DL N +L++++ + DFGL+K + S D + +S
Sbjct: 121 DIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSG--DYYRQGCAS 175
Query: 855 SKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFN 903
K V ++A E + DV++FG+ + E+ TR + P G+ N
Sbjct: 176 ----KLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN 221
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 60/224 (26%), Positives = 96/224 (42%), Gaps = 27/224 (12%)
Query: 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVK---VINLKQKGASNGFVAECQALRNIRHR 736
+F IG+G F VY+ + VA+K + + A V E L+ + H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 737 NLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINI---I 793
N+IK + F + IV E G L + + Q+ LI +
Sbjct: 63 NVIKYLD-----SFIEDNELNIVLELADAGDLSQMIKYFKKQKR-----LIPERTVWKYF 112
Query: 794 IDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPS 853
+ + SA+E++H V+H D+KP+NV + V LGD GL +F SS +
Sbjct: 113 VQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--------TT 161
Query: 854 SSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897
++ + GT Y++PE + D++S G LL EM + P
Sbjct: 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 57/216 (26%), Positives = 100/216 (46%), Gaps = 23/216 (10%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLK--QKGASNGFVAECQALRNIR---HRNLIKI 741
IG G++G VYK +G VA+K + ++ + G V E L+ + H N++++
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 742 ITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIE 801
+ +C++ +V+E++ L +L D+ L +++ ++
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQ-DLRTYL----DKVPPPGLPAETIKDLMRQFLRGLD 122
Query: 802 YIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGT 861
++H +C +VH DLKP N+L+ L DFGLA+ S T V T
Sbjct: 123 FLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV---------T 170
Query: 862 VGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897
+ Y APE + + D++S G + EMF RR+P
Sbjct: 171 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMF-RRKP 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 79/314 (25%), Positives = 137/314 (43%), Gaps = 67/314 (21%)
Query: 687 IGQGSFGFVYKGNLGENGM----MVAVKVI-NLKQKGASNGFVAECQALRNIRHRNLIKI 741
+G+ +FG +YKG+L GM +VA+K + ++ F E + + H N++ +
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 742 ITICSSIDFKGVDFQ----AIVYEYMQNGSLEDWL-----------HQSEDQQEARSLTL 786
+ GV Q +++EY+ G L ++L ED SL
Sbjct: 73 L---------GVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDH 123
Query: 787 IQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLD 846
++I I +A+ +EY+ H VH DL N+L+ + L + D GL++ + S+ D
Sbjct: 124 GDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSA--D 178
Query: 847 TAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQG 905
P S I+ ++ PE M G+ S D++SFG++L E+F+ +P G NQ
Sbjct: 179 YYRVQPKSLLPIR----WMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ- 233
Query: 906 LTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMES 965
+V+E+V LL S C R+ +++ C E
Sbjct: 234 -------------EVIEMVRKRQLLPC----SEDC-------PPRMYSLMTE---CWQEG 266
Query: 966 PTERMEMRDVVAKL 979
P+ R +D+ +L
Sbjct: 267 PSRRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 63/230 (27%), Positives = 104/230 (45%), Gaps = 37/230 (16%)
Query: 686 MIGQGSFGFVYKGNL---GENGMMVAVKVINLKQKGASN----GFVAECQALRNIRHRNL 738
++G G FG + +G L + + VA+ + + G S+ GF+AE L H N+
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTL---RAGCSDKQRRGFLAEALTLGQFDHSNI 68
Query: 739 IK---IITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIID 795
++ +IT +++ IV EYM NG+L+ +L + E Q L Q + ++
Sbjct: 69 VRLEGVITRGNTM--------MIVTEYMSNGALDSFLRKHEGQ-----LVAGQLMGMLPG 115
Query: 796 VASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSS 855
+AS ++Y+ + VH L VL++ DLV + F + + E ++
Sbjct: 116 LASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQ-------EDKSEAIYTT 165
Query: 856 KGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLE-MFTRRRPTDGMFNQ 904
K V + APE S DV+SFGI++ E M RP M Q
Sbjct: 166 MSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ 215
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 63/223 (28%), Positives = 99/223 (44%), Gaps = 46/223 (20%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHRNLIKIITI 744
IG+G++G VYK G +VA+K I L+ +G + + E L+ + H N+++++ +
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 745 CSS-------IDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVA 797
S +F +D + +YM + D +S L Q +
Sbjct: 67 VHSENKLYLVFEFLDLDLK----KYMDSSP-----LTGLDPPLIKSY-LYQLL------- 109
Query: 798 SAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDT----AVETPS 853
I Y H H V+H DLKP N+L+D++ L DFGLA+ P+ T V
Sbjct: 110 QGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTHEVV---- 161
Query: 854 SSKGIKGTVGYIAPEYGMGGEASMTG-DVYSFGILLLEMFTRR 895
T+ Y APE +G T D++S G + EM RR
Sbjct: 162 -------TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 3e-13
Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 27/207 (13%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICS 746
IGQG+ G VY G VA+K +NL+Q+ + E +R +H N++ +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLD--- 83
Query: 747 SIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHH 806
+ D +V EY+ GSL D + +E + + + R + A+E++H +
Sbjct: 84 --SYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCR-----ECLQALEFLHSN 134
Query: 807 CQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSK--GIKGTVGY 864
V+H D+K N+LL D L DFG A TP SK + GT +
Sbjct: 135 ---QVIHRDIKSDNILLGMDGSVKLTDFGFC----------AQITPEQSKRSTMVGTPYW 181
Query: 865 IAPEYGMGGEASMTGDVYSFGILLLEM 891
+APE D++S GI+ +EM
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEM 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 3e-13
Identities = 56/217 (25%), Positives = 96/217 (44%), Gaps = 22/217 (10%)
Query: 686 MIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGAS-----NGFVAECQALRNIRHRNLIK 740
++GQG+FG VY + G +A K + + + E Q L+N++H +
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHE---R 65
Query: 741 IITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAI 800
I+ + + I EYM GS++D L E+ + ++I +
Sbjct: 66 IVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQI------LEGM 119
Query: 801 EYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKG 860
Y+H + +VH D+K +N+L D LGDFG +S L T + + + + G
Sbjct: 120 SYLHSNM---IVHRDIKGANILRDSAGNVKLGDFG-----ASKRLQTICMSGTGIRSVTG 171
Query: 861 TVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897
T +++PE G DV+S G ++EM T + P
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 57/228 (25%), Positives = 101/228 (44%), Gaps = 33/228 (14%)
Query: 680 DFSSSN---MIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHR 736
++ + ++G+G++G VY + +A+K I + E ++HR
Sbjct: 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR 65
Query: 737 NLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDV 796
N+++ + S F F+ I E + GSL L + T+I I++
Sbjct: 66 NIVQYLGSDSENGF----FK-IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILE- 119
Query: 797 ASAIEYIHHHCQPPVVHGDLKPSNVLLDQ-DLVAHLGDFGLAKFLSSSPLDTAVETPSSS 855
++Y+H + +VH D+K NVL++ V + DFG +K L+ ++ ET
Sbjct: 120 --GLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG--INPCTET---- 168
Query: 856 KGIKGTVGYIAPEY------GMGGEASMTGDVYSFGILLLEMFTRRRP 897
GT+ Y+APE G G A D++S G ++EM T + P
Sbjct: 169 --FTGTLQYMAPEVIDKGPRGYGAPA----DIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 3e-13
Identities = 59/219 (26%), Positives = 108/219 (49%), Gaps = 26/219 (11%)
Query: 687 IGQGSFGFVYKG---NL--GENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKI 741
+G+G+FG V+ NL ++ ++VAVK + A F E + L N++H +++K
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 742 ITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQS-------EDQQEARSLTLIQRINIII 794
+C +G D +V+EYM++G L +L + LT Q ++I
Sbjct: 73 YGVC----VEG-DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 795 DVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSS 854
+A+ + Y+ VH DL N L+ ++L+ +GDFG+++ + S+ D +
Sbjct: 128 QIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYST--DYYRVGGHT 182
Query: 855 SKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT 893
I+ ++ PE M + + DV+S G++L E+FT
Sbjct: 183 MLPIR----WMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 71/267 (26%), Positives = 116/267 (43%), Gaps = 34/267 (12%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICS 746
IG+GS G V G VAVK ++L+++ E +R+ H N++ +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYN--- 86
Query: 747 SIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHH 806
+ D +V E+++ G+L D + + +E Q + + V A+ Y+H+
Sbjct: 87 --SYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-------QIATVCLSVLRALSYLHNQ 137
Query: 807 CQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIA 866
V+H D+K ++LL D L DFG +S E P K + GT ++A
Sbjct: 138 ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK-------EVP-KRKSLVGTPYWMA 186
Query: 867 PEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQ-GLTLHEFARTALPDKVMEI-- 923
PE D++S GI+++EM P FN+ L R LP +V +
Sbjct: 187 PEVISRLPYGTEVDIWSLGIMVIEMIDGEPP---YFNEPPLQAMRRIRDNLPPRVKDSHK 243
Query: 924 VDSVL-----LLEVQASNSRSCGDERL 945
V SVL L+ V+ + R+ E L
Sbjct: 244 VSSVLRGFLDLMLVREPSQRATAQELL 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 35/218 (16%)
Query: 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLI 739
+ IG+GS G V G VAVK ++L+++ E +R+ +H N
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPN-- 77
Query: 740 KIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASA 799
I+ + SS + D +V E+++ G+L D + + +E Q + + V A
Sbjct: 78 -IVEMYSS--YLVGDELWVVMEFLEGGALTDIVTHTRMNEE-------QIATVCLAVLKA 127
Query: 800 IEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIK 859
+ ++H V+H D+K ++LL D L DFG +S E P K +
Sbjct: 128 LSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK-------EVP-RRKSLV 176
Query: 860 GTVGYIAPE------YGMGGEASMTGDVYSFGILLLEM 891
GT ++APE YG E D++S GI+++EM
Sbjct: 177 GTPYWMAPEVISRLPYGT--EV----DIWSLGIMVIEM 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-13
Identities = 56/217 (25%), Positives = 102/217 (47%), Gaps = 24/217 (11%)
Query: 687 IGQGSFGFVYKG-NLGENGMMVAVKVINLK--QKGASNGFVAECQALRNIR---HRNLIK 740
IG+G++G V+K +L G VA+K + ++ ++G + E LR++ H N+++
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 741 IITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAI 800
+ +C+ +V+E++ L +L + + +++ + +
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIK----DMMFQLLRGL 123
Query: 801 EYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKG 860
+++H H VVH DLKP N+L+ L DFGLA+ S T+V
Sbjct: 124 DFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--------- 171
Query: 861 TVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897
T+ Y APE + + D++S G + EMF RR+P
Sbjct: 172 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKP 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-13
Identities = 60/235 (25%), Positives = 111/235 (47%), Gaps = 43/235 (18%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNG---FVAECQALRNI-R 734
ND ++IG+G+FG V K + ++G+ + + +K+ + + F E + L +
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 735 HRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSE----------DQQEARSL 784
H N+I ++ C + +G + AI EY +G+L D+L +S A +L
Sbjct: 67 HPNIINLLGAC---EHRGYLYLAI--EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 121
Query: 785 TLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSP 844
+ Q ++ DVA ++Y+ Q +H DL N+L+ ++ VA + DFGL++
Sbjct: 122 SSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR------ 172
Query: 845 LDTAVETPSSSKGIKGTVGYIAPEYGMGGEA------SMTGDVYSFGILLLEMFT 893
+K T+G + P M E+ + DV+S+G+LL E+ +
Sbjct: 173 --------GQEVYVKKTMGRL-PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 6e-13
Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 30/218 (13%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICS 746
+G G+FG VYK E G+ A K+I ++ + F+ E L +H N++ +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLY---E 69
Query: 747 SIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHH 806
+ ++ + I+ E+ G+L+ + + E R LT Q + + A+ ++H H
Sbjct: 70 AYFYENKLW--ILIEFCDGGALDSIMLELE-----RGLTEPQIRYVCRQMLEALNFLHSH 122
Query: 807 CQPPVVHGDLKPSNVLLDQDLVAHLGDFGL-AKFLSS-SPLDTAVETPSSSKGIKGTVGY 864
V+H DLK N+LL D L DFG+ AK S+ DT + TP +
Sbjct: 123 ---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPY----------W 169
Query: 865 IAPEYGMGGEASMT-----GDVYSFGILLLEMFTRRRP 897
+APE D++S GI L+E+ P
Sbjct: 170 MAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 6e-13
Identities = 36/85 (42%), Positives = 54/85 (63%)
Query: 473 LDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSI 532
L L L G +P ++ L++L N+S N G IP +L + TSL+ L L NSF+GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 533 PSSLSSLKSIKELDMSSNNLSGQIP 557
P SL L S++ L+++ N+LSG++P
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 7e-13
Identities = 63/226 (27%), Positives = 109/226 (48%), Gaps = 33/226 (14%)
Query: 686 MIGQGSFGFVYKGNL-----GENGMMVAVKVI--NLKQKGASNGFVAECQALRNI-RHRN 737
+G+G+FG V K VAVK++ + +K S+ V+E + ++ I +H+N
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSD-LVSEMEMMKMIGKHKN 77
Query: 738 LIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARS----------LTLI 787
+I ++ +C+ +G + +V EY +G+L D+L E S LT
Sbjct: 78 IINLLGVCTQ---EGPLY--VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQK 132
Query: 788 QRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDT 847
++ VA +E++ +H DL NVL+ +D V + DFGLA+ + +D
Sbjct: 133 DLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHH--IDY 187
Query: 848 AVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT 893
+T + +K ++APE + DV+SFG+LL E+FT
Sbjct: 188 YRKTTNGRLPVK----WMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 9e-13
Identities = 56/217 (25%), Positives = 96/217 (44%), Gaps = 22/217 (10%)
Query: 686 MIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGAS-----NGFVAECQALRNIRHRNLIK 740
++GQG+FG VY + G +AVK + + N E Q L+N+ H +++
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 741 IITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAI 800
+ + +I E+M GS++D L E + ++I +
Sbjct: 69 YYGCLRDPMERTL---SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI------LEGV 119
Query: 801 EYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKG 860
Y+H + +VH D+K +N+L D LGDFG +S L T + + K + G
Sbjct: 120 SYLHSNM---IVHRDIKGANILRDSVGNVKLGDFG-----ASKRLQTICLSGTGMKSVTG 171
Query: 861 TVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897
T +++PE G D++S G ++EM T + P
Sbjct: 172 TPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 9e-13
Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 30/211 (14%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLK-QKGASNGFVAECQALRNIRHRNLI---KII 742
+G+GS+ VYKG NG +VA+KVI++K ++G + E L+ ++H N++ II
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 743 TICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEY 802
++ F V+EYM L ++ Q ++ L + + + Y
Sbjct: 73 HTKETLTF--------VFEYMHT-DLAQYMIQHPGGLHPYNVRL-----FMFQLLRGLAY 118
Query: 803 IHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTV 862
IH ++H DLKP N+L+ L DFGLA+ S P T SS+ + T+
Sbjct: 119 IHGQ---HILHRDLKPQNLLISYLGELKLADFGLAR-AKSIPSQT-----YSSEVV--TL 167
Query: 863 GYIAPEYGMGG-EASMTGDVYSFGILLLEMF 892
Y P+ +G + S D++ G + +EM
Sbjct: 168 WYRPPDVLLGATDYSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-12
Identities = 36/85 (42%), Positives = 51/85 (60%)
Query: 376 LCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSI 435
L +D+ L G IP+ I +L++LQ + L N + G IP SLG++T L L LS N GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 436 PPSLGNCKNLIELHMADIELTGALP 460
P SLG +L L++ L+G +P
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 1e-12
Identities = 61/245 (24%), Positives = 101/245 (41%), Gaps = 52/245 (21%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVIN----LKQKGASNGFVAECQALRNIR 734
+DF +IG+G+FG V+ + G + A+KV+ +K+ ++ AE L +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH-VRAERDILADAD 59
Query: 735 HRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSE--DQQEARSLTLIQRINI 792
++K+ S F+ + +V EYM G L + L + + ++ AR
Sbjct: 60 SPWIVKLY--YS---FQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFY-------- 106
Query: 793 IIDVASAIEYIH--HHCQPPVVHGDLKPSNVLLDQDLVAH--LGDFGLAK---------- 838
I ++ A++ +H +H D+KP N+L+D D H L DFGL K
Sbjct: 107 IAELVLALDSVHKLGF-----IHRDIKPDNILIDAD--GHIKLADFGLCKKMNKAKDREY 159
Query: 839 -----FLSSSPLDTAVETPSSSKGIK------GTVGYIAPEYGMGGEASMTGDVYSFGIL 887
+ V + GT YIAPE G + D +S G++
Sbjct: 160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVI 219
Query: 888 LLEMF 892
L EM
Sbjct: 220 LYEML 224
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 54/223 (24%), Positives = 108/223 (48%), Gaps = 15/223 (6%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLK----QKGASNGFVAECQALRNIRHRNLIKII 742
+G+G FG V +G L ++ ++ V V +K + F++E ++ H N++++I
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 743 TIC-SSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIE 801
+C +++ +G ++ +M++G L +L S + L + + D+AS +E
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 802 YIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGT 861
Y+ +H DL N +L++++ + DFGL+K + + + + K
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNG------DYYRQGRIAKMP 177
Query: 862 VGYIAPEYGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFN 903
V +IA E + DV+SFG+ + E+ TR + P G+ N
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN 220
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 58/222 (26%), Positives = 110/222 (49%), Gaps = 26/222 (11%)
Query: 686 MIGQGSFGFVYKGNLGENG----MMVAVKVINLKQKGASN-GFVAECQALRNIRHRNLIK 740
++G G+FG VYKG G + VA+K++N +N F+ E + ++ H +L++
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 741 IITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAI 800
++ +C S + +V + M +G L D++H+ +D ++ L +N + +A +
Sbjct: 74 LLGVCLSPTIQ------LVTQLMPHGCLLDYVHEHKDNIGSQLL-----LNWCVQIAKGM 122
Query: 801 EYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKG 860
Y+ + +VH DL NVL+ + DFGLA+ L E ++ G K
Sbjct: 123 MYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD------EKEYNADGGKM 173
Query: 861 TVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGM 901
+ ++A E + + DV+S+G+ + E+ T +P DG+
Sbjct: 174 PIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI 215
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 55/219 (25%), Positives = 96/219 (43%), Gaps = 37/219 (16%)
Query: 686 MIGQGSFGFVYKGNLGENG----MMVAVKVINLKQKGASNGFVA---ECQALRNIRHRNL 738
++G G FG V+KG G + VA+K I + + F A+ ++ H +
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTI--QDRSGRQTFQEITDHMLAMGSLDHAYI 71
Query: 739 IKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVAS 798
++++ IC G Q +V + GSL D + Q D + + L +N + +A
Sbjct: 72 VRLLGICP-----GASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRL-----LNWCVQIAK 120
Query: 799 AIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSK-- 856
+ Y+ H +VH +L N+LL D + + DFG+A L P K
Sbjct: 121 GMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY----------PDDKKYF 167
Query: 857 --GIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT 893
K + ++A E + G + DV+S+G+ + EM +
Sbjct: 168 YSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-12
Identities = 39/122 (31%), Positives = 60/122 (49%), Gaps = 4/122 (3%)
Query: 40 WTGVTCG----HRHQRVTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIG 95
W+G C + L L N+ + G + + L L+ +NL+ N+ G IP +G
Sbjct: 404 WSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG 463
Query: 96 RLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIA 155
+ LE L L+ NSF+G IP +L + ++L N N+L G +PA LG L +
Sbjct: 464 SITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFT 523
Query: 156 DN 157
DN
Sbjct: 524 DN 525
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-12
Identities = 39/99 (39%), Positives = 55/99 (55%), Gaps = 2/99 (2%)
Query: 506 GEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSF 565
G IP +S LQ + L GNS G+IP SL S+ S++ LD+S N+ +G IPE L L+
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 566 LEYLNLSYNHFEGEVPTK--GVFSNKTGISLSGNGKVCG 602
L LNL+ N G VP G ++ + + N +CG
Sbjct: 492 LRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCG 530
|
Length = 623 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 62/234 (26%), Positives = 110/234 (47%), Gaps = 35/234 (14%)
Query: 687 IGQGSFGFVYKGNL-----GENGMMVAVKVINLKQKGASN----GFVAECQALRNIRHRN 737
+GQGSFG VY+G E VA+K +N + AS F+ E ++ +
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVN---EAASMRERIEFLNEASVMKEFNCHH 70
Query: 738 LIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSL----TLIQRINII 793
+++++ + S +G ++ E M G L+ +L + E + +L + I +
Sbjct: 71 VVRLLGVVS----QGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMA 125
Query: 794 IDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPS 853
++A + Y++ + VH DL N ++ +D +GDFG+ + + ET
Sbjct: 126 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI--------YETDY 174
Query: 854 SSKGIKG--TVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQ 904
KG KG V +++PE G + DV+SFG++L E+ T +P GM N+
Sbjct: 175 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE 228
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 53/199 (26%), Positives = 97/199 (48%), Gaps = 29/199 (14%)
Query: 706 MVAVKVINLK-QKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQ 764
+VAVK++ K A N F+ E + + +++ N+I+++ +C S D ++ EYM+
Sbjct: 46 LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVS-----DDPLCMITEYME 100
Query: 765 NGSLEDWLHQSEDQQE---ARSLTLIQRINII---IDVASAIEYIHHHCQPPVVHGDLKP 818
NG L +L Q E + A ++ + N++ + +AS ++Y+ VH DL
Sbjct: 101 NGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLAT 157
Query: 819 SNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKG----TVGYIAPEYGMGGE 874
N L+ + DFG+++ L S I+G + ++A E + G+
Sbjct: 158 RNCLVGNHYTIKIADFGMSRNLYS----------GDYYRIQGRAVLPIRWMAWESILLGK 207
Query: 875 ASMTGDVYSFGILLLEMFT 893
+ DV++FG+ L EMFT
Sbjct: 208 FTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 3e-12
Identities = 57/219 (26%), Positives = 101/219 (46%), Gaps = 27/219 (12%)
Query: 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK--GASNGFVAECQALRNIRHRN 737
+F N IG+G++G VY+ +G +VA+K + + + G + E L N+RH N
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 738 LIKIITICSSIDFKGVDFQAIVYEYMQN--GSLEDWLHQSEDQQEARSLTLIQRINIIID 795
++++ + K +D +V EY + SL D + + + + L L
Sbjct: 68 IVELKEVVVG---KHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLML--------Q 116
Query: 796 VASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSS 855
+ ++Y+H + ++H DLK SN+LL + DFGLA+ P +
Sbjct: 117 LLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA------KPMTP 167
Query: 856 KGIKGTVGYIAPEYGMGGEASMTG-DVYSFGILLLEMFT 893
K + T+ Y APE +G T D+++ G +L E+
Sbjct: 168 KVV--TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLA 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 3e-12
Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 25/213 (11%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHRNLIKIITI 744
IG+G++G VYK +A+K I L+Q +G + + E L+ ++H N++++ +
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 745 CSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIH 804
S + + +V+EY+ L+ H A++ LI+ + + I Y H
Sbjct: 70 VHS-EKR----LYLVFEYL---DLDLKKHMDSSPDFAKNPRLIK--TYLYQILRGIAYCH 119
Query: 805 HHCQPPVVHGDLKPSNVLLDQDLVA-HLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVG 863
H V+H DLKP N+L+D+ A L DFGLA+ P+ T T+
Sbjct: 120 SH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEVV-------TLW 168
Query: 864 YIAPEYGMGGEASMTG-DVYSFGILLLEMFTRR 895
Y APE +G T D++S G + EM ++
Sbjct: 169 YRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 4e-12
Identities = 87/287 (30%), Positives = 130/287 (45%), Gaps = 15/287 (5%)
Query: 292 KNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTD 351
NLE + + L L + L+ L + +
Sbjct: 40 SNLESVAVNRLALNLSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGS--ENLLNLLPLPS 97
Query: 352 IVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELK-NLQLLYLDSNFLAGG 410
+ + N++ I + L NL L +D+N +T IP IG LK NL+ L L N +
Sbjct: 98 LDLNLNRLRSNISE-LLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIES- 154
Query: 411 IPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLS 470
+P+ L NL L NL LS NDL +P L N NL L ++ +++ LPP+I +S L
Sbjct: 155 LPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALE 212
Query: 471 LSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSG 530
LDLS N + L + NLKNL +S N+ ++P ++ ++L+ L L N
Sbjct: 213 -ELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQ--I 267
Query: 531 SIPSSLSSLKSIKELDMSSNNLSGQIPE--YLENLSFLEYLNLSYNH 575
S SSL SL +++ELD+S N+LS +P L L L L
Sbjct: 268 SSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLK 314
|
Length = 394 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 57/217 (26%), Positives = 97/217 (44%), Gaps = 22/217 (10%)
Query: 686 MIGQGSFGFVYKGNLGENGMMVAVKVINL-----KQKGASNGFVAECQALRNIRHRNLIK 740
++G+G+FG VY + G +AVK + + N E Q L+N+RH +++
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 741 IITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAI 800
+ K + +I EYM GS++D L E + ++I +
Sbjct: 69 YYGCLRDPEEKKL---SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQI------LQGV 119
Query: 801 EYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKG 860
Y+H + +VH D+K +N+L D LGDFG +S + T + + K + G
Sbjct: 120 SYLHSNM---IVHRDIKGANILRDSAGNVKLGDFG-----ASKRIQTICMSGTGIKSVTG 171
Query: 861 TVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897
T +++PE G DV+S ++EM T + P
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 5e-12
Identities = 62/244 (25%), Positives = 115/244 (47%), Gaps = 43/244 (17%)
Query: 687 IGQGSFGFVYKGNL-----GENGMMVAVKVINLKQKGAS----NGFVAECQALRNIRHRN 737
IGQG+FG V++ E MVAVK++ ++ AS F E + H N
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKML---KEEASADMQADFQREAALMAEFDHPN 69
Query: 738 LIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWL-HQSEDQQEARS------------- 783
++K++ +C+ +++EYM G L ++L H+S Q + S
Sbjct: 70 IVKLLGVCAV-----GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 784 --LTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLS 841
L+ +++ I VA+ + Y+ + VH DL N L+ +++V + DFGL++ +
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181
Query: 842 SSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTR-RRPTDG 900
S+ A S + I + ++ PE + DV+++G++L E+F+ +P G
Sbjct: 182 SADYYKA----SENDAIP--IRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG 235
Query: 901 MFNQ 904
M ++
Sbjct: 236 MAHE 239
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 5e-12
Identities = 61/209 (29%), Positives = 88/209 (42%), Gaps = 26/209 (12%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVIN----LKQKGASNGFVAECQALRNIRHRNLIKII 742
IG+GSFG V +G AVKV+ LK+K + L+N++H L+ +
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 743 TICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEY 802
F+ D V +Y+ G L L + E R+ I ASA+ Y
Sbjct: 62 ----HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEI------ASALGY 111
Query: 803 IHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTV 862
+H +++ DLKP N+LLD L DFGL K +E ++ GT
Sbjct: 112 LH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK--------EGIEHSKTTSTFCGTP 160
Query: 863 GYIAPEYGMGGEASMTGDVYSFGILLLEM 891
Y+APE T D + G +L EM
Sbjct: 161 EYLAPEVLRKQPYDRTVDWWCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 5e-12
Identities = 55/220 (25%), Positives = 82/220 (37%), Gaps = 40/220 (18%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICS 746
I +G+FG VY G A+KV+ A N V +A R I
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQ-VTNVKAERAIMMIQGESPYVAKL 62
Query: 747 SIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRI---------NIIIDVA 797
F+ D+ +V EY+ G +LI+ + I +V
Sbjct: 63 YYSFQSKDYLYLVMEYLNGGDCA---------------SLIKTLGGLPEDWAKQYIAEVV 107
Query: 798 SAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKG 857
+E +H Q ++H D+KP N+L+DQ L DFGL++ K
Sbjct: 108 LGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSR---------NGLEN---KK 152
Query: 858 IKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897
GT Y+APE +G D +S G ++ E P
Sbjct: 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 6e-12
Identities = 61/235 (25%), Positives = 106/235 (45%), Gaps = 27/235 (11%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICS 746
IG+GS G V + +G +VAVK ++L+++ E +R+ +H N++++
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN--- 84
Query: 747 SIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHH 806
+ D +V E+++ G+L D + + +E Q + + V A+ +H
Sbjct: 85 --SYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-------QIAAVCLAVLKALSVLHAQ 135
Query: 807 CQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIA 866
V+H D+K ++LL D L DFG +S E P K + GT ++A
Sbjct: 136 ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-------EVP-RRKSLVGTPYWMA 184
Query: 867 PEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQ-GLTLHEFARTALPDKV 920
PE D++S GI+++EM P FN+ L + R LP K+
Sbjct: 185 PELISRLPYGPEVDIWSLGIMVIEMVDGEPP---YFNEPPLKAMKMIRDNLPPKL 236
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 7e-12
Identities = 60/216 (27%), Positives = 88/216 (40%), Gaps = 30/216 (13%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLK---QKGASNGFVAECQALRNIRHRNLIKIIT 743
+G G FG V + A+K + + + G +E + L H ++K+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59
Query: 744 ICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQ--SEDQQEARSLTLIQRINIIIDVASAIE 801
+ D K + + EY G L L D+ AR I V A E
Sbjct: 60 -RTFKDKKYIYM---LMEYCLGGELWTILRDRGLFDEYTARF--------YIACVVLAFE 107
Query: 802 YIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGT 861
Y+H+ +++ DLKP N+LLD + L DFG AK L S + GT
Sbjct: 108 YLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG---------QKTWTFCGT 155
Query: 862 VGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897
Y+APE + + D +S GILL E+ T R P
Sbjct: 156 PEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 8e-12
Identities = 66/247 (26%), Positives = 108/247 (43%), Gaps = 41/247 (16%)
Query: 681 FSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGF---VAECQALRNIRHRN 737
FS IG GSFG VY N +VA+K ++ K ++ + + E + L+ +RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 738 LIKIITICSSIDFKGVDFQA----IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINII 793
+I ++G + +V EY GS D L + + L ++ +
Sbjct: 77 ---------TIQYRGCYLREHTAWLVMEYCL-GSASDLL-----EVHKKPLQEVEIAAVT 121
Query: 794 IDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPS 853
+ Y+H H ++H D+K N+LL + + LGDFG A + +P + V TP
Sbjct: 122 HGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM--APANXFVGTPY 176
Query: 854 SSKGIKGTVGYIAPEYGMG---GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHE 910
++APE + G+ DV+S GI +E+ R+ P M N L+
Sbjct: 177 ----------WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYH 225
Query: 911 FARTALP 917
A+ P
Sbjct: 226 IAQNESP 232
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 8e-12
Identities = 62/224 (27%), Positives = 106/224 (47%), Gaps = 32/224 (14%)
Query: 687 IGQGSFGFVYKGNLGENGM-MVAVKVINL---------KQKGASNG-FVAECQALR-NIR 734
+G G+FG VYK NG ++A+K IN+ +++ S G V+E ++ +R
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 735 HRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIII 794
H N+++ F D IV + ++ L + H + +++ + T + NI +
Sbjct: 68 HPNIVRYYKT-----FLENDRLYIVMDLIEGAPLGE--HFNSLKEKKQRFTEERIWNIFV 120
Query: 795 DVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLS-SSPLDTAVETPS 853
+ A+ Y+H + +VH DL P+N++L +D + DFGLAK S L + V
Sbjct: 121 QMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVV---- 174
Query: 854 SSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897
GT+ Y PE DV++FG +L +M T + P
Sbjct: 175 ------GTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 9e-12
Identities = 56/237 (23%), Positives = 97/237 (40%), Gaps = 45/237 (18%)
Query: 674 LSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK---QKGASNGFVAECQAL 730
L T F +IG+G++G VYK + G +VA+K++++ ++ E L
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIK----EEYNIL 56
Query: 731 RNI-RHRNLIKIITICSSIDFKGVDFQA----------IVYEYMQNGSLEDWLHQSEDQQ 779
R H N+ F G + +V E GS+ D + +
Sbjct: 57 RKYSNHPNI---------ATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKG 107
Query: 780 EARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKF 839
+ I I+ + + Y+H + V+H D+K N+LL ++ L DFG+
Sbjct: 108 KRLKEEWIAY--ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV--- 159
Query: 840 LSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEA-----SMTGDVYSFGILLLEM 891
S+ LD+ + ++ GT ++APE E DV+S GI +E+
Sbjct: 160 --SAQLDSTLGRRNTF---IGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIEL 211
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 9e-12
Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 26/210 (12%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICS 746
+G G+FG VYK E G + A KVI K + ++ E + L H ++K++
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLL---G 76
Query: 747 SIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHH 806
+ + G I+ E+ G+++ + + + R LT Q I + A++Y+H
Sbjct: 77 AFYWDGK--LWIMIEFCPGGAVDAIMLELD-----RGLTEPQIQVICRQMLEALQYLH-- 127
Query: 807 CQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIA 866
++H DLK NVLL D L DFG++ V+T GT ++A
Sbjct: 128 -SMKIIHRDLKAGNVLLTLDGDIKLADFGVSA--------KNVKTLQRRDSFIGTPYWMA 178
Query: 867 PEYGMGGEASMT-----GDVYSFGILLLEM 891
PE M T D++S GI L+EM
Sbjct: 179 PEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 1e-11
Identities = 64/211 (30%), Positives = 93/211 (44%), Gaps = 26/211 (12%)
Query: 686 MIGQGSFGFVYKGNLGENGMMVAVKVIN----LKQKGASNGFVAECQALRNIRHRNLIKI 741
+IG+GSFG V +G AVKV+ LK+K ++ L+N++H L+ +
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 742 ITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIE 801
F+ + V +Y+ G L + H Q+E L R +VASAI
Sbjct: 62 -----HYSFQTAEKLYFVLDYVNGGEL--FFHL---QRERCFLEPRARF-YAAEVASAIG 110
Query: 802 YIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGT 861
Y+H +++ DLKP N+LLD L DFGL K VE ++ GT
Sbjct: 111 YLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK--------EGVEPEETTSTFCGT 159
Query: 862 VGYIAPEYGMGGEASMTGDVYSFGILLLEMF 892
Y+APE T D + G +L EM
Sbjct: 160 PEYLAPEVLRKEPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 75/275 (27%), Positives = 116/275 (42%), Gaps = 51/275 (18%)
Query: 686 MIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIIT-- 743
+IG+G FG VY + G M A+K ++ K+ G E AL R ++ +++
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG---ETLALN---ERIMLSLVSTG 54
Query: 744 -----ICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSE--DQQEARSLTLIQRINIIIDV 796
+C + F D + + M G L L Q ++E R ++
Sbjct: 55 DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYA--------TEI 106
Query: 797 ASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSK 856
+E++H+ VV+ DLKP+N+LLD+ + D GLA D + + P +S
Sbjct: 107 ILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA-------CDFSKKKPHAS- 155
Query: 857 GIKGTVGYIAPEYGMGGEA-SMTGDVYSFGILLLEMFTRRRPTDGMFNQGLT--LHEFAR 913
GT GY+APE G A + D +S G +L ++ P F Q T HE R
Sbjct: 156 --VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP----FRQHKTKDKHEIDR 209
Query: 914 TA------LPDKVMEIVDSVL--LLEVQASNSRSC 940
LPD + S+L LL+ S C
Sbjct: 210 MTLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGC 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 1e-11
Identities = 65/234 (27%), Positives = 103/234 (44%), Gaps = 40/234 (17%)
Query: 684 SNMIGQGSFGFVYKGNLGENGMMVAVKVINLK--QKGASNGFVAECQALRNIRHRNLIKI 741
S ++G G+ G V +G AVKV++++ + N AE L N +++K
Sbjct: 37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVK- 95
Query: 742 ITICSSIDF--------KGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRIN-- 791
C DF + V A+V +Y G L +QE +S R
Sbjct: 96 ---CHE-DFAKKDPRNPENVLMIALVLDYANAGDL---------RQEIKSRAKTNRTFRE 142
Query: 792 -----IIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLD 846
+ I V A+ ++H ++H D+K +N+LL + + LGDFG +K +++ D
Sbjct: 143 HEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSD 199
Query: 847 TAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDG 900
T GT Y+APE S D++S G+LL E+ T +RP DG
Sbjct: 200 DVGRT------FCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG 247
|
Length = 496 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 1e-11
Identities = 75/284 (26%), Positives = 118/284 (41%), Gaps = 52/284 (18%)
Query: 681 FSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGF---VAECQALRNIRHRN 737
F+ IG GSFG VY +VA+K ++ K ++ + + E + L+ I+H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 738 LIKIITICSSIDFKGVDFQA----IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINII 793
SI++KG + +V EY GS D L + + L ++ I
Sbjct: 87 ---------SIEYKGCYLREHTAWLVMEYCL-GSASDLL-----EVHKKPLQEVEIAAIT 131
Query: 794 IDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPS 853
+ Y+H H ++H D+K N+LL + L DFG A +SP ++ V TP
Sbjct: 132 HGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASI--ASPANSFVGTPY 186
Query: 854 SSKGIKGTVGYIAPEYGMG---GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHE 910
++APE + G+ DV+S GI +E+ R+ P M N L+
Sbjct: 187 ----------WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYH 235
Query: 911 FARTALP--------DKVMEIVDSVLLLEVQASNSRSCGDERLR 946
A+ P D VDS L + R +E L+
Sbjct: 236 IAQNESPTLQSNEWSDYFRNFVDSCLQ---KIPQDRPTSEELLK 276
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 59/218 (27%), Positives = 93/218 (42%), Gaps = 34/218 (15%)
Query: 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVK------VINLKQKGASNGFVAECQALRNI 733
D +G G+FG V+ + A+K VI LKQ+ + E + L+ +
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHN---EKRVLKEV 58
Query: 734 RHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINII 793
H +I++ + D + F ++ EY+ G L +L S + L I
Sbjct: 59 SHPFIIRLF--WTEHDQR---FLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEI--- 110
Query: 794 IDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPS 853
A+EY+H +V+ DLKP N+LLD++ L DFG AK L
Sbjct: 111 ---VCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLR-----------D 153
Query: 854 SSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEM 891
+ + GT Y+APE + D ++ GIL+ EM
Sbjct: 154 RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEM 191
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 62/228 (27%), Positives = 106/228 (46%), Gaps = 29/228 (12%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINL-----KQKGASNGFVAECQALRNIRHRNLIKI 741
IG+GSFG +Y + +K I+L K+K AS E L ++H N I
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASK---KEVILLAKMKHPN---I 61
Query: 742 ITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIE 801
+T +S G F IV EY G L + ++Q + Q ++ + ++ ++
Sbjct: 62 VTFFASFQENGRLF--IVMEYCDGGDL----MKRINRQRGVLFSEDQILSWFVQISLGLK 115
Query: 802 YIHHHCQPPVVHGDLKPSNVLLDQD-LVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKG 860
+IH ++H D+K N+ L ++ +VA LGDFG+A+ L+ ++ + G
Sbjct: 116 HIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN--------DSMELAYTCVG 164
Query: 861 TVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTL 908
T Y++PE + D++S G +L E+ T + P +G L L
Sbjct: 165 TPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVL 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-11
Identities = 63/227 (27%), Positives = 105/227 (46%), Gaps = 38/227 (16%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGA-SNGFVAECQALRNIRHRN 737
+DF + +G G+ G V K +G+++A K+I+L+ K A N + E Q L
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHE----- 59
Query: 738 LIKIITICSS---IDFKGVDFQ----AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRI 790
C+S + F G + +I E+M GSL+ L +EA+ +
Sbjct: 60 -------CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL------KEAKRIPEEILG 106
Query: 791 NIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVE 850
+ I V + Y+ Q ++H D+KPSN+L++ L DFG++ L S ++ V
Sbjct: 107 KVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV- 163
Query: 851 TPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897
GT Y++PE G S+ D++S G+ L+E+ R P
Sbjct: 164 ---------GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 61/248 (24%), Positives = 115/248 (46%), Gaps = 31/248 (12%)
Query: 687 IGQGSFGFVYKGNL-----GENGMMVAVKVINLKQKGA-SNGFVAECQALRNIRHRNLIK 740
+G+ FG VYKG+L GE VA+K + K +G F E ++H N++
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 741 IITICSSIDFKGVDFQAIVYEYMQNGSLEDWL----------HQSEDQQEARSLTLIQRI 790
++ + + ++++ Y + L ++L +D+ +L +
Sbjct: 73 LLGVVTK-----EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFV 127
Query: 791 NIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVE 850
+I+ +A+ +E++ H VVH DL NVL+ L + D GL + + ++ D
Sbjct: 128 HIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAA--DYYKL 182
Query: 851 TPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFNQGLTLH 909
+S I+ +++PE M G+ S+ D++S+G++L E+F+ +P G NQ +
Sbjct: 183 MGNSLLPIR----WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM 238
Query: 910 EFARTALP 917
R LP
Sbjct: 239 IRNRQVLP 246
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-11
Identities = 66/241 (27%), Positives = 104/241 (43%), Gaps = 41/241 (17%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGF---VAECQALRNIRHRNLIKIIT 743
IG GSFG VY +VAVK ++ K + + + E + L+ ++H N
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN------ 82
Query: 744 ICSSIDFKGVDFQA----IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASA 799
+I++KG + +V EY GS D L + + L ++ I
Sbjct: 83 ---TIEYKGCYLKEHTAWLVMEYCL-GSASDLL-----EVHKKPLQEVEIAAITHGALQG 133
Query: 800 IEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIK 859
+ Y+H H ++H D+K N+LL + L DFG A SSP ++ V TP
Sbjct: 134 LAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASK--SSPANSFVGTPY------ 182
Query: 860 GTVGYIAPEYGMG---GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTAL 916
++APE + G+ DV+S GI +E+ R+ P M N L+ A+
Sbjct: 183 ----WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNDS 237
Query: 917 P 917
P
Sbjct: 238 P 238
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 57/224 (25%), Positives = 96/224 (42%), Gaps = 32/224 (14%)
Query: 681 FSSSNMIGQGSFGFVYKGNLGENGMMVAVKVIN---LKQKGASNGFVAECQALRNIRHRN 737
F ++G+G FG V + G M A K + +K++ + + E Q L + R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 738 LIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQ--QEARSLTLIQRINIIID 795
++ + + ++ D +V M G L+ ++ + +E R+ + +
Sbjct: 62 VVSL-----AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRA------VFYAAE 110
Query: 796 VASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSS 855
+ +E +H Q +V+ DLKP N+LLD + D GLA V P
Sbjct: 111 ICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLA-----------VHVPEGQ 156
Query: 856 --KGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897
KG GTVGY+APE + + D ++ G LL EM + P
Sbjct: 157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 58/229 (25%), Positives = 108/229 (47%), Gaps = 43/229 (18%)
Query: 685 NMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNG---FVAECQALRNI-RHRNLIK 740
++IG+G+FG V K + ++G+ + + +K+ + + F E + L + H N+I
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 741 IITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSE----------DQQEARSLTLIQRI 790
++ C +G + AI EY +G+L D+L +S A +L+ Q +
Sbjct: 61 LLGACEH---RGYLYLAI--EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 115
Query: 791 NIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVE 850
+ DVA ++Y+ Q +H DL N+L+ ++ VA + DFGL++
Sbjct: 116 HFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR------------ 160
Query: 851 TPSSSKGIKGTVGYIAPEYGMGGEA------SMTGDVYSFGILLLEMFT 893
+K T+G + P M E+ + DV+S+G+LL E+ +
Sbjct: 161 --GQEVYVKKTMGRL-PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 26/210 (12%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICS 746
+G G+FG VYK E G++ A KVI+ K + ++ E L + H N++K++
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA-- 70
Query: 747 SIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHH 806
F + I+ E+ G+++ + + E R LT Q + A+ Y+H
Sbjct: 71 ---FYYENNLWILIEFCAGGAVDAVMLELE-----RPLTEPQIRVVCKQTLEALNYLH-- 120
Query: 807 CQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIA 866
+ ++H DLK N+L D L DFG++ T GT ++A
Sbjct: 121 -ENKIIHRDLKAGNILFTLDGDIKLADFGVSA--------KNTRTIQRRDSFIGTPYWMA 171
Query: 867 PEYGMGGEAS-----MTGDVYSFGILLLEM 891
PE M + DV+S GI L+EM
Sbjct: 172 PEVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 23/211 (10%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICS 746
IG+GS G V +G VAVK+++L+++ E +R+ +H+N++++
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY- 87
Query: 747 SIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHH 806
G + ++ E++Q G+L D + Q+ +E Q + V A+ Y+H
Sbjct: 88 ---LVGEELWVLM-EFLQGGALTDIVSQTRLNEE-------QIATVCESVLQALCYLHSQ 136
Query: 807 CQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIA 866
V+H D+K ++LL D L DFG +S + P K + GT ++A
Sbjct: 137 ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK-------DVP-KRKSLVGTPYWMA 185
Query: 867 PEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897
PE D++S GI+++EM P
Sbjct: 186 PEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 3e-11
Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 39/217 (17%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICS 746
IG+G+FG VY+ + + A+KV++ K+ VA+ + I RN++ +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKE------IVAKKEVAHTIGERNILVRTLLDE 54
Query: 747 SIDFKGVDFQ-------AIVYEYMQNGSLEDWLHQSE---DQQEARSLTLIQRINIIIDV 796
S G+ F +V +YM G L W Q E + A+ I ++
Sbjct: 55 SPFIVGLKFSFQTDSDLYLVTDYMSGGELF-WHLQKEGRFSEDRAKFY--------IAEL 105
Query: 797 ASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSK 856
A+E++H + +V+ DLKP N+LLD L DFGL+K T +T ++
Sbjct: 106 VLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSK-----ANLTDNKTTNT-- 155
Query: 857 GIKGTVGYIAPEYGMGGEASMTG--DVYSFGILLLEM 891
GT Y+APE + E T D +S G+L+ EM
Sbjct: 156 -FCGTTEYLAPEV-LLDEKGYTKHVDFWSLGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 56/228 (24%), Positives = 107/228 (46%), Gaps = 26/228 (11%)
Query: 680 DFSSSNMIGQGSFGFVYKGNL---GEN-GMMVAVKVINLKQKGASNGFVA-ECQALRNIR 734
+F ++G G+FG VYKG GE + VA+K + +N + E + ++
Sbjct: 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67
Query: 735 HRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIII 794
+ ++ +++ IC + + ++ + M G L D++ + +D ++ L +N +
Sbjct: 68 NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 116
Query: 795 DVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSS 854
+A + Y+ +VH DL NVL+ + DFGLAK L A E
Sbjct: 117 QIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL------GADEKEYH 167
Query: 855 SKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGM 901
++G K + ++A E + + DV+S+G+ + E+ T +P DG+
Sbjct: 168 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 215
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 4e-11
Identities = 57/219 (26%), Positives = 89/219 (40%), Gaps = 21/219 (9%)
Query: 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINL-KQKGASNGFVAECQALRNIRHRNL 738
++ ++G+GSFG + A+K I L K A E L ++H N
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPN- 59
Query: 739 IKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVAS 798
I+ S F+ IV EY G L Q Q + + + +
Sbjct: 60 --IVAFKES--FEADGHLYIVMEYCDGGDL----MQKIKLQRGKLFPEDTILQWFVQMCL 111
Query: 799 AIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGI 858
+++IH + V+H D+K N+ L Q+ LGDFG A+ L +SP A
Sbjct: 112 GVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLL-TSPGAYACT-------Y 160
Query: 859 KGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897
GT Y+ PE + D++S G +L E+ T + P
Sbjct: 161 VGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 4e-11
Identities = 62/227 (27%), Positives = 109/227 (48%), Gaps = 38/227 (16%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGA-SNGFVAECQALRNIRHRN 737
+DF + +G G+ G V+K + +G+++A K+I+L+ K A N + E Q L
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHE----- 59
Query: 738 LIKIITICSS---IDFKGVDFQ----AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRI 790
C+S + F G + +I E+M GSL+ L ++ E ++ ++
Sbjct: 60 -------CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE----QILGKV 108
Query: 791 NIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVE 850
+I V + Y+ + ++H D+KPSN+L++ L DFG++ L S ++ V
Sbjct: 109 SIA--VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV- 163
Query: 851 TPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897
GT Y++PE G S+ D++S G+ L+EM R P
Sbjct: 164 ---------GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 5e-11
Identities = 32/95 (33%), Positives = 56/95 (58%), Gaps = 1/95 (1%)
Query: 326 AIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTG 385
+GLD+ G +P+ I+ L + I ++GN I G IP + ++ +L L + N G
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRH-LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNG 480
Query: 386 TIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTL 420
+IP ++G+L +L++L L+ N L+G +P +LG L
Sbjct: 481 SIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLL 515
|
Length = 623 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 5e-11
Identities = 58/219 (26%), Positives = 111/219 (50%), Gaps = 33/219 (15%)
Query: 685 NMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGF----VAECQALRNIRHRNLIK 740
N I +G++G VY+ + G +VA+K + ++++ GF + E L ++H N++
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK--EGFPITSLREINILLKLQHPNIVT 68
Query: 741 IITICSSIDFKGVDFQAIVYEYMQNG--SLEDWLHQSEDQQEARSLTLIQRINIIIDVAS 798
+ + +D +V EY+++ SL + + Q Q E + L ++Q + S
Sbjct: 69 VKEVVVG---SNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCL-MLQ-------LLS 117
Query: 799 AIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA-KFLSSSPLDTAVETPSSSKG 857
+ ++H + ++H DLK SN+LL+ + + DFGLA ++ SPL P +
Sbjct: 118 GVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREY--GSPLK-----PYTQLV 167
Query: 858 IKGTVGYIAPEYGMGGEASMTG-DVYSFGILLLEMFTRR 895
+ T+ Y APE +G + T D++S G + E+ T++
Sbjct: 168 V--TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 6e-11
Identities = 35/93 (37%), Positives = 52/93 (55%), Gaps = 1/93 (1%)
Query: 100 LEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHL 159
++ L L N G IP ++S+ +L S N N++ G IP LG + LE L ++ N
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG-SITSLEVLDLSYNSF 478
Query: 160 TGHFPASIGNLSTLERINVLGNGLWGRIPNNLG 192
G P S+G L++L +N+ GN L GR+P LG
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 6e-11
Identities = 47/165 (28%), Positives = 79/165 (47%), Gaps = 32/165 (19%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVK---------VINLKQKGASNGFVAECQALRNIRHRN 737
IG+GS+G V+K E G +VA+K VI +K A + E + L+ ++H N
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVI---KKIA----LREIRMLKQLKHPN 61
Query: 738 LIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVA 797
L+ +I + F+ +V+EY + L +E ++ R + II
Sbjct: 62 LVNLIEV-----FRRKRKLHLVFEYCDHTVL------NELEKNPRGVPEHLIKKIIWQTL 110
Query: 798 SAIEYIH-HHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLS 841
A+ + H H+C +H D+KP N+L+ + L DFG A+ L+
Sbjct: 111 QAVNFCHKHNC----IHRDVKPENILITKQGQIKLCDFGFARILT 151
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 60/228 (26%), Positives = 102/228 (44%), Gaps = 36/228 (15%)
Query: 681 FSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIK 740
F+ IG+GSFG V+KG +VA+K+I+L++ AE + +I+ I
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--------AE-DEIEDIQQE--IT 54
Query: 741 IITICSS---IDFKGVDFQA----IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINII 793
+++ C S + G + I+ EY+ GS D L A Q ++
Sbjct: 55 VLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLL-------RAGPFDEFQIATML 107
Query: 794 IDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPS 853
++ ++Y+H + +H D+K +NVLL + L DFG+A L+ DT ++ +
Sbjct: 108 KEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLT----DTQIKRNT 160
Query: 854 SSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGM 901
GT ++APE D++S GI +E+ P M
Sbjct: 161 ----FVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 64.4 bits (156), Expect = 6e-11
Identities = 62/243 (25%), Positives = 106/243 (43%), Gaps = 30/243 (12%)
Query: 657 SVSQLMDQQFPMISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ 716
S +++++ ++S + K F IGQG+ G VY G VA++ +NL+Q
Sbjct: 1 SDEEILEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQ 57
Query: 717 KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSE 776
+ + E +R ++ N++ + + D +V EY+ GSL D + +E
Sbjct: 58 QPKKELIINEILVMRENKNPNIVNYLD-----SYLVGDELWVVMEYLAGGSLTDVV--TE 110
Query: 777 DQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836
+ + + R + A+E++H + V+H D+K N+LL D L DFG
Sbjct: 111 TCMDEGQIAAVCR-----ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGF 162
Query: 837 AKFLSSSPLDTAVETPSSSK--GIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTR 894
A TP SK + GT ++APE D++S GI+ +EM
Sbjct: 163 C----------AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212
Query: 895 RRP 897
P
Sbjct: 213 EPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 7e-11
Identities = 63/225 (28%), Positives = 105/225 (46%), Gaps = 36/225 (16%)
Query: 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLI 739
DF +G G+ G V K +G+++A K+I+L+ K A+RN R L
Sbjct: 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK----------PAIRNQIIREL- 50
Query: 740 KIITICSS---IDFKGVDFQ----AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINI 792
K++ C+S + F G + +I E+M GSL+ L ++A + I
Sbjct: 51 KVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL------KKAGRIPENILGKI 104
Query: 793 IIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETP 852
I V + Y+ + ++H D+KPSN+L++ L DFG++ L S ++ V
Sbjct: 105 SIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV--- 159
Query: 853 SSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897
GT Y++PE G ++ D++S G+ L+EM R P
Sbjct: 160 -------GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 7e-11
Identities = 63/239 (26%), Positives = 105/239 (43%), Gaps = 40/239 (16%)
Query: 677 ATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVK-VINLKQKGASNGF----VAECQALR 731
D+ +G+G+FG VYK + G +VA+K ++ +K +GF + E + L+
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK---DGFPITALREIKILK 62
Query: 732 NIRHRNLIKIITICSSIDFKGVDFQAIVY---EYMQ---NGSLEDWLHQSEDQQEARSLT 785
++H N++ +I + K + VY YM +G LE+ + LT
Sbjct: 63 KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLEN---------PSVKLT 113
Query: 786 LIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPL 845
Q ++ + I Y+H + ++H D+K +N+L+D + + DFGLA+ P
Sbjct: 114 ESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLAR-----PY 165
Query: 846 DTAVETPSSSKGIKG--------TVGYIAPEYGMGGEASMTG-DVYSFGILLLEMFTRR 895
D P G T Y PE +G T D++ G + EMFTRR
Sbjct: 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 8e-11
Identities = 32/82 (39%), Positives = 50/82 (60%), Gaps = 1/82 (1%)
Query: 455 LTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSA 514
L G +P I + L S++LS N + G +P +G++ +L ++S N F+G IP +L
Sbjct: 430 LRGFIPNDISKLRHLQ-SINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQ 488
Query: 515 CTSLQQLYLQGNSFSGSIPSSL 536
TSL+ L L GNS SG +P++L
Sbjct: 489 LTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 8e-11
Identities = 60/218 (27%), Positives = 102/218 (46%), Gaps = 36/218 (16%)
Query: 681 FSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIK 740
F+ IG+GSFG VYKG +VA+K+I+L++ AE + +I+ I
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--------AE-DEIEDIQQE--IT 54
Query: 741 IITICSS---IDFKGVDFQA----IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINII 793
+++ C S + G + I+ EY+ GS D L + +E T+++ I
Sbjct: 55 VLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLL-KPGPLEETYIATILREI--- 110
Query: 794 IDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPS 853
++Y+H + +H D+K +NVLL + L DFG+A L+ DT ++ +
Sbjct: 111 ---LKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLT----DTQIKRNT 160
Query: 854 SSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEM 891
GT ++APE D++S GI +E+
Sbjct: 161 ----FVGTPFWMAPEVIKQSAYDFKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 8e-11
Identities = 61/222 (27%), Positives = 98/222 (44%), Gaps = 37/222 (16%)
Query: 686 MIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIIT-- 743
+IG+G FG VY + G M A+K ++ K+ G E AL R ++ +++
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG---ETLALN---ERIMLSLVSTG 54
Query: 744 -----ICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSE--DQQEARSLTLIQRINIIIDV 796
+C S F D + + + M G L L Q + E R ++
Sbjct: 55 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYA--------AEI 106
Query: 797 ASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSK 856
+E++H+ VV+ DLKP+N+LLD+ + D GLA D + + P +S
Sbjct: 107 ILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA-------CDFSKKKPHAS- 155
Query: 857 GIKGTVGYIAPEYGMGGEA-SMTGDVYSFGILLLEMFTRRRP 897
GT GY+APE G A + D +S G +L ++ P
Sbjct: 156 --VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 9e-11
Identities = 34/85 (40%), Positives = 48/85 (56%), Gaps = 1/85 (1%)
Query: 357 NQ-ISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSL 415
NQ + G IP I L +L + + N + G IP ++G + +L++L L N G IP SL
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486
Query: 416 GNLTLLTNLALSSNDLQGSIPPSLG 440
G LT L L L+ N L G +P +LG
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 67/234 (28%), Positives = 101/234 (43%), Gaps = 42/234 (17%)
Query: 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLI 739
D ++G G+ G VYK ++AVKVI L E Q + I +
Sbjct: 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLD-------ITVELQ--KQIMSE--L 50
Query: 740 KIITICSS---IDFKGVDFQ----AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINI 792
+I+ C S I F G F +I E+M GSL+ + E ++ RI +
Sbjct: 51 EILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEH--------VLGRIAV 102
Query: 793 IIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETP 852
V + Y+ ++H D+KPSN+L++ L DFG++ L +S T V
Sbjct: 103 A--VVKGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV--- 154
Query: 853 SSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMF-NQG 905
GT Y+APE G + + DV+S GI +E+ R P + NQG
Sbjct: 155 -------GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQG 201
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 64.1 bits (157), Expect = 1e-10
Identities = 66/227 (29%), Positives = 102/227 (44%), Gaps = 49/227 (21%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVI-----NLKQKGASNGF--VAECQALRNIRHRNLI 739
+G+G++G V+K +VA+K I N A F + Q L + H N++
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRN--ATDAQRTFREIMFLQELGD--HPNIV 70
Query: 740 KIITICSSIDFKGVDFQAI--VYEYM--------QNGSLEDWLHQSEDQQEARSLTLIQR 789
K++ + K + + I V+EYM + LED + +
Sbjct: 71 KLLNV-----IKAENDKDIYLVFEYMETDLHAVIRANILED----------------VHK 109
Query: 790 INIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAV 849
I+ + A++YIH V+H DLKPSN+LL+ D L DFGLA+ LS L+
Sbjct: 110 RYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE--LEENP 164
Query: 850 ETPSSSKGIKGTVGYIAPEYGMGGEASMTG-DVYSFGILLLEMFTRR 895
E P + + T Y APE +G G D++S G +L EM +
Sbjct: 165 ENPVLTDYV-ATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 47/199 (23%), Positives = 98/199 (49%), Gaps = 28/199 (14%)
Query: 705 MMVAVKVINLK-QKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYM 763
++VAVK++ K A N F+ E + + ++ N+I+++ +C + D ++ EYM
Sbjct: 47 VLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCIT-----SDPLCMITEYM 101
Query: 764 QNGSLEDWL--HQSED---QQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKP 818
+NG L +L H+ ++ + + +++ I + +AS ++Y+ VH DL
Sbjct: 102 ENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLAT 158
Query: 819 SNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKG----TVGYIAPEYGMGGE 874
N L+ ++ + DFG+++ L S I+G + +++ E + G+
Sbjct: 159 RNCLVGKNYTIKIADFGMSRNLYS----------GDYYRIQGRAVLPIRWMSWESILLGK 208
Query: 875 ASMTGDVYSFGILLLEMFT 893
+ DV++FG+ L E+ T
Sbjct: 209 FTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 1e-10
Identities = 58/222 (26%), Positives = 97/222 (43%), Gaps = 28/222 (12%)
Query: 686 MIGQGSFGFVYKGNLGENGMMVAVKVIN---LKQKGASNGFVAECQALRNIRHRNLIKII 742
++G+G+FG V +G A+K++ + K + E + L+N RH L +
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL- 60
Query: 743 TICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEY 802
F+ D V EY+ G L + H S ++ + T I+ SA++Y
Sbjct: 61 ----KYSFQTKDRLCFVMEYVNGGEL--FFHLSRERVFSEDRTRFYGAEIV----SALDY 110
Query: 803 IHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTV 862
+H +V+ DLK N++LD+D + DFGL K + ++ K GT
Sbjct: 111 LH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCK--------EGITDAATMKTFCGTP 159
Query: 863 GYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQ 904
Y+APE + D + G+++ EM R P +NQ
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP---FYNQ 198
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 1e-10
Identities = 60/218 (27%), Positives = 100/218 (45%), Gaps = 36/218 (16%)
Query: 681 FSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIK 740
F+ IG+GSFG V+KG +VA+K+I+L++ AE + +I+ I
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--------AE-DEIEDIQQE--IT 54
Query: 741 IITICSS---IDFKGVDFQA----IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINII 793
+++ C S + G + I+ EY+ GS D L E L Q I+
Sbjct: 55 VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-------EPGPLDETQIATIL 107
Query: 794 IDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPS 853
++ ++Y+H + +H D+K +NVLL + L DFG+A L+ DT ++
Sbjct: 108 REILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLT----DTQIK--- 157
Query: 854 SSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEM 891
GT ++APE D++S GI +E+
Sbjct: 158 -RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 62/240 (25%), Positives = 107/240 (44%), Gaps = 30/240 (12%)
Query: 660 QLMDQQFPMISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGA 719
++M++ ++S + K ++ IGQG+ G V+ G VA+K INL+++
Sbjct: 3 EIMEKLRTIVSIGDPKK---KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPK 59
Query: 720 SNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQ 779
+ E ++ +++ N++ + F D +V EY+ GSL D + +E
Sbjct: 60 KELIINEILVMKELKNPNIVNFLD-----SFLVGDELFVVMEYLAGGSLTDVV--TETCM 112
Query: 780 EARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKF 839
+ + + R + A+E++H + V+H D+K NVLL D L DFG
Sbjct: 113 DEAQIAAVCR-----ECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFC-- 162
Query: 840 LSSSPLDTAVETPSSSK--GIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897
A TP SK + GT ++APE D++S GI+ +EM P
Sbjct: 163 --------AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 61/240 (25%), Positives = 105/240 (43%), Gaps = 30/240 (12%)
Query: 660 QLMDQQFPMISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGA 719
+++++ ++S + K F IGQG+ G VY G VA+K +NL+Q+
Sbjct: 3 EILEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK 59
Query: 720 SNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQ 779
+ E +R ++ N++ + + D +V EY+ GSL D + +E
Sbjct: 60 KELIINEILVMRENKNPNIVNYLD-----SYLVGDELWVVMEYLAGGSLTDVV--TETCM 112
Query: 780 EARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKF 839
+ + + R + A++++H + V+H D+K N+LL D L DFG
Sbjct: 113 DEGQIAAVCR-----ECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC-- 162
Query: 840 LSSSPLDTAVETPSSSK--GIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897
A TP SK + GT ++APE D++S GI+ +EM P
Sbjct: 163 --------AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 58/222 (26%), Positives = 92/222 (41%), Gaps = 32/222 (14%)
Query: 686 MIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQ-------ALRNIRHRNL 738
++G+GSFG V L + AVKV LK+ EC AL +H L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKV--LKKDVILQDDDVECTMTEKRVLALAG-KHPFL 58
Query: 739 IKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVAS 798
++ + C F+ D V EY+ G L + +S E R+ ++
Sbjct: 59 TQLHS-C----FQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRA------RFYAAEIVL 107
Query: 799 AIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGI 858
++++H +++ DLK NVLLD + + DFG+ K + ++
Sbjct: 108 GLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCK--------EGILGGVTTSTF 156
Query: 859 KGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDG 900
GT YIAPE D ++ G+LL EM + P +G
Sbjct: 157 CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEG 198
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 58/221 (26%), Positives = 102/221 (46%), Gaps = 27/221 (12%)
Query: 687 IGQGSFGFVYKG--NLGENGMMVAVKVINLKQKGAS--NGFVAECQALRNIRHRNLIKII 742
+G G+FG V KG + ++ VAVK++ + + + E ++ + + ++++I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 743 TICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEY 802
IC + + +V E + G L +L Q+ + +T ++ V+ ++Y
Sbjct: 63 GICEAESW------MLVMELAELGPLNKFL------QKNKHVTEKNITELVHQVSMGMKY 110
Query: 803 IHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGI-KGT 861
+ VH DL NVLL A + DFGL+K L + E +K K
Sbjct: 111 LEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGAD------ENYYKAKTHGKWP 161
Query: 862 VGYIAPEYGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGM 901
V + APE + S DV+SFG+L+ E F+ ++P GM
Sbjct: 162 VKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM 202
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 26/208 (12%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLK-QKGASNGFVAECQALRNIRHRNLIKIITIC 745
+G+GS+ VYKG NG +VA+KVI L+ ++G + E L+ ++H N++ + I
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 746 SSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHH 805
+ + +V+EY+ L ++ + ++ L + + + YIH
Sbjct: 73 HT-----KETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKL-----FLFQLLRGLSYIH- 120
Query: 806 HCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIK-GTVGY 864
Q ++H DLKP N+L+ L DFGLA+ A PS + + T+ Y
Sbjct: 121 --QRYILHRDLKPQNLLISDTGELKLADFGLAR---------AKSVPSHTYSNEVVTLWY 169
Query: 865 IAPEYGMGG-EASMTGDVYSFGILLLEM 891
P+ +G E S D++ G + +EM
Sbjct: 170 RPPDVLLGSTEYSTCLDMWGVGCIFVEM 197
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 53/227 (23%), Positives = 90/227 (39%), Gaps = 32/227 (14%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVIN---LKQKGASNGFVAECQALRNIRH 735
DF +GQG +G V+ + G +VA+K + L + + E L +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 736 RNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSE--DQQEARSLTLIQRINII 793
L+K++ F+ ++ + EY+ G L+ + AR +
Sbjct: 61 EWLVKLL-----YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFY--------M 107
Query: 794 IDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPS 853
++ A++ +H + +H DLKP N L+D L DFGL+K +
Sbjct: 108 AEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSK-----------GIVT 153
Query: 854 SSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDG 900
+ + G+ Y+APE G T D +S G +L E P G
Sbjct: 154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSG 200
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 61/226 (26%), Positives = 106/226 (46%), Gaps = 29/226 (12%)
Query: 685 NMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQ---------ALRNIRH 735
++G+G++G VY G L G ++AVK + L SN AE + L++++H
Sbjct: 6 EVLGKGAYGTVYCG-LTNQGQLIAVKQVELD---TSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 736 RNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIID 795
N+++ + C +D + I E++ GS+ L++ E + I+D
Sbjct: 62 VNIVQYLGTC--LDDNTIS---IFMEFVPGGSISSILNRFGPLPE---PVFCKYTKQILD 113
Query: 796 VASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSS 855
+ Y+H++C VVH D+K +NV+L + + L DFG A+ L+ L +
Sbjct: 114 ---GVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH--GTHSNML 165
Query: 856 KGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGM 901
K + GT ++APE D++S G + EM T + P M
Sbjct: 166 KSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASM 211
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 22/209 (10%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLK--QKGASNGFVAECQALRNIRHRNLIKIITI 744
IG+GSFG E+G +K IN+ E L N++H N I+
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN---IVQY 64
Query: 745 CSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIH 804
S + G + IV +Y + G L ++ + Q Q ++ + + A++++H
Sbjct: 65 QESFEENGNLY--IVMDYCEGGDL----YKKINAQRGVLFPEDQILDWFVQICLALKHVH 118
Query: 805 HHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGY 864
++H D+K N+ L +D LGDFG+A+ L+S T ++ GT Y
Sbjct: 119 DR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS--------TVELARTCIGTPYY 167
Query: 865 IAPEYGMGGEASMTGDVYSFGILLLEMFT 893
++PE + D+++ G +L EM T
Sbjct: 168 LSPEICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 62/248 (25%), Positives = 109/248 (43%), Gaps = 44/248 (17%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICS 746
+G G+ G V K G ++A KV+++ K + Q LR + +I+ C
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSS-----VRKQILREL------QIMHECR 61
Query: 747 S---IDFKGVDFQA-----IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVAS 798
S + F G F + E+M GSL+ ++ + + I + V
Sbjct: 62 SPYIVSFYGA-FLNENNICMCMEFMDCGSLDRIY------KKGGPIPVEILGKIAVAVVE 114
Query: 799 AIEYIH--HHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSK 856
+ Y++ H ++H D+KPSN+L++ L DFG++ L +S DT V
Sbjct: 115 GLTYLYNVHR----IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV------- 163
Query: 857 GIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTAL 916
GT Y++PE GG+ ++ DV+S GI ++E+ + P F+ + +
Sbjct: 164 ---GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFA--FSNIDDDGQDDPMGI 218
Query: 917 PDKVMEIV 924
D + +IV
Sbjct: 219 LDLLQQIV 226
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-10
Identities = 60/222 (27%), Positives = 95/222 (42%), Gaps = 28/222 (12%)
Query: 686 MIGQGSFGFVYKGNLGENGMMVAVKVIN---LKQKGASNGFVAECQALRNIRHRNLIKII 742
++G+G+FG V G A+K++ + K V E + L+N RH L +
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL- 60
Query: 743 TICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEY 802
F+ D V EY G L + H S + R T + ++ SA+EY
Sbjct: 61 ----KYAFQTHDRLCFVMEYANGGEL--FFHLSRE----RVFTEERARFYGAEIVSALEY 110
Query: 803 IHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTV 862
+H VV+ D+K N++LD+D + DFGL K + ++ K GT
Sbjct: 111 LHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK--------EGISDGATMKTFCGTP 159
Query: 863 GYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQ 904
Y+APE + D + G+++ EM R P +NQ
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP---FYNQ 198
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-10
Identities = 60/227 (26%), Positives = 108/227 (47%), Gaps = 35/227 (15%)
Query: 687 IGQGSFGFVYKGN-LG------ENGMMVAVKVI--NLKQKGASNGFVAECQALRNI-RHR 736
+G+G FG V LG + + VAVK++ + +K S+ V+E + ++ I +H+
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMIGKHK 81
Query: 737 NLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARS----------LTL 786
N+I ++ C+ + IV EY G+L ++L S +T
Sbjct: 82 NIINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTF 136
Query: 787 IQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLD 846
++ VA +EY+ +H DL NVL+ ++ V + DFGLA+ +++ +D
Sbjct: 137 KDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNN--ID 191
Query: 847 TAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT 893
+T + +K ++APE + DV+SFG+L+ E+FT
Sbjct: 192 YYKKTTNGRLPVK----WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 53/227 (23%), Positives = 101/227 (44%), Gaps = 29/227 (12%)
Query: 681 FSSSNM-----IGQGSFGFVY----KGNLGENG-MMVAVKVIN-LKQKGASNGFVAECQA 729
F SN+ +G+G FG V+ KG E G +V VK + K + + F E
Sbjct: 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61
Query: 730 LRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARS---LTL 786
R + H+N+++++ +C + + ++ EY G L+ +L ++ + E L+
Sbjct: 62 FRKLSHKNVVRLLGLC-----REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLST 116
Query: 787 IQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLD 846
Q++ + +A ++++ + VH DL N L+ + L+K + +S
Sbjct: 117 KQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYY 173
Query: 847 TAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT 893
+ ++APE + S DV+SFG+L+ E+FT
Sbjct: 174 KLRNA-------LIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 4e-10
Identities = 67/225 (29%), Positives = 96/225 (42%), Gaps = 23/225 (10%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNL 738
DF +++G+G FG V G + A+KV+ A V+ + R+I +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQET-VSFFEEERDILSISN 59
Query: 739 IKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVAS 798
I F+ D +V EY G L L++ EDQ + + Q +A
Sbjct: 60 SPWIPQLQYA-FQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDE---DMAQ-----FYLAE 110
Query: 799 AIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGI 858
+ IH Q VH D+KP NVL+D+ L DFG A L++ + V +SK
Sbjct: 111 LVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTA---NKMV----NSKLP 163
Query: 859 KGTVGYIAPEY--GM-GGEASMTG---DVYSFGILLLEMFTRRRP 897
GT YIAPE M G G D +S G++ EM R P
Sbjct: 164 VGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 5e-10
Identities = 61/255 (23%), Positives = 98/255 (38%), Gaps = 65/255 (25%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNI---RH 735
+DF S +IG+G+FG V + G + A+K + K + VA +A R+I
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKL-RKSEMLEKEQVAHVRAERDILAEAD 59
Query: 736 RNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINI--- 792
+ + S F+ ++ ++ EY+ G + +TL+ + +
Sbjct: 60 NPWV-VKLYYS---FQDENYLYLIMEYLPGGDM---------------MTLLMKKDTFTE 100
Query: 793 ------IIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFL------ 840
I + AI+ IH +H D+KP N+LLD L DFGL L
Sbjct: 101 EETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157
Query: 841 -------SSSPLDTAVE--TPSSSKG---------------IKGTVGYIAPEYGMGGEAS 876
+ P + P SSK GT YIAPE + +
Sbjct: 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYN 217
Query: 877 MTGDVYSFGILLLEM 891
D +S G+++ EM
Sbjct: 218 KECDWWSLGVIMYEM 232
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 5e-10
Identities = 62/237 (26%), Positives = 101/237 (42%), Gaps = 33/237 (13%)
Query: 680 DFSSSNMIGQGSFGFVY---KGNLGENGMMVAVKVIN-----LKQKGASNGFVAECQALR 731
+F ++G G++G V+ K + G + A+KV+ K K A + E Q L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHT-RTERQVLE 59
Query: 732 NIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRIN 791
+R + + D K ++ +Y+ G L L+Q E E+ I I
Sbjct: 60 AVRRCPFLVTLHYAFQTDTK----LHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIV 115
Query: 792 IIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVET 851
+ A++++H Q +++ D+K N+LLD + L DFGL+K + + A
Sbjct: 116 L------ALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS- 165
Query: 852 PSSSKGIKGTVGYIAPEYGMGGEA--SMTGDVYSFGILLLEMFTRRRP--TDGMFNQ 904
GT+ Y+APE GG D +S G+L E+ T P DG N
Sbjct: 166 ------FCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS 216
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 5e-10
Identities = 58/240 (24%), Positives = 103/240 (42%), Gaps = 30/240 (12%)
Query: 686 MIGQGSFGFVY----KGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKI 741
+IG G FG VY + N VA K+ NL+ + V E NI + I +
Sbjct: 19 LIGCGGFGCVYETQCASDHCINNQAVA-KIENLE----NETIVMETLVYNNIYDIDKIAL 73
Query: 742 ITICSSIDFKGV---------DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRI-- 790
+ID G+ + Y ++ L + L ++ + R +++
Sbjct: 74 WKNIHNIDHLGIPKYYGCGSFKRCRMYYRFI----LLEKLVENTKEIFKRIKCKNKKLIK 129
Query: 791 NIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVE 850
NI+ D+ + +EYIH H + HGD+KP N+++D + ++ D+G+A +E
Sbjct: 130 NIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIH--GKHIE 184
Query: 851 TPSSSKGI-KGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLH 909
K + +GT+ Y + G + GD+ S G +L+ + P G + G +H
Sbjct: 185 YSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244
|
Length = 294 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 26/212 (12%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLK-QKGASNGFVAECQALRNIRHRNLIKIITIC 745
+G+G++ V+KG +VA+K I L+ ++GA + E L+N++H N++ + I
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 746 SSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIII-DVASAIEYIH 804
+ +V+EY+ + L+ +L +L + + I + + + Y H
Sbjct: 73 HT-----ERCLTLVFEYLDS-DLKQYL------DNCGNLMSMHNVKIFMFQLLRGLSYCH 120
Query: 805 HHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGY 864
++H DLKP N+L+++ L DFGLA+ S V T + S + T+ Y
Sbjct: 121 KR---KILHRDLKPQNLLINEKGELKLADFGLARAKS-------VPTKTYSNEVV-TLWY 169
Query: 865 IAPEYGMGG-EASMTGDVYSFGILLLEMFTRR 895
P+ +G E S D++ G +L EM T R
Sbjct: 170 RPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 57/227 (25%), Positives = 97/227 (42%), Gaps = 32/227 (14%)
Query: 681 FSSSNMIGQGSFGFVYKGNLGENGMMVAVKVIN---LKQKGASNGFVAECQALRNIRHRN 737
F ++G+G FG V + G M A K + +K++ + + E Q L + +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 738 LIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQ--QEARSLTLIQRINIIID 795
++ + + ++ D +V M G L+ ++ + +E R+L I
Sbjct: 62 VVNL-----AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEI----- 111
Query: 796 VASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPS-- 853
+E +H + V+ DLKP N+LLD + D GL AV+ P
Sbjct: 112 -LCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGL-----------AVKIPEGE 156
Query: 854 SSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDG 900
S +G GTVGY+APE +++ D + G L+ EM + P G
Sbjct: 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRG 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 8e-10
Identities = 65/245 (26%), Positives = 104/245 (42%), Gaps = 36/245 (14%)
Query: 686 MIGQGSFGFVYKGNLGENGMMVAVKVIN---LKQKGASNGFVAECQALRNIRHRNLIKII 742
++G+G+FG V G A+K++ + K + E + L+N RH L +
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL- 60
Query: 743 TICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEY 802
F+ D V EY G L + H S ++ + I+ SA++Y
Sbjct: 61 ----KYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIV----SALDY 110
Query: 803 IHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTV 862
+H + VV+ DLK N++LD+D + DFGL K ++ ++ K GT
Sbjct: 111 LH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--------EGIKDGATMKTFCGTP 160
Query: 863 GYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQG------LTLHE---FAR 913
Y+APE + D + G+++ EM R P +NQ L L E F R
Sbjct: 161 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP---FYNQDHEKLFELILMEEIRFPR 217
Query: 914 TALPD 918
T P+
Sbjct: 218 TLSPE 222
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 8e-10
Identities = 58/228 (25%), Positives = 109/228 (47%), Gaps = 37/228 (16%)
Query: 687 IGQGSFGFVYKG-------NLGENGMMVAVKVI--NLKQKGASNGFVAECQALRNI-RHR 736
+G+G FG V + + + + VAVK++ N K ++ ++E + ++ I +H+
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLAD-LISEMELMKLIGKHK 78
Query: 737 NLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSE----------DQQEARSLTL 786
N+I ++ +C+ +G + ++ EY G+L ++L + L+
Sbjct: 79 NIINLLGVCTQ---EGPLY--VIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSF 133
Query: 787 IQRINIIIDVASAIEYIH-HHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPL 845
++ VA +EY+ C +H DL NVL+ +D V + DFGLA+ + +
Sbjct: 134 KDLVSCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLARGVHD--I 187
Query: 846 DTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT 893
D +T + +K ++APE + DV+SFGIL+ E+FT
Sbjct: 188 DYYKKTSNGRLPVK----WMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 8e-10
Identities = 63/236 (26%), Positives = 104/236 (44%), Gaps = 48/236 (20%)
Query: 687 IGQGSFGFVYKGNL----GENGMM-VAVKVINLKQKGASN----GFVAECQALRNIRHRN 737
+G+G FG V K G G VAVK++ ++ AS+ ++E L+ + H +
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKML---KENASSSELRDLLSEFNLLKQVNHPH 64
Query: 738 LIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSE------------------DQQ 779
+IK+ CS G ++ EY + GSL +L +S D
Sbjct: 65 VIKLYGACSQ---DGPLL--LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119
Query: 780 EARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKF 839
+ R+LT+ I+ ++ ++Y+ + +VH DL NVL+ + + DFGL++
Sbjct: 120 DERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR- 175
Query: 840 LSSSPLDTAVETPSSSKGIKG--TVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT 893
E S K KG V ++A E + DV+SFG+LL E+ T
Sbjct: 176 -------DVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 9e-10
Identities = 52/222 (23%), Positives = 98/222 (44%), Gaps = 31/222 (13%)
Query: 686 MIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASN------GFVAECQALRNIRHRNLI 739
+G G+F Y+ + G ++AVK + + +S E + + + H ++I
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 740 KII-TICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVAS 798
+++ C F + E+M GS+ L + +EA IN +
Sbjct: 67 RMLGATCEDSHFN------LFVEWMAGGSVSHLLSKYGAFKEAVI------INYTEQLLR 114
Query: 799 AIEYIHHHCQPPVVHGDLKPSNVLLD---QDLVAHLGDFGLAKFLSSSPLDTAVETPSSS 855
+ Y+H + ++H D+K +N+L+D Q L + DFG A L++
Sbjct: 115 GLSYLHEN---QIIHRDVKGANLLIDSTGQRL--RIADFGAAARLAA----KGTGAGEFQ 165
Query: 856 KGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897
+ GT+ ++APE G + + DV+S G +++EM T + P
Sbjct: 166 GQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 9e-10
Identities = 46/197 (23%), Positives = 94/197 (47%), Gaps = 26/197 (13%)
Query: 687 IGQGSFGFVYKGNLGEN--GMMVAVKVI---NLKQKGASNGFVAECQALRNIRHRNLIKI 741
IG+G++G VYK G A+K + G S E LR ++H N++ +
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 742 ITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRI--NIIIDVASA 799
+ + K V ++++Y ++ D + ++A+ +++ + +++ + +
Sbjct: 68 VEVFLEHADKSV---YLLFDYAEH----DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 800 IEYIHHHCQPPVVHGDLKPSNVLL----DQDLVAHLGDFGLAKFLSSSPLDTAVETPSSS 855
+ Y+H + V+H DLKP+N+L+ + V +GD GLA+ ++PL + +
Sbjct: 121 VHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLF-NAPL----KPLADL 172
Query: 856 KGIKGTVGYIAPEYGMG 872
+ T+ Y APE +G
Sbjct: 173 DPVVVTIWYRAPELLLG 189
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 34/106 (32%), Positives = 57/106 (53%), Gaps = 11/106 (10%)
Query: 795 DVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSS 854
++A A++++H +++ DLKP N+LLD++ L DFGL+K +++
Sbjct: 106 ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--------ESIDHEKK 154
Query: 855 SKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDG 900
+ GTV Y+APE + + D +SFG+L+ EM T P G
Sbjct: 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQG 200
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 1e-09
Identities = 23/41 (56%), Positives = 26/41 (63%), Gaps = 1/41 (2%)
Query: 6 NETDRLALLAIGSQLEDDPLGVTSSWN-NSTNLCQWTGVTC 45
DR ALLA S L DP G SSWN +S++ C WTGVTC
Sbjct: 1 LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTC 41
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-09
Identities = 32/86 (37%), Positives = 50/86 (58%), Gaps = 1/86 (1%)
Query: 156 DNH-LTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPS 214
DN L G P I L L+ IN+ GN + G IP +LG++ +L +L+L N F+G +P S
Sbjct: 426 DNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPES 485
Query: 215 IFNISSLENVFLPTNRFNGSLPLDIG 240
+ ++SL + L N +G +P +G
Sbjct: 486 LGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 57/224 (25%), Positives = 103/224 (45%), Gaps = 29/224 (12%)
Query: 679 NDFSSSNMIGQGSFGFVYKGN---LGENGMMVAVKVINLKQKGASN---GFVAECQALRN 732
N+ S +G G+FG V + L ++ ++ V V LK S+ ++E + + +
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 733 I-RHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRIN 791
+ H N++ ++ C+ G ++ EY G L ++L + + LTL ++
Sbjct: 95 LGNHENIVNLLGACTI---GGPIL--VITEYCCYGDLLNFLRRKRES----FLTLEDLLS 145
Query: 792 IIIDVASAIEYI-HHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVE 850
VA + ++ +C +H DL NVLL + + DFGLA+ D +
Sbjct: 146 FSYQVAKGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLAR-------DIMND 194
Query: 851 TPSSSKG-IKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT 893
+ KG + V ++APE + DV+S+GILL E+F+
Sbjct: 195 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAE--CQALRNIRHRNLIKIITI 744
+G+GS+G V +G +K +NL+ AE Q L ++H N I+
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN---IVAY 64
Query: 745 CSSIDFKGVDFQA-IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYI 803
S ++G D IV + + G L + +Q+ + L Q + + +A A++Y+
Sbjct: 65 RES--WEGEDGLLYIVMGFCEGGDL----YHKLKEQKGKLLPENQVVEWFVQIAMALQYL 118
Query: 804 HHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVG 863
H + ++H DLK NV L + + +GD G+A+ L + D A + GT
Sbjct: 119 H---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ-CDMA-------STLIGTPY 167
Query: 864 YIAPEYGMGGEASMTGDVYSFGILLLEMFTRR 895
Y++PE + DV++ G + EM T +
Sbjct: 168 YMSPELFSNKPYNYKSDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 56/228 (24%), Positives = 100/228 (43%), Gaps = 30/228 (13%)
Query: 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLI 739
DF IG G++G VYK G + A+KVI L+ E +++ +H N++
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69
Query: 740 KIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASA 799
+ D I E+ GSL+D H + E++ + + R +
Sbjct: 70 AYFG-----SYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQ-IAYVSR-----ETLQG 118
Query: 800 IEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIK 859
+ Y+H + +H D+K +N+LL + L DFG++ +++ T + K
Sbjct: 119 LYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITA--------TIAKRKSFI 167
Query: 860 GTVGYIAPEYGM----GGEASMTGDVYSFGILLLEMFTRRRPTDGMFN 903
GT ++APE GG + D+++ GI +E+ + P MF+
Sbjct: 168 GTPYWMAPEVAAVERKGGYNQLC-DIWAVGITAIELAELQPP---MFD 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 59/223 (26%), Positives = 108/223 (48%), Gaps = 28/223 (12%)
Query: 686 MIGQGSFGFVYKGNL---GEN-GMMVAVKVI--NLKQKGASNGFVAECQALRNIRHRNLI 739
++G G+FG VYKG GEN + VA+KV+ N K A+ + E + + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPK-ANKEILDEAYVMAGVGSPYVC 72
Query: 740 KIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASA 799
+++ IC + + +V + M G L D++ +++D+ ++ L +N + +A
Sbjct: 73 RLLGICLTSTVQ------LVTQLMPYGCLLDYVRENKDRIGSQDL-----LNWCVQIAKG 121
Query: 800 IEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIK 859
+ Y+ + +VH DL NVL+ + DFGLA+ L ET + G K
Sbjct: 122 MSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID------ETEYHADGGK 172
Query: 860 GTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGM 901
+ ++A E + + DV+S+G+ + E+ T +P DG+
Sbjct: 173 VPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI 215
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 58/211 (27%), Positives = 89/211 (42%), Gaps = 26/211 (12%)
Query: 686 MIGQGSFGFVYKGNLGENGMMVAVKVINLK---QKGASNGFVAECQAL-RNIRHRNLIKI 741
+IG+GSFG V +G AVKV+ K + +AE L +N++H L+ +
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 742 ITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIE 801
F+ + V +++ G L L + E R+ ++ASA+
Sbjct: 62 -----HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA------EIASALG 110
Query: 802 YIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGT 861
Y+H +V+ DLKP N+LLD L DFGL K + ++ GT
Sbjct: 111 YLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCK--------EGIAQSDTTTTFCGT 159
Query: 862 VGYIAPEYGMGGEASMTGDVYSFGILLLEMF 892
Y+APE T D + G +L EM
Sbjct: 160 PEYLAPEVIRKQPYDNTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 58/228 (25%), Positives = 104/228 (45%), Gaps = 31/228 (13%)
Query: 680 DFSSSNMIGQGSFGFVY---KGNLGENGMMVAVKVI---NLKQKGASNGFV-AECQALRN 732
+F ++G G++G V+ K + ++G + A+KV+ + QK + E Q L +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 733 IRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINI 792
IR + + D K ++ +Y+ G L L Q E +E Q + I
Sbjct: 61 IRQSPFLVTLHYAFQTDTK----LHLILDYINGGELFTHLSQRERFKE-------QEVQI 109
Query: 793 II-DVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVET 851
++ A+E++H + +++ D+K N+LLD + L DFGL+K ++ A
Sbjct: 110 YSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS- 165
Query: 852 PSSSKGIKGTVGYIAPEYGMGGEASMTG--DVYSFGILLLEMFTRRRP 897
GT+ Y+AP+ GG+ D +S G+L+ E+ T P
Sbjct: 166 ------FCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 54/219 (24%), Positives = 96/219 (43%), Gaps = 29/219 (13%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGAS----NGFVAECQALRNIRHRNLIKII 742
IG G FG V G GM A V+ + A+ F+ E Q R + H N+++ +
Sbjct: 3 IGNGWFGKVLLGEA-HRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 743 TIC-SSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIE 801
C SI + +V E+ G L+++L + + + + + +VAS +
Sbjct: 62 GQCIESIPY------LLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQ-RMACEVASGLL 114
Query: 802 YIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGT 861
++H Q +H DL N L DL +GD+GLA L P D + + ++
Sbjct: 115 WLH---QADFIHSDLALRNCQLTADLSVKIGDYGLA--LEQYPEDYYITKDCHAVPLR-- 167
Query: 862 VGYIAPEYG-------MGGEASMTGDVYSFGILLLEMFT 893
++APE + + + +++S G+ + E+FT
Sbjct: 168 --WLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 61/211 (28%), Positives = 87/211 (41%), Gaps = 26/211 (12%)
Query: 686 MIGQGSFGFVYKGNLGENGMMVAVKVIN----LKQKGASNGFVAECQALRNIRHRNLIKI 741
+IG+GSFG V AVKV+ LK+K + L+N++H L+ +
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 742 ITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIE 801
F+ D V +Y+ G L L + E R+ I ASA+
Sbjct: 62 -----HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEI------ASALG 110
Query: 802 YIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGT 861
Y+H +V+ DLKP N+LLD L DFGL K +E ++ GT
Sbjct: 111 YLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK--------ENIEHNGTTSTFCGT 159
Query: 862 VGYIAPEYGMGGEASMTGDVYSFGILLLEMF 892
Y+APE T D + G +L EM
Sbjct: 160 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 53/200 (26%), Positives = 97/200 (48%), Gaps = 28/200 (14%)
Query: 707 VAVKVI--NLKQKGASNGFVAECQALRNI-RHRNLIKIITICSSIDFKGVDFQAIVYEYM 763
VAVK++ + +K S+ ++E + ++ I +H+N+I ++ C+ G + ++ EY
Sbjct: 53 VAVKMLKSDATEKDLSD-LISEMEMMKMIGKHKNIINLLGACTQ---DGPLY--VIVEYA 106
Query: 764 QNGSLEDWLHQ----------SEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVH 813
G+L ++L + Q L+ ++ VA +EY+ +H
Sbjct: 107 SKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIH 163
Query: 814 GDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG 873
DL NVL+ +D V + DFGLA+ + +D +T + +K ++APE
Sbjct: 164 RDLAARNVLVTEDNVMKIADFGLARDIHH--IDYYKKTTNGRLPVK----WMAPEALFDR 217
Query: 874 EASMTGDVYSFGILLLEMFT 893
+ DV+SFG+LL E+FT
Sbjct: 218 IYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 41/122 (33%), Positives = 63/122 (51%), Gaps = 22/122 (18%)
Query: 792 IIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVET 851
I + + A+EY+H + V+H D+KPSNVL++++ L DFG++ +L
Sbjct: 108 IAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL----------V 155
Query: 852 PSSSKGIK-GTVGYIAPEYGMGGEASMTG-----DVYSFGILLLEMFTRRRPTDG---MF 902
S +K I G Y+APE + E + G DV+S GI ++E+ T R P D F
Sbjct: 156 DSVAKTIDAGCKPYMAPER-INPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF 214
Query: 903 NQ 904
Q
Sbjct: 215 QQ 216
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 3e-09
Identities = 67/236 (28%), Positives = 89/236 (37%), Gaps = 69/236 (29%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGF---------VAECQALRNIRHRN 737
IG+G++G V E VA+K I N F + E + LR++ H N
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIA-------NAFDNRIDAKRTLREIKLLRHLDHEN 65
Query: 738 LIKIITICSSID---FKGVDFQAIVYEYMQNGSLEDWLHQ--------SEDQ------QE 780
+I I I F V IVYE M LHQ S+D Q
Sbjct: 66 VIAIKDIMPPPHREAFNDV---YIVYELMDTD-----LHQIIRSSQTLSDDHCQYFLYQL 117
Query: 781 ARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFL 840
R L +YIH V+H DLKPSN+LL+ + + DFGLA+
Sbjct: 118 LRGL----------------KYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLAR-- 156
Query: 841 SSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTG-DVYSFGILLLEMFTRR 895
T E T Y APE + T DV+S G + E+ R+
Sbjct: 157 ------TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-09
Identities = 60/228 (26%), Positives = 103/228 (45%), Gaps = 37/228 (16%)
Query: 687 IGQGSFGFVYKGN-LG------ENGMMVAVKVINLKQKGAS---NGFVAECQALRNI-RH 735
+G+G FG V +G + VAVK+ LK + V+E + ++ I +H
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKM--LKDDATDKDLSDLVSEMEMMKMIGKH 77
Query: 736 RNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSED----------QQEARSLT 785
+N+I ++ C+ + +V EY G+L ++L + LT
Sbjct: 78 KNIINLLGACT----QDGPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLT 132
Query: 786 LIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPL 845
++ VA +EY+ +H DL NVL+ +D V + DFGLA+ + + +
Sbjct: 133 FKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHN--I 187
Query: 846 DTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT 893
D +T + +K ++APE + DV+SFG+LL E+FT
Sbjct: 188 DYYKKTTNGRLPVK----WMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 3e-09
Identities = 55/216 (25%), Positives = 87/216 (40%), Gaps = 30/216 (13%)
Query: 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVIN----LKQKGASNGFVAECQALRNIRH 735
DF +G GSFG V G A+K + LK K + E L + H
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQH-VAQEKSILMELSH 77
Query: 736 RNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIID 795
++ ++ CS D V F + E++ G L + H + + + +++
Sbjct: 78 PFIVNMM--CSFQDENRVYF---LLEFVVGGEL--FTHLRKAGRFPNDVAKFYHAELVL- 129
Query: 796 VASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSS 855
A EY+H +++ DLKP N+LLD + DFG AK + P +
Sbjct: 130 ---AFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----------KVPDRT 172
Query: 856 KGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEM 891
+ GT Y+APE D ++ G+LL E
Sbjct: 173 FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEF 208
|
Length = 329 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 4e-09
Identities = 55/217 (25%), Positives = 98/217 (45%), Gaps = 31/217 (14%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHRNLIKIITI 744
IG+G++G V+K E +VA+K + L +G + + E L+ ++H+N++++ +
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 745 CSSIDFKGVDFQAIVYEYMQNGSLE---DWLHQSEDQQEARSLTLIQRINIIIDVASAIE 801
S D K +V+EY L+ D + D + +S + +
Sbjct: 68 LHS-DKK----LTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMF--------QLLKGLA 113
Query: 802 YIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGT 861
+ H H V+H DLKP N+L++++ L DFGLA+ V S+ T
Sbjct: 114 FCHSH---NVLHRDLKPQNLLINKNGELKLADFGLAR-----AFGIPVRCYSAE---VVT 162
Query: 862 VGYIAPEYGMGGEASMTG-DVYSFGILLLEMFTRRRP 897
+ Y P+ G + T D++S G + E+ RP
Sbjct: 163 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 4e-09
Identities = 52/233 (22%), Positives = 97/233 (41%), Gaps = 42/233 (18%)
Query: 685 NMIGQGSFGFVYKGNLGENGMMVAVK----------VINLKQKGASNG--FVA--ECQAL 730
+G+G++G V K G +VA+K V +Q G F E + +
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 731 RNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNG---SLEDWLHQSEDQQEARSLTLI 787
I+H N++ ++ + + DF +V + M + ++ + +E Q + L ++
Sbjct: 75 NEIKHENIMGLVDV-----YVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQIL 129
Query: 788 QRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLD- 846
+N++ H +H DL P+N+ ++ + + DFGLA+ P
Sbjct: 130 NGLNVL-----------HKWY--FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSD 176
Query: 847 --TAVETPSSSKGIKG---TVGYIAPEYGMGGEA-SMTGDVYSFGILLLEMFT 893
+ ET + + T+ Y APE MG E D++S G + E+ T
Sbjct: 177 TLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT 229
|
Length = 335 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-09
Identities = 54/228 (23%), Positives = 99/228 (43%), Gaps = 28/228 (12%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNL 738
+D+ +G G++G VYK G + AVK+I L+ + E ++ +H N+
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNI 68
Query: 739 IKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVAS 798
+ + + I EY GSL+D H + L+ +Q + +
Sbjct: 69 VAYFG-----SYLSREKLWICMEYCGGGSLQDIYHVTG------PLSELQIAYVCRETLQ 117
Query: 799 AIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGI 858
+ Y+H + +H D+K +N+LL + L DFG+A +++ T + K
Sbjct: 118 GLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITA--------TIAKRKSF 166
Query: 859 KGTVGYIAPEYGM---GGEASMTGDVYSFGILLLEMFTRRRPTDGMFN 903
GT ++APE G + D+++ GI +E+ + P MF+
Sbjct: 167 IGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPP---MFD 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 7e-09
Identities = 37/103 (35%), Positives = 49/103 (47%), Gaps = 25/103 (24%)
Query: 182 GLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGV 241
GL G IPN++ LR+L +NL N G +PPS+ +I+SLE + L N FNGS
Sbjct: 429 GLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS------- 481
Query: 242 SLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKV 284
IPESL ++L L L N G+V
Sbjct: 482 ------------------IPESLGQLTSLRILNLNGNSLSGRV 506
|
Length = 623 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 7e-09
Identities = 57/223 (25%), Positives = 100/223 (44%), Gaps = 22/223 (9%)
Query: 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQAL--RNIRHRN 737
DF+ ++G+GSFG V + A+K+ LK+ EC + R + ++
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEKRVLALQD 58
Query: 738 LIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVA 797
+T S F+ VD V EY+ G L + Q +E Q + +++
Sbjct: 59 KPPFLTQLHSC-FQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP------QAVFYAAEIS 111
Query: 798 SAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKG 857
+ ++H + +++ DLK NV+LD + + DFG+ K + V+ +++
Sbjct: 112 VGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK-------EHMVDG-VTTRT 160
Query: 858 IKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDG 900
GT YIAPE + D +++G+LL EM + P DG
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 7e-09
Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 34/216 (15%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLI---KII 742
+G+GS+ VYKG G +VA+K I L+ +GA + E L++++H N++ II
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII 72
Query: 743 TICSSIDFKGVDFQAIVYEYMQNGSLEDWL--HQSEDQQEARSLTLIQRINIIIDVASAI 800
++ V+EY+ L+ ++ L L Q + +
Sbjct: 73 HTKKTLTL--------VFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLR-------GL 116
Query: 801 EYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKG 860
Y H V+H DLKP N+L+ + L DFGLA+ S P T S++ +
Sbjct: 117 AYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKT-----YSNEVV-- 165
Query: 861 TVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRR 895
T+ Y P+ +G E S + D++ G + EM T R
Sbjct: 166 TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 8e-09
Identities = 59/223 (26%), Positives = 91/223 (40%), Gaps = 34/223 (15%)
Query: 686 MIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRN------IRHRNLI 739
M+G+GSFG V+ L A+K LK+ EC + H L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59
Query: 740 KIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASA 799
+ C+ F+ + V EY+ G L + Q L + ++
Sbjct: 60 HLY--CT---FQTKENLFFVMEYLNGGDLMFHI------QSCHKFDLPRATFYAAEIICG 108
Query: 800 IEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAK--FLSSSPLDTAVETPSSSKG 857
++++H +V+ DLK N+LLD D + DFG+ K L + T TP
Sbjct: 109 LQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPD---- 161
Query: 858 IKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDG 900
YIAPE +G + + + D +SFG+LL EM + P G
Sbjct: 162 ------YIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 8e-09
Identities = 61/239 (25%), Positives = 96/239 (40%), Gaps = 29/239 (12%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVIN---LKQKGASNGFVAECQALRNIRHRNLIKIIT 743
+G+G FG V + G M A K ++ LK+K + E + L + N I+
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV---NSPFIVN 57
Query: 744 ICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYI 803
+ + + K +V M G L+ ++ + R L + + I+ + I ++
Sbjct: 58 LAYAFESK--THLCLVMSLMNGGDLKYHIYNVGE----RGLEMERVIHYSAQITCGILHL 111
Query: 804 HHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIK--GT 861
H +V+ D+KP NVLLD L D GL AVE + GT
Sbjct: 112 H---SMDIVYRDMKPENVLLDDQGNCRLSDLGL-----------AVELKDGKTITQRAGT 157
Query: 862 VGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKV 920
GY+APE S D ++ G + EM R P + + E R L D+V
Sbjct: 158 NGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKD-HKEKVAKEELKRRTLEDEV 215
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 9e-09
Identities = 64/223 (28%), Positives = 102/223 (45%), Gaps = 37/223 (16%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGAS-NGFVAECQALRNIRHRNLIKIITIC 745
+G+G++G VYK G+ +A+K I L+ + N + E L H+ + I
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDIL----HKAVSPYI--- 61
Query: 746 SSIDFKGVDFQ-AIVY---EYMQNGSLEDWLHQSEDQQEARSLTLIQRI-NIIIDVASAI 800
+DF G F VY EYM GSL D L+ E +++RI ++ +
Sbjct: 62 --VDFYGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118
Query: 801 EYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKG 860
+ H+ ++H D+KP+NVL++ + L DFG++ L +S T + G
Sbjct: 119 KEEHN-----IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI----------G 163
Query: 861 TVGYIAPEY----GMGGEASMT--GDVYSFGILLLEMFTRRRP 897
Y+APE G + T DV+S G+ +LEM R P
Sbjct: 164 CQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-09
Identities = 54/210 (25%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 687 IGQGSFGFVYKG--NLGENGMMVAVKVI-NLKQKGASNGFVAECQALRNIRHRNLIKIIT 743
+G G+FG V KG + + + VA+KV+ N +K + + E + + + + ++++I
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 744 ICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYI 803
+C + + +V E G L +L +D+ +T+ + ++ V+ ++Y+
Sbjct: 63 VCEA------EALMLVMEMASGGPLNKFLSGKKDE-----ITVSNVVELMHQVSMGMKYL 111
Query: 804 HHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVG 863
VH DL NVLL A + DFGL+K L + D + S K +
Sbjct: 112 E---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGA---DDSYYKARS--AGKWPLK 163
Query: 864 YIAPEYGMGGEASMTGDVYSFGILLLEMFT 893
+ APE + S DV+S+GI + E F+
Sbjct: 164 WYAPECINFRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 9e-09
Identities = 49/169 (28%), Positives = 75/169 (44%), Gaps = 27/169 (15%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICS 746
+G GS G V+ + VAVK I L + + E + +R + H N++K+ +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 747 SIDFKGVDFQA------------IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIII 794
G D IV EYM+ L + L Q +E L + Q +
Sbjct: 73 P---SGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQLLR--- 125
Query: 795 DVASAIEYIHHHCQPPVVHGDLKPSNVLLDQ-DLVAHLGDFGLAKFLSS 842
++YIH V+H DLKP+NV ++ DLV +GDFGLA+ +
Sbjct: 126 ----GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDP 167
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 9e-09
Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 24/215 (11%)
Query: 686 MIGQGSFGFVYKGNLGENGMMVAVKVIN---LKQKGASNGFVAECQALRNIRHRNLIKII 742
++G+GSFG V L E+G + AVKV+ + Q + E + L R+ + +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 743 TICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEY 802
C F+ D V E++ G L + +S EAR+ ++ SA+ +
Sbjct: 62 YCC----FQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAA------EITSALMF 111
Query: 803 IHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTV 862
+H +++ DLK NVLLD + L DFG+ K + ++ GT
Sbjct: 112 LH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--------EGIFNGKTTSTFCGTP 160
Query: 863 GYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897
YIAPE + D ++ G+LL EM P
Sbjct: 161 DYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 9e-09
Identities = 48/157 (30%), Positives = 69/157 (43%), Gaps = 21/157 (13%)
Query: 749 DFKGVDFQAIVYEYMQNGSLEDWLHQSEDQ----QEARSLTLIQRINIIIDVASAIEYIH 804
DFK D ++ EY G L + Q + QE L +I + A++ +H
Sbjct: 133 DFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVL------ALDEVH 186
Query: 805 HHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSS-PLDTAVETPSSSKGIKGTVG 863
++H DLK +N+ L + LGDFG +K S S LD A GT
Sbjct: 187 SRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVA-------SSFCGTPY 236
Query: 864 YIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDG 900
Y+APE S D++S G++L E+ T RP G
Sbjct: 237 YLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG 273
|
Length = 478 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 60/214 (28%), Positives = 106/214 (49%), Gaps = 30/214 (14%)
Query: 687 IGQGSFGFVYKG--NLGENGMMVAVKVINLK-QKGASNGFVAECQALRNIRHRNLIKIIT 743
+G+G++ V+KG L EN +VA+K I L+ ++GA + E L++++H N++ +
Sbjct: 14 LGEGTYATVFKGRSKLTEN--LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 744 ICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIII-DVASAIEY 802
I + K + +V+EY L+ L Q D + ++ + + I + + + Y
Sbjct: 72 IVHTD--KSL---TLVFEY-----LDKDLKQYMD--DCGNIMSMHNVKIFLYQILRGLAY 119
Query: 803 IHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTV 862
H V+H DLKP N+L+++ L DFGLA+ S V T + S + T+
Sbjct: 120 CHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKS-------VPTKTYSNEVV-TL 168
Query: 863 GYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRR 895
Y P+ +G E S D++ G + EM + R
Sbjct: 169 WYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 1e-08
Identities = 49/214 (22%), Positives = 87/214 (40%), Gaps = 42/214 (19%)
Query: 691 SFGFVYKGNL---GENGMMVAVK-------VINLKQKGASNGFVAECQALRNIRHRNLIK 740
S G+ L E + VA K V+ + QKG + + E L+N+ H ++I+
Sbjct: 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTT---LIEAMLLQNVNHPSVIR 121
Query: 741 IITICSSIDFKGV---DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVA 797
+ S + + + +Y Y+ +R L + Q + I +
Sbjct: 122 MKDTLVSGAITCMVLPHYSSDLYTYLTK--------------RSRPLPIDQALIIEKQIL 167
Query: 798 SAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKG 857
+ Y+H ++H D+K N+ ++ +GD G A+F +P G
Sbjct: 168 EGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL---------G 215
Query: 858 IKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEM 891
+ GTV APE + + D++S GI+L EM
Sbjct: 216 LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 46/161 (28%), Positives = 75/161 (46%), Gaps = 26/161 (16%)
Query: 687 IGQGSFGFVYKG--NLGENGMMVAVKVINLKQKGAS----NGFVAECQALRNIRHRNLIK 740
IG G FG V G N G V VK + + AS F+ E Q R+++H NL++
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKEL---RVSASVQEQMKFLEEAQPYRSLQHSNLLQ 59
Query: 741 IITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLT----LIQRINIIIDV 796
+ C+ V +V E+ G L+ +L ++A +T +QR+ ++
Sbjct: 60 CLGQCTE-----VTPYLLVMEFCPLGDLKGYL---RSCRKAELMTPDPTTLQRM--ACEI 109
Query: 797 ASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837
A + ++H + +H DL N LL DL +GD+GL+
Sbjct: 110 ALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 2e-08
Identities = 58/218 (26%), Positives = 90/218 (41%), Gaps = 30/218 (13%)
Query: 686 MIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQAL-RNI-----RHRNLI 739
++G+GSFG V L + A+KV LK+ +C + I +H L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKV--LKKDVILQDDDVDCTMTEKRILALAAKHPFLT 59
Query: 740 KIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASA 799
+ F+ D V EY+ G L + +S E RS +V A
Sbjct: 60 ---ALHCC--FQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAA------EVTLA 108
Query: 800 IEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIK 859
+ ++H H V++ DLK N+LLD + L DFG+ K + ++
Sbjct: 109 LMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCK--------EGILNGVTTTTFC 157
Query: 860 GTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897
GT YIAPE E + D ++ G+L+ EM + P
Sbjct: 158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 61/239 (25%), Positives = 107/239 (44%), Gaps = 28/239 (11%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLK--QKGASNGFVAECQALRNIRHRNLI-KIIT 743
IG+G++G VYK G +VA+K L+ ++G + E L+ + I +++
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68
Query: 744 ICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSL--TLIQRI--NIIIDVASA 799
+ + G +V+EY+ + L+ ++ S + R L I+ ++ VA
Sbjct: 69 VEHVEEKNGKPSLYLVFEYL-DSDLKKFM-DSNGRGPGRPLPAKTIKSFMYQLLKGVA-- 124
Query: 800 IEYIHHHCQPPVVHGDLKPSNVLLDQDL-VAHLGDFGLAKFLSSSPLDTAVETPSSSKGI 858
+ H H V+H DLKP N+L+D+ + + D GL + S + S + I
Sbjct: 125 --HCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS-------IPVKSYTHEI 172
Query: 859 KGTVGYIAPEYGMGGEA-SMTGDVYSFGILLLEMFTRRR--PTDGMFNQGLTLHEFART 914
T+ Y APE +G S D++S G + EM ++ P D Q L + + T
Sbjct: 173 V-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGT 230
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 2e-08
Identities = 65/230 (28%), Positives = 97/230 (42%), Gaps = 42/230 (18%)
Query: 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQ-ALRNIR---- 734
+ + + IG+G++G V G+ VA+K I+ + F CQ LR I+
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH---QTF---CQRTLREIKILRR 59
Query: 735 --HRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINI 792
H N+I I+ I F+ + IV E M E L++ Q S IQ
Sbjct: 60 FKHENIIGILDIIRPPSFESFNDVYIVQELM-----ETDLYKLIKTQHL-SNDHIQY--F 111
Query: 793 IIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETP 852
+ + ++YIH V+H DLKPSN+LL+ + + DFGLA+ + P
Sbjct: 112 LYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLAR----------IADP 158
Query: 853 SSSKGIK-----GTVGYIAPEYGMGGEASMTG--DVYSFGILLLEMFTRR 895
T Y APE M T D++S G +L EM + R
Sbjct: 159 EHDHTGFLTEYVATRWYRAPEI-MLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 54/211 (25%), Positives = 100/211 (47%), Gaps = 24/211 (11%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLK-QKGASNGFVAECQALRNIRHRNLIKIITIC 745
+G+G++ VYKG +VA+K I L+ ++GA + E L++++H N++ + I
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 746 SSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHH 805
+ +V+EY+ + L+ +L + ++ L + + + Y H
Sbjct: 74 HT-----EKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLF-----LFQLLRGLNYCHR 122
Query: 806 HCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYI 865
V+H DLKP N+L+++ L DFGLA+ S + T + S + T+ Y
Sbjct: 123 R---KVLHRDLKPQNLLINERGELKLADFGLARAKS-------IPTKTYSNEVV-TLWYR 171
Query: 866 APEYGMGG-EASMTGDVYSFGILLLEMFTRR 895
P+ +G + S D++ G + EM T R
Sbjct: 172 PPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 69/274 (25%), Positives = 116/274 (42%), Gaps = 23/274 (8%)
Query: 686 MIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITIC 745
+IG+GS+ V L +N + A+KV+ K+ + + Q +++ + +
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVK-KELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 746 SSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHH 805
F+ +V EY+ G L + + E + I I A+ ++H
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICI------ALNFLH- 113
Query: 806 HCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYI 865
+ +++ DLK NVLLD D L D+G+ K P DT + GT YI
Sbjct: 114 --ERGIIYRDLKLDNVLLDADGHIKLTDYGMCK-EGLGPGDT-------TSTFCGTPNYI 163
Query: 866 APEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMF-NQGLTLHEFARTALPDKVMEIV 924
APE G E + D ++ G+L+ EM R P D + N + ++ + +K + I
Sbjct: 164 APEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIP 223
Query: 925 DSVLLLEVQASNSRSCGDERLRTEERLVAVVETG 958
L V+AS+ G +ERL +TG
Sbjct: 224 RF---LSVKASHVLK-GFLNKDPKERLGCQPQTG 253
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-08
Identities = 60/220 (27%), Positives = 92/220 (41%), Gaps = 28/220 (12%)
Query: 686 MIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITIC 745
++G+GSFG V L A+K LK+ EC + R ++ +
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKA--LKKDVVLEDDDVECTMVE----RRVLALAWEH 55
Query: 746 SSIDFKGVDFQA-----IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAI 800
+ FQ V EY+ G L + S EAR+ I +
Sbjct: 56 PFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEI------ICGL 109
Query: 801 EYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKG 860
+++H +++ DLK NVLLD+D + DFG+ K + E +S+ G
Sbjct: 110 QFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCK------ENMNGEGKAST--FCG 158
Query: 861 TVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDG 900
T YIAPE G + + + D +SFG+LL EM + P G
Sbjct: 159 TPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 2e-08
Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 25/219 (11%)
Query: 681 FSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNI-RHRNLI 739
F ++G G++G VYKG + G + A+KV+++ E L+ HRN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIA 66
Query: 740 KIITICSSIDFKGVDFQA-IVYEYMQNGSLEDWLHQSE-DQQEARSLTLIQRINIIIDVA 797
+ G+D Q +V E+ GS+ D + ++ + + + I R ++
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR-----EIL 121
Query: 798 SAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKG 857
+ ++H H V+H D+K NVLL ++ L DFG+ S+ LD V ++
Sbjct: 122 RGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGV-----SAQLDRTVGRRNT--- 170
Query: 858 IKGTVGYIAPEYGMGGEA-----SMTGDVYSFGILLLEM 891
GT ++APE E D++S GI +EM
Sbjct: 171 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 209
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 2e-08
Identities = 47/174 (27%), Positives = 72/174 (41%), Gaps = 27/174 (15%)
Query: 726 ECQALRNIRHRNLIKIITICSSIDFKGV---DFQAIVYEYMQNGSLEDWLHQSEDQQEAR 782
E AL + H N++KI I S + + +Y +M + + DW
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAF-DW---------KD 262
Query: 783 SLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSS 842
L Q I+ + A+EYIH ++H D+K N+ L+ D LGDFG A
Sbjct: 263 RPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTA----- 314
Query: 843 SPLDTAVETPSSSK--GIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTR 894
E + G GTV +PE G D++S G++LL+M +
Sbjct: 315 ----MPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSH 364
|
Length = 501 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 53/212 (25%), Positives = 99/212 (46%), Gaps = 32/212 (15%)
Query: 706 MVAVKVINLKQKGASNG---FVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEY 762
+VAVKV L+ + N F+ E + L + N+ +++ +C+ ++ EY
Sbjct: 48 LVAVKV--LRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTV-----DPPLCMIMEY 100
Query: 763 MQNGSLEDWL--HQSEDQQEA---RSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLK 817
M+NG L +L H +E A +SL+ + + +AS + Y+ VH DL
Sbjct: 101 MENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLA 157
Query: 818 PSNVLLDQDLVAHLGDFGLAKFLSSSP---LDTAVETPSSSKGIKGTVGYIAPEYGMGGE 874
N L+ ++ + DFG+++ L SS + P + ++A E + G+
Sbjct: 158 TRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLP---------IRWMAWESVLLGK 208
Query: 875 ASMTGDVYSFGILLLEMFT--RRRPTDGMFNQ 904
+ DV++FG+ L E+ T R +P + + +Q
Sbjct: 209 FTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 59/231 (25%), Positives = 100/231 (43%), Gaps = 25/231 (10%)
Query: 669 ISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQ 728
I + L F ++G G++G VYKG + G + A+KV+++ + E
Sbjct: 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEIN 64
Query: 729 ALRNI-RHRNLIKIITICSSIDFKGVDFQA-IVYEYMQNGSLEDWLHQSE-DQQEARSLT 785
L+ HRN+ G D Q +V E+ GS+ D + ++ + + +
Sbjct: 65 MLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIA 124
Query: 786 LIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPL 845
I R ++ + ++H H V+H D+K NVLL ++ L DFG+ S+ L
Sbjct: 125 YICR-----EILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGV-----SAQL 171
Query: 846 DTAVETPSSSKGIKGTVGYIAPEYGMGGEA-----SMTGDVYSFGILLLEM 891
D V ++ GT ++APE E D++S GI +EM
Sbjct: 172 DRTVGRRNT---FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 4e-08
Identities = 24/68 (35%), Positives = 44/68 (64%)
Query: 148 KLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRF 207
L+++ ++ N + G+ P S+G++++LE +++ N G IP +LG L +L +LNL N
Sbjct: 443 HLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSL 502
Query: 208 SGIVPPSI 215
SG VP ++
Sbjct: 503 SGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 4e-08
Identities = 59/217 (27%), Positives = 91/217 (41%), Gaps = 29/217 (13%)
Query: 686 MIGQGSFGFVYKGNLGENGMMVAVK-----VINLKQKGASNGFVAECQALRNIRHRNLIK 740
++G+G+FG V G A+K VI K + A + E + L+N RH L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHT--LTESRVLQNTRHPFLTA 59
Query: 741 IITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAI 800
+ F+ D V EY G L + H S ++ + I+ SA+
Sbjct: 60 L-----KYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIV----SAL 108
Query: 801 EYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKG 860
Y+H VV+ DLK N++LD+D + DFGL K + ++ K G
Sbjct: 109 GYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK--------EGISDGATMKTFCG 157
Query: 861 TVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897
T Y+APE + D + G+++ EM R P
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 5e-08
Identities = 52/163 (31%), Positives = 78/163 (47%), Gaps = 28/163 (17%)
Query: 686 MIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNG--FVAECQALRNIRHRNLIKIIT 743
+IG+GS+G V G VA+K IN + S+ + E + LR +RH ++++I
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 744 IC---SSIDFKGVDFQAIVYEYMQNGSLEDWLHQ----SED-QQEARSLTLIQRINIIID 795
I S +FK + +V+E M E LHQ ++D E L Q +
Sbjct: 67 IMLPPSRREFKDI---YVVFELM-----ESDLHQVIKANDDLTPEHHQFFLYQLLR---- 114
Query: 796 VASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAK 838
A++YIH V H DLKP N+L + D + DFGLA+
Sbjct: 115 ---ALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 5e-08
Identities = 57/219 (26%), Positives = 91/219 (41%), Gaps = 26/219 (11%)
Query: 686 MIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRN----IRHRNLIKI 741
++G+GSFG V L G AVK LK+ EC + + N
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKA--LKKDVVLIDDDVECTMVEKRVLALAWENPFLT 59
Query: 742 ITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIE 801
C+ F+ + V E++ G L H Q+ L + ++ ++
Sbjct: 60 HLYCT---FQTKEHLFFVMEFLNGGDL--MFHI----QDKGRFDLYRATFYAAEIVCGLQ 110
Query: 802 YIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGT 861
++H +++ DLK NV+LD+D + DFG+ K V + + GT
Sbjct: 111 FLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCK--------ENVFGDNRASTFCGT 159
Query: 862 VGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDG 900
YIAPE G + + + D +SFG+LL EM + P G
Sbjct: 160 PDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 6e-08
Identities = 65/241 (26%), Positives = 100/241 (41%), Gaps = 48/241 (19%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFV---AECQALRNIRHRNLIKIIT 743
+G+G G V+ L G + A+KV++ K+ N E + L + H + T
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP---FLPT 65
Query: 744 ICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINII----IDVASA 799
+ +S F+ + +V +Y G L L +Q + L+ + +V A
Sbjct: 66 LYAS--FQTETYLCLVMDYCPGGELFRLL----QRQPGKCLS----EEVARFYAAEVLLA 115
Query: 800 IEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSP--------------- 844
+EY+H +V+ DLKP N+LL + L DF L+K P
Sbjct: 116 LEYLH--LLG-IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSS 172
Query: 845 -----LDTAVETPSS-SKGIKGTVGYIAPEY--GMGGEASMTGDVYSFGILLLEMFTRRR 896
+T E PS S GT YIAPE G G +++ D ++ GILL EM
Sbjct: 173 VNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV--DWWTLGILLYEMLYGTT 230
Query: 897 P 897
P
Sbjct: 231 P 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 6e-08
Identities = 57/228 (25%), Positives = 102/228 (44%), Gaps = 48/228 (21%)
Query: 687 IGQGSFGFVYKGNLGENG----------MMVAVKVINLKQKG-ASNGFVAECQALRNIRH 735
+GQG+F +YKG L + V +KV L S F + + H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKV--LGSDHRDSLAFFETASLMSQLSH 60
Query: 736 RNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIID 795
++L+K+ +C D +V EY++ G L+ +LH +E +++L ++++
Sbjct: 61 KHLVKLYGVCVR------DENIMVEEYVKFGPLDVFLH-----REKNNVSLHWKLDVAKQ 109
Query: 796 VASAIEYIHHHCQPPVVHGDLKPSNVLLDQD-------LVAHLGDFGLAKFLSSSPLDTA 848
+ASA+ Y+ +VHG++ N+L+ + L D G+ ++ +
Sbjct: 110 LASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP--ITVLSREER 164
Query: 849 VETPSSSKGIKGTVGYIAPEYGMGGEASMT--GDVYSFGILLLEMFTR 894
VE + +IAPE G+AS+T D +SFG LLE+ +
Sbjct: 165 VE----------RIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 6e-08
Identities = 60/228 (26%), Positives = 101/228 (44%), Gaps = 32/228 (14%)
Query: 680 DFSSSNMIGQGSFGFVY---KGNLGENGMMVAVKVIN---LKQKGASNGFV-AECQALRN 732
+F ++G G++G V+ K + G + A+KV+ L QK + E L +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 733 IRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINI 792
+R + + + K ++ +Y+ G + L+Q ++ E I +
Sbjct: 61 VRQSPFLVTLHYAFQTEAK----LHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIIL 116
Query: 793 IIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAK-FLSSSPLDTAVET 851
A+E++H + +V+ D+K N+LLD + L DFGL+K FLS E
Sbjct: 117 ------ALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS--------EE 159
Query: 852 PSSSKGIKGTVGYIAPEY--GMGGEASMTGDVYSFGILLLEMFTRRRP 897
+ GT+ Y+APE G GG D +S GIL+ E+ T P
Sbjct: 160 KERTYSFCGTIEYMAPEIIRGKGGHGKAV-DWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 13/94 (13%)
Query: 811 VVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEY- 869
V+H D+KPSN+LLD L DFG++ L V++ + ++ G Y+APE
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGISGRL--------VDSKAKTRS-AGCAAYMAPERI 186
Query: 870 ---GMGGEASMTGDVYSFGILLLEMFTRRRPTDG 900
+ + DV+S GI L+E+ T + P
Sbjct: 187 DPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 56/211 (26%), Positives = 88/211 (41%), Gaps = 26/211 (12%)
Query: 687 IGQGSFGFVY-----KGNLGEN-GMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIK 740
+G+GSFG VY K E ++ + V L E Q L + H ++K
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQ-EAQLLSKLDHPAIVK 66
Query: 741 IITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAI 800
F D I+ EY + L+ L E + ++L+ Q I + +
Sbjct: 67 FHA-----SFLERDAFCIITEYCEGRDLDCKLE--ELKHTGKTLSENQVCEWFIQLLLGV 119
Query: 801 EYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKG 860
Y+H Q ++H DLK N+ L +L+ +GDFG+++ L S D A G
Sbjct: 120 HYMH---QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGS-CDLATT-------FTG 167
Query: 861 TVGYIAPEYGMGGEASMTGDVYSFGILLLEM 891
T Y++PE D++S G +L EM
Sbjct: 168 TPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 52/217 (23%), Positives = 96/217 (44%), Gaps = 27/217 (12%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKG--ASNGFVAECQALRNIRHR 736
N F ++G+G++G V K E +VA+K ++ + E + LR ++
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 737 NLIKIITICSSIDFKGVDFQAIVYEYMQNGSLE--DWLHQSEDQQEARSLTLIQRINIII 794
N++++ F+ +V+EY++ LE + + ++ RS I
Sbjct: 61 NIVELKEA-----FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSY--------IY 107
Query: 795 DVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSS 854
+ AI + H + +VH D+KP N+L+ + V L DFG A+ LS + ++
Sbjct: 108 QLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG-------SNAN 157
Query: 855 SKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEM 891
T Y +PE +G D++S G +L E+
Sbjct: 158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 57/224 (25%), Positives = 94/224 (41%), Gaps = 32/224 (14%)
Query: 681 FSSSNMIGQGSFGFVYKGNLGENGMMVAVKVIN---LKQKGASNGFVAECQALRNIRHRN 737
F ++G+G FG V + G M A K + +K++ + E Q L + R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 738 LIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQ--QEARSLTLIQRINIIID 795
++ + + ++ D +V M G L+ ++ + E R++ I
Sbjct: 62 VVSL-----AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITC--- 113
Query: 796 VASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSS 855
+E +H +V+ DLKP N+LLD D+G + S L AVE P
Sbjct: 114 ---GLEDLHRE---RIVYRDLKPENILLD--------DYGHIRI---SDLGLAVEIPEGE 156
Query: 856 --KGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897
+G GTVGY+APE + + D + G L+ EM + P
Sbjct: 157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 1e-07
Identities = 52/227 (22%), Positives = 95/227 (41%), Gaps = 59/227 (25%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFV---AECQALRNIR-HRNLIKII 742
IG+G+F V K + G A+K +K+ S V E QALR + H N++++I
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIK--CMKKHFKSLEQVNNLREIQALRRLSPHPNILRLI 64
Query: 743 TI-------CSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIID 795
+ ++ F+ +D +YE ++ + E R + +
Sbjct: 65 EVLFDRKTGRLALVFELMDMN--LYELIKG--------RKRPLPEKRVK------SYMYQ 108
Query: 796 VASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSS 855
+ +++++H + + H D+KP N+L+ D++ L DFG + + S P T E S
Sbjct: 109 LLKSLDHMHRN---GIFHRDIKPENILIKDDIL-KLADFGSCRGIYSKPPYT--EYIS-- 160
Query: 856 KGIKGTVGYIAPE---------YGMGGEASMTGDVYSFGILLLEMFT 893
T Y APE M D+++ G + E+ +
Sbjct: 161 -----TRWYRAPECLLTDGYYGPKM--------DIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-07
Identities = 65/189 (34%), Positives = 96/189 (50%), Gaps = 8/189 (4%)
Query: 410 GIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQI-LSIST 468
+L NL L +L L+ N L+ +I L NL L + + +T +PP I L S
Sbjct: 84 DGSENLLNLLPLPSLDLNLNRLRSNISELLEL-TNLTSLDLDNNNIT-DIPPLIGLLKSN 141
Query: 469 LSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSF 528
L LDLS N + +LP + NL NL ++S N S ++P LS ++L L L GN
Sbjct: 142 LK-ELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKI 198
Query: 529 SGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSN 588
S +P + L +++ELD+S+N++ ++ L NL L L LS N E + G SN
Sbjct: 199 S-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSN 256
Query: 589 KTGISLSGN 597
+ LS N
Sbjct: 257 LETLDLSNN 265
|
Length = 394 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-07
Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 34/217 (15%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVA----ECQALRNIRHRNLIKII 742
+G G++G V G VA+K L + S F E + L++++H N+I ++
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIK--KLYRPFQSELFAKRAYRELRLLKHMKHENVIGLL 80
Query: 743 TICS---SIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASA 799
+ + S+D + DF +V +M G+ L + E E R L+ ++
Sbjct: 81 DVFTPDLSLD-RFHDFY-LVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQM------LKG 130
Query: 800 IEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIK 859
++YIH ++H DLKP N+ +++D + DFGLA+ +T S G
Sbjct: 131 LKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----------QTDSEMTGYV 176
Query: 860 GTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRR 895
T Y APE + + T D++S G ++ EM T +
Sbjct: 177 VTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-07
Identities = 50/164 (30%), Positives = 79/164 (48%), Gaps = 21/164 (12%)
Query: 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLI 739
+F I +G+FG VY G N + AVKV+ K + V + QA R+ L
Sbjct: 5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVK-KADMINKNMVHQVQAERDAL--ALS 61
Query: 740 K---IITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSE--DQQEARSLTLIQRINIII 794
K I+ + S+ + + +V EY+ G ++ LH D++ A I
Sbjct: 62 KSPFIVHLYYSL--QSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKY--------IS 111
Query: 795 DVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAK 838
+VA A++Y+H H ++H DLKP N+L+ + L DFGL+K
Sbjct: 112 EVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 15/154 (9%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGAS---NGFVAECQALRNIRHRNLIKIIT 743
IG G FG V + + + V V LK +S N F+ + R ++H N+++ +
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 744 IC-SSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEY 802
C +I + +V+EY + G L+ +L Q + + L L+QR+ ++A+ + +
Sbjct: 63 QCVEAIPY------LLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRM--ACEIAAGVTH 114
Query: 803 IHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836
+H H +H DL N L DL +GD+G+
Sbjct: 115 MHKH---NFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 56/227 (24%), Positives = 95/227 (41%), Gaps = 38/227 (16%)
Query: 681 FSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ----KGASNGFVAECQALRNIRHR 736
F ++G+G FG V + G M A K + K+ KG + + E + L + R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA-LNEKRILEKVNSR 60
Query: 737 NLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQ----SEDQQEARSLTLIQRINI 792
++ + + ++ D +V M G L+ ++ D+Q A I
Sbjct: 61 FVVSL-----AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRA--------IFY 107
Query: 793 IIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETP 852
++ +E + + +V+ DLKP N+LLD + D GLA V+ P
Sbjct: 108 AAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLA-----------VQIP 153
Query: 853 SSS--KGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897
+G GTVGY+APE + + + D + G L+ EM + P
Sbjct: 154 EGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 49/206 (23%), Positives = 98/206 (47%), Gaps = 36/206 (17%)
Query: 705 MMVAVKVINLK-QKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYM 763
++VAVK++ K A N F+ E + L ++ N+I+++ +C D ++ EYM
Sbjct: 47 LLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVD-----EDPLCMITEYM 101
Query: 764 QNGSLEDWL--HQSEDQQEARSLTLIQR-----------INIIIDVASAIEYIHHHCQPP 810
+NG L +L H +D++E + + +++ + +AS ++Y+
Sbjct: 102 ENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLN 158
Query: 811 VVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKG----TVGYIA 866
VH DL N L+ ++L + DFG+++ L + I+G + ++A
Sbjct: 159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYA----------GDYYRIQGRAVLPIRWMA 208
Query: 867 PEYGMGGEASMTGDVYSFGILLLEMF 892
E + G+ + DV++FG+ L E+
Sbjct: 209 WECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 2e-07
Identities = 56/226 (24%), Positives = 93/226 (41%), Gaps = 52/226 (23%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVA----ECQALRNIRHRN---LI 739
+G G++G V + G VA+K L + S E + L+++ H N L+
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIK--KLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLL 80
Query: 740 KIITICSSIDFKGVDFQAI--VYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIII-DV 796
+ T SS++ DFQ + V M L+ Q+ I ++ +
Sbjct: 81 DVFTPASSLE----DFQDVYLVTHLMGAD-----LNNIVKCQKLSD----DHIQFLVYQI 127
Query: 797 ASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSK 856
++YIH ++H DLKPSN+ +++D + DFGLA+ T
Sbjct: 128 LRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLAR-----------HTDDEMT 173
Query: 857 GIKGTVGYIAPE-------YGMGGEASMTGDVYSFGILLLEMFTRR 895
G T Y APE Y + T D++S G ++ E+ T +
Sbjct: 174 GYVATRWYRAPEIMLNWMHY------NQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 3e-07
Identities = 40/153 (26%), Positives = 58/153 (37%), Gaps = 24/153 (15%)
Query: 688 GQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFV---AECQALRNIRHRNLIKIITI 744
+ K +VAVK INL + E R ++H N++ +T
Sbjct: 11 EDLMIVHLAKHK--PTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVT- 66
Query: 745 CSSIDFKGVDFQAIVYEYMQNGSLEDWL--HQSEDQQEARSLTLIQRINIIIDVASAIEY 802
S I + +V M GS ED L H E E I I+ DV +A++Y
Sbjct: 67 -SFIVDSEL---YVVSPLMAYGSCEDLLKTHFPEGLPE----LAIA--FILKDVLNALDY 116
Query: 803 IHH-HCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834
IH +H +K S++LL D L
Sbjct: 117 IHSKGF----IHRSVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 3e-07
Identities = 59/235 (25%), Positives = 92/235 (39%), Gaps = 63/235 (26%)
Query: 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVA-----ECQALRN 732
TN + +G G+FG V G VA+K I K S +A E + L++
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKI---MKPFSTPVLAKRTYRELKLLKH 65
Query: 733 IRHRNLIKIITICSS--------IDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSL 784
+RH N+I + I S + G D + + + LE Q Q R L
Sbjct: 66 LRHENIISLSDIFISPLEDIYFVTELLGTDLHRL----LTSRPLEKQFIQYFLYQILRGL 121
Query: 785 TLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSP 844
+Y+H VVH DLKPSN+L++++ + DFGLA+
Sbjct: 122 ----------------KYVH---SAGVVHRDLKPSNILINENCDLKICDFGLAR------ 156
Query: 845 LDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTG-------DVYSFGILLLEMF 892
++ P + GY++ Y E +T D++S G + EM
Sbjct: 157 ----IQDPQMT-------GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 47/222 (21%), Positives = 93/222 (41%), Gaps = 35/222 (15%)
Query: 694 FVYKGNLGENGMMVAVKVINLKQKGA---SNGFVAECQALRNIRHRNLIKI----ITICS 746
+YKG N V ++ KG + E + LR I N++KI I I
Sbjct: 35 SIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD 92
Query: 747 SIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHH 806
+ +++ EY G L + L + +D L+ ++++ ID + ++ +
Sbjct: 93 DLPR-----LSLILEYCTRGYLREVLDKEKD------LSFKTKLDMAIDCCKGLYNLYKY 141
Query: 807 CQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIA 866
P + +L + L+ ++ + GL K LSS P K + + Y +
Sbjct: 142 TNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPP----------FKNVN-FMVYFS 188
Query: 867 PEY--GMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGL 906
+ + E ++ D+YS G++L E+FT + P + + + +
Sbjct: 189 YKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI 230
|
Length = 283 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 4e-07
Identities = 30/88 (34%), Positives = 52/88 (59%), Gaps = 4/88 (4%)
Query: 521 LYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEV 580
L L G IP+ +S L+ ++ +++S N++ G IP L +++ LE L+LSYN F G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 581 P-TKGVFSNKTGISLSGN---GKVCGGL 604
P + G ++ ++L+GN G+V L
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 4e-07
Identities = 44/131 (33%), Positives = 62/131 (47%), Gaps = 21/131 (16%)
Query: 781 ARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFL 840
R L L Q + + SAI+YIH + ++H D+K NVL++ LGDFG A F
Sbjct: 254 LRPLGLAQVTAVARQLLSAIDYIH--GEG-IIHRDIKTENVLVNGPEDICLGDFGAACFA 310
Query: 841 SSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLE-------MFT 893
S TP GI GTV APE G + + D++S G+++ E +F+
Sbjct: 311 RGS-----WSTPFHY-GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFS 364
Query: 894 -----RRRPTD 899
RRP D
Sbjct: 365 ASRGDERRPYD 375
|
Length = 461 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 5e-07
Identities = 59/223 (26%), Positives = 96/223 (43%), Gaps = 41/223 (18%)
Query: 680 DFSSSNMIGQGSFGFV----YKGNLGENGMMVAVKVIN----LKQKGASNGFVAECQALR 731
DF+ +G GSFG V YK E+ VA+K +KQK + F +E + L
Sbjct: 31 DFNFIRTLGTGSFGRVILATYKN---EDFPPVAIKRFEKSKIIKQKQVDHVF-SERKILN 86
Query: 732 NIRHRNLIKIITICSSI--DFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQR 789
I H C ++ FK + +V E++ G +L +++ +
Sbjct: 87 YINH-------PFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQ 139
Query: 790 INIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAV 849
I +I + ++ +V+ DLKP N+LLD+D + DFG AK V
Sbjct: 140 IVLIFEYLQSLN---------IVYRDLKPENLLLDKDGFIKMTDFGFAKV---------V 181
Query: 850 ETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMF 892
+T + + + GT YIAPE + D ++ GI + E+
Sbjct: 182 DTRTYT--LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 5e-07
Identities = 60/251 (23%), Positives = 101/251 (40%), Gaps = 48/251 (19%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNL 738
+DF S +IG+G+FG V + G + A+K++ K VA +A R+I L
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILR-KADMLEKEQVAHIRAERDI----L 55
Query: 739 IK-----IITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINII 793
++ ++ + S F+ ++ E++ G + L + + E + I +
Sbjct: 56 VEADGAWVVKMFYS--FQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLA 113
Query: 794 IDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSS---------- 843
ID + +IH D+KP N+LLD L DFGL L +
Sbjct: 114 IDAIHQLGFIHR---------DIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLT 164
Query: 844 ---PLDTAVETPSSSKGIK--------------GTVGYIAPEYGMGGEASMTGDVYSFGI 886
P D + + +S + + GT YIAPE M + D +S G+
Sbjct: 165 HNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGV 224
Query: 887 LLLEMFTRRRP 897
++ EM P
Sbjct: 225 IMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 6e-07
Identities = 31/105 (29%), Positives = 52/105 (49%), Gaps = 11/105 (10%)
Query: 795 DVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSS 854
+++ A+ Y+H + +++ DLK NVLLD + L D+G+ K + +
Sbjct: 104 EISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--------EGLRPGDT 152
Query: 855 SKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTD 899
+ GT YIAPE G + + D ++ G+L+ EM R P D
Sbjct: 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 7e-07
Identities = 62/227 (27%), Positives = 93/227 (40%), Gaps = 28/227 (12%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVIN---LKQKGASNGFVAECQALRNIRH 735
+DF +IG+G+FG V + + A+K++N + ++ + F E RN+
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREE----RNVLV 56
Query: 736 RNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIID 795
+ IT F+ ++ +V +Y G L L + ED+ I +
Sbjct: 57 NGDCQWITTLHYA-FQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY-----IAE 110
Query: 796 VASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSS 855
+ AI IH Q VH D+KP NVLLD + L DFG S L + S
Sbjct: 111 MVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFG-------SCLKMNQDGTVQS 160
Query: 856 KGIKGTVGYIAPEYGMGGEASMTG-----DVYSFGILLLEMFTRRRP 897
GT YI+PE E M D +S G+ + EM P
Sbjct: 161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 8e-07
Identities = 44/181 (24%), Positives = 78/181 (43%), Gaps = 17/181 (9%)
Query: 723 FVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEAR 782
F E + H N++ ++ + V+EY+ +L + L
Sbjct: 25 FRRETALCARLYHPNIVALLDSGEAPP----GLLFAVFEYVPGRTLREVL------AADG 74
Query: 783 SLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQ-DLVAH--LGDFGLAKF 839
+L + +++ V A+ H+ +VH DLKP N+++ Q + H + DFG+
Sbjct: 75 ALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTL 131
Query: 840 LSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTD 899
L D V T + + + GT Y APE G + D+Y++G++ LE T +R
Sbjct: 132 LPGVR-DADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQ 190
Query: 900 G 900
G
Sbjct: 191 G 191
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 9e-07
Identities = 58/223 (26%), Positives = 95/223 (42%), Gaps = 22/223 (9%)
Query: 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQAL--RNIRHRN 737
DF+ ++G+GSFG V + A+K+ LK+ EC + R +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEKRVLALSG 58
Query: 738 LIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVA 797
+T S F+ +D V EY+ G L + Q +E ++ I I
Sbjct: 59 KPPFLTQLHSC-FQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAI----- 112
Query: 798 SAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKG 857
+ ++H +++ DLK NV+LD + + DFG+ K + D ++K
Sbjct: 113 -GLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGV-----TTKT 160
Query: 858 IKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDG 900
GT YIAPE + D ++FG+LL EM + P +G
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 56/187 (29%), Positives = 83/187 (44%), Gaps = 6/187 (3%)
Query: 411 IPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLS 470
+P+SL L L L+ S +L N L L + L + L T
Sbjct: 62 LPSSLSRLLSLDLLSPSGISS-LDGSENLLNLLPLPSLDLNLNRLRSNISE--LLELTNL 118
Query: 471 LSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSG 530
SLDL N ++ PL NL ++S N+ +P L +L+ L L N S
Sbjct: 119 TSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS- 176
Query: 531 SIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNKT 590
+P LS+L ++ LD+S N +S +P +E LS LE L+LS N + + N +
Sbjct: 177 DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLS 235
Query: 591 GISLSGN 597
G+ LS N
Sbjct: 236 GLELSNN 242
|
Length = 394 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 57/226 (25%), Positives = 92/226 (40%), Gaps = 43/226 (19%)
Query: 687 IGQGSFGFV----YKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIR-------- 734
+GQG++G V E VA+K I +N F + A R +R
Sbjct: 8 LGQGAYGIVCSARNAETSEEET--VAIKKI-------TNVFSKKILAKRALRELKLLRHF 58
Query: 735 --HRNLIKII--TICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRI 790
H+N+ + I +F + +YE + L + + +A + I +I
Sbjct: 59 RGHKNITCLYDMDIVFPGNFNEL----YLYEELMEADLHQIIRSGQPLTDAHFQSFIYQI 114
Query: 791 NIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVE 850
++YIH V+H DLKP N+L++ D + DFGLA+ S +P E
Sbjct: 115 ------LCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP----GE 161
Query: 851 TPSSSKGIKGTVGYIAPEYGMGGEASMTG-DVYSFGILLLEMFTRR 895
T Y APE + ++ DV+S G +L E+ R+
Sbjct: 162 NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 53/206 (25%), Positives = 80/206 (38%), Gaps = 40/206 (19%)
Query: 707 VAVKVINLKQKGASNGFVAECQALRNIRHRNLIKII-------TICSSIDFKGVDFQAIV 759
V VK + G + G E L+ I HR +I +I T+C + D +
Sbjct: 122 VIVKAVT---GGKTPG--REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCD----L 172
Query: 760 YEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPS 819
+ Y+ L L Q I I + A+ Y+H ++H D+K
Sbjct: 173 FTYVDRSG---------------PLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTE 214
Query: 820 NVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTG 879
N+ LD+ A LGDFG A LD +TP G GT+ +PE
Sbjct: 215 NIFLDEPENAVLGDFGAA-----CKLDAHPDTPQCY-GWSGTLETNSPELLALDPYCAKT 268
Query: 880 DVYSFGILLLEMFTRRRPTDGMFNQG 905
D++S G++L EM + G +
Sbjct: 269 DIWSAGLVLFEMSVKNVTLFGKQVKS 294
|
Length = 392 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-06
Identities = 62/246 (25%), Positives = 101/246 (41%), Gaps = 40/246 (16%)
Query: 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIR-HRNL 738
DF S +IG+G+FG V + G + A+K++ K V +A R+I +
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILR-KADMLEKEQVGHIRAERDILVEADS 60
Query: 739 IKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVAS 798
+ ++ + S K + ++ E++ G + L + + +LT + I +
Sbjct: 61 LWVVKMFYSFQDKLNLY--LIMEFLPGGDMMTLLMKKD------TLTEEETQFYIAETVL 112
Query: 799 AIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLS-------------SSPL 845
AI+ IH Q +H D+KP N+LLD L DFGL L S P
Sbjct: 113 AIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPS 169
Query: 846 DTAVETPSSSKGIK--------------GTVGYIAPEYGMGGEASMTGDVYSFGILLLEM 891
D + +S + + GT YIAPE M + D +S G+++ EM
Sbjct: 170 DFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229
Query: 892 FTRRRP 897
P
Sbjct: 230 LIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-06
Identities = 59/223 (26%), Positives = 96/223 (43%), Gaps = 42/223 (18%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNI------RHRNLIK 740
IG G+FG V+ +G VA+K K V+ + R + +H N++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALK----KMPNVFQNLVSCKRVFRELKMLCFFKHDNVLS 63
Query: 741 IITICSS--IDFKGVDFQAI--VYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDV 796
+ I ID F+ I V E MQ+ LH+ + S ++ + +
Sbjct: 64 ALDILQPPHIDP----FEEIYVVTELMQSD-----LHKIIVSPQPLSSDHVKVF--LYQI 112
Query: 797 ASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSK 856
++Y+H ++H D+KP N+L++ + V + DFGLA+ VE P SK
Sbjct: 113 LRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLAR----------VEEPDESK 159
Query: 857 GIKGTV---GYIAPEYGMGGEASMTG-DVYSFGILLLEMFTRR 895
+ V Y APE MG + D++S G + E+ RR
Sbjct: 160 HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-06
Identities = 33/105 (31%), Positives = 53/105 (50%), Gaps = 11/105 (10%)
Query: 795 DVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSS 854
+++ A+ ++H + +++ DLK NVLLD + L D+G+ K P DT
Sbjct: 104 EISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK-EGIRPGDT------- 152
Query: 855 SKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTD 899
+ GT YIAPE G + + D ++ G+L+ EM R P D
Sbjct: 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 61/231 (26%), Positives = 98/231 (42%), Gaps = 36/231 (15%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVIN---LKQKGASNGFVAECQALRNIRH 735
+DF +IG+G+FG V + G + A+K++N + ++ + F E L N
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 736 RNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSED---QQEARSLTLIQRINI 792
R + + F+ + +V +Y G L L + ED + AR
Sbjct: 61 RWITNL-----HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY-------- 107
Query: 793 IIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG-LAKFLSSSPLDTAVET 851
+ ++ AI+ +H Q VH D+KP NVLLD++ L DFG + L+ + + V
Sbjct: 108 LAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAV 164
Query: 852 PSSSKGIKGTVGYIAPEY--GMGGEASMTG---DVYSFGILLLEMFTRRRP 897
GT YI+PE M G D +S G+ + EM P
Sbjct: 165 --------GTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 65/241 (26%), Positives = 99/241 (41%), Gaps = 57/241 (23%)
Query: 672 AELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVIN---LKQKGASNGFVAECQ 728
+L DF +IG+G+FG V + + A+K+++ + ++ S F E
Sbjct: 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEE-- 93
Query: 729 ALRNIR-HRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSL----------EDWLHQSED 777
R+I H N I+ + + F+ + +V EYM G L E W
Sbjct: 94 --RDIMAHANSEWIVQLHYA--FQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKW------ 143
Query: 778 QQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837
AR T +V A++ IH +H D+KP N+LLD+ L DFG
Sbjct: 144 ---ARFYTA--------EVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTC 189
Query: 838 KFLSSSPL---DTAVETPSSSKGIKGTVGYIAPEY----GMGGEASMTGDVYSFGILLLE 890
+ ++ + DTAV TP YI+PE G G D +S G+ L E
Sbjct: 190 MKMDANGMVRCDTAVGTPD----------YISPEVLKSQGGDGYYGRECDWWSVGVFLYE 239
Query: 891 M 891
M
Sbjct: 240 M 240
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 3e-06
Identities = 55/223 (24%), Positives = 93/223 (41%), Gaps = 22/223 (9%)
Query: 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLI 739
DF+ ++G+GSFG V + A+K+ LK+ EC + R L
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKI--LKKDVIIQDDDVEC-TMVEKRVLALP 57
Query: 740 KIITICSSID--FKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVA 797
+ + F+ +D V EY+ G L + Q +E + ++A
Sbjct: 58 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEP------HAVFYAAEIA 111
Query: 798 SAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKG 857
+ ++H +++ DLK NV+LD + + DFG+ K + +++
Sbjct: 112 IGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCK--------ENIFGGKTTRT 160
Query: 858 IKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDG 900
GT YIAPE + D ++FG+LL EM + P DG
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 4e-06
Identities = 85/348 (24%), Positives = 132/348 (37%), Gaps = 46/348 (13%)
Query: 58 SNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTN 117
+ L + L L L+ + + + L+ L +L L N +
Sbjct: 54 LSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSE-NLLNLLPLPSLDLNLNRLR-SNISE 111
Query: 118 LSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERIN 177
L +NL S + NN+ +IP +G L+ L ++DN + P+ + NL L+ ++
Sbjct: 112 LLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLD 169
Query: 178 VLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPL 237
+ N L +P L NL NL L+L N+ S +PP I +S+LE
Sbjct: 170 LSFNDL-SDLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALE--------------- 212
Query: 238 DIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWL 297
+ NN + SLSN NL L L +N+ L NLE L
Sbjct: 213 -----------ELDLSNNSIIELLSSLSNLKNLSGLELSNNKLEDLPESIGN-LSNLETL 260
Query: 298 NLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGN 357
+L SNN + + L LTN EL L N LP L + +
Sbjct: 261 DL-SNNQIS----SISSLGSLTNLRELD---LSGNSLSNALPLIALLLLLLELLLNLLLT 312
Query: 358 QISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSN 405
+ + L N + N T + P A+ L++L L+ N
Sbjct: 313 LKALELKLNSILLNNNI----LSNGET-SSPEALSILESLNNLWTLDN 355
|
Length = 394 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 4e-06
Identities = 55/228 (24%), Positives = 94/228 (41%), Gaps = 32/228 (14%)
Query: 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVIN---LKQKGASNGFVAECQALRNIRHR 736
DF +IG+G+FG V L + A+K++N + ++ + F E L N ++
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 737 NLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQ-QEARSLTLIQRINIIID 795
+ + F+ + +V +Y G L L + ED+ E + + + I ID
Sbjct: 62 WITTL-----HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAID 116
Query: 796 VASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG-LAKFLSSSPLDTAVETPSS 854
+ Y+H D+KP N+L+D + L DFG K + + ++V
Sbjct: 117 SVHQLHYVHR---------DIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV--- 164
Query: 855 SKGIKGTVGYIAPEYGMG-----GEASMTGDVYSFGILLLEMFTRRRP 897
GT YI+PE G+ D +S G+ + EM P
Sbjct: 165 -----GTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 4e-06
Identities = 52/219 (23%), Positives = 97/219 (44%), Gaps = 38/219 (17%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVK--------VINLKQKGASNGFVAECQALRNIRHRNL 738
+G G++G V + G+ VAVK +I+ K+ E + L++++H N+
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT------YRELRLLKHMKHENV 78
Query: 739 IKIITICS-SIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVA 797
I ++ + + + + + +V M L + + + + LT +I +
Sbjct: 79 IGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-------KCQKLTDDHVQFLIYQIL 130
Query: 798 SAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKG 857
++YIH ++H DLKPSN+ +++D + DFGLA+ T G
Sbjct: 131 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------HTDDEMTG 176
Query: 858 IKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRR 895
T Y APE + + T D++S G ++ E+ T R
Sbjct: 177 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 5e-06
Identities = 59/238 (24%), Positives = 105/238 (44%), Gaps = 33/238 (13%)
Query: 662 MDQQFPMISYAELS-KATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGAS 720
D QF + A+ + + IG G+ G V G+ VAVK ++ + +
Sbjct: 3 EDSQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQT 62
Query: 721 NGFVA--ECQALRNIRHRNLIKIITICS---SIDFKGVDFQAI--VYEYMQNGSLEDWLH 773
+ A E L+ + H+N+I ++ + + S++ +FQ + V E M + +L +H
Sbjct: 63 HAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE----EFQDVYLVMELM-DANLCQVIH 117
Query: 774 QSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGD 833
D E S L Q + I+++H ++H DLKPSN+++ D + D
Sbjct: 118 MELDH-ERMSYLLYQ-------MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILD 166
Query: 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEM 891
FGLA+ ++ + T T Y APE +G D++S G ++ E+
Sbjct: 167 FGLARTACTNFMMTPYVV---------TRYYRAPEVILGMGYKENVDIWSVGCIMGEL 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 6e-06
Identities = 54/223 (24%), Positives = 94/223 (42%), Gaps = 39/223 (17%)
Query: 681 FSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVA----ECQALRNIRHR 736
++S +G G++G V G VA+K L + S F E L++++H
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIK--KLSRPFQSEIFAKRAYRELTLLKHMQHE 74
Query: 737 NLIKIITI-CSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTL----IQRIN 791
N+I ++ + S++ +V YMQ D Q+ L +Q +
Sbjct: 75 NVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-----------DLQKIMGHPLSEDKVQYL- 122
Query: 792 IIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVET 851
+ + ++YIH ++H DLKP N+ +++D + DFGLA+
Sbjct: 123 -VYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----------HA 167
Query: 852 PSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFT 893
+ G T Y APE + + T D++S G ++ EM T
Sbjct: 168 DAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLT 210
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 6e-06
Identities = 61/212 (28%), Positives = 91/212 (42%), Gaps = 21/212 (9%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHR-NLIKIITIC 745
IG+GSFG V + + + A+K I K S V A R + + N I+ +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIR-KAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK 59
Query: 746 SSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHH 805
S + +V ++ G L L Q+E R R ++ A+E +H
Sbjct: 60 FSFQSPEKLY--LVLAFINGGELFHHL-----QREGRFDLSRARF-YTAELLCALENLH- 110
Query: 806 HCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYI 865
+ V++ DLKP N+LLD L DFGL K L+ D + GT Y+
Sbjct: 111 --KFNVIYRDLKPENILLDYQGHIALCDFGLCK-LNMKDDDK-------TNTFCGTPEYL 160
Query: 866 APEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897
APE +G + D ++ G+LL EM T P
Sbjct: 161 APELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 7e-06
Identities = 42/144 (29%), Positives = 65/144 (45%), Gaps = 15/144 (10%)
Query: 754 DFQAIVYEY--MQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYI-HHHCQPP 810
D Q Y+ GS + + + LT + ++ VA +E++ +C
Sbjct: 202 DIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNC--- 258
Query: 811 VVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKG-TVGYIAPEY 869
VH DL NVLL Q + + DFGLA+ D ++ SKG V ++APE
Sbjct: 259 -VHRDLAARNVLLAQGKIVKICDFGLAR-------DIMHDSNYVSKGSTFLPVKWMAPES 310
Query: 870 GMGGEASMTGDVYSFGILLLEMFT 893
+ DV+S+GILL E+F+
Sbjct: 311 IFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 8e-06
Identities = 31/99 (31%), Positives = 47/99 (47%), Gaps = 11/99 (11%)
Query: 799 AIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGI 858
A+E++H +++ DLKP N+LLD L DFGL K ++ + +
Sbjct: 112 ALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCK--------ESIHEGTVTHTF 160
Query: 859 KGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897
GT+ Y+APE M D +S G L+ +M T P
Sbjct: 161 CGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 9e-06
Identities = 58/218 (26%), Positives = 97/218 (44%), Gaps = 34/218 (15%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNI-----RHRNLIKI 741
IG+G++G V+K +NG AVK+++ + E +A NI H N++K
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILD-----PIHDIDEEIEAEYNILKALSDHPNVVKF 80
Query: 742 ITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIE 801
+ D K D +V E GS+ D + + E +I I + A+
Sbjct: 81 YGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYI-----LHEALM 135
Query: 802 YIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPL--DTAVETPSSSKGIK 859
+ H +H D+K +N+LL + L DFG++ L+S+ L +T+V TP
Sbjct: 136 GLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPF------ 189
Query: 860 GTVGYIAPEYGMGGEASMTG------DVYSFGILLLEM 891
++APE + E + DV+S GI +E+
Sbjct: 190 ----WMAPEV-IACEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 1e-05
Identities = 48/186 (25%), Positives = 78/186 (41%), Gaps = 31/186 (16%)
Query: 711 VINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGV---DFQAIVYEYMQNGS 767
VI Q+G G E LR I H ++I++ + F + ++ +Y Y+
Sbjct: 121 VIKAGQRG---GTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLA--- 174
Query: 768 LEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDL 827
R++ + + I V AI+Y+H + ++H D+K N+ ++
Sbjct: 175 ------------AKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPG 219
Query: 828 VAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGIL 887
LGDFG A F P+D + G GT+ APE D++S GI+
Sbjct: 220 DVCLGDFGAACF----PVDI---NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIV 272
Query: 888 LLEMFT 893
L EM T
Sbjct: 273 LFEMAT 278
|
Length = 391 |
| >gnl|CDD|185268 PRK15370, PRK15370, E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-05
Identities = 61/199 (30%), Positives = 94/199 (47%), Gaps = 31/199 (15%)
Query: 372 NLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSL-GNLTLLTNLALSSND 430
N EL + LT TIP I E + L LD+N L +P +L GN+ L +SN
Sbjct: 179 NKTELRLKILGLT-TIPACIPE--QITTLILDNNELKS-LPENLQGNIK---TLYANSNQ 231
Query: 431 LQGSIPPSLGNCKNLIELHMADI-ELTGALPPQILSISTLSLSLDLSYNLLSG---TLPL 486
L SIP +L + +EL + I EL LP S L SLDL +N +S LP
Sbjct: 232 LT-SIPATLPDTIQEMELSINRITELPERLP------SALQ-SLDLFHNKISCLPENLPE 283
Query: 487 EVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLS-SLKSIKEL 545
E L+ L ++ S+ +P + + L +Q NS + ++P +L LK+++
Sbjct: 284 E---LRYLSVYDNSIRTLPAHLP------SGITHLNVQSNSLT-ALPETLPPGLKTLEAG 333
Query: 546 DMSSNNLSGQIPEYLENLS 564
+ + +L +P L+ L
Sbjct: 334 ENALTSLPASLPPELQVLD 352
|
Length = 754 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 37/140 (26%), Positives = 57/140 (40%), Gaps = 38/140 (27%)
Query: 793 IIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL---------AKFL--- 840
I ++ AIE +H + +H D+KP N+L+D+D L DFGL +K+
Sbjct: 107 IAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKG 163
Query: 841 ------SSSPLDTAVE-TPSSSKGIK----------------GTVGYIAPEYGMGGEASM 877
S P + E K ++ GT YIAPE + +
Sbjct: 164 DHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ 223
Query: 878 TGDVYSFGILLLEMFTRRRP 897
D +S G++L EM + P
Sbjct: 224 LCDWWSVGVILYEMLVGQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-05
Identities = 61/232 (26%), Positives = 103/232 (44%), Gaps = 39/232 (16%)
Query: 673 ELSKATN-DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALR 731
+++++ N + N+IG GSFG VY+ + VA+K + L+ N E ++
Sbjct: 59 DINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV-LQDPQYKN---RELLIMK 114
Query: 732 NIRHRNLIKI----ITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLI 787
N+ H N+I + T C + K + F +V E++ ++ ++ A L L+
Sbjct: 115 NLNHINIIFLKDYYYTECFKKNEKNI-FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLV 172
Query: 788 QRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDL-VAHLGDFGLAKFLSSSPLD 846
+ + + A+ YIH + H DLKP N+L+D + L DFG AK L
Sbjct: 173 KLYS--YQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL------ 221
Query: 847 TAVETPSSSKGIKGTVGYI------APEYGMGGEASMTG-DVYSFGILLLEM 891
+ +V YI APE +G T D++S G ++ EM
Sbjct: 222 ---------LAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEM 264
|
Length = 440 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 58/234 (24%), Positives = 100/234 (42%), Gaps = 35/234 (14%)
Query: 674 LSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALR 731
L D+ +IG+G+FG V + + A+K+++ + K + + F E + +
Sbjct: 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIM 97
Query: 732 NIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSE-DQQEARSLTLIQRI 790
+ + + C+ F+ + +V EYM G L + + + ++ A+ T
Sbjct: 98 AFANSPWV-VQLFCA---FQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYT----- 148
Query: 791 NIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPL---DT 847
+V A++ IH ++H D+KP N+LLD+ L DFG + + + DT
Sbjct: 149 ---AEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDT 202
Query: 848 AVETPSSSKGIKGTVGYIAPEY----GMGGEASMTGDVYSFGILLLEMFTRRRP 897
AV TP YI+PE G G D +S G+ L EM P
Sbjct: 203 AVGTPD----------YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-05
Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 11/134 (8%)
Query: 762 YMQNGSLEDWLHQSEDQQE--ARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPS 819
+++ SL D + +Q++ + LTL I VA +E++ +H DL
Sbjct: 152 FVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAAR 208
Query: 820 NVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTG 879
N+LL ++ V + DFGLA+ + P V + +K ++APE ++
Sbjct: 209 NILLSENNVVKICDFGLARDIYKDP--DYVRKGDARLPLK----WMAPETIFDRVYTIQS 262
Query: 880 DVYSFGILLLEMFT 893
DV+SFG+LL E+F+
Sbjct: 263 DVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 3e-05
Identities = 64/252 (25%), Positives = 112/252 (44%), Gaps = 61/252 (24%)
Query: 681 FSSSNM-----IGQGSFGFVYKGNLGENGMMVAVK-----VINLKQKGASNGFVAECQAL 730
F++ ++ IG+G+FG V K +G ++AVK V +QK + + +
Sbjct: 1 FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKR----LLMDLDVV 56
Query: 731 RNIRHRNLIKIITICSSIDFKGVDFQA----IVYEYMQNGSLEDWLHQSEDQQEARSLTL 786
+R + I+ F G F+ I E M + SL+ + + ++ +
Sbjct: 57 --MRSSDCPYIVK------FYGALFREGDCWICMELM-DISLDKFYKYVYEVLKSV---I 104
Query: 787 IQRINIIIDVAS--AIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSP 844
+ I I VA+ A+ Y+ + ++H D+KPSN+LLD++ L DFG++ L
Sbjct: 105 PEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQL---- 158
Query: 845 LDTAVETPSSSKGIKGTVGYIAPE---------YGMGGEASMTGDVYSFGILLLEMFTRR 895
+D+ +T + G Y+APE Y + DV+S GI L E+ T +
Sbjct: 159 VDSIAKTRDA-----GCRPYMAPERIDPSARDGY------DVRSDVWSLGITLYEVATGK 207
Query: 896 RPTDG---MFNQ 904
P +F+Q
Sbjct: 208 FPYPKWNSVFDQ 219
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 50/216 (23%), Positives = 97/216 (44%), Gaps = 22/216 (10%)
Query: 687 IGQGSFGFVYKGNL--GENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITI 744
+G+G++G VYK G++ A+K I + G S E LR ++H N+I + +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQI--EGTGISMSACREIALLRELKHPNVIALQKV 66
Query: 745 CSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRI--NIIIDVASAIEY 802
S + V ++++Y ++ + + + L + + +++ + I Y
Sbjct: 67 FLSHSDRKV---WLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123
Query: 803 IHHHCQPPVVHGDLKPSNVLL----DQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGI 858
+H + V+H DLKP+N+L+ + + D G A+ L +SPL + +
Sbjct: 124 LHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR-LFNSPLKPLADLDP----V 175
Query: 859 KGTVGYIAPEYGMGGEASMTG-DVYSFGILLLEMFT 893
T Y APE +G D+++ G + E+ T
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 62/230 (26%), Positives = 99/230 (43%), Gaps = 40/230 (17%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRH--R 736
DF + +I G++G VY E A+K IN KQ + + R+I
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKIN-KQNLILRNQIQQVFVERDILTFAE 59
Query: 737 NLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINII-ID 795
N + CS F+ +V EY++ G TL++ I + +D
Sbjct: 60 NPFVVSMFCS---FETKRHLCMVMEYVEGGDCA---------------TLLKNIGALPVD 101
Query: 796 VAS--------AIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKF----LSSS 843
+A A+EY+H++ +VH DLKP N+L+ L DFGL+K L+++
Sbjct: 102 MARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158
Query: 844 PLDTAVETPS---SSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLE 890
+ +E + K + GT YIAPE + D ++ GI+L E
Sbjct: 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYE 208
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 4e-05
Identities = 35/111 (31%), Positives = 55/111 (49%), Gaps = 11/111 (9%)
Query: 784 LTLIQRINIIIDVASAIEYI-HHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSS 842
LTL I+ VA +E++ C +H DL N+LL ++ V + DFGLA+ +
Sbjct: 170 LTLEDLISYSFQVARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYK 225
Query: 843 SPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT 893
P V + +K ++APE + DV+SFG+LL E+F+
Sbjct: 226 DP--DYVRKGDARLPLK----WMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 5e-05
Identities = 35/135 (25%), Positives = 61/135 (45%), Gaps = 17/135 (12%)
Query: 792 IIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVET 851
+I + ++YIH ++H DLKPSNV +++D + DFGLA+ +
Sbjct: 123 LIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR-----------QA 168
Query: 852 PSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRRR--PTDGMFNQGLTL 908
G T Y APE + + T D++S G ++ E+ + P + +Q +
Sbjct: 169 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRI 228
Query: 909 HEFARTALPDKVMEI 923
E T P+ + +I
Sbjct: 229 MEVVGTPSPEVLKKI 243
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 5e-05
Identities = 43/180 (23%), Positives = 79/180 (43%), Gaps = 27/180 (15%)
Query: 735 HRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIII 794
+ N IK+ +++ ++ +Y+++G L D L + L+ + II
Sbjct: 68 NPNFIKLYYSVTTLKG-----HVLIMDYIKDGDLFDLLKKE------GKLSEAEVKKIIR 116
Query: 795 DVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLV-AHLGDFGLAKFLSSSPLDTAVETPS 853
+ A+ +H H ++H D+K NVL D+ +L D+GL K + TPS
Sbjct: 117 QLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCK---------IIGTPS 164
Query: 854 SSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913
GT+ Y +PE G ++ D ++ G+L E+ T + P ++ L L +
Sbjct: 165 C---YDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLK 221
|
Length = 267 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 5e-05
Identities = 31/95 (32%), Positives = 49/95 (51%), Gaps = 15/95 (15%)
Query: 812 VHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGT----VGYIAP 867
+H D+ NVLL VA + DFGLA+ + + S+ +KG V ++AP
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMN----------DSNYVVKGNARLPVKWMAP 283
Query: 868 EYGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGM 901
E ++ DV+S+GILL E+F+ + P G+
Sbjct: 284 ESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGI 318
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 62/247 (25%), Positives = 108/247 (43%), Gaps = 54/247 (21%)
Query: 668 MISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAEC 727
M+ L T+ + IG+G++G VYK ++G + AVK+++ AE
Sbjct: 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD-PISDVDEEIEAEY 69
Query: 728 QALRNI-RHRNLIKIITICSSIDFKGVDFQA---------IVYEYMQNGSLED----WLH 773
L+++ H N++K F G+ ++A +V E GS+ + L
Sbjct: 70 NILQSLPNHPNVVK---------FYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLI 120
Query: 774 QSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGD 833
+ EA +I I + A+ + H ++H D+K +N+LL + L D
Sbjct: 121 CGQRLDEA----MISYI-----LYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVD 171
Query: 834 FGLAKFLSSSPL--DTAVETPSSSKGIKGTVGYIAPE-------YGMGGEASMTGDVYSF 884
FG++ L+S+ L +T+V TP ++APE Y +A DV+S
Sbjct: 172 FGVSAQLTSTRLRRNTSVGTPF----------WMAPEVIACEQQYDYSYDARC--DVWSL 219
Query: 885 GILLLEM 891
GI +E+
Sbjct: 220 GITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 6e-05
Identities = 51/218 (23%), Positives = 98/218 (44%), Gaps = 31/218 (14%)
Query: 687 IGQGSFGFVYKG---NLGENG----MMVAVKVINLKQKGASNGFVAECQALRNIRHRNLI 739
+GQG+F ++KG +G+ G V +KV++ + S F + + H++L+
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 740 KIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINII--IDVA 797
+C D +V EY++ GSL+ +L ++++ INI ++VA
Sbjct: 63 LNYGVCV-----CGDESIMVQEYVKFGSLDTYLKKNKN-----------LINISWKLEVA 106
Query: 798 SAIEYIHHHCQPP-VVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSK 856
+ + H + + HG++ NVLL ++ G+ K LS + V +
Sbjct: 107 KQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIK-LSDPGISITVL---PKE 162
Query: 857 GIKGTVGYIAPEYGMGGEA-SMTGDVYSFGILLLEMFT 893
+ + ++ PE + S+ D +SFG L E+F+
Sbjct: 163 ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFS 200
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 9e-05
Identities = 58/235 (24%), Positives = 97/235 (41%), Gaps = 35/235 (14%)
Query: 673 ELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQAL 730
+L D+ +IG+G+FG V + A+K+++ + K + + F E + +
Sbjct: 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 96
Query: 731 RNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSE-DQQEARSLTLIQR 789
+ + + F+ + +V EYM G L + + + ++ AR T
Sbjct: 97 MAFANSPWVVQLFYA----FQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYT---- 148
Query: 790 INIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPL---D 846
+V A++ IH +H D+KP N+LLD+ L DFG ++ + D
Sbjct: 149 ----AEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCD 201
Query: 847 TAVETPSSSKGIKGTVGYIAPEY----GMGGEASMTGDVYSFGILLLEMFTRRRP 897
TAV TP YI+PE G G D +S G+ L EM P
Sbjct: 202 TAVGTPD----------YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 50/216 (23%), Positives = 97/216 (44%), Gaps = 22/216 (10%)
Query: 687 IGQGSFGFVYKGNL--GENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITI 744
+G+G++G VYK G++ A+K I + G S E LR ++H N+I + +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQI--EGTGISMSACREIALLRELKHPNVISLQKV 66
Query: 745 CSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRI--NIIIDVASAIEY 802
S + V ++++Y ++ + + + L + + +++ + I Y
Sbjct: 67 FLSHADRKV---WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 123
Query: 803 IHHHCQPPVVHGDLKPSNVLL----DQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGI 858
+H + V+H DLKP+N+L+ + + D G A+ L +SPL + +
Sbjct: 124 LHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR-LFNSPLKPLADLDP----V 175
Query: 859 KGTVGYIAPEYGMGGEASMTG-DVYSFGILLLEMFT 893
T Y APE +G D+++ G + E+ T
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 1e-04
Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 36/214 (16%)
Query: 687 IGQGSFGFV---YKGNLGENGMMVAVKVINLKQKGASNGFVA--ECQALRNIRHRNLIKI 741
IG G+ G V Y L N VA+K ++ + ++ A E ++ + H+N+I +
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 742 ITICSSI----DFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVA 797
+ + + +F+ V +V E M + + Q E E S L Q +
Sbjct: 82 LNVFTPQKSLEEFQDV---YLVMELMDANLCQ--VIQMELDHERMSYLLYQML------- 129
Query: 798 SAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKG 857
I+++H ++H DLKPSN+++ D + DFGLA+ +S + T
Sbjct: 130 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV------ 180
Query: 858 IKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEM 891
T Y APE +G D++S G ++ EM
Sbjct: 181 ---TRYYRAPEVILGMGYKENVDIWSVGCIMGEM 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 1e-04
Identities = 20/60 (33%), Positives = 30/60 (50%)
Query: 517 SLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHF 576
+L+ L L N + + L ++K LD+S NNL+ PE L L L+LS N+
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 35/111 (31%), Positives = 55/111 (49%), Gaps = 11/111 (9%)
Query: 784 LTLIQRINIIIDVASAIEYI-HHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSS 842
LT+ I VA +E++ C +H DL N+LL ++ V + DFGLA+ +
Sbjct: 171 LTMEDLICYSFQVARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYK 226
Query: 843 SPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT 893
P V S+ +K ++APE + DV+SFG+LL E+F+
Sbjct: 227 DP--DYVRKGSARLPLK----WMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 2e-04
Identities = 27/86 (31%), Positives = 43/86 (50%), Gaps = 14/86 (16%)
Query: 812 VHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGT----VGYIAP 867
+H DL N+LL + + DFGLA+ + + S+ +KG V ++AP
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDIRN----------DSNYVVKGNARLPVKWMAP 285
Query: 868 EYGMGGEASMTGDVYSFGILLLEMFT 893
E + DV+S+GILL E+F+
Sbjct: 286 ESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 36/116 (31%), Positives = 59/116 (50%), Gaps = 13/116 (11%)
Query: 780 EARSLTLIQRINIIIDVASAIEYI-HHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAK 838
E+ +L+ + + VA+ +E++ +C VH DL NVL+ + + + DFGLA+
Sbjct: 232 ESPALSYMDLVGFSYQVANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLAR 287
Query: 839 FLSSSPLDTAVETPSSSKGIKG-TVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT 893
D ++ SKG + ++APE + DV+SFGILL E+FT
Sbjct: 288 -------DIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-04
Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 38/215 (17%)
Query: 687 IGQGSFGFV---YKGNLGENGMMVAVKVINLKQKGASNGFVA--ECQALRNIRHRNLIKI 741
IG G+ G V Y L N VA+K ++ + ++ A E ++ + H+N+I +
Sbjct: 32 IGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 742 ITICS---SIDFKGVDFQA--IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDV 796
+ + + S++ +FQ IV E M + + Q E E S L Q +
Sbjct: 89 LNVFTPQKSLE----EFQDVYIVMELMDANLCQ--VIQMELDHERMSYLLYQML------ 136
Query: 797 ASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSK 856
I+++H ++H DLKPSN+++ D + DFGLA+ +S + T
Sbjct: 137 -CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV----- 187
Query: 857 GIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEM 891
T Y APE +G D++S G ++ EM
Sbjct: 188 ----TRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 4e-04
Identities = 62/224 (27%), Positives = 97/224 (43%), Gaps = 56/224 (25%)
Query: 687 IGQGSFGFV---YKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIR--------- 734
IG G+ G V Y G+N VA+K + S F A R R
Sbjct: 24 IGSGAQGIVCAAYDTVTGQN---VAIKKL-------SRPFQNVTHAKRAYRELVLMKLVN 73
Query: 735 HRNLIKII---TICSSIDFKGVDFQA--IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQR 789
H+N+I ++ T S++ +FQ +V E M + +L + D E S L Q
Sbjct: 74 HKNIIGLLNVFTPQKSLE----EFQDVYLVMELM-DANLCQVIQMDLDH-ERMSYLLYQ- 126
Query: 790 INIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAV 849
+ I+++H ++H DLKPSN+++ D + DFGLA+ +S + T
Sbjct: 127 ------MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 177
Query: 850 ETPSSSKGIKGTVGYIAPE--YGMGGEASMTGDVYSFGILLLEM 891
T Y APE GMG + ++ D++S G ++ EM
Sbjct: 178 VV---------TRYYRAPEVILGMGYKENV--DIWSVGCIMGEM 210
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 6e-04
Identities = 33/129 (25%), Positives = 53/129 (41%), Gaps = 25/129 (19%)
Query: 728 QALRNIRHRNLIKIITICSSID-------FKGVDFQAIVYEYMQNGSLEDWLHQSEDQQE 780
+ LR R R +I+ D IV EY++ L+D L ++
Sbjct: 39 EKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA----- 93
Query: 781 ARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFL 840
R +++ +V + +H +VHGDL SN++L + + DFGL +F
Sbjct: 94 --------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGRI-YFIDFGLGEF- 140
Query: 841 SSSPLDTAV 849
S D AV
Sbjct: 141 SDEVEDKAV 149
|
Length = 204 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 38.3 bits (90), Expect = 8e-04
Identities = 22/60 (36%), Positives = 30/60 (50%)
Query: 372 NLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDL 431
NL L + +N+LT A L NL++L L N L P + L L +L LS N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.5 bits (88), Expect = 0.001
Identities = 20/60 (33%), Positives = 31/60 (51%)
Query: 493 NLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNL 552
NL ++S NR + +L+ L L GN+ + P + S L S++ LD+S NNL
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 0.001
Identities = 61/265 (23%), Positives = 105/265 (39%), Gaps = 49/265 (18%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVIN---LKQKGASNGFVAECQALRNIRH 735
N++ IG G FG V+ K I+ LK++ S V E +R ++H
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQ-LVIEVNVMRELKH 71
Query: 736 RNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIID 795
+N+++ I K I+ E+ G L S + Q+ + + I+D
Sbjct: 72 KNIVRYI---DRFLNKANQKLYILMEFCDAGDL------SRNIQKCYKMFGKIEEHAIVD 122
Query: 796 VAS----AIEYIHHHCQPP----VVHGDLKPSNVLLDQDL-----------------VAH 830
+ A+ Y H+ P V+H DLKP N+ L + +A
Sbjct: 123 ITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAK 182
Query: 831 LGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASM--TGDVYSFGILL 888
+GDFGL+K + +E+ + S GT Y +PE + S D+++ G ++
Sbjct: 183 IGDFGLSK-------NIGIESMAHS--CVGTPYYWSPELLLHETKSYDDKSDMWALGCII 233
Query: 889 LEMFTRRRPTDGMFNQGLTLHEFAR 913
E+ + + P N + E R
Sbjct: 234 YELCSGKTPFHKANNFSQLISELKR 258
|
Length = 1021 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 30/147 (20%), Positives = 63/147 (42%), Gaps = 24/147 (16%)
Query: 695 VYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLI--KIITICSSIDFKG 752
VY LG +K+ ++KGA E L+ + + L K++ +
Sbjct: 14 VYL--LGTKDEDYVLKINPSREKGA--DREREVAILQLLARKGLPVPKVLAS-----GES 64
Query: 753 VDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVV 812
+ ++ E+++ +L++ SE+++E +I +A + +H +
Sbjct: 65 DGWSYLLMEWIEGETLDE---VSEEEKE----------DIAEQLAELLAKLHQLPLLVLC 111
Query: 813 HGDLKPSNVLLDQDLVAHLGDFGLAKF 839
HGDL P N+L+D + + D+ A +
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 49/218 (22%), Positives = 99/218 (45%), Gaps = 31/218 (14%)
Query: 687 IGQGSFGFVYKGNLG------------ENGMMVAVKVINLKQKGASNGFVAECQALRNIR 734
+G+G+ +Y G L E + V +KV++ + S F +R +
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 735 HRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIII 794
H++++ + +C D + + +V E+++ G L+ ++H+ D LT + +
Sbjct: 63 HKHIVLLYGVCVR-DVENI----MVEEFVEFGPLDLFMHRKSD-----VLTTPWKFKVAK 112
Query: 795 DVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSS 854
+ASA+ Y+ +VHG++ N+LL ++ + G+ G F+ S + S
Sbjct: 113 QLASALSYLE---DKDLVHGNVCTKNILLAREGID--GECG--PFIKLSDPGIPITVLSR 165
Query: 855 SKGIKGTVGYIAPE-YGMGGEASMTGDVYSFGILLLEM 891
+ ++ + +IAPE S+ D +SFG L E+
Sbjct: 166 QECVE-RIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.002
Identities = 36/144 (25%), Positives = 60/144 (41%), Gaps = 42/144 (29%)
Query: 793 IIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL---------AKFLSS- 842
I ++ A+E +H + +H D+KP N+L+D+D L DFGL +K+ S
Sbjct: 107 IAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSG 163
Query: 843 -----SPLDTAVE--TPSSSK----------------------GIKGTVGYIAPEYGMGG 873
+D + E P++ + + GT YIAPE +
Sbjct: 164 DHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT 223
Query: 874 EASMTGDVYSFGILLLEMFTRRRP 897
+ D +S G++L EM + P
Sbjct: 224 GYTQLCDWWSVGVILYEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.002
Identities = 54/227 (23%), Positives = 88/227 (38%), Gaps = 43/227 (18%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVA---ECQALR----------NI 733
+G+G FG V + G + A+K LK+ G + E ++L +
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKA--LKK-----GDIIARDEVESLMCEKRIFETANSE 59
Query: 734 RHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINII 793
RH L+ + C F+ D V EY G L +H D + + +
Sbjct: 60 RHPFLVNLFA-C----FQTEDHVCFVMEYAAGGDL--MMHIHTDV-----FSEPRAVFYA 107
Query: 794 IDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPS 853
V ++Y+H + +V+ DLK N+LLD + + DFGL K +
Sbjct: 108 ACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK--------EGMGFGD 156
Query: 854 SSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDG 900
+ GT ++APE + D + G+L+ EM P G
Sbjct: 157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPG 203
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 992 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.93 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.89 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.88 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.88 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.85 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.82 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.81 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.79 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.78 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.77 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.75 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.74 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.74 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.73 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.72 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.72 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.71 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.66 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.65 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.65 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.64 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.64 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.62 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.54 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.53 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.53 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.52 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.51 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.47 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.44 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.42 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.38 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.37 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.37 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.3 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.28 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.24 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.21 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.19 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.18 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.17 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.14 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.14 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.11 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.11 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.1 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.09 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.08 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.07 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.07 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 99.06 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.0 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.0 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.97 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.95 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.94 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.9 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.89 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.87 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.85 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.84 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.83 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.81 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.8 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.72 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.69 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.65 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.5 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.49 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.49 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.46 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-113 Score=1086.53 Aligned_cols=916 Identities=31% Similarity=0.520 Sum_probs=775.6
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCCCCcCCCCCCceEeeEEcCCCCeEEEeeccccccCCccCCCCCCCCcCCeeeccCCC
Q 037275 6 NETDRLALLAIGSQLEDDPLGVTSSWNNSTNLCQWTGVTCGHRHQRVTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNN 85 (992)
Q Consensus 6 ~~~~~~~ll~~~~~~~~~~~~~~~~w~~~~~~c~w~gv~c~~~~~~v~~ldl~~~~l~~~l~~~l~~l~~L~~L~L~~n~ 85 (992)
.++|+.||++||+++ .+|.+.+++|+.+.+||.|.||+|+. ..+|+.|||+++.+.+.+++.+..+++|++|+|++|+
T Consensus 27 ~~~~~~~l~~~~~~~-~~~~~~~~~w~~~~~~c~w~gv~c~~-~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~ 104 (968)
T PLN00113 27 HAEELELLLSFKSSI-NDPLKYLSNWNSSADVCLWQGITCNN-SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQ 104 (968)
T ss_pred CHHHHHHHHHHHHhC-CCCcccCCCCCCCCCCCcCcceecCC-CCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCc
Confidence 678999999999998 47888889998888999999999975 4689999999999999999999999999999999999
Q ss_pred CCccCCcccc-CCCCCCEEEeecccCCCCCCcccccCCCCcEeecccccccccCChhhcccccccccccccccccCCCCC
Q 037275 86 FHGEIPHQIG-RLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFP 164 (992)
Q Consensus 86 l~~~~p~~~~-~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~~L~L~~n~l~~~~p 164 (992)
+.+.+|..+. .+++|++|+|++|++++.+|. +.+++|++|++++|.+++.+|..+. ++++|++|+|++|.+.+.+|
T Consensus 105 ~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~-~l~~L~~L~L~~n~l~~~~p 181 (968)
T PLN00113 105 LSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIG-SFSSLKVLDLGGNVLVGKIP 181 (968)
T ss_pred cCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHh-cCCCCCEEECccCcccccCC
Confidence 9999998766 999999999999999988886 5689999999999999999998876 79999999999999999999
Q ss_pred CccccccccceEEecCCcccCCcCCccCCCCcccEEeccCcccccccCccccccCCCcEEeccCCccCCCCCcccccccc
Q 037275 165 ASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLP 244 (992)
Q Consensus 165 ~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~ 244 (992)
..++++++|++|++++|.+.+.+|..++++++|++|+|++|++++.+|..+.++++|++|++++|++.+.+|..+ ..++
T Consensus 182 ~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l-~~l~ 260 (968)
T PLN00113 182 NSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSL-GNLK 260 (968)
T ss_pred hhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhH-hCCC
Confidence 999999999999999999999999999999999999999999999999999999999999999999998888654 4689
Q ss_pred ccchhhccccccCCCCchhhhccccCceeeeccccccccccccccccCccceEecCCCCCCCCCCCCchhhhhccCCCcc
Q 037275 245 KLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTEL 324 (992)
Q Consensus 245 ~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~~L 324 (992)
+|+.|++++|++.+.+|..+.++++|++|++++|.+.+..|..+.++++|++|++++|.+....+ ..+..+++|
T Consensus 261 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~------~~~~~l~~L 334 (968)
T PLN00113 261 NLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIP------VALTSLPRL 334 (968)
T ss_pred CCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCC------hhHhcCCCC
Confidence 99999999999999999999999999999999999999999999999999999999999876433 346788999
Q ss_pred eEeecCCCcCCCcCCcccccccccceeEEeeCCccccccCCCccCCCcccEEEccCCcCCCCCCccccCCCCCcEEeccC
Q 037275 325 TAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDS 404 (992)
Q Consensus 325 ~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 404 (992)
+.|++++|.+.+.+|..+..+. +|+.|++++|++++.+|..+..+++|+.|++++|.+.+.+|..+..+++|+.|++++
T Consensus 335 ~~L~L~~n~l~~~~p~~l~~~~-~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~ 413 (968)
T PLN00113 335 QVLQLWSNKFSGEIPKNLGKHN-NLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQD 413 (968)
T ss_pred CEEECcCCCCcCcCChHHhCCC-CCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcC
Confidence 9999999999999999888774 699999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCccccCceeccCCcccCCCCCCccccccccccccccccccccCchhhhhhcccccccccccccccCcc
Q 037275 405 NFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTL 484 (992)
Q Consensus 405 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~ 484 (992)
|++++..|..|..+++|+.|++++|.+++.+|..+..+++|+.|++++|++.+.+|..+. ...++.|++++|++++..
T Consensus 414 n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~--~~~L~~L~ls~n~l~~~~ 491 (968)
T PLN00113 414 NSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFG--SKRLENLDLSRNQFSGAV 491 (968)
T ss_pred CEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccc--cccceEEECcCCccCCcc
Confidence 999999999999999999999999999999999999999999999999999988887653 356778999999999999
Q ss_pred cccccCCCCccEEeeecccccccCCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcccCCCChhhhhcCC
Q 037275 485 PLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLS 564 (992)
Q Consensus 485 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 564 (992)
|..+.++++|++|+|++|++++.+|..+..+++|++|+|++|.+++.+|..|..+++|+.|+|++|++++.+|..+..++
T Consensus 492 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~ 571 (968)
T PLN00113 492 PRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVE 571 (968)
T ss_pred ChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcceEecCCCcCcccCCCCCccCCcccccccCCCCcCCCCCCCCCCCCCCCCCCcccceEEEEeeceehhhHHHH-HHHh
Q 037275 565 FLEYLNLSYNHFEGEVPTKGVFSNKTGISLSGNGKVCGGLDELNLPPCPSRGLKKRTDFLLKVVVPVTVSGVILS-LCLV 643 (992)
Q Consensus 565 ~L~~L~l~~N~l~~~~~~~~~~~~~~~~~l~~N~~~C~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~v~~~~l~-l~~~ 643 (992)
+|++|++++|++.|.+|..+.+..+....+.||+..|+.+.....++|..... .. .++.+++.++++.++++ ++++
T Consensus 572 ~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~--~~-~~~~~~~~~~~~~~~~~~~~~~ 648 (968)
T PLN00113 572 SLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRK--TP-SWWFYITCTLGAFLVLALVAFG 648 (968)
T ss_pred ccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccc--cc-eeeeehhHHHHHHHHHHHHHHH
Confidence 99999999999999999988888888889999999999765555677854321 11 11122221111112222 2222
Q ss_pred hhheecccccccccchhh---hc------cCCCcccHHHHHHHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeec
Q 037275 644 LFLARRRRSAHKSSVSQL---MD------QQFPMISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINL 714 (992)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~---~~------~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~ 714 (992)
++++++|+.......+.. .. .....+++ ......|...++||+|+||.||+|+...+++.||||.++.
T Consensus 649 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~ 725 (968)
T PLN00113 649 FVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITI---NDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEIND 725 (968)
T ss_pred HHHHHhhhcccccccccccccccccccccccchhhhH---HHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccC
Confidence 333332221111111100 00 00011223 3334567888999999999999999988999999998853
Q ss_pred cCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHH
Q 037275 715 KQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIII 794 (992)
Q Consensus 715 ~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~ 794 (992)
... ...+|++++++++||||++++|+|.+ ....++||||+++|+|.++++ .++|.++.+++.
T Consensus 726 ~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~-----~~~~~lv~Ey~~~g~L~~~l~---------~l~~~~~~~i~~ 787 (968)
T PLN00113 726 VNS----IPSSEIADMGKLQHPNIVKLIGLCRS-----EKGAYLIHEYIEGKNLSEVLR---------NLSWERRRKIAI 787 (968)
T ss_pred Ccc----ccHHHHHHHhhCCCCCcceEEEEEEc-----CCCCEEEEeCCCCCcHHHHHh---------cCCHHHHHHHHH
Confidence 322 12356889999999999999999754 334599999999999999995 278999999999
Q ss_pred HHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCC
Q 037275 795 DVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGE 874 (992)
Q Consensus 795 qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 874 (992)
|+|+||+|||..+.++|+|||+||+||+++.++.+++. ||.+..... .....+++.|+|||++.+..
T Consensus 788 ~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------------~~~~~~t~~y~aPE~~~~~~ 854 (968)
T PLN00113 788 GIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------------DTKCFISSAYVAPETRETKD 854 (968)
T ss_pred HHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc------------CCCccccccccCcccccCCC
Confidence 99999999996555599999999999999999988875 665443211 11225789999999999999
Q ss_pred cCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCChh-HHHHHHhhHhHhhhccCCCCCCccccchHHHHHH
Q 037275 875 ASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDK-VMEIVDSVLLLEVQASNSRSCGDERLRTEERLVA 953 (992)
Q Consensus 875 ~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 953 (992)
++.++|||||||++|||+||+.||+..........+|.+...... ...++++.... ......++..+
T Consensus 855 ~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~ 922 (968)
T PLN00113 855 ITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG------------DVSVNQNEIVE 922 (968)
T ss_pred CCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccC------------CCCccHHHHHH
Confidence 999999999999999999999999765444455555555433221 22222221110 11123455677
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 037275 954 VVETGVVCSMESPTERMEMRDVVAKLCRARDT 985 (992)
Q Consensus 954 l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 985 (992)
+.+++.+||+.||++||||+||+++|+++.+.
T Consensus 923 ~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 923 VMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred HHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 89999999999999999999999999988653
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-59 Score=596.24 Aligned_cols=519 Identities=33% Similarity=0.494 Sum_probs=484.2
Q ss_pred CcCCeeeccCCCCCccCCccccCCCCCCEEEeecccCCCCCCcccc-cCCCCcEeecccccccccCChhhcccccccccc
Q 037275 74 SFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLS-RCSNLISFNARRNNLVGEIPAELGYNWLKLENL 152 (992)
Q Consensus 74 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~-~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~~L 152 (992)
.+++.|||++|++++.+|..|..+++|++|+|++|++++.+|..+. .+++|++|++++|++++.+|.. .+++|++|
T Consensus 69 ~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~---~l~~L~~L 145 (968)
T PLN00113 69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRG---SIPNLETL 145 (968)
T ss_pred CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCcc---ccCCCCEE
Confidence 4789999999999999999999999999999999999999998876 9999999999999999988874 47899999
Q ss_pred cccccccCCCCCCccccccccceEEecCCcccCCcCCccCCCCcccEEeccCcccccccCccccccCCCcEEeccCCccC
Q 037275 153 TIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFN 232 (992)
Q Consensus 153 ~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~ 232 (992)
+|++|.+++.+|..++++++|++|++++|.+.+.+|..++++++|++|+|++|++++.+|..+.++++|++|+|++|++.
T Consensus 146 ~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~ 225 (968)
T PLN00113 146 DLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLS 225 (968)
T ss_pred ECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCccccccccccchhhccccccCCCCchhhhccccCceeeeccccccccccccccccCccceEecCCCCCCCCCCCCc
Q 037275 233 GSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDL 312 (992)
Q Consensus 233 ~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 312 (992)
+.+|..+ ..+++|++|++++|++.+.+|..++++++|++|++++|++.+..|..+.++++|++|+|++|.+....+
T Consensus 226 ~~~p~~l-~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p--- 301 (968)
T PLN00113 226 GEIPYEI-GGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIP--- 301 (968)
T ss_pred CcCChhH-hcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCC---
Confidence 8888765 478999999999999999999999999999999999999999999999999999999999999875332
Q ss_pred hhhhhccCCCcceEeecCCCcCCCcCCcccccccccceeEEeeCCccccccCCCccCCCcccEEEccCCcCCCCCCcccc
Q 037275 313 DFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIG 392 (992)
Q Consensus 313 ~~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 392 (992)
..+.++++|+.|++++|.+.+..|..+..++ +|+.|++++|.+++.+|..++.+++|+.|++++|++++.+|..+.
T Consensus 302 ---~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~-~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~ 377 (968)
T PLN00113 302 ---ELVIQLQNLEILHLFSNNFTGKIPVALTSLP-RLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLC 377 (968)
T ss_pred ---hhHcCCCCCcEEECCCCccCCcCChhHhcCC-CCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHh
Confidence 3467889999999999999999999988875 599999999999999999999999999999999999999999999
Q ss_pred CCCCCcEEeccCccccccCCCCCCCccccCceeccCCcccCCCCCCccccccccccccccccccccCchhhhhhcccccc
Q 037275 393 ELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLS 472 (992)
Q Consensus 393 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~ 472 (992)
.+++|+.|++++|++.+.+|..+..+++|+.|++++|++++..|..|..+++|+.|++++|.+++.+|..+... ..++.
T Consensus 378 ~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~~L~~ 456 (968)
T PLN00113 378 SSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDM-PSLQM 456 (968)
T ss_pred CcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccC-CCCcE
Confidence 99999999999999999999999999999999999999999999999999999999999999999888776654 45678
Q ss_pred cccccccccCcccccccCCCCccEEeeecccccccCCcccccccccceeeccCCcccccCCccccccCCCCEEECCCccc
Q 037275 473 LDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNL 552 (992)
Q Consensus 473 L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 552 (992)
|++++|++.+.+|..+ ..++|+.|++++|++++.+|..|.++++|+.|+|++|++.+.+|..+.++++|++|+|++|++
T Consensus 457 L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 535 (968)
T PLN00113 457 LSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQL 535 (968)
T ss_pred EECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcc
Confidence 9999999999888766 468999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCcceEecCCCcCcccCCC-CCccCCcccccccCCCCcCCCCC
Q 037275 553 SGQIPEYLENLSFLEYLNLSYNHFEGEVPT-KGVFSNKTGISLSGNGKVCGGLD 605 (992)
Q Consensus 553 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~~~~~~l~~N~~~C~~~~ 605 (992)
++.+|..|..+++|+.|+|++|++++.+|. ...++.+..+++.+|+..+.-|.
T Consensus 536 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~ 589 (968)
T PLN00113 536 SGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPS 589 (968)
T ss_pred cccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCC
Confidence 999999999999999999999999988775 35577889999999998875553
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-47 Score=413.96 Aligned_cols=289 Identities=41% Similarity=0.668 Sum_probs=239.4
Q ss_pred CCCcccHHHHHHHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEE
Q 037275 665 QFPMISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITI 744 (992)
Q Consensus 665 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 744 (992)
....|++.|+..+|++|...++||+|+||.||+|... +|+.||||++.........+|.+|+.++.+++|||+|+++||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence 4567999999999999999999999999999999996 569999998864433215569999999999999999999999
Q ss_pred eecccccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeC
Q 037275 745 CSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLD 824 (992)
Q Consensus 745 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 824 (992)
|.+.+. ..++|||||++|+|.++++..... +++|.+|++||.++|+||+|||+.+.+.||||||||+|||+|
T Consensus 140 C~e~~~----~~~LVYEym~nGsL~d~L~~~~~~----~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD 211 (361)
T KOG1187|consen 140 CLEGGE----HRLLVYEYMPNGSLEDHLHGKKGE----PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD 211 (361)
T ss_pred EecCCc----eEEEEEEccCCCCHHHHhCCCCCC----CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC
Confidence 975332 469999999999999999876532 689999999999999999999999888899999999999999
Q ss_pred CCCcEEEeecccceecCCCCCCCCcccCCCCCcc-cccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCc-
Q 037275 825 QDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGI-KGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMF- 902 (992)
Q Consensus 825 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~- 902 (992)
+++.+||+|||+|+..... ....... .||.+|+|||+...+..+.|+|||||||++.|++||+.|.+...
T Consensus 212 ~~~~aKlsDFGLa~~~~~~--------~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~ 283 (361)
T KOG1187|consen 212 EDFNAKLSDFGLAKLGPEG--------DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRP 283 (361)
T ss_pred CCCCEEccCccCcccCCcc--------ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCC
Confidence 9999999999999654320 0000111 69999999999999999999999999999999999999887643
Q ss_pred cCCccHHHHHhhhCCh-hHHHHHHhhHh-HhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 037275 903 NQGLTLHEFARTALPD-KVMEIVDSVLL-LEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLC 980 (992)
Q Consensus 903 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 980 (992)
.....+.+|+.....+ .+.+++|+.+. ..+ ...+++.++.+++.+|++.+|++||+|.||+++|+
T Consensus 284 ~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~-------------~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~ 350 (361)
T KOG1187|consen 284 RGELSLVEWAKPLLEEGKLREIVDPRLKEGEY-------------PDEKEVKKLAELALRCLRPDPKERPTMSQVVKELE 350 (361)
T ss_pred cccccHHHHHHHHHHCcchhheeCCCccCCCC-------------ChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHH
Confidence 3344477777655544 46677776543 111 11256788999999999999999999999999996
Q ss_pred HHH
Q 037275 981 RAR 983 (992)
Q Consensus 981 ~~~ 983 (992)
.+.
T Consensus 351 ~~~ 353 (361)
T KOG1187|consen 351 GIL 353 (361)
T ss_pred hhc
Confidence 654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-46 Score=377.57 Aligned_cols=253 Identities=25% Similarity=0.346 Sum_probs=209.0
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC-CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcc-eEE
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVD-FQA 757 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~-~~~ 757 (992)
+.+..+.||+|..|+||+++++.+++.+|+|++.... ....+++.+|++++++.+||+||.++|.|.. .. ...
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~-----~~~~is 154 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS-----NGEEIS 154 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe-----CCceEE
Confidence 3455689999999999999999999999999995443 3345789999999999999999999999643 33 589
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHH-HCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
|+||||++|+|++++...+ .+++....+|+.++++||.|||+ + +||||||||+|||++..|.+||||||.
T Consensus 155 I~mEYMDgGSLd~~~k~~g------~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGV 225 (364)
T KOG0581|consen 155 ICMEYMDGGSLDDILKRVG------RIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGV 225 (364)
T ss_pred eehhhcCCCCHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccc
Confidence 9999999999999998653 48999999999999999999996 6 999999999999999999999999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhC
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTAL 916 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 916 (992)
+..+.+. ....++||..|||||.+.+..|+.++||||||++++|+++|+.||......
T Consensus 226 S~~lvnS----------~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~------------ 283 (364)
T KOG0581|consen 226 SGILVNS----------IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP------------ 283 (364)
T ss_pred cHHhhhh----------hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC------------
Confidence 9876543 334568999999999999999999999999999999999999999764111
Q ss_pred ChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 917 PDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
+..+.+.++.+..+..+. .+ ......++..++..||++||.+|||++|+++.
T Consensus 284 ~~~~~~Ll~~Iv~~ppP~-----lP-----~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 284 YLDIFELLCAIVDEPPPR-----LP-----EGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCCHHHHHHHHhcCCCCC-----CC-----cccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 122334444433222111 11 11345679999999999999999999999863
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=377.19 Aligned_cols=255 Identities=23% Similarity=0.342 Sum_probs=204.9
Q ss_pred HhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC-------CCchhHHHHHHHHHHhccCCcceeEEEEeeccc
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ-------KGASNGFVAECQALRNIRHRNLIKIITICSSID 749 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 749 (992)
..+.|.+.+.||+|+||.|-+|..+.+|+.||||+++... ......+.+|+++|++++|||||++.+++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f---- 245 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF---- 245 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee----
Confidence 3457888999999999999999999999999999996432 11234468999999999999999999995
Q ss_pred ccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCC---
Q 037275 750 FKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQD--- 826 (992)
Q Consensus 750 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--- 826 (992)
...++.|+||||++||+|.+++-.++ .+.+.....+++|++.|+.|||+. ||+||||||+|||+..+
T Consensus 246 -~~~ds~YmVlE~v~GGeLfd~vv~nk------~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~ 315 (475)
T KOG0615|consen 246 -EVPDSSYMVLEYVEGGELFDKVVANK------YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAED 315 (475)
T ss_pred -ecCCceEEEEEEecCccHHHHHHhcc------ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcc
Confidence 44555699999999999999998765 467777788999999999999999 99999999999999765
Q ss_pred CcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCc---CcccchhhHHHHHHHHHhCCCCCCCCcc
Q 037275 827 LVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEA---SMTGDVYSFGILLLEMFTRRRPTDGMFN 903 (992)
Q Consensus 827 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwSlG~il~elltg~~pf~~~~~ 903 (992)
..+||+|||+|+..+. .......+||+.|.|||++.++.+ ..++||||+||++|-+++|.+||.+...
T Consensus 316 ~llKItDFGlAK~~g~---------~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~ 386 (475)
T KOG0615|consen 316 CLLKITDFGLAKVSGE---------GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT 386 (475)
T ss_pred eEEEecccchhhcccc---------ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC
Confidence 7899999999998753 234456789999999999987643 3478999999999999999999987544
Q ss_pred CCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 904 QGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
+.....+.....+.. ..+...+..++..++|.+||..||++|||++|+++.
T Consensus 387 ~~sl~eQI~~G~y~f------------------------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 387 DPSLKEQILKGRYAF------------------------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred CccHHHHHhcCcccc------------------------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 322222222222211 111223345568899999999999999999999863
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-46 Score=362.50 Aligned_cols=264 Identities=26% Similarity=0.390 Sum_probs=212.5
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc--CCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK--QKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
..+|++.++||+|+||+||++....+|..||.|.++.. +..+......|+.+|++++|||||+++++.. .++...
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f---~~~~ev 94 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSF---IEDNEV 94 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhh---hccchh
Confidence 34688889999999999999999999999999998743 3344567899999999999999999988522 223344
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCC-CeEeccCCCCCeeeCCCCcEEEeec
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQP-PVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~-~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
.+||||||++|+|...++..+.. .+.+++..+|+++.|++.||.++|...+. -|+||||||.||+++.+|.+||+||
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~q--kr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf 172 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKKQ--KRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF 172 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHhc--cccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence 78999999999999999887654 56799999999999999999999994221 2889999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
|+++.+.... ......+|||.||+||.+.+..|+.|+||||+||++|||+.-++||.+. .
T Consensus 173 GL~r~l~s~~--------tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n------- 232 (375)
T KOG0591|consen 173 GLGRFLSSKT--------TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----N------- 232 (375)
T ss_pred hhHhHhcchh--------HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----c-------
Confidence 9999887532 2334578999999999999999999999999999999999999999873 1
Q ss_pred hCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 037275 915 ALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCR 981 (992)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 981 (992)
+...-.++-.+++ .....+-...++.+++..|+..||+.||+.-.++..+..
T Consensus 233 -----~~~L~~KI~qgd~----------~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 233 -----LLSLCKKIEQGDY----------PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred -----HHHHHHHHHcCCC----------CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 1111222221222 112224456778999999999999999997666655544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=388.74 Aligned_cols=248 Identities=25% Similarity=0.409 Sum_probs=213.8
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc---CCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK---QKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
.+|...+.||+|||+.||.+++..+|+.||+|++... .....+.+.+|++|.+.++|||||+++++ |++..+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~-----FEDs~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHF-----FEDSNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeE-----eecCCc
Confidence 5799999999999999999999889999999999743 45567789999999999999999999999 567778
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
+|+|.|+|+.++|..+++..+ ++++.++..+++||+.||.|||++ +|+|||||..|+|++++.++||+|||
T Consensus 93 VYivLELC~~~sL~el~Krrk------~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFG 163 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLKRRK------PLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFG 163 (592)
T ss_pred eEEEEEecCCccHHHHHHhcC------CCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccc
Confidence 899999999999999998443 699999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 915 (992)
+|..+..+ .......+|||.|.|||++.....+..+||||+|||+|.|++|++||+..
T Consensus 164 LAt~le~~--------~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk-------------- 221 (592)
T KOG0575|consen 164 LATQLEYD--------GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK-------------- 221 (592)
T ss_pred eeeeecCc--------ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc--------------
Confidence 99988642 23455678999999999999999999999999999999999999999752
Q ss_pred CChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 916 LPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.+.+..+++...+|... .....+..++|.++|+.||.+|||+++|+.
T Consensus 222 ---~vkety~~Ik~~~Y~~P------------~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 222 ---TVKETYNKIKLNEYSMP------------SHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ---hHHHHHHHHHhcCcccc------------cccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 23334444443333211 122345789999999999999999999985
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-45 Score=373.00 Aligned_cols=202 Identities=31% Similarity=0.570 Sum_probs=180.5
Q ss_pred HhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc--CCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcc
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK--QKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
..++|...+.||+|+||+||+|+++.++..||||.+... .....+.+..|+.+|+.++|||||++++++. ..+
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~-----~~~ 82 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIE-----DDD 82 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEe-----cCC
Confidence 356899999999999999999999999999999999755 3445567899999999999999999999954 455
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCC------Cc
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQD------LV 828 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~------~~ 828 (992)
.+|+|||||.||+|.+|++..+ .+++..+..++.|+|.||++||++ +||||||||+|||++.. -.
T Consensus 83 ~i~lVMEyC~gGDLs~yi~~~~------~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~ 153 (429)
T KOG0595|consen 83 FIYLVMEYCNGGDLSDYIRRRG------RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPV 153 (429)
T ss_pred eEEEEEEeCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCce
Confidence 7799999999999999999775 489999999999999999999999 99999999999999765 46
Q ss_pred EEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCC
Q 037275 829 AHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGM 901 (992)
Q Consensus 829 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 901 (992)
+||+|||+|+.+.... .....+|++.|||||++...+|+.|+|+||+|+|+|++++|++||+..
T Consensus 154 LKIADFGfAR~L~~~~---------~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 154 LKIADFGFARFLQPGS---------MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred EEecccchhhhCCchh---------HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 8999999999887433 233457999999999999999999999999999999999999999853
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=386.27 Aligned_cols=260 Identities=30% Similarity=0.459 Sum_probs=208.8
Q ss_pred CCCCCccccccceEEEEeEECCCCeE-EEEEEeeccCCCc--hhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 681 FSSSNMIGQGSFGFVYKGNLGENGMM-VAVKVINLKQKGA--SNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~~~~~~-vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
+...+.+|+|+||+||+|.+. |+. ||||++....... .+.|.+|+.+|.+++|||||+++|+|.... ...+
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~----~~~~ 116 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP----GSLC 116 (362)
T ss_pred hhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC----CceE
Confidence 344566999999999999995 556 9999997544332 458999999999999999999999986532 1569
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCC-eEeccCCCCCeeeCCCC-cEEEeecc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPP-VVHGDLKPSNVLLDQDL-VAHLGDFG 835 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~-ivH~Dlkp~NIll~~~~-~~kl~Dfg 835 (992)
+||||+++|+|.++++... ...+++..+++++.|||+||.|||++ + ||||||||+|||++.++ ++||+|||
T Consensus 117 iVtEy~~~GsL~~~l~~~~----~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFG 189 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKKR----KRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFG 189 (362)
T ss_pred EEEEeCCCCcHHHHHhhcc----cCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCc
Confidence 9999999999999998741 23699999999999999999999999 7 99999999999999998 99999999
Q ss_pred cceecCCCCCCCCcccCCCCCccccccccccccccc--CCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGM--GGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 913 (992)
+++...... .......||+.|||||++. ...|+.|+||||||+++|||+||+.||.+.... ......+.
T Consensus 190 lsr~~~~~~--------~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~-~~~~~v~~ 260 (362)
T KOG0192|consen 190 LSREKVISK--------TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV-QVASAVVV 260 (362)
T ss_pred cceeecccc--------ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHh
Confidence 998765421 2223357999999999999 669999999999999999999999999875331 11111110
Q ss_pred hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhh
Q 037275 914 TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTFLG 988 (992)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 988 (992)
....... .......+..++.+||..||+.||++.|++..|+.+......
T Consensus 261 ----------------~~~Rp~~----------p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 261 ----------------GGLRPPI----------PKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred ----------------cCCCCCC----------CccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 0000000 011455688999999999999999999999999999876654
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-48 Score=392.95 Aligned_cols=478 Identities=29% Similarity=0.437 Sum_probs=395.8
Q ss_pred EEEeeccccccCCccCCCCCCCCcCCeeeccCCCCCccCCccccCCCCCCEEEeecccCCCCCCcccccCCCCcEeeccc
Q 037275 52 VTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARR 131 (992)
Q Consensus 52 v~~ldl~~~~l~~~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~ 131 (992)
..++++++|++ ..+.+.+.++..|.+|++++|++. ++|++++.+..++.|+.|+|+++ .+|+.++.+.+|++|+.++
T Consensus 47 l~~lils~N~l-~~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~ 123 (565)
T KOG0472|consen 47 LQKLILSHNDL-EVLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSS 123 (565)
T ss_pred hhhhhhccCch-hhccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhccc
Confidence 57899999998 678888999999999999999999 89999999999999999999999 9999999999999999999
Q ss_pred ccccccCChhhcccccccccccccccccCCCCCCccccccccceEEecCCcccCCcCCccCCCCcccEEeccCccccccc
Q 037275 132 NNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIV 211 (992)
Q Consensus 132 n~l~~~~p~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~ 211 (992)
|.+. ++|++++ .+..|+.|+..+|+++ ..|++++++.+|..|++.+|++.. +|+..-+++.|++||+..|.++ .+
T Consensus 124 n~~~-el~~~i~-~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~-l~~~~i~m~~L~~ld~~~N~L~-tl 198 (565)
T KOG0472|consen 124 NELK-ELPDSIG-RLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKA-LPENHIAMKRLKHLDCNSNLLE-TL 198 (565)
T ss_pred ccee-ecCchHH-HHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhh-CCHHHHHHHHHHhcccchhhhh-cC
Confidence 9999 8999988 6889999999999999 889999999999999999999954 5555555999999999999998 79
Q ss_pred CccccccCCCcEEeccCCccCCCCCccccccccccchhhccccccCCCCchh-hhccccCceeeeccccccccccccccc
Q 037275 212 PPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPES-LSNASNLVELTLFDNQFRGKVSIYFRS 290 (992)
Q Consensus 212 p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~-l~~l~~L~~L~L~~N~l~~~~~~~~~~ 290 (992)
|+.++.+.+|+.|||..|++. .+|+ |.+...|++++++.|+|. .+|.+ ..+++++..|||.+|+++ ..|..+..
T Consensus 199 P~~lg~l~~L~~LyL~~Nki~-~lPe--f~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~cl 273 (565)
T KOG0472|consen 199 PPELGGLESLELLYLRRNKIR-FLPE--FPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICL 273 (565)
T ss_pred ChhhcchhhhHHHHhhhcccc-cCCC--CCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHH
Confidence 999999999999999999998 7883 446778999999999998 55555 558999999999999999 68888999
Q ss_pred cCccceEecCCCCCCCCCCCCchhhhhccCCCcceEeecCCCcCCCcCCccc--------ccccccceeEEeeCCc---c
Q 037275 291 LKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSI--------ANLSSTMTDIVIAGNQ---I 359 (992)
Q Consensus 291 l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~l~~~~~~~~--------~~l~~~L~~L~l~~n~---i 359 (992)
+++|+.||+|+|.|+..+. .++++ +|+.|.+.+|.+..+-..-+ ..+.+.++.=-++... -
T Consensus 274 LrsL~rLDlSNN~is~Lp~-------sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e 345 (565)
T KOG0472|consen 274 LRSLERLDLSNNDISSLPY-------SLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTE 345 (565)
T ss_pred hhhhhhhcccCCccccCCc-------ccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCccccc
Confidence 9999999999999998776 48888 99999999999874322111 1111111110111110 0
Q ss_pred c-c----ccCCCccCCCcccEEEccCCcCCCCCCccccCCCC---CcEEeccCccccccCCCCCCCccccCc-eeccCCc
Q 037275 360 S-G----IIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKN---LQLLYLDSNFLAGGIPTSLGNLTLLTN-LALSSND 430 (992)
Q Consensus 360 ~-~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~---L~~L~L~~N~l~~~~~~~~~~l~~L~~-L~L~~N~ 430 (992)
+ . ........+.+.+.|++++-+++ .+|+....... ....+++.|++. ++|..+..+..+.+ +.+++|.
T Consensus 346 ~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~ 423 (565)
T KOG0472|consen 346 TAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNK 423 (565)
T ss_pred ccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCc
Confidence 0 0 11122344567888999988888 56665554444 788899999998 78888777776544 5566666
Q ss_pred ccCCCCCCccccccccccccccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeecccccccCCc
Q 037275 431 LQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPV 510 (992)
Q Consensus 431 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 510 (992)
++ .+|..++.+++|..|++++| .+. .+|..++.+..|+.||+|+|+|. ..|.
T Consensus 424 is-fv~~~l~~l~kLt~L~L~NN-------------------------~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~ 475 (565)
T KOG0472|consen 424 IS-FVPLELSQLQKLTFLDLSNN-------------------------LLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPE 475 (565)
T ss_pred cc-cchHHHHhhhcceeeecccc-------------------------hhh-hcchhhhhhhhhheecccccccc-cchH
Confidence 65 78888888888887755544 444 78899999999999999999998 8999
Q ss_pred ccccccccceeeccCCcccccCCccccccCCCCEEECCCcccCCCChhhhhcCCCcceEecCCCcCcccCCC
Q 037275 511 TLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPT 582 (992)
Q Consensus 511 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~ 582 (992)
.+..+..|+.+-.++|++..+.|+.+.+|.+|.+|||.+|.|. .+|+.+++|++|++|+++||+|. .++.
T Consensus 476 ~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr-~Pr~ 545 (565)
T KOG0472|consen 476 CLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR-QPRH 545 (565)
T ss_pred HHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC-CCHH
Confidence 9999999999999999999777888999999999999999998 89999999999999999999998 4443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=353.96 Aligned_cols=275 Identities=21% Similarity=0.311 Sum_probs=206.7
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC--CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK--GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
+.|+...++|+|+||+||+++++.+|+.||||.+....+ ...+-.++|++++++++|||+|.++++ |.....+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEV-----Frrkrkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEV-----FRRKRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHH-----HHhccee
Confidence 468888999999999999999999999999999853332 223456899999999999999999998 4566778
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
++|+|||+. ++.+-+...+. .++...+.++++|++.|+.|+|++ ++|||||||+|||++.+|.+||||||+
T Consensus 77 hLVFE~~dh-TvL~eLe~~p~-----G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGF 147 (396)
T KOG0593|consen 77 HLVFEYCDH-TVLHELERYPN-----GVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGF 147 (396)
T ss_pred EEEeeecch-HHHHHHHhccC-----CCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchh
Confidence 999999987 55555555544 389999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHH-HHhh
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHE-FART 914 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~-~~~~ 914 (992)
|+.+... ....+.++.|.+|+|||.+.+ .+|+..+||||+||++.||++|.+.|.+..+-+..+.- ..-.
T Consensus 148 AR~L~~p--------gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG 219 (396)
T KOG0593|consen 148 ARTLSAP--------GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLG 219 (396)
T ss_pred hHhhcCC--------cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHc
Confidence 9987631 122334578999999999887 68999999999999999999999999986554332211 1111
Q ss_pred hCChhHHHHHHhhH-hHhh--hccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 915 ALPDKVMEIVDSVL-LLEV--QASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 915 ~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
......+.++...- -... +........+. ........+.+++..|++.||.+|++.+|++.
T Consensus 220 ~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~--k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 220 NLIPRHQSIFSSNPFFHGVRLPEPEHPEPLER--KYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ccCHHHHHHhccCCceeeeecCCCCCccchhh--hcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 12222222222110 0000 00000000000 11123346889999999999999999999874
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=378.37 Aligned_cols=258 Identities=31% Similarity=0.478 Sum_probs=210.1
Q ss_pred CCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEEE
Q 037275 681 FSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVY 760 (992)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 760 (992)
+...+.||+|.||+||.|.+. ....||+|.++.. ....+.|.+|+++|++++|++||+++|+|.. ...++|||
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~-----~~piyIVt 280 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTK-----QEPIYIVT 280 (468)
T ss_pred HHHHHHhcCCccceEEEEEEc-CCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEec-----CCceEEEE
Confidence 445689999999999999996 4458999999754 3455778899999999999999999999854 23679999
Q ss_pred EeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceec
Q 037275 761 EYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFL 840 (992)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 840 (992)
|||+.|+|.+|++... ...+...+.+.++.|||+|++||+++ ++|||||.++||||+++..+||+|||+|+..
T Consensus 281 E~m~~GsLl~yLr~~~----~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~ 353 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRTRE----GGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLI 353 (468)
T ss_pred EecccCcHHHHhhhcC----CCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEccccccccc
Confidence 9999999999999732 33689999999999999999999999 9999999999999999999999999999965
Q ss_pred CCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhhhCChh
Q 037275 841 SSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFARTALPDK 919 (992)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 919 (992)
.++.+.. ..+..-+..|.|||.+..+.++.|||||||||++|||+| |+.||.++...
T Consensus 354 ~d~~Y~~-------~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~--------------- 411 (468)
T KOG0197|consen 354 GDDEYTA-------SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE--------------- 411 (468)
T ss_pred CCCceee-------cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH---------------
Confidence 5543222 122235788999999999999999999999999999999 99999876433
Q ss_pred HHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhh
Q 037275 920 VMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTFL 987 (992)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 987 (992)
+++... ...+....+ ..++..+.++|..||+.+|++|||++.+...++++.....
T Consensus 412 --ev~~~l-e~GyRlp~P----------~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~~ 466 (468)
T KOG0197|consen 412 --EVLELL-ERGYRLPRP----------EGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTSTE 466 (468)
T ss_pred --HHHHHH-hccCcCCCC----------CCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhccc
Confidence 222211 112222222 2345669999999999999999999999998888766543
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=369.65 Aligned_cols=277 Identities=23% Similarity=0.306 Sum_probs=211.5
Q ss_pred HhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchh-HHHHHHHHHHhcc-CCcceeEEEEeecccccCcc
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASN-GFVAECQALRNIR-HRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 754 (992)
..++|.++++||.|+||.||+|+...+|+.||||.++..-....+ .-.+|+..+++++ |||||++.+++.+ ...
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d----~~~ 83 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRD----NDR 83 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhc----cCc
Confidence 345899999999999999999999999999999999755443222 2378999999998 9999999998643 222
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
.+++|||||+. +|.++++.+. +.+++.++..|++||++||+|+|.+ |+.|||+||+|||+.....+||+||
T Consensus 84 ~L~fVfE~Md~-NLYqLmK~R~-----r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDF 154 (538)
T KOG0661|consen 84 ILYFVFEFMDC-NLYQLMKDRN-----RLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADF 154 (538)
T ss_pred eEeeeHHhhhh-hHHHHHhhcC-----CcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccc
Confidence 88999999955 9999998764 3699999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCccccccccccccccc-CCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccH--HHH
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGM-GGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTL--HEF 911 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~--~~~ 911 (992)
|+|+.+...+.+ +.++.|.+|+|||++. .+.|+.+.||||+|||++|+.+-++.|.|..+-+..+ .+.
T Consensus 155 GLARev~SkpPY---------TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~V 225 (538)
T KOG0661|consen 155 GLAREVRSKPPY---------TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEV 225 (538)
T ss_pred ccccccccCCCc---------chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHH
Confidence 999987654432 3356899999999865 5678999999999999999999999999865543322 222
Q ss_pred HhhhCChhHHHH--HHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 912 ARTALPDKVMEI--VDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 912 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
......+.+.+- +...+.-..+...+... .... .....+..+++.+|+++||.+||||.|+++.
T Consensus 226 LGtP~~~~~~eg~~La~~mnf~~P~~~~~~l--~~L~-p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 226 LGTPDKDSWPEGYNLASAMNFRFPQVKPSPL--KDLL-PNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred hCCCccccchhHHHHHHHhccCCCcCCCCCh--HHhC-cccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 222222222221 11111111111100000 0011 1256778999999999999999999999863
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=378.49 Aligned_cols=479 Identities=25% Similarity=0.383 Sum_probs=371.0
Q ss_pred CCCcCCeeeccCCCCCccCCccccCCCCCCEEEeecccCCCCCCcccccCCCCcEeecccccccccCChhhccccccccc
Q 037275 72 NLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLEN 151 (992)
Q Consensus 72 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~~ 151 (992)
+-..|+.|++++|.+. .+-+.+..+..|.+|++++|+++ .+|.+++.+..++.|+.++|+++ ++|++++ .+.+|..
T Consensus 43 ~qv~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~-s~~~l~~ 118 (565)
T KOG0472|consen 43 EQVDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIG-SLISLVK 118 (565)
T ss_pred hhcchhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHh-hhhhhhh
Confidence 3456778888888887 66667888888888888888887 88888888888888888888887 7777776 5677777
Q ss_pred ccccccccCCCCCCccccccccceEEecCCcccCCcCCccCCCCcccEEeccCcccccccCccccccCCCcEEeccCCcc
Q 037275 152 LTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRF 231 (992)
Q Consensus 152 L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l 231 (992)
|+.+.|.+. ++|++++.+-.|+.|+..+|++ ...|+.+.++.+|..|++.+|+++. .|+..-+++.|++|+...|-+
T Consensus 119 l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i-~slp~~~~~~~~l~~l~~~~n~l~~-l~~~~i~m~~L~~ld~~~N~L 195 (565)
T KOG0472|consen 119 LDCSSNELK-ELPDSIGRLLDLEDLDATNNQI-SSLPEDMVNLSKLSKLDLEGNKLKA-LPENHIAMKRLKHLDCNSNLL 195 (565)
T ss_pred hhcccccee-ecCchHHHHhhhhhhhcccccc-ccCchHHHHHHHHHHhhccccchhh-CCHHHHHHHHHHhcccchhhh
Confidence 777777777 6777777777777777777777 5567777777777777777777773 444444477777777666665
Q ss_pred CCCCCccccccccccchhhccccccCCCCchhhhccccCceeeeccccccccccccccccCccceEecCCCCCCCCCCCC
Q 037275 232 NGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEAND 311 (992)
Q Consensus 232 ~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 311 (992)
. .+|+.++.+.+|..|+|.+|+|.. .| .|.++..|++|+++.|+|..+++.
T Consensus 196 ~--------------------------tlP~~lg~l~~L~~LyL~~Nki~~-lP-ef~gcs~L~Elh~g~N~i~~lpae- 246 (565)
T KOG0472|consen 196 E--------------------------TLPPELGGLESLELLYLRRNKIRF-LP-EFPGCSLLKELHVGENQIEMLPAE- 246 (565)
T ss_pred h--------------------------cCChhhcchhhhHHHHhhhccccc-CC-CCCccHHHHHHHhcccHHHhhHHH-
Confidence 5 667777778888888888888873 33 777888888888888888776653
Q ss_pred chhhhhccCCCcceEeecCCCcCCCcCCcccccccccceeEEeeCCccccccCCCccCCCcccEEEccCCcCCCCCCccc
Q 037275 312 LDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAI 391 (992)
Q Consensus 312 ~~~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 391 (992)
.+.++++|..|||.+|++. ..|+.++-+. .|.+|++++|.|+ ..|..++++ .|+.|.+.+|.+..+-.+.+
T Consensus 247 -----~~~~L~~l~vLDLRdNklk-e~Pde~clLr-sL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii 317 (565)
T KOG0472|consen 247 -----HLKHLNSLLVLDLRDNKLK-EVPDEICLLR-SLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREII 317 (565)
T ss_pred -----Hhcccccceeeeccccccc-cCchHHHHhh-hhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHH
Confidence 3556777777888888777 5677776664 3788888888888 467778888 88999999998864322222
Q ss_pred cCCCC--CcEEec-------cCccc---c-cc-CC---CCCCCccccCceeccCCcccCCCCCCcccccc---ccccccc
Q 037275 392 GELKN--LQLLYL-------DSNFL---A-GG-IP---TSLGNLTLLTNLALSSNDLQGSIPPSLGNCKN---LIELHMA 451 (992)
Q Consensus 392 ~~l~~--L~~L~L-------~~N~l---~-~~-~~---~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~---L~~L~l~ 451 (992)
.+-+. |++|.= +.-+= + +. .+ .....+.+.+.|+++.-+++ .+|..+..... ....+++
T Consensus 318 ~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~Vnfs 396 (565)
T KOG0472|consen 318 SKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFS 396 (565)
T ss_pred cccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecc
Confidence 22111 333321 11100 0 00 11 11233557899999999999 56665554444 7889999
Q ss_pred cccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeecccccccCCcccccccccceeeccCCccccc
Q 037275 452 DIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGS 531 (992)
Q Consensus 452 ~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 531 (992)
.|++. ++|+...........+++++|.++ .+|..++.+++|+.|+|++|-+. .+|..++.+..|+.|++|.|++. .
T Consensus 397 kNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~ 472 (565)
T KOG0472|consen 397 KNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-M 472 (565)
T ss_pred cchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-c
Confidence 99998 899999999999989999999998 88999999999999999999998 78999999999999999999998 8
Q ss_pred CCccccccCCCCEEECCCcccCCCChhhhhcCCCcceEecCCCcCcccCCCCCccCCcccccccCCCCc
Q 037275 532 IPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNKTGISLSGNGKV 600 (992)
Q Consensus 532 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~l~~N~~~ 600 (992)
+|..+..+..|+.+-.++|++....|..+.+|.+|..|||.+|.+...+|..+...+++++.+.|||+.
T Consensus 473 lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 473 LPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred chHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCccC
Confidence 999999988999999999999977777799999999999999999999999999999999999999875
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=363.87 Aligned_cols=261 Identities=25% Similarity=0.388 Sum_probs=214.0
Q ss_pred HHHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc---CCCchhHHHHHHHHHHhc-cCCcceeEEEEeecccc
Q 037275 675 SKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK---QKGASNGFVAECQALRNI-RHRNLIKIITICSSIDF 750 (992)
Q Consensus 675 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 750 (992)
.+...+|.+.+.||+|+|++|++|+...+++.||||++... .+...+.+..|-.+|.+| .||.|++++-. |
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~T-----F 143 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFT-----F 143 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEE-----e
Confidence 44456899999999999999999999999999999999633 234456678899999999 89999999887 6
Q ss_pred cCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEE
Q 037275 751 KGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAH 830 (992)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 830 (992)
++...+|+|+||+++|+|.++|++.+ .+++.....++.+|+.||+|||++ |||||||||+|||+|+||++|
T Consensus 144 QD~~sLYFvLe~A~nGdll~~i~K~G------sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhik 214 (604)
T KOG0592|consen 144 QDEESLYFVLEYAPNGDLLDLIKKYG------SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIK 214 (604)
T ss_pred ecccceEEEEEecCCCcHHHHHHHhC------cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEE
Confidence 67788899999999999999999875 488999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCCCCC-----cccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCC
Q 037275 831 LGDFGLAKFLSSSPLDTA-----VETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQG 905 (992)
Q Consensus 831 l~Dfg~a~~~~~~~~~~~-----~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~ 905 (992)
|+|||.|+.+.+...... .........++||..|.+||++..+..++.+|||+||||+|+|+.|++||.+..+-
T Consensus 215 ITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney- 293 (604)
T KOG0592|consen 215 ITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY- 293 (604)
T ss_pred EeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH-
Confidence 999999999876543311 11112225589999999999999999999999999999999999999999874211
Q ss_pred ccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 906 LTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
-++.+++..+|... +..++.+.+|+.+.|..||.+|+|++||.+.
T Consensus 294 ----------------liFqkI~~l~y~fp------------~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 294 ----------------LIFQKIQALDYEFP------------EGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred ----------------HHHHHHHHhcccCC------------CCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 12222332333211 1112457889999999999999999888653
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=349.64 Aligned_cols=243 Identities=28% Similarity=0.382 Sum_probs=201.8
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc---CCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK---QKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
.++|++.++||+|+||+||.++.+.+++.+|+|++++. .....+....|..++.+++||.||++.-. |++.+
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ys-----FQt~~ 98 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYS-----FQTEE 98 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEe-----cccCC
Confidence 45899999999999999999999999999999999744 23456778999999999999999999876 77888
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
..|+|+||+.||.|...+++.+ .+++..+.-++..|+.||.|||++ +|||||+||+|||+|++|+++|+||
T Consensus 99 kLylVld~~~GGeLf~hL~~eg------~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDF 169 (357)
T KOG0598|consen 99 KLYLVLDYLNGGELFYHLQREG------RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDF 169 (357)
T ss_pred eEEEEEeccCCccHHHHHHhcC------CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEecc
Confidence 9999999999999999998665 488999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
|+++.... ....+..++||+.|||||++.+..|+.++|-||+|+++|||++|.+||.+..
T Consensus 170 gL~k~~~~--------~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~------------ 229 (357)
T KOG0598|consen 170 GLCKEDLK--------DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED------------ 229 (357)
T ss_pred ccchhccc--------CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc------------
Confidence 99985432 2233445789999999999999999999999999999999999999998631
Q ss_pred hCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCC
Q 037275 915 ALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERM 970 (992)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 970 (992)
...+.+.+....... .. .--..+..+++.+.+..||++|.
T Consensus 230 -----~~~~~~~I~~~k~~~--~p---------~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 230 -----VKKMYDKILKGKLPL--PP---------GYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred -----HHHHHHHHhcCcCCC--CC---------ccCCHHHHHHHHHHhccCHHHhc
Confidence 122233322211000 00 00123467889999999999996
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=330.06 Aligned_cols=272 Identities=24% Similarity=0.337 Sum_probs=209.1
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC--CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK--GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
.+|...+++|+|.||.||+|++.++|+.||||.++.... +-.....+|++.|+.++|+||+.++++ |...+..
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~-----F~~~~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDV-----FPHKSNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhh-----ccCCCce
Confidence 468888999999999999999999999999999975532 234567899999999999999999999 4556677
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
.+|+||++. +|...++.... .++..++..++.++++|++|+|++ .|+|||+||.|+|++.+|.+||+|||+
T Consensus 77 ~lVfEfm~t-dLe~vIkd~~i-----~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGL 147 (318)
T KOG0659|consen 77 SLVFEFMPT-DLEVVIKDKNI-----ILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGL 147 (318)
T ss_pred EEEEEeccc-cHHHHhccccc-----ccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccc
Confidence 999999965 99999987653 589999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHH--h
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFA--R 913 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~--~ 913 (992)
|+.+...... ....+-|.+|+|||.+.|. .|+..+||||.|||+.||+-|.+-|.+..+-++...-+. .
T Consensus 148 Ar~f~~p~~~--------~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LG 219 (318)
T KOG0659|consen 148 ARFFGSPNRI--------QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALG 219 (318)
T ss_pred hhccCCCCcc--------cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcC
Confidence 9988754321 1222679999999988875 699999999999999999999998887554332221111 1
Q ss_pred hhCChhHHHH---HHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 914 TALPDKVMEI---VDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 914 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
+..++.+.++ .|......++. .... .-...+..+..+++..|+.+||.+|+|+.|++++
T Consensus 220 TP~~~~WP~~~~lpdY~~~~~~P~-----~~~~-~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 220 TPTPDQWPEMTSLPDYVKIQQFPK-----PPLN-NLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred CCCcccCccccccccHHHHhcCCC-----Cccc-cccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 1222222221 11111111110 0000 0122334556999999999999999999999863
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=361.48 Aligned_cols=277 Identities=25% Similarity=0.340 Sum_probs=210.0
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC--CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
+.|+.+++||+|.||.||+|++..+|+.||+|.++... .+......+|+.||++++||||+++.+...+. ....+
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---~~~si 193 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---LSGSI 193 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---CCceE
Confidence 35777889999999999999999999999999998665 44456678999999999999999999987642 34678
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
|+|+|||+. ||..++....- .+++.++..+++|++.||+|+|++ ||+|||||.+|||+|.+|.+||+|||+
T Consensus 194 YlVFeYMdh-DL~GLl~~p~v-----kft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGL 264 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSSPGV-----KFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGL 264 (560)
T ss_pred EEEEecccc-hhhhhhcCCCc-----ccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccc
Confidence 999999977 99999876543 499999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 915 (992)
|+++.... ....+..+.|.+|+|||.+.|. .|+.++|+||.|||+.||++|++.|.+..+-+ ++..+...-
T Consensus 265 Ar~y~~~~-------~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEve-Ql~kIfklc 336 (560)
T KOG0600|consen 265 ARFYTPSG-------SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVE-QLHKIFKLC 336 (560)
T ss_pred eeeccCCC-------CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHH-HHHHHHHHh
Confidence 99876542 1223455789999999998875 79999999999999999999999998854332 122221111
Q ss_pred -CC-hhHHHHHHhhHhHhhh-ccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 916 -LP-DKVMEIVDSVLLLEVQ-ASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 916 -~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.| +......+--....+. .....++..+. .........+++..+|..||.+|.||.++++
T Consensus 337 GSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~--~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 337 GSPTEDYWPVSKLPHATIFKPQQPYKRRLRET--FKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CCCChhccccccCCcccccCCCCcccchHHHH--hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 11 1111100000000000 01111111111 1123455788999999999999999999874
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=383.30 Aligned_cols=265 Identities=27% Similarity=0.484 Sum_probs=218.0
Q ss_pred hcCCCCCCccccccceEEEEeEEC-----CCCeEEEEEEeeccCCC-chhHHHHHHHHHHhccCCcceeEEEEeeccccc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLG-----ENGMMVAVKVINLKQKG-ASNGFVAECQALRNIRHRNLIKIITICSSIDFK 751 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 751 (992)
..+....+.||+|.||+||+|+.. ++...||||.++..... ...+|++|++++..++|||||+++|+|..
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~---- 560 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE---- 560 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc----
Confidence 345567789999999999999873 34577999999866655 67899999999999999999999999864
Q ss_pred CcceEEEEEEeccCCCHHHHHhhcccchh--------hcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeee
Q 037275 752 GVDFQAIVYEYMQNGSLEDWLHQSEDQQE--------ARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLL 823 (992)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 823 (992)
++..++|+|||..|||.+|++....... ..+++..+.+.||.|||.|++||-++ .+|||||..+|+||
T Consensus 561 -~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLV 636 (774)
T KOG1026|consen 561 -GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLV 636 (774)
T ss_pred -CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhcee
Confidence 4456999999999999999987654311 33489999999999999999999999 99999999999999
Q ss_pred CCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCc
Q 037275 824 DQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMF 902 (992)
Q Consensus 824 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~ 902 (992)
.++..|||+|||+++.+...+++... ....-+.+|||||.+..++|+.+||||||||++||+++ |+.||.+..
T Consensus 637 ge~l~VKIsDfGLsRdiYssDYYk~~------~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS 710 (774)
T KOG1026|consen 637 GENLVVKISDFGLSRDIYSSDYYKVR------GNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS 710 (774)
T ss_pred ccceEEEecccccchhhhhhhhhccc------CCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc
Confidence 99999999999999988766544422 12245789999999999999999999999999999999 999998865
Q ss_pred cCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 037275 903 NQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRA 982 (992)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 982 (992)
++ ++++.+..+.. -. ..+.++.+++++|..||+.+|++||+++||-..|+..
T Consensus 711 n~-----------------EVIe~i~~g~l-L~----------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~ 762 (774)
T KOG1026|consen 711 NQ-----------------EVIECIRAGQL-LS----------CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW 762 (774)
T ss_pred hH-----------------HHHHHHHcCCc-cc----------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence 54 22222222221 11 2234466799999999999999999999999999886
Q ss_pred HH
Q 037275 983 RD 984 (992)
Q Consensus 983 ~~ 984 (992)
..
T Consensus 763 ~~ 764 (774)
T KOG1026|consen 763 AQ 764 (774)
T ss_pred Hh
Confidence 54
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=348.38 Aligned_cols=265 Identities=24% Similarity=0.341 Sum_probs=210.9
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCc-hhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGA-SNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
.++|++.++||.|..++||+|+....++.||||++..+.-.. .+.+.+|+..|+.++||||++++..| ..+...
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sF-----vv~~~L 99 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSF-----VVDSEL 99 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEE-----Eeccee
Confidence 458999999999999999999999999999999998654333 58899999999999999999998874 456778
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
|+||+||.+|++.+.++..... .+++..+..|.+++++||.|||.+ |.||||||+.|||++.+|.|||+|||.
T Consensus 100 WvVmpfMa~GS~ldIik~~~~~----Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgv 172 (516)
T KOG0582|consen 100 WVVMPFMAGGSLLDIIKTYYPD----GLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGV 172 (516)
T ss_pred EEeehhhcCCcHHHHHHHHccc----cccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCcee
Confidence 9999999999999999876543 599999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccC--CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG--GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
+..+.... .. .......++||+.|||||++.. ..|+.|+||||||++..|+++|..||..+......+... ..
T Consensus 173 sa~l~~~G-~R---~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL-qn 247 (516)
T KOG0582|consen 173 SASLFDSG-DR---QVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL-QN 247 (516)
T ss_pred eeeecccC-ce---eeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh-cC
Confidence 98776543 11 1111156789999999999654 369999999999999999999999998753321111111 11
Q ss_pred hCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 915 ALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
..|..... .....+.......+.+++..||+.||.+||||+++++
T Consensus 248 ~pp~~~t~------------------~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 248 DPPTLLTS------------------GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CCCCcccc------------------cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 11100000 0011111223457889999999999999999999975
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=355.28 Aligned_cols=261 Identities=26% Similarity=0.405 Sum_probs=203.4
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAI 758 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 758 (992)
.+|...+.||+|+||+||++....+|+..|||.+...+....+.+.+|+.+|++++|||||+++|.....+ + ..+++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~--~-~~~~i 93 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRE--N-DEYNI 93 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCcccccc--C-eeeEe
Confidence 35778899999999999999999889999999987554333667899999999999999999999633211 1 46799
Q ss_pred EEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCC-CCcEEEeecccc
Q 037275 759 VYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQ-DLVAHLGDFGLA 837 (992)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a 837 (992)
.|||+++|+|.+++...+. .+++..+..++.||++||+|||++ |||||||||+|||++. ++.+||+|||.+
T Consensus 94 ~mEy~~~GsL~~~~~~~g~-----~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a 165 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGG-----KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLA 165 (313)
T ss_pred eeeccCCCcHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccc
Confidence 9999999999999987653 499999999999999999999999 9999999999999999 799999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTAL 916 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 916 (992)
+...... ..........||+.|||||++..+ ...+++||||+||++.||+||++||....... ....
T Consensus 166 ~~~~~~~-----~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~---~~~~---- 233 (313)
T KOG0198|consen 166 KKLESKG-----TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEA---EALL---- 233 (313)
T ss_pred ccccccc-----ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchH---HHHH----
Confidence 8765311 122233456799999999999853 34469999999999999999999997631110 0000
Q ss_pred ChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 037275 917 PDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCR 981 (992)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 981 (992)
........ +..+ .....+..+++.+|+..||++||||+|+++.--.
T Consensus 234 ---------~ig~~~~~----P~ip------~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 234 ---------LIGREDSL----PEIP------DSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred ---------HHhccCCC----CCCC------cccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 00000000 0000 1123457889999999999999999999976543
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=364.44 Aligned_cols=265 Identities=27% Similarity=0.389 Sum_probs=210.9
Q ss_pred HHHHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC--CchhHHHHHHHHHHhccCCcceeEEEEeeccccc
Q 037275 674 LSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK--GASNGFVAECQALRNIRHRNLIKIITICSSIDFK 751 (992)
Q Consensus 674 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 751 (992)
.....+.+.+.+.||+|.||+||+|++.. .||||+++.... +..+.|++|+.++++-+|.||+-+.|||...
T Consensus 387 WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p--- 460 (678)
T KOG0193|consen 387 WEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP--- 460 (678)
T ss_pred cccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC---
Confidence 33444566788999999999999999964 599999986643 3457899999999999999999999997542
Q ss_pred CcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEE
Q 037275 752 GVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHL 831 (992)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 831 (992)
. +.||+.+|+|-+|+.+++..+. .++..+.+.||+|||+|+.|||.+ +|||||||..||++++++.|||
T Consensus 461 --~-~AIiTqwCeGsSLY~hlHv~et-----kfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkI 529 (678)
T KOG0193|consen 461 --P-LAIITQWCEGSSLYTHLHVQET-----KFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKI 529 (678)
T ss_pred --c-eeeeehhccCchhhhhccchhh-----hhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEE
Confidence 2 3899999999999999997765 499999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCCCCCcccCCCCCcccccccccccccccCC---CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccH
Q 037275 832 GDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG---EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTL 908 (992)
Q Consensus 832 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~ 908 (992)
+|||++....... .........|...|||||+++.. +|++.+||||||+|+|||+||..||.. ...+..+
T Consensus 530 gDFGLatvk~~w~------g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~~dqIi 602 (678)
T KOG0193|consen 530 GDFGLATVKTRWS------GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QNRDQII 602 (678)
T ss_pred ecccceeeeeeec------cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CChhheE
Confidence 9999997654331 12222334588899999998754 799999999999999999999999983 2222222
Q ss_pred HHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 037275 909 HEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDT 985 (992)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 985 (992)
...-+.... ++.......+.+++.+|+..||..+|++||.+.+|+..|+.+..+
T Consensus 603 fmVGrG~l~-----------------------pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 603 FMVGRGYLM-----------------------PDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred EEecccccC-----------------------ccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 111111111 111112234466799999999999999999999999999888765
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=362.36 Aligned_cols=252 Identities=23% Similarity=0.327 Sum_probs=210.6
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
...|...++||+|+.|.||.|....+++.||||++........+-+.+|+.+|+..+|+|||++++.|. ..+..|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Syl-----v~deLW 346 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYL-----VGDELW 346 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhc-----ccceeE
Confidence 446888899999999999999999999999999998887777888999999999999999999999753 336789
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+|||||++|+|.|.+.... +++.++..|++++++||+|||.+ +|+|||||.+|||++.+|.+||+|||++
T Consensus 347 VVMEym~ggsLTDvVt~~~-------~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFc 416 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVTKTR-------MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFC 416 (550)
T ss_pred EEEeecCCCchhhhhhccc-------ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeee
Confidence 9999999999999998654 89999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALP 917 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 917 (992)
..+.... ......+||++|||||+.....|++|+||||||++++||+.|++||-. + ..+......+..
T Consensus 417 aqi~~~~--------~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln---E-~PlrAlyLIa~n 484 (550)
T KOG0578|consen 417 AQISEEQ--------SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN---E-NPLRALYLIATN 484 (550)
T ss_pred ecccccc--------CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC---C-ChHHHHHHHhhc
Confidence 8776432 234557899999999999999999999999999999999999999853 1 111111111000
Q ss_pred hhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 918 DKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
+ .......+.....+.+++.+||..||++||+|+|+|+.
T Consensus 485 ------------g----------~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 485 ------------G----------TPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred ------------C----------CCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 0 00011122335668999999999999999999999863
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=367.31 Aligned_cols=384 Identities=23% Similarity=0.243 Sum_probs=225.6
Q ss_pred eecccccccccCChhhcccccccccccccccccCCCCCCccccccccceEEecCCcccCCcCCccCCCCcccEEeccCcc
Q 037275 127 FNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENR 206 (992)
Q Consensus 127 L~l~~n~l~~~~p~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~ 206 (992)
||+++|.+. .+-...+.++++|++++|.+|.++ .+|.......+|+.|+|.+|.|...-.+++..++.|+.||||.|.
T Consensus 83 LdlsnNkl~-~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~ 160 (873)
T KOG4194|consen 83 LDLSNNKLS-HIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNL 160 (873)
T ss_pred eeccccccc-cCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhch
Confidence 333333333 333333345555555555555555 555555555566666666666666666666666666677777766
Q ss_pred cccccCccccccCCCcEEeccCCccCCCCCccccccccccchhhccccccCCCCchhhhccccCceeeeccccccccccc
Q 037275 207 FSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSI 286 (992)
Q Consensus 207 l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~ 286 (992)
|+.+--.+|..-.++++|+|++|+|+ .+-.+-|.++.+|..|.+++|+++...+..|.+++.|+.|+|..|+|.-..-.
T Consensus 161 is~i~~~sfp~~~ni~~L~La~N~It-~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~l 239 (873)
T KOG4194|consen 161 ISEIPKPSFPAKVNIKKLNLASNRIT-TLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGL 239 (873)
T ss_pred hhcccCCCCCCCCCceEEeecccccc-ccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhh
Confidence 66443345555566666666666665 44444444444555555555555544455566666667777777766644455
Q ss_pred cccccCccceEecCCCCCCCCCCCCchhhhhccCCCcceEeecCCCcCCCcCCcccccccccceeEEeeCCccccccCCC
Q 037275 287 YFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTG 366 (992)
Q Consensus 287 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~ 366 (992)
.|.++++|+.|.|..|++..+.. ..
T Consensus 240 tFqgL~Sl~nlklqrN~I~kL~D-------------------------------------------------------G~ 264 (873)
T KOG4194|consen 240 TFQGLPSLQNLKLQRNDISKLDD-------------------------------------------------------GA 264 (873)
T ss_pred hhcCchhhhhhhhhhcCcccccC-------------------------------------------------------cc
Confidence 66666666666666666554332 33
Q ss_pred ccCCCcccEEEccCCcCCCCCCccccCCCCCcEEeccCccccccCCCCCCCccccCceeccCCcccCCCCCCcccccccc
Q 037275 367 IRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLI 446 (992)
Q Consensus 367 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 446 (992)
|..+.++++|+|+.|+++..-..++.+++.|+.|+||+|.|..+-++.....++|++|+|++|+|+...+.+|..+..|+
T Consensus 265 Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le 344 (873)
T KOG4194|consen 265 FYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLE 344 (873)
T ss_pred eeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhh
Confidence 44455555555555555555555555566666666666665555555555555666666666666655555555555555
Q ss_pred ccccccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeecccccccCC---cccccccccceeec
Q 037275 447 ELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIP---VTLSACTSLQQLYL 523 (992)
Q Consensus 447 ~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~L 523 (992)
+|+|++|+++ ..-...|..+.+|+.|||++|.|++.+. ..|.++++|+.|+|
T Consensus 345 ~LnLs~Nsi~-------------------------~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l 399 (873)
T KOG4194|consen 345 ELNLSHNSID-------------------------HLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRL 399 (873)
T ss_pred hhcccccchH-------------------------HHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheee
Confidence 5544444443 2222334455556666666666554433 23666777777777
Q ss_pred cCCcccccCCccccccCCCCEEECCCcccCCCChhhhhcCCCcceEecCCCcCcccCCCCCccCCcccccc
Q 037275 524 QGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNKTGISL 594 (992)
Q Consensus 524 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~l 594 (992)
.+|+|..+...+|.+++.|+.|||.+|-|.++-|++|..+ .|+.|-++.-.|-|+|...+..+|+....+
T Consensus 400 ~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSssflCDCql~Wl~qWl~~~~l 469 (873)
T KOG4194|consen 400 TGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSSFLCDCQLKWLAQWLYRRKL 469 (873)
T ss_pred cCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcccceEEeccHHHHHHHHHhccc
Confidence 7777775555677777777777777777777777777777 677777777777777766655555544333
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=354.51 Aligned_cols=247 Identities=30% Similarity=0.445 Sum_probs=209.3
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC--CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK--GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+..+ .+.+.+.+|+++++.++||||+.++++ |+...+.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~es-----fEt~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLES-----FETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHh-----hcccceE
Confidence 578889999999999999999999999999999965443 334668999999999999999999998 5677888
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
|+|+||+.| +|..++.+.+ .++++.+..++.|++.||.|||+. +|.|||+||+||+++.+|.+|+||||+
T Consensus 77 ~vVte~a~g-~L~~il~~d~------~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~ 146 (808)
T KOG0597|consen 77 WVVTEYAVG-DLFTILEQDG------KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGL 146 (808)
T ss_pred EEEehhhhh-hHHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhh
Confidence 999999976 9999998765 489999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhC
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTAL 916 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 916 (992)
|+.+... ......+.|||.|||||+..++.|+..+|+||+|||+||+++|++||..
T Consensus 147 Ar~m~~~--------t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a---------------- 202 (808)
T KOG0597|consen 147 ARAMSTN--------TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA---------------- 202 (808)
T ss_pred hhhcccC--------ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH----------------
Confidence 9976542 2334556799999999999999999999999999999999999999864
Q ss_pred ChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 917 PDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
..+...+..+..... .........+..++...|..||..|.|..+++.
T Consensus 203 -~si~~Lv~~I~~d~v------------~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 203 -RSITQLVKSILKDPV------------KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred -HHHHHHHHHHhcCCC------------CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 123334433332211 111234556889999999999999999999875
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=341.74 Aligned_cols=277 Identities=23% Similarity=0.309 Sum_probs=206.5
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEE
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIV 759 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 759 (992)
.|...+++|.|+||.||+|+..++++.||||.+-.+.+ .-.+|+++|++++|||||++.-++......+.-+..+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 56677999999999999999999999999998753332 22379999999999999999998876444434566799
Q ss_pred EEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCC-CcEEEeecccce
Q 037275 760 YEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQD-LVAHLGDFGLAK 838 (992)
Q Consensus 760 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~ 838 (992)
||||+. +|.++++..... ...++...+.-+.+||.+||+|||+. +|+||||||.|+|+|.+ |.+||||||.|+
T Consensus 101 leymP~-tL~~~~r~~~~~--~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRA--NQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHhchH-HHHHHHHHHhhc--CCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcce
Confidence 999976 999999864322 33578888899999999999999998 99999999999999977 899999999999
Q ss_pred ecCCCCCCCCcccCCCCCcccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCC
Q 037275 839 FLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALP 917 (992)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 917 (992)
.+..+. ....+..|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|.+... ..++.+.....-.
T Consensus 175 ~L~~~e---------pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~-~dQL~eIik~lG~ 244 (364)
T KOG0658|consen 175 VLVKGE---------PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS-VDQLVEIIKVLGT 244 (364)
T ss_pred eeccCC---------CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH-HHHHHHHHHHhCC
Confidence 876542 22445789999999998875 799999999999999999999999998422 2233343332211
Q ss_pred hhHHHHHHhhHhH--hhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 918 DKVMEIVDSVLLL--EVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 918 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
....+ +..+... +............+........+..+++.++++++|.+|.++.|++.
T Consensus 245 Pt~e~-I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 245 PTRED-IKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred CCHHH-HhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 11111 1111111 10001111111111122334567899999999999999999999974
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=330.08 Aligned_cols=280 Identities=20% Similarity=0.281 Sum_probs=208.4
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC--CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK--GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
.+.|+..++|++|+||.||+|+++.+++.||+|.++.... +-.-.-.+|+.++.+.+|||||.+-.+... ...+.
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG---~~~d~ 151 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVG---SNMDK 151 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEec---cccce
Confidence 4468888999999999999999999999999999975442 223446899999999999999999998654 33456
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
+|+|||||+. +|...+...+. ++...++.-+..|+++|++|||.+ .|+|||+||+|+|+...|.+||+|||
T Consensus 152 iy~VMe~~Eh-DLksl~d~m~q-----~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFG 222 (419)
T KOG0663|consen 152 IYIVMEYVEH-DLKSLMETMKQ-----PFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFG 222 (419)
T ss_pred eeeeHHHHHh-hHHHHHHhccC-----CCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccc
Confidence 8999999977 99999987763 589999999999999999999999 89999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
+|+.++.. ....+..+-|.+|+|||.+.+. .|+.+.|+||+|||+.|++++++.|.+..+-++...-+...
T Consensus 223 LAR~ygsp--------~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~ll 294 (419)
T KOG0663|consen 223 LAREYGSP--------LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLL 294 (419)
T ss_pred hhhhhcCC--------cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHh
Confidence 99987753 2233455789999999988775 69999999999999999999999999865543322222222
Q ss_pred hCChh--HHHHHHhhHhHhhhc-cCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 915 ALPDK--VMEIVDSVLLLEVQA-SNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 915 ~~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
..|.+ +..+...-....... ..+............-...-.+++..++.+||.+|.||+|.++
T Consensus 295 GtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 295 GTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred CCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 22211 111111000000000 0000000000000001244678899999999999999999875
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=336.69 Aligned_cols=284 Identities=23% Similarity=0.283 Sum_probs=214.1
Q ss_pred HhcCCCCCCccccccceEEEEeEECCCCeEEEEEEee--ccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcc
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVIN--LKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
...+|...+.||+|+||.|+.|.++.+|+.||||.+. .......++..+|+.+++.++|+||+.+.+++.......-.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3456777899999999999999999999999999986 45555667889999999999999999999998765555667
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
.+|+|+|+| +.+|...++... .++...+.-+++|+++||+|+|+. +|+|||+||.|++++.+..+||+||
T Consensus 100 DvYiV~elM-etDL~~iik~~~------~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DF 169 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQQ------DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDF 169 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcCc------cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccc
Confidence 789999999 559999998654 488899999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCccccccccccccccc-CCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCc--cHHHH
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGM-GGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGL--TLHEF 911 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~--~~~~~ 911 (992)
|+|+..... ......+.++.|.+|+|||++. ...|+.+.||||.|||+.||++|++-|.+...-.. ...+.
T Consensus 170 GLAR~~~~~------~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~ 243 (359)
T KOG0660|consen 170 GLARYLDKF------FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILEL 243 (359)
T ss_pred cceeecccc------CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHh
Confidence 999987643 1233445677899999999765 45899999999999999999999999988432211 11111
Q ss_pred HhhhCChhHHHHHHhhHhHhhhccCCCCCCcc-ccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 912 ARTALPDKVMEIVDSVLLLEVQASNSRSCGDE-RLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.... +++....+.......+-...+...... ............+++.+||..||.+|+|++|+++
T Consensus 244 lGtP-~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 244 LGTP-SEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred cCCC-CHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 1111 222222222111111111111110000 0001123456789999999999999999999986
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=322.01 Aligned_cols=277 Identities=20% Similarity=0.264 Sum_probs=220.4
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
.++|++.+.+|+|||+.||.++...+++.||+|.+.....+..+..++|++..++++|||++++++++....-.+....|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 45899999999999999999999889999999999877777788899999999999999999999987665555677889
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
++++|+..|+|.+.+...... +..+++.++++|+.++++||++||+. .++++||||||.||++.+++.+++.|||.+
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~k--g~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIK--GNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEeehhccccHHHHHHHHhhc--CCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCc
Confidence 999999999999999876543 45799999999999999999999998 335999999999999999999999999999
Q ss_pred eecCCCCCCCCc-ccCCCCCccccccccccccccc---CCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh
Q 037275 838 KFLSSSPLDTAV-ETPSSSKGIKGTVGYIAPEYGM---GGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 838 ~~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 913 (992)
....-....... ..-.......+|..|+|||.+. +...++++|||||||++|+|+.|..||+....++..+.-.+.
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~ 256 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQ 256 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeee
Confidence 764322111100 0111122345799999999864 446789999999999999999999999875554433322111
Q ss_pred hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 037275 914 TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRA 982 (992)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 982 (992)
.. .+ . .++.....+.+.+++..|++.||.+||++.|++..++.+
T Consensus 257 n~---------------q~------s----~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 257 NA---------------QI------S----IPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred cc---------------cc------c----cCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 10 00 0 001111355689999999999999999999999998865
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=353.25 Aligned_cols=249 Identities=22% Similarity=0.360 Sum_probs=211.6
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
.+-|+.++.||.|+-|.|-.|++..+|+.+|||++.... ......+.+|+-+|+.+.||||++++++ +....
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydV-----we~~~ 85 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDV-----WENKQ 85 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeee-----eccCc
Confidence 456889999999999999999999999999999996442 2334668899999999999999999999 56677
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
++|+|.||+++|-|.+++-..+ ++++.+.+++++||+.|+.|+|.. +|+|||+||+|+|+|..+.+||+||
T Consensus 86 ~lylvlEyv~gGELFdylv~kG------~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADF 156 (786)
T KOG0588|consen 86 HLYLVLEYVPGGELFDYLVRKG------PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADF 156 (786)
T ss_pred eEEEEEEecCCchhHHHHHhhC------CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeecc
Confidence 8899999999999999998765 589999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCc-CcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEA-SMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 913 (992)
|+|.....+ ......+|++.|.|||++.|..| +.++||||.|||+|.|+||+.||++.
T Consensus 157 GMAsLe~~g---------klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd------------ 215 (786)
T KOG0588|consen 157 GMASLEVPG---------KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD------------ 215 (786)
T ss_pred ceeecccCC---------ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc------------
Confidence 999865433 22344589999999999999988 56899999999999999999999852
Q ss_pred hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 914 TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
.+..++.+...+.++.. .....+.++++.+|+..||++|.|++||++.
T Consensus 216 -----Nir~LLlKV~~G~f~MP------------s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 216 -----NIRVLLLKVQRGVFEMP------------SNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred -----cHHHHHHHHHcCcccCC------------CcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 33344444444444221 2234568999999999999999999999864
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=353.61 Aligned_cols=251 Identities=27% Similarity=0.369 Sum_probs=204.0
Q ss_pred HHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc----CC-CchhHHHHHHHHHHhcc-CCcceeEEEEeeccc
Q 037275 676 KATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK----QK-GASNGFVAECQALRNIR-HRNLIKIITICSSID 749 (992)
Q Consensus 676 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 749 (992)
...++|.+.+.||+|+||+|+.|.+..+++.||+|++... .. ...+.+.+|+.++++++ ||||+++++++.
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~--- 90 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFA--- 90 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEe---
Confidence 4467899999999999999999999999999999977543 11 23456778999999998 999999999954
Q ss_pred ccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCC-Cc
Q 037275 750 FKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQD-LV 828 (992)
Q Consensus 750 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~ 828 (992)
....+++||||+.+|+|.+++.... .+.+.....+++|++.|++|+|++ ||+||||||+||+++.+ +.
T Consensus 91 --t~~~~~ivmEy~~gGdL~~~i~~~g------~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~ 159 (370)
T KOG0583|consen 91 --TPTKIYIVMEYCSGGDLFDYIVNKG------RLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGN 159 (370)
T ss_pred --cCCeEEEEEEecCCccHHHHHHHcC------CCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCC
Confidence 4455899999999999999999733 488899999999999999999999 99999999999999999 99
Q ss_pred EEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCC-cC-cccchhhHHHHHHHHHhCCCCCCCCccCCc
Q 037275 829 AHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGE-AS-MTGDVYSFGILLLEMFTRRRPTDGMFNQGL 906 (992)
Q Consensus 829 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DiwSlG~il~elltg~~pf~~~~~~~~ 906 (992)
+||+|||++..... ........+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||++..
T Consensus 160 ~Kl~DFG~s~~~~~--------~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~---- 227 (370)
T KOG0583|consen 160 LKLSDFGLSAISPG--------EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN---- 227 (370)
T ss_pred EEEeccccccccCC--------CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc----
Confidence 99999999987631 223344568999999999999977 75 78999999999999999999998621
Q ss_pred cHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 037275 907 TLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVV 976 (992)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 976 (992)
.......+..+.+.. +.... ..++..++.+|+..||.+|+|+.||+
T Consensus 228 -------------~~~l~~ki~~~~~~~------p~~~~-----S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 228 -------------VPNLYRKIRKGEFKI------PSYLL-----SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred -------------HHHHHHHHhcCCccC------CCCcC-----CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 111111122121111 00000 34588999999999999999999998
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=368.14 Aligned_cols=271 Identities=26% Similarity=0.447 Sum_probs=221.8
Q ss_pred cccHHHHHHHhcC---------CCCCCccccccceEEEEeEECCCC---eEEEEEEeeccC-CCchhHHHHHHHHHHhcc
Q 037275 668 MISYAELSKATND---------FSSSNMIGQGSFGFVYKGNLGENG---MMVAVKVINLKQ-KGASNGFVAECQALRNIR 734 (992)
Q Consensus 668 ~~~~~~~~~~~~~---------~~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~ 734 (992)
.++|+|.-++... ..+.++||.|.||.||+|+.+..| ..||||.++... +....+|..|+.||.+++
T Consensus 609 P~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd 688 (996)
T KOG0196|consen 609 PHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD 688 (996)
T ss_pred CccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCC
Confidence 3556665555443 356789999999999999997555 579999997543 445678999999999999
Q ss_pred CCcceeEEEEeecccccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 037275 735 HRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHG 814 (992)
Q Consensus 735 h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~ 814 (992)
||||+++.|+.. .....+||+|||++|+|+.|++++..+ +++.+...++++||.|++||-+. ++|||
T Consensus 689 HPNIIrLEGVVT-----ks~PvMIiTEyMENGsLDsFLR~~DGq-----ftviQLVgMLrGIAsGMkYLsdm---~YVHR 755 (996)
T KOG0196|consen 689 HPNIIRLEGVVT-----KSKPVMIITEYMENGSLDSFLRQNDGQ-----FTVIQLVGMLRGIASGMKYLSDM---NYVHR 755 (996)
T ss_pred CCcEEEEEEEEe-----cCceeEEEhhhhhCCcHHHHHhhcCCc-----eEeehHHHHHHHHHHHhHHHhhc---Cchhh
Confidence 999999999953 455679999999999999999988754 99999999999999999999999 99999
Q ss_pred cCCCCCeeeCCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-
Q 037275 815 DLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT- 893 (992)
Q Consensus 815 Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt- 893 (992)
||.++||||+.+..+|++|||+++.+++++. ......+-.-+.+|.|||.+..++++.++||||||++|||.++
T Consensus 756 DLAARNILVNsnLvCKVsDFGLSRvledd~~-----~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSy 830 (996)
T KOG0196|consen 756 DLAARNILVNSNLVCKVSDFGLSRVLEDDPE-----AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSY 830 (996)
T ss_pred hhhhhheeeccceEEEeccccceeecccCCC-----ccccccCCccceeecChhHhhhcccCchhhccccceEEEEeccc
Confidence 9999999999999999999999998876651 1122222234689999999999999999999999999999999
Q ss_pred CCCCCCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHH
Q 037275 894 RRRPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMR 973 (992)
Q Consensus 894 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 973 (992)
|..||.++.+++ ++.. ...+|.-. ...+++..+.+||..||++|-.+||++.
T Consensus 831 GERPYWdmSNQd-----------------VIka-Ie~gyRLP----------pPmDCP~aL~qLMldCWqkdR~~RP~F~ 882 (996)
T KOG0196|consen 831 GERPYWDMSNQD-----------------VIKA-IEQGYRLP----------PPMDCPAALYQLMLDCWQKDRNRRPKFA 882 (996)
T ss_pred CCCcccccchHH-----------------HHHH-HHhccCCC----------CCCCCcHHHHHHHHHHHHHHhhcCCCHH
Confidence 999999876652 1111 12222222 2234567799999999999999999999
Q ss_pred HHHHHHHHHHH
Q 037275 974 DVVAKLCRARD 984 (992)
Q Consensus 974 evl~~L~~~~~ 984 (992)
||+..|+++.+
T Consensus 883 qiV~~lDklIr 893 (996)
T KOG0196|consen 883 QIVSTLDKLIR 893 (996)
T ss_pred HHHHHHHHHhc
Confidence 99999998764
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=345.27 Aligned_cols=250 Identities=24% Similarity=0.352 Sum_probs=205.6
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC-CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
..|+..+.||+|.||.||+|.+..+++.||+|++.... ....+++++|+.++..++++||.+++|.+ -.+..++
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsy-----l~g~~Lw 87 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSY-----LKGTKLW 87 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhhe-----eecccHH
Confidence 35777899999999999999999999999999998654 44567899999999999999999999974 3456679
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
++||||.||++.+.++... .+++..+.-|++++..|+.|||.+ +.+|||||+.||++..+|.+|++|||.+
T Consensus 88 iiMey~~gGsv~~lL~~~~------~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa 158 (467)
T KOG0201|consen 88 IIMEYCGGGSVLDLLKSGN------ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVA 158 (467)
T ss_pred HHHHHhcCcchhhhhccCC------CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEeccee
Confidence 9999999999999998654 347788888999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALP 917 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 917 (992)
..+... ......++||+.|||||++.+..|+.|+||||||++.+||++|.+|+......... ...... .|
T Consensus 159 ~ql~~~--------~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl-flIpk~-~P 228 (467)
T KOG0201|consen 159 GQLTNT--------VKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL-FLIPKS-AP 228 (467)
T ss_pred eeeech--------hhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE-EeccCC-CC
Confidence 877643 23336678999999999999989999999999999999999999999764321100 000000 00
Q ss_pred hhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 918 DKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
. .... ...+.+.+++..||..||+.||||.++++.
T Consensus 229 P-------------------------~L~~-~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 229 P-------------------------RLDG-DFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred C-------------------------cccc-ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 0 0000 224458899999999999999999999863
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=359.18 Aligned_cols=267 Identities=22% Similarity=0.345 Sum_probs=204.5
Q ss_pred hcCCCCCCccccccceEEEEeEEC-----CCCeEEEEEEeeccCC-CchhHHHHHHHHHHhc-cCCcceeEEEEeecccc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLG-----ENGMMVAVKVINLKQK-GASNGFVAECQALRNI-RHRNLIKIITICSSIDF 750 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 750 (992)
.++|++.++||+|+||.||+|.+. .+++.||||+++.... .....+.+|+.+++++ +||||+++++++..
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--- 82 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK--- 82 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC---
Confidence 458999999999999999999752 3457899999864322 2345688999999999 89999999998743
Q ss_pred cCcceEEEEEEeccCCCHHHHHhhcccch---------------------------------------------------
Q 037275 751 KGVDFQAIVYEYMQNGSLEDWLHQSEDQQ--------------------------------------------------- 779 (992)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------------------------------------------------- 779 (992)
.....++||||+++|+|.+++.......
T Consensus 83 -~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 83 -PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred -CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 3345789999999999999997542110
Q ss_pred -----hhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceecCCCCCCCCcccCCC
Q 037275 780 -----EARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSS 854 (992)
Q Consensus 780 -----~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 854 (992)
...++++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++....... ...
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~------~~~ 232 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD------YVR 232 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcc------hhc
Confidence 013478889999999999999999999 999999999999999999999999999986543211 111
Q ss_pred CCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhh
Q 037275 855 SKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQ 933 (992)
Q Consensus 855 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 933 (992)
.....+++.|+|||++.+..++.++|||||||++|||++ |..||.+..... .. ...+ ..+..
T Consensus 233 ~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-~~------------~~~~---~~~~~- 295 (338)
T cd05102 233 KGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-EF------------CQRL---KDGTR- 295 (338)
T ss_pred ccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-HH------------HHHH---hcCCC-
Confidence 122346788999999999999999999999999999997 999997632211 00 0000 00000
Q ss_pred ccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 037275 934 ASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARD 984 (992)
Q Consensus 934 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 984 (992)
. .. ......++.+++.+||+.||++|||+.|+++.|+++..
T Consensus 296 ~----~~------~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 296 M----RA------PENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred C----CC------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0 00 01123458899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=335.29 Aligned_cols=283 Identities=25% Similarity=0.350 Sum_probs=208.5
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHh--ccCCcceeEEEEeecccccCcce
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRN--IRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
....+..++||+|.||.||+|+. +++.||||++... ..+.+++|-+|.+. ++|+||++++++-...... ...
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~-~~e 282 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD-RME 282 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc--cCceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCcc-ccc
Confidence 45667778999999999999999 5799999999643 34567777777665 5899999999985443322 447
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcC------CCCeEeccCCCCCeeeCCCCcE
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHC------QPPVVHGDLKPSNVLLDQDLVA 829 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~------~~~ivH~Dlkp~NIll~~~~~~ 829 (992)
+++|+||.+.|+|.+|++.+ .++|....+|+..+++||+|||+.. +|+|+|||||++||||..|+++
T Consensus 283 ywLVt~fh~kGsL~dyL~~n-------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTc 355 (534)
T KOG3653|consen 283 YWLVTEFHPKGSLCDYLKAN-------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTC 355 (534)
T ss_pred eeEEeeeccCCcHHHHHHhc-------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcE
Confidence 79999999999999999865 4899999999999999999999763 6789999999999999999999
Q ss_pred EEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCC------cCcccchhhHHHHHHHHHhCCCCCCC-C-
Q 037275 830 HLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGE------ASMTGDVYSFGILLLEMFTRRRPTDG-M- 901 (992)
Q Consensus 830 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwSlG~il~elltg~~pf~~-~- 901 (992)
.|+|||+|..+.... .....-+.+||.+|||||++.+.. .-.+.||||+|.|+|||+++..-++. .
T Consensus 356 cIaDFGLAl~~~p~~------~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~v 429 (534)
T KOG3653|consen 356 CIADFGLALRLEPGK------PQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPV 429 (534)
T ss_pred EeeccceeEEecCCC------CCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCC
Confidence 999999999887543 222333478999999999987753 22468999999999999998765532 1
Q ss_pred ccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 037275 902 FNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCR 981 (992)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 981 (992)
.+-...+.+-+.... .+.++-+...... .|............+..+.+.+..||..||+.|.||.=|.+++.+
T Consensus 430 p~Yqlpfe~evG~hP--t~e~mq~~VV~kK-----~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~ 502 (534)
T KOG3653|consen 430 PEYQLPFEAEVGNHP--TLEEMQELVVRKK-----QRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAE 502 (534)
T ss_pred CcccCchhHHhcCCC--CHHHHHHHHHhhc-----cCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHH
Confidence 111122222222111 1111111111111 111111112222456779999999999999999999999999988
Q ss_pred HHHhh
Q 037275 982 ARDTF 986 (992)
Q Consensus 982 ~~~~~ 986 (992)
+..-.
T Consensus 503 l~~~~ 507 (534)
T KOG3653|consen 503 LMMLW 507 (534)
T ss_pred HhccC
Confidence 76543
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=336.16 Aligned_cols=263 Identities=22% Similarity=0.339 Sum_probs=205.4
Q ss_pred HHHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC--------------CCchhHHHHHHHHHHhccCCccee
Q 037275 675 SKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--------------KGASNGFVAECQALRNIRHRNLIK 740 (992)
Q Consensus 675 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~~E~~~l~~l~h~niv~ 740 (992)
.+..+.|++.+.||+|.||.|-+|++..+++.||||++.... ....+...+|+.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 456789999999999999999999999999999999996321 112357899999999999999999
Q ss_pred EEEEeecccccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCC
Q 037275 741 IITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSN 820 (992)
Q Consensus 741 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~N 820 (992)
++.+..+ ...+.+|+|+|||..|.+...=.. ...+++.+.++++++++.||+|||.+ |||||||||+|
T Consensus 173 LiEvLDD---P~s~~~YlVley~s~G~v~w~p~d------~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsN 240 (576)
T KOG0585|consen 173 LIEVLDD---PESDKLYLVLEYCSKGEVKWCPPD------KPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSN 240 (576)
T ss_pred EEEeecC---cccCceEEEEEeccCCccccCCCC------cccccHHHHHHHHHHHHHHHHHHHhc---Ceeccccchhh
Confidence 9998654 345678999999988877554221 12289999999999999999999999 99999999999
Q ss_pred eeeCCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCC----cCcccchhhHHHHHHHHHhCCC
Q 037275 821 VLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGE----ASMTGDVYSFGILLLEMFTRRR 896 (992)
Q Consensus 821 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~il~elltg~~ 896 (992)
+|++++|++||+|||.+........ . ..........|||.|+|||...++. .+.+.||||+||++|.|+.|+.
T Consensus 241 LLl~~~g~VKIsDFGVs~~~~~~~~-~--~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~ 317 (576)
T KOG0585|consen 241 LLLSSDGTVKISDFGVSNEFPQGSD-E--GSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQL 317 (576)
T ss_pred eEEcCCCcEEeeccceeeecccCCc-c--ccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccC
Confidence 9999999999999999987744311 1 1122233468999999999887632 4568999999999999999999
Q ss_pred CCCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 037275 897 PTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVV 976 (992)
Q Consensus 897 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 976 (992)
||-+.. ..+..+++...... -+...+.-.++.+++.+||.+||+.|.+..+|.
T Consensus 318 PF~~~~-----------------~~~l~~KIvn~pL~----------fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik 370 (576)
T KOG0585|consen 318 PFFDDF-----------------ELELFDKIVNDPLE----------FPENPEINEDLKDLIKRLLEKDPEQRITLPDIK 370 (576)
T ss_pred Ccccch-----------------HHHHHHHHhcCccc----------CCCcccccHHHHHHHHHHhhcChhheeehhhhe
Confidence 997632 22333333321110 111123455689999999999999999999987
Q ss_pred HHH
Q 037275 977 AKL 979 (992)
Q Consensus 977 ~~L 979 (992)
...
T Consensus 371 ~Hp 373 (576)
T KOG0585|consen 371 LHP 373 (576)
T ss_pred ecc
Confidence 544
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=331.59 Aligned_cols=249 Identities=25% Similarity=0.359 Sum_probs=208.6
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
..+|++.+.||+|.||.|-+|.....|+.||||.++... ..+.-.+.+|++||+.++||||+.++.+ |+..+
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEV-----FENkd 126 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEV-----FENKD 126 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhh-----hcCCc
Confidence 347888899999999999999998899999999997543 3344567899999999999999999998 67778
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
.+.|||||..+|.|.+|+.+.+ .+++.+..++++||.+|+.|+|.+ +|||||+|.+|||+|.++.+||+||
T Consensus 127 KIvivMEYaS~GeLYDYiSer~------~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADF 197 (668)
T KOG0611|consen 127 KIVIVMEYASGGELYDYISERG------SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADF 197 (668)
T ss_pred eEEEEEEecCCccHHHHHHHhc------cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeecc
Confidence 8899999999999999998765 589999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCc-CcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEA-SMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 913 (992)
|++..+... .....++|++-|.+||++.|.+| ++.+|.||+||++|.++.|.+||++..
T Consensus 198 GLSNly~~~---------kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D----------- 257 (668)
T KOG0611|consen 198 GLSNLYADK---------KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD----------- 257 (668)
T ss_pred chhhhhccc---------cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch-----------
Confidence 999877643 33455789999999999999988 578999999999999999999999731
Q ss_pred hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 037275 914 TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKL 979 (992)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 979 (992)
...++..+-.+.|.. . +.+....-+|.+||..+|++|.|+.+|....
T Consensus 258 ------hk~lvrQIs~GaYrE-----P--------~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 258 ------HKRLVRQISRGAYRE-----P--------ETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ------HHHHHHHhhcccccC-----C--------CCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 112233332233211 1 1122356688999999999999999998654
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=376.91 Aligned_cols=270 Identities=26% Similarity=0.431 Sum_probs=217.8
Q ss_pred cCCCCCCccccccceEEEEeEECCCC-----eEEEEEEeecc-CCCchhHHHHHHHHHHhccCCcceeEEEEeecccccC
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENG-----MMVAVKVINLK-QKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKG 752 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 752 (992)
...+..+.||+|.||.||.|...... ..||||.++.. +.+...+|.+|..+|++++|||||+++|+|.+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~----- 766 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD----- 766 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC-----
Confidence 34566789999999999999985332 34899988644 34566789999999999999999999999865
Q ss_pred cceEEEEEEeccCCCHHHHHhhcccc-hhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEE
Q 037275 753 VDFQAIVYEYMQNGSLEDWLHQSEDQ-QEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHL 831 (992)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 831 (992)
....+|++|||++|+|..|+++.+.. .....++..+.+.++.|||+|+.||+++ ++|||||..+|+|+++...|||
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKI 843 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKI 843 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEE
Confidence 34459999999999999999987432 1245699999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHH
Q 037275 832 GDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHE 910 (992)
Q Consensus 832 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~ 910 (992)
+|||+|+.+....++..... -.-+..|||||.+..+.++.|+|||||||++||++| |..||....+.
T Consensus 844 aDFGlArDiy~~~yyr~~~~------a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~------ 911 (1025)
T KOG1095|consen 844 ADFGLARDIYDKDYYRKHGE------AMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF------ 911 (1025)
T ss_pred cccchhHhhhhchheeccCc------cccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH------
Confidence 99999997665544332211 134678999999999999999999999999999999 99999874332
Q ss_pred HHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhhcc
Q 037275 911 FARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTFLGRM 990 (992)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~ 990 (992)
+++...+.+. .-..+..| +..++++|.+||+.+|++||++..|++++..+.....+..
T Consensus 912 -----------~v~~~~~~gg-RL~~P~~C----------P~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~ 969 (1025)
T KOG1095|consen 912 -----------EVLLDVLEGG-RLDPPSYC----------PEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTI 969 (1025)
T ss_pred -----------HHHHHHHhCC-ccCCCCCC----------ChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCc
Confidence 2222222222 22223334 4568999999999999999999999999999988877654
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=352.97 Aligned_cols=375 Identities=22% Similarity=0.205 Sum_probs=241.7
Q ss_pred ccEEeccCcccccccCccccccCCCcEEeccCCccCCCCCccccccccccchhhccccccCCCCchhhhccccCceeeec
Q 037275 197 LILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLF 276 (992)
Q Consensus 197 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~ 276 (992)
-+.||+++|+++.+-+..|.++++|+++++..|.++ .+|.... ....++.|++.+|.|+.+-.+.++.++.|+.||||
T Consensus 80 t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~-~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLS 157 (873)
T KOG4194|consen 80 TQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGH-ESGHLEKLDLRHNLISSVTSEELSALPALRSLDLS 157 (873)
T ss_pred eeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccc-cccceeEEeeeccccccccHHHHHhHhhhhhhhhh
Confidence 345666666666555555666666666666666665 3332111 11223333333344443445556666666666666
Q ss_pred cccccccccccccccCccceEecCCCCCCCCCCCCchhhhhccCCCcceEeecCCCcCCCcCCcccccccccceeEEeeC
Q 037275 277 DNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAG 356 (992)
Q Consensus 277 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~ 356 (992)
.|.|+.+....|..-.++++|+|++|.|+++..+.|+ ++.+|..|.|+.|+++
T Consensus 158 rN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~------~lnsL~tlkLsrNrit--------------------- 210 (873)
T KOG4194|consen 158 RNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFD------SLNSLLTLKLSRNRIT--------------------- 210 (873)
T ss_pred hchhhcccCCCCCCCCCceEEeecccccccccccccc------ccchheeeecccCccc---------------------
Confidence 6666666666666666666666666666666655432 2334555555555555
Q ss_pred CccccccCCCccCCCcccEEEccCCcCCCCCCccccCCCCCcEEeccCccccccCCCCCCCccccCceeccCCcccCCCC
Q 037275 357 NQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIP 436 (992)
Q Consensus 357 n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 436 (992)
...+..|.++++|+.|+|..|+|.-.---.|.++++|+.|.|..|.|.....+.|-.+.++++|+|+.|+++..-.
T Consensus 211 ----tLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~ 286 (873)
T KOG4194|consen 211 ----TLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNE 286 (873)
T ss_pred ----ccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhc
Confidence 4444444445555555555555442223344445555555555555444444444445555555555555544444
Q ss_pred CCccccccccccccccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeecccccccCCccccccc
Q 037275 437 PSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACT 516 (992)
Q Consensus 437 ~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 516 (992)
.++.+++.|+.|+++.|.|. .+-...++..+.+..|||++|+|+...+..|..|..|++|+|++|+++..-..+|.++.
T Consensus 287 g~lfgLt~L~~L~lS~NaI~-rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~ls 365 (873)
T KOG4194|consen 287 GWLFGLTSLEQLDLSYNAIQ-RIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLS 365 (873)
T ss_pred ccccccchhhhhccchhhhh-eeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhh
Confidence 44445555555555555544 22233333444444558888888877788899999999999999999988888999999
Q ss_pred ccceeeccCCcccccC---CccccccCCCCEEECCCcccCCCChhhhhcCCCcceEecCCCcCcccCCCCCccCCccccc
Q 037275 517 SLQQLYLQGNSFSGSI---PSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNKTGIS 593 (992)
Q Consensus 517 ~L~~L~L~~N~l~~~~---~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~ 593 (992)
+|++|||++|.|++.+ ...|.+|++|+.|+|.+|+|..+...+|..+++|+.|||.+|.+...-+....-..++.+.
T Consensus 366 sL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~Lk~Lv 445 (873)
T KOG4194|consen 366 SLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMELKELV 445 (873)
T ss_pred hhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccchhhhhh
Confidence 9999999999999766 3568899999999999999997666899999999999999999998877754444778888
Q ss_pred ccCCCCcCCCCC
Q 037275 594 LSGNGKVCGGLD 605 (992)
Q Consensus 594 l~~N~~~C~~~~ 605 (992)
+..-.+.|+|..
T Consensus 446 ~nSssflCDCql 457 (873)
T KOG4194|consen 446 MNSSSFLCDCQL 457 (873)
T ss_pred hcccceEEeccH
Confidence 888889999864
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=344.54 Aligned_cols=246 Identities=26% Similarity=0.384 Sum_probs=199.9
Q ss_pred CCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEEEEe
Q 037275 683 SSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEY 762 (992)
Q Consensus 683 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 762 (992)
..+.||.|+.|.||.|+. .++.||||.++.- -..+++-|++++||||+.+.|+|.. ...+||||||
T Consensus 128 ELeWlGSGaQGAVF~Grl--~netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtq-----sPcyCIiMEf 193 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRL--HNETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQ-----SPCYCIIMEF 193 (904)
T ss_pred hhhhhccCcccceeeeec--cCceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecC-----CceeEEeeec
Confidence 347899999999999999 4889999987421 2357888999999999999999865 3456999999
Q ss_pred ccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceecCC
Q 037275 763 MQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSS 842 (992)
Q Consensus 763 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 842 (992)
|..|-|...++... +++......|..+||.|+.|||.+ .|||||||.-||||..+..|||+|||.++....
T Consensus 194 Ca~GqL~~VLka~~------~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~ 264 (904)
T KOG4721|consen 194 CAQGQLYEVLKAGR------PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSD 264 (904)
T ss_pred cccccHHHHHhccC------ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhh
Confidence 99999999998654 578888999999999999999999 999999999999999999999999999986653
Q ss_pred CCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCChhHHH
Q 037275 843 SPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKVME 922 (992)
Q Consensus 843 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 922 (992)
. .....+.||..|||||+++..+.++|+||||||||+|||+||..||.+..... ++...-..
T Consensus 265 ~---------STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA-----IIwGVGsN---- 326 (904)
T KOG4721|consen 265 K---------STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA-----IIWGVGSN---- 326 (904)
T ss_pred h---------hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe-----eEEeccCC----
Confidence 2 22345789999999999999999999999999999999999999997642221 01100000
Q ss_pred HHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhh
Q 037275 923 IVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTFL 987 (992)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 987 (992)
....+....+++.+.-++++||...|..||++.+|+..|+-+..+++
T Consensus 327 ------------------sL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell 373 (904)
T KOG4721|consen 327 ------------------SLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELL 373 (904)
T ss_pred ------------------cccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHh
Confidence 00111223445668899999999999999999999999876554444
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=337.65 Aligned_cols=260 Identities=24% Similarity=0.318 Sum_probs=204.5
Q ss_pred HhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCc
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 753 (992)
..++|+.+.+||+|+||.||+|+-+.+|..+|+|+++... ....+.+..|-++|...++|.||+++-. |++.
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYs-----FQD~ 213 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYS-----FQDK 213 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEE-----ecCC
Confidence 4578999999999999999999999999999999997543 4556778999999999999999999877 6778
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGD 833 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 833 (992)
.++|+||||++||++.++|.... .+++..+..++.+++.|++.+|+. |+|||||||+|+|||..|++||+|
T Consensus 214 ~~LYLiMEylPGGD~mTLL~~~~------~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSD 284 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLMRKD------TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSD 284 (550)
T ss_pred CeeEEEEEecCCccHHHHHHhcC------cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeecc
Confidence 88999999999999999998765 589999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCC----------------CcccC-----------------------CCCCcccccccccccccccCCC
Q 037275 834 FGLAKFLSSSPLDT----------------AVETP-----------------------SSSKGIKGTVGYIAPEYGMGGE 874 (992)
Q Consensus 834 fg~a~~~~~~~~~~----------------~~~~~-----------------------~~~~~~~gt~~y~aPE~~~~~~ 874 (992)
||++.-+....... ..+.. ......+|||.|||||++.+..
T Consensus 285 FGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg 364 (550)
T KOG0605|consen 285 FGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG 364 (550)
T ss_pred ccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC
Confidence 99996433211000 00000 0112367999999999999999
Q ss_pred cCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHH
Q 037275 875 ASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAV 954 (992)
Q Consensus 875 ~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 954 (992)
|+..+|.||+|||+|||+.|.+||.+.... .. +..++.-.. .. ..+...+...+.
T Consensus 365 Y~~~cDwWSLG~ImyEmLvGyPPF~s~tp~-~T------------~rkI~nwr~--~l----------~fP~~~~~s~eA 419 (550)
T KOG0605|consen 365 YGKECDWWSLGCIMYEMLVGYPPFCSETPQ-ET------------YRKIVNWRE--TL----------KFPEEVDLSDEA 419 (550)
T ss_pred CCccccHHHHHHHHHHHHhCCCCCCCCCHH-HH------------HHHHHHHhh--hc----------cCCCcCcccHHH
Confidence 999999999999999999999999873221 11 111111100 00 001111223567
Q ss_pred HHHHhhccCCCCCCCCC---HHHHH
Q 037275 955 VETGVVCSMESPTERME---MRDVV 976 (992)
Q Consensus 955 ~~li~~cl~~dP~~RPs---~~evl 976 (992)
.++|.+|+. ||++|.- ++||.
T Consensus 420 ~DLI~rll~-d~~~RLG~~G~~EIK 443 (550)
T KOG0605|consen 420 KDLITRLLC-DPENRLGSKGAEEIK 443 (550)
T ss_pred HHHHHHHhc-CHHHhcCcccHHHHh
Confidence 899999999 9999986 45543
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=328.69 Aligned_cols=283 Identities=23% Similarity=0.365 Sum_probs=210.8
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC--CchhHHHHHHHHHHhccCCc-ceeEEEEeeccc-ccCc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK--GASNGFVAECQALRNIRHRN-LIKIITICSSID-FKGV 753 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~-~~~~ 753 (992)
...|+.+++||+|+||+||+|+...+|+.||+|.++.... +......+|+.+++.++|+| |+++.+++.... +...
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 3456777899999999999999999999999999986543 45667789999999999999 999999986543 2334
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGD 833 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 833 (992)
...++||||++. +|.+++....... ..++...+..+++|+++||+|||++ +|+||||||+||+++++|.+||+|
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~--~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaD 163 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKP--QGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLAD 163 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeec
Confidence 577899999955 9999998766321 2467788999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHH
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFA 912 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~ 912 (992)
||+|+...-.. ......++|..|+|||++.+. .|+...||||+|||++||+++++.|.+..+.+....-+.
T Consensus 164 FGlAra~~ip~--------~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~ 235 (323)
T KOG0594|consen 164 FGLARAFSIPM--------RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFR 235 (323)
T ss_pred cchHHHhcCCc--------ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHH
Confidence 99999654221 113345689999999998887 799999999999999999999999998765322222221
Q ss_pred hhhCCh--hHHHHHHhhHhHhhhccCCCCCCccccchHH---HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 913 RTALPD--KVMEIVDSVLLLEVQASNSRSCGDERLRTEE---RLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 913 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
-...|. .+..... ..++.... +.......-... ......+++.+|++++|.+|.||+.++..
T Consensus 236 ~lGtP~e~~Wp~v~~---~~~~k~~f-~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 236 LLGTPNEKDWPGVSS---LPDYKAPF-PKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred HcCCCCccCCCCccc---cccccccC-cCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 111121 1111110 00111000 000000111111 11468899999999999999999999875
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=314.92 Aligned_cols=199 Identities=29% Similarity=0.399 Sum_probs=179.4
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
..+|+..+.||.|+||+|.+++.+.+|..+|+|+++... ....+...+|..+++.+.||.++++.+. +.+..
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t-----~~d~~ 117 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGT-----FKDNS 117 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEe-----eccCC
Confidence 347889999999999999999999999999999997543 2345667889999999999999999988 45667
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
..++||||++||.|..++++.+ .+++..+..+|.||+.||+|||+. +|++||+||+|||+|.+|.+||+||
T Consensus 118 ~lymvmeyv~GGElFS~Lrk~~------rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDF 188 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYLRKSG------RFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDF 188 (355)
T ss_pred eEEEEEeccCCccHHHHHHhcC------CCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEec
Confidence 7899999999999999999765 489999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCC
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGM 901 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 901 (992)
|+|+..... +...+|||.|+|||++..+.|..++|-|||||++|||+.|.+||...
T Consensus 189 GFAK~v~~r-----------T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~ 244 (355)
T KOG0616|consen 189 GFAKRVSGR-----------TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDD 244 (355)
T ss_pred cceEEecCc-----------EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCC
Confidence 999976532 34468999999999999999999999999999999999999999763
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=313.83 Aligned_cols=253 Identities=21% Similarity=0.330 Sum_probs=205.4
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc--CCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK--QKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
.+.|++.++||+|.|+.||++.++.+|+.+|+|++... .....+++.+|+.|-+.++||||+++.+. +....+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~t-----i~~~~~ 84 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS-----IQEESF 84 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhh-----hcccce
Confidence 45788889999999999999999999999999998633 34467889999999999999999999987 445666
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCC---CCcEEEe
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQ---DLVAHLG 832 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~ 832 (992)
.++|+|+|+|++|..-+-.. ..+++..+-..++||++||.|+|.+ +|||||+||+|+++.. .--+||+
T Consensus 85 ~ylvFe~m~G~dl~~eIV~R------~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~ 155 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIVAR------EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLA 155 (355)
T ss_pred eEEEEecccchHHHHHHHHH------HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeec
Confidence 79999999999998666543 2578889999999999999999999 9999999999999943 3479999
Q ss_pred ecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHH
Q 037275 833 DFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFA 912 (992)
Q Consensus 833 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~ 912 (992)
|||+|..+.. .....++.|||+|||||+++..+|+..+|||+.|||+|-++.|++||.+...
T Consensus 156 ~FGvAi~l~~---------g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~--------- 217 (355)
T KOG0033|consen 156 DFGLAIEVND---------GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--------- 217 (355)
T ss_pred ccceEEEeCC---------ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH---------
Confidence 9999998762 2334567899999999999999999999999999999999999999987321
Q ss_pred hhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 913 RTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
.++...+..+.++.... ++ ....++..+++.+||..||.+|.|+.|++..
T Consensus 218 --------~rlye~I~~g~yd~~~~-----~w---~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 218 --------HRLYEQIKAGAYDYPSP-----EW---DTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred --------HHHHHHHhccccCCCCc-----cc---CcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 12333333333322111 11 1123346889999999999999999998753
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=362.91 Aligned_cols=270 Identities=23% Similarity=0.272 Sum_probs=213.4
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhcc-CCcceeEEEEe-ecccccC-cceE
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIR-HRNLIKIITIC-SSIDFKG-VDFQ 756 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~-~~~~~~~-~~~~ 756 (992)
++++.++|.+|||+.||.|++...|..||+|++-..++...+.+.+|+++|++|+ |+|||.++|.. ....-.+ ..++
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev 117 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV 117 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence 5678899999999999999998777999999987777777888999999999996 99999999943 2221222 4677
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
++.||||++|.|-|++..+... .+++.++++|++|+++|+++||.. +|+|||||||-+|||++.+|..||||||.
T Consensus 118 llLmEyC~gg~Lvd~mn~Rlq~----~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 118 LLLMEYCKGGSLVDFMNTRLQT----RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred EeehhhccCCcHHHHHHHHHhc----cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccc
Confidence 8999999999999999876543 499999999999999999999998 66799999999999999999999999999
Q ss_pred ceecCCCCC-CCCcccCCCCCcccccccccccccc---cCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHH
Q 037275 837 AKFLSSSPL-DTAVETPSSSKGIKGTVGYIAPEYG---MGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFA 912 (992)
Q Consensus 837 a~~~~~~~~-~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~ 912 (992)
|......+. ..........-....|+.|+|||++ .+..+++|+|||||||++|-|+....||++...-.
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la------- 265 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA------- 265 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee-------
Confidence 975433221 0000011111223479999999975 56789999999999999999999999998642211
Q ss_pred hhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 037275 913 RTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDT 985 (992)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 985 (992)
++.+.|.. +....+...+.+||..||+.||.+||++-||+..+.++...
T Consensus 266 --------------Ilng~Y~~----------P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 266 --------------ILNGNYSF----------PPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred --------------EEeccccC----------CCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 01111110 01123456689999999999999999999999999998754
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=341.91 Aligned_cols=254 Identities=21% Similarity=0.312 Sum_probs=212.1
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC--CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK--GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
.++|..++++|+|+||.++.++++.+++.||+|.+..... ...+...+|+.++++++|||||.+.+.+. .++..
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~----~~~~~ 78 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFE----EDGQL 78 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchh----cCCce
Confidence 3578999999999999999999999999999999975542 33446789999999999999999999852 33444
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.+|||+||+||++.+.+.+.+. ..++++.++.|+.|++.|+.|||+. +|+|||||+.|||++.++.|||+|||
T Consensus 79 l~Ivm~Y~eGg~l~~~i~~~k~----~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfG 151 (426)
T KOG0589|consen 79 LCIVMEYCEGGDLAQLIKEQKG----VLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFG 151 (426)
T ss_pred EEEEEeecCCCCHHHHHHHHhh----ccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchh
Confidence 8999999999999999998763 3699999999999999999999998 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 915 (992)
+|+.+.... ......+||+.||.||.+.+.+|..|+||||+||++|||++-+++|....
T Consensus 152 laK~l~~~~--------~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~------------- 210 (426)
T KOG0589|consen 152 LAKILNPED--------SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN------------- 210 (426)
T ss_pred hhhhcCCch--------hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc-------------
Confidence 999887532 23445689999999999999999999999999999999999999998631
Q ss_pred CChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 916 LPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
....+.++....+.+ ....+..++..++..|++.+|+.||++.+++.+
T Consensus 211 ----m~~Li~ki~~~~~~P-----------lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 211 ----MSELILKINRGLYSP-----------LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ----hHHHHHHHhhccCCC-----------CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 122222222222111 112335668999999999999999999999987
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=346.95 Aligned_cols=260 Identities=27% Similarity=0.410 Sum_probs=207.0
Q ss_pred CCCCCCccccccceEEEEeEECCCC----eEEEEEEeecc---CCCchhHHHHHHHHHHhccCCcceeEEEEeecccccC
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENG----MMVAVKVINLK---QKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKG 752 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 752 (992)
+....++||+|+||.||+|+....+ ..||||..+.. ......++.+|+++|+.++|||||+++|++..
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~----- 232 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL----- 232 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC-----
Confidence 4455689999999999999986432 23899998742 24556789999999999999999999999653
Q ss_pred cceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEe
Q 037275 753 VDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLG 832 (992)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 832 (992)
...+++|||+|.||+|.+|+++.+. .++..++..++.+.|.||+|||++ +++||||.++|+|++.++.+||+
T Consensus 233 ~~Pl~ivmEl~~gGsL~~~L~k~~~-----~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKIS 304 (474)
T KOG0194|consen 233 EEPLMLVMELCNGGSLDDYLKKNKK-----SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKIS 304 (474)
T ss_pred CCccEEEEEecCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeC
Confidence 4556999999999999999998764 489999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHH
Q 037275 833 DFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEF 911 (992)
Q Consensus 833 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~ 911 (992)
|||+++.-..-. .......-+..|+|||.+..+.|++++|||||||++||+++ |..||.+....
T Consensus 305 DFGLs~~~~~~~--------~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~------- 369 (474)
T KOG0194|consen 305 DFGLSRAGSQYV--------MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY------- 369 (474)
T ss_pred ccccccCCccee--------eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH-------
Confidence 999987543100 00001135689999999999999999999999999999999 89999875322
Q ss_pred HhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhh
Q 037275 912 ARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTFL 987 (992)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 987 (992)
++........+....+ ...+.++..++.+||..+|++||||.++.+.++.+.....
T Consensus 370 ----------~v~~kI~~~~~r~~~~----------~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 370 ----------EVKAKIVKNGYRMPIP----------SKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred ----------HHHHHHHhcCccCCCC----------CCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 1111111222211111 1234567888899999999999999999999999876644
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=334.22 Aligned_cols=252 Identities=20% Similarity=0.301 Sum_probs=198.8
Q ss_pred CCccccccceEEEEeEECCCCeEEEEEEeeccCCCc---hhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEEE
Q 037275 684 SNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGA---SNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVY 760 (992)
Q Consensus 684 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 760 (992)
...||+|++|.||+|+. +|+.||||+++...... .+.+.+|+.++++++||||++++|++.+. ..+....++||
T Consensus 25 ~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~-~~~~~~~~lv~ 101 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDI-VDDLPRLSLIL 101 (283)
T ss_pred CeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEec-ccCCCceEEEE
Confidence 36899999999999998 68999999997543333 46678999999999999999999987541 12345678999
Q ss_pred EeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceec
Q 037275 761 EYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFL 840 (992)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 840 (992)
||+++|+|.+++.... .+++....+++.|++.||+|||+.. +++||||||+||++++++.+||+|||+++..
T Consensus 102 Ey~~~g~L~~~l~~~~------~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~ 173 (283)
T PHA02988 102 EYCTRGYLREVLDKEK------DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKIL 173 (283)
T ss_pred EeCCCCcHHHHHhhCC------CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhh
Confidence 9999999999997643 4789999999999999999999732 7889999999999999999999999999865
Q ss_pred CCCCCCCCcccCCCCCcccccccccccccccC--CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCCh
Q 037275 841 SSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG--GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPD 918 (992)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 918 (992)
.... ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||.+....
T Consensus 174 ~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~-------------- 228 (283)
T PHA02988 174 SSPP-----------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK-------------- 228 (283)
T ss_pred cccc-----------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH--------------
Confidence 4321 12357889999999876 68999999999999999999999999753211
Q ss_pred hHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 037275 919 KVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARD 984 (992)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 984 (992)
++.+........... .......+.+++.+||+.||++|||++|+++.|+.+..
T Consensus 229 ---~~~~~i~~~~~~~~~----------~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 229 ---EIYDLIINKNNSLKL----------PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred ---HHHHHHHhcCCCCCC----------CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 111111111110000 01124468899999999999999999999999998753
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=303.60 Aligned_cols=251 Identities=23% Similarity=0.350 Sum_probs=208.5
Q ss_pred HhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCc
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 753 (992)
..++|++.+.||+|-||.||.|+.++++..||+|++...+ .....++.+|++|.+.++||||+++++++ .+.
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f-----hd~ 94 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF-----HDS 94 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe-----ecc
Confidence 3568999999999999999999999999999999996432 34457789999999999999999999995 456
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGD 833 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 833 (992)
...|+++||...|++...++..+.. .+++...+.++.|+|.|+.|+|.. +|+||||||+|+|++.++..||+|
T Consensus 95 ~riyLilEya~~gel~k~L~~~~~~----~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAd 167 (281)
T KOG0580|consen 95 KRIYLILEYAPRGELYKDLQEGRMK----RFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIAD 167 (281)
T ss_pred ceeEEEEEecCCchHHHHHHhcccc----cccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccC
Confidence 6779999999999999999865533 588888899999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 913 (992)
||.+.... .......+||..|.+||...+...+..+|+|++|++.||++.|.+||.... .+..+.+...
T Consensus 168 fGwsV~~p----------~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k 236 (281)
T KOG0580|consen 168 FGWSVHAP----------SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRK 236 (281)
T ss_pred CCceeecC----------CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHH
Confidence 99987543 233445689999999999999999999999999999999999999998643 2222222211
Q ss_pred hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 914 TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
..+.. ......+..+++.+|+..+|.+|.+..|+++.
T Consensus 237 ~~~~~----------------------------p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 237 VDLKF----------------------------PSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ccccC----------------------------CcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 11100 01123457899999999999999999999864
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=349.30 Aligned_cols=280 Identities=22% Similarity=0.277 Sum_probs=202.3
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeecc--CCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK--QKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
+|++.++||+|+||.||+|++..+++.||||++... .......+.+|+.++++++||||+++++++...........+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 588899999999999999999989999999998632 222345688999999999999999999987654444445679
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||+. ++|.+++.... .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 81 lv~e~~~-~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~ 150 (338)
T cd07859 81 VVFELME-SDLHQVIKAND------DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLA 150 (338)
T ss_pred EEEecCC-CCHHHHHHhcc------cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccc
Confidence 9999995 69999887543 488999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccC--CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHH---
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG--GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFA--- 912 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~--- 912 (992)
+....... .........||+.|+|||++.+ ..++.++|||||||++|||++|++||.+..... ......
T Consensus 151 ~~~~~~~~-----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~-~~~~~~~~~ 224 (338)
T cd07859 151 RVAFNDTP-----TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH-QLDLITDLL 224 (338)
T ss_pred cccccccC-----ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHHHh
Confidence 76432211 1111234568999999999866 678999999999999999999999997632210 010000
Q ss_pred hhhCChhHHHHHHhhHh---HhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 913 RTALPDKVMEIVDSVLL---LEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 913 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
....+.....+...... ............ .........+.+++.+||+.||++|||++|+++.
T Consensus 225 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 225 GTPSPETISRVRNEKARRYLSSMRKKQPVPFS---QKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred CCCCHHHHHHhhhhhHHHHHHhhcccCCCchH---HhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00001111111100000 000000000000 0000123457899999999999999999999853
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=320.69 Aligned_cols=273 Identities=23% Similarity=0.381 Sum_probs=214.4
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHh--ccCCcceeEEEEeecccccCcce
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRN--IRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
..+....+.||+|.||.||+|+++ |+.||||++...++ +...+|.+|++. ++|+||+.+++.-... -....+
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~-~gs~TQ 283 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKD-NGSWTQ 283 (513)
T ss_pred hheeEEEEEecCccccceeecccc--CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccC-CCceEE
Confidence 446778899999999999999994 89999999964333 344566666655 5999999999873322 234567
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEeccCCCCCeeeCCCCcEE
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHH-----CQPPVVHGDLKPSNVLLDQDLVAH 830 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-----~~~~ivH~Dlkp~NIll~~~~~~k 830 (992)
.++|++|.+.|||.||+... .++....++++..+|.||+|||.. .+|.|+|||||++||||..++.+.
T Consensus 284 LwLvTdYHe~GSL~DyL~r~-------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~ 356 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNRN-------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 356 (513)
T ss_pred EEEeeecccCCcHHHHHhhc-------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence 89999999999999999864 489999999999999999999964 478999999999999999999999
Q ss_pred EeecccceecCCCCCCCCcccCCCCCcccccccccccccccCC------CcCcccchhhHHHHHHHHHhCC---------
Q 037275 831 LGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG------EASMTGDVYSFGILLLEMFTRR--------- 895 (992)
Q Consensus 831 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~il~elltg~--------- 895 (992)
|+|+|+|.....+... ........+||.+|||||++... .....+||||||.|+||++.+.
T Consensus 357 IADLGLAv~h~~~t~~----idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey 432 (513)
T KOG2052|consen 357 IADLGLAVRHDSDTDT----IDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEY 432 (513)
T ss_pred EeeceeeEEecccCCc----ccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhh
Confidence 9999999887654311 22334556899999999997653 2234699999999999998743
Q ss_pred -CCCCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 037275 896 -RPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRD 974 (992)
Q Consensus 896 -~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 974 (992)
.||.+....+..++++..... .+..+.....+....+.+..+.++|+.||..+|..|.||=.
T Consensus 433 ~~Pyyd~Vp~DPs~eeMrkVVC-----------------v~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALr 495 (513)
T KOG2052|consen 433 QLPYYDVVPSDPSFEEMRKVVC-----------------VQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALR 495 (513)
T ss_pred cCCcccCCCCCCCHHHHhccee-----------------ecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHH
Confidence 466665555544444332211 12334455667777888999999999999999999999999
Q ss_pred HHHHHHHHHH
Q 037275 975 VVAKLCRARD 984 (992)
Q Consensus 975 vl~~L~~~~~ 984 (992)
|-+.|.++.+
T Consensus 496 iKKtl~~l~~ 505 (513)
T KOG2052|consen 496 IKKTLAKLSN 505 (513)
T ss_pred HHHHHHHHhc
Confidence 9999988864
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=339.80 Aligned_cols=275 Identities=22% Similarity=0.334 Sum_probs=199.1
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC-CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
.++|++.+.||+|+||+||+|+...+++.||+|+++.... .....+.+|+.+++.++||||+++++++. .....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~ 78 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIH-----TKETL 78 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEe-----cCCeE
Confidence 3689999999999999999999988999999999864432 23446788999999999999999999854 44567
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
++||||+. ++|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 79 ~lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~ 149 (303)
T cd07869 79 TLVFEYVH-TDLCQYMDKHPG-----GLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGL 149 (303)
T ss_pred EEEEECCC-cCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCc
Confidence 99999995 688888875432 478899999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 915 (992)
+....... .......+++.|+|||++.+ ..++.++||||+||++|||++|+.||.+..+....+.......
T Consensus 150 ~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 221 (303)
T cd07869 150 ARAKSVPS--------HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVL 221 (303)
T ss_pred ceeccCCC--------ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHh
Confidence 87543211 11223457899999998765 4588899999999999999999999986433222221111110
Q ss_pred C-Ch--hHHHHHHhhHhHhhhccCCC-CCCccc---cchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 916 L-PD--KVMEIVDSVLLLEVQASNSR-SCGDER---LRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 916 ~-~~--~~~~~~~~~~~~~~~~~~~~-~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
. +. .+..... .......... ..+... .........+.+++.+||+.||++|||++|+++
T Consensus 222 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 222 GTPNEDTWPGVHS---LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred CCCChhhccchhh---ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0 00 0000000 0000000000 000000 000011245789999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=336.66 Aligned_cols=252 Identities=23% Similarity=0.308 Sum_probs=198.2
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
.|+..+.||+|+||+||+|.+..+++.||+|.+.... ......+.+|++++++++|++|+++.+++. ..+..
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~-----~~~~~ 75 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYE-----TKDAL 75 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEc-----cCCeE
Confidence 3678899999999999999998899999999986432 222345788999999999999999999853 44567
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 76 ~lv~e~~~~g~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~ 148 (285)
T cd05631 76 CLVLTIMNGGDLKFHIYNMGN----PGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGL 148 (285)
T ss_pred EEEEEecCCCcHHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCC
Confidence 999999999999988865432 2588999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhC
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTAL 916 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 916 (992)
+....... ......||..|+|||++.+..++.++||||+||++|||++|+.||........ .
T Consensus 149 ~~~~~~~~---------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-~-------- 210 (285)
T cd05631 149 AVQIPEGE---------TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK-R-------- 210 (285)
T ss_pred cEEcCCCC---------eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh-H--------
Confidence 98654221 11234689999999999999999999999999999999999999986432210 0
Q ss_pred ChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 037275 917 PDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERME-----MRDVVA 977 (992)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 977 (992)
+.++....... . ........++.+++.+||+.||++||+ ++|+++
T Consensus 211 -----~~~~~~~~~~~-~----------~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 211 -----EEVDRRVKEDQ-E----------EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred -----HHHHHHhhccc-c----------cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 00111000000 0 000112345889999999999999997 788875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=342.86 Aligned_cols=245 Identities=24% Similarity=0.350 Sum_probs=204.1
Q ss_pred HHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc---CCCchhHHHHHHHHHHhc-cCCcceeEEEEeeccccc
Q 037275 676 KATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK---QKGASNGFVAECQALRNI-RHRNLIKIITICSSIDFK 751 (992)
Q Consensus 676 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 751 (992)
...++|...++||+|.||+|++|..+.+++.+|||++++. ..++.+..+.|.+|+... +||.+++++.. |+
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~-----fQ 439 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSC-----FQ 439 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccc-----cc
Confidence 3456899999999999999999999999999999999855 355677788999998888 59999999987 67
Q ss_pred CcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEE
Q 037275 752 GVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHL 831 (992)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 831 (992)
..+++++||||+.||++..+.+. ..+++..+.-++..|+.||.|||++ +||+||||.+|||+|.+|.+||
T Consensus 440 T~~~l~fvmey~~Ggdm~~~~~~-------~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~ki 509 (694)
T KOG0694|consen 440 TKEHLFFVMEYVAGGDLMHHIHT-------DVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKI 509 (694)
T ss_pred cCCeEEEEEEecCCCcEEEEEec-------ccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEe
Confidence 88899999999999994433332 2589999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHH
Q 037275 832 GDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEF 911 (992)
Q Consensus 832 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~ 911 (992)
+|||+++.-- .....+..++|||.|||||++.+..|+.++|-|||||++|||+.|+.||.+..++
T Consensus 510 ADFGlcKe~m--------~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe------- 574 (694)
T KOG0694|consen 510 ADFGLCKEGM--------GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE------- 574 (694)
T ss_pred cccccccccC--------CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH-------
Confidence 9999998432 1334566789999999999999999999999999999999999999999974333
Q ss_pred HhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCH
Q 037275 912 ARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEM 972 (992)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 972 (992)
++.|.++..++. .+++ ...+.+.++.++|..+|++|.-+
T Consensus 575 ----------e~FdsI~~d~~~--yP~~----------ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 575 ----------EVFDSIVNDEVR--YPRF----------LSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ----------HHHHHHhcCCCC--CCCc----------ccHHHHHHHHHHhccCcccccCC
Confidence 344444432221 1111 23457899999999999999876
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=336.96 Aligned_cols=276 Identities=21% Similarity=0.311 Sum_probs=199.2
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC-CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
.++|++.++||+|+||+||+|+...+++.||+|+++... ......+.+|+.++++++||||+++++++. .....
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~ 78 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIH-----TERCL 78 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEc-----CCCeE
Confidence 357999999999999999999999899999999986443 233456789999999999999999999853 34567
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
++||||++ |+|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 79 ~lv~e~~~-~~l~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~ 149 (288)
T cd07871 79 TLVFEYLD-SDLKQYLDNCGN-----LMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGL 149 (288)
T ss_pred EEEEeCCC-cCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcc
Confidence 99999997 599999875432 478899999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh-
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART- 914 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~- 914 (992)
++...... .......+++.|+|||++.+ ..++.++||||+||++|||++|++||.+....+ .+......
T Consensus 150 ~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~ 220 (288)
T cd07871 150 ARAKSVPT--------KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE-ELHLIFRLL 220 (288)
T ss_pred eeeccCCC--------ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHh
Confidence 97643211 11223457899999998865 568999999999999999999999997642211 11111110
Q ss_pred --hCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 915 --ALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 915 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
..++.+..+.+............+..... ........+..+++.+||++||.+|||++|+++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 221 GTPTEETWPGITSNEEFRSYLFPQYRAQPLI-NHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred CCCChHHhhccccchhhhccccCccCCCchH-HhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00111111110000000000000000000 000011345789999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=303.82 Aligned_cols=257 Identities=23% Similarity=0.351 Sum_probs=207.9
Q ss_pred HHHHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCC----c----hhHHHHHHHHHHhc-cCCcceeEEEE
Q 037275 674 LSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKG----A----SNGFVAECQALRNI-RHRNLIKIITI 744 (992)
Q Consensus 674 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~----~~~~~~E~~~l~~l-~h~niv~~~~~ 744 (992)
-+.....|...+.+|.|..++|-++..+++|..+|+|++...... . .+.-.+|+.|++++ .||+|+.+.++
T Consensus 12 a~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ 91 (411)
T KOG0599|consen 12 AKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV 91 (411)
T ss_pred HhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence 345566888999999999999999999999999999999643221 1 13347799999998 69999999999
Q ss_pred eecccccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeC
Q 037275 745 CSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLD 824 (992)
Q Consensus 745 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 824 (992)
| +.+...++|+|.|+.|.|.||+...- .++++...+|++|+.+|++|||.+ +|||||+||+|||++
T Consensus 92 y-----es~sF~FlVFdl~prGELFDyLts~V------tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILld 157 (411)
T KOG0599|consen 92 Y-----ESDAFVFLVFDLMPRGELFDYLTSKV------TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLD 157 (411)
T ss_pred c-----cCcchhhhhhhhcccchHHHHhhhhe------eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeec
Confidence 5 45556699999999999999998643 689999999999999999999999 999999999999999
Q ss_pred CCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccC------CCcCcccchhhHHHHHHHHHhCCCCC
Q 037275 825 QDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG------GEASMTGDVYSFGILLLEMFTRRRPT 898 (992)
Q Consensus 825 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwSlG~il~elltg~~pf 898 (992)
++.++||+|||+|+.+.++ ......+|||+|.|||.+.- ..|+..+|+||+|||+|.++.|.+||
T Consensus 158 dn~~i~isDFGFa~~l~~G---------ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPF 228 (411)
T KOG0599|consen 158 DNMNIKISDFGFACQLEPG---------EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPF 228 (411)
T ss_pred cccceEEeccceeeccCCc---------hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCch
Confidence 9999999999999987643 23345689999999998752 36888999999999999999999999
Q ss_pred CCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 899 DGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
... .-+-++.-+..+.++.. .++..+......+++.+||+.||.+|.|++|+++.
T Consensus 229 wHR-----------------kQmlMLR~ImeGkyqF~--------speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 229 WHR-----------------KQMLMLRMIMEGKYQFR--------SPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred hHH-----------------HHHHHHHHHHhcccccC--------CcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 641 11112222233333321 22334456678999999999999999999999863
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=335.98 Aligned_cols=275 Identities=21% Similarity=0.348 Sum_probs=200.6
Q ss_pred cCCCCCCccccccceEEEEeEECC-CCeEEEEEEeeccC--CCchhHHHHHHHHHHhc---cCCcceeEEEEeecccccC
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGE-NGMMVAVKVINLKQ--KGASNGFVAECQALRNI---RHRNLIKIITICSSIDFKG 752 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~ 752 (992)
.+|++.+.||+|+||+||+|++.. +++.||+|+++... ......+.+|+.+++.+ +||||+++++++.......
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 378999999999999999999853 46889999986433 22334566788777766 6999999999986544445
Q ss_pred cceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEe
Q 037275 753 VDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLG 832 (992)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 832 (992)
....++||||+. ++|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~ 152 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 152 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEc
Confidence 667899999996 699999976432 2488999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHH
Q 037275 833 DFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFA 912 (992)
Q Consensus 833 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~ 912 (992)
|||+++..... .......|++.|+|||++.+..++.++|||||||++|||++|++||.+..+.+ .+....
T Consensus 153 Dfg~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~-~~~~i~ 222 (290)
T cd07862 153 DFGLARIYSFQ---------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKIL 222 (290)
T ss_pred cccceEeccCC---------cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHH
Confidence 99999865432 11233468999999999988899999999999999999999999998643221 111111
Q ss_pred hhh---CChhHHHHHHhhHhHhhhccCCCCCCcccc--chHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 913 RTA---LPDKVMEIVDSVLLLEVQASNSRSCGDERL--RTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 913 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
... .+..+..... .............. ........+.+++.+||+.||++|||+.|+++
T Consensus 223 ~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 223 DVIGLPGEEDWPRDVA------LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred HHhCCCChhhchhhhc------ccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 110 0111000000 00000000000000 00112355789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=347.59 Aligned_cols=264 Identities=22% Similarity=0.387 Sum_probs=202.4
Q ss_pred hcCCCCCCccccccceEEEEeEE-----CCCCeEEEEEEeeccC-CCchhHHHHHHHHHHhc-cCCcceeEEEEeecccc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNL-----GENGMMVAVKVINLKQ-KGASNGFVAECQALRNI-RHRNLIKIITICSSIDF 750 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 750 (992)
.++|++.++||+|+||+||+|++ ..++..||||+++... ....+.+.+|+++++.+ +||||+++++++..
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~--- 110 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV--- 110 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc---
Confidence 45789999999999999999974 3456789999986433 23345688999999999 89999999998643
Q ss_pred cCcceEEEEEEeccCCCHHHHHhhcccc----------------------------------------------------
Q 037275 751 KGVDFQAIVYEYMQNGSLEDWLHQSEDQ---------------------------------------------------- 778 (992)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~---------------------------------------------------- 778 (992)
....++||||+++|+|.++++.....
T Consensus 111 --~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 111 --GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred --CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 44569999999999999999754310
Q ss_pred -----------------hhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceecC
Q 037275 779 -----------------QEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLS 841 (992)
Q Consensus 779 -----------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 841 (992)
.....+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIR 265 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceecc
Confidence 0112578899999999999999999999 99999999999999999999999999998664
Q ss_pred CCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhhhCChhH
Q 037275 842 SSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFARTALPDKV 920 (992)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 920 (992)
..... .......++..|+|||++.+..++.++|||||||++|||++ |..||....... ..
T Consensus 266 ~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-------------~~ 326 (375)
T cd05104 266 NDSNY------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-------------KF 326 (375)
T ss_pred Ccccc------cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-------------HH
Confidence 32110 11112335678999999999999999999999999999998 889987542211 01
Q ss_pred HHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 037275 921 MEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRA 982 (992)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 982 (992)
...+.. ....... .....++.+++.+||+.||++|||+.||++.|++.
T Consensus 327 ~~~~~~----~~~~~~~----------~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 327 YKMIKE----GYRMLSP----------ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHHHHh----CccCCCC----------CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 111110 0000000 01134688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=369.36 Aligned_cols=483 Identities=27% Similarity=0.325 Sum_probs=290.2
Q ss_pred eeccccccCCccCCCCCCCCcCCeeeccCCCCCccCC-ccccCCCCCCEEEeecccCCCCCCcccccCCCCcEeeccccc
Q 037275 55 LDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIP-HQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNN 133 (992)
Q Consensus 55 ldl~~~~l~~~l~~~l~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n~ 133 (992)
+|.++..+ ..+|..+..-..++.|+++.|-+- ..| +.+.+..+|+.||||+|+++ ..|..+..+..|+.|+++.|.
T Consensus 3 vd~s~~~l-~~ip~~i~~~~~~~~ln~~~N~~l-~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~ 79 (1081)
T KOG0618|consen 3 VDASDEQL-ELIPEQILNNEALQILNLRRNSLL-SRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNY 79 (1081)
T ss_pred cccccccC-cccchhhccHHHHHhhhccccccc-cCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhh
Confidence 45555555 455555555555666666666555 222 22333444666666666665 566666655555555555555
Q ss_pred ccccCChhhcccccccccccccccccCCCCCCccccccccceEEecCCcccCCcCCccCCCCcccEEeccCcccccccCc
Q 037275 134 LVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPP 213 (992)
Q Consensus 134 l~~~~p~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~ 213 (992)
+. .+|.+.. ++.+|++|.|.+|.+. .+|.++..+.+|+.|+++.|++ +.+|..+..+..+..++.++|.....
T Consensus 80 i~-~vp~s~~-~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f-~~~Pl~i~~lt~~~~~~~s~N~~~~~--- 152 (1081)
T KOG0618|consen 80 IR-SVPSSCS-NMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHF-GPIPLVIEVLTAEEELAASNNEKIQR--- 152 (1081)
T ss_pred Hh-hCchhhh-hhhcchhheeccchhh-cCchhHHhhhcccccccchhcc-CCCchhHHhhhHHHHHhhhcchhhhh---
Confidence 55 4443333 4445555555555544 4455555555555555555544 44444444444444444444411101
Q ss_pred cccccCCCcEEeccCCccCCCCCccccccccccchhhccccccCCCCchhhhccccCceeeeccccccccccccccccCc
Q 037275 214 SIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKN 293 (992)
Q Consensus 214 ~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 293 (992)
++.. ..+.+++..|.+.+.++..+..+.. .|+|++|.+. ...+..+.+
T Consensus 153 -lg~~--------------------------~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~~dls~~~~ 200 (1081)
T KOG0618|consen 153 -LGQT--------------------------SIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME---VLDLSNLAN 200 (1081)
T ss_pred -hccc--------------------------cchhhhhhhhhcccchhcchhhhhe--eeecccchhh---hhhhhhccc
Confidence 1111 1344444455555555555554444 5666666665 223455666
Q ss_pred cceEecCCCCCCCCCCCCchhhhhccCCCcceEeecCCCcCCCcCCcccccccccceeEEeeCCccccccCCCccCCCcc
Q 037275 294 LEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNL 373 (992)
Q Consensus 294 L~~L~L~~N~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L 373 (992)
|+.|....|++..+.. ..++|+.|+.++|.+....+. ..+.+|+++++++|++++. |+.+..+.+|
T Consensus 201 l~~l~c~rn~ls~l~~----------~g~~l~~L~a~~n~l~~~~~~---p~p~nl~~~dis~n~l~~l-p~wi~~~~nl 266 (1081)
T KOG0618|consen 201 LEVLHCERNQLSELEI----------SGPSLTALYADHNPLTTLDVH---PVPLNLQYLDISHNNLSNL-PEWIGACANL 266 (1081)
T ss_pred hhhhhhhhcccceEEe----------cCcchheeeeccCcceeeccc---cccccceeeecchhhhhcc-hHHHHhcccc
Confidence 6666666666655322 235566666666666632222 2334577777777777754 3777777777
Q ss_pred cEEEccCCcCCCCCCccccCCCCCcEEeccCccccccCCCCCCCccccCceeccCCcccCCCCCCcccccc-cccccccc
Q 037275 374 VELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKN-LIELHMAD 452 (992)
Q Consensus 374 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~l~~ 452 (992)
+.|...+|+++ .+|..+...++|+.|++.+|.+. .+|.....++.|++|+|..|+|....+..|..+.. |..|+.+.
T Consensus 267 e~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~ 344 (1081)
T KOG0618|consen 267 EALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSS 344 (1081)
T ss_pred eEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhh
Confidence 77777777775 66777777777777777777777 66666677777777777777777433323333322 56666666
Q ss_pred ccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeecccccccCCcccccccccceeeccCCcccccC
Q 037275 453 IELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSI 532 (992)
Q Consensus 453 n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 532 (992)
|++. ..|..-......++.|.+.+|.++...-..+.+.+.|+.|+|++|+|...+...+.++..|++|+||+|+|+ .+
T Consensus 345 n~l~-~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~L 422 (1081)
T KOG0618|consen 345 NKLS-TLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TL 422 (1081)
T ss_pred cccc-ccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hh
Confidence 6665 333222333344566777777777766667777778888888888877555566777778888888888887 67
Q ss_pred CccccccCCCCEEECCCcccCCCChhhhhcCCCcceEecCCCcCcccC-CCCCccCCcccccccCCCC
Q 037275 533 PSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEV-PTKGVFSNKTGISLSGNGK 599 (992)
Q Consensus 533 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~~~~~~~~~l~~N~~ 599 (992)
|+.+.+++.|++|...+|+|. ..| .+..++.|+.+|+|.|+|+-.. |.....++++.++++||.|
T Consensus 423 p~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 423 PDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred hHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 777777888888888888876 666 6777778888888888776432 3322336777777788876
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=337.90 Aligned_cols=246 Identities=24% Similarity=0.315 Sum_probs=198.2
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.++++++||||+++++++ .+...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTE-----HDQRF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhh-----ccCCe
Confidence 37889999999999999999999899999999986432 22345688999999999999999999874 44567
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg 146 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRNSG------RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFG 146 (291)
T ss_pred EEEEEeCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecC
Confidence 899999999999999997543 478899999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 915 (992)
+++..... .....|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.... +
T Consensus 147 ~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-----~----- 205 (291)
T cd05612 147 FAKKLRDR-----------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF-----G----- 205 (291)
T ss_pred cchhccCC-----------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----H-----
Confidence 98765321 11245899999999999889999999999999999999999999753211 0
Q ss_pred CChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 037275 916 LPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERME-----MRDVVAK 978 (992)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 978 (992)
........... .+ ......+.+++.+||+.||.+||+ ++|+++.
T Consensus 206 -------~~~~i~~~~~~------~~------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 206 -------IYEKILAGKLE------FP------RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred -------HHHHHHhCCcC------CC------ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 11111100000 00 011335789999999999999995 8887753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=341.71 Aligned_cols=242 Identities=24% Similarity=0.315 Sum_probs=193.6
Q ss_pred CccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEEEE
Q 037275 685 NMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYE 761 (992)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 761 (992)
+.||+|+||.||+|+...+|+.||+|+++... ......+.+|+.++++++||||+++.+++ ......++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF-----QTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EcCCEEEEEEe
Confidence 46999999999999999899999999997432 23345678899999999999999999985 34567799999
Q ss_pred eccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceecC
Q 037275 762 YMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLS 841 (992)
Q Consensus 762 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 841 (992)
|+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 76 ~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~ 146 (323)
T cd05571 76 YANGGELFFHLSRER------VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 146 (323)
T ss_pred CCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccc
Confidence 999999999987543 488999999999999999999999 99999999999999999999999999987532
Q ss_pred CCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCChhHH
Q 037275 842 SSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKVM 921 (992)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 921 (992)
.. ........||+.|+|||++.+..++.++||||+||++|||++|+.||...... .
T Consensus 147 ~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-----~----------- 202 (323)
T cd05571 147 SD--------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----K----------- 202 (323)
T ss_pred cC--------CCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH-----H-----------
Confidence 21 11123356899999999999999999999999999999999999999652110 0
Q ss_pred HHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 037275 922 EIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERM-----EMRDVVA 977 (992)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 977 (992)
.......... ..+ .....++.+++.+||+.||++|| +++|+++
T Consensus 203 -~~~~~~~~~~------~~p------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 203 -LFELILMEEI------RFP------RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred -HHHHHHcCCC------CCC------CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 0111110000 000 11234578999999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=333.50 Aligned_cols=275 Identities=22% Similarity=0.293 Sum_probs=201.0
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC--CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
++|++.+.||+|+||+||+|++..+++.||+|+++... ....+.+.+|+.+++.++||||+++++++. .....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFR-----RRGKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEe-----cCCEE
Confidence 47899999999999999999999899999999986432 233456789999999999999999998853 45567
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
++||||++++.+..+... . ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 ~lv~e~~~~~~l~~~~~~-~-----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~ 146 (287)
T cd07848 76 YLVFEYVEKNMLELLEEM-P-----NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGF 146 (287)
T ss_pred EEEEecCCCCHHHHHHhc-C-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccC
Confidence 999999998776655432 2 2488999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh--h
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR--T 914 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~--~ 914 (992)
+....... ........|++.|+|||++.+..++.++||||+||++|||++|++||.+....+. ...... .
T Consensus 147 ~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~ 218 (287)
T cd07848 147 ARNLSEGS-------NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQ-LFTIQKVLG 218 (287)
T ss_pred cccccccc-------cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhhC
Confidence 98654321 1112234689999999999988999999999999999999999999986432211 111111 1
Q ss_pred hCChhHHHHHHhhHhHhhhccCCCCCCc----cccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 915 ALPDKVMEIVDSVLLLEVQASNSRSCGD----ERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
..+.......... ............. ..........++.+++.+||+.||++|||++|+++
T Consensus 219 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 219 PLPAEQMKLFYSN--PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred CCCHHHHHhhhcc--chhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1111111111000 0000000000000 00000113456899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=346.36 Aligned_cols=265 Identities=23% Similarity=0.387 Sum_probs=202.4
Q ss_pred hcCCCCCCccccccceEEEEeEECC-----CCeEEEEEEeeccC-CCchhHHHHHHHHHHhc-cCCcceeEEEEeecccc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGE-----NGMMVAVKVINLKQ-KGASNGFVAECQALRNI-RHRNLIKIITICSSIDF 750 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 750 (992)
.++|++.+.||+|+||.||+|++.. ++..||+|+++... ......+.+|+.+++.+ +||||+++++++.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~---- 112 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT---- 112 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec----
Confidence 4478999999999999999998643 33579999996433 22345688999999999 8999999999864
Q ss_pred cCcceEEEEEEeccCCCHHHHHhhcccc----------------------------------------------------
Q 037275 751 KGVDFQAIVYEYMQNGSLEDWLHQSEDQ---------------------------------------------------- 778 (992)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~---------------------------------------------------- 778 (992)
.....++||||+++|+|.+++......
T Consensus 113 -~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 113 -HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred -CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 345679999999999999999753210
Q ss_pred ------------hhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceecCCCCCC
Q 037275 779 ------------QEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLD 846 (992)
Q Consensus 779 ------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 846 (992)
.....+++.++++++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++.......
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~- 267 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN- 267 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc-
Confidence 0123478899999999999999999999 999999999999999999999999999976543211
Q ss_pred CCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhhhCChhHHHHHH
Q 037275 847 TAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFARTALPDKVMEIVD 925 (992)
Q Consensus 847 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 925 (992)
........++..|+|||++.+..++.++|||||||++|||++ |+.||....... . ......
T Consensus 268 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~------------~~~~~~ 329 (374)
T cd05106 268 -----YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-K------------FYKMVK 329 (374)
T ss_pred -----eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-H------------HHHHHH
Confidence 011112235678999999998899999999999999999997 999997532211 0 011111
Q ss_pred hhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 037275 926 SVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRAR 983 (992)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 983 (992)
. ..... .+ .....++.+++.+||+.||++|||+.||++.|+++.
T Consensus 330 ~----~~~~~----~~------~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 330 R----GYQMS----RP------DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred c----ccCcc----CC------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 0 00000 00 011346889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=332.76 Aligned_cols=257 Identities=26% Similarity=0.402 Sum_probs=212.3
Q ss_pred cCCCCCCccccccceEEEEeEECCC----CeEEEEEEeecc-CCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCc
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGEN----GMMVAVKVINLK-QKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 753 (992)
+.....++||.|.||.||+|.+..- .-.||||..+.. ..+..+.|..|..+|+.++||||++++|+|.+
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e------ 462 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE------ 462 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec------
Confidence 3455668999999999999998422 245899998753 44557889999999999999999999999854
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGD 833 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 833 (992)
...|||||.++.|.|..|++..+. .++......+++||..||+|||+. +.|||||..+||||.....+||+|
T Consensus 463 ~P~WivmEL~~~GELr~yLq~nk~-----sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaD 534 (974)
T KOG4257|consen 463 QPMWIVMELAPLGELREYLQQNKD-----SLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLAD 534 (974)
T ss_pred cceeEEEecccchhHHHHHHhccc-----cchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecc
Confidence 346999999999999999998765 489999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHH
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFA 912 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~ 912 (992)
||+++.+.++.++... ...-+..|||||.+.-++++.++|||-|||++||++. |..||.+..+.+....-
T Consensus 535 FGLSR~~ed~~yYkaS-------~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i-- 605 (974)
T KOG4257|consen 535 FGLSRYLEDDAYYKAS-------RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI-- 605 (974)
T ss_pred cchhhhccccchhhcc-------ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe--
Confidence 9999998876554332 1234678999999999999999999999999999998 99999986555321100
Q ss_pred hhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 037275 913 RTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARD 984 (992)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 984 (992)
-. ++..+..+.++..++.++.+||++||.+||.+.|+.+.|+.++.
T Consensus 606 ---------------En-----------GeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 606 ---------------EN-----------GERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred ---------------cC-----------CCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 00 01111223345679999999999999999999999999988875
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=339.41 Aligned_cols=200 Identities=27% Similarity=0.403 Sum_probs=173.9
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC-CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
.++|++.+.||+|+||.||+|++..++..||+|++..... .....+.+|++++++++||||+++++++. ..+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 78 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI 78 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----ECCEE
Confidence 3689999999999999999999999999999999875432 23457899999999999999999999864 34567
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
++||||+++|+|.+++.... .+++..+..++.|++.||+|||+.. +|+||||||+||+++.++.+||+|||+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 150 (331)
T cd06649 79 SICMEHMDGGSLDQVLKEAK------RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGV 150 (331)
T ss_pred EEEeecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcc
Confidence 99999999999999997543 4789999999999999999999852 699999999999999999999999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCC
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDG 900 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 900 (992)
+...... ......|++.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 151 ~~~~~~~----------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 151 SGQLIDS----------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred ccccccc----------ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 8755321 11234689999999999999999999999999999999999999965
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=342.85 Aligned_cols=270 Identities=20% Similarity=0.242 Sum_probs=199.3
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
..+|++.+.||+|+||.||+|.+..+++.||+|... ...+.+|++++++++||||+++++++. .....+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~ 159 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFT-----YNKFTC 159 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEE-----ECCeeE
Confidence 357999999999999999999999999999999753 234678999999999999999999864 345669
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+|||++. ++|..++.... .+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+|
T Consensus 160 lv~e~~~-~~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a 229 (391)
T PHA03212 160 LILPRYK-TDLYCYLAAKR------NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA 229 (391)
T ss_pred EEEecCC-CCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcc
Confidence 9999994 68998886543 478999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccC------CccHHHH
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQ------GLTLHEF 911 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~------~~~~~~~ 911 (992)
+...... ........||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...+...
T Consensus 230 ~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i 302 (391)
T PHA03212 230 CFPVDIN-------ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLI 302 (391)
T ss_pred ccccccc-------ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHH
Confidence 7533211 11223456999999999999999999999999999999999999887543211 1111111
Q ss_pred Hhhh------CChhHHHHHHhhHhHhhhccCCCCCCccc---cchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 912 ARTA------LPDKVMEIVDSVLLLEVQASNSRSCGDER---LRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 912 ~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.... ++.......+......... .......+ ....+...++.+++.+||+.||++||||+|+++
T Consensus 303 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 303 IRRSGTHPNEFPIDAQANLDEIYIGLAKK--SSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHhcCChhhcCcchhHHHHHHHHHHHhc--cCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 1111 0111111111111000000 00000111 111234567899999999999999999999985
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=341.48 Aligned_cols=254 Identities=21% Similarity=0.296 Sum_probs=201.1
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
++|++.+.||+|+||.||+|++..+++.||+|+++... ......+.+|+++++.++||||+++++++. ....
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~-----~~~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ-----DDEY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE-----cCCE
Confidence 46899999999999999999999889999999997432 234456889999999999999999999853 4556
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg 146 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLNNLG------VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFG 146 (333)
T ss_pred EEEEEeCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCc
Confidence 799999999999999997543 478999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 915 (992)
++..... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... +..
T Consensus 147 ~a~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-----~~~--- 207 (333)
T cd05600 147 LSKGIVT-----------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN-----ETW--- 207 (333)
T ss_pred CCccccc-----------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHH-----HHH---
Confidence 9975432 122346899999999999999999999999999999999999999753211 000
Q ss_pred CChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 916 LPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
............. .... .......++.+++.+||..+|++||+++|+++.
T Consensus 208 ---------~~i~~~~~~~~~~-~~~~---~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 208 ---------ENLKYWKETLQRP-VYDD---PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ---------HHHHhccccccCC-CCCc---cccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0000000000000 0000 001224568899999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=336.32 Aligned_cols=268 Identities=23% Similarity=0.372 Sum_probs=199.1
Q ss_pred hcCCCCCCccccccceEEEEeEECC----------------CCeEEEEEEeeccCC-CchhHHHHHHHHHHhccCCccee
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGE----------------NGMMVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIK 740 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~----------------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~ 740 (992)
.++|++.++||+|+||.||+|.+.. ++..||+|++..... .....+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3578899999999999999998632 345799999864432 23457899999999999999999
Q ss_pred EEEEeecccccCcceEEEEEEeccCCCHHHHHhhcccc-------------hhhcccCHHHHHHHHHHHHHHHHHHHhcC
Q 037275 741 IITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQ-------------QEARSLTLIQRINIIIDVASAIEYIHHHC 807 (992)
Q Consensus 741 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ 807 (992)
+++++.+ ....++||||+++|+|.+++...... .....+++..+++++.|++.||+|||+.
T Consensus 84 ~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~- 157 (304)
T cd05096 84 LLGVCVD-----EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL- 157 (304)
T ss_pred EEEEEec-----CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC-
Confidence 9998643 34569999999999999999754321 0123478889999999999999999999
Q ss_pred CCCeEeccCCCCCeeeCCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHH
Q 037275 808 QPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGIL 887 (992)
Q Consensus 808 ~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~i 887 (992)
+|+||||||+||+++.++.+||+|||+++....... ........++..|+|||++.++.++.++|||||||+
T Consensus 158 --~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~ 229 (304)
T cd05096 158 --NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDY------YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVT 229 (304)
T ss_pred --CccccCcchhheEEcCCccEEECCCccceecccCce------eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHH
Confidence 999999999999999999999999999986543211 111122345788999999988899999999999999
Q ss_pred HHHHHh--CCCCCCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCC
Q 037275 888 LLEMFT--RRRPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMES 965 (992)
Q Consensus 888 l~ellt--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 965 (992)
+|||++ +..||....... ..... ........ ..... .........+.+++.+||+.|
T Consensus 230 l~el~~~~~~~p~~~~~~~~--~~~~~--------~~~~~~~~---~~~~~--------~~~~~~~~~~~~li~~cl~~~ 288 (304)
T cd05096 230 LWEILMLCKEQPYGELTDEQ--VIENA--------GEFFRDQG---RQVYL--------FRPPPCPQGLYELMLQCWSRD 288 (304)
T ss_pred HHHHHHccCCCCCCcCCHHH--HHHHH--------HHHhhhcc---ccccc--------cCCCCCCHHHHHHHHHHccCC
Confidence 999987 556776532110 00000 00000000 00000 000112346899999999999
Q ss_pred CCCCCCHHHHHHHHH
Q 037275 966 PTERMEMRDVVAKLC 980 (992)
Q Consensus 966 P~~RPs~~evl~~L~ 980 (992)
|++|||+.||.+.|+
T Consensus 289 p~~RPs~~~i~~~l~ 303 (304)
T cd05096 289 CRERPSFSDIHAFLT 303 (304)
T ss_pred chhCcCHHHHHHHHh
Confidence 999999999988875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=329.17 Aligned_cols=257 Identities=24% Similarity=0.361 Sum_probs=200.4
Q ss_pred hcCCCCCCccccccceEEEEeEEC---CCCeEEEEEEeeccCC-CchhHHHHHHHHHHhccCCcceeEEEEeecccccCc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLG---ENGMMVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 753 (992)
.++|++.+.||+|+||.||+|.+. ..+..||+|+++.... .....+.+|+.++++++||||+++++++. ..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~ 78 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVIT-----RG 78 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEe-----cC
Confidence 357889999999999999999874 3567899999874432 23456889999999999999999999864 34
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGD 833 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 833 (992)
...++||||+++|+|.+++..... .+++..++.++.|++.||+|||+. +++||||||+||+++.++.+|++|
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~-----~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~d 150 (266)
T cd05064 79 NTMMIVTEYMSNGALDSFLRKHEG-----QLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISG 150 (266)
T ss_pred CCcEEEEEeCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECC
Confidence 567999999999999999976432 489999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHH
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFA 912 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~ 912 (992)
||.+........ .......++..|+|||++.+..++.++|||||||++||+++ |+.||......
T Consensus 151 fg~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~-------- 215 (266)
T cd05064 151 FRRLQEDKSEAI-------YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ-------- 215 (266)
T ss_pred Ccccccccccch-------hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--------
Confidence 998765322110 11112235678999999999999999999999999999875 99999763211
Q ss_pred hhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 037275 913 RTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRA 982 (992)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 982 (992)
+...... ..... ......+..+.+++.+||+.+|++|||++||.+.|.++
T Consensus 216 ---------~~~~~~~-~~~~~----------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 216 ---------DVIKAVE-DGFRL----------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ---------HHHHHHH-CCCCC----------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0011000 00000 00112345688999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=339.58 Aligned_cols=246 Identities=22% Similarity=0.260 Sum_probs=198.2
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.++++++||||+++++++. ..+
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~ 91 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ-----DEN 91 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----cCC
Confidence 357899999999999999999999899999999996432 233466889999999999999999999854 455
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
..++||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 92 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Df 162 (329)
T PTZ00263 92 RVYFLLEFVVGGELFTHLRKAG------RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDF 162 (329)
T ss_pred EEEEEEcCCCCChHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeec
Confidence 6799999999999999997643 478888999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
|+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.... +
T Consensus 163 g~~~~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-----~---- 222 (329)
T PTZ00263 163 GFAKKVPDRT-----------FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF-----R---- 222 (329)
T ss_pred cCceEcCCCc-----------ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH-----H----
Confidence 9998654321 1245899999999999999999999999999999999999999652110 0
Q ss_pred hCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 037275 915 ALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERME-----MRDVVA 977 (992)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 977 (992)
........... .+. .....+.+++.+||+.||++||+ ++|++.
T Consensus 223 --------~~~~i~~~~~~--~p~----------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 223 --------IYEKILAGRLK--FPN----------WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred --------HHHHHhcCCcC--CCC----------CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 11111101000 000 01235789999999999999997 577764
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=328.38 Aligned_cols=258 Identities=24% Similarity=0.415 Sum_probs=216.2
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
..+....++||-|.||.||.|.+++..-.||||.++ .+....++|.+|+.+|+.++|||+|+++|+|.. ...+|
T Consensus 266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLK-EDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~-----EpPFY 339 (1157)
T KOG4278|consen 266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTH-----EPPFY 339 (1157)
T ss_pred chheeeeeccCCCcccceeeeeeeccceeeehhhhh-hcchhHHHHHHHHHHHHhhcCccHHHHhhhhcc-----CCCeE
Confidence 346677899999999999999999999999999996 555678899999999999999999999999864 34469
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
||+|||..|+|.+|+++.... .++....+.+|.||+.|++||..+ ++|||||..+|+||.++..+|++|||++
T Consensus 340 IiTEfM~yGNLLdYLRecnr~----ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLs 412 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECNRS----EVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLS 412 (1157)
T ss_pred EEEecccCccHHHHHHHhchh----hcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchh
Confidence 999999999999999987643 577778889999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhhhC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFARTAL 916 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 916 (992)
+++..+.++.+.. -.-+..|.|||.+....++.|+|||+|||++||+.| |-.||.+..-. +
T Consensus 413 RlMtgDTYTAHAG-------AKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS-----q------ 474 (1157)
T KOG4278|consen 413 RLMTGDTYTAHAG-------AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----Q------ 474 (1157)
T ss_pred hhhcCCceecccC-------ccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH-----H------
Confidence 9998765544332 224678999999999999999999999999999999 98999874211 1
Q ss_pred ChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 037275 917 PDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRAR 983 (992)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 983 (992)
+.+ .+..+|....+.. ++..++++|..||+++|.+||++.|+-+.++.+.
T Consensus 475 ---VY~----LLEkgyRM~~PeG----------CPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 475 ---VYG----LLEKGYRMDGPEG----------CPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred ---HHH----HHhccccccCCCC----------CCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 112 2333443333333 4567999999999999999999999999887654
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=336.40 Aligned_cols=199 Identities=27% Similarity=0.376 Sum_probs=173.1
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhcc-C-----CcceeEEEEeecccccCc
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIR-H-----RNLIKIITICSSIDFKGV 753 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~~~~~~~~~~~~~~ 753 (992)
+|.+.++||+|+||.|.+|.+.++++.||||+++.. ..-..+-..|+.+|..++ | -|+|+++++ |...
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~-----F~fr 260 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDY-----FYFR 260 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeec-----cccc
Confidence 789999999999999999999999999999999733 334456678999999996 3 389999999 4566
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCC--cEEE
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDL--VAHL 831 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~--~~kl 831 (992)
++.|||+|.+ ..+|.++++.+.-. .++...+..++.||+.||..||+. +|||+||||+|||+.+.+ .+||
T Consensus 261 ~HlciVfELL-~~NLYellK~n~f~----Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKV 332 (586)
T KOG0667|consen 261 NHLCIVFELL-STNLYELLKNNKFR----GLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKV 332 (586)
T ss_pred cceeeeehhh-hhhHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeE
Confidence 7889999998 55999999987643 699999999999999999999999 999999999999996543 8999
Q ss_pred eecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCcc
Q 037275 832 GDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFN 903 (992)
Q Consensus 832 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 903 (992)
+|||.|+....... .++-+..|+|||++.|.+|+.+.||||||||++||++|.+.|.+..+
T Consensus 333 IDFGSSc~~~q~vy-----------tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne 393 (586)
T KOG0667|consen 333 IDFGSSCFESQRVY-----------TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE 393 (586)
T ss_pred EecccccccCCcce-----------eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence 99999997654322 34578899999999999999999999999999999999998887533
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=349.74 Aligned_cols=276 Identities=21% Similarity=0.295 Sum_probs=196.6
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccc---cCcc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDF---KGVD 754 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~~~ 754 (992)
..+|++.++||+|+||+||+|....+++.||||++.... ....+|+.+++.++||||+++.+++....+ ....
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 457999999999999999999998899999999885322 234579999999999999999998654322 2234
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCC-cEEEee
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDL-VAHLGD 833 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~D 833 (992)
..++||||++ +++.+++...... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++ .+||+|
T Consensus 141 ~l~lvmE~~~-~~l~~~~~~~~~~--~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 141 FLNVVMEFIP-QTVHKYMKHYARN--NHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred EEEEEEecCC-ccHHHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeec
Confidence 5679999996 5788877643221 23589999999999999999999999 999999999999998665 799999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHH
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFA 912 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~ 912 (992)
||+|+.+.... ......||+.|+|||++.+. .++.++||||+||++|||++|++||.+....+ .+....
T Consensus 215 FGla~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~-~~~~i~ 284 (440)
T PTZ00036 215 FGSAKNLLAGQ---------RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD-QLVRII 284 (440)
T ss_pred cccchhccCCC---------CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHH
Confidence 99998654221 12234689999999987664 68999999999999999999999998643221 111111
Q ss_pred hhh-CC-hhHHHHHHhhHhHhhhccCCCCCC-cc--ccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 913 RTA-LP-DKVMEIVDSVLLLEVQASNSRSCG-DE--RLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 913 ~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
... .+ ........+ .+......... .. .........++.+++.+||++||.+|||+.|+++
T Consensus 285 ~~~~~p~~~~~~~~~~----~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 285 QVLGTPTEDQLKEMNP----NYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHhCCCCHHHHHHhch----hhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 111 01 000000000 00000000000 00 0000112356889999999999999999999984
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=337.31 Aligned_cols=267 Identities=22% Similarity=0.359 Sum_probs=204.4
Q ss_pred hcCCCCCCccccccceEEEEeEEC-----CCCeEEEEEEeeccCC-CchhHHHHHHHHHHhc-cCCcceeEEEEeecccc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLG-----ENGMMVAVKVINLKQK-GASNGFVAECQALRNI-RHRNLIKIITICSSIDF 750 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 750 (992)
.++|++.++||+|+||.||+|... .+++.||+|+++.... .....+.+|+.+++++ +||||++++++|..
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~--- 82 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTK--- 82 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEec---
Confidence 347999999999999999999753 2457899999864322 2345678899999999 89999999998743
Q ss_pred cCcceEEEEEEeccCCCHHHHHhhcccc----------------------------------------------------
Q 037275 751 KGVDFQAIVYEYMQNGSLEDWLHQSEDQ---------------------------------------------------- 778 (992)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~---------------------------------------------------- 778 (992)
.....+++|||+++++|.+++......
T Consensus 83 -~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 83 -PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred -CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 345678999999999999999653210
Q ss_pred ---hhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceecCCCCCCCCcccCCCC
Q 037275 779 ---QEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSS 855 (992)
Q Consensus 779 ---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~ 855 (992)
.....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++..+...... ...
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~------~~~ 232 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY------VRK 232 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcch------hhc
Confidence 0013689999999999999999999999 9999999999999999999999999999876432211 111
Q ss_pred CcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhc
Q 037275 856 KGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQA 934 (992)
Q Consensus 856 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (992)
....++..|+|||++.+..++.++|||||||++|||++ |..||.+....+ .+ ...+. .....
T Consensus 233 ~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~------------~~~~~----~~~~~ 295 (337)
T cd05054 233 GDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EF------------CRRLK----EGTRM 295 (337)
T ss_pred cCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HH------------HHHHh----ccCCC
Confidence 22345778999999999999999999999999999998 999997532211 00 01110 00000
Q ss_pred cCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 037275 935 SNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARD 984 (992)
Q Consensus 935 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 984 (992)
.. ......++.+++.+||+.+|++||++.||++.|+++..
T Consensus 296 ----~~------~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 296 ----RA------PEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred ----CC------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 00 01123468899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=335.71 Aligned_cols=240 Identities=23% Similarity=0.305 Sum_probs=190.5
Q ss_pred cccccceEEEEeEECCCCeEEEEEEeecc---CCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEEEEec
Q 037275 687 IGQGSFGFVYKGNLGENGMMVAVKVINLK---QKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYM 763 (992)
Q Consensus 687 lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 763 (992)
||+|+||.||+|++..+++.||+|+++.. .......+.+|+.++++++||||+++++++. .....++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQ-----SPEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEe-----cCCeEEEEEcCC
Confidence 79999999999999989999999998643 2334456788999999999999999998853 455679999999
Q ss_pred cCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceecCCC
Q 037275 764 QNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSS 843 (992)
Q Consensus 764 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 843 (992)
++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 76 ~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 146 (312)
T cd05585 76 NGGELFHHLQREG------RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD 146 (312)
T ss_pred CCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccC
Confidence 9999999997543 488999999999999999999999 9999999999999999999999999998753321
Q ss_pred CCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCChhHHHH
Q 037275 844 PLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKVMEI 923 (992)
Q Consensus 844 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (992)
........||+.|+|||++.+..++.++||||+||++|||++|+.||.+... .+.
T Consensus 147 --------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~-----~~~------------ 201 (312)
T cd05585 147 --------DDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV-----NEM------------ 201 (312)
T ss_pred --------CCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH-----HHH------------
Confidence 1112335689999999999999999999999999999999999999975211 111
Q ss_pred HHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCC---HHHHHH
Q 037275 924 VDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERME---MRDVVA 977 (992)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~ 977 (992)
......... ..+ .....++.+++.+||+.||++||+ +.|++.
T Consensus 202 ~~~~~~~~~------~~~------~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 202 YRKILQEPL------RFP------DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred HHHHHcCCC------CCC------CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 111110000 000 112345789999999999999985 556553
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=336.78 Aligned_cols=242 Identities=25% Similarity=0.327 Sum_probs=192.8
Q ss_pred CccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEEEE
Q 037275 685 NMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYE 761 (992)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 761 (992)
+.||+|+||.||+|+...+|+.||+|+++... ......+.+|+.+++.++||||+++++++. .....++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~-----~~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-----THDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEe-----cCCEEEEEEe
Confidence 46999999999999999899999999997432 233456778999999999999999999853 4456799999
Q ss_pred eccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceecC
Q 037275 762 YMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLS 841 (992)
Q Consensus 762 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 841 (992)
|+++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 76 ~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 146 (323)
T cd05595 76 YANGGELFFHLSRER------VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 146 (323)
T ss_pred CCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhcccc
Confidence 999999999887543 488999999999999999999999 99999999999999999999999999987532
Q ss_pred CCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCChhHH
Q 037275 842 SSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKVM 921 (992)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 921 (992)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 147 ~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~----------------- 201 (323)
T cd05595 147 SD--------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----------------- 201 (323)
T ss_pred CC--------CCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-----------------
Confidence 21 11122346899999999999999999999999999999999999999653211
Q ss_pred HHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 037275 922 EIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERM-----EMRDVVA 977 (992)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 977 (992)
............ .+ .....++.+++.+||+.||++|| ++.++++
T Consensus 202 ~~~~~~~~~~~~------~p------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 202 RLFELILMEEIR------FP------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred HHHHHHhcCCCC------CC------CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 001111000000 00 01234578999999999999998 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=334.68 Aligned_cols=248 Identities=23% Similarity=0.331 Sum_probs=202.0
Q ss_pred CccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEEEEecc
Q 037275 685 NMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQ 764 (992)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~ 764 (992)
-++|+|.||+||.|++..+...+|||.+...+.....-+..|+..-++++|.|||+++|.+. .++++-|.||-++
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~s-----enGf~kIFMEqVP 655 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVS-----ENGFFKIFMEQVP 655 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccC-----CCCeEEEEeecCC
Confidence 37999999999999999999999999998777777788999999999999999999999854 4456789999999
Q ss_pred CCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeC-CCCcEEEeecccceecCCC
Q 037275 765 NGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLD-QDLVAHLGDFGLAKFLSSS 843 (992)
Q Consensus 765 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~ 843 (992)
||+|.+.++..-.. ..-.+.++-.+.+||++||.|||+. .|||||||-+||+|+ -.|.+||+|||.++.+..
T Consensus 656 GGSLSsLLrskWGP---lKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg- 728 (1226)
T KOG4279|consen 656 GGSLSSLLRSKWGP---LKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG- 728 (1226)
T ss_pred CCcHHHHHHhccCC---CccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhcc-
Confidence 99999999865432 1127788888999999999999999 999999999999995 578999999999987653
Q ss_pred CCCCCcccCCCCCcccccccccccccccCC--CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCChhHH
Q 037275 844 PLDTAVETPSSSKGIKGTVGYIAPEYGMGG--EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKVM 921 (992)
Q Consensus 844 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 921 (992)
....+..+.||..|||||++..+ .|+.++|||||||++.||.||++||......... +.+..
T Consensus 729 -------inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA---MFkVG------ 792 (1226)
T KOG4279|consen 729 -------INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA---MFKVG------ 792 (1226)
T ss_pred -------CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh---hhhhc------
Confidence 23345567799999999999876 5899999999999999999999999764333111 11000
Q ss_pred HHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 922 EIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
-+ ....+..++...+...++.+|+.+||.+||+|+++++
T Consensus 793 ---------my--------KvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 793 ---------MY--------KVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred ---------ce--------ecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 00 0001122445567889999999999999999999975
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=336.33 Aligned_cols=243 Identities=23% Similarity=0.332 Sum_probs=193.8
Q ss_pred CccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEEEE
Q 037275 685 NMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYE 761 (992)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 761 (992)
++||+|+||.||+|++..+++.||+|++.... ......+.+|+.+++.++||||+++.+++ ......++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF-----QTKDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCEEEEEEe
Confidence 46899999999999999899999999997432 23445678899999999999999999885 34567799999
Q ss_pred eccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceecC
Q 037275 762 YMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLS 841 (992)
Q Consensus 762 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 841 (992)
|+++|+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 76 y~~~g~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~ 146 (328)
T cd05593 76 YVNGGELFFHLSRER------VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGI 146 (328)
T ss_pred CCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCC
Confidence 999999999887543 488999999999999999999999 99999999999999999999999999987532
Q ss_pred CCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCChhHH
Q 037275 842 SSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKVM 921 (992)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 921 (992)
.. ........||+.|+|||++.+..++.++||||+||++|||++|+.||...... +.
T Consensus 147 ~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-----~~---------- 203 (328)
T cd05593 147 TD--------AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KL---------- 203 (328)
T ss_pred Cc--------ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH-----HH----------
Confidence 21 11122346899999999999999999999999999999999999999653111 11
Q ss_pred HHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 037275 922 EIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERM-----EMRDVVAK 978 (992)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 978 (992)
.......... .+ .....++.+++.+||+.||++|| ++.|+++.
T Consensus 204 --~~~~~~~~~~------~p------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 204 --FELILMEDIK------FP------RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred --HHHhccCCcc------CC------CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 1111100000 00 01234578999999999999997 89998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=352.98 Aligned_cols=266 Identities=24% Similarity=0.335 Sum_probs=207.5
Q ss_pred HHHHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC--CCchhHHHHHHHHHHhccCCcceeEEEEeeccccc
Q 037275 674 LSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHRNLIKIITICSSIDFK 751 (992)
Q Consensus 674 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 751 (992)
.....++|++.++||+|+||+||+|++..+++.||||++.... ......+.+|+..+..++|+|++++.+.+...+..
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 3445579999999999999999999998899999999986543 23345678899999999999999998775432211
Q ss_pred ---CcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCc
Q 037275 752 ---GVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLV 828 (992)
Q Consensus 752 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 828 (992)
.....++||||+++|+|.+++...... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~--~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~ 181 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKT--NRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGL 181 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCC
Confidence 122468999999999999999764322 34689999999999999999999999 9999999999999999999
Q ss_pred EEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccH
Q 037275 829 AHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTL 908 (992)
Q Consensus 829 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~ 908 (992)
+||+|||+++.+.... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.+.. .
T Consensus 182 vkL~DFGls~~~~~~~------~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~-----~ 250 (496)
T PTZ00283 182 VKLGDFGFSKMYAATV------SDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-----M 250 (496)
T ss_pred EEEEecccCeeccccc------cccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-----H
Confidence 9999999998764321 1112234568999999999999999999999999999999999999997531 1
Q ss_pred HHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 909 HEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
. +++.......... .......++.+++.+||+.||++||++.++++.
T Consensus 251 ~------------~~~~~~~~~~~~~-----------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 251 E------------EVMHKTLAGRYDP-----------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred H------------HHHHHHhcCCCCC-----------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1 1111111111100 001123468899999999999999999999864
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=324.67 Aligned_cols=262 Identities=26% Similarity=0.358 Sum_probs=206.3
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
++|++.++||+|+||.||+|+...+++.||||.+.... ......+.+|+++++.++||||+++++++.. ...
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE-----DNE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE-----CCe
Confidence 57999999999999999999998899999999876432 2234567899999999999999999998643 356
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++||||+++|+|.+++...... ...+++..++.++.|++.||+|||++ +++||||||+||+++.++.++|+|||
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g 151 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQ--KRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLG 151 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhc--cCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccc
Confidence 69999999999999998754321 23578999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 915 (992)
.+........ ......+++.|+|||.+.+..++.++||||+|+++|||++|+.||....... ..
T Consensus 152 ~~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~---~~----- 215 (267)
T cd08228 152 LGRFFSSKTT--------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL---FS----- 215 (267)
T ss_pred cceeccchhH--------HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH---HH-----
Confidence 9987643211 1122357889999999988889999999999999999999999986422111 11
Q ss_pred CChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 037275 916 LPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRAR 983 (992)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 983 (992)
+.......... ..........+.+++.+||+.+|++||++.||++.+++++
T Consensus 216 -------~~~~~~~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 216 -------LCQKIEQCDYP----------PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred -------HHHHHhcCCCC----------CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 11110000000 0011223456899999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=329.14 Aligned_cols=276 Identities=21% Similarity=0.308 Sum_probs=200.0
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC--CCchhHHHHHHHHHHhc---cCCcceeEEEEeecccccCcc
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNI---RHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~ 754 (992)
+|++.+.||+|+||+||+|++..+++.||+|.++... ......+.+|+.+++.+ +||||+++++++.........
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5888999999999999999999999999999986432 22234566777777765 699999999987665445566
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
..++||||+. ++|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~df 152 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPP----PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADF 152 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcc
Confidence 7899999997 589998876432 2489999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
|+++...... ......|+..|+|||++.+..++.++||||+||++|+|++|++||.+....+ .+......
T Consensus 153 g~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~ 222 (288)
T cd07863 153 GLARIYSCQM---------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDL 222 (288)
T ss_pred CccccccCcc---------cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH-HHHHHHHH
Confidence 9998654221 1123457899999999998899999999999999999999999997532211 11111110
Q ss_pred h-CCh--hHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 915 A-LPD--KVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 915 ~-~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
. .+. .+...... ....+.... ... ......+...++.+++.+||+.||++|||+.|++.
T Consensus 223 ~~~~~~~~~~~~~~~-~~~~~~~~~-~~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 223 IGLPPEDDWPRDVTL-PRGAFSPRG-PRP--VQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hCCCChhhCcccccc-cccccCCCC-CCc--hHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 000 00000000 000000000 000 00000123456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=351.68 Aligned_cols=254 Identities=21% Similarity=0.277 Sum_probs=202.2
Q ss_pred CCCCCCccccccceEEEEeEECCC-CeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEE
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGEN-GMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAI 758 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 758 (992)
.|.+.+.||+|+||.||+|....+ ++.||+|.+..........+.+|+.+++.++||||+++++++. ..+..++
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~-----~~~~~~l 142 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFK-----SDDKLLL 142 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE-----ECCEEEE
Confidence 488999999999999999998767 7889999876555445566788999999999999999999864 3456799
Q ss_pred EEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccce
Q 037275 759 VYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAK 838 (992)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 838 (992)
||||+++|+|.+++..... ...++++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 143 v~E~~~gg~L~~~l~~~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~ 217 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLK--EHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSK 217 (478)
T ss_pred EEECCCCCCHHHHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCce
Confidence 9999999999999875422 123588999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCCh
Q 037275 839 FLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPD 918 (992)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 918 (992)
...... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.+...
T Consensus 218 ~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~--------------- 276 (478)
T PTZ00267 218 QYSDSV------SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ--------------- 276 (478)
T ss_pred ecCCcc------ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH---------------
Confidence 764321 11122345689999999999999999999999999999999999999965211
Q ss_pred hHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 919 KVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.+++.....+.+.. . ......++.+++.+||+.||++||+++|++.
T Consensus 277 --~~~~~~~~~~~~~~-----~------~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 277 --REIMQQVLYGKYDP-----F------PCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred --HHHHHHHHhCCCCC-----C------CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 11111111111100 0 0112345889999999999999999999975
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=324.38 Aligned_cols=265 Identities=25% Similarity=0.408 Sum_probs=204.4
Q ss_pred CCCCCccccccceEEEEeEECCC---CeEEEEEEeeccCC--CchhHHHHHHHHHHhccCCcceeEEEEeecccc-cCcc
Q 037275 681 FSSSNMIGQGSFGFVYKGNLGEN---GMMVAVKVINLKQK--GASNGFVAECQALRNIRHRNLIKIITICSSIDF-KGVD 754 (992)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 754 (992)
|++.+.||+|+||.||+|....+ +..||+|.++.... .....+.+|+..++.++||||+++++++..... .+..
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 56789999999999999997543 47899999874332 234578899999999999999999998765332 3344
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
..++||||+++|+|.+++...........+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 5799999999999999997654332334689999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 913 (992)
|.++......... ......++..|+|||++.+..++.++|||||||++|||++ |..||.+....
T Consensus 158 g~~~~~~~~~~~~------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--------- 222 (273)
T cd05035 158 GLSKKIYSGDYYR------QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--------- 222 (273)
T ss_pred cceeecccccccc------ccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---------
Confidence 9998765332111 1112234678999999988899999999999999999999 88998653211
Q ss_pred hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 037275 914 TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRA 982 (992)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 982 (992)
+..+....... . .. .......+.+++.+||+.||++|||+.|+++.|+++
T Consensus 223 --------~~~~~~~~~~~-~----~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 223 --------EIYDYLRHGNR-L----KQ------PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred --------HHHHHHHcCCC-C----CC------CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11111110000 0 00 012245689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=331.68 Aligned_cols=260 Identities=23% Similarity=0.404 Sum_probs=202.8
Q ss_pred cCCCCCCccccccceEEEEeEECCCCe----EEEEEEeeccC-CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCc
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGM----MVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 753 (992)
.+|+..+.||+|+||.||+|++..+++ .||+|+++... .....++.+|+.+++.++||||++++|+|..
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~------ 80 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------ 80 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC------
Confidence 478999999999999999999765554 48999986432 2345678899999999999999999998753
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGD 833 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 833 (992)
...++|+||+++|+|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 81 ~~~~~v~e~~~~g~l~~~l~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~D 152 (316)
T cd05108 81 STVQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITD 152 (316)
T ss_pred CCceeeeecCCCCCHHHHHHhccc-----cCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcc
Confidence 234799999999999999986543 478899999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHH
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFA 912 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~ 912 (992)
||+++....... ........++..|+|||++.+..++.++|||||||++|||++ |+.||.+.... +
T Consensus 153 fG~a~~~~~~~~------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~-----~-- 219 (316)
T cd05108 153 FGLAKLLGADEK------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-----E-- 219 (316)
T ss_pred ccccccccCCCc------ceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-----H--
Confidence 999987653221 111112234678999999999999999999999999999998 99998753111 0
Q ss_pred hhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 037275 913 RTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTF 986 (992)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 986 (992)
....... ....... .....++.+++.+||+.+|++|||+.|++..+.++.++.
T Consensus 220 -------~~~~~~~----~~~~~~~----------~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 220 -------ISSILEK----GERLPQP----------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred -------HHHHHhC----CCCCCCC----------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 1111110 0000000 011245789999999999999999999999998886543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=333.58 Aligned_cols=200 Identities=28% Similarity=0.419 Sum_probs=173.2
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC-CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
.++|++.++||+|+||.||+|.+..++..+|+|++..... .....+.+|++++++++||||+++++++.. .+..
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 78 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEI 78 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE-----CCEE
Confidence 3689999999999999999999998999999999865422 234568899999999999999999999643 4567
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
++||||+++|+|.+++.... .+++..+..++.|++.||+|||+.. +|+||||||+||+++.++.+||+|||+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~ 150 (333)
T cd06650 79 SICMEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGV 150 (333)
T ss_pred EEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCc
Confidence 99999999999999997543 4788999999999999999999742 699999999999999999999999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCC
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDG 900 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 900 (992)
+...... ......|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 151 ~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 151 SGQLIDS----------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred chhhhhh----------ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 8754321 11234588999999999988999999999999999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=340.08 Aligned_cols=265 Identities=24% Similarity=0.386 Sum_probs=204.0
Q ss_pred hcCCCCCCccccccceEEEEeEECC-----CCeEEEEEEeeccCC-CchhHHHHHHHHHHhcc-CCcceeEEEEeecccc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGE-----NGMMVAVKVINLKQK-GASNGFVAECQALRNIR-HRNLIKIITICSSIDF 750 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 750 (992)
.++|++.++||+|+||.||+|++.. .+..||||+++.... ...+.+.+|+++++++. ||||+++++++.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~---- 111 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT---- 111 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc----
Confidence 5688999999999999999998742 235799999964432 23457899999999996 999999999964
Q ss_pred cCcceEEEEEEeccCCCHHHHHhhcccc----------------------------------------------------
Q 037275 751 KGVDFQAIVYEYMQNGSLEDWLHQSEDQ---------------------------------------------------- 778 (992)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~---------------------------------------------------- 778 (992)
.....++||||+++|+|.+++......
T Consensus 112 -~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 112 -KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred -cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 345679999999999999999764210
Q ss_pred --------------------------------------hhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCC
Q 037275 779 --------------------------------------QEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSN 820 (992)
Q Consensus 779 --------------------------------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~N 820 (992)
.....+++..+..++.|++.||+|||+. +|+||||||+|
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~N 267 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARN 267 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHh
Confidence 0012478889999999999999999999 99999999999
Q ss_pred eeeCCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCC
Q 037275 821 VLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTD 899 (992)
Q Consensus 821 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~ 899 (992)
|+++.++.+||+|||+++....... ........++..|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 268 ill~~~~~~kL~DfGla~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~ 341 (400)
T cd05105 268 VLLAQGKIVKICDFGLARDIMHDSN------YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYP 341 (400)
T ss_pred EEEeCCCEEEEEeCCcceecccccc------ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCc
Confidence 9999999999999999986543211 111222346788999999998899999999999999999997 999987
Q ss_pred CCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 037275 900 GMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKL 979 (992)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 979 (992)
....... ....+. ..... ........++.+++.+||+.||++|||+.+|.+.|
T Consensus 342 ~~~~~~~-------------~~~~~~----~~~~~----------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l 394 (400)
T cd05105 342 GMIVDST-------------FYNKIK----SGYRM----------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIV 394 (400)
T ss_pred ccchhHH-------------HHHHHh----cCCCC----------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHH
Confidence 5322110 000000 00000 00112345689999999999999999999999999
Q ss_pred HHHH
Q 037275 980 CRAR 983 (992)
Q Consensus 980 ~~~~ 983 (992)
+++.
T Consensus 395 ~~l~ 398 (400)
T cd05105 395 ESLL 398 (400)
T ss_pred HHHc
Confidence 8864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=327.62 Aligned_cols=265 Identities=24% Similarity=0.429 Sum_probs=206.9
Q ss_pred cCCCCCCccccccceEEEEeEE-----CCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCc
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNL-----GENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 753 (992)
.+|.+.+.||+|+||.||++.. ..++..+|+|.+..........+.+|++++++++||||+++++++. ..
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 79 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV-----EG 79 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cC
Confidence 4788999999999999999985 2345679999986555455667899999999999999999999864 34
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccc-------hhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCC
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQ-------QEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQD 826 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 826 (992)
...++||||+++++|.+++...... .....+++..++.++.|++.||+|||++ +++||||||+||+++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~ 156 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN 156 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccC
Confidence 5669999999999999999755321 1123589999999999999999999999 99999999999999999
Q ss_pred CcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCC
Q 037275 827 LVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQG 905 (992)
Q Consensus 827 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~ 905 (992)
+.+||+|||.++....... ........++..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 157 ~~~kl~dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~- 229 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDY------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN- 229 (288)
T ss_pred CcEEeccCCccccccCCce------eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 9999999999986543211 111122345788999999998899999999999999999999 99998653211
Q ss_pred ccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 037275 906 LTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDT 985 (992)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 985 (992)
+.......+.... .. .....++.+++.+||+.||.+|||++|+.+.|+++..+
T Consensus 230 ----------------~~~~~i~~~~~~~-~~----------~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 230 ----------------EVIECITQGRVLQ-RP----------RTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred ----------------HHHHHHHcCCcCC-CC----------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 0111111111000 00 01234589999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=321.37 Aligned_cols=256 Identities=24% Similarity=0.450 Sum_probs=203.0
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAI 758 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 758 (992)
.+|++.++||+|+||.||+|.+..+++.||+|++... ......+.+|+++++.++||||+++++++.. ....++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l 79 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPFYI 79 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcC-----CCCcEE
Confidence 3578889999999999999999888999999998633 3345678899999999999999999998643 445699
Q ss_pred EEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccce
Q 037275 759 VYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAK 838 (992)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 838 (992)
||||+++++|.+++..... ..+++..++.++.|+++||+|||+. +++||||||+||++++++.+||+|||.+.
T Consensus 80 v~e~~~~~~L~~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~ 152 (263)
T cd05052 80 ITEFMTYGNLLDYLRECNR----QEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR 152 (263)
T ss_pred EEEeCCCCcHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccc
Confidence 9999999999999975432 2589999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhhhCC
Q 037275 839 FLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFARTALP 917 (992)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 917 (992)
........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+.... +.
T Consensus 153 ~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-----~~------ 214 (263)
T cd05052 153 LMTGDTYT-------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----QV------ 214 (263)
T ss_pred ccccceee-------ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----HH------
Confidence 66432211 1111234668999999988899999999999999999998 99998753111 10
Q ss_pred hhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 037275 918 DKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRA 982 (992)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 982 (992)
...+.. ..... .....+.++.+++.+||+.||++|||+.|+++.|+.+
T Consensus 215 ---~~~~~~----~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 215 ---YELLEK----GYRME----------RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ---HHHHHC----CCCCC----------CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 011100 00000 0011235688999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=324.49 Aligned_cols=265 Identities=24% Similarity=0.403 Sum_probs=201.7
Q ss_pred CCCCCccccccceEEEEeEECCCCe--EEEEEEeeccC--CCchhHHHHHHHHHHhccCCcceeEEEEeecccc-cCcce
Q 037275 681 FSSSNMIGQGSFGFVYKGNLGENGM--MVAVKVINLKQ--KGASNGFVAECQALRNIRHRNLIKIITICSSIDF-KGVDF 755 (992)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 755 (992)
|.+.++||+|+||.||+|++..++. .||+|.++... ....+.+.+|+++++.++||||+++++++..... .....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4567899999999999999876654 69999886432 3345678899999999999999999998754221 22335
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++||||+++|+|.+++...........+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 689999999999999986443222234589999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhh
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~ 914 (992)
+++........ .......+++.|+|||+..+..++.++|||||||++|||++ |+.||.+.... +
T Consensus 158 ~~~~~~~~~~~------~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-----~---- 222 (272)
T cd05075 158 LSKKIYNGDYY------RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS-----E---- 222 (272)
T ss_pred cccccCcccce------ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH-----H----
Confidence 99876432210 01112245678999999999999999999999999999999 88998753211 0
Q ss_pred hCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 037275 915 ALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRA 982 (992)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 982 (992)
..+........ . ........+.+++.+||+.||++|||+.|+++.|+++
T Consensus 223 --------~~~~~~~~~~~-----~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 223 --------IYDYLRQGNRL-----K------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred --------HHHHHHcCCCC-----C------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11110000000 0 0011234588999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=338.49 Aligned_cols=249 Identities=23% Similarity=0.358 Sum_probs=191.2
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC-CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
.+|+..++||+|+||+||+|++..+++.||||++..... .....+.+|+++++.++|+||+++++++ ......+
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 148 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHNGEIQ 148 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccCCeEE
Confidence 356677899999999999999988999999999864332 2346788999999999999999999985 3455679
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||+++|+|.+.. ...+..+..++.||+.||+|||++ +|+||||||+||++++++.+||+|||++
T Consensus 149 lv~e~~~~~~L~~~~----------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~ 215 (353)
T PLN00034 149 VLLEFMDGGSLEGTH----------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVS 215 (353)
T ss_pred EEEecCCCCcccccc----------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccc
Confidence 999999999986532 256677889999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccC-----CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHH
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-----GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFA 912 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~ 912 (992)
+...... .......||..|+|||++.. ...+.++|||||||++|||++|+.||...... ...
T Consensus 216 ~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--~~~--- 282 (353)
T PLN00034 216 RILAQTM--------DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG--DWA--- 282 (353)
T ss_pred eeccccc--------ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--cHH---
Confidence 8654321 11223468999999998743 23456899999999999999999999732111 111
Q ss_pred hhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 913 RTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
........... . ........++.+++.+||+.||++|||++|+++.
T Consensus 283 ---------~~~~~~~~~~~-----~------~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 283 ---------SLMCAICMSQP-----P------EAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ---------HHHHHHhccCC-----C------CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11110000000 0 0001223468999999999999999999999864
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=326.96 Aligned_cols=261 Identities=26% Similarity=0.481 Sum_probs=203.4
Q ss_pred cCCCCCCccccccceEEEEeEECCCC-----eEEEEEEeeccCC-CchhHHHHHHHHHHhccCCcceeEEEEeecccccC
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENG-----MMVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIITICSSIDFKG 752 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 752 (992)
++|++.+.||+|+||.||+|.....+ ..||+|.+..... .....+.+|+.++++++||||+++++++. .
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-----~ 79 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT-----K 79 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEc-----C
Confidence 47889999999999999999975444 6899999864332 23456889999999999999999999864 3
Q ss_pred cceEEEEEEeccCCCHHHHHhhcccchh----------hcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCee
Q 037275 753 VDFQAIVYEYMQNGSLEDWLHQSEDQQE----------ARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVL 822 (992)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~----------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIl 822 (992)
....+++|||+++|+|.+++........ ...+++..++.++.|++.||+|||++ +++||||||+||+
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil 156 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCL 156 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEE
Confidence 4456999999999999999986532111 13588999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCC
Q 037275 823 LDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGM 901 (992)
Q Consensus 823 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~ 901 (992)
+++++.+||+|||++........ ........+++.|+|||++.+..++.++|||||||++|||++ |..||.+.
T Consensus 157 ~~~~~~~~L~dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~ 230 (283)
T cd05048 157 VGEGLTVKISDFGLSRDIYSADY------YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGF 230 (283)
T ss_pred EcCCCcEEECCCcceeecccccc------ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999986543211 111223346788999999988899999999999999999998 99998763
Q ss_pred ccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 037275 902 FNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCR 981 (992)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 981 (992)
... .....+.. ... .. .....+.++.+++.+||+.||++||++.||++.|++
T Consensus 231 ~~~--------------~~~~~i~~---~~~-----~~------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 231 SNQ--------------EVIEMIRS---RQL-----LP------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred CHH--------------HHHHHHHc---CCc-----CC------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 221 11111110 000 00 011234568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=330.87 Aligned_cols=245 Identities=27% Similarity=0.363 Sum_probs=198.5
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC---CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK---GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
.|.-.+.||.|+||.||-|++..+.+.||||.+..... ..+.++.+|+..+++++|||++.+-|+|. .....
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyL-----re~Ta 101 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYL-----REHTA 101 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceee-----ccchH
Confidence 35566789999999999999999999999999975433 44678999999999999999999999853 34556
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
|+||||| -|+-.|++.-++. ++.+.++..|+.+.+.||+|||++ +.||||||+.|||+++.|.|||+|||.
T Consensus 102 WLVMEYC-lGSAsDlleVhkK-----plqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGS 172 (948)
T KOG0577|consen 102 WLVMEYC-LGSASDLLEVHKK-----PLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGS 172 (948)
T ss_pred HHHHHHH-hccHHHHHHHHhc-----cchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccc
Confidence 9999999 5699999987764 589999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCCCcccCCCCCccccccccccccccc---CCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGM---GGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 913 (992)
|....+ ...++|||.|||||++. .++|+-++||||+|++..|+..+++|+..+..-
T Consensus 173 Asi~~P------------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM--------- 231 (948)
T KOG0577|consen 173 ASIMAP------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------- 231 (948)
T ss_pred hhhcCc------------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH---------
Confidence 986543 23468999999999875 468999999999999999999999997653211
Q ss_pred hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 914 TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
..+..+-..+. +.....+-...+..++..||+.-|.+|||.++++.
T Consensus 232 --------SALYHIAQNes----------PtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 232 --------SALYHIAQNES----------PTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred --------HHHHHHHhcCC----------CCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 11110000000 01112223445888899999999999999999875
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=337.03 Aligned_cols=247 Identities=21% Similarity=0.264 Sum_probs=197.0
Q ss_pred hcCCCCCCccccccceEEEEeEECCCC-eEEEEEEeecc---CCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENG-MMVAVKVINLK---QKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 753 (992)
.++|++.+.||+|+||.||+|++..++ ..||+|++... .......+.+|+.+++.++||||+++++++. +.
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~~ 103 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFK-----DE 103 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEE-----eC
Confidence 447999999999999999999875444 78999998643 2234566889999999999999999999864 44
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGD 833 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 833 (992)
...++||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~D 174 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRRNK------RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTD 174 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEec
Confidence 56799999999999999997643 488999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 913 (992)
||++...... .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+.... .
T Consensus 175 FG~a~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~--- 235 (340)
T PTZ00426 175 FGFAKVVDTR-----------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-----L--- 235 (340)
T ss_pred CCCCeecCCC-----------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-----H---
Confidence 9999865421 12346899999999999888999999999999999999999999753111 0
Q ss_pred hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 037275 914 TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERM-----EMRDVVAK 978 (992)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 978 (992)
.......... ..+ ......+.+++.+|++.||++|+ |++|+++.
T Consensus 236 ---------~~~~i~~~~~------~~p------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 236 ---------IYQKILEGII------YFP------KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ---------HHHHHhcCCC------CCC------CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 0000110000 000 01123478899999999999995 88888753
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=326.74 Aligned_cols=262 Identities=27% Similarity=0.487 Sum_probs=204.1
Q ss_pred hcCCCCCCccccccceEEEEeEEC-----CCCeEEEEEEeeccCCC-chhHHHHHHHHHHhccCCcceeEEEEeeccccc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLG-----ENGMMVAVKVINLKQKG-ASNGFVAECQALRNIRHRNLIKIITICSSIDFK 751 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 751 (992)
..+|.+.+.||+|+||.||+|+.. .+++.||+|.++..... ..+.+.+|++++++++||||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---- 79 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTE---- 79 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEec----
Confidence 346888999999999999999874 23578999998654433 35678999999999999999999999643
Q ss_pred CcceEEEEEEeccCCCHHHHHhhccc--------chhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeee
Q 037275 752 GVDFQAIVYEYMQNGSLEDWLHQSED--------QQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLL 823 (992)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 823 (992)
....++||||+++++|.+++..... ......+++.++..++.|++.|++|||++ +++||||||+||++
T Consensus 80 -~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili 155 (280)
T cd05049 80 -GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLV 155 (280)
T ss_pred -CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEE
Confidence 3567999999999999999986532 11234588999999999999999999999 99999999999999
Q ss_pred CCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCc
Q 037275 824 DQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMF 902 (992)
Q Consensus 824 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~ 902 (992)
+.++.+||+|||.++....... ........+++.|+|||++.+..++.++|||||||++|||++ |..||.+..
T Consensus 156 ~~~~~~kl~d~g~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~ 229 (280)
T cd05049 156 GYDLVVKIGDFGMSRDVYTTDY------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS 229 (280)
T ss_pred cCCCeEEECCcccceecccCcc------eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999976533211 011122345788999999999999999999999999999999 999986532
Q ss_pred cCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 037275 903 NQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCR 981 (992)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 981 (992)
.. +..+....+... . ........+.+++.+||+.||++|||++||++.|++
T Consensus 230 ~~-----------------~~~~~~~~~~~~-----~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 230 NE-----------------EVIECITQGRLL-----Q------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HH-----------------HHHHHHHcCCcC-----C------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 21 011111100000 0 001123568999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=327.62 Aligned_cols=253 Identities=25% Similarity=0.332 Sum_probs=207.8
Q ss_pred HhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCC---chhHHHHHHHHHHhcc-CCcceeEEEEeecccccC
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKG---ASNGFVAECQALRNIR-HRNLIKIITICSSIDFKG 752 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 752 (992)
....|++.+.||+|.||.||+++.+.+|+.+|+|++...... ....+.+|+.+|+++. |||||.+.+++ +.
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~-----e~ 107 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF-----ED 107 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE-----Ec
Confidence 345788999999999999999999999999999999755432 3468999999999998 99999999995 45
Q ss_pred cceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCC----Cc
Q 037275 753 VDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQD----LV 828 (992)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~~ 828 (992)
....++|||++.||.|.+.+... .+++..+..++.|++.|++|||+. ||+|||+||+|+|+... +.
T Consensus 108 ~~~~~lvmEL~~GGeLfd~i~~~-------~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ 177 (382)
T KOG0032|consen 108 PDSVYLVMELCEGGELFDRIVKK-------HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGR 177 (382)
T ss_pred CCeEEEEEEecCCchHHHHHHHc-------cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCc
Confidence 55789999999999999999865 289999999999999999999999 99999999999999543 48
Q ss_pred EEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccH
Q 037275 829 AHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTL 908 (992)
Q Consensus 829 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~ 908 (992)
+|++|||+|..... .......+||+.|+|||++.+..|+..+||||+||++|.|++|.+||.+..+.....
T Consensus 178 ik~~DFGla~~~~~---------~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~ 248 (382)
T KOG0032|consen 178 IKLIDFGLAKFIKP---------GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL 248 (382)
T ss_pred EEEeeCCCceEccC---------CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH
Confidence 99999999998764 223445689999999999999999999999999999999999999998753331111
Q ss_pred HHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 909 HEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
....+++.. .............+++..|+..||.+|+|+.++++.
T Consensus 249 -----------------~i~~~~~~f--------~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 249 -----------------AILRGDFDF--------TSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred -----------------HHHcCCCCC--------CCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 111111111 111122334568899999999999999999999984
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=310.51 Aligned_cols=250 Identities=24% Similarity=0.342 Sum_probs=204.9
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEE
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIV 759 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 759 (992)
-|+++++||+|+||.||+|.++++|+.+|+|.+... ....++.+|+.+|++++.|++|+++|.| -.....|+|
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSY-----FK~sDLWIV 106 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSY-----FKHSDLWIV 106 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhh-----ccCCceEee
Confidence 356778999999999999999999999999988543 3567899999999999999999999975 234567999
Q ss_pred EEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccccee
Q 037275 760 YEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKF 839 (992)
Q Consensus 760 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 839 (992)
||||..|+..+.++.... ++.+.++..+++..+.||+|||.. .-+|||||..|||+..+|.+||+|||.|..
T Consensus 107 MEYCGAGSiSDI~R~R~K-----~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQ 178 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRARRK-----PLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQ 178 (502)
T ss_pred hhhcCCCcHHHHHHHhcC-----CccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccch
Confidence 999999999999987654 699999999999999999999999 889999999999999999999999999976
Q ss_pred cCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCChh
Q 037275 840 LSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDK 919 (992)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 919 (992)
+.+ +-......+||+.|||||++..-.|..++||||+|++..||..|++||.+...-...+ ++....|.
T Consensus 179 LTD--------TMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF--MIPT~PPP- 247 (502)
T KOG0574|consen 179 LTD--------TMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF--MIPTKPPP- 247 (502)
T ss_pred hhh--------hHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE--eccCCCCC-
Confidence 543 2223345689999999999999999999999999999999999999997642211100 00000000
Q ss_pred HHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 920 VMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
--...++-..++.+++++||...|++|-||-++++.
T Consensus 248 -----------------------TF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 248 -----------------------TFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred -----------------------CCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 001123335568999999999999999999998764
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=320.63 Aligned_cols=251 Identities=26% Similarity=0.423 Sum_probs=197.4
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAI 758 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 758 (992)
++|++.+.||+|+||.||+|+.+ ++..+|+|.+.. .......+.+|+.++++++||||+++++++. .....++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~i 76 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINE-GAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT-----QQKPLYI 76 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEeccc-CCccHHHHHHHHHHHHHCCCCCceeEEEEEc-----cCCCEEE
Confidence 46888999999999999999986 567899998753 3334567889999999999999999999864 3445799
Q ss_pred EEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccce
Q 037275 759 VYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAK 838 (992)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 838 (992)
||||+++|+|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.++
T Consensus 77 v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~ 148 (256)
T cd05114 77 VTEFMENGCLLNYLRQRQG-----KLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTR 148 (256)
T ss_pred EEEcCCCCcHHHHHHhCcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCcc
Confidence 9999999999999975432 488999999999999999999999 99999999999999999999999999987
Q ss_pred ecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhhhCC
Q 037275 839 FLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFARTALP 917 (992)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 917 (992)
....... .......++..|+|||++.+..++.++||||||+++|||++ |+.||......
T Consensus 149 ~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~------------- 208 (256)
T cd05114 149 YVLDDEY-------TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY------------- 208 (256)
T ss_pred ccCCCce-------eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH-------------
Confidence 6543211 11122235678999999988889999999999999999999 89998653211
Q ss_pred hhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 037275 918 DKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKL 979 (992)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 979 (992)
+.......... ... .......+.+++.+||+.+|++|||++|+++.|
T Consensus 209 ----~~~~~i~~~~~-------~~~----~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 209 ----EVVEMISRGFR-------LYR----PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ----HHHHHHHCCCC-------CCC----CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 01110000000 000 001134589999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=340.57 Aligned_cols=259 Identities=24% Similarity=0.298 Sum_probs=198.4
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
++|++.++||+|+||+||+|++..+++.||||++.... ......+.+|+++++.++||||+++++++ .....
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF-----QDENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCe
Confidence 47899999999999999999999899999999997432 23345678899999999999999999985 44567
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~E~~~~g~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 146 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMKKD------TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFG 146 (364)
T ss_pred EEEEECCCCCcHHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecc
Confidence 799999999999999997543 489999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCccc------------------------------CCCCCcccccccccccccccCCCcCcccchhhHH
Q 037275 836 LAKFLSSSPLDTAVET------------------------------PSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFG 885 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 885 (992)
++..+........... .......+||+.|+|||++.+..++.++||||||
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 226 (364)
T cd05599 147 LCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG 226 (364)
T ss_pred cceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecch
Confidence 9976532211000000 0011124699999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCC
Q 037275 886 ILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMES 965 (992)
Q Consensus 886 ~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 965 (992)
|++|||++|+.||.+.... +. ...+.. ..... ..+.. .....++.+++.+|+. +
T Consensus 227 ~il~el~~G~~Pf~~~~~~-----~~--------~~~i~~----~~~~~----~~~~~----~~~s~~~~~li~~ll~-~ 280 (364)
T cd05599 227 VIMYEMLVGYPPFCSDNPQ-----ET--------YRKIIN----WKETL----QFPDE----VPLSPEAKDLIKRLCC-E 280 (364)
T ss_pred hHHHHhhcCCCCCCCCCHH-----HH--------HHHHHc----CCCcc----CCCCC----CCCCHHHHHHHHHHcc-C
Confidence 9999999999999753211 00 000100 00000 00000 0113457788888996 9
Q ss_pred CCCCCC---HHHHHH
Q 037275 966 PTERME---MRDVVA 977 (992)
Q Consensus 966 P~~RPs---~~evl~ 977 (992)
|.+|++ ++|+++
T Consensus 281 p~~R~~~~~~~~ll~ 295 (364)
T cd05599 281 AERRLGNNGVNEIKS 295 (364)
T ss_pred HhhcCCCCCHHHHhc
Confidence 999998 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=339.70 Aligned_cols=208 Identities=25% Similarity=0.324 Sum_probs=173.6
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
.|+.++.||+|+||+||+|++..+++.||+|++.... ......+.+|++++++++||||+++++++. +....
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~-----~~~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQ-----DKDNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEe-----cCCEE
Confidence 5888999999999999999999999999999996432 233456889999999999999999999854 45567
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
++||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~------~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl 147 (381)
T cd05626 77 YFVMDYIPGGDMMSLLIRME------VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGL 147 (381)
T ss_pred EEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcC
Confidence 99999999999999997543 478899999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCCCc---------------------------------------ccCCCCCcccccccccccccccCCCcCc
Q 037275 837 AKFLSSSPLDTAV---------------------------------------ETPSSSKGIKGTVGYIAPEYGMGGEASM 877 (992)
Q Consensus 837 a~~~~~~~~~~~~---------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 877 (992)
+............ ..........||+.|+|||++.+..++.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 227 (381)
T cd05626 148 CTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQ 227 (381)
T ss_pred CcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCC
Confidence 8643211000000 0000112357999999999999889999
Q ss_pred ccchhhHHHHHHHHHhCCCCCCCC
Q 037275 878 TGDVYSFGILLLEMFTRRRPTDGM 901 (992)
Q Consensus 878 ~~DiwSlG~il~elltg~~pf~~~ 901 (992)
++|||||||++|||++|+.||...
T Consensus 228 ~~DiwSlG~il~elltG~~Pf~~~ 251 (381)
T cd05626 228 LCDWWSVGVILFEMLVGQPPFLAP 251 (381)
T ss_pred ccceeehhhHHHHHHhCCCCCcCC
Confidence 999999999999999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=320.47 Aligned_cols=259 Identities=24% Similarity=0.372 Sum_probs=200.2
Q ss_pred cCCCCCCccccccceEEEEeEECCCCe----EEEEEEeeccCC-CchhHHHHHHHHHHhccCCcceeEEEEeecccccCc
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGM----MVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 753 (992)
++|++.+.||+|+||+||+|.+..+++ .|++|.+..... ....++..|+.++++++||||+++++++..
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~------ 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG------ 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC------
Confidence 478889999999999999999876665 477777643222 233567788889999999999999998632
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGD 833 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 833 (992)
...++++||+++|+|.+++..... .+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~D 152 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHRD-----SLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIAD 152 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcC
Confidence 235789999999999999976442 489999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHH
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFA 912 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~ 912 (992)
||.++....... ........++..|+|||++.++.++.++|||||||++||+++ |+.||.+....
T Consensus 153 fg~~~~~~~~~~------~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-------- 218 (279)
T cd05111 153 FGVADLLYPDDK------KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH-------- 218 (279)
T ss_pred CccceeccCCCc------ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--------
Confidence 999986543211 111223456788999999988899999999999999999998 99998753211
Q ss_pred hhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 037275 913 RTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDT 985 (992)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 985 (992)
...+.+.. +.. .. .. ......+.+++.+||..||++|||+.|+++.|.++.++
T Consensus 219 ------~~~~~~~~---~~~-~~----~~------~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 219 ------EVPDLLEK---GER-LA----QP------QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred ------HHHHHHHC---CCc-CC----CC------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 01111110 000 00 00 01123578899999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=323.85 Aligned_cols=256 Identities=30% Similarity=0.486 Sum_probs=205.7
Q ss_pred HhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
...+|++.++||.|+||.||+|.+.. ++.+|+|++..........+.+|+.+++.++||||+++++++. .....
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~ 77 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS-----VGEPV 77 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEe-----cCCCe
Confidence 34578999999999999999999985 8999999997665555677899999999999999999999864 34556
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
++||||+++++|.+++..... ..+++..++.++.|++.|++|||++ +|+||||||+||++++++.+||+|||.
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~ 150 (261)
T cd05148 78 YIITELMEKGSLLAFLRSPEG----QVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGL 150 (261)
T ss_pred EEEEeecccCCHHHHHhcCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccc
Confidence 999999999999999986432 3589999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhhh
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~ 915 (992)
+......... .....++..|+|||++.+..++.++||||||+++|+|++ |+.||......
T Consensus 151 ~~~~~~~~~~--------~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~----------- 211 (261)
T cd05148 151 ARLIKEDVYL--------SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH----------- 211 (261)
T ss_pred hhhcCCcccc--------ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH-----------
Confidence 9866432111 112335778999999988899999999999999999998 89999653211
Q ss_pred CChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 037275 916 LPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCR 981 (992)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 981 (992)
+..+... ...... ........+.+++.+||+.||++|||++++++.|+.
T Consensus 212 ------~~~~~~~-~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 212 ------EVYDQIT-AGYRMP----------CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred ------HHHHHHH-hCCcCC----------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 1111111 000000 001223458899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=334.27 Aligned_cols=280 Identities=19% Similarity=0.240 Sum_probs=201.3
Q ss_pred HhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc--CCCchhHHHHHHHHHHhccCCcceeEEEEeeccc-ccCc
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK--QKGASNGFVAECQALRNIRHRNLIKIITICSSID-FKGV 753 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~ 753 (992)
..++|++.+.||+|+||.||+|.+..+|+.||+|++... .......+.+|+.+++.++||||+++++++.... ....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 457899999999999999999999889999999998633 2233466789999999999999999999875432 1223
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGD 833 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 833 (992)
...++||||+++ ++.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~D 166 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 166 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc--------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEec
Confidence 457999999965 67666642 378888999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 913 (992)
||+++..... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.... ........
T Consensus 167 fg~a~~~~~~---------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~-~~~~~~~~ 236 (359)
T cd07876 167 FGLARTACTN---------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHI-DQWNKVIE 236 (359)
T ss_pred CCCccccccC---------ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH
Confidence 9999754321 1122346899999999999999999999999999999999999999864221 11111111
Q ss_pred hhC-C-hhHHHHHHhhHhHhhhcc-CCCC-----------CCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 914 TAL-P-DKVMEIVDSVLLLEVQAS-NSRS-----------CGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 914 ~~~-~-~~~~~~~~~~~~~~~~~~-~~~~-----------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
... + .............-.... .... .............++.+++.+||+.||++|||++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 237 QLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred hcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 110 0 011111110000000000 0000 000000011123568899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=315.29 Aligned_cols=249 Identities=21% Similarity=0.340 Sum_probs=207.3
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC--CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK--GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
.+-|+..+.||+|.|++|-+|++..+|++||||++....- -....+.+|++-|+.++|||||+++.+ ......
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEV-----iDTQTK 91 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEV-----IDTQTK 91 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeeh-----hcccce
Confidence 3458888999999999999999999999999999975533 345678999999999999999999998 455677
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeee-CCCCcEEEeec
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLL-DQDLVAHLGDF 834 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~Df 834 (992)
+|+|+|.-++|+|.+|+.++... +.+....+++.||+.|+.|+|+. .|||||+||+||.+ ..-|-+||.||
T Consensus 92 lyLiLELGD~GDl~DyImKHe~G-----l~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDF 163 (864)
T KOG4717|consen 92 LYLILELGDGGDLFDYIMKHEEG-----LNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDF 163 (864)
T ss_pred EEEEEEecCCchHHHHHHhhhcc-----ccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeec
Confidence 89999999999999999988754 89999999999999999999999 99999999999876 56689999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcC-cccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEAS-MTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 913 (992)
|++..+.++ ......+|+..|-|||++.|..|+ +++||||+|||+|-+++|++||+...+.+
T Consensus 164 GFSNkf~PG---------~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE-------- 226 (864)
T KOG4717|consen 164 GFSNKFQPG---------KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE-------- 226 (864)
T ss_pred cccccCCCc---------chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh--------
Confidence 999876543 233456899999999999999886 57899999999999999999998754432
Q ss_pred hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 914 TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.+..++|.... .......++.++|..||..||.+|.|.+||..
T Consensus 227 -----TLTmImDCKYt----------------vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 227 -----TLTMIMDCKYT----------------VPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred -----hhhhhhccccc----------------CchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 12223332110 01233567899999999999999999999874
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=323.42 Aligned_cols=274 Identities=22% Similarity=0.338 Sum_probs=204.2
Q ss_pred cCCCCCCccccccceEEEEeEE----CCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcc
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNL----GENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
.+|++.+.||+|+||.||+|.. ..+++.||+|.+........+.+.+|++++++++||||+++.+++.. .+..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEcc---CCCC
Confidence 4788999999999999999984 34688999999875555456678999999999999999999998653 2334
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
..++||||+++|+|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||++++++.+||+||
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~-----~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~df 152 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRE-----RLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDF 152 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCc-----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCC
Confidence 57899999999999999975432 489999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
|++........... ......++..|+|||++.+..++.++|||||||++|||++|..|+...... ..+....
T Consensus 153 g~~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~ 224 (284)
T cd05081 153 GLTKVLPQDKEYYK-----VREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE---FMRMMGN 224 (284)
T ss_pred cccccccCCCccee-----ecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh---hhhhccc
Confidence 99987643221100 011122455699999998889999999999999999999988775432111 1111111
Q ss_pred hCC--hhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 037275 915 ALP--DKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRA 982 (992)
Q Consensus 915 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 982 (992)
... .......+. ...... . ........++.+++.+||+.+|++||||+||++.|+.+
T Consensus 225 ~~~~~~~~~~~~~~-~~~~~~------~----~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 225 DKQGQMIVYHLIEL-LKNNGR------L----PAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred ccccccchHHHHHH-HhcCCc------C----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 100 011111110 100000 0 00112235689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=332.48 Aligned_cols=245 Identities=23% Similarity=0.343 Sum_probs=191.4
Q ss_pred CCCCCccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHH---HhccCCcceeEEEEeecccccCcc
Q 037275 681 FSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQAL---RNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
|++.+.||+|+||.||+|.+..+++.||||+++... ....+.+.+|++++ +.++||||+++++++. ...
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~-----~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQ-----TED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEE-----cCC
Confidence 677899999999999999999899999999997432 23345566776665 4567999999999853 455
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
..++||||+++|+|..++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 76 ~~~lv~E~~~~~~L~~~~~~~-------~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Df 145 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIHTD-------VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADF 145 (324)
T ss_pred EEEEEEcCCCCCcHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcc
Confidence 679999999999999888642 489999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
|+++..... ........|++.|+|||++.+..++.++|||||||++|||++|+.||.+....
T Consensus 146 g~~~~~~~~--------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~---------- 207 (324)
T cd05589 146 GLCKEGMGF--------GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE---------- 207 (324)
T ss_pred cCCccCCCC--------CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH----------
Confidence 998743211 11223456899999999999999999999999999999999999999753211
Q ss_pred hCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 037275 915 ALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERM-----EMRDVVA 977 (992)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 977 (992)
+..+........ .+ ......+.+++.+||+.||++|| ++.++++
T Consensus 208 -------~~~~~i~~~~~~------~p------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 208 -------EVFDSIVNDEVR------YP------RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred -------HHHHHHHhCCCC------CC------CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 111111111000 00 01234578999999999999999 4666554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=321.82 Aligned_cols=255 Identities=27% Similarity=0.442 Sum_probs=201.0
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
.++|++.++||+|+||.||+|... ++..||+|.+... ....+.+.+|+.++++++|+||+++++++. .....+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 77 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVT-----KEEPIY 77 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEc-----CCCCcE
Confidence 357899999999999999999975 6778999987543 234567899999999999999999999854 345569
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||+++|+|.+++..... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||.+
T Consensus 78 lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~ 150 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEG----GKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLA 150 (261)
T ss_pred EEEecCCCCcHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccc
Confidence 99999999999999976432 2578889999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhhhC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFARTAL 916 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 916 (992)
........ .......++..|+|||++.+..++.++|||||||++|+|++ |+.||....... ..
T Consensus 151 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--~~------- 214 (261)
T cd05072 151 RVIEDNEY-------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD--VM------- 214 (261)
T ss_pred eecCCCce-------eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH--HH-------
Confidence 87643211 11122345678999999988889999999999999999998 999987532110 00
Q ss_pred ChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 037275 917 PDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCR 981 (992)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 981 (992)
..+. ..... ........++.+++.+|+..+|++|||++++.+.|++
T Consensus 215 -----~~~~----~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 215 -----SALQ----RGYRM----------PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred -----HHHH----cCCCC----------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0000 00000 0001123458899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=322.64 Aligned_cols=249 Identities=23% Similarity=0.305 Sum_probs=192.7
Q ss_pred cccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEEEEec
Q 037275 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYM 763 (992)
Q Consensus 687 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 763 (992)
||+|+||.||+++...+|+.||+|++.... ......+..|++++++++||||+++.+++ ......++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-----ESKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-----ecCCeEEEEEecC
Confidence 799999999999998899999999986322 12234456799999999999999999885 3456679999999
Q ss_pred cCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceecCCC
Q 037275 764 QNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSS 843 (992)
Q Consensus 764 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 843 (992)
++++|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++......
T Consensus 76 ~g~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 148 (277)
T cd05607 76 NGGDLKYHIYNVGE----RGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG 148 (277)
T ss_pred CCCCHHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCC
Confidence 99999998865432 2588999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCChhHHHH
Q 037275 844 PLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKVMEI 923 (992)
Q Consensus 844 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (992)
. ......|+..|+|||++.+..++.++||||+||++|||++|+.||....... ...+ +
T Consensus 149 ~---------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~-~~~~------------~ 206 (277)
T cd05607 149 K---------TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV-AKEE------------L 206 (277)
T ss_pred c---------eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh-hHHH------------H
Confidence 1 1122358899999999998889999999999999999999999997532211 0001 1
Q ss_pred HHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 037275 924 VDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLC 980 (992)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 980 (992)
........... .......++.+++.+||+.||++||+++|+++.+.
T Consensus 207 ~~~~~~~~~~~-----------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 207 KRRTLEDEVKF-----------EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred HHHhhcccccc-----------ccccCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 11111000000 00112345789999999999999999988765443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=324.52 Aligned_cols=253 Identities=23% Similarity=0.308 Sum_probs=198.4
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
.|++.++||+|+||+||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++. .....
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE-----TKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeec-----CCCeE
Confidence 4788899999999999999998889999999986432 122345678999999999999999999853 34567
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||+
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~ 148 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNMGN----PGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGL 148 (285)
T ss_pred EEEEeccCCCcHHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCC
Confidence 999999999999998865432 2589999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhC
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTAL 916 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 916 (992)
+....... ......|++.|+|||++.+..++.++||||+||++|||++|+.||.+..... ....
T Consensus 149 ~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~-~~~~------ 212 (285)
T cd05605 149 AVEIPEGE---------TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV-KREE------ 212 (285)
T ss_pred ceecCCCC---------ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh-HHHH------
Confidence 98654221 1123468999999999998899999999999999999999999997632210 0000
Q ss_pred ChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 037275 917 PDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERM-----EMRDVVAK 978 (992)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 978 (992)
+... ..... . .........+.+++.+||+.||++|| +++++++.
T Consensus 213 ------~~~~-~~~~~-~----------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 213 ------VERR-VKEDQ-E----------EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ------HHHH-hhhcc-c----------ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 0000 00000 0 00012244588999999999999999 88888653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=322.56 Aligned_cols=248 Identities=24% Similarity=0.333 Sum_probs=192.7
Q ss_pred cccccceEEEEeEECCCCeEEEEEEeeccCC---CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEEEEec
Q 037275 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQK---GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYM 763 (992)
Q Consensus 687 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 763 (992)
||+|+||+||+|.+..+++.||+|.+..... ...+.+..|+++++.++||||+++.+++ ......++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF-----QTKTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEE-----cCCCeEEEEEeCC
Confidence 7999999999999998999999999864322 2235567899999999999999999885 3445679999999
Q ss_pred cCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceecCCC
Q 037275 764 QNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSS 843 (992)
Q Consensus 764 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 843 (992)
++|+|.+++..... ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+......
T Consensus 76 ~~g~L~~~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 150 (280)
T cd05608 76 NGGDLRYHIYNVDE--ENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG 150 (280)
T ss_pred CCCCHHHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCC
Confidence 99999988864322 123589999999999999999999999 9999999999999999999999999999765432
Q ss_pred CCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCChhHHHH
Q 037275 844 PLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKVMEI 923 (992)
Q Consensus 844 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (992)
. .......|++.|+|||++.+..++.++|||||||++|||++|+.||........ .. ..
T Consensus 151 ~--------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~------------~~ 209 (280)
T cd05608 151 Q--------SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NK------------EL 209 (280)
T ss_pred C--------ccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh-HH------------HH
Confidence 1 112234689999999999999999999999999999999999999975322110 00 00
Q ss_pred HHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 037275 924 VDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERM-----EMRDVVA 977 (992)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 977 (992)
........ ..........+.+++.+||+.||++|| +++|+++
T Consensus 210 ~~~~~~~~------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 210 KQRILNDS------------VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred HHhhcccC------------CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 00000000 000012245688999999999999999 6777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=334.92 Aligned_cols=243 Identities=23% Similarity=0.314 Sum_probs=192.6
Q ss_pred CccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEEEE
Q 037275 685 NMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYE 761 (992)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 761 (992)
+.||+|+||.||+|++..+++.||+|++.... ......+.+|+++++.++||||+++.+++ ......++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~-----~~~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EcCCEEEEEEe
Confidence 46999999999999998899999999997432 23345678899999999999999999885 34567799999
Q ss_pred eccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCCCCCeeeCCCCcEEEeecccceec
Q 037275 762 YMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHH-HCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFL 840 (992)
Q Consensus 762 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 840 (992)
|+++|+|.+++.... .+++..+..++.|++.||+|||+ . +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 ~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~ 146 (325)
T cd05594 76 YANGGELFFHLSRER------VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG 146 (325)
T ss_pred CCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeec
Confidence 999999999887543 48999999999999999999997 7 9999999999999999999999999998753
Q ss_pred CCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCChhH
Q 037275 841 SSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKV 920 (992)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 920 (992)
... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.+.... ..
T Consensus 147 ~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~-----~~--------- 204 (325)
T cd05594 147 IKD--------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KL--------- 204 (325)
T ss_pred CCC--------CcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH-----HH---------
Confidence 221 11122346899999999999999999999999999999999999999653111 00
Q ss_pred HHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 037275 921 MEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERM-----EMRDVVAK 978 (992)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 978 (992)
.......... .+ .....++.+++.+||+.||++|+ ++.|+++.
T Consensus 205 ---~~~i~~~~~~------~p------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 205 ---FELILMEEIR------FP------RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred ---HHHHhcCCCC------CC------CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 0000000000 00 01134578999999999999997 89998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=323.22 Aligned_cols=251 Identities=31% Similarity=0.527 Sum_probs=189.9
Q ss_pred CCCccccccceEEEEeEEC----CCCeEEEEEEeeccCC-CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 683 SSNMIGQGSFGFVYKGNLG----ENGMMVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 683 ~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
+.+.||.|.||.||+|.+. ..+..|+||+++.... ...+.+.+|++.+++++||||++++|++.. ....+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~-----~~~~~ 77 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE-----NEPLF 77 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES-----SSSEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccc-----ccccc
Confidence 3578999999999999996 3468899999964333 236789999999999999999999999862 33469
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||+++|+|.+++..... ..+++..++.|+.|+++||+|||++ +++||||+++||+++.++.+||+|||++
T Consensus 78 lv~e~~~~g~L~~~L~~~~~----~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~ 150 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSKNK----EPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLS 150 (259)
T ss_dssp EEEE--TTEBHHHHHHHTCT----TTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTG
T ss_pred cccccccccccccccccccc----ccccccccccccccccccccccccc---cccccccccccccccccccccccccccc
Confidence 99999999999999997621 2589999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhhhC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFARTAL 916 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 916 (992)
........ ........+...|+|||.+.+..++.++||||||+++||+++ |+.||......
T Consensus 151 ~~~~~~~~------~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~------------ 212 (259)
T PF07714_consen 151 RPISEKSK------YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE------------ 212 (259)
T ss_dssp EETTTSSS------EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH------------
T ss_pred cccccccc------cccccccccccccccccccccccccccccccccccccccccccccccccccccc------------
Confidence 87632211 111222346789999999998899999999999999999999 78888653111
Q ss_pred ChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 037275 917 PDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKL 979 (992)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 979 (992)
++......... ... .......+.+++.+||+.||++|||+.|++++|
T Consensus 213 -----~~~~~~~~~~~-~~~----------~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 213 -----EIIEKLKQGQR-LPI----------PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -----HHHHHHHTTEE-TTS----------BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -----ccccccccccc-cee----------ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 11111100000 000 011234588999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=331.84 Aligned_cols=248 Identities=24% Similarity=0.411 Sum_probs=206.4
Q ss_pred CCCCccccccceEEEEeEECCCCeEEEEEEeec----cCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 682 SSSNMIGQGSFGFVYKGNLGENGMMVAVKVINL----KQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 682 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
+...+||+|+|-+||+|.+..+|..||--.++. +.....++|..|+.+|+.|+||||+++++++.+.. ...+.
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~---n~~in 119 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTD---NKTIN 119 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCC---Cceee
Confidence 456899999999999999998998888655432 23344578999999999999999999999876532 35678
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCC-CCcEEEeeccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQ-DLVAHLGDFGL 836 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~ 836 (992)
+|+|.+..|+|..|.++.+. ++.+.+..|++||++||.|||++ .|+|+|||||.+||||+. -|.|||+|+|+
T Consensus 120 ~iTEL~TSGtLr~Y~kk~~~------vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGL 192 (632)
T KOG0584|consen 120 FITELFTSGTLREYRKKHRR------VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGL 192 (632)
T ss_pred eeeecccCCcHHHHHHHhcc------CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhH
Confidence 99999999999999998874 78889999999999999999998 678999999999999965 58999999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhC
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTAL 916 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 916 (992)
|...... .....+|||.|||||+.. ..|++.+||||||++++||+|+..||.........+........
T Consensus 193 Atl~r~s----------~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiK 261 (632)
T KOG0584|consen 193 ATLLRKS----------HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIK 261 (632)
T ss_pred HHHhhcc----------ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCC
Confidence 9876542 223368999999999866 78999999999999999999999999876665555555555555
Q ss_pred ChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 917 PDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
|..+..+-| .++.++|.+|+.. .++|||+.|+++
T Consensus 262 P~sl~kV~d--------------------------Pevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 262 PAALSKVKD--------------------------PEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred HHHhhccCC--------------------------HHHHHHHHHHhcC-chhccCHHHHhh
Confidence 554444433 2478999999999 999999999985
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=359.50 Aligned_cols=465 Identities=28% Similarity=0.329 Sum_probs=312.6
Q ss_pred eEEEeeccccccCCccCCCCCCCCcCCeeeccCCCCCccCCccccCCCCCCEEEeecccCCCCCCcccccCCCCcEeecc
Q 037275 51 RVTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNAR 130 (992)
Q Consensus 51 ~v~~ldl~~~~l~~~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~ 130 (992)
.++.|+++.|.+-..--+.+...-+|+.|||++|++. ..|..+..+.+|+.|+++.|-|. .+|.+.+++.+|++|.|.
T Consensus 22 ~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~ 99 (1081)
T KOG0618|consen 22 ALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLK 99 (1081)
T ss_pred HHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheec
Confidence 3788888888663222234445556999999999998 89999999999999999999998 999999999999999999
Q ss_pred cccccccCChhhcccccccccccccccccCCCCCCccccccccceEEecCCcccCCcCCccCCCCcccEEeccCcccccc
Q 037275 131 RNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGI 210 (992)
Q Consensus 131 ~n~l~~~~p~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~ 210 (992)
.|.+. .+|.++. .+.+|++|+++.|++. .+|..+..+..+..+..++|.....++ ... ++.+++..|.+.+.
T Consensus 100 ~n~l~-~lP~~~~-~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg----~~~-ik~~~l~~n~l~~~ 171 (1081)
T KOG0618|consen 100 NNRLQ-SLPASIS-ELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLG----QTS-IKKLDLRLNVLGGS 171 (1081)
T ss_pred cchhh-cCchhHH-hhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhhc----ccc-chhhhhhhhhcccc
Confidence 99998 8998886 7899999999999999 899999999999999999993323333 322 88999999999988
Q ss_pred cCccccccCCCcEEeccCCccCCCCCccccccccccchhhccccccCCCCchhhhccccCceeeeccccccccccccccc
Q 037275 211 VPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRS 290 (992)
Q Consensus 211 ~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~ 290 (992)
++..+..++. .|+|++|++. .+ .+.++.+|+.|.++.|++.... -.
T Consensus 172 ~~~~i~~l~~--~ldLr~N~~~-~~---------------------------dls~~~~l~~l~c~rn~ls~l~----~~ 217 (1081)
T KOG0618|consen 172 FLIDIYNLTH--QLDLRYNEME-VL---------------------------DLSNLANLEVLHCERNQLSELE----IS 217 (1081)
T ss_pred hhcchhhhhe--eeecccchhh-hh---------------------------hhhhccchhhhhhhhcccceEE----ec
Confidence 8888887776 7999999876 11 2333444444444444444211 12
Q ss_pred cCccceEecCCCCCCCCCCCCchhhhhccCCCcceEeecCCCcCCCcCCcccccccccceeEEeeCCccccccCCCccCC
Q 037275 291 LKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNL 370 (992)
Q Consensus 291 l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l 370 (992)
.++|+.|+.++|.+.++... ..-.+|+.++++.|++++ +|.++..+. +|+.+...+|+++ .+|..+..+
T Consensus 218 g~~l~~L~a~~n~l~~~~~~--------p~p~nl~~~dis~n~l~~-lp~wi~~~~-nle~l~~n~N~l~-~lp~ri~~~ 286 (1081)
T KOG0618|consen 218 GPSLTALYADHNPLTTLDVH--------PVPLNLQYLDISHNNLSN-LPEWIGACA-NLEALNANHNRLV-ALPLRISRI 286 (1081)
T ss_pred CcchheeeeccCcceeeccc--------cccccceeeecchhhhhc-chHHHHhcc-cceEecccchhHH-hhHHHHhhh
Confidence 33455555555554432211 112345555555555553 233333332 3566666666664 455666666
Q ss_pred CcccEEEccCCcCCCCCCccccCCCCCcEEeccCccccccCCCC-CCCcc-ccCceeccCCcccCCCCCCcccccccccc
Q 037275 371 VNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTS-LGNLT-LLTNLALSSNDLQGSIPPSLGNCKNLIEL 448 (992)
Q Consensus 371 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 448 (992)
++|+.|.+.+|.+. .+|....+++.|++|+|..|+|. .+|+. |..+. .|+.|+.+.|++.....-.=..++.|+.|
T Consensus 287 ~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~L 364 (1081)
T KOG0618|consen 287 TSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQEL 364 (1081)
T ss_pred hhHHHHHhhhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHH
Confidence 67777777777776 56666666777777777777776 33432 22222 26666667777663221112234567777
Q ss_pred ccccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeecccccccCCcccccccccceeeccCCcc
Q 037275 449 HMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSF 528 (992)
Q Consensus 449 ~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l 528 (992)
++.+|.++...-+. +.....++.|+|++|++.......+.++..|++|+||+|+++ .+|..+..+..|++|...+|+|
T Consensus 365 ylanN~Ltd~c~p~-l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l 442 (1081)
T KOG0618|consen 365 YLANNHLTDSCFPV-LVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQL 442 (1081)
T ss_pred HHhcCcccccchhh-hccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCce
Confidence 77777776332222 223344556777777777444455677777777777777777 5677777777777777777777
Q ss_pred cccCCccccccCCCCEEECCCcccCCCChhhhhcCCCcceEecCCCcC
Q 037275 529 SGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHF 576 (992)
Q Consensus 529 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l 576 (992)
. ..| .+..+++|+.+|||.|+|+...-+.-..-++|++||++||..
T Consensus 443 ~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 443 L-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred e-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 7 566 677777777777777777643222222226777777777774
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=323.36 Aligned_cols=256 Identities=21% Similarity=0.324 Sum_probs=200.1
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
.++|++.+.||+|+||.||+|+...+++.||+|++..........+.+|+.++++++||||+++++++. .....+
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~-----~~~~~~ 82 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL-----SREKLW 82 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEE-----eCCEEE
Confidence 357999999999999999999998899999999997555555567889999999999999999999864 345679
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||+++++|.++++... .+++..+..++.|++.|++|||+. +|+|||++|+||+++.++.+||+|||++
T Consensus 83 iv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~ 153 (267)
T cd06646 83 ICMEYCGGGSLQDIYHVTG------PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVA 153 (267)
T ss_pred EEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccc
Confidence 9999999999999987532 478999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCccccccccccccccc---CCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGM---GGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
....... .......|+..|+|||.+. ...++.++||||+||++|||++|+.||......... ..+...
T Consensus 154 ~~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~-~~~~~~ 224 (267)
T cd06646 154 AKITATI--------AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-FLMSKS 224 (267)
T ss_pred eeecccc--------cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh-eeeecC
Confidence 8654211 1122345888999999874 345788999999999999999999998643211000 000000
Q ss_pred hCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 037275 915 ALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKL 979 (992)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 979 (992)
. ... ... .........+.+++.+||+.+|++|||++++++.+
T Consensus 225 ~----------------~~~---~~~----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 225 N----------------FQP---PKL----KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred C----------------CCC---CCC----ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0 000 000 00011234688999999999999999999998643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=328.23 Aligned_cols=274 Identities=20% Similarity=0.315 Sum_probs=199.0
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC-CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
++|.+.+.||+|+||+||+|++..+++.||+|+++... ......+.+|+.++++++||||+++++++. .....+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 80 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVH-----TDKSLT 80 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEe-----eCCeEE
Confidence 57899999999999999999998899999999987443 233456788999999999999999999864 345679
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||+++ +|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+
T Consensus 81 lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 151 (309)
T cd07872 81 LVFEYLDK-DLKQYMDDCGN-----IMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLA 151 (309)
T ss_pred EEEeCCCC-CHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccc
Confidence 99999964 89888865432 478899999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh--
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART-- 914 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~-- 914 (992)
+...... .......+++.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+ ......+.
T Consensus 152 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~ 222 (309)
T cd07872 152 RAKSVPT--------KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED-ELHLIFRLLG 222 (309)
T ss_pred eecCCCc--------cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhC
Confidence 7543221 11122357899999998765 468899999999999999999999997643221 11111111
Q ss_pred -hCChhHHHHHHhhHhHhhhccCCCCCCccc-cchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 915 -ALPDKVMEIVDSVLLLEVQASNSRSCGDER-LRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 915 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
..++.+..+............ ....... ........++.+++.+||+.||++|||++|+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 223 TPTEETWPGISSNDEFKNYNFP--KYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred CCCHHHHhhhcchhhhhhhhcC--ccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 011111111110000000000 0000000 000112345789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=336.83 Aligned_cols=255 Identities=21% Similarity=0.258 Sum_probs=198.8
Q ss_pred HhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCc
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 753 (992)
..++|++.++||+|+||.||+|++..+++.||+|++.... ......+.+|+.+++.++||||+++++++ .+.
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~-----~~~ 115 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF-----QDD 115 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----ecC
Confidence 4568999999999999999999999899999999996422 23345578899999999999999999885 345
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGD 833 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 833 (992)
...++||||+++|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~-------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~D 185 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSNY-------DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLAD 185 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEe
Confidence 6779999999999999998643 378888899999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccCC----CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHH
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG----EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLH 909 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~ 909 (992)
||.+........ .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+....
T Consensus 186 fG~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~----- 253 (370)
T cd05596 186 FGTCMKMDANGM-------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV----- 253 (370)
T ss_pred ccceeeccCCCc-------ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-----
Confidence 999986543211 112234689999999987653 4788999999999999999999999753211
Q ss_pred HHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 037275 910 EFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTE--RMEMRDVVAK 978 (992)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 978 (992)
.. ...+... ... ...+. ......++.+++.+||+.+|++ |||++|+++.
T Consensus 254 ~~--------~~~i~~~----~~~----~~~~~----~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 254 GT--------YSKIMDH----KNS----LTFPD----DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred HH--------HHHHHcC----CCc----CCCCC----cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 00 0111110 000 00000 0112356789999999999998 9999999754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=323.29 Aligned_cols=271 Identities=25% Similarity=0.369 Sum_probs=202.3
Q ss_pred CCCCCccccccceEEEEeEE----CCCCeEEEEEEeeccCC-CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 681 FSSSNMIGQGSFGFVYKGNL----GENGMMVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
|++.+.||+|+||+||++.. ..++..||+|+++.... .....+.+|++++++++||||+++++++.. .....
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~ 82 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSE---QGGKG 82 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCCce
Confidence 38899999999999988653 34678999999864432 245678899999999999999999998653 23445
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++||||+++++|.+++... .+++.+++.++.|++.||+|||++ +|+||||||+||++++++.+||+|||
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~-------~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg 152 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKH-------KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFG 152 (283)
T ss_pred EEEEecCCCCCCHHHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecc
Confidence 78999999999999999643 389999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 915 (992)
++.......... .......++..|+|||.+.+..++.++||||||+++|||++|..||...... ..+.....
T Consensus 153 ~~~~~~~~~~~~-----~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~---~~~~~~~~ 224 (283)
T cd05080 153 LAKAVPEGHEYY-----RVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK---FEEMIGPK 224 (283)
T ss_pred cccccCCcchhh-----ccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch---hhhhhccc
Confidence 998664322110 0111223567799999998888999999999999999999999998653221 11111111
Q ss_pred CCh-hHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 037275 916 LPD-KVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRAR 983 (992)
Q Consensus 916 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 983 (992)
... ......+. ..... .... ......++.+++.+||+.+|++|||+++|++.|+++.
T Consensus 225 ~~~~~~~~~~~~-~~~~~----~~~~------~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 225 QGQMTVVRLIEL-LERGM----RLPC------PKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred ccccchhhhhhh-hhcCC----CCCC------CCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 100 00011100 00000 0000 1122456899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=324.34 Aligned_cols=264 Identities=23% Similarity=0.367 Sum_probs=208.5
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCC-chhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKG-ASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
....+.++||+|-||.|.+++.. .+..||||.++..+.. ...+|.+|+++|.+++||||++++|+|.. ++.++
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~-----DePic 611 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQ-----DDPLC 611 (807)
T ss_pred hheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeec-----CCchH
Confidence 35678899999999999999985 4699999999866543 45889999999999999999999999865 34459
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+|+|||++|+|.+|+..+... ........+|+.|||.|++||.+. ++||||+.++|+|++.++++||+|||++
T Consensus 612 mI~EYmEnGDLnqFl~aheap----t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgms 684 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELP----TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMS 684 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCc----ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccc
Confidence 999999999999999987532 245566778999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh--CCCCCCCCccCCccHHHHHhhh
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT--RRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt--g~~pf~~~~~~~~~~~~~~~~~ 915 (992)
+-+...++.. .....+-+.+|||||.+.-++++.++|||+||+++||+++ .+.||....+++.
T Consensus 685 R~lysg~yy~------vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v--------- 749 (807)
T KOG1094|consen 685 RNLYSGDYYR------VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV--------- 749 (807)
T ss_pred cccccCCcee------eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH---------
Confidence 9766554322 2233456789999999999999999999999999999876 7788876544311
Q ss_pred CChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 037275 916 LPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRA 982 (992)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 982 (992)
-+....+.+..-...+ ......++.+++++|.+||+.|-++|||++++...|++.
T Consensus 750 -ven~~~~~~~~~~~~~-----------l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 750 -VENAGEFFRDQGRQVV-----------LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred -HHhhhhhcCCCCccee-----------ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1111111111000000 001122355689999999999999999999999888765
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=338.35 Aligned_cols=163 Identities=29% Similarity=0.458 Sum_probs=136.0
Q ss_pred ccCCCccCCCcccEEEccCCcCCCCCCccccCCCCCcEEeccCccccccCCCCCCCccccCceeccCCcccCCCCCCccc
Q 037275 362 IIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGN 441 (992)
Q Consensus 362 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 441 (992)
.+|.++..+.+|..+|||.|.+. .+|+.+.++.+|+.|+||+|+|+ .+.-....-.+|++|+||.|+++ .+|.+++.
T Consensus 213 N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcK 289 (1255)
T KOG0444|consen 213 NIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCK 289 (1255)
T ss_pred cCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhh
Confidence 46777888899999999999998 89999999999999999999998 55555666678999999999999 78999999
Q ss_pred cccccccccccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeecccccccCCccccccccccee
Q 037275 442 CKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQL 521 (992)
Q Consensus 442 l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 521 (992)
+++|+.|++.+|+++. . -+|..++.|.+|+.+..++|.+. .+|+.++.|..|+.|
T Consensus 290 L~kL~kLy~n~NkL~F-----------------------e-GiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL 344 (1255)
T KOG0444|consen 290 LTKLTKLYANNNKLTF-----------------------E-GIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKL 344 (1255)
T ss_pred hHHHHHHHhccCcccc-----------------------c-CCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHh
Confidence 9999999888888761 2 46777888888888888888887 788888888888888
Q ss_pred eccCCcccccCCccccccCCCCEEECCCcccC
Q 037275 522 YLQGNSFSGSIPSSLSSLKSIKELDMSSNNLS 553 (992)
Q Consensus 522 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 553 (992)
.|+.|++. .+|+++.-|+.|+.|||..|.=-
T Consensus 345 ~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnL 375 (1255)
T KOG0444|consen 345 KLDHNRLI-TLPEAIHLLPDLKVLDLRENPNL 375 (1255)
T ss_pred ccccccee-echhhhhhcCCcceeeccCCcCc
Confidence 88888877 67888888888888888887543
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=331.85 Aligned_cols=242 Identities=24% Similarity=0.301 Sum_probs=191.4
Q ss_pred CccccccceEEEEeEECCCCeEEEEEEeecc---CCCchhHHHHHHHHHHhc-cCCcceeEEEEeecccccCcceEEEEE
Q 037275 685 NMIGQGSFGFVYKGNLGENGMMVAVKVINLK---QKGASNGFVAECQALRNI-RHRNLIKIITICSSIDFKGVDFQAIVY 760 (992)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 760 (992)
++||+|+||.||+|++..+++.||+|+++.. .......+..|.+++..+ +||||+++++++. .....++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~-----~~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQ-----TKDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCeEEEEE
Confidence 4699999999999999888999999999643 223345677888888876 7999999999853 455679999
Q ss_pred EeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceec
Q 037275 761 EYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFL 840 (992)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 840 (992)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++...
T Consensus 76 E~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~ 146 (321)
T cd05591 76 EYVNGGDLMFQIQRSR------KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEG 146 (321)
T ss_pred eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceec
Confidence 9999999999987543 478899999999999999999999 9999999999999999999999999998754
Q ss_pred CCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCChhH
Q 037275 841 SSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKV 920 (992)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 920 (992)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||......
T Consensus 147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~---------------- 202 (321)
T cd05591 147 ILNG--------VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED---------------- 202 (321)
T ss_pred ccCC--------ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH----------------
Confidence 3211 1123346899999999999889999999999999999999999999753211
Q ss_pred HHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCC-------CHHHHHH
Q 037275 921 MEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERM-------EMRDVVA 977 (992)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-------s~~evl~ 977 (992)
+............ . .....++.+++.+||+.||++|| +++++++
T Consensus 203 -~~~~~i~~~~~~~--p----------~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 203 -DLFESILHDDVLY--P----------VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred -HHHHHHHcCCCCC--C----------CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 1111111110000 0 00124578999999999999999 7777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=331.00 Aligned_cols=238 Identities=26% Similarity=0.315 Sum_probs=188.7
Q ss_pred CccccccceEEEEeEECCCCeEEEEEEeecc---CCCchhHHHHHHHHHHhc-cCCcceeEEEEeecccccCcceEEEEE
Q 037275 685 NMIGQGSFGFVYKGNLGENGMMVAVKVINLK---QKGASNGFVAECQALRNI-RHRNLIKIITICSSIDFKGVDFQAIVY 760 (992)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 760 (992)
++||+|+||+||+|++..+++.||+|++... .....+.+..|..++..+ +||||+++++++ ......++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~-----~~~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF-----QTPDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE-----EcCCEEEEEE
Confidence 4799999999999999989999999998643 233445677888888876 699999999985 3456679999
Q ss_pred EeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceec
Q 037275 761 EYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFL 840 (992)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 840 (992)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 Ey~~~g~L~~~i~~~~------~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~ 146 (320)
T cd05590 76 EFVNGGDLMFHIQKSR------RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 146 (320)
T ss_pred cCCCCchHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence 9999999999987543 488999999999999999999999 9999999999999999999999999998753
Q ss_pred CCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCChhH
Q 037275 841 SSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKV 920 (992)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 920 (992)
... ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+.... +
T Consensus 147 ~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-----~---------- 203 (320)
T cd05590 147 IFN--------GKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED-----D---------- 203 (320)
T ss_pred CcC--------CCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-----H----------
Confidence 221 11123346899999999999989999999999999999999999999753211 1
Q ss_pred HHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHH
Q 037275 921 MEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMR 973 (992)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 973 (992)
+........... + .....++.+++.+||+.||++||++.
T Consensus 204 --~~~~i~~~~~~~------~------~~~~~~~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 204 --LFEAILNDEVVY------P------TWLSQDAVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred --HHHHHhcCCCCC------C------CCCCHHHHHHHHHHcccCHHHCCCCC
Confidence 111111000000 0 01134578999999999999999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=318.27 Aligned_cols=262 Identities=25% Similarity=0.378 Sum_probs=207.5
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
++|++.+.||+|+||.||+|....+|+.||+|.++... ....+.+.+|++++++++|++++++++++.. ...
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~-----~~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE-----NNE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec-----CCe
Confidence 57999999999999999999998899999999886322 2335678899999999999999999998643 456
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++||||+++|+|.+++...... ...+++.+++.++.|++.||+|||+. +|+||||+|+||+++.++.++|+|||
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~ 151 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQ--KRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLG 151 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhccc--CCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccc
Confidence 69999999999999998754321 23588999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 915 (992)
.+....... .......++..|+|||.+.+..++.++|||||||++|+|++|+.||...... ..
T Consensus 152 ~~~~~~~~~--------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~------ 214 (267)
T cd08224 152 LGRFFSSKT--------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LY------ 214 (267)
T ss_pred eeeeccCCC--------cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc---HH------
Confidence 987654321 1112235788999999998888999999999999999999999998643211 11
Q ss_pred CChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 037275 916 LPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRAR 983 (992)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 983 (992)
+..+........ ..........+.+++.+||..+|++|||+.+|++.|++++
T Consensus 215 ------~~~~~~~~~~~~----------~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 215 ------SLCKKIEKCDYP----------PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ------HHHhhhhcCCCC----------CCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 111111000000 0001123446889999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=308.56 Aligned_cols=259 Identities=25% Similarity=0.333 Sum_probs=207.0
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
++|+..+.||+|.-|+||+++...++..+|+|++.... .....+.+.|-+||+.++||.++.+++. ++...+
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~-----fet~~~ 151 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYAS-----FETDKY 151 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhe-----eeccce
Confidence 35677889999999999999999889999999997543 3344667889999999999999999998 556677
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.|+|||||+||+|....+++... .+++..+..++..++-||+|||-. |||.|||||+||||.++|++.|+||.
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp~~----~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFD 224 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQPGK----RFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFD 224 (459)
T ss_pred eEEEEecCCCccHHHHHhhCCCC----ccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeecc
Confidence 79999999999999999877643 799999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCC-------------------------------C-----------------CcccCCCCCccccccccccc
Q 037275 836 LAKFLSSSPLD-------------------------------T-----------------AVETPSSSKGIKGTVGYIAP 867 (992)
Q Consensus 836 ~a~~~~~~~~~-------------------------------~-----------------~~~~~~~~~~~~gt~~y~aP 867 (992)
++......+.. . ..........++||-.|.||
T Consensus 225 LS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAP 304 (459)
T KOG0610|consen 225 LSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAP 304 (459)
T ss_pred ccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccc
Confidence 98654221100 0 00111234557899999999
Q ss_pred ccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccch
Q 037275 868 EYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRT 947 (992)
Q Consensus 868 E~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 947 (992)
|++.|..-+.++|-|+||+++|||+.|..||.+....+. +..++.+.+ ..+ ..
T Consensus 305 EvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T-------------l~NIv~~~l----------~Fp----~~ 357 (459)
T KOG0610|consen 305 EVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET-------------LRNIVGQPL----------KFP----EE 357 (459)
T ss_pred eeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh-------------HHHHhcCCC----------cCC----CC
Confidence 999999999999999999999999999999998644421 111111100 000 01
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCC----HHHHH
Q 037275 948 EERLVAVVETGVVCSMESPTERME----MRDVV 976 (992)
Q Consensus 948 ~~~~~~l~~li~~cl~~dP~~RPs----~~evl 976 (992)
.+....+.++|++.|.+||++|.. |.||-
T Consensus 358 ~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 358 PEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK 390 (459)
T ss_pred CcchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence 123456899999999999999998 77664
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=319.44 Aligned_cols=257 Identities=27% Similarity=0.427 Sum_probs=201.8
Q ss_pred cCCCCCCccccccceEEEEeEECCC---CeEEEEEEeeccCC-CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcc
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGEN---GMMVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
++|++.+.||+|+||+||+|.+... ...||+|+++.... .....+.+|+.++++++||||+++++++. ...
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 78 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVT-----KSR 78 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEe-----cCC
Confidence 5789999999999999999998533 46899999864432 23457889999999999999999999853 345
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
..++||||+++++|.+++..... .+++..++.++.|++.|++|||++ +|+||||||+||++++++.++|+||
T Consensus 79 ~~~iv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~df 150 (266)
T cd05033 79 PVMIITEYMENGSLDKFLRENDG-----KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDF 150 (266)
T ss_pred ceEEEEEcCCCCCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECcc
Confidence 56999999999999999976442 489999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 913 (992)
|+++....... ........++..|+|||.+.+..++.++||||||+++|++++ |..||......
T Consensus 151 g~~~~~~~~~~------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--------- 215 (266)
T cd05033 151 GLSRRLEDSEA------TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--------- 215 (266)
T ss_pred chhhccccccc------ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---------
Confidence 99987652111 111112235678999999998899999999999999999998 99998653211
Q ss_pred hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 037275 914 TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRA 982 (992)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 982 (992)
+..+.... ..... ........+.+++.+||+.+|++||+++||++.|+++
T Consensus 216 --------~~~~~~~~-~~~~~----------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 216 --------DVIKAVED-GYRLP----------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred --------HHHHHHHc-CCCCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01111000 00000 0011234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=323.12 Aligned_cols=263 Identities=22% Similarity=0.379 Sum_probs=200.5
Q ss_pred HhcCCCCCCccccccceEEEEeEEC-----CCCeEEEEEEeeccCC-CchhHHHHHHHHHHhccCCcceeEEEEeecccc
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLG-----ENGMMVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIITICSSIDF 750 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 750 (992)
..++|++.+.||+|+||.||+|.+. .++..||+|++..... ....++.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~---- 79 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS---- 79 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc----
Confidence 4568999999999999999999864 2457899999853322 23456889999999999999999999863
Q ss_pred cCcceEEEEEEeccCCCHHHHHhhcccch----hhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCC
Q 037275 751 KGVDFQAIVYEYMQNGSLEDWLHQSEDQQ----EARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQD 826 (992)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 826 (992)
.....++||||+++|+|.+++....... ....+++..+..++.|++.||+|||+. +++||||||+||+++++
T Consensus 80 -~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~ 155 (277)
T cd05062 80 -QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 155 (277)
T ss_pred -CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCC
Confidence 3456699999999999999997643211 123467889999999999999999999 99999999999999999
Q ss_pred CcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCC
Q 037275 827 LVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQG 905 (992)
Q Consensus 827 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~ 905 (992)
+.++|+|||+++......... ......+++.|+|||++.+..++.++|||||||++|||++ |..||.+...+
T Consensus 156 ~~~~l~dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~- 228 (277)
T cd05062 156 FTVKIGDFGMTRDIYETDYYR------KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE- 228 (277)
T ss_pred CCEEECCCCCccccCCcceee------cCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-
Confidence 999999999987654322110 1111245788999999998899999999999999999999 78888653211
Q ss_pred ccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 037275 906 LTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCR 981 (992)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 981 (992)
+.. +.+ ..... .... ......+.+++.+||+.||++|||+.|+++.|++
T Consensus 229 ----~~~---------~~~---~~~~~-----~~~~------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 229 ----QVL---------RFV---MEGGL-----LDKP------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred ----HHH---------HHH---HcCCc-----CCCC------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 110 000 00000 0000 1123458999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=333.84 Aligned_cols=208 Identities=26% Similarity=0.341 Sum_probs=174.9
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
++|++.+.||+|+||+||+|+...+++.||+|+++... ......+.+|+.++++++||+|+++++++. +...
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~-----~~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQ-----DKLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cCCe
Confidence 47899999999999999999999899999999996432 223456788999999999999999999853 4556
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFG 146 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMKKD------TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFG 146 (363)
T ss_pred EEEEEcCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeecc
Confidence 799999999999999997643 489999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCc---------------------------ccCCCCCcccccccccccccccCCCcCcccchhhHHHHH
Q 037275 836 LAKFLSSSPLDTAV---------------------------ETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILL 888 (992)
Q Consensus 836 ~a~~~~~~~~~~~~---------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 888 (992)
+++........... .........+||+.|+|||++.+..++.++|||||||++
T Consensus 147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil 226 (363)
T cd05628 147 LCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226 (363)
T ss_pred CcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHH
Confidence 99765422110000 000011245799999999999999999999999999999
Q ss_pred HHHHhCCCCCCC
Q 037275 889 LEMFTRRRPTDG 900 (992)
Q Consensus 889 ~elltg~~pf~~ 900 (992)
|||++|+.||.+
T Consensus 227 ~ell~G~~Pf~~ 238 (363)
T cd05628 227 YEMLIGYPPFCS 238 (363)
T ss_pred HHHHhCCCCCCC
Confidence 999999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=335.25 Aligned_cols=257 Identities=26% Similarity=0.411 Sum_probs=209.4
Q ss_pred CCCCCccccccceEEEEeEECCCCe----EEEEEEeecc-CCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 681 FSSSNMIGQGSFGFVYKGNLGENGM----MVAVKVINLK-QKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
.+..++||+|+||+||+|.+...|+ +||+|++... ......++.+|+.+|.+++|||+++++|+|....
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~------ 771 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST------ 771 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch------
Confidence 3456799999999999999966554 6899988533 4455788999999999999999999999986533
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
..||++|++.|+|.+|++.++.. +.....+.|..|||+||.|||++ ++|||||..+||||.+...+||.|||
T Consensus 772 ~qlvtq~mP~G~LlDyvr~hr~~-----igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfg 843 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREHRDN-----IGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFG 843 (1177)
T ss_pred HHHHHHhcccchHHHHHHHhhcc-----ccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecc
Confidence 47999999999999999987764 88899999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhh
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~ 914 (992)
+|+....+... .......-.+.|||=|.+....|+.++|||||||++||++| |..|+++...+
T Consensus 844 la~ll~~d~~e------y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~---------- 907 (1177)
T KOG1025|consen 844 LAKLLAPDEKE------YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE---------- 907 (1177)
T ss_pred hhhccCccccc------ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH----------
Confidence 99988765422 22223345788999999999999999999999999999999 99999875332
Q ss_pred hCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 037275 915 ALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDT 985 (992)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 985 (992)
++.+.+.. ++. -..+ .-+..++..++.+||..|+..||+++++.+++.+..++
T Consensus 908 ----eI~dlle~---geR-LsqP----------piCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 908 ----EIPDLLEK---GER-LSQP----------PICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred ----HhhHHHhc---ccc-CCCC----------CCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 12222211 111 1111 22355689999999999999999999999999887554
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=328.41 Aligned_cols=241 Identities=24% Similarity=0.331 Sum_probs=187.9
Q ss_pred CccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhc-cCCcceeEEEEeecccccCcceEEEEE
Q 037275 685 NMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNI-RHRNLIKIITICSSIDFKGVDFQAIVY 760 (992)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 760 (992)
++||+|+||+||+|++..+++.||+|+++... ....+.+..|..++... +||||+++++++. .....++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~-----~~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQ-----TKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCEEEEEE
Confidence 47999999999999999899999999997432 23344556677777654 8999999999853 455679999
Q ss_pred EeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceec
Q 037275 761 EYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFL 840 (992)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 840 (992)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 e~~~gg~L~~~~~~~~------~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~ 146 (316)
T cd05592 76 EYLNGGDLMFHIQSSG------RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKEN 146 (316)
T ss_pred cCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeEC
Confidence 9999999999987543 488999999999999999999999 9999999999999999999999999999754
Q ss_pred CCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCChhH
Q 037275 841 SSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKV 920 (992)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 920 (992)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.... +
T Consensus 147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~-----~---------- 203 (316)
T cd05592 147 MNGE--------GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED-----E---------- 203 (316)
T ss_pred CCCC--------CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH-----H----------
Confidence 3211 1223356899999999999999999999999999999999999999763211 1
Q ss_pred HHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 037275 921 MEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMR-DVV 976 (992)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl 976 (992)
.......... ..+ .....++.+++.+||+.||++||++. +++
T Consensus 204 --~~~~i~~~~~------~~~------~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 204 --LFDSILNDRP------HFP------RWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred --HHHHHHcCCC------CCC------CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1111000000 000 01134578899999999999999975 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=335.69 Aligned_cols=258 Identities=20% Similarity=0.251 Sum_probs=198.0
Q ss_pred HHHHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc---CCCchhHHHHHHHHHHhccCCcceeEEEEeecccc
Q 037275 674 LSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK---QKGASNGFVAECQALRNIRHRNLIKIITICSSIDF 750 (992)
Q Consensus 674 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 750 (992)
+....++|++.++||+|+||.||+|++..+++.||+|++... .......+.+|+.+++.++||||+++++++
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~----- 112 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF----- 112 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----
Confidence 334457899999999999999999999989999999998632 222345678899999999999999999985
Q ss_pred cCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEE
Q 037275 751 KGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAH 830 (992)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 830 (992)
.+....++||||+++|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+||++++++.+|
T Consensus 113 ~~~~~~~lv~Ey~~gg~L~~~l~~~-------~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~k 182 (370)
T cd05621 113 QDDKYLYMVMEYMPGGDLVNLMSNY-------DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLK 182 (370)
T ss_pred EcCCEEEEEEcCCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEE
Confidence 3456789999999999999999643 378889999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCCCCCcccCCCCCcccccccccccccccCC----CcCcccchhhHHHHHHHHHhCCCCCCCCccCCc
Q 037275 831 LGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG----EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGL 906 (992)
Q Consensus 831 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~ 906 (992)
|+|||+|........ .......||+.|+|||++.+. .++.++||||+||++|||++|+.||.+....
T Consensus 183 L~DFG~a~~~~~~~~-------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~-- 253 (370)
T cd05621 183 LADFGTCMKMDETGM-------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV-- 253 (370)
T ss_pred EEecccceecccCCc-------eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH--
Confidence 999999987643211 112345699999999998654 3788999999999999999999999753211
Q ss_pred cHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 037275 907 TLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTE--RMEMRDVVAK 978 (992)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 978 (992)
. ....+.+... .. .. +........+.+++..|+..+|.+ |||++|+++.
T Consensus 254 ---~--------~~~~i~~~~~--~~------~~----p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 254 ---G--------TYSKIMDHKN--SL------NF----PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ---H--------HHHHHHhCCc--cc------CC----CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0 0111111000 00 00 001122345778888899755544 8999999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=350.46 Aligned_cols=272 Identities=24% Similarity=0.319 Sum_probs=204.4
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC---CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK---GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
++|++.++||+|+||.||+|++..+++.||+|+++.... ...+++.+|++++++++||||+++++++. +.+.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~-----d~~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS-----DGDP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe-----eCCE
Confidence 589999999999999999999998999999999864322 22457889999999999999999999864 3456
Q ss_pred EEEEEEeccCCCHHHHHhhcccc-----hhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEE
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQ-----QEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAH 830 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~-----~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 830 (992)
.++||||+++|+|.+++...... ......++..++.++.|+++||+|||++ +|+||||||+||+++.++.+|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vK 153 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVV 153 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEE
Confidence 79999999999999999753211 1123467788899999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCCCCC----------cccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCC
Q 037275 831 LGDFGLAKFLSSSPLDTA----------VETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDG 900 (992)
Q Consensus 831 l~Dfg~a~~~~~~~~~~~----------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 900 (992)
|+|||+++.......... ...........||+.|+|||++.+..++.++||||+||++|||+||+.||..
T Consensus 154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 999999987632110000 0001112235699999999999999999999999999999999999999975
Q ss_pred CccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHH
Q 037275 901 MFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERM-EMRDVVAKL 979 (992)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L 979 (992)
........ ..... ++. ......+.+..+.+++.+|++.||++|| +++++++.|
T Consensus 234 ~~~~ki~~----~~~i~-------~P~---------------~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~L 287 (932)
T PRK13184 234 KKGRKISY----RDVIL-------SPI---------------EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDL 287 (932)
T ss_pred cchhhhhh----hhhcc-------Chh---------------hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 22111000 00000 000 0000012234578899999999999996 566677777
Q ss_pred HHHHH
Q 037275 980 CRARD 984 (992)
Q Consensus 980 ~~~~~ 984 (992)
+....
T Consensus 288 e~~lq 292 (932)
T PRK13184 288 EPHLQ 292 (932)
T ss_pred HHHHh
Confidence 66543
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=335.47 Aligned_cols=281 Identities=20% Similarity=0.245 Sum_probs=200.8
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeecc--CCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK--QKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
+|++.++||+|+||+||+|.+..+++.||+|.+... .....+.+.+|+.+++.++||||+++++++...+.......+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999999889999999998533 222346788999999999999999999997654333334679
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||+. ++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 81 lv~e~~~-~~l~~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a 150 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ------PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLA 150 (372)
T ss_pred EEeeccc-cCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccce
Confidence 9999996 58888876432 489999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTAL 916 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 916 (992)
+...... ........+++.|+|||++.+. .++.++||||+||++|||++|+.||.+.... ..+........
T Consensus 151 ~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~g 222 (372)
T cd07853 151 RVEEPDE-------SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI-QQLDLITDLLG 222 (372)
T ss_pred eecccCc-------cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHHcC
Confidence 8654321 1112234578999999998774 5789999999999999999999999764321 11111111100
Q ss_pred ---ChhHHHHHHhhHhHhhhccCCCCCCcc-ccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 917 ---PDKVMEIVDSVLLLEVQASNSRSCGDE-RLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 917 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
.+............-............ .....+...++.+++.+||+.||++|||++|+++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 223 TPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred CCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 011111100000000000000000000 00001124568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=324.31 Aligned_cols=265 Identities=26% Similarity=0.443 Sum_probs=206.5
Q ss_pred cCCCCCCccccccceEEEEeEEC-----CCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCc
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLG-----ENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 753 (992)
.+|.+.+.||+|+||.||+|+.. .++..+++|.+........+.+.+|++++++++||||+++++++. ..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 79 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCG-----DG 79 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEc-----cC
Confidence 46888899999999999999853 245679999986554444567899999999999999999999864 34
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccc----------hhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQ----------QEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLL 823 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 823 (992)
...++||||+++++|.+++...... .....+++..++.++.|++.|++|||++ +|+||||||+||++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~ 156 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLV 156 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEE
Confidence 5579999999999999999764321 0123488999999999999999999999 99999999999999
Q ss_pred CCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCc
Q 037275 824 DQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMF 902 (992)
Q Consensus 824 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~ 902 (992)
+.++.++|+|||++........ ........++..|+|||++.+..++.++|||||||++|||+| |+.||....
T Consensus 157 ~~~~~~~l~dfg~a~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 230 (291)
T cd05094 157 GANLLVKIGDFGMSRDVYSTDY------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS 230 (291)
T ss_pred ccCCcEEECCCCcccccCCCce------eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999976543211 111223446788999999999999999999999999999999 999986532
Q ss_pred cCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 037275 903 NQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRA 982 (992)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 982 (992)
.. +.++......... .....+..+.+++.+||+.||++|||+++|++.|+++
T Consensus 231 ~~-----------------~~~~~~~~~~~~~-----------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~ 282 (291)
T cd05094 231 NT-----------------EVIECITQGRVLE-----------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282 (291)
T ss_pred HH-----------------HHHHHHhCCCCCC-----------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 11 0111110000000 0011234688999999999999999999999999998
Q ss_pred HHh
Q 037275 983 RDT 985 (992)
Q Consensus 983 ~~~ 985 (992)
...
T Consensus 283 ~~~ 285 (291)
T cd05094 283 GKA 285 (291)
T ss_pred Hhh
Confidence 664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=322.51 Aligned_cols=259 Identities=22% Similarity=0.342 Sum_probs=202.3
Q ss_pred HHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhc-cCCcceeEEEEeecccccC-c
Q 037275 676 KATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNI-RHRNLIKIITICSSIDFKG-V 753 (992)
Q Consensus 676 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~-~ 753 (992)
.+.+.|++.+.||+|+||.||+|....+++.||+|++.... .....+.+|+.+++++ +||||+++++++......+ .
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45678999999999999999999999899999999986443 3456788999999998 7999999999986543322 3
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGD 833 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 833 (992)
...++||||+++++|.+++..... ..+++..+..++.|++.|++|||++ +|+||||||+||++++++.+||+|
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~D 154 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKG----NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVD 154 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEcc
Confidence 567899999999999999986432 2588999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCCCcccCCCCCccccccccccccccc-----CCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccH
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGM-----GGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTL 908 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~ 908 (992)
||++....... .......|+..|+|||++. +..++.++||||+||++|||++|+.||.......
T Consensus 155 fg~~~~~~~~~--------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~--- 223 (272)
T cd06637 155 FGVSAQLDRTV--------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR--- 223 (272)
T ss_pred CCCceeccccc--------ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH---
Confidence 99998653211 1223356889999999876 3467889999999999999999999986431110
Q ss_pred HHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 909 HEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
... ... .. ..+. ........++.+++.+||..+|.+|||++|+++
T Consensus 224 -~~~---------~~~------~~---~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 224 -ALF---------LIP------RN---PAPR-----LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred -HHH---------HHh------cC---CCCC-----CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 000 000 00 0000 000112345889999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=336.49 Aligned_cols=260 Identities=23% Similarity=0.322 Sum_probs=202.6
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
++|++.+.||+|+||+||+|++..+++.||+|+++... ......+.+|+++++.++||||+++++++ .+...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF-----QDEEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe-----ecCCe
Confidence 47899999999999999999999899999999997432 23456788999999999999999999885 44567
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg 146 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIRKD------VFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFG 146 (350)
T ss_pred EEEEEcCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCC
Confidence 799999999999999998652 488999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCC---------------------cccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhC
Q 037275 836 LAKFLSSSPLDTA---------------------VETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTR 894 (992)
Q Consensus 836 ~a~~~~~~~~~~~---------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg 894 (992)
++........... ...........||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g 226 (350)
T cd05573 147 LCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226 (350)
T ss_pred CCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccC
Confidence 9986654320000 0001122345689999999999999999999999999999999999
Q ss_pred CCCCCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCC-HH
Q 037275 895 RRPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERME-MR 973 (992)
Q Consensus 895 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~ 973 (992)
+.||...... +. ...+.... .... .+. ......++.+++.+|+. ||++||+ ++
T Consensus 227 ~~Pf~~~~~~-----~~--------~~~i~~~~--~~~~------~p~----~~~~~~~~~~li~~ll~-dp~~R~~s~~ 280 (350)
T cd05573 227 FPPFYSDTLQ-----ET--------YNKIINWK--ESLR------FPP----DPPVSPEAIDLICRLLC-DPEDRLGSFE 280 (350)
T ss_pred CCCCCCCCHH-----HH--------HHHHhccC--Cccc------CCC----CCCCCHHHHHHHHHHcc-ChhhcCCCHH
Confidence 9999763211 00 00111000 0000 000 00124568889999997 9999999 99
Q ss_pred HHHHH
Q 037275 974 DVVAK 978 (992)
Q Consensus 974 evl~~ 978 (992)
|+++.
T Consensus 281 ~ll~h 285 (350)
T cd05573 281 EIKSH 285 (350)
T ss_pred HHhcC
Confidence 99864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=324.62 Aligned_cols=251 Identities=24% Similarity=0.321 Sum_probs=201.3
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
..+|++.+.||+|+||.||+|.+..+++.||+|.+..........+.+|+.+++.++|||++++++++.. ....+
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~-----~~~~~ 93 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELW 93 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEe-----CCEEE
Confidence 3578999999999999999999988999999999976655556778999999999999999999998643 45679
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||+++++|.+++... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+
T Consensus 94 lv~e~~~~~~L~~~~~~~-------~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~ 163 (296)
T cd06654 94 VVMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC 163 (296)
T ss_pred EeecccCCCCHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccc
Confidence 999999999999998643 378889999999999999999999 9999999999999999999999999998
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALP 917 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 917 (992)
....... .......+++.|+|||.+.+..++.++|||||||++|+|++|+.||........ .........+
T Consensus 164 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-~~~~~~~~~~ 234 (296)
T cd06654 164 AQITPEQ--------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGTP 234 (296)
T ss_pred hhccccc--------cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh-HHHHhcCCCC
Confidence 7643221 111223588899999999888899999999999999999999999965321110 0000000000
Q ss_pred hhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 918 DKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
. ..........+.+++.+||..||++|||++|+++
T Consensus 235 ---------------------~----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 235 ---------------------E----LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred ---------------------C----CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 0 0001122345889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=328.91 Aligned_cols=243 Identities=22% Similarity=0.320 Sum_probs=190.9
Q ss_pred CCccccccceEEEEeEEC---CCCeEEEEEEeeccC----CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 684 SNMIGQGSFGFVYKGNLG---ENGMMVAVKVINLKQ----KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 684 ~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
.++||+|+||.||+|+.. .+++.||+|+++... ......+.+|+.+++.++||||+++++++. .....
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~-----~~~~~ 75 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQ-----TGGKL 75 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEe-----cCCeE
Confidence 368999999999999863 468899999986432 223455788999999999999999999854 34567
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
++||||+++|+|.+++.... .+.+..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 146 (323)
T cd05584 76 YLILEYLSGGELFMHLEREG------IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGL 146 (323)
T ss_pred EEEEeCCCCchHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcC
Confidence 99999999999999997543 478888899999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhC
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTAL 916 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 916 (992)
++...... .......|++.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 147 ~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~------------ 206 (323)
T cd05584 147 CKESIHEG--------TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK------------ 206 (323)
T ss_pred CeecccCC--------CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH------------
Confidence 87543211 1122346899999999999888999999999999999999999999753211
Q ss_pred ChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 037275 917 PDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERM-----EMRDVVA 977 (992)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 977 (992)
............ .+ .....++.+++.+||+.||++|| +++++++
T Consensus 207 -----~~~~~~~~~~~~------~~------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 207 -----KTIDKILKGKLN------LP------PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred -----HHHHHHHcCCCC------CC------CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 111111111000 00 01134578999999999999999 7888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=333.55 Aligned_cols=281 Identities=17% Similarity=0.211 Sum_probs=202.1
Q ss_pred HHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC--CCchhHHHHHHHHHHhccCCcceeEEEEeeccc-ccC
Q 037275 676 KATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHRNLIKIITICSSID-FKG 752 (992)
Q Consensus 676 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~ 752 (992)
...++|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++.... ...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 34578999999999999999999998889999999986432 223456788999999999999999999875432 223
Q ss_pred cceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEe
Q 037275 753 VDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLG 832 (992)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 832 (992)
....++||||+++ ++.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~--------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~ 161 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL 161 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEe
Confidence 3467999999965 67776642 378888999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHH
Q 037275 833 DFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFA 912 (992)
Q Consensus 833 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~ 912 (992)
|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..... ......
T Consensus 162 Dfg~~~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~ 231 (355)
T cd07874 162 DFGLARTAGTSF---------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVI 231 (355)
T ss_pred eCcccccCCCcc---------ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH
Confidence 999998653221 1223468999999999999899999999999999999999999997632111 111111
Q ss_pred hhhC--ChhHHHHHHhhHhHhhhccC-------CCCC-----CccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 913 RTAL--PDKVMEIVDSVLLLEVQASN-------SRSC-----GDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 913 ~~~~--~~~~~~~~~~~~~~~~~~~~-------~~~~-----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
.... .........+.......... .... ............++.+++.+||+.||++|||+.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 232 EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 1100 00011101000000000000 0000 00000111123567899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=330.68 Aligned_cols=242 Identities=24% Similarity=0.316 Sum_probs=190.5
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeecc---CCCchhHHHHHHHHHHhccCC-cceeEEEEeecccccCcce
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK---QKGASNGFVAECQALRNIRHR-NLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~~~~ 755 (992)
+|++.+.||+|+||.||+|+...+++.||+|++... .....+.+..|.+++..+.|+ +|+++.+++ ...+.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTMDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEE-----EcCCE
Confidence 578899999999999999999988999999999743 233456678899999999765 577777774 34556
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg 146 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQVG------KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFG 146 (324)
T ss_pred EEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecC
Confidence 799999999999999987543 478899999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 915 (992)
++...... ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+.... +
T Consensus 147 ~~~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-----~----- 208 (324)
T cd05587 147 MCKENIFG--------GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-----E----- 208 (324)
T ss_pred cceecCCC--------CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-----H-----
Confidence 98743211 11123346899999999999999999999999999999999999999753211 0
Q ss_pred CChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCH
Q 037275 916 LPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEM 972 (992)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 972 (992)
.......... ..+ .....++.+++.+||..||++|+++
T Consensus 209 -------~~~~i~~~~~------~~~------~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 209 -------LFQSIMEHNV------SYP------KSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred -------HHHHHHcCCC------CCC------CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 0110000000 000 0113457899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=320.77 Aligned_cols=262 Identities=25% Similarity=0.363 Sum_probs=206.3
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
++|++.+.||+|+||.||+|....+++.||||.+.... .....++.+|+.+++.++||||+++++++. ....
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI-----EDNE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE-----eCCe
Confidence 47888999999999999999998899999999886432 223457889999999999999999999864 3456
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++||||+++++|.+++...... ...+++..++.++.|++.||+|||++ +++|+||||+||+++.++.++|+|||
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg 151 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKKQ--KRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLG 151 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcch
Confidence 79999999999999998753321 23589999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 915 (992)
.+....... .......++..|+|||++.+..++.++||||||+++|+|++|..||.+..... ..
T Consensus 152 ~~~~~~~~~--------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~----- 215 (267)
T cd08229 152 LGRFFSSKT--------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL---YS----- 215 (267)
T ss_pred hhhccccCC--------cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH---HH-----
Confidence 987654321 11123457889999999988889999999999999999999999986532110 00
Q ss_pred CChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 037275 916 LPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRAR 983 (992)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 983 (992)
.........+. .........++.+++.+||+.||++|||+.+|++.++++.
T Consensus 216 -------~~~~~~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 216 -------LCKKIEQCDYP----------PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred -------HhhhhhcCCCC----------CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 00000000000 0001123456889999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=316.76 Aligned_cols=249 Identities=28% Similarity=0.408 Sum_probs=194.4
Q ss_pred CccccccceEEEEeEECCCCeEEEEEEeeccC-CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEEEEec
Q 037275 685 NMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYM 763 (992)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 763 (992)
+.||+|+||.||+|++..+++.||+|.+.... ......+.+|++++++++||||+++++++.. ....++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-----KQPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----CCCeEEEEeec
Confidence 47999999999999998899999999875332 2234678999999999999999999998643 44569999999
Q ss_pred cCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceecCCC
Q 037275 764 QNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSS 843 (992)
Q Consensus 764 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 843 (992)
++++|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+......
T Consensus 76 ~~~~L~~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 147 (252)
T cd05084 76 QGGDFLTFLRTEGP-----RLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDG 147 (252)
T ss_pred cCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccc
Confidence 99999999975432 478999999999999999999999 9999999999999999999999999998754322
Q ss_pred CCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhhhCChhHHH
Q 037275 844 PLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFARTALPDKVME 922 (992)
Q Consensus 844 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 922 (992)
... .......++..|+|||.+.++.++.++|||||||++|||++ |..||...... ....
T Consensus 148 ~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--------------~~~~ 207 (252)
T cd05084 148 VYA------STGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--------------QTRE 207 (252)
T ss_pred ccc------ccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--------------HHHH
Confidence 110 00111223567999999988899999999999999999998 88888643111 0111
Q ss_pred HHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 037275 923 IVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLC 980 (992)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 980 (992)
.+.... .... .......+.+++.+||+.+|++|||+.||+++|+
T Consensus 208 ~~~~~~--------~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 208 AIEQGV--------RLPC------PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHcCC--------CCCC------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 111000 0000 0112446889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=338.14 Aligned_cols=208 Identities=23% Similarity=0.321 Sum_probs=173.0
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
++|++.++||+|+||+||+|+...+++.||||++.... ......+.+|++++++++||||+++++++. +...
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~-----~~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ-----DAQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE-----cCCe
Confidence 47899999999999999999999999999999986432 223456788999999999999999999854 4567
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfG 146 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIKYD------TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFG 146 (377)
T ss_pred eEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecc
Confidence 799999999999999997543 478889999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCC--------Cccc-------------------------------CCCCCcccccccccccccccCCCcC
Q 037275 836 LAKFLSSSPLDT--------AVET-------------------------------PSSSKGIKGTVGYIAPEYGMGGEAS 876 (992)
Q Consensus 836 ~a~~~~~~~~~~--------~~~~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~ 876 (992)
+++.+....... .... ........||+.|+|||++.+..++
T Consensus 147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 226 (377)
T cd05629 147 LSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG 226 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCC
Confidence 996432210000 0000 0001124699999999999999999
Q ss_pred cccchhhHHHHHHHHHhCCCCCCC
Q 037275 877 MTGDVYSFGILLLEMFTRRRPTDG 900 (992)
Q Consensus 877 ~~~DiwSlG~il~elltg~~pf~~ 900 (992)
.++|||||||++|||++|+.||.+
T Consensus 227 ~~~DiwSlGvil~elltG~~Pf~~ 250 (377)
T cd05629 227 QECDWWSLGAIMFECLIGWPPFCS 250 (377)
T ss_pred CceeeEecchhhhhhhcCCCCCCC
Confidence 999999999999999999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=317.08 Aligned_cols=255 Identities=31% Similarity=0.473 Sum_probs=201.8
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
.++|++.+.||+|+||.||+|.+. +++.||+|.++... ...+.+.+|+.++++++||||+++++++. .....+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 77 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCT-----LEEPIY 77 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEe-----cCCCee
Confidence 457899999999999999999975 56789999986433 34567889999999999999999999854 344569
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||+++++|.+++.... ...+++..+..++.|++.|+.|||+. +|+||||||+||++++++.+||+|||++
T Consensus 78 lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~ 150 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGA----GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLA 150 (261)
T ss_pred eeeecccCCcHHHHHhccC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceE
Confidence 9999999999999997643 23589999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhhhC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFARTAL 916 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 916 (992)
........ ....+...+..|+|||++.+..++.++||||||+++|||++ |+.||.+....
T Consensus 151 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------------ 211 (261)
T cd05068 151 RVIKEDIY-------EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA------------ 211 (261)
T ss_pred EEccCCcc-------cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH------------
Confidence 87653211 11112234568999999998899999999999999999999 99998753211
Q ss_pred ChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 037275 917 PDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCR 981 (992)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 981 (992)
.....+.. .... . ........+.+++.+|++.+|++||+++++++.|+.
T Consensus 212 --~~~~~~~~----~~~~----~------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 212 --EVLQQVDQ----GYRM----P------CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred --HHHHHHHc----CCCC----C------CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 00011110 0000 0 001123568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=332.72 Aligned_cols=280 Identities=18% Similarity=0.206 Sum_probs=203.3
Q ss_pred HhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc--CCCchhHHHHHHHHHHhccCCcceeEEEEeeccc-ccCc
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK--QKGASNGFVAECQALRNIRHRNLIKIITICSSID-FKGV 753 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~ 753 (992)
..++|++.+.||+|+||.||+|.+..+++.||||++... .......+.+|+.+++.++||||+++++++.... ....
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 456899999999999999999999889999999998643 2233456789999999999999999999865422 2334
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGD 833 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 833 (992)
...++||||+++ ++.+++.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~D 169 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 169 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh--------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEe
Confidence 567999999964 77777742 378888999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 913 (992)
||+++...... ......+|+.|+|||++.+..++.++|||||||++|||++|+.||.+..... .......
T Consensus 170 fG~a~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~~~~ 239 (364)
T cd07875 170 FGLARTAGTSF---------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIE 239 (364)
T ss_pred CCCccccCCCC---------cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH
Confidence 99997654321 1223468999999999999999999999999999999999999997643211 1111111
Q ss_pred hhC--ChhHHHHHHhhHhHhhhccCC-CC-----------CCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 914 TAL--PDKVMEIVDSVLLLEVQASNS-RS-----------CGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 914 ~~~--~~~~~~~~~~~~~~~~~~~~~-~~-----------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
... .......+............. .. .............++.+++.+||+.||++|||++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 240 QLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 100 111111111111110000000 00 000000011123467899999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=330.10 Aligned_cols=248 Identities=22% Similarity=0.307 Sum_probs=191.5
Q ss_pred CccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhc-cCCcceeEEEEeecccccCcceEEEEE
Q 037275 685 NMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNI-RHRNLIKIITICSSIDFKGVDFQAIVY 760 (992)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 760 (992)
++||+|+||.||+|++..+++.||+|+++... ......+.+|..+++.+ +||||+++++++. .....++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~-----~~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQ-----TESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEE-----cCCEEEEEE
Confidence 47999999999999999899999999997432 22345678899999998 7999999999853 455679999
Q ss_pred EeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceec
Q 037275 761 EYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFL 840 (992)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 840 (992)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 e~~~~g~L~~~~~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~ 146 (329)
T cd05588 76 EFVSGGDLMFHMQRQR------KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 146 (329)
T ss_pred eCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCcccccc
Confidence 9999999999886543 489999999999999999999999 9999999999999999999999999998742
Q ss_pred CCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCC---ccHHHHHhhhCC
Q 037275 841 SSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQG---LTLHEFARTALP 917 (992)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~---~~~~~~~~~~~~ 917 (992)
... ........||+.|+|||++.+..++.++||||+||++|||++|+.||+...... ....++
T Consensus 147 ~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~------ 212 (329)
T cd05588 147 IRP--------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDY------ 212 (329)
T ss_pred ccC--------CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHH------
Confidence 211 111223568999999999999999999999999999999999999997432111 000000
Q ss_pred hhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCC------HHHHHH
Q 037275 918 DKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERME------MRDVVA 977 (992)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl~ 977 (992)
... ....... ..+ .....++.+++.+||+.||++||| ++|+++
T Consensus 213 --~~~---~~~~~~~------~~p------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 213 --LFQ---VILEKQI------RIP------RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred --HHH---HHHcCCC------CCC------CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 000 0000000 000 011345789999999999999998 566653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=329.74 Aligned_cols=246 Identities=22% Similarity=0.281 Sum_probs=188.1
Q ss_pred CccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhc-cCCcceeEEEEeecccccCcceEEEEE
Q 037275 685 NMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNI-RHRNLIKIITICSSIDFKGVDFQAIVY 760 (992)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 760 (992)
+.||+|+||+||+|++..+++.||+|+++... ......+.+|+.++.++ +||||+++++++. .....++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~-----~~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-----TESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEE-----eCCEEEEEE
Confidence 47999999999999999899999999997432 22345577888888877 8999999999853 455679999
Q ss_pred EeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceec
Q 037275 761 EYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFL 840 (992)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 840 (992)
||+++|+|..++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 E~~~~~~L~~~~~~~~------~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~ 146 (329)
T cd05618 76 EYVNGGDLMFHMQRQR------KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 146 (329)
T ss_pred eCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence 9999999999886543 489999999999999999999999 9999999999999999999999999998753
Q ss_pred CCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCChhH
Q 037275 841 SSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKV 920 (992)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 920 (992)
... ........||+.|+|||++.+..++.++|||||||++|||++|+.||........... ...
T Consensus 147 ~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~--------~~~ 210 (329)
T cd05618 147 LRP--------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ--------NTE 210 (329)
T ss_pred cCC--------CCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCccc--------ccH
Confidence 221 1112235689999999999999999999999999999999999999964221110000 000
Q ss_pred HHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCH
Q 037275 921 MEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEM 972 (992)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 972 (992)
............ ..+ .....++.+++.+||+.||++||++
T Consensus 211 ~~~~~~i~~~~~------~~p------~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 211 DYLFQVILEKQI------RIP------RSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred HHHHHHHhcCCC------CCC------CCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 000111110000 000 1123457899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=317.10 Aligned_cols=252 Identities=25% Similarity=0.404 Sum_probs=198.0
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAI 758 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 758 (992)
++|++.+.||+|+||+||.|+.. .+..||+|.+... ......+.+|+.++++++||||+++++++.. ....++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l 76 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK-----QRPIYI 76 (256)
T ss_pred HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEcc-----CCCcEE
Confidence 46888899999999999999885 4557999988633 3345678999999999999999999998643 345699
Q ss_pred EEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccce
Q 037275 759 VYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAK 838 (992)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 838 (992)
||||+.+|+|.+++..... .+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||.++
T Consensus 77 v~e~~~~~~l~~~i~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~ 148 (256)
T cd05113 77 VTEYMSNGCLLNYLREHGK-----RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSR 148 (256)
T ss_pred EEEcCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccce
Confidence 9999999999999976432 489999999999999999999999 99999999999999999999999999988
Q ss_pred ecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhhhCC
Q 037275 839 FLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFARTALP 917 (992)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 917 (992)
....... .......++..|+|||+..+..++.++|||||||++|+|++ |..||......
T Consensus 149 ~~~~~~~-------~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~------------- 208 (256)
T cd05113 149 YVLDDEY-------TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS------------- 208 (256)
T ss_pred ecCCCce-------eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-------------
Confidence 6543211 11122346678999999988889999999999999999999 99998653211
Q ss_pred hhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 037275 918 DKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLC 980 (992)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 980 (992)
+..+........ . .. ......+.+++.+||+.+|++|||+.++++.|+
T Consensus 209 ----~~~~~~~~~~~~----~-~~------~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 209 ----ETVEKVSQGLRL----Y-RP------HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ----HHHHHHhcCCCC----C-CC------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 011111100000 0 00 011356899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=332.68 Aligned_cols=253 Identities=24% Similarity=0.281 Sum_probs=198.2
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
++|++.+.||+|+||+||+|+...+++.||+|+++... ......+.+|+.+++.++||||+++++++. ....
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~-----~~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQ-----DKDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEe-----cCCe
Confidence 46889999999999999999999999999999997432 234456889999999999999999998853 4556
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++||||+++|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg 147 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRYED-----QFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFG 147 (330)
T ss_pred EEEEECCCCCCCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCC
Confidence 7999999999999999986532 489999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCccccccccccccccc------CCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHH
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGM------GGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLH 909 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~ 909 (992)
++........ .......||+.|+|||++. +..++.++|||||||++|||++|+.||......
T Consensus 148 ~a~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~----- 215 (330)
T cd05601 148 SAARLTANKM-------VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA----- 215 (330)
T ss_pred CCeECCCCCc-------eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-----
Confidence 9987643211 1122346899999999876 456789999999999999999999999753211
Q ss_pred HHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 910 EFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.. ...+... .. ....+. ......++.+++..|++ +|++|||++++++
T Consensus 216 ~~--------~~~i~~~----~~----~~~~~~----~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 216 KT--------YNNIMNF----QR----FLKFPE----DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred HH--------HHHHHcC----CC----ccCCCC----CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 00 0111100 00 000000 01123457888999998 9999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=327.61 Aligned_cols=241 Identities=23% Similarity=0.323 Sum_probs=188.8
Q ss_pred CccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhc-cCCcceeEEEEeecccccCcceEEEEE
Q 037275 685 NMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNI-RHRNLIKIITICSSIDFKGVDFQAIVY 760 (992)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 760 (992)
++||+|+||.||+|++..+|+.||+|+++... .........|..++... +||+|+++++++. ..+..++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQ-----TKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEE-----eCCEEEEEE
Confidence 47999999999999999899999999997432 23345567788887764 8999999999853 456779999
Q ss_pred EeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceec
Q 037275 761 EYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFL 840 (992)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 840 (992)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 E~~~~g~L~~~i~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05620 76 EFLNGGDLMFHIQDKG------RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKEN 146 (316)
T ss_pred CCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence 9999999999987543 478899999999999999999999 9999999999999999999999999998743
Q ss_pred CCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCChhH
Q 037275 841 SSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKV 920 (992)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 920 (992)
... ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+.... +
T Consensus 147 ~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~-----~---------- 203 (316)
T cd05620 147 VFG--------DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED-----E---------- 203 (316)
T ss_pred ccC--------CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-----H----------
Confidence 211 11123356899999999999999999999999999999999999999753211 0
Q ss_pred HHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 037275 921 MEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMR-DVV 976 (992)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl 976 (992)
.......... .... ....++.+++.+||+.||++||++. +++
T Consensus 204 --~~~~~~~~~~--~~~~----------~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 204 --LFESIRVDTP--HYPR----------WITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred --HHHHHHhCCC--CCCC----------CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 0110000000 0000 0134578899999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=323.83 Aligned_cols=270 Identities=21% Similarity=0.267 Sum_probs=208.5
Q ss_pred ccHHHHHHHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhc-cCCcceeEEEEeec
Q 037275 669 ISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNI-RHRNLIKIITICSS 747 (992)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 747 (992)
+.++.+....++|++.+.||+|+||.||+|++..+++.||+|++... ......+.+|+.+++++ +||||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 44566677888999999999999999999999889999999987532 22345678899999999 69999999998865
Q ss_pred ccccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCC
Q 037275 748 IDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDL 827 (992)
Q Consensus 748 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 827 (992)
.....+...++||||+++++|.+++...... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~ 161 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKR--GERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEG 161 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhcc--CccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCC
Confidence 5555667789999999999999988643211 23578999999999999999999999 999999999999999999
Q ss_pred cEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccC-----CCcCcccchhhHHHHHHHHHhCCCCCCCCc
Q 037275 828 VAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-----GEASMTGDVYSFGILLLEMFTRRRPTDGMF 902 (992)
Q Consensus 828 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~pf~~~~ 902 (992)
.+||+|||+++...... .......|++.|+|||++.. ..++.++||||+||++|||++|+.||....
T Consensus 162 ~~kl~dfg~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~ 233 (286)
T cd06638 162 GVKLVDFGVSAQLTSTR--------LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH 233 (286)
T ss_pred CEEEccCCceeecccCC--------CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCc
Confidence 99999999998654321 11122358899999998753 457889999999999999999999986532
Q ss_pred cCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 903 NQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
.. .... .. ..... ...........++.+++.+||+.||++|||+.||++.
T Consensus 234 ~~----~~~~---------~~----~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 234 PM----RALF---------KI----PRNPP---------PTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred hh----HHHh---------hc----cccCC---------CcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 11 0000 00 00000 0000000112458899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=326.02 Aligned_cols=241 Identities=24% Similarity=0.352 Sum_probs=188.8
Q ss_pred CccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhc-cCCcceeEEEEeecccccCcceEEEEE
Q 037275 685 NMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNI-RHRNLIKIITICSSIDFKGVDFQAIVY 760 (992)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 760 (992)
+.||+|+||+||+|++..+++.||+|+++... .........|..+++.. +||||+++++++. .....++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~-----~~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQ-----TKENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEE-----eCCEEEEEE
Confidence 46999999999999999899999999997432 23345567788888764 8999999999854 445679999
Q ss_pred EeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceec
Q 037275 761 EYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFL 840 (992)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 840 (992)
||+++|+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 ey~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05619 76 EYLNGGDLMFHIQSCH------KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKEN 146 (316)
T ss_pred eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence 9999999999997543 478899999999999999999999 9999999999999999999999999998753
Q ss_pred CCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCChhH
Q 037275 841 SSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKV 920 (992)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 920 (992)
... ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+.... +
T Consensus 147 ~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-----~---------- 203 (316)
T cd05619 147 MLG--------DAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE-----E---------- 203 (316)
T ss_pred CCC--------CCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH-----H----------
Confidence 211 11122346899999999999989999999999999999999999999753211 1
Q ss_pred HHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 037275 921 MEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMR-DVV 976 (992)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl 976 (992)
.......... ..+ .....++.+++.+||+.||++||++. ++.
T Consensus 204 --~~~~i~~~~~------~~~------~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 204 --LFQSIRMDNP------CYP------RWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred --HHHHHHhCCC------CCC------ccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 1110000000 000 01124578999999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=329.69 Aligned_cols=268 Identities=22% Similarity=0.368 Sum_probs=203.0
Q ss_pred hcCCCCCCccccccceEEEEeEE-----CCCCeEEEEEEeeccCC-CchhHHHHHHHHHHhc-cCCcceeEEEEeecccc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNL-----GENGMMVAVKVINLKQK-GASNGFVAECQALRNI-RHRNLIKIITICSSIDF 750 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 750 (992)
.++|++.++||+|+||+||+|.+ ..+++.||||+++.... .....+.+|+.++.++ +||||+++++++..
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--- 82 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK--- 82 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec---
Confidence 35899999999999999999984 24578999999964332 2345688999999999 68999999998743
Q ss_pred cCcceEEEEEEeccCCCHHHHHhhcccc----------------------------------------------------
Q 037275 751 KGVDFQAIVYEYMQNGSLEDWLHQSEDQ---------------------------------------------------- 778 (992)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~---------------------------------------------------- 778 (992)
.+...++||||+++|+|.+++......
T Consensus 83 -~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 83 -PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred -CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 234568999999999999999753210
Q ss_pred ---------hhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceecCCCCCCCCc
Q 037275 779 ---------QEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAV 849 (992)
Q Consensus 779 ---------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 849 (992)
.....+++..+..++.|+++||+|||++ +|+||||||+||++++++.+||+|||++........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~---- 234 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD---- 234 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcc----
Confidence 0012478889999999999999999999 999999999999999999999999999986533211
Q ss_pred ccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhhhCChhHHHHHHhhH
Q 037275 850 ETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFARTALPDKVMEIVDSVL 928 (992)
Q Consensus 850 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 928 (992)
........++..|+|||++.+..++.++||||||+++|+|++ |..||....... .....+.
T Consensus 235 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------------~~~~~~~--- 296 (343)
T cd05103 235 --YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-------------EFCRRLK--- 296 (343)
T ss_pred --hhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-------------HHHHHHh---
Confidence 011112345678999999988899999999999999999997 999986532110 0000000
Q ss_pred hHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 037275 929 LLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDT 985 (992)
Q Consensus 929 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 985 (992)
..... ..+ .....++.+++.+||+.||++|||+.||++.|+++.++
T Consensus 297 -~~~~~----~~~------~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 297 -EGTRM----RAP------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred -ccCCC----CCC------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 00000 000 00123588999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=315.45 Aligned_cols=251 Identities=24% Similarity=0.347 Sum_probs=201.8
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeecc--CCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK--QKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
+|++.+.||+|++|.||+|+...+++.|++|.+... .......+.+|++++++++|||++++++++. .....+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFL-----DKGKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeec-----cCCEEE
Confidence 477889999999999999999989999999998643 2334567889999999999999999999854 345679
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||+++++|.+++..... ..+++..++.++.|++.||.|||+. +++||||||+||+++.++.++|+|||++
T Consensus 76 lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~ 148 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQRG----RPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVA 148 (256)
T ss_pred EEEEeCCCCcHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccc
Confidence 99999999999999986532 3589999999999999999999999 9999999999999999999999999998
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALP 917 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 917 (992)
....... .......|++.|+|||+..+..++.++|||||||++|+|++|+.||...... .
T Consensus 149 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~------- 208 (256)
T cd08529 149 KLLSDNT--------NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG-----A------- 208 (256)
T ss_pred eeccCcc--------chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-----H-------
Confidence 8665321 1112345788999999999999999999999999999999999999753211 0
Q ss_pred hhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 918 DKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
........... . ........+.+++.+||+.+|++||++.|+++.
T Consensus 209 -----~~~~~~~~~~~-----~------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 209 -----LILKIIRGVFP-----P------VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -----HHHHHHcCCCC-----C------CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 01111100000 0 001234568999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=328.75 Aligned_cols=242 Identities=23% Similarity=0.304 Sum_probs=190.8
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhc-cCCcceeEEEEeecccccCcce
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNI-RHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 755 (992)
+|++.+.||+|+||+||+|++..+++.||+|+++... ......+..|..++..+ +|++|+++.+++. ..+.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQ-----TMDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEe-----cCCE
Confidence 5788999999999999999999899999999987432 22334567788888777 5888999988853 4456
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG 146 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQVG------RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFG 146 (323)
T ss_pred EEEEEcCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCC
Confidence 799999999999999987543 478999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 915 (992)
+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.... .
T Consensus 147 ~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-----~----- 208 (323)
T cd05616 147 MCKENMWDG--------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-----E----- 208 (323)
T ss_pred CceecCCCC--------CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH-----H-----
Confidence 987543211 1123346899999999999999999999999999999999999999753211 0
Q ss_pred CChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCH
Q 037275 916 LPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEM 972 (992)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 972 (992)
.......... ..+ .....++.+++.+|++.||++|+++
T Consensus 209 -------~~~~i~~~~~------~~p------~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 209 -------LFQSIMEHNV------AYP------KSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -------HHHHHHhCCC------CCC------CcCCHHHHHHHHHHcccCHHhcCCC
Confidence 1111110000 000 0123457899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=315.15 Aligned_cols=255 Identities=30% Similarity=0.479 Sum_probs=200.6
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
.++|++.++||+|+||.||+|++..+ ..||+|+++... ...+.+.+|++++++++||||+++++++. ....+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~~~ 76 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEPIY 76 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC------CCCcE
Confidence 35799999999999999999998644 569999986432 23467899999999999999999998752 23458
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||+++|+|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||.+
T Consensus 77 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~ 149 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMG----KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLA 149 (262)
T ss_pred EEEEcCCCCcHHHHHhhccc----cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCce
Confidence 99999999999999975432 2578999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhhhC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFARTAL 916 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 916 (992)
+........ ......++..|+|||+..+..++.++|||||||++|||++ |..||.+....
T Consensus 150 ~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~------------ 210 (262)
T cd05071 150 RLIEDNEYT-------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------------ 210 (262)
T ss_pred eeccccccc-------cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH------------
Confidence 866532211 1122346778999999988899999999999999999999 88888653211
Q ss_pred ChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 037275 917 PDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRA 982 (992)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 982 (992)
+..+..... .. . ....+....+.+++.+|++.||++||+++++++.|+..
T Consensus 211 -----~~~~~~~~~-~~----~------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 211 -----EVLDQVERG-YR----M------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred -----HHHHHHhcC-CC----C------CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 001110000 00 0 00122345688999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=327.59 Aligned_cols=242 Identities=24% Similarity=0.307 Sum_probs=192.0
Q ss_pred CccccccceEEEEeEECCCCeEEEEEEeecc---CCCchhHHHHHHHHHHhc-cCCcceeEEEEeecccccCcceEEEEE
Q 037275 685 NMIGQGSFGFVYKGNLGENGMMVAVKVINLK---QKGASNGFVAECQALRNI-RHRNLIKIITICSSIDFKGVDFQAIVY 760 (992)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 760 (992)
+.||+|+||+||+|++..+++.||+|+++.. .......+.+|..+++.+ +||||+++++++. .....++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~-----~~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQ-----TKDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCEEEEEE
Confidence 4699999999999999988999999999743 233445677888998888 7999999999853 455679999
Q ss_pred EeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceec
Q 037275 761 EYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFL 840 (992)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 840 (992)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 76 e~~~~~~L~~~~~~~~------~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 146 (318)
T cd05570 76 EYVNGGDLMFHIQRSG------RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEG 146 (318)
T ss_pred cCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeec
Confidence 9999999999987543 489999999999999999999999 9999999999999999999999999998743
Q ss_pred CCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCChhH
Q 037275 841 SSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKV 920 (992)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 920 (992)
... ........|++.|+|||++.+..++.++||||+||++|+|++|+.||.+.... ..
T Consensus 147 ~~~--------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~-----~~--------- 204 (318)
T cd05570 147 ILG--------GVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED-----EL--------- 204 (318)
T ss_pred CcC--------CCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH-----HH---------
Confidence 211 11122346899999999999999999999999999999999999999753211 10
Q ss_pred HHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 037275 921 MEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEM-----RDVVA 977 (992)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 977 (992)
.......... .+ ......+.+++.+||+.||++|||+ .++++
T Consensus 205 ---~~~i~~~~~~------~~------~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 205 ---FQSILEDEVR------YP------RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred ---HHHHHcCCCC------CC------CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 0100000000 00 0123457899999999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=330.50 Aligned_cols=279 Identities=19% Similarity=0.236 Sum_probs=200.2
Q ss_pred HHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC--CCchhHHHHHHHHHHhccCCcceeEEEEeecccc-cC
Q 037275 676 KATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHRNLIKIITICSSIDF-KG 752 (992)
Q Consensus 676 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~ 752 (992)
...++|++.+.||+|+||+||+|.+..+++.||||++.... ......+.+|+.++++++||||+++++++..... ..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 34578999999999999999999998899999999986432 2234567789999999999999999998653221 22
Q ss_pred cceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEe
Q 037275 753 VDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLG 832 (992)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 832 (992)
....++++|++ +++|.+++... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~ 160 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKCQ-------KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRIL 160 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEc
Confidence 34568999988 78999887632 489999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCCCCCcccCCCCCcccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHH
Q 037275 833 DFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEF 911 (992)
Q Consensus 833 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~ 911 (992)
|||+++..... .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.... ..+..+
T Consensus 161 Dfg~~~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~ 228 (343)
T cd07878 161 DFGLARQADDE-----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-DQLKRI 228 (343)
T ss_pred CCccceecCCC-----------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHH
Confidence 99999865321 123468999999999876 56889999999999999999999999753211 111111
Q ss_pred Hhhh--CChhHHHHHHhhHhHhhhccCCCCCCcccc--chHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 912 ARTA--LPDKVMEIVDSVLLLEVQASNSRSCGDERL--RTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 912 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
.... .+......+.......+.... ........ ........+.+++.+|++.||++|||++|+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 229 MEVVGTPSPEVLKKISSEHARKYIQSL-PHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHhCCCCHHHHHhcchhhHHHHhhcc-ccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1110 011111000000000000000 00000000 000112347899999999999999999999854
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=329.92 Aligned_cols=252 Identities=21% Similarity=0.263 Sum_probs=193.8
Q ss_pred CCCCCCccccccceEEEEeEEC---CCCeEEEEEEeeccC----CCchhHHHHHHHHHHhc-cCCcceeEEEEeeccccc
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLG---ENGMMVAVKVINLKQ----KGASNGFVAECQALRNI-RHRNLIKIITICSSIDFK 751 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 751 (992)
+|++.+.||+|+||+||+|+.. .+++.||+|++.... ....+.+.+|+.+++++ +||+|+++++++ .
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~ 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF-----Q 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE-----e
Confidence 4788999999999999998873 468999999986421 22345678899999999 599999999884 4
Q ss_pred CcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEE
Q 037275 752 GVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHL 831 (992)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 831 (992)
.....++||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||
T Consensus 76 ~~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl 146 (332)
T cd05614 76 TEAKLHLILDYVSGGEMFTHLYQRD------NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVL 146 (332)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEE
Confidence 4566799999999999999997543 488999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCCCCCcccCCCCCcccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHH
Q 037275 832 GDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHE 910 (992)
Q Consensus 832 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~ 910 (992)
+|||+++...... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ....
T Consensus 147 ~DfG~~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~ 218 (332)
T cd05614 147 TDFGLSKEFLSEE-------KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN-TQSE 218 (332)
T ss_pred eeCcCCccccccC-------CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC-CHHH
Confidence 9999997653221 1112235689999999998765 47889999999999999999999997532211 1111
Q ss_pred HHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 037275 911 FARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERM-----EMRDVVA 977 (992)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 977 (992)
. ......... ..+ ......+.+++.+||+.||++|| +++|+++
T Consensus 219 ~------------~~~~~~~~~------~~~------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 219 V------------SRRILKCDP------PFP------SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred H------------HHHHhcCCC------CCC------CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 1 111110000 000 11234578999999999999999 6777764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=339.46 Aligned_cols=209 Identities=24% Similarity=0.307 Sum_probs=173.7
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
.+|++.+.||+|+||.||+|++..+++.||+|++.... ......+.+|+++++.++||||+++++++ .+.+.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~ 75 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF-----QDKDN 75 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCE
Confidence 36899999999999999999999899999999986332 23346688999999999999999999985 44567
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++||||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~E~~~~g~L~~~i~~~~------~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG 146 (376)
T cd05598 76 LYFVMDYIPGGDMMSLLIRLG------IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFG 146 (376)
T ss_pred EEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCC
Confidence 899999999999999997643 478888999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCC-----------------------------------cccCCCCCcccccccccccccccCCCcCcccc
Q 037275 836 LAKFLSSSPLDTA-----------------------------------VETPSSSKGIKGTVGYIAPEYGMGGEASMTGD 880 (992)
Q Consensus 836 ~a~~~~~~~~~~~-----------------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 880 (992)
+|..+........ ...........||+.|+|||++.+..++.++|
T Consensus 147 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 226 (376)
T cd05598 147 LCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD 226 (376)
T ss_pred CCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCccee
Confidence 9853321000000 00001112357999999999999999999999
Q ss_pred hhhHHHHHHHHHhCCCCCCCC
Q 037275 881 VYSFGILLLEMFTRRRPTDGM 901 (992)
Q Consensus 881 iwSlG~il~elltg~~pf~~~ 901 (992)
||||||++|||++|+.||.+.
T Consensus 227 iwSlGvilyell~G~~Pf~~~ 247 (376)
T cd05598 227 WWSVGVILYEMLVGQPPFLAD 247 (376)
T ss_pred eeeccceeeehhhCCCCCCCC
Confidence 999999999999999999763
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=320.45 Aligned_cols=263 Identities=23% Similarity=0.370 Sum_probs=201.7
Q ss_pred CCCCCCccccccceEEEEeEECC-----CCeEEEEEEeeccCC-CchhHHHHHHHHHHhccCCcceeEEEEeecccccCc
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGE-----NGMMVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 753 (992)
+|++.+.||+|+||.||+|+... ....+|+|.+..... .....+.+|+.+++.++||||+++++.+.. .
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~ 75 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ-----D 75 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEec-----C
Confidence 47888999999999999998742 235799998864332 234578899999999999999999998643 3
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccc------------------hhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecc
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQ------------------QEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGD 815 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~------------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~D 815 (992)
+..++||||+.+|+|.+++...... .....+++..++.++.|++.||+|||+. +++|||
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~d 152 (290)
T cd05045 76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRD 152 (290)
T ss_pred CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhh
Confidence 4569999999999999998754321 1123588999999999999999999999 999999
Q ss_pred CCCCCeeeCCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-C
Q 037275 816 LKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-R 894 (992)
Q Consensus 816 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g 894 (992)
|||+||++++++.+||+|||+++....... ........++..|+|||++.+..++.++||||||+++|||++ |
T Consensus 153 ikp~nill~~~~~~kl~dfg~~~~~~~~~~------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g 226 (290)
T cd05045 153 LAARNVLVAEGRKMKISDFGLSRDVYEEDS------YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG 226 (290)
T ss_pred hhhheEEEcCCCcEEeccccccccccCccc------hhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcC
Confidence 999999999999999999999976543211 011122345678999999988889999999999999999999 9
Q ss_pred CCCCCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 037275 895 RRPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRD 974 (992)
Q Consensus 895 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 974 (992)
..||.+...+ .+....... .... .......++.+++.+||+.+|++||+++|
T Consensus 227 ~~p~~~~~~~--------------~~~~~~~~~----~~~~----------~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~ 278 (290)
T cd05045 227 GNPYPGIAPE--------------RLFNLLKTG----YRME----------RPENCSEEMYNLMLTCWKQEPDKRPTFAD 278 (290)
T ss_pred CCCCCCCCHH--------------HHHHHHhCC----CCCC----------CCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 9998653211 111111110 0000 00112346889999999999999999999
Q ss_pred HHHHHHHHHH
Q 037275 975 VVAKLCRARD 984 (992)
Q Consensus 975 vl~~L~~~~~ 984 (992)
+++.|+++..
T Consensus 279 i~~~l~~~~~ 288 (290)
T cd05045 279 ISKELEKMMV 288 (290)
T ss_pred HHHHHHHHHh
Confidence 9999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=317.33 Aligned_cols=260 Identities=23% Similarity=0.404 Sum_probs=202.5
Q ss_pred cCCCCCCccccccceEEEEeEECCCCe----EEEEEEeeccCC-CchhHHHHHHHHHHhccCCcceeEEEEeecccccCc
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGM----MVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 753 (992)
.+|++.++||+|+||+||+|++..+++ +||+|+++.... .....+.+|+.+++.++||||+++++++..
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~------ 80 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT------ 80 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC------
Confidence 478899999999999999999866665 489999864332 234678899999999999999999998743
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGD 833 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 833 (992)
...+++|||+++|+|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|
T Consensus 81 ~~~~l~~~~~~~g~l~~~l~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~d 152 (279)
T cd05109 81 STVQLVTQLMPYGCLLDYVRENKD-----RIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITD 152 (279)
T ss_pred CCcEEEEEcCCCCCHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECC
Confidence 234799999999999999976432 489999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHH
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFA 912 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~ 912 (992)
||+++........ .......++..|+|||...+..++.++|||||||++|||++ |..||......
T Consensus 153 fG~~~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------- 218 (279)
T cd05109 153 FGLARLLDIDETE------YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR-------- 218 (279)
T ss_pred CCceeecccccce------eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--------
Confidence 9999876432211 11112235678999999988899999999999999999998 99998653211
Q ss_pred hhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 037275 913 RTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTF 986 (992)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 986 (992)
.....+... .. .. .......++.+++.+||+.||++||++.|+++.|.++..+.
T Consensus 219 ------~~~~~~~~~---~~-~~----------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 219 ------EIPDLLEKG---ER-LP----------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred ------HHHHHHHCC---Cc-CC----------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 011111100 00 00 00112345889999999999999999999999998876554
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=320.07 Aligned_cols=261 Identities=25% Similarity=0.384 Sum_probs=201.0
Q ss_pred hcCCCCCCccccccceEEEEeEECC-----CCeEEEEEEeeccCC-CchhHHHHHHHHHHhccCCcceeEEEEeeccccc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGE-----NGMMVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIITICSSIDFK 751 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 751 (992)
.++|++.+.||+|+||.||+|.+.. .+..||+|.+..... .....+.+|+.++++++|+||+++++++.+
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---- 80 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE---- 80 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc----
Confidence 4678999999999999999999976 678899998864332 234568899999999999999999998643
Q ss_pred CcceEEEEEEeccCCCHHHHHhhcccc-hhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCC---
Q 037275 752 GVDFQAIVYEYMQNGSLEDWLHQSEDQ-QEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDL--- 827 (992)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~--- 827 (992)
....++||||+++++|.+++...... .....+++..+++++.||+.||+|||++ +++||||||+||+++.++
T Consensus 81 -~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~ 156 (277)
T cd05036 81 -RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGR 156 (277)
T ss_pred -CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCc
Confidence 34458999999999999999876432 1123589999999999999999999999 999999999999998654
Q ss_pred cEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCc
Q 037275 828 VAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGL 906 (992)
Q Consensus 828 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~ 906 (992)
.+||+|||+++........ ........+..|+|||++.+..++.++|||||||++|||++ |+.||.....+
T Consensus 157 ~~kl~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~-- 228 (277)
T cd05036 157 VAKIADFGMARDIYRASYY------RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ-- 228 (277)
T ss_pred ceEeccCccccccCCccce------ecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--
Confidence 6999999999866432111 11112234568999999998999999999999999999997 99998753221
Q ss_pred cHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 037275 907 TLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLC 980 (992)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 980 (992)
...+.+... .. ... .......+.+++.+|++.+|++|||+.||++.|+
T Consensus 229 ------------~~~~~~~~~---~~-~~~----------~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 229 ------------EVMEFVTGG---GR-LDP----------PKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred ------------HHHHHHHcC---Cc-CCC----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 011111100 00 000 0112346889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=319.38 Aligned_cols=253 Identities=22% Similarity=0.316 Sum_probs=198.3
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAI 758 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 758 (992)
++|++.+.||+|+||.||+|++..+++.||+|+++.........+.+|+.+++.++||||+++++++. .....++
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~-----~~~~~~l 83 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL-----RRDKLWI 83 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEE-----eCCEEEE
Confidence 47888899999999999999998899999999997655555567889999999999999999999854 3456799
Q ss_pred EEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccce
Q 037275 759 VYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAK 838 (992)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 838 (992)
||||+++++|.+++.... .+++.+++.++.|++.|++|||+. +++|+||||+||+++.++.+||+|||.+.
T Consensus 84 v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~ 154 (267)
T cd06645 84 CMEFCGGGSLQDIYHVTG------PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSA 154 (267)
T ss_pred EEeccCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeee
Confidence 999999999999987543 488999999999999999999999 99999999999999999999999999987
Q ss_pred ecCCCCCCCCcccCCCCCccccccccccccccc---CCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh
Q 037275 839 FLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGM---GGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 915 (992)
...... .......|+..|+|||++. ...++.++||||+||++|+|++|..||........ ......
T Consensus 155 ~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-~~~~~~-- 223 (267)
T cd06645 155 QITATI--------AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMTK-- 223 (267)
T ss_pred EccCcc--------cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-HHhhhc--
Confidence 654211 1122346889999999874 45688899999999999999999999864321100 000000
Q ss_pred CChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 916 LPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
..... .... ........+.+++.+||+.+|++|||+++|++
T Consensus 224 --------------~~~~~---~~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 224 --------------SNFQP---PKLK----DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred --------------cCCCC---Cccc----ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 00000 0000 00011235788999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=337.91 Aligned_cols=208 Identities=23% Similarity=0.311 Sum_probs=173.0
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
+|+.+++||+|+||+||+|+...+++.||+|++.... ......+.+|++++++++||||+++++++. +....
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~-----~~~~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQ-----DKDNL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEE-----eCCEE
Confidence 6889999999999999999999899999999986432 233456889999999999999999999854 45677
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
++||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~------~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGl 147 (382)
T cd05625 77 YFVMDYIPGGDMMSLLIRMG------IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGL 147 (382)
T ss_pred EEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCC
Confidence 99999999999999997543 478888999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCCC---------------------------------------cccCCCCCcccccccccccccccCCCcCc
Q 037275 837 AKFLSSSPLDTA---------------------------------------VETPSSSKGIKGTVGYIAPEYGMGGEASM 877 (992)
Q Consensus 837 a~~~~~~~~~~~---------------------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 877 (992)
+........... ...........||+.|+|||++.+..++.
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 227 (382)
T cd05625 148 CTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ 227 (382)
T ss_pred CccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCC
Confidence 864321100000 00000112356999999999999999999
Q ss_pred ccchhhHHHHHHHHHhCCCCCCCC
Q 037275 878 TGDVYSFGILLLEMFTRRRPTDGM 901 (992)
Q Consensus 878 ~~DiwSlG~il~elltg~~pf~~~ 901 (992)
++||||+||++|||++|+.||.+.
T Consensus 228 ~~DiwSlGvil~elltG~~Pf~~~ 251 (382)
T cd05625 228 LCDWWSVGVILYEMLVGQPPFLAQ 251 (382)
T ss_pred eeeEEechHHHHHHHhCCCCCCCC
Confidence 999999999999999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=321.67 Aligned_cols=266 Identities=25% Similarity=0.411 Sum_probs=204.4
Q ss_pred HHhcCCCCCCccccccceEEEEeEECCC-----CeEEEEEEeeccC-CCchhHHHHHHHHHHhc-cCCcceeEEEEeecc
Q 037275 676 KATNDFSSSNMIGQGSFGFVYKGNLGEN-----GMMVAVKVINLKQ-KGASNGFVAECQALRNI-RHRNLIKIITICSSI 748 (992)
Q Consensus 676 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 748 (992)
...++|++.+.||+|+||.||+|..... ...+|+|.+.... ......+.+|+++++++ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~-- 86 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT-- 86 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc--
Confidence 3456789999999999999999997533 3789999986432 22345688999999999 8999999999864
Q ss_pred cccCcceEEEEEEeccCCCHHHHHhhcccc----------hhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCC
Q 037275 749 DFKGVDFQAIVYEYMQNGSLEDWLHQSEDQ----------QEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKP 818 (992)
Q Consensus 749 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp 818 (992)
.....++||||+++|+|.++++..... .....+++..++.++.|++.||+|||+. +|+||||||
T Consensus 87 ---~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp 160 (293)
T cd05053 87 ---QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAA 160 (293)
T ss_pred ---CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Cccccccce
Confidence 344579999999999999999754210 1234689999999999999999999999 999999999
Q ss_pred CCeeeCCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCC
Q 037275 819 SNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRP 897 (992)
Q Consensus 819 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p 897 (992)
+||+++.++.+||+|||.++.+....... ......++..|+|||++.+..++.++|||||||++||+++ |..|
T Consensus 161 ~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p 234 (293)
T cd05053 161 RNVLVTEDHVMKIADFGLARDIHHIDYYR------KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 234 (293)
T ss_pred eeEEEcCCCeEEeCcccccccccccccee------ccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCC
Confidence 99999999999999999998765322111 1111235678999999988899999999999999999998 9999
Q ss_pred CCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 898 TDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 898 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
|...... + ..+.+.. ..... ........+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~-----~---------~~~~~~~----~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~ 286 (293)
T cd05053 235 YPGIPVE-----E---------LFKLLKE----GYRME----------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVE 286 (293)
T ss_pred CCCCCHH-----H---------HHHHHHc----CCcCC----------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 8653211 0 0111100 00000 00112346889999999999999999999999
Q ss_pred HHHHHH
Q 037275 978 KLCRAR 983 (992)
Q Consensus 978 ~L~~~~ 983 (992)
.|+++.
T Consensus 287 ~l~~~~ 292 (293)
T cd05053 287 DLDRML 292 (293)
T ss_pred HHHHhh
Confidence 998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=328.92 Aligned_cols=238 Identities=27% Similarity=0.324 Sum_probs=186.0
Q ss_pred CccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHH-HHHhccCCcceeEEEEeecccccCcceEEEEE
Q 037275 685 NMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQ-ALRNIRHRNLIKIITICSSIDFKGVDFQAIVY 760 (992)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 760 (992)
+.||+|+||+||+|++..+|+.||+|++.... ......+..|.. +++.++||||+++++++. .....++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~-----~~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ-----TADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEE-----eCCEEEEEE
Confidence 46999999999999999899999999996432 222334455544 567899999999998853 455679999
Q ss_pred EeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceec
Q 037275 761 EYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFL 840 (992)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 840 (992)
||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++...
T Consensus 76 e~~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~ 146 (323)
T cd05575 76 DYVNGGELFFHLQRER------SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (323)
T ss_pred cCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence 9999999999987543 488899999999999999999999 9999999999999999999999999998743
Q ss_pred CCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCChhH
Q 037275 841 SSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKV 920 (992)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 920 (992)
... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+
T Consensus 147 ~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-----~~---------- 203 (323)
T cd05575 147 IEH--------SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-----AE---------- 203 (323)
T ss_pred ccC--------CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH-----HH----------
Confidence 211 1122334689999999999999999999999999999999999999975311 11
Q ss_pred HHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHH
Q 037275 921 MEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMR 973 (992)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 973 (992)
..+........ .. ......+.+++.+||+.||++||++.
T Consensus 204 --~~~~i~~~~~~------~~------~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 204 --MYDNILNKPLR------LK------PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred --HHHHHHcCCCC------CC------CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 11111111000 00 01134588999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=323.11 Aligned_cols=265 Identities=25% Similarity=0.381 Sum_probs=201.4
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCe--EEEEEEeeccC-CCchhHHHHHHHHHHhc-cCCcceeEEEEeecccccCc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGM--MVAVKVINLKQ-KGASNGFVAECQALRNI-RHRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 753 (992)
.++|++.+.||+|+||.||+|.+..++. .+|+|.++... ......+.+|++++.++ +||||+++++++. ..
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~-----~~ 80 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HR 80 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEEC-----CC
Confidence 3578899999999999999999876665 45777665322 23345788999999999 8999999999864 34
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccch----------hhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQ----------EARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLL 823 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 823 (992)
...++||||+++|+|.++++...... ....+++.+++.++.|++.|++|||++ +|+||||||+||++
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili 157 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILV 157 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEe
Confidence 55799999999999999998654211 123588999999999999999999999 99999999999999
Q ss_pred CCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCc
Q 037275 824 DQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMF 902 (992)
Q Consensus 824 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~ 902 (992)
++++.+||+|||++...... .......++..|+|||++.+..++.++|||||||++|||+| |..||.+..
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 228 (303)
T cd05088 158 GENYVAKIADFGLSRGQEVY---------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 228 (303)
T ss_pred cCCCcEEeCccccCcccchh---------hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCC
Confidence 99999999999998632210 01111224667999999988889999999999999999998 999986532
Q ss_pred cCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 037275 903 NQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRA 982 (992)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 982 (992)
.. +. ..... ..... .. .......+.+++.+||+.+|++||+++++++.+.++
T Consensus 229 ~~-----~~------------~~~~~-~~~~~----~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 229 CA-----EL------------YEKLP-QGYRL----EK------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred hH-----HH------------HHHHh-cCCcC----CC------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11 10 00000 00000 00 001234578999999999999999999999999887
Q ss_pred HHhhh
Q 037275 983 RDTFL 987 (992)
Q Consensus 983 ~~~~~ 987 (992)
.....
T Consensus 281 ~~~~~ 285 (303)
T cd05088 281 LEERK 285 (303)
T ss_pred HHhhh
Confidence 65543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=312.38 Aligned_cols=250 Identities=30% Similarity=0.408 Sum_probs=198.2
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAI 758 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 758 (992)
.+|++.+.||+|+||.||+|.. .|..||+|.++. ....+.+.+|+.++++++|+|++++++++. ......++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~l 77 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYI 77 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCC--CchHHHHHHHHHHHHhCCCCCeeeEEEEEE----cCCCceEE
Confidence 4788999999999999999987 478899999853 233567889999999999999999999753 23455799
Q ss_pred EEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccce
Q 037275 759 VYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAK 838 (992)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 838 (992)
||||+++++|.+++..... ..+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||++.
T Consensus 78 v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~ 150 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK 150 (256)
T ss_pred EEECCCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccce
Confidence 9999999999999976542 2488999999999999999999999 99999999999999999999999999987
Q ss_pred ecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhhhCC
Q 037275 839 FLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFARTALP 917 (992)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 917 (992)
...... ....++..|+|||++.+..++.++|||||||++|||++ |+.||.... ..+..
T Consensus 151 ~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~-----~~~~~----- 209 (256)
T cd05082 151 EASSTQ-----------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----LKDVV----- 209 (256)
T ss_pred eccccC-----------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC-----HHHHH-----
Confidence 543211 11234568999999988899999999999999999998 999986421 11110
Q ss_pred hhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 037275 918 DKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRA 982 (992)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 982 (992)
.. ....... .. .......+.+++.+||+.+|++|||++++++.|+++
T Consensus 210 -------~~-~~~~~~~----~~------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 210 -------PR-VEKGYKM----DA------PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred -------HH-HhcCCCC----CC------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 00 0000000 00 012245688999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=342.53 Aligned_cols=278 Identities=22% Similarity=0.282 Sum_probs=196.4
Q ss_pred HHHHHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccC------CcceeEEEEee
Q 037275 673 ELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRH------RNLIKIITICS 746 (992)
Q Consensus 673 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~~~~~~~ 746 (992)
++....++|++.++||+|+||+||+|.+..+++.||||+++... ........|+.+++.++| ++++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34445678999999999999999999998889999999996332 223456678888887754 45888888764
Q ss_pred cccccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCCCCCeeeCC
Q 037275 747 SIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHH-HCQPPVVHGDLKPSNVLLDQ 825 (992)
Q Consensus 747 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~ 825 (992)
. ...+.++|||++ +++|.+++.... .+++..+..|+.||+.||+|||+ . +||||||||+|||++.
T Consensus 202 ~----~~~~~~iv~~~~-g~~l~~~l~~~~------~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~ 267 (467)
T PTZ00284 202 N----ETGHMCIVMPKY-GPCLLDWIMKHG------PFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMET 267 (467)
T ss_pred c----CCceEEEEEecc-CCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEec
Confidence 2 335679999988 779999887543 48999999999999999999997 6 8999999999999987
Q ss_pred CC----------------cEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHH
Q 037275 826 DL----------------VAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLL 889 (992)
Q Consensus 826 ~~----------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 889 (992)
++ .+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|
T Consensus 268 ~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----------~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~ 336 (467)
T PTZ00284 268 SDTVVDPVTNRALPPDPCRVRICDLGGCCDERH-----------SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIY 336 (467)
T ss_pred CCcccccccccccCCCCceEEECCCCccccCcc-----------ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHH
Confidence 65 499999998754221 123356899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCccCCccHHHHHh--hhCChhHHHHHHhhHhHh-hh-ccCCCCCCcc----------ccchHHHHHHHH
Q 037275 890 EMFTRRRPTDGMFNQGLTLHEFAR--TALPDKVMEIVDSVLLLE-VQ-ASNSRSCGDE----------RLRTEERLVAVV 955 (992)
Q Consensus 890 elltg~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~----------~~~~~~~~~~l~ 955 (992)
||++|+.||.+.... ..+..+.. ...+..+........... +. ....+.+... ..........+.
T Consensus 337 elltG~~pf~~~~~~-~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (467)
T PTZ00284 337 ELYTGKLLYDTHDNL-EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLC 415 (467)
T ss_pred HHHhCCCCCCCCChH-HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHH
Confidence 999999999764321 11111111 112221111000000000 00 0000000000 000011234578
Q ss_pred HHHhhccCCCCCCCCCHHHHHH
Q 037275 956 ETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 956 ~li~~cl~~dP~~RPs~~evl~ 977 (992)
+++.+||++||++||||+|+++
T Consensus 416 dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 416 DLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HHHHHhCCcChhhCCCHHHHhc
Confidence 9999999999999999999986
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=324.32 Aligned_cols=205 Identities=22% Similarity=0.343 Sum_probs=164.4
Q ss_pred CCccccccceEEEEeEEC--CCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEEEE
Q 037275 684 SNMIGQGSFGFVYKGNLG--ENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYE 761 (992)
Q Consensus 684 ~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 761 (992)
.++||+|+||+||+|+.. .+++.||+|.+... .....+.+|+.++++++||||+++++++.. ......++|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLS---HADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEec---CCCcEEEEEEe
Confidence 468999999999999965 46789999998533 234557899999999999999999998643 23456799999
Q ss_pred eccCCCHHHHHhhcccc---hhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeee----CCCCcEEEeec
Q 037275 762 YMQNGSLEDWLHQSEDQ---QEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLL----DQDLVAHLGDF 834 (992)
Q Consensus 762 ~~~~gsL~~~l~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Df 834 (992)
|+. ++|.+++...... .....+++..+..++.|++.||+|||++ +|+||||||+||++ +.++.+||+||
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 985 5898888654321 1123588999999999999999999999 99999999999999 45679999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCCCc
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRRRPTDGMF 902 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~ 902 (992)
|+|+....... .........||+.|+|||++.+. .++.++||||+||++|||++|++||....
T Consensus 157 G~a~~~~~~~~-----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 157 GFARLFNSPLK-----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred CceeccCCCCc-----cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 99987643211 11122345689999999998764 58999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=296.66 Aligned_cols=257 Identities=23% Similarity=0.278 Sum_probs=203.0
Q ss_pred hcCCCCC-CccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhc-cCCcceeEEEEeecccccCcce
Q 037275 678 TNDFSSS-NMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNI-RHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 678 ~~~~~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 755 (992)
+++|++. ++||-|-.|.|-.+..+.+|+.+|+|++. +....++|++.--.. .|||||.++++|.. .+.+...
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-----Ds~KARrEVeLHw~~s~h~~iV~IidVyeN-s~~~rkc 133 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-----DSPKARREVELHWMASGHPHIVSIIDVYEN-SYQGRKC 133 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHh-----cCHHHHhHhhhhhhhcCCCceEEeehhhhh-hccCcee
Confidence 4456554 68999999999999999999999999985 223455788764444 69999999998754 4667788
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCC---CCcEEEe
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQ---DLVAHLG 832 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~ 832 (992)
..+|||.|+||.|...+++++.. .+++.++..|+.||..|+.|||+. +|.||||||+|+|.+. +-.+||+
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~----afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLt 206 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQ----AFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLT 206 (400)
T ss_pred eEeeeecccchHHHHHHHHcccc----cchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEec
Confidence 89999999999999999988754 799999999999999999999999 9999999999999964 4489999
Q ss_pred ecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHH
Q 037275 833 DFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFA 912 (992)
Q Consensus 833 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~ 912 (992)
|||+|+.... .......+.|+.|.|||++....|+...|+||+||++|-|++|.+||....-. .
T Consensus 207 DfGFAK~t~~---------~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~--a----- 270 (400)
T KOG0604|consen 207 DFGFAKETQE---------PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--A----- 270 (400)
T ss_pred ccccccccCC---------CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc--c-----
Confidence 9999986542 23334457899999999999999999999999999999999999999764221 1
Q ss_pred hhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 913 RTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
++.. +-.++..+.|.. ..++.....++..++|+.+|..+|.+|.|+.|+++
T Consensus 271 ---ispg---Mk~rI~~gqy~F--------P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 271 ---ISPG---MKRRIRTGQYEF--------PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred ---CChh---HHhHhhccCccC--------CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 1111 111111222211 11223445566888999999999999999999875
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=312.12 Aligned_cols=251 Identities=28% Similarity=0.463 Sum_probs=197.2
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAI 758 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 758 (992)
.+|++.+.||+|+||.||+|.+. ++..+|+|++... ......+.+|++++++++||||+++++++. .....++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~l 76 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCT-----KQRPIFI 76 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEc-----CCCceEE
Confidence 35888999999999999999986 5678999998533 223456888999999999999999999854 3445799
Q ss_pred EEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccce
Q 037275 759 VYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAK 838 (992)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 838 (992)
||||+++++|.+++..... .+++..++.++.|++.|++|||+. +++||||||+||++++++.+||+|||.++
T Consensus 77 v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~ 148 (256)
T cd05059 77 VTEYMANGCLLNYLRERKG-----KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLAR 148 (256)
T ss_pred EEecCCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccce
Confidence 9999999999999976432 489999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhhhCC
Q 037275 839 FLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFARTALP 917 (992)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 917 (992)
....... .......++..|+|||.+.+..++.++||||||+++||+++ |+.||.......
T Consensus 149 ~~~~~~~-------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------------ 209 (256)
T cd05059 149 YVLDDQY-------TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE------------ 209 (256)
T ss_pred ecccccc-------cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH------------
Confidence 6543211 11112224568999999998899999999999999999999 899987532110
Q ss_pred hhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 037275 918 DKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKL 979 (992)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 979 (992)
...... ........ .....++.+++.+||..+|++|||+.|+++.|
T Consensus 210 -----~~~~~~-~~~~~~~~----------~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 210 -----VVESVS-AGYRLYRP----------KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred -----HHHHHH-cCCcCCCC----------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 000000 00000000 01244689999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=320.00 Aligned_cols=261 Identities=25% Similarity=0.445 Sum_probs=199.5
Q ss_pred cCCCCCCccccccceEEEEeEE----CCCCeEEEEEEeeccCC-CchhHHHHHHHHHHhccCCcceeEEEEeecccccCc
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNL----GENGMMVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 753 (992)
.+|++.+.||+|+||+||+|.. ..++..||+|.+..... .....+.+|+.++++++||||+++++++. ..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~ 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVT-----QE 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEe-----cC
Confidence 4688889999999999999985 34567899999864332 23357889999999999999999999854 34
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccc-----------hhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQ-----------QEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVL 822 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIl 822 (992)
...++||||+++++|.+++...... .....+++.++..++.|++.||+|||++ +|+||||||+||+
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nil 156 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNIL 156 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEE
Confidence 4569999999999999999643210 0123478899999999999999999999 9999999999999
Q ss_pred eCCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCC
Q 037275 823 LDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGM 901 (992)
Q Consensus 823 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~ 901 (992)
+++++.+||+|||+++....... ........++..|+|||++.+..++.++|||||||++|||++ |..||.+.
T Consensus 157 i~~~~~~kl~dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~ 230 (283)
T cd05090 157 IGEQLHVKISDLGLSREIYSADY------YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF 230 (283)
T ss_pred EcCCCcEEeccccccccccCCcc------eecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999986543221 111122345678999999988889999999999999999999 99998653
Q ss_pred ccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 037275 902 FNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCR 981 (992)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 981 (992)
... ...+.+... .. ... ......++.+++.+||+.||++||++.+|.+.|..
T Consensus 231 ~~~--------------~~~~~~~~~---~~-----~~~------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 231 SNQ--------------EVIEMVRKR---QL-----LPC------SEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred CHH--------------HHHHHHHcC---Cc-----CCC------CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111 111111100 00 000 01123458889999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=314.75 Aligned_cols=251 Identities=21% Similarity=0.279 Sum_probs=200.1
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeecc-CCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEE
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK-QKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAI 758 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 758 (992)
+|++.++||+|+||.||++++..+++.||+|.++.. .....+.+.+|+.+++.++||||+++.+++. +....++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFE-----ADGHLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEE-----ECCEEEE
Confidence 578889999999999999999989999999998643 2334567889999999999999999999853 4567799
Q ss_pred EEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccce
Q 037275 759 VYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAK 838 (992)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 838 (992)
||||+++|+|.+++..... ..+++..++.++.|++.||.|||++ +|+|+||||+||++++++.++++|||.+.
T Consensus 76 v~e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~ 148 (255)
T cd08219 76 VMEYCDGGDLMQKIKLQRG----KLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSAR 148 (255)
T ss_pred EEeeCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcce
Confidence 9999999999999875432 2578999999999999999999999 99999999999999999999999999997
Q ss_pred ecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCCh
Q 037275 839 FLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPD 918 (992)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 918 (992)
...... .......|++.|+|||++.+..++.++||||||+++|+|++|..||..... ..
T Consensus 149 ~~~~~~--------~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-----~~-------- 207 (255)
T cd08219 149 LLTSPG--------AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW-----KN-------- 207 (255)
T ss_pred eecccc--------cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH-----HH--------
Confidence 654321 111234588899999999888899999999999999999999999975211 00
Q ss_pred hHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 919 KVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
........... .. .......+.+++.+||+.||++|||+.|++..
T Consensus 208 ----~~~~~~~~~~~-----~~------~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 208 ----LILKVCQGSYK-----PL------PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ----HHHHHhcCCCC-----CC------CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 01110000000 00 01123457899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=331.96 Aligned_cols=208 Identities=23% Similarity=0.310 Sum_probs=176.1
Q ss_pred HHHHHHHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhccCCcceeEEEEeec
Q 037275 671 YAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNIRHRNLIKIITICSS 747 (992)
Q Consensus 671 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 747 (992)
..++....++|++.+.||+|+||.||+|++..+++.||+|++.... ......+.+|+.+++.++||||+++++++
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-- 112 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-- 112 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE--
Confidence 3445556689999999999999999999999999999999986322 22345578899999999999999999985
Q ss_pred ccccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCC
Q 037275 748 IDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDL 827 (992)
Q Consensus 748 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 827 (992)
.+....++||||+++|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++
T Consensus 113 ---~~~~~~~lv~Ey~~gg~L~~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~ 179 (371)
T cd05622 113 ---QDDRYLYMVMEYMPGGDLVNLMSNY-------DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSG 179 (371)
T ss_pred ---EcCCEEEEEEcCCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCC
Confidence 3456779999999999999998643 378888899999999999999999 999999999999999999
Q ss_pred cEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCC----CcCcccchhhHHHHHHHHHhCCCCCCC
Q 037275 828 VAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG----EASMTGDVYSFGILLLEMFTRRRPTDG 900 (992)
Q Consensus 828 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwSlG~il~elltg~~pf~~ 900 (992)
.+||+|||+++...... ........||+.|+|||++.+. .++.++||||+||++|||++|+.||.+
T Consensus 180 ~ikL~DfG~a~~~~~~~-------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 249 (371)
T cd05622 180 HLKLADFGTCMKMNKEG-------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249 (371)
T ss_pred CEEEEeCCceeEcCcCC-------cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC
Confidence 99999999998764321 1112335699999999998654 378899999999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=319.25 Aligned_cols=265 Identities=25% Similarity=0.392 Sum_probs=202.2
Q ss_pred cCCCCCCccccccceEEEEeEECCCCe--EEEEEEeecc-CCCchhHHHHHHHHHHhc-cCCcceeEEEEeecccccCcc
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGM--MVAVKVINLK-QKGASNGFVAECQALRNI-RHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 754 (992)
++|++.++||+|+||.||+|....++. .+++|.++.. .....+.+.+|+.+++++ +||||+++++++.. ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-----~~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN-----RG 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc-----CC
Confidence 578999999999999999999876654 4788887632 223346788999999999 79999999998643 34
Q ss_pred eEEEEEEeccCCCHHHHHhhcccch----------hhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeC
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQ----------EARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLD 824 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 824 (992)
..++||||+++|+|.+++....... ....+++..++.++.|++.||+|||++ +|+||||||+||+++
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~ 153 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVG 153 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEEC
Confidence 5699999999999999997643211 113588999999999999999999999 999999999999999
Q ss_pred CCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCcc
Q 037275 825 QDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFN 903 (992)
Q Consensus 825 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~ 903 (992)
+++.+||+|||++....... .......+..|+|||+..+..++.++|||||||++|||++ |..||.+...
T Consensus 154 ~~~~~kl~dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~ 224 (297)
T cd05089 154 ENLASKIADFGLSRGEEVYV---------KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC 224 (297)
T ss_pred CCCeEEECCcCCCcccccee---------ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99999999999986422110 0111123567999999988889999999999999999998 9999965321
Q ss_pred CCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 037275 904 QGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRAR 983 (992)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 983 (992)
. +. ..... ...... ........+.+++.+||+.+|.+|||++++++.|+++.
T Consensus 225 ~-----~~------------~~~~~-~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 276 (297)
T cd05089 225 A-----EL------------YEKLP-QGYRME----------KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276 (297)
T ss_pred H-----HH------------HHHHh-cCCCCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1 10 00000 000000 00112345889999999999999999999999999888
Q ss_pred Hhhhh
Q 037275 984 DTFLG 988 (992)
Q Consensus 984 ~~~~~ 988 (992)
.....
T Consensus 277 ~~~~~ 281 (297)
T cd05089 277 EARKA 281 (297)
T ss_pred Hhhcc
Confidence 76543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=321.92 Aligned_cols=260 Identities=23% Similarity=0.405 Sum_probs=201.8
Q ss_pred hcCCCCCCccccccceEEEEeEE-----CCCCeEEEEEEeeccC-CCchhHHHHHHHHHHhc-cCCcceeEEEEeecccc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNL-----GENGMMVAVKVINLKQ-KGASNGFVAECQALRNI-RHRNLIKIITICSSIDF 750 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 750 (992)
.++|.+.+.||+|+||.||+|.. ..++..||+|+++... ....+.+.+|+.+++++ +||||+++++++..
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--- 110 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI--- 110 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec---
Confidence 45799999999999999999975 2345689999986443 23345688999999999 79999999998643
Q ss_pred cCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEE
Q 037275 751 KGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAH 830 (992)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 830 (992)
....++||||+.+|+|.++++.... ..+++.++..++.|++.||+|||++ +|+|+||||+||+++.++.++
T Consensus 111 --~~~~~lv~e~~~~~~L~~~i~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~ 181 (302)
T cd05055 111 --GGPILVITEYCCYGDLLNFLRRKRE----SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVK 181 (302)
T ss_pred --CCceEEEEEcCCCCcHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEE
Confidence 3456999999999999999975432 2389999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHH
Q 037275 831 LGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLH 909 (992)
Q Consensus 831 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~ 909 (992)
++|||.++....... ........++..|+|||.+.+..++.++||||+||++|||++ |..||.+.....
T Consensus 182 l~dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~---- 251 (302)
T cd05055 182 ICDFGLARDIMNDSN------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS---- 251 (302)
T ss_pred ECCCcccccccCCCc------eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH----
Confidence 999999976543211 011122346788999999998899999999999999999998 999987532210
Q ss_pred HHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 037275 910 EFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRA 982 (992)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 982 (992)
........ .... .. ......++.+++.+||..+|++|||+.|+++.|+++
T Consensus 252 ---------~~~~~~~~----~~~~----~~------~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 252 ---------KFYKLIKE----GYRM----AQ------PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ---------HHHHHHHc----CCcC----CC------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 01111110 0000 00 001134688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=313.42 Aligned_cols=254 Identities=30% Similarity=0.526 Sum_probs=199.7
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
.++|++.++||+|+||.||+|... ++..||+|.+..... ..+.+.+|+.++++++||+++++++++.. ...+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~~~ 76 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE------EPIY 76 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC------CCcE
Confidence 347899999999999999999876 667899999864333 45678999999999999999999998532 3358
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||+++++|.+++..... ..+++.+++.++.|++.||+|||+. +++||||||+||++++++.++|+|||.+
T Consensus 77 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~ 149 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEG----RALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLA 149 (260)
T ss_pred EEEEecCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceee
Confidence 99999999999999976432 2589999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhhhC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFARTAL 916 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 916 (992)
......... ......++..|+|||+..+..++.++||||||+++|+|++ |..||.+....
T Consensus 150 ~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~------------ 210 (260)
T cd05070 150 RLIEDNEYT-------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR------------ 210 (260)
T ss_pred eeccCcccc-------cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH------------
Confidence 876432111 1112235678999999988889999999999999999999 89998653211
Q ss_pred ChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 037275 917 PDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCR 981 (992)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 981 (992)
+..+..... . .... .......+.+++.+|+..+|++|||++++.+.|++
T Consensus 211 -----~~~~~~~~~-~----~~~~------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 211 -----EVLEQVERG-Y----RMPC------PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred -----HHHHHHHcC-C----CCCC------CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 111111000 0 0000 11223568999999999999999999999988874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=321.13 Aligned_cols=269 Identities=22% Similarity=0.289 Sum_probs=208.2
Q ss_pred ccHHHHHHHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhc-cCCcceeEEEEeec
Q 037275 669 ISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNI-RHRNLIKIITICSS 747 (992)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 747 (992)
+...++.++.++|++.+.||+|+||.||+|....+++.+|+|++... ......+.+|+.+++++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc-ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 44566677788999999999999999999999889999999998633 22345678899999999 89999999999876
Q ss_pred ccccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCC
Q 037275 748 IDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDL 827 (992)
Q Consensus 748 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 827 (992)
.+.......++||||+++|+|.++++..... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~ 165 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLIC--GQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEG 165 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCC
Confidence 5444456789999999999999998753211 23589999999999999999999999 999999999999999999
Q ss_pred cEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCC-----CcCcccchhhHHHHHHHHHhCCCCCCCCc
Q 037275 828 VAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-----EASMTGDVYSFGILLLEMFTRRRPTDGMF 902 (992)
Q Consensus 828 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~il~elltg~~pf~~~~ 902 (992)
.+||+|||.+........ ......|+..|+|||++... .++.++|||||||++|||++|+.||....
T Consensus 166 ~~kl~dfg~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~ 237 (291)
T cd06639 166 GVKLVDFGVSAQLTSTRL--------RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH 237 (291)
T ss_pred CEEEeecccchhcccccc--------cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc
Confidence 999999999886543211 11223578899999987543 36889999999999999999999987532
Q ss_pred cCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 903 NQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
... .......... .. .....+....+.+++.+||+.+|++||++.|+++
T Consensus 238 ~~~-~~~~~~~~~~---------------------~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 238 PVK-TLFKIPRNPP---------------------PT----LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HHH-HHHHHhcCCC---------------------CC----CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 110 0000000000 00 0001122345889999999999999999999985
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=318.73 Aligned_cols=262 Identities=25% Similarity=0.416 Sum_probs=202.2
Q ss_pred hcCCCCCCccccccceEEEEeEE-----CCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccC
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNL-----GENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKG 752 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 752 (992)
..+|+..++||+|+||.||+|.. ..++..+|+|.+..........+.+|+++++.++||||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 78 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTE----- 78 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEec-----
Confidence 34788899999999999999974 23567899998875555556789999999999999999999998643
Q ss_pred cceEEEEEEeccCCCHHHHHhhcccc---------hhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeee
Q 037275 753 VDFQAIVYEYMQNGSLEDWLHQSEDQ---------QEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLL 823 (992)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~---------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 823 (992)
....++||||+++|+|.+++...... .....+++..++.++.|++.|++|||+. +++||||||+||++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~ 155 (280)
T cd05092 79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLV 155 (280)
T ss_pred CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEE
Confidence 34569999999999999999865421 0113488999999999999999999999 99999999999999
Q ss_pred CCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCc
Q 037275 824 DQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMF 902 (992)
Q Consensus 824 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~ 902 (992)
++++.+||+|||++........ ........+++.|+|||++.+..++.++|||||||++|||++ |.+||....
T Consensus 156 ~~~~~~kL~dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 229 (280)
T cd05092 156 GQGLVVKIGDFGMSRDIYSTDY------YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS 229 (280)
T ss_pred cCCCCEEECCCCceeEcCCCce------eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCC
Confidence 9999999999999976543211 011122335788999999998999999999999999999998 999986432
Q ss_pred cCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 037275 903 NQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCR 981 (992)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 981 (992)
... .......... ... .......+.+++.+||+.||++||+++||++.|++
T Consensus 230 ~~~-----------------~~~~~~~~~~-~~~----------~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 230 NTE-----------------AIECITQGRE-LER----------PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHH-----------------HHHHHHcCcc-CCC----------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 110 0111100000 000 01123458899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=351.65 Aligned_cols=261 Identities=20% Similarity=0.306 Sum_probs=200.4
Q ss_pred HHHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC--CCchhHHHHHHHHHHhccCCcceeEEEEeecccccC
Q 037275 675 SKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKG 752 (992)
Q Consensus 675 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 752 (992)
....++|++.+.||+|+||+||+|++..++..||+|++.... ......+..|+.+++.++||||+++++++.. ..
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d---e~ 85 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLN---KA 85 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe---cC
Confidence 344568999999999999999999999899999999986432 2334678899999999999999999998643 23
Q ss_pred cceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCC----CCeEeccCCCCCeeeCC---
Q 037275 753 VDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQ----PPVVHGDLKPSNVLLDQ--- 825 (992)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~----~~ivH~Dlkp~NIll~~--- 825 (992)
...+++||||+++|+|.+++...... ...+++..++.|+.||+.||+|||+... .+||||||||+|||++.
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~~~~--~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~ 163 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKCYKM--FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR 163 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence 45679999999999999999764321 2358999999999999999999998521 25999999999999964
Q ss_pred --------------CCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccC--CCcCcccchhhHHHHHH
Q 037275 826 --------------DLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG--GEASMTGDVYSFGILLL 889 (992)
Q Consensus 826 --------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ 889 (992)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|
T Consensus 164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---------~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILY 234 (1021)
T PTZ00266 164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---------MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234 (1021)
T ss_pred ccccccccccccCCCCceEEccCCccccccccc---------cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHH
Confidence 2358999999998654321 1223468999999998854 45889999999999999
Q ss_pred HHHhCCCCCCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCC
Q 037275 890 EMFTRRRPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTER 969 (992)
Q Consensus 890 elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 969 (992)
||++|+.||..... .... +.... .... . .......++.+++..||+.+|.+|
T Consensus 235 ELLTGk~PF~~~~~----~~ql------------i~~lk-~~p~------l-----pi~~~S~eL~dLI~~~L~~dPeeR 286 (1021)
T PTZ00266 235 ELCSGKTPFHKANN----FSQL------------ISELK-RGPD------L-----PIKGKSKELNILIKNLLNLSAKER 286 (1021)
T ss_pred HHHHCCCCCCcCCc----HHHH------------HHHHh-cCCC------C-----CcCCCCHHHHHHHHHHhcCChhHC
Confidence 99999999975321 1111 11000 0000 0 001123458899999999999999
Q ss_pred CCHHHHHH
Q 037275 970 MEMRDVVA 977 (992)
Q Consensus 970 Ps~~evl~ 977 (992)
|++.|++.
T Consensus 287 PSa~QlL~ 294 (1021)
T PTZ00266 287 PSALQCLG 294 (1021)
T ss_pred cCHHHHhc
Confidence 99999984
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=330.38 Aligned_cols=266 Identities=23% Similarity=0.357 Sum_probs=202.9
Q ss_pred HhcCCCCCCccccccceEEEEeEEC-----CCCeEEEEEEeeccCC-CchhHHHHHHHHHHhcc-CCcceeEEEEeeccc
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLG-----ENGMMVAVKVINLKQK-GASNGFVAECQALRNIR-HRNLIKIITICSSID 749 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 749 (992)
..++|.+.++||+|+||.||+|++. ..++.||+|+++.... .....+.+|+.++.++. ||||+++++++..
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~-- 112 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK-- 112 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc--
Confidence 3447888999999999999999964 3457899999974432 22356889999999997 9999999998643
Q ss_pred ccCcceEEEEEEeccCCCHHHHHhhcccc---------------------------------------------------
Q 037275 750 FKGVDFQAIVYEYMQNGSLEDWLHQSEDQ--------------------------------------------------- 778 (992)
Q Consensus 750 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------------------------------------- 778 (992)
....++||||+++|+|.++++..+..
T Consensus 113 ---~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 113 ---GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred ---CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 34579999999999999999764320
Q ss_pred -----------------------------------------hhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCC
Q 037275 779 -----------------------------------------QEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLK 817 (992)
Q Consensus 779 -----------------------------------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlk 817 (992)
.....+++..+..++.|++.||+|||+. +|+|||||
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlk 266 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLA 266 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCC
Confidence 0113467888999999999999999999 99999999
Q ss_pred CCCeeeCCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCC
Q 037275 818 PSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRR 896 (992)
Q Consensus 818 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~ 896 (992)
|+||++++++.+||+|||+++....... ........+++.|+|||.+.+..++.++|||||||++|||++ |..
T Consensus 267 p~NiLl~~~~~~kL~DfGla~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~ 340 (401)
T cd05107 267 ARNVLICEGKLVKICDFGLARDIMRDSN------YISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGT 340 (401)
T ss_pred cceEEEeCCCEEEEEecCcceecccccc------cccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCC
Confidence 9999999999999999999986543211 011122346788999999988889999999999999999998 889
Q ss_pred CCCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 037275 897 PTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVV 976 (992)
Q Consensus 897 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 976 (992)
||......+ .....+.. ..... . ......++.+++.+||..+|++||+++||+
T Consensus 341 P~~~~~~~~-------------~~~~~~~~----~~~~~----~------p~~~~~~l~~li~~cl~~~P~~RPs~~ell 393 (401)
T cd05107 341 PYPELPMNE-------------QFYNAIKR----GYRMA----K------PAHASDEIYEIMQKCWEEKFEIRPDFSQLV 393 (401)
T ss_pred CCCCCCchH-------------HHHHHHHc----CCCCC----C------CCCCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 986532111 00111110 00000 0 001234689999999999999999999999
Q ss_pred HHHHHHH
Q 037275 977 AKLCRAR 983 (992)
Q Consensus 977 ~~L~~~~ 983 (992)
+.|+++.
T Consensus 394 ~~L~~~~ 400 (401)
T cd05107 394 HLVGDLL 400 (401)
T ss_pred HHHHHHh
Confidence 9998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=326.22 Aligned_cols=281 Identities=19% Similarity=0.187 Sum_probs=196.5
Q ss_pred CCCccccc--cceEEEEeEECCCCeEEEEEEeeccC--CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEE
Q 037275 683 SSNMIGQG--SFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAI 758 (992)
Q Consensus 683 ~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 758 (992)
+.++||+| +|++||++..+.+|+.||+|+++... ....+.+.+|+++++.++||||+++++++. .....++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~-----~~~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFI-----ADNELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE-----ECCEEEE
Confidence 46789999 78999999999999999999986442 223456788999999999999999999864 3456799
Q ss_pred EEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccce
Q 037275 759 VYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAK 838 (992)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 838 (992)
||||+++|+|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.++++||+.+.
T Consensus 77 v~e~~~~~~l~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~ 149 (327)
T cd08227 77 VTSFMAYGSAKDLICTHFM----DGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNL 149 (327)
T ss_pred EEeccCCCcHHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhh
Confidence 9999999999999975432 2488999999999999999999999 99999999999999999999999998765
Q ss_pred ecCCCCCCCCcccCCCCCcccccccccccccccC--CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhC
Q 037275 839 FLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG--GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTAL 916 (992)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 916 (992)
........... .........++..|+|||++.+ ..++.++|||||||++|||++|+.||........ .........
T Consensus 150 ~~~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~ 227 (327)
T cd08227 150 SMINHGQRLRV-VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM-LLEKLNGTV 227 (327)
T ss_pred ccccccccccc-cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH-HHHHhcCCc
Confidence 43221110000 0111122356788999999876 4588999999999999999999999976433211 111111111
Q ss_pred ChhHH--HHHHhhHh-------------HhhhccCCCC---CCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 917 PDKVM--EIVDSVLL-------------LEVQASNSRS---CGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 917 ~~~~~--~~~~~~~~-------------~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
+.... ........ ........+. .............++.+++.+||+.||++|||++|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 228 PCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred cccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 10000 00000000 0000000000 00000011223457889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=320.84 Aligned_cols=251 Identities=23% Similarity=0.315 Sum_probs=201.7
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
..+|++.+.||+|+||.||+|....+++.||+|.+........+.+.+|+.+++.++||||+++++++. .....+
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~ 92 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELW 92 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCEEE
Confidence 468999999999999999999998899999999997655555677889999999999999999999864 345679
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||+++++|.+++.+. .+++.++..++.|++.||.|||+. +++||||||+||+++.++.++|+|||.+
T Consensus 93 lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~ 162 (297)
T cd06656 93 VVMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC 162 (297)
T ss_pred EeecccCCCCHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccc
Confidence 999999999999998643 378889999999999999999999 9999999999999999999999999998
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALP 917 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 917 (992)
....... .......+++.|+|||.+.+..++.++|||||||++|++++|+.||........... ......+
T Consensus 163 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-~~~~~~~ 233 (297)
T cd06656 163 AQITPEQ--------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-IATNGTP 233 (297)
T ss_pred eEccCCc--------cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-eccCCCC
Confidence 7654321 111233578899999999888899999999999999999999999965322110000 0000000
Q ss_pred hhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 918 DKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
. ..........+.+++.+||+.+|++||+++++++
T Consensus 234 ~-------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 234 E-------------------------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred C-------------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 0001112345788999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=332.63 Aligned_cols=196 Identities=27% Similarity=0.328 Sum_probs=166.5
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
...|.+.+.||+|+||.||+|.+..+++.||||... ...+.+|++++++++||||+++++++.. ....+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~-----~~~~~ 236 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVV-----GGLTC 236 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEE-----CCEEE
Confidence 347999999999999999999999899999999642 2345789999999999999999998643 34568
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+|||++ .++|.+++..... .+++.+++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 237 lv~e~~-~~~L~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla 307 (461)
T PHA03211 237 LVLPKY-RSDLYTYLGARLR-----PLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAA 307 (461)
T ss_pred EEEEcc-CCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCc
Confidence 999999 4799998875432 589999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTD 899 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~ 899 (992)
+....... ........||+.|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus 308 ~~~~~~~~------~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 308 CFARGSWS------TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred eecccccc------cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 86543211 111224569999999999999999999999999999999999887653
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=322.10 Aligned_cols=270 Identities=23% Similarity=0.369 Sum_probs=206.0
Q ss_pred hcCCCCCCccccccceEEEEeEECC-------CCeEEEEEEeeccC-CCchhHHHHHHHHHHhc-cCCcceeEEEEeecc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGE-------NGMMVAVKVINLKQ-KGASNGFVAECQALRNI-RHRNLIKIITICSSI 748 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 748 (992)
.++|.+.+.||+|+||.||+|++.. +...||+|.++... ......+.+|+.+++++ +||||+++++++..
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~- 95 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ- 95 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-
Confidence 3579999999999999999998642 23579999986432 23345688899999999 79999999998643
Q ss_pred cccCcceEEEEEEeccCCCHHHHHhhcccch----------hhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCC
Q 037275 749 DFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQ----------EARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKP 818 (992)
Q Consensus 749 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp 818 (992)
....++||||+++|+|.+++....... ....+++.+++.++.|++.||+|||++ +++||||||
T Consensus 96 ----~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp 168 (307)
T cd05098 96 ----DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAA 168 (307)
T ss_pred ----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccH
Confidence 345699999999999999998653210 123588999999999999999999999 999999999
Q ss_pred CCeeeCCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCC
Q 037275 819 SNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRP 897 (992)
Q Consensus 819 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p 897 (992)
+||+++.++.+||+|||.++........ .......+++.|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p 242 (307)
T cd05098 169 RNVLVTEDNVMKIADFGLARDIHHIDYY------KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 242 (307)
T ss_pred HheEEcCCCcEEECCCcccccccccchh------hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCC
Confidence 9999999999999999998765421110 01111224568999999988889999999999999999998 8888
Q ss_pred CCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 898 TDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 898 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
|.+... .+ ....+.. .... ........++.+++.+||..+|++|||+.||++
T Consensus 243 ~~~~~~-----~~---------~~~~~~~----~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 294 (307)
T cd05098 243 YPGVPV-----EE---------LFKLLKE----GHRM----------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294 (307)
T ss_pred CCcCCH-----HH---------HHHHHHc----CCCC----------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 864211 11 1111110 0000 001122356889999999999999999999999
Q ss_pred HHHHHHHhhhhc
Q 037275 978 KLCRARDTFLGR 989 (992)
Q Consensus 978 ~L~~~~~~~~~~ 989 (992)
.|+++......+
T Consensus 295 ~l~~~~~~~~~~ 306 (307)
T cd05098 295 DLDRILALTSNQ 306 (307)
T ss_pred HHHHHHHHhhcC
Confidence 999998876554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=318.52 Aligned_cols=276 Identities=22% Similarity=0.334 Sum_probs=197.8
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC--CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
+|++.+.||+|++|.||+|+...+++.||+|.++... ......+.+|+.+++.++||||+++++++. .....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLM-----QESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEe-----eCCeEE
Confidence 4788899999999999999998889999999986432 223467889999999999999999999864 345679
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||++ ++|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 76 ~v~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~ 148 (285)
T cd07861 76 LIFEFLS-MDLKKYLDSLPK---GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLA 148 (285)
T ss_pred EEEecCC-CCHHHHHhcCCC---CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccce
Confidence 9999997 689998875432 23589999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh-h
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART-A 915 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~-~ 915 (992)
....... .......+++.|+|||++.+. .++.++|||||||++|+|+||++||.+.............. .
T Consensus 149 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~ 220 (285)
T cd07861 149 RAFGIPV--------RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGT 220 (285)
T ss_pred eecCCCc--------ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCC
Confidence 7653221 111223568899999987654 57889999999999999999999997643221111100000 0
Q ss_pred CChhHHHHHHhhHhHhhhccCCCCCC-ccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 916 LPDKVMEIVDSVLLLEVQASNSRSCG-DERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
..+......... ..+......... ...........++.+++.+||..||++|||++||++
T Consensus 221 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 221 PTEDVWPGVTSL--PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred CChhhhhcchhh--HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000000000 000000000000 000000112356789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=317.61 Aligned_cols=252 Identities=25% Similarity=0.352 Sum_probs=197.6
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC---CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK---GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
.|+..++||+|+||.||+|.+..+++.||+|.+..... .....+.+|+.++++++|++++++.+.+. .....
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~ 75 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYE-----TKDAL 75 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEe-----cCCEE
Confidence 36778899999999999999999999999999864322 12345678999999999999999999854 34567
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
++||||+++++|.+++..... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||+
T Consensus 76 ~lv~e~~~g~~L~~~l~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~ 148 (285)
T cd05630 76 CLVLTLMNGGDLKFHIYHMGE----AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGL 148 (285)
T ss_pred EEEEEecCCCcHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccc
Confidence 999999999999999865432 2589999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhC
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTAL 916 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 916 (992)
+....... ......|+..|+|||++.+..++.++||||+||++|+|++|+.||........ .+
T Consensus 149 ~~~~~~~~---------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~--~~------ 211 (285)
T cd05630 149 AVHVPEGQ---------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK--RE------ 211 (285)
T ss_pred eeecCCCc---------cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch--HH------
Confidence 87643211 11234689999999999999999999999999999999999999976322110 00
Q ss_pred ChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 037275 917 PDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERME-----MRDVVA 977 (992)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 977 (992)
.......... ... .......+.+++.+||+.||++||| ++|+++
T Consensus 212 --~~~~~~~~~~-~~~--------------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 212 --EVERLVKEVQ-EEY--------------SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred --HHHhhhhhhh-hhc--------------CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 0001110000 000 0112345789999999999999999 888886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=327.37 Aligned_cols=244 Identities=26% Similarity=0.307 Sum_probs=187.8
Q ss_pred CccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHH-HHHhccCCcceeEEEEeecccccCcceEEEEE
Q 037275 685 NMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQ-ALRNIRHRNLIKIITICSSIDFKGVDFQAIVY 760 (992)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 760 (992)
+.||+|+||+||+|++..+++.||+|++.... ......+..|.. +++.++||||+++++++. ..+..++||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~-----~~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ-----TADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEE-----cCCeEEEEE
Confidence 47999999999999999899999999996432 122234444444 567889999999999853 455679999
Q ss_pred EeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceec
Q 037275 761 EYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFL 840 (992)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 840 (992)
||+++|+|.+++.... .+.+..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~ 146 (325)
T cd05602 76 DYINGGELFYHLQRER------CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN 146 (325)
T ss_pred eCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCccc
Confidence 9999999999997543 477888889999999999999999 9999999999999999999999999998753
Q ss_pred CCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCChhH
Q 037275 841 SSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKV 920 (992)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 920 (992)
... ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+.... +
T Consensus 147 ~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~---------- 203 (325)
T cd05602 147 IEH--------NGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-----E---------- 203 (325)
T ss_pred ccC--------CCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH-----H----------
Confidence 221 11223456899999999999999999999999999999999999999753211 1
Q ss_pred HHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 037275 921 MEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKL 979 (992)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 979 (992)
..+........ . .......+.+++.+|++.||.+||++.+.+.++
T Consensus 204 --~~~~i~~~~~~------~------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i 248 (325)
T cd05602 204 --MYDNILNKPLQ------L------KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 248 (325)
T ss_pred --HHHHHHhCCcC------C------CCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHH
Confidence 11111100000 0 011234578999999999999999988654433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=315.49 Aligned_cols=274 Identities=22% Similarity=0.368 Sum_probs=203.3
Q ss_pred cCCCCCCccccccceEEEEeEE----CCCCeEEEEEEeeccC-CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCc
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNL----GENGMMVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 753 (992)
..|++.+.||+|+||.||.|+. ..++..||+|.++... ......+.+|+.++++++|||++++.+++.. .+.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~ 80 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE---DGG 80 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEec---CCC
Confidence 3578899999999999999985 3468899999986443 3334678999999999999999999998754 223
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGD 833 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 833 (992)
...++||||+++++|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 81 ~~~~lv~e~~~g~~L~~~l~~~~~-----~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~d 152 (284)
T cd05079 81 NGIKLIMEFLPSGSLKEYLPRNKN-----KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGD 152 (284)
T ss_pred CceEEEEEccCCCCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECC
Confidence 556899999999999999975432 489999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 913 (992)
||.++........ ........++..|+|||++.+..++.++|||||||++|||++++.|+...... ......
T Consensus 153 fg~~~~~~~~~~~-----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~---~~~~~~ 224 (284)
T cd05079 153 FGLTKAIETDKEY-----YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTL---FLKMIG 224 (284)
T ss_pred CccccccccCccc-----eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccch---hhhhcc
Confidence 9999866432211 01112345677899999998888999999999999999999988765432110 000000
Q ss_pred hhCCh-hHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 037275 914 TALPD-KVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRA 982 (992)
Q Consensus 914 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 982 (992)
....+ .....+.... .. .... ........+.+++.+||+.+|++|||++++++.++++
T Consensus 225 ~~~~~~~~~~~~~~~~-~~------~~~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 225 PTHGQMTVTRLVRVLE-EG------KRLP----RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cccccccHHHHHHHHH-cC------ccCC----CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00000 0111111100 00 0000 0112345689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=320.30 Aligned_cols=269 Identities=23% Similarity=0.352 Sum_probs=199.0
Q ss_pred hcCCCCCCccccccceEEEEeEECCC--------------CeEEEEEEeeccC-CCchhHHHHHHHHHHhccCCcceeEE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGEN--------------GMMVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIKII 742 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~--------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~ 742 (992)
.++|++.++||+|+||.||+|+.... ...||+|.++... ......+.+|++++++++|||+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 35899999999999999999987532 2358999986432 22345688999999999999999999
Q ss_pred EEeecccccCcceEEEEEEeccCCCHHHHHhhcccc------hhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccC
Q 037275 743 TICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQ------QEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDL 816 (992)
Q Consensus 743 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dl 816 (992)
+++. .....++||||+++++|.+++...... .....+++..++.++.|++.||+|||++ +++||||
T Consensus 84 ~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dl 155 (295)
T cd05097 84 GVCV-----SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDL 155 (295)
T ss_pred EEEc-----CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---Ceecccc
Confidence 9964 345669999999999999999754311 1112478899999999999999999999 9999999
Q ss_pred CCCCeeeCCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh--C
Q 037275 817 KPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT--R 894 (992)
Q Consensus 817 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt--g 894 (992)
||+||++++++.+||+|||++........ ........++..|+|||+..++.++.++|||||||++|+|++ |
T Consensus 156 kp~Nill~~~~~~kl~dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~ 229 (295)
T cd05097 156 ATRNCLVGNHYTIKIADFGMSRNLYSGDY------YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCK 229 (295)
T ss_pred ChhhEEEcCCCcEEecccccccccccCcc------eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCC
Confidence 99999999999999999999976543211 111122345778999999988899999999999999999998 5
Q ss_pred CCCCCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 037275 895 RRPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRD 974 (992)
Q Consensus 895 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 974 (992)
..||...... +.... ............+ .. .....+..+.+++.+||+.||++|||+++
T Consensus 230 ~~p~~~~~~~-----~~~~~-----~~~~~~~~~~~~~------~~-----~~~~~~~~l~~li~~~l~~~p~~RPs~~~ 288 (295)
T cd05097 230 EQPYSLLSDE-----QVIEN-----TGEFFRNQGRQIY------LS-----QTPLCPSPVFKLMMRCWSRDIKDRPTFNK 288 (295)
T ss_pred CCCCcccChH-----HHHHH-----HHHhhhhcccccc------CC-----CCCCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence 6677643211 00000 0000000000000 00 00012346899999999999999999999
Q ss_pred HHHHHHH
Q 037275 975 VVAKLCR 981 (992)
Q Consensus 975 vl~~L~~ 981 (992)
|++.|++
T Consensus 289 i~~~l~~ 295 (295)
T cd05097 289 IHHFLRE 295 (295)
T ss_pred HHHHHhC
Confidence 9998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=316.56 Aligned_cols=252 Identities=24% Similarity=0.331 Sum_probs=196.4
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC-CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
++|++.++||+|+||.||+|.+..+++.||+|++.... ......+.+|++++++++||||+++++++.. ....+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 75 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV-----ENRIS 75 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE-----CCEEE
Confidence 36888999999999999999998899999999986442 2234568899999999999999999998654 34568
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||+++++|..+. .+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||++
T Consensus 76 lv~e~~~~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~ 142 (279)
T cd06619 76 ICTEFMDGGSLDVYR----------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVS 142 (279)
T ss_pred EEEecCCCCChHHhh----------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcc
Confidence 999999999997653 367888899999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALP 917 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 917 (992)
...... ......|+..|+|||++.+..++.++|||||||++|+|++|+.||.......... .+
T Consensus 143 ~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~-------~~ 205 (279)
T cd06619 143 TQLVNS----------IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL-------MP 205 (279)
T ss_pred eecccc----------cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc-------ch
Confidence 765322 1223468899999999998899999999999999999999999997632221110 00
Q ss_pred hhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 918 DKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
.. ......... .... .......++.+++.+||+.+|++||+++|+++.
T Consensus 206 ~~---~~~~~~~~~-----~~~~-----~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 206 LQ---LLQCIVDED-----PPVL-----PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HH---HHHHHhccC-----CCCC-----CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00 000000000 0000 001123457899999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=328.27 Aligned_cols=243 Identities=25% Similarity=0.288 Sum_probs=188.1
Q ss_pred CccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHH-HHHhccCCcceeEEEEeecccccCcceEEEEE
Q 037275 685 NMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQ-ALRNIRHRNLIKIITICSSIDFKGVDFQAIVY 760 (992)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 760 (992)
+.||+|+||+||+|++..+|+.||+|++.... ......+..|.. +++.++||||+++++++. ..+..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~-----~~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ-----TTEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEe-----cCCEEEEEE
Confidence 46999999999999999899999999996432 223344555554 467789999999998853 455679999
Q ss_pred EeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceec
Q 037275 761 EYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFL 840 (992)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 840 (992)
||+++|+|..++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~ 146 (325)
T cd05604 76 DFVNGGELFFHLQRER------SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (325)
T ss_pred cCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence 9999999999887543 488999999999999999999999 9999999999999999999999999998743
Q ss_pred CCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCChhH
Q 037275 841 SSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKV 920 (992)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 920 (992)
... ........||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 147 ~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---------------- 202 (325)
T cd05604 147 IAQ--------SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA---------------- 202 (325)
T ss_pred CCC--------CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH----------------
Confidence 211 11223456899999999999999999999999999999999999999753111
Q ss_pred HHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 921 MEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
+..+......... .......+.+++.+|++.+|++||++.+.++.
T Consensus 203 -~~~~~~~~~~~~~------------~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 203 -EMYDNILHKPLVL------------RPGASLTAWSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred -HHHHHHHcCCccC------------CCCCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence 1111111110000 00123457889999999999999998644433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=312.73 Aligned_cols=254 Identities=24% Similarity=0.335 Sum_probs=199.3
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC-----CchhHHHHHHHHHHhccCCcceeEEEEeecccccCc
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK-----GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 753 (992)
++|++.+.||+|++|.||+|....+++.||+|.+..... .....+.+|++++++++||||+++++++. ..
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~ 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLR-----DD 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEc-----cC
Confidence 468999999999999999999988899999999864322 12356788999999999999999999964 34
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGD 833 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 833 (992)
...++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||+|+||++++++.++|+|
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~d 147 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKAYG------ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGD 147 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEee
Confidence 57799999999999999987543 478889999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 913 (992)
||.++....... .........++..|+|||++.+..++.++||||+|+++|||++|+.||...... ....
T Consensus 148 fg~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~- 217 (263)
T cd06625 148 FGASKRLQTICS-----SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM----AAIF- 217 (263)
T ss_pred cccceecccccc-----ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH----HHHH-
Confidence 999976543211 011112345788999999999988999999999999999999999998642111 0000
Q ss_pred hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 914 TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
.... ... . ..........+.+++.+||..+|++|||+.|+++.
T Consensus 218 --------~~~~----~~~-----~-----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 218 --------KIAT----QPT-----N-----PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred --------HHhc----cCC-----C-----CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0000 000 0 00001223458899999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=329.04 Aligned_cols=239 Identities=24% Similarity=0.315 Sum_probs=188.7
Q ss_pred CccccccceEEEEeEE---CCCCeEEEEEEeeccC--CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEE
Q 037275 685 NMIGQGSFGFVYKGNL---GENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIV 759 (992)
Q Consensus 685 ~~lg~G~~g~V~~~~~---~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 759 (992)
+.||+|+||.||+++. ..+|+.||+|++.... ......+.+|++++++++||||+++++++. .....++|
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~lv 76 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQ-----TEGKLYLI 76 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEE-----cCCEEEEE
Confidence 6799999999999886 3578999999997432 223345678999999999999999999853 45577999
Q ss_pred EEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccccee
Q 037275 760 YEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKF 839 (992)
Q Consensus 760 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 839 (992)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 77 ~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 147 (318)
T cd05582 77 LDFLRGGDLFTRLSKEV------MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKE 147 (318)
T ss_pred EcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcc
Confidence 99999999999986533 489999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCChh
Q 037275 840 LSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDK 919 (992)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 919 (992)
.... ........|++.|+|||++.+..++.++|||||||++|||++|+.||...... +
T Consensus 148 ~~~~--------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-----~--------- 205 (318)
T cd05582 148 SIDH--------EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK-----E--------- 205 (318)
T ss_pred cCCC--------CCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH-----H---------
Confidence 4322 11122356899999999999888999999999999999999999999753211 0
Q ss_pred HHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 037275 920 VMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRD 974 (992)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 974 (992)
........... .+ ......+.+++.+||+.||++||++.+
T Consensus 206 ---~~~~i~~~~~~------~p------~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 206 ---TMTMILKAKLG------MP------QFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred ---HHHHHHcCCCC------CC------CCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 11111100000 00 112345789999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=313.84 Aligned_cols=254 Identities=24% Similarity=0.331 Sum_probs=202.7
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAI 758 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 758 (992)
++|++.+.||+|+||.||+|....+++.+|+|++........+.+.+|++++++++||||+++++++. .....++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~l 77 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL-----RRDKLWI 77 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEE-----eCCEEEE
Confidence 57889999999999999999998889999999997665556678999999999999999999999853 3456799
Q ss_pred EEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccce
Q 037275 759 VYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAK 838 (992)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 838 (992)
+|||+++++|.+++.... ..+++..++.++.|++.||+|||++ +++||||+|+||+++.++.+||+|||.+.
T Consensus 78 ~~e~~~~~~l~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~ 149 (262)
T cd06613 78 VMEYCGGGSLQDIYQVTR-----GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSA 149 (262)
T ss_pred EEeCCCCCcHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccch
Confidence 999999999999987642 2488999999999999999999999 99999999999999999999999999987
Q ss_pred ecCCCCCCCCcccCCCCCcccccccccccccccCC---CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh
Q 037275 839 FLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG---EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 915 (992)
...... .......++..|+|||.+.+. .++.++|||||||++|||++|+.||........ .....
T Consensus 150 ~~~~~~--------~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-~~~~~--- 217 (262)
T cd06613 150 QLTATI--------AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-LFLIS--- 217 (262)
T ss_pred hhhhhh--------hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHH---
Confidence 654211 112234578899999998776 889999999999999999999999875321100 00000
Q ss_pred CChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 916 LPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
...+.. ...........++.+++.+||..+|.+|||+++|+.
T Consensus 218 -------------~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 218 -------------KSNFPP-------PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred -------------hccCCC-------ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000 000011223456899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=314.91 Aligned_cols=258 Identities=26% Similarity=0.453 Sum_probs=200.4
Q ss_pred cCCCCCCccccccceEEEEeEECCCCe---EEEEEEeeccC-CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcc
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGM---MVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
++|+..+.||+|+||.||+|+...++. .+|+|.++... ....+.+.+|++++++++|||++++.+++.. .+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 79 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK-----FK 79 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc-----CC
Confidence 467888999999999999999865443 79999886442 2335678899999999999999999998643 34
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
..++||||+++++|.+++..... .+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+||
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~df 151 (268)
T cd05063 80 PAMIITEYMENGALDKYLRDHDG-----EFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDF 151 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCC
Confidence 56999999999999999975432 489999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 913 (992)
|++.......... ........+..|+|||++.+..++.++|||||||++||+++ |+.||......
T Consensus 152 g~~~~~~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~--------- 217 (268)
T cd05063 152 GLSRVLEDDPEGT-----YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH--------- 217 (268)
T ss_pred ccceecccccccc-----eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH---------
Confidence 9998664321110 01111223567999999988889999999999999999998 99998653211
Q ss_pred hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 037275 914 TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRA 982 (992)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 982 (992)
.....+.. . .. . ....+...++.+++.+||+.+|++||++.+|++.|.++
T Consensus 218 -----~~~~~i~~---~-~~------~----~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 218 -----EVMKAIND---G-FR------L----PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -----HHHHHHhc---C-CC------C----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11111110 0 00 0 00112245688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=324.72 Aligned_cols=243 Identities=23% Similarity=0.318 Sum_probs=190.7
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeecc---CCCchhHHHHHHHHHHhcc-CCcceeEEEEeecccccCcce
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK---QKGASNGFVAECQALRNIR-HRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 755 (992)
+|+..+.||+|+||+||+|++..+++.||+|+++.. .....+.+..|..+++.+. |++|+++.+++ ...+.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF-----QTVDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEE-----ecCCE
Confidence 477889999999999999999989999999998743 2233456778889988886 56777788774 34456
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++||||+++|+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~~~------~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg 146 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQVG------KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFG 146 (323)
T ss_pred EEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccc
Confidence 799999999999999987543 488999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 915 (992)
+++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....
T Consensus 147 ~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~----------- 207 (323)
T cd05615 147 MCKEHMVDG--------VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED----------- 207 (323)
T ss_pred cccccCCCC--------ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH-----------
Confidence 987533211 1123346899999999999889999999999999999999999999763211
Q ss_pred CChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHH
Q 037275 916 LPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMR 973 (992)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 973 (992)
............ .+ .....++.+++.+||+.+|.+|+++.
T Consensus 208 ------~~~~~i~~~~~~------~p------~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 208 ------ELFQSIMEHNVS------YP------KSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred ------HHHHHHHhCCCC------CC------ccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 011111110000 00 01134578899999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=317.17 Aligned_cols=269 Identities=22% Similarity=0.370 Sum_probs=200.1
Q ss_pred hcCCCCCCccccccceEEEEeEEC----------------CCCeEEEEEEeeccC-CCchhHHHHHHHHHHhccCCccee
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLG----------------ENGMMVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIK 740 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~----------------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 740 (992)
.++|++.++||+|+||.||+|... .++..||+|+++... ......+.+|+.+++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 357999999999999999998643 234579999986442 233467899999999999999999
Q ss_pred EEEEeecccccCcceEEEEEEeccCCCHHHHHhhcccch-----hhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecc
Q 037275 741 IITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQ-----EARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGD 815 (992)
Q Consensus 741 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-----~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~D 815 (992)
+++++.. ....++||||+++|+|.+++....... ....+++.+++.++.|++.||+|||+. +++|||
T Consensus 84 ~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~d 155 (296)
T cd05095 84 LLAVCIT-----SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRD 155 (296)
T ss_pred EEEEEec-----CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Ceeccc
Confidence 9998643 345699999999999999998654221 123478889999999999999999999 999999
Q ss_pred CCCCCeeeCCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh--
Q 037275 816 LKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-- 893 (992)
Q Consensus 816 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-- 893 (992)
|||+||+++.++.++|+|||+++.+..... ........++..|+|||+..++.++.++|||||||++|||++
T Consensus 156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~------~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~ 229 (296)
T cd05095 156 LATRNCLVGKNYTIKIADFGMSRNLYSGDY------YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLC 229 (296)
T ss_pred CChheEEEcCCCCEEeccCcccccccCCcc------eeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhC
Confidence 999999999999999999999986543211 011122334678999999888889999999999999999998
Q ss_pred CCCCCCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHH
Q 037275 894 RRRPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMR 973 (992)
Q Consensus 894 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 973 (992)
|..||...... +.... ............. . .........+.+++.+||+.||++|||+.
T Consensus 230 ~~~p~~~~~~~-----~~~~~-----~~~~~~~~~~~~~-------~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ 288 (296)
T cd05095 230 KEQPYSQLSDE-----QVIEN-----TGEFFRDQGRQVY-------L----PKPALCPDSLYKLMLSCWRRNAKERPSFQ 288 (296)
T ss_pred CCCCccccChH-----HHHHH-----HHHHHhhcccccc-------C----CCCCCCCHHHHHHHHHHcCCCcccCCCHH
Confidence 77888653221 11100 0000000000000 0 00011235688999999999999999999
Q ss_pred HHHHHHHH
Q 037275 974 DVVAKLCR 981 (992)
Q Consensus 974 evl~~L~~ 981 (992)
||.+.|++
T Consensus 289 ~i~~~l~~ 296 (296)
T cd05095 289 EIHATLLE 296 (296)
T ss_pred HHHHHHhC
Confidence 99998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=318.06 Aligned_cols=251 Identities=24% Similarity=0.337 Sum_probs=196.6
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEE
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIV 759 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 759 (992)
.|++.+.||+|+||.||+|.+..++..+|+|.+..........+.+|+++++.++|||++++++++.. ....++|
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-----~~~~~~v 80 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENNLWIL 80 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee-----CCEEEEE
Confidence 36778899999999999999998899999999865554456678899999999999999999998643 4567999
Q ss_pred EEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccccee
Q 037275 760 YEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKF 839 (992)
Q Consensus 760 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 839 (992)
|||+++++|..++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++..
T Consensus 81 ~e~~~~~~l~~~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~ 152 (282)
T cd06643 81 IEFCAGGAVDAVMLELE-----RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAK 152 (282)
T ss_pred EEecCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccc
Confidence 99999999999886532 2589999999999999999999999 999999999999999999999999999875
Q ss_pred cCCCCCCCCcccCCCCCccccccccccccccc-----CCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 840 LSSSPLDTAVETPSSSKGIKGTVGYIAPEYGM-----GGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
..... .......++..|+|||++. +..++.++||||+||++|||++|++||....... .....
T Consensus 153 ~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~--- 220 (282)
T cd06643 153 NTRTI--------QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR-VLLKI--- 220 (282)
T ss_pred ccccc--------cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH-HHHHH---
Confidence 43211 1122345889999999874 3457889999999999999999999987532110 00000
Q ss_pred hCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 915 ALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
...... . .........++.+++.+||+.||++|||++++++
T Consensus 221 -------------~~~~~~-----~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 221 -------------AKSEPP-----T----LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred -------------hhcCCC-----C----CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000 0 0000112345889999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=318.62 Aligned_cols=268 Identities=23% Similarity=0.379 Sum_probs=202.7
Q ss_pred HhcCCCCCCccccccceEEEEeEEC-----CCCeEEEEEEeeccCC-CchhHHHHHHHHHHhccCCcceeEEEEeecccc
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLG-----ENGMMVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIITICSSIDF 750 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 750 (992)
..++|++.++||+|+||.||+|..+ ..+..||+|.+..... .....+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--- 80 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK--- 80 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC---
Confidence 4568999999999999999999764 2356899998753322 223457889999999999999999998643
Q ss_pred cCcceEEEEEEeccCCCHHHHHhhcccch----hhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCC
Q 037275 751 KGVDFQAIVYEYMQNGSLEDWLHQSEDQQ----EARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQD 826 (992)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 826 (992)
....++||||+++|+|.+++....... .....++..+..++.|++.||+|||++ +|+||||||+||+++++
T Consensus 81 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~ 155 (288)
T cd05061 81 --GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHD 155 (288)
T ss_pred --CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCC
Confidence 345699999999999999998643211 123457788899999999999999999 99999999999999999
Q ss_pred CcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCC
Q 037275 827 LVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQG 905 (992)
Q Consensus 827 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~ 905 (992)
+.+||+|||+++........ .......++..|+|||.+.++.++.++|||||||++|||++ |..||.+...+
T Consensus 156 ~~~~L~Dfg~~~~~~~~~~~------~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~- 228 (288)
T cd05061 156 FTVKIGDFGMTRDIYETDYY------RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE- 228 (288)
T ss_pred CcEEECcCCccccccccccc------cccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 99999999998865432211 11111235678999999988899999999999999999999 78888652111
Q ss_pred ccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 037275 906 LTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDT 985 (992)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 985 (992)
+..+........ . ........+.+++.+||+.||++|||+.|+++.|++....
T Consensus 229 ----------------~~~~~~~~~~~~----~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 281 (288)
T cd05061 229 ----------------QVLKFVMDGGYL----D-------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP 281 (288)
T ss_pred ----------------HHHHHHHcCCCC----C-------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCC
Confidence 111111100000 0 0011235689999999999999999999999998876544
Q ss_pred h
Q 037275 986 F 986 (992)
Q Consensus 986 ~ 986 (992)
.
T Consensus 282 ~ 282 (288)
T cd05061 282 S 282 (288)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=317.67 Aligned_cols=262 Identities=25% Similarity=0.386 Sum_probs=201.9
Q ss_pred hcCCCCCCccccccceEEEEeEECC-----CCeEEEEEEeeccCC-CchhHHHHHHHHHHhccCCcceeEEEEeeccccc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGE-----NGMMVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIITICSSIDFK 751 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 751 (992)
.++|++.+.||+|+||.||+|.... ++..||+|.+..... .....+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---- 80 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVST---- 80 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC----
Confidence 4578899999999999999999853 347899999864322 234568899999999999999999998643
Q ss_pred CcceEEEEEEeccCCCHHHHHhhcccch----hhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCC
Q 037275 752 GVDFQAIVYEYMQNGSLEDWLHQSEDQQ----EARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDL 827 (992)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 827 (992)
....++||||+++|+|.+++....... ....+++..++.++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 81 -~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~ 156 (277)
T cd05032 81 -GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDL 156 (277)
T ss_pred -CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCC
Confidence 355699999999999999997644321 123478899999999999999999999 999999999999999999
Q ss_pred cEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCc
Q 037275 828 VAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGL 906 (992)
Q Consensus 828 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~ 906 (992)
.+||+|||+++........ .......++..|+|||.+.++.++.++|||||||++||+++ |..||.+....
T Consensus 157 ~~kl~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-- 228 (277)
T cd05032 157 TVKIGDFGMTRDIYETDYY------RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE-- 228 (277)
T ss_pred CEEECCcccchhhccCccc------ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH--
Confidence 9999999999865432211 11122346788999999988889999999999999999998 99998642211
Q ss_pred cHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 037275 907 TLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCR 981 (992)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 981 (992)
+ ....+. .... ...+ .....++.+++.+||+.+|++|||+.|+++.|++
T Consensus 229 ---~---------~~~~~~---~~~~-----~~~~------~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 229 ---E---------VLKFVI---DGGH-----LDLP------ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred ---H---------HHHHHh---cCCC-----CCCC------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 0 111110 0000 0000 0114568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=314.18 Aligned_cols=258 Identities=22% Similarity=0.310 Sum_probs=198.1
Q ss_pred HHHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcc
Q 037275 675 SKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 675 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
+.+++.+.....||+|+||.||+|++..++..||+|.+........+.+.+|+.++++++|+||+++++++. ...
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~ 78 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS-----ENG 78 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeec-----cCC
Confidence 345566667789999999999999998889999999987655555678899999999999999999999864 345
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCC-CCcEEEee
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQ-DLVAHLGD 833 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~D 833 (992)
..++|+||+++++|.+++...... ...++..+..++.|++.||+|||+. +|+||||||+||+++. ++.++|+|
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~d 152 (268)
T cd06624 79 FFKIFMEQVPGGSLSALLRSKWGP---LKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISD 152 (268)
T ss_pred EEEEEEecCCCCCHHHHHHHhccc---CCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEec
Confidence 679999999999999999864321 1127888899999999999999999 9999999999999976 67999999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccCC--CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHH
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG--EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEF 911 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~ 911 (992)
||.+....... .......+++.|+|||++.+. .++.++||||+|+++|+|++|+.||.......... +
T Consensus 153 fg~~~~~~~~~--------~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~--~ 222 (268)
T cd06624 153 FGTSKRLAGIN--------PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM--F 222 (268)
T ss_pred chhheecccCC--------CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH--h
Confidence 99987654211 111223478899999998654 37889999999999999999999986432111000 0
Q ss_pred HhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 912 ARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
. ....... .. .......++.+++.+||+.+|++|||+.|+++
T Consensus 223 ~-------------~~~~~~~-----~~------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 223 K-------------VGMFKIH-----PE------IPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred h-------------hhhhccC-----CC------CCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 0 0000000 00 00112345889999999999999999999975
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=319.52 Aligned_cols=268 Identities=22% Similarity=0.366 Sum_probs=205.3
Q ss_pred hcCCCCCCccccccceEEEEeEEC-------CCCeEEEEEEeeccC-CCchhHHHHHHHHHHhc-cCCcceeEEEEeecc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLG-------ENGMMVAVKVINLKQ-KGASNGFVAECQALRNI-RHRNLIKIITICSSI 748 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 748 (992)
.++|++.+.||+|+||.||+|+.. .++..||+|.+.... ......+.+|+.+++.+ +||||+++++++..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~- 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec-
Confidence 457889999999999999999752 234679999986432 23346789999999999 89999999998643
Q ss_pred cccCcceEEEEEEeccCCCHHHHHhhcccch----------hhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCC
Q 037275 749 DFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQ----------EARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKP 818 (992)
Q Consensus 749 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp 818 (992)
....++||||+++|+|.+++....... ....+++.+++.++.|++.||+|||++ +|+||||||
T Consensus 93 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp 165 (304)
T cd05101 93 ----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAA 165 (304)
T ss_pred ----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeeccccc
Confidence 456699999999999999998653211 123578899999999999999999999 999999999
Q ss_pred CCeeeCCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCC
Q 037275 819 SNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRP 897 (992)
Q Consensus 819 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p 897 (992)
+||++++++.+||+|||.++........ .......+++.|+|||++.+..++.++||||||+++|++++ |..|
T Consensus 166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p 239 (304)
T cd05101 166 RNVLVTENNVMKIADFGLARDVNNIDYY------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239 (304)
T ss_pred ceEEEcCCCcEEECCCccceeccccccc------ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence 9999999999999999999876432211 11122235678999999988889999999999999999998 7888
Q ss_pred CCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 898 TDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 898 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
|.+... .+ +..... ..... .........+.+++.+||+.+|++|||+.|+++
T Consensus 240 ~~~~~~-----~~------------~~~~~~-~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~ 291 (304)
T cd05101 240 YPGIPV-----EE------------LFKLLK-EGHRM----------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVE 291 (304)
T ss_pred cccCCH-----HH------------HHHHHH-cCCcC----------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 764311 11 111110 00000 000123456889999999999999999999999
Q ss_pred HHHHHHHhhh
Q 037275 978 KLCRARDTFL 987 (992)
Q Consensus 978 ~L~~~~~~~~ 987 (992)
.|+++..--.
T Consensus 292 ~l~~~~~~~~ 301 (304)
T cd05101 292 DLDRILTLTT 301 (304)
T ss_pred HHHHHHHhhh
Confidence 9999876433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=317.43 Aligned_cols=266 Identities=22% Similarity=0.327 Sum_probs=206.1
Q ss_pred ccHHHHHHHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhc-cCCcceeEEEEeec
Q 037275 669 ISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNI-RHRNLIKIITICSS 747 (992)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 747 (992)
.+..++....+.|++.+.||+|+||.||+|++..+++.||+|++.... .....+..|+.+++++ +||||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 345566667789999999999999999999998899999999986433 3345688899999998 79999999998754
Q ss_pred ccc-cCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCC
Q 037275 748 IDF-KGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQD 826 (992)
Q Consensus 748 ~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 826 (992)
... ......++||||+++|+|.+++..... ..+++..++.++.|++.|++|||+. +|+||||+|+||+++++
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~ 157 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG----NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTEN 157 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCC
Confidence 322 235678999999999999999976542 2578888999999999999999999 99999999999999999
Q ss_pred CcEEEeecccceecCCCCCCCCcccCCCCCccccccccccccccc-----CCCcCcccchhhHHHHHHHHHhCCCCCCCC
Q 037275 827 LVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGM-----GGEASMTGDVYSFGILLLEMFTRRRPTDGM 901 (992)
Q Consensus 827 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~pf~~~ 901 (992)
+.++|+|||.+...... ........|++.|+|||.+. +..++.++|||||||++|||++|..||...
T Consensus 158 ~~~~l~dfg~~~~~~~~--------~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~ 229 (282)
T cd06636 158 AEVKLVDFGVSAQLDRT--------VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229 (282)
T ss_pred CCEEEeeCcchhhhhcc--------ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcccc
Confidence 99999999998754321 11122346889999999875 346788999999999999999999999653
Q ss_pred ccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 902 FNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
..... . ..... . . .. ..........+.+++.+||+.||.+|||+.|+++
T Consensus 230 ~~~~~----~---------~~~~~----~-~----~~-----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 230 HPMRA----L---------FLIPR----N-P----PP-----KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred CHHhh----h---------hhHhh----C-C----CC-----CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 21100 0 00000 0 0 00 0001122456899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=317.84 Aligned_cols=268 Identities=22% Similarity=0.366 Sum_probs=201.2
Q ss_pred hcCCCCCCccccccceEEEEeEECCC----------------CeEEEEEEeeccCC-CchhHHHHHHHHHHhccCCccee
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGEN----------------GMMVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIK 740 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~----------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~ 740 (992)
..+|++.+.||+|+||.||+|++... +..||+|.+..... ...+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 45899999999999999999987543 35689999864432 34567889999999999999999
Q ss_pred EEEEeecccccCcceEEEEEEeccCCCHHHHHhhcccc-----hhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecc
Q 037275 741 IITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQ-----QEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGD 815 (992)
Q Consensus 741 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~D 815 (992)
+++++.. ....++||||+++++|.+++...... .....+++..++.++.|++.||+|||++ +|+|||
T Consensus 84 ~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~d 155 (296)
T cd05051 84 LLGVCTV-----DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRD 155 (296)
T ss_pred EEEEEec-----CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccc
Confidence 9998643 35669999999999999999765421 0123589999999999999999999999 999999
Q ss_pred CCCCCeeeCCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh--
Q 037275 816 LKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-- 893 (992)
Q Consensus 816 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-- 893 (992)
|||+||+++.++.++|+|||.++....... ........+++.|+|||++.+..++.++|||||||++|||++
T Consensus 156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 229 (296)
T cd05051 156 LATRNCLVGKNYTIKIADFGMSRNLYSSDY------YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLC 229 (296)
T ss_pred cchhceeecCCCceEEccccceeecccCcc------eeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcC
Confidence 999999999999999999999976543211 111223346788999999988889999999999999999998
Q ss_pred CCCCCCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHH
Q 037275 894 RRRPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMR 973 (992)
Q Consensus 894 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 973 (992)
|..||....... . ............ .... .........++.+++.+||+.||++|||+.
T Consensus 230 ~~~p~~~~~~~~--~------------~~~~~~~~~~~~----~~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ 288 (296)
T cd05051 230 REQPYEHLTDQQ--V------------IENAGHFFRDDG----RQIY---LPRPPNCPKDIYELMLECWRRDEEDRPTFR 288 (296)
T ss_pred CCCCCCCcChHH--H------------HHHHHhcccccc----cccc---CCCccCCCHHHHHHHHHHhccChhcCCCHH
Confidence 677775432110 0 000000000000 0000 000111235689999999999999999999
Q ss_pred HHHHHHH
Q 037275 974 DVVAKLC 980 (992)
Q Consensus 974 evl~~L~ 980 (992)
||++.|+
T Consensus 289 el~~~L~ 295 (296)
T cd05051 289 EIHLFLQ 295 (296)
T ss_pred HHHHHhc
Confidence 9998886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=319.38 Aligned_cols=261 Identities=23% Similarity=0.406 Sum_probs=199.2
Q ss_pred cCCCCCCccccccceEEEEeEECC-----CCeEEEEEEeeccCCC-chhHHHHHHHHHHhccCCcceeEEEEeecccccC
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGE-----NGMMVAVKVINLKQKG-ASNGFVAECQALRNIRHRNLIKIITICSSIDFKG 752 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 752 (992)
.+|++.+.||+|+||.||+|.... .+..||+|+++..... ..+.+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~----- 79 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK----- 79 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-----
Confidence 357788999999999999998743 3578999998744332 23568899999999999999999998643
Q ss_pred cceEEEEEEeccCCCHHHHHhhcccc----------hhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCee
Q 037275 753 VDFQAIVYEYMQNGSLEDWLHQSEDQ----------QEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVL 822 (992)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIl 822 (992)
....++++||+.+++|.+++...... .....+++..+..++.|++.||+|||++ +|+||||||+||+
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil 156 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVL 156 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheE
Confidence 34568999999999999998643210 1123578889999999999999999999 9999999999999
Q ss_pred eCCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCC
Q 037275 823 LDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGM 901 (992)
Q Consensus 823 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~ 901 (992)
+++++.+||+|||+++....... ........+++.|+|||.+.++.++.++|||||||++|||++ |..||.+.
T Consensus 157 ~~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 230 (283)
T cd05091 157 VFDKLNVKISDLGLFREVYAADY------YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 230 (283)
T ss_pred ecCCCceEecccccccccccchh------eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999886543211 111222346789999999988889999999999999999998 88888653
Q ss_pred ccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 037275 902 FNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCR 981 (992)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 981 (992)
... ++.+....... ... .......+.+++.+||+.+|++||+++||++.|+.
T Consensus 231 ~~~-----------------~~~~~i~~~~~-----~~~------~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 231 SNQ-----------------DVIEMIRNRQV-----LPC------PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred CHH-----------------HHHHHHHcCCc-----CCC------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 211 11111110000 000 01234458899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=322.97 Aligned_cols=202 Identities=28% Similarity=0.369 Sum_probs=171.6
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc---CCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK---QKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
++|++.+.||+|+||+||+|+...+++.||+|++... .....+.+.+|+.+++.++|+||+++++++. ....
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQ-----DENN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEe-----cCCe
Confidence 4789999999999999999999989999999998642 2233456888999999999999999999853 4567
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++||||+++|+|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg 147 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKFED-----RLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFG 147 (331)
T ss_pred EEEEEecCCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECC
Confidence 7999999999999999975432 488999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccC-----CCcCcccchhhHHHHHHHHHhCCCCCCC
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-----GEASMTGDVYSFGILLLEMFTRRRPTDG 900 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~pf~~ 900 (992)
++........ .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+
T Consensus 148 ~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 148 SCLRLLADGT-------VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred ceeecCCCCC-------ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 9876543211 11122458999999999863 4578899999999999999999999975
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=322.58 Aligned_cols=251 Identities=24% Similarity=0.341 Sum_probs=205.1
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEE
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIV 759 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 759 (992)
.|.++..||.|+||.||+|..+.++-..|.|++........+++.-|++||..++||+||++++.| ...+.++|.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ay-----y~enkLwil 107 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAY-----YFENKLWIL 107 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHH-----hccCceEEE
Confidence 466778899999999999999988888999999888888889999999999999999999999974 345667999
Q ss_pred EEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccccee
Q 037275 760 YEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKF 839 (992)
Q Consensus 760 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 839 (992)
.|||.||-.+..+-.-. +.+++.++.-+++|++.||.|||+. +|||||+|+.|||++-+|.++|+|||.+..
T Consensus 108 iEFC~GGAVDaimlEL~-----r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAK 179 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLELG-----RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAK 179 (1187)
T ss_pred EeecCCchHhHHHHHhc-----cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeeccccccc
Confidence 99999999999887654 3699999999999999999999999 999999999999999999999999999865
Q ss_pred cCCCCCCCCcccCCCCCcccccccccccccc-----cCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 840 LSSSPLDTAVETPSSSKGIKGTVGYIAPEYG-----MGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
... .......++|||+|||||+. ...+|++++||||||+++.||..+.+|-....
T Consensus 180 n~~--------t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln------------ 239 (1187)
T KOG0579|consen 180 NKS--------TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN------------ 239 (1187)
T ss_pred chh--------HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc------------
Confidence 432 23344567899999999975 45689999999999999999999999965421
Q ss_pred hCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 915 ALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.+.++-++-..+++. ......-...+.+++.+||..||..||++.++++
T Consensus 240 -----pMRVllKiaKSePPT---------LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 240 -----PMRVLLKIAKSEPPT---------LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred -----hHHHHHHHhhcCCCc---------ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 122222221111111 0011112345889999999999999999999985
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=312.02 Aligned_cols=254 Identities=28% Similarity=0.472 Sum_probs=200.8
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
.++|++.++||+|+||.||+|... +++.||+|.+... ......+.+|+.++++++||||+++++++. ....+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~ 76 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQG-SMSPEAFLAEANLMKQLQHPRLVRLYAVVT------QEPIY 76 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCC-CCcHHHHHHHHHHHHhcCCcCeeeEEEEEc------cCCcE
Confidence 457899999999999999999975 6788999998633 334567899999999999999999998742 23469
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||+++++|.+++..... ..+++.++..++.|++.||+|||+. +++||||||+||++++++.++|+|||.+
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~ 149 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEG----IKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLA 149 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcce
Confidence 99999999999999875432 2588999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhhhC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFARTAL 916 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 916 (992)
......... ......++..|+|||++.+..++.++||||||+++||+++ |+.||.+.....
T Consensus 150 ~~~~~~~~~-------~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----------- 211 (260)
T cd05067 150 RLIEDNEYT-------AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE----------- 211 (260)
T ss_pred eecCCCCcc-------cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH-----------
Confidence 866532111 1122345678999999988889999999999999999999 999997532110
Q ss_pred ChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 037275 917 PDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCR 981 (992)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 981 (992)
....+.. .... .. ......++.+++.+||..+|++|||++++...|+.
T Consensus 212 ---~~~~~~~----~~~~----~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 212 ---VIQNLER----GYRM----PR------PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ---HHHHHHc----CCCC----CC------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0000000 0000 00 01123468999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=315.88 Aligned_cols=267 Identities=22% Similarity=0.343 Sum_probs=206.5
Q ss_pred hcCCCCCCccccccceEEEEeEECC----CCeEEEEEEeeccC-CCchhHHHHHHHHHHhccCCcceeEEEEeecccccC
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGE----NGMMVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKG 752 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 752 (992)
.++|++.++||+|+||.||+|.+.. .+..||+|++.... ......+.+|+.++++++||||+++++++.. .
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~----~ 80 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIE----D 80 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec----C
Confidence 4688999999999999999999864 26889999886332 2334668899999999999999999998743 2
Q ss_pred cceEEEEEEeccCCCHHHHHhhcccc--hhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEE
Q 037275 753 VDFQAIVYEYMQNGSLEDWLHQSEDQ--QEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAH 830 (992)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 830 (992)
....++++||+++|+|.+++...... .....+++..++.++.|++.||+|||+. +++||||||+||++++++.+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~k 157 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVK 157 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEE
Confidence 44568999999999999999765321 1124689999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHH
Q 037275 831 LGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLH 909 (992)
Q Consensus 831 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~ 909 (992)
|+|||+++.+....... ......++..|+|||++.+..++.++|||||||++||+++ |+.||...... ..
T Consensus 158 l~d~g~~~~~~~~~~~~------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~- 228 (280)
T cd05043 158 ITDNALSRDLFPMDYHC------LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF--EM- 228 (280)
T ss_pred ECCCCCcccccCCceEE------eCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH--HH-
Confidence 99999998654322110 1112235678999999988889999999999999999999 99998753111 01
Q ss_pred HHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 037275 910 EFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDT 985 (992)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 985 (992)
...+.. ..... .......++.+++.+||+.||++|||+.|+++.|+.+..+
T Consensus 229 -----------~~~~~~----~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 229 -----------AAYLKD----GYRLA----------QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred -----------HHHHHc----CCCCC----------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 011100 00000 0011234588999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=310.15 Aligned_cols=250 Identities=24% Similarity=0.394 Sum_probs=192.8
Q ss_pred ccccccceEEEEeEEC--CCCeEEEEEEeeccCC-CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEEEEe
Q 037275 686 MIGQGSFGFVYKGNLG--ENGMMVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEY 762 (992)
Q Consensus 686 ~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 762 (992)
.||+|+||.||+|.+. ..+..||+|++..... ...+.+.+|+.++++++||||+++++++.. ...++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~------~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA------EALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC------CCeEEEEEe
Confidence 4899999999999774 4456799999864432 234568899999999999999999998632 346899999
Q ss_pred ccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceecCC
Q 037275 763 MQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSS 842 (992)
Q Consensus 763 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 842 (992)
+++|+|.+++..... .+++..+++++.|++.||+|||++ +++||||||+||+++.++.+||+|||.+.....
T Consensus 76 ~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 147 (257)
T cd05115 76 ASGGPLNKFLSGKKD-----EITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGA 147 (257)
T ss_pred CCCCCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccC
Confidence 999999999975432 489999999999999999999999 999999999999999999999999999976543
Q ss_pred CCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhhhCChhHH
Q 037275 843 SPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFARTALPDKVM 921 (992)
Q Consensus 843 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 921 (992)
..... .......++..|+|||++.+..++.++|||||||++||+++ |..||...... ...
T Consensus 148 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------------~~~ 208 (257)
T cd05115 148 DDSYY-----KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP--------------EVM 208 (257)
T ss_pred Cccce-----eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH--------------HHH
Confidence 21110 01111224678999999888889999999999999999996 99998753211 011
Q ss_pred HHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 037275 922 EIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRA 982 (992)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 982 (992)
..+.... .. .+ ......++.+++.+||..+|++||++.+|.+.|+..
T Consensus 209 ~~~~~~~----~~----~~------~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 209 SFIEQGK----RL----DC------PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HHHHCCC----CC----CC------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 1111100 00 00 011245688999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=320.02 Aligned_cols=251 Identities=23% Similarity=0.312 Sum_probs=201.2
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
..+|++.+.||.|+||.||+|.+..+++.||+|.+........+.+.+|+.+++.++|||++++++++. .....+
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 92 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL-----VGDELF 92 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEe-----cCceEE
Confidence 346899999999999999999998899999999997665555677899999999999999999999864 345679
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||+++++|.+++... .+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++
T Consensus 93 lv~e~~~~~~L~~~~~~~-------~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~ 162 (296)
T cd06655 93 VVMEYLAGGSLTDVVTET-------CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFC 162 (296)
T ss_pred EEEEecCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccc
Confidence 999999999999998643 478999999999999999999999 9999999999999999999999999998
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALP 917 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 917 (992)
....... .......++..|+|||.+.+..++.++|||||||++|++++|+.||...... ....
T Consensus 163 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~----~~~~----- 225 (296)
T cd06655 163 AQITPEQ--------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL----RALY----- 225 (296)
T ss_pred hhccccc--------ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHH-----
Confidence 7654321 1112235788999999998888999999999999999999999999753211 0000
Q ss_pred hhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 918 DKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
... ...... ..........+.+++.+||..||++|||+.++++
T Consensus 226 ----~~~----~~~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 226 ----LIA----TNGTPE---------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred ----HHH----hcCCcc---------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 000 000000 0001112345888999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=325.29 Aligned_cols=244 Identities=23% Similarity=0.296 Sum_probs=189.3
Q ss_pred CccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhc-cCCcceeEEEEeecccccCcceEEEEE
Q 037275 685 NMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNI-RHRNLIKIITICSSIDFKGVDFQAIVY 760 (992)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 760 (992)
++||+|+||+||+|+...+++.||+|+++... ....+.+.+|+.++.++ +||+|+++++++. .....++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQ-----TTSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEE-----eCCEEEEEE
Confidence 47999999999999999899999999997432 23345678899999888 6999999999853 455679999
Q ss_pred EeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceec
Q 037275 761 EYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFL 840 (992)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 840 (992)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 e~~~~~~L~~~~~~~~------~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~ 146 (327)
T cd05617 76 EYVNGGDLMFHMQRQR------KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEG 146 (327)
T ss_pred eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceec
Confidence 9999999999887543 489999999999999999999999 9999999999999999999999999998743
Q ss_pred CCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCc-cHHHHHhhhCChh
Q 037275 841 SSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGL-TLHEFARTALPDK 919 (992)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~-~~~~~~~~~~~~~ 919 (992)
... ........||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+.
T Consensus 147 ~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~-------- 210 (327)
T cd05617 147 LGP--------GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDY-------- 210 (327)
T ss_pred cCC--------CCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHH--------
Confidence 211 1112235689999999999999999999999999999999999999975322111 11110
Q ss_pred HHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHH
Q 037275 920 VMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMR 973 (992)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 973 (992)
......... ...+ ......+.+++.+||+.||++||++.
T Consensus 211 ----~~~~~~~~~-----~~~p------~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 211 ----LFQVILEKP-----IRIP------RFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred ----HHHHHHhCC-----CCCC------CCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 000000000 0000 01124578999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=320.75 Aligned_cols=275 Identities=22% Similarity=0.326 Sum_probs=199.0
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC-CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
.++|++.++||+|+||.||+|++..+++.||+|.++... ......+.+|+.+++.++||||+++++++. .....
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~-----~~~~~ 79 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-----TEKSL 79 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEe-----cCCeE
Confidence 357899999999999999999998889999999986443 333456788999999999999999999954 34567
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
++||||++ ++|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||.
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~ 150 (301)
T cd07873 80 TLVFEYLD-KDLKQYLDDCGN-----SINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGL 150 (301)
T ss_pred EEEEeccc-cCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcc
Confidence 99999996 599998875432 478999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh-
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART- 914 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~- 914 (992)
+....... .......+++.|+|||++.+. .++.++|||||||++|||++|++||......+ ........
T Consensus 151 ~~~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~-~~~~~~~~~ 221 (301)
T cd07873 151 ARAKSIPT--------KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE-QLHFIFRIL 221 (301)
T ss_pred hhccCCCC--------CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHc
Confidence 87543211 111223568899999987654 57889999999999999999999997642211 11111110
Q ss_pred --hCChhHHHHHHhhHhHhhhccC-CCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 915 --ALPDKVMEIVDSVLLLEVQASN-SRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 915 --~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.....+..+.+........... ...+.. .........+.+++.+|++.||.+|||++|+++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 222 GTPTEETWPGILSNEEFKSYNYPKYRADCLH--NHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred CCCChhhchhhhccccccccccCccccccHH--hhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0111111111110000000000 000000 000112345789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=318.70 Aligned_cols=265 Identities=23% Similarity=0.344 Sum_probs=201.1
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC-CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
++|++.++||+|+||.||+|++..++..||+|.+..... .....+.+|++++++++||||+++++++. ..+..+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 75 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFY-----SDGEIS 75 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCCEEE
Confidence 368999999999999999999998999999999864422 23356889999999999999999999864 345679
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||+++++|.++++... .+++..+..++.|+++||+|||+.. +++||||||+||+++.++.+||+|||.+
T Consensus 76 lv~ey~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~ 147 (308)
T cd06615 76 ICMEHMDGGSLDQVLKKAG------RIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVS 147 (308)
T ss_pred EEeeccCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCc
Confidence 9999999999999997643 4789999999999999999999731 8999999999999999999999999998
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALP 917 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 917 (992)
...... ......++..|+|||++.+..++.++|||||||++|+|++|+.||...... ...........
T Consensus 148 ~~~~~~----------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~ 215 (308)
T cd06615 148 GQLIDS----------MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK--ELEAMFGRPVS 215 (308)
T ss_pred cccccc----------ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh--hHHHhhcCccc
Confidence 754321 112346889999999998888999999999999999999999998653211 11111110000
Q ss_pred ---------------------hhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 037275 918 ---------------------DKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVV 976 (992)
Q Consensus 918 ---------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 976 (992)
....+..+...... .. .........++.+++.+||..+|++|||++||+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~-----~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll 285 (308)
T cd06615 216 EGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEP-----PP-----KLPSGAFSDEFQDFVDKCLKKNPKERADLKELT 285 (308)
T ss_pred cccccCCcccccCCCCCccchhhHHHHHHHHhcCC-----Cc-----cCcCcccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 00111111110000 00 000011344688999999999999999999998
Q ss_pred HH
Q 037275 977 AK 978 (992)
Q Consensus 977 ~~ 978 (992)
+.
T Consensus 286 ~~ 287 (308)
T cd06615 286 KH 287 (308)
T ss_pred cC
Confidence 76
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=324.05 Aligned_cols=238 Identities=28% Similarity=0.334 Sum_probs=184.9
Q ss_pred CccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHH-HHHhccCCcceeEEEEeecccccCcceEEEEE
Q 037275 685 NMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQ-ALRNIRHRNLIKIITICSSIDFKGVDFQAIVY 760 (992)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 760 (992)
++||+|+||.||+|++..+++.||+|++.... ......+.+|.. +++.++||||+++++++. +.+..++||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~-----~~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQ-----TAEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEE-----cCCEEEEEE
Confidence 47999999999999999899999999986432 222334555554 578899999999998853 455679999
Q ss_pred EeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceec
Q 037275 761 EYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFL 840 (992)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 840 (992)
||+++|+|..++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 146 (321)
T cd05603 76 DYVNGGELFFHLQRER------CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (321)
T ss_pred cCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence 9999999998886532 478888999999999999999999 9999999999999999999999999998743
Q ss_pred CCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCChhH
Q 037275 841 SSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKV 920 (992)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 920 (992)
... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ..
T Consensus 147 ~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~---------- 203 (321)
T cd05603 147 VEP--------EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-----SQ---------- 203 (321)
T ss_pred CCC--------CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-----HH----------
Confidence 211 1122334689999999999988999999999999999999999999975311 11
Q ss_pred HHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHH
Q 037275 921 MEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMR 973 (992)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 973 (992)
..+....... ..+ .....++.+++.+||+.||++||++.
T Consensus 204 --~~~~i~~~~~------~~~------~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 204 --MYDNILHKPL------QLP------GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred --HHHHHhcCCC------CCC------CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 1111111000 000 01234578999999999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=312.99 Aligned_cols=253 Identities=28% Similarity=0.487 Sum_probs=197.5
Q ss_pred CCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchh--HHHHHHHHHHhccCCcceeEEEEeecccccCcceEEE
Q 037275 681 FSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASN--GFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAI 758 (992)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 758 (992)
|++.+.||+|+||+||+|+...+++.||+|++......... ...+|+.++++++||||+++++++.. ....++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-----DNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----cccccc
Confidence 56788999999999999999999999999999755433222 33569999999999999999999644 556689
Q ss_pred EEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccce
Q 037275 759 VYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAK 838 (992)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 838 (992)
||||+++++|.+++... ..+++..++.++.|+++||+|||+. +|+||||||+||++++++.++|+|||.+.
T Consensus 76 v~~~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~ 146 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQKN------KPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSV 146 (260)
T ss_dssp EEEEETTEBHHHHHHHH------SSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTE
T ss_pred ccccccccccccccccc------ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccc
Confidence 99999999999999832 2589999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCCCCcccCCCCCccccccccccccccc-CCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCC
Q 037275 839 FLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGM-GGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALP 917 (992)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 917 (992)
.... .........++..|+|||++. +..++.++||||+|+++|+|++|..||...... ..
T Consensus 147 ~~~~--------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~--~~--------- 207 (260)
T PF00069_consen 147 KLSE--------NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD--DQ--------- 207 (260)
T ss_dssp ESTS--------TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH--HH---------
T ss_pred cccc--------cccccccccccccccccccccccccccccccccccccccccccccccccccccch--hh---------
Confidence 6411 112223446889999999988 788999999999999999999999999864100 00
Q ss_pred hhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 918 DKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
............... .........++.+++.+||+.||++|||+.|+++
T Consensus 208 ---~~~~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 208 ---LEIIEKILKRPLPSS--------SQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp ---HHHHHHHHHTHHHHH--------TTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ---hhhhhhccccccccc--------ccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011111110000000 0000011257999999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=330.05 Aligned_cols=274 Identities=22% Similarity=0.237 Sum_probs=197.5
Q ss_pred hcCCCCCCccccccceEEEEeEEC--CCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLG--ENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
..+|.+.+.||+|+||.||+|... ..++.||+|.+... ....+|++++++++||||+++++++. ....
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~-----~~~~ 160 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYR-----WKST 160 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEe-----eCCE
Confidence 347999999999999999999764 34678999987532 23568999999999999999999853 3456
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++||||+. ++|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 161 ~~lv~e~~~-~~l~~~l~~~------~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG 230 (392)
T PHA03207 161 VCMVMPKYK-CDLFTYVDRS------GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFG 230 (392)
T ss_pred EEEEehhcC-CCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCc
Confidence 799999995 6899888432 2589999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCC--ccHHHHHh
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQG--LTLHEFAR 913 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~--~~~~~~~~ 913 (992)
+++...... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.+..... ..+.....
T Consensus 231 ~a~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~ 304 (392)
T PHA03207 231 AACKLDAHP------DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIR 304 (392)
T ss_pred cccccCccc------ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHH
Confidence 997654321 1112234568999999999999999999999999999999999999997643321 11111111
Q ss_pred hh------CChh-HHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 914 TA------LPDK-VMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 914 ~~------~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
.. ++.. ...+............. ...............++.+++.+||..||++|||+.|++..
T Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 305 CMQVHPLEFPQNGSTNLCKHFKQYAIVLRP-PYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HhccCccccCCccchhHHHHHHhhcccccC-CccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 10 1110 00000000000000000 00000001111223567889999999999999999999864
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=310.16 Aligned_cols=248 Identities=26% Similarity=0.400 Sum_probs=192.8
Q ss_pred ccccccceEEEEeEE--CCCCeEEEEEEeeccCC--CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEEEE
Q 037275 686 MIGQGSFGFVYKGNL--GENGMMVAVKVINLKQK--GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYE 761 (992)
Q Consensus 686 ~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 761 (992)
.||+|+||.||+|.+ ..++..||+|+++.... ...+.+.+|+.+++.++||||+++++++. ....++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE------AESWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc------CCCcEEEEe
Confidence 689999999999965 45678999999864432 23467889999999999999999999863 234589999
Q ss_pred eccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceecC
Q 037275 762 YMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLS 841 (992)
Q Consensus 762 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 841 (992)
|+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+....
T Consensus 76 ~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~ 146 (257)
T cd05116 76 LAELGPLNKFLQKNK------HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALG 146 (257)
T ss_pred cCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccC
Confidence 999999999997543 488999999999999999999999 99999999999999999999999999998664
Q ss_pred CCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhhhCChhH
Q 037275 842 SSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFARTALPDKV 920 (992)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 920 (992)
..... ........++..|+|||.+....++.++|||||||++|||++ |+.||...... + .
T Consensus 147 ~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~---------~ 207 (257)
T cd05116 147 ADENY-----YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN-----E---------V 207 (257)
T ss_pred CCCCe-----eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-----H---------H
Confidence 32210 001112234678999999888889999999999999999998 99999753111 0 1
Q ss_pred HHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 037275 921 MEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCR 981 (992)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 981 (992)
...+.. ... ...+ .....++.+++.+||+.||++||++++|.+.|++
T Consensus 208 ~~~i~~---~~~-----~~~~------~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 208 TQMIES---GER-----MECP------QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred HHHHHC---CCC-----CCCC------CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 111111 000 0000 1123468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=314.90 Aligned_cols=252 Identities=23% Similarity=0.325 Sum_probs=195.8
Q ss_pred CCCCCccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 681 FSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
|+..+.||+|+||+||+|.+..+++.||+|.+.... ......+.+|++++++++|++++++.+++. .++..+
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~~ 76 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYE-----TKDALC 76 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEe-----cCCEEE
Confidence 667789999999999999999899999999986432 222345778999999999999999998853 445679
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||+++++|.+++..... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++
T Consensus 77 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~ 149 (285)
T cd05632 77 LVLTIMNGGDLKFHIYNMGN----PGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLA 149 (285)
T ss_pred EEEEeccCccHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcc
Confidence 99999999999998875432 2589999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALP 917 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 917 (992)
....... ......|+..|+|||++.+..++.++||||+||++|||++|+.||........ ...
T Consensus 150 ~~~~~~~---------~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-~~~------- 212 (285)
T cd05632 150 VKIPEGE---------SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-REE------- 212 (285)
T ss_pred eecCCCC---------cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHH-------
Confidence 7653211 11234689999999999888999999999999999999999999975321100 000
Q ss_pred hhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 037275 918 DKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERME-----MRDVVAK 978 (992)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 978 (992)
+........ . .........+.+++..||+.||++||+ ++|+++.
T Consensus 213 ------~~~~~~~~~-~----------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 213 ------VDRRVLETE-E----------VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ------HHHhhhccc-c----------ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 000000000 0 000112345788999999999999999 6666653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=317.24 Aligned_cols=262 Identities=25% Similarity=0.435 Sum_probs=201.3
Q ss_pred hcCCCCCCccccccceEEEEeEEC-----CCCeEEEEEEeeccCC-CchhHHHHHHHHHHhccCCcceeEEEEeeccccc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLG-----ENGMMVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIITICSSIDFK 751 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 751 (992)
.++|++.+.||+|+||.||+|.+. .++..||+|++..... .....+.+|+.++++++||||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~---- 79 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV---- 79 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC----
Confidence 468999999999999999999874 2578999999864332 234568899999999999999999998643
Q ss_pred CcceEEEEEEeccCCCHHHHHhhcccc----------------hhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecc
Q 037275 752 GVDFQAIVYEYMQNGSLEDWLHQSEDQ----------------QEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGD 815 (992)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~D 815 (992)
....++||||+++|+|.+++...... .....+++..++.++.|++.||+|||+. +++|||
T Consensus 80 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~d 155 (288)
T cd05050 80 -GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRD 155 (288)
T ss_pred -CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Ceeccc
Confidence 34569999999999999999754321 1123578899999999999999999999 999999
Q ss_pred CCCCCeeeCCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-C
Q 037275 816 LKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-R 894 (992)
Q Consensus 816 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g 894 (992)
|||+||++++++.++|+|||.+......... .......++..|+|||.+.+..++.++|||||||++|||++ |
T Consensus 156 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~ 229 (288)
T cd05050 156 LATRNCLVGENMVVKIADFGLSRNIYSADYY------KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 229 (288)
T ss_pred ccHhheEecCCCceEECccccceecccCccc------cccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCC
Confidence 9999999999999999999998765432110 11112234677999999988899999999999999999998 8
Q ss_pred CCCCCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 037275 895 RRPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRD 974 (992)
Q Consensus 895 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 974 (992)
..||.+.... +. ......... ..+. .....++.+++.+||+.||++|||+.|
T Consensus 230 ~~p~~~~~~~-----~~------------~~~~~~~~~-----~~~~------~~~~~~l~~li~~~l~~~p~~Rpt~~e 281 (288)
T cd05050 230 MQPYYGMAHE-----EV------------IYYVRDGNV-----LSCP------DNCPLELYNLMRLCWSKLPSDRPSFAS 281 (288)
T ss_pred CCCCCCCCHH-----HH------------HHHHhcCCC-----CCCC------CCCCHHHHHHHHHHcccCcccCCCHHH
Confidence 8888643111 11 110000000 0000 112356889999999999999999999
Q ss_pred HHHHHHH
Q 037275 975 VVAKLCR 981 (992)
Q Consensus 975 vl~~L~~ 981 (992)
+++.|++
T Consensus 282 l~~~l~~ 288 (288)
T cd05050 282 INRILQR 288 (288)
T ss_pred HHHHhhC
Confidence 9999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=317.62 Aligned_cols=272 Identities=19% Similarity=0.291 Sum_probs=196.1
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC--CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
+|++.+.||+|+||.||+|++..+|+.||+|+++... ......+.+|++++++++||||+++++++ .+....+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVL-----HSDKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHh-----ccCCceE
Confidence 4788899999999999999999899999999986432 22335678899999999999999999984 4456679
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+|+||++ ++|.+++..... .+++..++.++.||++||+|||+. +|+||||||+||+++.++.+||+|||.+
T Consensus 76 lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~ 146 (284)
T cd07839 76 LVFEYCD-QDLKKYFDSCNG-----DIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLA 146 (284)
T ss_pred EEEecCC-CCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchh
Confidence 9999996 588888765432 489999999999999999999999 9999999999999999999999999998
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTAL 916 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 916 (992)
+...... .......++..|+|||++.+. .++.++|||||||++|+|++|..||....+....+........
T Consensus 147 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~ 218 (284)
T cd07839 147 RAFGIPV--------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG 218 (284)
T ss_pred hccCCCC--------CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhC
Confidence 7553211 111223578899999988765 4789999999999999999999886543222111111111110
Q ss_pred Ch--hHHHHHHhhHhHhhhccCCCCCCccc---cchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 917 PD--KVMEIVDSVLLLEVQASNSRSCGDER---LRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 917 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.. .....+... ..+. ......... ........++.+++.+||+.||.+|||++|+++
T Consensus 219 ~~~~~~~~~~~~~--~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 219 TPTEESWPGVSKL--PDYK--PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred CCChHHhHHhhhc--cccc--ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00 000000000 0000 000000000 000112356789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=310.57 Aligned_cols=253 Identities=28% Similarity=0.486 Sum_probs=198.5
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAI 758 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 758 (992)
++|++.+.||+|+||.||+|.+.. +..+|+|.+.... ...+.+.+|++++++++|||++++++++. ....++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~~ 77 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNG-TTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS------EEPIYI 77 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcC-CceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc------CCCcEE
Confidence 468899999999999999999864 4569999875332 34567889999999999999999998753 234589
Q ss_pred EEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccce
Q 037275 759 VYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAK 838 (992)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 838 (992)
||||+++|+|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||.+.
T Consensus 78 v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~ 150 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGDG----KYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLAR 150 (260)
T ss_pred EEEcCCCCCHHHHHhhCCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccce
Confidence 9999999999999976432 2478999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhhhCC
Q 037275 839 FLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFARTALP 917 (992)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 917 (992)
........ ......++..|+|||+..+..++.++||||||+++|||++ |+.||.+.....
T Consensus 151 ~~~~~~~~-------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------------ 211 (260)
T cd05069 151 LIEDNEYT-------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE------------ 211 (260)
T ss_pred EccCCccc-------ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH------------
Confidence 76432211 1112345778999999988899999999999999999999 999987532110
Q ss_pred hhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 037275 918 DKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCR 981 (992)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 981 (992)
...... ..... . ........+.+++.+||+.||++||++++|++.|++
T Consensus 212 -----~~~~~~-~~~~~----~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 212 -----VLEQVE-RGYRM----P------CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -----HHHHHH-cCCCC----C------CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 000000 00000 0 001224568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=329.21 Aligned_cols=209 Identities=26% Similarity=0.344 Sum_probs=175.1
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
++|+..+.||+|+||+||+|+...+++.||+|+++... ......+.+|+.++..++||+|+++++++ .+...
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~~~~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF-----QDKRN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence 46889999999999999999999899999999996432 33456678899999999999999999985 44567
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG 146 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLMKKD------TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFG 146 (360)
T ss_pred EEEEEeCCCCccHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeecc
Confidence 799999999999999997543 488999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCc---------------------------ccCCCCCcccccccccccccccCCCcCcccchhhHHHHH
Q 037275 836 LAKFLSSSPLDTAV---------------------------ETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILL 888 (992)
Q Consensus 836 ~a~~~~~~~~~~~~---------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 888 (992)
++............ ..........||+.|+|||++.+..++.++|||||||++
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil 226 (360)
T cd05627 147 LCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226 (360)
T ss_pred CCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceecccccee
Confidence 98755321100000 000011235799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCC
Q 037275 889 LEMFTRRRPTDGM 901 (992)
Q Consensus 889 ~elltg~~pf~~~ 901 (992)
|||++|+.||.+.
T Consensus 227 yel~tG~~Pf~~~ 239 (360)
T cd05627 227 YEMLIGYPPFCSE 239 (360)
T ss_pred eecccCCCCCCCC
Confidence 9999999999753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=317.83 Aligned_cols=252 Identities=24% Similarity=0.314 Sum_probs=198.3
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAI 758 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 758 (992)
+.|++.++||+|+||.||+|++..+++.||+|++..........+.+|+.+++.++||||+++++++. .....++
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 86 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY-----WDGKLWI 86 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEE-----eCCeEEE
Confidence 56889999999999999999999889999999997665555677889999999999999999999864 3446799
Q ss_pred EEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccce
Q 037275 759 VYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAK 838 (992)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 838 (992)
||||+++++|..++.+... .+++..+..++.|++.|++|||++ +++||||||+||+++.++.+||+|||.+.
T Consensus 87 v~e~~~~~~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~ 158 (292)
T cd06644 87 MIEFCPGGAVDAIMLELDR-----GLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSA 158 (292)
T ss_pred EEecCCCCcHHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccce
Confidence 9999999999988865432 489999999999999999999999 99999999999999999999999999987
Q ss_pred ecCCCCCCCCcccCCCCCccccccccccccccc-----CCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh
Q 037275 839 FLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGM-----GGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 913 (992)
..... ........+++.|+|||++. ...++.++|||||||++|||++|+.||...... .....
T Consensus 159 ~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~~~--- 226 (292)
T cd06644 159 KNVKT--------LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-RVLLK--- 226 (292)
T ss_pred ecccc--------ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-HHHHH---
Confidence 54321 11112345788999999874 345788999999999999999999998652110 00000
Q ss_pred hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 914 TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
. ..... .. .........++.+++.+||..+|++||+++|+++
T Consensus 227 ---------~----~~~~~-----~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 227 ---------I----AKSEP-----PT----LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ---------H----hcCCC-----cc----CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0 00000 00 0001122345889999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=313.92 Aligned_cols=260 Identities=26% Similarity=0.454 Sum_probs=200.0
Q ss_pred cCCCCCCccccccceEEEEeEECCCCe---EEEEEEeecc-CCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcc
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGM---MVAVKVINLK-QKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
.+|++.+.||+|+||.||+|+...+++ .||+|++... .......+..|+.+++.++||||+++.+++. ...
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----~~~ 78 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-----KSR 78 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEEC-----CCC
Confidence 357889999999999999999875554 6999998643 2233567899999999999999999999853 445
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
..++||||+++|+|.+++..... .+++.+++.++.|++.|++|||++ +++||||||+||+++.++.+||+||
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~df 150 (269)
T cd05065 79 PVMIITEFMENGALDSFLRQNDG-----QFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDF 150 (269)
T ss_pred ceEEEEecCCCCcHHHHHhhCCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCC
Confidence 66999999999999999976432 488999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 913 (992)
|.+............ ........+..|+|||++.+..++.++||||+||++||+++ |..||......
T Consensus 151 g~~~~~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--------- 218 (269)
T cd05065 151 GLSRFLEDDTSDPTY---TSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--------- 218 (269)
T ss_pred ccccccccCcccccc---ccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---------
Confidence 998765432211100 00111112467999999998899999999999999999987 99998753211
Q ss_pred hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 037275 914 TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRA 982 (992)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 982 (992)
+...... ..... ....+.+..+.+++.+||+.+|.+||++++|+..|+++
T Consensus 219 --------~~~~~i~-~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 219 --------DVINAIE-QDYRL----------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred --------HHHHHHH-cCCcC----------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0111000 00000 00112244588999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=327.12 Aligned_cols=193 Identities=23% Similarity=0.348 Sum_probs=163.4
Q ss_pred HhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
...+|++.+.||+|+||.||+|+...+++.||+|+... .....|+.++++++||||+++++++.. ....
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 132 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVS-----GAIT 132 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEe-----CCee
Confidence 34579999999999999999999988899999998532 223569999999999999999998643 3456
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
++||||+ .++|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||.
T Consensus 133 ~lv~e~~-~~~l~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~ 203 (357)
T PHA03209 133 CMVLPHY-SSDLYTYLTKRS-----RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGA 203 (357)
T ss_pred EEEEEcc-CCcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcc
Confidence 8999999 469999887543 2589999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCC
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPT 898 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf 898 (992)
++..... .......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 204 a~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 204 AQFPVVA---------PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccccccC---------cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 8753221 1122346899999999999999999999999999999999955443
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=308.07 Aligned_cols=251 Identities=32% Similarity=0.473 Sum_probs=200.8
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
.++|++.+.||+|+||.||+|.. .|+.||+|.+..... ..+++.+|+.++++++|+||+++++++.. ....+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 76 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ-----GNPLY 76 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcC-----CCCeE
Confidence 35788999999999999999998 478999999964433 46778999999999999999999998643 45669
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||+++++|.+++..... ..+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||.+
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~ 149 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGR----AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLA 149 (256)
T ss_pred EEEEecCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccc
Confidence 99999999999999976542 2589999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhhhC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFARTAL 916 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 916 (992)
+...... .....+..|+|||++.++.++.++||||||+++||+++ |+.||...... +
T Consensus 150 ~~~~~~~-----------~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~------ 207 (256)
T cd05039 150 KEASQGQ-----------DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----D------ 207 (256)
T ss_pred ccccccc-----------ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH-----H------
Confidence 8653211 01224567999999988899999999999999999998 99998643111 0
Q ss_pred ChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 037275 917 PDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRA 982 (992)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 982 (992)
....+.. .... .. ....+..+.+++.+||..+|++|||++|++++|+++
T Consensus 208 ---~~~~~~~----~~~~----~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 208 ---VVPHVEK----GYRM----EA------PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred ---HHHHHhc----CCCC----CC------ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 0010000 0000 00 011245688999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=311.74 Aligned_cols=256 Identities=26% Similarity=0.405 Sum_probs=192.8
Q ss_pred CccccccceEEEEeEECC---CCeEEEEEEeeccC-CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEEE
Q 037275 685 NMIGQGSFGFVYKGNLGE---NGMMVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVY 760 (992)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 760 (992)
+.||+|+||.||+|.+.. .+..||+|.+.... ....+.+.+|+.+++.++||||+++++++.. .+...++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLP----SEGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeec----CCCCcEEEE
Confidence 468999999999998642 34679999885322 2335678899999999999999999997643 233468999
Q ss_pred EeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceec
Q 037275 761 EYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFL 840 (992)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 840 (992)
||+.+|+|.+++..... ..++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++..
T Consensus 77 e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~ 148 (262)
T cd05058 77 PYMKHGDLRNFIRSETH-----NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDI 148 (262)
T ss_pred ecCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccc
Confidence 99999999999975432 367788899999999999999999 9999999999999999999999999999765
Q ss_pred CCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhC-CCCCCCCccCCccHHHHHhhhCChh
Q 037275 841 SSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFNQGLTLHEFARTALPDK 919 (992)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~ 919 (992)
...... .........++..|+|||++.+..++.++|||||||++|||++| .+||......
T Consensus 149 ~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~--------------- 209 (262)
T cd05058 149 YDKEYY----SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF--------------- 209 (262)
T ss_pred cCCcce----eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH---------------
Confidence 432110 01111223467789999999888999999999999999999995 5566532110
Q ss_pred HHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 037275 920 VMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARD 984 (992)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 984 (992)
+.......... .. .....+..+.+++.+||+.+|++||++.||++.|+++..
T Consensus 210 --~~~~~~~~~~~-------~~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 210 --DITVYLLQGRR-------LL----QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred --HHHHHHhcCCC-------CC----CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 01111100000 00 001123458899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=310.92 Aligned_cols=251 Identities=24% Similarity=0.345 Sum_probs=201.2
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
.++|++.++||+|+||.||+|....+++.||+|.+..... ...+.+|++++++++||||+++++++.. ....+
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~ 74 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFK-----NTDLW 74 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeec-----CCcEE
Confidence 3579999999999999999999988889999999864432 6789999999999999999999998643 45679
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+++||+++++|.+++.... ..+++..++.++.|++.|++|||+. +++||||+|+||+++.++.+||+|||.+
T Consensus 75 l~~e~~~~~~L~~~l~~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~ 146 (256)
T cd06612 75 IVMEYCGAGSVSDIMKITN-----KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVS 146 (256)
T ss_pred EEEecCCCCcHHHHHHhCc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccc
Confidence 9999999999999997543 2589999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALP 917 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 917 (992)
........ ......++..|+|||++.+..++.++||||||+++|+|++|+.||..........
T Consensus 147 ~~~~~~~~--------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~--------- 209 (256)
T cd06612 147 GQLTDTMA--------KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF--------- 209 (256)
T ss_pred hhcccCcc--------ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh---------
Confidence 86543211 1122347889999999988899999999999999999999999987532211000
Q ss_pred hhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 918 DKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
..... .............++.+++.+||+.||++|||++||++
T Consensus 210 -----~~~~~------------~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 210 -----MIPNK------------PPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred -----hhccC------------CCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 00000 00000011122346889999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=315.02 Aligned_cols=263 Identities=22% Similarity=0.319 Sum_probs=204.5
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC-CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
.++|++.+.||+|+||+||+|....+++.||+|++.... ....+.+.+|+++++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~ 78 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN-----ENNI 78 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEec-----CCEE
Confidence 357888999999999999999998889999999986443 2335678999999999999999999999643 3567
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
++||||+++++|.+++.... .+++..+..++.|++.||.|||+.. +++||||+|+||++++++.++|+|||+
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl 150 (284)
T cd06620 79 CMCMEFMDCGSLDRIYKKGG------PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGV 150 (284)
T ss_pred EEEEecCCCCCHHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCc
Confidence 99999999999999987543 4889999999999999999999731 899999999999999999999999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhC
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTAL 916 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 916 (992)
+...... ......|+..|+|||++.+..++.++|||||||++|++++|+.||........ ....
T Consensus 151 ~~~~~~~----------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~------~~~~ 214 (284)
T cd06620 151 SGELINS----------IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDD------GQDD 214 (284)
T ss_pred ccchhhh----------ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhh------hhhh
Confidence 8654221 11234588999999999888999999999999999999999999986433211 0011
Q ss_pred ChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 037275 917 PDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKL 979 (992)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 979 (992)
+..+.+.+........ . .....+...++.+++.+|++.||++|||++|+++..
T Consensus 215 ~~~~~~~~~~~~~~~~-----~-----~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 215 PMGILDLLQQIVQEPP-----P-----RLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred hhHHHHHHHHHhhccC-----C-----CCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 1111222222111100 0 001112345688999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=315.88 Aligned_cols=252 Identities=23% Similarity=0.305 Sum_probs=192.8
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeec--cCCCchhHHHHHHHHHHhc-cCCcceeEEEEeecccccCcce
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINL--KQKGASNGFVAECQALRNI-RHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 755 (992)
..|++.++||+||.+.||++... +.+.||+|.+.. .+......+.+|+..|.++ .|.+||++++| .-++++
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DY-----Ev~d~~ 434 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDY-----EVTDGY 434 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeee-----eccCce
Confidence 46889999999999999999986 455666665542 2344567799999999999 49999999999 456788
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
+|+||||- ..+|..++++.... .+...++.+.+||+.|+.++|.+ ||||.||||.|+++ -.|.+||+|||
T Consensus 435 lYmvmE~G-d~DL~kiL~k~~~~-----~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLl-VkG~LKLIDFG 504 (677)
T KOG0596|consen 435 LYMVMECG-DIDLNKILKKKKSI-----DPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLL-VKGRLKLIDFG 504 (677)
T ss_pred EEEEeecc-cccHHHHHHhccCC-----CchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEE-EeeeEEeeeec
Confidence 99999976 45999999877643 34337888999999999999999 99999999999999 56899999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccCC-----------CcCcccchhhHHHHHHHHHhCCCCCCCCccC
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-----------EASMTGDVYSFGILLLEMFTRRRPTDGMFNQ 904 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DiwSlG~il~elltg~~pf~~~~~~ 904 (992)
.|..+..+. ..-.....+||+.||+||.+... ..++++||||+|||+|+|+.|++||......
T Consensus 505 IA~aI~~DT------TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~ 578 (677)
T KOG0596|consen 505 IANAIQPDT------TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ 578 (677)
T ss_pred hhcccCccc------cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH
Confidence 999877653 22333456899999999987543 2567999999999999999999999753211
Q ss_pred CccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 905 GLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.. .+..+.++--..+++. - .. ..+++++|+.||+.||.+|||+.|+++
T Consensus 579 ~a------------Kl~aI~~P~~~Iefp~--------~-~~----~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 579 IA------------KLHAITDPNHEIEFPD--------I-PE----NDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred HH------------HHHhhcCCCccccccC--------C-CC----chHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 10 1112222211111110 0 00 112899999999999999999999986
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=318.82 Aligned_cols=268 Identities=23% Similarity=0.396 Sum_probs=203.6
Q ss_pred hcCCCCCCccccccceEEEEeEEC-------CCCeEEEEEEeeccCC-CchhHHHHHHHHHHhc-cCCcceeEEEEeecc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLG-------ENGMMVAVKVINLKQK-GASNGFVAECQALRNI-RHRNLIKIITICSSI 748 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 748 (992)
.++|.+.++||+|+||.||+|+.. .....||+|.++.... .....+.+|+.+++++ +||||+++++++..
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 89 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ- 89 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc-
Confidence 357889999999999999999863 2346799999864322 2345688999999999 69999999998643
Q ss_pred cccCcceEEEEEEeccCCCHHHHHhhcccc----------hhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCC
Q 037275 749 DFKGVDFQAIVYEYMQNGSLEDWLHQSEDQ----------QEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKP 818 (992)
Q Consensus 749 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp 818 (992)
....++||||+++|+|.+++...... .....+++.++..++.|++.||+|||++ +++||||||
T Consensus 90 ----~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp 162 (314)
T cd05099 90 ----EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAA 162 (314)
T ss_pred ----CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeeccccc
Confidence 34579999999999999999764321 0123589999999999999999999999 999999999
Q ss_pred CCeeeCCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCC
Q 037275 819 SNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRP 897 (992)
Q Consensus 819 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p 897 (992)
+||+++.++.+||+|||.++......... ......++..|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p 236 (314)
T cd05099 163 RNVLVTEDNVMKIADFGLARGVHDIDYYK------KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSP 236 (314)
T ss_pred eeEEEcCCCcEEEcccccccccccccccc------ccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCC
Confidence 99999999999999999998654321110 0111124567999999988899999999999999999999 8889
Q ss_pred CCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 898 TDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 898 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
|...... + ....+.. .... . .......++.+++.+||..+|++|||+.|+++
T Consensus 237 ~~~~~~~-----~---------~~~~~~~----~~~~----~------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 237 YPGIPVE-----E---------LFKLLRE----GHRM----D------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred CCCCCHH-----H---------HHHHHHc----CCCC----C------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 8653211 1 0111100 0000 0 00112345789999999999999999999999
Q ss_pred HHHHHHHhhh
Q 037275 978 KLCRARDTFL 987 (992)
Q Consensus 978 ~L~~~~~~~~ 987 (992)
.|+++.....
T Consensus 289 ~l~~~~~~~~ 298 (314)
T cd05099 289 ALDKVLAAVS 298 (314)
T ss_pred HHHHHHHHhc
Confidence 9999876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=314.68 Aligned_cols=275 Identities=24% Similarity=0.364 Sum_probs=206.3
Q ss_pred cCCCCCCccccccceEEEEeEEC----CCCeEEEEEEeeccCCC-chhHHHHHHHHHHhccCCcceeEEEEeecccccCc
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLG----ENGMMVAVKVINLKQKG-ASNGFVAECQALRNIRHRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 753 (992)
++|++.+.||+|+||.||+|+.. .+++.||||++...... ....+.+|+++++.+.||||+++++++.. .+.
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~---~~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEK---PGG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeec---CCC
Confidence 46788899999999999999964 34789999999754443 45678999999999999999999998643 234
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGD 833 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 833 (992)
...++||||+++++|.+++..... .+++..++.++.|++.||+|||+. +++||||||+||+++.++.++|+|
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~-----~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~d 152 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRD-----QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISD 152 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCcc-----ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcc
Confidence 567999999999999999976543 489999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 913 (992)
||.+.......... .......++..|+|||.+.+..++.++||||||+++|||++|+.|+......... +..
T Consensus 153 fg~~~~~~~~~~~~-----~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~---~~~ 224 (284)
T cd05038 153 FGLAKVLPEDKDYY-----YVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR---MIG 224 (284)
T ss_pred cccccccccCCcce-----eccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc---ccc
Confidence 99998765321111 0111123556799999998889999999999999999999999998653222111 000
Q ss_pred hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 037275 914 TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRA 982 (992)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 982 (992)
..........+.......... ........++.+++.+||+.+|++||||.||+++|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 225 IAQGQMIVTRLLELLKEGERL----------PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cccccccHHHHHHHHHcCCcC----------CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 000001111111111111000 00112235689999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=317.46 Aligned_cols=254 Identities=23% Similarity=0.364 Sum_probs=200.3
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
.++|++.+.||+|+||.||+|.+..+++.||+|++..........+.+|++++++++||||+++++++. .....+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 78 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF-----YENKLW 78 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEe-----cCCeEE
Confidence 357899999999999999999998889999999997655555667889999999999999999999864 345679
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||+++++|.+++..... .+++..++.++.|++.||.|||+. +|+||||+|+||+++.++.++|+|||.+
T Consensus 79 lv~e~~~~~~L~~~~~~~~~-----~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~ 150 (280)
T cd06611 79 ILIEFCDGGALDSIMLELER-----GLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVS 150 (280)
T ss_pred EEeeccCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccc
Confidence 99999999999999876432 489999999999999999999999 9999999999999999999999999988
Q ss_pred eecCCCCCCCCcccCCCCCccccccccccccccc-----CCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHH
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGM-----GGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFA 912 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~ 912 (992)
....... .......+++.|+|||++. +..++.++|||||||++|||++|+.||...... +
T Consensus 151 ~~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-----~-- 215 (280)
T cd06611 151 AKNKSTL--------QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-----R-- 215 (280)
T ss_pred hhhcccc--------cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-----H--
Confidence 7543211 1122345889999999874 345778999999999999999999998753111 0
Q ss_pred hhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 913 RTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
........... .. ........++.+++.+||+.+|++||+++++++.
T Consensus 216 ----------~~~~~~~~~~~-----~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 216 ----------VLLKILKSEPP-----TL----DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ----------HHHHHhcCCCC-----Cc----CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 00000000000 00 0001123457899999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=333.25 Aligned_cols=365 Identities=27% Similarity=0.393 Sum_probs=283.5
Q ss_pred CeEEEeeccccccC-CccCCCCCCCCcCCeeeccCCCCCccCCccccCCCCCCEEEeecccCCCCCCcccccCCCCcEee
Q 037275 50 QRVTKLDLSNRTIG-GTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFN 128 (992)
Q Consensus 50 ~~v~~ldl~~~~l~-~~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~ 128 (992)
.-|..+|+++|+++ +..|..+..+++++-|.|...++. .+|+.++.|.+|++|.+++|++. ++-.+++.|+.|+.++
T Consensus 7 pFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~ 84 (1255)
T KOG0444|consen 7 PFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVI 84 (1255)
T ss_pred ceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHh
Confidence 45889999999998 579999999999999999999999 99999999999999999999998 8888899999999999
Q ss_pred cccccccc-cCChhhcccccccccccccccccCCCCCCccccccccceEEecCCcccCCcCCccCCCCcccEEeccCccc
Q 037275 129 ARRNNLVG-EIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRF 207 (992)
Q Consensus 129 l~~n~l~~-~~p~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l 207 (992)
+.+|++.. .||.++| .+..|+.|+|++|+++ ..|..+..-.++-.|+||+|+|.++.-..|-+|..|-.||||+|++
T Consensus 85 ~R~N~LKnsGiP~diF-~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrL 162 (1255)
T KOG0444|consen 85 VRDNNLKNSGIPTDIF-RLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRL 162 (1255)
T ss_pred hhccccccCCCCchhc-ccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchh
Confidence 99999974 5899998 7899999999999999 8899999999999999999999544444577889999999999999
Q ss_pred ccccCccccccCCCcEEeccCCccCCCCCccccccccccchhhccccccCCCCchhhhccccCceeeecccccc-ccccc
Q 037275 208 SGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFR-GKVSI 286 (992)
Q Consensus 208 ~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~-~~~~~ 286 (992)
. .+|+.+..|..|++|.|++|.+.- .. | ..+..+++|+.|.+++.+-+ ..+|.
T Consensus 163 e-~LPPQ~RRL~~LqtL~Ls~NPL~h-fQ---------L---------------rQLPsmtsL~vLhms~TqRTl~N~Pt 216 (1255)
T KOG0444|consen 163 E-MLPPQIRRLSMLQTLKLSNNPLNH-FQ---------L---------------RQLPSMTSLSVLHMSNTQRTLDNIPT 216 (1255)
T ss_pred h-hcCHHHHHHhhhhhhhcCCChhhH-HH---------H---------------hcCccchhhhhhhcccccchhhcCCC
Confidence 8 788889999999999999987651 00 0 11223566777777765533 23444
Q ss_pred cccccCccceEecCCCCCCCCCCCCchhhhhccCCCcceEeecCCCcCCCcCCcccccccccceeEEeeCCccccccCCC
Q 037275 287 YFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTG 366 (992)
Q Consensus 287 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~ 366 (992)
.+..+.||..+|+|.|++. +.|..
T Consensus 217 sld~l~NL~dvDlS~N~Lp--------------------------------------------------------~vPec 240 (1255)
T KOG0444|consen 217 SLDDLHNLRDVDLSENNLP--------------------------------------------------------IVPEC 240 (1255)
T ss_pred chhhhhhhhhccccccCCC--------------------------------------------------------cchHH
Confidence 4555555555555555442 34555
Q ss_pred ccCCCcccEEEccCCcCCCCCCccccCCCCCcEEeccCccccccCCCCCCCccccCceeccCCccc-CCCCCCccccccc
Q 037275 367 IRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQ-GSIPPSLGNCKNL 445 (992)
Q Consensus 367 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L 445 (992)
+.++++|+.|+||+|+|+ ...-..+...+|++|+||.|+++ .+|.+++.+++|+.|.+.+|+++ .-+|..++.+.+|
T Consensus 241 ly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~L 318 (1255)
T KOG0444|consen 241 LYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQL 318 (1255)
T ss_pred HhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhh
Confidence 666677777777777776 44444555667777777777777 77777788888888888888776 2367778888888
Q ss_pred cccccccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeecccccccCCcccccccccceeeccC
Q 037275 446 IELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQG 525 (992)
Q Consensus 446 ~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 525 (992)
+.+..++|.+. ..|+.++.+.+|+.|.|++|++. .+|+++--++.|+.|||..
T Consensus 319 evf~aanN~LE--------------------------lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlre 371 (1255)
T KOG0444|consen 319 EVFHAANNKLE--------------------------LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRE 371 (1255)
T ss_pred HHHHhhccccc--------------------------cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccC
Confidence 87766666555 67777777888888888888877 6777887788888888888
Q ss_pred Cccc
Q 037275 526 NSFS 529 (992)
Q Consensus 526 N~l~ 529 (992)
|.=-
T Consensus 372 NpnL 375 (1255)
T KOG0444|consen 372 NPNL 375 (1255)
T ss_pred CcCc
Confidence 8644
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=314.74 Aligned_cols=261 Identities=23% Similarity=0.392 Sum_probs=203.5
Q ss_pred cCCCCCCccccccceEEEEeEECCCCe----EEEEEEeeccCC-CchhHHHHHHHHHHhccCCcceeEEEEeecccccCc
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGM----MVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 753 (992)
.+|++.+.||+|+||+||+|....+|+ .||+|....... .....+.+|+.++++++||||+++++++..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------ 80 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS------ 80 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec------
Confidence 478899999999999999999865554 689998764432 234678899999999999999999998753
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGD 833 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 833 (992)
...++||||+++|+|.+++..... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~d 152 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHKD-----NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITD 152 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECC
Confidence 456899999999999999976543 389999999999999999999998 999999999999999999999999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHH
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFA 912 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~ 912 (992)
||.++....... ........++..|+|||.+....++.++|||||||++||+++ |+.||.+....
T Consensus 153 fg~~~~~~~~~~------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------- 218 (279)
T cd05057 153 FGLAKLLDVDEK------EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV-------- 218 (279)
T ss_pred CcccccccCccc------ceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH--------
Confidence 999987643211 011111224678999999988889999999999999999999 99998753211
Q ss_pred hhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhh
Q 037275 913 RTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTFL 987 (992)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 987 (992)
.+...+. .... . .. .......+.+++.+||..+|.+|||+.++++.|.++.++..
T Consensus 219 ------~~~~~~~---~~~~-~------~~----~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (279)
T cd05057 219 ------EIPDLLE---KGER-L------PQ----PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQ 273 (279)
T ss_pred ------HHHHHHh---CCCC-C------CC----CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCc
Confidence 1111111 0000 0 00 00112357899999999999999999999999999866543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=312.12 Aligned_cols=258 Identities=26% Similarity=0.435 Sum_probs=199.9
Q ss_pred cCCCCCCccccccceEEEEeEECCC---CeEEEEEEeeccC-CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcc
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGEN---GMMVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
.+|++.+.||+|+||.||+|+...+ +..+|+|.++... ....+.+.+|+.++++++||||+++++++. ..+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 78 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-----KSK 78 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cCC
Confidence 4788999999999999999987533 3479999886432 223457899999999999999999999864 345
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
..++||||+++++|.+++..... .+++.+++.++.|++.|++|||+. +++||||||+||+++.++.++|+||
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~df 150 (267)
T cd05066 79 PVMIVTEYMENGSLDAFLRKHDG-----QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDF 150 (267)
T ss_pred ccEEEEEcCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCC
Confidence 66999999999999999976432 478999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 913 (992)
|.+........ .........++..|+|||++.+..++.++|||||||++||+++ |..||......+
T Consensus 151 g~~~~~~~~~~-----~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~-------- 217 (267)
T cd05066 151 GLSRVLEDDPE-----AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD-------- 217 (267)
T ss_pred Ccccccccccc-----eeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--------
Confidence 99987643211 0011111223568999999998899999999999999999887 999987532110
Q ss_pred hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 037275 914 TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRA 982 (992)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 982 (992)
..+... ..... + .....+..+.+++.+|++.+|++||++.++++.|+++
T Consensus 218 ---------~~~~~~-~~~~~------~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 218 ---------VIKAIE-EGYRL------P----APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ---------HHHHHh-CCCcC------C----CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 000000 00000 0 0011234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=308.74 Aligned_cols=251 Identities=24% Similarity=0.374 Sum_probs=195.1
Q ss_pred CccccccceEEEEeEECCCC---eEEEEEEeeccCC-CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEEE
Q 037275 685 NMIGQGSFGFVYKGNLGENG---MMVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVY 760 (992)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 760 (992)
++||+|+||.||+|.+...+ ..||+|.+..... ...+.+.+|+++++.++||||+++++++. ....++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK------GEPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc------CCceEEEE
Confidence 47999999999999875444 7899999864433 24567889999999999999999999853 23458999
Q ss_pred EeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceec
Q 037275 761 EYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFL 840 (992)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 840 (992)
||+++|+|.+++.... .+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||.++..
T Consensus 75 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~ 145 (257)
T cd05060 75 ELAPLGPLLKYLKKRR------EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRAL 145 (257)
T ss_pred EeCCCCcHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEecccccccee
Confidence 9999999999998654 478999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhhhCChh
Q 037275 841 SSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFARTALPDK 919 (992)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 919 (992)
...... ........++..|+|||.+.+..++.++|||||||++|+|++ |+.||...... .....
T Consensus 146 ~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~--~~~~~-------- 210 (257)
T cd05060 146 GAGSDY-----YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA--EVIAM-------- 210 (257)
T ss_pred ecCCcc-----cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH--HHHHH--------
Confidence 432210 011111224568999999998899999999999999999998 99998653211 11111
Q ss_pred HHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 037275 920 VMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRAR 983 (992)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 983 (992)
+.. ... . . ........+.+++.+||..+|++||++.++++.|+++.
T Consensus 211 ----~~~---~~~-~----~------~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 211 ----LES---GER-L----P------RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred ----HHc---CCc-C----C------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 100 000 0 0 00112346889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=350.20 Aligned_cols=257 Identities=26% Similarity=0.375 Sum_probs=205.2
Q ss_pred HhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC--CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcc
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
.+-+|+...+||.|.||.||.|....+|+-.|+|-++... ....+...+|+.++..++|||+|+++|+ ..+.+
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGV-----EvHRe 1307 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGV-----EVHRE 1307 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCce-----eecHH
Confidence 3456788899999999999999999999999999886443 3344667899999999999999999998 45566
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
..+|.||||++|+|.+.+...+ ..++.....+..|++.|++|||++ |||||||||.||+++.+|.+|++||
T Consensus 1308 kv~IFMEyC~~GsLa~ll~~gr------i~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DF 1378 (1509)
T KOG4645|consen 1308 KVYIFMEYCEGGSLASLLEHGR------IEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDF 1378 (1509)
T ss_pred HHHHHHHHhccCcHHHHHHhcc------hhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecc
Confidence 6789999999999999998654 356666667888999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCC---CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHH
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG---EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEF 911 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~ 911 (992)
|.|..+.....+ .+.......||+.|||||++.+. .-..++||||+|||+.||+||+.||.....+.......
T Consensus 1379 Gsa~ki~~~~~~----~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V 1454 (1509)
T KOG4645|consen 1379 GSAVKIKNNAQT----MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHV 1454 (1509)
T ss_pred cceeEecCchhc----CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHH
Confidence 999988765211 22344567899999999998764 34668999999999999999999998765543332222
Q ss_pred HhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 912 ARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
.-...|.-. +....+=.+++..||..||++|.++.|+++.
T Consensus 1455 ~~gh~Pq~P---------------------------~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1455 AAGHKPQIP---------------------------ERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred hccCCCCCc---------------------------hhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 222222111 0123345788999999999999999988753
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=311.21 Aligned_cols=254 Identities=26% Similarity=0.405 Sum_probs=193.8
Q ss_pred CccccccceEEEEeEECCCCe--EEEEEEeeccC-CCchhHHHHHHHHHHhc-cCCcceeEEEEeecccccCcceEEEEE
Q 037275 685 NMIGQGSFGFVYKGNLGENGM--MVAVKVINLKQ-KGASNGFVAECQALRNI-RHRNLIKIITICSSIDFKGVDFQAIVY 760 (992)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 760 (992)
+.||+|+||.||+|+...++. .+|+|.++... ......+.+|+++++++ +||||+++++++.. ....++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-----~~~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----RGYLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec-----CCCceEEE
Confidence 468999999999999976665 46888876322 33446788999999999 89999999998643 34569999
Q ss_pred EeccCCCHHHHHhhcccc----------hhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEE
Q 037275 761 EYMQNGSLEDWLHQSEDQ----------QEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAH 830 (992)
Q Consensus 761 e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 830 (992)
||+++|+|.+++...... .....+++.+++.++.|++.|++|||+. +++||||||+||++++++.+|
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~k 152 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAK 152 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEE
Confidence 999999999999865321 1123478999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHH
Q 037275 831 LGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLH 909 (992)
Q Consensus 831 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~ 909 (992)
|+|||++...... ........+..|+|||++.+..++.++|||||||++|||++ |..||.+....
T Consensus 153 l~dfgl~~~~~~~---------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~----- 218 (270)
T cd05047 153 IADFGLSRGQEVY---------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA----- 218 (270)
T ss_pred ECCCCCccccchh---------hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH-----
Confidence 9999998632210 00111224567999999988889999999999999999997 99998653211
Q ss_pred HHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 037275 910 EFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRAR 983 (992)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 983 (992)
+.. ..+.. .... . .......++.+++.+||+.+|.+|||+.|+++.|.++.
T Consensus 219 ~~~---------~~~~~----~~~~----~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 219 ELY---------EKLPQ----GYRL----E------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred HHH---------HHHhC----CCCC----C------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 000 00000 0000 0 00112345889999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=318.66 Aligned_cols=255 Identities=23% Similarity=0.355 Sum_probs=204.6
Q ss_pred CCCCCccccccceEEEEeEECCC---CeEEEEEEeeccCCC-chhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 681 FSSSNMIGQGSFGFVYKGNLGEN---GMMVAVKVINLKQKG-ASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
....+.||+|.||+|++|.+... ...||||.++..... ...+|.+|+.+|.+|+|||+++++|+..+ ...
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~------qp~ 185 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD------QPA 185 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc------chh
Confidence 34557999999999999999632 356999999866544 56889999999999999999999999643 345
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
.+|||.++.|+|.+.+++... ..+.......++.|||.|+.||.++ +.||||+..+|+++-....+||+|||+
T Consensus 186 mMV~ELaplGSLldrLrka~~----~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGL 258 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKAKK----AILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGL 258 (1039)
T ss_pred hHHhhhcccchHHHHHhhccc----cceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccc
Confidence 799999999999999998332 3688889999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhhh
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~ 915 (992)
.+-+......+.+ .....-+..|+|||.+....++.++|||+|||++|||+| |+.||.+....
T Consensus 259 mRaLg~ned~Yvm-----~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~----------- 322 (1039)
T KOG0199|consen 259 MRALGENEDMYVM-----APQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI----------- 322 (1039)
T ss_pred eeccCCCCcceEe-----cCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH-----------
Confidence 9988754322221 112234678999999999999999999999999999999 99999873211
Q ss_pred CChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 037275 916 LPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCR 981 (992)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 981 (992)
.+.+.+| .+ +...+...+.+++++++.+||..+|++|||+..|.+.+-.
T Consensus 323 ---qIL~~iD---~~-----------erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 323 ---QILKNID---AG-----------ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred ---HHHHhcc---cc-----------ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 1111222 11 1112234567789999999999999999999999865543
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=312.35 Aligned_cols=258 Identities=24% Similarity=0.361 Sum_probs=201.7
Q ss_pred cCCCCCCccccccceEEEEeEECCC---CeEEEEEEeeccC-CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcc
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGEN---GMMVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
.+|.+.++||+|+||.||+|.+... ...||+|...... ....+.+.+|+.++++++||||+++++++.. .
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~------~ 79 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE------N 79 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC------C
Confidence 4688889999999999999987533 3579999886444 3345678999999999999999999998643 2
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
..++||||+++|+|.+++..... .+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+||
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~ 151 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNKY-----SLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDF 151 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccC
Confidence 35899999999999999976432 489999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 913 (992)
|.++........ ......++..|+|||.+....++.++||||||+++||+++ |..||.+......
T Consensus 152 g~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~------- 217 (270)
T cd05056 152 GLSRYLEDESYY-------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV------- 217 (270)
T ss_pred ceeeecccccce-------ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH-------
Confidence 999866433110 1112234578999999888889999999999999999996 9999976422110
Q ss_pred hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 037275 914 TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDT 985 (992)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 985 (992)
......... .. ........+.+++.+|+..+|++|||+.|+++.|+++..+
T Consensus 218 ----------~~~~~~~~~-~~----------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 218 ----------IGRIENGER-LP----------MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred ----------HHHHHcCCc-CC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 000000000 00 0011234688999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=307.49 Aligned_cols=251 Identities=22% Similarity=0.333 Sum_probs=202.2
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC--CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
+|+..++||+|+||.||.++...+++.+++|.+.... ......+.+|++++++++|+||+++++++. .....+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFM-----DDNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEe-----cCCeEE
Confidence 5889999999999999999999899999999986442 334567889999999999999999999964 345679
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||+++|+|.+++..... ..+++.++..++.|++.|++|||+. +++||||+|+||++++++.+||+|||.+
T Consensus 76 ~~~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~ 148 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQKG----QLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGIS 148 (256)
T ss_pred EEEEecCCCcHHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcce
Confidence 99999999999999986532 2589999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALP 917 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 917 (992)
........ ......+++.|+|||+..+..++.++||||||+++|||++|..||......
T Consensus 149 ~~~~~~~~--------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------------- 207 (256)
T cd08221 149 KILGSEYS--------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL------------- 207 (256)
T ss_pred EEcccccc--------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-------------
Confidence 86643221 122345889999999998888999999999999999999999998652111
Q ss_pred hhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 918 DKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
+.......+.... .......++.+++.+||+.+|++||+++|+++.
T Consensus 208 ----~~~~~~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 208 ----NLVVKIVQGNYTP-----------VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred ----HHHHHHHcCCCCC-----------CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 1111111111000 001224558899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=306.75 Aligned_cols=251 Identities=21% Similarity=0.334 Sum_probs=199.5
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC--CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
+|++.+.||+|++|.||+|++..+++.||+|.+.... ....+.+.+|++++++++|||++++.+.+.. .....+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG----EDGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC----CCCEEE
Confidence 4888999999999999999998889999999986433 2334568899999999999999999887432 234578
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||+++++|.+++..... ..+++.+++.++.|++.|++|||+. +++||||||+||+++.++.++|+|||.+
T Consensus 77 lv~e~~~~~~l~~~l~~~~~----~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~ 149 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQKG----KLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIA 149 (257)
T ss_pred EEecccCCCcHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccce
Confidence 99999999999999986432 2589999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALP 917 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 917 (992)
....... .......+++.|+|||+..+..++.++||||+||++|++++|+.||..... ...
T Consensus 150 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-----~~~------ 210 (257)
T cd08223 150 RVLENQC--------DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-----NSL------ 210 (257)
T ss_pred EEecccC--------CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----HHH------
Confidence 8664321 112234578999999999999999999999999999999999999864211 111
Q ss_pred hhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 918 DKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.......... . ........+.+++.+|++.+|++|||+.|+++
T Consensus 211 ------~~~~~~~~~~-----~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 211 ------VYRIIEGKLP-----P------MPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred ------HHHHHhcCCC-----C------CccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000000000 0 00123456889999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=309.97 Aligned_cols=254 Identities=23% Similarity=0.397 Sum_probs=198.5
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCc---------hhHHHHHHHHHHhccCCcceeEEEEeecccc
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGA---------SNGFVAECQALRNIRHRNLIKIITICSSIDF 750 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 750 (992)
+|.+...||+|+||.||+|.+..+++.||+|.+....... .+.+.+|+.++++++||||+++++++..
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 77 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD--- 77 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe---
Confidence 4778899999999999999998889999999886433221 2457889999999999999999998643
Q ss_pred cCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEE
Q 037275 751 KGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAH 830 (992)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 830 (992)
....++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+|
T Consensus 78 --~~~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~ 146 (267)
T cd06628 78 --ADHLNIFLEYVPGGSVAALLNNYG------AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIK 146 (267)
T ss_pred --CCccEEEEEecCCCCHHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEE
Confidence 456699999999999999997643 478889999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHH
Q 037275 831 LGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHE 910 (992)
Q Consensus 831 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~ 910 (992)
|+|||.++.......... .........|+..|+|||.+.+..++.++||||+||++|+|++|+.||...... ..
T Consensus 147 l~dfg~~~~~~~~~~~~~--~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~ 220 (267)
T cd06628 147 ISDFGISKKLEANSLSTK--TNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL----QA 220 (267)
T ss_pred ecccCCCcccccccccCC--ccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH----HH
Confidence 999999987653221111 111122345888999999998888999999999999999999999999753111 00
Q ss_pred HHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 911 FARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
...... .. .... .......+.+++.+||+.||.+||++.||++
T Consensus 221 ---------~~~~~~-----~~----~~~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 221 ---------IFKIGE-----NA----SPEI------PSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ---------HHHHhc-----cC----CCcC------CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 000000 00 0000 0112356889999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=315.39 Aligned_cols=276 Identities=22% Similarity=0.319 Sum_probs=199.3
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC--CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK--GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+.+|+.++++++|||++++++++. .....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFR-----RKRKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEe-----eCCEE
Confidence 478899999999999999999988899999999864322 23356789999999999999999999854 34567
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
++||||++++++..+..... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||.
T Consensus 76 ~~v~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 146 (286)
T cd07847 76 HLVFEYCDHTVLNELEKNPR------GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGF 146 (286)
T ss_pred EEEEeccCccHHHHHHhCCC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECcccc
Confidence 99999999988888765432 489999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh-
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART- 914 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~- 914 (992)
+........ ......++..|+|||++.+ ..++.++||||||+++|+|++|+.||.+....+. .......
T Consensus 147 ~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~-~~~~~~~~ 217 (286)
T cd07847 147 ARILTGPGD--------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ-LYLIRKTL 217 (286)
T ss_pred ceecCCCcc--------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHh
Confidence 987643211 1122357889999998876 4578999999999999999999999976432211 1111100
Q ss_pred -hCChhHHHHHHhhHh-HhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 915 -ALPDKVMEIVDSVLL-LEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 915 -~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
..........+.... ........................+.+++.+||+.+|++|||+.|++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 218 GDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred CCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000000011000000 000000000000000000122456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=309.82 Aligned_cols=255 Identities=29% Similarity=0.500 Sum_probs=201.5
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
.++|++.++||+|+||.||+|... +++.||||.+... ....+++.+|+.++++++||||+++++++. .....+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 77 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCS-----EEEPIY 77 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeee-----cCCceE
Confidence 468999999999999999999986 5688999998643 334567899999999999999999999853 345569
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||+++++|.+++..... ..+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||.+
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~----~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~ 150 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEG----KKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLA 150 (261)
T ss_pred EEEeccCCCCHHHHHhcccc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccc
Confidence 99999999999999976542 2589999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhhhC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFARTAL 916 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 916 (992)
........ .......++..|+|||.+.+..++.++||||+|+++|++++ |+.||.+....
T Consensus 151 ~~~~~~~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~------------ 211 (261)
T cd05034 151 RLIEDDEY-------TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR------------ 211 (261)
T ss_pred eeccchhh-------hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH------------
Confidence 86643211 11112234678999999998889999999999999999999 99998653211
Q ss_pred ChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 037275 917 PDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCR 981 (992)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 981 (992)
...+.... .+.. . .....+.++.+++.+|++.+|++||+++|+.+.|+.
T Consensus 212 -----~~~~~~~~-~~~~-----~-----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 212 -----EVLEQVER-GYRM-----P-----RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -----HHHHHHHc-CCCC-----C-----CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 01111000 0000 0 001113468899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=322.95 Aligned_cols=288 Identities=24% Similarity=0.288 Sum_probs=211.0
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC-CCchhHHHHHHHHHHhccCCcceeEEEEeeccc-ccCcceEE
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIKIITICSSID-FKGVDFQA 757 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~~~~ 757 (992)
.|...+.||+|+||.||+|+++++|+.||||.++... ....+...+|++++++++|||||+++++-.+.. .-......
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 3456689999999999999999999999999997543 445677899999999999999999999733211 11134568
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeee--CCCC--cEEEee
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLL--DQDL--VAHLGD 833 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll--~~~~--~~kl~D 833 (992)
+|||||.+|||..++.+... ...+++.+.+.++.+++.||.|||++ +||||||||.||++ .++| ..||+|
T Consensus 94 lvmEyC~gGsL~~~L~~PEN---~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtD 167 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPEN---AYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTD 167 (732)
T ss_pred EEEeecCCCcHHHHhcCccc---ccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeec
Confidence 99999999999999986543 35699999999999999999999999 99999999999998 3334 689999
Q ss_pred cccceecCCCCCCCCcccCCCCCccccccccccccccc-CCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHH
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGM-GGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFA 912 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~ 912 (992)
||.|+...++. .....+||..|.+||... .+.|+..+|.|||||++|+.+||..||...........-..
T Consensus 168 fG~Arel~d~s---------~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~ 238 (732)
T KOG4250|consen 168 FGAARELDDNS---------LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMW 238 (732)
T ss_pred ccccccCCCCC---------eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhh
Confidence 99999876542 345678999999999988 48899999999999999999999999987544322211111
Q ss_pred h--hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCC--CHHHHHHHHHHHHH
Q 037275 913 R--TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERM--EMRDVVAKLCRARD 984 (992)
Q Consensus 913 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP--s~~evl~~L~~~~~ 984 (992)
. ...|..+.-...+...+ +.......+............+-..+..+|..+|++|- ...+.-+.+..+..
T Consensus 239 ~~~tkkp~~v~i~~~~~eNg--pv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 239 HIITKKPSGVAIGAQEEENG--PVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred hhhccCCCceeEeeecccCC--ceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 1 11111111111111100 00111111111112223345567778889999999999 88887777777654
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=324.08 Aligned_cols=283 Identities=22% Similarity=0.262 Sum_probs=205.5
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC-CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
.++|++.++||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.++++++||||+++++++....+......
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999998899999999986432 2334567889999999999999999998776656566678
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
++|+||+. +++.+++... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 84 ~lv~e~~~-~~l~~~~~~~-------~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~ 152 (336)
T cd07849 84 YIVQELME-TDLYKLIKTQ-------HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGL 152 (336)
T ss_pred EEEehhcc-cCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccc
Confidence 99999996 5888887542 489999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh--
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR-- 913 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~-- 913 (992)
+........ .........|+..|+|||.+.+ ..++.++||||+||++|+|++|+.||.+.... .....+..
T Consensus 153 ~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~-~~~~~~~~~~ 226 (336)
T cd07849 153 ARIADPEHD-----HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL-HQLNLILGVL 226 (336)
T ss_pred eeecccccc-----ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHc
Confidence 986543221 1112233568899999998654 46889999999999999999999999753211 01111111
Q ss_pred -hhCChhHHHHHHhhHhHhhhccCCCCCCccc-cchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 914 -TALPDKVMEIVDSVLLLEVQASNSRSCGDER-LRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 914 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
...++....+.+.......... ........ ........++.+++.+||+.||++|||+.|+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 227 GTPSQEDLNCIISLRARNYIKSL-PFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred CCCCHHHHHHhhchhhhhHHhhc-CcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1111112211111111000000 00000000 0001124568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=307.69 Aligned_cols=240 Identities=22% Similarity=0.365 Sum_probs=184.9
Q ss_pred CccccccceEEEEeEECC------------CCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccC
Q 037275 685 NMIGQGSFGFVYKGNLGE------------NGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKG 752 (992)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~------------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 752 (992)
+.||+|+||.||+|+... ....||+|++..........+.+|+.+++.++||||+++++++..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~----- 75 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVR----- 75 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----
Confidence 468999999999998632 233689998865555555678889999999999999999999653
Q ss_pred cceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCc----
Q 037275 753 VDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLV---- 828 (992)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---- 828 (992)
....++||||+++|+|..++..... .+++..++.++.|+++||+|||++ +|+||||||+||+++.++.
T Consensus 76 ~~~~~lv~e~~~~~~l~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~ 147 (262)
T cd05077 76 DVENIMVEEFVEFGPLDLFMHRKSD-----VLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGEC 147 (262)
T ss_pred CCCCEEEEecccCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCC
Confidence 3345899999999999999875432 488999999999999999999999 9999999999999987664
Q ss_pred ---EEEeecccceecCCCCCCCCcccCCCCCccccccccccccccc-CCCcCcccchhhHHHHHHHHH-hCCCCCCCCcc
Q 037275 829 ---AHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGM-GGEASMTGDVYSFGILLLEMF-TRRRPTDGMFN 903 (992)
Q Consensus 829 ---~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~ell-tg~~pf~~~~~ 903 (992)
++++|||.+...... ....++..|+|||++. +..++.++|||||||++|||+ +|..||.....
T Consensus 148 ~~~~~l~d~g~~~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~ 215 (262)
T cd05077 148 GPFIKLSDPGIPITVLSR------------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL 215 (262)
T ss_pred CceeEeCCCCCCccccCc------------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch
Confidence 899999998654321 1234778899999886 467899999999999999998 48888764211
Q ss_pred CCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 037275 904 QGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKL 979 (992)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 979 (992)
. +. ..... .... . ......++.+++.+||+.||++||++.||++.+
T Consensus 216 ~-----~~---------~~~~~----~~~~-----~-------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 216 A-----EK---------ERFYE----GQCM-----L-------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred h-----HH---------HHHHh----cCcc-----C-------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 1 00 00000 0000 0 001134578999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=318.89 Aligned_cols=204 Identities=23% Similarity=0.356 Sum_probs=163.3
Q ss_pred CCccccccceEEEEeEECC--CCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEEEE
Q 037275 684 SNMIGQGSFGFVYKGNLGE--NGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYE 761 (992)
Q Consensus 684 ~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 761 (992)
..+||+|+||+||+|+... ++..||+|.+... .....+.+|+.++++++||||+++++++.. ......++|||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT--GISMSACREIALLRELKHPNVIALQKVFLS---HSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCC--CCcHHHHHHHHHHHhCCCCCeeeEEEEEec---cCCCeEEEEEe
Confidence 3689999999999999753 5688999988533 234567899999999999999999998753 23456799999
Q ss_pred eccCCCHHHHHhhcccc---hhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeee----CCCCcEEEeec
Q 037275 762 YMQNGSLEDWLHQSEDQ---QEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLL----DQDLVAHLGDF 834 (992)
Q Consensus 762 ~~~~gsL~~~l~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Df 834 (992)
|++ ++|.+++...... .....+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+||
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07867 81 YAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred eeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence 986 5888887643211 1123588999999999999999999999 99999999999999 56679999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCCC
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRRRPTDGM 901 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~ 901 (992)
|+++....... .........||+.|+|||++.+. .++.++||||+||++|||+||++||...
T Consensus 157 G~a~~~~~~~~-----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 157 GFARLFNSPLK-----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cceeccCCCcc-----cccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 99987643211 11122345689999999998764 5889999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=317.32 Aligned_cols=260 Identities=24% Similarity=0.424 Sum_probs=201.4
Q ss_pred cCCCCCCccccccceEEEEeEECCCCe----EEEEEEeeccCC-CchhHHHHHHHHHHhccCCcceeEEEEeecccccCc
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGM----MVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 753 (992)
++|+..+.||+|+||.||+|.+..+++ .||+|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~----- 81 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP----- 81 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-----
Confidence 478888999999999999999866665 578888754322 2234678999999999999999999987431
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGD 833 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 833 (992)
..++++||+++|+|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~D 152 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHEHKD-----NIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITD 152 (303)
T ss_pred -CceeeehhcCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcc
Confidence 24789999999999999976542 478999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHH
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFA 912 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~ 912 (992)
||.++....... ........++..|+|||++.+..++.++|||||||++||+++ |+.||.+....
T Consensus 153 fg~~~~~~~~~~------~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~-------- 218 (303)
T cd05110 153 FGLARLLEGDEK------EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR-------- 218 (303)
T ss_pred ccccccccCccc------ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------
Confidence 999986543211 111222345778999999998899999999999999999998 89998653111
Q ss_pred hhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 037275 913 RTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTF 986 (992)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 986 (992)
...+.+.. .... ... ......+.+++.+||..+|++||+++|+++.+.++.++.
T Consensus 219 ------~~~~~~~~----~~~~------~~~----~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 219 ------EIPDLLEK----GERL------PQP----PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred ------HHHHHHHC----CCCC------CCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 01111110 0000 000 012345789999999999999999999999999987554
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=312.96 Aligned_cols=277 Identities=23% Similarity=0.360 Sum_probs=197.7
Q ss_pred HhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC-CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
++++|++.+.||+|+||.||+|....+++.||+|++..... .....+.+|+.+++.++|+||+++.+++. ....
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----~~~~ 77 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIH-----TKET 77 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEe-----cCCe
Confidence 34689999999999999999999988899999999864432 23346788999999999999999999854 3456
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++||||+. +++.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 78 ~~lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg 148 (291)
T cd07870 78 LTFVFEYMH-TDLAQYMIQHPG-----GLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFG 148 (291)
T ss_pred EEEEEeccc-CCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccc
Confidence 799999995 688877754332 377888899999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
+++...... .......+++.|+|||++.+. .++.++|||||||++|+|++|+.||.+..+....+.+....
T Consensus 149 ~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~ 220 (291)
T cd07870 149 LARAKSIPS--------QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTV 220 (291)
T ss_pred cccccCCCC--------CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHH
Confidence 987543211 111223468899999998764 57889999999999999999999997643322212111110
Q ss_pred -hCChh-HHHHHHhhHhHhhhccCCCCCCcc----ccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 915 -ALPDK-VMEIVDSVLLLEVQASNSRSCGDE----RLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 915 -~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
..+.. ........ ..+.......+... ..........+.+++.+|++.||++|||++|++.
T Consensus 221 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 221 LGVPTEDTWPGVSKL--PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cCCCChhhhhhhhhc--ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 01110 00000000 00000000000000 0000112356789999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=310.63 Aligned_cols=249 Identities=25% Similarity=0.322 Sum_probs=200.3
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC-CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
++|++.+.||.|+||.||+|++..+++.||+|++.... ......+.+|+++++.++|||++++.+++. +....+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFL-----KGSKLW 75 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEE-----ECCeEE
Confidence 36888999999999999999999899999999987543 334567889999999999999999999854 345679
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+|+||+++++|.+++... .+++..++.++.|++.|+.|||+. +++||||+|+||++++++.++|+|||.+
T Consensus 76 ~v~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~ 145 (274)
T cd06609 76 IIMEYCGGGSCLDLLKPG-------KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVS 145 (274)
T ss_pred EEEEeeCCCcHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccc
Confidence 999999999999998753 489999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALP 917 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 917 (992)
+...... .......++..|+|||++.+..++.++|||||||++|+|++|+.||...... .
T Consensus 146 ~~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~-----~------- 205 (274)
T cd06609 146 GQLTSTM--------SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM-----R------- 205 (274)
T ss_pred eeecccc--------cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH-----H-------
Confidence 8765421 1122345788999999999888999999999999999999999999653210 0
Q ss_pred hhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 918 DKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.......... .... .......+.+++.+||..+|++|||++++++
T Consensus 206 -----~~~~~~~~~~-----~~~~-----~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 206 -----VLFLIPKNNP-----PSLE-----GNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred -----HHHHhhhcCC-----CCCc-----ccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 0000000000 0000 0002345889999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=308.20 Aligned_cols=254 Identities=22% Similarity=0.338 Sum_probs=194.6
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC-----CchhHHHHHHHHHHhccCCcceeEEEEeecccccCc
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK-----GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 753 (992)
.+|+..+.||+|+||.||+|....++..||+|.+..... .....+.+|+.++++++||||+++++++.. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~ 78 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRD---RAE 78 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc---CCC
Confidence 378999999999999999999988899999999864321 123467889999999999999999998643 224
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGD 833 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 833 (992)
...+++|||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||+|+||+++.++.+||+|
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~d 149 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLKAYG------ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGD 149 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEcc
Confidence 56789999999999999997543 478899999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 913 (992)
||+++....... .........++..|+|||++.+..++.++||||+||++||+++|+.||...... ..
T Consensus 150 fg~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~----~~--- 217 (266)
T cd06651 150 FGASKRLQTICM-----SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM----AA--- 217 (266)
T ss_pred CCCccccccccc-----cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH----HH---
Confidence 999876532110 111112345788999999999888999999999999999999999999753111 00
Q ss_pred hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 914 TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
+.. ...... ...........+.+++ +||..+|++||+++||++
T Consensus 218 ---------~~~-~~~~~~----------~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 218 ---------IFK-IATQPT----------NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ---------HHH-HhcCCC----------CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 000 000000 0000011223455666 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=319.84 Aligned_cols=202 Identities=28% Similarity=0.359 Sum_probs=171.9
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc---CCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK---QKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
++|++.+.||+|+||+||+|+...+++.||+|++... .......+.+|..++..++|++|+++.+++. +.+.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~-----~~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQ-----DENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----cCCE
Confidence 4789999999999999999999989999999998642 2223455788999999999999999999853 4567
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++||||+++|+|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG 147 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKFED-----RLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFG 147 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEecc
Confidence 7999999999999999976432 488899999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccC-----CCcCcccchhhHHHHHHHHHhCCCCCCC
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-----GEASMTGDVYSFGILLLEMFTRRRPTDG 900 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~pf~~ 900 (992)
++........ .......||+.|+|||++.+ +.++.++||||+||++|||++|+.||..
T Consensus 148 ~a~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 210 (331)
T cd05624 148 SCLKMNQDGT-------VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred ceeeccCCCc-------eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence 9986543211 11123468999999998865 4678899999999999999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=311.95 Aligned_cols=239 Identities=23% Similarity=0.349 Sum_probs=183.1
Q ss_pred ccccccceEEEEeEECC------------------------CCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeE
Q 037275 686 MIGQGSFGFVYKGNLGE------------------------NGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKI 741 (992)
Q Consensus 686 ~lg~G~~g~V~~~~~~~------------------------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 741 (992)
.||+|+||.||+|.... ....||+|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999998521 124589998865444445678889999999999999999
Q ss_pred EEEeecccccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCe
Q 037275 742 ITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNV 821 (992)
Q Consensus 742 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NI 821 (992)
++++.. ....++||||+++|+|..++..... .+++..+..++.|+++||+|||++ +|+||||||+||
T Consensus 82 ~~~~~~-----~~~~~lv~ey~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Ni 148 (274)
T cd05076 82 HGVCVR-----GSENIMVEEFVEHGPLDVCLRKEKG-----RVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNI 148 (274)
T ss_pred EEEEEe-----CCceEEEEecCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccE
Confidence 999754 3455899999999999999875432 478899999999999999999999 999999999999
Q ss_pred eeCCCC-------cEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccC-CCcCcccchhhHHHHHHHHH-
Q 037275 822 LLDQDL-------VAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMF- 892 (992)
Q Consensus 822 ll~~~~-------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell- 892 (992)
+++..+ .+|++|||.+...... ....++..|+|||.+.+ ..++.++|||||||++||++
T Consensus 149 ll~~~~~~~~~~~~~kl~d~g~~~~~~~~------------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~ 216 (274)
T cd05076 149 LLARLGLAEGTSPFIKLSDPGVSFTALSR------------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICF 216 (274)
T ss_pred EEeccCcccCccceeeecCCccccccccc------------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHh
Confidence 997644 4899999987643211 11246788999998865 56899999999999999995
Q ss_pred hCCCCCCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCH
Q 037275 893 TRRRPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEM 972 (992)
Q Consensus 893 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 972 (992)
+|+.||....... ....... .. ..+ .....++.+++.+||+.+|++|||+
T Consensus 217 ~g~~p~~~~~~~~--------------~~~~~~~----~~------~~~------~~~~~~~~~li~~cl~~~p~~Rps~ 266 (274)
T cd05076 217 DGEVPLKERTPSE--------------KERFYEK----KH------RLP------EPSCKELATLISQCLTYEPTQRPSF 266 (274)
T ss_pred CCCCCccccChHH--------------HHHHHHh----cc------CCC------CCCChHHHHHHHHHcccChhhCcCH
Confidence 6999987532111 0011110 00 000 0012358899999999999999999
Q ss_pred HHHHHHH
Q 037275 973 RDVVAKL 979 (992)
Q Consensus 973 ~evl~~L 979 (992)
+||++.|
T Consensus 267 ~~il~~L 273 (274)
T cd05076 267 RTILRDL 273 (274)
T ss_pred HHHHHhh
Confidence 9999877
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=289.85 Aligned_cols=210 Identities=24% Similarity=0.380 Sum_probs=176.3
Q ss_pred hcCCCCCCccccccceEEEEeEECCCC----eEEEEEEeeccC--CCchhHHHHHHHHHHhccCCcceeEEEEeeccccc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENG----MMVAVKVINLKQ--KGASNGFVAECQALRNIRHRNLIKIITICSSIDFK 751 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 751 (992)
...|+.+..||+|.||.||+|....+. +.+|+|.++.+. .+-.....+|+..++.++|||++.+..++..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~---- 98 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLS---- 98 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhc----
Confidence 447899999999999999999765332 378999986442 2345567899999999999999999998643
Q ss_pred CcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCC----C
Q 037275 752 GVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQD----L 827 (992)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~ 827 (992)
.+..+++++||++. +|...++.++... ...++...+..|++||+.|+.|||++ =|+|||+||.||||..+ |
T Consensus 99 ~d~~v~l~fdYAEh-DL~~II~fHr~~~-~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG 173 (438)
T KOG0666|consen 99 HDKKVWLLFDYAEH-DLWHIIKFHRASK-AKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERG 173 (438)
T ss_pred cCceEEEEehhhhh-hHHHHHHHhccch-hccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccC
Confidence 35678999999977 9999998877653 36799999999999999999999999 69999999999999877 8
Q ss_pred cEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCCC
Q 037275 828 VAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRRRPTDGM 901 (992)
Q Consensus 828 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~ 901 (992)
.|||+|||+|+.+...-. .-......+-|..|+|||.+.|. .||++.||||.|||+.||+|-++.|.+.
T Consensus 174 ~VKIaDlGlaR~~~~plk-----pl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 174 RVKIADLGLARLFNNPLK-----PLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred eeEeecccHHHHhhcccc-----ccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 999999999998765321 22234556789999999988775 6999999999999999999999998774
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=324.18 Aligned_cols=241 Identities=23% Similarity=0.268 Sum_probs=183.6
Q ss_pred cccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhc---cCCcceeEEEEeecccccCcceEEEEE
Q 037275 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNI---RHRNLIKIITICSSIDFKGVDFQAIVY 760 (992)
Q Consensus 687 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~~~~lv~ 760 (992)
||+|+||+||+|++..+++.||+|++.... .........|..++... +||+|+++++++ ......++||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~-----~~~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF-----QTDSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE-----ecCCeEEEEE
Confidence 799999999999999899999999986432 12233455666776665 699999999985 3456679999
Q ss_pred EeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceec
Q 037275 761 EYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFL 840 (992)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 840 (992)
||+++|+|.+++.... .+++..+..++.||++||+|||++ +|+||||||+||+++.++.+||+|||++...
T Consensus 76 e~~~~g~L~~~l~~~~------~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~ 146 (330)
T cd05586 76 DYMSGGELFWHLQKEG------RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKAN 146 (330)
T ss_pred cCCCCChHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCC
Confidence 9999999999987543 488999999999999999999999 9999999999999999999999999998753
Q ss_pred CCCCCCCCcccCCCCCcccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCChh
Q 037275 841 SSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDK 919 (992)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 919 (992)
... ........||+.|+|||++.+. .++.++||||+||++|||++|+.||.+... .+
T Consensus 147 ~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~-----~~--------- 204 (330)
T cd05586 147 LTD--------NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT-----QQ--------- 204 (330)
T ss_pred CCC--------CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH-----HH---------
Confidence 221 1112345689999999998764 489999999999999999999999975311 11
Q ss_pred HHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCC----HHHHHH
Q 037275 920 VMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERME----MRDVVA 977 (992)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~evl~ 977 (992)
........... .+ ......++.+++.+||+.||++||+ +.|+++
T Consensus 205 ---~~~~i~~~~~~------~~-----~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 205 ---MYRNIAFGKVR------FP-----KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred ---HHHHHHcCCCC------CC-----CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 11111100000 00 0112345788999999999999994 555544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=311.97 Aligned_cols=262 Identities=23% Similarity=0.322 Sum_probs=204.2
Q ss_pred HHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhc-cCCcceeEEEEeecccc-cCc
Q 037275 676 KATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNI-RHRNLIKIITICSSIDF-KGV 753 (992)
Q Consensus 676 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~-~~~ 753 (992)
..+++|++.+.||+|+||.||+|....+++.||+|++..... ....+.+|+.+++++ +||||+++++++..... ...
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 356899999999999999999999988899999999864433 446789999999999 79999999999865443 345
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGD 833 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 833 (992)
...++||||+++++|.+++...... ...+++..++.++.|++.||+|||+. +++||||+|+||++++++.+||+|
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d 156 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKK--GKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVD 156 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECC
Confidence 6779999999999999998754311 23589999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccC-----CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccH
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-----GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTL 908 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~ 908 (992)
||.+....... .......|+..|+|||++.. ..++.++|||||||++|+|++|+.||...... ...
T Consensus 157 ~~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~ 227 (275)
T cd06608 157 FGVSAQLDSTL--------GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-RAL 227 (275)
T ss_pred Cccceecccch--------hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-HHH
Confidence 99987654321 11223458899999998753 34778999999999999999999999642111 000
Q ss_pred HHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 909 HEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
. .+.. ... ...........++.+++.+||..||++|||++|+++
T Consensus 228 ~------------~~~~----~~~---------~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 228 F------------KIPR----NPP---------PTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred H------------Hhhc----cCC---------CCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0 0000 000 000111223456889999999999999999999985
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=307.50 Aligned_cols=254 Identities=29% Similarity=0.493 Sum_probs=200.0
Q ss_pred CccccccceEEEEeEECCC---CeEEEEEEeeccCCCc-hhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEEE
Q 037275 685 NMIGQGSFGFVYKGNLGEN---GMMVAVKVINLKQKGA-SNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVY 760 (992)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 760 (992)
++||+|+||.||+|..... +..||+|+++...... .+.+.+|+++++.++|+|++++++++.. ....++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-----EEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC-----CCceEEEE
Confidence 4799999999999999765 8899999997544333 6788999999999999999999998643 55679999
Q ss_pred EeccCCCHHHHHhhcccc---hhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 761 EYMQNGSLEDWLHQSEDQ---QEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 761 e~~~~gsL~~~l~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
||+++++|.+++...... .....+++..++.++.|++.||+|||++ +++||||+|+||++++++.+||+|||.+
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~ 152 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLS 152 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccc
Confidence 999999999999875210 0013589999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhhhC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFARTAL 916 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 916 (992)
........ ........++..|+|||.+.+..++.++||||+||++|||++ |..||......
T Consensus 153 ~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------------ 214 (262)
T cd00192 153 RDVYDDDY------YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE------------ 214 (262)
T ss_pred cccccccc------cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH------------
Confidence 87654321 111233457889999999988899999999999999999999 69998764111
Q ss_pred ChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 037275 917 PDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLC 980 (992)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 980 (992)
+..+....... . ........++.+++.+||..+|++|||+.|+++.|+
T Consensus 215 -----~~~~~~~~~~~-~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 215 -----EVLEYLRKGYR-L----------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -----HHHHHHHcCCC-C----------CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11111110000 0 001112456889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=309.80 Aligned_cols=257 Identities=22% Similarity=0.323 Sum_probs=187.0
Q ss_pred CccccccceEEEEeEEC--CCCeEEEEEEeeccCC-CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEEEE
Q 037275 685 NMIGQGSFGFVYKGNLG--ENGMMVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYE 761 (992)
Q Consensus 685 ~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 761 (992)
+.||+|+||.||+|... .++..+|+|.++.... .....+.+|+.++++++||||+++++++.+ ....++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE-----VTPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-----CCCcEEEEE
Confidence 46899999999999864 3456799998864432 233568889999999999999999998643 345699999
Q ss_pred eccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceecC
Q 037275 762 YMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLS 841 (992)
Q Consensus 762 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 841 (992)
|+++|+|.+++...... .....++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+....
T Consensus 76 ~~~~g~L~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~ 151 (269)
T cd05087 76 FCPLGDLKGYLRSCRKA-ELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKY 151 (269)
T ss_pred CCCCCcHHHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCcccccccc
Confidence 99999999999764321 123467778889999999999999999 99999999999999999999999999987543
Q ss_pred CCCCCCCcccCCCCCcccccccccccccccCC-------CcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHh
Q 037275 842 SSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-------EASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 913 (992)
.... ........++..|+|||++.+. .++.++|||||||++|||++ |+.||........ ...
T Consensus 152 ~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~--~~~-- 221 (269)
T cd05087 152 KEDY------YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV--LTY-- 221 (269)
T ss_pred Ccce------eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH--HHH--
Confidence 2211 1112234578889999987542 35789999999999999996 9999965322110 000
Q ss_pred hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 037275 914 TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLC 980 (992)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 980 (992)
.+ .... ........ . ......+.+++..|+ .+|++|||++||++.|+
T Consensus 222 ---------~~----~~~~-~~~~~~~~--~---~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 222 ---------TV----REQQ-LKLPKPRL--K---LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred ---------Hh----hccc-CCCCCCcc--C---CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 00 0000 00000000 0 011234677888998 58999999999998774
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=312.95 Aligned_cols=240 Identities=22% Similarity=0.395 Sum_probs=185.1
Q ss_pred CccccccceEEEEeEECCCCe-------EEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 685 NMIGQGSFGFVYKGNLGENGM-------MVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
+.||+|+||.||+|.....+. .||+|.+........+.+.+|+.+++.++||||+++++++.. +...+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-----~~~~~ 75 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVC-----GDESI 75 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEe-----CCCcE
Confidence 479999999999999865443 488888765444455678899999999999999999999653 34458
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCc--------E
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLV--------A 829 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------~ 829 (992)
+||||+++|+|.++++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++. +
T Consensus 76 lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~ 147 (258)
T cd05078 76 MVQEYVKFGSLDTYLKKNKN-----LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFI 147 (258)
T ss_pred EEEecCCCCcHHHHHhcCCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceE
Confidence 99999999999999986542 488999999999999999999999 9999999999999987765 6
Q ss_pred EEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCC-CcCcccchhhHHHHHHHHHhCC-CCCCCCccCCcc
Q 037275 830 HLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRR-RPTDGMFNQGLT 907 (992)
Q Consensus 830 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~-~pf~~~~~~~~~ 907 (992)
+++|||.+...... ....++..|+|||++.+. .++.++|||||||++|||++|. .||......
T Consensus 148 ~l~d~g~~~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~--- 212 (258)
T cd05078 148 KLSDPGISITVLPK------------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ--- 212 (258)
T ss_pred EecccccccccCCc------------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH---
Confidence 99999988644321 123477889999998764 5789999999999999999985 555431110
Q ss_pred HHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 037275 908 LHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKL 979 (992)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 979 (992)
........ .. ..+ .....++.+++.+||+.||++|||++|+++.|
T Consensus 213 -----------~~~~~~~~----~~------~~~------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 213 -----------KKLQFYED----RH------QLP------APKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred -----------HHHHHHHc----cc------cCC------CCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 00000000 00 000 01124588999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=318.68 Aligned_cols=202 Identities=27% Similarity=0.347 Sum_probs=170.8
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc---CCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK---QKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
++|++.++||+|+||+||+++...+++.||+|++... .......+.+|+.++..++|++|+++.+++. +...
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ-----DENN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEe-----cCCE
Confidence 4788999999999999999999988999999998632 2223345788999999999999999999853 4566
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++||||+++|+|.+++.+... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG 147 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKFED-----RLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFG 147 (332)
T ss_pred EEEEEeccCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecc
Confidence 7999999999999999976432 488899999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCccccccccccccccc-----CCCcCcccchhhHHHHHHHHHhCCCCCCC
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGM-----GGEASMTGDVYSFGILLLEMFTRRRPTDG 900 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~pf~~ 900 (992)
++....... ........||+.|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 148 ~a~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~ 210 (332)
T cd05623 148 SCLKLMEDG-------TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (332)
T ss_pred hheecccCC-------cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence 987543221 11122346899999999876 34688999999999999999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=311.76 Aligned_cols=274 Identities=25% Similarity=0.377 Sum_probs=197.7
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC--CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
+|+..+.||.|++|.||+|++..+++.||||.++... ......+.+|++++++++||||+++++++ .+....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhc-----ccCCcEE
Confidence 4788999999999999999998899999999886433 22335788999999999999999999985 3455679
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||+. ++|.+++..... ..+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+||+|||.+
T Consensus 76 ~v~e~~~-~~l~~~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~ 147 (284)
T cd07860 76 LVFEFLH-QDLKKFMDASPL----SGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 147 (284)
T ss_pred EEeeccc-cCHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccch
Confidence 9999995 689998876432 3589999999999999999999999 9999999999999999999999999998
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCCC-cCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh-
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGE-ASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA- 915 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~- 915 (992)
....... .......++..|+|||++.+.. ++.++|||||||++|||+||+.||.+..+.. ...+.....
T Consensus 148 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~ 218 (284)
T cd07860 148 RAFGVPV--------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLG 218 (284)
T ss_pred hhcccCc--------cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhC
Confidence 7554221 1112224678899999877654 6889999999999999999999997643221 111111111
Q ss_pred CCh-hHHHHHHhhHhHhhhccCCCCCCccccc-hHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 916 LPD-KVMEIVDSVLLLEVQASNSRSCGDERLR-TEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 916 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.+. ......... ..+.............. ......++.+++.+||+.||++|||++|+++
T Consensus 219 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 219 TPDEVVWPGVTSL--PDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred CCChhhhhhhhHH--HHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 111 111000000 00000000000000000 0112345789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=318.71 Aligned_cols=264 Identities=24% Similarity=0.366 Sum_probs=202.3
Q ss_pred cCCCCCCccccccceEEEEeEECC-------CCeEEEEEEeeccC-CCchhHHHHHHHHHHhc-cCCcceeEEEEeeccc
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGE-------NGMMVAVKVINLKQ-KGASNGFVAECQALRNI-RHRNLIKIITICSSID 749 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 749 (992)
.+|++.+.||+|+||.||+|++.. .+..||+|.++... ....+.+.+|+.+++++ +||||+++++++..
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 89 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-- 89 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc--
Confidence 468999999999999999998632 23468999886432 22346788999999999 79999999998643
Q ss_pred ccCcceEEEEEEeccCCCHHHHHhhcccc----------hhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCC
Q 037275 750 FKGVDFQAIVYEYMQNGSLEDWLHQSEDQ----------QEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPS 819 (992)
Q Consensus 750 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~ 819 (992)
....++||||+++|+|.+++...... .....+++.++..++.|++.||+|||++ +++||||||+
T Consensus 90 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~ 163 (334)
T cd05100 90 ---DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAAR 163 (334)
T ss_pred ---CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccc
Confidence 44569999999999999999864321 1123588999999999999999999999 9999999999
Q ss_pred CeeeCCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCC
Q 037275 820 NVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPT 898 (992)
Q Consensus 820 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf 898 (992)
||+++.++.+||+|||.++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~ 237 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYY------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 237 (334)
T ss_pred eEEEcCCCcEEECCcccceeccccccc------ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCC
Confidence 999999999999999999865432111 11112234568999999999999999999999999999998 88888
Q ss_pred CCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 899 DGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
.+... .+.. ........ . ........++.+++.+||+.+|++|||+.|+++.
T Consensus 238 ~~~~~-----~~~~------------~~~~~~~~-~----------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 238 PGIPV-----EELF------------KLLKEGHR-M----------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred CCCCH-----HHHH------------HHHHcCCC-C----------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 65321 1111 11000000 0 0001223468899999999999999999999999
Q ss_pred HHHHHH
Q 037275 979 LCRARD 984 (992)
Q Consensus 979 L~~~~~ 984 (992)
|+++..
T Consensus 290 l~~~~~ 295 (334)
T cd05100 290 LDRVLT 295 (334)
T ss_pred HHHHhh
Confidence 998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=312.81 Aligned_cols=275 Identities=23% Similarity=0.357 Sum_probs=197.6
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC-CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
.++|++.+.||+|++|.||+|+...+++.||+|.+..... .....+.+|++++++++||||+++++++. .....
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~ 78 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIH-----TKKTL 78 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEe-----cCCeE
Confidence 3578999999999999999999988899999999864432 23345678999999999999999999854 44567
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
++||||+. ++|.+++..... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||.
T Consensus 79 ~lv~e~~~-~~L~~~~~~~~~-----~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~ 149 (291)
T cd07844 79 TLVFEYLD-TDLKQYMDDCGG-----GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGL 149 (291)
T ss_pred EEEEecCC-CCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECcccc
Confidence 99999997 599999875432 488999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 915 (992)
++...... .......++..|+|||++.+ ..++.++||||+|+++|+|++|+.||.+...............
T Consensus 150 ~~~~~~~~--------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~ 221 (291)
T cd07844 150 ARAKSVPS--------KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVL 221 (291)
T ss_pred ccccCCCC--------ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhc
Confidence 87543211 01112246788999998865 4588999999999999999999999976432211111111110
Q ss_pred ---CChhHHHHHHhhHhHhhhccCCCCCCcc----ccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 916 ---LPDKVMEIVDSVLLLEVQASNSRSCGDE----RLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 916 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.++.+...... .............. ..........+.+++.+|++.+|++|||+.|+++
T Consensus 222 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 222 GTPTEETWPGVSSN---PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred CCCChhhhhhhhhc---cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 01101010000 00000000000000 0000011256789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=309.59 Aligned_cols=264 Identities=25% Similarity=0.300 Sum_probs=202.0
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC-CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
++|+..++||.|++|.||+|.+..+++.||+|.+..... .....+.+|++++++++||||+++++++.. ......+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~~~ 77 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLD---ESSSSIG 77 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEc---cCCCeEE
Confidence 367888999999999999999988899999999864432 345678999999999999999999998754 2344679
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||+++++|.+++..... ....+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++
T Consensus 78 lv~e~~~~~~L~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~ 152 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVKK--RGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS 152 (287)
T ss_pred EEEEecCCCCHHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccc
Confidence 99999999999998865332 133578899999999999999999999 9999999999999999999999999998
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALP 917 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 917 (992)
....... .....++..|+|||.+.+..++.++||||+||++|+|++|+.||.....+.....+..
T Consensus 153 ~~~~~~~----------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----- 217 (287)
T cd06621 153 GELVNSL----------AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELL----- 217 (287)
T ss_pred ccccccc----------cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHH-----
Confidence 7543211 1123467889999999888999999999999999999999999976422111111111
Q ss_pred hhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 918 DKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
..+....... ..............+.+++.+||+.+|++|||+.|+++
T Consensus 218 ----~~~~~~~~~~--------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 218 ----SYIVNMPNPE--------LKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred ----HHHhcCCchh--------hccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 0000000000 00000000112456889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=306.25 Aligned_cols=250 Identities=21% Similarity=0.320 Sum_probs=200.5
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC--CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
+|++.+.||+|+||.||.++...+++.||+|.+.... ....+.+.+|+.++++++||||+++.+++ ......+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-----EENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-----cCCCeEE
Confidence 5888999999999999999998899999999986432 23445789999999999999999999985 3456779
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||+++++|.+++..... ..+++.++..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||.+
T Consensus 76 lv~e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~ 148 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQRG----VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIA 148 (256)
T ss_pred EEEecCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccce
Confidence 99999999999999975432 2478899999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALP 917 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 917 (992)
....... .......|++.|+|||+..+..++.++|||||||++|+|++|+.||....
T Consensus 149 ~~~~~~~--------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~--------------- 205 (256)
T cd08218 149 RVLNSTV--------ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN--------------- 205 (256)
T ss_pred eecCcch--------hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC---------------
Confidence 8654321 11122357889999999988889999999999999999999999986421
Q ss_pred hhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 918 DKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
..+..+....+.... .......++.+++.+||+.+|++||++.||++
T Consensus 206 --~~~~~~~~~~~~~~~-----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 206 --MKNLVLKIIRGSYPP-----------VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred --HHHHHHHHhcCCCCC-----------CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 111122211111100 01122456899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=306.57 Aligned_cols=254 Identities=27% Similarity=0.448 Sum_probs=199.7
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
.++|++.+.||+|+||.||+|... .+..+|+|.+... ......+.+|++++++++|+||+++.+++.. ...+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~ 76 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPIY 76 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CCeE
Confidence 457899999999999999999875 5677999988633 2345678899999999999999999998643 3468
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
++|||+++++|.+++..... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||.+
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~ 149 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEG----SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLA 149 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCc----cccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcce
Confidence 99999999999999976432 2578889999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhhhC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFARTAL 916 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 916 (992)
........ .......++..|+|||++.+..++.++|||||||++|++++ |+.||.+.... .....
T Consensus 150 ~~~~~~~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~----- 215 (260)
T cd05073 150 RVIEDNEY-------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRA----- 215 (260)
T ss_pred eeccCCCc-------ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH--HHHHH-----
Confidence 76543211 11122345678999999988889999999999999999999 99998753211 00000
Q ss_pred ChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 037275 917 PDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCR 981 (992)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 981 (992)
+. ..... ........++.+++.+|++.+|++||++.++.+.|+.
T Consensus 216 -------~~----~~~~~----------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 216 -------LE----RGYRM----------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -------Hh----CCCCC----------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 00 00000 0001223568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=307.18 Aligned_cols=254 Identities=22% Similarity=0.303 Sum_probs=195.9
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC-----CchhHHHHHHHHHHhccCCcceeEEEEeecccccCc
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK-----GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 753 (992)
.+|++.++||+|+||.||.|.+..+++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+. ..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDP---ME 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccC---CC
Confidence 478899999999999999999988999999998863321 1235678899999999999999999986431 23
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGD 833 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 833 (992)
...++||||+++++|.+++.... .+++..+.+++.|++.||+|||+. +++||||||+||+++.++.++|+|
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~D 149 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKSYG------ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGD 149 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECc
Confidence 45689999999999999987543 378888999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 913 (992)
||.+........ .........++..|+|||++.+..++.++|||||||++|||++|+.||...... .....
T Consensus 150 fg~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----~~~~~ 220 (265)
T cd06652 150 FGASKRLQTICL-----SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM----AAIFK 220 (265)
T ss_pred Cccccccccccc-----cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH----HHHHH
Confidence 999886542211 111122345888999999998888999999999999999999999998642111 00000
Q ss_pred hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 914 TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.. ... . ...........+.+++.+|+. +|++||+++|+++
T Consensus 221 -------------~~-~~~-----~----~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 221 -------------IA-TQP-----T----NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred -------------Hh-cCC-----C----CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 00 000 0 000111234457888899985 9999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=308.97 Aligned_cols=265 Identities=25% Similarity=0.396 Sum_probs=200.6
Q ss_pred CCCCCccccccceEEEEeEEC---CCCeEEEEEEeeccC--CCchhHHHHHHHHHHhccCCcceeEEEEeecccccC-cc
Q 037275 681 FSSSNMIGQGSFGFVYKGNLG---ENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKG-VD 754 (992)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~-~~ 754 (992)
|++.++||+|+||.||+|... .+++.||||++.... ....+++.+|+++++.++||||+++++++......+ ..
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567889999999999999864 357899999986432 233456889999999999999999999875432221 22
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
..++++||+++|+|.+++...........+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 3478999999999999886443222233578999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 913 (992)
|.++........ .......+++.|++||.+.+..++.++|||||||++|||++ |++||.+.... +
T Consensus 158 g~~~~~~~~~~~------~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~-----~--- 223 (273)
T cd05074 158 GLSKKIYSGDYY------RQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS-----E--- 223 (273)
T ss_pred cccccccCCcce------ecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH-----H---
Confidence 999865432110 11112235678999999988889999999999999999999 88888653211 0
Q ss_pred hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 037275 914 TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRA 982 (992)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 982 (992)
....+. .... .. ........+.+++.+||+.+|++|||+.|+++.|+++
T Consensus 224 ------~~~~~~---~~~~----~~-------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 224 ------IYNYLI---KGNR----LK-------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ------HHHHHH---cCCc----CC-------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000000 0000 00 0011234689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=307.11 Aligned_cols=251 Identities=25% Similarity=0.394 Sum_probs=196.5
Q ss_pred CccccccceEEEEeEECC-CC--eEEEEEEeeccCC-CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEEE
Q 037275 685 NMIGQGSFGFVYKGNLGE-NG--MMVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVY 760 (992)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~-~~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 760 (992)
++||+|++|.||+|.+.. .+ ..||+|.+..... ...+.+.+|+.++++++||||+++++++.. ...++||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEEE
Confidence 478999999999999854 23 3699999975544 456788999999999999999999998643 5679999
Q ss_pred EeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceec
Q 037275 761 EYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFL 840 (992)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 840 (992)
||+++|+|.+++..... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||.+...
T Consensus 75 e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~ 147 (257)
T cd05040 75 ELAPLGSLLDRLRKDAL----GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRAL 147 (257)
T ss_pred EecCCCcHHHHHHhccc----ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccc
Confidence 99999999999986542 3589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhhhCChh
Q 037275 841 SSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFARTALPDK 919 (992)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 919 (992)
....... .......++..|+|||++.+..++.++|||||||++|||++ |+.||...... +...
T Consensus 148 ~~~~~~~-----~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~~~~------ 211 (257)
T cd05040 148 PQNEDHY-----VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS-----QILK------ 211 (257)
T ss_pred cccccce-----ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH-----HHHH------
Confidence 5422110 11112346788999999988899999999999999999999 99998643111 0000
Q ss_pred HHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 037275 920 VMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLC 980 (992)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 980 (992)
.+.. ... . .......+..+.+++.+||+.+|++|||+.|+++.|.
T Consensus 212 ---~~~~---~~~-----~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 212 ---KIDK---EGE-----R-----LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ---HHHh---cCC-----c-----CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0000 000 0 0001122456889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=308.67 Aligned_cols=249 Identities=24% Similarity=0.336 Sum_probs=200.2
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC-CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
..|+..+.||.|+||.||+|.+..+++.||+|++.... ......+.+|+.+++++.||||+++++++. +....+
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 78 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KGTKLW 78 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECCEEE
Confidence 36778899999999999999998889999999986443 334567889999999999999999999864 345679
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||+++|+|.+++... .+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++++|||.+
T Consensus 79 lv~e~~~~~~L~~~i~~~-------~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~ 148 (277)
T cd06640 79 IIMEYLGGGSALDLLRAG-------PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVA 148 (277)
T ss_pred EEEecCCCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccc
Confidence 999999999999998642 378889999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALP 917 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 917 (992)
....... .......++..|+|||++.+..++.++|||||||++|||++|..||........
T Consensus 149 ~~~~~~~--------~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~----------- 209 (277)
T cd06640 149 GQLTDTQ--------IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV----------- 209 (277)
T ss_pred eeccCCc--------cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH-----------
Confidence 7654321 111224578899999999888899999999999999999999999875321100
Q ss_pred hhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 918 DKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
...... ... ..........+.+++.+||+.+|++||++++++..
T Consensus 210 ---~~~~~~---~~~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 210 ---LFLIPK---NNP-----------PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred ---hhhhhc---CCC-----------CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 000000 000 00112345668899999999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=302.00 Aligned_cols=247 Identities=29% Similarity=0.444 Sum_probs=192.3
Q ss_pred CccccccceEEEEeEECCCCeEEEEEEeeccCC-CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEEEEec
Q 037275 685 NMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYM 763 (992)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 763 (992)
++||+|+||.||+|... ++..||+|.++.... .....+.+|++++++++||||+++++++.. ....++||||+
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~ 74 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ-----RQPIYIVMELV 74 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec-----CCccEEEEECC
Confidence 47999999999999975 788999999864432 223468899999999999999999998643 34569999999
Q ss_pred cCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceecCCC
Q 037275 764 QNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSS 843 (992)
Q Consensus 764 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 843 (992)
++++|.+++..... .+++..++.++.|++.||.|+|++ +++||||||+||+++.++.+||+|||++......
T Consensus 75 ~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 146 (250)
T cd05085 75 PGGDFLSFLRKKKD-----ELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG 146 (250)
T ss_pred CCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceecccc
Confidence 99999999875432 478999999999999999999999 9999999999999999999999999998754332
Q ss_pred CCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhhhCChhHHH
Q 037275 844 PLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFARTALPDKVME 922 (992)
Q Consensus 844 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 922 (992)
.. .......++..|+|||++.+..++.++||||||+++|++++ |..||.+.... .. ..
T Consensus 147 ~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~-----~~---------~~ 205 (250)
T cd05085 147 IY-------SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-----QA---------RE 205 (250)
T ss_pred cc-------ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH-----HH---------HH
Confidence 11 01111234678999999988889999999999999999999 99998753211 00 00
Q ss_pred HHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 037275 923 IVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLC 980 (992)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 980 (992)
.+.. .... .. ......++.+++.+|++.+|++||++.|++++|.
T Consensus 206 ~~~~----~~~~----~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 206 QVEK----GYRM----SC------PQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHc----CCCC----CC------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 0000 0000 00 0112356899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=314.91 Aligned_cols=249 Identities=22% Similarity=0.326 Sum_probs=196.0
Q ss_pred CCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEEE
Q 037275 681 FSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVY 760 (992)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 760 (992)
|.....||+|+||.||++....++..||||.+........+.+.+|+.++++++||||+++++.+. ..+..++||
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~lv~ 98 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL-----VGDELWVVM 98 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhee-----cCCeEEEEE
Confidence 444567999999999999998889999999987555555667889999999999999999999854 345679999
Q ss_pred EeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceec
Q 037275 761 EYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFL 840 (992)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 840 (992)
||+++++|.+++... .+++.+++.++.|++.||+|||++ +|+||||||+||++++++.++|+|||++...
T Consensus 99 e~~~~~~L~~~~~~~-------~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (292)
T cd06658 99 EFLEGGALTDIVTHT-------RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQV 168 (292)
T ss_pred eCCCCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhc
Confidence 999999999988542 378899999999999999999999 9999999999999999999999999998754
Q ss_pred CCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCChhH
Q 037275 841 SSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKV 920 (992)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 920 (992)
.... .......|+..|+|||...+..++.++||||||+++|||++|+.||...... ...
T Consensus 169 ~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~----~~~--------- 227 (292)
T cd06658 169 SKEV--------PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL----QAM--------- 227 (292)
T ss_pred cccc--------ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHH---------
Confidence 3211 1122345889999999998888999999999999999999999998652110 000
Q ss_pred HHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 921 MEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
..+. ..... ... ........+.+++.+||..||++|||++|+++.
T Consensus 228 -~~~~----~~~~~----~~~----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 228 -RRIR----DNLPP----RVK----DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred -HHHH----hcCCC----ccc----cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0000 00000 000 001123457889999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=307.40 Aligned_cols=254 Identities=25% Similarity=0.343 Sum_probs=201.7
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC--CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
+|++.+.||.|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++||||+++++++.. ......+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIID---RSNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeec---CCCCEEE
Confidence 4788899999999999999998899999999986433 2334568889999999999999999997643 2345678
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHH-----hcCCCCeEeccCCCCCeeeCCCCcEEEe
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIH-----HHCQPPVVHGDLKPSNVLLDQDLVAHLG 832 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH-----~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 832 (992)
++|||+++++|.+++..... ....+++..++.++.|++.||+||| +. +++||||+|+||+++.++.+||+
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~ 152 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKK--ERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLG 152 (265)
T ss_pred EEehhccCCCHHHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEe
Confidence 99999999999999976532 1346899999999999999999999 77 99999999999999999999999
Q ss_pred ecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHH
Q 037275 833 DFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFA 912 (992)
Q Consensus 833 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~ 912 (992)
|||.+....... .......+++.|+|||++.+..++.++||||||+++|+|++|+.||.... .....
T Consensus 153 d~g~~~~~~~~~--------~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~ 219 (265)
T cd08217 153 DFGLAKILGHDS--------SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN-----QLQLA 219 (265)
T ss_pred cccccccccCCc--------ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC-----HHHHH
Confidence 999998765321 11123458899999999998889999999999999999999999997532 11111
Q ss_pred hhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 913 RTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
+.+. .... + ........++.+++.+|++.+|++|||++||++
T Consensus 220 ---------~~~~---~~~~-----~------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 220 ---------SKIK---EGKF-----R------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred ---------HHHh---cCCC-----C------CCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0000 0000 0 001123456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=304.01 Aligned_cols=252 Identities=26% Similarity=0.457 Sum_probs=197.7
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAI 758 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 758 (992)
.+|++.+.||+|+||.||+|.+. .+..+|+|.+... ......+.+|++++++++||+++++++++. .....++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~ 76 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCT-----ERSPICL 76 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEc-----cCCceEE
Confidence 46788899999999999999985 5778999988633 234567889999999999999999999853 3446799
Q ss_pred EEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccce
Q 037275 759 VYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAK 838 (992)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 838 (992)
||||+++++|.+++..... .+++..++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+.
T Consensus 77 v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~ 148 (256)
T cd05112 77 VFEFMEHGCLSDYLRAQRG-----KFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTR 148 (256)
T ss_pred EEEcCCCCcHHHHHHhCcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCccee
Confidence 9999999999999975432 478999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhhhCC
Q 037275 839 FLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFARTALP 917 (992)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 917 (992)
....... .......++..|+|||++.++.++.++||||+|+++|||++ |+.||...... .
T Consensus 149 ~~~~~~~-------~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----~------- 209 (256)
T cd05112 149 FVLDDQY-------TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS-----E------- 209 (256)
T ss_pred ecccCcc-------cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH-----H-------
Confidence 6543211 11122335678999999988899999999999999999998 99998652211 1
Q ss_pred hhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 037275 918 DKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLC 980 (992)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 980 (992)
..+..... ... ... .....++.+++.+||+.+|++|||++|+++.|+
T Consensus 210 -----~~~~~~~~-~~~------~~~----~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 210 -----VVETINAG-FRL------YKP----RLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred -----HHHHHhCC-CCC------CCC----CCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 11110000 000 000 001346899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=312.00 Aligned_cols=276 Identities=22% Similarity=0.292 Sum_probs=198.5
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCC-----chhHHHHHHHHHHhccCCcceeEEEEeecccccCcc
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKG-----ASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
+|++.+.||+|+||.||+|.+..+++.||+|.++..... ....+..|++++++++|+||+++++++.+ ..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-----KS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-----CC
Confidence 478889999999999999999888999999999744322 23456789999999999999999998643 55
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
..++||||+ +|+|.+++.... ..+++..++.++.|+++||+|||++ +|+||||+|+||+++.++.++|+||
T Consensus 76 ~~~lv~e~~-~~~L~~~i~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~df 146 (298)
T cd07841 76 NINLVFEFM-ETDLEKVIKDKS-----IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADF 146 (298)
T ss_pred EEEEEEccc-CCCHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccc
Confidence 679999999 899999997543 2489999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 913 (992)
|.+....... .......+++.|+|||.+.+ ..++.++|||||||++|||++|.+||.+..+.+ .+.....
T Consensus 147 g~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~-~~~~~~~ 217 (298)
T cd07841 147 GLARSFGSPN--------RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID-QLGKIFE 217 (298)
T ss_pred eeeeeccCCC--------ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH-HHHHHHH
Confidence 9998765321 11122346788999998755 467889999999999999999988876532211 1111111
Q ss_pred hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 914 TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
...........+............................+.+++.+||+.||++|||++|+++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 218 ALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred HcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 10000000000000000000000000000000111234678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=313.23 Aligned_cols=250 Identities=23% Similarity=0.341 Sum_probs=205.5
Q ss_pred HhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCc--hhHHHHHHHHHHhccCCcceeEEEEeecccccCcc
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGA--SNGFVAECQALRNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
..+.|.+...||+|.|++|.+|++..++..||+|+++...-.. ...+.+|+++|+.++|||||+++.+. ....
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~-----~t~~ 128 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVI-----ETEA 128 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeee-----eecc
Confidence 4568999999999999999999999999999999997654433 34588999999999999999999984 4456
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
.+|+||||+.+|.+.+|+.++.. +.+..+..++.|+.+|++|+|++ .|||||||++||+++.+..+||+||
T Consensus 129 ~lylV~eya~~ge~~~yl~~~gr------~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDf 199 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKHGR------MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADF 199 (596)
T ss_pred eeEEEEEeccCchhHHHHHhccc------chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeecc
Confidence 77999999999999999998764 45578888999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCc-CcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEA-SMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 913 (992)
|++.++... .....++|++.|.|||++.+..| ++++|+||+|+++|-|+.|..||++..-.
T Consensus 200 gfS~~~~~~---------~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk--------- 261 (596)
T KOG0586|consen 200 GFSTFFDYG---------LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK--------- 261 (596)
T ss_pred ccceeeccc---------ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc---------
Confidence 999987643 23445689999999999998876 67899999999999999999999974221
Q ss_pred hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 914 TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
..-++.+.+.+..... ...++.+++.+++..+|.+|++++++.+.
T Consensus 262 --------~Lr~rvl~gk~rIp~~------------ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 262 --------ELRPRVLRGKYRIPFY------------MSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred --------cccchheeeeecccce------------eechhHHHHHHhhccCccccCCHHHhhhh
Confidence 1111111122211111 12346788999999999999999999764
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=311.64 Aligned_cols=252 Identities=24% Similarity=0.318 Sum_probs=201.3
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
.++|++.+.||+|+||.||+|....++..||+|.+........+.+.+|+.++++++|||++++++++.. ....+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~ 92 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLV-----GDELW 92 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeee-----CCcEE
Confidence 3689999999999999999999887899999999875555556778999999999999999999998643 45569
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+|+||+++++|.+++... .+++..+..++.|++.|++|||++ +++||||+|+||+++.++.+||+|||.+
T Consensus 93 lv~e~~~~~~L~~~~~~~-------~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~ 162 (293)
T cd06647 93 VVMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC 162 (293)
T ss_pred EEEecCCCCcHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcce
Confidence 999999999999999753 378889999999999999999999 9999999999999999999999999998
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALP 917 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 917 (992)
....... .......+++.|+|||.+.+..++.++|||||||++|++++|+.||.......... .....
T Consensus 163 ~~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~-~~~~~--- 230 (293)
T cd06647 163 AQITPEQ--------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATN--- 230 (293)
T ss_pred ecccccc--------cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee-ehhcC---
Confidence 7554321 11223458889999999988889999999999999999999999997532211000 00000
Q ss_pred hhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 918 DKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
.. . ...........+.+++.+||+.+|++||++.|++..
T Consensus 231 -------------~~----~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 231 -------------GT----P-----ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred -------------CC----C-----CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 0 000011223458899999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=285.83 Aligned_cols=276 Identities=18% Similarity=0.279 Sum_probs=208.4
Q ss_pred HHHHHHHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhc-cCCcceeEEEEeeccc
Q 037275 671 YAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNI-RHRNLIKIITICSSID 749 (992)
Q Consensus 671 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 749 (992)
+.|+-+.++ +.||+|+|+.|-.+....+|..||||++.+.......++.+|++++... .|+||+.++++
T Consensus 75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLief----- 144 (463)
T KOG0607|consen 75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEF----- 144 (463)
T ss_pred HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHH-----
Confidence 455555544 5899999999999999999999999999877777788899999999999 59999999999
Q ss_pred ccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCC--
Q 037275 750 FKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDL-- 827 (992)
Q Consensus 750 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-- 827 (992)
|+++...|+|||-|.||+|...+++++ .+++.++.++.++|+.||.+||.+ ||.|||+||+|||-....
T Consensus 145 FEdd~~FYLVfEKm~GGplLshI~~~~------~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~v 215 (463)
T KOG0607|consen 145 FEDDTRFYLVFEKMRGGPLLSHIQKRK------HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKV 215 (463)
T ss_pred hcccceEEEEEecccCchHHHHHHHhh------hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCc
Confidence 567778899999999999999998765 589999999999999999999999 999999999999997654
Q ss_pred -cEEEeecccceecCCCCCCCCcccCCCCCccccccccccccccc-----CCCcCcccchhhHHHHHHHHHhCCCCCCCC
Q 037275 828 -VAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGM-----GGEASMTGDVYSFGILLLEMFTRRRPTDGM 901 (992)
Q Consensus 828 -~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~pf~~~ 901 (992)
-+|||||.++.-+.-...-... .......++|+..|||||+.. ...|+.+.|.||+|||+|-|++|.+||.+.
T Consensus 216 sPvKiCDfDLgSg~k~~~~~spa-stP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~ 294 (463)
T KOG0607|consen 216 SPVKICDFDLGSGIKLNNDCSPA-STPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGH 294 (463)
T ss_pred CceeeeccccccccccCCCCCCC-CCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCc
Confidence 6899999887644322111111 223344578999999999743 235889999999999999999999999886
Q ss_pred ccCCccHHHHHhhhC-ChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 902 FNQGLTLHEFARTAL-PDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 902 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
-..+-. |-+... +.--..++..+..+.|.. ++ ........+..+++...+..||..|.++.+++.
T Consensus 295 Cg~dCG---WdrGe~Cr~CQ~~LFesIQEGkYeF------Pd--kdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 295 CGADCG---WDRGEVCRVCQNKLFESIQEGKYEF------PD--KDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred cCCcCC---ccCCCccHHHHHHHHHHHhccCCcC------Ch--hhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 433211 111111 111122233333222211 11 112233455677888889999999999999876
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=315.75 Aligned_cols=260 Identities=25% Similarity=0.339 Sum_probs=201.4
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCC---chhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKG---ASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
++|+..+.||+|+||+||+|....+++.||+|.+...... ..+.+.+|+++++.++||||+++++++. ....
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQ-----TETY 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeee-----cCCE
Confidence 3688899999999999999999888999999999754322 3456889999999999999999999853 4556
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++||||+.+++|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg 148 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQRQPG----KCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFD 148 (316)
T ss_pred EEEEEEecCCCCHHHHHHhCCC----CccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecc
Confidence 7999999999999999875432 2589999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCc---------------------ccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhC
Q 037275 836 LAKFLSSSPLDTAV---------------------ETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTR 894 (992)
Q Consensus 836 ~a~~~~~~~~~~~~---------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg 894 (992)
++............ ..........|+..|+|||++.+..++.++||||||+++|+|++|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g 228 (316)
T cd05574 149 LSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228 (316)
T ss_pred hhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhC
Confidence 98765432111000 001112235688999999999988899999999999999999999
Q ss_pred CCCCCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCC---
Q 037275 895 RRPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERME--- 971 (992)
Q Consensus 895 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs--- 971 (992)
+.||.+..... ....+... .. .. .........+.+++.+||+.||++|||
T Consensus 229 ~~pf~~~~~~~-------------~~~~~~~~----~~------~~----~~~~~~~~~~~~li~~~l~~~p~~R~s~~~ 281 (316)
T cd05574 229 TTPFKGSNRDE-------------TFSNILKK----EV------TF----PGSPPVSSSARDLIRKLLVKDPSKRLGSKR 281 (316)
T ss_pred CCCCCCCchHH-------------HHHHHhcC----Cc------cC----CCccccCHHHHHHHHHHccCCHhHCCCchh
Confidence 99997532110 01111100 00 00 001113456899999999999999999
Q ss_pred -HHHHHH
Q 037275 972 -MRDVVA 977 (992)
Q Consensus 972 -~~evl~ 977 (992)
++|+++
T Consensus 282 ~~~~ll~ 288 (316)
T cd05574 282 GAAEIKQ 288 (316)
T ss_pred hHHHHHc
Confidence 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=308.87 Aligned_cols=255 Identities=27% Similarity=0.438 Sum_probs=195.0
Q ss_pred CccccccceEEEEeEECCCC------eEEEEEEeeccC-CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 685 NMIGQGSFGFVYKGNLGENG------MMVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
+.||+|+||.||+|+..... +.||+|.+.... ......+.+|+.+++.++||||+++++++.. ....+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL-----NEPQY 75 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecC-----CCCeE
Confidence 46999999999999985433 689999885432 2345678899999999999999999998643 34569
Q ss_pred EEEEeccCCCHHHHHhhcccch-hhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCC-----cEEE
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQ-EARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDL-----VAHL 831 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~~kl 831 (992)
+||||+++++|.+++....... ....+++.+++.++.|++.||+|||+. +++|+||||+||+++.++ .+++
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l 152 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKI 152 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEE
Confidence 9999999999999997643221 233578999999999999999999999 999999999999999877 8999
Q ss_pred eecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHH
Q 037275 832 GDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHE 910 (992)
Q Consensus 832 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~ 910 (992)
+|||++......... .......++..|+|||++.++.++.++|||||||++|||++ |+.||...... ...
T Consensus 153 ~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~--~~~- 223 (269)
T cd05044 153 GDFGLARDIYKSDYY------RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--EVL- 223 (269)
T ss_pred CCccccccccccccc------ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH--HHH-
Confidence 999999765432111 11122345678999999999999999999999999999998 99998643111 000
Q ss_pred HHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 037275 911 FARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCR 981 (992)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 981 (992)
..+.. .. .. .........+.+++.+||+.+|++||++++|++.|++
T Consensus 224 -----------~~~~~---~~-~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 224 -----------QHVTA---GG-RL----------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred -----------HHHhc---CC-cc----------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 00000 00 00 0001224568899999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=310.24 Aligned_cols=273 Identities=23% Similarity=0.300 Sum_probs=200.5
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC--CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
+|++.+.||+|+||.||+|++..+|+.||+|++.... ......+.+|+.++++++||||+++++++. .....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFP-----HGSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEe-----cCCeeE
Confidence 5888999999999999999998889999999987543 333567899999999999999999999854 355679
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||+ +++|.+++.... ..+++.+++.++.|+++||+|||+. +++|+||||+||+++.++.++|+|||.+
T Consensus 76 ~v~e~~-~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~ 146 (286)
T cd07832 76 LVMEYM-PSDLSEVLRDEE-----RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLA 146 (286)
T ss_pred EEeccc-CCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeec
Confidence 999999 999999987544 2589999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTAL 916 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 916 (992)
........ .......++..|+|||++.+. .++.++||||+||++|||++|.+||.+..+. ..+........
T Consensus 147 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~~~~~ 218 (286)
T cd07832 147 RLFSEEEP-------RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI-EQLAIVFRTLG 218 (286)
T ss_pred ccccCCCC-------CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH-HHHHHHHHHcC
Confidence 86643211 112234588999999987654 4689999999999999999998888653221 11111111100
Q ss_pred -C--hhHHHHHHhhHhHhhhccCCCCCCccc--cchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 917 -P--DKVMEIVDSVLLLEVQASNSRSCGDER--LRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 917 -~--~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
+ ..+.+..+....... ......... ....+....+.+++.+|++.+|++|||++++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 219 TPNEETWPGLTSLPDYNKI---TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred CCChHHHhhccCcchhhcc---cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0 000000000000000 000000000 000122467899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=303.51 Aligned_cols=248 Identities=28% Similarity=0.424 Sum_probs=194.2
Q ss_pred CccccccceEEEEeEECCCCeEEEEEEeeccCCC-chhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEEEEec
Q 037275 685 NMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKG-ASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYM 763 (992)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 763 (992)
++||+|+||.||+|.+.. ++.||+|.+...... ....+.+|++++++++||||+++++++. .....++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~v~e~~ 74 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV-----QKQPIYIVMELV 74 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEe-----cCCCeEEEEEcC
Confidence 479999999999999976 999999998654333 4567899999999999999999999864 345569999999
Q ss_pred cCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceecCCC
Q 037275 764 QNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSS 843 (992)
Q Consensus 764 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 843 (992)
++++|.+++..... .+++..+..++.|++.|++|||++ +++||||+|+||+++.++.+||+|||.+......
T Consensus 75 ~~~~l~~~l~~~~~-----~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 146 (251)
T cd05041 75 PGGSLLTFLRKKKN-----RLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGG 146 (251)
T ss_pred CCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCC
Confidence 99999999975432 478999999999999999999999 9999999999999999999999999999765421
Q ss_pred CCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhhhCChhHHH
Q 037275 844 PLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFARTALPDKVME 922 (992)
Q Consensus 844 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 922 (992)
.. ........++..|+|||.+.++.++.++|||||||++|||++ |..||...... ....
T Consensus 147 ~~------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--------------~~~~ 206 (251)
T cd05041 147 IY------TVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--------------QTRE 206 (251)
T ss_pred cc------eeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--------------HHHH
Confidence 11 001111224567999999988899999999999999999999 88888653211 0001
Q ss_pred HHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 037275 923 IVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLC 980 (992)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 980 (992)
.+.. .... . .......++.+++.+||..+|++|||+.|+++.|+
T Consensus 207 ~~~~----~~~~----~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 207 RIES----GYRM----P------APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHhc----CCCC----C------CCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 1100 0000 0 00122446899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=306.11 Aligned_cols=255 Identities=23% Similarity=0.347 Sum_probs=196.8
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC------CchhHHHHHHHHHHhccCCcceeEEEEeecccccCc
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK------GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 753 (992)
+|++.+.||+|+||+||+|... +++.+|+|.+..... .....+.+|++++++++|+||+++.+++.+ .
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~ 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD-----D 74 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec-----C
Confidence 4788999999999999999875 788999998864321 123457889999999999999999999643 4
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGD 833 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 833 (992)
...++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+|+||+|+||++++++.++|+|
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~d 145 (265)
T cd06631 75 NTISIFMEFVPGGSISSILNRFG------PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLID 145 (265)
T ss_pred CeEEEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEecc
Confidence 56799999999999999997543 478899999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 913 (992)
||.+........... .........++..|+|||++.+..++.++||||+||++|+|++|+.||....... ...
T Consensus 146 fg~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~----~~~- 218 (265)
T cd06631 146 FGCARRLAWVGLHGT--HSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA----AMF- 218 (265)
T ss_pred chhhHhhhhcccccc--ccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH----HHH-
Confidence 999876532111110 1112233458899999999998889999999999999999999999997531110 000
Q ss_pred hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 914 TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.... ... ..... ......++.+++.+||+.+|++||++.|++.
T Consensus 219 --------~~~~----~~~---~~~~~------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 219 --------YIGA----HRG---LMPRL------PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred --------Hhhh----ccC---CCCCC------CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000 000 00000 0112355789999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=307.04 Aligned_cols=260 Identities=20% Similarity=0.366 Sum_probs=200.4
Q ss_pred cCCCCCCccccccceEEEEeEECC-----CCeEEEEEEeeccCCC-chhHHHHHHHHHHhccCCcceeEEEEeecccccC
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGE-----NGMMVAVKVINLKQKG-ASNGFVAECQALRNIRHRNLIKIITICSSIDFKG 752 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 752 (992)
++|++.+.||+|+||.||+|+... +.+.||+|.+...... ....+.+|++++++++||||+++++++..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----- 79 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCRE----- 79 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECC-----
Confidence 578899999999999999999743 3467999988644333 34678999999999999999999998643
Q ss_pred cceEEEEEEeccCCCHHHHHhhcccch---hhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcE
Q 037275 753 VDFQAIVYEYMQNGSLEDWLHQSEDQQ---EARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVA 829 (992)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 829 (992)
....++||||+++|+|.+++....... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~ 156 (275)
T cd05046 80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREV 156 (275)
T ss_pred CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcE
Confidence 345699999999999999998654221 112589999999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccH
Q 037275 830 HLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTL 908 (992)
Q Consensus 830 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~ 908 (992)
+++|||.+....... ........++..|+|||.+.+..++.++||||||+++|++++ |..||....+..
T Consensus 157 ~l~~~~~~~~~~~~~-------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~--- 226 (275)
T cd05046 157 KVSLLSLSKDVYNSE-------YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE--- 226 (275)
T ss_pred EEcccccccccCccc-------ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---
Confidence 999999987543221 111223356788999999888889999999999999999999 888886432110
Q ss_pred HHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 037275 909 HEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLC 980 (992)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 980 (992)
.+........ ... ........+.+++.+||+.+|++|||+.|+++.|.
T Consensus 227 --------------~~~~~~~~~~-----~~~-----~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 227 --------------VLNRLQAGKL-----ELP-----VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred --------------HHHHHHcCCc-----CCC-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 0110000000 000 00112346899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=309.38 Aligned_cols=255 Identities=21% Similarity=0.303 Sum_probs=197.1
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC-CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
++|++.+.||+|+||.||+|.+..+++.||+|.+.... ......+.+|++++++++||||+++++++. .....+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~ 75 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFF-----IEGAVY 75 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhee-----cCCeEE
Confidence 36889999999999999999998899999999886432 233467889999999999999999999854 345679
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||+++++|..++..... ...+++..+..++.|++.||.|||+.. +|+||||||+||+++.++.+||+|||.+
T Consensus 76 lv~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~ 150 (286)
T cd06622 76 MCMEYMDAGSLDKLYAGGVA---TEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVS 150 (286)
T ss_pred EEEeecCCCCHHHHHHhccc---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCc
Confidence 99999999999999875421 125899999999999999999999632 8999999999999999999999999998
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCC------CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHH
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG------EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEF 911 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~ 911 (992)
....... .....+++.|+|||.+.+. .++.++||||+||++|+|++|+.||......
T Consensus 151 ~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~------- 213 (286)
T cd06622 151 GNLVASL----------AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA------- 213 (286)
T ss_pred ccccCCc----------cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh-------
Confidence 7553211 1223478899999987554 3588999999999999999999999652111
Q ss_pred HhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 912 ARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
.....+........ .. .......++.+++.+||+.+|++||+++++++.
T Consensus 214 -------~~~~~~~~~~~~~~-----~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 214 -------NIFAQLSAIVDGDP-----PT------LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred -------hHHHHHHHHhhcCC-----CC------CCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 00011111100000 00 011234568899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=312.86 Aligned_cols=276 Identities=23% Similarity=0.354 Sum_probs=198.4
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC--CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK--GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
++|++.++||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+++++.++||||+++++++ ......
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeE
Confidence 468899999999999999999988899999998854322 2345678999999999999999999985 445677
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
++||||++++++.++..... .+++..++.++.|++.||+|||+. +++|||++|+||++++++.++|+|||+
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~ 146 (286)
T cd07846 76 YLVFEFVDHTVLDDLEKYPN------GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGF 146 (286)
T ss_pred EEEEecCCccHHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeee
Confidence 99999999998888765432 489999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh--
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR-- 913 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~-- 913 (992)
+....... .......++..|+|||++.+ ..++.++||||||+++|||++|++||...... ........
T Consensus 147 ~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~-~~~~~~~~~~ 217 (286)
T cd07846 147 ARTLAAPG--------EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI-DQLYHIIKCL 217 (286)
T ss_pred eeeccCCc--------cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH-HHHHHHHHHh
Confidence 88654321 11123457889999998765 35788999999999999999999998653211 00011100
Q ss_pred hhCChhHHHHHHhhHhH-hhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 914 TALPDKVMEIVDSVLLL-EVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 914 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
...........+..... .......................+.+++.+||+.+|++||+++|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 218 GNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred CCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00111111111100000 00000000000000001123456899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=336.19 Aligned_cols=268 Identities=24% Similarity=0.333 Sum_probs=198.3
Q ss_pred HHHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC-CCchhHHHHHHHHHHhccCCcceeEEEEeecccc---
Q 037275 675 SKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIKIITICSSIDF--- 750 (992)
Q Consensus 675 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--- 750 (992)
.+...+|+..+.||+||||.||+++.+-+|+.||||.+.... ......+.+|+..+.+++|||||+++..+.+...
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 456778899999999999999999999999999999997543 3445678899999999999999999854322100
Q ss_pred --------------------------------------------------------------------------------
Q 037275 751 -------------------------------------------------------------------------------- 750 (992)
Q Consensus 751 -------------------------------------------------------------------------------- 750 (992)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred --c-----------------------------CcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHH
Q 037275 751 --K-----------------------------GVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASA 799 (992)
Q Consensus 751 --~-----------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~ 799 (992)
. .....||=||||+..++.++++.+.-. -.....|+++++|++|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-----~~~d~~wrLFreIlEG 709 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-----SQRDEAWRLFREILEG 709 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-----hhhHHHHHHHHHHHHH
Confidence 0 003568899999998888888865421 1456789999999999
Q ss_pred HHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceecC----C-----CCC-CCCcccCCCCCccccccccccccc
Q 037275 800 IEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLS----S-----SPL-DTAVETPSSSKGIKGTVGYIAPEY 869 (992)
Q Consensus 800 L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~----~-----~~~-~~~~~~~~~~~~~~gt~~y~aPE~ 869 (992)
|+|+|+. |||||||||.||++++++.|||+|||+|.... . ... ..........++.+||..|+|||+
T Consensus 710 LaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEl 786 (1351)
T KOG1035|consen 710 LAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPEL 786 (1351)
T ss_pred HHHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHH
Confidence 9999999 99999999999999999999999999998722 0 000 111112234567889999999999
Q ss_pred ccCC---CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccc
Q 037275 870 GMGG---EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLR 946 (992)
Q Consensus 870 ~~~~---~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 946 (992)
+.+. .|+.|+|+||+|+|++||+. ||....+....+.......+|.. . ..
T Consensus 787 l~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~-~-----------------------~f 839 (1351)
T KOG1035|consen 787 LSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEP-A-----------------------DF 839 (1351)
T ss_pred hcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCC-c-----------------------cc
Confidence 8765 49999999999999999996 46532221111111111111111 0 11
Q ss_pred hHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 947 TEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 947 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
..+....-.+++.+|++.||.+||||.|++.
T Consensus 840 ~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 840 FDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred ccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 1223344578899999999999999999985
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=307.73 Aligned_cols=257 Identities=21% Similarity=0.289 Sum_probs=185.0
Q ss_pred CccccccceEEEEeEEC--CCCeEEEEEEeeccCC-CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEEEE
Q 037275 685 NMIGQGSFGFVYKGNLG--ENGMMVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYE 761 (992)
Q Consensus 685 ~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 761 (992)
+.||+|+||+||+|+.. .....+|+|.+..... .....+.+|+.+++.++||||+++++++. .....++|||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~-----~~~~~~lv~e 75 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCI-----ESIPYLLVLE 75 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEEC-----CCCceEEEEE
Confidence 36999999999999753 2346788888753322 23456789999999999999999999864 3455699999
Q ss_pred eccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceecC
Q 037275 762 YMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLS 841 (992)
Q Consensus 762 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 841 (992)
|+++|+|.+++...... .....++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||.+....
T Consensus 76 ~~~~g~L~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 151 (269)
T cd05042 76 FCPLGDLKNYLRSNRGM-VAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQY 151 (269)
T ss_pred eCCCCcHHHHHHhcccc-ccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccc
Confidence 99999999999875432 112356778899999999999999999 99999999999999999999999999987543
Q ss_pred CCCCCCCcccCCCCCcccccccccccccccC-------CCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHh
Q 037275 842 SSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-------GEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 913 (992)
.... ........++..|+|||++.. ..++.++|||||||++|||++ |..||....+..
T Consensus 152 ~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-------- 217 (269)
T cd05042 152 PEDY------YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-------- 217 (269)
T ss_pred cchh------eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH--------
Confidence 2211 011123346778999998643 456889999999999999999 788886532110
Q ss_pred hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 037275 914 TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLC 980 (992)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 980 (992)
........... ..... .........+.+++..|| .||++|||++||++.|.
T Consensus 218 ---------~~~~~~~~~~~-~~~~~-----~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 218 ---------VLKQVVREQDI-KLPKP-----QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred ---------HHHHHhhccCc-cCCCC-----cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 00000000000 00000 001122344677888888 59999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=313.80 Aligned_cols=249 Identities=22% Similarity=0.313 Sum_probs=196.7
Q ss_pred CCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEEE
Q 037275 681 FSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVY 760 (992)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 760 (992)
|+....||+|+||.||+|....+++.||+|++........+.+.+|+.+++.++|||++++++++. .....++||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~iv~ 97 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL-----VGEELWVLM 97 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhhee-----eCCeEEEEE
Confidence 444568999999999999998889999999997655555677889999999999999999999854 345679999
Q ss_pred EeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceec
Q 037275 761 EYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFL 840 (992)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 840 (992)
||+++++|.+++... .+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 98 e~~~~~~L~~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~ 167 (297)
T cd06659 98 EFLQGGALTDIVSQT-------RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQI 167 (297)
T ss_pred ecCCCCCHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhc
Confidence 999999999987542 478999999999999999999999 9999999999999999999999999998754
Q ss_pred CCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCChhH
Q 037275 841 SSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKV 920 (992)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 920 (992)
.... .......|+..|+|||++.+..++.++|||||||++|||++|+.||...... .. .
T Consensus 168 ~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----~~-~-------- 226 (297)
T cd06659 168 SKDV--------PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV----QA-M-------- 226 (297)
T ss_pred cccc--------ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HH-H--------
Confidence 3221 1112345889999999998888999999999999999999999998642111 00 0
Q ss_pred HHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 921 MEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
..+.. .... . ..........+.+++.+||+.+|++||+++|+++.
T Consensus 227 -~~~~~----~~~~----~----~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 227 -KRLRD----SPPP----K----LKNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred -HHHhc----cCCC----C----ccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000 0000 0 00001123457899999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=304.57 Aligned_cols=238 Identities=26% Similarity=0.452 Sum_probs=187.4
Q ss_pred CccccccceEEEEeEECCCC----------eEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcc
Q 037275 685 NMIGQGSFGFVYKGNLGENG----------MMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
+.||+|+||.||+|.+..++ ..|++|++...... ...+.+|+.++++++||||+++++++.. .
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~ 73 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR------D 73 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec------C
Confidence 47999999999999997655 35888887544333 6788999999999999999999998754 2
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCC-------
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDL------- 827 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~------- 827 (992)
..++||||+++|+|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~ 145 (259)
T cd05037 74 ENIMVEEYVKFGPLDVFLHREKN-----NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVP 145 (259)
T ss_pred CcEEEEEcCCCCcHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCce
Confidence 34899999999999999986542 488999999999999999999999 999999999999999888
Q ss_pred cEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCC--CcCcccchhhHHHHHHHHHh-CCCCCCCCccC
Q 037275 828 VAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG--EASMTGDVYSFGILLLEMFT-RRRPTDGMFNQ 904 (992)
Q Consensus 828 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~ 904 (992)
.+||+|||.+..... .....++..|+|||++.+. .++.++|||||||++|||++ |..||......
T Consensus 146 ~~kl~Dfg~a~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~ 213 (259)
T cd05037 146 FIKLSDPGIPITVLS------------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS 213 (259)
T ss_pred eEEeCCCCccccccc------------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch
Confidence 799999999986432 1122466789999998876 78999999999999999999 57777653211
Q ss_pred CccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 037275 905 GLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKL 979 (992)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 979 (992)
....+.. . .. . .... ....+.+++.+||..+|.+|||+.||++.|
T Consensus 214 --~~~~~~~-----------~----~~------~-~~~~------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 214 --EKERFYQ-----------D----QH------R-LPMP------DCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred --hHHHHHh-----------c----CC------C-CCCC------CchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0000000 0 00 0 0000 015688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=303.02 Aligned_cols=249 Identities=24% Similarity=0.396 Sum_probs=198.2
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC--CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
+|+..+.||+|+||.||+|....+++.+|+|.+.... ......+.+|+++++.++|||++++++++ ......+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENF-----LEDKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeE-----ecCCEEE
Confidence 5888999999999999999998899999999986442 23356788999999999999999999984 3455679
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCC-CcEEEeeccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQD-LVAHLGDFGL 836 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~ 836 (992)
+||||+++++|.+++..... ..+++..++.++.|++.|++|||++ +++||||+|+||+++++ +.+||+|||.
T Consensus 76 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~ 148 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRCN----SLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGI 148 (256)
T ss_pred EEEecCCCCCHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCC
Confidence 99999999999999976432 3589999999999999999999999 99999999999999865 4689999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhC
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTAL 916 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 916 (992)
+....... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ..
T Consensus 149 ~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-----~~----- 209 (256)
T cd08220 149 SKILSSKS---------KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP-----AL----- 209 (256)
T ss_pred ceecCCCc---------cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH-----HH-----
Confidence 98764321 112245788999999999888999999999999999999999998653211 00
Q ss_pred ChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 917 PDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
......... .... .....++.+++.+||+.+|++|||+.|+++
T Consensus 210 -------~~~~~~~~~-----~~~~------~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 210 -------VLKIMSGTF-----APIS------DRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred -------HHHHHhcCC-----CCCC------CCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 000000000 0000 112345889999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=310.87 Aligned_cols=248 Identities=23% Similarity=0.342 Sum_probs=197.2
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC-CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEE
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAI 758 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 758 (992)
.|+..+.||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|+.++++++||||+++++++. .....++
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 79 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYL-----KGTKLWI 79 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccc-----cCCceEE
Confidence 4666788999999999999998889999999986433 334457889999999999999999999853 4556799
Q ss_pred EEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccce
Q 037275 759 VYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAK 838 (992)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 838 (992)
||||+++++|.+++... .+++..+..++.|++.|+.|||++ +++|+||+|+||++++++.++++|||++.
T Consensus 80 v~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~ 149 (277)
T cd06642 80 IMEYLGGGSALDLLKPG-------PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAG 149 (277)
T ss_pred EEEccCCCcHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccc
Confidence 99999999999998642 478899999999999999999999 99999999999999999999999999987
Q ss_pred ecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCCh
Q 037275 839 FLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPD 918 (992)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 918 (992)
...... .......++..|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 150 ~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~------------ 209 (277)
T cd06642 150 QLTDTQ--------IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV------------ 209 (277)
T ss_pred cccCcc--------hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH------------
Confidence 654321 111223578899999999988899999999999999999999999864321100
Q ss_pred hHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 919 KVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
...+.. .. ... ........+.+++.+||+.+|++|||+.|+++.
T Consensus 210 --~~~~~~----~~----~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 210 --LFLIPK----NS----PPT------LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred --Hhhhhc----CC----CCC------CCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 000000 00 000 001224568899999999999999999999973
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=308.01 Aligned_cols=254 Identities=25% Similarity=0.376 Sum_probs=201.3
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC-CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
++|+..+.||+|+||.||+|.+..+++.||+|.+.... ......+.+|+++++.++||||+++++++.. ....+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~ 75 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYN-----NGDIS 75 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeec-----CCEEE
Confidence 36788899999999999999999899999999986543 2344678899999999999999999998643 36679
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHH-HCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
+|+||+++++|.+++.... ..+++..+..++.|++.|++|||+ . +++||||||+||++++++.++|+|||.
T Consensus 76 lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~ 147 (265)
T cd06605 76 ICMEYMDGGSLDKILKEVQ-----GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGV 147 (265)
T ss_pred EEEEecCCCcHHHHHHHcc-----CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeeccc
Confidence 9999999999999998653 258899999999999999999999 8 999999999999999999999999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhC
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTAL 916 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 916 (992)
+....... .....++..|+|||++.+..++.++||||+|+++|+|++|+.||..........
T Consensus 148 ~~~~~~~~----------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-------- 209 (265)
T cd06605 148 SGQLVNSL----------AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGI-------- 209 (265)
T ss_pred chhhHHHH----------hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccH--------
Confidence 87553211 011457889999999998899999999999999999999999997543211111
Q ss_pred ChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 917 PDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.+.+........ . .........++.+++.+||..||++|||+.|++.
T Consensus 210 ----~~~~~~~~~~~~-----~-----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 210 ----FELLQYIVNEPP-----P-----RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred ----HHHHHHHhcCCC-----C-----CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 111111110000 0 0001113456889999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=304.83 Aligned_cols=256 Identities=20% Similarity=0.344 Sum_probs=199.2
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC------CchhHHHHHHHHHHhccCCcceeEEEEeecccccCc
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK------GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 753 (992)
+|+..+.||+|+||.||+|....+++.||+|++..... ...+.+.+|+.++++++||||+++++++. +.
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATC-----ED 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceec-----cC
Confidence 47888999999999999999988999999999864331 12457889999999999999999999853 45
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCC-cEEEe
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDL-VAHLG 832 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~ 832 (992)
...++||||+++++|.+++.... ++++..+..++.|++.||+|||++ +++||||+|+||+++.++ .+||+
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~ 146 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSKYG------AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIA 146 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEc
Confidence 56799999999999999997543 478999999999999999999999 999999999999998776 69999
Q ss_pred ecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHH
Q 037275 833 DFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFA 912 (992)
Q Consensus 833 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~ 912 (992)
|||.+......... .........++..|+|||.+.+..++.++||||+|+++|++++|..||........ .....
T Consensus 147 dfg~~~~~~~~~~~----~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~ 221 (268)
T cd06630 147 DFGAAARLAAKGTG----AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH-LALIF 221 (268)
T ss_pred cccccccccccccc----CCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch-HHHHH
Confidence 99999876543110 11112334688999999999888899999999999999999999999864321110 00000
Q ss_pred hhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 913 RTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.... ... ..........++.+++.+|+..+|++|||+.|+++
T Consensus 222 ---------~~~~----~~~----------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 222 ---------KIAS----ATT----------APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ---------HHhc----cCC----------CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0000 000 00011123456889999999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=315.69 Aligned_cols=280 Identities=19% Similarity=0.227 Sum_probs=204.0
Q ss_pred HhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc--CCCchhHHHHHHHHHHhccCCcceeEEEEeeccc-ccCc
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK--QKGASNGFVAECQALRNIRHRNLIKIITICSSID-FKGV 753 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~ 753 (992)
..++|++.+.||+|+||.||+|.+..+++.||+|++... .......+.+|+.++++++||||+++++++.... +.+.
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 456899999999999999999999989999999998532 2233456778999999999999999999875322 2334
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGD 833 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 833 (992)
...++||||+. ++|.+++.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~--------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~D 161 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM--------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 161 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEcc
Confidence 56799999995 588888753 278888999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 913 (992)
||.++...... ......++..|+|||.+.+..++.++||||+||++|+|++|+.||...... ........
T Consensus 162 fg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~ 231 (353)
T cd07850 162 FGLARTAGTSF---------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI-DQWNKIIE 231 (353)
T ss_pred CccceeCCCCC---------CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHH
Confidence 99998654321 122235788999999999999999999999999999999999999753211 11111111
Q ss_pred hh--CChhHHHHHHhhHhHhhhccCCC----------CC--Cc-cccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 914 TA--LPDKVMEIVDSVLLLEVQASNSR----------SC--GD-ERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 914 ~~--~~~~~~~~~~~~~~~~~~~~~~~----------~~--~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
.. .+..+.+.++............. .. .. ..........++.+++.+||+.||++|||++|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 232 QLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 10 11122222222111111100000 00 00 000011235568899999999999999999999853
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=303.63 Aligned_cols=248 Identities=25% Similarity=0.355 Sum_probs=196.9
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC-----CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcc
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK-----GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
+|+..+.||+|+||.||+|....+++.||+|.+..... ...+.+.+|+++++.++||||+++++++. ...
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTER-----EED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEe-----cCC
Confidence 47788999999999999999988899999999864432 23467889999999999999999999854 345
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
..++||||+++++|.+++.... .+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.+||+||
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~ 146 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKKYG------SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADF 146 (258)
T ss_pred eEEEEEEecCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccC
Confidence 6799999999999999997543 478999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCC-cCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGE-ASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 913 (992)
|.+....... ......++..|+|||.+.... ++.++|+|||||++|+|++|+.||...... ...
T Consensus 147 ~~~~~~~~~~---------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~----~~~-- 211 (258)
T cd06632 147 GMAKQVVEFS---------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV----AAV-- 211 (258)
T ss_pred ccceeccccc---------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH----HHH--
Confidence 9988654321 122345788999999987766 899999999999999999999998753211 000
Q ss_pred hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 914 TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
..... .... .. ........+.+++.+||+.+|++||+++|++.
T Consensus 212 -------~~~~~---~~~~-----~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 212 -------FKIGR---SKEL-----PP------IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred -------HHHHh---cccC-----CC------cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 00000 0000 00 00112345788999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=307.73 Aligned_cols=273 Identities=25% Similarity=0.375 Sum_probs=197.0
Q ss_pred CCCCCccccccceEEEEeEECCCCeEEEEEEeeccC--CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEE
Q 037275 681 FSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAI 758 (992)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 758 (992)
|++.+.||.|++|.||+|.+..+|+.||+|++.... ......+.+|+++++.++|||++++++++. +....++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~-----~~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVH-----SENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheec-----cCCeEEE
Confidence 678899999999999999998899999999987543 223456889999999999999999999864 3466799
Q ss_pred EEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccce
Q 037275 759 VYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAK 838 (992)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 838 (992)
||||++ ++|.+++..... ..+++..++.++.|+++||+|||++ +++||||+|+||+++.++.++|+|||.+.
T Consensus 76 v~e~~~-~~l~~~~~~~~~----~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~ 147 (283)
T cd07835 76 VFEFLD-LDLKKYMDSSPL----TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLAR 147 (283)
T ss_pred EEeccC-cCHHHHHhhCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeeccccc
Confidence 999995 699999876542 2589999999999999999999999 99999999999999999999999999997
Q ss_pred ecCCCCCCCCcccCCCCCcccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh-C
Q 037275 839 FLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA-L 916 (992)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~-~ 916 (992)
...... .......++..|+|||++.+. .++.++||||||+++|+|++|++||........ .....+.. .
T Consensus 148 ~~~~~~--------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~ 218 (283)
T cd07835 148 AFGVPV--------RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ-LFRIFRTLGT 218 (283)
T ss_pred ccCCCc--------cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCC
Confidence 543211 111122468899999987664 578899999999999999999999976422111 11111111 1
Q ss_pred Chh-HHHHHHhhHhHhhhccCCCCC-CccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 917 PDK-VMEIVDSVLLLEVQASNSRSC-GDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 917 ~~~-~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
+.. ........ .++........ .............+.+++.+||+.||++|||++|+++
T Consensus 219 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 219 PDEDVWPGVTSL--PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred CChHHhhhhhhc--hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 110 00000000 00000000000 0000001112356889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=308.16 Aligned_cols=254 Identities=23% Similarity=0.323 Sum_probs=192.0
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC-CchhHHHHHHHH-HHhccCCcceeEEEEeecccccCcceE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK-GASNGFVAECQA-LRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
++|++.+.||+|+||.||+|++..+|+.||+|+++.... .....+..|+.. ++..+||||+++++++. .....
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~-----~~~~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALF-----REGDV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEe-----cCCcE
Confidence 478899999999999999999998999999999864422 223445556665 66678999999999864 34457
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
++||||++ |+|.+++...... ...+++..++.++.|++.||+|||++. +++||||||+||+++.++.+||+|||.
T Consensus 76 ~lv~e~~~-~~l~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~ 150 (283)
T cd06617 76 WICMEVMD-TSLDKFYKKVYDK--GLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGI 150 (283)
T ss_pred EEEhhhhc-ccHHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccc
Confidence 99999996 6998888754322 246899999999999999999999853 799999999999999999999999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccC----CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHH
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG----GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFA 912 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~ 912 (992)
+....... ......++..|+|||++.+ ..++.++||||+||++|+|++|+.||...... ...
T Consensus 151 ~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~-- 216 (283)
T cd06617 151 SGYLVDSV---------AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP---FQQ-- 216 (283)
T ss_pred cccccccc---------ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC---HHH--
Confidence 87653211 1122357889999998765 45688999999999999999999998642211 100
Q ss_pred hhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 913 RTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
...... ... ... .......++.+++.+||..+|++||+++++++
T Consensus 217 -------~~~~~~----~~~-----~~~-----~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 217 -------LKQVVE----EPS-----PQL-----PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred -------HHHHHh----cCC-----CCC-----CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000 000 000 00112356889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=301.12 Aligned_cols=247 Identities=30% Similarity=0.459 Sum_probs=195.7
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAI 758 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 758 (992)
.+|++.+.||+|+||.||++.. +++.||+|.++.. .....+.+|+.++++++|||++++++++.. ...++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~------~~~~~ 75 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILH------NGLYI 75 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcC------CCcEE
Confidence 4688999999999999999976 6888999998532 234678899999999999999999998642 22589
Q ss_pred EEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccce
Q 037275 759 VYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAK 838 (992)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 838 (992)
||||+++++|.+++..... ..+++..++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+.
T Consensus 76 v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~ 148 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGR----ALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLAR 148 (254)
T ss_pred EEECCCCCCHHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccce
Confidence 9999999999999976432 2578999999999999999999999 99999999999999999999999999987
Q ss_pred ecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhhhCC
Q 037275 839 FLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFARTALP 917 (992)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 917 (992)
...... .....+..|+|||++.+..++.++|||||||++|||++ |+.||...... +.
T Consensus 149 ~~~~~~-----------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----~~------ 206 (254)
T cd05083 149 VGSMGV-----------DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK-----EV------ 206 (254)
T ss_pred eccccC-----------CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH-----HH------
Confidence 543210 11234578999999988899999999999999999998 99998653211 10
Q ss_pred hhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 037275 918 DKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCR 981 (992)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 981 (992)
...... ..... .....+..+.+++.+||+.+|++||+++++++.|++
T Consensus 207 ---~~~~~~----~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 207 ---KECVEK----GYRME----------PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ---HHHHhC----CCCCC----------CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 011100 00000 001224568899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=281.17 Aligned_cols=252 Identities=22% Similarity=0.278 Sum_probs=194.7
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC-CCchhHHHHHHHHHHhcc-CCcceeEEEEeecccccCcceEE
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ-KGASNGFVAECQALRNIR-HRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
+.+.+.-||.|+-|.||+++.+.+|..+|||.+.... .++.+++...++++.+-+ .|.||+.+||+.. +...+
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~-----n~dV~ 167 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT-----NTDVF 167 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee-----CchHH
Confidence 4456678999999999999999999999999996443 344567777888776664 8999999999643 34457
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+.||.| ...++.+++.... ++++..+-++...++.||.||.+++ +|+|||+||+|||+|+.|.+|+||||.+
T Consensus 168 IcMelM-s~C~ekLlkrik~-----piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIs 239 (391)
T KOG0983|consen 168 ICMELM-STCAEKLLKRIKG-----PIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGIS 239 (391)
T ss_pred HHHHHH-HHHHHHHHHHhcC-----CchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeeccccc
Confidence 889988 3356666665443 5899888999999999999999875 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCC---CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG---EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
.++-++. ......|-+.|||||.+.-. .|+.++||||||++++|++||+.||.+...+.
T Consensus 240 GrlvdSk---------AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF--------- 301 (391)
T KOG0983|consen 240 GRLVDSK---------AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF--------- 301 (391)
T ss_pred ceeeccc---------ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH---------
Confidence 8765432 22334688999999987643 68899999999999999999999998753332
Q ss_pred hCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 915 ALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
+++...+..+.+ +..+ .......+.+++..||+.|+.+||...++++.
T Consensus 302 -------e~ltkvln~ePP------~L~~---~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 302 -------EVLTKVLNEEPP------LLPG---HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred -------HHHHHHHhcCCC------CCCc---ccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 222222221110 0000 11135668999999999999999999998763
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=308.30 Aligned_cols=263 Identities=23% Similarity=0.277 Sum_probs=199.4
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
++|++.+.||+|+||.||+|.+..+++.||+|.+.... ......+.+|+++++.++||||+++++.+. ...+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~ 75 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE-----TKRH 75 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe-----cCCE
Confidence 36889999999999999999999899999999986443 223456789999999999999999999853 4557
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg 146 (305)
T cd05609 76 LCMVMEYVEGGDCATLLKNIG------ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFG 146 (305)
T ss_pred EEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCC
Confidence 799999999999999997543 488999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCc-------ccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccH
Q 037275 836 LAKFLSSSPLDTAV-------ETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTL 908 (992)
Q Consensus 836 ~a~~~~~~~~~~~~-------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~ 908 (992)
.++........... ..........++..|+|||.+.+..++.++|||||||++||+++|+.||.+....
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~---- 222 (305)
T cd05609 147 LSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE---- 222 (305)
T ss_pred CccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----
Confidence 98742211100000 0001112345788999999998888999999999999999999999999653111
Q ss_pred HHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 037275 909 HEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCR 981 (992)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 981 (992)
+ +........... +.. .......+.+++.+||+.||++||++.++.+.|+.
T Consensus 223 -~------------~~~~~~~~~~~~------~~~---~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 223 -E------------LFGQVISDDIEW------PEG---DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred -H------------HHHHHHhcccCC------CCc---cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 1 111111100000 000 00123458899999999999999997666555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=308.44 Aligned_cols=278 Identities=20% Similarity=0.292 Sum_probs=199.0
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC--CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK--GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
++|++.+.||+|+||.||+|++..+++.||+|.++.... .....+.+|+.++++++||||+++.+++... .....
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---~~~~~ 81 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGS---NLDKI 81 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEec---CCCcE
Confidence 578899999999999999999988899999999974432 2234567899999999999999999986532 23677
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
++||||++ ++|.+++..... .+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||.
T Consensus 82 ~lv~e~~~-~~L~~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~ 152 (293)
T cd07843 82 YMVMEYVE-HDLKSLMETMKQ-----PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGL 152 (293)
T ss_pred EEEehhcC-cCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCc
Confidence 99999996 599999876442 489999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 915 (992)
+....... .......+++.|+|||.+.+. .++.++||||+|+++|+|++|++||....... .........
T Consensus 153 ~~~~~~~~--------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~ 223 (293)
T cd07843 153 AREYGSPL--------KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID-QLNKIFKLL 223 (293)
T ss_pred eeeccCCc--------cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHh
Confidence 98665321 111223468899999988664 46889999999999999999999997543211 111111000
Q ss_pred -CC--hhHHHHHHhhHhHhhh-ccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 916 -LP--DKVMEIVDSVLLLEVQ-ASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 916 -~~--~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.+ ..+.....-....... ....................+.+++.+||+.||++|||++|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 224 GTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred CCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00 0000000000000000 00000000000000002456889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=317.24 Aligned_cols=282 Identities=22% Similarity=0.266 Sum_probs=202.8
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc--CCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK--QKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
.++|.+.+.||+|+||+||+|++..+++.||||.+... .......+.+|+.+++.++||||+++++++..........
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45799999999999999999999989999999998643 2333456778999999999999999999876543333456
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++||||+. ++|.+++.... .+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg 153 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ------TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFG 153 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCc
Confidence 799999995 68998887543 489999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh-
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR- 913 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~- 913 (992)
+++...... .......++..|+|||.+.+ ..++.++|||||||++|+|++|++||.+.... ........
T Consensus 154 ~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~ 224 (337)
T cd07858 154 LARTTSEKG--------DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV-HQLKLITEL 224 (337)
T ss_pred cccccCCCc--------ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHHH
Confidence 998654321 11123457889999998765 46889999999999999999999999753211 01111110
Q ss_pred --hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 914 --TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 914 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
...++....+.+...........................++.+++.+||+.+|++|||++|+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 225 LGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00111111111110000000000000000000011234668899999999999999999999876
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=302.97 Aligned_cols=253 Identities=25% Similarity=0.364 Sum_probs=203.6
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC-CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
++|++.+.||+|++|.||+|++..+++.||+|++..... .....+.+|+.++++++|||++++++++. .....+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFY-----KEGEIS 75 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-----cCCeEE
Confidence 368899999999999999999998899999999875543 34577899999999999999999999864 346679
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHH-HCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
+||||+++++|.+++.... .+++..++.++.|+++|++|||+ . +++||||+|+||+++.++.++|+|||.
T Consensus 76 lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~ 146 (264)
T cd06623 76 IVLEYMDGGSLADLLKKVG------KIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGI 146 (264)
T ss_pred EEEEecCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCcc
Confidence 9999999999999997642 58999999999999999999999 8 999999999999999999999999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhC
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTAL 916 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 916 (992)
+........ ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...... .
T Consensus 147 ~~~~~~~~~--------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~--------- 207 (264)
T cd06623 147 SKVLENTLD--------QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP--S--------- 207 (264)
T ss_pred ceecccCCC--------cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc--C---------
Confidence 986643221 112345788999999999889999999999999999999999998764320 0
Q ss_pred ChhHHHHHHhhHhHhhhccCCCCCCccccchHH-HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 917 PDKVMEIVDSVLLLEVQASNSRSCGDERLRTEE-RLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
..+.......... ... ... ....+.+++.+||..+|++|||+.|+++.
T Consensus 208 ---~~~~~~~~~~~~~-----~~~------~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 208 ---FFELMQAICDGPP-----PSL------PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ---HHHHHHHHhcCCC-----CCC------CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1111111110000 000 011 34568999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=300.79 Aligned_cols=252 Identities=30% Similarity=0.519 Sum_probs=198.3
Q ss_pred CCCCCccccccceEEEEeEECCCC----eEEEEEEeeccCCC-chhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 681 FSSSNMIGQGSFGFVYKGNLGENG----MMVAVKVINLKQKG-ASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
+++.+.||.|+||.||+|+....+ ..||+|++...... ..+.+.+|+.+++.++|+||+++++++.. ...
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~ 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTE-----EEP 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcC-----CCe
Confidence 457789999999999999997655 89999999644433 46788999999999999999999998643 356
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.+++|||+++++|.+++...... .+++..++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg 148 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNRPK----ELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFG 148 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhhhc----cCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccC
Confidence 79999999999999999764421 289999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhh
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~ 914 (992)
.+.......... .....+++.|+|||.+.+..++.++||||+|+++|+|++ |+.||..... .
T Consensus 149 ~~~~~~~~~~~~-------~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~-----~----- 211 (258)
T smart00219 149 LSRDLYDDDYYK-------KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN-----E----- 211 (258)
T ss_pred Cceecccccccc-------cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH-----H-----
Confidence 998765432111 111236789999999988889999999999999999999 8888865211 0
Q ss_pred hCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 037275 915 ALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKL 979 (992)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 979 (992)
........... .. .......++.+++.+|+..||++|||+.|+++.|
T Consensus 212 -------~~~~~~~~~~~------~~-----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 212 -------EVLEYLKKGYR------LP-----KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -------HHHHHHhcCCC------CC-----CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 01110000000 00 0011345688999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=307.46 Aligned_cols=282 Identities=20% Similarity=0.272 Sum_probs=199.9
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC--CCchhHHHHHHHHHHhcc-CCcceeEEEEeecccccCcce
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNIR-HRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 755 (992)
++|++.+.||+|+||.||+|.+..+++.||+|.++... ......+.+|+.+++++. ||||+++++++...+..+...
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46889999999999999999998899999999986432 223456888999999995 699999999876544434455
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCC-CCcEEEeec
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQ-DLVAHLGDF 834 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Df 834 (992)
.++||||+++ +|.+++...... ....+++..++.++.||+.||+|||++ +|+||||+|+||+++. ++.+||+||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~df 155 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRG-PGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADL 155 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhccc-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeec
Confidence 7999999975 899988754321 123589999999999999999999999 9999999999999998 889999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 913 (992)
|.+....... .......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.+..+.... .....
T Consensus 156 g~~~~~~~~~--------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~-~~~~~ 226 (295)
T cd07837 156 GLGRAFSIPV--------KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL-LHIFK 226 (295)
T ss_pred ccceecCCCc--------cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH-HHHHH
Confidence 9998653321 11112246788999998765 45789999999999999999999999764222111 11110
Q ss_pred h-hCChh--HHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 914 T-ALPDK--VMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 914 ~-~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
. ..+.. +...........+... ..............++.+++.+||+.||++|||++|++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 227 LLGTPTEQVWPGVSKLRDWHEFPQW---KPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred HhCCCChhhCcchhhccchhhcCcc---cchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 00000 0000000000000000 000000000123456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=301.10 Aligned_cols=255 Identities=27% Similarity=0.390 Sum_probs=199.7
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCC--chhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKG--ASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
+|++.+.||+|+||.||+|....+++.||+|+++..... ..+.+.+|+.++++++|+||+++++++. .....+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEV-----HREKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEe-----cCCEEE
Confidence 588899999999999999999888999999998755443 5677899999999999999999999843 445679
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+|+||+++++|.+++.... .+++..+..++.|++.|++|||+. +|+||||+|+||++++++.+||+|||.+
T Consensus 76 lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~ 146 (264)
T cd06626 76 IFMEYCSGGTLEELLEHGR------ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCA 146 (264)
T ss_pred EEEecCCCCcHHHHHhhcC------CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccc
Confidence 9999999999999997543 378889999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCCC---cCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGE---ASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
.......... ........++..|+|||++.+.. ++.++||||||+++|++++|+.||........ ....
T Consensus 147 ~~~~~~~~~~----~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~-~~~~--- 218 (264)
T cd06626 147 VKLKNNTTTM----GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ-IMFH--- 218 (264)
T ss_pred cccCCCCCcc----cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH-HHHH---
Confidence 8765432111 01012345788999999988766 88999999999999999999999975321100 0000
Q ss_pred hCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 915 ALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.. ... ... .+........+.+++.+||+.+|++|||+.|++.
T Consensus 219 ------------~~-~~~----~~~----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 219 ------------VG-AGH----KPP----IPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ------------Hh-cCC----CCC----CCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00 000 000 0001112345789999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=309.49 Aligned_cols=277 Identities=22% Similarity=0.317 Sum_probs=198.3
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC--CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK--GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
.++|++.+.||+|+||.||+|.+..+|+.||+|+++.... .....+.+|+.++++++|+||+++++++.. .....
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~ 82 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVG---KHLDS 82 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEec---CCCCe
Confidence 4689999999999999999999998999999999874432 223356789999999999999999998643 22345
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++||||++ ++|.+++.... ..+++.+++.++.|++.||+|||+. +++||||||+||++++++.+||+|||
T Consensus 83 ~~lv~e~~~-~~l~~~l~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg 153 (309)
T cd07845 83 IFLVMEYCE-QDLASLLDNMP-----TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFG 153 (309)
T ss_pred EEEEEecCC-CCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccc
Confidence 799999996 58998887543 2589999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
.+....... .......++..|+|||++.+ ..++.++||||+||++|||++|++||....... .+.....
T Consensus 154 ~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~-~~~~~~~- 223 (309)
T cd07845 154 LARTYGLPA--------KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE-QLDLIIQ- 223 (309)
T ss_pred eeeecCCcc--------CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH-
Confidence 998765321 11122245788999998865 457899999999999999999999997532211 1111111
Q ss_pred hCChhHHHHH---Hh-hHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 915 ALPDKVMEIV---DS-VLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 915 ~~~~~~~~~~---~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.......... +. .....+........ ...........++.+++.+|++.||++|||++|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 224 LLGTPNESIWPGFSDLPLVGKFTLPKQPYN-NLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hcCCCChhhchhhhcccccccccccCCCCC-chHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000000 00 00000000000000 000000112456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=313.97 Aligned_cols=284 Identities=24% Similarity=0.305 Sum_probs=203.6
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC--CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
.++|++.+.||+|+||.||+|....+++.||+|++.... ......+.+|+.++++++||||+++.+++.... .....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCce
Confidence 368999999999999999999999899999999986432 233456788999999999999999998765432 34457
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++||||+. |+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg 152 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSDQ------PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFG 152 (334)
T ss_pred EEEEEehhh-hhHHHHhccCC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccc
Confidence 799999995 68999886432 489999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
.+......... .........++..|+|||++.+ ..++.++|||||||++|||++|+.||.+..... ........
T Consensus 153 ~~~~~~~~~~~----~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~-~~~~~~~~ 227 (334)
T cd07855 153 MARGLSSSPTE----HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH-QLKLILSV 227 (334)
T ss_pred cceeecccCcC----CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH-HHHHHHHH
Confidence 99765432211 1111223468899999998765 468899999999999999999999997632211 11111110
Q ss_pred --hCChhHH-HHHHhhHhHhhhccCCCCCCccc-cchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 915 --ALPDKVM-EIVDSVLLLEVQASNSRSCGDER-LRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 915 --~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
..+.... ...........+ .......... ........++.+++.+||+.+|++|||+++++..
T Consensus 228 ~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 228 LGSPSEEVLNRIGSDRVRKYIQ-NLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hCCChhHhhhhhchhhHHHHHh-hcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0111111 111110000000 0000000000 0011235678999999999999999999998863
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=300.98 Aligned_cols=255 Identities=23% Similarity=0.370 Sum_probs=197.1
Q ss_pred CCCCCCccccccceEEEEeEECC-CCeEEEEEEeeccC----------CCchhHHHHHHHHHHh-ccCCcceeEEEEeec
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGE-NGMMVAVKVINLKQ----------KGASNGFVAECQALRN-IRHRNLIKIITICSS 747 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~ 747 (992)
.|++.+.||+|+||.||+|.+.. .++.+|+|.+.... .....++.+|+.++.+ ++||||+++++++.
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~- 79 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL- 79 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc-
Confidence 47888999999999999999976 67899999885322 1223456778888765 79999999999864
Q ss_pred ccccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCCCCCeeeCCC
Q 037275 748 IDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHH-HCQPPVVHGDLKPSNVLLDQD 826 (992)
Q Consensus 748 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~ 826 (992)
.....++||||+++++|.+++...... ...+++..++.++.|++.||.|||+ . +++||||+|+||+++.+
T Consensus 80 ----~~~~~~lv~e~~~~~~l~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~ 150 (269)
T cd08528 80 ----ENDRLYIVMDLIEGAPLGEHFNSLKEK--KQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGED 150 (269)
T ss_pred ----cCCeEEEEEecCCCCcHHHHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCC
Confidence 345679999999999999998653221 2358999999999999999999996 5 89999999999999999
Q ss_pred CcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCc
Q 037275 827 LVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGL 906 (992)
Q Consensus 827 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~ 906 (992)
+.+||+|||.+....... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus 151 ~~~~l~dfg~~~~~~~~~---------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~--- 218 (269)
T cd08528 151 DKVTITDFGLAKQKQPES---------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM--- 218 (269)
T ss_pred CcEEEecccceeeccccc---------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH---
Confidence 999999999998654321 12234578899999999988899999999999999999999999864211
Q ss_pred cHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 037275 907 TLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLC 980 (992)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 980 (992)
... .......... ... .......+.+++.+||+.||++||++.|+.++++
T Consensus 219 --~~~------------~~~~~~~~~~-----~~~-----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 219 --LSL------------ATKIVEAVYE-----PLP-----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred --HHH------------HHHHhhccCC-----cCC-----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 000 0000000000 000 0012346889999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=304.06 Aligned_cols=255 Identities=22% Similarity=0.357 Sum_probs=195.1
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC---C-------chhHHHHHHHHHHhccCCcceeEEEEeeccc
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK---G-------ASNGFVAECQALRNIRHRNLIKIITICSSID 749 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 749 (992)
+|...+.||+|+||.||+|....+++.||+|.++.... . ..+.+.+|+.+++.++|||++++++++.
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--- 78 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFET--- 78 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEec---
Confidence 57788999999999999999988899999998853211 0 1245788999999999999999999854
Q ss_pred ccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcE
Q 037275 750 FKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVA 829 (992)
Q Consensus 750 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 829 (992)
.....++||||+++++|.+++.... .+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+
T Consensus 79 --~~~~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~ 147 (272)
T cd06629 79 --TEEYLSIFLEYVPGGSIGSCLRTYG------RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGIC 147 (272)
T ss_pred --cCCceEEEEecCCCCcHHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeE
Confidence 3456799999999999999997652 488899999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCC--cCcccchhhHHHHHHHHHhCCCCCCCCccCCcc
Q 037275 830 HLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGE--ASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLT 907 (992)
Q Consensus 830 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~ 907 (992)
+++|||.++...... .........++..|+|||++.... ++.++||||+|+++|++++|..||......
T Consensus 148 ~l~d~~~~~~~~~~~------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--- 218 (272)
T cd06629 148 KISDFGISKKSDDIY------DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI--- 218 (272)
T ss_pred EEeeccccccccccc------cccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH---
Confidence 999999997643211 111122345788999999887654 789999999999999999999998642111
Q ss_pred HHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 908 LHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.... +.... .. ...... ....+....+.+++.+||..+|++|||++||++
T Consensus 219 -~~~~---------~~~~~----~~----~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 219 -AAMF---------KLGNK----RS----APPIPP--DVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred -HHHH---------Hhhcc----cc----CCcCCc--cccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 0000 00000 00 000000 000123456889999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=304.71 Aligned_cols=249 Identities=21% Similarity=0.283 Sum_probs=197.2
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEE
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIV 759 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 759 (992)
.|...++||+|++|.||+|....+++.||+|++........+.+.+|+.+++.++||||+++++++. ..+..++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~-----~~~~~~~v 94 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL-----VGDELWVV 94 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEE-----cCCeEEEE
Confidence 4555679999999999999998889999999987555555567889999999999999999999854 34567999
Q ss_pred EEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccccee
Q 037275 760 YEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKF 839 (992)
Q Consensus 760 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 839 (992)
+||+++++|.+++... .+++..+..++.|++.||+|||++ +++||||+|+||+++.++.++|+|||.+..
T Consensus 95 ~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~ 164 (285)
T cd06648 95 MEFLEGGALTDIVTHT-------RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQ 164 (285)
T ss_pred EeccCCCCHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchh
Confidence 9999999999998752 378899999999999999999999 999999999999999999999999998875
Q ss_pred cCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCChh
Q 037275 840 LSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDK 919 (992)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 919 (992)
..... .......|++.|+|||...+..++.++|||||||++|||++|+.||..... ...
T Consensus 165 ~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~-----~~~-------- 223 (285)
T cd06648 165 VSKEV--------PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP-----LQA-------- 223 (285)
T ss_pred hccCC--------cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH-----HHH--------
Confidence 43211 111234588999999999888899999999999999999999999864211 000
Q ss_pred HHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 920 VMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
......... .... ........+.+++.+||+.+|++|||+.|+++
T Consensus 224 ----~~~~~~~~~-----~~~~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 224 ----MKRIRDNLP-----PKLK----NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred ----HHHHHhcCC-----CCCc----ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 000000000 0000 00112346899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=304.80 Aligned_cols=268 Identities=19% Similarity=0.274 Sum_probs=189.4
Q ss_pred cCCCCCCccccccceEEEEeEECCC---CeEEEEEEeeccCCCch-----------hHHHHHHHHHHhccCCcceeEEEE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGEN---GMMVAVKVINLKQKGAS-----------NGFVAECQALRNIRHRNLIKIITI 744 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~~~~~ 744 (992)
++|++.++||+|+||+||+|....+ +..+|+|+......... .....+...+..+.|+++++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 5799999999999999999998766 66788887543322111 111223344556689999999987
Q ss_pred eecccccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeC
Q 037275 745 CSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLD 824 (992)
Q Consensus 745 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 824 (992)
+.... ......++++|++. .++.+.+.... ..++..+..++.|++.||+|||+. +|+||||||+||+++
T Consensus 92 ~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~ 160 (294)
T PHA02882 92 GSFKR-CRMYYRFILLEKLV-ENTKEIFKRIK------CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVD 160 (294)
T ss_pred eeEec-CCceEEEEEEehhc-cCHHHHHHhhc------cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEc
Confidence 54322 22234578888774 47777765432 256788899999999999999999 999999999999999
Q ss_pred CCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccC
Q 037275 825 QDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQ 904 (992)
Q Consensus 825 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~ 904 (992)
.++.++|+|||+|+.+......... .........||+.|+|||+..+..++.++|||||||++|||++|+.||.+....
T Consensus 161 ~~~~~~l~DFGla~~~~~~~~~~~~-~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~ 239 (294)
T PHA02882 161 GNNRGYIIDYGIASHFIIHGKHIEY-SKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN 239 (294)
T ss_pred CCCcEEEEEcCCceeeccCCccccc-ccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc
Confidence 9999999999999876432211110 111122346999999999999999999999999999999999999999875322
Q ss_pred CccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 037275 905 GLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKL 979 (992)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 979 (992)
........ .+++......... .......+.+++..|+..+|++||+++++.+.+
T Consensus 240 ~~~~~~~~--------~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 240 GNLIHAAK--------CDFIKRLHEGKIK-------------IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred hHHHHHhH--------HHHHHHhhhhhhc-------------cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 11111100 0111111111110 011235688999999999999999999999875
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=301.09 Aligned_cols=256 Identities=22% Similarity=0.338 Sum_probs=183.3
Q ss_pred CccccccceEEEEeEECCC--CeEEEEEEeeccC-CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEEEE
Q 037275 685 NMIGQGSFGFVYKGNLGEN--GMMVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYE 761 (992)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~--~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 761 (992)
+.||+|+||+||+|+.... ...+++|.+.... ....+.+.+|+.+++.++||||+++++++.. ....++|||
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-----~~~~~lv~e 75 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE-----AIPYLLVFE 75 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecC-----CCccEEEEe
Confidence 3699999999999976422 2456677665333 2345678999999999999999999998643 345699999
Q ss_pred eccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceecC
Q 037275 762 YMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLS 841 (992)
Q Consensus 762 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 841 (992)
|+++|+|.+++.+.... ....++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||.+....
T Consensus 76 ~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~ 150 (268)
T cd05086 76 YCELGDLKSYLSQEQWH--RRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRY 150 (268)
T ss_pred cCCCCcHHHHHHhhhcc--cccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccC
Confidence 99999999999865322 22467778889999999999999999 99999999999999999999999999986432
Q ss_pred CCCCCCCcccCCCCCcccccccccccccccC-------CCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHh
Q 037275 842 SSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-------GEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 913 (992)
... .........++..|+|||++.. ..++.++|||||||++|||++ |..||...... +
T Consensus 151 ~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-----~--- 216 (268)
T cd05086 151 KED------YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR-----E--- 216 (268)
T ss_pred cch------hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH-----H---
Confidence 211 0111223457889999998753 245789999999999999997 56787543211 0
Q ss_pred hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 037275 914 TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLC 980 (992)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 980 (992)
.......... ....+.... ......+.+++..|| .+|++||+++||++.|.
T Consensus 217 ---------~~~~~~~~~~-~~~~~~~~~-----~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 217 ---------VLNHVIKDQQ-VKLFKPQLE-----LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ---------HHHHHHhhcc-cccCCCccC-----CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 1111111100 000000000 012345777888899 67999999999998773
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=306.91 Aligned_cols=287 Identities=23% Similarity=0.349 Sum_probs=200.3
Q ss_pred HhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC--CchhHHHHHHHHHHhccCCcceeEEEEeecccc---c
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK--GASNGFVAECQALRNIRHRNLIKIITICSSIDF---K 751 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~ 751 (992)
..++|++.++||+|+||.||+|+...+++.||||.+..... .....+.+|+.++++++||||+++++++..... .
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 34579999999999999999999998999999999864332 223456789999999999999999998865432 1
Q ss_pred CcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEE
Q 037275 752 GVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHL 831 (992)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 831 (992)
.....++||||+. +++.+++.... ..+++.+++.++.|++.||+|||++ +++|+||||+||+++.++.+||
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl 160 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSNKN-----VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKL 160 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEE
Confidence 2356699999996 58888886543 2489999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCCCCCcccCCCCCcccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHH
Q 037275 832 GDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHE 910 (992)
Q Consensus 832 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~ 910 (992)
+|||.+......... .........++..|+|||.+.+. .++.++||||||+++|||++|+.||.+.... .....
T Consensus 161 ~dfg~~~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~-~~~~~ 235 (310)
T cd07865 161 ADFGLARAFSLSKNS----KPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ-HQLTL 235 (310)
T ss_pred CcCCCcccccCCccc----CCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHH
Confidence 999999866432211 01112334578899999987664 4788999999999999999999998753221 11110
Q ss_pred --HHhhhCChhHHHHHHhh-HhHhhhc-cCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 911 --FARTALPDKVMEIVDSV-LLLEVQA-SNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 911 --~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
......+.......+.. ....... .........+.........+.+++.+||..||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 236 ISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred HHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 01111111100000000 0000000 0000000000000011245678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=310.66 Aligned_cols=280 Identities=18% Similarity=0.248 Sum_probs=193.2
Q ss_pred Cccccc--cceEEEEeEECCCCeEEEEEEeeccCC--CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEEE
Q 037275 685 NMIGQG--SFGFVYKGNLGENGMMVAVKVINLKQK--GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVY 760 (992)
Q Consensus 685 ~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 760 (992)
..||+| +||+||+|++..+|+.||+|++..... ...+.+.+|+.+++.++||||+++++++. .....++||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~-----~~~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFT-----TGSWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEe-----cCCceEEEE
Confidence 356666 999999999988999999999864432 23467889999999999999999999964 345669999
Q ss_pred EeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceec
Q 037275 761 EYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFL 840 (992)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 840 (992)
||+.++++.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||+.+...
T Consensus 79 e~~~~~~l~~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~ 151 (328)
T cd08226 79 PFMAYGSANSLLKTYFP----EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSL 151 (328)
T ss_pred ecccCCCHHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhh
Confidence 99999999999986542 2488999999999999999999999 9999999999999999999999999866433
Q ss_pred CCCCCCCCcccCCCCCcccccccccccccccCC--CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhC--
Q 037275 841 SSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG--EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTAL-- 916 (992)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-- 916 (992)
......... .........++..|+|||++.+. .++.++||||+||++|||++|+.||..................
T Consensus 152 ~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 230 (328)
T cd08226 152 VRNGQKAKV-VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSP 230 (328)
T ss_pred hccCccccc-cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCC
Confidence 221111000 00111112356779999998764 4789999999999999999999999764322111111100000
Q ss_pred ------ChhHHHHHHhhHhHhhh------cc----CCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 917 ------PDKVMEIVDSVLLLEVQ------AS----NSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 917 ------~~~~~~~~~~~~~~~~~------~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
+.......+........ .. .................++.+++.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 231 LDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred ccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 00000000000000000 00 000000001112345677899999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=299.60 Aligned_cols=261 Identities=24% Similarity=0.318 Sum_probs=202.5
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC-CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
++|++.+.||.|+||+||+|....++..+|+|++.... ......+.+|+++++.++|+|++++++.+. .....+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFV-----VGDELW 75 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEe-----eCCEEE
Confidence 47899999999999999999998889999999986432 224567899999999999999999999853 345679
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||+++++|.+++..... ...+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||.+
T Consensus 76 iv~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~ 149 (267)
T cd06610 76 LVMPYLSGGSLLDIMKSSYP---RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVS 149 (267)
T ss_pred EEEeccCCCcHHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchH
Confidence 99999999999999976432 12589999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTAL 916 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 916 (992)
.......... ........|+..|+|||++... .++.++|+|||||++|+|++|+.||....... ........
T Consensus 150 ~~~~~~~~~~----~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~-- 222 (267)
T cd06610 150 ASLADGGDRT----RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-VLMLTLQN-- 222 (267)
T ss_pred HHhccCcccc----ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-hHHHHhcC--
Confidence 7665432110 0112334588999999998776 78999999999999999999999997532211 01110000
Q ss_pred ChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 917 PDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.. .... ...........+.+++.+||+.||++|||++|+++
T Consensus 223 --------------~~-----~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 223 --------------DP-----PSLE-TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred --------------CC-----CCcC-CccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00 0000 00001123456889999999999999999999985
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=307.25 Aligned_cols=247 Identities=26% Similarity=0.357 Sum_probs=193.9
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC---CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK---GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
..|+..+.||+|+||+||+|+...+++.||+|++..... .....+.+|+.+++.++||||+++.+++.. ...
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~-----~~~ 89 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR-----EHT 89 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe-----CCe
Confidence 468899999999999999999988899999999864332 223568899999999999999999999653 345
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++||||+. |++.+++..... .+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.+||+|||
T Consensus 90 ~~lv~e~~~-g~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg 160 (307)
T cd06607 90 AWLVMEYCL-GSASDILEVHKK-----PLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFG 160 (307)
T ss_pred EEEEHHhhC-CCHHHHHHHccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecC
Confidence 699999996 688887764332 489999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCccccccccccccccc---CCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHH
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGM---GGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFA 912 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~ 912 (992)
++...... ....+++.|+|||++. ...++.++||||||+++|||++|+.||....... .
T Consensus 161 ~~~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~----~-- 222 (307)
T cd06607 161 SASLVSPA------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----A-- 222 (307)
T ss_pred cceecCCC------------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH----H--
Confidence 98754321 1235788999999874 4568899999999999999999999986532110 0
Q ss_pred hhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 913 RTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
..... .... ...........+.+++.+||+.+|++||++.+|+..
T Consensus 223 -------~~~~~----~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 223 -------LYHIA----QNDS----------PTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred -------HHHHh----cCCC----------CCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000 0000 000111234568999999999999999999999873
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=303.50 Aligned_cols=248 Identities=26% Similarity=0.371 Sum_probs=196.4
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC-CCchhHHHHHHHHHHhcc---CCcceeEEEEeecccccCcce
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ-KGASNGFVAECQALRNIR---HRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~~~ 755 (992)
.|+..+.||+|+||.||+|.+..+++.||+|+++... ......+.+|+.+++.++ |||++++++++. ....
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~-----~~~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL-----KGPR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee-----eCCE
Confidence 4778899999999999999998899999999986442 334567889999999996 999999999864 3456
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++||||+++++|.+++... .+++..++.++.|++.||+|||+. +|+||||+|+||+++.++.++|+|||
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~-------~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg 146 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKAG-------PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFG 146 (277)
T ss_pred EEEEEecCCCCcHHHHHHcc-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCC
Confidence 79999999999999998643 488999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
.+....... .......|+..|+|||.+.++ .++.++|||||||++|+|++|+.||....... ...
T Consensus 147 ~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-----~~~- 212 (277)
T cd06917 147 VAALLNQNS--------SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-----AMM- 212 (277)
T ss_pred ceeecCCCc--------cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh-----hhh-
Confidence 998765422 112234588899999987654 56889999999999999999999997532110 000
Q ss_pred hCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 915 ALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.... . ...... ......++.+++.+||+.||++||++.|++.
T Consensus 213 --------~~~~---~-----~~~~~~-----~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 213 --------LIPK---S-----KPPRLE-----DNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred --------cccc---C-----CCCCCC-----cccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 0000 0 000000 0113456889999999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=301.12 Aligned_cols=243 Identities=23% Similarity=0.283 Sum_probs=183.8
Q ss_pred ccccccceEEEEeEECCCCeEEEEEEeeccCC---CchhHHHHHHHHHHh---ccCCcceeEEEEeecccccCcceEEEE
Q 037275 686 MIGQGSFGFVYKGNLGENGMMVAVKVINLKQK---GASNGFVAECQALRN---IRHRNLIKIITICSSIDFKGVDFQAIV 759 (992)
Q Consensus 686 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~---l~h~niv~~~~~~~~~~~~~~~~~~lv 759 (992)
+||+|+||.||+|....+++.||+|.+..... .....+.+|..+++. .+||+++.+.+++. ..+..++|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFH-----TPDKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEe-----cCCeEEEE
Confidence 48999999999999988899999999864322 112234455444443 47999999988854 34467999
Q ss_pred EEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccccee
Q 037275 760 YEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKF 839 (992)
Q Consensus 760 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 839 (992)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++..
T Consensus 76 ~e~~~~~~L~~~i~~~~------~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~ 146 (279)
T cd05633 76 LDLMNGGDLHYHLSQHG------VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 146 (279)
T ss_pred EecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCccee
Confidence 99999999999987543 489999999999999999999999 999999999999999999999999999875
Q ss_pred cCCCCCCCCcccCCCCCcccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCCh
Q 037275 840 LSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPD 918 (992)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 918 (992)
..... .....|+..|+|||.+.+ ..++.++||||+||++|+|++|..||........ ........
T Consensus 147 ~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~-- 212 (279)
T cd05633 147 FSKKK----------PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTL-- 212 (279)
T ss_pred ccccC----------ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH--HHHHHHhh--
Confidence 43211 112358999999998764 5688999999999999999999999976422211 00000000
Q ss_pred hHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 037275 919 KVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERM-----EMRDVVAK 978 (992)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 978 (992)
... .. .......++.+++.+||+.||++|| |++|+++.
T Consensus 213 ------------~~~----~~------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 213 ------------TVN----VE------LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ------------cCC----cC------CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 000 00 0011234688999999999999999 59988764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=297.44 Aligned_cols=251 Identities=21% Similarity=0.297 Sum_probs=193.5
Q ss_pred HHHHHHHhcCCCCCCcc--ccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhc-cCCcceeEEEEeec
Q 037275 671 YAELSKATNDFSSSNMI--GQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNI-RHRNLIKIITICSS 747 (992)
Q Consensus 671 ~~~~~~~~~~~~~~~~l--g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 747 (992)
..+.....++|++.+.+ |+|+||.||+++...++..+|+|++........ |+.....+ +||||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEec
Confidence 44555666788888887 999999999999998999999999864322211 22222222 79999999998643
Q ss_pred ccccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCC
Q 037275 748 IDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDL 827 (992)
Q Consensus 748 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 827 (992)
.+..++||||+++++|.+++.... .+++.++..++.|+++||+|||+. +++||||||+||+++.++
T Consensus 81 -----~~~~~iv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~ 146 (267)
T PHA03390 81 -----LKGHVLIMDYIKDGDLFDLLKKEG------KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAK 146 (267)
T ss_pred -----CCeeEEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCC
Confidence 446799999999999999997643 589999999999999999999999 999999999999999998
Q ss_pred -cEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCc
Q 037275 828 -VAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGL 906 (992)
Q Consensus 828 -~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~ 906 (992)
.++|+|||.+...... ....++..|+|||++.+..++.++||||+||++|||++|+.||.....+..
T Consensus 147 ~~~~l~dfg~~~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~ 214 (267)
T PHA03390 147 DRIYLCDYGLCKIIGTP------------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL 214 (267)
T ss_pred CeEEEecCccceecCCC------------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh
Confidence 9999999998765422 123478899999999988999999999999999999999999985433321
Q ss_pred cHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCC-HHHHHH
Q 037275 907 TLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERME-MRDVVA 977 (992)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~ 977 (992)
....+.... . .. . . ........+.+++.+||+.+|.+||+ ++|+++
T Consensus 215 ~~~~~~~~~-~------------~~-----~-~------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 215 DLESLLKRQ-Q------------KK-----L-P------FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred hHHHHHHhh-c------------cc-----C-C------cccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 111111100 0 00 0 0 00123456889999999999999996 588874
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=305.00 Aligned_cols=245 Identities=26% Similarity=0.299 Sum_probs=197.1
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++||||+++++++. ....
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ-----DDSN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE-----cCCe
Confidence 46889999999999999999999899999999986432 233466889999999999999999999853 4556
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+||+|||
T Consensus 76 ~~~v~e~~~~~~L~~~~~~~~------~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg 146 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRKSG------RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFG 146 (290)
T ss_pred EEEEEecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCC
Confidence 799999999999999997653 488999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 915 (992)
++...... .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||..... .+
T Consensus 147 ~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~----- 205 (290)
T cd05580 147 FAKRVKGR-----------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP-----IQ----- 205 (290)
T ss_pred CccccCCC-----------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-----HH-----
Confidence 98865432 1223578999999999888889999999999999999999999865321 00
Q ss_pred CChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 037275 916 LPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERM-----EMRDVVA 977 (992)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 977 (992)
.......... ..+ ......+.+++.+||..||.+|| +++|+++
T Consensus 206 -------~~~~~~~~~~------~~~------~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 206 -------IYEKILEGKV------RFP------SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred -------HHHHHhcCCc------cCC------ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 0000000000 000 01134578999999999999999 7777763
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=302.97 Aligned_cols=274 Identities=23% Similarity=0.335 Sum_probs=198.8
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC-CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEE
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAI 758 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 758 (992)
+|++.++||.|++|.||+|++..+|+.||+|+++.... .....+.+|+.++++++||||+++++++.. .+..++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHT-----ENKLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEee-----CCcEEE
Confidence 58889999999999999999988999999999875433 234567789999999999999999998643 456699
Q ss_pred EEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccce
Q 037275 759 VYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAK 838 (992)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 838 (992)
||||+++ +|.+++..... ...+++..+..++.|+++||+|||+. +++||||||+||++++++.++|+|||.+.
T Consensus 76 v~e~~~~-~l~~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~ 148 (284)
T cd07836 76 VFEYMDK-DLKKYMDTHGV---RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLAR 148 (284)
T ss_pred EEecCCc-cHHHHHHhcCC---CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhh
Confidence 9999974 89998875442 23589999999999999999999999 99999999999999999999999999997
Q ss_pred ecCCCCCCCCcccCCCCCcccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh--
Q 037275 839 FLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA-- 915 (992)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~-- 915 (992)
...... .......++..|+|||++.+. .++.++||||+||++|+|++|+.||.+....+ .........
T Consensus 149 ~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~ 219 (284)
T cd07836 149 AFGIPV--------NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED-QLLKIFRIMGT 219 (284)
T ss_pred hhcCCc--------cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCC
Confidence 543211 111223468899999987654 57889999999999999999999997643221 111111110
Q ss_pred -CChhHHHHHHhhHhHhhhccCCCCCCccc-cchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 916 -LPDKVMEIVDSVLLLEVQASNSRSCGDER-LRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 916 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
....+..+... ..+............ .........+.+++.+|++.||.+||+++|+++
T Consensus 220 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 220 PTESTWPGISQL---PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred CChhhHHHHhcC---chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 01111111100 000000000000000 000122456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=307.47 Aligned_cols=211 Identities=22% Similarity=0.393 Sum_probs=172.6
Q ss_pred CCCCCCccccccceEEEEeEECC--CCeEEEEEEeeccC---CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcc
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGE--NGMMVAVKVINLKQ---KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
+|++.++||+|+||.||+|.... +++.||+|.+.... ......+.+|+.++++++||||+++++++.+. ...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence 47888999999999999999987 78999999997532 33456778899999999999999999997542 235
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCC----CCcEE
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQ----DLVAH 830 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~k 830 (992)
..++||||+++ ++.+++...... ....+++..++.++.|++.||+|||+. +|+||||||+||+++. ++.+|
T Consensus 78 ~~~lv~e~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~k 152 (316)
T cd07842 78 SVYLLFDYAEH-DLWQIIKFHRQA-KRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVK 152 (316)
T ss_pred eEEEEEeCCCc-CHHHHHHhhccC-CCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEE
Confidence 67999999964 787777654322 123688999999999999999999999 9999999999999999 99999
Q ss_pred EeecccceecCCCCCCCCcccCCCCCcccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCCCcc
Q 037275 831 LGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRRRPTDGMFN 903 (992)
Q Consensus 831 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~ 903 (992)
|+|||++........ .........++..|+|||++.+. .++.++|||||||++|+|++|++||.+...
T Consensus 153 l~Dfg~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 153 IGDLGLARLFNAPLK-----PLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred ECCCccccccCCCcc-----cccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 999999986643221 11122344678999999987664 578999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=305.06 Aligned_cols=275 Identities=23% Similarity=0.336 Sum_probs=199.4
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC--CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
++|++.+.||+|+||.||+|.+..+++.||+|+++... ......+.+|++++++++|+||+++++++.. ....
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-----KGRL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-----CCEE
Confidence 36889999999999999999999889999999986432 3345678999999999999999999998643 4567
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
++||||++++.+..+.... ..+++..++.++.|++.|++|||+. +++|||++|+||++++++.+||+|||.
T Consensus 76 ~iv~e~~~~~~l~~~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~ 146 (288)
T cd07833 76 YLVFEYVERTLLELLEASP------GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGF 146 (288)
T ss_pred EEEEecCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeec
Confidence 9999999887776655432 2488999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh--
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR-- 913 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~-- 913 (992)
+........ .......++..|+|||++.+. .++.++||||||+++|+|++|++||.+....+. ......
T Consensus 147 ~~~~~~~~~-------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~ 218 (288)
T cd07833 147 ARALRARPA-------SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQ-LYLIQKCL 218 (288)
T ss_pred ccccCCCcc-------ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHh
Confidence 886653211 112234578899999999888 889999999999999999999999975322110 000000
Q ss_pred hhCChhHHHHHHhhHhHhhhccCCCCCCccc----cchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 914 TALPDKVMEIVDSVLLLEVQASNSRSCGDER----LRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
...+.......... ..+............ ........++.+++.+||..+|++|||++++++
T Consensus 219 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 219 GPLPPSHQELFSSN--PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred CCCCHHHhhhcccC--ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00010000000000 000000000000000 000112567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=302.39 Aligned_cols=272 Identities=20% Similarity=0.260 Sum_probs=193.9
Q ss_pred CCCCCccccccceEEEEeEECCCCeEEEEEEeeccC-CCchhHHHHHHHHHHhcc-CCcceeEEEEeecccccCcceEEE
Q 037275 681 FSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ-KGASNGFVAECQALRNIR-HRNLIKIITICSSIDFKGVDFQAI 758 (992)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l 758 (992)
|++.++||+|+||.||+|+...+++.||+|+++... ........+|+.+++++. |||++++++++.+. ..+..++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEEE
Confidence 677889999999999999998899999999986432 222334457888899885 99999999997542 2256799
Q ss_pred EEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccce
Q 037275 759 VYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAK 838 (992)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 838 (992)
||||++ |++.+++.... ..+++.+++.++.|++.||+|||+. +++||||+|+||+++. +.+||+|||.++
T Consensus 78 v~e~~~-~~l~~~l~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~ 147 (282)
T cd07831 78 VFELMD-MNLYELIKGRK-----RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCR 147 (282)
T ss_pred EEecCC-ccHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEeccccc
Confidence 999996 58888887543 2489999999999999999999999 9999999999999999 999999999998
Q ss_pred ecCCCCCCCCcccCCCCCcccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCC
Q 037275 839 FLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALP 917 (992)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 917 (992)
...... ......++..|+|||++.+ ..++.++||||+||++|||++|..||.+....+ ..........
T Consensus 148 ~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~--~~~~~~~~~~ 216 (282)
T cd07831 148 GIYSKP---------PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD--QIAKIHDVLG 216 (282)
T ss_pred ccccCC---------CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH--HHHHHHHHcC
Confidence 654321 1122357889999997644 557889999999999999999999997632211 1111111111
Q ss_pred hhHHHHHHhhHhHhhhc--cCCCCCCc-cccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 918 DKVMEIVDSVLLLEVQA--SNSRSCGD-ERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 918 ~~~~~~~~~~~~~~~~~--~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.....+. ......... ........ -.........++.+++.+||+.+|++|||++|+++
T Consensus 217 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 217 TPDAEVL-KKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred CCCHHHH-HhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 1111110 000000000 00000000 00001123577999999999999999999999985
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=305.81 Aligned_cols=275 Identities=23% Similarity=0.338 Sum_probs=195.1
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC--CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK--GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
++|++.+.||+|++|+||+|++..+++.||+|.+..... ...+.+.+|++++++++||||+++++++. .....
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH-----SEKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEe-----cCCeE
Confidence 578999999999999999999988999999999864322 23456889999999999999999999964 44567
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCC-CCcEEEeecc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQ-DLVAHLGDFG 835 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg 835 (992)
++||||++ +++.+++..... ..+++..+..++.|++.||+|||++ +++||||+|+||+++. ++.+||+|||
T Consensus 77 ~lv~e~~~-~~l~~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg 148 (294)
T PLN00009 77 YLVFEYLD-LDLKKHMDSSPD----FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFG 148 (294)
T ss_pred EEEEeccc-ccHHHHHHhCCC----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccc
Confidence 99999995 588888765432 2467888899999999999999999 9999999999999985 5679999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
.+....... .......+++.|+|||++.+. .++.++||||+||++|+|+||++||......+.....+...
T Consensus 149 ~~~~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~ 220 (294)
T PLN00009 149 LARAFGIPV--------RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRIL 220 (294)
T ss_pred cccccCCCc--------cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 997653211 111223568899999987664 57889999999999999999999997642221111100000
Q ss_pred hCC-hh-HHHHHHhhHhHhhhccCCC-CCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 915 ALP-DK-VMEIVDSVLLLEVQASNSR-SCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 915 ~~~-~~-~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
..+ +. +....+ ..++.....+ ..............++.+++.+|++.+|++||++.++++
T Consensus 221 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 221 GTPNEETWPGVTS---LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred CCCChhhcccccc---chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 00 000000 0000000000 000000001112345789999999999999999999986
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=301.79 Aligned_cols=276 Identities=21% Similarity=0.301 Sum_probs=199.4
Q ss_pred CCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC--CchhHHHHHHHHHHhc---cCCcceeEEEEeecccccCcce
Q 037275 681 FSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK--GASNGFVAECQALRNI---RHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~~ 755 (992)
|++.+.||+|+||.||+|++..+++.||+|+++.... .....+.+|+.+++++ +|||++++++++...+..+...
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 6778899999999999999987899999999964322 2234566788877766 5999999999987655444455
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.+++|||+. ++|.+++..... ..+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~----~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg 152 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPK----PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFG 152 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccC
Confidence 799999996 589998876442 2489999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 915 (992)
.+....... ......++..|+|||++.+..++.++|||||||++|||++|++||.+.... .....+....
T Consensus 153 ~~~~~~~~~---------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~ 222 (287)
T cd07838 153 LARIYSFEM---------ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA-DQLDKIFDVI 222 (287)
T ss_pred cceeccCCc---------ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH-HHHHHHHHHc
Confidence 997764321 112234788999999999989999999999999999999999998763322 1111111111
Q ss_pred CChhHHHHHHhhH--hHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 916 LPDKVMEIVDSVL--LLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 916 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
............. ...+. ............+....+.+++.+||+.||++||+++|++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 223 GLPSEEEWPRNVSLPRSSFP---SYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCCChHhcCCCcccchhhcc---cccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000000000000 00000 00000001111233466889999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=301.13 Aligned_cols=248 Identities=23% Similarity=0.338 Sum_probs=197.3
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC-CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEE
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAI 758 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 758 (992)
-|+..+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.++++++||||+++++++. .+...++
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~l 79 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KDTKLWI 79 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEE-----eCCeEEE
Confidence 4778889999999999999998889999999986332 233456889999999999999999999864 3456799
Q ss_pred EEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccce
Q 037275 759 VYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAK 838 (992)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 838 (992)
||||+++++|.+++... .+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 80 v~e~~~~~~l~~~i~~~-------~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~ 149 (277)
T cd06641 80 IMEYLGGGSALDLLEPG-------PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAG 149 (277)
T ss_pred EEEeCCCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccce
Confidence 99999999999998642 478999999999999999999999 99999999999999999999999999987
Q ss_pred ecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCCh
Q 037275 839 FLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPD 918 (992)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 918 (992)
...... .......++..|+|||.+.+..++.++|||||||++|+|++|..||...... ..
T Consensus 150 ~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~------- 209 (277)
T cd06641 150 QLTDTQ--------IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-----KV------- 209 (277)
T ss_pred ecccch--------hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-----HH-------
Confidence 654321 1112235788999999998888999999999999999999999998642111 00
Q ss_pred hHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 919 KVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
...+.. ... .. .......++.+++.+||+.+|++||+++++++.
T Consensus 210 --~~~~~~---~~~-----~~------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 210 --LFLIPK---NNP-----PT------LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred --HHHHhc---CCC-----CC------CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000000 000 00 011224558899999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=284.92 Aligned_cols=287 Identities=22% Similarity=0.333 Sum_probs=206.7
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc--CCCchhHHHHHHHHHHhccCCcceeEEEEeecccc---cCc
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK--QKGASNGFVAECQALRNIRHRNLIKIITICSSIDF---KGV 753 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~~ 753 (992)
+.|.-..+||+|.||.||+|+.+.+|+.||+|++-.. ..+-.....+|++++..++|+|++.++++|....- ...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 4566778999999999999999999999999976432 23334567899999999999999999999876442 234
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGD 833 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 833 (992)
..+++||.+|+. +|...+..... .++..++.+++.++.+||.|+|.. .|+|||+||.|++++.+|.+||+|
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~v-----r~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklAD 167 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRKV-----RFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLAD 167 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCccc-----cccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeec
Confidence 567999999977 99999986543 488999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCcc-HHHH
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLT-LHEF 911 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~-~~~~ 911 (992)
||+++.+...... .....+..+-|..|++||.+.| +.|+++.|||+.|||+.||+||.+.+.+..++... +...
T Consensus 168 FGlar~fs~~~n~----~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~ 243 (376)
T KOG0669|consen 168 FGLARAFSTSKNV----VKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQ 243 (376)
T ss_pred cccccceeccccc----CCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHH
Confidence 9999766533211 1122334556999999998776 47999999999999999999999999886554221 1111
Q ss_pred H-hhhCChhHHHHHHhhHhHhhhc----cCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 912 A-RTALPDKVMEIVDSVLLLEVQA----SNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 912 ~-~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
. ....++.+.....-.+...... ....+...++........+..+++..++..||.+|+++++++..
T Consensus 244 LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 244 LCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred HhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 1 1111222221111111111100 00001111111111112356788999999999999999998753
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=302.81 Aligned_cols=254 Identities=24% Similarity=0.341 Sum_probs=202.3
Q ss_pred HHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 676 KATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 676 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
...+.|+..+.||+|+||.||+|.+..++..||+|++..... ....+.+|+++++.++|+|++++++++.. ...
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~ 89 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLV-----GDE 89 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEE-----CCE
Confidence 456678899999999999999999988899999999975444 45678899999999999999999998643 356
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++|+||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~ 161 (286)
T cd06614 90 LWVVMEYMDGGSLTDIITQNF-----VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFG 161 (286)
T ss_pred EEEEEeccCCCcHHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccc
Confidence 799999999999999998654 2589999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 915 (992)
.+....... .......++..|+|||++.+..++.++|||||||++|+|++|+.||...... ....
T Consensus 162 ~~~~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~----~~~~--- 226 (286)
T cd06614 162 FAAQLTKEK--------SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL----RALF--- 226 (286)
T ss_pred hhhhhccch--------hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH----HHHH---
Confidence 987554321 1112234788999999998888999999999999999999999998642111 0000
Q ss_pred CChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 916 LPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.... .... ...........+.+++.+||+.+|.+|||+.|+++
T Consensus 227 ------~~~~----~~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 227 ------LITT----KGIP---------PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred ------HHHh----cCCC---------CCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 0000 0000 00001112356889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=308.86 Aligned_cols=283 Identities=22% Similarity=0.293 Sum_probs=201.4
Q ss_pred HhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc--CCCchhHHHHHHHHHHhc-cCCcceeEEEEeecccccCc
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK--QKGASNGFVAECQALRNI-RHRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 753 (992)
..++|++.+.||+|+||.||+|.+..+++.||+|.+... .......+.+|+.+++++ +||||+++++++.. .+.
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~---~~~ 81 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---END 81 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc---CCC
Confidence 356889999999999999999999888999999988532 223345677899999999 99999999998643 234
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGD 833 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 833 (992)
...++||||++ ++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d 150 (337)
T cd07852 82 KDIYLVFEYME-TDLHAVIRAN-------ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLAD 150 (337)
T ss_pred ceEEEEecccc-cCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEee
Confidence 46799999996 5999988643 478889999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHH
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFA 912 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~ 912 (992)
||.+.......... .........|+..|+|||++.+ ..++.++||||||+++|+|++|+.||.+...... .....
T Consensus 151 ~g~~~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-~~~~~ 226 (337)
T cd07852 151 FGLARSLSELEENP---ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-LEKII 226 (337)
T ss_pred ccchhccccccccc---cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHH
Confidence 99998664322110 1112233568899999998755 4678899999999999999999999976432211 11111
Q ss_pred hhh--CChhHHHHHHhhHhHhhhc--cCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 913 RTA--LPDKVMEIVDSVLLLEVQA--SNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 913 ~~~--~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
... .+......+.......... ......... ........++.+++.+||+.||++|||+.++++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 227 EVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLD-ELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHhCCCCHHHHHHHHhhhHHHhhhhcccccccchh-hhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 110 1111101000000000000 000000000 0001134568999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=301.06 Aligned_cols=248 Identities=23% Similarity=0.351 Sum_probs=198.5
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
+|++.+.||.|+||.||+|++..+++.||+|++.... ....+.+.+|++++++++||||+++++++ .+....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-----QDEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-----cCCCeE
Confidence 4788899999999999999998889999999997433 23456789999999999999999999874 456678
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
++|+||+++++|.+++.... .+++..+..++.|+++||+|||+. +++|+||+|+||++++++.++|+|||.
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~ 146 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQKV------KFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNI 146 (258)
T ss_pred EEEEeCCCCCCHHHHHHhcC------CcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeeccc
Confidence 99999999999999997642 588999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhC
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTAL 916 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 916 (992)
+....... ......|+..|+|||++.+..++.++||||+|+++|+|++|+.||...... ......
T Consensus 147 ~~~~~~~~---------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~---- 211 (258)
T cd05578 147 ATKVTPDT---------LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIR---- 211 (258)
T ss_pred ccccCCCc---------cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHHH----
Confidence 88654321 112345788999999998888999999999999999999999999764321 000100
Q ss_pred ChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCH--HHHH
Q 037275 917 PDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEM--RDVV 976 (992)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~evl 976 (992)
..... . ... ........+.+++.+||+.||.+||++ +|++
T Consensus 212 -----~~~~~----~-----~~~------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 212 -----AKQET----A-----DVL------YPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -----HHhcc----c-----ccc------CcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 00000 0 000 001123568899999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=311.89 Aligned_cols=279 Identities=21% Similarity=0.282 Sum_probs=198.5
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccc--------
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDF-------- 750 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-------- 750 (992)
.+|++.+.||.|+||.||+|....+++.||+|.+........+.+.+|++++++++||||+++++++.....
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 589999999999999999999998999999999976665566778899999999999999999987644221
Q ss_pred -cCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCC-CCc
Q 037275 751 -KGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQ-DLV 828 (992)
Q Consensus 751 -~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~ 828 (992)
......++||||++ ++|.+++... .+++..++.++.|+++||+|||+. +|+||||||+||+++. ++.
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~ 153 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQG-------PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLV 153 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCce
Confidence 12245789999996 5898887532 478999999999999999999999 9999999999999974 568
Q ss_pred EEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCcc
Q 037275 829 AHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLT 907 (992)
Q Consensus 829 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~ 907 (992)
+|++|||.+........ .........++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+......
T Consensus 154 ~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~- 227 (342)
T cd07854 154 LKIGDFGLARIVDPHYS-----HKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ- 227 (342)
T ss_pred EEECCcccceecCCccc-----cccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-
Confidence 89999999986543211 1111122357889999997654 5688899999999999999999999976432111
Q ss_pred HHHHHhh-hCC-h-hHHHHHHhhHhHhhh--ccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 908 LHEFART-ALP-D-KVMEIVDSVLLLEVQ--ASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 908 ~~~~~~~-~~~-~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
....... ... . ......... ..... ....+.... ........++.+++.+||+.||++|||+.|++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 228 MQLILESVPVVREEDRNELLNVI-PSFVRNDGGEPRRPLR--DLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHHHHHhcCCCChHHhhhhhhhh-hhhhhhcccccCCCHH--HHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 1111110 000 0 011110000 00000 000000000 000112356889999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=257.97 Aligned_cols=200 Identities=24% Similarity=0.433 Sum_probs=171.3
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC--CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
+|...++||+|.||+||+|+..++++.||+|.++..+ ++......+|+.+++.++|.|||+++++ ...+....
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dv-----lhsdkklt 77 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV-----LHSDKKLT 77 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhh-----hccCceeE
Confidence 4666789999999999999999999999999997553 3445678899999999999999999998 44566779
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+|+|||. .+|..|...-.. .++...+..++.|+++||.++|++ ++.|||+||+|.++..+|..|++|||+|
T Consensus 78 lvfe~cd-qdlkkyfdslng-----~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfgla 148 (292)
T KOG0662|consen 78 LVFEFCD-QDLKKYFDSLNG-----DLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLA 148 (292)
T ss_pred EeHHHhh-HHHHHHHHhcCC-----cCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchh
Confidence 9999995 499999876544 488899999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCCC-cCcccchhhHHHHHHHHHh-CCCCCCCC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGE-ASMTGDVYSFGILLLEMFT-RRRPTDGM 901 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ellt-g~~pf~~~ 901 (992)
+.++-.. ......+-|..|++|.++.+.. |+...|+||.|||+.|+.. |++.|.+.
T Consensus 149 rafgipv--------rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~ 206 (292)
T KOG0662|consen 149 RAFGIPV--------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN 206 (292)
T ss_pred hhcCCce--------EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCC
Confidence 8765421 1222345789999999998864 8889999999999999998 88778774
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=283.11 Aligned_cols=201 Identities=28% Similarity=0.374 Sum_probs=175.8
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
.++|+..++||+|.||+|.+++.+.+++.||+|+++..- ++....-..|-++++..+||.+..+--. |+..+
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYs-----FQt~d 241 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYS-----FQTQD 241 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhh-----hccCc
Confidence 457889999999999999999999999999999997543 3344455778899999999998776543 67888
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
.+|+||||+.||.|.-++...+ .+++.....+...|+.||.|||++ +||.||+|.+|.++|.||++||+||
T Consensus 242 rlCFVMeyanGGeLf~HLsrer------~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDF 312 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSRER------VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDF 312 (516)
T ss_pred eEEEEEEEccCceEeeehhhhh------cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeec
Confidence 9999999999999999987644 578888888999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCC
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDG 900 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 900 (992)
|+++.-- ........++|||.|.|||++....|+.++|-|.+||++|||++|+.||..
T Consensus 313 GLCKE~I--------~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn 370 (516)
T KOG0690|consen 313 GLCKEEI--------KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN 370 (516)
T ss_pred ccchhcc--------cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc
Confidence 9997422 133345668999999999999999999999999999999999999999975
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=326.05 Aligned_cols=282 Identities=21% Similarity=0.213 Sum_probs=188.5
Q ss_pred HhcCCCCCCccccccceEEEEeEECCCC-eEEEEEEe--------------ec---cCCCchhHHHHHHHHHHhccCCcc
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLGENG-MMVAVKVI--------------NL---KQKGASNGFVAECQALRNIRHRNL 738 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~--------------~~---~~~~~~~~~~~E~~~l~~l~h~ni 738 (992)
..++|++.+.||+|+||+||+|..+... ..+++|.+ .. ........+.+|+.++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 4568999999999999999998764322 22222211 00 111233567899999999999999
Q ss_pred eeEEEEeecccccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCC
Q 037275 739 IKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKP 818 (992)
Q Consensus 739 v~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp 818 (992)
+++++++.. .+..++|+|++. +++.+++...... .........+..++.|++.||+|||++ +||||||||
T Consensus 226 v~l~~~~~~-----~~~~~lv~e~~~-~~l~~~l~~~~~~-~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP 295 (501)
T PHA03210 226 LKIEEILRS-----EANTYMITQKYD-FDLYSFMYDEAFD-WKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKL 295 (501)
T ss_pred CcEeEEEEE-----CCeeEEEEeccc-cCHHHHHhhcccc-ccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCH
Confidence 999999643 445689999984 5888877643321 111234566788999999999999999 999999999
Q ss_pred CCeeeCCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCC-
Q 037275 819 SNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP- 897 (992)
Q Consensus 819 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p- 897 (992)
+|||++.++.+||+|||+++.+.... ........||+.|+|||++.+..++.++|||||||++|||++|..+
T Consensus 296 ~NILl~~~~~vkL~DFGla~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 296 ENIFLNCDGKIVLGDFGTAMPFEKER-------EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred HHEEECCCCCEEEEeCCCceecCccc-------ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 99999999999999999998764321 1112235689999999999999999999999999999999998764
Q ss_pred CCCCcc-CCccHHHHHh------hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCC
Q 037275 898 TDGMFN-QGLTLHEFAR------TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERM 970 (992)
Q Consensus 898 f~~~~~-~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 970 (992)
+..... ....+.+... ..+++......+......+... ................+.+++.+||++||++||
T Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rp 446 (501)
T PHA03210 369 IGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHA--GHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRP 446 (501)
T ss_pred ccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccC--ccchhhHHHhcCCChHHHHHHHHHhccCcccCc
Confidence 433211 1111111111 1112211112211111111000 000000000011223567889999999999999
Q ss_pred CHHHHHH
Q 037275 971 EMRDVVA 977 (992)
Q Consensus 971 s~~evl~ 977 (992)
|+.|+++
T Consensus 447 sa~elL~ 453 (501)
T PHA03210 447 GAAELLA 453 (501)
T ss_pred CHHHHhh
Confidence 9999986
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=303.18 Aligned_cols=246 Identities=23% Similarity=0.327 Sum_probs=194.4
Q ss_pred CCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEEEEe
Q 037275 683 SSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEY 762 (992)
Q Consensus 683 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 762 (992)
...+||+|+||.||+|....+++.||+|.+..........+.+|+.+++.++|+|++++++++. ..+..++||||
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~ 98 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDELWVVMEF 98 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEE-----eCCEEEEEEec
Confidence 3468999999999999998899999999986544445567889999999999999999999854 34567999999
Q ss_pred ccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceecCC
Q 037275 763 MQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSS 842 (992)
Q Consensus 763 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 842 (992)
+++++|.+++... .+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||.+.....
T Consensus 99 ~~~~~L~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~ 168 (292)
T cd06657 99 LEGGALTDIVTHT-------RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 168 (292)
T ss_pred CCCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccc
Confidence 9999999987542 378899999999999999999999 999999999999999999999999999875543
Q ss_pred CCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCChhHHH
Q 037275 843 SPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKVME 922 (992)
Q Consensus 843 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 922 (992)
.. .......|++.|+|||.+.+..++.++||||+|+++|+|++|..||.+.... ..........+..
T Consensus 169 ~~--------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--~~~~~~~~~~~~~--- 235 (292)
T cd06657 169 EV--------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIRDNLPPK--- 235 (292)
T ss_pred cc--------ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhhCCcc---
Confidence 21 1122345788999999988888899999999999999999999998652111 0000000000000
Q ss_pred HHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 923 IVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
..........+.+++.+||+.+|.+||++.|+++
T Consensus 236 ---------------------~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 236 ---------------------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred ---------------------cCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 0000112345788999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=298.09 Aligned_cols=250 Identities=22% Similarity=0.335 Sum_probs=197.5
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC--CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
+|++.+.||+|+||.||+|....+|..||+|.+.... ....+.+.+|+.++++++|+||+++++++. .....+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~-----~~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQ-----ENGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheec-----cCCeEE
Confidence 4788899999999999999999899999999986542 234457789999999999999999999853 445679
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCC-cEEEeeccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDL-VAHLGDFGL 836 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~ 836 (992)
+|+||+++++|.+++..... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++ .+||+|||.
T Consensus 76 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~ 148 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQRG----VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGI 148 (257)
T ss_pred EEEecCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEeccccc
Confidence 99999999999999976432 2478999999999999999999999 999999999999998886 569999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhC
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTAL 916 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 916 (992)
+....... .......|++.|+|||+..+..++.++||||||+++|||++|+.||..... .+....
T Consensus 149 ~~~~~~~~--------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~-- 213 (257)
T cd08225 149 ARQLNDSM--------ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL-----HQLVLK-- 213 (257)
T ss_pred chhccCCc--------ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHH--
Confidence 87654321 111223578899999998888899999999999999999999999864211 111110
Q ss_pred ChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 917 PDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
... ... ... ......++.+++.+||..+|++|||++|+++
T Consensus 214 ------~~~----~~~-----~~~------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 214 ------ICQ----GYF-----API------SPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred ------Hhc----ccC-----CCC------CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 000 000 000 0112345889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=295.27 Aligned_cols=249 Identities=24% Similarity=0.317 Sum_probs=200.3
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
.+.|+..++||+||||.||-++.+.+|+.||.|.+.... +.......+|-.|+.+++.+.||.+--. ++..+
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYA-----feTkd 258 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYA-----FETKD 258 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeee-----ecCCC
Confidence 457888899999999999999999999999999885332 2334556889999999999999887655 56778
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
..|+|+..|.||+|.-+|.+... +.+++..+..++.+|+.||++||.. +||.||+||+|||+|+.|+++|+|.
T Consensus 259 ~LClVLtlMNGGDLkfHiyn~g~----~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDL 331 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYNHGN----PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDL 331 (591)
T ss_pred ceEEEEEeecCCceeEEeeccCC----CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeecc
Confidence 88999999999999999987663 3699999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
|+|..+.... ...+.+||.+|||||++....|+...|-||+||++|||+.|+.||....+..
T Consensus 332 GLAvei~~g~---------~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv--------- 393 (591)
T KOG0986|consen 332 GLAVEIPEGK---------PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV--------- 393 (591)
T ss_pred ceEEecCCCC---------ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh---------
Confidence 9999876432 2334579999999999999999999999999999999999999997532110
Q ss_pred hCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCH
Q 037275 915 ALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEM 972 (992)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 972 (992)
-.+.+|++...+. ....+...++..++....|+.||++|...
T Consensus 394 -----k~eEvdrr~~~~~-----------~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 394 -----KREEVDRRTLEDP-----------EEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred -----hHHHHHHHHhcch-----------hhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 0112222221111 01112234557788888999999999743
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=296.32 Aligned_cols=254 Identities=23% Similarity=0.311 Sum_probs=197.2
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC-----CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCc
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ-----KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 753 (992)
.+|++.+.||+|+||.||+|++..+++.||+|.+.... ......+.+|++++++++||||+++++++.+ ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~---~~~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRD---PEE 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEc---CCC
Confidence 47899999999999999999998899999999875321 2234578899999999999999999998643 223
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGD 833 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 833 (992)
...++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~~~------~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~d 149 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKAYG------ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGD 149 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECc
Confidence 45689999999999999987543 478889999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 913 (992)
||.++....... .........++..|+|||++.+..++.++|||||||++|++++|+.||......
T Consensus 150 fg~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------- 215 (264)
T cd06653 150 FGASKRIQTICM-----SGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM--------- 215 (264)
T ss_pred cccccccccccc-----cCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH---------
Confidence 999986532110 111112345889999999998888999999999999999999999998652111
Q ss_pred hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 914 TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
..+.. ...... . ..........+.+++.+||. +|..|||+.+++.
T Consensus 216 -------~~~~~-~~~~~~----~------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 216 -------AAIFK-IATQPT----K------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred -------HHHHH-HHcCCC----C------CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 00110 000000 0 00011234568899999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=307.01 Aligned_cols=289 Identities=22% Similarity=0.295 Sum_probs=200.6
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC--CchhHHHHHHHHHHhccCCcceeEEEEeecccc---cC
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK--GASNGFVAECQALRNIRHRNLIKIITICSSIDF---KG 752 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~ 752 (992)
.++|++.++||+|+||.||+|++..+++.||+|++..... .....+.+|++++++++||||+++++++..... ..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 4689999999999999999999998999999999864332 223457889999999999999999997654221 23
Q ss_pred cceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEe
Q 037275 753 VDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLG 832 (992)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 832 (992)
....++||||+.+ ++...+.... ..+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~-----~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~ 157 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS-----VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIA 157 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEC
Confidence 4567899999964 7777776432 2489999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCCCCCcc---cCCCCCcccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccH
Q 037275 833 DFGLAKFLSSSPLDTAVE---TPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTL 908 (992)
Q Consensus 833 Dfg~a~~~~~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~ 908 (992)
|||+++............ .........+++.|+|||.+.+. .++.++|||||||++|||++|++||.+..... ..
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~-~~ 236 (311)
T cd07866 158 DFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID-QL 236 (311)
T ss_pred cCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH-HH
Confidence 999998654332111100 11112334578889999987654 58899999999999999999999997643221 11
Q ss_pred HHHHhh-hC-ChhHHHHHHhhHhHhhhccCCCCCCccc-cchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 909 HEFART-AL-PDKVMEIVDSVLLLEVQASNSRSCGDER-LRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 909 ~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
...... .. ++......+.... .............. .........+.+++.+||+.||++|||+.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 237 HLIFKLCGTPTEETWPGWRSLPG-CEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHHhCCCChhhchhhhhccc-ccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 111110 00 0000000000000 00000000000000 000112356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=305.42 Aligned_cols=279 Identities=20% Similarity=0.190 Sum_probs=190.7
Q ss_pred CCccccccceEEEEeEECCCCeEEEEEEeecc--CCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEEEE
Q 037275 684 SNMIGQGSFGFVYKGNLGENGMMVAVKVINLK--QKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYE 761 (992)
Q Consensus 684 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 761 (992)
.+.+|.| |.||.++...+++.||+|++... .......+.+|+++++.++||||+++++++. .....+++||
T Consensus 7 ~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~-----~~~~~~~~~e 79 (314)
T cd08216 7 GKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI-----VDSELYVVSP 79 (314)
T ss_pred hHhhcCC--ceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheee-----cCCeEEEEEe
Confidence 3344444 45555555558999999998754 2344567899999999999999999999853 4456799999
Q ss_pred eccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceecC
Q 037275 762 YMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLS 841 (992)
Q Consensus 762 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 841 (992)
|+++|+|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+....
T Consensus 80 ~~~~~~l~~~l~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~ 152 (314)
T cd08216 80 LMAYGSCEDLLKTHFP----EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMI 152 (314)
T ss_pred ccCCCCHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeec
Confidence 9999999999986532 2478899999999999999999999 99999999999999999999999999987654
Q ss_pred CCCCCCCcccCCCCCcccccccccccccccCC--CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCChh
Q 037275 842 SSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG--EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDK 919 (992)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 919 (992)
........ .........++..|+|||++.+. .++.++|||||||++|||++|+.||.......... +......+..
T Consensus 153 ~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~-~~~~~~~~~~ 230 (314)
T cd08216 153 KHGKRQRV-VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLL-EKVRGTVPCL 230 (314)
T ss_pred cccccccc-cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhccCccc
Confidence 32211100 11122334577889999998763 58889999999999999999999997642221111 1111111100
Q ss_pred HHHHHHhhHhHhhhc------cCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 920 VMEIVDSVLLLEVQA------SNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 920 ~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
.....-+........ ..................++.+++.+||+.||++|||++|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 231 LDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred cccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000000000000000 00000000111112234578899999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=304.24 Aligned_cols=247 Identities=26% Similarity=0.367 Sum_probs=192.7
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC---CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK---GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
.|+..+.||+|+||.||+|++..++..||+|++..... .....+.+|++++++++|||++++++++.. ....
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~ 100 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR-----EHTA 100 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----CCeE
Confidence 36778899999999999999988899999999864322 233568889999999999999999998643 3456
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
++||||+. |++.+++.... ..+++.++..++.|++.|+.|||+. +|+||||+|+||+++.++.+||+|||.
T Consensus 101 ~lv~e~~~-g~l~~~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~ 171 (317)
T cd06635 101 WLVMEYCL-GSASDLLEVHK-----KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGS 171 (317)
T ss_pred EEEEeCCC-CCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCC
Confidence 99999996 58888776443 2489999999999999999999999 999999999999999999999999998
Q ss_pred ceecCCCCCCCCcccCCCCCccccccccccccccc---CCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGM---GGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 913 (992)
+...... ....+++.|+|||++. ++.++.++|||||||++|||++|+.||....... .
T Consensus 172 ~~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~------ 232 (317)
T cd06635 172 ASIASPA------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-A------ 232 (317)
T ss_pred ccccCCc------------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH-H------
Confidence 8654321 1235788999999873 4568899999999999999999999986521110 0
Q ss_pred hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 037275 914 TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKL 979 (992)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 979 (992)
...+.. ... ...........+.+++.+||+.+|++||++.|+++..
T Consensus 233 ------~~~~~~----~~~----------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 233 ------LYHIAQ----NES----------PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred ------HHHHHh----ccC----------CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 000000 000 0001112234588999999999999999999999754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=301.70 Aligned_cols=275 Identities=22% Similarity=0.315 Sum_probs=198.3
Q ss_pred CCCCCccccccceEEEEeEECCCCeEEEEEEeeccC--CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEE
Q 037275 681 FSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAI 758 (992)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 758 (992)
|++.+.||+|+||.||+|+...+++.||+|++.... ......+.+|+++++.++|||++++++++.... ....++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEE
Confidence 677889999999999999998889999999997553 334456889999999999999999999975421 356799
Q ss_pred EEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccce
Q 037275 759 VYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAK 838 (992)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 838 (992)
||||++ ++|.+++.... ..+++..++.++.|++.||+|||+. +++|+||+|+||++++++.+||+|||.+.
T Consensus 78 v~e~~~-~~l~~~~~~~~-----~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~ 148 (287)
T cd07840 78 VFEYMD-HDLTGLLDSPE-----VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLAR 148 (287)
T ss_pred Eecccc-ccHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEcccccee
Confidence 999997 48998887543 2589999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCCCCcccCCCCCcccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhC-
Q 037275 839 FLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTAL- 916 (992)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~- 916 (992)
....... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ...........
T Consensus 149 ~~~~~~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~-~~~~~~~~~~~~ 220 (287)
T cd07840 149 PYTKRNS-------ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL-EQLEKIFELCGS 220 (287)
T ss_pred eccCCCc-------ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCC
Confidence 7654321 11122346788999997765 45789999999999999999999999753321 11111111000
Q ss_pred --ChhHHHHHHhhHhHhhhccCCCCCCccccc-hHH-HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 917 --PDKVMEIVDSVLLLEVQASNSRSCGDERLR-TEE-RLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 917 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
+..+....+......... .......... ... ...++.+++.+||+.+|++||+++++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 221 PTDENWPGVSKLPWFENLKP--KKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred Cchhhccccccchhhhhccc--cccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000000000000000000 0000000000 001 2567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=288.71 Aligned_cols=274 Identities=22% Similarity=0.296 Sum_probs=203.5
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhcc--CC----cceeEEEEeeccccc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIR--HR----NLIKIITICSSIDFK 751 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~----niv~~~~~~~~~~~~ 751 (992)
.++|.+...+|+|.||.|-++.+.+++..||||+++.... ..+..+-|++++.++. .| -++.+.+| |.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~w-----Fd 161 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDW-----FD 161 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehh-----hh
Confidence 6799999999999999999999999999999999974332 3345567999999993 22 25666666 44
Q ss_pred CcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCC------
Q 037275 752 GVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQ------ 825 (992)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~------ 825 (992)
..++.|||+|.+ |-|+.+++..+... +++...+..+++|+++++++||+. +++|-|+||+||++.+
T Consensus 162 yrghiCivfell-G~S~~dFlk~N~y~----~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~ 233 (415)
T KOG0671|consen 162 YRGHICIVFELL-GLSTFDFLKENNYI----PFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKT 233 (415)
T ss_pred ccCceEEEEecc-ChhHHHHhccCCcc----ccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEE
Confidence 567789999988 66999999876543 789999999999999999999999 9999999999999831
Q ss_pred --------------CCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHH
Q 037275 826 --------------DLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEM 891 (992)
Q Consensus 826 --------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 891 (992)
...+|++|||.|++.... ....+.|..|+|||++.+-.++.++||||+|||++|+
T Consensus 234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----------hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~El 302 (415)
T KOG0671|consen 234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH-----------HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVEL 302 (415)
T ss_pred eccCCccceeccCCCcceEEEecCCcceeccC-----------cceeeeccccCCchheeccCcCCccCceeeeeEEEEe
Confidence 346899999999865432 2445789999999999999999999999999999999
Q ss_pred HhCCCCCCCCccCCccH--HHHHhhhCChhHHHHHHhh--H---hHhhhccC-----------CCCCCccccchHHHHHH
Q 037275 892 FTRRRPTDGMFNQGLTL--HEFARTALPDKVMEIVDSV--L---LLEVQASN-----------SRSCGDERLRTEERLVA 953 (992)
Q Consensus 892 ltg~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~--~---~~~~~~~~-----------~~~~~~~~~~~~~~~~~ 953 (992)
.||...|+.-.+. ..+ .+.+-..+|.....-.+.. . ..+.+... .+..........++..+
T Consensus 303 ytG~~LFqtHen~-EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~ 381 (415)
T KOG0671|consen 303 YTGETLFQTHENL-EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQ 381 (415)
T ss_pred eccceecccCCcH-HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhH
Confidence 9999999874422 122 2222223333322211000 0 00000000 00001112223456778
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHH
Q 037275 954 VVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 954 l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
+.+++.+||.+||.+|+|+.|++.
T Consensus 382 LfDLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 382 LFDLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred HHHHHHHHHccCccccccHHHHhc
Confidence 999999999999999999999975
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=308.74 Aligned_cols=280 Identities=20% Similarity=0.261 Sum_probs=198.0
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC--CCchhHHHHHHHHHHhccCCcceeEEEEeecccc-cCcc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHRNLIKIITICSSIDF-KGVD 754 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 754 (992)
.++|.+.+.||+|+||.||+|++..+|+.||+|++.... ......+.+|+.++++++||||+++++++..... ....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 378999999999999999999998889999999986432 2234567899999999999999999998754322 2234
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
.+++|+||+. .++..+.. ..+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+||
T Consensus 94 ~~~lv~e~~~-~~l~~~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~df 161 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG--------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDF 161 (342)
T ss_pred eEEEEecccc-cCHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeC
Confidence 5689999995 47776642 1478899999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 913 (992)
|+++.... ......++..|+|||++.+ ..++.++|||||||++|||++|+.||.+..... .+.....
T Consensus 162 g~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~~~~~~~ 229 (342)
T cd07879 162 GLARHADA-----------EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILK 229 (342)
T ss_pred CCCcCCCC-----------CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH
Confidence 99875421 1123457889999998876 468899999999999999999999997632111 1111111
Q ss_pred h-hCC-hhHHHHHHhhHhHhhhccCCCCCCccccc--hHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHHH
Q 037275 914 T-ALP-DKVMEIVDSVLLLEVQASNSRSCGDERLR--TEERLVAVVETGVVCSMESPTERMEMRDVVAK--LCRA 982 (992)
Q Consensus 914 ~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~ 982 (992)
. ..+ ....+............. .......... ......++.+++.+||+.||++||+++|++.. +++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 230 VTGVPGPEFVQKLEDKAAKSYIKS-LPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred hcCCCCHHHHHHhcccchHHHHhh-cCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 0 001 111111110000000000 0000000000 00123457899999999999999999999854 4444
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=309.25 Aligned_cols=283 Identities=20% Similarity=0.244 Sum_probs=204.7
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC--CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
+|++.+.||+|+||.||+|+...+++.||+|++.... ....+.+.+|+.+++.++||||+++.+++...........+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5889999999999999999998889999999986433 33456789999999999999999999987654433345679
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||++ ++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.++|+|||.+
T Consensus 81 lv~e~~~-~~l~~~l~~~~------~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~ 150 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ------PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLA 150 (330)
T ss_pred EEecchh-hhHHHHHhCCC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCce
Confidence 9999997 58988886543 589999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh-
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA- 915 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~- 915 (992)
......... ........++..|+|||++.+. .++.++||||+|+++|+|++|++||.+..... .........
T Consensus 151 ~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~ 224 (330)
T cd07834 151 RGVDPDEDE-----KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID-QLNLIVEVLG 224 (330)
T ss_pred Eeecccccc-----cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHhcC
Confidence 876543210 1112234578899999999887 78999999999999999999999997643211 111111100
Q ss_pred C-Chh-HHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 916 L-PDK-VMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 916 ~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
. +.. .......................-..........+.+++.+||+.+|++|||++++++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 225 TPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred CCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0 000 00000000000000000000000000001134568999999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=298.76 Aligned_cols=245 Identities=24% Similarity=0.330 Sum_probs=190.0
Q ss_pred cccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEEEEec
Q 037275 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYM 763 (992)
Q Consensus 687 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 763 (992)
||+|+||+||+|....+|+.||+|++.... ......+.+|+++++.++||||+++++++. ..+..++||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFE-----TKDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEe-----cCCeEEEEEecC
Confidence 699999999999998899999999986432 223445678999999999999999998853 445679999999
Q ss_pred cCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceecCCC
Q 037275 764 QNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSS 843 (992)
Q Consensus 764 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 843 (992)
++++|.+++..... ..+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||.+......
T Consensus 76 ~~~~L~~~l~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~ 148 (277)
T cd05577 76 NGGDLKYHIYNVGE----PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG 148 (277)
T ss_pred CCCcHHHHHHHcCc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC
Confidence 99999999976542 2589999999999999999999999 9999999999999999999999999998765421
Q ss_pred CCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCChhHHHH
Q 037275 844 PLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKVMEI 923 (992)
Q Consensus 844 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (992)
. ......++..|+|||++.+..++.++||||+||++|+|++|+.||....... .........
T Consensus 149 ~---------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~-------- 210 (277)
T cd05577 149 K---------KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV-EKEELKRRT-------- 210 (277)
T ss_pred C---------ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc-cHHHHHhcc--------
Confidence 1 1122347789999999988889999999999999999999999997532210 001100000
Q ss_pred HHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 037275 924 VDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERM-----EMRDVVA 977 (992)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 977 (992)
.... . .........+.+++.+||+.||++|| ++.+++.
T Consensus 211 ----~~~~------~------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 211 ----LEMA------V------EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred ----cccc------c------cCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 0000 0 00011234588999999999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=303.36 Aligned_cols=284 Identities=22% Similarity=0.312 Sum_probs=200.5
Q ss_pred HHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC--CCchhHHHHHHHHHHhccCCcceeEEEEeeccc----
Q 037275 676 KATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHRNLIKIITICSSID---- 749 (992)
Q Consensus 676 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 749 (992)
...++|++.+.||+|+||.||+|....+++.||+|+++... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 35678999999999999999999998889999999997543 223356788999999999999999999876533
Q ss_pred -ccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCc
Q 037275 750 -FKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLV 828 (992)
Q Consensus 750 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 828 (992)
..+....++|+||+++ ++.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~ 154 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGL-----VHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQ 154 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCc
Confidence 1223478999999975 7777776532 2489999999999999999999999 9999999999999999999
Q ss_pred EEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCcc
Q 037275 829 AHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLT 907 (992)
Q Consensus 829 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~ 907 (992)
+||+|||.+........ .......++..|+|||.+.+ ..++.++||||+||++|||++|++||...... ..
T Consensus 155 ~kl~dfg~~~~~~~~~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~-~~ 226 (302)
T cd07864 155 IKLADFGLARLYNSEES-------RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL-AQ 226 (302)
T ss_pred EEeCcccccccccCCcc-------cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HH
Confidence 99999999986643221 11112245778999998765 35788999999999999999999999753211 11
Q ss_pred HHHHHhh---hCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 908 LHEFART---ALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 908 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
+...... ..+..+..+............. .....-+.........+.+++.+||+.||++|||++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 227 LELISRLCGSPCPAVWPDVIKLPYFNTMKPKK-QYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HHHHHHHhCCCChhhccccccccccccccccc-ccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1111110 0111111100000000000000 0000000000112456899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=292.83 Aligned_cols=250 Identities=27% Similarity=0.381 Sum_probs=201.1
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEE
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIV 759 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 759 (992)
+|+..+.||+|++|.||+|....+++.+++|++..........+.+|++++++++||+++++++++.. ....+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLK-----KDELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----CCeEEEE
Confidence 47888999999999999999988899999999975554466789999999999999999999998643 3566999
Q ss_pred EEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccccee
Q 037275 760 YEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKF 839 (992)
Q Consensus 760 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 839 (992)
+||+++++|.+++.... ..+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||.+..
T Consensus 76 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~ 147 (253)
T cd05122 76 MEFCSGGSLKDLLKSTN-----QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQ 147 (253)
T ss_pred EecCCCCcHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccc
Confidence 99999999999997653 2589999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCChh
Q 037275 840 LSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDK 919 (992)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 919 (992)
...... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||......
T Consensus 148 ~~~~~~---------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------------- 203 (253)
T cd05122 148 LSDTKA---------RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM--------------- 203 (253)
T ss_pred cccccc---------ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH---------------
Confidence 653211 22345788999999998888999999999999999999999998753210
Q ss_pred HHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 920 VMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
........... .. ..........+.+++.+||+.||++|||+.|+++
T Consensus 204 --~~~~~~~~~~~-----~~----~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 204 --KALFKIATNGP-----PG----LRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred --HHHHHHHhcCC-----CC----cCcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00000000000 00 0000111356899999999999999999999985
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=306.54 Aligned_cols=278 Identities=23% Similarity=0.287 Sum_probs=199.2
Q ss_pred HHHHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc--CCCchhHHHHHHHHHHhccCCcceeEEEEeeccccc
Q 037275 674 LSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK--QKGASNGFVAECQALRNIRHRNLIKIITICSSIDFK 751 (992)
Q Consensus 674 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 751 (992)
+....++|++.+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|++++++++||||+++.+++..
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~---- 80 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFIS---- 80 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEec----
Confidence 345678999999999999999999999989999999987532 22334677899999999999999999998643
Q ss_pred CcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEE
Q 037275 752 GVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHL 831 (992)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 831 (992)
.....++||||+ +++|.++++.. .+++..+..++.|+++||+|||+. +|+||||+|+||++++++.+||
T Consensus 81 ~~~~~~lv~e~~-~~~L~~~~~~~-------~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l 149 (328)
T cd07856 81 PLEDIYFVTELL-GTDLHRLLTSR-------PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKI 149 (328)
T ss_pred CCCcEEEEeehh-ccCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEe
Confidence 234568999998 56999888642 377888889999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCCCCCcccCCCCCcccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHH
Q 037275 832 GDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHE 910 (992)
Q Consensus 832 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~ 910 (992)
+|||.+...... .....++..|+|||++.+ ..++.++||||+||++|+|++|+.||...... .....
T Consensus 150 ~dfg~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~-~~~~~ 217 (328)
T cd07856 150 CDFGLARIQDPQ-----------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV-NQFSI 217 (328)
T ss_pred CccccccccCCC-----------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHH
Confidence 999998754221 122356888999998765 56899999999999999999999999754211 00111
Q ss_pred HHh--hhCChhHHHH-HHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 911 FAR--TALPDKVMEI-VDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 911 ~~~--~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
... ...++++.+. .+.....-......................+.+++.+||+.+|++|||++|++..
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 218 ITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 110 0111111111 0000000000000000000000001123568899999999999999999999754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=304.37 Aligned_cols=258 Identities=22% Similarity=0.264 Sum_probs=191.3
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC-CchhHHHHHHHHHHhcc-CCcceeEEEEeecccccCcceEE
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK-GASNGFVAECQALRNIR-HRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
+|...+.||+|+||.||++.+..+++.||+|.+..... .....+.+|+.++.++. ||||+++++++.. ....+
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~-----~~~~~ 79 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR-----EGDCW 79 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec-----CCcEE
Confidence 55667899999999999999998999999999864332 33456889999999996 9999999998643 34568
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
++|||+. +++.++....... ....+++..+..++.|++.||+|||+.. +++||||||+||+++.++.+||+|||++
T Consensus 80 ~~~e~~~-~~l~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 155 (288)
T cd06616 80 ICMELMD-ISLDKFYKYVYEV-LKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGIS 155 (288)
T ss_pred EEEeccc-CCHHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchh
Confidence 9999985 4666554321110 1235899999999999999999999732 8999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCC---CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG---EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
....... ......|+..|+|||++.+. .++.++||||+||++|||++|+.||..... ..+.
T Consensus 156 ~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~--- 219 (288)
T cd06616 156 GQLVDSI---------AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS----VFDQ--- 219 (288)
T ss_pred HHhccCC---------ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch----HHHH---
Confidence 7654221 11223478899999998776 689999999999999999999999865310 0000
Q ss_pred hCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 915 ALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
+......... ... .........++.+++.+||+.||++|||++||++.
T Consensus 220 ---------~~~~~~~~~~-----~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 220 ---------LTQVVKGDPP-----ILS--NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred ---------HhhhcCCCCC-----cCC--CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000000 000 00001234568999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=298.32 Aligned_cols=273 Identities=23% Similarity=0.340 Sum_probs=200.0
Q ss_pred CCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC--CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEE
Q 037275 681 FSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK--GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAI 758 (992)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 758 (992)
|++.+.||+|++|.||+|....+++.+|+|.+..... .....+.+|++++++++||||+++++++. .....++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFR-----HKGDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhc-----cCCCEEE
Confidence 6778899999999999999988999999999864432 23567889999999999999999999854 3466799
Q ss_pred EEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccce
Q 037275 759 VYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAK 838 (992)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 838 (992)
||||+++ ++.+++.... ..+++..++.++.|++.||+|||+. +|+||||+|+||+++.++.+||+|||.+.
T Consensus 76 v~e~~~~-~l~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~ 146 (283)
T cd05118 76 VFEFMDT-DLYKLIKDRQ-----RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLAR 146 (283)
T ss_pred EEeccCC-CHHHHHHhhc-----ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeE
Confidence 9999965 8988887643 2589999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCCCCcccCCCCCcccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh---
Q 037275 839 FLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART--- 914 (992)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~--- 914 (992)
...... .......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||......+ ........
T Consensus 147 ~~~~~~--------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~~~~~~~~~ 217 (283)
T cd05118 147 SFGSPV--------RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID-QLFKIFRTLGT 217 (283)
T ss_pred ecCCCc--------ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCC
Confidence 765432 011223477889999998776 78999999999999999999999997643211 11111111
Q ss_pred hCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 915 ALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
..+.......+............ ..........+...++.+++.+||+.||.+||++.|++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 218 PDPEVWPKFTSLARNYKFSFPKK-AGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred CchHhcccchhhhhhhhhhhccc-cccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 01111111111000000000000 000000111234567899999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=306.79 Aligned_cols=282 Identities=20% Similarity=0.244 Sum_probs=202.5
Q ss_pred HHHHHHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC--CCchhHHHHHHHHHHhccCCcceeEEEEeeccc
Q 037275 672 AELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHRNLIKIITICSSID 749 (992)
Q Consensus 672 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 749 (992)
.++....++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.++++++||||+++.+++....
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 456667889999999999999999999998899999999986432 223456788999999999999999999875422
Q ss_pred -ccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCc
Q 037275 750 -FKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLV 828 (992)
Q Consensus 750 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 828 (992)
+......+++++++ +++|.+++... .+++..++.++.|+++||+|||+. +|+||||||+||++++++.
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~ 158 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKCQ-------KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCE 158 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCC
Confidence 22334567888887 78998887642 388999999999999999999999 9999999999999999999
Q ss_pred EEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCcc
Q 037275 829 AHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLT 907 (992)
Q Consensus 829 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~ 907 (992)
+||+|||++...... .....++..|+|||.+.+ ..++.++||||+||++|||++|+.||...... ..
T Consensus 159 ~kl~dfg~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~ 226 (345)
T cd07877 159 LKILDFGLARHTDDE-----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQ 226 (345)
T ss_pred EEEeccccccccccc-----------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HH
Confidence 999999998754321 123457889999998766 46888999999999999999999999653221 11
Q ss_pred HHHHHhhh--CChhHHHHHHhhHhHhhhc---cCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 908 LHEFARTA--LPDKVMEIVDSVLLLEVQA---SNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 908 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
........ .+......+.......+.. .......... ......++.+++.+|++.||.+|||+.|++..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 227 LKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV--FIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhh--cCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 11111111 1111111111000000000 0000000000 00123458899999999999999999998754
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=281.04 Aligned_cols=275 Identities=23% Similarity=0.337 Sum_probs=217.5
Q ss_pred HHHHHHHhcCCCCCCccccccceEEEEeEECCCC-----eEEEEEEeeccC-CCchhHHHHHHHHHHhccCCcceeEEEE
Q 037275 671 YAELSKATNDFSSSNMIGQGSFGFVYKGNLGENG-----MMVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIKIITI 744 (992)
Q Consensus 671 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~ 744 (992)
.+++.....+++....+.+|.||.||.|.+++.+ +.|-+|.++... +-....+..|.-.+....|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 4456666778888899999999999999876433 446677665332 3345667888888999999999999999
Q ss_pred eecccccCcceEEEEEEeccCCCHHHHHhhccc--chhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCee
Q 037275 745 CSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSED--QQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVL 822 (992)
Q Consensus 745 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIl 822 (992)
+.+ +....++++.++.-|+|..|+...+. ......++..+...++.|++.|++|||++ +|||.||..+|.+
T Consensus 356 ~ie----~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCv 428 (563)
T KOG1024|consen 356 SIE----DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCV 428 (563)
T ss_pred Eee----ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcce
Confidence 854 44556899999999999999984432 22356788899999999999999999999 9999999999999
Q ss_pred eCCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCC
Q 037275 823 LDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGM 901 (992)
Q Consensus 823 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~ 901 (992)
+|+..++||+|=.+++...+.++.-- ......+..||+||.+....|+.++|||||||++|||+| |+.||...
T Consensus 429 Idd~LqVkltDsaLSRDLFP~DYhcL------GDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeI 502 (563)
T KOG1024|consen 429 IDDQLQVKLTDSALSRDLFPGDYHCL------GDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEI 502 (563)
T ss_pred ehhheeEEeccchhccccCccccccc------CCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcccc
Confidence 99999999999999998876543222 222335788999999999999999999999999999999 99998652
Q ss_pred ccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 037275 902 FNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCR 981 (992)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 981 (992)
. |.+ +...+...+...++..|++ +++.+|.-||+.+|++||+++|++.-|.+
T Consensus 503 D--------------PfE----m~~ylkdGyRlaQP~NCPD----------eLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 503 D--------------PFE----MEHYLKDGYRLAQPFNCPD----------ELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred C--------------HHH----HHHHHhccceecCCCCCcH----------HHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 1 111 2223334454445555554 58999999999999999999999999888
Q ss_pred HHHhh
Q 037275 982 ARDTF 986 (992)
Q Consensus 982 ~~~~~ 986 (992)
...++
T Consensus 555 F~~ql 559 (563)
T KOG1024|consen 555 FHTQL 559 (563)
T ss_pred HHHHH
Confidence 76544
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=293.18 Aligned_cols=254 Identities=24% Similarity=0.375 Sum_probs=202.3
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC--CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK--GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
+|+..+.||+|++|.||+|....+++.|++|++..... ...+.+.+|++++++++||||+++++++.... ....+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence 47788999999999999999988899999999865442 34677899999999999999999999865321 25679
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||+++++|.+++.... .+++..++.++.|++.||+|||+. +++||||+|+||+++.++.++|+|||.+
T Consensus 78 lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~ 148 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKFG------KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCA 148 (260)
T ss_pred EEEEecCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccE
Confidence 9999999999999997653 589999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALP 917 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 917 (992)
......... .......++..|+|||...+..++.++||||||+++|+|++|..||....+. .....
T Consensus 149 ~~~~~~~~~------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~----- 214 (260)
T cd06606 149 KRLGDIETG------EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP---MAALY----- 214 (260)
T ss_pred Eeccccccc------ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch---HHHHH-----
Confidence 876543210 0122345788999999998888999999999999999999999999764311 00000
Q ss_pred hhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 918 DKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.... .. .... ........+.+++.+|++.+|++||++.|++.
T Consensus 215 ----~~~~----~~----~~~~------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 215 ----KIGS----SG----EPPE------IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred ----hccc----cC----CCcC------CCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 0000 00 0000 01112456899999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=293.38 Aligned_cols=250 Identities=25% Similarity=0.322 Sum_probs=200.6
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC--CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
+|++.++||+|+||.||+++...+++.+|+|.+.... ......+.+|++++++++||||+++.+++. +....+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFL-----DGNKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhc-----cCCEEE
Confidence 5788999999999999999998899999999986433 233456788999999999999999998853 346779
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||+++++|.+++...... ...+++..++.++.|++.||+|||+. +++||||+|+||+++.++.+||+|||.+
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~ 150 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKK--RKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGIS 150 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccch
Confidence 999999999999999764321 34689999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALP 917 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 917 (992)
...... ......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...... +
T Consensus 151 ~~~~~~----------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-----~------- 208 (256)
T cd08530 151 KVLKKN----------MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-----D------- 208 (256)
T ss_pred hhhccC----------CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----H-------
Confidence 876542 111234788999999999889999999999999999999999999753211 0
Q ss_pred hhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 918 DKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.......... . ........++.+++.+|++.+|++|||+.|+++
T Consensus 209 -----~~~~~~~~~~-----~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 209 -----LRYKVQRGKY-----P------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred -----HHHHHhcCCC-----C------CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000000000 0 001123456899999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=293.42 Aligned_cols=252 Identities=25% Similarity=0.414 Sum_probs=202.0
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC--CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK--GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
+|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+++++.++|||++++.+.+.. ....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~-----~~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE-----KGKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec-----CCEEE
Confidence 57888999999999999999988899999999975433 455678899999999999999999998543 36779
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+|+||+++++|.+++..... ....+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+
T Consensus 76 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~ 150 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKK--EGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGIS 150 (258)
T ss_pred EEEEecCCCcHHHHHHHhhc--cCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccce
Confidence 99999999999999987532 124689999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALP 917 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 917 (992)
....... .......|++.|+|||...+..++.++||||+|+++|+|++|+.||..... .+
T Consensus 151 ~~~~~~~--------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~------- 210 (258)
T cd08215 151 KVLSSTV--------DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL-----LE------- 210 (258)
T ss_pred eecccCc--------ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH-----HH-------
Confidence 8664321 112224578899999998888899999999999999999999999865321 11
Q ss_pred hhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 918 DKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.......... ...+ .....++.+++.+||..+|++|||+.|+++
T Consensus 211 -----~~~~~~~~~~-----~~~~------~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 211 -----LALKILKGQY-----PPIP------SQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred -----HHHHHhcCCC-----CCCC------CCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1111110000 0000 012345889999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=291.63 Aligned_cols=243 Identities=26% Similarity=0.338 Sum_probs=192.3
Q ss_pred cccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEEEEec
Q 037275 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYM 763 (992)
Q Consensus 687 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 763 (992)
||.|+||.||+|++..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++. ++...++||||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFK-----DKKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEE-----cCCccEEEEecC
Confidence 699999999999998889999999986432 234467899999999999999999999854 445679999999
Q ss_pred cCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceecCCC
Q 037275 764 QNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSS 843 (992)
Q Consensus 764 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 843 (992)
++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+......
T Consensus 76 ~~~~L~~~l~~~~------~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~ 146 (262)
T cd05572 76 LGGELWTILRDRG------LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG 146 (262)
T ss_pred CCCcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc
Confidence 9999999997643 378999999999999999999999 9999999999999999999999999999866432
Q ss_pred CCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCChhHHHH
Q 037275 844 PLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKVMEI 923 (992)
Q Consensus 844 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (992)
. ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||....... .+.
T Consensus 147 ~---------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---------------~~~ 202 (262)
T cd05572 147 Q---------KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP---------------MEI 202 (262)
T ss_pred c---------ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH---------------HHH
Confidence 1 1122357889999999888889999999999999999999999997643210 011
Q ss_pred HHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 037275 924 VDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERME-----MRDVVA 977 (992)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 977 (992)
......... ....+ ......+.+++.+||+.+|++||+ ++|+++
T Consensus 203 ~~~~~~~~~----~~~~~------~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 203 YNDILKGNG----KLEFP------NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHhccCC----CCCCC------cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 111110000 00000 011356899999999999999999 777765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=305.76 Aligned_cols=280 Identities=20% Similarity=0.241 Sum_probs=200.1
Q ss_pred HHHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC--CCchhHHHHHHHHHHhccCCcceeEEEEeecccc-c
Q 037275 675 SKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHRNLIKIITICSSIDF-K 751 (992)
Q Consensus 675 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~ 751 (992)
....++|++.+.||+|+||.||+|....+++.||||++.... ......+.+|++++++++||||+++++++..... .
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 345678999999999999999999998899999999985332 2223567899999999999999999998754221 1
Q ss_pred CcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEE
Q 037275 752 GVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHL 831 (992)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 831 (992)
.....++||||+ +++|.+++... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~~-------~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl 159 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKHE-------KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKI 159 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEE
Confidence 223568999999 77999888632 488999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCCCCCcccCCCCCcccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHH
Q 037275 832 GDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHE 910 (992)
Q Consensus 832 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~ 910 (992)
+|||.+...... .....+++.|+|||.+.+ ..++.++||||+||++|++++|+.||.+..... ....
T Consensus 160 ~dfg~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~-~~~~ 227 (343)
T cd07880 160 LDFGLARQTDSE-----------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD-QLME 227 (343)
T ss_pred eecccccccccC-----------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH
Confidence 999998754321 122357889999998876 458889999999999999999999997532211 1111
Q ss_pred HHhh--hCChhHHHHHHhhHhHhhhccCCCCCCcc-ccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 911 FART--ALPDKVMEIVDSVLLLEVQASNSRSCGDE-RLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 911 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.... ..+..+...+.......+........... ..........+.+++.+|++.||++|||+.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 228 IMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1110 01111111111100000000000000000 0000122345889999999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=294.17 Aligned_cols=242 Identities=23% Similarity=0.286 Sum_probs=183.1
Q ss_pred ccccccceEEEEeEECCCCeEEEEEEeeccCCC---chhHHHHHHH---HHHhccCCcceeEEEEeecccccCcceEEEE
Q 037275 686 MIGQGSFGFVYKGNLGENGMMVAVKVINLKQKG---ASNGFVAECQ---ALRNIRHRNLIKIITICSSIDFKGVDFQAIV 759 (992)
Q Consensus 686 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~---~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 759 (992)
+||+|+||.||+|....+++.||+|.+...... ....+..|.. .++...||+|+++.+++. .....++|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH-----TPDKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeee-----cCCEEEEE
Confidence 489999999999999888999999998643211 1122334443 344457999999998853 44567999
Q ss_pred EEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccccee
Q 037275 760 YEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKF 839 (992)
Q Consensus 760 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 839 (992)
|||+.+|+|.+++.... .+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||.+..
T Consensus 76 ~e~~~g~~L~~~l~~~~------~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~ 146 (278)
T cd05606 76 LDLMNGGDLHYHLSQHG------VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 146 (278)
T ss_pred EecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccc
Confidence 99999999999886532 589999999999999999999999 999999999999999999999999999875
Q ss_pred cCCCCCCCCcccCCCCCcccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCCh
Q 037275 840 LSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPD 918 (992)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 918 (992)
..... .....|+..|+|||++.++ .++.++||||+||++|||++|+.||........ ...
T Consensus 147 ~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~--~~~------- 207 (278)
T cd05606 147 FSKKK----------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEI------- 207 (278)
T ss_pred cCccC----------CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch--HHH-------
Confidence 43211 1223588999999998754 688999999999999999999999976322111 000
Q ss_pred hHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 037275 919 KVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERM-----EMRDVVA 977 (992)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 977 (992)
...... .. ...+ .....++.+++.+|+..+|++|| +++|+++
T Consensus 208 ------~~~~~~-~~----~~~~------~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 208 ------DRMTLT-MA----VELP------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred ------HHHhhc-cC----CCCC------CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 000000 00 0000 01134688999999999999999 9999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=302.85 Aligned_cols=281 Identities=22% Similarity=0.270 Sum_probs=197.0
Q ss_pred CCCCCCccccccceEEEEeEECCC--CeEEEEEEeeccC--CCchhHHHHHHHHHHhc-cCCcceeEEEEeecccccCcc
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGEN--GMMVAVKVINLKQ--KGASNGFVAECQALRNI-RHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 754 (992)
+|++.+.||+|+||.||+|+...+ +..||+|.+.... ......+.+|+.+++++ +||||+++++++.... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence 477889999999999999999877 8899999986322 22345678899999999 5999999999754321 2334
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
..++++||+. ++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Df 149 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQ------PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDF 149 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcC
Confidence 5688999985 69999886433 588999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 913 (992)
|.++........ .........|+..|+|||++.+ ..++.++||||+||++|++++|++||....... .......
T Consensus 150 g~a~~~~~~~~~----~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~-~~~~~~~ 224 (332)
T cd07857 150 GLARGFSENPGE----NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD-QLNQILQ 224 (332)
T ss_pred CCceeccccccc----ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH-HHHHHHH
Confidence 999866532211 1112234568999999998765 468899999999999999999999987532111 1111111
Q ss_pred hh-CC-h-hHHHHHHhhHhHhhhc-cCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 914 TA-LP-D-KVMEIVDSVLLLEVQA-SNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 914 ~~-~~-~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.. .+ . ....+........... ......... .........+.+++.+|++.||++|||++|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 225 VLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HhCCCCHHHHHhhhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 10 01 1 1111111100000000 000000000 000112356889999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=291.45 Aligned_cols=248 Identities=27% Similarity=0.407 Sum_probs=199.4
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC--CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK--GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
+|++.+.||+|++|.||+|+...+++.||+|.+..... .....+.+|++++++++|||++++++++. .....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIE-----TSDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEE-----eCCEEE
Confidence 57888999999999999999988899999999975543 34567899999999999999999999864 345679
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||+++++|.+++.... .+++..++.++.|++.|+.|||+. +|+||||+|+||+++.++.++|+|||.+
T Consensus 76 ~v~e~~~~~~L~~~~~~~~------~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~ 146 (254)
T cd06627 76 IILEYAENGSLRQIIKKFG------PFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVA 146 (254)
T ss_pred EEEecCCCCcHHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccc
Confidence 9999999999999997642 589999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALP 917 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 917 (992)
........ ......++..|+|||...+..++.++||||+|+++|+|++|+.||...... ...
T Consensus 147 ~~~~~~~~--------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~----~~~------ 208 (254)
T cd06627 147 TKLNDVSK--------DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM----AAL------ 208 (254)
T ss_pred eecCCCcc--------cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH----HHH------
Confidence 87654321 112345788999999988888899999999999999999999998642210 000
Q ss_pred hhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 918 DKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
... ..... ... .......+.+++.+||..+|++|||+.|++.
T Consensus 209 ------~~~-~~~~~-----~~~------~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 209 ------FRI-VQDDH-----PPL------PEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred ------HHH-hccCC-----CCC------CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 000 00000 000 0112345889999999999999999999974
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=298.91 Aligned_cols=245 Identities=26% Similarity=0.362 Sum_probs=190.5
Q ss_pred CCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC---CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 681 FSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK---GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
|...++||+|+||+||+|+...+++.||+|++..... .....+.+|+++++.++|||++++++++.+ ....+
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 97 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK-----EHTAW 97 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCEEE
Confidence 6667889999999999999988999999999864332 223567889999999999999999999643 45569
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||+. |++.+++.... ..+++.+++.++.|++.|++|||+. +++||||+|+||+++.++.+||+|||.+
T Consensus 98 lv~e~~~-~~l~~~l~~~~-----~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~ 168 (313)
T cd06633 98 LVMEYCL-GSASDLLEVHK-----KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSA 168 (313)
T ss_pred EEEecCC-CCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCC
Confidence 9999995 68888876543 2489999999999999999999999 9999999999999999999999999988
Q ss_pred eecCCCCCCCCcccCCCCCccccccccccccccc---CCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGM---GGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
..... .....|+..|+|||++. ...++.++|||||||++|+|++|..||....... ..
T Consensus 169 ~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~----~~--- 229 (313)
T cd06633 169 SKSSP------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----AL--- 229 (313)
T ss_pred cccCC------------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH----HH---
Confidence 64221 12345788999999874 4568889999999999999999999986531110 00
Q ss_pred hCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 915 ALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
........ .. .........+.+++.+||+.+|++||++.+++..
T Consensus 230 ----------~~~~~~~~-----~~-----~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 230 ----------YHIAQNDS-----PT-----LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ----------HHHHhcCC-----CC-----CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000 00 0001122357889999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=296.47 Aligned_cols=252 Identities=26% Similarity=0.355 Sum_probs=193.3
Q ss_pred cccccceEEEEeEECCCCeEEEEEEeeccCC---CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEEEEec
Q 037275 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQK---GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYM 763 (992)
Q Consensus 687 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 763 (992)
||+|+||.||+|++..+++.||+|++..... .....+.+|++++++++||||+++++.+ ......++||||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-----QGKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-----ecCcEEEEEEecC
Confidence 6899999999999988899999999864432 3456788999999999999999998874 3456779999999
Q ss_pred cCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceecCCC
Q 037275 764 QNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSS 843 (992)
Q Consensus 764 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 843 (992)
++++|.+++.... .+++..+..++.|+++||+|||+. +++||||+|+||++++++.++|+|||++......
T Consensus 76 ~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~ 146 (265)
T cd05579 76 PGGDLASLLENVG------SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVR 146 (265)
T ss_pred CCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccC
Confidence 9999999997643 489999999999999999999999 9999999999999999999999999998764432
Q ss_pred CCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCChhHHHH
Q 037275 844 PLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKVMEI 923 (992)
Q Consensus 844 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (992)
................++..|+|||...+..++.++||||||+++|++++|+.||...... +.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----------------~~ 209 (265)
T cd05579 147 RQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE-----------------EI 209 (265)
T ss_pred cccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-----------------HH
Confidence 1110000011223345788999999998888999999999999999999999998753211 11
Q ss_pred HHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 037275 924 VDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKL 979 (992)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 979 (992)
.......... ..........+.+++.+||+.+|++|||+.++.+.|
T Consensus 210 ~~~~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 210 FQNILNGKIE----------WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred HHHHhcCCcC----------CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 1111100000 000001245688999999999999999995555444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=292.18 Aligned_cols=244 Identities=23% Similarity=0.290 Sum_probs=185.7
Q ss_pred CccccccceEEEEeEECCCCeEEEEEEeeccCC---CchhHHHHHHHHH-HhccCCcceeEEEEeecccccCcceEEEEE
Q 037275 685 NMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK---GASNGFVAECQAL-RNIRHRNLIKIITICSSIDFKGVDFQAIVY 760 (992)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 760 (992)
+.||+|+||.||+|....+++.||+|+++.... .....+..|..++ ...+|||++++++++. ..+..++||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ-----SKDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEE-----cCCeEEEEE
Confidence 579999999999999988899999999864322 1223344555444 4458999999999864 345679999
Q ss_pred EeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceec
Q 037275 761 EYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFL 840 (992)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 840 (992)
||+++++|.+++.... .+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||.+...
T Consensus 77 e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 147 (260)
T cd05611 77 EYLNGGDCASLIKTLG------GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNG 147 (260)
T ss_pred eccCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceec
Confidence 9999999999997543 478999999999999999999999 9999999999999999999999999998754
Q ss_pred CCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCChhH
Q 037275 841 SSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKV 920 (992)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 920 (992)
.. .....++..|+|||.+.+..++.++||||+|+++|+|++|..||...... .
T Consensus 148 ~~------------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~---------- 200 (260)
T cd05611 148 LE------------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-----A---------- 200 (260)
T ss_pred cc------------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-----H----------
Confidence 32 12235788999999998888899999999999999999999999653211 0
Q ss_pred HHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 037275 921 MEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKL 979 (992)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 979 (992)
........... .. ..........+.+++.+||+.+|++||++.++.+.+
T Consensus 201 --~~~~~~~~~~~------~~--~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 201 --VFDNILSRRIN------WP--EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred --HHHHHHhcccC------CC--CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 01110000000 00 000012345689999999999999999886665443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=303.29 Aligned_cols=280 Identities=20% Similarity=0.298 Sum_probs=195.0
Q ss_pred cCCCC-CCccccccceEEEEeEECCCCeEEEEEEeeccCCCc--------------hhHHHHHHHHHHhccCCcceeEEE
Q 037275 679 NDFSS-SNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGA--------------SNGFVAECQALRNIRHRNLIKIIT 743 (992)
Q Consensus 679 ~~~~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~~~~ 743 (992)
++|.. .+.||+|+||+||+|.+..+++.||||+++...... ...+.+|+++++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45654 577999999999999998899999999986432211 124778999999999999999999
Q ss_pred EeecccccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeee
Q 037275 744 ICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLL 823 (992)
Q Consensus 744 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 823 (992)
++. .....++||||+. |+|.+++.... .+++..+..++.|++.||+|||+. +|+||||+|+||++
T Consensus 88 ~~~-----~~~~~~lv~e~~~-~~l~~~l~~~~------~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill 152 (335)
T PTZ00024 88 VYV-----EGDFINLVMDIMA-SDLKKVVDRKI------RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFI 152 (335)
T ss_pred EEe-----cCCcEEEEEeccc-cCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEE
Confidence 864 3456799999996 69999986532 488999999999999999999999 99999999999999
Q ss_pred CCCCcEEEeecccceecCCCCCCCCc------ccCCCCCcccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCC
Q 037275 824 DQDLVAHLGDFGLAKFLSSSPLDTAV------ETPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRRR 896 (992)
Q Consensus 824 ~~~~~~kl~Dfg~a~~~~~~~~~~~~------~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~ 896 (992)
+.++.+||+|||.+............ ..........++..|+|||.+.+. .++.++||||+||++|||++|+.
T Consensus 153 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~ 232 (335)
T PTZ00024 153 NSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232 (335)
T ss_pred CCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 99999999999999876522111000 001111223468889999988764 46889999999999999999999
Q ss_pred CCCCCccCCccHHHHHhhh---CChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHH
Q 037275 897 PTDGMFNQGLTLHEFARTA---LPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMR 973 (992)
Q Consensus 897 pf~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 973 (992)
||.+..+.+ .+....... .+..+...........+..... ............++.+++.+||+.+|++|||++
T Consensus 233 p~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~ 308 (335)
T PTZ00024 233 LFPGENEID-QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKP---KDLKTIFPNASDDAIDLLQSLLKLNPLERISAK 308 (335)
T ss_pred CCCCCCHHH-HHHHHHHHhCCCchhhCcchhhcccccccCcCCc---ccHHHhCcCCChHHHHHHHHHcCCCchhccCHH
Confidence 997643221 111111100 0000000000000000000000 000000011235688999999999999999999
Q ss_pred HHHH
Q 037275 974 DVVA 977 (992)
Q Consensus 974 evl~ 977 (992)
|++.
T Consensus 309 ~~l~ 312 (335)
T PTZ00024 309 EALK 312 (335)
T ss_pred HHhc
Confidence 9985
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=294.30 Aligned_cols=242 Identities=24% Similarity=0.369 Sum_probs=192.1
Q ss_pred CCccccccceEEEEeEECCCCeEEEEEEeecc--CCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEEEE
Q 037275 684 SNMIGQGSFGFVYKGNLGENGMMVAVKVINLK--QKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYE 761 (992)
Q Consensus 684 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 761 (992)
.++||+|.||+||-|+++.+|+.||||++.+. .......+.+|+.|++.++||.||.+.-. ++..+.+++|||
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M-----~ET~ervFVVME 643 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECM-----FETPERVFVVME 643 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEe-----ecCCceEEEEeh
Confidence 37999999999999999999999999999643 23445778999999999999999999877 456677899999
Q ss_pred eccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCC---CcEEEeecccce
Q 037275 762 YMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQD---LVAHLGDFGLAK 838 (992)
Q Consensus 762 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfg~a~ 838 (992)
.+ .|+..+.+-.... ..+++.....++.||+.||.|||.+ +|||.|+||+|||+... -++||||||+|+
T Consensus 644 Kl-~GDMLEMILSsEk----gRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfAR 715 (888)
T KOG4236|consen 644 KL-HGDMLEMILSSEK----GRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFAR 715 (888)
T ss_pred hh-cchHHHHHHHhhc----ccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeecccccee
Confidence 99 5576666654432 2588888888999999999999999 99999999999999654 389999999999
Q ss_pred ecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh---
Q 037275 839 FLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA--- 915 (992)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~--- 915 (992)
+++... .....+||+.|.|||++..+.|...-|+||.|||+|.-++|..||....+ +.+.+..+
T Consensus 716 iIgEks---------FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd----IndQIQNAaFM 782 (888)
T KOG4236|consen 716 IIGEKS---------FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED----INDQIQNAAFM 782 (888)
T ss_pred ecchhh---------hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc----hhHHhhccccc
Confidence 987543 33456899999999999999999999999999999999999999975322 22211111
Q ss_pred CChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 916 LPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
+|.. ...+.....+++|...|+..-++|.|.++.+.
T Consensus 783 yPp~--------------------------PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 783 YPPN--------------------------PWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred cCCC--------------------------chhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 1111 11223344677788888888888888876553
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=299.91 Aligned_cols=248 Identities=26% Similarity=0.362 Sum_probs=192.4
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
..|+..+.||+|+||.||+|+...+++.||+|.+.... .....++.+|+++++.++|+|++++.+++.. ...
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 89 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHT 89 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc-----CCe
Confidence 34777889999999999999998889999999986432 2234567889999999999999999998643 355
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++||||+. |++.+++..... .+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||
T Consensus 90 ~~lv~e~~~-~~l~~~~~~~~~-----~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg 160 (308)
T cd06634 90 AWLVMEYCL-GSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG 160 (308)
T ss_pred eEEEEEccC-CCHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcc
Confidence 699999996 688887764332 488999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCccccccccccccccc---CCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHH
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGM---GGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFA 912 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~ 912 (992)
.+...... ....+++.|+|||.+. ...++.++|||||||++|+|++|..||....... ......
T Consensus 161 ~~~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~ 227 (308)
T cd06634 161 SASIMAPA------------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIA 227 (308)
T ss_pred cceeecCc------------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-HHHHHh
Confidence 98765321 1234788999999874 3567889999999999999999999986521110 000000
Q ss_pred hhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 037275 913 RTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKL 979 (992)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 979 (992)
. ... ...........+.+++.+||+.+|++||+++++++.-
T Consensus 228 ~----------------~~~----------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 228 Q----------------NES----------PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred h----------------cCC----------CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 0 000 0000112235588999999999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=296.91 Aligned_cols=272 Identities=23% Similarity=0.295 Sum_probs=195.3
Q ss_pred CCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC-CchhHHHHHHHHHHhcc-CCcceeEEEEeecccccCcceEEE
Q 037275 681 FSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK-GASNGFVAECQALRNIR-HRNLIKIITICSSIDFKGVDFQAI 758 (992)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l 758 (992)
|++.+.||+|+||+||+|+...+++.||+|.+..... .......+|+..+++++ |||++++++++. .....++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~-----~~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFR-----ENDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhh-----cCCcEEE
Confidence 6778999999999999999988899999999864322 22234567999999998 999999999854 3566799
Q ss_pred EEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccce
Q 037275 759 VYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAK 838 (992)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 838 (992)
||||+ +|+|.+++..... ..+++..+..++.|++.||+|||++ +++|+||+|+||++++++.++|+|||.+.
T Consensus 76 v~e~~-~~~l~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~ 147 (283)
T cd07830 76 VFEYM-EGNLYQLMKDRKG----KPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAR 147 (283)
T ss_pred EEecC-CCCHHHHHHhccc----ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccce
Confidence 99999 8899999876541 2589999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCCCCcccCCCCCcccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh---h
Q 037275 839 FLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR---T 914 (992)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~---~ 914 (992)
...... ......++..|+|||++.+ ..++.++||||||+++|||++|++||......+. ...... .
T Consensus 148 ~~~~~~---------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~-~~~~~~~~~~ 217 (283)
T cd07830 148 EIRSRP---------PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQ-LYKICSVLGT 217 (283)
T ss_pred eccCCC---------CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHH-HHHHHHhcCC
Confidence 654321 1122357889999998754 4678999999999999999999999976422111 111110 0
Q ss_pred hCChhHHHHHHhhHhHhhhccCCCCC-CccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 915 ALPDKVMEIVDSVLLLEVQASNSRSC-GDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
...+.+.+..... ........... ............++.+++.+||+.+|++|||++|++.
T Consensus 218 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 218 PTKQDWPEGYKLA--SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred CChhhhhhHhhhh--ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0010010000000 00000000000 0000000111356889999999999999999999975
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=294.73 Aligned_cols=273 Identities=23% Similarity=0.337 Sum_probs=198.2
Q ss_pred CCCCCccccccceEEEEeEECCCCeEEEEEEeeccC--CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEE
Q 037275 681 FSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAI 758 (992)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 758 (992)
|+..+.||+|+||.||+|+...+++.||+|++.... ......+.+|+.++++++|+|++++.+++. +....++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIH-----TERKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhh-----cCCceEE
Confidence 567789999999999999999889999999997543 333467788999999999999999999854 3456799
Q ss_pred EEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccce
Q 037275 759 VYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAK 838 (992)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 838 (992)
||||++ ++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||+|+||++++++.+||+|||.+.
T Consensus 76 v~e~~~-~~l~~~i~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~ 146 (282)
T cd07829 76 VFEYCD-MDLKKYLDKRP-----GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLAR 146 (282)
T ss_pred EecCcC-cCHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCccc
Confidence 999997 59999998653 2489999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCCCCcccCCCCCcccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh-C
Q 037275 839 FLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA-L 916 (992)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~-~ 916 (992)
....... ......++..|+|||.+.+. .++.++|||||||++||+++|++||....... .+....... .
T Consensus 147 ~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~-~~~~~~~~~~~ 217 (282)
T cd07829 147 AFGIPLR--------TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID-QLFKIFQILGT 217 (282)
T ss_pred ccCCCcc--------ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHH-HHHHHHHHhCC
Confidence 6543211 11223457789999998776 78999999999999999999999997632211 111111100 0
Q ss_pred C-hhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 917 P-DKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 917 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
+ +........................ ..........+.+++.+||+.||++||++.|++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 218 PTEESWPGVTKLPDYKPTFPKFPPKDL-EKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred CcHHHHHhhcccccccccccccCccch-HHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0 0000000000000000000000000 0000112456899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=304.30 Aligned_cols=266 Identities=23% Similarity=0.320 Sum_probs=217.7
Q ss_pred cHHHHHHHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhc-cCCcceeEEEEeecc
Q 037275 670 SYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNI-RHRNLIKIITICSSI 748 (992)
Q Consensus 670 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 748 (992)
.++.+...++.|++.++||.|.+|.||+++...+++.+|+|+..... ...+++..|..+++.. .|||++.++|++.-.
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 34455566778999999999999999999999999999999986443 3456678889999888 699999999999887
Q ss_pred cccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCc
Q 037275 749 DFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLV 828 (992)
Q Consensus 749 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 828 (992)
+...++.+|+|||||.+||.-|+++.... ..+.|..+.-|++.++.|+.|||.. .++|||||-.||+++.++.
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g----~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~ 161 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKG----NRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAE 161 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhcc----cchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCc
Confidence 77888999999999999999999998763 4689999999999999999999999 9999999999999999999
Q ss_pred EEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccC-----CCcCcccchhhHHHHHHHHHhCCCCCCCCcc
Q 037275 829 AHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-----GEASMTGDVYSFGILLLEMFTRRRPTDGMFN 903 (992)
Q Consensus 829 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 903 (992)
||++|||.+..... +.......+||+.|||||++.- ..|+.++|+||+|++..||.-|.+|+.++..
T Consensus 162 VKLvDFGvSaQlds--------T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP 233 (953)
T KOG0587|consen 162 VKLVDFGVSAQLDS--------TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP 233 (953)
T ss_pred EEEeeeeeeeeeec--------ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch
Confidence 99999999987764 3344455689999999999854 3577899999999999999999999876422
Q ss_pred CCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 904 QGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.. .-+. .++..+.-......-.+++.++|..||..|-++||++.++++
T Consensus 234 mr---aLF~-----------------------IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 234 MR---ALFL-----------------------IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred hh---hhcc-----------------------CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 10 0000 011111112222333567999999999999999999999875
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=296.99 Aligned_cols=253 Identities=24% Similarity=0.321 Sum_probs=191.1
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC-CchhHHHHHHHHHHhc-cCCcceeEEEEeecccccCcce
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK-GASNGFVAECQALRNI-RHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 755 (992)
.++|++.+.||+|+||.||+|.+..+++.||||.++.... .....+.+|+.++.+. .||||+++++++.+ ...
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~~ 88 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT-----DSD 88 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec-----CCe
Confidence 4578899999999999999999987899999999964432 2344566777777666 49999999999643 445
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHH-HCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
.++||||+. +++.+++..... .+++..+..++.|++.|++|||+ . +|+||||+|+||++++++.+||+||
T Consensus 89 ~~~v~e~~~-~~l~~l~~~~~~-----~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~df 159 (296)
T cd06618 89 VFICMELMS-TCLDKLLKRIQG-----PIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDF 159 (296)
T ss_pred EEEEeeccC-cCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECcc
Confidence 799999984 578887765332 58999999999999999999997 5 8999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCC----cCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHH
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGE----ASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHE 910 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~ 910 (992)
|.+....... ......++..|+|||.+.+.. ++.++||||||+++|+|++|+.||.......
T Consensus 160 g~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----- 225 (296)
T cd06618 160 GISGRLVDSK---------AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF----- 225 (296)
T ss_pred ccchhccCCC---------cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-----
Confidence 9987654321 111234778999999987553 7889999999999999999999986421110
Q ss_pred HHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 911 FARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
+.......... ..... ......++.+++.+||+.||++||+++++++.
T Consensus 226 -----------~~~~~~~~~~~-----~~~~~----~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 226 -----------EVLTKILQEEP-----PSLPP----NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -----------HHHHHHhcCCC-----CCCCC----CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00111010000 00000 00123458999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=304.32 Aligned_cols=278 Identities=19% Similarity=0.262 Sum_probs=198.6
Q ss_pred HhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc--CCCchhHHHHHHHHHHhccCCcceeEEEEeecccc-cCc
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK--QKGASNGFVAECQALRNIRHRNLIKIITICSSIDF-KGV 753 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~ 753 (992)
..++|++.+.||+|+||.||+|++..+++.||+|++... .......+.+|+.++++++|||++++.+++...+. ...
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 456899999999999999999999888999999998643 22234567789999999999999999887543222 233
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGD 833 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 833 (992)
...++|+||+ +++|.+++... .+++..++.++.|+++||+|||+. +|+||||||+||++++++.+||+|
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~d 161 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKCQ-------KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILD 161 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcc
Confidence 4579999998 67999998742 489999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHH
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFA 912 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~ 912 (992)
||.+...... .....++..|+|||.+.+ ..++.++||||+||++|++++|+.||.+..... .+....
T Consensus 162 fg~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~-~~~~i~ 229 (343)
T cd07851 162 FGLARHTDDE-----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID-QLKRIM 229 (343)
T ss_pred cccccccccc-----------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHH
Confidence 9999765321 122357888999998765 367889999999999999999999997532211 111111
Q ss_pred hh--hCChhHHHHHHhhHhHhhhccCCCC-CCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 913 RT--ALPDKVMEIVDSVLLLEVQASNSRS-CGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 913 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.. ..++.+..-+.......+....... ...-.........++.+++.+||..||++|||+.||++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 230 NLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 10 0111110000000000000000000 00000000112456899999999999999999999975
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-32 Score=293.43 Aligned_cols=256 Identities=25% Similarity=0.374 Sum_probs=200.9
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhcc-CCcceeEEEEeecccccCcc
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNIR-HRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 754 (992)
++|.+.+.||+|+||.||+|+...+++.||+|++.... ......+.+|+++++++. ||||+++++++ .+..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF-----QDEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh-----cCCc
Confidence 47889999999999999999998899999999986432 233466889999999998 99999999874 4456
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
..++||||+++++|.+++.... .+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++++||
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df 146 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRKYG------SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDF 146 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCC
Confidence 7799999999999999997643 589999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCc------------ccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCc
Q 037275 835 GLAKFLSSSPLDTAV------------ETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMF 902 (992)
Q Consensus 835 g~a~~~~~~~~~~~~------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 902 (992)
|.+............ ..........++..|+|||+..+..++.++||||+|+++|++++|+.||....
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (280)
T cd05581 147 GTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226 (280)
T ss_pred ccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 999876543221100 00122334567899999999888889999999999999999999999997532
Q ss_pred cCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCH----HHHHH
Q 037275 903 NQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEM----RDVVA 977 (992)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~evl~ 977 (992)
.. .. ...... ... . ........+.+++.+||+.+|++|||+ +|+++
T Consensus 227 ~~----~~---------~~~~~~----~~~------~------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 227 EY----LT---------FQKILK----LEY------S------FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HH----HH---------HHHHHh----cCC------C------CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 10 00 000000 000 0 001113458899999999999999999 77654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-34 Score=277.00 Aligned_cols=255 Identities=23% Similarity=0.245 Sum_probs=190.0
Q ss_pred CCCccccccceEEEEeEECCCCeEEEEEEeeccCC-CchhHHHHHHHHHHh-ccCCcceeEEEEeecccccCcceEEEEE
Q 037275 683 SSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK-GASNGFVAECQALRN-IRHRNLIKIITICSSIDFKGVDFQAIVY 760 (992)
Q Consensus 683 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~~~~~lv~ 760 (992)
-...||.|+||+|++..++++|+..|||.++.... .+..++..|.+...+ -+.||||+++|.+. . ++..|+.|
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F----~-EGdcWiCM 142 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALF----S-EGDCWICM 142 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhh----c-CCceeeeH
Confidence 34679999999999999999999999999975543 456678888876444 47999999999863 3 33459999
Q ss_pred EeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceec
Q 037275 761 EYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFL 840 (992)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 840 (992)
|.|+ .+++.+-+.-... ....+++.-+-+|....+.||.||.+.. .|+|||+||+|||++..|.+||||||.+..+
T Consensus 143 ELMd-~SlDklYk~vy~v-q~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqL 218 (361)
T KOG1006|consen 143 ELMD-ISLDKLYKRVYSV-QKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQL 218 (361)
T ss_pred HHHh-hhHHHHHHHHHHH-HhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhH
Confidence 9994 5877765543222 2345888888899999999999998775 8999999999999999999999999999766
Q ss_pred CCCCCCCCcccCCCCCcccccccccccccccC--CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCCh
Q 037275 841 SSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG--GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPD 918 (992)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 918 (992)
..+. ..+.-.|-..|||||.+.. ..|+.++||||+|+++||+.||..||.+-.. .
T Consensus 219 v~Si---------AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s----v---------- 275 (361)
T KOG1006|consen 219 VDSI---------AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS----V---------- 275 (361)
T ss_pred HHHH---------HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH----H----------
Confidence 4322 1222357889999998864 3589999999999999999999999875211 1
Q ss_pred hHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 919 KVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.+-+.....++.+. ........+....+..++..|+..|-.+||...++.+
T Consensus 276 --feql~~Vv~gdpp~------l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 276 --FEQLCQVVIGDPPI------LLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred --HHHHHHHHcCCCCe------ecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 11111111111111 0000111234556889999999999999999998865
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=287.94 Aligned_cols=251 Identities=21% Similarity=0.268 Sum_probs=193.0
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC-----CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcc
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ-----KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
+|.+.+.||+|+||.||+|++...+..+++|+++... ......+..|+.++++++||||+++++++. +..
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFL-----ERD 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHh-----cCC
Confidence 5888999999999999999998777777777765321 223345678999999999999999998853 344
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
..++||||+++++|.+++...... ...+++..++.++.|++.|+.|||+. +++|+||+|+||+++. +.+||+||
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~ 149 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHT--GKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDF 149 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhc--ccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeeccc
Confidence 579999999999999998754321 34689999999999999999999999 9999999999999975 57999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
|.+....... .......|++.|+|||...+..++.++|+||||+++|+|++|..||..... ....
T Consensus 150 g~~~~~~~~~--------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-----~~~~-- 214 (260)
T cd08222 150 GVSRLLMGSC--------DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-----LSVV-- 214 (260)
T ss_pred CceeecCCCc--------ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHH--
Confidence 9987654321 112234578899999998888889999999999999999999999864211 0100
Q ss_pred hCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 915 ALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
........ . ........++.+++.+||+.+|++||++.|+++
T Consensus 215 ----------~~~~~~~~-----~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 215 ----------LRIVEGPT-----P------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ----------HHHHcCCC-----C------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 00000000 0 001223456889999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=313.90 Aligned_cols=265 Identities=25% Similarity=0.414 Sum_probs=206.0
Q ss_pred cCCCCCCccccccceEEEEeEEC---C----CCeEEEEEEeeccC-CCchhHHHHHHHHHHhc-cCCcceeEEEEeeccc
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLG---E----NGMMVAVKVINLKQ-KGASNGFVAECQALRNI-RHRNLIKIITICSSID 749 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~---~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 749 (992)
++..+.+.+|+|.||.||+|... . ....||||..+... ..+.+.+..|+++|+.+ +||||+.++|+|..
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~-- 373 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ-- 373 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc--
Confidence 34456679999999999999853 1 14679999986443 34567899999999999 69999999999865
Q ss_pred ccCcceEEEEEEeccCCCHHHHHhhcc---cchhh-------cccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCC
Q 037275 750 FKGVDFQAIVYEYMQNGSLEDWLHQSE---DQQEA-------RSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPS 819 (992)
Q Consensus 750 ~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~ 819 (992)
....++|+||++.|+|.++++..+ ..... ..++..+.+.++.|||.|++||++. ++||||+..+
T Consensus 374 ---~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaR 447 (609)
T KOG0200|consen 374 ---DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAAR 447 (609)
T ss_pred ---CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhhh
Confidence 456799999999999999999877 11001 2489999999999999999999999 9999999999
Q ss_pred CeeeCCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCC
Q 037275 820 NVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPT 898 (992)
Q Consensus 820 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf 898 (992)
||+++++..+||+|||+|+........... ...+. -+..|||||.+....|+.++||||||+++||++| |..||
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~----~~~~~-LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PY 522 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTK----SSAGT-LPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPY 522 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEec----CCCCc-cceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCC
Confidence 999999999999999999976554322211 01111 3567999999999999999999999999999999 99999
Q ss_pred CCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 899 DGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
.+.... . +++. .+...+....+ ..+..+++++|+.||+.+|++||++.|+.+.
T Consensus 523 p~~~~~-------------~---~l~~-~l~~G~r~~~P----------~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~ 575 (609)
T KOG0200|consen 523 PGIPPT-------------E---ELLE-FLKEGNRMEQP----------EHCSDEIYDLMKSCWNADPEDRPTFSECVEF 575 (609)
T ss_pred CCCCcH-------------H---HHHH-HHhcCCCCCCC----------CCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 763211 1 1111 11112211112 2234568999999999999999999999999
Q ss_pred HHHHH
Q 037275 979 LCRAR 983 (992)
Q Consensus 979 L~~~~ 983 (992)
+....
T Consensus 576 ~~~~l 580 (609)
T KOG0200|consen 576 FEKHL 580 (609)
T ss_pred HHHHH
Confidence 99854
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=292.22 Aligned_cols=256 Identities=22% Similarity=0.274 Sum_probs=194.2
Q ss_pred CCCCCCccccccceEEEEeEEC---CCCeEEEEEEeeccC----CCchhHHHHHHHHHHhc-cCCcceeEEEEeeccccc
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLG---ENGMMVAVKVINLKQ----KGASNGFVAECQALRNI-RHRNLIKIITICSSIDFK 751 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 751 (992)
+|++.+.||+|+||.||+|+.. .+++.||||+++... ......+.+|+++++++ +||+|+++.+.+ .
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----~ 75 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF-----Q 75 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee-----e
Confidence 4778899999999999999863 367889999986332 22345678899999999 599999999874 3
Q ss_pred CcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEE
Q 037275 752 GVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHL 831 (992)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 831 (992)
.....++||||+++|+|.+++.... .+++..+..++.|+++||+|||+. +++||||+|+||+++.++.++|
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l 146 (288)
T cd05583 76 TDTKLHLILDYVNGGELFTHLYQRE------HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVL 146 (288)
T ss_pred cCCEEEEEEecCCCCcHHHHHhhcC------CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEE
Confidence 4556799999999999999987532 478899999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCCCCCcccCCCCCcccccccccccccccCCC--cCcccchhhHHHHHHHHHhCCCCCCCCccCCccHH
Q 037275 832 GDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGE--ASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLH 909 (992)
Q Consensus 832 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~ 909 (992)
+|||+++...... ........|+..|+|||...+.. .+.++||||||+++|||++|..||...... ....
T Consensus 147 ~dfg~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~~~ 218 (288)
T cd05583 147 TDFGLSKEFLAEE-------EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NSQS 218 (288)
T ss_pred EECcccccccccc-------ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-chHH
Confidence 9999987654321 11112245788999999987654 788999999999999999999998642111 0111
Q ss_pred HHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 037275 910 EFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCR 981 (992)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 981 (992)
+. ......... . ........+.+++.+||+.||++|||++++.+.|..
T Consensus 219 ~~------------~~~~~~~~~------~------~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 219 EI------------SRRILKSKP------P------FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred HH------------HHHHHccCC------C------CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 11 110000000 0 001123457899999999999999999888776654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=319.46 Aligned_cols=148 Identities=29% Similarity=0.451 Sum_probs=130.3
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC---CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK---GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
.++|.+.++||+|+||+||+|.+..+++.||||+++.... .....+.+|+.+++.++||||+++++++. ...
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~~~ 77 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ-----SAN 77 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEE-----ECC
Confidence 3579999999999999999999998999999999964322 22356888999999999999999998753 445
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
..++||||+.+++|.+++.... .+++..++.++.||+.||+|||.+ +|+||||||+|||++.++.+||+||
T Consensus 78 ~~~lVmEy~~g~~L~~li~~~~------~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DF 148 (669)
T cd05610 78 NVYLVMEYLIGGDVKSLLHIYG------YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDF 148 (669)
T ss_pred EEEEEEeCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeC
Confidence 6799999999999999997543 478889999999999999999999 9999999999999999999999999
Q ss_pred cccee
Q 037275 835 GLAKF 839 (992)
Q Consensus 835 g~a~~ 839 (992)
|+++.
T Consensus 149 Gls~~ 153 (669)
T cd05610 149 GLSKV 153 (669)
T ss_pred CCCcc
Confidence 99863
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=288.98 Aligned_cols=252 Identities=22% Similarity=0.312 Sum_probs=191.7
Q ss_pred CCCCCCccccccceEEEEeEEC---CCCeEEEEEEeeccC----CCchhHHHHHHHHHHhc-cCCcceeEEEEeeccccc
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLG---ENGMMVAVKVINLKQ----KGASNGFVAECQALRNI-RHRNLIKIITICSSIDFK 751 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 751 (992)
+|++.+.||+|+||.||.|+.. .+|+.||+|+++... ....+.+.+|+.+++++ +|++|+++.+++ .
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~ 75 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----Q 75 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-----e
Confidence 4788899999999999999874 478999999986432 22345678899999999 599999999874 3
Q ss_pred CcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEE
Q 037275 752 GVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHL 831 (992)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 831 (992)
.+...++||||+++++|.+++.... .+++..+..++.|+++||+|||+. +++||||+|+||+++.++.+||
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl 146 (290)
T cd05613 76 TDTKLHLILDYINGGELFTHLSQRE------RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVL 146 (290)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEE
Confidence 4456789999999999999997543 478889999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCCCCCcccCCCCCcccccccccccccccCC--CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHH
Q 037275 832 GDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG--EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLH 909 (992)
Q Consensus 832 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~ 909 (992)
+|||++........ .......|+..|+|||.+.+. .++.++||||||+++|+|++|+.||...... ....
T Consensus 147 ~dfg~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-~~~~ 218 (290)
T cd05613 147 TDFGLSKEFHEDEV-------ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK-NSQA 218 (290)
T ss_pred eeCccceecccccc-------cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc-ccHH
Confidence 99999976543211 111234578899999998653 4678999999999999999999998642111 1111
Q ss_pred HHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 037275 910 EFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERM-----EMRDVVA 977 (992)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 977 (992)
+. .+........ ........+.+++.+||+.||++|| ++++++.
T Consensus 219 ~~------------~~~~~~~~~~------------~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 219 EI------------SRRILKSEPP------------YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred HH------------HHHhhccCCC------------CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 11 1111100000 0011234578999999999999997 6777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-32 Score=294.63 Aligned_cols=241 Identities=24% Similarity=0.260 Sum_probs=192.5
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhc-cCCcceeEEEEeecccccCcceE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNI-RHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
+..|.....+|.|+|+.|-.+.+..+++..++|++... ..+..+|+.++... +||||+++.+.+ .+..+.
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~-----~~~~~~ 391 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVY-----EDGKEI 391 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeeccee-----cCCcee
Confidence 44677888899999999999999999999999999644 22334677666655 799999999985 456677
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeee-CCCCcEEEeecc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLL-DQDLVAHLGDFG 835 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~Dfg 835 (992)
++|||++.++-+.+.+...+. ....+..|+.+|+.|+.|||++ ||||||+||+|||+ +++++++|+|||
T Consensus 392 ~~v~e~l~g~ell~ri~~~~~-------~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG 461 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSKPE-------FCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFG 461 (612)
T ss_pred eeeehhccccHHHHHHHhcch-------hHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEec
Confidence 999999999988888876542 2267778999999999999999 99999999999999 699999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 915 (992)
.++....+ ....+-|..|.|||+.....|++++|+||||+++|+|++|+.||.....+ .
T Consensus 462 ~a~~~~~~-----------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~----~------ 520 (612)
T KOG0603|consen 462 FWSELERS-----------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG----I------ 520 (612)
T ss_pred hhhhCchh-----------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch----H------
Confidence 99876543 22335688999999999999999999999999999999999999764333 1
Q ss_pred CChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 916 LPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
++...+..+. .......+..+++.+||+.||.+||+|+|+...
T Consensus 521 ------ei~~~i~~~~--------------~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 521 ------EIHTRIQMPK--------------FSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred ------HHHHhhcCCc--------------cccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 1111111000 012234557899999999999999999999753
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=282.80 Aligned_cols=264 Identities=23% Similarity=0.342 Sum_probs=200.9
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC--C-----CchhHHHHHHHHHHhccCCcceeEEEEeecccc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--K-----GASNGFVAECQALRNIRHRNLIKIITICSSIDF 750 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 750 (992)
.++|-..+.||+|||+.||+|.+....++||||+-.... . ...+...+|.+|-+.++||.||++++|+.-
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl--- 538 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL--- 538 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee---
Confidence 456778899999999999999998889999999874321 1 112456889999999999999999999753
Q ss_pred cCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCC---CC
Q 037275 751 KGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQ---DL 827 (992)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~ 827 (992)
+.+.+|-|+|||+|.+|+-|++.++ .++++++..|+.||+.||.||.+. +++|||-|+||.|||+.. -|
T Consensus 539 -DtdsFCTVLEYceGNDLDFYLKQhk------lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacG 610 (775)
T KOG1151|consen 539 -DTDSFCTVLEYCEGNDLDFYLKQHK------LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACG 610 (775)
T ss_pred -ccccceeeeeecCCCchhHHHHhhh------hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccc
Confidence 4566799999999999999999876 489999999999999999999998 678999999999999944 47
Q ss_pred cEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCC----CcCcccchhhHHHHHHHHHhCCCCCCCCcc
Q 037275 828 VAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG----EASMTGDVYSFGILLLEMFTRRRPTDGMFN 903 (992)
Q Consensus 828 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwSlG~il~elltg~~pf~~~~~ 903 (992)
.+||+|||+++++..+...... ....+....||.+|.+||.+.-+ ..+.|+||||.|||+|+.+.|+.||.....
T Consensus 611 eIKITDFGLSKIMdddSy~~vd-GmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs 689 (775)
T KOG1151|consen 611 EIKITDFGLSKIMDDDSYNSVD-GMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS 689 (775)
T ss_pred eeEeeecchhhhccCCccCccc-ceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh
Confidence 8999999999999876543221 22334456799999999976433 578899999999999999999999986433
Q ss_pred CCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 037275 904 QGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVV 976 (992)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 976 (992)
+...+.+-. ++. .....+ . .......+...+|.+||++--++|....|+.
T Consensus 690 QQdILqeNT----------Ilk-AtEVqF-------P-----~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 690 QQDILQENT----------ILK-ATEVQF-------P-----PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred HHHHHhhhc----------hhc-ceeccC-------C-----CCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 221111100 000 000000 0 0111223467889999999999998877764
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=276.04 Aligned_cols=136 Identities=24% Similarity=0.409 Sum_probs=118.3
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhcc-----C---CcceeEEEEeecccc
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIR-----H---RNLIKIITICSSIDF 750 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~~~~~~~~~~~ 750 (992)
++|.+.++||.|.|++||+|.+....+.||+|+.+. ...-.+....|+.+|++++ | .+||+++++|....
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG- 155 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG- 155 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC-
Confidence 589999999999999999999999999999999963 3334566789999999983 2 47999999987644
Q ss_pred cCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeee
Q 037275 751 KGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLL 823 (992)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 823 (992)
..+.++|+|+|++ |.+|..+|.....+ .++...+.+|++||+.||.|||..+ ||||-||||+|||+
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~Yr----Glpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNYR----GLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCCC----CCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 4577889999999 77999999876543 5899999999999999999999998 99999999999998
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=279.24 Aligned_cols=237 Identities=29% Similarity=0.357 Sum_probs=189.5
Q ss_pred cccccceEEEEeEECCCCeEEEEEEeeccCC---CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEEEEec
Q 037275 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQK---GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYM 763 (992)
Q Consensus 687 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 763 (992)
||+|+||.||++....+++.||+|++..... .....+..|++++++++||||+++++.+ ..+...++||||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF-----QTEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe-----ecCCeeEEEEecC
Confidence 6999999999999988899999999864432 2345788999999999999999999874 4556779999999
Q ss_pred cCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceecCCC
Q 037275 764 QNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSS 843 (992)
Q Consensus 764 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 843 (992)
++++|.+++.... .+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||.+......
T Consensus 76 ~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~ 146 (250)
T cd05123 76 PGGELFSHLSKEG------RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSE 146 (250)
T ss_pred CCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccC
Confidence 9999999997543 489999999999999999999998 9999999999999999999999999999865432
Q ss_pred CCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCChhHHHH
Q 037275 844 PLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKVMEI 923 (992)
Q Consensus 844 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (992)
. .......++..|+|||...+...+.++|+||||+++|++++|+.||..... .+ .
T Consensus 147 ~--------~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~------------~ 201 (250)
T cd05123 147 G--------SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----KE------------I 201 (250)
T ss_pred C--------CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HH------------H
Confidence 1 112334578899999999888889999999999999999999999965321 01 0
Q ss_pred HHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 037275 924 VDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRD 974 (992)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 974 (992)
......... .. .......+.+++.+||..||++||++++
T Consensus 202 ~~~~~~~~~------~~------~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 202 YEKILKDPL------RF------PEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHhcCCC------CC------CCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 111100000 00 0011345789999999999999999944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-32 Score=309.02 Aligned_cols=209 Identities=26% Similarity=0.362 Sum_probs=181.4
Q ss_pred HHHHHHHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeec---cCCCchhHHHHHHHHHHhccCCcceeEEEEeec
Q 037275 671 YAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINL---KQKGASNGFVAECQALRNIRHRNLIKIITICSS 747 (992)
Q Consensus 671 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 747 (992)
..++.-..++|.++++||+|+||.|..++.+.+++.||+|++.. -......-|..|-++|..-+.+=|+.+.-.
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyA--- 143 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYA--- 143 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHH---
Confidence 34555567899999999999999999999999999999999975 234456778999999998888888887654
Q ss_pred ccccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCC
Q 037275 748 IDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDL 827 (992)
Q Consensus 748 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 827 (992)
|++..+.|+|||||+||+|-.++.+.. .+++..+..++..|+-||.-+|+. |+|||||||+|||+|..|
T Consensus 144 --FQD~~~LYlVMdY~pGGDlltLlSk~~------~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~G 212 (1317)
T KOG0612|consen 144 --FQDERYLYLVMDYMPGGDLLTLLSKFD------RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSG 212 (1317)
T ss_pred --hcCccceEEEEecccCchHHHHHhhcC------CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccC
Confidence 788899999999999999999998765 489999999999999999999999 999999999999999999
Q ss_pred cEEEeecccceecCCCCCCCCcccCCCCCccccccccccccccc----C-CCcCcccchhhHHHHHHHHHhCCCCCCC
Q 037275 828 VAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGM----G-GEASMTGDVYSFGILLLEMFTRRRPTDG 900 (992)
Q Consensus 828 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DiwSlG~il~elltg~~pf~~ 900 (992)
++||+|||.+-.+..+. .......+|||.|.+||++. + +.|++.+|-||+||++|||+.|..||..
T Consensus 213 HikLADFGsClkm~~dG-------~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa 283 (1317)
T KOG0612|consen 213 HIKLADFGSCLKMDADG-------TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA 283 (1317)
T ss_pred cEeeccchhHHhcCCCC-------cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence 99999999998776442 12233457999999999874 2 5799999999999999999999999964
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=304.49 Aligned_cols=274 Identities=20% Similarity=0.185 Sum_probs=171.7
Q ss_pred HhcCCCCCCccccccceEEEEeEECCC----CeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeec-cccc
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLGEN----GMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSS-IDFK 751 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~ 751 (992)
..++|++.++||+|+||.||+|++..+ +..||+|.+..... .+....| .++...+.++..++..+.. ....
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 567899999999999999999999878 89999998753221 1111111 1122222222222221111 1113
Q ss_pred CcceEEEEEEeccCCCHHHHHhhcccch--------------hhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCC
Q 037275 752 GVDFQAIVYEYMQNGSLEDWLHQSEDQQ--------------EARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLK 817 (992)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlk 817 (992)
.....++||||+.+++|.+++....... .........+..++.|++.||+|||++ +|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 4567799999999999999987542100 001122345678999999999999999 99999999
Q ss_pred CCCeeeCC-CCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCC----------------------C
Q 037275 818 PSNVLLDQ-DLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG----------------------E 874 (992)
Q Consensus 818 p~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~ 874 (992)
|+|||++. ++.+||+|||+|+.+.... ........+++.|+|||.+... .
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~-------~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~ 355 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGI-------NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLN 355 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccc-------ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhcccc
Confidence 99999986 5799999999998654321 1122345689999999965322 2
Q ss_pred cCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh----hCCh-hHHHHHHhhHhHhhhccCCCCCCccccchHH
Q 037275 875 ASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART----ALPD-KVMEIVDSVLLLEVQASNSRSCGDERLRTEE 949 (992)
Q Consensus 875 ~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 949 (992)
++.++||||+||++|||+++..|++.. ...+... .... .+..........+. +. .......
T Consensus 356 ~~~k~DVwSlGviL~el~~~~~~~~~~------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~-----~~---~~~~~d~ 421 (566)
T PLN03225 356 LPDRFDIYSAGLIFLQMAFPNLRSDSN------LIQFNRQLKRNDYDLVAWRKLVEPRASPDL-----RR---GFEVLDL 421 (566)
T ss_pred CCCCcccHHHHHHHHHHHhCcCCCchH------HHHHHHHHHhcCCcHHHHHHhhccccchhh-----hh---hhhhccc
Confidence 345679999999999999977665431 1111110 0000 01111100000000 00 0000000
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 950 RLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 950 ~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
......+++.+||+.||++|||++|+++.
T Consensus 422 ~~~~~~dLi~~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 422 DGGAGWELLKSMMRFKGRQRISAKAALAH 450 (566)
T ss_pred cchHHHHHHHHHccCCcccCCCHHHHhCC
Confidence 12235689999999999999999999863
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=274.84 Aligned_cols=223 Identities=18% Similarity=0.118 Sum_probs=174.5
Q ss_pred ccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEEEEeccCCCHH
Q 037275 690 GSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLE 769 (992)
Q Consensus 690 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~ 769 (992)
|.+|.||+|++..+++.||+|++.... ...+|...+....||||+++++++. .....++||||+++|+|.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~ 73 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIV-----SEDSVFLVLQHAEGGKLW 73 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhhee-----cCCeEEEEEecCCCCCHH
Confidence 899999999999999999999986432 2334555555667999999999853 446679999999999999
Q ss_pred HHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceecCCCCCCCCc
Q 037275 770 DWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAV 849 (992)
Q Consensus 770 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 849 (992)
+++.... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.++++|||.+......
T Consensus 74 ~~l~~~~------~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~------ 138 (237)
T cd05576 74 SHISKFL------NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS------ 138 (237)
T ss_pred HHHHHhc------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc------
Confidence 9987543 489999999999999999999999 9999999999999999999999999987654321
Q ss_pred ccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCChhHHHHHHhhHh
Q 037275 850 ETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLL 929 (992)
Q Consensus 850 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 929 (992)
.....++..|+|||...+..++.++||||+|+++|||++|+.|+........ ....
T Consensus 139 -----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~-------~~~~------------ 194 (237)
T cd05576 139 -----CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN-------THTT------------ 194 (237)
T ss_pred -----cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc-------cccc------------
Confidence 1122356789999999888899999999999999999999988753211100 0000
Q ss_pred HhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 037275 930 LEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDV 975 (992)
Q Consensus 930 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 975 (992)
. ..+ ......+.+++.+|++.||++||++.+.
T Consensus 195 --~------~~~------~~~~~~~~~li~~~l~~dp~~R~~~~~~ 226 (237)
T cd05576 195 --L------NIP------EWVSEEARSLLQQLLQFNPTERLGAGVA 226 (237)
T ss_pred --c------CCc------ccCCHHHHHHHHHHccCCHHHhcCCCcc
Confidence 0 000 0113457889999999999999997433
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=247.56 Aligned_cols=218 Identities=23% Similarity=0.318 Sum_probs=173.3
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC-CCchhHHHHHHHHHHh-ccCCcceeEEEEeecccccCcce
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ-KGASNGFVAECQALRN-IRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
.++...+..||+|+||.|-+.++..+|...|+|.++..- .+..++..+|+++..+ ...|.+|.++|.+ .....
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~-----~regd 119 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGAL-----FREGD 119 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhh-----hcccc
Confidence 344556678999999999999999999999999997443 3345667788887554 4799999999974 34556
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++.||.|+ .||+.+-++.-.. +..+++..+-+||..+.+||.|||++. .|+|||+||+|||++.+|++|+||||
T Consensus 120 vwIcME~M~-tSldkfy~~v~~~--g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFG 194 (282)
T KOG0984|consen 120 VWICMELMD-TSLDKFYRKVLKK--GGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFG 194 (282)
T ss_pred EEEeHHHhh-hhHHHHHHHHHhc--CCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccc
Confidence 799999995 4888887664433 457899999999999999999999986 89999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccC----CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHH
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG----GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEF 911 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~ 911 (992)
.+..+.++-.. +-..|-..|||||.+.. ..|+-++||||+|+++.||.+++.||+.-..+...+.+.
T Consensus 195 IsG~L~dSiAk---------t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqv 265 (282)
T KOG0984|consen 195 ISGYLVDSIAK---------TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQV 265 (282)
T ss_pred cceeehhhhHH---------HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHH
Confidence 99877643211 11236778999998753 478999999999999999999999998654444444444
Q ss_pred Hhh
Q 037275 912 ART 914 (992)
Q Consensus 912 ~~~ 914 (992)
+..
T Consensus 266 Vee 268 (282)
T KOG0984|consen 266 VEE 268 (282)
T ss_pred hcC
Confidence 433
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=271.57 Aligned_cols=201 Identities=26% Similarity=0.372 Sum_probs=171.0
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc---CCCchhHHHHHHHHHHhc-cCCcceeEEEEeecccccCcc
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK---QKGASNGFVAECQALRNI-RHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 754 (992)
.+|..+.+||+|+||.|.+|..+.+.+.||||+++.. +.+..+--+.|-++|... +-|.++.+..+ ++..+
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHSc-----FQTmD 423 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSC-----FQTMD 423 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHH-----hhhhh
Confidence 4788999999999999999999999999999999743 223333345666676665 46777777665 56677
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
.+|+||||+.||+|-..+++.+. +.+..+..+|..||-||-+||++ ||+.||+|.+|||+|.+|++||+||
T Consensus 424 RLyFVMEyvnGGDLMyhiQQ~Gk------FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DF 494 (683)
T KOG0696|consen 424 RLYFVMEYVNGGDLMYHIQQVGK------FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADF 494 (683)
T ss_pred heeeEEEEecCchhhhHHHHhcc------cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeec
Confidence 88999999999999999987664 66777888999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCC
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGM 901 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 901 (992)
|+++.--- ....+..++|||.|+|||++...+|+.++|-||+||++|||+.|++||++.
T Consensus 495 GmcKEni~--------~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe 553 (683)
T KOG0696|consen 495 GMCKENIF--------DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 553 (683)
T ss_pred cccccccc--------CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC
Confidence 99974221 233456689999999999999999999999999999999999999999984
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=248.12 Aligned_cols=274 Identities=19% Similarity=0.283 Sum_probs=205.5
Q ss_pred HhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhcc-CCcceeEEEEeecccccCcce
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIR-HRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 755 (992)
..++|++.+++|+|-|+.||.|....+.++++||++++. ..+.+.+|+.+++.+. ||||++++++..+.. ...
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~---Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPE---SKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCcc---ccC
Confidence 346899999999999999999999889999999999743 3467889999999996 999999999976643 334
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCC-CcEEEeec
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQD-LVAHLGDF 834 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Df 834 (992)
..+|+||+.+.+...... .++..++..++.+++.||.|+|+. ||.|||+||.|+++|.. -..+|+|+
T Consensus 110 paLiFE~v~n~Dfk~ly~---------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDW 177 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLYP---------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDW 177 (338)
T ss_pred chhHhhhhccccHHHHhh---------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeec
Confidence 589999999988777654 478888999999999999999999 99999999999999865 48999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 913 (992)
|+|.++.+.... .-.+.+..|.-||.+-. ..|+..-|+|||||++..|+..+.||-...+...++...+.
T Consensus 178 GLAEFYHp~~eY---------nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIak 248 (338)
T KOG0668|consen 178 GLAEFYHPGKEY---------NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAK 248 (338)
T ss_pred chHhhcCCCcee---------eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHH
Confidence 999988754321 12346778899998765 45888999999999999999999998765555555555554
Q ss_pred hhCChhHHHHHHhhHhH---hhhc--cCCCCCCcccc----chHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 914 TALPDKVMEIVDSVLLL---EVQA--SNSRSCGDERL----RTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 914 ~~~~~~~~~~~~~~~~~---~~~~--~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
..-.+++...+.+-... .+.. ....+....+. ...-...+..+++.+.|.+|-.+||||+|+++
T Consensus 249 VLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 249 VLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 44444444433321110 0000 00000000000 00012356789999999999999999999975
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=279.74 Aligned_cols=200 Identities=26% Similarity=0.381 Sum_probs=176.2
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc---CCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK---QKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
.+++.+..||-||||.|-++........+|+|+++.. +....+.+..|-.+|...+.|.||+++-. |.+..+
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrT-----frd~ky 494 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRT-----FRDSKY 494 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHH-----hccchh
Confidence 3556778899999999999999755556899988643 34456778899999999999999999876 567778
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.|+.||-|-||.+++.++... .++..+...++..+++|++|||++ +||.||+||+|.+++.+|-+||.|||
T Consensus 495 vYmLmEaClGGElWTiLrdRg------~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFG 565 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDRG------SFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFG 565 (732)
T ss_pred hhhhHHhhcCchhhhhhhhcC------CcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehh
Confidence 899999999999999998765 478888888999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCC
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGM 901 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 901 (992)
+|+.+.. ...+..++|||.|.|||++..+..+.++|.||+|+++||+++|.+||.+.
T Consensus 566 FAKki~~---------g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~ 622 (732)
T KOG0614|consen 566 FAKKIGS---------GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGV 622 (732)
T ss_pred hHHHhcc---------CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence 9998764 33455678999999999999999999999999999999999999999874
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-30 Score=288.31 Aligned_cols=248 Identities=26% Similarity=0.316 Sum_probs=187.6
Q ss_pred CCCCCccccccce-EEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhc-cCCcceeEEEEeecccccCcceEEE
Q 037275 681 FSSSNMIGQGSFG-FVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNI-RHRNLIKIITICSSIDFKGVDFQAI 758 (992)
Q Consensus 681 ~~~~~~lg~G~~g-~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~l 758 (992)
|...+++|.|+.| .||+|.. .|+.||||++-. +......+|++.++.- +|||||++++. ..+....||
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~-----E~d~qF~YI 580 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCS-----EQDRQFLYI 580 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEee-----ccCCceEEE
Confidence 3444688999987 5799999 689999998742 2334568999999988 69999999987 566778899
Q ss_pred EEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCC---C--CcEEEee
Q 037275 759 VYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQ---D--LVAHLGD 833 (992)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~--~~~kl~D 833 (992)
+.|.|. .+|.+++...... .........+.+..|+++||+|||+. +||||||||.||||+. + ..++|+|
T Consensus 581 alELC~-~sL~dlie~~~~d--~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSD 654 (903)
T KOG1027|consen 581 ALELCA-CSLQDLIESSGLD--VEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISD 654 (903)
T ss_pred EehHhh-hhHHHHHhccccc--hhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecc
Confidence 999995 5999999875111 11112245677899999999999998 9999999999999965 3 4899999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHH
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFA 912 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~ 912 (992)
||+++.+..+.. ......+..||-+|+|||++....-+.++||||+||++|+.++ |..||.+....+..+.
T Consensus 655 fglsKkl~~~~s-----S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl--- 726 (903)
T KOG1027|consen 655 FGLSKKLAGGKS-----SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANIL--- 726 (903)
T ss_pred cccccccCCCcc-----hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhh---
Confidence 999998875432 2223455679999999999999888889999999999999999 5999987433321111
Q ss_pred hhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 913 RTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.+.+ +........++ +..++|.+|+.+||..||+|.+|+.
T Consensus 727 ----------------~~~~-------~L~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 727 ----------------TGNY-------TLVHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ----------------cCcc-------ceeeeccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 0111 00001111111 5789999999999999999999974
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-31 Score=257.04 Aligned_cols=281 Identities=20% Similarity=0.266 Sum_probs=195.5
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeecc--CCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK--QKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
+.+..+.||.|+||.||.+++..+|+.||+|.+... .-...+++.+|++++..++|.|++..+++.......--..+|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 345568999999999999999999999999988522 233457889999999999999999998875433222223457
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+++|.|.. +|...+-.. ..++...+.-+++||++||+|||+. +|.||||||.|.+++.+...||||||+|
T Consensus 134 V~TELmQS-DLHKIIVSP------Q~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLA 203 (449)
T KOG0664|consen 134 VLTELMQS-DLHKIIVSP------QALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLA 203 (449)
T ss_pred HHHHHHHh-hhhheeccC------CCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccc
Confidence 88888844 787777542 2578888888999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTAL 916 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 916 (992)
+..+.+. ....+..+-|..|+|||+++|. .|+.+.||||.|||+.|++.++..|.....- ..-+.+....
T Consensus 204 Rvee~d~-------~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Pi--qQL~lItdLL 274 (449)
T KOG0664|consen 204 RTWDQRD-------RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPI--EQLQMIIDLL 274 (449)
T ss_pred cccchhh-------hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChH--HHHHHHHHHh
Confidence 9765432 1222334568899999998875 6999999999999999999999988753211 1111111111
Q ss_pred ChhHHHHHHhhHhHhhh---ccCCCCCCcccc----chHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 037275 917 PDKVMEIVDSVLLLEVQ---ASNSRSCGDERL----RTEERLVAVVETGVVCSMESPTERMEMRDVVAKL 979 (992)
Q Consensus 917 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 979 (992)
...-.+.+.....+... ....+.....+. .....-.+...+...++..||.+|.+.++.+..+
T Consensus 275 GTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 275 GTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred CCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 11111111111111100 000000000000 0011223356777889999999999999887654
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-29 Score=280.02 Aligned_cols=275 Identities=17% Similarity=0.185 Sum_probs=181.6
Q ss_pred HhcCCCCCCccccccceEEEEeEEC----------------CCCeEEEEEEeeccCCCchhH--------------HHHH
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLG----------------ENGMMVAVKVINLKQKGASNG--------------FVAE 726 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E 726 (992)
..++|++.++||+|+||+||+|... ..++.||||.+........++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4668999999999999999999752 245689999986443322222 3446
Q ss_pred HHHHHhccCCcc-----eeEEEEeeccc---ccCcceEEEEEEeccCCCHHHHHhhcccc------------------hh
Q 037275 727 CQALRNIRHRNL-----IKIITICSSID---FKGVDFQAIVYEYMQNGSLEDWLHQSEDQ------------------QE 780 (992)
Q Consensus 727 ~~~l~~l~h~ni-----v~~~~~~~~~~---~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------------~~ 780 (992)
+.++.+++|.++ ++++++|.... .......++||||+++|+|.++++..... ..
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766544 67777765321 11234579999999999999999753210 01
Q ss_pred hcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceecCCCCCCCCcccCCCCCcccc
Q 037275 781 ARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKG 860 (992)
Q Consensus 781 ~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~g 860 (992)
...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........ .......+
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-------~~~~~g~~ 372 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-------FNPLYGML 372 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-------cCccccCC
Confidence 12356788999999999999999999 999999999999999999999999999976543211 11111235
Q ss_pred cccccccccccCCC--------------------c--CcccchhhHHHHHHHHHhCCC-CCCCCccCCccHHHHHhhhCC
Q 037275 861 TVGYIAPEYGMGGE--------------------A--SMTGDVYSFGILLLEMFTRRR-PTDGMFNQGLTLHEFARTALP 917 (992)
Q Consensus 861 t~~y~aPE~~~~~~--------------------~--~~~~DiwSlG~il~elltg~~-pf~~~~~~~~~~~~~~~~~~~ 917 (992)
++.|+|||.+.... + ..+.||||+||++|+|++|.. ||.....-...... ..
T Consensus 373 tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~-----~~ 447 (507)
T PLN03224 373 DPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQ-----YD 447 (507)
T ss_pred CcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhh-----cc
Confidence 78999999875432 1 124799999999999999875 66532111000000 00
Q ss_pred hhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCC---CCCCCHHHHHH
Q 037275 918 DKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESP---TERMEMRDVVA 977 (992)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~evl~ 977 (992)
..... +.......+.. ...........+++.+|+..+| .+|+|++|+++
T Consensus 448 ~~~~~-~r~~~~~~~~~----------~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 448 NDLNR-WRMYKGQKYDF----------SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred chHHH-HHhhcccCCCc----------ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 00000 00000000000 0011223457888999998766 68999999985
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-29 Score=263.92 Aligned_cols=239 Identities=27% Similarity=0.389 Sum_probs=190.4
Q ss_pred cceEEEEeEECCCCeEEEEEEeeccCCCc-hhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEEEEeccCCCHH
Q 037275 691 SFGFVYKGNLGENGMMVAVKVINLKQKGA-SNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLE 769 (992)
Q Consensus 691 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~ 769 (992)
+||.||+|+...+++.+|+|++....... .+.+.+|++.+++++|+|++++++++.. ....+++|||+++++|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED-----EDKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee-----CCEEEEEEeCCCCCCHH
Confidence 58999999998889999999997555444 6789999999999999999999998643 35669999999999999
Q ss_pred HHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceecCCCCCCCCc
Q 037275 770 DWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAV 849 (992)
Q Consensus 770 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 849 (992)
+++.... .+++..++.++.+++.+++|||+. +++|+||+|+||+++.++.++++|||.+.......
T Consensus 76 ~~~~~~~------~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----- 141 (244)
T smart00220 76 DLLKKRG------RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----- 141 (244)
T ss_pred HHHHhcc------CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-----
Confidence 9987543 278899999999999999999999 99999999999999999999999999998765431
Q ss_pred ccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCChhHHHHHHhhHh
Q 037275 850 ETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLL 929 (992)
Q Consensus 850 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 929 (992)
......++..|+|||...+..++.++||||+|+++|++++|..||....+.. ...+....
T Consensus 142 ----~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~----------------~~~~~~~~ 201 (244)
T smart00220 142 ----LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL----------------ELFKKIGK 201 (244)
T ss_pred ----ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH----------------HHHHHHhc
Confidence 2223457889999999988889999999999999999999999986531110 11111100
Q ss_pred HhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 930 LEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 930 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
..... .........++.+++.+|+..+|++||++.++++
T Consensus 202 ~~~~~---------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 202 PKPPF---------PPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred cCCCC---------ccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 00000 0000002356889999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=251.77 Aligned_cols=203 Identities=25% Similarity=0.365 Sum_probs=175.9
Q ss_pred HhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc---CCCchhHHHHHHHHHHhc-cCCcceeEEEEeecccccC
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK---QKGASNGFVAECQALRNI-RHRNLIKIITICSSIDFKG 752 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 752 (992)
...+|+..++||+|+|++|..++.+++.+.||+|+++.. +.+...-++.|-.+.... +||.+|-+..+ |+.
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhsc-----fqt 322 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSC-----FQT 322 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhh-----hcc
Confidence 346899999999999999999999999999999999743 334445567777777766 79999988876 567
Q ss_pred cceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEe
Q 037275 753 VDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLG 832 (992)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 832 (992)
....++|.||++||+|--.+++.+ .++++.+..+...|.-||.|||++ ||+.||+|.+||++|..|++|++
T Consensus 323 esrlffvieyv~ggdlmfhmqrqr------klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghiklt 393 (593)
T KOG0695|consen 323 ESRLFFVIEYVNGGDLMFHMQRQR------KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLT 393 (593)
T ss_pred cceEEEEEEEecCcceeeehhhhh------cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeec
Confidence 778899999999999988887654 489999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCC
Q 037275 833 DFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGM 901 (992)
Q Consensus 833 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 901 (992)
|+|+++.--. ....+..++|||.|.|||++++..|+..+|-|++||+++||+.|+.||+-.
T Consensus 394 dygmcke~l~--------~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdiv 454 (593)
T KOG0695|consen 394 DYGMCKEGLG--------PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIV 454 (593)
T ss_pred ccchhhcCCC--------CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCccee
Confidence 9999974221 233455678999999999999999999999999999999999999999853
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-30 Score=268.07 Aligned_cols=278 Identities=19% Similarity=0.261 Sum_probs=204.3
Q ss_pred HhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhcc------CCcceeEEEEeecccc
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIR------HRNLIKIITICSSIDF 750 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~~~~ 750 (992)
...+|.+....|+|-|++|..|.+...|..||||+++.. ....+.=.+|+++|++|. --|+++++-. |
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~-----F 503 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRH-----F 503 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHH-----h
Confidence 345899999999999999999999988999999999733 223344568999999994 2367777665 5
Q ss_pred cCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCC-CcE
Q 037275 751 KGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQD-LVA 829 (992)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~ 829 (992)
...+++|+|+|-+ ..+|.+.+++.+.. ..+....+..+++|+.-||..|... +|+|.||||+||||.+. ..+
T Consensus 504 ~hknHLClVFE~L-slNLRevLKKyG~n---vGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iL 576 (752)
T KOG0670|consen 504 KHKNHLCLVFEPL-SLNLREVLKKYGRN---VGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNIL 576 (752)
T ss_pred hhcceeEEEehhh-hchHHHHHHHhCcc---cceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCccee
Confidence 6778999999988 56999999987643 4588889999999999999999998 99999999999999865 489
Q ss_pred EEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCcc-H
Q 037275 830 HLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLT-L 908 (992)
Q Consensus 830 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~-~ 908 (992)
||||||.|........ +.+.-+..|.|||++.|-.|+...|+||.||++||+.||+..|++..+.+.. +
T Consensus 577 KLCDfGSA~~~~enei----------tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl 646 (752)
T KOG0670|consen 577 KLCDFGSASFASENEI----------TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRL 646 (752)
T ss_pred eeccCccccccccccc----------cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHH
Confidence 9999999987654332 2234567899999999999999999999999999999999999985443211 1
Q ss_pred HHHHhhhCChhHHH---HHHhhHhHhh-------hc-------------c-------CCCCCCccccchHHHHHHHHHHH
Q 037275 909 HEFARTALPDKVME---IVDSVLLLEV-------QA-------------S-------NSRSCGDERLRTEERLVAVVETG 958 (992)
Q Consensus 909 ~~~~~~~~~~~~~~---~~~~~~~~~~-------~~-------------~-------~~~~~~~~~~~~~~~~~~l~~li 958 (992)
..-....+|..+.. +.+.-...+. +. . ....+..-.......+.++.+|+
T Consensus 647 ~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLL 726 (752)
T KOG0670|consen 647 FMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLL 726 (752)
T ss_pred HHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHH
Confidence 11112222221110 1111000000 00 0 00001111112234567899999
Q ss_pred hhccCCCCCCCCCHHHHHH
Q 037275 959 VVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 959 ~~cl~~dP~~RPs~~evl~ 977 (992)
..|+..||++|.|..|+++
T Consensus 727 dkml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 727 DKMLILDPEKRITVNQALK 745 (752)
T ss_pred HHHhccChhhcCCHHHHhc
Confidence 9999999999999999875
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-29 Score=265.75 Aligned_cols=199 Identities=27% Similarity=0.415 Sum_probs=171.5
Q ss_pred HhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC--------CCchhHHHHHHHHHHhcc---CCcceeEEEEe
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--------KGASNGFVAECQALRNIR---HRNLIKIITIC 745 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---h~niv~~~~~~ 745 (992)
...+|...+.+|+|+||.|+.|.++.+...|+||.+.+.. ......+-.|++||..++ |+||++++++
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf- 637 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF- 637 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe-
Confidence 3457999999999999999999999899999999986432 112233567999999997 9999999999
Q ss_pred ecccccCcceEEEEEEec-cCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeC
Q 037275 746 SSIDFKGVDFQAIVYEYM-QNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLD 824 (992)
Q Consensus 746 ~~~~~~~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 824 (992)
|++++++|++||.. ++.+|.+++...+ .+++.+..-|++|++.|+++||+. +|||||||-+||.++
T Consensus 638 ----FEddd~yyl~te~hg~gIDLFd~IE~kp------~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd 704 (772)
T KOG1152|consen 638 ----FEDDDYYYLETEVHGEGIDLFDFIEFKP------RMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVD 704 (772)
T ss_pred ----eecCCeeEEEecCCCCCcchhhhhhccC------ccchHHHHHHHHHHHhcccccccc---CceecccccccEEEe
Confidence 56777889999975 4559999998665 489999999999999999999999 999999999999999
Q ss_pred CCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCc-CcccchhhHHHHHHHHHhCCCCCC
Q 037275 825 QDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEA-SMTGDVYSFGILLLEMFTRRRPTD 899 (992)
Q Consensus 825 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~ 899 (992)
.+|.+||+|||.|.....++. ..++||..|.|||++.|..| +..-|||++|+++|.++....||.
T Consensus 705 ~~g~~klidfgsaa~~ksgpf----------d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 705 SNGFVKLIDFGSAAYTKSGPF----------DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cCCeEEEeeccchhhhcCCCc----------ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999999999999987765443 34579999999999999887 456899999999999999999985
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=262.61 Aligned_cols=211 Identities=25% Similarity=0.306 Sum_probs=174.9
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
-|..++.||-|+||+|.++.-..+...||.|.+++.+ +.....++.|-+||..-+.+=||+++-. |++.+.+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS-----FQDkdnL 704 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYS-----FQDKDNL 704 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE-----eccCCce
Confidence 4677889999999999999998888999999986543 3345667889999999999999999876 6778889
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
|+||+|++||++-.++-+.+ .+.+..+..++..+..|+++.|.. |+|||||||+|||||.+|++||+|||+
T Consensus 705 YFVMdYIPGGDmMSLLIrmg------IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGL 775 (1034)
T KOG0608|consen 705 YFVMDYIPGGDMMSLLIRMG------IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGL 775 (1034)
T ss_pred EEEEeccCCccHHHHHHHhc------cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccc
Confidence 99999999999999998665 477778888899999999999999 999999999999999999999999999
Q ss_pred ceecCC---CCCCCCc--------ccC-----------------------CCCCcccccccccccccccCCCcCcccchh
Q 037275 837 AKFLSS---SPLDTAV--------ETP-----------------------SSSKGIKGTVGYIAPEYGMGGEASMTGDVY 882 (992)
Q Consensus 837 a~~~~~---~~~~~~~--------~~~-----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 882 (992)
+.-+.. ..++... +.. ......+||+.|+|||++....|+..+|-|
T Consensus 776 CTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdww 855 (1034)
T KOG0608|consen 776 CTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWW 855 (1034)
T ss_pred cccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhh
Confidence 864321 1111100 000 001124699999999999999999999999
Q ss_pred hHHHHHHHHHhCCCCCCCCccC
Q 037275 883 SFGILLLEMFTRRRPTDGMFNQ 904 (992)
Q Consensus 883 SlG~il~elltg~~pf~~~~~~ 904 (992)
|.|||+|||+.|++||......
T Consensus 856 s~gvil~em~~g~~pf~~~tp~ 877 (1034)
T KOG0608|consen 856 SVGVILYEMLVGQPPFLADTPG 877 (1034)
T ss_pred HhhHHHHHHhhCCCCccCCCCC
Confidence 9999999999999999875443
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-29 Score=247.36 Aligned_cols=274 Identities=20% Similarity=0.246 Sum_probs=200.0
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc--CCCchhHHHHHHHHHHhccCCcceeEEEEeeccc-ccCcc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK--QKGASNGFVAECQALRNIRHRNLIKIITICSSID-FKGVD 754 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~ 754 (992)
..+|.....+|.|.- .|..|.+.-.+++||+|..... .....++..+|...+..++|+||++++.++.-.. .....
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 347888889999998 7888888878999999987422 2334567789999999999999999999875422 22234
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
..|+||||| .++|...+.. .++-.++..|..|++.|++|||+. +|+||||||+||++..+..+||.||
T Consensus 95 e~y~v~e~m-~~nl~~vi~~--------elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~df 162 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVILM--------ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDF 162 (369)
T ss_pred hHHHHHHhh-hhHHHHHHHH--------hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccc
Confidence 568999999 5599998872 367788999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
|+|+....+ ...+.++.|..|+|||++.+..+.+.+||||.||++.||++|...|.+.. .+.+|...
T Consensus 163 g~ar~e~~~---------~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d----~idQ~~ki 229 (369)
T KOG0665|consen 163 GLARTEDTD---------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD----HIDQWNKI 229 (369)
T ss_pred hhhcccCcc---------cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch----HHHHHHHH
Confidence 999864432 34455678999999999999899999999999999999999999988631 22222211
Q ss_pred h----CC-hhHHHHHHhhHh------Hhhhc-cCCCCCCcccc-----chHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 915 A----LP-DKVMEIVDSVLL------LEVQA-SNSRSCGDERL-----RTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 915 ~----~~-~~~~~~~~~~~~------~~~~~-~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
. -| +.+.+-+.+... .+++. ...+..++... ...-......+++.+||..||++|.++++++.
T Consensus 230 ~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 230 IEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 1 01 111111111110 11111 00011111111 01112345778999999999999999999985
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-29 Score=274.20 Aligned_cols=254 Identities=23% Similarity=0.342 Sum_probs=202.3
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
.++|+...++|.|+||.||+|+++.+++..|+|+++.........+++|+-+++..+||||+.++|-+ ...+..+
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsy-----lr~dklw 88 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSY-----LRRDKLW 88 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhh-----hhhcCcE
Confidence 45899999999999999999999999999999999988888888899999999999999999999974 3455669
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
++||||.+|+|++.-+-.. ++++.++..+++...+|++|||+. +-+|||||-.||++++.|.+|++|||.+
T Consensus 89 icMEycgggslQdiy~~Tg------plselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvs 159 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHVTG------PLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVS 159 (829)
T ss_pred EEEEecCCCcccceeeecc------cchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCch
Confidence 9999999999999876543 689999999999999999999999 8999999999999999999999999998
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccc---cCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYG---MGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
..+.. .......++||+.|||||+. +.+.|...+|||+.|+...|+-.-++|-.+....
T Consensus 160 aqita--------ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm---------- 221 (829)
T KOG0576|consen 160 AQITA--------TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM---------- 221 (829)
T ss_pred hhhhh--------hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH----------
Confidence 76542 33445667899999999974 4567999999999999999999888874321100
Q ss_pred hCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 915 ALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
....++. ...++.. .+.....-...+-++++.|+..+|++|||++.++.
T Consensus 222 ----r~l~LmT---kS~~qpp-------~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 222 ----RALFLMT---KSGFQPP-------TLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ----HHHHHhh---ccCCCCC-------cccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 0000111 0111100 00000111234778888999999999999988764
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=246.72 Aligned_cols=285 Identities=26% Similarity=0.335 Sum_probs=206.4
Q ss_pred HHHHhcCCCCCCccccccceEEEEeEECC---CCeEEEEEEeeccCCCchhHHHHHHHHHHhc-cCCcceeEEEEeeccc
Q 037275 674 LSKATNDFSSSNMIGQGSFGFVYKGNLGE---NGMMVAVKVINLKQKGASNGFVAECQALRNI-RHRNLIKIITICSSID 749 (992)
Q Consensus 674 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 749 (992)
+....+.|..+++||+|.|++||+|.+.. .++.||+|.+...+ ...++.+|+++|..+ .+.||+++.++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~----- 103 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGC----- 103 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhh-----
Confidence 44456679999999999999999999976 68899999885443 356688999999999 58999999998
Q ss_pred ccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCC-CCc
Q 037275 750 FKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQ-DLV 828 (992)
Q Consensus 750 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~ 828 (992)
+..++...+|+||++.....++.. .++..++..+++.+..||+++|.. |||||||||.|++.+. .+.
T Consensus 104 ~rnnd~v~ivlp~~~H~~f~~l~~---------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~r 171 (418)
T KOG1167|consen 104 FRNNDQVAIVLPYFEHDRFRDLYR---------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQR 171 (418)
T ss_pred hccCCeeEEEecccCccCHHHHHh---------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCC
Confidence 567788899999999999999886 367888999999999999999999 9999999999999975 468
Q ss_pred EEEeecccceecCCCC------C-----CCC-------------------------cccCCCCCcccccccccccccccC
Q 037275 829 AHLGDFGLAKFLSSSP------L-----DTA-------------------------VETPSSSKGIKGTVGYIAPEYGMG 872 (992)
Q Consensus 829 ~kl~Dfg~a~~~~~~~------~-----~~~-------------------------~~~~~~~~~~~gt~~y~aPE~~~~ 872 (992)
-.|+|||+|....... . ... ...........||++|+|||++..
T Consensus 172 g~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k 251 (418)
T KOG1167|consen 172 GVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFR 251 (418)
T ss_pred ceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhh
Confidence 8999999998321110 0 000 000011123569999999999876
Q ss_pred C-CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCChhHHHH---HHh-------------hHhHhhhcc
Q 037275 873 G-EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKVMEI---VDS-------------VLLLEVQAS 935 (992)
Q Consensus 873 ~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~~-------------~~~~~~~~~ 935 (992)
. ..++++||||.|||+.-+++++.||-...++-..+.+.+...-+..+... ... .....+...
T Consensus 252 ~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~ 331 (418)
T KOG1167|consen 252 CPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETL 331 (418)
T ss_pred ccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhcc
Confidence 4 57889999999999999999999998766665555555433322221111 000 000001000
Q ss_pred CCCCCCc------cccc-hHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 936 NSRSCGD------ERLR-TEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 936 ~~~~~~~------~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
....|.. .+.. .+.....+++++.+|+..||.+|.||+|+++
T Consensus 332 ~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 332 HIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred ChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 0001111 1111 1223347899999999999999999999985
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-28 Score=234.60 Aligned_cols=252 Identities=18% Similarity=0.258 Sum_probs=188.9
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhc-cCCcceeEEEEeecccccCcceE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNI-RHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
.+.|.+.+.+|+|.||.+-+++++.+.+.+++|-++. .....++|.+|...--.+ .|.||+.-+++. |+..+.+
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~-p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~va----Fqt~d~Y 97 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR-PQTTQADFVREFHYSFFLSPHQHIIDTYEVA----FQTSDAY 97 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc-chhhHHHHHHHhccceeeccchhhhHHHHHH----hhcCceE
Confidence 4578999999999999999999999999999998863 333567888888764445 589999887763 6677788
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeC--CCCcEEEeec
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLD--QDLVAHLGDF 834 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~Df 834 (992)
++++||++.|+|..-+... .+.+....+++.|+++|+.|+|++ ++||||||.+||||- +..++|+|||
T Consensus 98 vF~qE~aP~gdL~snv~~~-------GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDF 167 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEAA-------GIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDF 167 (378)
T ss_pred EEeeccCccchhhhhcCcc-------cccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeec
Confidence 9999999999999988754 377888899999999999999999 999999999999993 3349999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCC-----CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHH
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-----EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLH 909 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~ 909 (992)
|.++..+... .....+..|.|||..... ...+.+|||.||+++|..+||++||+.....+..+.
T Consensus 168 G~t~k~g~tV-----------~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~ 236 (378)
T KOG1345|consen 168 GLTRKVGTTV-----------KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYW 236 (378)
T ss_pred ccccccCcee-----------hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHH
Confidence 9988654311 112245679999975432 457789999999999999999999987655555555
Q ss_pred HHHhhhCChh--HHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 910 EFARTALPDK--VMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 910 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
+|........ ..+.+ ......+.++.++-+..+|++|--..++.++
T Consensus 237 ~~~~w~~rk~~~~P~~F-----------------------~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 237 EWEQWLKRKNPALPKKF-----------------------NPFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred HHHHHhcccCccCchhh-----------------------cccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 5543221100 00000 0112346677788889999998444444433
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-26 Score=235.41 Aligned_cols=211 Identities=30% Similarity=0.541 Sum_probs=180.3
Q ss_pred cccccceEEEEeEECCCCeEEEEEEeeccCCC-chhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEEEEeccC
Q 037275 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKG-ASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQN 765 (992)
Q Consensus 687 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~ 765 (992)
||+|++|.||++....+++.+++|++...... ....+.+|++.++.++|++++++++++.. ....+++|||+.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFED-----ENHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeec-----CCeEEEEEecCCC
Confidence 68999999999999877999999999644332 34678999999999999999999998643 3567999999999
Q ss_pred CCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCC-CCcEEEeecccceecCCCC
Q 037275 766 GSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQ-DLVAHLGDFGLAKFLSSSP 844 (992)
Q Consensus 766 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~ 844 (992)
++|.+++.... ..+++..++.++.+++++++|||+. +++|+||+|.||+++. ++.++|+|||.+.......
T Consensus 76 ~~l~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~ 147 (215)
T cd00180 76 GSLKDLLKENE-----GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK 147 (215)
T ss_pred CcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCc
Confidence 99999997642 2488999999999999999999999 9999999999999999 8999999999998765432
Q ss_pred CCCCcccCCCCCcccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCChhHHHH
Q 037275 845 LDTAVETPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKVMEI 923 (992)
Q Consensus 845 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (992)
. ......+...|++||..... .++.++|+|++|++++++
T Consensus 148 ~--------~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------- 187 (215)
T cd00180 148 S--------LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------- 187 (215)
T ss_pred c--------hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------
Confidence 1 12223477889999998877 888999999999999999
Q ss_pred HHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 924 VDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
..+.+++..|++.+|++||++.++++.
T Consensus 188 ----------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ----------------------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ----------------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 126788899999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=234.04 Aligned_cols=200 Identities=32% Similarity=0.534 Sum_probs=171.4
Q ss_pred CCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCC-chhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEE
Q 037275 681 FSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKG-ASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIV 759 (992)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 759 (992)
|++.+.||+|++|.||+|....+++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++.. ....+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~-----~~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFED-----PEPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeec-----CCceEEE
Confidence 56778999999999999999877899999999755544 56788999999999999999999998643 3556899
Q ss_pred EEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccccee
Q 037275 760 YEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKF 839 (992)
Q Consensus 760 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 839 (992)
+||+++++|.+++..... .+++..+..++.+++.++.|||+. +++|+|++|+||+++.++.++|+|||.+..
T Consensus 76 ~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~ 147 (225)
T smart00221 76 MEYCEGGDLFDYLRKKGG-----KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARF 147 (225)
T ss_pred EeccCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeE
Confidence 999999999999986542 178899999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCCCcccCCCCCcccccccccccccc-cCCCcCcccchhhHHHHHHHHHhCCCCCCC
Q 037275 840 LSSSPLDTAVETPSSSKGIKGTVGYIAPEYG-MGGEASMTGDVYSFGILLLEMFTRRRPTDG 900 (992)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~elltg~~pf~~ 900 (992)
..... ........++..|++||.. ....++.++|||+||+++++|++|+.||..
T Consensus 148 ~~~~~-------~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 148 IHRDL-------AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ecCcc-------cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 65432 0112234577889999998 666788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-28 Score=247.62 Aligned_cols=417 Identities=21% Similarity=0.244 Sum_probs=186.6
Q ss_pred EeecccCCCCCCcccccCCCCcEeecccccccccCChhhcccccccccccccccccCCCCCCccccccccceEEecC-Cc
Q 037275 104 VLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLG-NG 182 (992)
Q Consensus 104 ~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~-n~ 182 (992)
+-++-.++ .+|.++- ..-..++|..|+|+ .||+..|..+++|+.|+|++|.|+..-|++|.++.+|.+|.+.+ |+
T Consensus 52 dCr~~GL~-eVP~~LP--~~tveirLdqN~I~-~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~Nk 127 (498)
T KOG4237|consen 52 DCRGKGLT-EVPANLP--PETVEIRLDQNQIS-SIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNK 127 (498)
T ss_pred EccCCCcc-cCcccCC--CcceEEEeccCCcc-cCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCc
Confidence 33444444 4444332 12344555555555 55555555555555555555555555555555555555554444 55
Q ss_pred ccCCcCCccCCCCcccEEeccCcccccccCccccccCCCcEEeccCCccCCCCCccccccccccchhhccccccCCCCch
Q 037275 183 LWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPE 262 (992)
Q Consensus 183 l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~ 262 (992)
|+......|++|..|+.|.+.-|++..+....|..+++|..|.+-+|.+. .++...+..+..++.+++..|.+..
T Consensus 128 I~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~ic---- 202 (498)
T KOG4237|consen 128 ITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFIC---- 202 (498)
T ss_pred hhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCcccc----
Confidence 54433444555555555555555555444455555555555555555554 3333333334444444444443220
Q ss_pred hhhccccCceeeeccccccccccccccccCccceEecCCCCCCCCCCCCchhhhhccCCCcceEeecCCCcCCCcCCccc
Q 037275 263 SLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSI 342 (992)
Q Consensus 263 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~l~~~~~~~~ 342 (992)
..+++.+.. +....+..++...-.....+.++++..+.+..|
T Consensus 203 -dCnL~wla~-------~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf------------------------------ 244 (498)
T KOG4237|consen 203 -DCNLPWLAD-------DLAMNPIETSGARCVSPYRLYYKRINQEDARKF------------------------------ 244 (498)
T ss_pred -ccccchhhh-------HHhhchhhcccceecchHHHHHHHhcccchhhh------------------------------
Confidence 011111000 001112222233333333333333333333221
Q ss_pred ccccccceeEEeeCCccccccC-CCccCCCcccEEEccCCcCCCCCCccccCCCCCcEEeccCccccccCCCCCCCcccc
Q 037275 343 ANLSSTMTDIVIAGNQISGIIP-TGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLL 421 (992)
Q Consensus 343 ~~l~~~L~~L~l~~n~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 421 (992)
......+..-..+.+.+.++.| ..|..+++|+.|+|++|+|+++-+.+|.++..++.|.|..|+|..+-...|.++..|
T Consensus 245 ~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L 324 (498)
T KOG4237|consen 245 LCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGL 324 (498)
T ss_pred hhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccc
Confidence 1100001111112222222222 235555566666666666655555566666666666666666554445555555566
Q ss_pred CceeccCCcccCCCCCCccccccccccccccccccccCchhhh-h--------------hcccccccccccccccC---c
Q 037275 422 TNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQIL-S--------------ISTLSLSLDLSYNLLSG---T 483 (992)
Q Consensus 422 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~-~--------------~~~~~~~L~l~~N~l~~---~ 483 (992)
+.|+|.+|+|+...|.+|..+..|..|++-.|.+...-.-.++ . -...+..++++.+.+.. .
T Consensus 325 ~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~~~~~~~Cq~p~~~~~~~~~dv~~~~~~c~ 404 (498)
T KOG4237|consen 325 KTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKSVVGNPRCQSPGFVRQIPISDVAFGDFRCG 404 (498)
T ss_pred eeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhCCCCCCCCCCCCchhccccchhccccccccC
Confidence 6666666666655555555555565555555554321110000 0 01111122333222211 1
Q ss_pred cccccc---------CCCCccE-EeeecccccccCCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcccC
Q 037275 484 LPLEVG---------NLKNLVY-FNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLS 553 (992)
Q Consensus 484 ~~~~~~---------~l~~L~~-L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 553 (992)
-|++.+ ..+-+.. ..-|++.++ .+|..+.. .-.+|++.+|.++ .+|.. .+.+| .+||++|+++
T Consensus 405 ~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~iP~--d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~ 477 (498)
T KOG4237|consen 405 GPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGIPV--DVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRIS 477 (498)
T ss_pred CccccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCCCc--hhHHHhcccchhc-ccCHH--HHhhh-hcccccCcee
Confidence 111111 0111111 122333333 33333322 3456667777766 45554 45566 6677777766
Q ss_pred CCChhhhhcCCCcceEecCCC
Q 037275 554 GQIPEYLENLSFLEYLNLSYN 574 (992)
Q Consensus 554 ~~~p~~~~~l~~L~~L~l~~N 574 (992)
..-...|.+++.|.+|-|++|
T Consensus 478 ~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 478 SLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred hhhcccccchhhhheeEEecC
Confidence 555556666666666666655
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-27 Score=241.43 Aligned_cols=412 Identities=21% Similarity=0.237 Sum_probs=240.6
Q ss_pred CCeeeccCCCCCccCCccccCCCCCCEEEeecccCCCCCCcccccCCCCcEeeccc-ccccccCChhhcccccccccccc
Q 037275 76 LRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARR-NNLVGEIPAELGYNWLKLENLTI 154 (992)
Q Consensus 76 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~-n~l~~~~p~~~~~~l~~L~~L~L 154 (992)
-..++|..|+|+...|.+|+.+++|+.||||+|.|+..-|..|..+.+|..|-+-+ |+|+ .+|...|.++..|+.|.+
T Consensus 69 tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~-~l~k~~F~gL~slqrLll 147 (498)
T KOG4237|consen 69 TVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT-DLPKGAFGGLSSLQRLLL 147 (498)
T ss_pred ceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh-hhhhhHhhhHHHHHHHhc
Confidence 36788889999944456888999999999999999977788999999888877766 7777 899999999999999999
Q ss_pred cccccCCCCCCccccccccceEEecCCcccCCcCCccCCCCcccEEeccCcccc------------cccCccccccCCCc
Q 037275 155 ADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFS------------GIVPPSIFNISSLE 222 (992)
Q Consensus 155 ~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~------------~~~p~~l~~l~~L~ 222 (992)
.-|++.-...+.|..|++|..|.+.+|.+...--..|..+..++.+.+..|.+- ...|..++......
T Consensus 148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~ 227 (498)
T KOG4237|consen 148 NANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVS 227 (498)
T ss_pred ChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecc
Confidence 999999777788899999999999999995444448899999999999988743 12233333333333
Q ss_pred EEeccCCccCCCCCccccccccccchhhccccccCCCCch-hhhccccCceeeeccccccccccccccccCccceEecCC
Q 037275 223 NVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPE-SLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGS 301 (992)
Q Consensus 223 ~L~l~~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~-~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 301 (992)
-..+.++++...-+......+..+..-..+.....++-|. .|..+++|+.|+|++|+|+.+...+|.++..+++|.|..
T Consensus 228 p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~ 307 (498)
T KOG4237|consen 228 PYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTR 307 (498)
T ss_pred hHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCc
Confidence 3333333333111111111111222222222223333332 466666666666666666666666666666666666666
Q ss_pred CCCCCCCCCCchhhhhccCCCcceEeecCCCcCCCcCCcccccccccceeEEeeCCccccccCCCccCCCcccEEEccCC
Q 037275 302 NNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDN 381 (992)
Q Consensus 302 N~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N 381 (992)
|+|..+.... |.++. .|+.|+|.+|+|+...|.+|..+.+|.+|+|-.|
T Consensus 308 N~l~~v~~~~------------------------------f~~ls-~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~N 356 (498)
T KOG4237|consen 308 NKLEFVSSGM------------------------------FQGLS-GLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSN 356 (498)
T ss_pred chHHHHHHHh------------------------------hhccc-cceeeeecCCeeEEEecccccccceeeeeehccC
Confidence 6655433321 11221 2455555556666566666666666666666666
Q ss_pred cCCCC-CCccccCCCCCcEEeccCccccccCCCCCCCccccCceeccCCcccCC---CCCCccccccccccccccccccc
Q 037275 382 KLTGT-IPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGS---IPPSLGNCKNLIELHMADIELTG 457 (992)
Q Consensus 382 ~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~~~~~~~l~~L~~L~l~~n~l~~ 457 (992)
.+.-. .-.|++.. |..+.-.|..| -.+-..++.+.++.+.+... .|+..+-.+ .+
T Consensus 357 p~~CnC~l~wl~~W-------lr~~~~~~~~~--Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~------------s~ 415 (498)
T KOG4237|consen 357 PFNCNCRLAWLGEW-------LRKKSVVGNPR--CQSPGFVRQIPISDVAFGDFRCGGPEELGCLT------------SS 415 (498)
T ss_pred cccCccchHHHHHH-------HhhCCCCCCCC--CCCCchhccccchhccccccccCCccccCCCC------------CC
Confidence 55311 01111110 11111111111 01112455666666555421 111111000 00
Q ss_pred cCchhhhhhcccccccccccccccCcccccccCCCCccEEeeecccccccCCcccccccccceeeccCCcccccCCcccc
Q 037275 458 ALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLS 537 (992)
Q Consensus 458 ~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 537 (992)
.-|+.. .-..+...-|++.++ .+|..+- ..-++|++.+|.++ .+|.. .+.+| .+++++|+|+..-...|.
T Consensus 416 ~cP~~c---~c~~tVvRcSnk~lk-~lp~~iP--~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~ 485 (498)
T KOG4237|consen 416 PCPPPC---TCLDTVVRCSNKLLK-LLPRGIP--VDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFS 485 (498)
T ss_pred CCCCCc---chhhhhHhhcccchh-hcCCCCC--chhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhccccc
Confidence 011100 001111233444343 4444332 34567788888887 56655 55677 888888888866677788
Q ss_pred ccCCCCEEECCCc
Q 037275 538 SLKSIKELDMSSN 550 (992)
Q Consensus 538 ~l~~L~~L~Ls~N 550 (992)
++.+|.+|-||+|
T Consensus 486 n~tql~tlilsyn 498 (498)
T KOG4237|consen 486 NMTQLSTLILSYN 498 (498)
T ss_pred chhhhheeEEecC
Confidence 8888888888876
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.1e-24 Score=213.18 Aligned_cols=169 Identities=21% Similarity=0.231 Sum_probs=127.3
Q ss_pred CCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceecCCCCC
Q 037275 766 GSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPL 845 (992)
Q Consensus 766 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 845 (992)
|+|.++++.... .+++.+++.++.|++.||+|||++ + ||+||+++.++.+|+ ||.+.......
T Consensus 1 GsL~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~- 63 (176)
T smart00750 1 VSLADILEVRGR-----PLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ- 63 (176)
T ss_pred CcHHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc-
Confidence 689999976432 499999999999999999999999 6 999999999999999 99998654311
Q ss_pred CCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCChhHHHHHH
Q 037275 846 DTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKVMEIVD 925 (992)
Q Consensus 846 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 925 (992)
..|++.|+|||++.+..++.++|||||||++|||++|+.||.........+... ..
T Consensus 64 ------------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~------------~~ 119 (176)
T smart00750 64 ------------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEIL------------LN 119 (176)
T ss_pred ------------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHH------------HH
Confidence 147899999999999999999999999999999999999986532211111111 11
Q ss_pred hhHhHhhhccCCCCCCccccchHHHH--HHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 037275 926 SVLLLEVQASNSRSCGDERLRTEERL--VAVVETGVVCSMESPTERMEMRDVVAKLCRARD 984 (992)
Q Consensus 926 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 984 (992)
... . .....+....... .++.+++.+||..+|++|||+.|+++.+.....
T Consensus 120 ~~~-----~----~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 120 GMP-----A----DDPRDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred Hhc-----c----CCccccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 000 0 0000001111122 258999999999999999999999998877654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-24 Score=266.72 Aligned_cols=207 Identities=16% Similarity=0.218 Sum_probs=138.2
Q ss_pred hccC-CcceeEEEEeeccc--ccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCC
Q 037275 732 NIRH-RNLIKIITICSSID--FKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQ 808 (992)
Q Consensus 732 ~l~h-~niv~~~~~~~~~~--~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ 808 (992)
.++| +||+++++++.... .......+.++||+ +++|.+++.... ..+++.+++.++.||++||+|||++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~-- 99 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD-----RSVDAFECFHVFRQIVEIVNAAHSQ-- 99 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc-----ccccHHHHHHHHHHHHHHHHHHHhC--
Confidence 4455 57888888763222 12234567788987 669999997532 2489999999999999999999999
Q ss_pred CCeEeccCCCCCeeeCCCCc-------------------EEEeecccceecCCCCC---CC---Ccc--cCCCCCccccc
Q 037275 809 PPVVHGDLKPSNVLLDQDLV-------------------AHLGDFGLAKFLSSSPL---DT---AVE--TPSSSKGIKGT 861 (992)
Q Consensus 809 ~~ivH~Dlkp~NIll~~~~~-------------------~kl~Dfg~a~~~~~~~~---~~---~~~--~~~~~~~~~gt 861 (992)
+|+||||||+|||++..+. +|++|||+++....... .. ... .........||
T Consensus 100 -gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 178 (793)
T PLN00181 100 -GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEM 178 (793)
T ss_pred -CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCC
Confidence 9999999999999965444 45555555543211000 00 000 00011124588
Q ss_pred ccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCC
Q 037275 862 VGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCG 941 (992)
Q Consensus 862 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 941 (992)
+.|||||++.+..++.++|||||||++|||++|.+|+.... ...........+..
T Consensus 179 ~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---~~~~~~~~~~~~~~---------------------- 233 (793)
T PLN00181 179 SWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS---RTMSSLRHRVLPPQ---------------------- 233 (793)
T ss_pred cceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---HHHHHHHHhhcChh----------------------
Confidence 99999999999999999999999999999999988764310 00000000000000
Q ss_pred ccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 942 DERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 942 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
......+...++.+||+++|.+|||+.||++
T Consensus 234 -----~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 234 -----ILLNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred -----hhhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 0011223467788999999999999999975
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=256.50 Aligned_cols=132 Identities=19% Similarity=0.225 Sum_probs=72.9
Q ss_pred ccCCCCCCEEEeeccc------CCCCCCcccccCC-CCcEeecccccccccCChhhcccccccccccccccccCCCCCCc
Q 037275 94 IGRLVRLEALVLANNS------FSGKIPTNLSRCS-NLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPAS 166 (992)
Q Consensus 94 ~~~l~~L~~L~Ls~n~------l~~~~p~~l~~l~-~L~~L~l~~n~l~~~~p~~~~~~l~~L~~L~L~~n~l~~~~p~~ 166 (992)
|..+.+|+.|.+..+. +...+|..+..++ +|+.|++.++.+. .+|..+ ...+|++|+|.+|++. .+|.+
T Consensus 554 F~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f--~~~~L~~L~L~~s~l~-~L~~~ 629 (1153)
T PLN03210 554 FKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF--RPENLVKLQMQGSKLE-KLWDG 629 (1153)
T ss_pred HhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC--CccCCcEEECcCcccc-ccccc
Confidence 4444555555554332 1223444444432 3555555555544 455443 2455666666666655 45666
Q ss_pred cccccccceEEecCCcccCCcCCccCCCCcccEEeccCcccccccCccccccCCCcEEeccCCc
Q 037275 167 IGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNR 230 (992)
Q Consensus 167 ~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~ 230 (992)
+..+++|+.|+|++|...+.+|. +..+++|+.|+|++|.....+|..+..+++|+.|++++|.
T Consensus 630 ~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~ 692 (1153)
T PLN03210 630 VHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCE 692 (1153)
T ss_pred cccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCC
Confidence 66666666666666554355553 5666666666666665444566666666666666666654
|
syringae 6; Provisional |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.7e-23 Score=222.99 Aligned_cols=175 Identities=18% Similarity=0.165 Sum_probs=131.5
Q ss_pred HHHhcCCCCCCccccccceEEEEeEECC-CCeEEEEEEeecc-----CCCchhHHHHHHHHHHhccCCcceeEEEEeecc
Q 037275 675 SKATNDFSSSNMIGQGSFGFVYKGNLGE-NGMMVAVKVINLK-----QKGASNGFVAECQALRNIRHRNLIKIITICSSI 748 (992)
Q Consensus 675 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 748 (992)
....++|++.++||+|+||+||+|.+.. +++.||||+.... .......+.+|++++++++|+|+++.+..+
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 3445689999999999999999999875 6788899987522 112245689999999999999998533221
Q ss_pred cccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccC-CCCCeeeCCCC
Q 037275 749 DFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDL-KPSNVLLDQDL 827 (992)
Q Consensus 749 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dl-kp~NIll~~~~ 827 (992)
...++||||+++++|... . . .. ...++.|+++||+|||++ ||+|||| ||+||+++.++
T Consensus 91 -----~~~~LVmE~~~G~~L~~~-~--~-------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~ 149 (365)
T PRK09188 91 -----GKDGLVRGWTEGVPLHLA-R--P-------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDG 149 (365)
T ss_pred -----CCcEEEEEccCCCCHHHh-C--c-------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCC
Confidence 134899999999999632 1 1 11 135788999999999999 9999999 99999999999
Q ss_pred cEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCC
Q 037275 828 VAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG 873 (992)
Q Consensus 828 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 873 (992)
.+||+|||+|+.+...................+++.|+|||++...
T Consensus 150 ~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 150 EAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred CEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 9999999999987653211111111122356688899999987543
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.1e-23 Score=240.75 Aligned_cols=112 Identities=21% Similarity=0.341 Sum_probs=51.4
Q ss_pred CEEEeecccCCCCCCcccccCCCCcEeecccccccccCChhhcccccccccccccccccCCCCCCccccccccceEEecC
Q 037275 101 EALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLG 180 (992)
Q Consensus 101 ~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~ 180 (992)
..|+|++|+++ .+|..+. ++|+.|++++|+++ .+|.. .++|++|+|++|+++ .+|.. .++|+.|++++
T Consensus 204 ~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l----p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~ 271 (788)
T PRK15387 204 AVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL----PPELRTLEVSGNQLT-SLPVL---PPGLLELSIFS 271 (788)
T ss_pred cEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC----CCCCcEEEecCCccC-cccCc---ccccceeeccC
Confidence 34444444444 3444332 23444444444444 33321 234555555555555 33332 23455555555
Q ss_pred CcccCCcCCccCCCCcccEEeccCcccccccCccccccCCCcEEeccCCccC
Q 037275 181 NGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFN 232 (992)
Q Consensus 181 n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~ 232 (992)
|.+. .+|..+ .+|+.|+|++|+++ .+|.. .++|++|++++|+++
T Consensus 272 N~L~-~Lp~lp---~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~ 315 (788)
T PRK15387 272 NPLT-HLPALP---SGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLA 315 (788)
T ss_pred Cchh-hhhhch---hhcCEEECcCCccc-ccccc---ccccceeECCCCccc
Confidence 5552 333322 34555666666665 33432 245666666666555
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.1e-22 Score=253.87 Aligned_cols=198 Identities=22% Similarity=0.244 Sum_probs=107.1
Q ss_pred hhhcccccccccccccccc------cCCCCCCcccccc-ccceEEecCCcccCCcCCccCCCCcccEEeccCcccccccC
Q 037275 140 AELGYNWLKLENLTIADNH------LTGHFPASIGNLS-TLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVP 212 (992)
Q Consensus 140 ~~~~~~l~~L~~L~L~~n~------l~~~~p~~~~~l~-~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p 212 (992)
...+.++.+|+.|.+..+. +...+|..+..++ +|+.|++.++.+ ..+|..| ...+|+.|+|++|++. .++
T Consensus 551 ~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l-~~lP~~f-~~~~L~~L~L~~s~l~-~L~ 627 (1153)
T PLN03210 551 ENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPL-RCMPSNF-RPENLVKLQMQGSKLE-KLW 627 (1153)
T ss_pred HHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCC-CCCCCcC-CccCCcEEECcCcccc-ccc
Confidence 3344455666666654432 2224555555543 466666666666 4556555 3466677777776666 456
Q ss_pred ccccccCCCcEEeccCCccCCCCCccccccccccchhhccccccCCCCchhhhccccCceeeeccccccccccccccccC
Q 037275 213 PSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLK 292 (992)
Q Consensus 213 ~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 292 (992)
..+..+++|+.|+|++|...+. +| .++.+++|++|+|++|..-...|..+..++
T Consensus 628 ~~~~~l~~Lk~L~Ls~~~~l~~-------------------------ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~ 681 (1153)
T PLN03210 628 DGVHSLTGLRNIDLRGSKNLKE-------------------------IP-DLSMATNLETLKLSDCSSLVELPSSIQYLN 681 (1153)
T ss_pred cccccCCCCCEEECCCCCCcCc-------------------------CC-ccccCCcccEEEecCCCCccccchhhhccC
Confidence 6666666666666666543323 33 244556666666666554445555666666
Q ss_pred ccceEecCCC-CCCCCCCCCchhhhhccCCCcceEeecCCCcCCCcCCcccccccccceeEEeeCCccccccCCCccCCC
Q 037275 293 NLEWLNLGSN-NLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLV 371 (992)
Q Consensus 293 ~L~~L~L~~N-~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~ 371 (992)
+|+.|++++| .++.++.. .++++|+.|++++|.....+|. ...+|+.|++++|.+.. +|..+ .++
T Consensus 682 ~L~~L~L~~c~~L~~Lp~~--------i~l~sL~~L~Lsgc~~L~~~p~----~~~nL~~L~L~~n~i~~-lP~~~-~l~ 747 (1153)
T PLN03210 682 KLEDLDMSRCENLEILPTG--------INLKSLYRLNLSGCSRLKSFPD----ISTNISWLDLDETAIEE-FPSNL-RLE 747 (1153)
T ss_pred CCCEEeCCCCCCcCccCCc--------CCCCCCCEEeCCCCCCcccccc----ccCCcCeeecCCCcccc-ccccc-ccc
Confidence 6666666664 34433321 1445566666666544333332 12345555666665542 33332 345
Q ss_pred cccEEEccC
Q 037275 372 NLVELCMDD 380 (992)
Q Consensus 372 ~L~~L~L~~ 380 (992)
+|++|++.+
T Consensus 748 ~L~~L~l~~ 756 (1153)
T PLN03210 748 NLDELILCE 756 (1153)
T ss_pred ccccccccc
Confidence 555555554
|
syringae 6; Provisional |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-21 Score=214.55 Aligned_cols=270 Identities=20% Similarity=0.235 Sum_probs=196.4
Q ss_pred CCCCCCccccccceEEEEeEECCCC-eEEEEEEeeccCCCchhHHHHHHHHHHhccC----CcceeEEEEeecccccCcc
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENG-MMVAVKVINLKQKGASNGFVAECQALRNIRH----RNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~~~~~~~~~~~~~~~ 754 (992)
+|.+.++||+|+||.||.|.+..++ ..+|+|+...........+..|..++..+.. +++..+++... ....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence 7999999999999999999997554 6899998865544333378889999999863 68888888742 3445
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCC-----CcE
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQD-----LVA 829 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-----~~~ 829 (992)
+.++||+.+ |.+|.++..... ...++..++.+|+.|++.+|+++|+. |++||||||.|+.+... ..+
T Consensus 95 ~~~iVM~l~-G~sL~dl~~~~~----~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~ 166 (322)
T KOG1164|consen 95 FNFIVMSLL-GPSLEDLRKRNP----PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTL 166 (322)
T ss_pred eeEEEEecc-CccHHHHHHhCC----CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceE
Confidence 569999988 889999887655 23699999999999999999999999 99999999999999765 369
Q ss_pred EEeecccce--ecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCcc
Q 037275 830 HLGDFGLAK--FLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLT 907 (992)
Q Consensus 830 kl~Dfg~a~--~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~ 907 (992)
.|.|||+|+ .+..................+||..|+++.+..+...+++.|+||++.++.|+..|..||........
T Consensus 167 ~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~- 245 (322)
T KOG1164|consen 167 YLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL- 245 (322)
T ss_pred EEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-
Confidence 999999998 33222211101111112456799999999999999999999999999999999999999966432211
Q ss_pred HHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 037275 908 LHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDT 985 (992)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 985 (992)
....... ........ ........+.++...+-..+..++|....+...++.....
T Consensus 246 ~~~~~~~---------~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 246 KSKFEKD---------PRKLLTDR--------------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred HHHHHHH---------hhhhcccc--------------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 1110000 00000000 0000123345555555568999999999999988777654
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-22 Score=236.15 Aligned_cols=63 Identities=27% Similarity=0.384 Sum_probs=33.3
Q ss_pred CccEEeeecccccccCCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcccCCCChhhh
Q 037275 493 NLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYL 560 (992)
Q Consensus 493 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 560 (992)
+|+.|++++|+|++ +|..+ .+|+.|+|++|+|+ .+|..+.++++|+.|+|++|+|++..|..+
T Consensus 403 ~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L 465 (788)
T PRK15387 403 ELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL 465 (788)
T ss_pred CCCEEEccCCcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHH
Confidence 45555555555552 33322 24555555555555 455555555555555555555555555544
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.5e-22 Score=190.99 Aligned_cols=208 Identities=25% Similarity=0.353 Sum_probs=170.8
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccC-CcceeEEEEeecccccCcceE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRH-RNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~ 756 (992)
.+.|.++++||.|+||.+|.|....+|+.||||+-+.. .....+..|..+.+.+++ ..|..+..|..+ ..+-
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e-----~~yn 86 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTE-----KDYN 86 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccc-----cccc
Confidence 46899999999999999999999999999999987433 334567889999999964 556666665433 3444
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCC---CcEEEee
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQD---LVAHLGD 833 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~D 833 (992)
.+||+.. |.+|.+.+.-... .++.++++-++-|++.-++|+|.+ +++||||||+|+++.-+ ..+.++|
T Consensus 87 vlVMdLL-GPsLEdLfnfC~R-----~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LID 157 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCSR-----RFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLID 157 (341)
T ss_pred eeeeecc-CccHHHHHHHHhh-----hhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEe
Confidence 8999988 8899999876543 489999999999999999999999 99999999999999644 4799999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCc
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMF 902 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 902 (992)
||+|+.+.+....... .-.......||..|.+-....+...+.+.|+=|+|.++.++-.|..||++..
T Consensus 158 FGLaKky~d~~t~~HI-pyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglk 225 (341)
T KOG1163|consen 158 FGLAKKYRDIRTRQHI-PYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLK 225 (341)
T ss_pred ccchhhhccccccccC-ccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccc
Confidence 9999987654433332 2233455679999999888888888899999999999999999999999864
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-21 Score=194.97 Aligned_cols=205 Identities=22% Similarity=0.377 Sum_probs=172.9
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhcc-CCcceeEEEEeecccccCcceEEE
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIR-HRNLIKIITICSSIDFKGVDFQAI 758 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l 758 (992)
.|++.++||+|+||+++.|+.--++++||||.-... ....++..|.+..+.|. .++|..++-|- +.+-+=.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFG-----qeG~~NiL 101 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFG-----QEGKYNIL 101 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeec-----cccchhhh
Confidence 789999999999999999999989999999986433 34567888999999884 68888877663 23333479
Q ss_pred EEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCC-----CcEEEee
Q 037275 759 VYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQD-----LVAHLGD 833 (992)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-----~~~kl~D 833 (992)
|+|.+ |.+|.|++.-... .++.+++..+|.|++.-++|+|++ .+|.|||||+|+||... ..+.++|
T Consensus 102 VidLL-GPSLEDLFD~CgR-----~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiD 172 (449)
T KOG1165|consen 102 VIDLL-GPSLEDLFDLCGR-----RFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIID 172 (449)
T ss_pred hhhhh-CcCHHHHHHHhcC-----cccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEe
Confidence 99988 8899999876654 499999999999999999999999 99999999999999754 3799999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCC
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGM 901 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 901 (992)
||+|+.+.+....... .-...+...||.+||+-....++.-+.+.|+=|+|-++.+.+.|..||.+.
T Consensus 173 FGmAK~YrDp~TkqHI-PYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL 239 (449)
T KOG1165|consen 173 FGMAKEYRDPKTKQHI-PYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 239 (449)
T ss_pred ccchhhhcCccccccC-ccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence 9999988765443333 233455677999999999999999999999999999999999999999985
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2e-22 Score=237.87 Aligned_cols=268 Identities=18% Similarity=0.240 Sum_probs=143.6
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCCC----CcCCCCCCceEe----------------eEEcCCCCeEEEeeccccccCCc
Q 037275 6 NETDRLALLAIGSQLEDDPLGVTSS----WNNSTNLCQWTG----------------VTCGHRHQRVTKLDLSNRTIGGT 65 (992)
Q Consensus 6 ~~~~~~~ll~~~~~~~~~~~~~~~~----w~~~~~~c~w~g----------------v~c~~~~~~v~~ldl~~~~l~~~ 65 (992)
+..+-+.++.+.+.+..++ +.++ |+.++++|-=.+ |.|. +..|+.+..-+......
T Consensus 61 ~~~~~~~~~~~~~~l~~p~--~~~~~~~~~~~~~~fc~~~~~~~~~l~~~~~~~~~tv~~~--~~~vt~l~~~g~~~~~~ 136 (754)
T PRK15370 61 SPEEIKSKFECLRMLAFPA--YADNIQYSRGGADQYCILSENSQEILSIVFNTEGYTVEGG--GKSVTYTRVTESEQASS 136 (754)
T ss_pred CHHHHHHHHHHHHHhcCCc--hhhccccccCCCCcccccCCcchhhheeeecCCceEEecC--CCccccccccccccccc
Confidence 4567789999999997765 4455 999999995433 6774 34456665544221111
Q ss_pred cCCCCCCCCcCCeeec----cCCCCCcc----------CCccccCCCCCCEEEeecccCCCCCCcccccCCCCcEeeccc
Q 037275 66 LSPYVGNLSFLRYLNL----ADNNFHGE----------IPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARR 131 (992)
Q Consensus 66 l~~~l~~l~~L~~L~L----~~n~l~~~----------~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~ 131 (992)
-..+- ..-.+... ..+.-.++ +.+ +-..+...|+|++++++ .+|..+. ++|+.|++++
T Consensus 137 ~~~~~---~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~--Cl~~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~ 208 (754)
T PRK15370 137 ASGSK---DAVNYELIWSEWVKEAPAKEAANREEAVQRMRD--CLKNNKTELRLKILGLT-TIPACIP--EQITTLILDN 208 (754)
T ss_pred CCCCC---ChhhHHHHHHHHHhcCCCCccccHHHHHHHHHh--hcccCceEEEeCCCCcC-cCCcccc--cCCcEEEecC
Confidence 10000 00000000 00000000 001 11123455555555555 4554442 3455555555
Q ss_pred ccccccCChhhcccccccccccccccccCCCCCCccccccccceEEecCCcccCCcCCccCCCCcccEEeccCccccccc
Q 037275 132 NNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIV 211 (992)
Q Consensus 132 n~l~~~~p~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~ 211 (992)
|+++ .+|..++ .+|++|++++|+++ .+|..+. .+|+.|+|++|.+. .+|..+. .+|+.|+|++|+|+ .+
T Consensus 209 N~Lt-sLP~~l~---~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~L 277 (754)
T PRK15370 209 NELK-SLPENLQ---GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CL 277 (754)
T ss_pred CCCC-cCChhhc---cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-cc
Confidence 5555 4555443 25555566666555 3454432 35666666666663 4554443 35666666666666 34
Q ss_pred CccccccCCCcEEeccCCccCCCCCccccccccccchhhccccccCCCCchhhhccccCceeeecccccccccccccccc
Q 037275 212 PPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSL 291 (992)
Q Consensus 212 p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l 291 (992)
|..+. ++|+.|++++|+++ .+|..+. +.|+.|++++|++.. +|..+. ++|+.|++++|.++.+ |..+.
T Consensus 278 P~~l~--~sL~~L~Ls~N~Lt-~LP~~lp---~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~L-P~~l~-- 345 (754)
T PRK15370 278 PENLP--EELRYLSVYDNSIR-TLPAHLP---SGITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALTSL-PASLP-- 345 (754)
T ss_pred ccccC--CCCcEEECCCCccc-cCcccch---hhHHHHHhcCCcccc-CCcccc--ccceeccccCCccccC-Chhhc--
Confidence 55443 35666666666666 3443322 356667777777764 444332 5788888888888753 33332
Q ss_pred CccceEecCCCCCCCCC
Q 037275 292 KNLEWLNLGSNNLGTGE 308 (992)
Q Consensus 292 ~~L~~L~L~~N~l~~~~ 308 (992)
++|+.|+|++|+++.++
T Consensus 346 ~sL~~L~Ls~N~L~~LP 362 (754)
T PRK15370 346 PELQVLDVSKNQITVLP 362 (754)
T ss_pred CcccEEECCCCCCCcCC
Confidence 57888888888876544
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.2e-22 Score=232.08 Aligned_cols=257 Identities=20% Similarity=0.224 Sum_probs=187.2
Q ss_pred CCCCccccccceEEEEeEECCCCeEEEEEEeecc--CCCc----hhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 682 SSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK--QKGA----SNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 682 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
...+++|.|.+|.|+.+......+.++.|.++.. .... ...+..|+.+-..++|||++..+..+.+.. .
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~-----~ 395 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID-----G 395 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc-----c
Confidence 3557899999998888888666665666654311 1111 122667888888899999988777654322 1
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
..-+||||++ +|..++.... .+...++..+++|+..|++|+|+. ||.|||+|++|+++..+|.+||+|||
T Consensus 396 ~~~~mE~~~~-Dlf~~~~~~~------~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg 465 (601)
T KOG0590|consen 396 ILQSMEYCPY-DLFSLVMSNG------KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFG 465 (601)
T ss_pred chhhhhcccH-HHHHHHhccc------ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecC
Confidence 2334999999 9999998652 377888889999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcc-cchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMT-GDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
.+....-.... ......+.+|+..|+|||++.+..|.+. .||||.|++++.|++|+.||......+..+.....
T Consensus 466 ~~~vf~~~~e~----~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~- 540 (601)
T KOG0590|consen 466 AASVFRYPWEK----NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNY- 540 (601)
T ss_pred cceeeccCcch----hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcc-
Confidence 99765432211 1244567889999999999999999775 89999999999999999999875444333211000
Q ss_pred hCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 915 ALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
..... ............+.+...++.+||++||.+|.|+++|++
T Consensus 541 --~~~~~-----------------~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 541 --SDQRN-----------------IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred --ccccc-----------------cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00000 000001111233556788999999999999999999975
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.7e-22 Score=192.38 Aligned_cols=246 Identities=23% Similarity=0.348 Sum_probs=185.1
Q ss_pred CCCCCccccccceEEEEeEECCCCeEEEEEEeeccC--CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEE
Q 037275 681 FSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAI 758 (992)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 758 (992)
.....+|.+...|..|+|++. |..+++|++...+ ....++|..|.-.++-+.||||.+++|.|.. .....+
T Consensus 192 lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacns-----ppnlv~ 264 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNS-----PPNLVI 264 (448)
T ss_pred hhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccC-----CCCceE
Confidence 345568899999999999995 5568888886543 3345779999999999999999999999854 345689
Q ss_pred EEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEe--eccc
Q 037275 759 VYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLG--DFGL 836 (992)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~--Dfg~ 836 (992)
+..||+.|+|...+++... ..++..+..+++.++|+|++|||+.. |-|----+.+..|++|++.+++|+ |--+
T Consensus 265 isq~mp~gslynvlhe~t~----vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kf 339 (448)
T KOG0195|consen 265 ISQYMPFGSLYNVLHEQTS----VVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKF 339 (448)
T ss_pred eeeeccchHHHHHHhcCcc----EEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheeccccee
Confidence 9999999999999997654 36888899999999999999999984 223344688999999999987774 3322
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccCCCc---CcccchhhHHHHHHHHHhCCCCCCCCccCCccHH---H
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEA---SMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLH---E 910 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~---~ 910 (992)
+.. ..+..-.+.||+||.+..++- -.++|+|||++++||+.|+..||.+...-+-... +
T Consensus 340 sfq---------------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkiale 404 (448)
T KOG0195|consen 340 SFQ---------------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALE 404 (448)
T ss_pred eee---------------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhc
Confidence 221 122345789999999877653 3579999999999999999999986432211110 0
Q ss_pred HHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 037275 911 FARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRAR 983 (992)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 983 (992)
-.+..+| ......+.+++.-|+..||.+||.++.|+-.|++..
T Consensus 405 glrv~ip------------------------------pgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 405 GLRVHIP------------------------------PGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred cccccCC------------------------------CCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 0011111 112345677888899999999999999999988764
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.8e-21 Score=228.17 Aligned_cols=256 Identities=20% Similarity=0.323 Sum_probs=152.8
Q ss_pred eEEcCCCCeEEEeeccccccCCccCCCCCCCCcCCeeeccCCCCCccCCccccCCCCCCEEEeecccCCCCCCcccccCC
Q 037275 43 VTCGHRHQRVTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCS 122 (992)
Q Consensus 43 v~c~~~~~~v~~ldl~~~~l~~~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~ 122 (992)
..|-. ...+.|+++++++. .+|..+. ++|+.|+|++|+++ .+|..+. ++|++|+|++|+++ .+|..+. .
T Consensus 173 ~~Cl~--~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~ 241 (754)
T PRK15370 173 RDCLK--NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--D 241 (754)
T ss_pred Hhhcc--cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--c
Confidence 35632 23567777777774 4666553 46777777777777 5666554 47777777777777 6666543 3
Q ss_pred CCcEeecccccccccCChhhcccccccccccccccccCCCCCCccccccccceEEecCCcccCCcCCccCCCCcccEEec
Q 037275 123 NLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNL 202 (992)
Q Consensus 123 ~L~~L~l~~n~l~~~~p~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L 202 (992)
+|+.|++++|++. .+|..+. .+|+.|++++|+++ .+|..+. .+|+.|++++|++. .+|..+. ++|+.|++
T Consensus 242 ~L~~L~Ls~N~L~-~LP~~l~---s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~L 311 (754)
T PRK15370 242 TIQEMELSINRIT-ELPERLP---SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNV 311 (754)
T ss_pred cccEEECcCCccC-cCChhHh---CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHh
Confidence 5777777777776 6666554 35666677777666 4555543 35666666666663 3444332 35666666
Q ss_pred cCcccccccCccccccCCCcEEeccCCccCCCCCccccccccccchhhccccccCCCCchhhhccccCceeeeccccccc
Q 037275 203 GENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRG 282 (992)
Q Consensus 203 ~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~ 282 (992)
++|+++ .+|..+. ++|+.|++++|.++ + +|..+. ++|+.|++++|+|+.
T Consensus 312 s~N~Lt-~LP~~l~--~sL~~L~Ls~N~Lt-------------------------~-LP~~l~--~sL~~L~Ls~N~L~~ 360 (754)
T PRK15370 312 QSNSLT-ALPETLP--PGLKTLEAGENALT-------------------------S-LPASLP--PELQVLDVSKNQITV 360 (754)
T ss_pred cCCccc-cCCcccc--ccceeccccCCccc-------------------------c-CChhhc--CcccEEECCCCCCCc
Confidence 666665 2443332 35555555555554 2 343332 577777888777774
Q ss_pred cccccccccCccceEecCCCCCCCCCCCCchhhhhccCCCcceEeecCCCcCCCcCCcccccccccceeEEeeCCccccc
Q 037275 283 KVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGI 362 (992)
Q Consensus 283 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~ 362 (992)
+|..+ .++|++|+|++|+++.++.. +. ..|+.|++++|++. .+|..+..
T Consensus 361 -LP~~l--p~~L~~LdLs~N~Lt~LP~~-------l~--~sL~~LdLs~N~L~-~LP~sl~~------------------ 409 (754)
T PRK15370 361 -LPETL--PPTITTLDVSRNALTNLPEN-------LP--AALQIMQASRNNLV-RLPESLPH------------------ 409 (754)
T ss_pred -CChhh--cCCcCEEECCCCcCCCCCHh-------HH--HHHHHHhhccCCcc-cCchhHHH------------------
Confidence 33333 25778888888887766542 11 24667777777776 33433322
Q ss_pred cCCCccCCCcccEEEccCCcCC
Q 037275 363 IPTGIRNLVNLVELCMDDNKLT 384 (992)
Q Consensus 363 ~~~~~~~l~~L~~L~L~~N~l~ 384 (992)
.+..++++..|++.+|.++
T Consensus 410 ---~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 410 ---FRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred ---HhhcCCCccEEEeeCCCcc
Confidence 2233456666677777665
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.2e-20 Score=189.64 Aligned_cols=177 Identities=14% Similarity=0.142 Sum_probs=135.6
Q ss_pred HhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhH---------HHHHHHHHHhccCCcceeEEEEeec
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNG---------FVAECQALRNIRHRNLIKIITICSS 747 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h~niv~~~~~~~~ 747 (992)
..++|+..+++|.|+||.||.+.. ++..+|+|+++......... +.+|+..+.++.||+|..+.+++..
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 467899999999999999999766 46689999997554333322 6789999999999999999988654
Q ss_pred cccc---CcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeC
Q 037275 748 IDFK---GVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLD 824 (992)
Q Consensus 748 ~~~~---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 824 (992)
.... .....++||||++|.+|.++.. ++. ....+++.++..+|+. |++|||++|.||+++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~ 169 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE----------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVS 169 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh----------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEe
Confidence 3221 2345789999999999988732 222 2455899999999999 999999999999999
Q ss_pred CCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh
Q 037275 825 QDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT 893 (992)
Q Consensus 825 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt 893 (992)
.+| ++++|||.+.....+. ....+.....+..++||||||+++..+..
T Consensus 170 ~~g-i~liDfg~~~~~~e~~--------------------a~d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 170 KNG-LRIIDLSGKRCTAQRK--------------------AKDRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred CCC-EEEEECCCcccccchh--------------------hHHHHHHHhHhcccccccceeEeehHHHH
Confidence 988 9999999876442211 00113445567789999999998776543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.5e-19 Score=199.33 Aligned_cols=266 Identities=30% Similarity=0.459 Sum_probs=194.1
Q ss_pred CCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCC---chhHHHHHHHHHHhccCC-cceeEEEEeecccccCcceE
Q 037275 681 FSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKG---ASNGFVAECQALRNIRHR-NLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~~~~~ 756 (992)
|.+.+.||.|+||.||++.+. ..+|+|.+...... ....+.+|+.+++.+.|+ +++++.+++. .....
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQ-----DEGSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEe-----cCCEE
Confidence 677889999999999999996 78999998654433 367789999999999988 7999999862 33336
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCC-cEEEeecc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDL-VAHLGDFG 835 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg 835 (992)
+++++|+.++++.+++...... ..+.......++.|++.+++|+|+. +++|||+||+||+++..+ .++++|||
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg 147 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRK---GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFG 147 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccC
Confidence 9999999999999777654321 2488899999999999999999999 999999999999999988 79999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccC---CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHH
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG---GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFA 912 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~ 912 (992)
.+............ ........|+..|+|||.+.+ ..+....|+||+|++++++++|..||......
T Consensus 148 ~~~~~~~~~~~~~~--~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~-------- 217 (384)
T COG0515 148 LAKLLPDPGSTSSI--PALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS-------- 217 (384)
T ss_pred cceecCCCCccccc--cccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc--------
Confidence 99855432211100 012355679999999999887 57888999999999999999999997654321
Q ss_pred hhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 913 RTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
.......+........ .......... .......+.+++..|+..+|..|.++.+....
T Consensus 218 -----~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 218 -----SATSQTLKIILELPTP-SLASPLSPSN--PELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred -----ccHHHHHHHHHhcCCc-ccccccCccc--cchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0000000000000000 0000000000 01223457888999999999999999987764
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.7e-20 Score=188.10 Aligned_cols=206 Identities=21% Similarity=0.249 Sum_probs=143.6
Q ss_pred cCCcceeEEEEeeccc----------------------ccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHH
Q 037275 734 RHRNLIKIITICSSID----------------------FKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRIN 791 (992)
Q Consensus 734 ~h~niv~~~~~~~~~~----------------------~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~ 791 (992)
+|||||++.++|.+.- ...+...|+||..++. +|..|+.... .+.....-
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-------~s~r~~~~ 345 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-------RSYRTGRV 345 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-------CchHHHHH
Confidence 5999999998765421 1235677899998855 9999997543 56667777
Q ss_pred HHHHHHHHHHHHHhcCCCCeEeccCCCCCeee--CCCC--cEEEeecccceecCCCCCCCCcccCCCCCccccccccccc
Q 037275 792 IIIDVASAIEYIHHHCQPPVVHGDLKPSNVLL--DQDL--VAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAP 867 (992)
Q Consensus 792 i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll--~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 867 (992)
++.|+++|+.|||.+ ||.|||+|++||++ ++|+ ...++|||++---......-. .........|...-|||
T Consensus 346 ~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlp--y~S~~Vd~GGNa~lmAP 420 (598)
T KOG4158|consen 346 ILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLP--YESDEVDLGGNAKLMAP 420 (598)
T ss_pred HHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccc--cccccccCCCcceecch
Confidence 999999999999999 99999999999999 3443 688999998754332221111 12222334578889999
Q ss_pred ccccCCC------cCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCC
Q 037275 868 EYGMGGE------ASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCG 941 (992)
Q Consensus 868 E~~~~~~------~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 941 (992)
|+....+ -..|+|.|+.|.+.||+++...||.+..+.......+.+...|. .
T Consensus 421 Ei~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPa---------------------l- 478 (598)
T KOG4158|consen 421 EIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPA---------------------L- 478 (598)
T ss_pred hhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCC---------------------C-
Confidence 9865432 24589999999999999999999986322211111111111110 0
Q ss_pred ccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 037275 942 DERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKL 979 (992)
Q Consensus 942 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 979 (992)
.+..+..+.+++...|+.||++|+++.-....|
T Consensus 479 -----p~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 479 -----PSRVPPVARQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred -----cccCChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence 112234578889999999999999987665554
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.7e-20 Score=190.94 Aligned_cols=241 Identities=21% Similarity=0.271 Sum_probs=151.9
Q ss_pred CCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC---CchhHHHHHHHHHHhcc----------CCcceeEEEEeec
Q 037275 681 FSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK---GASNGFVAECQALRNIR----------HRNLIKIITICSS 747 (992)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~----------h~niv~~~~~~~~ 747 (992)
+...+.||.|+++.||.+++.++++++|||++..... ...+.+.+|.-....+. |-.++..++....
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 4456789999999999999999999999999865442 23345556554443321 2222222222211
Q ss_pred cc-------ccCcc-----eEEEEEEeccCCCHHHHHhhcccchh-hcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 037275 748 ID-------FKGVD-----FQAIVYEYMQNGSLEDWLHQSEDQQE-ARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHG 814 (992)
Q Consensus 748 ~~-------~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~ 814 (992)
.. ..+.. ..+++|+-+ .+||.+++..-..... ...+....+..+..|+++.+++||+. |+||+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence 00 00111 236788887 5699888764222111 12355666778889999999999999 99999
Q ss_pred cCCCCCeeeCCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccC--------CCcCcccchhhHHH
Q 037275 815 DLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG--------GEASMTGDVYSFGI 886 (992)
Q Consensus 815 Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~ 886 (992)
||+|+|++++++|.++|+||+.....+.... ....+..|.+||.... -.++.+.|.|++|+
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~-----------~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~ 238 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYR-----------CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGI 238 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEE-----------GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceee-----------ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHH
Confidence 9999999999999999999998876543110 0124577999997533 25788999999999
Q ss_pred HHHHHHhCCCCCCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCC
Q 037275 887 LLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESP 966 (992)
Q Consensus 887 il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 966 (992)
++|.|++|+.||+.......... ....|. +.++.+.++|..+|+.+|
T Consensus 239 ~ly~lWC~~lPf~~~~~~~~~~~--------------------------~f~~C~-------~~Pe~v~~LI~~lL~~~~ 285 (288)
T PF14531_consen 239 TLYSLWCGRLPFGLSSPEADPEW--------------------------DFSRCR-------DMPEPVQFLIRGLLQRNP 285 (288)
T ss_dssp HHHHHHHSS-STCCCGGGSTSGG--------------------------GGTTSS----------HHHHHHHHHHT-SSG
T ss_pred HHHHHHHccCCCCCCCccccccc--------------------------cchhcC-------CcCHHHHHHHHHHccCCc
Confidence 99999999999986533211110 011221 335568899999999999
Q ss_pred CCC
Q 037275 967 TER 969 (992)
Q Consensus 967 ~~R 969 (992)
++|
T Consensus 286 ~~R 288 (288)
T PF14531_consen 286 EDR 288 (288)
T ss_dssp GGS
T ss_pred ccC
Confidence 988
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.1e-19 Score=181.85 Aligned_cols=139 Identities=17% Similarity=0.157 Sum_probs=107.6
Q ss_pred CCccccccceEEEEeEECCCCeEEEEEEeeccCCC--c-------hh-----------------HHHHHHHHHHhccCCc
Q 037275 684 SNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKG--A-------SN-----------------GFVAECQALRNIRHRN 737 (992)
Q Consensus 684 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~-------~~-----------------~~~~E~~~l~~l~h~n 737 (992)
...||+|+||.||+|... +|++||||+++..... . .. ...+|++.+.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999997 8999999999744211 1 11 1235999999998877
Q ss_pred ceeEEEEeecccccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHH-HhcCCCCeEeccC
Q 037275 738 LIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYI-HHHCQPPVVHGDL 816 (992)
Q Consensus 738 iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~~~~ivH~Dl 816 (992)
+.....+. .. ..++||||++++++....... ..++..++..++.|++.+|+|+ |+. +|+||||
T Consensus 81 v~~p~~~~----~~---~~~iVmE~i~g~~l~~~~~~~------~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDl 144 (190)
T cd05147 81 IPCPEPIL----LK---SHVLVMEFIGDDGWAAPRLKD------APLSESKARELYLQVIQIMRILYQDC---RLVHADL 144 (190)
T ss_pred CCCCcEEE----ec---CCEEEEEEeCCCCCcchhhhc------CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCC
Confidence 64333221 11 127999999988776553322 2478899999999999999999 688 9999999
Q ss_pred CCCCeeeCCCCcEEEeecccceec
Q 037275 817 KPSNVLLDQDLVAHLGDFGLAKFL 840 (992)
Q Consensus 817 kp~NIll~~~~~~kl~Dfg~a~~~ 840 (992)
||+||+++ ++.++|+|||+|...
T Consensus 145 kP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 145 SEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred CHHHEEEE-CCcEEEEEccccccC
Confidence 99999998 578999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.8e-21 Score=216.67 Aligned_cols=252 Identities=21% Similarity=0.239 Sum_probs=175.9
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC-CCchhHHH---HHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ-KGASNGFV---AECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~---~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
+|...+.+|.+.|=+|.+|++. .|. |+||++-..+ .-..+.+. +|++ ...++|||++++.-+ ......
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~-----~~t~kA 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKV-----LVTDKA 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHH-----HHhhHH
Confidence 6777899999999999999996 454 9999986444 22333343 3444 555689999998765 334455
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.|+|-+|..+ +|.|.+.-++ .+...+.+.|+.|++.|+.-+|.. ||+|||||.+|||++.=+-+.|+||.
T Consensus 96 AylvRqyvkh-nLyDRlSTRP------FL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFA 165 (1431)
T KOG1240|consen 96 AYLVRQYVKH-NLYDRLSTRP------FLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFA 165 (1431)
T ss_pred HHHHHHHHhh-hhhhhhccch------HHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhccc
Confidence 5788888855 9999997543 477888889999999999999999 99999999999999999999999997
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccCC----------C-cCcccchhhHHHHHHHHHh-CCCCCCCCcc
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG----------E-ASMTGDVYSFGILLLEMFT-RRRPTDGMFN 903 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DiwSlG~il~ellt-g~~pf~~~~~ 903 (992)
.-+...-. .+.+.+..........-..|.|||.+... . .+++-||||+||++.|+++ |++||.-.
T Consensus 166 sFKPtYLP-eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-- 242 (1431)
T KOG1240|consen 166 SFKPTYLP-EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-- 242 (1431)
T ss_pred ccCCccCC-CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH--
Confidence 65422110 00111111111122234579999976431 2 5778999999999999999 89998631
Q ss_pred CCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 904 QGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
++..+.... .......+..+- ...+..++..|++.||++|.+|++.++.
T Consensus 243 ---QL~aYr~~~-~~~~e~~Le~Ie----------------------d~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 243 ---QLLAYRSGN-ADDPEQLLEKIE----------------------DVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred ---HHHhHhccC-ccCHHHHHHhCc----------------------CccHHHHHHHHHccCchhccCHHHHHHh
Confidence 111111110 111111111110 1237889999999999999999999876
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.3e-18 Score=175.10 Aligned_cols=139 Identities=20% Similarity=0.193 Sum_probs=109.7
Q ss_pred CCccccccceEEEEeEECCCCeEEEEEEeeccCCCc--------------------------hhHHHHHHHHHHhccCCc
Q 037275 684 SNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGA--------------------------SNGFVAECQALRNIRHRN 737 (992)
Q Consensus 684 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~h~n 737 (992)
.+.||+|+||.||+|++. +|+.||||+++...... ...+.+|.+.+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 468999999999999987 89999999997542110 112357899999999998
Q ss_pred ceeEEEEeecccccCcceEEEEEEeccCCCHHHH-HhhcccchhhcccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecc
Q 037275 738 LIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDW-LHQSEDQQEARSLTLIQRINIIIDVASAIEYIHH-HCQPPVVHGD 815 (992)
Q Consensus 738 iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~D 815 (992)
+.....+... ..++||||++++++... +.. ..++..+...++.|++.++.++|+ . ||+|||
T Consensus 81 i~~p~~~~~~-------~~~lVmE~~~g~~~~~~~l~~-------~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrD 143 (190)
T cd05145 81 VPVPEPILLK-------KNVLVMEFIGDDGSPAPRLKD-------VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGD 143 (190)
T ss_pred CCCceEEEec-------CCEEEEEEecCCCchhhhhhh-------ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCC
Confidence 7544443211 12899999988765443 322 136778899999999999999999 8 999999
Q ss_pred CCCCCeeeCCCCcEEEeecccceecC
Q 037275 816 LKPSNVLLDQDLVAHLGDFGLAKFLS 841 (992)
Q Consensus 816 lkp~NIll~~~~~~kl~Dfg~a~~~~ 841 (992)
|||+||+++ ++.++|+|||+|....
T Consensus 144 lkP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 144 LSEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred CChhhEEEE-CCCEEEEEcccceecC
Confidence 999999998 8899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=5.8e-21 Score=172.97 Aligned_cols=157 Identities=29% Similarity=0.466 Sum_probs=93.6
Q ss_pred CCCCCcCCeeeccCCCCCccCCccccCCCCCCEEEeecccCCCCCCcccccCCCCcEeecccccccccCChhhccccccc
Q 037275 70 VGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKL 149 (992)
Q Consensus 70 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L 149 (992)
+.++++.+.|-||+|+++ .+|..+..+.+|++|++++|+|+ .+|.+++.+++|+.|+++-|++. .+|.+++ .++.|
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfg-s~p~l 104 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFG-SFPAL 104 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccC-CCchh
Confidence 344555555555555555 45555555555555555555555 55555555555555555555554 5555554 45555
Q ss_pred ccccccccccCC-CCCCccccccccceEEecCCcccCCcCCccCCCCcccEEeccCcccccccCccccccCCCcEEeccC
Q 037275 150 ENLTIADNHLTG-HFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPT 228 (992)
Q Consensus 150 ~~L~L~~n~l~~-~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~ 228 (992)
++|||.+|++.. .+|..|..+..|+.|+|++|.+ ..+|..++++++||.|.+..|.+- .+|..++.++.|++|++.+
T Consensus 105 evldltynnl~e~~lpgnff~m~tlralyl~dndf-e~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqg 182 (264)
T KOG0617|consen 105 EVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDF-EILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQG 182 (264)
T ss_pred hhhhccccccccccCCcchhHHHHHHHHHhcCCCc-ccCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccc
Confidence 555555555543 4566666666666666666666 566666666666666666666665 4666666666666666666
Q ss_pred CccC
Q 037275 229 NRFN 232 (992)
Q Consensus 229 N~l~ 232 (992)
|+++
T Consensus 183 nrl~ 186 (264)
T KOG0617|consen 183 NRLT 186 (264)
T ss_pred ceee
Confidence 6665
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.3e-19 Score=172.21 Aligned_cols=194 Identities=14% Similarity=0.037 Sum_probs=138.1
Q ss_pred CCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC----CchhHHHHHHHHHHhcc-CCcceeEEEEeecccccCcce
Q 037275 681 FSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK----GASNGFVAECQALRNIR-HRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 755 (992)
+.+...|++|+||+||.+.. .+.+++.+.+..... -....+.+|+++|+++. |+++.+++++. .
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~---------~ 72 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD---------G 72 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc---------C
Confidence 34668999999999998776 678888777753322 11225789999999995 58899998861 2
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccC-CCCCeeeCCCCcEEEeec
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDL-KPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~Df 834 (992)
.+++|||++|.+|...... . ...++.|++.+|+++|++ ||+|||| ||+||+++.++.++|+||
T Consensus 73 ~~lvmeyI~G~~L~~~~~~----------~---~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDF 136 (218)
T PRK12274 73 RHLDRSYLAGAAMYQRPPR----------G---DLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDF 136 (218)
T ss_pred EEEEEeeecCccHHhhhhh----------h---hHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEEC
Confidence 3899999999998654321 0 124678999999999999 9999999 799999999999999999
Q ss_pred ccceecCCCCCC------CCcccCCCCCcccccccccccccccC-CCcC-cccchhhHHHHHHHHHhCCCCCCCCc
Q 037275 835 GLAKFLSSSPLD------TAVETPSSSKGIKGTVGYIAPEYGMG-GEAS-MTGDVYSFGILLLEMFTRRRPTDGMF 902 (992)
Q Consensus 835 g~a~~~~~~~~~------~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~-~~~DiwSlG~il~elltg~~pf~~~~ 902 (992)
|+|......... ..... -.......++.|++|+...- ...+ .+.+-++-|+-+|.++||..|+.+..
T Consensus 137 G~A~~~~~~~~~~r~L~~rDl~~-llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 137 QLAVRGNPRARWMRLLAREDLRH-LLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred CCceecCCcchHHHHHHHHHHHH-HHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 999865432210 00000 00011235677777874221 1223 45677799999999999998876543
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.2e-20 Score=170.92 Aligned_cols=181 Identities=30% Similarity=0.484 Sum_probs=113.3
Q ss_pred CccCCCcccEEEccCCcCCCCCCccccCCCCCcEEeccCccccccCCCCCCCccccCceeccCCcccCCCCCCccccccc
Q 037275 366 GIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNL 445 (992)
Q Consensus 366 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 445 (992)
++.++.+.+.|.||+|+++ .+|..+..+.+|+.|++++|+|+ .+|..++.+++|+.|+++-|++. ..|..|+.++.|
T Consensus 28 gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~l 104 (264)
T KOG0617|consen 28 GLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPAL 104 (264)
T ss_pred cccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchh
Confidence 3455666677777777776 56666677777777777777776 56666666666666666666666 556666666655
Q ss_pred cccccccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeecccccc-cCCcccccccccceeecc
Q 037275 446 IELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSG-EIPVTLSACTSLQQLYLQ 524 (992)
Q Consensus 446 ~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~ 524 (992)
+.| ||++|++.. ..|..|..++.|+.|+|+
T Consensus 105 evl-------------------------------------------------dltynnl~e~~lpgnff~m~tlralyl~ 135 (264)
T KOG0617|consen 105 EVL-------------------------------------------------DLTYNNLNENSLPGNFFYMTTLRALYLG 135 (264)
T ss_pred hhh-------------------------------------------------hccccccccccCCcchhHHHHHHHHHhc
Confidence 555 333333321 345555566666666666
Q ss_pred CCcccccCCccccccCCCCEEECCCcccCCCChhhhhcCCCcceEecCCCcCcccCCCCCccC---CcccccccCCCCc
Q 037275 525 GNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFS---NKTGISLSGNGKV 600 (992)
Q Consensus 525 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~---~~~~~~l~~N~~~ 600 (992)
+|.+. .+|..++++++|+.|.+.+|.+- ..|..++.++.|+.|.+.+|.++..+|+.+.+. ......++.|||.
T Consensus 136 dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~vlppel~~l~l~~~k~v~r~E~NPwv 212 (264)
T KOG0617|consen 136 DNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLTVLPPELANLDLVGNKQVMRMEENPWV 212 (264)
T ss_pred CCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceeeecChhhhhhhhhhhHHHHhhhhCCCC
Confidence 66665 56666666666666666666665 566666666666666666666666666554433 2344667788885
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.4e-18 Score=170.66 Aligned_cols=140 Identities=14% Similarity=0.258 Sum_probs=107.9
Q ss_pred CCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhc-----cCCcceeEEEEeecccccCcce
Q 037275 681 FSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNI-----RHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~~~~ 755 (992)
+...+.||+|+||.||. +..++.. +||++........+.+.+|+.+++.+ .||||++++|++.+.. +...
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~--g~g~ 78 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC--GTGY 78 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC--CCeE
Confidence 34567999999999995 5545555 69998765555567899999999999 5799999999976521 2233
Q ss_pred -EEEEEEe--ccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHH-HHHHhcCCCCeEeccCCCCCeeeCC----CC
Q 037275 756 -QAIVYEY--MQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAI-EYIHHHCQPPVVHGDLKPSNVLLDQ----DL 827 (992)
Q Consensus 756 -~~lv~e~--~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L-~~LH~~~~~~ivH~Dlkp~NIll~~----~~ 827 (992)
+.+|+|| +.+|+|.+++.+.. +++. ..++.|++.++ +|||++ +|+||||||+||+++. ++
T Consensus 79 v~~~I~e~~G~~~~tL~~~l~~~~-------~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~ 146 (210)
T PRK10345 79 VYDVIADFDGKPSITLTEFAEQCR-------YEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEV 146 (210)
T ss_pred EEEEEecCCCCcchhHHHHHHccc-------ccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCC
Confidence 4488999 55799999996532 4444 35677888777 999999 9999999999999974 33
Q ss_pred cEEEeecccc
Q 037275 828 VAHLGDFGLA 837 (992)
Q Consensus 828 ~~kl~Dfg~a 837 (992)
.++|+||+.+
T Consensus 147 ~~~LiDg~G~ 156 (210)
T PRK10345 147 IPVVCDNIGE 156 (210)
T ss_pred cEEEEECCCC
Confidence 8999995443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.4e-18 Score=187.55 Aligned_cols=218 Identities=29% Similarity=0.419 Sum_probs=160.5
Q ss_pred HHhccCCcceeEEEEeecccccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCC
Q 037275 730 LRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQP 809 (992)
Q Consensus 730 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~ 809 (992)
|+.+.|.|+.+++|.+.+. ...++|.+||..|+|.|.+..... .+++.....++++++.||+|+|..
T Consensus 1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~~~~-----~~d~~F~~s~~rdi~~Gl~ylh~s--- 67 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSNEDI-----KLDYFFILSFIRDISKGLAYLHNS--- 67 (484)
T ss_pred CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhcccc-----CccHHHHHHHHHHHHHHHHHHhcC---
Confidence 3567899999999998653 566999999999999999987443 589999999999999999999998
Q ss_pred Ce-EeccCCCCCeeeCCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCC-------CcCcccch
Q 037275 810 PV-VHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-------EASMTGDV 881 (992)
Q Consensus 810 ~i-vH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Di 881 (992)
.| .|+.+++.|.+++....+|++|||+........ .........-..-|.|||.+.+. ..+.++||
T Consensus 68 ~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~------~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdi 141 (484)
T KOG1023|consen 68 PIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETA------EPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDI 141 (484)
T ss_pred cceeeeeeccccceeeeeEEEEechhhhcccccccc------cccccchhHHHHhccCHHHhcccccccccccccccCCe
Confidence 55 899999999999999999999999988765311 11111112245679999988764 14678999
Q ss_pred hhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhc
Q 037275 882 YSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVC 961 (992)
Q Consensus 882 wSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 961 (992)
||||++++|+++.+.||+........ . +++.+... ......+.... ...+...++..++.+|
T Consensus 142 Ys~~ii~~ei~~r~~~~~~~~~~~~~-~------------eii~~~~~--~~~~~~rP~i~---~~~e~~~~l~~l~~~c 203 (484)
T KOG1023|consen 142 YSFGIIMYEILFRSGPFDLRNLVEDP-D------------EIILRVKK--GGSNPFRPSIE---LLNELPPELLLLVARC 203 (484)
T ss_pred ehHHHHHHHHHhccCccccccccCCh-H------------HHHHHHHh--cCCCCcCcchh---hhhhcchHHHHHHHHh
Confidence 99999999999999999864333221 1 11111111 00000111110 0113344689999999
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHH
Q 037275 962 SMESPTERMEMRDVVAKLCRARD 984 (992)
Q Consensus 962 l~~dP~~RPs~~evl~~L~~~~~ 984 (992)
|..+|++||++++|-..++.+..
T Consensus 204 w~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 204 WEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cccChhhCccHHHHHhhhhhhcc
Confidence 99999999999999988877654
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.5e-18 Score=200.30 Aligned_cols=201 Identities=22% Similarity=0.281 Sum_probs=155.3
Q ss_pred HHHHHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhcc---CCcceeEEEEeeccc
Q 037275 673 ELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIR---HRNLIKIITICSSID 749 (992)
Q Consensus 673 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~ 749 (992)
+.+.....|.+.+.||+|+||+||+|.... |+.||+|+-+... ..+|.--.+++.+|+ -+.|..+...+
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~---~WEfYI~~q~~~RLk~~~~~~~~~~~~a~---- 763 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPN---PWEFYICLQVMERLKPQMLPSIMHISSAH---- 763 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCC---ceeeeehHHHHHhhchhhhcchHHHHHHH----
Confidence 344455678899999999999999999974 9999999865332 233333445566665 12233332221
Q ss_pred ccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCC----
Q 037275 750 FKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQ---- 825 (992)
Q Consensus 750 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---- 825 (992)
...+.-++|+||.+.|+|.+++...+ .++|.-++.++.|++..+++||.. +||||||||+|.++..
T Consensus 764 -~~~~~S~lv~ey~~~Gtlld~~N~~~------~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~ 833 (974)
T KOG1166|consen 764 -VFQNASVLVSEYSPYGTLLDLINTNK------VMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICA 833 (974)
T ss_pred -ccCCcceeeeeccccccHHHhhccCC------CCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCC
Confidence 12233379999999999999998433 589999999999999999999999 9999999999999942
Q ss_pred ---CCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCC
Q 037275 826 ---DLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897 (992)
Q Consensus 826 ---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p 897 (992)
...++|+|||.|..+.--+ ......+.++|-.+-.+|+..|+.+++.+|.|.++.+++.|+.|+.-
T Consensus 834 ~~~~~~l~lIDfG~siDm~lfp------~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 834 DSDSKGLYLIDFGRSIDMKLFP------DGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred CCcccceEEEecccceeeeEcC------CCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 3479999999998654211 12234567789999999999999999999999999999999999763
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.1e-19 Score=200.89 Aligned_cols=291 Identities=21% Similarity=0.262 Sum_probs=133.9
Q ss_pred eeeccCCCCC-ccCCccccCCCCCCEEEeecccCCC----CCCcccccCCCCcEeecccccccccCChhhcccccccccc
Q 037275 78 YLNLADNNFH-GEIPHQIGRLVRLEALVLANNSFSG----KIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENL 152 (992)
Q Consensus 78 ~L~L~~n~l~-~~~p~~~~~l~~L~~L~Ls~n~l~~----~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~~L 152 (992)
.|+|..++++ +..+..+..+.+|++|++++|.++. .++..+...++|++|+++++.+.+ .+..+.
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~-~~~~~~--------- 71 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGR-IPRGLQ--------- 71 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCC-cchHHH---------
Confidence 4566666665 3344555566667777777777642 234445555666666666665541 111110
Q ss_pred cccccccCCCCCCccccccccceEEecCCcccCCcCCccCCCCc---ccEEeccCccccc----ccCcccccc-CCCcEE
Q 037275 153 TIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRN---LILLNLGENRFSG----IVPPSIFNI-SSLENV 224 (992)
Q Consensus 153 ~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~---L~~L~L~~n~l~~----~~p~~l~~l-~~L~~L 224 (992)
.++..+..+++|++|++++|.+.+..+..+..+.+ |++|++++|++++ .+...+..+ ++|++|
T Consensus 72 ---------~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L 142 (319)
T cd00116 72 ---------SLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKL 142 (319)
T ss_pred ---------HHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEE
Confidence 12233333444444444444443333333333333 5555555555541 112233334 455555
Q ss_pred eccCCccCCCCCccccccccccchhhccccccCCCCchhhhccccCceeeeccccccccc----cccccccCccceEecC
Q 037275 225 FLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKV----SIYFRSLKNLEWLNLG 300 (992)
Q Consensus 225 ~l~~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~ 300 (992)
++++|.+++.... .++..+..+++|++|++++|.+++.. +..+..+++|++|+|+
T Consensus 143 ~L~~n~l~~~~~~---------------------~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~ 201 (319)
T cd00116 143 VLGRNRLEGASCE---------------------ALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLN 201 (319)
T ss_pred EcCCCcCCchHHH---------------------HHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEecc
Confidence 5555555421110 11223444455555555555555221 1223334456666666
Q ss_pred CCCCCCCCCCCchhhhhccCCCcceEeecCCCcCCCcCCcccccccccceeEEeeCCccccccCCCccCCCcccEEEccC
Q 037275 301 SNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDD 380 (992)
Q Consensus 301 ~N~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~ 380 (992)
+|.++...... ....+..+++|+.|++++|.+++.....+.... ....+.|+.|++++
T Consensus 202 ~n~i~~~~~~~--l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~--------------------~~~~~~L~~L~l~~ 259 (319)
T cd00116 202 NNGLTDEGASA--LAETLASLKSLEVLNLGDNNLTDAGAAALASAL--------------------LSPNISLLTLSLSC 259 (319)
T ss_pred CCccChHHHHH--HHHHhcccCCCCEEecCCCcCchHHHHHHHHHH--------------------hccCCCceEEEccC
Confidence 66554322211 122344455566666666555532222211110 00124555555555
Q ss_pred CcCCC----CCCccccCCCCCcEEeccCcccccc----CCCCCCCc-cccCceeccCCc
Q 037275 381 NKLTG----TIPHAIGELKNLQLLYLDSNFLAGG----IPTSLGNL-TLLTNLALSSND 430 (992)
Q Consensus 381 N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l-~~L~~L~L~~N~ 430 (992)
|.++. .+...+..+++|+.+++++|.++.. ....+... +.|+.|++.+|.
T Consensus 260 n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (319)
T cd00116 260 NDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDS 318 (319)
T ss_pred CCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCC
Confidence 55541 1223334445566666666666532 22223333 456666666554
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.3e-19 Score=198.50 Aligned_cols=284 Identities=24% Similarity=0.263 Sum_probs=162.3
Q ss_pred hccccccC-CCCchhhhccccCceeeecccccccc----ccccccccCccceEecCCCCCCCCCCCCchhhhhccCCCcc
Q 037275 250 IVAENNFA-GSIPESLSNASNLVELTLFDNQFRGK----VSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTEL 324 (992)
Q Consensus 250 ~l~~n~l~-~~~p~~l~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~~L 324 (992)
++..+++. ...+..+..+.+|++|+++++.++.. ++..+...+++++|+++++.+...+.........+..+++|
T Consensus 4 ~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L 83 (319)
T cd00116 4 SLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGL 83 (319)
T ss_pred ccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCce
Confidence 33344443 23445566777788888888887533 34445566778888888887764222212223345556777
Q ss_pred eEeecCCCcCCCcCCcccccccccceeEEeeCCccccccCCCccCCCcccEEEccCCcCCC----CCCccccCC-CCCcE
Q 037275 325 TAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTG----TIPHAIGEL-KNLQL 399 (992)
Q Consensus 325 ~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~----~~~~~~~~l-~~L~~ 399 (992)
+.|++++|.+.+..+..+..+.. . ++|++|++++|++++ .+...+..+ ++|+.
T Consensus 84 ~~L~l~~~~~~~~~~~~~~~l~~---------------------~-~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~ 141 (319)
T cd00116 84 QELDLSDNALGPDGCGVLESLLR---------------------S-SSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEK 141 (319)
T ss_pred eEEEccCCCCChhHHHHHHHHhc---------------------c-CcccEEEeeCCccchHHHHHHHHHHHhCCCCceE
Confidence 77777777776544433332221 1 336666666665542 122233444 56666
Q ss_pred EeccCccccc----cCCCCCCCccccCceeccCCcccCC----CCCCccccccccccccccccccccCchhhhhhccccc
Q 037275 400 LYLDSNFLAG----GIPTSLGNLTLLTNLALSSNDLQGS----IPPSLGNCKNLIELHMADIELTGALPPQILSISTLSL 471 (992)
Q Consensus 400 L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~ 471 (992)
|++++|.+++ .++..+..+++|++|++++|.+++. ++..+..+++|+.|++++|.+++...
T Consensus 142 L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~----------- 210 (319)
T cd00116 142 LVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGA----------- 210 (319)
T ss_pred EEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHH-----------
Confidence 6666666652 1233344555677777777766631 12223344466666555555441100
Q ss_pred ccccccccccCcccccccCCCCccEEeeecccccccCCccccc-----ccccceeeccCCcccc----cCCccccccCCC
Q 037275 472 SLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSA-----CTSLQQLYLQGNSFSG----SIPSSLSSLKSI 542 (992)
Q Consensus 472 ~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-----l~~L~~L~L~~N~l~~----~~~~~~~~l~~L 542 (992)
+.++..+..+++|++|++++|.+++.....+.. .+.|+.|++++|.+++ .+...+..+++|
T Consensus 211 ----------~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L 280 (319)
T cd00116 211 ----------SALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESL 280 (319)
T ss_pred ----------HHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCc
Confidence 022334556778888888888877533333222 3678888888888762 233455566788
Q ss_pred CEEECCCcccCCC----ChhhhhcC-CCcceEecCCCcC
Q 037275 543 KELDMSSNNLSGQ----IPEYLENL-SFLEYLNLSYNHF 576 (992)
Q Consensus 543 ~~L~Ls~N~l~~~----~p~~~~~l-~~L~~L~l~~N~l 576 (992)
+++++++|.++.. ....+... +.|+.|++.+|+|
T Consensus 281 ~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 281 LELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred cEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 8888888888744 33344444 6778888877765
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.6e-18 Score=189.92 Aligned_cols=187 Identities=26% Similarity=0.324 Sum_probs=152.9
Q ss_pred ccccccceEEEEeEE---CCCCeEEEEEEeeccCC--CchhHHHHHHHHHHhcc-CCcceeEEEEeecccccCcceEEEE
Q 037275 686 MIGQGSFGFVYKGNL---GENGMMVAVKVINLKQK--GASNGFVAECQALRNIR-HRNLIKIITICSSIDFKGVDFQAIV 759 (992)
Q Consensus 686 ~lg~G~~g~V~~~~~---~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv 759 (992)
++|+|.||.|+.+.- .+.|..+|+|+.+.... ........|..++...+ ||.++++.-. ++.....+++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhya-----fqt~~kl~l~ 75 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYA-----FQTDGKLYLI 75 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeee-----eccccchhHh
Confidence 479999999997653 34577899998864321 11124566788888886 9999998766 5566677999
Q ss_pred EEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccccee
Q 037275 760 YEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKF 839 (992)
Q Consensus 760 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 839 (992)
++|..+|.+...+.+.. .+++.....+...++-|++++|+. +|+|||+|++||+++.+|++++.|||.++.
T Consensus 76 ld~~rgg~lft~l~~~~------~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske 146 (612)
T KOG0603|consen 76 LDFLRGGDLFTRLSKEV------MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKE 146 (612)
T ss_pred hhhcccchhhhccccCC------chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhH
Confidence 99999999999987655 367777888888999999999999 999999999999999999999999999986
Q ss_pred cCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCC
Q 037275 840 LSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDG 900 (992)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 900 (992)
.-... ..+||..|||||++. ....++|-||||++++||+||..||.+
T Consensus 147 ~v~~~------------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 147 AVKEK------------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred hHhhh------------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 53221 117899999999987 556789999999999999999999975
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.8e-18 Score=185.86 Aligned_cols=129 Identities=30% Similarity=0.523 Sum_probs=109.6
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGD 833 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 833 (992)
.+.+|.|++|+..+|.+++...+.. ...++.....++.|++.|++| + +.+|+|+||.||+...+..+||+|
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~---e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgD 399 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTG---EERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGD 399 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcc---cccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhh
Confidence 4578999999999999999765532 346788889999999999999 6 899999999999999999999999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT 893 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt 893 (992)
||+........ .............||..||+||.+.+..|+.++||||+|++++|++.
T Consensus 400 Fgl~ts~~~~~--~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 400 FGLVTSQDKDE--TVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred hhheeecccCC--cccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 99998766543 11112333455679999999999999999999999999999999998
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.8e-17 Score=167.84 Aligned_cols=143 Identities=18% Similarity=0.145 Sum_probs=111.2
Q ss_pred CCCCCCccccccceEEEEeE-ECCCCeEEEEEEeeccCCC------------------------chhHHHHHHHHHHhcc
Q 037275 680 DFSSSNMIGQGSFGFVYKGN-LGENGMMVAVKVINLKQKG------------------------ASNGFVAECQALRNIR 734 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~-~~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 734 (992)
-|++.+.||+|+||.||+|. +..+|+.||+|+++..... ....+.+|++.++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47888999999999999998 5568999999998743210 0123568999999997
Q ss_pred CC--cceeEEEEeecccccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCC-e
Q 037275 735 HR--NLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPP-V 811 (992)
Q Consensus 735 h~--niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~-i 811 (992)
+. .+.+++++. ..++||||++++++........ .....+...++.|++.++++||++ + |
T Consensus 109 ~~~i~~p~~~~~~---------~~~lV~E~~~g~~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---g~i 170 (237)
T smart00090 109 EAGVPVPKPIAWR---------RNVLVMEFIGGDGLPAPRLKDV------EPEEEEEFELYDDILEEMRKLYKE---GEL 170 (237)
T ss_pred hcCCCCCeeeEec---------CceEEEEEecCCcccccccccC------CcchHHHHHHHHHHHHHHHHHHhc---CCE
Confidence 53 344444431 1379999999988876543221 245566788999999999999999 9 9
Q ss_pred EeccCCCCCeeeCCCCcEEEeecccceecC
Q 037275 812 VHGDLKPSNVLLDQDLVAHLGDFGLAKFLS 841 (992)
Q Consensus 812 vH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 841 (992)
+||||||+||+++ ++.++|+|||.|....
T Consensus 171 iH~Dikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 171 VHGDLSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EeCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence 9999999999999 8899999999987543
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.9e-16 Score=185.79 Aligned_cols=150 Identities=31% Similarity=0.533 Sum_probs=122.3
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCCcCCCCCC----ceEeeEEcCC--C--CeEEEeeccccccCCccCCCCCCCCcC
Q 037275 5 SNETDRLALLAIGSQLEDDPLGVTSSWNNSTNLC----QWTGVTCGHR--H--QRVTKLDLSNRTIGGTLSPYVGNLSFL 76 (992)
Q Consensus 5 ~~~~~~~~ll~~~~~~~~~~~~~~~~w~~~~~~c----~w~gv~c~~~--~--~~v~~ldl~~~~l~~~l~~~l~~l~~L 76 (992)
...+|.+||++||+++. +|.. .+|+ +..|| .|.||+|+.. . .+|+.|+|+++.+.|.+|+.++.+++|
T Consensus 369 t~~~~~~aL~~~k~~~~-~~~~--~~W~-g~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L 444 (623)
T PLN03150 369 TLLEEVSALQTLKSSLG-LPLR--FGWN-GDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHL 444 (623)
T ss_pred cCchHHHHHHHHHHhcC-Cccc--CCCC-CCCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCC
Confidence 35678999999999985 4432 5895 43443 7999999532 2 369999999999999999999999999
Q ss_pred CeeeccCCCCCccCCccccCCCCCCEEEeecccCCCCCCcccccCCCCcEeecccccccccCChhhcccccccccccccc
Q 037275 77 RYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIAD 156 (992)
Q Consensus 77 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~~L~L~~ 156 (992)
+.|+|++|++.|.+|..++.+++|++|+|++|+++|.+|..++++++|+.|+|++|++++.+|..+.....++..+++.+
T Consensus 445 ~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~ 524 (623)
T PLN03150 445 QSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTD 524 (623)
T ss_pred CEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecC
Confidence 99999999999999999999999999999999999999999999999999999999999888887753333444444444
Q ss_pred cc
Q 037275 157 NH 158 (992)
Q Consensus 157 n~ 158 (992)
|.
T Consensus 525 N~ 526 (623)
T PLN03150 525 NA 526 (623)
T ss_pred Cc
Confidence 43
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.2e-17 Score=186.70 Aligned_cols=218 Identities=25% Similarity=0.313 Sum_probs=148.4
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAI 758 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 758 (992)
.+|..++.|..|+||.||.++++.+.+.+|+|+=+ +. .|++ ||..+.|- .+.
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~-----------lilR-----nilt~a~n-----------pfv 134 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QN-----------LILR-----NILTFAGN-----------PFV 134 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcccc-cc-----------hhhh-----ccccccCC-----------cce
Confidence 47889999999999999999999889999995422 11 1111 13332221 122
Q ss_pred EEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccce
Q 037275 759 VYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAK 838 (992)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 838 (992)
| |+-.+.++..+. ++. +++.+++|+|+. +|+|||+||+|.+|+.-|++|++|||+++
T Consensus 135 v------gDc~tllk~~g~------lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk 191 (1205)
T KOG0606|consen 135 V------GDCATLLKNIGP------LPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSK 191 (1205)
T ss_pred e------chhhhhcccCCC------Ccc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhh
Confidence 3 455555554332 222 227899999999 99999999999999999999999999987
Q ss_pred ecCCCCCC---CC----cccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHH
Q 037275 839 FLSSSPLD---TA----VETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEF 911 (992)
Q Consensus 839 ~~~~~~~~---~~----~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~ 911 (992)
..-..... .. .......+..+||+.|+|||++....|+..+|-|++|+|+||.+.|+.||.+...+ ..+..+
T Consensus 192 ~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe-elfg~v 270 (1205)
T KOG0606|consen 192 KGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-ELFGQV 270 (1205)
T ss_pred hhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH-HHHhhh
Confidence 53221110 00 00122345568999999999999999999999999999999999999999874322 111111
Q ss_pred HhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHH
Q 037275 912 ARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMR 973 (992)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 973 (992)
+... . ..++ ..+....+..+++.+.|+.+|.+|--..
T Consensus 271 isd~----------------i------~wpE---~dea~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 271 ISDD----------------I------EWPE---EDEALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred hhhh----------------c------cccc---cCcCCCHHHHHHHHHHHHhChHhhcccc
Confidence 1110 0 0000 1223345678889999999999996443
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.1e-15 Score=155.58 Aligned_cols=144 Identities=24% Similarity=0.212 Sum_probs=110.8
Q ss_pred HHHHHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCC----------------------chhHHHHHHHHH
Q 037275 673 ELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKG----------------------ASNGFVAECQAL 730 (992)
Q Consensus 673 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l 730 (992)
++...-..|.+.+.||+|+||.||+|... +|+.||||+++..... .......|..++
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 33344445888899999999999999885 7999999987643210 012356788899
Q ss_pred HhccCCc--ceeEEEEeecccccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCC
Q 037275 731 RNIRHRN--LIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQ 808 (992)
Q Consensus 731 ~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~ 808 (992)
.++.|++ +.+.++. ...++||||+++++|...... .....++.+++.++.++|+.
T Consensus 88 ~~l~~~~i~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~~------------~~~~~~~~~i~~~l~~lh~~-- 144 (198)
T cd05144 88 KALYEEGFPVPKPIDW---------NRHAVVMEYIDGVELYRVRVL------------EDPEEVLDEILEEIVKAYKH-- 144 (198)
T ss_pred HHHHHcCCCCCceeec---------CCceEEEEEeCCcchhhcccc------------ccHHHHHHHHHHHHHHHHHC--
Confidence 9998874 4444432 223899999999998765421 23456889999999999999
Q ss_pred CCeEeccCCCCCeeeCCCCcEEEeecccceecC
Q 037275 809 PPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLS 841 (992)
Q Consensus 809 ~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 841 (992)
+|+||||||+||++++++.++|+|||.+....
T Consensus 145 -gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 145 -GIIHGDLSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred -CCCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence 99999999999999999999999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.7e-15 Score=177.95 Aligned_cols=144 Identities=24% Similarity=0.319 Sum_probs=111.3
Q ss_pred HHHHHHHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC--C------CchhHHHHHHHHHHhccCCcceeEE
Q 037275 671 YAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--K------GASNGFVAECQALRNIRHRNLIKII 742 (992)
Q Consensus 671 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~------~~~~~~~~E~~~l~~l~h~niv~~~ 742 (992)
+.........|...+.||+|+||+||+|.+. +..+++|+..... . ...+++.+|+++++.++|++++...
T Consensus 325 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~ 402 (535)
T PRK09605 325 WIKEEEVKRRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPV 402 (535)
T ss_pred eccccccccccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeE
Confidence 3333444556677899999999999999985 3344555432111 1 1134678999999999999998876
Q ss_pred EEeecccccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCee
Q 037275 743 TICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVL 822 (992)
Q Consensus 743 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIl 822 (992)
.++.. ....++||||+++++|.+++. ....++.|++++|+|||+. +++|||+||+||+
T Consensus 403 ~~~~~-----~~~~~lv~E~~~g~~L~~~l~--------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NIL 460 (535)
T PRK09605 403 IYDVD-----PEEKTIVMEYIGGKDLKDVLE--------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFI 460 (535)
T ss_pred EEEEe-----CCCCEEEEEecCCCcHHHHHH--------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEE
Confidence 66433 223489999999999999875 2356889999999999999 9999999999999
Q ss_pred eCCCCcEEEeeccccee
Q 037275 823 LDQDLVAHLGDFGLAKF 839 (992)
Q Consensus 823 l~~~~~~kl~Dfg~a~~ 839 (992)
+ .++.++|+|||+++.
T Consensus 461 l-~~~~~~liDFGla~~ 476 (535)
T PRK09605 461 V-RDDRLYLIDFGLGKY 476 (535)
T ss_pred E-ECCcEEEEeCccccc
Confidence 9 678999999999874
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.6e-15 Score=156.53 Aligned_cols=134 Identities=22% Similarity=0.360 Sum_probs=109.3
Q ss_pred CccccccceEEEEeEECCCCeEEEEEEeeccCCC--------chhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 685 NMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKG--------ASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
+.||+|++|.||+|.. .|..|++|+....... ....+.+|+.++..+.|+++.....++.. ....
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-----~~~~ 74 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD-----PENF 74 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe-----CCCC
Confidence 6799999999999988 6778999986533221 12357789999999999988766665432 2345
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
++||||++|++|.+++.... . .+..++.+++.+|+++|+. +++|||++|.||+++ ++.++++|||.
T Consensus 75 ~lv~e~~~G~~L~~~~~~~~---------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~ 140 (211)
T PRK14879 75 IIVMEYIEGEPLKDLINSNG---------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGL 140 (211)
T ss_pred EEEEEEeCCcCHHHHHHhcc---------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCc
Confidence 89999999999999986421 2 7788999999999999999 999999999999999 78999999998
Q ss_pred cee
Q 037275 837 AKF 839 (992)
Q Consensus 837 a~~ 839 (992)
+..
T Consensus 141 a~~ 143 (211)
T PRK14879 141 AEF 143 (211)
T ss_pred ccC
Confidence 863
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.8e-15 Score=152.07 Aligned_cols=130 Identities=25% Similarity=0.404 Sum_probs=102.3
Q ss_pred ccccccceEEEEeEECCCCeEEEEEEeeccCCC--------chhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 686 MIGQGSFGFVYKGNLGENGMMVAVKVINLKQKG--------ASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 686 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
.||+|+||.||+|.. ++..|++|+....... ...++.+|+++++.+.|+++.....++.. ....+
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-----~~~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD-----PDNKT 73 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE-----CCCCE
Confidence 489999999999996 5788999986432211 12456789999999988765444333221 22348
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||++|++|.+++.... . .++.+++.+|+++|+. +++|||++|+||+++ ++.++++|||.+
T Consensus 74 lv~e~~~g~~l~~~~~~~~-------~------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a 136 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEEGN-------D------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLG 136 (199)
T ss_pred EEEEEECCccHHHHHhhcH-------H------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCC
Confidence 9999999999999875421 0 6889999999999999 999999999999999 889999999988
Q ss_pred ee
Q 037275 838 KF 839 (992)
Q Consensus 838 ~~ 839 (992)
..
T Consensus 137 ~~ 138 (199)
T TIGR03724 137 KY 138 (199)
T ss_pred cC
Confidence 64
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=3.9e-14 Score=142.98 Aligned_cols=136 Identities=22% Similarity=0.259 Sum_probs=97.6
Q ss_pred CCccccccceEEEEeEECCCCeEEEEEEeeccCCC--chhH----------------------HHHHHHHHHhccCCc--
Q 037275 684 SNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKG--ASNG----------------------FVAECQALRNIRHRN-- 737 (992)
Q Consensus 684 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~n-- 737 (992)
.+.||+|+||+||+|... +++.||||+++..... .... ...|...+.++.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 468999999999999986 8999999998643211 1111 134566666664432
Q ss_pred ceeEEEEeecccccCcceEEEEEEeccCCCHHHH-HhhcccchhhcccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecc
Q 037275 738 LIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDW-LHQSEDQQEARSLTLIQRINIIIDVASAIEYIHH-HCQPPVVHGD 815 (992)
Q Consensus 738 iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~D 815 (992)
+.+.+++ ...++||||++++++... +.... .. .+...++.+++.++.++|. . +|+|||
T Consensus 81 ~~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~~~-------~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~D 140 (187)
T cd05119 81 VPKPIDL---------NRHVLVMEFIGGDGIPAPRLKDVR-------LL-EDPEELYDQILELMRKLYREA---GLVHGD 140 (187)
T ss_pred CCceEec---------CCCEEEEEEeCCCCccChhhhhhh-------hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCC
Confidence 4444443 123899999998554321 11110 11 5567899999999999999 7 999999
Q ss_pred CCCCCeeeCCCCcEEEeecccceecC
Q 037275 816 LKPSNVLLDQDLVAHLGDFGLAKFLS 841 (992)
Q Consensus 816 lkp~NIll~~~~~~kl~Dfg~a~~~~ 841 (992)
+||+||+++ ++.++++|||.+....
T Consensus 141 l~p~Nili~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 141 LSEYNILVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred CChhhEEEE-CCcEEEEECccccccc
Confidence 999999999 8999999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.53 E-value=4.6e-14 Score=137.39 Aligned_cols=135 Identities=18% Similarity=0.259 Sum_probs=109.5
Q ss_pred CCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccC--CcceeEEEEeecccccCcceEEEEE
Q 037275 683 SSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRH--RNLIKIITICSSIDFKGVDFQAIVY 760 (992)
Q Consensus 683 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~lv~ 760 (992)
+.+.||+|.++.||++... +..+++|+...... ...+.+|+.+++.++| .++.+++++.. ..+..+++|
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~-----~~~~~~~v~ 72 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGE-----SDGWSYLLM 72 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcC-----CCCccEEEE
Confidence 4578999999999999984 47899999854332 5678899999999976 58888888743 235569999
Q ss_pred EeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccccee
Q 037275 761 EYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKF 839 (992)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 839 (992)
||++++.+..+ +......++.+++++++++|.....+++|||++|+||++++.+.+++.|||.++.
T Consensus 73 e~~~g~~~~~~-------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 73 EWIEGETLDEV-------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred EecCCeecccC-------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 99988766554 3345566889999999999986434799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.1e-13 Score=143.78 Aligned_cols=139 Identities=19% Similarity=0.169 Sum_probs=105.6
Q ss_pred CCccc-cccceEEEEeEECCCCeEEEEEEeeccC-------------CCchhHHHHHHHHHHhccCCcc--eeEEEEeec
Q 037275 684 SNMIG-QGSFGFVYKGNLGENGMMVAVKVINLKQ-------------KGASNGFVAECQALRNIRHRNL--IKIITICSS 747 (992)
Q Consensus 684 ~~~lg-~G~~g~V~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~ 747 (992)
..+|| .||.|+||.++.. +..++||.+.... ......+.+|++++.++.|+++ ++.+++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 35787 8999999999884 7789999885311 1223567889999999998875 667766432
Q ss_pred ccccCcceEEEEEEeccC-CCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCC
Q 037275 748 IDFKGVDFQAIVYEYMQN-GSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQD 826 (992)
Q Consensus 748 ~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 826 (992)
.. ......++||||+++ .+|.+++... .++.. .+.+++.++.+||+. ||+||||||+|||++.+
T Consensus 114 ~~-~~~~~~~lV~e~l~G~~~L~~~l~~~-------~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~ 178 (239)
T PRK01723 114 RH-GLFYRADILIERIEGARDLVALLQEA-------PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPD 178 (239)
T ss_pred ec-CcceeeeEEEEecCCCCCHHHHHhcC-------CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCC
Confidence 11 111223699999997 6999988642 24433 356899999999999 99999999999999999
Q ss_pred CcEEEeeccccee
Q 037275 827 LVAHLGDFGLAKF 839 (992)
Q Consensus 827 ~~~kl~Dfg~a~~ 839 (992)
+.++|+|||.+..
T Consensus 179 ~~v~LIDfg~~~~ 191 (239)
T PRK01723 179 GKFWLIDFDRGEL 191 (239)
T ss_pred CCEEEEECCCccc
Confidence 9999999998864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=9e-16 Score=178.51 Aligned_cols=257 Identities=23% Similarity=0.263 Sum_probs=187.2
Q ss_pred hcCCCCCCccccccceEEEEeEEC-CCCeEEEEEEeeccC--CCchhHHHHHHHHHHhcc-CCcceeEEEEeecccccCc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLG-ENGMMVAVKVINLKQ--KGASNGFVAECQALRNIR-HRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~ 753 (992)
...|.+.+.||+|+|+.|-.+... .....+|+|.+.... .........|..+-+.+. |+|++.+++.. ...
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~-----~~~ 93 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS-----SSP 93 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc-----CCC
Confidence 346788888999999999888774 234567777665433 233344566888878886 99999999974 445
Q ss_pred ceEEEEEEeccCCCHHHHH-hhcccchhhcccCHHHHHHHHHHHHHHHHHHH-hcCCCCeEeccCCCCCeeeCCCC-cEE
Q 037275 754 DFQAIVYEYMQNGSLEDWL-HQSEDQQEARSLTLIQRINIIIDVASAIEYIH-HHCQPPVVHGDLKPSNVLLDQDL-VAH 830 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l-~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH-~~~~~~ivH~Dlkp~NIll~~~~-~~k 830 (992)
...+++++|.+++++.+.+ ..... ..+....-.++.|+..++.|+| .. +++|||+||+|.+++..+ ..+
T Consensus 94 ~~~~~~~~~s~g~~~f~~i~~~~~~-----~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~ 165 (601)
T KOG0590|consen 94 RSYLLSLSYSDGGSLFSKISHPDST-----GTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALK 165 (601)
T ss_pred cccccccCcccccccccccccCCcc-----CCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCccc
Confidence 5669999999999999988 33221 3555666778999999999999 77 999999999999999999 999
Q ss_pred EeecccceecCCCCCCCCcccCCCCCcccc-cccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccH
Q 037275 831 LGDFGLAKFLSSSPLDTAVETPSSSKGIKG-TVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTL 908 (992)
Q Consensus 831 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~ 908 (992)
++|||+|..+.... ..........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++........+
T Consensus 166 ~~df~~At~~~~~~-----g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~ 240 (601)
T KOG0590|consen 166 IADFGLATAYRNKN-----GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY 240 (601)
T ss_pred CCCchhhccccccC-----CcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc
Confidence 99999998776511 12333344567 9999999998874 45678999999999999999999988754444333
Q ss_pred HHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 037275 909 HEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVV 976 (992)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 976 (992)
..|........ .. ..........++..+++..+|+.|.+.+++.
T Consensus 241 ~~~~~~~~~~~-------------------~~-----~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 241 SSWKSNKGRFT-------------------QL-----PWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred eeecccccccc-------------------cC-----ccccCChhhhhcccccccCCchhcccccccc
Confidence 33332210000 00 0011122356777888889999999988874
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.51 E-value=3.9e-14 Score=167.82 Aligned_cols=118 Identities=35% Similarity=0.569 Sum_probs=99.8
Q ss_pred CccEEeeecccccccCCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcccCCCChhhhhcCCCcceEecC
Q 037275 493 NLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLS 572 (992)
Q Consensus 493 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 572 (992)
.++.|+|++|.++|.+|..+..+++|+.|+|++|+|+|.+|..+..+++|+.|+|++|+|+|.+|..+..+++|++|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 37788999999999999999999999999999999998999999999999999999999999999999999999999999
Q ss_pred CCcCcccCCCC--CccCCcccccccCCCCcCCCCCCCCCCCCC
Q 037275 573 YNHFEGEVPTK--GVFSNKTGISLSGNGKVCGGLDELNLPPCP 613 (992)
Q Consensus 573 ~N~l~~~~~~~--~~~~~~~~~~l~~N~~~C~~~~~~~~~~~~ 613 (992)
+|+++|.+|.. ..+..+..+++.+|+..|+.|. .++|.
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~---l~~C~ 538 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG---LRACG 538 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCCC---CCCCc
Confidence 99999888863 1223455678899999998754 35674
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.9e-15 Score=162.36 Aligned_cols=175 Identities=31% Similarity=0.473 Sum_probs=98.1
Q ss_pred CCcccEEEccCCcCCCCCCccccCCCCCcEEeccCccccccCCCCCCCccccCceeccCCcccCCCCCCccccccccccc
Q 037275 370 LVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELH 449 (992)
Q Consensus 370 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 449 (992)
+..-...||+.|++. .+|..+..+..|+.+.|.+|.|. .+|..++++..|+.|+|+.|+++ ..|..++.++ |+.|-
T Consensus 74 ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli 149 (722)
T KOG0532|consen 74 LTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLI 149 (722)
T ss_pred ccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEE
Confidence 344455667777776 66666666667777777777776 66666777777777777777776 5565555553 55554
Q ss_pred cccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeecccccccCCcccccccccceeeccCCccc
Q 037275 450 MADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFS 529 (992)
Q Consensus 450 l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 529 (992)
+++|+++ .+|..++.++.|..||.+.|++. .+|..++++.+|+.|++..|++.
T Consensus 150 ~sNNkl~--------------------------~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~ 202 (722)
T KOG0532|consen 150 VSNNKLT--------------------------SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE 202 (722)
T ss_pred EecCccc--------------------------cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh
Confidence 4554444 44444444445555555555554 34444555555555555555554
Q ss_pred ccCCccccccCCCCEEECCCcccCCCChhhhhcCCCcceEecCCCcCcc
Q 037275 530 GSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEG 578 (992)
Q Consensus 530 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 578 (992)
.+|..++.| .|..||+|.|+++ .+|-.|.+|..|++|-|.+|+|+.
T Consensus 203 -~lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqS 248 (722)
T KOG0532|consen 203 -DLPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQS 248 (722)
T ss_pred -hCCHHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCC
Confidence 334444432 3445555555554 445555555555555555555543
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.44 E-value=3.9e-15 Score=160.05 Aligned_cols=195 Identities=26% Similarity=0.419 Sum_probs=124.5
Q ss_pred CCCcCCeeeccCCCCCccCCccccCCCCCCEEEeecccCCCCCCcccccCCCCcEeecccccccccCChhhccccccccc
Q 037275 72 NLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLEN 151 (992)
Q Consensus 72 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~~ 151 (992)
.+..-...||+.|.+. ++|..+..+..|+.|.|.+|.+. .+|..++++..|++||++.|++. .+|..++ .--|++
T Consensus 73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC--~lpLkv 147 (722)
T KOG0532|consen 73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLC--DLPLKV 147 (722)
T ss_pred cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhh--cCccee
Confidence 4555566777777777 77777777777777777777777 77777777777777777777776 6666665 234666
Q ss_pred ccccccccCCCCCCccccccccceEEecCCcccCCcCCccCCCCcccEEeccCcccccccCccccccCCCcEEeccCCcc
Q 037275 152 LTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRF 231 (992)
Q Consensus 152 L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l 231 (992)
|-+++|+++ .+|+.++.+.+|..|+.+.|.+ ..+|..++++.+|+.|++..|++. .+|..++.| .|..||+|.|++
T Consensus 148 li~sNNkl~-~lp~~ig~~~tl~~ld~s~nei-~slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNki 223 (722)
T KOG0532|consen 148 LIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEI-QSLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKI 223 (722)
T ss_pred EEEecCccc-cCCcccccchhHHHhhhhhhhh-hhchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCce
Confidence 666666666 5666666666666666666666 345556666666666666666666 455555532 455566666655
Q ss_pred CCCCCccccccccccchhhccccccCCCCchhhhccccCceeeeccccccccccccccccCc---cceEecCCC
Q 037275 232 NGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKN---LEWLNLGSN 302 (992)
Q Consensus 232 ~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~---L~~L~L~~N 302 (992)
. .+|-.|.+|+.|++|-|.+|-++ .+|..++-... -++|+..-+
T Consensus 224 s--------------------------~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~ 270 (722)
T KOG0532|consen 224 S--------------------------YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQAC 270 (722)
T ss_pred e--------------------------ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhc
Confidence 5 56666777777777777777776 34444433222 244444444
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.42 E-value=2.6e-13 Score=136.65 Aligned_cols=163 Identities=22% Similarity=0.389 Sum_probs=125.4
Q ss_pred HHHHhccCCcceeEEEEeecccccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcC
Q 037275 728 QALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHC 807 (992)
Q Consensus 728 ~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ 807 (992)
+-+-.+.|.|+|++..|+.+..+.+.....+++|||..|++..++++.+.. ...+......+|+-||..||.|||+.
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~--~~a~~~~~wkkw~tqIlsal~yLhs~- 195 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKN--QKALFQKAWKKWCTQILSALSYLHSC- 195 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHh--hhhhhHHHHHHHHHHHHhhhhhhhcc-
Confidence 345556799999999998887777777888999999999999999987654 34577888889999999999999997
Q ss_pred CCCeEeccCCCCCeeeCCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHH
Q 037275 808 QPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGIL 887 (992)
Q Consensus 808 ~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~i 887 (992)
.|.|+|+++..+-|++..+|-+|++--.-......-... .........+-++|.|||+-.....+.++|||+||+.
T Consensus 196 ~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~----~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmc 271 (458)
T KOG1266|consen 196 DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNST----REAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMC 271 (458)
T ss_pred CCccccCCcchhheeecCCceEEecccCccccchhhhhh----hHhhhhccccCCccccCCcCcccccccchhhhhhhHH
Confidence 678999999999999999998887532211111100000 0111112346789999998777778889999999999
Q ss_pred HHHHHhCCCC
Q 037275 888 LLEMFTRRRP 897 (992)
Q Consensus 888 l~elltg~~p 897 (992)
..||..+..-
T Consensus 272 AlemailEiq 281 (458)
T KOG1266|consen 272 ALEMAILEIQ 281 (458)
T ss_pred HHHHHHheec
Confidence 9999998763
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.38 E-value=4.9e-13 Score=147.72 Aligned_cols=251 Identities=25% Similarity=0.276 Sum_probs=183.0
Q ss_pred CCCCCCcccc--ccceEEEEeEE--CCCCeEEEEEEeecc--CCCchhHHHHHHHHHHhc-cCCcceeEEEEeecccccC
Q 037275 680 DFSSSNMIGQ--GSFGFVYKGNL--GENGMMVAVKVINLK--QKGASNGFVAECQALRNI-RHRNLIKIITICSSIDFKG 752 (992)
Q Consensus 680 ~~~~~~~lg~--G~~g~V~~~~~--~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 752 (992)
.|.+.+.+|. |.+|.||.+.. ..++..+|+|.-+.. .......-.+|+...+++ .|++.++.... +.+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~-----~e~ 189 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA-----WEG 189 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc-----ccc
Confidence 4567788999 99999999998 788999999985422 223334445677777777 48999885544 566
Q ss_pred cceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHH----HHHHHHhcCCCCeEeccCCCCCeeeCCC-C
Q 037275 753 VDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVAS----AIEYIHHHCQPPVVHGDLKPSNVLLDQD-L 827 (992)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~----~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~ 827 (992)
.+..++-+|++ +.++.++...... .++....+.+..+..+ |+.++|.. +++|-|+||.||+...+ .
T Consensus 190 ~~~lfiqtE~~-~~sl~~~~~~~~~-----~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~ 260 (524)
T KOG0601|consen 190 SGILFIQTELC-GESLQSYCHTPCN-----FLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWT 260 (524)
T ss_pred CCcceeeeccc-cchhHHhhhcccc-----cCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccc
Confidence 77779999998 5789888876543 3788888889999999 99999999 99999999999999999 8
Q ss_pred cEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCc-cCCc
Q 037275 828 VAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMF-NQGL 906 (992)
Q Consensus 828 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~-~~~~ 906 (992)
..+++|||+...+......... .......|...|++||.. .+-++.+.|||++|.++.+..+|..+..... ....
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~---~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~ 336 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVF---KVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWS 336 (524)
T ss_pred eeecCCcceeEEccCCccccce---eeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCCCcc
Confidence 9999999999988765432222 111223578889999975 4567889999999999999999877654321 2211
Q ss_pred cHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 907 TLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
....+. ++.++-+- ...++...+.+|++.+|-.|++++.+.+
T Consensus 337 ~~r~~~---ip~e~~~~--------------------------~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 337 QLRQGY---IPLEFCEG--------------------------GSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred cccccc---CchhhhcC--------------------------cchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 111111 12111110 0122344788899999999999988753
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.37 E-value=9.3e-13 Score=149.84 Aligned_cols=197 Identities=32% Similarity=0.464 Sum_probs=109.3
Q ss_pred EEEeecccCCCCCCcccccCCCCcEeecccccccccCChhhccccc-ccccccccccccCCCCCCccccccccceEEecC
Q 037275 102 ALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWL-KLENLTIADNHLTGHFPASIGNLSTLERINVLG 180 (992)
Q Consensus 102 ~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~ 180 (992)
.|+++.|.+. ..+..+..++.+..|++..|+++ .+|.... .+. +|++|++++|.+. .+|..+..+++|+.|++++
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~-~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~ 172 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIG-LLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSF 172 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccc-cchhhcccccccccchh-hhhhhhhccccccccccCC
Confidence 5666666654 33334445566666666666666 5555543 232 5666666666666 4555566666666666666
Q ss_pred CcccCCcCCccCCCCcccEEeccCcccccccCccccccCCCcEEeccCCccCCCCCccccccccccchhhccccccCCCC
Q 037275 181 NGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSI 260 (992)
Q Consensus 181 n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~ 260 (992)
|++ ..+|...+.+++|+.|++++|+++ .+|.....+..|++|.+++|.+. .+
T Consensus 173 N~l-~~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~--------------------------~~ 224 (394)
T COG4886 173 NDL-SDLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII--------------------------EL 224 (394)
T ss_pred chh-hhhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce--------------------------ec
Confidence 666 345544445566666666666666 45555444455666666665322 23
Q ss_pred chhhhccccCceeeeccccccccccccccccCccceEecCCCCCCCCCCCCchhhhhccCCCcceEeecCCCcCCCcCC
Q 037275 261 PESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLP 339 (992)
Q Consensus 261 p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~l~~~~~ 339 (992)
+..+.++.++..|.+.+|++.. .+..+..+.++++|++++|+++.++. +....+++.|++++|.+....|
T Consensus 225 ~~~~~~~~~l~~l~l~~n~~~~-~~~~~~~l~~l~~L~~s~n~i~~i~~--------~~~~~~l~~L~~s~n~~~~~~~ 294 (394)
T COG4886 225 LSSLSNLKNLSGLELSNNKLED-LPESIGNLSNLETLDLSNNQISSISS--------LGSLTNLRELDLSGNSLSNALP 294 (394)
T ss_pred chhhhhcccccccccCCceeee-ccchhccccccceecccccccccccc--------ccccCccCEEeccCccccccch
Confidence 3445555555555556665552 24455555556666666666655432 4444555555555555554443
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.37 E-value=4.1e-12 Score=143.78 Aligned_cols=162 Identities=19% Similarity=0.248 Sum_probs=109.5
Q ss_pred ccCCCcccHHHHHHHh------------cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCch----------
Q 037275 663 DQQFPMISYAELSKAT------------NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGAS---------- 720 (992)
Q Consensus 663 ~~~~~~~~~~~~~~~~------------~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---------- 720 (992)
+...|.++++++++.. ..|+ .+.||.|++|.||+|+.. +|+.||||+.++......
T Consensus 90 qd~v~p~~~~~~~~~l~~elg~~~~~~F~~fd-~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~ 167 (437)
T TIGR01982 90 QDRVPPFDFKVARKVIEAALGGPLEELFAEFE-EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRL 167 (437)
T ss_pred hcCCCCCCHHHHHHHHHHHhCcCHHHHHhhCC-CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHH
Confidence 3455666666554432 2233 368999999999999986 799999999864311000
Q ss_pred ------------------------------hHHHHHHHHHHhcc----CCcceeEEEEeecccccCcceEEEEEEeccCC
Q 037275 721 ------------------------------NGFVAECQALRNIR----HRNLIKIITICSSIDFKGVDFQAIVYEYMQNG 766 (992)
Q Consensus 721 ------------------------------~~~~~E~~~l~~l~----h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g 766 (992)
-++.+|+..+.++. |.+-+.+-.++.+ + ....++||||++|+
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~--~--~~~~vLvmE~i~G~ 243 (437)
T TIGR01982 168 ARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRREAANASELGENFKNDPGVYVPEVYWD--R--TSERVLTMEWIDGI 243 (437)
T ss_pred HHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehh--h--cCCceEEEEeECCc
Confidence 02445555555552 3333444344322 1 22348999999999
Q ss_pred CHHHHHhhcccchhhcccCHHHHHHHHHHHHH-HHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceecC
Q 037275 767 SLEDWLHQSEDQQEARSLTLIQRINIIIDVAS-AIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLS 841 (992)
Q Consensus 767 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~-~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 841 (992)
+|.++...... .. .+.+++.+++. .+..+|.. |++|+|++|.||+++.++.++++|||++..+.
T Consensus 244 ~L~~~~~~~~~-----~~---~~~~ia~~~~~~~l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 244 PLSDIAALDEA-----GL---DRKALAENLARSFLNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ccccHHHHHhc-----CC---CHHHHHHHHHHHHHHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99988754221 12 23456666666 47888998 99999999999999999999999999998664
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.8e-12 Score=145.87 Aligned_cols=214 Identities=29% Similarity=0.394 Sum_probs=159.0
Q ss_pred CceEeeEEcCCCCeEE---EeeccccccCCccCCCCCCCCcCCeeeccCCCCCccCCccccCCC-CCCEEEeecccCCCC
Q 037275 38 CQWTGVTCGHRHQRVT---KLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLV-RLEALVLANNSFSGK 113 (992)
Q Consensus 38 c~w~gv~c~~~~~~v~---~ldl~~~~l~~~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~-~L~~L~Ls~n~l~~~ 113 (992)
+.+.+..+.... +. .++++.+.+. .....+..++.++.|++.+|.++ .+|.....+. +|++|++++|++. .
T Consensus 80 ~~~l~~~~~~~~--~~~~~~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~ 154 (394)
T COG4886 80 ISSLDGSENLLN--LLPLPSLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-S 154 (394)
T ss_pred cccccccccccC--CCCCceeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-h
Confidence 455555553222 22 4666666552 23344556678888888888888 7887777775 8888888888888 7
Q ss_pred CCcccccCCCCcEeecccccccccCChhhcccccccccccccccccCCCCCCccccccccceEEecCCcccCCcCCccCC
Q 037275 114 IPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGN 193 (992)
Q Consensus 114 ~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~ 193 (992)
+|..++.+++|+.|++++|++. .+|...+ ..+.|+.|++++|+++ .+|..+..+..|++|.+++|.+ -..+..+.+
T Consensus 155 l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~-~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~-~~~~~~~~~ 230 (394)
T COG4886 155 LPSPLRNLPNLKNLDLSFNDLS-DLPKLLS-NLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSI-IELLSSLSN 230 (394)
T ss_pred hhhhhhccccccccccCCchhh-hhhhhhh-hhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcc-eecchhhhh
Confidence 7778888888888888888888 7776654 5678888888888888 6777777777788888888864 356667888
Q ss_pred CCcccEEeccCcccccccCccccccCCCcEEeccCCccCCCCCccccccccccchhhccccccCCCCchhh
Q 037275 194 LRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESL 264 (992)
Q Consensus 194 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l 264 (992)
+.++..|.+++|++. .++..+..+++++.|++++|.++ .++. ...+.++..+++++|.+....|...
T Consensus 231 ~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~-~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~ 297 (394)
T COG4886 231 LKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS-SISS--LGSLTNLRELDLSGNSLSNALPLIA 297 (394)
T ss_pred cccccccccCCceee-eccchhccccccceecccccccc-cccc--ccccCccCEEeccCccccccchhhh
Confidence 888888888888887 34777888888888888888887 4443 4567788888888888887666544
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.28 E-value=2.2e-11 Score=138.89 Aligned_cols=165 Identities=18% Similarity=0.212 Sum_probs=104.2
Q ss_pred ccCCCcccHHHHHH------------HhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCC------------
Q 037275 663 DQQFPMISYAELSK------------ATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKG------------ 718 (992)
Q Consensus 663 ~~~~~~~~~~~~~~------------~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------------ 718 (992)
+...|.+++.++.+ ....|+. +.||+|++|.||+|+.+.+|+.||||+.++.-..
T Consensus 92 qd~vpp~~~~~~~~~ie~elG~~~~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~ 170 (537)
T PRK04750 92 QDRVPPFDGALARAIIEKALGGPVEEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRL 170 (537)
T ss_pred HcCCCCCCHHHHHHHHHHHhCCCHHHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHH
Confidence 34556666554433 2335776 7999999999999999866999999999643100
Q ss_pred ----------------------chh------HHHHHHHHHHhcc----CCcceeEEEEeecccccCcceEEEEEEeccCC
Q 037275 719 ----------------------ASN------GFVAECQALRNIR----HRNLIKIITICSSIDFKGVDFQAIVYEYMQNG 766 (992)
Q Consensus 719 ----------------------~~~------~~~~E~~~l~~l~----h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g 766 (992)
-.+ ++.+|+..+.+++ +...+.+-.++.+ + ....++||||++|+
T Consensus 171 a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d--~--st~~VLvmE~i~G~ 246 (537)
T PRK04750 171 ARWVERLLPDGRRLKPREVVAEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWD--Y--CSETVMVMERMYGI 246 (537)
T ss_pred HHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecc--c--CCCceEEEeeecCc
Confidence 001 2344554444442 4444444444322 1 22348999999999
Q ss_pred CHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCC----cEEEeecccceecCC
Q 037275 767 SLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDL----VAHLGDFGLAKFLSS 842 (992)
Q Consensus 767 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Dfg~a~~~~~ 842 (992)
.+.++-.-.........+....+..++.|+ +.. |++|+|+||.||+++.++ .+++.|||++..+..
T Consensus 247 ~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 247 PVSDVAALRAAGTDMKLLAERGVEVFFTQV-------FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred cHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 998753211111001123333333344444 345 999999999999999888 999999999987754
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.24 E-value=7e-11 Score=131.64 Aligned_cols=170 Identities=19% Similarity=0.254 Sum_probs=129.3
Q ss_pred EeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEEEEeccCCCHHHHHhhcc
Q 037275 697 KGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSE 776 (992)
Q Consensus 697 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~ 776 (992)
.|..+.++.+|.|.+++...........+-++.++.++||||+++++. .......|+|+|.+. .|..++.+.
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t-----~e~~~~~ylvTErV~--Pl~~~lk~l- 101 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDT-----TEEEGTLYLVTERVR--PLETVLKEL- 101 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhh-----hcccCceEEEeeccc--cHHHHHHHh-
Confidence 466677899999999876555445567788899999999999999997 344557899999983 678888743
Q ss_pred cchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceecCCCCCCCCcccCCCCC
Q 037275 777 DQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSK 856 (992)
Q Consensus 777 ~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~ 856 (992)
....+.--+.||+.||.+||+.+ +++|++|.-.-|+|++.|..||++|..+........ ...
T Consensus 102 --------~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--------~~~ 163 (690)
T KOG1243|consen 102 --------GKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--------PAK 163 (690)
T ss_pred --------HHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--------ccc
Confidence 35566678899999999999765 899999999999999999999999998865432211 111
Q ss_pred cccccccccccccccCCCcCcccchhhHHHHHHHHHhC
Q 037275 857 GIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTR 894 (992)
Q Consensus 857 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg 894 (992)
..+---.|..|+.+.... ...|.|.|||+++|++.|
T Consensus 164 ~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 164 SLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 112223466676543322 356999999999999999
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.21 E-value=2.5e-10 Score=112.74 Aligned_cols=138 Identities=17% Similarity=0.190 Sum_probs=99.2
Q ss_pred CCccccccceEEEEeEECC------CCeEEEEEEeeccC------------C----------CchhHH----HHHHHHHH
Q 037275 684 SNMIGQGSFGFVYKGNLGE------NGMMVAVKVINLKQ------------K----------GASNGF----VAECQALR 731 (992)
Q Consensus 684 ~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~------------~----------~~~~~~----~~E~~~l~ 731 (992)
...||.|--+.||.|.... .+..+|||+++... + .....+ .+|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999998653 35799999986311 0 011223 37999999
Q ss_pred hccC--CcceeEEEEeecccccCcceEEEEEEeccCCCHHH-HHhhcccchhhcccCHHHHHHHHHHHHHHHHHH-HhcC
Q 037275 732 NIRH--RNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLED-WLHQSEDQQEARSLTLIQRINIIIDVASAIEYI-HHHC 807 (992)
Q Consensus 732 ~l~h--~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~ 807 (992)
++.. -++.+.+++. .-++||||+.++.+.. .++.. .++..+...+..+++.+|.++ |..
T Consensus 82 rl~~~Gv~vP~pi~~~---------~~~lvME~Ig~~~~~~~~Lkd~-------~~~~~~~~~i~~~i~~~l~~l~H~~- 144 (197)
T cd05146 82 RMQKAGIPCPEVVVLK---------KHVLVMSFIGDDQVPAPKLKDA-------KLNDEEMKNAYYQVLSMMKQLYKEC- 144 (197)
T ss_pred HHHHcCCCCCeEEEec---------CCEEEEEEcCCCCccchhhhcc-------ccCHHHHHHHHHHHHHHHHHHHHhC-
Confidence 9853 4566666641 1289999997654422 22211 244456677889999999999 888
Q ss_pred CCCeEeccCCCCCeeeCCCCcEEEeecccceecC
Q 037275 808 QPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLS 841 (992)
Q Consensus 808 ~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 841 (992)
++||||+++.||+++ ++.++++|||.|....
T Consensus 145 --glVHGDLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 145 --NLVHADLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred --CeecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 999999999999996 5689999999987553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.19 E-value=6.8e-10 Score=116.24 Aligned_cols=277 Identities=15% Similarity=0.097 Sum_probs=171.9
Q ss_pred CCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhc-cCCcceeEEEEeec--ccccCcceEEE
Q 037275 682 SSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNI-RHRNLIKIITICSS--IDFKGVDFQAI 758 (992)
Q Consensus 682 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~~~~~~~~~l 758 (992)
...+.||+|+.+.+|..-.- ...+-|++......... +-+..|.+. .||-+-.-+.+=.. ........+.+
T Consensus 14 ~~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred CCCccccCCccceeeecchh---hchhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 45678999999999975442 23466887644332222 223333333 45543331221100 00122233667
Q ss_pred EEEeccCC-CHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 759 VYEYMQNG-SLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 759 v~e~~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
.|+.+.+. ....+.+.....+.-....|....++++.+|.+.+.||++ |.+-||+.++|+||++++.+.|.|-..-
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccce
Confidence 88887664 2333333222222334688999999999999999999999 9999999999999999999999987544
Q ss_pred eecCCCCCCCCcccCCCCCccccccccccccccc-----CCCcCcccchhhHHHHHHHHHhC-CCCCCCCccC---CccH
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGM-----GGEASMTGDVYSFGILLLEMFTR-RRPTDGMFNQ---GLTL 908 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg-~~pf~~~~~~---~~~~ 908 (992)
.... ......+.+|...|.+||.-. +...+...|-|.+|+++++++.| +.||.+.... ...+
T Consensus 165 qi~~---------ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~ 235 (637)
T COG4248 165 QINA---------NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPL 235 (637)
T ss_pred eecc---------CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcc
Confidence 3322 222334567899999999643 34567789999999999999995 9999985322 1111
Q ss_pred H-HHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCC--CCCCCCCHHHHHHHHHHHHHh
Q 037275 909 H-EFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSME--SPTERMEMRDVVAKLCRARDT 985 (992)
Q Consensus 909 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~--dP~~RPs~~evl~~L~~~~~~ 985 (992)
+ .+....+ ....+....+..........--...+..+..+|+.. .|.-|||++.++..|..+.++
T Consensus 236 E~~Ia~g~f------------~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 236 ETDIAHGRF------------AYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred hhhhhccee------------eechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 1 1111111 000111111222222222333345677788888864 356899999999999998887
Q ss_pred hhh
Q 037275 986 FLG 988 (992)
Q Consensus 986 ~~~ 988 (992)
+..
T Consensus 304 L~~ 306 (637)
T COG4248 304 LKK 306 (637)
T ss_pred hhh
Confidence 653
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.18 E-value=4.9e-12 Score=132.63 Aligned_cols=179 Identities=24% Similarity=0.269 Sum_probs=130.6
Q ss_pred EEEeeccccccCCccC--CCCCCCCcCCeeeccCCCCCc--cCCccccCCCCCCEEEeecccCCCCCCccc-ccCCCCcE
Q 037275 52 VTKLDLSNRTIGGTLS--PYVGNLSFLRYLNLADNNFHG--EIPHQIGRLVRLEALVLANNSFSGKIPTNL-SRCSNLIS 126 (992)
Q Consensus 52 v~~ldl~~~~l~~~l~--~~l~~l~~L~~L~L~~n~l~~--~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l-~~l~~L~~ 126 (992)
+..+.|.+..+ +..+ .....+++++.||||.|-|.. .+-.....|++|+.|+||.|++.-...+.. ..++.|+.
T Consensus 123 L~~IsLdn~~V-~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~ 201 (505)
T KOG3207|consen 123 LREISLDNYRV-EDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQ 201 (505)
T ss_pred hhheeecCccc-cccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhhe
Confidence 55556666655 2233 467899999999999998873 234455689999999999999974443332 36789999
Q ss_pred eecccccccccCChhhcccccccccccccccccCCCCCCccccccccceEEecCCcccCCcC--CccCCCCcccEEeccC
Q 037275 127 FNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIP--NNLGNLRNLILLNLGE 204 (992)
Q Consensus 127 L~l~~n~l~~~~p~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~--~~l~~l~~L~~L~L~~ 204 (992)
|.|+.|.++..--..+...+++|+.|+|..|............++.|++|+|++|++.. .+ ...+.++.|..|+++.
T Consensus 202 L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~-~~~~~~~~~l~~L~~Lnls~ 280 (505)
T KOG3207|consen 202 LVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLID-FDQGYKVGTLPGLNQLNLSS 280 (505)
T ss_pred EEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccc-cccccccccccchhhhhccc
Confidence 99999999865555555678999999999996433444556678899999999999843 33 3467888999999999
Q ss_pred ccccccc-Ccc-----ccccCCCcEEeccCCccC
Q 037275 205 NRFSGIV-PPS-----IFNISSLENVFLPTNRFN 232 (992)
Q Consensus 205 n~l~~~~-p~~-----l~~l~~L~~L~l~~N~l~ 232 (992)
+.++.+- |+. ....++|++|+++.|++.
T Consensus 281 tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~ 314 (505)
T KOG3207|consen 281 TGIASIAEPDVESLDKTHTFPKLEYLNISENNIR 314 (505)
T ss_pred cCcchhcCCCccchhhhcccccceeeecccCccc
Confidence 9888542 332 234567777777777775
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.17 E-value=7.6e-11 Score=116.89 Aligned_cols=130 Identities=16% Similarity=0.141 Sum_probs=95.3
Q ss_pred CCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcce-eEEEEeecccccCcceEEEEEEe
Q 037275 684 SNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLI-KIITICSSIDFKGVDFQAIVYEY 762 (992)
Q Consensus 684 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~~~~~~lv~e~ 762 (992)
++.++.|.++.||+++.. +..|++|+...... ....+.+|+.+++.+.+.+++ +++++.. ...++||||
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~-------~~~~lv~e~ 72 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP-------ETGVLITEF 72 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC-------CCCeEEEEe
Confidence 357899999999999974 78899999753322 234567899999998665544 4444321 123799999
Q ss_pred ccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcC--CCCeEeccCCCCCeeeCCCCcEEEeecccce
Q 037275 763 MQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHC--QPPVVHGDLKPSNVLLDQDLVAHLGDFGLAK 838 (992)
Q Consensus 763 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 838 (992)
+++.++.+.- . ....++.+++++|+.||+.. ..+++|||++|.||+++ ++.++++|||.+.
T Consensus 73 i~G~~l~~~~-----------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 73 IEGSELLTED-----------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cCCCcccccc-----------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 9998776430 0 01235678999999999982 12359999999999998 6789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.14 E-value=6e-12 Score=125.03 Aligned_cols=132 Identities=30% Similarity=0.294 Sum_probs=94.7
Q ss_pred ccCceeccCCcccCCCCCCccccccccccccccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEee
Q 037275 420 LLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNI 499 (992)
Q Consensus 420 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~L 499 (992)
.|+++|||+|.|+ .+..++.-+++++.| ++|+|.+. .+ ..+..|++|+.|||
T Consensus 285 ~LtelDLS~N~I~-~iDESvKL~Pkir~L-------------------------~lS~N~i~-~v-~nLa~L~~L~~LDL 336 (490)
T KOG1259|consen 285 ELTELDLSGNLIT-QIDESVKLAPKLRRL-------------------------ILSQNRIR-TV-QNLAELPQLQLLDL 336 (490)
T ss_pred hhhhccccccchh-hhhhhhhhccceeEE-------------------------ecccccee-ee-hhhhhcccceEeec
Confidence 4566666666666 455555555555555 55555554 22 33677888999999
Q ss_pred ecccccccCCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcccCCCCh-hhhhcCCCcceEecCCCcCcc
Q 037275 500 SVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIP-EYLENLSFLEYLNLSYNHFEG 578 (992)
Q Consensus 500 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~ 578 (992)
|+|.++ .+...-.++.+.+.|.|++|.|.. -+.++.|-+|..||+++|+|..... ..++++|-|+.+.|.+|++.+
T Consensus 337 S~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 337 SGNLLA-ECVGWHLKLGNIKTLKLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred ccchhH-hhhhhHhhhcCEeeeehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence 999988 556666678889999999998863 2467788889999999999874322 457888999999999999987
Q ss_pred cCCC
Q 037275 579 EVPT 582 (992)
Q Consensus 579 ~~~~ 582 (992)
.+.-
T Consensus 414 ~vdY 417 (490)
T KOG1259|consen 414 SVDY 417 (490)
T ss_pred cchH
Confidence 6653
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.14 E-value=7.6e-12 Score=131.25 Aligned_cols=204 Identities=22% Similarity=0.228 Sum_probs=114.3
Q ss_pred cCCCcccEEEccCCcCCCCCC--ccccCCCCCcEEeccCccccccC--CCCCCCccccCceeccCCcccCCCCC-Ccccc
Q 037275 368 RNLVNLVELCMDDNKLTGTIP--HAIGELKNLQLLYLDSNFLAGGI--PTSLGNLTLLTNLALSSNDLQGSIPP-SLGNC 442 (992)
Q Consensus 368 ~~l~~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l 442 (992)
+++.+|+++.|.+..+. ..+ .....+++++.|||+.|-+.... ......+|+|+.|+|+.|++...... .-..+
T Consensus 118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l 196 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL 196 (505)
T ss_pred hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence 45567777777777765 333 34556777777788777766432 23345677788888888877632111 12245
Q ss_pred ccccccccccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeecccccccCCcccccccccceee
Q 037275 443 KNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLY 522 (992)
Q Consensus 443 ~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 522 (992)
+.|+.|.++.|.++..- +......+|+|+.|+|+.|.....-.....-+..|++||
T Consensus 197 ~~lK~L~l~~CGls~k~------------------------V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~Ld 252 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKD------------------------VQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELD 252 (505)
T ss_pred hhhheEEeccCCCCHHH------------------------HHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhcc
Confidence 66777777776655211 111223456666666666643223333344456677777
Q ss_pred ccCCcccccCC--ccccccCCCCEEECCCcccCCC-Chhh-----hhcCCCcceEecCCCcCcccCC--CCCccCCcccc
Q 037275 523 LQGNSFSGSIP--SSLSSLKSIKELDMSSNNLSGQ-IPEY-----LENLSFLEYLNLSYNHFEGEVP--TKGVFSNKTGI 592 (992)
Q Consensus 523 L~~N~l~~~~~--~~~~~l~~L~~L~Ls~N~l~~~-~p~~-----~~~l~~L~~L~l~~N~l~~~~~--~~~~~~~~~~~ 592 (992)
|++|++.. .+ ...+.++.|+.|+++.+.+++. .|+. ...+++|++|+++.|++..... ....+.++..+
T Consensus 253 Ls~N~li~-~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l 331 (505)
T KOG3207|consen 253 LSNNNLID-FDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHL 331 (505)
T ss_pred ccCCcccc-cccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhh
Confidence 77776653 33 3455667777777777766532 2222 2455777777777777753221 12223444455
Q ss_pred cccCC
Q 037275 593 SLSGN 597 (992)
Q Consensus 593 ~l~~N 597 (992)
.+.+|
T Consensus 332 ~~~~n 336 (505)
T KOG3207|consen 332 RITLN 336 (505)
T ss_pred hcccc
Confidence 44444
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.7e-12 Score=132.64 Aligned_cols=240 Identities=25% Similarity=0.282 Sum_probs=109.8
Q ss_pred eEEEeeccccccCC----ccCCCCCCCCcCCeeeccCC---CCCccCCcc-------ccCCCCCCEEEeecccCCCCCCc
Q 037275 51 RVTKLDLSNRTIGG----TLSPYVGNLSFLRYLNLADN---NFHGEIPHQ-------IGRLVRLEALVLANNSFSGKIPT 116 (992)
Q Consensus 51 ~v~~ldl~~~~l~~----~l~~~l~~l~~L~~L~L~~n---~l~~~~p~~-------~~~l~~L~~L~Ls~n~l~~~~p~ 116 (992)
.++++|||+|.+.. .+.+.+.+.++|+.-++|+- .+..++|+. +...++|++||||+|-|.-.-+.
T Consensus 31 s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g~~ 110 (382)
T KOG1909|consen 31 SLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKGIR 110 (382)
T ss_pred ceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccchH
Confidence 45666666666622 14455566666666666652 222234432 23444566666666665533333
Q ss_pred ccccCCCCcEeecccccccccCChhhcccccccccccccccccCCCCC-------------CccccccccceEEecCCcc
Q 037275 117 NLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFP-------------ASIGNLSTLERINVLGNGL 183 (992)
Q Consensus 117 ~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~~L~L~~n~l~~~~p-------------~~~~~l~~L~~L~l~~n~l 183 (992)
.|.. +......|++|+|.+|.+.-.-- +....-+.|+.+...+|++
T Consensus 111 ~l~~---------------------ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrl 169 (382)
T KOG1909|consen 111 GLEE---------------------LLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRL 169 (382)
T ss_pred HHHH---------------------HHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeecccc
Confidence 3221 11123455555555555541110 1112233455555555554
Q ss_pred cCC----cCCccCCCCcccEEeccCccccc----ccCccccccCCCcEEeccCCccCCCCCccccccccccchhhccccc
Q 037275 184 WGR----IPNNLGNLRNLILLNLGENRFSG----IVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENN 255 (992)
Q Consensus 184 ~~~----~~~~l~~l~~L~~L~L~~n~l~~----~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~L~~l~l~~n~ 255 (992)
... +...|...+.|+.+.++.|.|.. .+...+..+++|+.|+|.+|-++.....
T Consensus 170 en~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~------------------ 231 (382)
T KOG1909|consen 170 ENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSV------------------ 231 (382)
T ss_pred ccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHH------------------
Confidence 211 11223334455555555554431 0112344455555555555544411100
Q ss_pred cCCCCchhhhccccCceeeeccccccccccccc-----cccCccceEecCCCCCCCCCCCCchhhhhccCCCcceEeecC
Q 037275 256 FAGSIPESLSNASNLVELTLFDNQFRGKVSIYF-----RSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLD 330 (992)
Q Consensus 256 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~~L~~L~l~ 330 (992)
.+...++.+++|++|++++|.+.......| ...++|++|.+.+|.|+......+ .......+.|..|+|+
T Consensus 232 ---~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~l--a~~~~ek~dL~kLnLn 306 (382)
T KOG1909|consen 232 ---ALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALAL--AACMAEKPDLEKLNLN 306 (382)
T ss_pred ---HHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHH--HHHHhcchhhHHhcCC
Confidence 223345555566666666666654443333 224566666666666654332211 1123335555666666
Q ss_pred CCcC
Q 037275 331 DNRF 334 (992)
Q Consensus 331 ~n~l 334 (992)
+|++
T Consensus 307 gN~l 310 (382)
T KOG1909|consen 307 GNRL 310 (382)
T ss_pred cccc
Confidence 6655
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=2.3e-12 Score=131.64 Aligned_cols=203 Identities=24% Similarity=0.275 Sum_probs=112.2
Q ss_pred cCCCCCCCCcCCeeeccCCCCCc----cCCccccCCCCCCEEEeecc---cCCCCCCcccccCCCCcEeecccccccccC
Q 037275 66 LSPYVGNLSFLRYLNLADNNFHG----EIPHQIGRLVRLEALVLANN---SFSGKIPTNLSRCSNLISFNARRNNLVGEI 138 (992)
Q Consensus 66 l~~~l~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~Ls~n---~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~ 138 (992)
+-+.+..+..++.|+||+|-|.. .+...+.+.++|+..++|+- ++...+|+.+-.+.
T Consensus 22 v~~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~---------------- 85 (382)
T KOG1909|consen 22 VEEELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLS---------------- 85 (382)
T ss_pred HHHHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHH----------------
Confidence 44556778889999999999873 35667778888999888865 22224454332111
Q ss_pred ChhhcccccccccccccccccCCCCCCc----cccccccceEEecCCcccCCcCC--------------ccCCCCcccEE
Q 037275 139 PAELGYNWLKLENLTIADNHLTGHFPAS----IGNLSTLERINVLGNGLWGRIPN--------------NLGNLRNLILL 200 (992)
Q Consensus 139 p~~~~~~l~~L~~L~L~~n~l~~~~p~~----~~~l~~L~~L~l~~n~l~~~~~~--------------~l~~l~~L~~L 200 (992)
+.+. ..++|++|+||+|.+....+.. +.++..|++|.|.+|.+. .... -.++-++|+++
T Consensus 86 -~aL~-~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg-~~ag~~l~~al~~l~~~kk~~~~~~Lrv~ 162 (382)
T KOG1909|consen 86 -KALL-GCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLG-PEAGGRLGRALFELAVNKKAASKPKLRVF 162 (382)
T ss_pred -HHHh-cCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCC-hhHHHHHHHHHHHHHHHhccCCCcceEEE
Confidence 0111 2235556666666555333333 356788999999999873 2211 12333456666
Q ss_pred eccCcccccc----cCccccccCCCcEEeccCCccCCCCCccccccccccchhhccccccCCCCchhhhccccCceeeec
Q 037275 201 NLGENRFSGI----VPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLF 276 (992)
Q Consensus 201 ~L~~n~l~~~----~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~ 276 (992)
..++|++... +...|...+.|+.+.++.|.|. |..+ ..+...|..+++|+.|||.
T Consensus 163 i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~---~eG~------------------~al~eal~~~~~LevLdl~ 221 (382)
T KOG1909|consen 163 ICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIR---PEGV------------------TALAEALEHCPHLEVLDLR 221 (382)
T ss_pred EeeccccccccHHHHHHHHHhccccceEEEeccccc---Cchh------------------HHHHHHHHhCCcceeeecc
Confidence 6666665421 1122334455555555555544 1111 0223456666677777777
Q ss_pred ccccccccc----ccccccCccceEecCCCCCCCCC
Q 037275 277 DNQFRGKVS----IYFRSLKNLEWLNLGSNNLGTGE 308 (992)
Q Consensus 277 ~N~l~~~~~----~~~~~l~~L~~L~L~~N~l~~~~ 308 (992)
+|.++.... ..++.+++|+.|++++|.+.+-+
T Consensus 222 DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~G 257 (382)
T KOG1909|consen 222 DNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEG 257 (382)
T ss_pred cchhhhHHHHHHHHHhcccchheeeccccccccccc
Confidence 776653322 33444555555555555555433
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.10 E-value=2.5e-11 Score=120.76 Aligned_cols=208 Identities=21% Similarity=0.228 Sum_probs=111.1
Q ss_pred cCCCCCCCCcCCeeeccCCCCCccCCccccCCCCCCEEEeecccCCCCCCcccccCCCCcEeeccccc-ccccCChhhcc
Q 037275 66 LSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNN-LVGEIPAELGY 144 (992)
Q Consensus 66 l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n~-l~~~~p~~~~~ 144 (992)
+|-.+.-+.+|..+.+|++.-. .|-+-...-+.|+++.+.+..++ ..|. +-..+.+..+.-+.-. ..|..-..+ .
T Consensus 206 l~f~l~~f~~l~~~~~s~~~~~-~i~~~~~~kptl~t~~v~~s~~~-~~~~-l~pe~~~~D~~~~E~~t~~G~~~~~~-d 281 (490)
T KOG1259|consen 206 LSFNLNAFRNLKTLKFSALSTE-NIVDIELLKPTLQTICVHNTTIQ-DVPS-LLPETILADPSGSEPSTSNGSALVSA-D 281 (490)
T ss_pred cccchHHhhhhheeeeeccchh-heeceeecCchhheeeeeccccc-cccc-ccchhhhcCccCCCCCccCCceEEec-c
Confidence 3444556667777777766544 33333334455666666655544 1111 1111111111111111 111111122 2
Q ss_pred cccccccccccccccCCCCCCccccccccceEEecCCcccCCcCCccCCCCcccEEeccCcccccccCccccccCCCcEE
Q 037275 145 NWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENV 224 (992)
Q Consensus 145 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L 224 (992)
.|..|++|||++|.|+ .+.++..-++.++.|++++|.|... +.+..+++|+.||||+|.++ .+..+-.++-+++.|
T Consensus 282 TWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL 357 (490)
T KOG1259|consen 282 TWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTL 357 (490)
T ss_pred hHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeee
Confidence 4556667777777766 5666666666666666666666322 23666666666666666666 334444455556666
Q ss_pred eccCCccCCCCCccccccccccchhhccccccCCCCchhhhccccCceeeeccccccccc-cccccccCccceEecCCCC
Q 037275 225 FLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKV-SIYFRSLKNLEWLNLGSNN 303 (992)
Q Consensus 225 ~l~~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~ 303 (992)
.|+.|.|.. -+.+.++-+|..||+++|+|.... ...+++++.|++|.|.+|.
T Consensus 358 ~La~N~iE~---------------------------LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NP 410 (490)
T KOG1259|consen 358 KLAQNKIET---------------------------LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNP 410 (490)
T ss_pred ehhhhhHhh---------------------------hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCC
Confidence 666665540 124566667777777777776332 2456667777777777776
Q ss_pred CCCCC
Q 037275 304 LGTGE 308 (992)
Q Consensus 304 l~~~~ 308 (992)
+..+.
T Consensus 411 l~~~v 415 (490)
T KOG1259|consen 411 LAGSV 415 (490)
T ss_pred ccccc
Confidence 65544
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.09 E-value=7.8e-11 Score=113.87 Aligned_cols=83 Identities=29% Similarity=0.335 Sum_probs=27.1
Q ss_pred ccCCCCccEEeeecccccccCCccc-ccccccceeeccCCcccccC-CccccccCCCCEEECCCcccCCCCh---hhhhc
Q 037275 488 VGNLKNLVYFNISVNRFSGEIPVTL-SACTSLQQLYLQGNSFSGSI-PSSLSSLKSIKELDMSSNNLSGQIP---EYLEN 562 (992)
Q Consensus 488 ~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~ 562 (992)
+..+++|+.|++++|+|+. +...+ ..+++|+.|+|++|+|.... -..+..+++|+.|+|.+|.++...- ..+..
T Consensus 60 l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~ 138 (175)
T PF14580_consen 60 LPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYK 138 (175)
T ss_dssp ----TT--EEE--SS---S--CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH
T ss_pred ccChhhhhhcccCCCCCCc-cccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHH
Confidence 3345556666666666653 22222 34556666666666665321 1334455666666666666652211 12345
Q ss_pred CCCcceEec
Q 037275 563 LSFLEYLNL 571 (992)
Q Consensus 563 l~~L~~L~l 571 (992)
+|+|+.||-
T Consensus 139 lP~Lk~LD~ 147 (175)
T PF14580_consen 139 LPSLKVLDG 147 (175)
T ss_dssp -TT-SEETT
T ss_pred cChhheeCC
Confidence 566665543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.08 E-value=8.9e-11 Score=130.03 Aligned_cols=252 Identities=22% Similarity=0.173 Sum_probs=170.6
Q ss_pred HHhcCCCCCCccccccceEEEEeEEC-CCCeEEEEEEeeccCCCchhH--HHHHHHHHHhc-cCCcceeEEEEeeccccc
Q 037275 676 KATNDFSSSNMIGQGSFGFVYKGNLG-ENGMMVAVKVINLKQKGASNG--FVAECQALRNI-RHRNLIKIITICSSIDFK 751 (992)
Q Consensus 676 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 751 (992)
....+|..+..||.|.|+.|+..... .++..|++|...........+ -..|+.+...+ .|.+++++...+.
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~----- 336 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWS----- 336 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcc-----
Confidence 44568899999999999999998876 678899999875333222222 24566555555 4777777655432
Q ss_pred CcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCC-CcEE
Q 037275 752 GVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQD-LVAH 830 (992)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~k 830 (992)
.....++--||+++++......-. ..+++..++++..|++.++.++|+. .++|+|+||+||++..+ +..+
T Consensus 337 ~~r~~~ip~e~~~~~s~~l~~~~~------~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~ 407 (524)
T KOG0601|consen 337 QLRQGYIPLEFCEGGSSSLRSVTS------QMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSK 407 (524)
T ss_pred ccccccCchhhhcCcchhhhhHHH------HhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhh
Confidence 233446888999999888776321 2477888899999999999999999 99999999999999886 7889
Q ss_pred EeecccceecCCCCCCCCcccCCCCCcccccccc-cccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHH
Q 037275 831 LGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGY-IAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLH 909 (992)
Q Consensus 831 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~ 909 (992)
++|||.+..+.-.. . ...-.+..| .+|+......+..++|+||||.-+.+.++|..--.. ..+....
T Consensus 408 ~~~~~~~t~~~~~~---~-------~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~-~~~~~~i- 475 (524)
T KOG0601|consen 408 LGDFGCWTRLAFSS---G-------VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES-GVQSLTI- 475 (524)
T ss_pred ccccccccccceec---c-------cccccccccccchhhccccccccccccccccccccccccCcccCcc-cccceee-
Confidence 99999986422110 0 001122334 356666667888999999999999999998753221 1110000
Q ss_pred HHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 037275 910 EFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRAR 983 (992)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 983 (992)
.....+ .. ......+..+...+...+|..||.+.++.......+
T Consensus 476 --~~~~~p--------------------------~~--~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 476 --RSGDTP--------------------------NL--PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred --eccccc--------------------------CC--CchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 000000 00 001133566677789999999999998876555443
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.07 E-value=6.9e-11 Score=114.25 Aligned_cols=129 Identities=27% Similarity=0.324 Sum_probs=37.5
Q ss_pred CCCCCcCCeeeccCCCCCccCCcccc-CCCCCCEEEeecccCCCCCCcccccCCCCcEeecccccccccCChhhcccccc
Q 037275 70 VGNLSFLRYLNLADNNFHGEIPHQIG-RLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLK 148 (992)
Q Consensus 70 l~~l~~L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~ 148 (992)
+.+...++.|+|++|+++ .|. .++ .+.+|++|+||+|+|+ .++ .+..++.|+.|++++|+++ .+...+...+++
T Consensus 15 ~~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~ 89 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPN 89 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT
T ss_pred cccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCc
Confidence 334456677777777776 443 355 4677777777777776 443 3556666666666666665 343333333455
Q ss_pred cccccccccccCCCCCCccccccccceEEecCCcccCCcCCccCCCCcccEEeccCccccccc---CccccccCCCcEEe
Q 037275 149 LENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIV---PPSIFNISSLENVF 225 (992)
Q Consensus 149 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~---p~~l~~l~~L~~L~ 225 (992)
|++|+|++|++...- .-..+..+++|++|+|.+|.++..- ...+..+++|+.||
T Consensus 90 L~~L~L~~N~I~~l~-----------------------~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 90 LQELYLSNNKISDLN-----------------------ELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp --EEE-TTS---SCC-----------------------CCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEET
T ss_pred CCEEECcCCcCCChH-----------------------HhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeC
Confidence 555555555554210 0122445556666666666655221 12456677777776
Q ss_pred c
Q 037275 226 L 226 (992)
Q Consensus 226 l 226 (992)
-
T Consensus 147 ~ 147 (175)
T PF14580_consen 147 G 147 (175)
T ss_dssp T
T ss_pred C
Confidence 4
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.2e-11 Score=138.39 Aligned_cols=43 Identities=33% Similarity=0.406 Sum_probs=24.6
Q ss_pred hhccccCceeeeccccccccccccccccCccceEecCCCCCCCC
Q 037275 264 LSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTG 307 (992)
Q Consensus 264 l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 307 (992)
+..+.+|..|++.+|+|..+.. .+..+.+|++|+|++|.|+.+
T Consensus 91 l~~~~~l~~l~l~~n~i~~i~~-~l~~~~~L~~L~ls~N~I~~i 133 (414)
T KOG0531|consen 91 LSKLKSLEALDLYDNKIEKIEN-LLSSLVNLQVLDLSFNKITKL 133 (414)
T ss_pred cccccceeeeeccccchhhccc-chhhhhcchheeccccccccc
Confidence 4455666666666666663222 255566666666666666553
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.1e-10 Score=84.39 Aligned_cols=40 Identities=55% Similarity=1.035 Sum_probs=31.9
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCCcCC--CCCCceEeeEEc
Q 037275 7 ETDRLALLAIGSQLEDDPLGVTSSWNNS--TNLCQWTGVTCG 46 (992)
Q Consensus 7 ~~~~~~ll~~~~~~~~~~~~~~~~w~~~--~~~c~w~gv~c~ 46 (992)
++|++||++||+++..+|.+.+++|+.+ ++||.|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 6899999999999988888999999876 799999999995
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.00 E-value=5.7e-09 Score=97.79 Aligned_cols=143 Identities=22% Similarity=0.263 Sum_probs=102.1
Q ss_pred CCCccccccceEEEEeEECCCCeEEEEEEeeccCC--------CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcc
Q 037275 683 SSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK--------GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 683 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
....+-+|+-+.|+++.+ .|+.+.||.=..+.. -...+..+|++.+.++.--.|.--.-++.+ ..
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D--~~--- 83 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFID--TY--- 83 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEe--cC---
Confidence 567899999999999998 688888885422221 123456789999998863333222222222 11
Q ss_pred eEEEEEEeccC-CCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCC---cEE
Q 037275 755 FQAIVYEYMQN-GSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDL---VAH 830 (992)
Q Consensus 755 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~k 830 (992)
.-.++|||+++ -++.+++...... .........++.+|-+.+.-||.. +|+|||+..+||++..++ .+.
T Consensus 84 ~~~i~ME~~~g~~~vk~~i~~~~~~----~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~ 156 (229)
T KOG3087|consen 84 GGQIYMEFIDGASTVKDFILSTMED----ESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPI 156 (229)
T ss_pred CCeEEEEeccchhHHHHHHHHHccC----cccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceE
Confidence 12799999966 4888998866533 223333367889999999999999 999999999999997665 458
Q ss_pred Eeeccccee
Q 037275 831 LGDFGLAKF 839 (992)
Q Consensus 831 l~Dfg~a~~ 839 (992)
++|||++..
T Consensus 157 lIdfgls~~ 165 (229)
T KOG3087|consen 157 LIDFGLSSV 165 (229)
T ss_pred EEeecchhc
Confidence 999999863
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.00 E-value=4.6e-09 Score=99.25 Aligned_cols=129 Identities=27% Similarity=0.412 Sum_probs=94.5
Q ss_pred CccccccceEEEEeEECCCCeEEEEEEeeccCCC--------chhHHHHHHHHHHhccCCc--ceeEEEEeecccccCcc
Q 037275 685 NMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKG--------ASNGFVAECQALRNIRHRN--LIKIITICSSIDFKGVD 754 (992)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~~~ 754 (992)
..+++|+-+.+|.+.+ -|.++++|.=.++... ...+-.+|+.++.+++--. ...++++ +..
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv-------D~~ 72 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV-------DPD 72 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE-------cCC
Confidence 4688999999999977 4556777754322211 1234578999998886433 3334443 223
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
...|+|||++|..|.+++... ...++..+-.-+.-||.. ||||||+.++||.+..++ +.++||
T Consensus 73 ~~~I~me~I~G~~lkd~l~~~-------------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDf 135 (204)
T COG3642 73 NGLIVMEYIEGELLKDALEEA-------------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDF 135 (204)
T ss_pred CCEEEEEEeCChhHHHHHHhc-------------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEEC
Confidence 347999999999999898754 134566777788899999 999999999999997665 999999
Q ss_pred cccee
Q 037275 835 GLAKF 839 (992)
Q Consensus 835 g~a~~ 839 (992)
|++.+
T Consensus 136 GLg~~ 140 (204)
T COG3642 136 GLGEF 140 (204)
T ss_pred Ccccc
Confidence 99874
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=1.2e-10 Score=132.44 Aligned_cols=152 Identities=24% Similarity=0.265 Sum_probs=80.2
Q ss_pred CCCCcCCeeeccCCCCCccCCccccCCCCCCEEEeecccCCCCCCcccccCCCCcEeecccccccccCChhhcccccccc
Q 037275 71 GNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLE 150 (992)
Q Consensus 71 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~ 150 (992)
..+..++.+++..|.+. .+-..+..+++|++|++.+|+|. .+...+..+++|++|++++|+|+..-+-. .++.|+
T Consensus 69 ~~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~~l~---~l~~L~ 143 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLEGLS---TLTLLK 143 (414)
T ss_pred HHhHhHHhhccchhhhh-hhhcccccccceeeeeccccchh-hcccchhhhhcchheeccccccccccchh---hccchh
Confidence 34566666667777666 34444666777777777777776 44444566666666666666666322211 233455
Q ss_pred cccccccccCCCCCCccccccccceEEecCCcccCCcC-CccCCCCcccEEeccCcccccccCccccccCCCcEEeccCC
Q 037275 151 NLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIP-NNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTN 229 (992)
Q Consensus 151 ~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~-~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N 229 (992)
.|++++|.++. ...+..+..|+.+++++|.+...-+ . ...+.+|+.+++++|.+.. ...+..+..+..+++..|
T Consensus 144 ~L~l~~N~i~~--~~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~~~l~~n 218 (414)
T KOG0531|consen 144 ELNLSGNLISD--ISGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE--IEGLDLLKKLVLLSLLDN 218 (414)
T ss_pred hheeccCcchh--ccCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc--ccchHHHHHHHHhhcccc
Confidence 55555555552 1334445555555555555532222 1 3444555555555555541 222333333344455555
Q ss_pred ccC
Q 037275 230 RFN 232 (992)
Q Consensus 230 ~l~ 232 (992)
.+.
T Consensus 219 ~i~ 221 (414)
T KOG0531|consen 219 KIS 221 (414)
T ss_pred cce
Confidence 544
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=8.1e-10 Score=133.64 Aligned_cols=128 Identities=25% Similarity=0.411 Sum_probs=68.8
Q ss_pred CcCCeeeccCCCCCccCCccccCCCCCCEEEeeccc--CCCCCCc-ccccCCCCcEeecccccccccCChhhcccccccc
Q 037275 74 SFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNS--FSGKIPT-NLSRCSNLISFNARRNNLVGEIPAELGYNWLKLE 150 (992)
Q Consensus 74 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~--l~~~~p~-~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~ 150 (992)
...+...+.+|++. .++..... +.|++|-+..|. +. .++. .|..++.|+.|||++|.-.+++|..++ .+-+|+
T Consensus 523 ~~~rr~s~~~~~~~-~~~~~~~~-~~L~tLll~~n~~~l~-~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~-~Li~Lr 598 (889)
T KOG4658|consen 523 NSVRRMSLMNNKIE-HIAGSSEN-PKLRTLLLQRNSDWLL-EISGEFFRSLPLLRVLDLSGNSSLSKLPSSIG-ELVHLR 598 (889)
T ss_pred hheeEEEEeccchh-hccCCCCC-CccceEEEeecchhhh-hcCHHHHhhCcceEEEECCCCCccCcCChHHh-hhhhhh
Confidence 44555555555554 44433322 245555555554 33 3332 244455555555555555455555554 455555
Q ss_pred cccccccccCCCCCCccccccccceEEecCCcccCCcCCccCCCCcccEEeccCcc
Q 037275 151 NLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENR 206 (992)
Q Consensus 151 ~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~ 206 (992)
+|+|++..++ .+|.++.+|..|.+|++..+.-...+|..+..+.+|++|.+..-.
T Consensus 599 yL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~ 653 (889)
T KOG4658|consen 599 YLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA 653 (889)
T ss_pred cccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence 5555555555 566666666666666666555444445555556666666665443
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.94 E-value=6.1e-09 Score=108.40 Aligned_cols=145 Identities=21% Similarity=0.300 Sum_probs=107.2
Q ss_pred CccccccceEEEEeEECCCCeEEEEEEeeccCC-CchhHHHHHHHHHHhccCC--cceeEEEEeecccccCcceEEEEEE
Q 037275 685 NMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK-GASNGFVAECQALRNIRHR--NLIKIITICSSIDFKGVDFQAIVYE 761 (992)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~~~~~~~~~~~lv~e 761 (992)
+.++.|.++.||+++.. +|+.+++|+...... .....+.+|+++++.+.+. .+.+++.+..... ..+..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEEEE
Confidence 57899999999999885 468899999754332 2356788999999999753 4566777643321 1134589999
Q ss_pred eccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcC----------------------------------
Q 037275 762 YMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHC---------------------------------- 807 (992)
Q Consensus 762 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---------------------------------- 807 (992)
|++|.++.+.+.. ..++..+...++.+++++|++||+..
T Consensus 81 ~i~G~~l~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (223)
T cd05154 81 RVDGRVLRDRLLR-------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDE 153 (223)
T ss_pred EeCCEecCCCCCC-------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccc
Confidence 9999888776531 13566677777888888888887521
Q ss_pred -------------------CCCeEeccCCCCCeeeCC--CCcEEEeeccccee
Q 037275 808 -------------------QPPVVHGDLKPSNVLLDQ--DLVAHLGDFGLAKF 839 (992)
Q Consensus 808 -------------------~~~ivH~Dlkp~NIll~~--~~~~kl~Dfg~a~~ 839 (992)
...++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 154 PPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred cHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246799999999999998 67789999998763
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.90 E-value=3.9e-10 Score=131.00 Aligned_cols=211 Identities=23% Similarity=0.307 Sum_probs=145.6
Q ss_pred HhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCc
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 753 (992)
..+.+.+.+-+.+|.++.++.++-..+|...+.|+..... ....+....+-.+.-..++|-+++...- +.-.
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s-----~~~r 876 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPS-----FPCR 876 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCC-----CCCC
Confidence 3456777788999999999999887777666666553221 1112222222222222334544443222 3345
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGD 833 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 833 (992)
...++|++|+.+++|...++..+. .+..........+..+.+|||.. .+.|+|++|.|++...++..+++|
T Consensus 877 sP~~L~~~~~~~~~~~Skl~~~~~------~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~ 947 (1205)
T KOG0606|consen 877 SPLPLVGHYLNGGDLPSKLHNSGC------LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTD 947 (1205)
T ss_pred CCcchhhHHhccCCchhhhhcCCC------cccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCc
Confidence 566899999999999999987652 33333344555678899999998 799999999999999999999999
Q ss_pred cccceecCCCCCCCCc---------------------cc--CCCCCcccccccccccccccCCCcCcccchhhHHHHHHH
Q 037275 834 FGLAKFLSSSPLDTAV---------------------ET--PSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLE 890 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~---------------------~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e 890 (992)
||......--...... .. ........||+.|.|||...+......+|.|+.|++++|
T Consensus 948 ~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e 1027 (1205)
T KOG0606|consen 948 FGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFE 1027 (1205)
T ss_pred cccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhh
Confidence 9854332211000000 00 012334679999999999999999999999999999999
Q ss_pred HHhCCCCCCCC
Q 037275 891 MFTRRRPTDGM 901 (992)
Q Consensus 891 lltg~~pf~~~ 901 (992)
.++|.+||...
T Consensus 1028 ~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 1028 VLTGIPPFNAE 1038 (1205)
T ss_pred hhcCCCCCCCc
Confidence 99999999864
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.89 E-value=2.8e-08 Score=107.35 Aligned_cols=177 Identities=18% Similarity=0.222 Sum_probs=136.8
Q ss_pred cceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEEEEeccC-CCHH
Q 037275 691 SFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQN-GSLE 769 (992)
Q Consensus 691 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-gsL~ 769 (992)
.-.+.|++...-+|..|++|+++.........-..-+++++++.|+|+|++.+++....| ++..+++||+|+++ ++|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF-~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTF-GDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhcc-CcceEEEEEecCCCCchHH
Confidence 446889999998999999999954443334445567899999999999999998875444 45667999999976 4777
Q ss_pred HHHhhcccc---------hhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceec
Q 037275 770 DWLHQSEDQ---------QEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFL 840 (992)
Q Consensus 770 ~~l~~~~~~---------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 840 (992)
++--..... ..+...++..+|.++.|+..||.++|+. |..-+-+.|.+|+++.+.+++|+..|....+
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeee
Confidence 665433222 2344578899999999999999999999 9999999999999999999999988887766
Q ss_pred CCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCC
Q 037275 841 SSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRR 896 (992)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~ 896 (992)
..++. |-+.+ -.+-|.=.||.++..|.||..
T Consensus 444 ~~d~~----------------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 444 QEDPT----------------------EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred cCCCC----------------------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 54320 11111 125688899999999999954
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.87 E-value=2.6e-09 Score=129.34 Aligned_cols=129 Identities=21% Similarity=0.240 Sum_probs=79.4
Q ss_pred cccccccccccccCCCCCCccccccccceEEecCCc--ccCCcCCccCCCCcccEEeccCcccccccCccccccCCCcEE
Q 037275 147 LKLENLTIADNHLTGHFPASIGNLSTLERINVLGNG--LWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENV 224 (992)
Q Consensus 147 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~--l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L 224 (992)
...+...+-+|.+. .++....+ ++|++|-+.+|. +....++.|..++.|++|||++|.=-+.+|..+++|-+|++|
T Consensus 523 ~~~rr~s~~~~~~~-~~~~~~~~-~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL 600 (889)
T KOG4658|consen 523 NSVRRMSLMNNKIE-HIAGSSEN-PKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYL 600 (889)
T ss_pred hheeEEEEeccchh-hccCCCCC-CccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcc
Confidence 44555555555554 33443332 256666666664 433333446666677777777665444666667766666666
Q ss_pred eccCCccCCCCCccccccccccchhhccccccCCCCchhhhccccCceeeeccccccccccccccccCccceEecCCCC
Q 037275 225 FLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNN 303 (992)
Q Consensus 225 ~l~~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 303 (992)
++++..++ .+|..++++..|.+|++..+.-...++.....|.+|++|.+-.-.
T Consensus 601 ~L~~t~I~--------------------------~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~ 653 (889)
T KOG4658|consen 601 DLSDTGIS--------------------------HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA 653 (889)
T ss_pred cccCCCcc--------------------------ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence 66666655 566677777777777777776555556666667777777765543
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.85 E-value=1.8e-09 Score=85.68 Aligned_cols=59 Identities=31% Similarity=0.474 Sum_probs=28.2
Q ss_pred CccEEeeecccccccCCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcc
Q 037275 493 NLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNN 551 (992)
Q Consensus 493 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 551 (992)
+|++|++++|+++.+.+..|.++++|++|++++|+|+...|..|.++++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 34444555554444444444444444444444444444444444444444444444444
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.84 E-value=2e-09 Score=85.48 Aligned_cols=61 Identities=38% Similarity=0.589 Sum_probs=57.4
Q ss_pred cccceeeccCCcccccCCccccccCCCCEEECCCcccCCCChhhhhcCCCcceEecCCCcC
Q 037275 516 TSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHF 576 (992)
Q Consensus 516 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l 576 (992)
++|++|++++|+|+...+..|.++++|++|++++|+|+...|..|..+++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4799999999999987788999999999999999999988889999999999999999986
|
... |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.83 E-value=3.6e-08 Score=97.21 Aligned_cols=126 Identities=25% Similarity=0.260 Sum_probs=81.7
Q ss_pred EEEEeEECCCCeEEEEEEeeccC-------------CC-------------chhHHHHHHHHHHhccCC--cceeEEEEe
Q 037275 694 FVYKGNLGENGMMVAVKVINLKQ-------------KG-------------ASNGFVAECQALRNIRHR--NLIKIITIC 745 (992)
Q Consensus 694 ~V~~~~~~~~~~~vavK~~~~~~-------------~~-------------~~~~~~~E~~~l~~l~h~--niv~~~~~~ 745 (992)
.||.|... +|.++|||+.+... .. ......+|.+.|.++..- ++.+.+++.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 48999985 78899999986321 00 012357899999999755 566776652
Q ss_pred ecccccCcceEEEEEEecc--CCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHH-HHhcCCCCeEeccCCCCCee
Q 037275 746 SSIDFKGVDFQAIVYEYMQ--NGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEY-IHHHCQPPVVHGDLKPSNVL 822 (992)
Q Consensus 746 ~~~~~~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~-LH~~~~~~ivH~Dlkp~NIl 822 (992)
. -++||||++ |..+..+.... ++......++.+++..+.. +|.. ||+|||+.+.||+
T Consensus 80 ~---------~~ivME~I~~~G~~~~~l~~~~--------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIl 139 (188)
T PF01163_consen 80 R---------NVIVMEYIGEDGVPLPRLKDVD--------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNIL 139 (188)
T ss_dssp T---------TEEEEE--EETTEEGGCHHHCG--------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEE
T ss_pred C---------CEEEEEecCCCccchhhHHhcc--------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEE
Confidence 1 189999998 54554443321 1123345577788886665 4687 9999999999999
Q ss_pred eCCCCcEEEeecccceecC
Q 037275 823 LDQDLVAHLGDFGLAKFLS 841 (992)
Q Consensus 823 l~~~~~~kl~Dfg~a~~~~ 841 (992)
++++ .+.++|||.|....
T Consensus 140 v~~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 140 VDDG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp EETT-CEEE--GTTEEETT
T ss_pred eecc-eEEEEecCcceecC
Confidence 9887 99999999987543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.81 E-value=7.8e-08 Score=100.95 Aligned_cols=146 Identities=16% Similarity=0.070 Sum_probs=101.5
Q ss_pred CccccccceEEEEeEECCCCeEEEEEEeeccCC-----------CchhHHHHHHHHHHhccCCc--ceeEEEEeeccccc
Q 037275 685 NMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK-----------GASNGFVAECQALRNIRHRN--LIKIITICSSIDFK 751 (992)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~ 751 (992)
+.+-......|+++.. .|+.|.||....... .....+.+|...+.++..-+ ..+.+++.......
T Consensus 28 e~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 28 EVFRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred cEEecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 4555445555777776 578999997742221 11124778999888884333 33445553221111
Q ss_pred CcceEEEEEEeccCC-CHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCC-----
Q 037275 752 GVDFQAIVYEYMQNG-SLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQ----- 825 (992)
Q Consensus 752 ~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~----- 825 (992)
.....++|||++++. +|.+++..... ...+...+..++.+++..++-||.. ||+|||+++.|||++.
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~~----~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~ 178 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWAT----NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGR 178 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCC
Confidence 123458999999876 89999864321 1345667778999999999999999 9999999999999975
Q ss_pred --CCcEEEeeccccee
Q 037275 826 --DLVAHLGDFGLAKF 839 (992)
Q Consensus 826 --~~~~kl~Dfg~a~~ 839 (992)
++.+.++||+.+..
T Consensus 179 ~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 179 EEDLKLSVIDLHRAQI 194 (268)
T ss_pred CCCceEEEEECCcccc
Confidence 46899999998753
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.6e-10 Score=128.17 Aligned_cols=199 Identities=26% Similarity=0.236 Sum_probs=102.4
Q ss_pred CcccEEEccCCcCCCCC-CccccCCCCCcEEeccCccccccCCCCCCCcc-ccCceeccCCccc----------CCCCCC
Q 037275 371 VNLVELCMDDNKLTGTI-PHAIGELKNLQLLYLDSNFLAGGIPTSLGNLT-LLTNLALSSNDLQ----------GSIPPS 438 (992)
Q Consensus 371 ~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~----------~~~~~~ 438 (992)
++++.|.+-.-.=.+.. |-.+..+.+|++|.|.++.|.. ...+..+. .|+.|..+ |.++ |.+..+
T Consensus 84 qkt~~lkl~~~pa~~pt~pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC~-~Sl~Al~~v~ascggd~~ns 160 (1096)
T KOG1859|consen 84 QKTKVLKLLPSPARDPTEPISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLICH-NSLDALRHVFASCGGDISNS 160 (1096)
T ss_pred hhheeeeecccCCCCCCCCceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhhh-ccHHHHHHHHHHhccccccc
Confidence 44444444433322222 5566778889999998888863 12222221 34444332 2222 111111
Q ss_pred ccccccccccccccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeecccccccCCccccccccc
Q 037275 439 LGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSL 518 (992)
Q Consensus 439 ~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 518 (992)
+. .-+|...+.+.|+++ .-+....+.+-++.|||++|+++.. +.+..+++|++|||++|.++.+.--...++. |
T Consensus 161 ~~-Wn~L~~a~fsyN~L~--~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L 234 (1096)
T KOG1859|consen 161 PV-WNKLATASFSYNRLV--LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-L 234 (1096)
T ss_pred hh-hhhHhhhhcchhhHH--hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhhh-h
Confidence 11 124555666666665 1223334444455666666666532 2566666666666666666633333333443 6
Q ss_pred ceeeccCCcccccCCccccccCCCCEEECCCcccCCCCh-hhhhcCCCcceEecCCCcCcccC
Q 037275 519 QQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIP-EYLENLSFLEYLNLSYNHFEGEV 580 (992)
Q Consensus 519 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~ 580 (992)
+.|.|++|.++.. ..+.+|++|+.|||++|-|.+.-- ..++.|..|+.|+|.||++.|.+
T Consensus 235 ~~L~lrnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p 295 (1096)
T KOG1859|consen 235 QLLNLRNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP 295 (1096)
T ss_pred eeeeecccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence 6666666666522 235566666666666666654222 22445566666666666665543
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.72 E-value=8.3e-10 Score=122.58 Aligned_cols=126 Identities=27% Similarity=0.212 Sum_probs=67.9
Q ss_pred ccCceeccCCcccCCCCCCccccccccccccccccccccCchhhhhhcccccccccccccccCccccc-ccCCCCccEEe
Q 037275 420 LLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLE-VGNLKNLVYFN 498 (992)
Q Consensus 420 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~-~~~l~~L~~L~ 498 (992)
.|.+.+.+.|.+. .+..++.-++.|+.|+|++|+++.. .+......+.+|||++|.+. .+|.. ...+ .|+.|.
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v---~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~ 238 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV---DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLLN 238 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh---HHHHhcccccccccccchhc-cccccchhhh-hheeee
Confidence 3555555556555 4455555555566666666655521 13333444555666666665 33321 2223 266666
Q ss_pred eecccccccCCcccccccccceeeccCCcccccC-CccccccCCCCEEECCCcccC
Q 037275 499 ISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSI-PSSLSSLKSIKELDMSSNNLS 553 (992)
Q Consensus 499 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~ 553 (992)
+++|.++. -..+.++.+|+.||+++|-|.+-- -.-++.|..|+.|+|.+|.+-
T Consensus 239 lrnN~l~t--L~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 239 LRNNALTT--LRGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred ecccHHHh--hhhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 77776652 123556666666677776665421 122445566666677777664
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.69 E-value=9.5e-08 Score=96.06 Aligned_cols=135 Identities=24% Similarity=0.217 Sum_probs=96.9
Q ss_pred CCCCCccccccceEEEEeEECCCCeEEEEEEeeccC-----------------C-----CchhHHHHHHHHHHhccCC--
Q 037275 681 FSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ-----------------K-----GASNGFVAECQALRNIRHR-- 736 (992)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------------~-----~~~~~~~~E~~~l~~l~h~-- 736 (992)
+.+...||-|--|.||.|.+. .|.++|||.-+... . -.....++|.++|.++...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 346689999999999999996 79999999654210 0 0113357899999999654
Q ss_pred cceeEEEEeecccccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccC
Q 037275 737 NLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDL 816 (992)
Q Consensus 737 niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dl 816 (992)
.+.+.+++ +..++||||++|--|...- ++....-.++..|++-+...-.. ||||||+
T Consensus 172 ~VP~P~~~---------nRHaVvMe~ieG~eL~~~r-----------~~~en~~~il~~il~~~~~~~~~---GiVHGDl 228 (304)
T COG0478 172 KVPKPIAW---------NRHAVVMEYIEGVELYRLR-----------LDVENPDEILDKILEEVRKAYRR---GIVHGDL 228 (304)
T ss_pred CCCCcccc---------ccceeeeehcccceeeccc-----------CcccCHHHHHHHHHHHHHHHHHc---CccccCC
Confidence 66666654 2338999999886555432 12223334455555555555566 9999999
Q ss_pred CCCCeeeCCCCcEEEeeccccee
Q 037275 817 KPSNVLLDQDLVAHLGDFGLAKF 839 (992)
Q Consensus 817 kp~NIll~~~~~~kl~Dfg~a~~ 839 (992)
.+-||++++||.+.++||-.+..
T Consensus 229 SefNIlV~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 229 SEFNILVTEDGDIVVIDWPQAVP 251 (304)
T ss_pred chheEEEecCCCEEEEeCccccc
Confidence 99999999999999999977653
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.65 E-value=5.9e-07 Score=88.76 Aligned_cols=142 Identities=18% Similarity=0.152 Sum_probs=104.7
Q ss_pred cccccceEEEEeEECCCCeEEEEEEeeccC------CCchhHHHHHHHHHHhccC--CcceeEEEEeecccccCcceEEE
Q 037275 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQ------KGASNGFVAECQALRNIRH--RNLIKIITICSSIDFKGVDFQAI 758 (992)
Q Consensus 687 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~l 758 (992)
-|+||.+.|+..... |..+-+|.-...- +-....|.+|...+.++.. -.+.+.+ ++...........++
T Consensus 26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 467999999998874 5568888653111 2345679999999999853 2244444 333222333455689
Q ss_pred EEEeccC-CCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCc--EEEeecc
Q 037275 759 VYEYMQN-GSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLV--AHLGDFG 835 (992)
Q Consensus 759 v~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg 835 (992)
|+|-+++ .+|.+++.+... .+.+...+..++.+++..++-||+. |+.|+|+.+.||+++.++. ++++||.
T Consensus 103 VTe~L~g~~~L~~~l~~~~~----~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlE 175 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHAV----SPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLE 175 (216)
T ss_pred EEEeCCCCccHHHHHhcCCc----CCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhh
Confidence 9998753 489998865432 1457777889999999999999999 9999999999999986666 9999998
Q ss_pred cce
Q 037275 836 LAK 838 (992)
Q Consensus 836 ~a~ 838 (992)
-++
T Consensus 176 k~r 178 (216)
T PRK09902 176 KSR 178 (216)
T ss_pred ccc
Confidence 665
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.50 E-value=7.6e-09 Score=91.54 Aligned_cols=59 Identities=24% Similarity=0.384 Sum_probs=27.0
Q ss_pred ccceeeccCCcccccCCccccccCCCCEEECCCcccCCCChhhhhcCCCcceEecCCCcCc
Q 037275 517 SLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFE 577 (992)
Q Consensus 517 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 577 (992)
.++.|+|++|.|+ .+|..+..++.|+.|+++.|.|. ..|..+..|.+|-.|+..+|...
T Consensus 78 t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~ 136 (177)
T KOG4579|consen 78 TATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA 136 (177)
T ss_pred hhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCCCCccc
Confidence 4444444444444 34444444444444444444444 34444444444444444444443
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.9e-06 Score=87.73 Aligned_cols=110 Identities=25% Similarity=0.277 Sum_probs=84.5
Q ss_pred hhHHHHHHHHHHhccC--CcceeEEEEeecccccCcceEEEEEEeccCC-CHHHHHhhcccchhhcccCHHHHHHHHHHH
Q 037275 720 SNGFVAECQALRNIRH--RNLIKIITICSSIDFKGVDFQAIVYEYMQNG-SLEDWLHQSEDQQEARSLTLIQRINIIIDV 796 (992)
Q Consensus 720 ~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi 796 (992)
.....+|...+..+.. =.+.+.+++....... ....++|+|++++. +|.+++..... .+......++.++
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~-~~~s~lite~l~~~~~L~~~~~~~~~------~~~~~~~~ll~~l 127 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGG-GYRSYLITEALPGAQDLRDLLQQWEQ------LDPSQRRELLRAL 127 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCC-ceeEEEEEEeCCCcccHHHHHHhhcc------cchhhHHHHHHHH
Confidence 3467888888888742 3345566664432222 24568999999874 89999876332 4556677899999
Q ss_pred HHHHHHHHhcCCCCeEeccCCCCCeeeCCCC---cEEEeeccccee
Q 037275 797 ASAIEYIHHHCQPPVVHGDLKPSNVLLDQDL---VAHLGDFGLAKF 839 (992)
Q Consensus 797 ~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~Dfg~a~~ 839 (992)
+..++-||+. ||+|+|+++.|||++.++ .+.++||+-++.
T Consensus 128 ~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 128 ARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999999 999999999999998887 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.49 E-value=5.5e-08 Score=109.47 Aligned_cols=104 Identities=21% Similarity=0.459 Sum_probs=77.6
Q ss_pred HHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceecCCCCCCCCcc-cCCCCCcccccccccccccccCC
Q 037275 795 DVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVE-TPSSSKGIKGTVGYIAPEYGMGG 873 (992)
Q Consensus 795 qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~ 873 (992)
+++.|+.|+|.+. ++||++|.|++|.++..+..||+.|+++............+ .....-...-...|.|||++.+.
T Consensus 107 ~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 4558999999885 89999999999999999999999999987655422111000 01111112235679999999998
Q ss_pred CcCcccchhhHHHHHHHHHh-CCCCCCC
Q 037275 874 EASMTGDVYSFGILLLEMFT-RRRPTDG 900 (992)
Q Consensus 874 ~~~~~~DiwSlG~il~ellt-g~~pf~~ 900 (992)
..+.++|+||+||.+|.+.. |+.-+..
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a 212 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAA 212 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhc
Confidence 89999999999999999994 6555443
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.6e-06 Score=85.89 Aligned_cols=142 Identities=16% Similarity=0.216 Sum_probs=95.4
Q ss_pred HhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHH---------HHHHHHHHhcc---CCcceeEEEE
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGF---------VAECQALRNIR---HRNLIKIITI 744 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~---h~niv~~~~~ 744 (992)
..++|...+++-......|.+... +|+.+++|..+.......+.+ .+++..+.++. -.....++.+
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 346788888888888888888777 688999999875544333222 23344444443 2233333333
Q ss_pred eecccccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeC
Q 037275 745 CSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLD 824 (992)
Q Consensus 745 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 824 (992)
.....+.-....+++|||++|..|.++.. +++ .++..+++++.-+|+. |++|||..|.|++++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~ 169 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED----------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVS 169 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh----------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEE
Confidence 22222333345578999999988876642 222 2445678889999999 999999999999998
Q ss_pred CCCcEEEeecccce
Q 037275 825 QDLVAHLGDFGLAK 838 (992)
Q Consensus 825 ~~~~~kl~Dfg~a~ 838 (992)
.+ .+++.||+..+
T Consensus 170 ~~-~i~iID~~~k~ 182 (229)
T PF06176_consen 170 NN-GIRIIDTQGKR 182 (229)
T ss_pred CC-cEEEEECcccc
Confidence 55 48999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 992 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-38 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-37 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 1e-32 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 1e-12 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 1e-32 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-12 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-28 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-27 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-23 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-22 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-22 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-22 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-22 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-22 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-22 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-22 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-22 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-21 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-21 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-21 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-21 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-21 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-21 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-21 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-21 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-21 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-21 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-21 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-21 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-21 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-20 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-20 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-18 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 7e-18 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-18 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-18 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 8e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 8e-18 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 8e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 9e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-17 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-17 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-17 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-17 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-17 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 9e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 9e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 9e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 9e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-17 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 9e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-16 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 3iok_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-16 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-16 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-16 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-16 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-16 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-16 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-16 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-16 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 8e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 8e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 9e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-15 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-15 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-15 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-15 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-15 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-15 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-15 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-15 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-15 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-15 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 9e-15 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-14 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-14 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-14 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 3e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-14 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-14 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-14 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-14 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 7e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-14 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-14 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-14 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 8e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 8e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 8e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-14 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-13 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-13 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-13 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 7e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 7e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 9e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 9e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-12 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-12 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 9e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 9e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 9e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-11 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-11 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-11 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-11 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-11 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-11 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-11 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-11 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-11 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 7e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 7e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 8e-11 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 8e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 8e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-10 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-10 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-10 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-10 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 8e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 8e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 8e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 9e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 9e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 9e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 9e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 9e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-09 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-09 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-09 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-09 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 6e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 6e-09 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 7e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 7e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 7e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 7e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 7e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-08 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-08 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-08 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-08 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-08 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-08 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-08 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-08 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 7e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 8e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 8e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 9e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-07 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-07 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 8e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 9e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 9e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 9e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-06 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-06 | ||
| 3e6j_A | 229 | Crystal Structure Of Variable Lymphocyte Receptor ( | 1e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-06 | ||
| 3m18_A | 251 | Crystal Structure Of Variable Lymphocyte Receptor V | 2e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-06 | ||
| 3m19_A | 251 | Crystal Structure Of Variable Lymphocyte Receptor V | 3e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-06 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-06 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-06 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 4e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 7e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 7e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 7e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 9e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 9e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 9e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 9e-06 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 1e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-05 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 1e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-05 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-05 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-05 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-05 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-05 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 2e-05 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-05 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-05 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 2e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-05 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-05 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-05 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 3e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-05 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-05 | ||
| 2ft3_A | 332 | Crystal Structure Of The Biglycan Dimer Core Protei | 4e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-05 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-05 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-05 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-05 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 4e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-05 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-05 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 5e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 6e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 6e-05 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 7e-05 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 7e-05 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 7e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 8e-05 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 8e-05 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 8e-05 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 8e-05 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 8e-05 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 8e-05 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 8e-05 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 8e-05 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-05 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 8e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 9e-05 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 9e-05 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 9e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-04 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-04 | ||
| 3kj4_A | 286 | Structure Of Rat Nogo Receptor Bound To 1d9 Antagon | 1e-04 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-04 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-04 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-04 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-04 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-04 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-04 | ||
| 2v62_A | 345 | Structure Of Vaccinia-Related Kinase 2 Length = 345 | 2e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-04 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-04 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-04 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-04 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-04 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-04 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-04 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-04 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-04 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-04 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-04 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-04 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-04 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 4e-04 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-04 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 5e-04 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-04 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-04 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-04 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3E6J|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor (Vlr) Rbc36 In Complex With H-Trisaccharide Length = 229 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3M18|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R2.1 In Complex With Hen Egg Lysozyme Length = 251 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3M19|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R5.1 Length = 251 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2FT3|A Chain A, Crystal Structure Of The Biglycan Dimer Core Protein Length = 332 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist Antibody Length = 286 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2V62|A Chain A, Structure Of Vaccinia-Related Kinase 2 Length = 345 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 506 bits (1305), Expect = e-166
Identities = 165/567 (29%), Positives = 263/567 (46%), Gaps = 24/567 (4%)
Query: 53 TKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSG 112
LD+S+ + P++G+ S L++L+++ N G+ I L+ L +++N F G
Sbjct: 203 EFLDVSSNNFSTGI-PFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVG 261
Query: 113 KIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLST 172
IP +L + N GEIP L L L ++ NH G P G+ S
Sbjct: 262 PIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSL 319
Query: 173 LERINVLGNGLWGRIPNN-LGNLRNLILLNLGENRFSGIVPPSIFNIS-SLENVFLPTNR 230
LE + + N G +P + L +R L +L+L N FSG +P S+ N+S SL + L +N
Sbjct: 320 LESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNN 379
Query: 231 FNGSLPLDIG-VSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFR 289
F+G + ++ L + N F G IP +LSN S LV L L N G +
Sbjct: 380 FSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLG 439
Query: 290 SLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTM 349
SL L L L N L GE L L + LD N G +P ++N ++ +
Sbjct: 440 SLSKLRDLKLWLNML-EGE-----IPQELMYVKTLETLILDFNDLTGEIPSGLSNCTN-L 492
Query: 350 TDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAG 409
I ++ N+++G IP I L NL L + +N +G IP +G+ ++L L L++N G
Sbjct: 493 NWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNG 552
Query: 410 GIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMAD--IELTGALPPQILSIS 467
IP ++ + +++N + G + N E H A +E G Q+ +S
Sbjct: 553 TIPAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLS 608
Query: 468 TLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNS 527
T + +++ + G N ++++ ++S N SG IP + + L L L N
Sbjct: 609 TRN-PCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHND 667
Query: 528 FSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFS 587
SGSIP + L+ + LD+SSN L G+IP+ + L+ L ++LS N+ G +P G F
Sbjct: 668 ISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFE 727
Query: 588 NKTGISLSGNGKVCGGLDELNLPPCPS 614
N +CG LP C
Sbjct: 728 TFPPAKFLNNPGLCG----YPLPRCDP 750
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 457 bits (1179), Expect = e-148
Identities = 160/593 (26%), Positives = 268/593 (45%), Gaps = 54/593 (9%)
Query: 2 SVPSNETDRLALLAIGSQLEDDPLGVTSSWNNSTNLCQWTGVTCGHRHQRVTKLDLSNRT 61
S + L++ L D + W+++ N C + GVTC R +VT +DLS++
Sbjct: 6 PSQSLYREIHQLISFKDVLPDK--NLLPDWSSNKNPCTFDGVTC--RDDKVTSIDLSSKP 61
Query: 62 I---GGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPT-- 116
+ +S + +L+ L L L++++ +G + L +L L+ NS SG + T
Sbjct: 62 LNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTTLT 120
Query: 117 NLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASI---GNLSTL 173
+L CS L N N L G LE L ++ N ++G L
Sbjct: 121 SLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGEL 180
Query: 174 ERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNG 233
+ + + GN + G + + NL L++ N FS + P + + S+L+++ + N+ +G
Sbjct: 181 KHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGI-PFLGDCSALQHLDISGNKLSG 237
Query: 234 SLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKN 293
I + +L ++ N F G IP +L L+L +N+F G++
Sbjct: 238 DFSRAIS-TCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIP-------- 286
Query: 294 LEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIV 353
L C LT + L N F G +P + S + +
Sbjct: 287 ---------------------DFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSL-LESLA 324
Query: 354 IAGNQISGIIPTG-IRNLVNLVELCMDDNKLTGTIPHAIGELK-NLQLLYLDSNFLAGGI 411
++ N SG +P + + L L + N+ +G +P ++ L +L L L SN +G I
Sbjct: 325 LSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPI 384
Query: 412 PTSLGNLTL--LTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTL 469
+L L L L +N G IPP+L NC L+ LH++ L+G +P + S+S L
Sbjct: 385 LPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKL 444
Query: 470 SLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFS 529
L L N+L G +P E+ +K L + N +GEIP LS CT+L + L N +
Sbjct: 445 RD-LKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLT 503
Query: 530 GSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPT 582
G IP + L+++ L +S+N+ SG IP L + L +L+L+ N F G +P
Sbjct: 504 GEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPA 556
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 2e-36
Identities = 54/213 (25%), Positives = 87/213 (40%), Gaps = 34/213 (15%)
Query: 392 GELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMA 451
++ ++ L N + +SL +LT L +L LS++ + GS+ +L
Sbjct: 50 DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLT----- 103
Query: 452 DIELTGALPPQILSISTLSLSLDLSYNLLSGTLP--LEVGNLKNLVYFNISVNRFSGEIP 509
SLDLS N LSG + +G+ L + N+S N
Sbjct: 104 --------------------SLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGK 143
Query: 510 VTLSA-CTSLQQLYLQGNSFSGSIPSSL---SSLKSIKELDMSSNNLSGQIPEYLENLSF 565
V+ SL+ L L NS SG+ +K L +S N +SG + +
Sbjct: 144 VSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVN 201
Query: 566 LEYLNLSYNHFEGEVPTKGVFSNKTGISLSGNG 598
LE+L++S N+F +P G S + +SGN
Sbjct: 202 LEFLDVSSNNFSTGIPFLGDCSALQHLDISGNK 234
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-23
Identities = 36/130 (27%), Positives = 58/130 (44%), Gaps = 2/130 (1%)
Query: 52 VTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFS 111
++++R GG SP N + +L+++ N G IP +IG + L L L +N S
Sbjct: 610 RNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDIS 669
Query: 112 GKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLS 171
G IP + L + N L G IP + L + +++N+L+G P +G
Sbjct: 670 GSIPDEVGDLRGLNILDLSSNKLDGRIPQAMS-ALTMLTEIDLSNNNLSGPIP-EMGQFE 727
Query: 172 TLERINVLGN 181
T L N
Sbjct: 728 TFPPAKFLNN 737
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 310 bits (797), Expect = 4e-98
Identities = 89/308 (28%), Positives = 145/308 (47%), Gaps = 14/308 (4%)
Query: 312 LDFLTLLTNCTEL----TAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISG--IIPT 365
L L N T L + + GVL + + ++ ++G + IP+
Sbjct: 12 LQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYR-VNNLDLSGLNLPKPYPIPS 70
Query: 366 GIRNLVNLVELCM-DDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNL 424
+ NL L L + N L G IP AI +L L LY+ ++G IP L + L L
Sbjct: 71 SLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130
Query: 425 ALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTL 484
S N L G++PPS+ + NL+ + ++GA+P S S L S+ +S N L+G +
Sbjct: 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKI 190
Query: 485 PLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKE 544
P NL NL + ++S N G+ V + + Q+++L NS + + + K++
Sbjct: 191 PPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNG 248
Query: 545 LDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNKTGISLSGNGKVCGGL 604
LD+ +N + G +P+ L L FL LN+S+N+ GE+P G + + N +CG
Sbjct: 249 LDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGS- 307
Query: 605 DELNLPPC 612
LP C
Sbjct: 308 ---PLPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 1e-65
Identities = 80/304 (26%), Positives = 121/304 (39%), Gaps = 37/304 (12%)
Query: 6 NETDRLALLAIGSQLEDDPLGVTSSWNNSTNLCQ--WTGVTCGHRHQ--RVTKLDLSNRT 61
N D+ ALL I L + SSW +T+ C W GV C Q RV LDLS
Sbjct: 4 NPQDKQALLQIKKDLGNPT--TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLN 61
Query: 62 IGGTLS---------------------------PYVGNLSFLRYLNLADNNFHGEIPHQI 94
+ P + L+ L YL + N G IP +
Sbjct: 62 LPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFL 121
Query: 95 GRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTI 154
++ L L + N+ SG +P ++S NL+ N + G IP G ++TI
Sbjct: 122 SQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTI 181
Query: 155 ADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPS 214
+ N LTG P + NL+ L +++ N L G G+ +N ++L +N + +
Sbjct: 182 SRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL-GK 239
Query: 215 IFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELT 274
+ +L + L NR G+LP + L L V+ NN G IP+ N
Sbjct: 240 VGLSKNLNGLDLRNNRIYGTLPQGLT-QLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSA 297
Query: 275 LFDN 278
+N
Sbjct: 298 YANN 301
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 7e-62
Identities = 84/361 (23%), Positives = 131/361 (36%), Gaps = 68/361 (18%)
Query: 163 FPASIGNLSTL----ERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSG--IVPPSIF 216
+GN +TL + G + + + L+L +P S+
Sbjct: 14 IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLA 73
Query: 217 NISSLENVFLP-TNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTL 275
N+ L +++ N G +P I L +L + N +G+IP+ LS LV L
Sbjct: 74 NLPYLNFLYIGGINNLVGPIPPAIA-KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDF 132
Query: 276 FDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFG 335
N G + SL NL + N +
Sbjct: 133 SYNALSGTLPPSISSLPNLVGITFDGNRI------------------------------S 162
Query: 336 GVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELK 395
G +P S + S T + I+ N+++G IP NL NL + + N L G G K
Sbjct: 163 GAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDK 221
Query: 396 NLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIEL 455
N Q ++L N LA + +G L L L +N + G++P L K L
Sbjct: 222 NTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLH--------- 271
Query: 456 TGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSAC 515
SL++S+N L G +P + GNL+ + N+ P L AC
Sbjct: 272 ----------------SLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP--LPAC 312
Query: 516 T 516
T
Sbjct: 313 T 313
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 321 bits (825), Expect = 5e-98
Identities = 99/620 (15%), Positives = 189/620 (30%), Gaps = 91/620 (14%)
Query: 9 DRLALLAIGSQLEDDPLGVT-------SSWNNSTNLCQWT---GVTCGHRHQRVTKLDLS 58
D LAL I L ++WN + L W GV+
Sbjct: 31 DYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLN------------ 78
Query: 59 NRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSG----KI 114
+ + L+L G +P IG+L LE L L ++
Sbjct: 79 -------------SNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFG 125
Query: 115 PTNLSRCSNLISFNARRNNLVGEIPAELGY-NWLKLENLTIADNHLTGHFPASIGNLSTL 173
P +S + R + ++ L I + S
Sbjct: 126 PKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKD 185
Query: 174 ERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNG 233
+I L N + + + L L +G + F + + E +
Sbjct: 186 TQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEY-----AQQYK 239
Query: 234 SLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIY------ 287
+ L +L L V +P L + + + N+ +
Sbjct: 240 TEDLKWD-NLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQAL 298
Query: 288 --FRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANL 345
+ ++ + +G NNL T T L +L + N+ G LP + +
Sbjct: 299 ADAPVGEKIQIIYIGYNNLKTFPVE-----TSLQKMKKLGMLECLYNQLEGKLP-AFGSE 352
Query: 346 SSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHA--IGELKNLQLLYLD 403
+ + +A NQI+ I + L NKL IP+ + + +
Sbjct: 353 IK-LASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFS 410
Query: 404 SNFLAG-------GIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELT 456
N + + + ++++ LS+N + L +++ LT
Sbjct: 411 YNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT 470
Query: 457 GALPPQILSISTLSLS-------LDLSYNLLSGTLP-LEVGNLKNLVYFNISVNRFSGEI 508
+P L + +DL +N L+ L LV ++S N FS
Sbjct: 471 E-IPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-F 528
Query: 509 PVTLSACTSLQQLYLQ------GNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLEN 562
P ++L+ ++ GN P ++ S+ +L + SN++ + E +
Sbjct: 529 PTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNE--KI 585
Query: 563 LSFLEYLNLSYNHFEGEVPT 582
+ L++ N +
Sbjct: 586 TPNISVLDIKDNPNISIDLS 605
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 6e-65
Identities = 84/558 (15%), Positives = 150/558 (26%), Gaps = 156/558 (27%)
Query: 53 TKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGE-------------------IPHQ 93
T++ + I +S V L+ LR + ++ F E +
Sbjct: 186 TQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLK 244
Query: 94 IGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLT 153
L L + + N K+PT L + N N ++
Sbjct: 245 WDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRG-----------------IS 287
Query: 154 IADNHLTGHFPASIGNLSTLERINVLGNGLW-GRIPNNLGNLRNLILLNLGENRFSGIVP 212
A ++ I + N L + +L ++ L +L N+ G
Sbjct: 288 GEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGK-L 346
Query: 213 PSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVE 272
P+ + L ++ L N+ IP +
Sbjct: 347 PAFGSEIKLASLNLAYNQITE--------------------------IPANF-------- 372
Query: 273 LTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDN 332
+ +E L+ N L + + + + ++AI N
Sbjct: 373 ---------------CGFTEQVENLSFAHNKLKY-----IPNIFDAKSVSVMSAIDFSYN 412
Query: 333 RFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIG 392
G V + + +N+ + + +N+++
Sbjct: 413 EIGSVDGKNFDP------------------LDPTPFKGINVSSINLSNNQISKFPKELFS 454
Query: 393 ELKNLQLLYLDSNFLAG-------GIPTSLGNLTLLTNLALSSNDLQGSIPPSL--GNCK 443
L + L N L + N LLT++ L N L +
Sbjct: 455 TGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLP 513
Query: 444 NLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNI---- 499
L+ +DLSYN S P + N L F I
Sbjct: 514 YLVG-------------------------IDLSYNSFSK-FPTQPLNSSTLKGFGIRNQR 547
Query: 500 --SVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIP 557
NR E P ++ C SL QL + N + + +I LD+ N
Sbjct: 548 DAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKI--TPNISVLDIKDNPNISIDL 604
Query: 558 EYLENLSFLEYLNLSYNH 575
Y+ L Y+
Sbjct: 605 SYVCPYIEAGMYMLFYDK 622
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 8e-40
Identities = 32/244 (13%), Positives = 80/244 (32%), Gaps = 13/244 (5%)
Query: 360 SGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGG----IPTSL 415
+ + + L ++ +G +P AIG+L L++L L S+ P +
Sbjct: 70 GAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGI 129
Query: 416 GNLTLLTNLALSSNDLQGSIPPSLG--NCKNLIELHMADIELTGALPPQILSISTLSLSL 473
Q + + +LI+ + ++ I+ +
Sbjct: 130 SANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSS-RITLKDTQI 188
Query: 474 DLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIP 533
N ++ + V L L F + + F E C + + + +
Sbjct: 189 GQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENI-----CEAWENENSEYAQQYKTED 242
Query: 534 SSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNKTGIS 593
+LK + ++++ + ++P +L+ L ++ +N++ N K +
Sbjct: 243 LKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAP 302
Query: 594 LSGN 597
+
Sbjct: 303 VGEK 306
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 278 bits (714), Expect = 5e-86
Identities = 103/317 (32%), Positives = 169/317 (53%), Gaps = 38/317 (11%)
Query: 670 SYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNG---FVAE 726
S EL A+++FS+ N++G+G FG VYKG L +G +VAVK LK++ G F E
Sbjct: 21 SLRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKR--LKEERTQGGELQFQTE 77
Query: 727 CQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTL 786
+ + HRNL+++ C + + +VY YM NGS+ L + + Q L
Sbjct: 78 VEMISMAVHRNLLRLRGFCMTPTER-----LLVYPYMANGSVASCLRERPESQPP--LDW 130
Query: 787 IQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLD 846
+R I + A + Y+H HC P ++H D+K +N+LLD++ A +GDFGLAK + D
Sbjct: 131 PKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK--D 188
Query: 847 TAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTD---GMFN 903
T V T ++GT+G+IAPEY G++S DV+ +G++LLE+ T +R D +
Sbjct: 189 THVTT-----AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 243
Query: 904 QGLTLHEFARTALPD-KVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCS 962
+ L ++ + L + K+ +VD L + +E + +++ ++C+
Sbjct: 244 DDVMLLDWVKGLLKEKKLEALVDVDL---------QGNYK-----DEEVEQLIQVALLCT 289
Query: 963 MESPTERMEMRDVVAKL 979
SP ER +M +VV L
Sbjct: 290 QSSPMERPKMSEVVRML 306
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 288 bits (738), Expect = 3e-85
Identities = 108/569 (18%), Positives = 188/569 (33%), Gaps = 48/569 (8%)
Query: 52 VTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFS 111
+T L+L++ + + S L L++ N P +L L+ L L +N S
Sbjct: 27 ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86
Query: 112 GKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLS 171
+ C+NL + N++ L L ++ N L+ + L
Sbjct: 87 QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFV-KQKNLITLDLSHNGLSSTKLGTQVQLE 145
Query: 172 TLERINVLGNGLWGRIPNNLGNLRN--LILLNLGENRFSGIVPPSIFNISSLENVFLPTN 229
L+ + + N + L N L L L N+ P I L +FL
Sbjct: 146 NLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNV 205
Query: 230 RFNGSLPLDIGV--SLPKLLGFIVAENNFAGSIPESLSN--ASNLVELTLFDNQFRGKVS 285
+ SL + + + + ++ + + + + +NL L L N +
Sbjct: 206 QLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGN 265
Query: 286 IYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANL 345
F L LE+ L NN+ ++ L + + L + +
Sbjct: 266 DSFAWLPQLEYFFLEYNNIQHLFSHS------LHGLFNVRYLNLKRSFTKQSISL----- 314
Query: 346 SSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSN 405
+ I + L L L M+DN + G + L NL+ L L ++
Sbjct: 315 -----------ASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNS 363
Query: 406 FLAGGIPTSLG----NLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPP 461
F + T+ + L L L+ N + + +L L + E+ L
Sbjct: 364 FTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTG 423
Query: 462 QILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSG--EIPVTLSACTSLQ 519
Q + LSYN + +L + P +L
Sbjct: 424 QEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLT 483
Query: 520 QLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLS--------GQIPEYLENLSFLEYLNL 571
L L N+ + L L+ ++ LD+ NNL+ G +L+ LS L LNL
Sbjct: 484 ILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNL 543
Query: 572 SYNHFEGEVPTKGVFSNKTG---ISLSGN 597
N F+ VF + I L N
Sbjct: 544 ESNGFDEIPV--EVFKDLFELKIIDLGLN 570
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 280 bits (718), Expect = 2e-82
Identities = 99/546 (18%), Positives = 186/546 (34%), Gaps = 46/546 (8%)
Query: 53 TKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPH--QIGRLVRLEALVLANNSF 110
LDLS+ + T L L+ L L++N I L+ L L++N
Sbjct: 124 ITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQI 183
Query: 111 SGKIPTNLSRCSNLISFNARRNNLVGEIPAEL--GYNWLKLENLTIADNHLTGHFPASIG 168
P L L + +L + NL+++++ L+ +
Sbjct: 184 KEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFL 243
Query: 169 NL--STLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFL 226
L + L +++ N L ++ L L L N + S+ + ++ + L
Sbjct: 244 GLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNL 303
Query: 227 PTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSI 286
+ S+ L + S L L + DN G S
Sbjct: 304 KRSFTKQSISL----------------ASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSN 347
Query: 287 YFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLS 346
F L NL++L+L ++ + F++L + L + L N+ + + + L
Sbjct: 348 MFTGLINLKYLSLSNSFTSLRTLTNETFVSL--AHSPLHILNLTKNKISKIESDAFSWLG 405
Query: 347 STMTDIVIAGNQISGIIPTG-IRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSN 405
+ + + N+I + R L N+ E+ + NK ++ + +LQ L L
Sbjct: 406 H-LEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRV 464
Query: 406 FLAG--GIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQI 463
L P+ L LT L LS+N++ L + L L + L
Sbjct: 465 ALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLA------- 517
Query: 464 LSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYL 523
L + G + L +L N+ N F L+ + L
Sbjct: 518 ----------RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDL 567
Query: 524 QGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLE-NLSFLEYLNLSYNHFEGEVPT 582
N+ + S ++ S+K L++ N ++ + L L++ +N F+ +
Sbjct: 568 GLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627
Query: 583 KGVFSN 588
F N
Sbjct: 628 IAWFVN 633
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 273 bits (701), Expect = 5e-80
Identities = 97/543 (17%), Positives = 187/543 (34%), Gaps = 55/543 (10%)
Query: 76 LRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLV 135
+ + ++P + + L L +N N +R S L S + N +
Sbjct: 6 HEVADCSHLKLT-QVPDDLPT--NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTIS 62
Query: 136 GEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLR 195
P L+ L + N L+ + + L ++++ N + N +
Sbjct: 63 KLEPELCQ-KLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121
Query: 196 NLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENN 255
NLI L+L N S + + +L+ + L + N
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLL-------------------------SNNK 156
Query: 256 FAGSIPESLSNASN--LVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLD 313
E L +N L +L L NQ + F ++ L L L + LG + +
Sbjct: 157 IQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGP---SLTE 213
Query: 314 FLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSST-MTDIVIAGNQISGIIPTGIRNLVN 372
L L T + + L +++ + L T +T + ++ N ++ + L
Sbjct: 214 KLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQ 273
Query: 373 LVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGI---------PTSLGNLTLLTN 423
L ++ N + H++ L N++ L L +F I S L L +
Sbjct: 274 LEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEH 333
Query: 424 LALSSNDLQGSIPPSLGNCKNLIELHMAD--IELTGALPPQILSISTLSL-SLDLSYNLL 480
L + ND+ G NL L +++ L +S++ L L+L+ N +
Sbjct: 334 LNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKI 393
Query: 481 SGTLPLEVGNLKNLVYFNISVNRFSGEIPV-TLSACTSLQQLYLQGNSFSGSIPSSLSSL 539
S L +L ++ +N E+ ++ ++YL N + +S + +
Sbjct: 394 SKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALV 453
Query: 540 KSIKELDMSSNNLSG--QIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNKTG---ISL 594
S++ L + L P + L L L+LS N+ + + L
Sbjct: 454 PSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANIND--DMLEGLEKLEILDL 511
Query: 595 SGN 597
N
Sbjct: 512 QHN 514
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 4e-48
Identities = 77/406 (18%), Positives = 130/406 (32%), Gaps = 38/406 (9%)
Query: 46 GHRHQRVTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVL 105
G + +T LDLS + + L L Y L NN H + L + L L
Sbjct: 244 GLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNL 303
Query: 106 ANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPA 165
+ I +L LE+L + DN + G
Sbjct: 304 KRSFTKQSIS---------------LASLPKIDDFSFQ-WLKCLEHLNMEDNDIPGIKSN 347
Query: 166 SIGNLSTLERINVLGNGLWGR--IPNNLGNLRNLIL--LNLGENRFSGIVPPSIFNISSL 221
L L+ +++ + R +L + L LNL +N+ S I + + L
Sbjct: 348 MFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHL 407
Query: 222 ENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFR 281
E + L N L L + ++ N + S + +L L L +
Sbjct: 408 EVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALK 467
Query: 282 GKVSIY--FRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNR------ 333
S F+ L+NL L+L +NN+ + +L +L + L N
Sbjct: 468 NVDSSPSPFQPLRNLTILDLSNNNIANINDD------MLEGLEKLEILDLQHNNLARLWK 521
Query: 334 --FGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAI 391
G + + LS + + + N I ++L L + + N L
Sbjct: 522 HANPGGPIYFLKGLSH-LHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVF 580
Query: 392 GELKNLQLLYLDSNFLAGGIPTSLG-NLTLLTNLALSSNDLQGSIP 436
+L+ L L N + G LT L + N +
Sbjct: 581 NNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 2e-47
Identities = 67/303 (22%), Positives = 114/303 (37%), Gaps = 20/303 (6%)
Query: 293 NLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDI 352
+ E + L + L TN +T + L N+ + + S +T +
Sbjct: 5 SHEVADCSHLKLTQVPDD------LPTN---ITVLNLTHNQLRRLPAANFTRYSQ-LTSL 54
Query: 353 VIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIP 412
+ N IS + P + L L L + N+L+ NL L+L SN +
Sbjct: 55 DVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKN 114
Query: 413 TSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLS-- 470
L L LS N L + + +NL EL +++ ++ L + L I S
Sbjct: 115 NPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQA-LKSEELDIFANSSL 173
Query: 471 LSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLS---ACTSLQQLYLQGNS 527
L+LS N + P + L ++ + + L A TS++ L L +
Sbjct: 174 KKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQ 233
Query: 528 FSGSIPSSLSSLK--SIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGV 585
S + ++ LK ++ LD+S NNL+ + L LEY L YN+ +
Sbjct: 234 LSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFS--HS 291
Query: 586 FSN 588
Sbjct: 292 LHG 294
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-11
Identities = 24/148 (16%), Positives = 45/148 (30%), Gaps = 1/148 (0%)
Query: 56 DLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIP 115
L G ++ LS L LNL N F L L+ + L N+ +
Sbjct: 518 RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPA 577
Query: 116 TNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLER 175
+ + +L S N ++N + G + L L + N + ++ +
Sbjct: 578 SVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINE 637
Query: 176 INVLGNGLWGRIP-NNLGNLRNLILLNL 202
+ L N + +
Sbjct: 638 THTNIPELSSHYLCNTPPHYHGFPVRLF 665
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 282 bits (724), Expect = 5e-84
Identities = 109/546 (19%), Positives = 195/546 (35%), Gaps = 37/546 (6%)
Query: 52 VTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFS 111
LDLS + S + L+ L+L+ L L L+L N
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 112 GKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTG-HFPASIGNL 170
S S+L A NL +G + L+ L +A N + P NL
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIG-HLKTLKELNVAHNLIQSFKLPEYFSNL 148
Query: 171 STLERINVLGNGLWGRIPNNLGNLRNL----ILLNLGENRFSGIVPPSIFNISSLENVFL 226
+ LE +++ N + +L L + + L+L N + I P F L + L
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFI-QPGAFKEIRLHKLTL 207
Query: 227 PTNRFNGSLPLDIGVSLPKL------LGFIVAENNFAGSIPESLSNASNLVELTL---FD 277
N + ++ L L LG E N +L NL +
Sbjct: 208 RNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 267
Query: 278 NQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGV 337
+ + + F L N+ +L S + + + + L + +FG
Sbjct: 268 DYYLDDIIDLFNCLTNVSSFSLVSVTIER--------VKDFSYNFGWQHLELVNCKFGQF 319
Query: 338 LPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLT--GTIPHAIGELK 395
+ +L + G +L +L L + N L+ G +
Sbjct: 320 PTLKLKSLKR------LTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTT 373
Query: 396 NLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPS-LGNCKNLIELHMADIE 454
+L+ L L N + + ++ L L +L ++L+ S + +NLI L ++
Sbjct: 374 SLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 432
Query: 455 LTGALPPQILSISTLSLSLDLSYNLLSGTLPLEV-GNLKNLVYFNISVNRFSGEIPVTLS 513
A +S+L L ++ N ++ L+NL + ++S + P +
Sbjct: 433 TRVAFNGIFNGLSSLE-VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 491
Query: 514 ACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENL-SFLEYLNLS 572
+ +SLQ L + N+F L S++ LD S N++ + L++ S L +LNL+
Sbjct: 492 SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLT 551
Query: 573 YNHFEG 578
N F
Sbjct: 552 QNDFAC 557
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 261 bits (669), Expect = 2e-76
Identities = 102/534 (19%), Positives = 173/534 (32%), Gaps = 47/534 (8%)
Query: 76 LRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLV 135
+ L+L+ N + L+ L L+ S+L + N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 136 GEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWG-RIPNNLGNL 194
L+ L + +L IG+L TL+ +NV N + ++P NL
Sbjct: 90 SLALGAFS-GLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148
Query: 195 RNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAEN 254
NL L+L N+ I + + + + L LD+
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS---------LDLS-------------L 186
Query: 255 NFAGSIPESLSNASNLVELTLFDNQFRGKV-SIYFRSLKNLEWLNLGSNNLGTGEANDLD 313
N I L +LTL +N V + L LE L +
Sbjct: 187 NPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKF 246
Query: 314 FLTLLTNCTELTAIGLDDNR---FGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNL 370
+ L LT + + L++ ++ + I +
Sbjct: 247 DKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTN-VSSFSLVSVTIERVKD--FSYN 303
Query: 371 VNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSND 430
L + + K + LK L S +L L L LS N
Sbjct: 304 FGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGG-----NAFSEVDLPSLEFLDLSRNG 358
Query: 431 LQ--GSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEV 488
L G S +L L ++ + + L + L LD ++ L V
Sbjct: 359 LSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLE-HLDFQHSNLKQMSEFSV 416
Query: 489 -GNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSI-PSSLSSLKSIKELD 546
+L+NL+Y +IS + +SL+ L + GNSF + P + L+++ LD
Sbjct: 417 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 476
Query: 547 MSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNKTG---ISLSGN 597
+S L P +LS L+ LN+S+N+F + + S N
Sbjct: 477 LSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT--FPYKCLNSLQVLDYSLN 528
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 248 bits (634), Expect = 2e-71
Identities = 103/553 (18%), Positives = 175/553 (31%), Gaps = 40/553 (7%)
Query: 53 TKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSG 112
LDLS I +LS L L L N L L+ LV + +
Sbjct: 55 QVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS 114
Query: 113 KIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLST 172
+ L N N + E N LE+L ++ N + + + L
Sbjct: 115 LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQ 174
Query: 173 LE----RINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIF-NISSLENVFLP 227
+ +++ N + P + L L L N S V + ++ LE L
Sbjct: 175 MPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLV 233
Query: 228 TNRFNGS--LPLDIGVSLPKLLGFIVAENN------FAGSIPESLSNASNLVELTLFDNQ 279
F L +L L + E + I + + +N+ +L
Sbjct: 234 LGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVT 293
Query: 280 FRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLT-------------NCTELTA 326
F + L L + G L L LT + L
Sbjct: 294 IER--VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEF 351
Query: 327 IGLDDNR--FGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLT 384
+ L N F G S +S + + ++ N + + + L L L + L
Sbjct: 352 LDLSRNGLSFKGCCSQSDFGTTS-LKYLDLSFNGVITM-SSNFLGLEQLEHLDFQHSNLK 409
Query: 385 GTIPH-AIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPP-SLGNC 442
L+NL L + L+ L L ++ N Q + P
Sbjct: 410 QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTEL 469
Query: 443 KNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVN 502
+NL L ++ +L P S+S+L L++S+N L +L + S+N
Sbjct: 470 RNLTFLDLSQCQLEQLSPTAFNSLSSLQ-VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN 528
Query: 503 RFSGEIPVTLSAC-TSLQQLYLQGNSFSGSIPSS--LSSLKSIKELDMSSNNLSGQIPEY 559
L +SL L L N F+ + L +K ++L + + P
Sbjct: 529 HIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSD 588
Query: 560 LENLSFLEYLNLS 572
+ + L LN++
Sbjct: 589 KQGMPVLS-LNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 4e-56
Identities = 85/459 (18%), Positives = 163/459 (35%), Gaps = 36/459 (7%)
Query: 156 DNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSI 215
+ + P ++ + + +++ N L + + L +L+L I +
Sbjct: 16 ELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAY 72
Query: 216 FNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTL 275
++S L + L N L L + E N A + + L EL +
Sbjct: 73 QSLSHLSTLILTGNPIQSLALGAFS-GLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131
Query: 276 FDNQFRG-KVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRF 334
N + K+ YF +L NLE L+L SN + + DL L + ++ L N
Sbjct: 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPL--LNLSLDLSLNPM 189
Query: 335 GGVLPHSIANLSSTMTDIVIAGNQISG-IIPTGIRNLVNLVELCMDDNKLTGT------I 387
+ P + + + + + N S ++ T I+ L L + +
Sbjct: 190 NFIQPGAFKEIR--LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFD 247
Query: 388 PHAIGELKNLQLLYLDSNFL---AGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKN 444
A+ L NL + +L I LT +++ +L S ++
Sbjct: 248 KSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFG 305
Query: 445 LIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNR- 503
L + + + L L++ G +L +L + ++S N
Sbjct: 306 WQHLELVNCKFGQ------FPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGL 359
Query: 504 -FSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIP-EYLE 561
F G + TSL+ L L N + S+ L+ ++ LD +NL
Sbjct: 360 SFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 418
Query: 562 NLSFLEYLNLSYNHFEGEVPTKGVFSNKTG---ISLSGN 597
+L L YL++S+ H G+F+ + + ++GN
Sbjct: 419 SLRNLIYLDISHTHTRVAFN--GIFNGLSSLEVLKMAGN 455
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 8e-30
Identities = 55/359 (15%), Positives = 119/359 (33%), Gaps = 47/359 (13%)
Query: 50 QRVTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNS 109
V+ L + TI ++L L + F ++ L L S
Sbjct: 282 TNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSL-----KRLTFTS 334
Query: 110 FSGKIPTNLSRCSNLISFNARRNNL--VGEIPAELGYNWLKLENLTIADNHLTGHFPASI 167
G + +L + RN L G L+ L ++ N + ++
Sbjct: 335 NKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDF-GTTSLKYLDLSFNGVIT-MSSNF 392
Query: 168 GNLSTLERINVLGNGLWGRIPNN-LGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFL 226
L LE ++ + L + +LRNLI L++ +SSLE + +
Sbjct: 393 LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKM 452
Query: 227 PTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSI 286
N F + DI L L +++ P + ++ S+L L + N F +
Sbjct: 453 AGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTF 512
Query: 287 YFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLS 346
++ L +L+ L+ N++ + +
Sbjct: 513 PYKCLNSLQVLDYSLNHI------------------------------MTSKKQELQHFP 542
Query: 347 STMTDIVIAGNQISGIIPTG--IRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLD 403
S++ + + N + ++ + + +L ++ ++ P + + + +L L+
Sbjct: 543 SSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATP---SDKQGMPVLSLN 598
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 277 bits (709), Expect = 1e-79
Identities = 104/660 (15%), Positives = 208/660 (31%), Gaps = 96/660 (14%)
Query: 6 NETDRLALLAIGSQLED----------DPLGVTSSWNNSTNLCQW---TGVTCGHRHQRV 52
D AL AI L+ + + +WN + L W GV + + RV
Sbjct: 267 YIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRV 325
Query: 53 TKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSG 112
T L L+ G + +G L+ L+ L+ ++ + + +
Sbjct: 326 TGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRM 385
Query: 113 KIPTNLS------RCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPAS 166
S+L+ RN + I + + LK + N +T +
Sbjct: 386 HYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRIS-LKDTQIGNLTNRITF-ISKA 443
Query: 167 IGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFL 226
I L+ L+ I + + N + S N+ L +V L
Sbjct: 444 IQRLTKLQIIYFANSPF-----TYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVEL 498
Query: 227 PTNRFNGSLPLDIGVSLPKLLGFIVAENNFAG---------SIPESLSNASNLVELTLFD 277
LP + LP+L +A N + + + +
Sbjct: 499 YNCPNMTQLPDFLY-DLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGY 557
Query: 278 NQFRG-KVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGG 336
N S + + L L+ N + L +LT + LD N+
Sbjct: 558 NNLEEFPASASLQKMVKLGLLDCVHNKVRH--------LEAFGTNVKLTDLKLDYNQIEE 609
Query: 337 VLPHSIANLSSTMTDIVIAGNQISGIIPT-GIRNLVNLVELCMDDNKLTGTIPHA----- 390
+P + + + + N++ I +++ + + NK+ +
Sbjct: 610 -IPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMD 668
Query: 391 IGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQ-------GSIPPSLGNCK 443
+ N + L N + + ++ + LS+N + + N
Sbjct: 669 DYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTY 728
Query: 444 NLIELHMADIELTGALPPQILSISTLSL-SLDLSYNLLSGTLPLEVGNLKNLVYFNISVN 502
L + + +LT L + + L ++D+SYN S + P + N L F I
Sbjct: 729 LLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQ 786
Query: 503 RFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLEN 562
R +GN P+ +++ S+ +L + SN++ + E L
Sbjct: 787 RD------------------AEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKL-- 825
Query: 563 LSFLEYLNLSYNHF-EGEVPTKGVFSNKTGISLSGNG--KVCGGLDELNLPPCPSRGLKK 619
L L+++ N +V + + L + + G C + G+++
Sbjct: 826 TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRG---------CDALGIER 876
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 244 bits (624), Expect = 3e-73
Identities = 95/313 (30%), Positives = 152/313 (48%), Gaps = 33/313 (10%)
Query: 669 ISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQ 728
+ +L +ATN+F +IG G FG VYKG L +G VA+K + F E +
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 729 ALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQ 788
L RH +L+ +I C + ++Y+YM+NG+L+ L+ S+ S++ Q
Sbjct: 88 TLSFCRHPHLVSLIGFCDE-----RNEMILIYKYMENGNLKRHLYGSDLPTM--SMSWEQ 140
Query: 789 RINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTA 848
R+ I I A + Y+H ++H D+K N+LLD++ V + DFG++K + T
Sbjct: 141 RLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISK-KGTELDQTH 196
Query: 849 VETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQG-LT 907
+ T +KGT+GYI PEY + G + DVYSFG++L E+ R + +
Sbjct: 197 LST-----VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVN 251
Query: 908 LHEFARTALPD-KVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESP 966
L E+A + + ++ +IVD L ++ E L +T V C S
Sbjct: 252 LAEWAVESHNNGQLEQIVDPNLADKI--------------RPESLRKFGDTAVKCLALSS 297
Query: 967 TERMEMRDVVAKL 979
+R M DV+ KL
Sbjct: 298 EDRPSMGDVLWKL 310
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 249 bits (637), Expect = 7e-72
Identities = 106/539 (19%), Positives = 187/539 (34%), Gaps = 24/539 (4%)
Query: 52 VTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFS 111
L+ S + + L L +L+L + RL+ LVL N
Sbjct: 35 TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLI 94
Query: 112 GKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLS 171
T LS L + + L N LE+L + NH++
Sbjct: 95 FMAETALSGPKALKHLFFIQTGISSIDFIPLH-NQKTLESLYLGSNHISSIKLPKGFPTE 153
Query: 172 TLERINVLGNGLWGRIPNNLGNLRNLIL--LNLGENRFSGIVPPSIFNISSLENVFLPTN 229
L+ ++ N + ++ +L+ LNL N +GI P F+ + +++
Sbjct: 154 KLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGI-EPGAFDSAVFQSLNFGGT 212
Query: 230 RFNGSLPLDI-GVSLPKLLGFIVAENNFAGSIPESLSN--ASNLVELTLFDNQFRGKVSI 286
+ + + ++ L + + P ++ + L + F S
Sbjct: 213 QNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSN 272
Query: 287 YFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLS 346
F L+ L+L + +L + L + L + L N+F + S +N
Sbjct: 273 TFHCFSGLQELDLTATHLSELPSG-------LVGLSTLKKLVLSANKFENLCQISASNFP 325
Query: 347 STMTDIVIAGNQISGIIPTG-IRNLVNLVELCMDDNKLT--GTIPHAIGELKNLQLLYLD 403
S +T + I GN + TG + NL NL EL + + + + L +LQ L L
Sbjct: 326 S-LTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLS 384
Query: 404 SNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPS-LGNCKNLIELHMADIELTGALPPQ 462
N + L L L+ L+ S N L L+++ L Q
Sbjct: 385 YNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDI-SSEQ 443
Query: 463 ILSISTLSLSLDLSYNLLSGTLPLEVG---NLKNLVYFNISVNRFSGEIPVTLSACTSLQ 519
+ L+L N + L L +S S ++ +
Sbjct: 444 LFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMN 503
Query: 520 QLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEG 578
+ L N + S +LS LK I L+++SN++S +P L LS +NL N +
Sbjct: 504 HVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 237 bits (608), Expect = 7e-68
Identities = 100/539 (18%), Positives = 174/539 (32%), Gaps = 27/539 (5%)
Query: 73 LSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRN 132
+ L + N RL+ L L L L + N
Sbjct: 32 PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91
Query: 133 NLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLG 192
L+ L L++L ++ + N TLE + + N +
Sbjct: 92 PLIFMAETALS-GPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGF 150
Query: 193 NLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNR-FNGSLPLDIGVSLPKLLGFIV 251
L +L+ N + + ++ N+ L N +
Sbjct: 151 PTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAF-DSAVFQSLNF 209
Query: 252 AENNFAGSIPESLSNAS--NLVELTLFDNQFRGKVSIYFRSLK--NLEWLNLGSNNLGTG 307
I + L N++ +L T D F L ++E +NL +
Sbjct: 210 GGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNI 269
Query: 308 EANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGI 367
+N + L + L LP + LS+ + +V++ N+ +
Sbjct: 270 SSN------TFHCFSGLQELDLTATHLSE-LPSGLVGLST-LKKLVLSANKFENLCQISA 321
Query: 368 RNLVNLVELCMDDNKLTGTI-PHAIGELKNLQLLYLDSNFLA--GGIPTSLGNLTLLTNL 424
N +L L + N + + L+NL+ L L + + L NL+ L +L
Sbjct: 322 SNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSL 381
Query: 425 ALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTL 484
LS N+ + C L L +A L L L+LS++LL +
Sbjct: 382 NLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISS 441
Query: 485 PLEVGNLKNLVYFNISVNRFSGEIPVTLSA---CTSLQQLYLQGNSFSGSIPSSLSSLKS 541
L L + N+ N F ++ L+ L L S + +SLK
Sbjct: 442 EQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKM 501
Query: 542 IKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNKTGIS---LSGN 597
+ +D+S N L+ E L +L + YLNL+ NH +P + + L N
Sbjct: 502 MNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILP--SLLPILSQQRTINLRQN 557
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 7e-55
Identities = 96/533 (18%), Positives = 179/533 (33%), Gaps = 49/533 (9%)
Query: 53 TKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSG 112
L I + N L L L N+ + +L+ L NN+
Sbjct: 108 KHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHY 167
Query: 113 KIPTNLSRCSNL--ISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGN- 169
++S +S N N++ I + ++L + N
Sbjct: 168 LSKEDMSSLQQATNLSLNLNGNDI-AGIEPGAF-DSAVFQSLNFGGTQNLLVIFKGLKNS 225
Query: 170 -LSTLERINVLGNGLWGRIPNNLGNLRNLIL--LNLGENRFSGIVPPSIFNISSLENVFL 226
+ +L P L + + +NL ++ F I + S L+ + L
Sbjct: 226 TIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDL 285
Query: 227 PTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSI 286
+ LP + L L +++ N F S SN +L L++ N R ++
Sbjct: 286 TATHLS-ELPSGLV-GLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGT 343
Query: 287 Y-FRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANL 345
+L+NL L+L +++ T + +L N + L ++ L N + +
Sbjct: 344 GCLENLENLRELDLSHDDIETSDCCNLQL----RNLSHLQSLNLSYNEPLSLKTEAFKEC 399
Query: 346 SSTMTDIVIAGNQISGIIPTGI-RNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDS 404
+ + +A ++ +NL L L + + L + L LQ L L
Sbjct: 400 PQ-LELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQG 458
Query: 405 NFLAGGI---PTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPP 461
N G SL L L L LS DL + + K + +
Sbjct: 459 NHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHV------------- 505
Query: 462 QILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQL 521
DLS+N L+ + + +LK + Y N++ N S +P L + + +
Sbjct: 506 ------------DLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTI 552
Query: 522 YLQGNSFSGSIPSS--LSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLS 572
L+ N + + L K + + + + P L + + + LS
Sbjct: 553 NLRQNPLDCTCSNIYFLEWYKENMQKLEDTEDTLCENPPLLRGVRLSD-VTLS 604
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 3e-52
Identities = 97/517 (18%), Positives = 173/517 (33%), Gaps = 54/517 (10%)
Query: 50 QRVTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVL--AN 107
+ + L L + I P L+ L+ +N H + L + L L
Sbjct: 129 KTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNG 188
Query: 108 NSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWL-KLENLTIADNHLTGHFPAS 166
N +G I + S N + I L + + L T D PA
Sbjct: 189 NDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAV 247
Query: 167 IGNLS--TLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENV 224
L ++E IN+ + + N L L+L S + P + +S+L+ +
Sbjct: 248 FEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSEL-PSGLVGLSTLKKL 306
Query: 225 FLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKV 284
L + N F S SN +L L++ N R ++
Sbjct: 307 VL-------------------------SANKFENLCQISASNFPSLTHLSIKGNTKRLEL 341
Query: 285 SIY-FRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIA 343
+L+NL L+L +++ T + +L N + L ++ L N + +
Sbjct: 342 GTGCLENLENLRELDLSHDDIETSDCCNLQL----RNLSHLQSLNLSYNEPLSLKTEAFK 397
Query: 344 NLSSTMTDIVIAGNQISGIIPTGI-RNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYL 402
+ + +A ++ +NL L L + + L + L LQ L L
Sbjct: 398 ECPQ-LELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNL 456
Query: 403 DSNFLAGGI---PTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGAL 459
N G SL L L L LS DL + + K + + ++ LT
Sbjct: 457 QGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTS-S 515
Query: 460 PPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTS-- 517
+ LS + L+L+ N +S LP + L N+ N C++
Sbjct: 516 SIEALSHLK-GIYLNLASNHISIILPSLLPILSQQRTINLRQNPLDCT-------CSNIY 567
Query: 518 -LQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLS 553
L+ + + + ++ + +S LS
Sbjct: 568 FLEWYKENMQKLEDTEDTLCENPPLLRGVRLSDVTLS 604
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 2e-50
Identities = 83/454 (18%), Positives = 151/454 (33%), Gaps = 51/454 (11%)
Query: 156 DNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSI 215
+ L P ++ ++ E + N L L NL L+L + I
Sbjct: 21 NLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI-HEDT 76
Query: 216 FNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTL 275
F S +L ++ N +LS L L
Sbjct: 77 FQ------------------------SQHRLDTLVLTANPLIFMAETALSGPKALKHLFF 112
Query: 276 FDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFG 335
I + K LE L LGSN++ + + L +L + +N
Sbjct: 113 IQTGISSIDFIPLHNQKTLESLYLGSNHISSIK------LPKGFPTEKLKVLDFQNNAIH 166
Query: 336 GVLPHSIANLSS-TMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHA---- 390
+ +++L T + + GN I+G I G + L + I
Sbjct: 167 YLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNS 225
Query: 391 -IGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELH 449
I L +D ++ + L +++ + + L + + L EL
Sbjct: 226 TIQSLWLGTFEDMDDEDISPAVFEGLCEMSVES-INLQKHYFFNISSNTFHCFSGLQELD 284
Query: 450 MADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEI- 508
+ L+ LP ++ +STL L LS N + N +L + +I N E+
Sbjct: 285 LTATHLS-ELPSGLVGLSTLK-KLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELG 342
Query: 509 PVTLSACTSLQQLYLQGN--SFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFL 566
L +L++L L + S L +L ++ L++S N E + L
Sbjct: 343 TGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQL 402
Query: 567 EYLNLSYNHFEGEVPTKGVFSNKTG---ISLSGN 597
E L+L++ + + F N ++LS +
Sbjct: 403 ELLDLAFTRLKV-KDAQSPFQNLHLLKVLNLSHS 435
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 231 bits (592), Expect = 5e-69
Identities = 89/332 (26%), Positives = 143/332 (43%), Gaps = 48/332 (14%)
Query: 660 QLMDQQFPMISYAELSKATNDFSS------SNMIGQGSFGFVYKGNLGENGMMVAVKVIN 713
++ D +F S+ EL TN+F N +G+G FG VYKG + N VAVK +
Sbjct: 6 EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLA 63
Query: 714 LKQKGASNG----FVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLE 769
+ F E + + +H NL++++ S D +VY YM NGSL
Sbjct: 64 AMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDL-----CLVYVYMPNGSLL 118
Query: 770 DWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVA 829
D L + L+ R I A+ I ++H + +H D+K +N+LLD+ A
Sbjct: 119 DRLSCLDGTP---PLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTA 172
Query: 830 HLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLL 889
+ DFGLA+ S T + + I GT Y+APE + GE + D+YSFG++LL
Sbjct: 173 KISDFGLAR-ASEKFAQTVMTS-----RIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLL 225
Query: 890 EMFTRRRPTDGMFNQGLTLHEFARTALPDK--VMEIVDSVLLLEVQASNSRSCGDERLRT 947
E+ T D L + ++ + + +D + D +
Sbjct: 226 EIITGLPAVDEHREPQ-LLLDIKEEIEDEEKTIEDYIDKKM------------NDADSTS 272
Query: 948 EERLVAVVETGVVCSMESPTERMEMRDVVAKL 979
E + +V C E +R +++ V L
Sbjct: 273 VEAMYSV---ASQCLHEKKNKRPDIKKVQQLL 301
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 8e-65
Identities = 99/541 (18%), Positives = 183/541 (33%), Gaps = 33/541 (6%)
Query: 52 VTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFS 111
+DLS + S N S L++L+L+ L L L+L N
Sbjct: 34 TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ 93
Query: 112 GKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTG-HFPASIGNL 170
P + S ++L + A L +G + L+ L +A N + PA NL
Sbjct: 94 SFSPGSFSGLTSLENLVAVETKLASLESFPIG-QLITLKKLNVAHNFIHSCKLPAYFSNL 152
Query: 171 STLERINVLGNGLWGRIPNNLGNLRNLIL----LNLGENRFSGIVPPSIFNISSLENVFL 226
+ L +++ N + N+L LR L++ N I F L + L
Sbjct: 153 TNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFI-QDQAFQGIKLHELTL 211
Query: 227 PTNRFNGSLPLDIGVSLPKL------LGFIVAENNFAGSIPESLSNASNLV--ELTLFDN 278
N + ++ +L L LG E N P + ++ E L
Sbjct: 212 RGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYT 271
Query: 279 QFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVL 338
+ F L N+ ++L ++ L + + ++ + +
Sbjct: 272 NDFSDDIVKFHCLANVSAMSLAGVSIKY--------LEDVPKHFKWQSLSIIRCQLKQFP 323
Query: 339 PHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQ 398
+ L + + N+ S L +L L + N L+ + + +L
Sbjct: 324 TLDLPFL----KSLTLTMNKGSISFK--KVALPSLSYLDLSRNALSFSGCCSYSDLGTNS 377
Query: 399 LLYLDSNFLA-GGIPTSLGNLTLLTNLALSSNDLQGSIPPS-LGNCKNLIELHMADIELT 456
L +LD +F + + L L +L + L+ S + + L+ L ++
Sbjct: 378 LRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTK 437
Query: 457 GALPPQILSISTLSLSLDLSYNLLSGTLPLEV-GNLKNLVYFNISVNRFSGEIPVTLSAC 515
L +++L+ +L ++ N V N NL + ++S +
Sbjct: 438 IDFDGIFLGLTSLN-TLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTL 496
Query: 516 TSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNH 575
LQ L + N+ S + L S+ LD S N + L + NL+ N
Sbjct: 497 HRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNS 556
Query: 576 F 576
Sbjct: 557 V 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 9e-60
Identities = 97/539 (17%), Positives = 172/539 (31%), Gaps = 30/539 (5%)
Query: 74 SFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNN 133
S + ++L+ N + L+ L L+ +L + N
Sbjct: 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91
Query: 134 LVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWG-RIPNNLG 192
+ LENL + L IG L TL+++NV N + ++P
Sbjct: 92 IQS-FSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFS 150
Query: 193 NLRNLILLNLGENRFSGIVPPSIFNISSLENVF----LPTNRFNGSLPLDIGVSLPKLLG 248
NL NL+ ++L N I + + V + N + + + KL
Sbjct: 151 NLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGI-KLHE 208
Query: 249 FIVAENNFAGSIPE-SLSNASNLVELTLFDNQFRGKVSIYF---RSLKNLEWLNLGSNNL 304
+ N + +I + L N + L L +F+ + ++ ++ L + + L
Sbjct: 209 LTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRL 268
Query: 305 GTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIP 364
D + ++A+ L + + + I Q+
Sbjct: 269 TYTNDFSDDIVK-FHCLANVSAMSLAGVSIKYL--EDVPKHFK-WQSLSIIRCQLKQFPT 324
Query: 365 TGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTL--LT 422
+L L L + NK +I L +L L L N L+ S +L L
Sbjct: 325 L---DLPFLKSLTLTMNKG--SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLR 379
Query: 423 NLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSG 482
+L LS N + + + L L L L LD+SY
Sbjct: 380 HLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKI 438
Query: 483 TLPLEVGNLKNLVYFNISVNRFSGEIPV-TLSACTSLQQLYLQGNSFSGSIPSSLSSLKS 541
L +L ++ N F + T+L L L +L
Sbjct: 439 DFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHR 498
Query: 542 IKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNKTGIS---LSGN 597
++ L+MS NNL + L L L+ S+N E + ++ L+ N
Sbjct: 499 LQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKG--ILQHFPKSLAFFNLTNN 555
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-29
Identities = 52/269 (19%), Positives = 92/269 (34%), Gaps = 15/269 (5%)
Query: 343 ANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYL 402
++ S+ +I ++ N + + N L L + ++ A L +L L L
Sbjct: 28 DDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLIL 87
Query: 403 DSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQ 462
N + P S LT L NL L +G L +L++A + P
Sbjct: 88 TGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPA 147
Query: 463 ILSISTLSLSLDLSYNLLSGTLPLEVGNLKNL----VYFNISVNRFSGEIPVTLSACTSL 518
S T + +DLSYN + ++ L+ + ++S+N I L
Sbjct: 148 YFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKL 206
Query: 519 QQLYLQGNSFSGSIPS-SLSSLKSIKELDMSSNNLSGQI------PEYLENLSFLEYLNL 571
+L L+GN S +I L +L + + + P +E L +
Sbjct: 207 HELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEF 266
Query: 572 SYNHFEGEVPTKGVFSNKTG---ISLSGN 597
+ F +SL+G
Sbjct: 267 RLTYTNDFSDDIVKFHCLANVSAMSLAGV 295
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 7e-26
Identities = 46/357 (12%), Positives = 106/357 (29%), Gaps = 65/357 (18%)
Query: 51 RVTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSF 110
+ + L+ L+ + ++LA + + + + + ++L +
Sbjct: 262 TIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQL 319
Query: 111 SGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNL 170
+L L++LT+ N + L
Sbjct: 320 KQFPTLDLPF----------------------------LKSLTLTMNKGS--ISFKKVAL 349
Query: 171 STLERINVLGNGLWGRIPNNLGNL--RNLILLNLGENRFSGIVPPSIFNISSLENVFLPT 228
+L +++ N L + +L +L L+L N I+ + + L+++
Sbjct: 350 PSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQH 408
Query: 229 NRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYF 288
+ +SL KLL ++ N
Sbjct: 409 STLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLG---------------------- 446
Query: 289 RSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSST 348
L +L L + N+ ++ + N T LT + L + + L
Sbjct: 447 --LTSLNTLKMAGNSFKDNTLSN-----VFANTTNLTFLDLSKCQLEQISWGVFDTLHR- 498
Query: 349 MTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSN 405
+ + ++ N + + + L +L L N++ + K+L L +N
Sbjct: 499 LQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNN 555
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-24
Identities = 43/243 (17%), Positives = 82/243 (33%), Gaps = 34/243 (13%)
Query: 361 GIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTL 420
G + I + N+ CMD KL+ +P I + + + L N L S N +
Sbjct: 2 GSLNPCIEVVPNITYQCMD-QKLS-KVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSE 57
Query: 421 LTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLL 480
L L LS +++ + +L +L L+ N +
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLS-------------------------NLILTGNPI 92
Query: 481 SGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSG-SIPSSLSSL 539
P L +L + + + +L++L + N +P+ S+L
Sbjct: 93 QSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNL 152
Query: 540 KSIKELDMSSNNLSGQIPEYLENLS----FLEYLNLSYNHFEGEVPTKGVFSNKTGISLS 595
++ +D+S N + L+ L L++S N + ++L
Sbjct: 153 TNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLR 212
Query: 596 GNG 598
GN
Sbjct: 213 GNF 215
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 2e-17
Identities = 31/181 (17%), Positives = 55/181 (30%), Gaps = 2/181 (1%)
Query: 53 TKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQ-IGRLVRLEALVLANNSFS 111
LDLS +S L L++L+ + L +L L ++ +
Sbjct: 379 RHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTK 437
Query: 112 GKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLS 171
++L + N+ + + N L L ++ L L
Sbjct: 438 IDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLH 497
Query: 172 TLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRF 231
L+ +N+ N L ++ L +L L+ NR SL L N
Sbjct: 498 RLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557
Query: 232 N 232
Sbjct: 558 A 558
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 2e-62
Identities = 71/323 (21%), Positives = 125/323 (38%), Gaps = 35/323 (10%)
Query: 669 ISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQ 728
+ L + + +G FG V+K L VAVK+ Q S E
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFP-IQDKQSWQNEYEVY 70
Query: 729 ALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQ 788
+L ++H N+++ I VD ++ + + GSL D+L ++ +
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDL-WLITAFHEKGSLSDFLKA-------NVVSWNE 122
Query: 789 RINIIIDVASAIEYIHHH-------CQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLS 841
+I +A + Y+H +P + H D+K NVLL +L A + DFGLA
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182
Query: 842 SSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-----EASMTGDVYSFGILLLEMFTRRR 896
+ ++ + G GT Y+APE G +A + D+Y+ G++L E+ +R
Sbjct: 183 AG------KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCT 236
Query: 897 PTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVE 956
DG ++ + F +E + V V R + + + + E
Sbjct: 237 AADGPVDEYMLP--FEEEIGQHPSLEDMQEV----VVHKKKRPVLRDYWQKHAGMAMLCE 290
Query: 957 TGVVCSMESPTERMEMRDVVAKL 979
T C R+ V ++
Sbjct: 291 TIEECWDHDAEARLSAGCVGERI 313
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 4e-56
Identities = 73/329 (22%), Positives = 129/329 (39%), Gaps = 36/329 (10%)
Query: 669 ISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQ 728
+ +E S ++ +IG+G +G VYKG+L + VAVKV + + F+ E
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR---QNFINEKN 57
Query: 729 --ALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTL 786
+ + H N+ + I + G +V EY NGSL +L +
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-------HTSDW 110
Query: 787 IQRINIIIDVASAIEYIH------HHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFL 840
+ + V + Y+H H +P + H DL NVL+ D + DFGL+ L
Sbjct: 111 VSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRL 170
Query: 841 SSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-------GEASMTGDVYSFGILLLEMFT 893
+ + L E +++ GT+ Y+APE G A D+Y+ G++ E+F
Sbjct: 171 TGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230
Query: 894 RRRPTDGMFNQGLTLHE--FARTALPDKVMEIVDSVLLLEVQASNSR-SCGDERLRTEER 950
R TD + + ++ F E + + V R +
Sbjct: 231 RC--TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVL----VSREKQRPKFPEAWKENSLA 284
Query: 951 LVAVVETGVVCSMESPTERMEMRDVVAKL 979
+ ++ ET C + R+ + ++
Sbjct: 285 VRSLKETIEDCWDQDAEARLTAQXAEERM 313
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 4e-53
Identities = 73/259 (28%), Positives = 122/259 (47%), Gaps = 30/259 (11%)
Query: 654 HKSSVSQLMDQQFPMISYAELSKATN------DFSS---SNMIGQGSFGFVYKGNLGENG 704
H + D P A + + IG GSFG V++ +G
Sbjct: 3 HHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HG 60
Query: 705 MMVAVKVINLKQKGAS--NGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEY 762
VAVK++ + A N F+ E ++ +RH N++ + + + + +IV EY
Sbjct: 61 SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT----QPPNL-SIVTEY 115
Query: 763 MQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVL 822
+ GSL LH+S + L +R+++ DVA + Y+H+ PP+VH +LK N+L
Sbjct: 116 LSRGSLYRLLHKSGAR---EQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLL 171
Query: 823 LDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVY 882
+D+ + DFGL++ +S T SSK GT ++APE ++ DVY
Sbjct: 172 VDKKYTVKVCDFGLSRLKAS--------TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVY 223
Query: 883 SFGILLLEMFTRRRPTDGM 901
SFG++L E+ T ++P +
Sbjct: 224 SFGVILWELATLQQPWGNL 242
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 5e-53
Identities = 60/228 (26%), Positives = 99/228 (43%), Gaps = 30/228 (13%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNL 738
+ ++G+G+FG V K VA+K ++ + F+ E + L + H N+
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQ--IESESERKAFIVELRQLSRVNHPNI 63
Query: 739 IKIITICSSIDFKGVDFQA--IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDV 796
+K G +V EY + GSL + LH +E T ++ +
Sbjct: 64 VK---------LYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPY---YTAAHAMSWCLQC 111
Query: 797 ASAIEYIHHHCQPPVVHGDLKPSNVLLDQD-LVAHLGDFGLAKFLSSSPLDTAVETPSSS 855
+ + Y+H ++H DLKP N+LL V + DFG A + +
Sbjct: 112 SQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ-----------THM 160
Query: 856 KGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFN 903
KG+ ++APE G S DV+S+GI+L E+ TRR+P D +
Sbjct: 161 TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGG 208
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 3e-52
Identities = 110/510 (21%), Positives = 185/510 (36%), Gaps = 70/510 (13%)
Query: 72 NLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARR 131
L+ L N + L ++ L + +NL N
Sbjct: 22 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQINFSN 77
Query: 132 NNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNL 191
N L P + N KL ++ + +N + + NL+ L + + N + + L
Sbjct: 78 NQLTDITPLK---NLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQI--TDIDPL 130
Query: 192 GNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIV 251
NL NL L L N S I ++ ++SL+ + N+ PL +L L +
Sbjct: 131 KNLTNLNRLELSSNTISDI--SALSGLTSLQQLSF-GNQVTDLKPLA---NLTTLERLDI 184
Query: 252 AENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEAND 311
+ N S L+ +NL L +NQ L NL+ L+L N L
Sbjct: 185 SSNKV--SDISVLAKLTNLESLIATNNQISD--ITPLGILTNLDELSLNGNQLKD----- 235
Query: 312 LDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLV 371
+ L + T LT + L +N+ + P ++ L+ +T++ + NQIS I P + L
Sbjct: 236 ---IGTLASLTNLTDLDLANNQISNLAP--LSGLTK-LTELKLGANQISNISP--LAGLT 287
Query: 372 NLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDL 431
L L +++N+L P I LKNL L L N ++ P + +LT L L +N +
Sbjct: 288 ALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKV 343
Query: 432 QGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNL 491
S SL N N+ L +N +S PL NL
Sbjct: 344 --SDVSSLANLTNINWL-------------------------SAGHNQISDLTPL--ANL 374
Query: 492 KNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNN 551
+ ++ ++ + + + + P+++S S E D++ N
Sbjct: 375 TRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--APATISDGGSYTEPDITWNL 432
Query: 552 LSGQIPEYLENLSFLEYLNLSYNHFEGEVP 581
S E S + F G V
Sbjct: 433 PS-YTNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 8e-48
Identities = 110/478 (23%), Positives = 195/478 (40%), Gaps = 72/478 (15%)
Query: 124 LISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGL 183
L S ++ + +I + + + ++T S +L + + G+
Sbjct: 3 LGSATITQDTPINQIFTDT--ALAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGI 58
Query: 184 WGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSL 243
+ + + L NL +N N+ + I + N++ L ++ + N+
Sbjct: 59 --KSIDGVEYLNNLTQINFSNNQLTDI--TPLKNLTKLVDILMNNNQIAD---------- 104
Query: 244 PKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNN 303
L+N +NL LTLF+NQ ++L NL L L SN
Sbjct: 105 -----------------ITPLANLTNLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNT 145
Query: 304 LGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGII 363
+ +D+ L+ LT+ L + + +ANL++ + + I+ N++S I
Sbjct: 146 I-----SDISALSGLTS---LQQLSFGNQVTD---LKPLANLTT-LERLDISSNKVSDIS 193
Query: 364 PTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTN 423
+ L NL L +N+++ P +G L NL L L+ N L +L +LT LT+
Sbjct: 194 V--LAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTD 247
Query: 424 LALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLS--LSLDLSYNLLS 481
L L++N + P L L EL + +++ I ++ L+ +L+L+ N L
Sbjct: 248 LDLANNQISNLAP--LSGLTKLTELKLGANQISN-----ISPLAGLTALTNLELNENQLE 300
Query: 482 GTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKS 541
P+ NLKNL Y + N S P +S+ T LQ+L+ N S SSL++L +
Sbjct: 301 DISPI--SNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTN 354
Query: 542 IKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNKTGISLSGNGK 599
I L N +S P L NL+ + L L+ + + + G
Sbjct: 355 INWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGA 410
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 4e-47
Identities = 104/463 (22%), Positives = 186/463 (40%), Gaps = 44/463 (9%)
Query: 52 VTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFS 111
VT L I ++ V L+ L +N ++N P + L +L +++ NN +
Sbjct: 48 VTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA 103
Query: 112 GKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLS 171
T L+ +NL N + P + N L L ++ N ++ +++ L+
Sbjct: 104 D--ITPLANLTNLTGLTLFNNQITDIDPLK---NLTNLNRLELSSNTISD--ISALSGLT 156
Query: 172 TLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRF 231
+L++++ GN + L NL L L++ N+ S I + +++LE++ N+
Sbjct: 157 SLQQLS-FGNQV--TDLKPLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQI 211
Query: 232 NGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSL 291
+ PL L L + N +L++ +NL +L L +NQ L
Sbjct: 212 SDITPLG---ILTNLDELSLNGNQL--KDIGTLASLTNLTDLDLANNQISN--LAPLSGL 264
Query: 292 KNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTD 351
L L LG+N + ++ L T LT + L++N+ + P I+NL + +T
Sbjct: 265 TKLTELKLGANQISN--------ISPLAGLTALTNLELNENQLEDISP--ISNLKN-LTY 313
Query: 352 IVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGI 411
+ + N IS I P + +L L L +NK++ ++ L N+ L N ++
Sbjct: 314 LTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLT 369
Query: 412 PTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSL 471
P L NLT +T L L+ + N + L P I + +
Sbjct: 370 P--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--APATISDGGSYT- 424
Query: 472 SLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSA 514
D+++NL S V FSG + L A
Sbjct: 425 EPDITWNLPSY-TNEVSYTFSQPVTIGKGTTTFSGTVTQPLKA 466
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 7e-52
Identities = 62/257 (24%), Positives = 107/257 (41%), Gaps = 44/257 (17%)
Query: 661 LMDQQFPMISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGAS 720
+ +FP L+ N+ IG+G FG V+KG L ++ +VA+K + L
Sbjct: 3 MGGSEFPKSRLPTLAD--NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGE 60
Query: 721 NG-------FVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA--IVYEYMQNGSLEDW 771
F E + N+ H N++K G+ +V E++ G L
Sbjct: 61 TEMIEKFQEFQREVFIMSNLNHPNIVK---------LYGLMHNPPRMVMEFVPCGDLYHR 111
Query: 772 LHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQ-----D 826
L +A + ++ +++D+A IEY+ + PP+VH DL+ N+ L
Sbjct: 112 LL-----DKAHPIKWSVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAP 165
Query: 827 LVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPE--YGMGGEASMTGDVYSF 884
+ A + DFGL++ ++ S G+ G ++APE + D YSF
Sbjct: 166 VCAKVADFGLSQ-----------QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSF 214
Query: 885 GILLLEMFTRRRPTDGM 901
++L + T P D
Sbjct: 215 AMILYTILTGEGPFDEY 231
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 2e-51
Identities = 47/231 (20%), Positives = 90/231 (38%), Gaps = 34/231 (14%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGA--SNGFVAECQALRNIRHR 736
+ + + G ++KG G + VKV+ ++ S F EC LR H
Sbjct: 10 KQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHP 67
Query: 737 NLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDV 796
N++ ++ C S ++ +M GSL + LH+ + Q + +D+
Sbjct: 68 NVLPVLGACQS---PPAPHPTLITHWMPYGSLYNVLHE----GTNFVVDQSQAVKFALDM 120
Query: 797 ASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSK 856
A + ++H +P + L +V++D+D+ A + + S
Sbjct: 121 ARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSF-------------QSP 166
Query: 857 GIKGTVGYIAPE------YGMGGEASMTGDVYSFGILLLEMFTRRRPTDGM 901
G ++APE ++ D++SF +LL E+ TR P +
Sbjct: 167 GRMYAPAWVAPEALQKKPEDTNRRSA---DMWSFAVLLWELVTREVPFADL 214
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 7e-51
Identities = 92/539 (17%), Positives = 180/539 (33%), Gaps = 37/539 (6%)
Query: 72 NLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTN-LSRCSNLISFNAR 130
L+ L L+ N L +L+ L L + I NL +
Sbjct: 22 VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLG 81
Query: 131 RNNLVGEIPAELGYNWLKLENLTIADNHLTGHF--PASIGNLSTLERINVLGNGLWG-RI 187
+ + + + L L + L+ NL L R+++ N + +
Sbjct: 82 SSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYL 140
Query: 188 PNNLGNLRNLILLNLGENRFSGIVPPSIFNIS--SLENVFLPTNRFNGSLPLDIGVSLPK 245
+ G L +L ++ N+ + + + +L L N + +D G +
Sbjct: 141 HPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNP 200
Query: 246 LLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLG 305
++ + +G N + F N + ++ G +N+
Sbjct: 201 FRNMVLEILDVSG-------NGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK 253
Query: 306 TGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPT 365
+ N L + + + L + L + +A N+I+ I
Sbjct: 254 DPDQNTFAGLARSS----VRHLDLSHGFVFSLNSRVFETLKDLKV-LNLAYNKINKIADE 308
Query: 366 GIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLA 425
L NL L + N L L + + L N +A + L L L
Sbjct: 309 AFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLD 368
Query: 426 LSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLP 485
L N L ++ ++ ++ ++ +L + I+ + + LS N L
Sbjct: 369 LRDNALT-----TIHFIPSIPDIFLSGNKLV-----TLPKINLTANLIHLSENRLENLDI 418
Query: 486 LEV-GNLKNLVYFNISVNRFSG-EIPVTLSACTSLQQLYLQGNSFSGSIPSSL-----SS 538
L + +L ++ NRFS T S SL+QL+L N + + L
Sbjct: 419 LYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEG 478
Query: 539 LKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNKTGISLSGN 597
L ++ L ++ N L+ P +L+ L L+L+ N + + +N + +S N
Sbjct: 479 LSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHNDLPANLEILDISRN 536
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 7e-36
Identities = 107/617 (17%), Positives = 199/617 (32%), Gaps = 74/617 (11%)
Query: 50 QRVTKLDLS-NRTIGGTLSP-YVGNLSFLRYLNLADNNFHG-EIPHQIGRLVRLEALVLA 106
+ +L L L Y NL L L+L+ N + G+L L+++ +
Sbjct: 97 FHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFS 156
Query: 107 NNSFSGKIPTNLS--RCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFP 164
+N L + L F+ N+L + + G N+ + ++
Sbjct: 157 SNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVS---- 212
Query: 165 ASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENV 224
GN T++ N + +L +++ G + + F + L
Sbjct: 213 ---GNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDP-DQNTF--AGLARS 266
Query: 225 FLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKV 284
+ + +L L L N+
Sbjct: 267 SVRHLDLSH--------------------GFVFSLNSRVFETLKDLKVLNLAYNKINKIA 306
Query: 285 SIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIAN 344
F L NL+ LNL N LG +++ L ++ I L N + +
Sbjct: 307 DEAFYGLDNLQVLNLSYNLLGELYSSNFYGL------PKVAYIDLQKNHIAIIQDQTFKF 360
Query: 345 LSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDS 404
L + + + N + T I + ++ ++ + NKL + L++L
Sbjct: 361 LEK-LQTLDLRDNAL-----TTIHFIPSIPDIFLSGNKLVTLPKINL----TANLIHLSE 410
Query: 405 NFLAG-GIPTSLGNLTLLTNLALSSNDLQGSIPPSL-GNCKNLIELHMADIELTGALPPQ 462
N L I L + L L L+ N +L +L + + L A +
Sbjct: 411 NRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETE 470
Query: 463 ILSISTLSLS----LDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSL 518
+ LS L L++N L+ P +L L +++ NR + L +L
Sbjct: 471 LCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANL 528
Query: 519 QQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEG 578
+ L + N P SL + D++ N + E +F+ +LN + G
Sbjct: 529 EILDISRNQLLAPNPDVFVSLSVL---DITHNKFICEC----ELSTFINWLNHTNVTIAG 581
Query: 579 EVPTKGVFSNKTGISLSGNGKVCGGLDELNLPPCPSRGLKKRTDFLLKVVVPVTVSGVIL 638
S SG L L+ C + K F L +V VT++ ++
Sbjct: 582 PPAD---IYCVYPDSFSGV-----SLFSLSTEGCDEEEVLKSLKFSLFIVCTVTLTLFLM 633
Query: 639 SLCLVLFLARRRRSAHK 655
++ V +K
Sbjct: 634 TILTVTKFRGFCFICYK 650
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 2e-48
Identities = 56/229 (24%), Positives = 91/229 (39%), Gaps = 36/229 (15%)
Query: 685 NMIGQGSFGFVYKGNLGENGMMVAVKVINLK----QKGASNGFVAECQALRNIRHRNLIK 740
+IG G FG VY+ G VAVK E + ++H N+I
Sbjct: 13 EIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 741 IITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAI 800
+ +C K + +V E+ + G L L + + +N + +A +
Sbjct: 71 LRGVCL----KEPNL-CLVMEFARGGPLNRVLSG-------KRIPPDILVNWAVQIARGM 118
Query: 801 EYIHHHCQPPVVHGDLKPSNVLLDQDLVAH--------LGDFGLAKFLSSSPLDTAVETP 852
Y+H P++H DLK SN+L+ Q + + DFGLA+
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR---------- 168
Query: 853 SSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGM 901
++ G ++APE S DV+S+G+LL E+ T P G+
Sbjct: 169 TTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI 217
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 4e-48
Identities = 95/513 (18%), Positives = 176/513 (34%), Gaps = 24/513 (4%)
Query: 76 LRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLV 135
+ L+L+ N + L+ L L+ S+L + N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 136 GEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGL-WGRIPNNLGNL 194
+ L+ L + +L IG+L TL+ +NV N + ++P NL
Sbjct: 90 -SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148
Query: 195 RNLILLNLGENRFSGIVPPSIFNISSLENVF----LPTNRFNGSLPLDIGVSLPKLLGFI 250
NL L+L N+ I + + + + L N N + + +L
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEI-RLHKLT 206
Query: 251 VAENNFAGSIPE-SLSNASNLVELTLFDNQFRGKVSIYFRS---LKNLEWLNLGSNNLGT 306
+ N + ++ + + + L L +FR + ++ L+ L L + L
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266
Query: 307 GEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTG 366
+ D + L T +++ L V S + + Q +
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTL---- 322
Query: 367 IRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLA--GGIPTSLGNLTLLTNL 424
L +L L NK + +L +L+ L L N L+ G S T L L
Sbjct: 323 --KLKSLKRLTFTSNKGGNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYL 378
Query: 425 ALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTL 484
LS N + ++ + + L L L + + LD+S+
Sbjct: 379 DLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAF 437
Query: 485 PLEVGNLKNLVYFNISVNRFSGEI-PVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIK 543
L +L ++ N F P + +L L L P++ +SL S++
Sbjct: 438 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 497
Query: 544 ELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHF 576
L+M+SN L + L+ L+ + L N +
Sbjct: 498 VLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 2e-42
Identities = 100/516 (19%), Positives = 168/516 (32%), Gaps = 42/516 (8%)
Query: 52 VTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFS 111
LDLS + S + L+ L+L+ L L L+L N
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 112 GKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLT-GHFPASIGNL 170
S S+L A NL +G + L+ L +A N + P NL
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIG-HLKTLKELNVAHNLIQSFKLPEYFSNL 148
Query: 171 STLERINVLGNGLWGRIPNNLGNLRNLIL----LNLGENRFSGIVPPSIFNISSLENVFL 226
+ LE +++ N + +L L + L L+L N + I P F L + L
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFI-QPGAFKEIRLHKLTL 207
Query: 227 PTNRFNGSLPLDIGVSLPKL------LGFIVAENNFAGSIPESLSNASNLVELTL---FD 277
N + ++ L L LG E N +L NL +
Sbjct: 208 RNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 267
Query: 278 NQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGV 337
+ + + F L N+ +L S + + + L + +F +
Sbjct: 268 DYYLDDIIDLFNCLTNVSSFSLVSVTI-----ERVKDFSYNFGWQHLELVNCKFGQFPTL 322
Query: 338 LPHSIANLS---------------STMTDIVIAGNQIS--GIIPTGIRNLVNLVELCMDD 380
S+ L+ ++ + ++ N +S G +L L +
Sbjct: 323 KLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSF 382
Query: 381 NKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTS-LGNLTLLTNLALSSNDLQGSIPPSL 439
N + T+ L+ L+ L + L S +L L L +S + +
Sbjct: 383 NGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIF 441
Query: 440 GNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEV-GNLKNLVYFN 498
+L L MA P I + LDLS L L +L +L N
Sbjct: 442 NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLN 500
Query: 499 ISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPS 534
++ N+ TSLQ+++L N + S P
Sbjct: 501 MASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 5e-41
Identities = 91/531 (17%), Positives = 173/531 (32%), Gaps = 52/531 (9%)
Query: 80 NLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIP 139
+ NF+ +IP + + L L+ N + L + R + I
Sbjct: 13 QCMELNFY-KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI-QTIE 68
Query: 140 AELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLIL 199
+ L L + N + + LS+L+++ + L +G+L+ L
Sbjct: 69 DGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKE 128
Query: 200 LNLGENRFSGIVPPSIF-NISSLENVFLPTNRFNGSLPLDIGV--SLPKLLGFIVAENNF 256
LN+ N P F N+++LE++ L +N+ D+ V +P L + N
Sbjct: 129 LNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188
Query: 257 AGSIPESLSNASNLVELTLFDNQFRGKV-SIYFRSLKNLEWLNLGSNNLGTGEANDLDFL 315
I L +LTL +N V + L LE L +L+
Sbjct: 189 MNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFR--NEGNLEKF 246
Query: 316 TL--LTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNL 373
L LT + I L N+
Sbjct: 247 DKSALEGLCNLTIEEFRLAYL----------------------DYYLDDIIDLFNCLTNV 284
Query: 374 VELCMDDNKLTGTIPHAI-GELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQ 432
+ + + ++L+L+ SL LT +N +
Sbjct: 285 SSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSN--------K 336
Query: 433 GSIPPSLGNCKNLIELHMADIELTG-ALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNL 491
G S + +L L ++ L+ Q +T LDLS+N + T+ L
Sbjct: 337 GGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGL 395
Query: 492 KNLVYFNISVNRFSGEIPV-TLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSN 550
+ L + + + + +L L + + + L S++ L M+ N
Sbjct: 396 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGN 455
Query: 551 NLSGQI-PEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNKTG---ISLSGN 597
+ P+ L L +L+LS E ++ F++ + ++++ N
Sbjct: 456 SFQENFLPDIFTELRNLTFLDLSQCQLE-QLS-PTAFNSLSSLQVLNMASN 504
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-26
Identities = 81/404 (20%), Positives = 141/404 (34%), Gaps = 36/404 (8%)
Query: 51 RVTKLDLSNRTIGGTLSPYVGNLSFLRY----LNLADNNFHGEIPHQIGRLVRLEALVLA 106
+ LDLS+ I + L + L+L+ N + I + +RL L L
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLR 208
Query: 107 NNSFSGKIPTNL------SRCSNLISFNARRNNLVGEIPAEL--GYNWLKLENLTIADNH 158
NN S + L+ R + + G L +E +A
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 268
Query: 159 LTG-HFPASIGNLSTLERINVLGNGLWGRIPN--NLGNLRNLILLNLGENRFSGIVPPSI 215
L+ + +++ + R+ + ++L L+N +F +
Sbjct: 269 YYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKFGQFPTL----- 322
Query: 216 FNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAEN--NFAGSIPESLSNASNLVEL 273
+ SL+ + +N+ + V LP L ++ N +F G +S ++L L
Sbjct: 323 -KLKSLKRLTFTSNKGGNAFS---EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYL 378
Query: 274 TLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNR 333
L N +S F L+ LE L+ +NL + ++ + L + +
Sbjct: 379 DLSFNGVI-TMSSNFLGLEQLEHLDFQHSNL-----KQMSEFSVFLSLRNLIYLDISHTH 432
Query: 334 FGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGI-RNLVNLVELCMDDNKLTGTIPHAIG 392
LSS + + +AGN I L NL L + +L P A
Sbjct: 433 TRVAFNGIFNGLSS-LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 491
Query: 393 ELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIP 436
L +LQ+L + SN L LT L + L +N S P
Sbjct: 492 SLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 3e-47
Identities = 56/242 (23%), Positives = 96/242 (39%), Gaps = 23/242 (9%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICS 746
+G+G FG K E G ++ +K + + F+ E + +R + H N++K I +
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 747 SIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHH 806
K + EY++ G+L + + Q QR++ D+AS + Y+H
Sbjct: 78 ----KDKRL-NFITEYIKGGTLRGIIKSMDSQ-----YPWSQRVSFAKDIASGMAYLHSM 127
Query: 807 CQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTA------VETPSSSKGIKG 860
++H DL N L+ ++ + DFGLA+ + + G
Sbjct: 128 ---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 861 TVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDG--MFNQ--GLTLHEFARTAL 916
++APE G DV+SFGI+L E+ R GL + F
Sbjct: 185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYC 244
Query: 917 PD 918
P
Sbjct: 245 PP 246
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 4e-47
Identities = 51/228 (22%), Positives = 97/228 (42%), Gaps = 26/228 (11%)
Query: 685 NMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITI 744
+G+G +G V++G+ G VAVK+ + + S E +RH N++ I
Sbjct: 14 ECVGKGRYGEVWRGSW--QGENVAVKIFS-SRDEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 745 CSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIH 804
+ ++ Y + GSL D+L +L + + I++ +AS + ++H
Sbjct: 71 DMTSRHSSTQL-WLITHYHEMGSLYDYLQL-------TTLDTVSCLRIVLSIASGLAHLH 122
Query: 805 -----HHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIK 859
+P + H DLK N+L+ ++ + D GLA S + + +
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQ----STNQLDVGNNPRV 178
Query: 860 GTVGYIAPE------YGMGGEASMTGDVYSFGILLLEMFTRRRPTDGM 901
GT Y+APE ++ D+++FG++L E+ R +
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV 226
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 5e-47
Identities = 68/223 (30%), Positives = 102/223 (45%), Gaps = 30/223 (13%)
Query: 687 IGQGSFGFVYKGNL-GENGMMVAVKVINLKQKGAS--NGFVAECQALRNIRHRNLIKIIT 743
IG GSFG VYKG G+ VAVK++N+ F E LR RH N++ +
Sbjct: 32 IGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 744 ICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYI 803
++ AIV ++ + SL LH SE + + + I+I A ++Y+
Sbjct: 88 YSTAPQL------AIVTQWCEGSSLYHHLHASETK-----FEMKKLIDIARQTARGMDYL 136
Query: 804 HHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVG 863
H ++H DLK +N+ L +D +GDFGLA S E G++
Sbjct: 137 H---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQL------SGSIL 187
Query: 864 YIAPE---YGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFN 903
++APE S DVY+FGI+L E+ T + P + N
Sbjct: 188 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 230
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 3e-46
Identities = 83/405 (20%), Positives = 155/405 (38%), Gaps = 60/405 (14%)
Query: 149 LENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFS 208
L + FP +L+ R + + + L ++ L + + +
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 209 GIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNAS 268
I I +++LE + L N+ PL +L KL + N + +L N +
Sbjct: 58 SI--QGIEYLTNLEYLNLNGNQITDISPLS---NLVKLTNLYIGTNKI--TDISALQNLT 110
Query: 269 NLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIG 328
NL EL L ++ +L + LNLG+N+ + L+ L+N T L +
Sbjct: 111 NLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLS-------DLSPLSNMTGLNYLT 161
Query: 329 LDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIP 388
+ +++ V P IANL+ + + + NQI I P + +L +L N++T P
Sbjct: 162 VTESKVKDVTP--IANLTD-LYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP 216
Query: 389 HAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIEL 448
+ + L L + +N + + L NL+ LT L + +N + ++ + L L
Sbjct: 217 --VANMTRLNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQISD--INAVKDLTKLKML 270
Query: 449 HMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEI 508
++ N +S L NL L ++ N+ E
Sbjct: 271 -------------------------NVGSNQISDISVL--NNLSQLNSLFLNNNQLGNED 303
Query: 509 PVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLS 553
+ T+L L+L N + P L+SL + D ++ +
Sbjct: 304 MEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-41
Identities = 69/352 (19%), Positives = 138/352 (39%), Gaps = 40/352 (11%)
Query: 262 ESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGT----GEANDLDFLTL 317
++ + + L + L+++ L + + + +L++L L
Sbjct: 16 FPDADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVASIQGIEYLTNLEYLNL 73
Query: 318 ----------LTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGI 367
L+N +LT + + N+ ++ NL++ + ++ + + IS I P +
Sbjct: 74 NGNQITDISPLSNLVKLTNLYIGTNKI--TDISALQNLTN-LRELYLNEDNISDISP--L 128
Query: 368 RNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALS 427
NL + L + N + + + L L + + + P + NLT L +L+L+
Sbjct: 129 ANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLN 185
Query: 428 SNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSL--SLDLSYNLLSGTLP 485
N ++ P L + +L ++T I ++ ++ SL + N ++ P
Sbjct: 186 YNQIEDISP--LASLTSLHYFTAYVNQITD-----ITPVANMTRLNSLKIGNNKITDLSP 238
Query: 486 LEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKEL 545
L NL L + I N+ S I + T L+ L + N S S L++L + L
Sbjct: 239 L--ANLSQLTWLEIGTNQISD-IN-AVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSL 292
Query: 546 DMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNKTGISLSGN 597
+++N L + E + L+ L L LS NH P S +
Sbjct: 293 FLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLAS-LSKMDSADFANQ 343
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-39
Identities = 80/380 (21%), Positives = 150/380 (39%), Gaps = 36/380 (9%)
Query: 53 TKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSG 112
L I + P +L+ L + + L + LV+A +
Sbjct: 3 ATLATLPAPIN-QIFP-DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA- 57
Query: 113 KIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLST 172
I + +NL N N + P N +KL NL I N +T +++ NL+
Sbjct: 58 SIQ-GIEYLTNLEYLNLNGNQITDISPLS---NLVKLTNLYIGTNKITD--ISALQNLTN 111
Query: 173 LERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFN 232
L + + + + + L NL + LNLG N + N++ L + + ++
Sbjct: 112 LRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSD-LSPLSNMTGLNYLTVTESKVK 168
Query: 233 GSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLK 292
P+ +L L + N P L++ ++L T + NQ ++
Sbjct: 169 DVTPIA---NLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD--ITPVANMT 221
Query: 293 NLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDI 352
L L +G+N + DL L L+ T L + N+ + +++ +L+ + +
Sbjct: 222 RLNSLKIGNNKI-----TDLSPLANLSQLTWLE---IGTNQISDI--NAVKDLTK-LKML 270
Query: 353 VIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIP 412
+ NQIS I + NL L L +++N+L IG L NL L+L N + P
Sbjct: 271 NVGSNQISDISV--LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328
Query: 413 TSLGNLTLLTNLALSSNDLQ 432
L +L+ + + ++ ++
Sbjct: 329 --LASLSKMDSADFANQVIK 346
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 4e-46
Identities = 55/228 (24%), Positives = 100/228 (43%), Gaps = 26/228 (11%)
Query: 685 NMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITI 744
IG+G FG V++G G VAVK+ + +++ S AE +RH N++ I
Sbjct: 48 ESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAA 104
Query: 745 CSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIH 804
+ + +V +Y ++GSL D+L++ ++T+ I + + AS + ++H
Sbjct: 105 DNKDNGTWTQL-WLVSDYHEHGSLFDYLNR-------YTVTVEGMIKLALSTASGLAHLH 156
Query: 805 -----HHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIK 859
+P + H DLK N+L+ ++ + D GLA S+ + +
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDI----APNHRV 212
Query: 860 GTVGYIAPE------YGMGGEASMTGDVYSFGILLLEMFTRRRPTDGM 901
GT Y+APE E+ D+Y+ G++ E+ R
Sbjct: 213 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 1e-45
Identities = 55/228 (24%), Positives = 90/228 (39%), Gaps = 26/228 (11%)
Query: 685 NMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITI 744
IG+G +G V+ G G VAVKV ++ AS E +RH N++ I
Sbjct: 43 KQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEE-ASWFRETEIYQTVLMRHENILGFIAA 99
Query: 745 CSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIH 804
++ +Y +NGSL D+L +L + + S + ++H
Sbjct: 100 DIKGTGSWTQL-YLITDYHENGSLYDYLKS-------TTLDAKSMLKLAYSSVSGLCHLH 151
Query: 805 -----HHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIK 859
+P + H DLK N+L+ ++ + D GLA S E
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDT----NEVDIPPNTRV 207
Query: 860 GTVGYIAPE------YGMGGEASMTGDVYSFGILLLEMFTRRRPTDGM 901
GT Y+ PE ++ + D+YSFG++L E+ R +
Sbjct: 208 GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV 255
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 5e-44
Identities = 50/229 (21%), Positives = 85/229 (37%), Gaps = 33/229 (14%)
Query: 685 NMIGQGSFGFVYKGNL-GENGMMVAVKVINLKQKGAS--NGFVAECQALRNIRHRNLIKI 741
+IG+G FG VY G GE VA+++I++++ F E A R RH N++
Sbjct: 39 ELIGKGRFGQVYHGRWHGE----VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 742 ITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIE 801
+ C AI+ + +L + ++ L + + I ++ +
Sbjct: 95 MGACM----SPPHL-AIITSLCKGRTLYSVVRDAKIV-----LDVNKTRQIAQEIVKGMG 144
Query: 802 YIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGT 861
Y+H ++H DLK NV D V + DFGL + G
Sbjct: 145 YLH---AKGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNG---W 197
Query: 862 VGYIAPEYGMGGEASMTG---------DVYSFGILLLEMFTRRRPTDGM 901
+ ++APE DV++ G + E+ R P
Sbjct: 198 LCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ 246
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 7e-43
Identities = 51/327 (15%), Positives = 107/327 (32%), Gaps = 27/327 (8%)
Query: 258 GSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTL 317
GS ++S L + + + + +AN +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE 61
Query: 318 LTNCTELTAIGLDDNRFGGVLPHSIANLSST-MTDIVIAGNQISGIIPTGIRNLVNLVEL 376
L A + + + + + + P L +L +
Sbjct: 62 TRTGRALKA-----------TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHM 109
Query: 377 CMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIP 436
+D L +P + + L+ L L N L +P S+ +L L L++ + +P
Sbjct: 110 TIDAAGLM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELP 167
Query: 437 PSLGNC---------KNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLE 487
L + NL L + + +LP I ++ L SL + + LS L
Sbjct: 168 EPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLK-SLKIRNSPLS-ALGPA 224
Query: 488 VGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDM 547
+ +L L ++ P L++L L+ S ++P + L +++LD+
Sbjct: 225 IHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDL 284
Query: 548 SSNNLSGQIPEYLENLSFLEYLNLSYN 574
++P + L + + +
Sbjct: 285 RGCVNLSRLPSLIAQLPANCIILVPPH 311
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-41
Identities = 57/305 (18%), Positives = 103/305 (33%), Gaps = 27/305 (8%)
Query: 287 YFRSLKNLEWLNL-GSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANL 345
+ E L GS L + +L+ + AN
Sbjct: 7 HHHHSSGRENLYFQGSTALRP-------YHDVLSQWQRHYNADRNRWH----SAWRQANS 55
Query: 346 SSTMTDIVIAGNQISGIIPT-GIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDS 404
++ + G + V L + L P L +LQ + +D+
Sbjct: 56 NNPQIETR-TGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDA 113
Query: 405 NFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQIL 464
L +P ++ L L L+ N L+ ++P S+ + L EL + LP +
Sbjct: 114 AGLME-LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLA 171
Query: 465 SISTLSL--------SLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACT 516
S SL L + + +LP + NL+NL I + S + +
Sbjct: 172 STDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLP 229
Query: 517 SLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHF 576
L++L L+G + + P +K L + + +P + L+ LE L+L
Sbjct: 230 KLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVN 289
Query: 577 EGEVP 581
+P
Sbjct: 290 LSRLP 294
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-38
Identities = 52/379 (13%), Positives = 114/379 (30%), Gaps = 66/379 (17%)
Query: 166 SIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVF 225
+ S E + G+ + L + + S + ++ N
Sbjct: 7 HHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNR-------WHSAWRQANSNNPQ 59
Query: 226 LPTNRFNG--SLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGK 283
+ T + + + + + P+ S+L +T+ +
Sbjct: 60 IETRTGRALKATADLLEDATQPGRVALELRSVPLPQFPDQAFRLSHLQHMTIDAAGLM-E 118
Query: 284 VSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTL---LTNCTELTAIGLDDNRFGGVLPH 340
+ + LE L L N L L + + L + + LP
Sbjct: 119 LPDTMQQFAGLETLTLARNPLRA----------LPASIASLNRLRELSIRACPELTELPE 168
Query: 341 SIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLL 400
+A+ + + LVNL L ++ + ++P +I L+NL+ L
Sbjct: 169 PLASTDA----------------SGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSL 211
Query: 401 YLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALP 460
+ ++ L+ + ++ +L L L L + PP G L L + D
Sbjct: 212 KIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKD-------- 262
Query: 461 PQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQ 520
+ L TLPL++ L L ++ +P ++ +
Sbjct: 263 ----------------CSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCI 305
Query: 521 LYLQGNSFSGSIPSSLSSL 539
+ + + + +
Sbjct: 306 ILVPPHLQAQLDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-36
Identities = 65/405 (16%), Positives = 110/405 (27%), Gaps = 84/405 (20%)
Query: 64 GTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSN 123
G+ + + S L + + + R + + SN
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQAN-----SN 56
Query: 124 LISFNARRNNLVGEIPAELGY-NWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNG 182
R + L L + L FP LS L+ + + G
Sbjct: 57 NPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115
Query: 183 LWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVS 242
L +P+ + L L L N + P SI +++ L L I
Sbjct: 116 L-MELPDTMQQFAGLETLTLARNPLRAL-PASIASLNRLRE-------------LSI--- 157
Query: 243 LPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSN 302
+PE L++ E L NL+ L L
Sbjct: 158 ---------RACPELTELPEPLASTDASGEHQ---------------GLVNLQSLRLEWT 193
Query: 303 NLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGI 362
+ + LP SIANL + + + I + +S
Sbjct: 194 GIRS-------------------------------LPASIANLQN-LKSLKIRNSPLSA- 220
Query: 363 IPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYL-DSNFLAGGIPTSLGNLTLL 421
+ I +L L EL + P G L+ L L D + L +P + LT L
Sbjct: 221 LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQL 279
Query: 422 TNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSI 466
L L +P + + + + ++
Sbjct: 280 EKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-25
Identities = 36/203 (17%), Positives = 64/203 (31%), Gaps = 18/203 (8%)
Query: 385 GTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKN 444
G+ H + LY + L N + N N
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNN 57
Query: 445 LIELHMADIELTGALPPQILSISTLSL-SLDLSYNLLSGTLPLEVGNLKNLVYFNISVNR 503
L A + + +L+L L P + L +L + I
Sbjct: 58 PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115
Query: 504 FSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENL 563
E+P T+ L+ L L N ++P+S++SL ++EL + + ++PE L +
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST 173
Query: 564 SF---------LEYLNLSYNHFE 577
L+ L L +
Sbjct: 174 DASGEHQGLVNLQSLRLEWTGIR 196
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 3e-21
Identities = 39/203 (19%), Positives = 76/203 (37%), Gaps = 14/203 (6%)
Query: 53 TKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGR---------LVRLEAL 103
L L+ + L + +L+ LR L++ E+P + LV L++L
Sbjct: 130 ETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSL 188
Query: 104 VLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHF 163
L +P +++ NL S R + L + + + KLE L + ++
Sbjct: 189 RLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIH-HLPKLEELDLRGCTALRNY 245
Query: 164 PASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLEN 223
P G + L+R+ + +P ++ L L L+L +P I + +
Sbjct: 246 PPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCI 305
Query: 224 VFLPTNRFNGSLPLDIGVSLPKL 246
+ +P + L V+ P
Sbjct: 306 ILVPPH-LQAQLDQHRPVARPAE 327
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 2e-42
Identities = 100/523 (19%), Positives = 170/523 (32%), Gaps = 87/523 (16%)
Query: 66 LSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLS------ 119
++P + +FL+ +N E+P + + A + + P
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 120 -------RCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLST 172
L +P LE+L + N LT P +L +
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLS-SLPELPP----HLESLVASCNSLT-ELPELPQSLKS 115
Query: 173 LERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFN 232
L N L P L L + N+ + P + N S L+ + + N
Sbjct: 116 LLVDNNNLKALSDLPPL-------LEYLGVSNNQLEKL--PELQNSSFLKIIDVDNNSLK 166
Query: 233 GSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLK 292
LP P L N +PE L N L + +N
Sbjct: 167 -KLP----DLPPSLEFIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSL----KKLPDLPL 215
Query: 293 NLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDI 352
+LE + G+N L L L N LT I D+N LP +L + +
Sbjct: 216 SLESIVAGNNILEE--------LPELQNLPFLTTIYADNNLLK-TLPDLPPSLEA----L 262
Query: 353 VIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIP 412
+ N ++ + P ++L L + L+ P NL L SN + +
Sbjct: 263 NVRDNYLTDL-PELPQSLTFLDVSENIFSGLSELPP-------NLYYLNASSNEIRS-LC 313
Query: 413 TSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLS 472
+L L +S+N L +P L L + L +P ++
Sbjct: 314 DLPPSLE---ELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVPELPQNLK----Q 361
Query: 473 LDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSI 532
L + YN L P ++++L +N E+P +L+QL+++ N
Sbjct: 362 LHVEYNPLR-EFPDIPESVEDL-----RMNSHLAEVP---ELPQNLKQLHVETNPLR-EF 411
Query: 533 PSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNH 575
P S+ ++L M+S + E LE ++H
Sbjct: 412 PDIPESV---EDLRMNSERVVDPYEFAHETTDKLEDDVFEHHH 451
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 8e-38
Identities = 92/431 (21%), Positives = 155/431 (35%), Gaps = 71/431 (16%)
Query: 147 LKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENR 206
L+ ++LT P N+ + + P G R + + L +
Sbjct: 11 TFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCL 69
Query: 207 FSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSN 266
+ L + SLP L L + + N+ +PE +
Sbjct: 70 -----------DRQAHELELNNLGLS-SLPELPP-HLESL---VASCNSLT-ELPELPQS 112
Query: 267 ASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTA 326
+L+ LE+L + +N L L L N + L
Sbjct: 113 LKSLLVDNNNLKALSD-------LPPLLEYLGVSNNQLEK--------LPELQNSSFLKI 157
Query: 327 IGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGT 386
I +D+N LP +L I NQ+ + ++NL L + D+N L
Sbjct: 158 IDVDNNSL-KKLPDLPPSL----EFIAAGNNQLEELPE--LQNLPFLTAIYADNNSLK-K 209
Query: 387 IPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLI 446
+P +L+ + +N L L NL LT + +N L+ ++P +L
Sbjct: 210 LP---DLPLSLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPP---SLE 260
Query: 447 ELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSG 506
L++ D LT LP S++ LD+S N+ S L NL L N S N
Sbjct: 261 ALNVRDNYLT-DLPELPQSLT----FLDVSENIFS-GLSELPPNLYYL---NASSNEIR- 310
Query: 507 EIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFL 566
+ SL++L + N +P+ L + L S N+L+ ++PE +N L
Sbjct: 311 SLCDLP---PSLEELNVSNNKLI-ELPALPPRL---ERLIASFNHLA-EVPELPQN---L 359
Query: 567 EYLNLSYNHFE 577
+ L++ YN
Sbjct: 360 KQLHVEYNPLR 370
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-36
Identities = 88/493 (17%), Positives = 156/493 (31%), Gaps = 86/493 (17%)
Query: 50 QRVTKLDLSNRTIGGTLSPYVGNLSFL-------------RYLNLADNNFHGEIPHQIGR 96
+ T+ + P G + L L + +P
Sbjct: 34 KSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPELPP- 91
Query: 97 LVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIAD 156
LE+LV + NS + ++P +L+ N L P LE L +++
Sbjct: 92 --HLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPP--------LLEYLGVSN 140
Query: 157 NHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIF 216
N L P + N S L+ I+V N L ++P+ +L + G N+ + P +
Sbjct: 141 NQLE-KLP-ELQNSSFLKIIDVDNNSL-KKLPDLPPSLEF---IAAGNNQLEEL--PELQ 192
Query: 217 NISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLF 276
N+ L ++ N LP L + N L N L +
Sbjct: 193 NLPFLTAIYADNNSLK-KLP----DLPLSLESIVAGNNIL--EELPELQNLPFLTTIYAD 245
Query: 277 DNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGG 336
+N + ++ +LE LN+ N L L + T L +
Sbjct: 246 NNLLK---TL-PDLPPSLEALNVRDNYLTD-------LPELPQSLTFLDVSENIFSG--- 291
Query: 337 VLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKN 396
L NL + + N+I + +L EL + +NKL +P
Sbjct: 292 -LSELPPNL----YYLNASSNEIRSLCD----LPPSLEELNVSNNKLI-ELPALPP---R 338
Query: 397 LQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELT 456
L+ L N LA +P N L L + N L+ P + ++L
Sbjct: 339 LERLIASFNHLA-EVPELPQN---LKQLHVEYNPLR-EFPDIPESVEDLRMNS-----HL 388
Query: 457 GALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACT 516
+P ++ L + N L P ++++L ++ R
Sbjct: 389 AEVPELPQNLKQ----LHVETNPLR-EFPDIPESVEDL---RMNSERVVDPYEFAHETTD 440
Query: 517 SLQQLYLQGNSFS 529
L+ + +
Sbjct: 441 KLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-28
Identities = 60/371 (16%), Positives = 132/371 (35%), Gaps = 76/371 (20%)
Query: 211 VPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNL 270
+ P + + L+ ++ +P++ ++ + A + + + P +
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAE-NVKSKTEYYNAWSEWERNAPPGNGEQREM 60
Query: 271 VELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLD 330
L D + L L + L +
Sbjct: 61 AVSRLRDC-----------LDRQAHELELNNLGLSS------------------------ 85
Query: 331 DNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHA 390
LP +L S +V + N ++ +P ++L +L+ + L+ P
Sbjct: 86 -------LPELPPHLES----LVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPP-- 131
Query: 391 IGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHM 450
L+ L + +N L +P L N + L + + +N L+ +P + L +
Sbjct: 132 -----LLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLK-KLPDLPPS---LEFIAA 180
Query: 451 ADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPV 510
+ +L P++ ++ L+ ++ N L LP +L+++ N E+P
Sbjct: 181 GNNQLEE--LPELQNLPFLT-AIYADNNSLK-KLPDLPLSLESI---VAGNNILE-ELP- 231
Query: 511 TLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLN 570
L L +Y N ++P SL++ L++ N L+ +PE ++L+FL+
Sbjct: 232 ELQNLPFLTTIYADNNLLK-TLPDLPPSLEA---LNVRDNYLT-DLPELPQSLTFLDVSE 286
Query: 571 LSYNHFEGEVP 581
++ P
Sbjct: 287 NIFSGLSELPP 297
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-25
Identities = 53/274 (19%), Positives = 101/274 (36%), Gaps = 42/274 (15%)
Query: 337 VLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGEL-- 394
+ P +++N + + + + ++ +P N+ + E ++ P GE
Sbjct: 3 INPRNVSNT--FLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQRE 59
Query: 395 -----------KNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCK 443
+ L L++ L +P + L +L S N L +P + K
Sbjct: 60 MAVSRLRDCLDRQAHELELNNLGL-SSLPELPPH---LESLVASCNSLT-ELPELPQSLK 114
Query: 444 NLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNR 503
+L+ + L+ LPP + L +S N L LP E+ N L ++ N
Sbjct: 115 SLLVDNNNLKALSD-LPPLL-------EYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNS 164
Query: 504 FSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENL 563
++P SL+ + N +P L +L + + +N+L ++P+ +
Sbjct: 165 LK-KLPDLP---PSLEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK-KLPDLPLS- 216
Query: 564 SFLEYLNLSYNHFEGEVPTKGVFSNKTGISLSGN 597
LE + N E E+P T I N
Sbjct: 217 --LESIVAGNNILE-ELPELQNLPFLTTIYADNN 247
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 8e-42
Identities = 100/539 (18%), Positives = 185/539 (34%), Gaps = 61/539 (11%)
Query: 79 LNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEI 138
+ +F IP + +++L L+ N + +L C+NL + + + I
Sbjct: 10 CDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRI-NTI 65
Query: 139 PAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNN--LGNLRN 196
+ Y+ LE+L ++DNHL+ + G LS+L+ +N++GN + NL N
Sbjct: 66 EGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPY-QTLGVTSLFPNLTN 124
Query: 197 LILLNLGENRFSGIVPPSIF-NISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENN 255
L L +G + F ++SL + + + S+ + + +
Sbjct: 125 LQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR-NYQSQSLKSIRDIHHLTLHLSE 183
Query: 256 FAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFL 315
A + S++ L L D + + + + L
Sbjct: 184 SAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNEL 243
Query: 316 T-LLTNCTELTAIGLDDNRFGGVL------PHSIANLSS----TMTDIVIAGNQISGIIP 364
LL EL+ + DD G+ ++ L T+ + I + +
Sbjct: 244 LKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLS 303
Query: 365 TGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGI---PTSLGNLTLL 421
T L + + ++++K+ LK+L+ L L N + G L
Sbjct: 304 TVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSL 363
Query: 422 TNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLS 481
L LS N L+ S+ + L L SLD+S N
Sbjct: 364 QTLVLSQNHLR-SMQKTGEILLTLKNLT----------------------SLDISRNTFH 400
Query: 482 GTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKS 541
+P + + + N+S V +L+ L + N+ S L L+
Sbjct: 401 -PMPDSCQWPEKMRFLNLSSTGIRV---VKTCIPQTLEVLDVSNNNLD-SFSLFLPRLQ- 454
Query: 542 IKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNKTGIS---LSGN 597
EL +S N L +P+ L + +S N + G+F T + L N
Sbjct: 455 --ELYISRNKLK-TLPDAS-LFPVLLVMKISRNQL--KSVPDGIFDRLTSLQKIWLHTN 507
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 9e-42
Identities = 79/501 (15%), Positives = 166/501 (33%), Gaps = 33/501 (6%)
Query: 71 GNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNAR 130
G + ++ L+L+ N + L+ L+L ++ + +L +
Sbjct: 23 GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLS 82
Query: 131 RNNLVGEIPAELGYNWLKLENLTIADNHLTG-HFPASIGNLSTLERINVLGNGLWGRIPN 189
N+L + + L+ L + N + NL+ L+ + + + I
Sbjct: 83 DNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRR 141
Query: 190 N-LGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLG 248
L +L L + S+ +I + ++ L + L L +
Sbjct: 142 IDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRY 200
Query: 249 FIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFR----------SLKNLEWLN 298
+ + N A L + + F L +E+ +
Sbjct: 201 LELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDD 260
Query: 299 LGSNNLGTGEANDLDFLTLLTN--CTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAG 356
N LG ++ D ++ L + + + L + L + I +
Sbjct: 261 CTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEK-VKRITVEN 319
Query: 357 NQISGIIPTGIRNLVNLVELCMDDNKLTGTIPH---AIGELKNLQLLYLDSNFLA--GGI 411
+++ + + ++L +L L + +N + G +LQ L L N L
Sbjct: 320 SKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKT 379
Query: 412 PTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSL 471
L L LT+L +S N +P S + + L+++ + + I +
Sbjct: 380 GEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQTLEV-- 435
Query: 472 SLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGS 531
LD+S N L + L + L+ L IS N+ +P S L + + N
Sbjct: 436 -LDVSNNNLD-SFSLFLPRLQEL---YISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSV 488
Query: 532 IPSSLSSLKSIKELDMSSNNL 552
L S++++ + +N
Sbjct: 489 PDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 8e-18
Identities = 48/370 (12%), Positives = 116/370 (31%), Gaps = 38/370 (10%)
Query: 53 TKLDLSNRTIGGTLSPYV-GNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFS 111
+L++ ++ ++ + +L L + + L + L L + + +
Sbjct: 151 NELEIKALSLR-NYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLA 209
Query: 112 G------KIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPA 165
+ S L + + +L L+L + D L G
Sbjct: 210 RFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDF 269
Query: 166 SIG-----------NLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPS 214
+ T+ R+++ L+ + L + + + ++ +
Sbjct: 270 NPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSF 329
Query: 215 IFNISSLENVFLPTNRFNGSLPLDIGV--SLPKLLGFIVAENNFA--GSIPESLSNASNL 270
++ SLE + L N + + P L ++++N+ E L NL
Sbjct: 330 SQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNL 389
Query: 271 VELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLL-----------T 319
L + N F + + + + +LNL S + + L +L
Sbjct: 390 TSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSL 448
Query: 320 NCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMD 379
L + + N+ + + + + I+ NQ+ + L +L ++ +
Sbjct: 449 FLPRLQELYISRNKLKTL--PDASLFPV-LLVMKISRNQLKSVPDGIFDRLTSLQKIWLH 505
Query: 380 DNKLTGTIPH 389
N + P
Sbjct: 506 TNPWDCSCPR 515
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 6e-11
Identities = 30/117 (25%), Positives = 54/117 (46%), Gaps = 4/117 (3%)
Query: 472 SLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGS 531
D + ++P + + ++S N+ + L AC +LQ L L+ + +
Sbjct: 9 VCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTI 65
Query: 532 IPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSN 588
+ SL S++ LD+S N+LS + LS L+YLNL N ++ + +F N
Sbjct: 66 EGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ-TLGVTSLFPN 121
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 4e-10
Identities = 35/187 (18%), Positives = 73/187 (39%), Gaps = 16/187 (8%)
Query: 51 RVTKLDLSN---RTIGGTLSPYVGNLSFLRYLNLADNNFH--GEIPHQIGRLVRLEALVL 105
+ LDLS S G L+ L L+ N+ + + L L +L +
Sbjct: 335 SLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDI 394
Query: 106 ANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPA 165
+ N+F +P + + N + + + LE L +++N+L F
Sbjct: 395 SRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQT---LEVLDVSNNNLD-SFSL 448
Query: 166 SIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVF 225
L L+ + + N L +P+ L+++ + N+ + ++SL+ ++
Sbjct: 449 ---FLPRLQELYISRNKL-KTLPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIW 503
Query: 226 LPTNRFN 232
L TN ++
Sbjct: 504 LHTNPWD 510
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 3e-37
Identities = 61/368 (16%), Positives = 126/368 (34%), Gaps = 29/368 (7%)
Query: 211 VPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNL 270
+ ++ +V + + + ++L + L + +
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFE-DITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71
Query: 271 VELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLD 330
L L D Q + F ++ L +G N + + + N LT + L+
Sbjct: 72 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPH------VFQNVPLLTVLVLE 125
Query: 331 DNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHA 390
N + N +T + ++ N + I + +L L + N+LT +
Sbjct: 126 RNDLSSLPRGIFHNTPK-LTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD-- 181
Query: 391 IGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHM 450
+ + +L + N L ++L + L S N + + + L L +
Sbjct: 182 LSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKL 233
Query: 451 ADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEV-GNLKNLVYFNISVNRFSGEIP 509
LT +L+ L +DLSYN L + ++ L IS NR +
Sbjct: 234 QHNNLTD--TAWLLNYPGLV-EVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALN 288
Query: 510 VTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYL 569
+ +L+ L L N + + ++ L + N++ + L L+ L
Sbjct: 289 LYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNL 344
Query: 570 NLSYNHFE 577
LS+N ++
Sbjct: 345 TLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 7e-32
Identities = 59/347 (17%), Positives = 121/347 (34%), Gaps = 26/347 (7%)
Query: 253 ENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDL 312
I +L ++ + +L N + + ++ + A L
Sbjct: 6 RQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALL 65
Query: 313 DFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVN 372
D ++ + L+D + + ++ A + + + + N I + P +N+
Sbjct: 66 DSFR------QVELLNLNDLQIEEIDTYAFAYAHT-IQKLYMGFNAIRYLPPHVFQNVPL 118
Query: 373 LVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQ 432
L L ++ N L+ L L + +N L + T L NL LSSN L
Sbjct: 119 LTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT 178
Query: 433 GSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLK 492
+ +L +++ L+ L+I LD S+N ++ +
Sbjct: 179 -HVDL--SLIPSLFHANVSYNLLS------TLAIPIAVEELDASHNSINV---VRGPVNV 226
Query: 493 NLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNL 552
L + N + + L L ++ L N + ++ ++ L +S+N L
Sbjct: 227 ELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRL 284
Query: 553 SGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNK--TGISLSGN 597
+ Y + + L+ L+LS+NH V + + L N
Sbjct: 285 V-ALNLYGQPIPTLKVLDLSHNHLL-HVE-RNQPQFDRLENLYLDHN 328
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 8e-32
Identities = 81/427 (18%), Positives = 146/427 (34%), Gaps = 58/427 (13%)
Query: 138 IPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNN-LGNLRN 196
I + L Y+ ++ I +F L+ + + + + ++P L + R
Sbjct: 13 IDSNLQYD-CVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTM-RKLPAALLDSFRQ 70
Query: 197 LILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNF 256
+ LLNL + + I + +++ +++ N LP
Sbjct: 71 VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLP-------------------- 109
Query: 257 AGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLT 316
P N L L L N F + L L++ +NNL E +
Sbjct: 110 ----PHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDD------ 159
Query: 317 LLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVEL 376
T L + L NR V I +L ++ N + + + + + EL
Sbjct: 160 TFQATTSLQNLQLSSNRLTHVDLSLIPSL----FHANVSYNLL-----STLAIPIAVEEL 210
Query: 377 CMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIP 436
N + + + L +L L N L L N L + LS N+L+ I
Sbjct: 211 DASHNSIN-VVRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELE-KIM 264
Query: 437 P-SLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLV 495
+ L L++++ L AL I TL LDLS+N L + L
Sbjct: 265 YHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLK-VLDLSHNHLL-HVERNQPQFDRLE 321
Query: 496 YFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQ 555
+ N + LS +L+ L L N + + S + +++ + + +
Sbjct: 322 NLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCN--SLRALFRNVARPAVDDADQHCK 376
Query: 556 IPEYLEN 562
I LE+
Sbjct: 377 IDYQLEH 383
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-31
Identities = 73/397 (18%), Positives = 133/397 (33%), Gaps = 35/397 (8%)
Query: 72 NLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTN-LSRCSNLISFNAR 130
+++ + L + + N++ K+P L + N
Sbjct: 19 YDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLN 77
Query: 131 RNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNN 190
+ EI ++ L + N + P N+ L + + N L +P
Sbjct: 78 DLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDL-SSLPRG 135
Query: 191 L-GNLRNLILLNLGENRFSGIVPPSIF-NISSLENVFLPTNRFNGSLPLDIGVSLPKLLG 248
+ N L L++ N I F +SL+N+ L +NR + L + +P L
Sbjct: 136 IFHNTPKLTTLSMSNNNLERI-EDDTFQATTSLQNLQLSSNRLT-HVDLSL---IPSLFH 190
Query: 249 FIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGE 308
V+ N +L+ + EL N + L L L NNL
Sbjct: 191 ANVSYNLL-----STLAIPIAVEELDASHNSIN---VVRGPVNVELTILKLQHNNLTD-- 240
Query: 309 ANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIR 368
L N L + L N ++ H + + + I+ N++ + +
Sbjct: 241 ------TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQR-LERLYISNNRLV-ALNLYGQ 292
Query: 369 NLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSS 428
+ L L + N L + + L+ LYLD N + + L L NL LS
Sbjct: 293 PIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSH 348
Query: 429 NDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILS 465
ND + +L +N+ + D + + Q+
Sbjct: 349 NDWDCNSLRALF--RNVARPAVDDADQHCKIDYQLEH 383
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 2e-20
Identities = 63/349 (18%), Positives = 120/349 (34%), Gaps = 33/349 (9%)
Query: 47 HRHQRVTKLDLSNRTIGGTLSPYV-GNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVL 105
++V L+L++ I + Y ++ L + N PH + L LVL
Sbjct: 66 DSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 124
Query: 106 ANNSFSGKIPTNL-SRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFP 164
N S +P + L + + NNL I + L+NL ++ N LT H
Sbjct: 125 ERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD 181
Query: 165 ASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENV 224
+ + +L NV N L + L + L+ N + + + L +
Sbjct: 182 --LSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSINVV-RGPVN--VELTIL 231
Query: 225 FLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKV 284
L N ++ P L+ ++ N + L L + +N+ +
Sbjct: 232 KLQHNNLT---DTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-AL 287
Query: 285 SIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIAN 344
++Y + + L+ L+L N+L E N L + LD N + +
Sbjct: 288 NLYGQPIPTLKVLDLSHNHLLHVERN-------QPQFDRLENLYLDHNSIVTLKLSTHHT 340
Query: 345 LSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGE 393
L + + ++ N + N+ +DD I + +
Sbjct: 341 LKN----LTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEH 383
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 63/236 (26%), Positives = 103/236 (43%), Gaps = 32/236 (13%)
Query: 675 SKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIR 734
+ +DF ++GQG+FG V K + A+K I ++ S ++E L ++
Sbjct: 2 LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLST-ILSEVMLLASLN 60
Query: 735 HRNLIKIITICSSIDFKGVDFQA--------IVYEYMQNGSLEDWLH-QSEDQQEARSLT 785
H+ +++ A I EY +NG+L D +H ++ +QQ
Sbjct: 61 HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120
Query: 786 LIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPL 845
L ++I A+ YIH ++H DLKP N+ +D+ +GDFGLAK + S
Sbjct: 121 LFRQI------LEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLD 171
Query: 846 DTAVETPSSSKGIK------GTVGYIAPE--YGMG--GEASMTGDVYSFGILLLEM 891
+++ + GT Y+A E G G E D+YS GI+ EM
Sbjct: 172 ILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKI---DMYSLGIIFFEM 224
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 55/217 (25%), Positives = 97/217 (44%), Gaps = 28/217 (12%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGAS--NGFVAECQALRNIRHRNLIKIITI 744
IG+GSF VYKG E + VA + ++ S F E + L+ ++H N+++
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD- 92
Query: 745 CSSIDFKGVDFQAIVY-EYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYI 803
S ++ E M +G+L+ +L + + + + + + ++++
Sbjct: 93 -SWESTVKGKKCIVLVTELMTSGTLKTYL------KRFKVMKIKVLRSWCRQILKGLQFL 145
Query: 804 HHHCQPPVVHGDLKPSNVLLD-QDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTV 862
H PP++H DLK N+ + +GD GLA + S +K + GT
Sbjct: 146 HTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----------SFAKAVIGTP 194
Query: 863 GYIAPEYGMGG--EASMTGDVYSFGILLLEMFTRRRP 897
++APE E+ DVY+FG+ +LEM T P
Sbjct: 195 EFMAPEMYEEKYDESV---DVYAFGMCMLEMATSEYP 228
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-36
Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 35/227 (15%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNG----FVAECQALRNIRHRNLIKII 742
IG+G+FG V+ G L + +VAVK + F+ E + L+ H N++++I
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCR---ETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 743 TICSSID--FKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAI 800
+C+ + IV E +Q G +L + E L + + ++ D A+ +
Sbjct: 179 GVCTQKQPIY-------IVMELVQGGDFLTFL-----RTEGARLRVKTLLQMVGDAAAGM 226
Query: 801 EYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKG--I 858
EY+ +H DL N L+ + V + DFG+++ + D + +
Sbjct: 227 EYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEA----DGVYAASGGLRQVPV 279
Query: 859 KGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFNQ 904
K T APE G S DV+SFGILL E F+ P + NQ
Sbjct: 280 KWT----APEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ 322
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 7e-36
Identities = 57/439 (12%), Positives = 122/439 (27%), Gaps = 53/439 (12%)
Query: 141 ELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILL 200
E+ N + + + D+ L + + ++ +++ GN L +L L LL
Sbjct: 4 EIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELL 63
Query: 201 NLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSI 260
NL N + ++S+L + L N
Sbjct: 64 NLSSNVLYET--LDLESLSTLRTLDLNNNYV----------------------------- 92
Query: 261 PESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTN 320
+ L ++ L +N + + + + L +N + D + +
Sbjct: 93 -QELLVGPSIETLHAANNNIS---RVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQY 148
Query: 321 CTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDD 380
+ L N V +A S T+ + + N I + + L L +
Sbjct: 149 ------LDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSS 200
Query: 381 NKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQ-GSIPPSL 439
NKL + + + L +N L I +L L + L N G++
Sbjct: 201 NKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFF 258
Query: 440 GNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNI 499
+ + + ++ L Q T+ L L
Sbjct: 259 SKNQRVQTVAKQTVKK---LTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEH 315
Query: 500 SVNRFSG----EIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQ 555
++ G + +++ + I ++ L+ L Q
Sbjct: 316 ALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQ 375
Query: 556 IPEYLENLSFLEYLNLSYN 574
+ + L+
Sbjct: 376 VSNGRRAHAELDGTLQQAV 394
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 3e-32
Identities = 53/396 (13%), Positives = 107/396 (27%), Gaps = 53/396 (13%)
Query: 187 IPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKL 246
I N + + ++ + + +++ + L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDL-------------------- 41
Query: 247 LGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGT 306
+ N + L+ + L L L N + SL L L+L +N
Sbjct: 42 -----SGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNY--- 91
Query: 307 GEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTG 366
+ L + + +N V +I +A N+I+ +
Sbjct: 92 --------VQELLVGPSIETLHAANNNISRVSCSRGQGK----KNIYLANNKITMLRDLD 139
Query: 367 IRNLVNLVELCMDDNKLTG-TIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLA 425
+ L + N++ L+ L L NF+ + + L L
Sbjct: 140 EGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLD 197
Query: 426 LSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLP 485
LSSN L + P + + + + + +L + + L DL N
Sbjct: 198 LSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLE-HFDLRGNGFH-CGT 253
Query: 486 LEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKEL 545
L KN ++ CT + L ++K
Sbjct: 254 LRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRK 313
Query: 546 DMSSNNLSGQIPEYLENLSF----LEYLNLSYNHFE 577
+ + + G E LE ++ +
Sbjct: 314 EHALLSGQGSETERLECERENQARQREIDALKEQYR 349
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 3e-32
Identities = 56/339 (16%), Positives = 126/339 (37%), Gaps = 25/339 (7%)
Query: 259 SIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLL 318
+I E N + + D+ + ++ +S N++ L+L N L A L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAA------DL 54
Query: 319 TNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCM 378
T+L + L N L + +LS+ + + + N + + ++ L
Sbjct: 55 APFTKLELLNLSSNVLYETLD--LESLST-LRTLDLNNNYV-----QELLVGPSIETLHA 106
Query: 379 DDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQG-SIPP 437
+N ++ + + + +YL +N + G + + L L N++ +
Sbjct: 107 ANNNIS-RVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAE 163
Query: 438 SLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYF 497
+ L L++ + + Q++ + L +LDLS N L+ + E + + +
Sbjct: 164 LAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLK-TLDLSSNKLA-FMGPEFQSAAGVTWI 219
Query: 498 NISVNRFSGEIPVTLSACTSLQQLYLQGNSFS-GSIPSSLSSLKSIKELDMSSN-NLSGQ 555
++ N+ I L +L+ L+GN F G++ S + ++ + + L+GQ
Sbjct: 220 SLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQ 278
Query: 556 IPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNKTGISL 594
E + Y + + + +L
Sbjct: 279 NEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHAL 317
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 3e-31
Identities = 63/497 (12%), Positives = 131/497 (26%), Gaps = 55/497 (11%)
Query: 90 IPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKL 149
I R + + ++S + A L + +
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLK-------------------------QALASLRQSAWNV 36
Query: 150 ENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSG 209
+ L ++ N L+ A + + LE +N+ N L +L +L L L+L N
Sbjct: 37 KELDLSGNPLSQISAADLAPFTKLELLNLSSNVL--YETLDLESLSTLRTLDLNNNYVQ- 93
Query: 210 IVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASN 269
+ S+E + N + + G + +A N S
Sbjct: 94 ----ELLVGPSIETLHAANNNIS-RVSCSRGQGKKNI---YLANNKITMLRDLDEGCRSR 145
Query: 270 LVELTLFDNQFRG-KVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIG 328
+ L L N+ + S LE LNL N + + +L +
Sbjct: 146 VQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD--------VKGQVVFAKLKTLD 197
Query: 329 LDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIP 388
L N+ + + + +T I + N++ +I +R NL + N
Sbjct: 198 LSSNKL-AFMGPEFQSAAG-VTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH-CGT 253
Query: 389 HAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIEL 448
KN ++ + + + T+ T + + P L
Sbjct: 254 LRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRK 313
Query: 449 HMADIELTGALPPQILSISTLSLSL---DLSYNLLSGTLPLEVGNLKNLVYFNISVNRFS 505
A + G+ ++ D + + +
Sbjct: 314 EHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALD 373
Query: 506 GEIPVTLSACTSLQQLYLQGNSFSG--SIPSSLSSLKSIKELDMSSNNLSGQI-PEYLEN 562
++ A L Q S L+ ++ + + +
Sbjct: 374 EQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNA 433
Query: 563 LSFLEYLNLSYNHFEGE 579
+ + E
Sbjct: 434 IRDWDMYQHKETQLAEE 450
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-29
Identities = 52/274 (18%), Positives = 105/274 (38%), Gaps = 18/274 (6%)
Query: 338 LPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNL 397
+ N + + + + + + ++ N+ EL + N L+ + L
Sbjct: 2 IHEIKQNGNRY-KIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 398 QLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTG 457
+LL L SN L L +L+ L L L++N +Q L ++ LH A+ ++
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112
Query: 458 ALPPQILSISTLSL-SLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSG-EIPVTLSAC 515
+ ++ L+ N ++ L+ G + Y ++ +N ++
Sbjct: 113 RVSCSRGQ----GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASS 168
Query: 516 TSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNH 575
+L+ L LQ N + + +K LD+SSN L+ + ++ + + +++L N
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNK 225
Query: 576 FEGEVPTKGVFSNKTGISLSGNGKVCGGLDELNL 609
N L GNG CG L +
Sbjct: 226 LVLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFS 259
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 5e-23
Identities = 63/444 (14%), Positives = 127/444 (28%), Gaps = 46/444 (10%)
Query: 53 TKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSG 112
LDL+N + + + L+ A+NN + R + + LANN +
Sbjct: 83 RTLDLNNNYVQE-----LLVGPSIETLHAANNNIS-RVS--CSRGQGKKNIYLANNKITM 134
Query: 113 KIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLST 172
+ S + + + N + AEL + LE+L + N + + +
Sbjct: 135 LRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAK 192
Query: 173 LERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFN 232
L+ +++ N L + + + ++L N+ I ++ +LE+ L N F+
Sbjct: 193 LKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLVLI-EKALRFSQNLEHFDLRGNGFH 250
Query: 233 GSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLK 292
D ++ T+ +
Sbjct: 251 CGTLRDFFSKNQRV--------------------------QTVAKQTVKKLTGQNEEECT 284
Query: 293 NLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDI 352
+ G+ A D L L E + + L N + +I
Sbjct: 285 VPTLGHYGAYCCEDLPAPFADRLIALKR-KEHALLSGQGSETER-LECERENQAR-QREI 341
Query: 353 VIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAG--G 410
Q +I + L L + + L +
Sbjct: 342 DALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQH 401
Query: 411 IPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLS 470
L LL + ++ + + + M + T L + + L+
Sbjct: 402 ATEEQSPLQLLRAIVKRYEEM--YVEQQSVQNNAIRDWDMYQHKET-QLAEENARLKKLN 458
Query: 471 LSLDLSYNLLSGTLPLEVGNLKNL 494
DL+ + TL V +NL
Sbjct: 459 GEADLALASANATLQELVVREQNL 482
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 52/234 (22%), Positives = 90/234 (38%), Gaps = 31/234 (13%)
Query: 675 SKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIR 734
+ DF +IG G FG V+K +G +K + + A E +AL +
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLD 62
Query: 735 HRNLIK-----------IITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARS 783
H N++ T + I E+ G+LE W+ + +
Sbjct: 63 HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK----RRGEK 118
Query: 784 LTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSS 843
L + + + + ++YIH +++ DLKPSN+ L +GDFGL L +
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND 175
Query: 844 PLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897
KGT+ Y++PE + D+Y+ G++L E+
Sbjct: 176 ---------GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-35
Identities = 59/262 (22%), Positives = 120/262 (45%), Gaps = 27/262 (10%)
Query: 646 LARRRRSAHKSSVSQLMDQQFPMISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGM 705
L + P E+ + D + + +G G +G VY+G + +
Sbjct: 189 LITTLHYPAPKRNKPTIYGVSPNYDKWEMER--TDITMKHKLGGGQYGEVYEGVWKKYSL 246
Query: 706 MVAVKVINLKQKGASNG--FVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYM 763
VAVK + + F+ E ++ I+H NL++++ +C+ + F I+ E+M
Sbjct: 247 TVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT----REPPFY-IITEFM 298
Query: 764 QNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLL 823
G+L D+L + Q+ ++ + + + ++SA+EY+ +H +L N L+
Sbjct: 299 TYGNLLDYLRECNRQE----VSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLV 351
Query: 824 DQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYS 883
++ + + DFGL++ ++ +T ++ G K + + APE + S+ DV++
Sbjct: 352 GENHLVKVADFGLSRLMTG-------DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 404
Query: 884 FGILLLEMFTR-RRPTDGMFNQ 904
FG+LL E+ T P G+
Sbjct: 405 FGVLLWEIATYGMSPYPGIDLS 426
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-35
Identities = 49/231 (21%), Positives = 97/231 (41%), Gaps = 20/231 (8%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICS 746
+G+G F +V +G A+K I ++ E R H N+++++
Sbjct: 37 LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVA--Y 94
Query: 747 SIDFKGVDFQA-IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHH 805
+ +G +A ++ + + G+L + + + + + LT Q + +++ + +E IH
Sbjct: 95 CLRERGAKHEAWLLLPFFKRGTLWNEIERL--KDKGNFLTEDQILWLLLGICRGLEAIH- 151
Query: 806 HCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIK--GTVG 863
H DLKP+N+LL + L D G + + + + T+
Sbjct: 152 --AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHV-EGSRQALTLQDWAAQRCTIS 208
Query: 864 YIAPE------YGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTL 908
Y APE + + E + DV+S G +L M P D +F +G ++
Sbjct: 209 YRAPELFSVQSHCVIDERT---DVWSLGCVLYAMMFGEGPYDMVFQKGDSV 256
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-35
Identities = 57/235 (24%), Positives = 107/235 (45%), Gaps = 33/235 (14%)
Query: 685 NMIGQGSFGFVYKGNL---GENGMMVAVKVINLKQKGAS----NGFVAECQALRNIRHRN 737
++G+G FG V +GNL + VAVK +K +S F++E +++ H N
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKT--MKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 738 LIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVA 797
+I+++ +C + +G+ ++ +M+ G L +L S + + + L + ++D+A
Sbjct: 98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 798 SAIEYI-HHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSK 856
+EY+ + + +H DL N +L D+ + DFGL+K + S
Sbjct: 158 LGMEYLSNRNF----LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD-----YYRQGRI 208
Query: 857 G---IKGTVGYIAPE---YGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFNQ 904
+K A E + S DV++FG+ + E+ TR P G+ N
Sbjct: 209 AKMPVKWI----AIESLADRVYTSKS---DVWAFGVTMWEIATRGMTPYPGVQNH 256
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 7e-35
Identities = 55/227 (24%), Positives = 97/227 (42%), Gaps = 18/227 (7%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKG-ASNGFVAECQALRNIRHRN 737
DF +G+G FG V++ + A+K I L + A + E +AL + H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 738 LIKIIT-------ICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRI 790
+++ + I + + +L+DW++ +E +
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL--- 121
Query: 791 NIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVE 850
+I + +A A+E++H ++H DLKPSN+ D V +GDFGL + + V
Sbjct: 122 HIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 851 TPSSSKGIK----GTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT 893
TP + GT Y++PE G S D++S G++L E+
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 62/228 (27%), Positives = 94/228 (41%), Gaps = 32/228 (14%)
Query: 687 IGQGSFGFVYKGNL---GENGMMVAVKVIN---LKQKGASNGFVAECQALRNIRHRNLIK 740
+G GSFG V +G + VAVK + L Q A + F+ E A+ ++ HRNLI+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 741 IITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAI 800
+ + + K +V E GSL D L + + L + VA +
Sbjct: 86 LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGH-----FLLGTLSRYAVQVAEGM 134
Query: 801 EYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKG 860
Y+ +H DL N+LL + +GDFGL + L + + + K
Sbjct: 135 GYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQND-----DHYVMQEHRKV 186
Query: 861 TVGYIAPE---YGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFNQ 904
+ APE AS D + FG+ L EMFT + P G+
Sbjct: 187 PFAWCAPESLKTRTFSHAS---DTWMFGVTLWEMFTYGQEPWIGLNGS 231
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-34
Identities = 65/226 (28%), Positives = 110/226 (48%), Gaps = 29/226 (12%)
Query: 687 IGQGSFGFVYKGNL---GENGMMVAVKVINLKQKGASNG----FVAECQALRNIRHRNLI 739
+G G FG V G L + + VA+K + G + F+ E + H N+I
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLK---VGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 740 KIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASA 799
++ + + K IV EYM+NGSL+ +L + + Q T+IQ + ++ +AS
Sbjct: 110 RLEGVVT----KSKPVM-IVTEYMENGSLDSFLRKHDAQ-----FTVIQLVGMLRGIASG 159
Query: 800 IEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIK 859
++Y+ VH DL N+L++ +LV + DFGL + L P E +++G K
Sbjct: 160 MKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP-----EAAYTTRGGK 211
Query: 860 GTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFNQ 904
+ + +PE + + DV+S+GI+L E+ + RP M NQ
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ 257
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-34
Identities = 66/229 (28%), Positives = 109/229 (47%), Gaps = 35/229 (15%)
Query: 687 IGQGSFGFVYKGNL---GENGMMVAVKVINLKQKGASNG----FVAECQALRNIRHRNLI 739
IG G G V G L G+ + VA+K + G + F++E + H N+I
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALK---AGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 740 KIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASA 799
++ + + +G IV EYM+NGSL+ +L + Q T++Q + ++ V +
Sbjct: 114 RLEGVVT----RGRLAM-IVTEYMENGSLDTFLRTHDGQ-----FTIMQLVGMLRGVGAG 163
Query: 800 IEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIK 859
+ Y+ VH DL NVL+D +LV + DFGL++ L P + ++ G K
Sbjct: 164 MRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP-----DAAYTTTGGK 215
Query: 860 GTVGYIAPE---YGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFNQ 904
+ + APE + AS DV+SFG+++ E+ RP M N+
Sbjct: 216 IPIRWTAPEAIAFRTFSSAS---DVWSFGVVMWEVLAYGERPYWNMTNR 261
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 7e-34
Identities = 67/231 (29%), Positives = 115/231 (49%), Gaps = 38/231 (16%)
Query: 687 IGQGSFGFVYKGNL----GENGMMVAVKVINLKQKGASNG----FVAECQALRNIRHRNL 738
IG G FG VYKG L G+ + VA+K + G + F+ E + H N+
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK---AGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 739 IKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVAS 798
I++ + S K I+ EYM+NG+L+ +L + + + +++Q + ++ +A+
Sbjct: 109 IRLEGVIS----KYKPMM-IITEYMENGALDKFLREKDGE-----FSVLQLVGMLRGIAA 158
Query: 799 AIEYI-HHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKG 857
++Y+ + + VH DL N+L++ +LV + DFGL++ L P E ++ G
Sbjct: 159 GMKYLANMNY----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-----EATYTTSG 209
Query: 858 IKGTVGYIAPE---YGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFNQ 904
K + + APE Y AS DV+SFGI++ E+ T RP + N
Sbjct: 210 GKIPIRWTAPEAISYRKFTSAS---DVWSFGIVMWEVMTYGERPYWELSNH 257
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 8e-34
Identities = 70/223 (31%), Positives = 101/223 (45%), Gaps = 35/223 (15%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICS 746
IG+G FG V G+ G VAVK +K + F+AE + +RH NL++++ +
Sbjct: 29 IGKGEFGDVMLGDY--RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 747 SIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYI-HH 805
+ IV EYM GSL D+L L + +DV A+EY+ +
Sbjct: 85 ----EEKGGLYIVTEYMAKGSLVDYLRSRGRSV----LGGDCLLKFSLDVCEAMEYLEGN 136
Query: 806 HCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYI 865
+ VH DL NVL+ +D VA + DFGL K E S+ K V +
Sbjct: 137 NF----VHRDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGKLPVKWT 181
Query: 866 APE---YGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFNQ 904
APE S DV+SFGILL E+++ R P + +
Sbjct: 182 APEALREKKFSTKS---DVWSFGILLWEIYSFGRVPYPRIPLK 221
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 8e-34
Identities = 59/227 (25%), Positives = 100/227 (44%), Gaps = 33/227 (14%)
Query: 687 IGQGSFGFVYKG--NLGENGMMVAVKVI--NLKQKGASNGFVAECQALRNIRHRNLIKII 742
+G G+FG V KG + + VAVK++ + +AE ++ + + ++++I
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 743 TICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEY 802
IC + + +V E + G L +L Q+ R + I ++ V+ ++Y
Sbjct: 85 GICEA------ESWMLVMEMAELGPLNKYL------QQNRHVKDKNIIELVHQVSMGMKY 132
Query: 803 I-HHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGT 861
+ + VH DL NVLL A + DFGL+K L + + K
Sbjct: 133 LEESNF----VHRDLAARNVLLVTQHYAKISDFGLSKALRADE-----NYYKAQTHGKWP 183
Query: 862 VGYIAPE---YGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFNQ 904
V + APE Y S DV+SFG+L+ E F+ ++P GM
Sbjct: 184 VKWYAPECINYYKFSSKS---DVWSFGVLMWEAFSYGQKPYRGMKGS 227
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-33
Identities = 55/238 (23%), Positives = 104/238 (43%), Gaps = 38/238 (15%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENG----MMVAVKVINLK---QKGASNGFVAECQALR 731
+F ++G G+FG VYKG G + VA+K L+ A+ + E +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPKANKEILDEAYVMA 72
Query: 732 NIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRIN 791
++ + ++ +++ IC + ++ + M G L D++ + +D + +N
Sbjct: 73 SVDNPHVCRLLGICLT------STVQLITQLMPFGCLLDYVREHKDN-----IGSQYLLN 121
Query: 792 IIIDVASAIEYI-HHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVE 850
+ +A + Y+ VH DL NVL+ + DFGLAK L + E
Sbjct: 122 WCVQIAKGMNYLEDRRL----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE------E 171
Query: 851 TPSSSKGIKGTVGYIAPE---YGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFNQ 904
++G K + ++A E + + S DV+S+G+ + E+ T +P DG+
Sbjct: 172 KEYHAEGGKVPIKWMALESILHRIYTHQS---DVWSYGVTVWELMTFGSKPYDGIPAS 226
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-33
Identities = 35/302 (11%), Positives = 76/302 (25%), Gaps = 43/302 (14%)
Query: 647 ARRRRSAHKSSVSQ-LMDQQFPMISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGM 705
A + +A +V+ + Q + LS+ + G V+ E
Sbjct: 29 ALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLE 88
Query: 706 MVAVKVINLKQKGASN---GFVAECQALRNIRHRNLI---------------------KI 741
A+KV + + + + A + +
Sbjct: 89 DFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPF 148
Query: 742 ITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARS-LTLIQRINIIIDVASAI 800
+ D V ++ LE + R ++ + +
Sbjct: 149 AQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLA 207
Query: 801 EYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKG 860
+ +VHG P N+ + D LGD + +
Sbjct: 208 ANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSA-----------LWKVGTRGPASSV 253
Query: 861 TVGYIAPEYGMGGEASMTG--DVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPD 918
V Y E+ A+ T + + G+ + ++ P + + +P
Sbjct: 254 PVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPG 313
Query: 919 KV 920
Sbjct: 314 TD 315
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-33
Identities = 70/219 (31%), Positives = 101/219 (46%), Gaps = 27/219 (12%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICS 746
IG+G FG V G+ G VAVK +K + F+AE + +RH NL++++ +
Sbjct: 201 IGKGEFGDVMLGDY--RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 256
Query: 747 SIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHH 806
+ IV EYM GSL D+L L + +DV A+EY+ +
Sbjct: 257 ----EEKGGLYIVTEYMAKGSLVDYLRSRGRSV----LGGDCLLKFSLDVCEAMEYLEGN 308
Query: 807 CQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIA 866
VH DL NVL+ +D VA + DFGL K E S+ K V + A
Sbjct: 309 N---FVHRDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGKLPVKWTA 354
Query: 867 PEYGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFNQ 904
PE + S DV+SFGILL E+++ R P + +
Sbjct: 355 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 393
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 46/282 (16%), Positives = 100/282 (35%), Gaps = 17/282 (6%)
Query: 317 LLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVEL 376
+ N + D+ L + + + ++ ++GN +S I + L L
Sbjct: 5 IKQNGNRYKIEKVTDSSLKQALASLRQSAWN-VKELDLSGNPLSQISAADLAPFTKLELL 63
Query: 377 CMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIP 436
+ N L + L L+ L L++N++ L + L ++N++ +
Sbjct: 64 NLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVS 115
Query: 437 PSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSG-TLPLEVGNLKNLV 495
S G + +++A+ ++T S + LDL N + + L
Sbjct: 116 CSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQ-YLDLKLNEIDTVNFAELAASSDTLE 172
Query: 496 YFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQ 555
+ N+ N ++ + L+ L L N + + S + + + +N L
Sbjct: 173 HLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-L 228
Query: 556 IPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNKTGISLSGN 597
I + L LE+ +L N F N+ +++
Sbjct: 229 IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-33
Identities = 55/316 (17%), Positives = 120/316 (37%), Gaps = 25/316 (7%)
Query: 259 SIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLL 318
+I E N + + D+ + ++ +S N++ L+L N L A L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAA------DL 54
Query: 319 TNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCM 378
T+L + L N L + +LS+ + + + N + + ++ L
Sbjct: 55 APFTKLELLNLSSNVLYETLD--LESLST-LRTLDLNNNYV-----QELLVGPSIETLHA 106
Query: 379 DDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQG-SIPP 437
+N ++ + + + +YL +N + G + + L L N++ +
Sbjct: 107 ANNNIS-RVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAE 163
Query: 438 SLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYF 497
+ L L++ + + Q+ + L +LDLS N L+ + E + + +
Sbjct: 164 LAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLK-TLDLSSNKLA-FMGPEFQSAAGVTWI 219
Query: 498 NISVNRFSGEIPVTLSACTSLQQLYLQGNSFS-GSIPSSLSSLKSIKELDMSSN-NLSGQ 555
++ N+ I L +L+ L+GN F G++ S + ++ + + L+GQ
Sbjct: 220 SLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQ 278
Query: 556 IPEYLENLSFLEYLNL 571
E + Y
Sbjct: 279 NEEECTVPTLGHYGAY 294
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-31
Identities = 52/274 (18%), Positives = 105/274 (38%), Gaps = 18/274 (6%)
Query: 338 LPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNL 397
+ N + + + + + + ++ N+ EL + N L+ + L
Sbjct: 2 IHEIKQNGNRY-KIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 398 QLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTG 457
+LL L SN L L +L+ L L L++N +Q L ++ LH A+ ++
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112
Query: 458 ALPPQILSISTLSL-SLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSG-EIPVTLSAC 515
+ ++ L+ N ++ L+ G + Y ++ +N ++
Sbjct: 113 RVSCSRGQ----GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASS 168
Query: 516 TSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNH 575
+L+ L LQ N + + +K LD+SSN L+ + ++ + + +++L N
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNK 225
Query: 576 FEGEVPTKGVFSNKTGISLSGNGKVCGGLDELNL 609
N L GNG CG L +
Sbjct: 226 LVLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFS 259
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 51/329 (15%), Positives = 104/329 (31%), Gaps = 22/329 (6%)
Query: 167 IGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFL 226
N + + V + L + + + N+ L+L N S I + + LE + L
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 227 PTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSI 286
+N +L L+ SL L + N + L ++ L +N +
Sbjct: 66 SSNVLYETLDLE---SLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS---RV 114
Query: 287 YFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLS 346
+ + + L +N + D + + + L N V +A S
Sbjct: 115 SCSRGQGKKNIYLANNKITMLRDLDEGCR------SRVQYLDLKLNEIDTVNFAELAASS 168
Query: 347 STMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNF 406
T+ + + N I + + L L + NKL + + + L +N
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNK 225
Query: 407 LAGGIPTSLGNLTLLTNLALSSNDLQ-GSIPPSLGNCKNLIELHMADIELTGALPPQILS 465
L I +L L + L N G++ + + + ++ + +
Sbjct: 226 LV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECT 284
Query: 466 ISTLSLSLDLSYNLLSGTLPLEVGNLKNL 494
+ TL L + L +
Sbjct: 285 VPTLGHYGAYCCEDLPAPFADRLIALGHH 313
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-21
Identities = 51/284 (17%), Positives = 102/284 (35%), Gaps = 18/284 (6%)
Query: 53 TKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSG 112
+LDLS + + + + L LNL+ N + E + L L L L NN
Sbjct: 37 KELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYV-- 92
Query: 113 KIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLST 172
L ++ + +A NN+ + G +N+ +A+N +T G S
Sbjct: 93 ---QELLVGPSIETLHAANNNI-SRVSCSRGQG---KKNIYLANNKITMLRDLDEGCRSR 145
Query: 173 LERINVLGNGLWG-RIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRF 231
++ +++ N + + L LNL N + + + L+ + L +N+
Sbjct: 146 VQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KGQVV-FAKLKTLDLSSNKL 203
Query: 232 NGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFR-GKVSIYFRS 290
+ + S + + N I ++L + NL L N F G + +F
Sbjct: 204 A-FMGPEFQ-SAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSK 260
Query: 291 LKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRF 334
+ ++ + + TG+ + + L + L
Sbjct: 261 NQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFA 304
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 33/183 (18%), Positives = 62/183 (33%), Gaps = 10/183 (5%)
Query: 50 QRVTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNS 109
+ L +N I +S + + LA+N G R++ L L N
Sbjct: 99 PSIETLHAANNNIS-RVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNE 155
Query: 110 FSG-KIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIG 168
+ L N + N + ++ ++ + KL+ L ++ N L
Sbjct: 156 IDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV--VFAKLKTLDLSSNKLA-FMGPEFQ 211
Query: 169 NLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIF-NISSLENVFLP 227
+ + + I++ N L I L +NL +L N F F ++ V
Sbjct: 212 SAAGVTWISLRNNKL-VLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270
Query: 228 TNR 230
T +
Sbjct: 271 TVK 273
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 6e-04
Identities = 7/47 (14%), Positives = 19/47 (40%)
Query: 531 SIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFE 577
+I + K ++ ++L + ++ ++ L+LS N
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS 47
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 54/233 (23%), Positives = 101/233 (43%), Gaps = 46/233 (19%)
Query: 687 IGQGSFGFVYKG---NLGENGMMVAVKVINLKQKGASNG----FVAECQALRNIRHRNLI 739
+G+G FG VY+G N + VAVK K + F++E ++N+ H +++
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCK---KDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 740 KIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASA 799
K+I I + I+ E G L +L ++ SL ++ + + + A
Sbjct: 77 KLIGIIEE------EPTWIIMELYPYGELGHYL-----ERNKNSLKVLTLVLYSLQICKA 125
Query: 800 IEYI-HHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKG- 857
+ Y+ +C VH D+ N+L+ LGDFGL++++ + +S
Sbjct: 126 MAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIEDE------DYYKASVTR 175
Query: 858 --IKGTVGYIAPE---YGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFNQ 904
IK +PE + AS DV+ F + + E+ + ++P + N+
Sbjct: 176 LPIKWM----SPESINFRRFTTAS---DVWMFAVCMWEILSFGKQPFFWLENK 221
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 51/228 (22%), Positives = 97/228 (42%), Gaps = 35/228 (15%)
Query: 687 IGQGSFGFVYKG--NLGENGMMVAVKVINLK---QKGASNGFVAECQALRNIRHRNLIKI 741
+G G+FG V +G + + + VA+KV LK +K + + E Q + + + ++++
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKV--LKQGTEKADTEEMMREAQIMHQLDNPYIVRL 75
Query: 742 ITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIE 801
I +C + +V E G L +L + + + ++ V+ ++
Sbjct: 76 IGVCQAEALM------LVMEMAGGGPLHKFL-----VGKREEIPVSNVAELLHQVSMGMK 124
Query: 802 YI-HHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKG 860
Y+ + VH DL NVLL A + DFGL+K L + ++ K
Sbjct: 125 YLEEKNF----VHRDLAARNVLLVNRHYAKISDFGLSKALGADD-----SYYTARSAGKW 175
Query: 861 TVGYIAPE---YGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFNQ 904
+ + APE + S DV+S+G+ + E + ++P M
Sbjct: 176 PLKWYAPECINFRKFSSRS---DVWSYGVTMWEALSYGQKPYKKMKGP 220
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-33
Identities = 67/219 (30%), Positives = 110/219 (50%), Gaps = 23/219 (10%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICS 746
+GQG FG V+ G VA+K + + F+ E Q ++ +RH L+++ + S
Sbjct: 192 LGQGCFGEVWMGTWNGTTR-VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 747 SIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHH 806
+ IV EYM GSL D+L + L L Q +++ +AS + Y+
Sbjct: 250 E------EPIYIVTEYMSKGSLLDFLKGETGK----YLRLPQLVDMAAQIASGMAYVERM 299
Query: 807 CQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIA 866
VH DL+ +N+L+ ++LV + DFGLA+ + ++ +G K + + A
Sbjct: 300 N---YVHRDLRAANILVGENLVCKVADFGLARLIED-------NEYTARQGAKFPIKWTA 349
Query: 867 PEYGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFNQ 904
PE + G ++ DV+SFGILL E+ T+ R P GM N+
Sbjct: 350 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 388
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 57/224 (25%), Positives = 110/224 (49%), Gaps = 31/224 (13%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNG--FVAECQALRNIRHRNLIKIITI 744
+G G +G VY+G + + VAVK + + F+ E ++ I+H NL++++ +
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 745 CSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIH 804
C+ + F I+ E+M G+L D+L + Q+ ++ + + + ++SA+EY+
Sbjct: 78 CT----REPPF-YIITEFMTYGNLLDYLRECNRQE----VSAVVLLYMATQISSAMEYLE 128
Query: 805 HHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGY 864
+H DL N L+ ++ + + DFGL++ ++ +T ++ G K + +
Sbjct: 129 KKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG-------DTYTAHAGAKFPIKW 178
Query: 865 IAPE---YGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFNQ 904
APE Y S DV++FG+LL E+ T P G+
Sbjct: 179 TAPESLAYNKFSIKS---DVWAFGVLLWEIATYGMSPYPGIDLS 219
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-33
Identities = 62/221 (28%), Positives = 104/221 (47%), Gaps = 27/221 (12%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNG--FVAECQALRNIRHRNLIKIITI 744
+G G FG V+ VAVK + G+ + F+AE ++ ++H L+K+ +
Sbjct: 196 LGAGQFGEVWMATY-NKHTKVAVKTMK---PGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 745 CSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIH 804
+ + I+ E+M GSL D+L E + L + I+ +A + +I
Sbjct: 252 VTK------EPIYIITEFMAKGSLLDFLKSDEGSK----QPLPKLIDFSAQIAEGMAFIE 301
Query: 805 HHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGY 864
+H DL+ +N+L+ LV + DFGLA+ + ++ +G K + +
Sbjct: 302 QRN---YIHRDLRAANILVSASLVCKIADFGLARVIED-------NEYTAREGAKFPIKW 351
Query: 865 IAPEYGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFNQ 904
APE G ++ DV+SFGILL+E+ T R P GM N
Sbjct: 352 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP 392
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-33
Identities = 59/223 (26%), Positives = 95/223 (42%), Gaps = 17/223 (7%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGAS--NGFVAECQALRNIRHR 736
D+ IG GS+G K +G ++ K ++ + V+E LR ++H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 737 NLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDV 796
N I+ I + IV EY + G L + ++ +E + L + ++ +
Sbjct: 66 N---IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI--TKGTKERQYLDEEFVLRVMTQL 120
Query: 797 ASAIEYIH--HHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSS 854
A++ H V+H DLKP+NV LD LGDFGLA+ L+ S
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--------DTSF 172
Query: 855 SKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897
+K GT Y++PE + D++S G LL E+ P
Sbjct: 173 AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-33
Identities = 67/225 (29%), Positives = 108/225 (48%), Gaps = 35/225 (15%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNG--FVAECQALRNIRHRNLIKIITI 744
+G G FG V+ G VAVK + +G+ + F+AE ++ ++H+ L+++ +
Sbjct: 21 LGAGQFGEVWMGYY-NGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 745 CSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIH 804
+ + I+ EYM+NGSL D+L + LT+ + +++ +A + +I
Sbjct: 77 VTQ------EPIYIITEYMENGSLVDFLKTPSGIK----LTINKLLDMAAQIAEGMAFIE 126
Query: 805 HHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSK-GIKGTVG 863
+H DL+ +N+L+ L + DFGLA+ + D +K IK T
Sbjct: 127 ERN---YIHRDLRAANILVSDTLSCKIADFGLARLI----EDNEYTAREGAKFPIKWT-- 177
Query: 864 YIAPE---YGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFNQ 904
APE YG S DV+SFGILL E+ T R P GM N
Sbjct: 178 --APEAINYGTFTIKS---DVWSFGILLTEIVTHGRIPYPGMTNP 217
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 135 bits (340), Expect = 5e-33
Identities = 65/333 (19%), Positives = 117/333 (35%), Gaps = 27/333 (8%)
Query: 266 NASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELT 325
+N +T ++ R + S + +E LNL + + +
Sbjct: 49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTY------AFAYAHTIQ 102
Query: 326 AIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTG 385
+ + N + PH N+ +T +V+ N +S + N L L M +N L
Sbjct: 103 KLYMGFNAIRYLPPHVFQNVPL-LTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLER 161
Query: 386 TIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNL 445
+LQ L L SN L + L + L + +S N L +L +
Sbjct: 162 IEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS-----TLAIPIAV 213
Query: 446 IELHMADIELTGALPPQILSISTLSL-SLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRF 504
EL + + + + L L L +N L+ + N LV ++S N
Sbjct: 214 EELDASHNSIN-VVRGPVNV----ELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNEL 266
Query: 505 SGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLS 564
+ L++LY+ N ++ + ++K LD+S N+L +
Sbjct: 267 EKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFD 324
Query: 565 FLEYLNLSYNHFEGEVPTKGVFSNKTGISLSGN 597
LE L L +N + ++LS N
Sbjct: 325 RLENLYLDHNSIV-TLKL-STHHTLKNLTLSHN 355
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-32
Identities = 75/449 (16%), Positives = 148/449 (32%), Gaps = 54/449 (12%)
Query: 187 IPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKL 246
I +NL +++ +++ + V + LP
Sbjct: 19 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLP---------- 67
Query: 247 LGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGT 306
L + + L L D Q + F ++ L +G N +
Sbjct: 68 --------------AALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY 113
Query: 307 GEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTG 366
+ + N LT + L+ N + N +T + ++ N + I
Sbjct: 114 LPPH------VFQNVPLLTVLVLERNDLSSLPRGIFHNTPK-LTTLSMSNNNLERIEDDT 166
Query: 367 IRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLAL 426
+ +L L + N+LT + + + +L + N L ++L + L
Sbjct: 167 FQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLL-----STLAIPIAVEELDA 218
Query: 427 SSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPL 486
S N + + + L L + LT +L+ L +DLSYN L +
Sbjct: 219 SHNSIN-VVRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLV-EVDLSYNELE-KIMY 271
Query: 487 EV-GNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKEL 545
++ L IS NR + + +L+ L L N + + ++ L
Sbjct: 272 HPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENL 329
Query: 546 DMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNKTGISLSGNGKVCGGLD 605
+ N++ + L L+ L LS+N ++ + +F N ++ + C
Sbjct: 330 YLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD-CNSLRALFRNVARPAVDDADQHCKIDY 385
Query: 606 ELNLPPCPSRGLKKRTDFLLKVVVPVTVS 634
+L C K D LL+ + +V
Sbjct: 386 QLEHGLCCKESDKPYLDRLLQYIALTSVV 414
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 7e-31
Identities = 82/509 (16%), Positives = 162/509 (31%), Gaps = 52/509 (10%)
Query: 72 NLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTN-LSRCSNLISFNAR 130
+++ + L + + N++ K+P L + N
Sbjct: 25 YDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLN 83
Query: 131 RNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNN 190
+ EI ++ L + N + P N+ L + + N L +P
Sbjct: 84 DLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDL-SSLPRG 141
Query: 191 L-GNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGF 249
+ N L L++ N I + +SL+N+ L +NR + L +P L
Sbjct: 142 IFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLS---LIPSLFHA 197
Query: 250 IVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEA 309
V+ N +L+ + EL N + L L L NNL
Sbjct: 198 NVSYNLL-----STLAIPIAVEELDASHNSIN---VVRGPVNVELTILKLQHNNLTD--- 246
Query: 310 NDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRN 369
L N L + L N ++ H + + + I+ N++ + +
Sbjct: 247 -----TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQR-LERLYISNNRLV-ALNLYGQP 299
Query: 370 LVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSN 429
+ L L + N L + + L+ LYLD N + + L L NL LS N
Sbjct: 300 IPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHN 355
Query: 430 DLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVG 489
D + +L +N+ + D + + Q+ L
Sbjct: 356 DWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEH------------GLCCKESDKPYL 401
Query: 490 NLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSS 549
+ I++ ++ C++ + + L+ ++L+
Sbjct: 402 DRLLQ---YIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEV 458
Query: 550 NNLSGQI----PEYLENLSFLEYLNLSYN 574
N L ++ E ++ L+ L+ +
Sbjct: 459 NELRAEVQQLTNEQIQQEQLLQGLHAEID 487
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 98.1 bits (244), Expect = 4e-21
Identities = 84/545 (15%), Positives = 170/545 (31%), Gaps = 53/545 (9%)
Query: 47 HRHQRVTKLDLSNRTIGGTLSPYV-GNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVL 105
++V L+L++ I + Y ++ L + N PH + L LVL
Sbjct: 72 DSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 130
Query: 106 ANNSFSGKIPTNL-SRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFP 164
N S +P + L + + NNL I + L+NL ++ N LT H
Sbjct: 131 ERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD 187
Query: 165 ASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENV 224
+ + +L NV N L + L + L+ N + + + L +
Sbjct: 188 --LSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSINVV-RGPVN--VELTIL 237
Query: 225 FLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKV 284
L N ++ P L+ ++ N + L L + +N+ +
Sbjct: 238 KLQHNNLT---DTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-AL 293
Query: 285 SIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIAN 344
++Y + + L+ L+L N+L E N L + LD N + +
Sbjct: 294 NLYGQPIPTLKVLDLSHNHLLHVERN-------QPQFDRLENLYLDHNSIVTLKLSTHHT 346
Query: 345 LSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIG----------EL 394
L + + ++ N + N+ +DD I + +
Sbjct: 347 LKN----LTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPY 400
Query: 395 KNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIE 454
+ L Y+ + + + G + + + + +L E
Sbjct: 401 LDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNE 460
Query: 455 LTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSA 514
L + L+ LL G NL+ + R S + +
Sbjct: 461 LR-------AEVQQLTNEQIQQEQLLQGLHAEIDTNLRRYRLPKDGLARSSDNLNKVFTH 513
Query: 515 CTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQI-PEYLENLSFLEYLNLSY 573
Q L+ + + K ++L+ + L Q+ + + + +L
Sbjct: 514 LKERQAFKLRETQA--RRTEADAKQKETEDLEQENIALEKQLDNKRAKQAELRQETSLKR 571
Query: 574 NHFEG 578
+
Sbjct: 572 QKVKQ 576
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 15/131 (11%), Positives = 47/131 (35%), Gaps = 10/131 (7%)
Query: 475 LSYNLLSGTLPL---EVGNLKNLVYFNISVNRFSGEIPVTLSACT--SLQQLYLQGNSFS 529
YN+ + + V++++ ++ + ++ T + + + + ++
Sbjct: 5 QRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR 64
Query: 530 GSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNK 589
+ L S + ++ L+++ + ++ L + +N +P VF N
Sbjct: 65 KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLP-PHVFQNV 122
Query: 590 TG---ISLSGN 597
+ L N
Sbjct: 123 PLLTVLVLERN 133
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 6e-33
Identities = 58/233 (24%), Positives = 96/233 (41%), Gaps = 46/233 (19%)
Query: 687 IGQGSFGFVYKGNL---GENGMMVAVKVINLKQKGASNG----FVAECQALRNIRHRNLI 739
IG+G FG V++G + VA+K S+ F+ E +R H +++
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCK---NCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 740 KIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASA 799
K+I + + + I+ E G L +L + L L I +++A
Sbjct: 80 KLIGVITE------NPVWIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTA 128
Query: 800 IEYI-HHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKG- 857
+ Y+ VH D+ NVL+ + LGDFGL++++ S +SKG
Sbjct: 129 LAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS------TYYKASKGK 178
Query: 858 --IKGTVGYIAPE---YGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFNQ 904
IK APE + AS DV+ FG+ + E+ +P G+ N
Sbjct: 179 LPIKWM----APESINFRRFTSAS---DVWMFGVCMWEILMHGVKPFQGVKNN 224
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 7e-33
Identities = 63/230 (27%), Positives = 100/230 (43%), Gaps = 45/230 (19%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNG--FVAECQALRNIRHRNLIKIITI 744
+G G FG V G VAVK+I +G+ + F E Q + + H L+K +
Sbjct: 16 LGSGQFGVVKLGKWKGQ-YDVAVKMIK---EGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 745 CSSID--FKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEY 802
CS + IV EY+ NG L ++L + + L Q + + DV + +
Sbjct: 72 CSKEYPIY-------IVTEYISNGCLLNYL-----RSHGKGLEPSQLLEMCYDVCEGMAF 119
Query: 803 I-HHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKG---I 858
+ H +H DL N L+D+DL + DFG+ +++ + SS +
Sbjct: 120 LESHQF----IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD------QYVSSVGTKFPV 169
Query: 859 KGTVGYIAPE---YGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFNQ 904
K + APE Y S DV++FGIL+ E+F+ + P D N
Sbjct: 170 KWS----APEVFHYFKYSSKS---DVWAFGILMWEVFSLGKMPYDLYTNS 212
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-32
Identities = 74/342 (21%), Positives = 125/342 (36%), Gaps = 39/342 (11%)
Query: 259 SIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLL 318
++PE + + L L N+ + F S +LE L L N + E
Sbjct: 25 AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPG------AF 76
Query: 319 TNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCM 378
N L +GL NR + LS+ +T + I+ N+I ++ ++L NL L +
Sbjct: 77 NNLFNLRTLGLRSNRLKLIPLGVFTGLSN-LTKLDISENKIVILLDYMFQDLYNLKSLEV 135
Query: 379 DDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPS 438
DN L A L +L+ L L+ L +L +L L L L ++ S
Sbjct: 136 GDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYS 195
Query: 439 LGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFN 498
L L ++ + P L L+ SL +++ L+ +P
Sbjct: 196 FKRLYRLKVLEISHWPYLDTMTPNCLYGLNLT-SLSITHCNLT-AVP------------- 240
Query: 499 ISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPE 558
+ + L+ L L N S S L L ++E+ + L+ P
Sbjct: 241 ----------YLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPY 290
Query: 559 YLENLSFLEYLNLSYNHFEGEVPTKGVFSNKTG---ISLSGN 597
L++L LN+S N + + VF + + L N
Sbjct: 291 AFRGLNYLRVLNVSGNQLT-TLE-ESVFHSVGNLETLILDSN 330
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-30
Identities = 69/335 (20%), Positives = 121/335 (36%), Gaps = 33/335 (9%)
Query: 243 LPKLLGFIVAENNFAGSIPE-SLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGS 301
+P + N ++ + ++ +L EL L +N F +L NL L L S
Sbjct: 30 IPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRS 89
Query: 302 NNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISG 361
N L + T + LT + + +N+ +L + +L + + + + N +
Sbjct: 90 NRLKLIPLG------VFTGLSNLTKLDISENKIVILLDYMFQDLYN-LKSLEVGDNDLVY 142
Query: 362 IIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLL 421
I L +L +L ++ LT A+ L L +L L + S L L
Sbjct: 143 ISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRL 202
Query: 422 TNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLS 481
L +S ++ P+ NL L + LT A+P + L+LSYN +S
Sbjct: 203 KVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS 261
Query: 482 GTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKS 541
I + LQ++ L G + P + L
Sbjct: 262 ----------------TIEGSMLHE--------LLRLQEIQLVGGQLAVVEPYAFRGLNY 297
Query: 542 IKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHF 576
++ L++S N L+ ++ LE L L N
Sbjct: 298 LRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-28
Identities = 66/327 (20%), Positives = 115/327 (35%), Gaps = 14/327 (4%)
Query: 156 DNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSI 215
P I + +++ N + + + +L L L EN S + P +
Sbjct: 20 RKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAF 76
Query: 216 FNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTL 275
N+ +L + L +NR +PL + L L ++EN + + NL L +
Sbjct: 77 NNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEV 135
Query: 276 FDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFG 335
DN F L +LE L L NL + L++ L + L
Sbjct: 136 GDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTE------ALSHLHGLIVLRLRHLNIN 189
Query: 336 GVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELK 395
+ +S L + + I+ + +NL L + LT A+ L
Sbjct: 190 AIRDYSFKRLYR-LKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLV 248
Query: 396 NLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPP-SLGNCKNLIELHMADIE 454
L+ L L N ++ + L L L + L L + P + L L+++ +
Sbjct: 249 YLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQ 307
Query: 455 LTGALPPQILSISTLSLSLDLSYNLLS 481
LT L + +L L N L+
Sbjct: 308 LT-TLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-24
Identities = 76/386 (19%), Positives = 124/386 (32%), Gaps = 78/386 (20%)
Query: 38 CQWTG--VTCGHRH---------QRVTKLDLSNRTIGGTLSPYV-GNLSFLRYLNLADNN 85
C V C + LDL I TL+ + L L L +N
Sbjct: 9 CSAQDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENI 67
Query: 86 FHGEIPHQI-GRLVRLEALVLANNSFSGKIPTN-LSRCSNLISFNARRNNLVGEIPAELG 143
+ L L L L +N IP + SNL + N +V + +
Sbjct: 68 VS-AVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMF 124
Query: 144 YNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNN-LGNLRNLILLNL 202
+ L++L + DN L I + L +L L L
Sbjct: 125 QDLYNLKSLEVGDNDLV-------------------------YISHRAFSGLNSLEQLTL 159
Query: 203 GENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPE 262
+ + I ++ ++ L + L N ++ L +L ++ + ++
Sbjct: 160 EKCNLTSIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTP 218
Query: 263 SLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCT 322
+ NL L++ + R L L +LNL N + T E + +L
Sbjct: 219 NCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGS------MLHELL 272
Query: 323 ELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNK 382
L I L G Q++ + P R L L L + N+
Sbjct: 273 RLQEIQLV-------------------------GGQLAVVEPYAFRGLNYLRVLNVSGNQ 307
Query: 383 LTGTIPH-AIGELKNLQLLYLDSNFL 407
LT T+ + NL+ L LDSN L
Sbjct: 308 LT-TLEESVFHSVGNLETLILDSNPL 332
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 59/232 (25%), Positives = 100/232 (43%), Gaps = 35/232 (15%)
Query: 685 NMIGQGSFGFVYKGNL---GENGMMVAVKVINLKQKGAS----NGFVAECQALRNIRHRN 737
+IG+G FG VY G +N + A+K ++ + F+ E +R + H N
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLS---RITEMQQVEAFLREGLLMRGLNHPN 83
Query: 738 LIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVA 797
++ +I I +G+ ++ YM +G L ++ + R+ T+ I+ + VA
Sbjct: 84 VLALIGIML--PPEGLPH--VLLPYMCHGDLLQFI-----RSPQRNPTVKDLISFGLQVA 134
Query: 798 SAIEYI-HHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSK 856
+EY+ VH DL N +LD+ + DFGLA+ + LD + +
Sbjct: 135 RGMEYLAEQKF----VHRDLAARNCMLDESFTVKVADFGLARDI----LDREYYSVQQHR 186
Query: 857 GIKGTVGYIAPE---YGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFNQ 904
+ V + A E S DV+SFG+LL E+ TR P +
Sbjct: 187 HARLPVKWTALESLQTYRFTTKS---DVWSFGVLLWELLTRGAPPYRHIDPF 235
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 57/224 (25%), Positives = 98/224 (43%), Gaps = 33/224 (14%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNG--FVAECQALRNIRHRNLIKIITI 744
IG G FG V+ G N VA+K I +GA + F+ E + + + H L+++ +
Sbjct: 16 IGSGQFGLVHLGYW-LNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 745 CSSID--FKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEY 802
C +V E+M++G L D+L + + +DV + Y
Sbjct: 72 CLEQAPIC-------LVTEFMEHGCLSDYLRTQRGL-----FAAETLLGMCLDVCEGMAY 119
Query: 803 I-HHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGT 861
+ +H DL N L+ ++ V + DFG+ +F+ + +SS G K
Sbjct: 120 LEEACV----IHRDLAARNCLVGENQVIKVSDFGMTRFVLD-------DQYTSSTGTKFP 168
Query: 862 VGYIAPEYGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFNQ 904
V + +PE S DV+SFG+L+ E+F+ + P + N
Sbjct: 169 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS 212
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 56/236 (23%), Positives = 104/236 (44%), Gaps = 34/236 (14%)
Query: 685 NMIGQGSFGFVYKGNL---GENGMMVAVKVINLKQKGAS----NGFVAECQALRNIRHRN 737
M+G+G FG V + L + + VAVK+ LK + F+ E ++ H +
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKM--LKADIIASSDIEEFLREAACMKEFDHPH 86
Query: 738 LIKIITICSSIDFKGVDFQA-IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDV 796
+ K++ + KG ++ +M++G L +L S + +L L + ++D+
Sbjct: 87 VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146
Query: 797 ASAIEYI-HHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSS 855
A +EY+ + +H DL N +L +D+ + DFGL++ + S D +
Sbjct: 147 ACGMEYLSSRNF----IHRDLAARNCMLAEDMTVCVADFGLSRKIYSG--DYYRQG---C 197
Query: 856 KG---IKGTVGYIAPE---YGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFNQ 904
+K A E + S DV++FG+ + E+ TR + P G+ N
Sbjct: 198 ASKLPVKWL----ALESLADNLYTVHS---DVWAFGVTMWEIMTRGQTPYAGIENA 246
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-32
Identities = 67/219 (30%), Positives = 110/219 (50%), Gaps = 23/219 (10%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICS 746
+GQG FG V+ G VA+K + + F+ E Q ++ +RH L+++ + S
Sbjct: 275 LGQGCFGEVWMGTWNGTTR-VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 747 SIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHH 806
+ IV EYM GSL D+L + L L Q +++ +AS + Y+
Sbjct: 333 E------EPIYIVTEYMSKGSLLDFLKGETGK----YLRLPQLVDMAAQIASGMAYVERM 382
Query: 807 CQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIA 866
VH DL+ +N+L+ ++LV + DFGLA+ + ++ +G K + + A
Sbjct: 383 N---YVHRDLRAANILVGENLVCKVADFGLARLIED-------NEYTARQGAKFPIKWTA 432
Query: 867 PEYGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFNQ 904
PE + G ++ DV+SFGILL E+ T+ R P GM N+
Sbjct: 433 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 471
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 56/227 (24%), Positives = 102/227 (44%), Gaps = 39/227 (17%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNG--FVAECQALRNIRHRNLIKIITI 744
+G G FG V G VA+K+I +G+ + F+ E + + N+ H L+++ +
Sbjct: 32 LGTGQFGVVKYGKWRGQ-YDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 745 CSSID--FKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEY 802
C+ F I+ EYM NG L ++L + + Q + + DV A+EY
Sbjct: 88 CTKQRPIF-------IITEYMANGCLLNYLREMRHR-----FQTQQLLEMCKDVCEAMEY 135
Query: 803 I-HHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKG---I 858
+ +H DL N L++ V + DFGL++++ E SS +
Sbjct: 136 LESKQF----LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD------EYTSSVGSKFPV 185
Query: 859 KGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFNQ 904
+ + PE M + S D+++FG+L+ E+++ + P + N
Sbjct: 186 RWS----PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS 228
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-32
Identities = 61/279 (21%), Positives = 105/279 (37%), Gaps = 40/279 (14%)
Query: 648 RRRRSAHKSSVSQLMDQQFPMISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMV 707
+ RR + + S+ + S E S F + +G GS+G V+K E+G +
Sbjct: 27 QPRRVSFRGEASETLQSPGYDPSRPE-SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLY 85
Query: 708 AVKVINLKQKGASN--GFVAECQALRNI-RHRNLIKIITICSSIDFKGVDFQA----IVY 760
AVK +G + +AE + + +H ++ + + +
Sbjct: 86 AVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVR---------LEQAWEEGGILYLQT 136
Query: 761 EYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSN 820
E SL+ + SL Q + D A+ ++H +VH D+KP+N
Sbjct: 137 ELCG-PSLQQHC-----EAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPAN 187
Query: 821 VLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGD 880
+ L LGDFGL L T + + +G Y+APE G D
Sbjct: 188 IFLGPRGRCKLGDFGLLVELG---------TAGAGEVQEGDPRYMAPELLQGS-YGTAAD 237
Query: 881 VYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDK 919
V+S G+ +LE+ + G + + LP +
Sbjct: 238 VFSLGLTILEVACNMEL----PHGGEGWQQLRQGYLPPE 272
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-32
Identities = 53/238 (22%), Positives = 101/238 (42%), Gaps = 30/238 (12%)
Query: 670 SYAELSKATNDFSSSNM--------IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGAS- 720
+ + T + +M IG+GSFG E+G +K IN+ + +
Sbjct: 7 HSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKE 66
Query: 721 -NGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQ 779
E L N++H N+++ F+ IV +Y + G L ++ Q
Sbjct: 67 REESRREVAVLANMKHPNIVQYRE-----SFEENGSLYIVMDYCEGGDLFKRINA----Q 117
Query: 780 EARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKF 839
+ Q ++ + + A++++H ++H D+K N+ L +D LGDFG+A+
Sbjct: 118 KGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARV 174
Query: 840 LSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897
L+S T ++ GT Y++PE + D+++ G +L E+ T +
Sbjct: 175 LNS--------TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-32
Identities = 60/245 (24%), Positives = 100/245 (40%), Gaps = 36/245 (14%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGAS--NGFVAECQALRNIRHR 736
+S IG G V++ L E + A+K +NL++ + + E L ++
Sbjct: 9 RIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67
Query: 737 NLIKIITICSSID-FKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIID 795
+ KII + D + +V E N L WL ++ +S+ +R + +
Sbjct: 68 S-DKIIRL---YDYEITDQYIYMVMEC-GNIDLNSWL------KKKKSIDPWERKSYWKN 116
Query: 796 VASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSS 855
+ A+ IH H +VH DLKP+N L+ ++ L DFG+A + ++
Sbjct: 117 MLEAVHTIHQHG---IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDS---- 168
Query: 856 KGIKGTVGYIAPE------YGMGGEASMTG-----DVYSFGILLLEMFTRRRPTDGMFNQ 904
GTV Y+ PE S + DV+S G +L M + P + NQ
Sbjct: 169 --QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 226
Query: 905 GLTLH 909
LH
Sbjct: 227 ISKLH 231
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 61/232 (26%), Positives = 102/232 (43%), Gaps = 35/232 (15%)
Query: 685 NMIGQGSFGFVYKGNL---GENGMMVAVKVINLKQKGASNG----FVAECQALRNIRHRN 737
+IG+G FG VY G L + AVK +N + G F+ E +++ H N
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN---RITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 738 LIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVA 797
++ ++ IC + + +V YM++G L +++ + E + T+ I + VA
Sbjct: 88 VLSLLGICLRSEGSPL----VVLPYMKHGDLRNFI-----RNETHNPTVKDLIGFGLQVA 138
Query: 798 SAIEYIH-HHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSK 856
++Y+ VH DL N +LD+ + DFGLA+ + D + +
Sbjct: 139 KGMKYLASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDM----YDKEYYSVHNKT 190
Query: 857 GIKGTVGYIAPE---YGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFNQ 904
G K V ++A E S DV+SFG+LL E+ TR P +
Sbjct: 191 GAKLPVKWMALESLQTQKFTTKS---DVWSFGVLLWELMTRGAPPYPDVNTF 239
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-32
Identities = 64/270 (23%), Positives = 108/270 (40%), Gaps = 36/270 (13%)
Query: 654 HKSSVSQLMDQQFPMISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVIN 713
H S +D + + +S +S IG G V++ L E + A+K +N
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVN 61
Query: 714 LKQ--KGASNGFVAECQALRNIRHRNLIKIITICSSID-FKGVDFQAIVYEYMQNGSLED 770
L++ + + E L ++ + KII + D + +V E N L
Sbjct: 62 LEEADNQTLDSYRNEIAYLNKLQQHS-DKIIRL---YDYEITDQYIYMVMECG-NIDLNS 116
Query: 771 WLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAH 830
WL ++ +S+ +R + ++ A+ IH H +VH DLKP+N L+ ++
Sbjct: 117 WL------KKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGML-K 166
Query: 831 LGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPE------YGMGGEASMTG----- 879
L DFG+A + ++ GTV Y+ PE S +
Sbjct: 167 LIDFGIANQMQPDTTSVVKDS------QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKS 220
Query: 880 DVYSFGILLLEMFTRRRPTDGMFNQGLTLH 909
DV+S G +L M + P + NQ LH
Sbjct: 221 DVWSLGCILYYMTYGKTPFQQIINQISKLH 250
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-32
Identities = 53/230 (23%), Positives = 93/230 (40%), Gaps = 38/230 (16%)
Query: 687 IGQGSFGFVYKGNL---GENGMM-VAVKVINLKQKGASNG---FVAECQALRNIRHRNLI 739
+G G FG V+KG GE+ + V +KV ++ K A+ ++ H +++
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKV--IEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 740 KIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASA 799
+++ +C +V +Y+ GSL D + Q L +N + +A
Sbjct: 79 RLLGLCPG------SSLQLVTQYLPLGSLLDHVRQHRGA-----LGPQLLLNWGVQIAKG 127
Query: 800 IEYIH-HHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGI 858
+ Y+ H VH +L NVLL + DFG+A L +
Sbjct: 128 MYYLEEHGM----VHRNLAARNVLLKSPSQVQVADFGVADLLPPD------DKQLLYSEA 177
Query: 859 KGTVGYIAPE---YGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFNQ 904
K + ++A E +G S DV+S+G+ + E+ T P G+
Sbjct: 178 KTPIKWMALESIHFGKYTHQS---DVWSYGVTVWELMTFGAEPYAGLRLA 224
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-32
Identities = 62/277 (22%), Positives = 107/277 (38%), Gaps = 36/277 (12%)
Query: 648 RRRRSAHKSSVSQLMDQQFPMISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMV 707
R+ + D + + +S +S IG G V++ L E +
Sbjct: 25 FERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQV-LNEKKQIY 83
Query: 708 AVKVINLKQKGAS--NGFVAECQALRNIRHRNLIKIITICSSID-FKGVDFQAIVYEYMQ 764
A+K +NL++ + + E L ++ + KII + D + +V E
Sbjct: 84 AIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKIIRL---YDYEITDQYIYMVMEC-G 138
Query: 765 NGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLD 824
N L WL ++ +S+ +R + ++ A+ IH H +VH DLKP+N L+
Sbjct: 139 NIDLNSWL------KKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV 189
Query: 825 QDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPE------YGMGGEASMT 878
++ L DFG+A + ++ G V Y+ PE S +
Sbjct: 190 DGML-KLIDFGIANQMQPDTTSVVKDS------QVGAVNYMPPEAIKDMSSSRENGKSKS 242
Query: 879 G-----DVYSFGILLLEMFTRRRPTDGMFNQGLTLHE 910
DV+S G +L M + P + NQ LH
Sbjct: 243 KISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 279
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 6e-32
Identities = 59/244 (24%), Positives = 101/244 (41%), Gaps = 34/244 (13%)
Query: 675 SKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASN--GFVAECQALRN 732
++ + +G G FG+V + + G VA+K ++ N + E Q ++
Sbjct: 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCR-QELSPKNRERWCLEIQIMKK 68
Query: 733 IRHRNLIKII-TICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQ-----QEARSLTL 786
+ H N++ D + EY + G L +L+Q E+ R+
Sbjct: 69 LNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT--- 125
Query: 787 IQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLD---QDLVAHLGDFGLAKFLSS- 842
++ D++SA+ Y+H + ++H DLKP N++L Q L+ + D G AK L
Sbjct: 126 -----LLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG 177
Query: 843 SPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMF 902
V GT+ Y+APE + ++T D +SFG L E T RP +
Sbjct: 178 ELCTEFV----------GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW 227
Query: 903 NQGL 906
Sbjct: 228 QPVQ 231
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-32
Identities = 58/225 (25%), Positives = 98/225 (43%), Gaps = 27/225 (12%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINL------KQKGASNGFVAECQALRN 732
+F IG+G F VY+ +G+ VA+K + + K + + E L+
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADC---IKEIDLLKQ 88
Query: 733 IRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINI 792
+ H N +I +S F + IV E G L + +++ R +
Sbjct: 89 LNHPN---VIKYYAS--FIEDNELNIVLELADAGDLSRMI--KHFKKQKRLIPERTVWKY 141
Query: 793 IIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETP 852
+ + SA+E++H V+H D+KP+NV + V LGD GL +F SS
Sbjct: 142 FVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS--------KT 190
Query: 853 SSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897
+++ + GT Y++PE + D++S G LL EM + P
Sbjct: 191 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-32
Identities = 49/244 (20%), Positives = 94/244 (38%), Gaps = 47/244 (19%)
Query: 675 SKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ-KGASNGFVAECQALRNI 733
S + + + S+++GQG+ V++G + G + A+KV N + + E + L+ +
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 734 RHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQ-------SEDQQEARSLTL 786
H+N++K+ I + + ++ E+ GSL L + E E
Sbjct: 65 NHKNIVKLFAI---EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES--EFL---- 115
Query: 787 IQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLL----DQDLVAHLGDFGLAKFLS- 841
++ DV + ++ + +VH ++KP N++ D V L DFG A+ L
Sbjct: 116 ----IVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168
Query: 842 SSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTG--------DVYSFGILLLEMFT 893
+ GT Y+ P+ D++S G+ T
Sbjct: 169 DEQFVSLY----------GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
Query: 894 RRRP 897
P
Sbjct: 219 GSLP 222
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 8e-32
Identities = 58/220 (26%), Positives = 91/220 (41%), Gaps = 38/220 (17%)
Query: 687 IGQGSFGFVYKGNL----GENGMMVAVKVINLKQKG--ASNGFVAECQALRNIRHRNLIK 740
+G+G+FG V G +VAVK L+ G F E Q L+ + ++K
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQ--LQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 741 IITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAI 800
+ + + +V EY+ +G L D+L + + L + + + +
Sbjct: 89 YRGVSYGPGRQSL---RLVMEYLPSGCLRDFLQRHRAR-----LDASRLLLYSSQICKGM 140
Query: 801 EYIH-HHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKG-- 857
EY+ C VH DL N+L++ + + DFGLAK L D V G
Sbjct: 141 EYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDK-DYYV---VREPGQS 192
Query: 858 -IKGTVGYIAPE---YGMGGEASMTGDVYSFGILLLEMFT 893
I APE + S DV+SFG++L E+FT
Sbjct: 193 PIFWY----APESLSDNIFSRQS---DVWSFGVVLYELFT 225
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 8e-32
Identities = 54/238 (22%), Positives = 104/238 (43%), Gaps = 38/238 (15%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNL----GENGMMVAVKVINLK---QKGASNGFVAECQALR 731
+F ++G G+FG VYKG + + VA+K L+ A+ + E +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPKANKEILDEAYVMA 72
Query: 732 NIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRIN 791
++ + ++ +++ IC + ++ + M G L D++ + +D + +N
Sbjct: 73 SVDNPHVCRLLGICLT------STVQLITQLMPFGCLLDYVREHKDN-----IGSQYLLN 121
Query: 792 IIIDVASAIEYI-HHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVE 850
+ +A + Y+ VH DL NVL+ + DFGLAK L + E
Sbjct: 122 WCVQIAKGMNYLEDRRL----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE------E 171
Query: 851 TPSSSKGIKGTVGYIAPE---YGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFNQ 904
++G K + ++A E + + S DV+S+G+ + E+ T +P DG+
Sbjct: 172 KEYHAEGGKVPIKWMALESILHRIYTHQS---DVWSYGVTVWELMTFGSKPYDGIPAS 226
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 59/256 (23%), Positives = 102/256 (39%), Gaps = 38/256 (14%)
Query: 687 IGQGSFGFVYKGNL----GENGMMVAVKVINLKQ---KGASNGFVAECQALRNIRHRNLI 739
+G+G FG V G VAVK LK E + LRN+ H N++
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKS--LKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 740 KIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASA 799
K IC+ G+ ++ E++ +GSL+++L +++++ + L Q++ + +
Sbjct: 87 KYKGICTEDGGNGI---KLIMEFLPSGSLKEYLPKNKNK-----INLKQQLKYAVQICKG 138
Query: 800 IEYIH-HHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGI 858
++Y+ VH DL NVL++ + +GDFGL K + + + +
Sbjct: 139 MDYLGSRQY----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDK-EYYTVKDDRDSPV 193
Query: 859 KGTVGYIAPE---YGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915
APE AS DV+SFG+ L E+ T +
Sbjct: 194 FWY----APECLMQSKFYIAS---DVWSFGVTLHELLTY-----CDSDSSPMALFLKMIG 241
Query: 916 LPDKVMEIVDSVLLLE 931
M + V L+
Sbjct: 242 PTHGQMTVTRLVNTLK 257
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-31
Identities = 58/235 (24%), Positives = 99/235 (42%), Gaps = 41/235 (17%)
Query: 685 NMIGQGSFGFVYKGNL---GENGMMVAVKVINLKQKGASNG----FVAECQALRNIRHRN 737
+IG+G FG VY G L + AVK +N + G F+ E +++ H N
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN---RITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 738 LIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVA 797
++ ++ IC + + +V YM++G L +++ + E + T+ I + VA
Sbjct: 152 VLSLLGICLRSEGSPL----VVLPYMKHGDLRNFI-----RNETHNPTVKDLIGFGLQVA 202
Query: 798 SAIEYI-HHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSK 856
++++ VH DL N +LD+ + DFGLA+ + D+ +
Sbjct: 203 KGMKFLASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK---TG 255
Query: 857 G---IKGTVGYIAPE---YGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFNQ 904
+K A E S DV+SFG+LL E+ TR P +
Sbjct: 256 AKLPVKWM----ALESLQTQKFTTKS---DVWSFGVLLWELMTRGAPPYPDVNTF 303
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 32/217 (14%)
Query: 687 IGQGSFGFVYKGNL----GENGMMVAVKVINLKQKGASNG--FVAECQALRNIRHRNLIK 740
+G+G+FG V G +VAVK L+ + F E + L++++H N++K
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKK--LQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 741 IITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAI 800
+C S + + ++ EY+ GSL D+L + +++ + I+ + + +
Sbjct: 76 YKGVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQICKGM 127
Query: 801 EYIH-HHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIK 859
EY+ +H DL N+L++ + +GDFGL K L V+ P S I
Sbjct: 128 EYLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESP-IF 182
Query: 860 GTVGYIAPE---YGMGGEASMTGDVYSFGILLLEMFT 893
APE AS DV+SFG++L E+FT
Sbjct: 183 WY----APESLTESKFSVAS---DVWSFGVVLYELFT 212
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 56/276 (20%), Positives = 101/276 (36%), Gaps = 63/276 (22%)
Query: 675 SKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVA-ECQALRNI 733
S+ DF +G+G FG V++ + A+K I L + + V E +AL +
Sbjct: 2 SRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL 61
Query: 734 RHRNLIKIITICSSIDFKGVDFQA------------------------------------ 757
H +++ + +
Sbjct: 62 EHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTK 121
Query: 758 ----------------IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIE 801
I + + +L+DW+++ ++ + +I I +A A+E
Sbjct: 122 NTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCL---HIFIQIAEAVE 178
Query: 802 YIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIK-- 859
++H ++H DLKPSN+ D V +GDFGL + + V TP +
Sbjct: 179 FLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTG 235
Query: 860 --GTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT 893
GT Y++PE G S D++S G++L E+
Sbjct: 236 QVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY 271
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-31
Identities = 68/427 (15%), Positives = 138/427 (32%), Gaps = 55/427 (12%)
Query: 173 LERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFN 232
+ + L L L+ + + + I ++ L + +N
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNNIT 77
Query: 233 GSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLK 292
+L L L N ++ ++ + L L N+ +
Sbjct: 78 -TLDL---SQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT---KLDVSQNP 127
Query: 293 NLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDI 352
L +LN N L ++D +++ T+LT + N+ L + + +T +
Sbjct: 128 LLTYLNCARNTL-----TEID----VSHNTQLTELDCHLNKKITKLD--VTPQTQ-LTTL 175
Query: 353 VIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIP 412
+ N+I+ + + L L D N +T + + + L L SN L
Sbjct: 176 DCSFNKITELD---VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKL----- 224
Query: 413 TSL--GNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLS 470
T + LT LT S N L + S L LH +L + ++ +
Sbjct: 225 TEIDVTPLTQLTYFDCSVNPLT-ELDVS--TLSKLTTLHCIQTDLL------EIDLTHNT 275
Query: 471 LSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSG 530
+ L+V + L + + E+ LS L LYL +
Sbjct: 276 QLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT- 331
Query: 531 SIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNKT 590
+ +S +K L + ++ + + L + +P + + +N
Sbjct: 332 ELD--VSHNTKLKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQTI-TMPKETLTNNSL 386
Query: 591 GISLSGN 597
I++S +
Sbjct: 387 TIAVSPD 393
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 9e-29
Identities = 72/407 (17%), Positives = 142/407 (34%), Gaps = 56/407 (13%)
Query: 193 NLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVA 252
N + + I S +++L ++ + + G+ L ++
Sbjct: 19 NFASEVAAAFEMQATDTI---SEEQLATLTSLDCHNSSIT-DMT---GIEKLTGLTKLIC 71
Query: 253 ENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDL 312
+N ++ LS +NL L N+ ++ L L +LN +N L L
Sbjct: 72 TSNNITTLD--LSQNTNLTYLACDSNKLT---NLDVTPLTKLTYLNCDTNKL-----TKL 121
Query: 313 DFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVN 372
D + LT + N + +++ + +T++ N+ + +
Sbjct: 122 DV----SQNPLLTYLNCARNTLTEI---DVSHNTQ-LTELDCHLNKKITKLD--VTPQTQ 171
Query: 373 LVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQ 432
L L NK+T + + + K L L D+N + L LT L SSN L
Sbjct: 172 LTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNITK---LDLNQNIQLTFLDCSSNKLT 225
Query: 433 GSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLS--LSLDLSYNLLSGTLPLEVGN 490
I + L + LT L +STLS +L L +++ +
Sbjct: 226 -EID--VTPLTQLTYFDCSVNPLT------ELDVSTLSKLTTLHCIQTDLLE---IDLTH 273
Query: 491 LKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSN 550
L+YF R E+ ++ T L L Q + + LS + L +++
Sbjct: 274 NTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNT 328
Query: 551 NLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNKTGISLSGN 597
L+ ++ + + + L+ L+ H + + + G +
Sbjct: 329 ELT-ELD--VSHNTKLKSLSCVNAHIQ-DFSSVGKIPALNNNFEAEG 371
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-28
Identities = 62/474 (13%), Positives = 128/474 (27%), Gaps = 99/474 (20%)
Query: 100 LEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHL 159
+ V A + + + L S + +++ ++ + L L N++
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKL-TGLTKLICTSNNI 76
Query: 160 TGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNIS 219
T + + L + N L + + L L LN N+ + + +
Sbjct: 77 TT---LDLSQNTNLTYLACDSNKL-TNLD--VTPLTKLTYLNCDTNKLTKL---DVSQNP 127
Query: 220 SLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQ 279
L + N +D+ +L N + ++ + L L N+
Sbjct: 128 LLTYLNCARNTLT---EIDVS-HNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNK 181
Query: 280 FRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLP 339
+ K L LN +NN+ LD +LT +
Sbjct: 182 IT---ELDVSQNKLLNRLNCDTNNI-----TKLDL----NQNIQLTFLDCSS-------- 221
Query: 340 HSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQL 399
N+++ I + L L N LT + + L L
Sbjct: 222 -----------------NKLTEI---DVTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTT 258
Query: 400 LYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGAL 459
L+ L + + + + + + L
Sbjct: 259 LHCIQTDL-----LEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYL------------ 301
Query: 460 PPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQ 519
LD ++ L++ LVY ++ + E+ +S T L+
Sbjct: 302 -------------LDCQAAGIT---ELDLSQNPKLVYLYLNNTELT-ELD--VSHNTKLK 342
Query: 520 QLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSY 573
L S+ + ++ + E L N S ++
Sbjct: 343 SLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDL 394
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-26
Identities = 81/488 (16%), Positives = 161/488 (32%), Gaps = 58/488 (11%)
Query: 54 KLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGK 113
+ + T + L+ L L+ +++ ++ I +L L L+ +N+ +
Sbjct: 22 SEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNNITT- 78
Query: 114 IPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTL 173
+LS+ +NL N L + KL L N LT + L
Sbjct: 79 --LDLSQNTNLTYLACDSNKLT-NLDVT---PLTKLTYLNCDTNKLT---KLDVSQNPLL 129
Query: 174 ERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNG 233
+N N L ++ + L L+ N+ I + + L + N+
Sbjct: 130 TYLNCARNTL---TEIDVSHNTQLTELDCHLNKK--ITKLDVTPQTQLTTLDCSFNKIT- 183
Query: 234 SLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKN 293
++ VS KLL + + N + L+ L L N+ I L
Sbjct: 184 ----ELDVSQNKLLNRLNCDTNNITKLD--LNQNIQLTFLDCSSNKLT---EIDVTPLTQ 234
Query: 294 LEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIV 353
L + + N L +LD + ++LT + + +L+ I
Sbjct: 235 LTYFDCSVNPL-----TELDV----STLSKLTTLHCIQTDLLEI------DLTHNTQLIY 279
Query: 354 IAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPT 413
I + + L L +T + + + L LYL++ L T
Sbjct: 280 FQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTEL-----T 331
Query: 414 SL--GNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSL 471
L + T L +L+ + +Q +G L A+ + +P + L+ ++L++
Sbjct: 332 ELDVSHNTKLKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQTI-TMPKETLTNNSLTI 388
Query: 472 SLDLSYNLLSG---TLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSF 528
++ G + G + + I+ S + P TS + +
Sbjct: 389 AVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNPAVTYTFTSENGAIVGTVTT 448
Query: 529 SGSIPSSL 536
P +
Sbjct: 449 PFEAPQPI 456
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 4e-25
Identities = 75/472 (15%), Positives = 149/472 (31%), Gaps = 68/472 (14%)
Query: 50 QRVTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNS 109
+T LD N +I T + L+ L L NN + + + L L +N
Sbjct: 42 ATLTSLDCHNSSI--TDMTGIEKLTGLTKLICTSNNI-TTLD--LSQNTNLTYLACDSNK 96
Query: 110 FSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGN 169
+ +++ + L N N L ++ L L A N LT + +
Sbjct: 97 LTN---LDVTPLTKLTYLNCDTNKLTKLDVSQN----PLLTYLNCARNTLTEI---DVSH 146
Query: 170 LSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTN 229
+ L ++ N ++ L L+ N+ + + + L + TN
Sbjct: 147 NTQLTELDCHLNKK--ITKLDVTPQTQLTTLDCSFNKITEL---DVSQNKLLNRLNCDTN 201
Query: 230 RFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFR 289
L L+ +L + N I ++ + L N +
Sbjct: 202 NIT-KLDLN---QNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT---ELDVS 251
Query: 290 SLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTM 349
+L L L+ +L ++D LT+ T+L + R L + + + +
Sbjct: 252 TLSKLTTLHCIQTDL-----LEID----LTHNTQLIYFQAEGCRKIKELD--VTHNTQ-L 299
Query: 350 TDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAG 409
+ I+ + + LV L +++ +LT + + L+ L + +
Sbjct: 300 YLLDCQAAGITELD---LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ- 352
Query: 410 GIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSIS-- 467
S+G + L N + ++P + LT A+ P +L
Sbjct: 353 DFS-SVGKIPALNNNFEAEGQTI-TMPKETLTNNS----------LTIAVSPDLLDQFGN 400
Query: 468 --TLSLSLDLSYNLLSGTLPLEVGNLKNLVY---FNISVNRFSGEIPVTLSA 514
+ Y+ + T+ E + N F G + A
Sbjct: 401 PMNIEPGDGGVYDQATNTITWENLSTDNPAVTYTFTSENGAIVGTVTTPFEA 452
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-22
Identities = 61/310 (19%), Positives = 104/310 (33%), Gaps = 60/310 (19%)
Query: 268 SNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAI 327
N + + +I L L L+ ++++ D+ + LT T+L
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSI-----TDMTGIEKLTGLTKL--- 69
Query: 328 GLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTI 387
+ N I+ + + NL L D NKLT +
Sbjct: 70 ----------------ICT---------SNNITTLD---LSQNTNLTYLACDSNKLT-NL 100
Query: 388 PHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIE 447
+ L L L D+N L + LLT L + N L I + + L E
Sbjct: 101 D--VTPLTKLTYLNCDTNKLT---KLDVSQNPLLTYLNCARNTLT-EID--VSHNTQLTE 152
Query: 448 LHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGE 507
L + + + L+ +LD S+N ++ L+V K L N N +
Sbjct: 153 LDCHLNKKIT--KLDVTPQTQLT-TLDCSFNKITE---LDVSQNKLLNRLNCDTNNITK- 205
Query: 508 IPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLE 567
+ L+ L L N + I ++ L + D S N L+ ++ + LS L
Sbjct: 206 --LDLNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELD--VSTLSKLT 257
Query: 568 YLNLSYNHFE 577
L+
Sbjct: 258 TLHCIQTDLL 267
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 28/215 (13%)
Query: 687 IGQGSFGFVYKGNL----GENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKII 742
+G+G+FG V G +VAVK + + F E + L++++H N++K
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 743 TICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEY 802
+C S + + ++ EY+ GSL D+L + +++ + I+ + + +EY
Sbjct: 109 GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQICKGMEY 160
Query: 803 IH-HHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGT 861
+ +H DL N+L++ + +GDFGL K L V+ P S I
Sbjct: 161 LGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP-IFWY 215
Query: 862 VGYIAPE---YGMGGEASMTGDVYSFGILLLEMFT 893
APE AS DV+SFG++L E+FT
Sbjct: 216 ----APESLTESKFSVAS---DVWSFGVVLYELFT 243
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-31
Identities = 70/258 (27%), Positives = 100/258 (38%), Gaps = 44/258 (17%)
Query: 687 IGQGSFGFVYKG---NLGEN-GMMVAVKVINLK---QKGASNGFVAECQALRNIRHRNLI 739
+G+G FG V + G MVAVK LK +G+ E LR + H ++I
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKA--LKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 740 KIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASA 799
K C + +V EY+ GSL D+L + S+ L Q + +
Sbjct: 97 KYKGCCEDAGAASL---QLVMEYVPLGSLRDYLPR-------HSIGLAQLLLFAQQICEG 146
Query: 800 IEYIH-HHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKG- 857
+ Y+H H +H DL NVLLD D + +GDFGLAK + P
Sbjct: 147 MAYLHAQHY----IHRDLAARNVLLDNDRLVKIGDFGLAKAV---PEGHEYYRVREDGDS 199
Query: 858 -IKGTVGYIAPE---YGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913
+ APE AS DV+SFG+ L E+ T +Q
Sbjct: 200 PVFWY----APECLKEYKFYYAS---DVWSFGVTLYELLTH-----CDSSQSPPTKFLEL 247
Query: 914 TALPDKVMEIVDSVLLLE 931
+ M ++ LLE
Sbjct: 248 IGIAQGQMTVLRLTELLE 265
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 6e-31
Identities = 57/228 (25%), Positives = 94/228 (41%), Gaps = 36/228 (15%)
Query: 687 IGQGSFGFVYKGNL---GENGMMVAVKVINLKQKGASNG----FVAECQALRNIRHRNLI 739
IG+G FG V++G M VA+K K S+ F+ E +R H +++
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKT--CKN-CTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 740 KIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASA 799
K+I + + + I+ E G L +L + L L I +++A
Sbjct: 455 KLIGVITE------NPVWIIMELCTLGELRSFLQVRKFS-----LDLASLILYAYQLSTA 503
Query: 800 IEYIH-HHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKG- 857
+ Y+ VH D+ NVL+ + LGDFGL++++ D+ S K
Sbjct: 504 LAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYME----DSTYYKASKGKLP 555
Query: 858 IKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFNQ 904
IK APE + DV+ FG+ + E+ +P G+ N
Sbjct: 556 IKWM----APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 599
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 8e-31
Identities = 50/237 (21%), Positives = 98/237 (41%), Gaps = 33/237 (13%)
Query: 675 SKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVIN-LKQKGASNGFVAECQALRNI 733
S + + + S+++GQG+ V++G + G + A+KV N + + + E + L+ +
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 734 RHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINII 793
H+N++K+ I + + ++ E+ GSL L E+ A L + + ++
Sbjct: 65 NHKNIVKLFAI---EEETTTRHKVLIMEFCPCGSLYTVL---EEPSNAYGLPESEFLIVL 118
Query: 794 IDVASAIEYIHHHCQPPVVHGDLKPSNVLL----DQDLVAHLGDFGLAKFL-SSSPLDTA 848
DV + ++ + +VH ++KP N++ D V L DFG A+ L +
Sbjct: 119 RDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL 175
Query: 849 VETPSSSKGIKGTVGYIAPEYGMGGEASMTG--------DVYSFGILLLEMFTRRRP 897
GT Y+ P+ D++S G+ T P
Sbjct: 176 Y----------GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 9e-31
Identities = 50/228 (21%), Positives = 97/228 (42%), Gaps = 35/228 (15%)
Query: 687 IGQGSFGFVYKGNL-GENGMM-VAVKVINLK---QKGASNGFVAECQALRNIRHRNLIKI 741
+G G+FG V +G + VA+KV LK +K + + E Q + + + ++++
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKV--LKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401
Query: 742 ITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIE 801
I +C + + +V E G L +L ++ + + ++ V+ ++
Sbjct: 402 IGVCQA------EALMLVMEMAGGGPLHKFLVGKREE-----IPVSNVAELLHQVSMGMK 450
Query: 802 YI-HHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKG 860
Y+ + VH +L NVLL A + DFGL+K L + ++ K
Sbjct: 451 YLEEKNF----VHRNLAARNVLLVNRHYAKISDFGLSKALGADD-----SYYTARSAGKW 501
Query: 861 TVGYIAPE---YGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFNQ 904
+ + APE + S DV+S+G+ + E + ++P M
Sbjct: 502 PLKWYAPECINFRKFSSRS---DVWSYGVTMWEALSYGQKPYKKMKGP 546
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-30
Identities = 56/221 (25%), Positives = 93/221 (42%), Gaps = 32/221 (14%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNG-----FVAECQALRNIRHRNLIKI 741
+G G VY + VA+K + F E + H+N++ +
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKA--IFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 742 ITICSSIDFKGVD--FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASA 799
I D + +V EY++ +L +++ L++ IN +
Sbjct: 77 I------DV-DEEDDCYYLVMEYIEGPTLSEYIE------SHGPLSVDTAINFTNQILDG 123
Query: 800 IEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIK 859
I++ H +VH D+KP N+L+D + + DFG+AK LS + L T ++ +
Sbjct: 124 IKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-----TQTNH--VL 173
Query: 860 GTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDG 900
GTV Y +PE G D+YS GI+L EM P +G
Sbjct: 174 GTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNG 214
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 57/256 (22%), Positives = 92/256 (35%), Gaps = 31/256 (12%)
Query: 647 ARRRRSAHKSSVSQLMDQQFPMISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMM 706
+R ++ + E + + + +G+GSFG V++ + G
Sbjct: 26 KLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQ 85
Query: 707 VAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA----IVYEY 762
AVK + L+ E A + ++ G + I E
Sbjct: 86 CAVKKVRLEVFRVE-----ELVACAGLSSPRIVP---------LYGAVREGPWVNIFMEL 131
Query: 763 MQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVL 822
++ GSL + Q E + +EY+H ++HGD+K NVL
Sbjct: 132 LEGGSLGQLIKQMGCLPE----DRAL--YYLGQALEGLEYLHTRR---ILHGDVKADNVL 182
Query: 823 LDQD-LVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDV 881
L D A L DFG A L L ++ T I GT ++APE MG D+
Sbjct: 183 LSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY---IPGTETHMAPEVVMGKPCDAKVDI 239
Query: 882 YSFGILLLEMFTRRRP 897
+S ++L M P
Sbjct: 240 WSSCCMMLHMLNGCHP 255
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 2e-30
Identities = 87/511 (17%), Positives = 170/511 (33%), Gaps = 48/511 (9%)
Query: 79 LNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEI 138
++ + N +P + + + L ++ N S +++ S L N + +
Sbjct: 5 VDRSKNGLI-HVPKDLSQ--KTTILNISQNYISELWTSDILSLSKLRILIISHNRI-QYL 60
Query: 139 PAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNN--LGNLRN 196
+ +LE L ++ N L S L+ +++ N + +P GN+
Sbjct: 61 DISVFKFNQELEYLDLSHNKLVK---ISCHPTVNLKHLDLSFN-AFDALPICKEFGNMSQ 116
Query: 197 LILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKL-LGFIVAENN 255
L L L I +++ + + + + + L + N
Sbjct: 117 LKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNK 176
Query: 256 FAGSIPESLSNASNLVELT-----LFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEAN 310
I + +EL+ L DN+ +SI + N + NL NN+ T N
Sbjct: 177 EFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIET-TWN 235
Query: 311 DLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIV----IAGNQISGIIPTG 366
+ L T + + + + G L + S T + + +
Sbjct: 236 SFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYI 295
Query: 367 IRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLAL 426
N+ + ++ L +N L + + G+LT L L L
Sbjct: 296 YEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLIL 355
Query: 427 SSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPL 486
N L+ + + L LD+S N +S
Sbjct: 356 QMNQLK-ELSKIAEMTTQMKSL----------------------QQLDISQNSVSYDEKK 392
Query: 487 EV-GNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKEL 545
K+L+ N+S N + I L ++ L L N SIP + L++++EL
Sbjct: 393 GDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQEL 449
Query: 546 DMSSNNLSGQIPEYLENLSFLEYLNLSYNHF 576
+++SN L + L+ L+ + L N +
Sbjct: 450 NVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 2e-20
Identities = 59/355 (16%), Positives = 113/355 (31%), Gaps = 33/355 (9%)
Query: 254 NNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLD 313
N + + + S L L + N+ + F+ + LE+L+L N L +
Sbjct: 31 NYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVK-----IS 85
Query: 314 FLTLLTNCTELTAIGLDDNRFGGVLPHS--IANLSSTMTDIVIAGNQISGIIPTGIRNLV 371
L + L N F LP N+S + + ++ + I +L
Sbjct: 86 CHPT----VNLKHLDLSFNAFD-ALPICKEFGNMSQ-LKFLGLSTTHLEKSSVLPIAHLN 139
Query: 372 NLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDL 431
L + L++ L F + ++++ T L +++
Sbjct: 140 ISKVLLVLGETYG--EKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNI 197
Query: 432 QG-----------SIPPSLGNCKNLIELHMADIELTGALPPQIL------SISTLSLS-L 473
+ SI L L L + +IE T +IL ++ S+S +
Sbjct: 198 KCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNV 257
Query: 474 DLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIP 533
L L +LK L + + F +++ +
Sbjct: 258 KLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHM 317
Query: 534 SSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSN 588
S + LD S+N L+ + E +L+ LE L L N + + +
Sbjct: 318 LCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQ 372
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 4e-10
Identities = 34/146 (23%), Positives = 53/146 (36%), Gaps = 4/146 (2%)
Query: 466 ISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQG 525
+S + L++S N +S ++ +L L IS NR L+ L L
Sbjct: 19 LSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSH 78
Query: 526 NSFSGSIPSSLSSLKSIKELDMSSNNL-SGQIPEYLENLSFLEYLNLSYNHFEGEVPTKG 584
N I ++K LD+S N + I + N+S L++L LS H E
Sbjct: 79 NKLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPI 135
Query: 585 VFSNKTGISLSGNGKVCGGLDELNLP 610
N + + L D L
Sbjct: 136 AHLNISKVLLVLGETYGEKEDPEGLQ 161
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 4e-08
Identities = 36/184 (19%), Positives = 74/184 (40%), Gaps = 7/184 (3%)
Query: 52 VTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFS 111
+ + + +S +L+ ++N + G L LE L+L N
Sbjct: 302 MNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK 361
Query: 112 --GKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGN 169
KI ++ +L + +N++ + L +L ++ N LT +
Sbjct: 362 ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL-- 419
Query: 170 LSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIF-NISSLENVFLPT 228
++ +++ N + IP + L L LN+ N+ VP IF ++SL+ ++L T
Sbjct: 420 PPRIKVLDLHSNKI-KSIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHT 477
Query: 229 NRFN 232
N ++
Sbjct: 478 NPWD 481
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 3e-06
Identities = 41/181 (22%), Positives = 70/181 (38%), Gaps = 11/181 (6%)
Query: 32 NNSTNLCQWTGVTCGHRHQRVTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIP 91
N + + + + C + LD SN + T+ G+L+ L L L N E+
Sbjct: 306 NFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELS 364
Query: 92 HQIG---RLVRLEALVLANNSFSGKIPTNL-SRCSNLISFNARRNNLVGEIPAELGYNWL 147
++ L+ L ++ NS S S +L+S N N L I L
Sbjct: 365 KIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPR-- 422
Query: 148 KLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNN-LGNLRNLILLNLGENR 206
++ L + N + P + L L+ +NV N L +P+ L +L + L N
Sbjct: 423 -IKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQL-KSVPDGIFDRLTSLQKIWLHTNP 479
Query: 207 F 207
+
Sbjct: 480 W 480
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 6e-30
Identities = 56/247 (22%), Positives = 98/247 (39%), Gaps = 40/247 (16%)
Query: 686 MIGQGSFGFVYKG---NLGENGMMVAVKVINLKQKGASNG---FVAECQALRNIRHRNLI 739
I G G++Y N+ NG V +K L G + +AE Q L + H +++
Sbjct: 87 CIAHGGLGWIYLALDRNV--NGRPVVLKG--LVHSGDAEAQAMAMAERQFLAEVVHPSIV 142
Query: 740 KIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASA 799
+I D G IV EY+ SL+ + + L + + I ++++ A
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKR--------SKGQKLPVAEAIAYLLEILPA 194
Query: 800 IEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIK 859
+ Y+H +V+ DLKP N++L ++ + L D G + +
Sbjct: 195 LSYLHSI---GLVYNDLKPENIMLTEEQLK-LIDLGAVSRI----------NSFGY--LY 238
Query: 860 GTVGYIAPEYGMGG--EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALP 917
GT G+ APE G A+ D+Y+ G L + +G + GL +
Sbjct: 239 GTPGFQAPEIVRTGPTVAT---DIYTVGRTLAALTLDLPTRNGRYVDGLP-EDDPVLKTY 294
Query: 918 DKVMEIV 924
D ++
Sbjct: 295 DSYGRLL 301
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-30
Identities = 42/236 (17%), Positives = 98/236 (41%), Gaps = 44/236 (18%)
Query: 687 IGQGSFGFVYKGNL-------GENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLI 739
+GQG+F ++KG + V +KV++ + S F + + H++L+
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 740 KIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASA 799
+C D +V E+++ GSL+ +L ++++ + ++ ++ + +A+A
Sbjct: 76 LNYGVCVC-----GDENILVQEFVKFGSLDTYLKKNKNC-----INILWKLEVAKQLAAA 125
Query: 800 IEYI-HHHCQPPVVHGDLKPSNVLLDQD--------LVAHLGDFGLAKFLSSSPLDTAVE 850
+ ++ + +HG++ N+LL ++ L D G++ + ++
Sbjct: 126 MHFLEENTL----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP---KDILQ 178
Query: 851 TPSSSKGIKGTVGYIAPE-YGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFNQ 904
I PE ++ D +SFG L E+ + +P + +Q
Sbjct: 179 ER-----IPWV----PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ 225
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-29
Identities = 59/229 (25%), Positives = 99/229 (43%), Gaps = 36/229 (15%)
Query: 680 DFSSSNMIGQGSFG-FVYKGNLGENGMMVAVKVINLKQ-KGASNGFVAECQALRNI-RHR 736
F +++G G+ G VY+G + VAVK I + A E Q LR H
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMF--DNRDVAVKRILPECFSFADR----EVQLLRESDEHP 78
Query: 737 NLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDV 796
N+I+ C+ K FQ I E +L++++ +Q+ + ++ I ++
Sbjct: 79 NVIRYF--CT---EKDRQFQYIAIELCA-ATLQEYV-----EQKDFAHLGLEPITLLQQT 127
Query: 797 ASAIEYIHHHCQPPVVHGDLKPSNVLL-----DQDLVAHLGDFGLAKFLSSSPLDTAVET 851
S + ++H +VH DLKP N+L+ + A + DFGL K L+ +
Sbjct: 128 TSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR-----HS 179
Query: 852 PSSSKGIKGTVGYIAPEY---GMGGEASMTGDVYSFGILLLEMFTRRRP 897
S G+ GT G+IAPE + T D++S G + + +
Sbjct: 180 FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-29
Identities = 49/293 (16%), Positives = 94/293 (32%), Gaps = 56/293 (19%)
Query: 647 ARRRRSAHKSSVSQ-LMDQQFPMISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGM 705
+ +SA S VS L + P +EL + ++GQ + E G
Sbjct: 40 SEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGE 99
Query: 706 MVAVKVINLKQKGASN----------------GFVAECQALRNIR---------HRNLIK 740
V V ++ SN G + QA ++R K
Sbjct: 100 SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKK 159
Query: 741 IITICSSIDFKGVDFQAIVYEYMQ--NGSLEDWLHQSEDQQEARSLTLIQRINIIIDVAS 798
+I + V + +Y MQ + + L + SL R+ + + V
Sbjct: 160 MIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHK--SLVHHARLQLTLQVIR 217
Query: 799 AIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGI 858
+ +HH+ +VH L+P +++LDQ L F + + +
Sbjct: 218 LLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSS----------- 263
Query: 859 KGTVGYIAPEY-----------GMGGEASMTGDVYSFGILLLEMFTRRRPTDG 900
+ G+ PE + + D ++ G+++ ++ P
Sbjct: 264 -VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITK 315
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 54/223 (24%), Positives = 95/223 (42%), Gaps = 28/223 (12%)
Query: 686 MIGQGSFGFVYKGN---LGENGMMVAVKVINLKQKGASNG-----FVAECQALRNIRHRN 737
++G G V+ + VAVKV L+ A + F E Q + H
Sbjct: 19 ILGFGGMSEVHLARDLRDHRD---VAVKV--LRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 738 LIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVA 797
++ + + + IV EY+ +L D +H +T + I +I D
Sbjct: 74 IVAVYDTGEA-ETPAGPLPYIVMEYVDGVTLRDIVH------TEGPMTPKRAIEVIADAC 126
Query: 798 SAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKG 857
A+ + H + ++H D+KP+N+++ + DFG+A+ ++ S T +++
Sbjct: 127 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADS---GNSVTQTAA-- 178
Query: 858 IKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDG 900
+ GT Y++PE G DVYS G +L E+ T P G
Sbjct: 179 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 221
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 49/223 (21%), Positives = 90/223 (40%), Gaps = 34/223 (15%)
Query: 686 MIGQGSFGFVYKGN---LGENGMMVAVKVINLKQKGASN-GFVA----ECQALRNIRHRN 737
++G+G G VY+ +VA+K+ + + +S+ F E + ++ +
Sbjct: 41 LVGRGGMGDVYEAEDTVRER---IVALKL--MSETLSSDPVFRTRMQREARTAGRLQEPH 95
Query: 738 LIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVA 797
++ I + G + + + L L + L + + I+ +
Sbjct: 96 ---VVPIHDFGEIDGQLY--VDMRLINGVDLAAML------RRQGPLAPPRAVAIVRQIG 144
Query: 798 SAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKG 857
SA++ H H D+KP N+L+ D A+L DFG+A + L T +
Sbjct: 145 SALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKL-TQLGN------ 194
Query: 858 IKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDG 900
GT+ Y+APE A+ D+Y+ +L E T P G
Sbjct: 195 TVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQG 237
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-29
Identities = 79/439 (17%), Positives = 130/439 (29%), Gaps = 129/439 (29%)
Query: 120 RCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVL 179
+ N + L +P L + + L I DN+LT PA L TL V
Sbjct: 38 LNNGNAVLNVGESGL-TTLPDCLPAH---ITTLVIPDNNLT-SLPALPPELRTL---EVS 89
Query: 180 GNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDI 239
GN L +P L L + +
Sbjct: 90 GNQL-TSLPVLPPGLLELSIFSNPLT---------------------------------- 114
Query: 240 GVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNL 299
LP L S L +L +F NQ L+ L++
Sbjct: 115 --HLPALP--------------------SGLCKLWIFGNQLTS----LPVLPPGLQELSV 148
Query: 300 GSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQI 359
N L + L + +L +N+ LP + L ++ ++ NQ+
Sbjct: 149 SDNQLAS-------LPALPSELCKLW---AYNNQLT-SLPMLPSGL----QELSVSDNQL 193
Query: 360 SGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLT 419
+ +PT L L +N+LT ++P L+ L + N L +P L
Sbjct: 194 A-SLPTLPSELYKLWAY---NNRLT-SLP---ALPSGLKELIVSGNRL-TSLPVLPSELK 244
Query: 420 LLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNL 479
L +S N L S+P SL + N
Sbjct: 245 ---ELMVSGNRLT-SLPMLPSGLL----------------------------SLSVYRNQ 272
Query: 480 LSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSL 539
L+ LP + +L + N+ N S TL A + + S+
Sbjct: 273 LT-RLPESLIHLSSETTVNLEGNPLS---ERTLQALREITSAPGYSGPIIRFDMAGASAP 328
Query: 540 KSIKELDMSSNNLSGQIPE 558
+ + L +++ + E
Sbjct: 329 RETRALHLAAADWLVPARE 347
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-29
Identities = 73/354 (20%), Positives = 130/354 (36%), Gaps = 51/354 (14%)
Query: 229 NRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYF 288
+R ++ + L + + ++P+ L ++ L + DN +
Sbjct: 24 SRGRAAVVQKMRACLNNGNAVLNVGESGLTTLPDCLPA--HITTLVIPDNNLT-SLP--- 77
Query: 289 RSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSST 348
L L + N L + L EL+ LP + L
Sbjct: 78 ALPPELRTLEVSGNQLTS-------LPVLPPGLLELSIFSNPLTH----LPALPSGL--- 123
Query: 349 MTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLA 408
+ I GNQ++ + L EL + DN+L ++P EL L + +N L
Sbjct: 124 -CKLWIFGNQLTSLPV----LPPGLQELSVSDNQLA-SLPALPSELCKL---WAYNNQLT 174
Query: 409 GGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSIST 468
+P L L+ +S N L S+P L +L + LT +LP +
Sbjct: 175 S-LPMLPSGLQELS---VSDNQLA-SLPTLPSE---LYKLWAYNNRLT-SLPALPSGLK- 224
Query: 469 LSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSF 528
L +S N L+ +LP+ LK L +S NR + +P+ + L L + N
Sbjct: 225 ---ELIVSGNRLT-SLPVLPSELKEL---MVSGNRLT-SLPMLP---SGLLSLSVYRNQL 273
Query: 529 SGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPT 582
+ +P SL L S +++ N LS + + L ++ + F+ +
Sbjct: 274 T-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGAS 326
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-24
Identities = 68/414 (16%), Positives = 119/414 (28%), Gaps = 105/414 (25%)
Query: 50 QRVTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNS 109
+T L + + + +L L R L ++ N +P L+ L
Sbjct: 61 AHITTLVIPDNNLT-SLPALPPEL---RTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTH 115
Query: 110 FSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGN 169
+P S L N L +P L+ L+++DN L PA
Sbjct: 116 ----LPALP---SGLCKLWIFGNQL-TSLPVLPP----GLQELSVSDNQLA-SLPALPSE 162
Query: 170 LSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTN 229
L L N L +P L+ L++ +N+ + + P S L ++ N
Sbjct: 163 LCKL---WAYNNQL-TSLPMLPSGLQE---LSVSDNQLASL-PTL---PSELYKLWAYNN 211
Query: 230 RFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFR 289
R SLP L L EL + N+ S+
Sbjct: 212 RLT---------SLPALPS--------------------GLKELIVSGNRLT---SL-PV 238
Query: 290 SLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTM 349
L+ L + N L + LP + L
Sbjct: 239 LPSELKELMVSGNRLTS-------------------------------LPMLPSGL---- 263
Query: 350 TDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLY---LDSNF 406
+ + NQ++ +P + +L + + ++ N L+ A+ E+ + + +
Sbjct: 264 LSLSVYRNQLTR-LPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDM 322
Query: 407 LAGGIPTSLGNLTLLTNLALSSNDLQGSIPP----SLGNCKNLIELHMADIELT 456
P L L L P G N + L+
Sbjct: 323 AGASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNADAFSLFLDRLS 376
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-29
Identities = 54/317 (17%), Positives = 98/317 (30%), Gaps = 48/317 (15%)
Query: 647 ARRRRSAHKSSVSQ-LMDQQFPMISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGM 705
+ +SA S VS L + P +EL + ++GQ + E G
Sbjct: 45 SEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGE 104
Query: 706 MVAVKVINLKQKGASN---GFVAECQALRNIRH----------------RNLIKIITICS 746
V V ++ SN E LR +R +L+K
Sbjct: 105 SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKK 164
Query: 747 SIDFKGVDFQAIVYEY-----MQNGSLEDWLHQ-SEDQQEARSLTLIQRINIIIDVASAI 800
I + + V +L+ + +SL R+ + + V +
Sbjct: 165 MIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLL 224
Query: 801 EYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPL---DTAVETPSSSKG 857
+HH+ +VH L+P +++LDQ L F +S + P
Sbjct: 225 ASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPE---- 277
Query: 858 IKGTVGYIAPEYGMGGEASMTG-----DVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFA 912
A G+ T D ++ G+ + ++ P G + F
Sbjct: 278 ------TTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFR 331
Query: 913 RTA-LPDKVMEIVDSVL 928
+P V +++ L
Sbjct: 332 SCKNIPQPVRALLEGFL 348
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 3e-29
Identities = 48/228 (21%), Positives = 94/228 (41%), Gaps = 20/228 (8%)
Query: 686 MIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIR-HRNLIKII-- 742
++ +G F FVY+ +G A+K + ++ + + E ++ + H N+++
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 743 TICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEY 802
+ + ++ + G L ++L + E + L+ + I A+++
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRG---PLSCDTVLKIFYQTCRAVQH 151
Query: 803 IHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSP--LDTAVETPSSSKGIK- 859
+H +PP++H DLK N+LL L DFG A +S P +A + I
Sbjct: 152 MHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 860 -GTVGYIAPE------YGMGGEASMTGDVYSFGILLLEMFTRRRPTDG 900
T Y PE GE D+++ G +L + R+ P +
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQ---DIWALGCILYLLCFRQHPFED 255
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 30/219 (13%)
Query: 686 MIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITIC 745
++G+G++G VY G N + +A+K I + S E ++++H+N+++
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ----- 83
Query: 746 SSIDFKGVDFQA----IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIE 801
+ G + I E + GSL L + I + ++
Sbjct: 84 ----YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNE-QTIG--FYTKQILEGLK 136
Query: 802 YIHHHCQPPVVHGDLKPSNVLLDQDL-VAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKG 860
Y+H + +VH D+K NVL++ V + DFG +K L+ ++ G
Sbjct: 137 YLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLA--------GINPCTETFTG 185
Query: 861 TVGYIAPE--YGMGGEASMTGDVYSFGILLLEMFTRRRP 897
T+ Y+APE D++S G ++EM T + P
Sbjct: 186 TLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 60/240 (25%), Positives = 103/240 (42%), Gaps = 47/240 (19%)
Query: 687 IGQGSFGFVYKGNL-----GENGMMVAVKVINLKQKGAS----NGFVAECQALRNIRHRN 737
+G G+FG VY+G + + + VAVK + + S F+ E + H+N
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALIISKFNHQN 94
Query: 738 LIKIITICSSIDFKGVDFQA----IVYEYMQNGSLEDWLHQSE-DQQEARSLTLIQRINI 792
+++ I GV Q+ I+ E M G L+ +L ++ + SL ++ +++
Sbjct: 95 IVRCI---------GVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 145
Query: 793 IIDVASAIEYI-HHHCQPPVVHGDLKPSNVLLD---QDLVAHLGDFGLAKFLSSSPLDTA 848
D+A +Y+ +H +H D+ N LL VA +GDFG+A+ + +
Sbjct: 146 ARDIACGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA--SY- 198
Query: 849 VETPSSSKG---IKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFNQ 904
+K PE M G + D +SFG+LL E+F+ P NQ
Sbjct: 199 --YRKGGCAMLPVKWM----PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 252
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 51/275 (18%), Positives = 99/275 (36%), Gaps = 65/275 (23%)
Query: 675 SKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASN--GFVAECQALRN 732
S+ T +F IG G FG V+K +G + A+K G+ + + E A
Sbjct: 7 SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 66
Query: 733 I-RHRNLIKIITICSSIDFKGVDFQA----IVYEYMQNGSLEDWLHQSEDQQEARSLTLI 787
+ +H ++++ + + I EY GSL D + ++ +
Sbjct: 67 LGQHSHVVR---------YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAEL 117
Query: 788 QRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQD-------------------LV 828
+ ++++ V + YIH +VH D+KPSN+ + + ++
Sbjct: 118 K--DLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVM 172
Query: 829 AHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPE-----YGMGGEASMTGDVYS 883
+GD G + SS + +G ++A E Y +A D+++
Sbjct: 173 FKIGDLGHVTRI------------SSPQVEEGDSRFLANEVLQENYTHLPKA----DIFA 216
Query: 884 FGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPD 918
+ ++ G HE + LP
Sbjct: 217 LALTVVCAAGAEPL----PRNGDQWHEIRQGRLPR 247
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-28
Identities = 51/249 (20%), Positives = 92/249 (36%), Gaps = 44/249 (17%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVA------------- 725
ND+ + QG F + ++ A+K F
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 726 ----ECQALRNIRHRNLIKIITICSSID--FKGVDFQAIVYEYMQNGSLEDWL--HQSED 777
E Q + +I++ + I ++ D + I+YEYM+N S+ + D
Sbjct: 89 DFKNELQIITDIKNEYCLTCEGIITNYDEVY-------IIYEYMENDSILKFDEYFFVLD 141
Query: 778 QQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837
+ + + II V ++ YIH+ + H D+KPSN+L+D++ L DFG +
Sbjct: 142 KNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGES 199
Query: 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPE--YGMGGEASMTGDVYSFGILLLEMFTRR 895
+++ + + GT ++ PE D++S GI L MF
Sbjct: 200 EYMVDKKIKGSR----------GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
Query: 896 RPTDGMFNQ 904
P +
Sbjct: 250 VPFSLKISL 258
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-28
Identities = 57/243 (23%), Positives = 105/243 (43%), Gaps = 53/243 (21%)
Query: 687 IGQGSFGFVYKGNL-----GENGMMVAVKVINLKQKGAS----NGFVAECQALRNIRHRN 737
+GQGSFG VY+G E VA+K +N + AS F+ E ++ +
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLNEASVMKEFNCHH 89
Query: 738 LIKIITICSSIDFKGVDFQA----IVYEYMQNGSLEDWL----HQSEDQQEARSLTLIQR 789
+++++ + S Q ++ E M G L+ +L + +L +
Sbjct: 90 VVRLLGVVS---------QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 140
Query: 790 INIIIDVASAIEYIH-HHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTA 848
I + ++A + Y++ + VH DL N ++ +D +GDFG+ + + + D
Sbjct: 141 IQMAGEIADGMAYLNANKF----VHRDLAARNCMVAEDFTVKIGDFGMTRDIYET--DYY 194
Query: 849 VETPSSSKG---IKGTVGYIAPE---YGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGM 901
KG ++ +PE G+ S DV+SFG++L E+ T +P G+
Sbjct: 195 R---KGGKGLLPVRWM----SPESLKDGVFTTYS---DVWSFGVVLWEIATLAEQPYQGL 244
Query: 902 FNQ 904
N+
Sbjct: 245 SNE 247
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-28
Identities = 47/302 (15%), Positives = 91/302 (30%), Gaps = 33/302 (10%)
Query: 645 FLARRRRSAHKSSVSQLMDQQFPMIS-YAELSKATNDFSSSNMIGQGSFGFVYKG----- 698
L+ + + + P I E + +++G+G+F VY+
Sbjct: 30 LLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDL 89
Query: 699 NLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAI 758
N +N +KV + L+ + S+ F+ + +
Sbjct: 90 NDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHM---FMKFYSAHLFQ--NGSVL 144
Query: 759 VYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKP 818
V E G+L + ++ ++ E + + I+ + + IE +H ++HGD+KP
Sbjct: 145 VGELYSYGTLLNAINLYKNTPE-KVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKP 200
Query: 819 SNVLLDQDLVAH-----------LGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAP 867
N +L + L D G + + P T T G+
Sbjct: 201 DNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIF------TAKCETSGFQCV 254
Query: 868 EYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHE-FARTALPDKVMEIVDS 926
E + D + + M F R D E
Sbjct: 255 EMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHV 314
Query: 927 VL 928
+L
Sbjct: 315 ML 316
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 6e-28
Identities = 66/289 (22%), Positives = 113/289 (39%), Gaps = 25/289 (8%)
Query: 343 ANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYL 402
+S T + + N IS + + L +L L + +NK++ A L+ LQ LY+
Sbjct: 50 KEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYI 109
Query: 403 DSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPP-SLGNCKNLIELHMADIELT-GALP 460
N L IP +L + L L + N ++ +P +N+ + M L
Sbjct: 110 SKNHLV-EIPPNL--PSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFE 165
Query: 461 PQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPV-TLSACTSLQ 519
P L+ L +S L+G + + L ++ N+ I + L + L
Sbjct: 166 PGAFDGLKLNY-LRISEAKLTG---IPKDLPETLNELHLDHNKIQ-AIELEDLLRYSKLY 220
Query: 520 QLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFE-- 577
+L L N SLS L +++EL + +N LS ++P L +L L+ + L N+
Sbjct: 221 RLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKV 279
Query: 578 -----GEVPTKGVFSNKTGISLSGNGKVCGGLDELNLPPCPSRGLKKRT 621
V + GISL N + + P R + R
Sbjct: 280 GVNDFCPVGFGVKRAYYNGISLFNN-----PVPYWEVQPATFRCVTDRL 323
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 4e-21
Identities = 58/301 (19%), Positives = 115/301 (38%), Gaps = 25/301 (8%)
Query: 186 RIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPK 245
+P + + LL+L N S + + L + L N+ + + L K
Sbjct: 47 AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRK 103
Query: 246 LLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLG 305
L +++N+ IP +L S+LVEL + DN+ R F L+N+ + +G N L
Sbjct: 104 LQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLE 160
Query: 306 TGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPT 365
F L +L + + + + G+ L ++ + N+I I
Sbjct: 161 NSGFEPGAFDGL-----KLNYLRISEAKLTGIPKDLPETL----NELHLDHNKIQAIELE 211
Query: 366 GIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLA 425
+ L L + N++ ++ L L+ L+LD+N L+ +P L +L LL +
Sbjct: 212 DLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVY 270
Query: 426 LSSNDLQGSIPPS-------LGNCKNLIELHMADIELT-GALPPQILSISTLSLSLDLSY 477
L +N++ + + + + + + + P T L++
Sbjct: 271 LHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGN 329
Query: 478 N 478
Sbjct: 330 Y 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 4e-18
Identities = 66/260 (25%), Positives = 97/260 (37%), Gaps = 12/260 (4%)
Query: 76 LRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTN-LSRCSNLISFNARRNNL 134
L+L +N+ L L ALVL NN S KI S L +N+L
Sbjct: 56 TTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKNHL 114
Query: 135 VGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGL-WGRIPNNLGN 193
V EIP L + L L I DN + L + I + GN L +
Sbjct: 115 V-EIPPNLPSS---LVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFD 170
Query: 194 LRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAE 253
L L + E + +GI P + +L + L N+ ++ L+ + KL +
Sbjct: 171 GLKLNYLRISEAKLTGI-PKDLP--ETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGH 226
Query: 254 NNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLD 313
N SLS L EL L +N+ +V LK L+ + L +NN+ ND
Sbjct: 227 NQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFC 285
Query: 314 FLTLLTNCTELTAIGLDDNR 333
+ I L +N
Sbjct: 286 PVGFGVKRAYYNGISLFNNP 305
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-27
Identities = 60/240 (25%), Positives = 103/240 (42%), Gaps = 47/240 (19%)
Query: 687 IGQGSFGFVYKGNL-----GENGMMVAVKVINLKQKGAS----NGFVAECQALRNIRHRN 737
+G G+FG VY+G + + + VAVK + + S F+ E + H+N
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALIISKFNHQN 135
Query: 738 LIKIITICSSIDFKGVDFQA----IVYEYMQNGSLEDWLHQSE-DQQEARSLTLIQRINI 792
+++ I GV Q+ I+ E M G L+ +L ++ + SL ++ +++
Sbjct: 136 IVRCI---------GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 186
Query: 793 IIDVASAIEYI-HHHCQPPVVHGDLKPSNVLLD---QDLVAHLGDFGLAKFLSSSPLDTA 848
D+A +Y+ +H +H D+ N LL VA +GDFG+A+ + +
Sbjct: 187 ARDIACGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA--GY- 239
Query: 849 VETPSSSKG---IKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFNQ 904
+K PE M G + D +SFG+LL E+F+ P NQ
Sbjct: 240 --YRKGGCAMLPVKWM----PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 293
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 61/242 (25%), Positives = 107/242 (44%), Gaps = 46/242 (19%)
Query: 687 IGQGSFGFVYKGNL-----GENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKI 741
+G+G+FG V+ ++ M+VAVK + A F E + L N++H +++K
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 742 ITICSSIDFKGVDFQA----IVYEYMQNGSLEDWL----------HQSEDQQEARSLTLI 787
+C +V+EYM++G L +L + +Q L L
Sbjct: 83 YGVCG---------DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 133
Query: 788 QRINIIIDVASAIEYI-HHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLD 846
Q ++I +AS + Y+ H VH DL N L+ +L+ +GDFG+++ + S+
Sbjct: 134 QMLHIASQIASGMVYLASQHF----VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD-- 187
Query: 847 TAVETPSSSKG---IKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMF 902
I+ PE M + + DV+SFG++L E+FT ++P +
Sbjct: 188 ---YYRVGGHTMLPIRWM----PPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS 240
Query: 903 NQ 904
N
Sbjct: 241 NT 242
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 53/218 (24%), Positives = 92/218 (42%), Gaps = 31/218 (14%)
Query: 686 MIGQGSFGFVYKGNLGENGMMVAVKVIN---LKQKGASNGFVAECQALRNIRHRNLIKII 742
+G+G F ++ + + + A K++ L + E R++ H++++
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 743 TICSSIDFKGVDFQAIVYEYMQNGSLEDWL--HQSEDQQEARSLTLIQRINIIIDVASAI 800
F+ DF +V E + SL + ++ + EAR + +
Sbjct: 82 GF-----FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR--------YYLRQIVLGC 128
Query: 801 EYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKG-IK 859
+Y+H + V+H DLK N+ L++DL +GDFGLA T VE K +
Sbjct: 129 QYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLA---------TKVEYDGERKKVLC 176
Query: 860 GTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897
GT YIAPE S DV+S G ++ + + P
Sbjct: 177 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 61/331 (18%), Positives = 117/331 (35%), Gaps = 61/331 (18%)
Query: 259 SIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLL 318
+P+ L + L L +N+ F++LKNL L L +N + L
Sbjct: 45 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLV-- 100
Query: 319 TNCTELTAIGLDDNRFGGV---LPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVE 375
+L + L N+ + +P ++ L + N+I+ + + L ++
Sbjct: 101 ----KLERLYLSKNQLKELPEKMPKTLQELR-------VHENEITKVRKSVFNGLNQMIV 149
Query: 376 LCMDDNKLTGTI--PHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQG 433
+ + N L + A +K L + + + IP L LT L L N +
Sbjct: 150 VELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKIT- 205
Query: 434 SIPP-SLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLK 492
+ SL NL +L LS+N +S + N
Sbjct: 206 KVDAASLKGLNNLAKL-------------------------GLSFNSISAVDNGSLANTP 240
Query: 493 NLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSS-------LSSLKSIKEL 545
+L +++ N+ ++P L+ +Q +YL N+ S +I S+ + S +
Sbjct: 241 HLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGV 298
Query: 546 DMSSNNLS-GQIPEYL-ENLSFLEYLNLSYN 574
+ SN + +I + + L
Sbjct: 299 SLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-27
Identities = 52/265 (19%), Positives = 107/265 (40%), Gaps = 19/265 (7%)
Query: 343 ANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYL 402
+L + + N+I+ I +NL NL L + +NK++ P A L L+ LYL
Sbjct: 48 KDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 107
Query: 403 DSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPP-SLGNCKNLIELHMADIELT-GALP 460
N L +P + L L + N++ + +I + + L +
Sbjct: 108 SKNQLKE-LPEKM--PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIE 163
Query: 461 PQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPV-TLSACTSLQ 519
+ ++ ++ + G +L ++ N+ + ++ +L +L
Sbjct: 164 NGAFQGMKKLSYIRIADTNITT---IPQGLPPSLTELHLDGNKIT-KVDAASLKGLNNLA 219
Query: 520 QLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFE-- 577
+L L NS S SL++ ++EL +++N L ++P L + +++ + L N+
Sbjct: 220 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAI 278
Query: 578 --GEVPTKGVFSNKT---GISLSGN 597
+ G + K G+SL N
Sbjct: 279 GSNDFCPPGYNTKKASYSGVSLFSN 303
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 64/346 (18%), Positives = 129/346 (37%), Gaps = 56/346 (16%)
Query: 119 SRCS-NLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERIN 177
RC +L L ++P +L + L + +N +T NL L +
Sbjct: 27 FRCQCHLRVVQCSDLGLE-KVPKDLPPD---TALLDLQNNKITEIKDGDFKNLKNLHTLI 82
Query: 178 VLGNGLWGRIPNN-LGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLP 236
++ N + +I L L L L +N+ + P + +L+ + + N
Sbjct: 83 LINNKI-SKISPGAFAPLVKLERLYLSKNQLKEL-PEKMP--KTLQELRVHENEIT---- 134
Query: 237 LDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKV--SIYFRSLKNL 294
+ + + ++ + L N + + F+ +K L
Sbjct: 135 -----KVR----------------KSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKL 173
Query: 295 EWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVI 354
++ + N+ T L + TEL LD N+ V S+ L++ + + +
Sbjct: 174 SYIRIADTNITTIPQG------LPPSLTELH---LDGNKITKVDAASLKGLNN-LAKLGL 223
Query: 355 AGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFL------A 408
+ N IS + + N +L EL +++NKL +P + + K +Q++YL +N +
Sbjct: 224 SFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSND 282
Query: 409 GGIPTSLGNLTLLTNLALSSNDLQ-GSIPPSLGNC-KNLIELHMAD 452
P + ++L SN +Q I PS C + + +
Sbjct: 283 FCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGN 328
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 60/310 (19%), Positives = 108/310 (34%), Gaps = 36/310 (11%)
Query: 76 LRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTN-LSRCSNLISFNARRNNL 134
L+L +N L L L+L NN S KI + L +N L
Sbjct: 54 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLSKNQL 112
Query: 135 VGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGL-WGRIPNN-LG 192
E+P ++ L+ L + +N +T + L+ + + + N L I N
Sbjct: 113 K-ELPEKMPKT---LQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 168
Query: 193 NLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVA 252
++ L + + + + I P + SL + L N+ + L L ++
Sbjct: 169 GMKKLSYIRIADTNITTI-PQGLP--PSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLS 224
Query: 253 ENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDL 312
N+ + SL+N +L EL L +N+ KV K ++ + L +NN+ +ND
Sbjct: 225 FNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDF 283
Query: 313 DFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVN 372
T + + L N Q I P+ R +
Sbjct: 284 CPPGYNTKKASYSGVSLFSNPV-----------------------QYWEIQPSTFRCVYV 320
Query: 373 LVELCMDDNK 382
+ + + K
Sbjct: 321 RAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 60/302 (19%), Positives = 114/302 (37%), Gaps = 28/302 (9%)
Query: 114 IPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTL 173
+P +L + + + N + EI N L L + +N ++ P + L L
Sbjct: 46 VPKDLP--PDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 102
Query: 174 ERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIF-NISSLENVFLPTNRF- 231
ER+ + N L +P + + L L + EN + + S+F ++ + V L TN
Sbjct: 103 ERLYLSKNQL-KELPEKM--PKTLQELRVHENEITKV-RKSVFNGLNQMIVVELGTNPLK 158
Query: 232 NGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSL 291
+ + + KL +A+ N +IP+ L +L EL L N+ + + L
Sbjct: 159 SSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGL 215
Query: 292 KNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTD 351
NL L L N++ + L N L + L++N+ +P +A+ +
Sbjct: 216 NNLAKLGLSFNSISAVDNG------SLANTPHLRELHLNNNKLV-KVPGGLADHKY-IQV 267
Query: 352 IVIAGNQISGI------IPTGIRNLVNLVELCMDDNKLTGTI--PHAIGELKNLQLLYLD 403
+ + N IS I P + + + N + P + + L
Sbjct: 268 VYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLG 327
Query: 404 SN 405
+
Sbjct: 328 NY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 5e-13
Identities = 56/294 (19%), Positives = 95/294 (32%), Gaps = 55/294 (18%)
Query: 53 TKLDLSN---RTIG-GTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANN 108
L L N I G + L L L L+ N E+P L+ L + N
Sbjct: 79 HTLILINNKISKISPGAFA----PLVKLERLYLSKNQLK-ELP--EKMPKTLQELRVHEN 131
Query: 109 SFSGKIPTN-LSRCSNLISFNARRNNL-VGEIPAELGYNWLKLENLTIADNHLTGHFPAS 166
+ K+ + + + +I N L I KL + IAD ++T P
Sbjct: 132 EIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ- 188
Query: 167 IGNLSTLERINVLGNGLWGRIPNN-LGNLRNLILLNLGENRFSGIVPPSIFNISSLENVF 225
G +L +++ GN + ++ L L NL L L N S + S+ N L +
Sbjct: 189 -GLPPSLTELHLDGNKI-TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELH 246
Query: 226 LPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRG--- 282
L N+ +P L++ + + L +N
Sbjct: 247 LNNNKLV--------------------------KVPGGLADHKYIQVVYLHNNNISAIGS 280
Query: 283 ---KVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNR 333
Y + ++L SN + E F + A+ L + +
Sbjct: 281 NDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCV----YVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 22/91 (24%), Positives = 36/91 (39%), Gaps = 4/91 (4%)
Query: 507 EIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFL 566
++P L L LQ N + +LK++ L + +N +S P L L
Sbjct: 45 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 102
Query: 567 EYLNLSYNHFEGEVPTKGVFSNKTGISLSGN 597
E L LS N + E+P + + + N
Sbjct: 103 ERLYLSKNQLK-ELPE-KMPKTLQELRVHEN 131
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-27
Identities = 54/243 (22%), Positives = 93/243 (38%), Gaps = 43/243 (17%)
Query: 679 NDFSSSNMIGQGSFG-FVYKGNLGENGMMVAVKVINL-KQKGASNGFVAECQALR-NIRH 735
N S ++G GS G V++G+ G VAVK + + A E + L + H
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLIDFCDIALM----EIKLLTESDDH 68
Query: 736 RNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQE-ARSLTLIQRINIII 794
N+I+ F I E N +L+D + E + I+++
Sbjct: 69 PNVIRYYCS-----ETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLR 122
Query: 795 DVASAIEYIHHHCQPPVVHGDLKPSNVLLD-------------QDLVAHLGDFGLAKFLS 841
+AS + ++H ++H DLKP N+L+ ++L + DFGL K L
Sbjct: 123 QIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179
Query: 842 SSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTG-------DVYSFGILLLEMFTR 894
++ GT G+ APE T D++S G + + ++
Sbjct: 180 ----SGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
Query: 895 RRP 897
+
Sbjct: 236 GKH 238
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-27
Identities = 61/245 (24%), Positives = 106/245 (43%), Gaps = 51/245 (20%)
Query: 687 IGQGSFGFVYKGNL-----GENGMMVAVKVINLKQKGASNG----FVAECQALRNIRHRN 737
+G+ FG VYKG+L GE VA+K LK A F E ++H N
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKT--LK-DKAEGPLREEFRHEAMLRARLQHPN 73
Query: 738 LIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWL----------HQSEDQQEARSLTLI 787
++ ++ + + K ++++ Y +G L ++L +D+ +L
Sbjct: 74 VVCLLGVVT----KD-QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 788 QRINIIIDVASAIEYI-HHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLD 846
++++ +A+ +EY+ HH VH DL NVL+ L + D GL + + ++ D
Sbjct: 129 DFVHLVAQIAAGMEYLSSHHV----VHKDLATRNVLVYDKLNVKISDLGLFREVYAA--D 182
Query: 847 TAVETPSSSKG---IKGTVGYIAPE---YGMGGEASMTGDVYSFGILLLEMFTR-RRPTD 899
I+ APE YG S D++S+G++L E+F+ +P
Sbjct: 183 YYK---LLGNSLLPIRWM----APEAIMYGKFSIDS---DIWSYGVVLWEVFSYGLQPYC 232
Query: 900 GMFNQ 904
G NQ
Sbjct: 233 GYSNQ 237
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-27
Identities = 54/222 (24%), Positives = 93/222 (41%), Gaps = 39/222 (17%)
Query: 686 MIGQGSFGFVYKGNLGENGMMVAVKVIN---LKQKGASNGFVAECQALRNIRHRNLIKII 742
+G+G F ++ + + + A K++ L + E R++ H++++
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 743 TICSSIDFKGVDFQAIVYEYMQNGSLEDWL--HQSEDQQEARSLTLIQRINIIIDVASAI 800
F+ DF +V E + SL + ++ + EAR + +
Sbjct: 108 GF-----FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR--------YYLRQIVLGC 154
Query: 801 EYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKG-IK 859
+Y+H + V+H DLK N+ L++DL +GDFGLA T VE K +
Sbjct: 155 QYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLA---------TKVEYDGERKKVLC 202
Query: 860 GTVGYIAPEY----GMGGEASMTGDVYSFGILLLEMFTRRRP 897
GT YIAPE G E DV+S G ++ + + P
Sbjct: 203 GTPNYIAPEVLSKKGHSFEV----DVWSIGCIMYTLLVGKPP 240
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 9e-27
Identities = 55/213 (25%), Positives = 91/213 (42%), Gaps = 39/213 (18%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICS 746
+G G+F V+ G + A+K I + E L+ I+H N++ + I
Sbjct: 17 LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI-- 74
Query: 747 SIDFKGVDFQAIVYEYMQNGSLEDWL----HQSEDQQEARSLTLIQRINIIIDVASAIEY 802
++ +V + + G L D + +E ++A +I V SA++Y
Sbjct: 75 ---YESTTHYYLVMQLVSGGELFDRILERGVYTE--KDAS--------LVIQQVLSAVKY 121
Query: 803 IHHHCQPPVVHGDLKPSNVLL---DQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIK 859
+H + +VH DLKP N+L +++ + DFGL+K + + TA
Sbjct: 122 LHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTAC---------- 168
Query: 860 GTVGYIAPEYGMGGEASMTGDVYSFG----ILL 888
GT GY+APE S D +S G ILL
Sbjct: 169 GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILL 201
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 9e-27
Identities = 59/241 (24%), Positives = 109/241 (45%), Gaps = 45/241 (18%)
Query: 687 IGQGSFGFVYKGNL-----GENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKI 741
+G+G+FG V+ ++ M+VAVK + + A F E + L ++H+++++
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 742 ITICSSIDFKGVDFQA----IVYEYMQNGSLEDWL---------HQSEDQQEARSLTLIQ 788
+C+ + +V+EYM++G L +L + L L Q
Sbjct: 109 FGVCT---------EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQ 159
Query: 789 RINIIIDVASAIEYI-HHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDT 847
+ + VA+ + Y+ H VH DL N L+ Q LV +GDFG+++ + S+ D
Sbjct: 160 LLAVASQVAAGMVYLAGLHF----VHRDLATRNCLVGQGLVVKIGDFGMSRDIYST--DY 213
Query: 848 AVETPSSSKG---IKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFN 903
+ I+ PE + + + DV+SFG++L E+FT ++P + N
Sbjct: 214 ---YRVGGRTMLPIRWM----PPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN 266
Query: 904 Q 904
Sbjct: 267 T 267
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 54/217 (24%), Positives = 89/217 (41%), Gaps = 29/217 (13%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVA----ECQALRNIR 734
DF +G+G FG VY ++ ++A+KV+ K + G E + ++R
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLF-KAQLEKAGVEHQLRREVEIQSHLR 67
Query: 735 HRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIII 794
H N++++ F ++ EY G++ L + E R+ T I +
Sbjct: 68 HPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL---- 118
Query: 795 DVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSS 854
A+A+ Y H V+H D+KP N+LL + DFG + SS
Sbjct: 119 --ANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----- 168
Query: 855 SKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEM 891
GT+ Y+ PE G D++S G+L E
Sbjct: 169 -----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEF 200
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 54/243 (22%), Positives = 90/243 (37%), Gaps = 14/243 (5%)
Query: 363 IPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLA--GGIPTSLGNLTL 420
+PTGI + L ++ NKL +L L L L SN L+ G S T
Sbjct: 22 VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTS 79
Query: 421 LTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLL 480
L L LS N + ++ + + L L L + + LD+S+
Sbjct: 80 LKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 138
Query: 481 SGTLPLEV-GNLKNLVYFNISVNRFSGEI-PVTLSACTSLQQLYLQGNSFSGSIPS-SLS 537
+ L +L ++ N F P + +L L L + + +
Sbjct: 139 R-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFN 196
Query: 538 SLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPT---KGVFSNKTGISL 594
SL S++ L+MS NN + L+ L+ L+ S NH + S+ ++L
Sbjct: 197 SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNL 255
Query: 595 SGN 597
+ N
Sbjct: 256 TQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 51/242 (21%), Positives = 101/242 (41%), Gaps = 13/242 (5%)
Query: 343 ANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLT--GTIPHAIGELKNLQLL 400
+ S+ T + + N++ + L L +L + N L+ G + +L+ L
Sbjct: 24 TGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYL 83
Query: 401 YLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPS--LGNCKNLIELHMADIELTGA 458
L N + + ++ L L +L ++L+ + + +NLI L ++
Sbjct: 84 DLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTR-V 140
Query: 459 LPPQILSISTLSL-SLDLSYNLLSGTLPLEV-GNLKNLVYFNISVNRFSGEIPVTLSAC- 515
I + SL L ++ N ++ L+NL + ++S + ++ T
Sbjct: 141 AFNGIFN-GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSL 198
Query: 516 TSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENL-SFLEYLNLSYN 574
+SLQ L + N+F L S++ LD S N++ + L++ S L +LNL+ N
Sbjct: 199 SSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN 258
Query: 575 HF 576
F
Sbjct: 259 DF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 54/276 (19%), Positives = 90/276 (32%), Gaps = 40/276 (14%)
Query: 259 SIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLL 318
S+P + S+ L L N+ + F L L L+L SN L
Sbjct: 21 SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGT- 77
Query: 319 TNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGI-RNLVNLVELC 377
T L + L N + + L + + + + + + +L NL+ L
Sbjct: 78 ---TSLKYLDLSFNGVI-TMSSNFLGLEQ-LEHLDFQHSNLKQMSEFSVFLSLRNLIYLD 132
Query: 378 MDDNKLTGTIPHAIGELKNLQLLYLDSN-FLAGGIPTSLGNLTLLTNLALSSNDLQGSIP 436
+ L +L++L + N F +P L LT L LS L+ +
Sbjct: 133 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLS 191
Query: 437 PSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEV-GNLKNLV 495
P+ N +L L L++S+N +L L +L
Sbjct: 192 PTAFN--SLSSLQ----------------------VLNMSHNNFF-SLDTFPYKCLNSLQ 226
Query: 496 YFNISVNRFSGEIPVTL--SACTSLQQLYLQGNSFS 529
+ S+N +SL L L N F+
Sbjct: 227 VLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 4e-20
Identities = 55/282 (19%), Positives = 91/282 (32%), Gaps = 41/282 (14%)
Query: 156 DNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENR--FSGIVPP 213
LT P I S+ R+ + N L L L L+L N F G
Sbjct: 16 SKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQ 72
Query: 214 SIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVEL 273
S F +SL+ + L N ++ + L L
Sbjct: 73 SDFGTTSLKYLDLSFNGVI--------------------------TMSSNFLGLEQLEHL 106
Query: 274 TLFDNQFRGKVSI-YFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDN 332
+ + F SL+NL +L++ + + + L + + N
Sbjct: 107 DFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNG------IFNGLSSLEVLKMAGN 160
Query: 333 RF-GGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAI 391
F LP L + +T + ++ Q+ + PT +L +L L M N
Sbjct: 161 SFQENFLPDIFTELRN-LTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPY 219
Query: 392 GELKNLQLLYLDSNFLAGGIPTSLGNL-TLLTNLALSSNDLQ 432
L +LQ+L N + L + + L L L+ ND
Sbjct: 220 KCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 42/272 (15%), Positives = 80/272 (29%), Gaps = 40/272 (14%)
Query: 186 RIPNNLGNLRNLILLNLGENRFSGIVPPSIF-NISSLENVFLPTNRFN-GSLPLDIGVSL 243
+P + + L L N+ + P +F ++ L + L +N +
Sbjct: 21 SVPTGI--PSSATRLELESNKLQSL-PHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGT 77
Query: 244 PKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSI-YFRSLKNLEWLNLGSN 302
L ++ N ++ + L L + + F SL+NL +L++
Sbjct: 78 TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 136
Query: 303 NLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGI 362
+ + + L + + N F
Sbjct: 137 HTRVAFNG------IFNGLSSLEVLKMAGNSF------------------------QENF 166
Query: 363 IPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLT 422
+P L NL L + +L P A L +LQ+L + N L L
Sbjct: 167 LPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQ 226
Query: 423 NLALSSNDLQGSIPPSL--GNCKNLIELHMAD 452
L S N + + +L L++
Sbjct: 227 VLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQ 257
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 49/263 (18%), Positives = 95/263 (36%), Gaps = 36/263 (13%)
Query: 76 LRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLV 135
L L N +L +L L L++N S
Sbjct: 30 ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLS-----------------------F 66
Query: 136 GEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNN--LGN 193
++ + L+ L ++ N + ++ L LE ++ + L ++ +
Sbjct: 67 KGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNL-KQMSEFSVFLS 124
Query: 194 LRNLILLNLGENRFSGIVPPSIF-NISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVA 252
LRNLI L++ IF +SSLE + + N F + DI L L ++
Sbjct: 125 LRNLIYLDISHTHTRVA-FNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 183
Query: 253 ENNFAGSIPE-SLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEAND 311
+ + + ++ S+L L + N F + ++ L +L+ L+ N++ T + +
Sbjct: 184 QCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQE 242
Query: 312 LDFLTLLTNCTELTAIGLDDNRF 334
L + L + L N F
Sbjct: 243 LQHFP-----SSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 9e-14
Identities = 58/260 (22%), Positives = 97/260 (37%), Gaps = 21/260 (8%)
Query: 38 CQWTGVTCGHRH---------QRVTKLDLSNRTIGGTLSPYV-GNLSFLRYLNLADNN-- 85
C T + C + T+L+L + + +L V L+ L L+L+ N
Sbjct: 7 CSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLS 65
Query: 86 FHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYN 145
F G L+ L L+ N + +N L + + +NL + +
Sbjct: 66 FKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS 124
Query: 146 WLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNN-LGNLRNLILLNLGE 204
L L I+ H F LS+LE + + GN + LRNL L+L +
Sbjct: 125 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 184
Query: 205 NRFSGIVPPSIF-NISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPES 263
+ + P+ F ++SSL+ + + N F SL L L + N+ + +
Sbjct: 185 CQLEQL-SPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIM-TSKKQ 241
Query: 264 L--SNASNLVELTLFDNQFR 281
S+L L L N F
Sbjct: 242 ELQHFPSSLAFLNLTQNDFA 261
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 6e-26
Identities = 62/249 (24%), Positives = 107/249 (42%), Gaps = 60/249 (24%)
Query: 685 NMIGQGSFGFVYKGNLGENG--MMVAVKVINLKQKGASNG----FVAECQALRNI-RHRN 737
++IG+G+FG V K + ++G M A+K +K + AS F E + L + H N
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKR--MK-EYASKDDHRDFAGELEVLCKLGHHPN 87
Query: 738 LIKIITICSSIDFKGVDFQA----IVYEYMQNGSLEDWLHQS----------EDQQEARS 783
+I ++ C + EY +G+L D+L +S A +
Sbjct: 88 IINLLGACE---------HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 138
Query: 784 LTLIQRINIIIDVASAIEYI-HHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSS 842
L+ Q ++ DVA ++Y+ +H DL N+L+ ++ VA + DFGL++
Sbjct: 139 LSSQQLLHFAADVARGMDYLSQKQF----IHRDLAARNILVGENYVAKIADFGLSRG--- 191
Query: 843 SPLDTAVETPSSSKG---IKGTVGYIAPE---YGMGGEASMTGDVYSFGILLLEMFTR-R 895
+ V + G ++ A E Y + S DV+S+G+LL E+ +
Sbjct: 192 --QEVYV---KKTMGRLPVRWM----AIESLNYSVYTTNS---DVWSYGVLLWEIVSLGG 239
Query: 896 RPTDGMFNQ 904
P GM
Sbjct: 240 TPYCGMTCA 248
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 53/222 (23%), Positives = 88/222 (39%), Gaps = 39/222 (17%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVA----ECQALRNIR 734
+DF +G+G FG VY +N ++A+KV+ K + G E + ++R
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLF-KSQLEKEGVEHQLRREIEIQSHLR 72
Query: 735 HRNLIKIITICSSIDFKGVDFQA-----IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQR 789
H N++++ F ++ E+ G L L + E RS T ++
Sbjct: 73 HPNILRM---------YNY-FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE 122
Query: 790 INIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAV 849
+ A A+ Y H V+H D+KP N+L+ + DFG + S T
Sbjct: 123 L------ADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC 173
Query: 850 ETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEM 891
GT+ Y+ PE G D++ G+L E
Sbjct: 174 ----------GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEF 205
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 8e-26
Identities = 53/234 (22%), Positives = 98/234 (41%), Gaps = 6/234 (2%)
Query: 343 ANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYL 402
+ S + + N I I R+L +L L + N + A L +L L L
Sbjct: 71 QGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLEL 130
Query: 403 DSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPP-SLGNCKNLIELHMADIELTGALPP 461
N+L + L+ L L L +N ++ SIP + +L+ L + +++ +
Sbjct: 131 FDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISE 189
Query: 462 QILSISTLSL-SLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQ 520
+L L+L + +P + L L +S N F P + +SL++
Sbjct: 190 GAFE-GLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKK 246
Query: 521 LYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYN 574
L++ + S ++ L S+ EL+++ NNLS + L +L L+L +N
Sbjct: 247 LWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 7e-20
Identities = 44/233 (18%), Positives = 80/233 (34%), Gaps = 7/233 (3%)
Query: 322 TELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDN 381
+ + L +N + + +L + + + N I I L +L L + DN
Sbjct: 75 SNTRYLNLMENNIQMIQADTFRHLHH-LEVLQLGRNSIRQIEVGAFNGLASLNTLELFDN 133
Query: 382 KLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPP-SLG 440
LT A L L+ L+L +N + + + L L L I +
Sbjct: 134 WLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFE 193
Query: 441 NCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEV-GNLKNLVYFNI 499
NL L++ + P + + L L++S N + L +L +
Sbjct: 194 GLFNLKYLNLGMCNIKD--MPNLTPLVGLE-ELEMSGNHFP-EIRPGSFHGLSSLKKLWV 249
Query: 500 SVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNL 552
++ S SL +L L N+ S + L+ + EL + N
Sbjct: 250 MNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 7e-20
Identities = 53/280 (18%), Positives = 97/280 (34%), Gaps = 42/280 (15%)
Query: 156 DNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSI 215
L+ P I S +N++ N + + +L +L +L LG N I +
Sbjct: 63 RRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAF 119
Query: 216 FNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTL 275
++SL + L N +P + S L EL L
Sbjct: 120 NGLASLNTLELFDNWL---------TVIP----------------SGAFEYLSKLRELWL 154
Query: 276 FDNQFRGKVSIY-FRSLKNLEWLNLGSNNLGTGEANDLDFLT--LLTNCTELTAIGLDDN 332
+N + Y F + +L L+LG L++++ L + L
Sbjct: 155 RNNPIE-SIPSYAFNRVPSLMRLDLGEL-------KKLEYISEGAFEGLFNLKYLNLGMC 206
Query: 333 RFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIG 392
+ ++ L + ++ ++GN I P L +L +L + +++++ +A
Sbjct: 207 NIKDM--PNLTPLVG-LEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFD 263
Query: 393 ELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQ 432
L +L L L N L+ L L L L N
Sbjct: 264 GLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 7e-20
Identities = 60/247 (24%), Positives = 103/247 (41%), Gaps = 17/247 (6%)
Query: 259 SIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLL 318
+P+ + SN L L +N + + FR L +LE L LG N++ E + L L
Sbjct: 68 EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASL 125
Query: 319 TNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCM 378
L L DN + + LS + ++ + N I I + +L+ L +
Sbjct: 126 ---NTLE---LFDNWLTVIPSGAFEYLSK-LRELWLRNNPIESIPSYAFNRVPSLMRLDL 178
Query: 379 DD-NKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPP 437
+ KL A L NL+ L L + +P L L L L +S N I P
Sbjct: 179 GELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFP-EIRP 235
Query: 438 -SLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEV-GNLKNLV 495
S +L +L + + +++ + + L+L++N LS +LP ++ L+ LV
Sbjct: 236 GSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLV 293
Query: 496 YFNISVN 502
++ N
Sbjct: 294 ELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 2e-14
Identities = 54/231 (23%), Positives = 84/231 (36%), Gaps = 7/231 (3%)
Query: 76 LRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTN-LSRCSNLISFNARRNNL 134
RYLNL +NN L LE L L NS +I + ++L + N L
Sbjct: 77 TRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWL 135
Query: 135 VGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNN-LGN 193
IP+ KL L + +N + + + +L R+++ I
Sbjct: 136 T-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEG 194
Query: 194 LRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAE 253
L NL LNLG + P++ + LE + + N F + L L V
Sbjct: 195 LFNLKYLNLGMCNIKDM--PNLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMN 251
Query: 254 NNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNL 304
+ + + ++LVEL L N F L+ L L+L N
Sbjct: 252 SQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 5e-13
Identities = 47/209 (22%), Positives = 79/209 (37%), Gaps = 9/209 (4%)
Query: 51 RVTKLDLSNRTIGGTLSPYV-GNLSFLRYLNLADNNFHGEIPHQI-GRLVRLEALVLANN 108
+ L L +I + L+ L L L DN IP L +L L L NN
Sbjct: 100 HLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNN 157
Query: 109 SFSGKIPTN-LSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASI 167
IP+ +R +L+ + + I L+ L + ++ P +
Sbjct: 158 PIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-L 214
Query: 168 GNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLP 227
L LE + + GN P + L +L L + ++ S I + ++SL + L
Sbjct: 215 TPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLA 274
Query: 228 TNRFNGSLPLDIGVSLPKLLGFIVAENNF 256
N + SLP D+ L L+ + N +
Sbjct: 275 HNNLS-SLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-25
Identities = 53/234 (22%), Positives = 99/234 (42%), Gaps = 6/234 (2%)
Query: 343 ANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYL 402
+S+ + + NQI I ++L +L L + N + A L NL L L
Sbjct: 60 DGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLEL 119
Query: 403 DSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSL-GNCKNLIELHMADIELTGALPP 461
N L + L+ L L L +N ++ SIP +L L + +++ +
Sbjct: 120 FDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISE 178
Query: 462 QILS-ISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQ 520
+S L L+L+ L +P + L L ++S N S P + LQ+
Sbjct: 179 GAFEGLSNLR-YLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQK 235
Query: 521 LYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYN 574
L++ + ++ +L+S+ E++++ NNL+ + L LE ++L +N
Sbjct: 236 LWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 1e-19
Identities = 54/250 (21%), Positives = 98/250 (39%), Gaps = 17/250 (6%)
Query: 186 RIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPK 245
+P+ + N LLNL EN+ I S ++ LE + L N ++ + L
Sbjct: 57 EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLAN 113
Query: 246 LLGFIVAENNFAGSIPE-SLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNL 304
L + +N +IP + S L EL L +N S F + +L L+LG
Sbjct: 114 LNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKR 172
Query: 305 GTGEANDLDFLT--LLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGI 362
L +++ + L + L + ++ L + ++ ++GN +S I
Sbjct: 173 -------LSYISEGAFEGLSNLRYLNLAMCNLREI--PNLTPLIK-LDELDLSGNHLSAI 222
Query: 363 IPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLT 422
P + L++L +L M +++ +A L++L + L N L L L
Sbjct: 223 RPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLE 282
Query: 423 NLALSSNDLQ 432
+ L N
Sbjct: 283 RIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 1e-19
Identities = 49/244 (20%), Positives = 96/244 (39%), Gaps = 15/244 (6%)
Query: 211 VPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNL 270
VP I ++ + L N+ + ++ L L ++ N+ + + +NL
Sbjct: 58 VPDGIS--TNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANL 114
Query: 271 VELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLD 330
L LFDN+ + F L L+ L L +N + + + L + L
Sbjct: 115 NTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSY------AFNRIPSLRRLDLG 168
Query: 331 D-NRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPH 389
+ R + + LS+ + + +A + I P + L+ L EL + N L+ P
Sbjct: 169 ELKRLSYISEGAFEGLSN-LRYLNLAMCNLREI-PN-LTPLIKLDELDLSGNHLSAIRPG 225
Query: 390 AIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPS-LGNCKNLIEL 448
+ L +LQ L++ + + + NL L + L+ N+L +P +L +
Sbjct: 226 SFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERI 284
Query: 449 HMAD 452
H+
Sbjct: 285 HLHH 288
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 9e-15
Identities = 50/231 (21%), Positives = 83/231 (35%), Gaps = 7/231 (3%)
Query: 76 LRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTN-LSRCSNLISFNARRNNL 134
R LNL +N + L LE L L+ N I + +NL + N L
Sbjct: 66 TRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRL 124
Query: 135 VGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNN-LGN 193
IP KL+ L + +N + + + +L R+++ I
Sbjct: 125 T-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEG 183
Query: 194 LRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAE 253
L NL LNL I P++ + L+ + L N + ++ L L + +
Sbjct: 184 LSNLRYLNLAMCNLREI--PNLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQ 240
Query: 254 NNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNL 304
+ + N +LVE+ L N F L +LE ++L N
Sbjct: 241 SQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 7e-13
Identities = 50/207 (24%), Positives = 79/207 (38%), Gaps = 9/207 (4%)
Query: 53 TKLDLSNRTIGGTLSPYV-GNLSFLRYLNLADNNFHGEIPHQI-GRLVRLEALVLANNSF 110
L LS I T+ L+ L L L DN IP+ L +L+ L L NN
Sbjct: 91 EILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPI 148
Query: 111 SGKIPTNL-SRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGN 169
IP+ +R +L + + I L L +A +L P +
Sbjct: 149 E-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTP 205
Query: 170 LSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTN 229
L L+ +++ GN L P + L +L L + +++ I + N+ SL + L N
Sbjct: 206 LIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHN 265
Query: 230 RFNGSLPLDIGVSLPKLLGFIVAENNF 256
LP D+ L L + N +
Sbjct: 266 NLT-LLPHDLFTPLHHLERIHLHHNPW 291
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-25
Identities = 61/391 (15%), Positives = 127/391 (32%), Gaps = 32/391 (8%)
Query: 200 LNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGS 259
++L N + + S + L+ + + + + L L+ + N F
Sbjct: 35 VDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-Q 93
Query: 260 IPES-LSNASNLVELTLFDNQFRGKV--SIYFRSLKNLEWLNLGSNNLGTGEANDLDFLT 316
+ + +NL LTL G V +F+ L +LE L L NN+ + +
Sbjct: 94 LETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKK-----IQPAS 148
Query: 317 LLTNCTELTAIGLDDNRFGGVLPHSIANLSST---------MTDIVIAGNQISGIIPTGI 367
N + L N+ + + N +T + +
Sbjct: 149 FFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNP 208
Query: 368 RNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALS 427
++ L + N ++ + + + + +S G+ +
Sbjct: 209 FKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFT 268
Query: 428 SNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLE 487
L+ S + ++ ++ AL + S T L L+ N ++ +
Sbjct: 269 FKGLEAS---------GVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDN 317
Query: 488 V-GNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPS-SLSSLKSIKEL 545
L +L+ N+S N L+ L L N ++ S L ++KEL
Sbjct: 318 AFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKEL 376
Query: 546 DMSSNNLSGQIPEYLENLSFLEYLNLSYNHF 576
+ +N L + L+ L+ + L N +
Sbjct: 377 ALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-25
Identities = 76/373 (20%), Positives = 127/373 (34%), Gaps = 50/373 (13%)
Query: 261 PESLSNASNLVELTLFDNQFRGKVSIY-FRSLKNLEWLNLGSNNLGTGEANDLDFLTLLT 319
S S +L L + + FR L +L L L N E + L
Sbjct: 47 ETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLA--- 103
Query: 320 NCTELTAIGLDDNRF-GGVLPHSI-ANLSSTMTDIVIAGNQISGIIPTGI-RNLVNLVEL 376
L + L G VL + L+S + +V+ N I I P N+ L
Sbjct: 104 ---NLEVLTLTQCNLDGAVLSGNFFKPLTS-LEMLVLRDNNIKKIQPASFFLNMRRFHVL 159
Query: 377 CMDDNKLTGTIPHAI-----------GELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLA 425
+ NK+ +I L ++ L ++ +L + T +T L
Sbjct: 160 DLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLD 218
Query: 426 LSSNDLQGSIPP---SLGNCKNLIELHMADIELTGALPP--QILSISTLSL--------- 471
LS N + S+ + L +++ G+ +
Sbjct: 219 LSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVK 278
Query: 472 SLDLSYNLLSGTLPLEV-GNLKNLVYFNISVNRFSGEIPV-TLSACTSLQQLYLQGNSFS 529
+ DLS + + L V + +L ++ N + +I T L +L L N
Sbjct: 279 TCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG 336
Query: 530 GSIPS-SLSSLKSIKELDMSSNNLSGQIPEYL-ENLSFLEYLNLSYNHFEGEVPTKGVFS 587
SI S +L ++ LD+S N++ + + L L+ L L N + VP G+F
Sbjct: 337 -SIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVP-DGIFD 392
Query: 588 NKTG---ISLSGN 597
T I L N
Sbjct: 393 RLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-24
Identities = 66/390 (16%), Positives = 128/390 (32%), Gaps = 35/390 (8%)
Query: 100 LEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHL 159
+ + L+ NS + T+ SR +L + I L L + N
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91
Query: 160 TGHFPASI-GNLSTLERINVLGNGL-WGRIPNNL-GNLRNLILLNLGENRFSGIVPPSIF 216
L+ LE + + L + N L +L +L L +N I P S F
Sbjct: 92 L-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFF 150
Query: 217 -NISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTL 275
N+ + L N+ S+ + ++ L +S + +
Sbjct: 151 LNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHF-------------TLLRLSSITL-QDM 195
Query: 276 FDNQFRGKVSIYFRSLKNLEWLNLGSNNLGT-------GEANDLDFLTLLTNCTELTAIG 328
+ + ++ L+L N +L+ + +
Sbjct: 196 NEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS 255
Query: 329 LDDNRFGGVLPHSIANLSSTMTDIV-IAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTI 387
F + L ++ ++ ++I ++ + + +L +L + N++
Sbjct: 256 FGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKID 315
Query: 388 PHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPP-SLGNCKNLI 446
+A L +L L L NFL NL L L LS N ++ ++ S NL
Sbjct: 316 DNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLK 374
Query: 447 ELHMADIELTGALPPQIL----SISTLSLS 472
EL + +L ++P I S+ + L
Sbjct: 375 ELALDTNQLK-SVPDGIFDRLTSLQKIWLH 403
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-23
Identities = 81/407 (19%), Positives = 136/407 (33%), Gaps = 50/407 (12%)
Query: 38 CQWTGVTCGHRH--------QRVTKLDLSNRTIGGTLSPYV-GNLSFLRYLNLADNNFHG 88
C +R V +DLS +I L+ L L++L +
Sbjct: 10 VIGYNAICINRGLHQVPELPAHVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGL 68
Query: 89 EIPHQI-GRLVRLEALVLANNSFSGKIPTN-LSRCSNLISFNARRNNL-VGEIPAELGYN 145
I + L L L L N F ++ T + +NL + NL +
Sbjct: 69 VIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKP 127
Query: 146 WLKLENLTIADNHLTGHFPASI-GNLSTLERINVLGNGLWGRIPNN-----------LGN 193
LE L + DN++ PAS N+ ++ L I L
Sbjct: 128 LTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLD-LTFNKVKSICEEDLLNFQGKHFTLLR 186
Query: 194 LRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLP------------LDIGV 241
L ++ L ++ E + F +S+ + L N F S+ + +
Sbjct: 187 LSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLIL 246
Query: 242 SLPKLLGFIVAENNFAGSIPESLSN--ASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNL 299
S +G NF + AS + L ++ + F +LE L L
Sbjct: 247 SNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTL 306
Query: 300 GSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQI 359
N + + N T L + L N G + NL + + ++ N I
Sbjct: 307 AQNEINKIDDNAFW------GLTHLLKLNLSQNFLGSIDSRMFENLDK-LEVLDLSYNHI 359
Query: 360 SGIIPTGIRNLVNLVELCMDDNKLTGTIPH-AIGELKNLQLLYLDSN 405
+ L NL EL +D N+L ++P L +LQ ++L +N
Sbjct: 360 RALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 2e-18
Identities = 50/290 (17%), Positives = 103/290 (35%), Gaps = 35/290 (12%)
Query: 340 HSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPH-AIGELKNLQ 398
H + L + + + ++ N I+ + T L +L L ++ I + L +L
Sbjct: 23 HQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLI 82
Query: 399 LLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPP--SLGNCKNLIELHMADIELT 456
+L LD N + L L L L+ +L G++ +L L + D +
Sbjct: 83 ILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK 142
Query: 457 GALPPQILSISTLSL-SLDLSYNLLS----------GTLPLEVGNLKNLVYFNISVNRFS 505
+ P ++ LDL++N + + L ++ +++
Sbjct: 143 -KIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLG 201
Query: 506 GEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKEL--------DMSSNNLSGQIP 557
E TS+ L L GN F S+ + ++ ++
Sbjct: 202 WEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNF 261
Query: 558 EYLENLSF-------LEYLNLSYNHFEGEVPTKGVFSNKTG---ISLSGN 597
+ +N +F ++ +LS + + K VFS+ T ++L+ N
Sbjct: 262 KDPDNFTFKGLEASGVKTCDLSKSKIF-ALL-KSVFSHFTDLEQLTLAQN 309
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 2e-08
Identities = 40/261 (15%), Positives = 91/261 (34%), Gaps = 33/261 (12%)
Query: 72 NLSFLRYLNLADNNFHGEIPHQI-----------GRLVRLEALVLANNSFSGKIPTNLSR 120
N+ L+L N I + RL + + + N +
Sbjct: 152 NMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFK 210
Query: 121 CSNLISFNARRNNL----VGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNL------ 170
+++ + + N + ++ L+ + N + + +
Sbjct: 211 NTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFK 270
Query: 171 ----STLERINVLGNGLWGRIPNNL-GNLRNLILLNLGENRFSGIVPPSIF-NISSLENV 224
S ++ ++ + + + ++ + +L L L +N + I + F ++ L +
Sbjct: 271 GLEASGVKTCDLSKSKI-FALLKSVFSHFTDLEQLTLAQNEINKI-DDNAFWGLTHLLKL 328
Query: 225 FLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPE-SLSNASNLVELTLFDNQFRGK 283
L N GS+ + +L KL ++ N+ ++ + S NL EL L NQ +
Sbjct: 329 NLSQNFL-GSIDSRMFENLDKLEVLDLSYNHI-RALGDQSFLGLPNLKELALDTNQLKSV 386
Query: 284 VSIYFRSLKNLEWLNLGSNNL 304
F L +L+ + L +N
Sbjct: 387 PDGIFDRLTSLQKIWLHTNPW 407
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 54/220 (24%), Positives = 99/220 (45%), Gaps = 32/220 (14%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVIN---LKQKGASNGFVAECQALRNIRH 735
DF N++G+GSF VY+ G+ VA+K+I+ + + G E + ++H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 736 RNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSE---DQQEARSLTLIQRINI 792
+++++ F+ ++ +V E NG + +L + EAR + +I
Sbjct: 71 PSILELYNY-----FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR--HFMHQI-- 121
Query: 793 IIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETP 852
+ + Y+H H ++H DL SN+LL +++ + DFGLA T ++ P
Sbjct: 122 ----ITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLA---------TQLKMP 165
Query: 853 SSSKG-IKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEM 891
+ GT YI+PE + DV+S G + +
Sbjct: 166 HEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTL 205
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 58/249 (23%), Positives = 109/249 (43%), Gaps = 56/249 (22%)
Query: 687 IGQGSFGFVYKGNL-------GENGMMVAVKVINLKQKGAS----NGFVAECQALRNI-R 734
+G+G+FG V + + VAVK++ A+ + V+E + ++ I +
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEMEMMKMIGK 99
Query: 735 HRNLIKIITICSSIDFKGVDFQA----IVYEYMQNGSLEDWL----------HQSEDQQE 780
H+N+I ++ C+ Q ++ EY G+L ++L ++
Sbjct: 100 HKNIINLLGACT---------QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 781 ARSLTLIQRINIIIDVASAIEYI-HHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKF 839
+T ++ +A +EY+ C +H DL NVL+ ++ V + DFGLA+
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 840 LSSSPLDTAVETPSSSKG---IKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTR-R 895
+++ D +T + G +K APE + DV+SFG+L+ E+FT
Sbjct: 207 INNI--DYYKKT---TNGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFTLGG 257
Query: 896 RPTDGMFNQ 904
P G+ +
Sbjct: 258 SPYPGIPVE 266
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 61/238 (25%), Positives = 107/238 (44%), Gaps = 26/238 (10%)
Query: 662 MDQQFPMISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGAS- 720
M + + + S +D+ +IG G+ V VA+K INL++ S
Sbjct: 1 MSEDSSALPW---SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSM 57
Query: 721 NGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQE 780
+ + E QA+ H N++ S + + +V + + GS+ D + + E
Sbjct: 58 DELLKEIQAMSQCHHPNIVSY--YTSFV--VKDEL-WLVMKLLSGGSVLDIIKHIVAKGE 112
Query: 781 ARSLTLIQR-INIII-DVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAK 838
+S L + I I+ +V +EY+H + Q +H D+K N+LL +D + DFG++
Sbjct: 113 HKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSA 169
Query: 839 FLSSSPLDTAVETPSSSKGIKGTVGYIAPE-----YGMGGEASMTGDVYSFGILLLEM 891
FL++ T K GT ++APE G +A D++SFGI +E+
Sbjct: 170 FLATGGDIT---RNKVRKTFVGTPCWMAPEVMEQVRGYDFKA----DIWSFGITAIEL 220
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 57/240 (23%), Positives = 100/240 (41%), Gaps = 45/240 (18%)
Query: 687 IGQGSFGFVYKGNL-----GENGMMVAVKVINLKQKGAS----NGFVAECQALRNI-RHR 736
+G+G+FG V + + VAVK++ +GA+ ++E + L +I H
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKILIHIGHHL 91
Query: 737 NLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWL----------HQSEDQQEARSLTL 786
N++ ++ C+ ++ E+ + G+L +L + + LTL
Sbjct: 92 NVVNLLGACTKPGGP----LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 147
Query: 787 IQRINIIIDVASAIEYI-HHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPL 845
I VA +E++ C +H DL N+LL + V + DFGLA+ + P
Sbjct: 148 EHLICYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203
Query: 846 DTAVETPSSSKG---IKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGM 901
+K APE ++ DV+SFG+LL E+F+ P G+
Sbjct: 204 YVR-----KGDARLPLKWM----APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-25
Identities = 77/488 (15%), Positives = 155/488 (31%), Gaps = 43/488 (8%)
Query: 100 LEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHL 159
+AL L+ NS S ++S S L N + + + LE L ++ N L
Sbjct: 54 TKALSLSQNSISELRMPDISFLSELRVLRLSHNRI-RSLDFHVFLFNQDLEYLDVSHNRL 112
Query: 160 TGHFPASIGNLSTLERINVLGNGLWGRIPNN--LGNLRNLILLNLGENRFSGIVPPSIFN 217
S +++L +++ N + +P GNL L L L +F +
Sbjct: 113 QN---ISCCPMASLRHLDLSFND-FDVLPVCKEFGNLTKLTFLGLSAAKFRQL-DLLPVA 167
Query: 218 ISSLENVFLPTNRFNGS-LPLDIGVSLPKLLGFIVAENNFAGSIPESLSNAS----NLVE 272
L + L ++ + + +V N S+ ++S + L
Sbjct: 168 HLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSN 227
Query: 273 LTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDN 332
+ L D + ++ + LN+ ++ T + + + + +
Sbjct: 228 IKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFF-WPRPVEYLNIYNL 286
Query: 333 RFGGVLPHSIANLSSTMTDIV----IAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIP 388
+ S T + + + + +
Sbjct: 287 TITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHM 346
Query: 389 HAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIEL 448
+ L N + L L L L N L+ + KN+ L
Sbjct: 347 VCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSL 405
Query: 449 HMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEI 508
D+ L +L S ++++ N+S N +G +
Sbjct: 406 ETLDVSLN---------------------SLNSHAYDRTCAWAESILVLNLSSNMLTGSV 444
Query: 509 PVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEY 568
L ++ L L N SIP ++ L++++EL+++SN L + L+ L+Y
Sbjct: 445 FRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQY 501
Query: 569 LNLSYNHF 576
+ L N +
Sbjct: 502 IWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 2e-18
Identities = 67/441 (15%), Positives = 127/441 (28%), Gaps = 65/441 (14%)
Query: 148 KLENLTIADNHLTGHFPASI-GNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENR 206
+L L ++ N + + LE ++V N L I + +L L+L N
Sbjct: 77 ELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQN-IS--CCPMASLRHLDLSFND 132
Query: 207 FSGIVPPSIF-NISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLS 265
F + F N++ L + L +F L L L + +
Sbjct: 133 FDVLPVCKEFGNLTKLTFLGLSAAKFR-QLDLLPVAHLHLSCILLDLVSYHIKGGETESL 191
Query: 266 NASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELT 325
N L L + S+ L L L + L NC L
Sbjct: 192 QIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLND------------ENCQRLM 239
Query: 326 AIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTG 385
+ R +L ++ ++ +T V + L + + +T
Sbjct: 240 TFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFF---------WPRPVEYLNIYNLTITE 290
Query: 386 TIPHAIG-----ELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLG 440
I LK+L + ++ + + LS +D
Sbjct: 291 RIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTP-------- 342
Query: 441 NCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNIS 500
+ + L+ + N+ + ++ LK L +
Sbjct: 343 -----------------FIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQ 385
Query: 501 VNRFSGEIPVTLSACTSLQQLYLQGNSF----SGSIPSSLSSLKSIKELDMSSNNLSGQI 556
N ++ L S S + + + +SI L++SSN L+G +
Sbjct: 386 RNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSV 444
Query: 557 PEYLENLSFLEYLNLSYNHFE 577
L ++ L+L N
Sbjct: 445 FRCLPPK--VKVLDLHNNRIM 463
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 1e-17
Identities = 64/417 (15%), Positives = 122/417 (29%), Gaps = 58/417 (13%)
Query: 188 PNNLGNLRNLILLNLGENRFSGIVPPSIF-NISSLENVFLPTNRFNGSLPLDIGVSLPKL 246
++ L L +L L NR + +F LE + + NR ++
Sbjct: 69 MPDISFLSELRVLRLSHNRIRSL-DFHVFLFNQDLEYLDVSHNRL-QNISCC-------- 118
Query: 247 LGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRG-KVSIYFRSLKNLEWLNLGSNNLG 305
++L L L N F V F +L L +L L +
Sbjct: 119 -------------------PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFR 159
Query: 306 TGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPT 365
+ + L L +L + + S+ ++T+ +V N + +
Sbjct: 160 QLDLLPVAHLHLSCILLDLVSYHIKGGETE-----SLQIPNTTVLHLVFHPNSLFSVQVN 214
Query: 366 GIRNLVNLVEL------CMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNL- 418
N + ++L + +L + L +
Sbjct: 215 MSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFW 274
Query: 419 -TLLTNLALSSNDLQGSIPPSLGNCKNLI--ELHMADIELTG--ALPPQILSISTLSLSL 473
+ L + + + I L + ++ + S+
Sbjct: 275 PRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIK 334
Query: 474 DLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIP 533
LS + + + + + N + N F+ + S LQ L LQ N +
Sbjct: 335 MLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFF 393
Query: 534 S---SLSSLKSIKELDMSSNNL-SGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVF 586
++ S++ LD+S N+L S + LNLS N T VF
Sbjct: 394 KVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNML-----TGSVF 445
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 8e-14
Identities = 40/244 (16%), Positives = 90/244 (36%), Gaps = 16/244 (6%)
Query: 343 ANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAI-GELKNLQLLY 401
+L + ++ N IS + I L L L + N++ ++ + ++L+ L
Sbjct: 48 KDLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLD 106
Query: 402 LDSNFLAGGIPTSL--GNLTLLTNLALSSNDLQGSIPPS--LGNCKNLIELHMADIELTG 457
+ N L ++ + L +L LS ND +P GN L L ++ +
Sbjct: 107 VSHNRL-----QNISCCPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQ 160
Query: 458 ALPPQILSISTLSLSLDLSYNLLSGTLP--LEVGNLKNLVYFNISVNRFSGEIPVTLSAC 515
+ + + LDL + G L++ N L + FS ++ ++++A
Sbjct: 161 LDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNAL 220
Query: 516 TSLQQLYLQGNSFSGSIPSSLS--SLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSY 573
LQ ++ N + + + L+++ ++ ++ F + Y
Sbjct: 221 GHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEY 280
Query: 574 NHFE 577
+
Sbjct: 281 LNIY 284
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 2e-12
Identities = 59/343 (17%), Positives = 110/343 (32%), Gaps = 46/343 (13%)
Query: 293 NLEWLNLGSNNLGTGEANDLDFLTLLT------------------NCTELTAIGLDDNRF 334
+ L+L N++ D+ FL+ L +L + + NR
Sbjct: 53 RTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRL 112
Query: 335 GGVLPHSIANLSSTMTDIVIAGNQISGIIPTGI-RNLVNLVELCMDDNKLTGTIPHAIGE 393
+ +A+L + ++ N + NL L L + K +
Sbjct: 113 QNISCCPMASL----RHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAH 168
Query: 394 LK-NLQLLYLDSNFLAGGIPTSLGNL-TLLTNLALSSNDLQGSIPPSLGNCKNLIELHMA 451
L + LL L S + GG SL T + +L N L N L L ++
Sbjct: 169 LHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVN--ALGHLQLS 226
Query: 452 DIELTGA----LPPQILSISTLSLSLDLSYNLLSGTLP-----LEVGNLKNLVYFNISVN 502
+I+L L + ++ L+++ + T + + + Y NI
Sbjct: 227 NIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNL 286
Query: 503 RFSGEIP-----VTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIP 557
+ I + +A SL +++ F S + S + +S ++
Sbjct: 287 TITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHM 346
Query: 558 EYLENLSFLEYLNLSYNHFEGEVPTKGVFS---NKTGISLSGN 597
+ S +LN + N F V S + L N
Sbjct: 347 VCPPSPSSFTFLNFTQNVFTDSVF--QGCSTLKRLQTLILQRN 387
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 9e-07
Identities = 37/186 (19%), Positives = 73/186 (39%), Gaps = 13/186 (6%)
Query: 52 VTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFS 111
+ LS + S +LN N F + L RL+ L+L N
Sbjct: 331 MNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK 390
Query: 112 -----GKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPAS 166
+ N+S +L + + N+L + L ++ N LTG
Sbjct: 391 NFFKVALMTKNMS---SLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRC 447
Query: 167 IGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIF-NISSLENVF 225
+ ++ +++ N + IP ++ +L+ L LN+ N+ + P +F ++SL+ ++
Sbjct: 448 L--PPKVKVLDLHNNRI-MSIPKDVTHLQALQELNVASNQLKSV-PDGVFDRLTSLQYIW 503
Query: 226 LPTNRF 231
L N +
Sbjct: 504 LHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 7e-06
Identities = 30/196 (15%), Positives = 67/196 (34%), Gaps = 10/196 (5%)
Query: 55 LDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKI 114
+ N+ + + + L+ ++ L N F+ +
Sbjct: 310 EHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSV 369
Query: 115 PTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLT----GHFPASIGNL 170
S L + +RN L ++ + +L D L + +
Sbjct: 370 FQGCSTLKRLQTLILQRNGLK-NFF-KVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWA 427
Query: 171 STLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNR 230
++ +N+ N L G + L + +L+L NR I P + ++ +L+ + + +N+
Sbjct: 428 ESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIMSI-PKDVTHLQALQELNVASNQ 484
Query: 231 FNGSLPLDIGVSLPKL 246
S+P + L L
Sbjct: 485 LK-SVPDGVFDRLTSL 499
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-25
Identities = 60/249 (24%), Positives = 105/249 (42%), Gaps = 56/249 (22%)
Query: 687 IGQGSFGFVYKG-------NLGENGMMVAVKVINLKQKGAS----NGFVAECQALRNI-R 734
+G+G+FG V + VAVK++ A+ + ++E + ++ I +
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK---SDATEKDLSDLISEMEMMKMIGK 133
Query: 735 HRNLIKIITICSSIDFKGVDFQA----IVYEYMQNGSLEDWL----------HQSEDQQE 780
H+N+I ++ C+ Q ++ EY G+L ++L +
Sbjct: 134 HKNIINLLGACT---------QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 184
Query: 781 ARSLTLIQRINIIIDVASAIEYI-HHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKF 839
L+ ++ VA +EY+ C +H DL NVL+ +D V + DFGLA+
Sbjct: 185 EEQLSSKDLVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARD 240
Query: 840 LSSSPLDTAVETPSSSKG---IKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTR-R 895
+ D +T + G +K APE + DV+SFG+LL E+FT
Sbjct: 241 IHHI--DYYKKT---TNGRLPVKWM----APEALFDRIYTHQSDVWSFGVLLWEIFTLGG 291
Query: 896 RPTDGMFNQ 904
P G+ +
Sbjct: 292 SPYPGVPVE 300
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 63/254 (24%), Positives = 103/254 (40%), Gaps = 61/254 (24%)
Query: 687 IGQGSFGFVYKGNL-----GENGMMVAVKVINLKQKGASNG----FVAECQALRNIRHRN 737
+G+G FG V K VAVK+ LK + AS ++E L+ + H +
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKM--LK-ENASPSELRDLLSEFNVLKQVNHPH 87
Query: 738 LIKIITICSSIDFKGVDFQA----IVYEYMQNGSLEDWL------------------HQS 775
+IK+ CS Q ++ EY + GSL +L S
Sbjct: 88 VIKLYGACS---------QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 776 EDQQEARSLTLIQRINIIIDVASAIEYI-HHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834
D + R+LT+ I+ ++ ++Y+ VH DL N+L+ + + DF
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAEMKL----VHRDLAARNILVAEGRKMKISDF 194
Query: 835 GLAKFLSSSPLDTAVETPSSSKG---IKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEM 891
GL++ + D+ V S+G +K A E + DV+SFG+LL E+
Sbjct: 195 GLSRDVYEE--DSYV---KRSQGRIPVKWM----AIESLFDHIYTTQSDVWSFGVLLWEI 245
Query: 892 FTR-RRPTDGMFNQ 904
T P G+ +
Sbjct: 246 VTLGGNPYPGIPPE 259
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-25
Identities = 53/229 (23%), Positives = 94/229 (41%), Gaps = 43/229 (18%)
Query: 687 IGQGSFGFVYKGNL-----GENGMMVAVKVINLKQKGASNG----FVAECQALRNI-RHR 736
+G G+FG V + + + VAVK+ LK A ++E + + ++ +H
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKM--LK-STAHADEKEALMSELKIMSHLGQHE 110
Query: 737 NLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWL--------HQSEDQQEARSLTLIQ 788
N++ ++ C+ G I EY G L ++L + +
Sbjct: 111 NIVNLLGACT----HGGPVLVIT-EYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 789 RINIIIDVASAIEYI-HHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDT 847
++ VA + ++ +C +H D+ NVLL VA +GDFGLA+ + +
Sbjct: 166 LLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 221
Query: 848 AVETPSSSKG---IKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT 893
+K APE ++ DV+S+GILL E+F+
Sbjct: 222 V-----KGNARLPVKWM----APESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 53/213 (24%), Positives = 83/213 (38%), Gaps = 47/213 (22%)
Query: 675 SKATNDFSS----SNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---------KGASN 721
S +T+ F ++G+G V + AVK+I++ +
Sbjct: 9 SHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 68
Query: 722 GFVAECQALRNI-RHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWL----HQSE 776
+ E LR + H N+I++ ++ F +V++ M+ G L D+L SE
Sbjct: 69 ATLKEVDILRKVSGHPNIIQLKDT-----YETNTFFFLVFDLMKKGELFDYLTEKVTLSE 123
Query: 777 DQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836
E R I+ + I +H +VH DLKP N+LLD D+ L DFG
Sbjct: 124 K--ETR--------KIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 170
Query: 837 AKFLSS-SPLDTAVETPSSSKGIKGTVGYIAPE 868
+ L L GT Y+APE
Sbjct: 171 SCQLDPGEKLREVC----------GTPSYLAPE 193
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-25
Identities = 60/249 (24%), Positives = 109/249 (43%), Gaps = 56/249 (22%)
Query: 687 IGQGSFGFVYKGNL-------GENGMMVAVKVINLKQKGAS----NGFVAECQALRNI-R 734
+G+G FG V + + VAVK+ LK A+ + V+E + ++ I +
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKM--LK-DDATEKDLSDLVSEMEMMKMIGK 145
Query: 735 HRNLIKIITICSSIDFKGVDFQA----IVYEYMQNGSLEDWL----------HQSEDQQE 780
H+N+I ++ C+ Q ++ EY G+L ++L ++
Sbjct: 146 HKNIINLLGACT---------QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 196
Query: 781 ARSLTLIQRINIIIDVASAIEYI-HHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKF 839
+T ++ +A +EY+ C +H DL NVL+ ++ V + DFGLA+
Sbjct: 197 EEQMTFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARD 252
Query: 840 LSSSPLDTAVETPSSSKG---IKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTR-R 895
+++ D +T + G +K APE + DV+SFG+L+ E+FT
Sbjct: 253 INNI--DYYKKT---TNGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFTLGG 303
Query: 896 RPTDGMFNQ 904
P G+ +
Sbjct: 304 SPYPGIPVE 312
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 5e-25
Identities = 59/240 (24%), Positives = 93/240 (38%), Gaps = 46/240 (19%)
Query: 647 ARRRRSAHKSSVSQLMDQQFPMISYAELSKATNDFSS----SNMIGQGSFGFVYKGNLGE 702
A++ A L Q A +F ++IG+G V +
Sbjct: 58 AKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRA 117
Query: 703 NGMMVAVKVINLKQKGASNGFVA--------ECQALRNIR-HRNLIKIITICSSIDFKGV 753
G AVK++ + + S + E LR + H ++I +I S
Sbjct: 118 TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES-----S 172
Query: 754 DFQAIVYEYMQNGSLEDWL----HQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQP 809
F +V++ M+ G L D+L SE E R +I+ + A+ ++H +
Sbjct: 173 SFMFLVFDLMRKGELFDYLTEKVALSEK--ETR--------SIMRSLLEAVSFLHANN-- 220
Query: 810 PVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLS-SSPLDTAVETPSSSKGIKGTVGYIAPE 868
+VH DLKP N+LLD ++ L DFG + L L GT GY+APE
Sbjct: 221 -IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC----------GTPGYLAPE 269
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 9e-25
Identities = 56/222 (25%), Positives = 92/222 (41%), Gaps = 50/222 (22%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVA---------ECQALRNIRHRN 737
+G G+ G V + VA+K+I+ K+K A E + L+ + H
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIIS-KRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 738 LIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWL----HQSEDQQEARSLTLIQRINII 793
+IKI + D+ IV E M+ G L D + E +
Sbjct: 77 IIKIKNFFDAEDY------YIVLELMEGGELFDKVVGNKRLKEA--TCK--------LYF 120
Query: 794 IDVASAIEYIHHHCQPPVVHGDLKPSNVLL---DQDLVAHLGDFGLAKFLS-SSPLDTAV 849
+ A++Y+H + ++H DLKP NVLL ++D + + DFG +K L +S + T
Sbjct: 121 YQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC 177
Query: 850 ETPSSSKGIKGTVGYIAPEYGMGGEASMTG---DVYSFGILL 888
GT Y+APE + + D +S G++L
Sbjct: 178 ----------GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 51/233 (21%), Positives = 91/233 (39%), Gaps = 47/233 (20%)
Query: 687 IGQGSFGFVYKGNL-----GENGMMVAVKVINLKQKGAS----NGFVAECQALRNI-RHR 736
+G G+FG V + + M VAVK++ A ++E + L + H
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSAHLTEREALMSELKVLSYLGNHM 87
Query: 737 NLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWL------------HQSEDQQEARSL 784
N++ ++ C+ G I EY G L ++L + + + +L
Sbjct: 88 NIVNLLGACT----IGGPTLVIT-EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 785 TLIQRINIIIDVASAIEYIH-HHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSS 843
L ++ VA + ++ +C +H DL N+LL + + DFGLA+ + +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKND 198
Query: 844 PLDTAVETPSSSKG---IKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT 893
+K APE + DV+S+GI L E+F+
Sbjct: 199 SNYVV-----KGNARLPVKWM----APESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 62/220 (28%), Positives = 100/220 (45%), Gaps = 32/220 (14%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASN--GFVAECQALRNIRHRNLIKIITI 744
IG+G+F V G VA+K+I+ Q ++ E + ++ + H N++K+ +
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 745 CSSIDFKGVDFQAIVYEYMQNGSLEDWL--HQSEDQQEARSLTLIQRINIIIDVASAIEY 802
I+ + + ++ EY G + D+L H ++EARS Q I+ SA++Y
Sbjct: 83 ---IETEKTLY--LIMEYASGGEVFDYLVAHGRMKEKEARSK-FRQ----IV---SAVQY 129
Query: 803 IHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL-AKFLSSSPLDTAVETPSSSKGIKGT 861
H +VH DLK N+LLD D+ + DFG +F LD P
Sbjct: 130 CHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPP-------- 178
Query: 862 VGYIAPEYGMGGE-ASMTGDVYSFGILLLEMFTRRRPTDG 900
Y APE G + DV+S G++L + + P DG
Sbjct: 179 --YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 216
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 60/228 (26%), Positives = 108/228 (47%), Gaps = 40/228 (17%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNL 738
+DF + +G G+ G V+K + +G+++A K+I+L+ K A IR++ +
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA-------------IRNQII 79
Query: 739 --IKIITICSS---IDFKGVDFQA----IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQR 789
++++ C+S + F G + I E+M GSL+ L ++ E
Sbjct: 80 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQ------IL 133
Query: 790 INIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAV 849
+ I V + Y+ + ++H D+KPSN+L++ L DFG++ L S ++ V
Sbjct: 134 GKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV 191
Query: 850 ETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897
GT Y++PE G S+ D++S G+ L+EM R P
Sbjct: 192 ----------GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-24
Identities = 55/246 (22%), Positives = 97/246 (39%), Gaps = 52/246 (21%)
Query: 666 FPMISYAELSKATNDFSS----SNMIGQGSFGFVYKGNLGENGMMVAVKVIN-------- 713
F ++ + S S +G G+ G V + VA+++I+
Sbjct: 118 FFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGS 177
Query: 714 LKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWL- 772
++ + E + L+ + H +IKI + D+ IV E M+ G L D +
Sbjct: 178 AREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY------YIVLELMEGGELFDKVV 231
Query: 773 ---HQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLL---DQD 826
E + + A++Y+H + ++H DLKP NVLL ++D
Sbjct: 232 GNKRLKEA--TCK--------LYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEED 278
Query: 827 LVAHLGDFGLAKFLS-SSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTG---DVY 882
+ + DFG +K L +S + T GT Y+APE + + D +
Sbjct: 279 CLIKITDFGHSKILGETSLMRTLC----------GTPTYLAPEVLVSVGTAGYNRAVDCW 328
Query: 883 SFGILL 888
S G++L
Sbjct: 329 SLGVIL 334
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-24
Identities = 63/230 (27%), Positives = 88/230 (38%), Gaps = 53/230 (23%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICS 746
IG G+FG +VAVK I + E R++RH N+++ +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIE-RGAAIDENVQREIINHRSLRHPNIVRFKEVIL 86
Query: 747 S---IDFKGVDFQAIVYEYMQNGSLEDWLHQ----SEDQQEARSLTLIQRINIIIDVASA 799
+ + AI+ EY G L + + SED EAR Q++ S
Sbjct: 87 TPTHL--------AIIMEYASGGELYERICNAGRFSED--EARF--FFQQL------LSG 128
Query: 800 IEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHL--GDFGLAK-FLSSSPLDTAVETPSSSK 856
+ Y H + H DLK N LLD L DFG +K + S + V TP+
Sbjct: 129 VSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--- 182
Query: 857 GIKGTVGYIAPE------YGMGGEASMTGDVYSFGILLLEMFTRRRPTDG 900
YIAPE Y G A DV+S G+ L M P +
Sbjct: 183 -------YIAPEVLLRQEYD-GKIA----DVWSCGVTLYVMLVGAYPFED 220
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 6e-24
Identities = 76/227 (33%), Positives = 105/227 (46%), Gaps = 45/227 (19%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVA----ECQALRNIRHRNLIKII 742
+G G+FG V G G VAVK++N +QK S V E Q L+ RH ++IK+
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILN-RQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 743 TICSSIDFKGVDFQAIVYEYMQNGSLEDWL--HQSEDQQEARSLTLIQRINIIIDVASAI 800
+ I F +V EY+ G L D++ H ++ EAR L Q+I SA+
Sbjct: 78 QV---ISTPTDFF--MVMEYVSGGELFDYICKHGRVEEMEAR--RLFQQI------LSAV 124
Query: 801 EYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL-AKFLSSSPLDTAVETPSSSKGIK 859
+Y H H VVH DLKP NVLLD + A + DFGL L T+ +P+
Sbjct: 125 DYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN------ 175
Query: 860 GTVGYIAPE------YGMGGEASMTGDVYSFGILLLEMFTRRRPTDG 900
Y APE Y G E D++S G++L + P D
Sbjct: 176 ----YAAPEVISGRLYA-GPEV----DIWSCGVILYALLCGTLPFDD 213
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-24
Identities = 66/222 (29%), Positives = 93/222 (41%), Gaps = 55/222 (24%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGAS---NGFVAECQALRNIRHRNLIKIIT 743
+G+GSFG V K AVKVIN K + + + E + L+ + H N++K+
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVIN-KASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 744 ICSSIDFKGVDFQAIVYEYMQNGSLEDWL----HQSEDQQEARSLTLIQRINIIIDVASA 799
I + IV E G L D + SE +A II V S
Sbjct: 89 I-----LEDSSSFYIVGELYTGGELFDEIIKRKRFSE--HDAA--------RIIKQVFSG 133
Query: 800 IEYIHHHCQPPVVHGDLKPSNVLL---DQDLVAHLGDFGLAKFLS-SSPLDTAVETPSSS 855
I Y+H H +VH DLKP N+LL ++D + DFGL+ ++ + +
Sbjct: 134 ITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI------ 184
Query: 856 KGIKGTVGYIAPE-----YGMGGEASMTGDVYSFG----ILL 888
GT YIAPE Y + DV+S G ILL
Sbjct: 185 ----GTAYYIAPEVLRGTYDE--KC----DVWSAGVILYILL 216
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-23
Identities = 59/259 (22%), Positives = 104/259 (40%), Gaps = 71/259 (27%)
Query: 687 IGQGSFGFVYKGNL-----GENGMMVAVKVINLKQKGAS----NGFVAECQALRNIRHRN 737
IG+G+FG V++ E MVAVK+ LK + AS F E + + N
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKM--LK-EEASADMQADFQREAALMAEFDNPN 111
Query: 738 LIKIITICSSIDFKGVDFQA----IVYEYMQNGSLEDWLHQS------------------ 775
++K++ +C+ +++EYM G L ++L
Sbjct: 112 IVKLLGVCA---------VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162
Query: 776 EDQQEARSLTLIQRINIIIDVASAIEYIH-HHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834
L+ +++ I VA+ + Y+ VH DL N L+ +++V + DF
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF----VHRDLATRNCLVGENMVVKIADF 218
Query: 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYI-----APE---YGMGGEASMTGDVYSFGI 886
GL++ + S+ D I PE Y S DV+++G+
Sbjct: 219 GLSRNIYSA--DYYK---------ADGNDAIPIRWMPPESIFYNRYTTES---DVWAYGV 264
Query: 887 LLLEMFTR-RRPTDGMFNQ 904
+L E+F+ +P GM ++
Sbjct: 265 VLWEIFSYGLQPYYGMAHE 283
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 57/221 (25%), Positives = 90/221 (40%), Gaps = 51/221 (23%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVA---------ECQALRNIRHRN 737
+G G+FGFV+ E V VK I K+K + ++ E L + H N
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIK-KEKVLEDCWIEDPKLGKVTLEIAILSRVEHAN 90
Query: 738 LIKIITICSSIDFKGVDFQAIVYEYMQNGS-LEDWL--HQSEDQQEARSLTLIQRINIII 794
+IK++ I F+ F +V E +G L ++ H D+ A I
Sbjct: 91 IIKVLDI-----FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLAS--------YIFR 137
Query: 795 DVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSS-SPLDTAVETPS 853
+ SA+ Y+ ++H D+K N+++ +D L DFG A +L T
Sbjct: 138 QLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC---- 190
Query: 854 SSKGIKGTVGYIAPE------YGMGGEASMTGDVYSFGILL 888
GT+ Y APE Y G E +++S G+ L
Sbjct: 191 ------GTIEYCAPEVLMGNPYR-GPEL----EMWSLGVTL 220
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 57/219 (26%), Positives = 82/219 (37%), Gaps = 51/219 (23%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICS 746
IG+GS+G V + A K I + F E + ++++ H N+I++
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET-- 74
Query: 747 SIDFKGVDFQAIVYEYMQNGSLEDWL----HQSEDQQEARSLTLIQRINIIIDVASAIEY 802
F+ +V E G L + + E +A I+ DV SA+ Y
Sbjct: 75 ---FEDNTDIYLVMELCTGGELFERVVHKRVFRE--SDAA--------RIMKDVLSAVAY 121
Query: 803 IHHHCQPPVVHGDLKPSNVLL---DQDLVAHLGDFGLAKFLS-SSPLDTAVETPSSSKGI 858
H V H DLKP N L D L DFGLA + T V
Sbjct: 122 CHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV--------- 169
Query: 859 KGTVGYIAPE-----YGMGGEASMTGDVYSFG----ILL 888
GT Y++P+ YG E D +S G +LL
Sbjct: 170 -GTPYYVSPQVLEGLYGP--EC----DEWSAGVMMYVLL 201
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-23
Identities = 59/249 (23%), Positives = 97/249 (38%), Gaps = 47/249 (18%)
Query: 674 LSKATNDFSS----SNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASN--GFVAEC 727
++ S +G G++G V + A+K+I S+ + E
Sbjct: 28 ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV 87
Query: 728 QALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWL----HQSEDQQEARS 783
L+ + H N++K+ F+ +V E + G L D + +E +A
Sbjct: 88 AVLKLLDHPNIMKLYDF-----FEDKRNYYLVMECYKGGELFDEIIHRMKFNE--VDAA- 139
Query: 784 LTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLL---DQDLVAHLGDFGLAKFL 840
II V S + Y+H H +VH DLKP N+LL ++D + + DFGL+
Sbjct: 140 -------VIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189
Query: 841 S-SSPLDTAVETPSSSKGIKGTVGYIAPE--YGMGGEASMTGDVYSFGILLLEMFTRRRP 897
+ + GT YIAPE E DV+S G++L + P
Sbjct: 190 ENQKKMKERL----------GTAYYIAPEVLRKKYDEKC---DVWSIGVILFILLAGYPP 236
Query: 898 TDGMFNQGL 906
G +Q +
Sbjct: 237 FGGQTDQEI 245
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 50/228 (21%), Positives = 87/228 (38%), Gaps = 41/228 (17%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVA-------ECQALRNIRHR--N 737
+G G FG VY G + + VA+K + K + + G + E L+ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVE-KDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 738 LIKIITICSSIDFKGVDFQAIVYEYMQN-GSLEDWL--HQSEDQQEARSLTLIQRINIII 794
+I+++ + ++ E + L D++ + ++ ARS Q
Sbjct: 110 VIRLLDW---FERPDSFV--LILERPEPVQDLFDFITERGALQEELARSF-FWQ------ 157
Query: 795 DVASAIEYIHHHCQPPVVHGDLKPSNVLLDQD-LVAHLGDFGLAKFLSSSPLDTAVETPS 853
V A+ + H+ V+H D+K N+L+D + L DFG L +
Sbjct: 158 -VLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD---- 209
Query: 854 SSKGIKGTVGYIAPEYGMGGE-ASMTGDVYSFGILLLEMFTRRRPTDG 900
GT Y PE+ + V+S GILL +M P +
Sbjct: 210 ------GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 53/212 (25%), Positives = 89/212 (41%), Gaps = 36/212 (16%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVIN-LKQKGASNGFVAECQALRNIRHRNLIKIITIC 745
+G G+FG V+ +G+ +K IN + + AE + L+++ H N+IKI +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV- 88
Query: 746 SSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHH 805
F+ IV E + G L + + Q ++L+ ++ + +A+ Y H
Sbjct: 89 ----FEDYHNMYIVMETCEGGELLERI--VSAQARGKALSEGYVAELMKQMMNALAYFHS 142
Query: 806 HCQPPVVHGDLKPSNVLL---DQDLVAHLGDFGLAKFLSS-SPLDTAVETPSSSKGIKGT 861
VVH DLKP N+L + DFGLA+ S A GT
Sbjct: 143 Q---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA----------GT 189
Query: 862 VGYIAPE-----YGMGGEASMTGDVYSFGILL 888
Y+APE + D++S G+++
Sbjct: 190 ALYMAPEVFKRDVTF--KC----DIWSAGVVM 215
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 63/323 (19%), Positives = 114/323 (35%), Gaps = 59/323 (18%)
Query: 259 SIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLL 318
SIP L+ + L L +N+ + + NL+ L L SN + T E + L L
Sbjct: 45 SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSL 102
Query: 319 TNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCM 378
L +LS N +S + + + L +L L +
Sbjct: 103 E---HL-------------------DLSY---------NYLSNLSSSWFKPLSSLTFLNL 131
Query: 379 DDNKLTGTIPHAI--GELKNLQLLYLDSNFLAGGIPT-SLGNLTLLTNLALSSNDLQGSI 435
N T+ L LQ+L + + I LT L L + ++DLQ S
Sbjct: 132 LGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SY 189
Query: 436 PP-SLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNL 494
P SL + +N+ L + + L + +++ L+L L
Sbjct: 190 EPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLD------------- 235
Query: 495 VYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSG 554
+ S +L + + + + S + L+ + + EL+ S N L
Sbjct: 236 ---TFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS 291
Query: 555 QIPEY-LENLSFLEYLNLSYNHF 576
+P+ + L+ L+ + L N +
Sbjct: 292 -VPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-23
Identities = 49/269 (18%), Positives = 113/269 (42%), Gaps = 19/269 (7%)
Query: 343 ANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYL 402
+ L+ + + ++ N+I+ I + ++ VNL L + N + + L +L+ L L
Sbjct: 48 SGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDL 107
Query: 403 DSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPS--LGNCKNLIELHMADIELTGALP 460
N+L+ + L+ LT L L N + ++ + + L L + +++ +
Sbjct: 108 SYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQ 166
Query: 461 PQILSISTLSLSLDLSYNLLSGTLPLEV-GNLKNLVYFNISVNRFSGEIPVTLSACTSLQ 519
+ + T L++ + L + + +++N+ + + + + + + + +S++
Sbjct: 167 RKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVE 225
Query: 520 QLYLQGNSFSGSIPSSLSS--------LKSIKELDMSSNNLSGQIPEYLENLSFLEYLNL 571
L L+ S LS+ + + + ++ +L Q+ + L +S L L
Sbjct: 226 CLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEF 284
Query: 572 SYNHFEGEVPTKGVFSNKTG---ISLSGN 597
S N + VP G+F T I L N
Sbjct: 285 SRNQLKS-VP-DGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 2e-21
Identities = 59/337 (17%), Positives = 111/337 (32%), Gaps = 35/337 (10%)
Query: 100 LEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHL 159
V+ + S C +L IP+ L +++L +++N +
Sbjct: 9 WVLGVIISLSKEESSNQASLSCDRNGICKGSSGSL-NSIPSGLTEA---VKSLDLSNNRI 64
Query: 160 TGHFPASIGNLSTLERINVLGNGLWGRIPNNL-GNLRNLILLNLGENRFSGIVPPSIF-N 217
T + + L+ + + NG+ I + +L +L L+L N S + S F
Sbjct: 65 TYISNSDLQRCVNLQALVLTSNGI-NTIEEDSFSSLGSLEHLDLSYNYLSNL-SSSWFKP 122
Query: 218 ISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPE-SLSNASNLVELTLF 276
+SSL + L N + + L KL V + I + + L EL +
Sbjct: 123 LSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEID 182
Query: 277 DNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGG 336
+ + +S++N+ L L +D + + C EL LD F
Sbjct: 183 ASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVE-CLELRDTDLDTFHF-- 239
Query: 337 VLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKN 396
+++S + + + D L + + ++
Sbjct: 240 --------------------SELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISG 278
Query: 397 LQLLYLDSNFLAGGIPTS-LGNLTLLTNLALSSNDLQ 432
L L N L +P LT L + L +N
Sbjct: 279 LLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 4e-16
Identities = 58/264 (21%), Positives = 95/264 (35%), Gaps = 15/264 (5%)
Query: 52 VTKLDLSNRTIGGTLSPYV-GNLSFLRYLNLADNNFHGEIPHQI-GRLVRLEALVLANNS 109
V LDLSN I +S L+ L L N + I L LE L L+ N
Sbjct: 54 VKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNY 111
Query: 110 FSGKIPTNL-SRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASI- 167
S + ++ S+L N N L + KL+ L + +
Sbjct: 112 LS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDF 170
Query: 168 GNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIF-NISSLENVFL 226
L+ LE + + + L P +L +++N+ L L + + SS+E + L
Sbjct: 171 AGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILL-LEIFVDVTSSVECLEL 229
Query: 227 PTNRFNG----SLPLDIGVSLPKLLGF--IVAENNFAGSIPESLSNASNLVELTLFDNQF 280
+ L SL K F + + + + L+ S L+EL NQ
Sbjct: 230 RDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQL 289
Query: 281 RGKVSIYFRSLKNLEWLNLGSNNL 304
+ F L +L+ + L +N
Sbjct: 290 KSVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 5e-07
Identities = 25/163 (15%), Positives = 54/163 (33%), Gaps = 22/163 (13%)
Query: 72 NLSFLRYLNLADNNFHGEIPHQI-GRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNAR 130
L+FL L + ++ + + + L+L +
Sbjct: 172 GLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHI-LLLEIF------------ 217
Query: 131 RNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNN 190
+ EL L + + L+ S+ T + + L ++
Sbjct: 218 VDVTSSVECLELRDTDLDTFHF----SELSTGETNSLIKKFTFRNVKITDESL-FQVMKL 272
Query: 191 LGNLRNLILLNLGENRFSGIVPPSIF-NISSLENVFLPTNRFN 232
L + L+ L N+ + P IF ++SL+ ++L TN ++
Sbjct: 273 LNQISGLLELEFSRNQLKSV-PDGIFDRLTSLQKIWLHTNPWD 314
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 52/216 (24%), Positives = 95/216 (43%), Gaps = 32/216 (14%)
Query: 686 MIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIR-HRNLIKIITI 744
++G+G+ V AVK+I + + E + L + HRN++++I
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 745 CSSIDFKGVDFQAIVYEYMQNGSLEDWLHQ----SEDQQEARSLTLIQRINIIIDVASAI 800
F+ D +V+E M+ GS+ +H+ +E EA ++ DVASA+
Sbjct: 80 -----FEEEDRFYLVFEKMRGGSILSHIHKRRHFNE--LEAS--------VVVQDVASAL 124
Query: 801 EYIHHHCQPPVVHGDLKPSNVLL---DQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKG 857
+++H+ + H DLKP N+L +Q + DF L + + + + TP
Sbjct: 125 DFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTP 181
Query: 858 IKGTVGYIAPEYGMGGEASMTG-----DVYSFGILL 888
G+ Y+APE + D++S G++L
Sbjct: 182 C-GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-23
Identities = 57/238 (23%), Positives = 94/238 (39%), Gaps = 52/238 (21%)
Query: 687 IGQGSFGFVYKGNL-----GENGMMVAVKVINLKQKGAS----NGFVAECQALRNI-RHR 736
+G G+FG V + VAVK+ LK + A ++E + + + H
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKM--LK-EKADSSEREALMSELKMMTQLGSHE 109
Query: 737 NLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWL-----------------HQSEDQQ 779
N++ ++ C+ I EY G L ++L + E+++
Sbjct: 110 NIVNLLGACT----LSGPIYLIF-EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 780 EARSLTLIQRINIIIDVASAIEYI-HHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAK 838
+ LT + VA +E++ C VH DL NVL+ V + DFGLA+
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKSC----VHRDLAARNVLVTHGKVVKICDFGLAR 220
Query: 839 FLSSSPLDTAVETPSSSKG---IKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT 893
+ S +K APE G ++ DV+S+GILL E+F+
Sbjct: 221 DIMSDSNYVV-----RGNARLPVKWM----APESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 54/235 (22%), Positives = 88/235 (37%), Gaps = 51/235 (21%)
Query: 686 MIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVA-------ECQALRNIR---- 734
++G+G FG V+ G+ + + VA+KVI + + ++ E L +
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIP-RNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 735 HRNLIKIITICSSIDFKGVDFQAIVYEYMQNGS-LEDWL--HQSEDQQEARSLTLIQRIN 791
H +I+++ + + +V E L D++ + +R Q
Sbjct: 97 HPGVIRLLDW---FETQEGFM--LVLERPLPAQDLFDYITEKGPLGEGPSRCF-FGQ--- 147
Query: 792 IIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQD-LVAHLGDFGLAKFLSSSPLDTAVE 850
V +AI++ H VVH D+K N+L+D A L DFG L P
Sbjct: 148 ----VVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD- 199
Query: 851 TPSSSKGIKGTVGYIAPEYGMGG-----EASMTGDVYSFGILLLEMFTRRRPTDG 900
GT Y PE+ A V+S GILL +M P +
Sbjct: 200 ---------GTRVYSPPEWISRHQYHALPA----TVWSLGILLYDMVCGDIPFER 241
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-23
Identities = 50/217 (23%), Positives = 88/217 (40%), Gaps = 47/217 (21%)
Query: 686 MIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQAL-RNIRHRNLIKIITI 744
++G G G V + G A+K++ A E + +++ I+ +
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLY-DSPKARQ----EVDHHWQASGGPHIVCILDV 90
Query: 745 CSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQ----QEARSLTLIQRINIIIDVASAI 800
++ I+ E M+ G L + + DQ +EA I+ D+ +AI
Sbjct: 91 YENMHHGKRCLL-IIMECMEGGELFSRIQERGDQAFTEREAA--------EIMRDIGTAI 141
Query: 801 EYIHHHCQPPVVHGDLKPSNVLL---DQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKG 857
+++H H + H D+KP N+L ++D V L DFG AK + + L T
Sbjct: 142 QFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPC-------- 190
Query: 858 IKGTVGYIAPE------YGMGGEASMTGDVYSFGILL 888
T Y+APE Y D++S G+++
Sbjct: 191 --YTPYYVAPEVLGPEKYDK--SC----DMWSLGVIM 219
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-23
Identities = 62/270 (22%), Positives = 98/270 (36%), Gaps = 56/270 (20%)
Query: 654 HKSSVSQLMDQQFPMISYAELSKATNDFSS----SNMIGQGSFGFVYKGNLGENGMMVAV 709
H S L Q + + K +G G++G V A+
Sbjct: 7 HSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAI 66
Query: 710 KVINLKQKGASNGFVA-------------ECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756
KVI Q E L+++ H N+IK+ + D K
Sbjct: 67 KVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFE--DKKYF--- 121
Query: 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDL 816
+V E+ + G L + + E + ++++I S I Y+H H +VH D+
Sbjct: 122 YLVTEFYEGGELFEQIINRHKFDECDAANIMKQI------LSGICYLHKHN---IVHRDI 172
Query: 817 KPSNVLL---DQDLVAHLGDFGLAKFLSSS-PLDTAVETPSSSKGIKGTVGYIAPE---- 868
KP N+LL + L + DFGL+ F S L + GT YIAPE
Sbjct: 173 KPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL----------GTAYYIAPEVLKK 222
Query: 869 -YGMGGEASMTGDVYSFGILLLEMFTRRRP 897
Y + DV+S G+++ + P
Sbjct: 223 KYNE--KC----DVWSCGVIMYILLCGYPP 246
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-23
Identities = 72/249 (28%), Positives = 106/249 (42%), Gaps = 46/249 (18%)
Query: 674 LSKATNDFSS----SNMIGQGSFGFVYKGNLGENGMMVAVKVIN---LKQKGASNGFVAE 726
+ +T FS ++G+GSFG V G AVKVI+ +KQK + E
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 727 CQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWL----HQSEDQQEAR 782
Q L+ + H N++K+ F+ + +V E G L D + SE +A
Sbjct: 77 VQLLKQLDHPNIMKLYEF-----FEDKGYFYLVGEVYTGGELFDEIISRKRFSE--VDAA 129
Query: 783 SLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLL---DQDLVAHLGDFGLAKF 839
II V S I Y+H + +VH DLKP N+LL +D + DFGL+
Sbjct: 130 --------RIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178
Query: 840 LSSSPLDTAVETPSSSKGIKGTVGYIAPE--YGMGGEASMTGDVYSFGILLLEMFTRRRP 897
+S K GT YIAPE +G E DV+S G++L + + P
Sbjct: 179 FEAS---------KKMKDKIGTAYYIAPEVLHGTYDEKC---DVWSTGVILYILLSGCPP 226
Query: 898 TDGMFNQGL 906
+G +
Sbjct: 227 FNGANEYDI 235
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 5e-23
Identities = 53/222 (23%), Positives = 91/222 (40%), Gaps = 54/222 (24%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASN--GFVAECQALRNIRHRNLIKIITI 744
+G+G+F V + G+ A K+IN K+ A + E + R ++H N++++
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 745 CSSIDFKGVDFQAIVYEYMQNGSLEDWL----HQSEDQQEARSLTLIQRINIIIDVASAI 800
+ F +V++ + G L + + SE +A + I + +I
Sbjct: 74 -----IQEESFHYLVFDLVTGGELFEDIVAREFYSEA--DAS--------HCIQQILESI 118
Query: 801 EYIHHHCQPPVVHGDLKPSNVLL---DQDLVAHLGDFGLAKFLS-SSPLDTAVETPSSSK 856
Y H + +VH +LKP N+LL + L DFGLA ++ S
Sbjct: 119 AYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA------- 168
Query: 857 GIKGTVGYIAPE------YGMGGEASMTGDVYSFG----ILL 888
GT GY++PE Y D+++ G ILL
Sbjct: 169 ---GTPGYLSPEVLKKDPYSK--PV----DIWACGVILYILL 201
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 6e-23
Identities = 56/225 (24%), Positives = 92/225 (40%), Gaps = 45/225 (20%)
Query: 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRN 737
++ IGQG+ G VY G VA++ +NL+Q+ + E +R ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 738 LIKIITICSSIDFKG---VDFQA-IVYEYMQNGSLEDWLHQ---SEDQQEARSLTLIQRI 790
++ + V + +V EY+ GSL D + + E Q I
Sbjct: 79 IVN---------YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ-----------I 118
Query: 791 NIII-DVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPL--DT 847
+ + A+E++H + V+H D+K N+LL D L DFG ++ T
Sbjct: 119 AAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175
Query: 848 AVETPSSSKGIKGTVGY-IAPEYGMGGEASMTGDVYSFGILLLEM 891
V TP Y +APE D++S GI+ +EM
Sbjct: 176 MVGTP-----------YWMAPEVVTRKAYGPKVDIWSLGIMAIEM 209
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 7e-23
Identities = 74/227 (32%), Positives = 105/227 (46%), Gaps = 45/227 (19%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVA----ECQALRNIRHRNLIKII 742
+G G+FG V G G VAVK++N +QK S V E Q L+ RH ++IK+
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILN-RQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 743 TICSSIDFKGVDFQAIVYEYMQNGSLEDWL--HQSEDQQEARSLTLIQRINIIIDVASAI 800
+ I F +V EY+ G L D++ + D++E+R L Q+I S +
Sbjct: 83 QV---ISTPSDIF--MVMEYVSGGELFDYICKNGRLDEKESRRL--FQQI------LSGV 129
Query: 801 EYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL-AKFLSSSPLDTAVETPSSSKGIK 859
+Y H H VVH DLKP NVLLD + A + DFGL L T+ +P+
Sbjct: 130 DYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN------ 180
Query: 860 GTVGYIAPE------YGMGGEASMTGDVYSFGILLLEMFTRRRPTDG 900
Y APE Y G E D++S G++L + P D
Sbjct: 181 ----YAAPEVISGRLYA-GPEV----DIWSSGVILYALLCGTLPFDD 218
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 9e-23
Identities = 58/248 (23%), Positives = 104/248 (41%), Gaps = 33/248 (13%)
Query: 650 RRSAHKSSVSQLMDQQFPMISYAELSKA--TNDFSSSNMIGQGSFGFVYKGNLGENGMMV 707
+ +QF + + S IG+GS G V +G V
Sbjct: 14 GTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQV 73
Query: 708 AVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGS 767
AVK+++L+++ E +R+ +H N++++ S G + ++ E++Q G+
Sbjct: 74 AVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMY---KSY-LVGEELW-VLMEFLQGGA 128
Query: 768 LEDWLHQ---SEDQQEARSLTLIQRINIII-DVASAIEYIHHHCQPPVVHGDLKPSNVLL 823
L D + Q +E+Q I + V A+ Y+H V+H D+K ++LL
Sbjct: 129 LTDIVSQVRLNEEQ-----------IATVCEAVLQALAYLHAQ---GVIHRDIKSDSILL 174
Query: 824 DQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYS 883
D L DFG +S + K + GT ++APE + D++S
Sbjct: 175 TLDGRVKLSDFGFCAQIS--------KDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWS 226
Query: 884 FGILLLEM 891
GI+++EM
Sbjct: 227 LGIMVIEM 234
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 1e-22
Identities = 51/226 (22%), Positives = 90/226 (39%), Gaps = 36/226 (15%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVA-ECQALRNIRHRNLIKIITIC 745
+G+G++G V VAVK++++K+ + E + + H N++K
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 746 SSIDFKGVDFQAIVYEYMQNGSLEDWL--HQSEDQQEARSLTLIQRINIIIDVASAIEYI 803
+ Q + EY G L D + + +A+ Q ++ + + Y+
Sbjct: 75 RE-----GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF-FHQ----LM---AGVVYL 121
Query: 804 HHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVG 863
H + H D+KP N+LLD+ + DFGLA + + + GT+
Sbjct: 122 HGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC------GTLP 172
Query: 864 YIAPE------YGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFN 903
Y+APE + DV+S GI+L M P D +
Sbjct: 173 YVAPELLKRREF-HAEPV----DVWSCGIVLTAMLAGELPWDQPSD 213
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 50/256 (19%), Positives = 84/256 (32%), Gaps = 44/256 (17%)
Query: 653 AHKSSVSQLMDQQFPMISYAELSKATNDFSSSNMIGQG--SFGFVYKGNLGENGMMVAVK 710
AH M S+ + +IG+G V G V V+
Sbjct: 2 AHHHHHHMENLYFQGMSSFLP---EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVR 58
Query: 711 VINLKQKGAS--NGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSL 768
INL+ E + H N++ + F + +V +M GS
Sbjct: 59 RINLEACSNEMVTFLQGELHVSKLFNHPNIVPY--RAT---FIADNELWVVTSFMAYGSA 113
Query: 769 EDWLHQ------SEDQQEARSLTLIQRINIII-DVASAIEYIHHHCQPPVVHGDLKPSNV 821
+D + +E I I+ V A++YIHH VH +K S++
Sbjct: 114 KDLICTHFMDGMNELA-----------IAYILQGVLKALDYIHHM---GYVHRSVKASHI 159
Query: 822 LLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPE------YGMGGEA 875
L+ D +L + S V + + +++PE G ++
Sbjct: 160 LISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV-KVLPWLSPEVLQQNLQGYDAKS 218
Query: 876 SMTGDVYSFGILLLEM 891
D+YS GI E+
Sbjct: 219 ----DIYSVGITACEL 230
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-22
Identities = 53/247 (21%), Positives = 96/247 (38%), Gaps = 24/247 (9%)
Query: 353 VIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIP 412
+ I+ I P L N +++ + +T T+ +L + L +
Sbjct: 3 ITQPTAINVIFP--DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT--I 56
Query: 413 TSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLS-- 470
+ L L L L N + + P L N + EL ++ L + +I+ L
Sbjct: 57 EGVQYLNNLIGLELKDNQIT-DLAP-LKNLTKITELELSGNPLK-----NVSAIAGLQSI 109
Query: 471 LSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSG 530
+LDL+ ++ PL L NL + +N+ + I L+ T+LQ L + S
Sbjct: 110 KTLDLTSTQITDVTPLA--GLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVS- 164
Query: 531 SIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNKT 590
+ + L++L + L N +S I L +L L ++L N P SN
Sbjct: 165 DL-TPLANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISDVSPLAN-TSNLF 220
Query: 591 GISLSGN 597
++L+
Sbjct: 221 IVTLTNQ 227
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 55/258 (21%), Positives = 102/258 (39%), Gaps = 30/258 (11%)
Query: 318 LTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELC 377
I + + A+L +T + G ++ I G++ L NL+ L
Sbjct: 15 DPALANAIKIAAGKSNVTDTVT--QADLDG-ITTLSAFGTGVTTI--EGVQYLNNLIGLE 69
Query: 378 MDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPP 437
+ DN++T P + L + L L N L +++ L + L L+S + + P
Sbjct: 70 LKDNQITDLAP--LKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQIT-DVTP 124
Query: 438 SLGNCKNLIELHMADIELTGALPPQILSISTLS-----LSLDLSYNLLSGTLPLEVGNLK 492
L NL L++ QI +IS L+ L + +S PL NL
Sbjct: 125 -LAGLSNLQVLYLDL--------NQITNISPLAGLTNLQYLSIGNAQVSDLTPLA--NLS 173
Query: 493 NLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNL 552
L N+ S P L++ +L +++L+ N S S L++ ++ + +++ +
Sbjct: 174 KLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQTI 229
Query: 553 SGQIPEYLENLSFLEYLN 570
+ Q Y NL +
Sbjct: 230 TNQPVFYNNNLVVPNVVK 247
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 7e-20
Identities = 57/313 (18%), Positives = 114/313 (36%), Gaps = 53/313 (16%)
Query: 190 NLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGF 249
L N I + G++ + V + ++ + + I
Sbjct: 14 PDPALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-----TI---------- 56
Query: 250 IVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEA 309
E + +NL+ L L DNQ ++ ++L + L L N L
Sbjct: 57 ------------EGVQYLNNLIGLELKDNQIT-DLA-PLKNLTKITELELSGNPL----- 97
Query: 310 NDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRN 369
++ + L + L L + V P +A LS+ + + + NQI+ I P +
Sbjct: 98 KNVSAIAGLQSIKTLD---LTSTQITDVTP--LAGLSN-LQVLYLDLNQITNISP--LAG 149
Query: 370 LVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSN 429
L NL L + + +++ P + L L L D N ++ + L +L L + L +N
Sbjct: 150 LTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISD--ISPLASLPNLIEVHLKNN 205
Query: 430 DLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVG 489
+ + P L N NL + + + +T ++ ++ S ++ P +
Sbjct: 206 QIS-DVSP-LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIA---PATIS 260
Query: 490 NLKNLVYFNISVN 502
+ N++ N
Sbjct: 261 DNGTYASPNLTWN 273
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 9e-18
Identities = 50/284 (17%), Positives = 107/284 (37%), Gaps = 50/284 (17%)
Query: 148 KLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRF 207
+ +++T + +L + ++ G G+ I + L NLI L L +N+
Sbjct: 20 NAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGV-TTIEG-VQYLNNLIGLELKDNQI 75
Query: 208 SGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNA 267
+ + P + N++ + + L N ++ +++
Sbjct: 76 TDLAP--LKNLTKITELELSGNPLK-----NV----------------------SAIAGL 106
Query: 268 SNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAI 327
++ L L Q L NL+ L L N + ++ L T L +
Sbjct: 107 QSIKTLDLTSTQITD--VTPLAGLSNLQVLYLDLNQITN--------ISPLAGLTNLQYL 156
Query: 328 GLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTI 387
+ + + + P +ANLS +T + N+IS I + + +L NL+E+ + +N+++
Sbjct: 157 SIGNAQVSDLTP--LANLSK-LTTLKADDNKISDI--SPLASLPNLIEVHLKNNQISDVS 211
Query: 388 PHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDL 431
P + NL ++ L + + NL + + S
Sbjct: 212 P--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAP 253
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 57/333 (17%), Positives = 116/333 (34%), Gaps = 77/333 (23%)
Query: 97 LVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIAD 156
L + ++ + + + + +A + I + Y L L + D
Sbjct: 18 LANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIEG-VQYL-NNLIGLELKD 72
Query: 157 NHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIF 216
N +T A + NL+ + + + GN L + + + L+++ L+L + + +
Sbjct: 73 NQITD--LAPLKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDV------ 122
Query: 217 NISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLF 276
L+ SNL L L
Sbjct: 123 ---------------------------------------------TPLAGLSNLQVLYLD 137
Query: 277 DNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGG 336
NQ + L NL++L++G+ + +DL L L+ T L DDN+
Sbjct: 138 LNQITNISPL--AGLTNLQYLSIGNAQV-----SDLTPLANLSKLTTLK---ADDNKISD 187
Query: 337 VLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKN 396
+ P +A+L + + ++ + NQIS + P + N NL + + + +T L
Sbjct: 188 ISP--LASLPN-LIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVV 242
Query: 397 LQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSN 429
++ S P ++ + + L+ N
Sbjct: 243 PNVVKGPSGAPI--APATISDNGTYASPNLTWN 273
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 8e-12
Identities = 52/255 (20%), Positives = 90/255 (35%), Gaps = 23/255 (9%)
Query: 52 VTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFS 111
K+ + T +L + L+ I + L L L L +N +
Sbjct: 21 AIKIAAGKSNVTDT--VTQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQIT 76
Query: 112 GKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLS 171
+ L + + N L + A G ++ L + +T + LS
Sbjct: 77 -DLA-PLKNLTKITELELSGNPLK-NVSAIAGLQ--SIKTLDLTSTQITD--VTPLAGLS 129
Query: 172 TLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRF 231
L+ + + N + + L L NL L++G + S + + N+S L + N+
Sbjct: 130 NLQVLYLDLNQI--TNISPLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKI 185
Query: 232 NGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSL 291
+ PL SLP L+ + N S L+N SNL +TL + + Y
Sbjct: 186 SDISPLA---SLPNLIEVHLKNNQI--SDVSPLANTSNLFIVTLTNQTITNQPVFYN--- 237
Query: 292 KNLEWLNLGSNNLGT 306
NL N+ G
Sbjct: 238 NNLVVPNVVKGPSGA 252
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 7e-07
Identities = 56/245 (22%), Positives = 91/245 (37%), Gaps = 22/245 (8%)
Query: 53 TKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSG 112
L+L + I L+P + NL+ + L L+ N + I L ++ L L + +
Sbjct: 66 IGLELKDNQIT-DLAP-LKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITD 121
Query: 113 KIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLST 172
T L+ SNL N + I L L+ L+I + ++ P + NLS
Sbjct: 122 --VTPLAGLSNLQVLYLDLNQIT-NISP-LA-GLTNLQYLSIGNAQVSDLTP--LANLSK 174
Query: 173 LERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFN 232
L + N + I L +L NLI ++L N+ S + + N S+L V L
Sbjct: 175 LTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQT-- 228
Query: 233 GSLPLDIGVSLPKLLGFIVAENNFAGSI-PESLSNASNLVELTLFDNQ--FRGKVSIYFR 289
+ L+ V + I P ++S+ L N F VS F
Sbjct: 229 --ITNQPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFINNVSYTFN 286
Query: 290 SLKNL 294
Sbjct: 287 QSVTF 291
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 59/225 (26%), Positives = 92/225 (40%), Gaps = 36/225 (16%)
Query: 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGAS-NGFVAECQALRNIRHRNL 738
F+ IG+GSFG V+KG +VA+K+I+L++ E L +
Sbjct: 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 82
Query: 739 IKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQ---SEDQQEARSLTLIQRINIII- 794
K S K I+ EY+ GS D L E Q I I+
Sbjct: 83 TKY--YGSY--LKDTKL-WIIMEYLGGGSALDLLEPGPLDETQ-----------IATILR 126
Query: 795 DVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPL--DTAVETP 852
++ ++Y+H +H D+K +NVLL + L DFG+A L+ + + +T V TP
Sbjct: 127 EILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTP 183
Query: 853 SSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897
++APE D++S GI +E+ P
Sbjct: 184 F----------WMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-22
Identities = 43/263 (16%), Positives = 89/263 (33%), Gaps = 43/263 (16%)
Query: 338 LPHSIANLSSTMTDIVIAG---NQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGEL 394
+ + G N+ ++ + + EL ++ L+ ++P +
Sbjct: 25 TYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSELQLNRLNLS-SLPDNLP-- 79
Query: 395 KNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIE 454
+ +L + N L +P +L L N L ++P + K L + + +
Sbjct: 80 PQITVLEITQNAL-ISLPELPASLE---YLDACDNRLS-TLPELPASLK---HLDVDNNQ 131
Query: 455 LTGALPPQILSISTLSLS----------------LDLSYNLLSGTLPLEVGNLKNLVYFN 498
LT LP + ++ L + N L+ LP +L+ L +
Sbjct: 132 LT-MLPELPALLEYINADNNQLTMLPELPTSLEVLSVRNNQLT-FLPELPESLEAL---D 186
Query: 499 ISVNRFSGEIPVTLSACTSLQQ----LYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSG 554
+S N +P ++ + N + IP ++ SL + + N LS
Sbjct: 187 VSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSS 244
Query: 555 QIPEYLENLSFLEYLNLSYNHFE 577
+I E L + + +F
Sbjct: 245 RIRESLSQQTAQPDYHGPRIYFS 267
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-22
Identities = 69/440 (15%), Positives = 140/440 (31%), Gaps = 77/440 (17%)
Query: 125 ISFNARRNNLVGEIPAELGYNWLKLENLTIAD---NHLTGHFPASIGNLSTLERINVLGN 181
+S N+ N + A+ W K E + N + ++ + +
Sbjct: 13 LSQNSFYNTIS-GTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSELQLNRL 69
Query: 182 GLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGV 241
L +P+NL + +L + +N + P +SLE + NR +
Sbjct: 70 NL-SSLPDNLPP--QITVLEITQNALISL-PELP---ASLEYLDACDNRLS--------- 113
Query: 242 SLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYF-RSLKNLEWLNLG 300
+LP+L +L L + +NQ LE++N
Sbjct: 114 TLPELPA--------------------SLKHLDVDNNQLT-----MLPELPALLEYINAD 148
Query: 301 SNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQIS 360
+N L L T L + + +N+ LP +L + ++ N +
Sbjct: 149 NNQLTM----------LPELPTSLEVLSVRNNQLT-FLPELPESL----EALDVSTNLLE 193
Query: 361 GIIPTGIRNLVNLVELC----MDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLG 416
+ P + E +N++T IP I L + L+ N L+ I SL
Sbjct: 194 SL-PAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLS 251
Query: 417 NLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLS 476
T + +N + +AD + +S + + +
Sbjct: 252 QQTAQPDYHGPRIYF-----SMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHE 306
Query: 477 YNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSL 536
+ + T + L + V + + F ++ L ++ +L Q + + S
Sbjct: 307 EH--ANTFSAFLDRLSDTVSAR-NTSGFREQVAAWLEKLSASAELRQQSFAVAADATESC 363
Query: 537 SSLKSIKELDMSSNNLSGQI 556
++ ++ L Q
Sbjct: 364 EDRVALTWNNLRKTLLVHQA 383
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 97.3 bits (242), Expect = 5e-21
Identities = 71/303 (23%), Positives = 113/303 (37%), Gaps = 37/303 (12%)
Query: 259 SIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLL 318
SI ++N +L F N G + YF + E L N EA L L+
Sbjct: 2 SIMLPINNNFSL-SQNSFYNTISGTYADYFSAWDKWEKQALPGENRN--EAVSLLKECLI 58
Query: 319 TNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCM 378
+EL L+ LP ++ +T + I N + +P +L L
Sbjct: 59 NQFSELQ---LNRLNLS-SLPDNLP---PQITVLEITQNALI-SLPELP---ASLEYLDA 107
Query: 379 DDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPS 438
DN+L+ T+P LK+L +D+N L +P L + +N L +P
Sbjct: 108 CDNRLS-TLPELPASLKHL---DVDNNQLTM-LPELPALLE---YINADNNQLT-MLPEL 158
Query: 439 LGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNL---- 494
+ L L + + +LT LP S+ L D+S NLL +LP +
Sbjct: 159 PTS---LEVLSVRNNQLT-FLPELPESLEAL----DVSTNLLE-SLPAVPVRNHHSEETE 209
Query: 495 VYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSG 554
++F NR + IP + + + L+ N S I SLS + + S
Sbjct: 210 IFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSM 268
Query: 555 QIP 557
Sbjct: 269 SDG 271
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 59.2 bits (143), Expect = 5e-09
Identities = 41/232 (17%), Positives = 71/232 (30%), Gaps = 25/232 (10%)
Query: 53 TKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSG 112
LD+ N + L L Y+N +N +P L L + NN +
Sbjct: 123 KHLDVDNNQLT-MLPELPALL---EYINADNNQLT-MLPELPTSLEVLS---VRNNQLT- 173
Query: 113 KIPTNLSRCSNLISFNARRNNLVGEIPAELGYNW---LKLENLTIADNHLTGHFPASIGN 169
+P +L + + N L +PA N +N +T H P +I +
Sbjct: 174 FLPELP---ESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILS 228
Query: 170 LSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTN 229
L I + N L RI +L + FS L +
Sbjct: 229 LDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTA-- 286
Query: 230 RFNGSLPLDIGVSLPKLLGFIVAENNFAG--SIPESLSNASNLVELTLFDNQ 279
P + + ++ E + + + LS+ + + F Q
Sbjct: 287 ----WFPENKQSDVSQIWHAFEHEEHANTFSAFLDRLSDTVSARNTSGFREQ 334
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 56/224 (25%), Positives = 95/224 (42%), Gaps = 29/224 (12%)
Query: 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNI-RHR 736
F ++G G++G VYKG + G + A+KV+++ E L+ HR
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEE-IKQEINMLKKYSHHR 81
Query: 737 NLIKIITICSSIDFKGVDFQA-IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIII- 794
N+ + G+D Q +V E+ GS+ D + ++ +L I I
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG----NTLKEEW-IAYICR 136
Query: 795 DVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSS--SPLDTAVETP 852
++ + ++H H V+H D+K NVLL ++ L DFG++ L +T + TP
Sbjct: 137 EILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTP 193
Query: 853 SSSKGIKGTVGYIAPEYGMGGEASMTG-----DVYSFGILLLEM 891
++APE E D++S GI +EM
Sbjct: 194 Y----------WMAPEVIACDENPDATYDFKSDLWSLGITAIEM 227
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 55/226 (24%), Positives = 93/226 (41%), Gaps = 35/226 (15%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVA-----ECQALRNIRHRNLIKI 741
+G+GS+G V + E AVK++ K+K E Q LR +RH+N+I++
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILK-KKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 742 ITICSSIDFKGVDFQAIVYEYMQNGSLE--DWLHQ---SEDQQEARSLTLIQRINIIIDV 796
+ + + + +V EY G E D + + +A Q +I
Sbjct: 72 VDV---LYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVC--QAHGY-FCQ----LI-- 119
Query: 797 ASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSK 856
+EY+H +VH D+KP N+LL + G+A+ L D T
Sbjct: 120 -DGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ--- 172
Query: 857 GIKGTVGYIAPE--YGMGGEASMTGDVYSFGILLLEMFTRRRPTDG 900
G+ + PE G+ + D++S G+ L + T P +G
Sbjct: 173 ---GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG 215
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-22
Identities = 55/236 (23%), Positives = 96/236 (40%), Gaps = 60/236 (25%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVIN----LKQKGASNGFVA----------------- 725
IG+GS+G V + A+KV++ ++Q G
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 726 -----ECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQ---SED 777
E L+ + H N++K++ + +D D +V+E + G + + SED
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEV---LDDPNEDHLYMVFELVNQGPVMEVPTLKPLSED 137
Query: 778 QQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837
+AR D+ IEY+H+ ++H D+KPSN+L+ +D + DFG++
Sbjct: 138 --QAR--------FYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVS 184
Query: 838 KFLSSSP--LDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTG---DVYSFGILL 888
S L V TP+ ++APE +G DV++ G+ L
Sbjct: 185 NEFKGSDALLSNTVGTPA----------FMAPESLSETRKIFSGKALDVWAMGVTL 230
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 59/214 (27%), Positives = 86/214 (40%), Gaps = 6/214 (2%)
Query: 363 IPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLT 422
+P GI + + N+++ + +NL +L+L SN LA + L LL
Sbjct: 26 VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 423 NLALSSNDLQGSIPPS-LGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLS 481
L LS N S+ P+ L LH+ L L P + L L N L
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ 142
Query: 482 GTLPLEV-GNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLK 540
LP + +L NL + + NR S SL +L L N + P + L
Sbjct: 143 -ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLG 201
Query: 541 SIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYN 574
+ L + +NNLS E L L L+YL L+ N
Sbjct: 202 RLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 6e-18
Identities = 55/254 (21%), Positives = 92/254 (36%), Gaps = 42/254 (16%)
Query: 156 DNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSI 215
L P I + +RI + GN + + RNL +L L N + I +
Sbjct: 20 QQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAF 76
Query: 216 FNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTL 275
++ LE + L N S+ P + L L L
Sbjct: 77 TGLALLEQLDLSDNAQLRSVD------------------------PATFHGLGRLHTLHL 112
Query: 276 FDNQFRGKVSI---YFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDN 332
+ + FR L L++L L N L + + LT + L N
Sbjct: 113 DRCGLQ---ELGPGLFRGLAALQYLYLQDNALQALPDD------TFRDLGNLTHLFLHGN 163
Query: 333 RFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPH-AI 391
R V + L S + +++ N+++ + P R+L L+ L + N L+ +P A+
Sbjct: 164 RISSVPERAFRGLHS-LDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEAL 221
Query: 392 GELKNLQLLYLDSN 405
L+ LQ L L+ N
Sbjct: 222 APLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 7e-18
Identities = 47/214 (21%), Positives = 81/214 (37%), Gaps = 24/214 (11%)
Query: 259 SIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLL 318
++P + + + L N+ + FR+ +NL L L SN L +A L LL
Sbjct: 25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 319 T-------------------NCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQI 359
L + LD + P L++ + + + N +
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAA-LQYLYLQDNAL 141
Query: 360 SGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLT 419
+ R+L NL L + N+++ A L +L L L N +A P + +L
Sbjct: 142 QALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLG 201
Query: 420 LLTNLALSSNDLQGSIPPS-LGNCKNLIELHMAD 452
L L L +N+L ++P L + L L + D
Sbjct: 202 RLMTLYLFANNLS-ALPTEALAPLRALQYLRLND 234
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 48/226 (21%), Positives = 71/226 (31%), Gaps = 40/226 (17%)
Query: 379 DDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPS 438
L +P I Q ++L N ++ S LT L L SN L I
Sbjct: 19 PQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDA- 73
Query: 439 LGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEV-GNLKNLVYF 497
L L LDLS N ++ L L
Sbjct: 74 -AAFTGLALLE----------------------QLDLSDNAQLRSVDPATFHGLGRLHTL 110
Query: 498 NISVNRFSGEIPV-TLSACTSLQQLYLQGNSFSGSIPS-SLSSLKSIKELDMSSNNLSGQ 555
++ E+ +LQ LYLQ N+ ++P + L ++ L + N +S
Sbjct: 111 HLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-S 167
Query: 556 IPEY-LENLSFLEYLNLSYNHFEGEVPTKGVFSNKTG---ISLSGN 597
+PE L L+ L L N V F + + L N
Sbjct: 168 VPERAFRGLHSLDRLLLHQNRVA-HVH-PHAFRDLGRLMTLYLFAN 211
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 8e-12
Identities = 43/233 (18%), Positives = 77/233 (33%), Gaps = 33/233 (14%)
Query: 76 LRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTN-LSRCSNLISFNARRNNL 134
+ + L N L L L +N + +I + + L + N
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQ 92
Query: 135 VGEIPAELGYNWLKLENLTIADNHLTGHFPASI-GNLSTLERINVLGNGLWGRIPNN-LG 192
+ + + +L L + L + L+ L+ + + N L +P++
Sbjct: 93 LRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNAL-QALPDDTFR 150
Query: 193 NLRNLILLNLGENRFSGIVPPSIF-NISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIV 251
+L NL L L NR S + P F + SL+ + L NR +
Sbjct: 151 DLGNLTHLFLHGNRISSV-PERAFRGLHSLDRLLLHQNRVA-HVH--------------- 193
Query: 252 AENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNL 304
P + + L+ L LF N + L+ L++L L N
Sbjct: 194 ---------PHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 44/209 (21%), Positives = 74/209 (35%), Gaps = 11/209 (5%)
Query: 53 TKLDLSNRTIGGTLSPYV-GNLSFLRYLNLADNNFHGEIPHQI-GRLVRLEALVLANNSF 110
++ L I + L L L N I L LE L L++N+
Sbjct: 35 QRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVL-ARIDAAAFTGLALLEQLDLSDNAQ 92
Query: 111 SGKIPTN-LSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASI-G 168
+ L + + R L E+ L L+ L + DN L P
Sbjct: 93 LRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFR 150
Query: 169 NLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIF-NISSLENVFLP 227
+L L + + GN + L +L L L +NR + + P F ++ L ++L
Sbjct: 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV-HPHAFRDLGRLMTLYLF 209
Query: 228 TNRFNGSLPLDIGVSLPKLLGFIVAENNF 256
N + +LP + L L + +N +
Sbjct: 210 ANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 9e-09
Identities = 35/184 (19%), Positives = 69/184 (37%), Gaps = 10/184 (5%)
Query: 51 RVTKLDLSNRTIGGTLSPYV-GNLSFLRYLNLADNNFHGEIPHQI-GRLVRLEALVLANN 108
+T L L + + + L+ L L+L+DN + L RL L L
Sbjct: 57 NLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRC 115
Query: 109 SFSGKIPTN-LSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASI 167
++ + L + N L +P + + L +L + N ++ +
Sbjct: 116 GLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAF 173
Query: 168 GNLSTLERINVLGNGLWGRIPNN-LGNLRNLILLNLGENRFSGIVPPSIF-NISSLENVF 225
L +L+R+ + N + + + +L L+ L L N S + P + +L+ +
Sbjct: 174 RGLHSLDRLLLHQNRV-AHVHPHAFRDLGRLMTLYLFANNLSAL-PTEALAPLRALQYLR 231
Query: 226 LPTN 229
L N
Sbjct: 232 LNDN 235
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 4e-22
Identities = 58/238 (24%), Positives = 97/238 (40%), Gaps = 61/238 (25%)
Query: 673 ELSKATNDFSS----SNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQ 728
+L + + F+ IG GS+ + M AVK+I+ ++ + E +
Sbjct: 12 QLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIE 67
Query: 729 AL-RNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQ----SEDQQEARS 783
L R +H N+I + + + + +V E M+ G L D + + SE +EA
Sbjct: 68 ILLRYGQHPNIITLKDV-----YDDGKYVYVVTELMKGGELLDKILRQKFFSE--REAS- 119
Query: 784 LTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLL-----DQDLVAHLGDFGLAK 838
++ + +EY+H VVH DLKPSN+L + + + + DFG AK
Sbjct: 120 -------AVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIR-ICDFGFAK 168
Query: 839 FLSS--SPLDTAVETPSSSKGIKGTVGYIAPE------YGMGGEASMTGDVYSFGILL 888
L + L T T ++APE Y D++S G+LL
Sbjct: 169 QLRAENGLLMTPC----------YTANFVAPEVLERQGYDA--AC----DIWSLGVLL 210
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 4e-22
Identities = 52/232 (22%), Positives = 88/232 (37%), Gaps = 48/232 (20%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVA-ECQALRNIRHRNLIKIITIC 745
+G+G++G V VAVK++++K+ + E + + H N++K
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 746 SSIDFKGVDFQAIVYEYMQNGSLEDWLHQ----SEDQQEARSLTLIQRINIIIDVASAIE 801
+ Q + EY G L D + E +A+ Q ++ + +
Sbjct: 75 RE-----GNIQYLFLEYCSGGELFDRIEPDIGMPEP--DAQRF-FHQ----LM---AGVV 119
Query: 802 YIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSP----LDTAVETPSSSKG 857
Y+H + H D+KP N+LLD+ + DFGLA + L+ T
Sbjct: 120 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP---- 172
Query: 858 IKGTVGYIAPE------YGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFN 903
Y+APE + DV+S GI+L M P D +
Sbjct: 173 ------YVAPELLKRREF-HAEPV----DVWSCGIVLTAMLAGELPWDQPSD 213
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 5e-22
Identities = 55/223 (24%), Positives = 91/223 (40%), Gaps = 40/223 (17%)
Query: 681 FSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIK 740
+ +G G+FG VYK E G + A KVI K + ++ E + L H ++K
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 741 IITICSSIDFKGVDFQA----IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDV 796
G + I+ E+ G+++ + + + R LT Q + +
Sbjct: 81 ---------LLGAYYHDGKLWIMIEFCPGGAVDAIMLELD-----RGLTEPQIQVVCRQM 126
Query: 797 ASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSS--SPLDTAVETPSS 854
A+ ++H ++H DLK NVL+ + L DFG++ D+ + TP
Sbjct: 127 LEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTP-- 181
Query: 855 SKGIKGTVGY-IAPEYGMGGEASMTG-----DVYSFGILLLEM 891
Y +APE M T D++S GI L+EM
Sbjct: 182 ---------YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 215
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 6e-22
Identities = 66/235 (28%), Positives = 97/235 (41%), Gaps = 49/235 (20%)
Query: 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASN--GFVAECQALRNIRH 735
++ M+G+GSFG V K AVKVIN + + E + L+ + H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 736 RNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWL----HQSEDQQEARSLTLIQRIN 791
N++K+ I D IV E G L D + SE +A
Sbjct: 81 PNIMKLFEILE--DSSSF---YIVGELYTGGELFDEIIKRKRFSE--HDAA--------R 125
Query: 792 IIIDVASAIEYIHHHCQPPVVHGDLKPSNVLL---DQDLVAHLGDFGLAKFLS-SSPLDT 847
II V S I Y+H H +VH DLKP N+LL ++D + DFGL+ ++ +
Sbjct: 126 IIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD 182
Query: 848 AVETPSSSKGIKGTVGYIAPE-----YGMGGEASMTGDVYSFGILLLEMFTRRRP 897
+ GT YIAPE Y + DV+S G++L + + P
Sbjct: 183 RI----------GTAYYIAPEVLRGTYDE--KC----DVWSAGVILYILLSGTPP 221
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 6e-22
Identities = 60/267 (22%), Positives = 98/267 (36%), Gaps = 46/267 (17%)
Query: 310 NDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRN 369
+ + E L + L+S + I+ + I + GI+
Sbjct: 9 TPIKQIFPDDAFAETIKDNLKKKSVTDAVT--QNELNS-IDQIIANNSDIKSV--QGIQY 63
Query: 370 LVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPT--SLGNLTLLTNLALS 427
L N+ +L ++ NKLT P + LKNL L+LD N I SL +L L +L+L
Sbjct: 64 LPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDEN----KIKDLSSLKDLKKLKSLSLE 117
Query: 428 SNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLE 487
N + I L + L L L N ++ L
Sbjct: 118 HNGIS-DING-LVHLPQLESL-------------------------YLGNNKITDITVLS 150
Query: 488 VGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDM 547
L L ++ N+ S +P L+ T LQ LYL N S + +L+ LK++ L++
Sbjct: 151 --RLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLEL 204
Query: 548 SSNNLSGQIPEYLENLSFLEYLNLSYN 574
S + + NL + +
Sbjct: 205 FSQECLNKPINHQSNLVVPNTVKNTDG 231
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 97.5 bits (242), Expect = 5e-21
Identities = 61/344 (17%), Positives = 115/344 (33%), Gaps = 61/344 (17%)
Query: 262 ESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNC 321
+ ++ L V+ L +++ + ++++ + + L N
Sbjct: 15 FPDDAFAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDI-----KSVQGIQYLPN- 66
Query: 322 TELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDN 381
+T + L+ N+ + P + NL + + + + N+I + + +++L L L ++ N
Sbjct: 67 --VTKLFLNGNKLTDIKP--LTNLKN-LGWLFLDENKIKDL--SSLKDLKKLKSLSLEHN 119
Query: 382 KLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGN 441
++ I + L L+ LYL +N + T L LT L L+L N + I P L
Sbjct: 120 GIS-DIN-GLVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS-DIVP-LAG 173
Query: 442 CKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISV 501
L L LS N +S L LKNL +
Sbjct: 174 LTKLQNL-------------------------YLSKNHISDLRALA--GLKNLDVLELFS 206
Query: 502 NRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLE 561
+ S + S S + D N+ +PE+
Sbjct: 207 QECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS-------DDGDYEKPNVKWHLPEFTN 259
Query: 562 NLSFLEYLNLSYNHFEGEVPTKGVFSNKTGISLSGNGKVCGGLD 605
+SF+ Y ++ K F + L V +D
Sbjct: 260 EVSFIFYQPVTIG------KAKARFHGRVTQPLKEVYTVSYDVD 297
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 91.7 bits (227), Expect = 3e-19
Identities = 61/326 (18%), Positives = 103/326 (31%), Gaps = 57/326 (17%)
Query: 190 NLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGF 249
I NL + + V + ++S++ + + +
Sbjct: 16 PDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-----SV---------- 58
Query: 250 IVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIY-FRSLKNLEWLNLGSNNLGTGE 308
+ + N+ +L L N+ I +LKNL WL L N +
Sbjct: 59 ------------QGIQYLPNVTKLFLNGNKLT---DIKPLTNLKNLGWLFLDENKI---- 99
Query: 309 ANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLS--STMTDIVIAGNQISGIIPTG 366
DL L L L ++ L+ N I L + + + N+I+ I T
Sbjct: 100 -KDLSSLKDLKK---LKSLSLEHNGI-----SDINGLVHLPQLESLYLGNNKITDI--TV 148
Query: 367 IRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLAL 426
+ L L L ++DN+++ I + L LQ LYL N ++ +L L L L L
Sbjct: 149 LSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHIS--DLRALAGLKNLDVLEL 204
Query: 427 SSNDLQGSIPPSLGNCKNLIELHMADIELTGALP---PQILSISTLSLSLDLSYNLLSGT 483
S + N + D L + L N +S
Sbjct: 205 FSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFI 264
Query: 484 LPLEVGNLKNLVYFNISVNRFSGEIP 509
V K F+ V + E+
Sbjct: 265 FYQPVTIGKAKARFHGRVTQPLKEVY 290
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 75.1 bits (184), Expect = 5e-14
Identities = 55/349 (15%), Positives = 109/349 (31%), Gaps = 101/349 (28%)
Query: 100 LEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHL 159
+ + + +I + I N ++ ++ + ++ + ++
Sbjct: 1 MGETITVSTPIK-QI-FPDDAFAETIKDNLKKKSVTDAVTQN---ELNSIDQIIANNS-- 53
Query: 160 TGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNIS 219
++ +++ + L N+ L L N+ + I P + N+
Sbjct: 54 ---------DIKSVQ---------------GIQYLPNVTKLFLNGNKLTDIKP--LTNLK 87
Query: 220 SLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQ 279
+L +FL N+ D+ SL + L L+L N
Sbjct: 88 NLGWLFLDENKIK-----DL----------------------SSLKDLKKLKSLSLEHNG 120
Query: 280 FRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLP 339
++ L LE L LG+N + D+ L+ LT L+
Sbjct: 121 IS-DIN-GLVHLPQLESLYLGNNKI-----TDITVLSRLTKLDTLS-------------- 159
Query: 340 HSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQL 399
+ NQIS I + L L L + N ++ + A+ LKNL +
Sbjct: 160 --------------LEDNQISDI--VPLAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDV 201
Query: 400 LYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIEL 448
L L S NL + + + L P + + + +
Sbjct: 202 LELFSQECLNKPINHQSNLVVPNTVKNTDGSLV--TPEIISDDGDYEKP 248
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 69.4 bits (169), Expect = 4e-12
Identities = 45/236 (19%), Positives = 87/236 (36%), Gaps = 24/236 (10%)
Query: 72 NLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARR 131
+ NL + + L ++ ++ N+ + + N+
Sbjct: 19 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNG 74
Query: 132 NNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVL---GNGLWGRIP 188
N L P N L L + +N + + +L L+++ L NG+
Sbjct: 75 NKLTDIKPLT---NLKNLGWLFLDENKIK-----DLSSLKDLKKLKSLSLEHNGI--SDI 124
Query: 189 NNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLG 248
N L +L L L LG N+ + I + ++ L+ + L N+ + +PL L KL
Sbjct: 125 NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLA---GLTKLQN 179
Query: 249 FIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNL 304
+++N+ S +L+ NL L LF + K + +L + +L
Sbjct: 180 LYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 233
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 53.6 bits (128), Expect = 3e-07
Identities = 40/172 (23%), Positives = 69/172 (40%), Gaps = 13/172 (7%)
Query: 53 TKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSG 112
TKL L+ + + P + NL L +L L +N ++ + L +L++L L +N S
Sbjct: 68 TKLFLNGNKLT-DIKP-LTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS- 122
Query: 113 KIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLST 172
I L L S N + +I L KL+ L++ DN ++ + L+
Sbjct: 123 DI-NGLVHLPQLESLYLGNNKIT-DITV-LS-RLTKLDTLSLEDNQISD--IVPLAGLTK 176
Query: 173 LERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENV 224
L+ + + N + L L+NL +L L N+ V
Sbjct: 177 LQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTV 226
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 9e-22
Identities = 54/286 (18%), Positives = 96/286 (33%), Gaps = 72/286 (25%)
Query: 652 SAHKSSVSQLMDQQFPMISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKV 711
H SS + + L + + IGQGS+G V + + A+K+
Sbjct: 4 HHHHSSGRENL-----YFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKI 58
Query: 712 INLKQKGASNG-----FVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNG 766
+N + N E + ++ + H N+ ++ + ++ + +V E G
Sbjct: 59 MNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEV-----YEDEQYICLVMELCHGG 113
Query: 767 SLEDWLHQSEDQQEARSLTLIQRI----------------------------------NI 792
L D L+ D + + + NI
Sbjct: 114 HLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNI 173
Query: 793 IIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHL--GDFGLAKFLSSSPLDTAVE 850
+ + SA+ Y+H+ + H D+KP N L + + DFGL+K
Sbjct: 174 MRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYG 230
Query: 851 TPSSSKGIKGTVGYIAPE--------YGMGGEASMTGDVYSFGILL 888
GT ++APE YG + D +S G+LL
Sbjct: 231 M----TTKAGTPYFVAPEVLNTTNESYGP--KC----DAWSAGVLL 266
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-21
Identities = 69/227 (30%), Positives = 98/227 (43%), Gaps = 46/227 (20%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVA----ECQALRNIRHRNLIKII 742
+G+GSFG V + VA+K I+ +Q + E L+ +RH ++IK+
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFIS-RQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 743 TICSSIDFKGVDFQAIVYEYMQNGSLEDWL--HQSEDQQEARSLTLIQRINIIIDVASAI 800
+ I +V EY G L D++ + + E R Q+I AI
Sbjct: 76 DV---ITTPTDIV--MVIEYA-GGELFDYIVEKKRMTEDEGR--RFFQQI------ICAI 121
Query: 801 EYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL-AKFLSSSPLDTAVETPSSSKGIK 859
EY H H +VH DLKP N+LLD +L + DFGL + L T+ +P+
Sbjct: 122 EYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPN------ 172
Query: 860 GTVGYIAPE------YGMGGEASMTGDVYSFGILLLEMFTRRRPTDG 900
Y APE Y G E DV+S GI+L M R P D
Sbjct: 173 ----YAAPEVINGKLYA-GPEV----DVWSCGIVLYVMLVGRLPFDD 210
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-21
Identities = 51/222 (22%), Positives = 89/222 (40%), Gaps = 50/222 (22%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVA-----ECQALRNIRHRNLIKI 741
IG+G F V + E G AVK++++ + +S G E ++H +++++
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 742 ITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQ------EARSLTLIQRINIIID 795
+ SS +V+E+M L + + D A + +
Sbjct: 92 LETYSS-----DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVAS--------HYMRQ 138
Query: 796 VASAIEYIHHHCQPPVVHGDLKPSNVLL---DQDLVAHLGDFGLAKFLSSSPLDTAVETP 852
+ A+ Y H + ++H D+KP VLL + LG FG+A L E+
Sbjct: 139 ILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG--------ESG 187
Query: 853 SSSKGIKGTVGYIAPE------YGMGGEASMTGDVYSFGILL 888
+ G GT ++APE YG DV+ G++L
Sbjct: 188 LVAGGRVGTPHFMAPEVVKREPYGK--PV----DVWGCGVIL 223
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 3e-21
Identities = 52/222 (23%), Positives = 89/222 (40%), Gaps = 54/222 (24%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHRNLIKIITI 744
+G+G+F V + G+ A K+IN K+ E + R ++H N++++
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 745 CSSIDFKGVDFQAIVYEYMQNGSLEDWL----HQSEDQQEARSLTLIQRINIIIDVASAI 800
+ F +V++ + G L + + SE +A + I + +I
Sbjct: 97 -----IQEESFHYLVFDLVTGGELFEDIVAREFYSE--ADAS--------HCIQQILESI 141
Query: 801 EYIHHHCQPPVVHGDLKPSNVLL---DQDLVAHLGDFGLAKFLS-SSPLDTAVETPSSSK 856
Y H + +VH +LKP N+LL + L DFGLA ++ S
Sbjct: 142 AYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA------- 191
Query: 857 GIKGTVGYIAPE------YGMGGEASMTGDVYSFG----ILL 888
GT GY++PE Y D+++ G ILL
Sbjct: 192 ---GTPGYLSPEVLKKDPYSK--PV----DIWACGVILYILL 224
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-21
Identities = 51/223 (22%), Positives = 87/223 (39%), Gaps = 55/223 (24%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASN--GFVAECQALRNIRHRNLIKIITI 744
+G+G+F V + G A +IN K+ A + E + R ++H N++++
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 745 CSSIDFKGVDFQAIVYEYMQNGSLEDWL----HQSEDQQEARSLTLIQRINIIIDVASAI 800
S ++++ + G L + + + SE +A + I + A+
Sbjct: 79 ISE-----EGHHYLIFDLVTGGELFEDIVAREYYSE--ADAS--------HCIQQILEAV 123
Query: 801 EYIHHHCQPPVVHGDLKPSNVLL---DQDLVAHLGDFGLAKFLSS--SPLDTAVETPSSS 855
+ H VVH +LKP N+LL + L DFGLA +
Sbjct: 124 LHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA------ 174
Query: 856 KGIKGTVGYIAPE------YGMGGEASMTGDVYSFG----ILL 888
GT GY++PE YG D+++ G ILL
Sbjct: 175 ----GTPGYLSPEVLRKDPYGK--PV----DLWACGVILYILL 207
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 5e-21
Identities = 47/250 (18%), Positives = 82/250 (32%), Gaps = 23/250 (9%)
Query: 346 SSTMTDIVIAGNQISGIIPTG---IRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYL 402
S ++ + + +I I G + + L EL +++ ++TGT P + E L L
Sbjct: 67 SLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNIL 126
Query: 403 D-SNFLAGGIPTSLGNL-----TLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELT 456
+ N L L L L+++ + L L ++D
Sbjct: 127 NLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPEL 186
Query: 457 G-------ALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIP 509
G P + ++ L+L + SG L ++S N
Sbjct: 187 GERGLISALCPLKFPTLQVLALR-NAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG 245
Query: 510 VTL-SACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEY 568
+ L L L +P L + + LD+S N L P + L +
Sbjct: 246 APSCDWPSQLNSLNLSFTGLK-QVPKGLPA--KLSVLDLSYNRLDR-NPS-PDELPQVGN 300
Query: 569 LNLSYNHFEG 578
L+L N F
Sbjct: 301 LSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 79.6 bits (196), Expect = 4e-16
Identities = 47/313 (15%), Positives = 76/313 (24%), Gaps = 44/313 (14%)
Query: 255 NFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDF 314
N G+ L +E L + + +K+L L
Sbjct: 29 NCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGA 88
Query: 315 LTLLTNCTELTAIGLDDNRFGGVLPHSIANLSST-MTDIVIAGNQISGI--IPTGIRNLV 371
L +L + L + L++ G P + + + + + + ++ +
Sbjct: 89 LRVL-GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWL 147
Query: 372 --NLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIP----TSLGNLTLLTNLA 425
L L + + L L L N G L LA
Sbjct: 148 KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLA 207
Query: 426 LSSN---DLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSG 482
L + G L L DLS+N L
Sbjct: 208 LRNAGMETPSGVCSALAAARVQLQGL-------------------------DLSHNSLRD 242
Query: 483 TLPLEV-GNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKS 541
L N+S ++P L L L L N PS L
Sbjct: 243 AAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLD-RNPSPDE-LPQ 297
Query: 542 IKELDMSSNNLSG 554
+ L + N
Sbjct: 298 VGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 42/252 (16%), Positives = 73/252 (28%), Gaps = 24/252 (9%)
Query: 48 RHQRVTKLDLSNRTIGGTLSPY---VGNLSFLRYLNLADNNFHGEIPHQIGRLV--RLEA 102
+ + +L + I + V +S L+ L L + G P + L
Sbjct: 66 KSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNI 125
Query: 103 LVLANNSFSGKIPTNLSRCSNLISFNARR----NNLVGEIPAELGYNWLKLENLTIADNH 158
L L N S++ L+ + + E + L L ++DN
Sbjct: 126 LNLRNVSWAT-RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNP 184
Query: 159 LTGHFP----ASIGNLSTLERINVLGNGLW---GRIPNNLGNLRNLILLNLGENRFSGIV 211
G TL+ + + G+ G L L+L N
Sbjct: 185 ELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAA 244
Query: 212 PPSIFNI-SSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNL 270
+ S L ++ L +P + L L ++ N P S +
Sbjct: 245 GAPSCDWPSQLNSLNLSFTGLK-QVPKGLPAKLSVL---DLSYNRLD-RNP-SPDELPQV 298
Query: 271 VELTLFDNQFRG 282
L+L N F
Sbjct: 299 GNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 46/270 (17%), Positives = 78/270 (28%), Gaps = 15/270 (5%)
Query: 173 LERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFN 232
L+R++ + +L+ L + + IS L+ + L
Sbjct: 49 LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108
Query: 233 GSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASN-----LVELTLFDNQFRGKVSIY 287
G+ P + + L + N + L+ L L++
Sbjct: 109 GTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQ 168
Query: 288 FRSLKNLEWLNLGSNNLGTGEANDLDFLTL--LTNCTELTAIGLDDNRFGGVLPHSIANL 345
R L L+L S+N GE + L L GV A
Sbjct: 169 VRVFPALSTLDL-SDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAAR 227
Query: 346 SSTMTDIVIAGNQISGIIPTGI-RNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDS 404
+ + ++ N + L L + L +P + L +L L
Sbjct: 228 VQ-LQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSY 283
Query: 405 NFLAGGIPTSLGNLTLLTNLALSSNDLQGS 434
N L P S L + NL+L N S
Sbjct: 284 NRLD-RNP-SPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 34/185 (18%), Positives = 58/185 (31%), Gaps = 12/185 (6%)
Query: 32 NNSTNLCQWTGVTCGHRHQRVTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIP 91
+ W + L ++ V L L+L+DN GE
Sbjct: 131 VSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG 190
Query: 92 HQI----GRLVRLEALVLANN---SFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGY 144
+ L+ L L N + SG + L + N+L A
Sbjct: 191 LISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCD 250
Query: 145 NWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGE 204
+L +L ++ L P + + L +++ N L R P+ L + L+L
Sbjct: 251 WPSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRL-DRNPSPDE-LPQVGNLSLKG 305
Query: 205 NRFSG 209
N F
Sbjct: 306 NPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 26/172 (15%), Positives = 47/172 (27%), Gaps = 28/172 (16%)
Query: 416 GNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLS--LSL 473
G +L L + + +L L + + + L + +S L
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 474 DLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIP 533
L ++GT P + L L L+ S++
Sbjct: 101 TLENLEVTGTAPPPLLEATGP----------------------DLNILNLRNVSWATRDA 138
Query: 534 SSLS----SLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVP 581
+K L ++ + E + L L+LS N GE
Sbjct: 139 WLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG 190
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 8e-06
Identities = 29/167 (17%), Positives = 59/167 (35%), Gaps = 16/167 (9%)
Query: 438 SLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYF 497
S NC ++ L S+ L +D +L T ++ +LK L
Sbjct: 26 SAFNCLGAADVE---------LYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVR 76
Query: 498 NISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSL--KSIKELDMSSNNLSGQ 555
+ + + + LQ+L L+ +G+ P L + L++ + + + +
Sbjct: 77 AARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR 136
Query: 556 IPEYLENLSF----LEYLNLSYNHFEG-EVPTKGVFSNKTGISLSGN 597
E + L+ L+++ H VF + + LS N
Sbjct: 137 DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDN 183
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 6e-21
Identities = 57/247 (23%), Positives = 103/247 (41%), Gaps = 41/247 (16%)
Query: 657 SVSQLMDQQFPMISYAELSKATND------FSSSNMIGQGSFGFVYKGNLGENGMMVAVK 710
S+ + + P +L + + F +G+GS+G VYK E G +VA+K
Sbjct: 1 SLETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIK 60
Query: 711 VINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKG---VDFQA-IVYEYMQNG 766
+ ++ + E ++ +++K + G + IV EY G
Sbjct: 61 QVPVESDLQE--IIKEISIMQQCDSPHVVK---------YYGSYFKNTDLWIVMEYCGAG 109
Query: 767 SLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQD 826
S+ D + ++LT + I+ +EY+H +H D+K N+LL+ +
Sbjct: 110 SVSDIIRLRN-----KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTE 161
Query: 827 LVAHLGDFGLAKFLSS--SPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSF 884
A L DFG+A L+ + +T + TP ++APE + D++S
Sbjct: 162 GHAKLADFGVAGQLTDTMAKRNTVIGTPF----------WMAPEVIQEIGYNCVADIWSL 211
Query: 885 GILLLEM 891
GI +EM
Sbjct: 212 GITAIEM 218
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 9e-21
Identities = 55/244 (22%), Positives = 111/244 (45%), Gaps = 28/244 (11%)
Query: 662 MDQQFPMISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASN 721
M +Q+ + + + + IGQG+FG V+K + G VA+K + ++
Sbjct: 1 MAKQYDSVECPFCDEV-SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN--EKE 57
Query: 722 GF----VAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVY---EYMQN--GSLEDWL 772
GF + E + L+ ++H N++ +I IC + + +Y ++ ++ L +
Sbjct: 58 GFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV 117
Query: 773 HQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLG 832
E + + + + + + YIH + ++H D+K +NVL+ +D V L
Sbjct: 118 LVKFTLSEIKRV-MQM-------LLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLA 166
Query: 833 DFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTG-DVYSFGILLLEM 891
DFGLA+ S ++ +++ + T+ Y PE +G D++ G ++ EM
Sbjct: 167 DFGLARAF-SLAKNSQ-PNRYTNRVV--TLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 222
Query: 892 FTRR 895
+TR
Sbjct: 223 WTRS 226
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 1e-20
Identities = 53/216 (24%), Positives = 87/216 (40%), Gaps = 30/216 (13%)
Query: 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLI 739
S + ++G G FG V+K G+ +A K+I + E + + H NLI
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 740 KIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASA 799
++ F+ + +V EY+ G L D + E+ +LT + I + +
Sbjct: 150 QLYDA-----FESKNDIVLVMEYVDGGELFDRI-----IDESYNLTELDTILFMKQICEG 199
Query: 800 IEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHL--GDFGLAKFLS-SSPLDTAVETPSSSK 856
I ++H ++H DLKP N+L + DFGLA+ L
Sbjct: 200 IRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF------- 249
Query: 857 GIKGTVGYIAPEYGMGGEASMTGDVYSFG----ILL 888
GT ++APE S D++S G +LL
Sbjct: 250 ---GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLL 282
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-20
Identities = 56/218 (25%), Positives = 87/218 (39%), Gaps = 50/218 (22%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICS 746
+G+G+ VY+ A+KV+ E L + H N+IK+ I
Sbjct: 61 LGRGATSIVYRCKQKGTQKPYALKVLKKTVD--KKIVRTEIGVLLRLSHPNIIKLKEI-- 116
Query: 747 SIDFKGVDFQAIVYEYMQNGSLEDWL----HQSEDQQEARSLTLIQRINIIIDVASAIEY 802
F+ ++V E + G L D + + SE ++A + + + A+ Y
Sbjct: 117 ---FETPTEISLVLELVTGGELFDRIVEKGYYSE--RDAA--------DAVKQILEAVAY 163
Query: 803 IHHHCQPPVVHGDLKPSNVLL---DQDLVAHLGDFGLAKFLS-SSPLDTAVETPSSSKGI 858
+H + +VH DLKP N+L D + DFGL+K + + T
Sbjct: 164 LHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC--------- 211
Query: 859 KGTVGYIAPE----YGMGGEASMTGDVYSFG----ILL 888
GT GY APE G E D++S G ILL
Sbjct: 212 -GTPGYCAPEILRGCAYGPEV----DMWSVGIITYILL 244
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-20
Identities = 49/218 (22%), Positives = 83/218 (38%), Gaps = 20/218 (9%)
Query: 353 VIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIP 412
+ I+ + P L N V+ + +T + EL +Q D++ +
Sbjct: 3 IQRPTPINQVFP--DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ--SL 56
Query: 413 TSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSL- 471
+ T L L LS N + + P L + L EL + L + I + L
Sbjct: 57 AGMQFFTNLKELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLK-----NLNGIPSACLS 109
Query: 472 SLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGS 531
L L N L T L +LKNL +I N+ I + L + L+ L L GN + +
Sbjct: 110 RLFLDNNELRDTDSLI--HLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEIT-N 164
Query: 532 IPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYL 569
L+ LK + +D++ + +Y L +
Sbjct: 165 T-GGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTV 201
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 43/242 (17%), Positives = 79/242 (32%), Gaps = 47/242 (19%)
Query: 190 NLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGF 249
L N + NLG+ S+ ++ S + L + F
Sbjct: 14 PDPGLANAVKQNLGKQ--------SVTDLVSQKE-------------------LSGVQNF 46
Query: 250 IVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEA 309
+N + +NL EL L NQ +S + L LE L++ N L
Sbjct: 47 NGDNSNI--QSLAGMQFFTNLKELHLSHNQIS-DLS-PLKDLTKLEELSVNRNRL----- 97
Query: 310 NDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRN 369
+L+ + L+ + LD+N + +L + + + I N++ I +
Sbjct: 98 KNLNGIPSAC----LSRLFLDNNELRDTDS--LIHLKN-LEILSIRNNKLKSI--VMLGF 148
Query: 370 LVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSN 429
L L L + N++T T + LK + + L L + +
Sbjct: 149 LSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDG 206
Query: 430 DL 431
Sbjct: 207 RW 208
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 7e-08
Identities = 25/138 (18%), Positives = 57/138 (41%), Gaps = 16/138 (11%)
Query: 439 LGNCKNLIELHMADIELTGALPPQILSISTLS--LSLDLSYNLLSGTLPLEVGNLKNLVY 496
N ++ ++ +T ++S LS + + + + ++ NL
Sbjct: 15 DPGLANAVKQNLGKQSVT-----DLVSQKELSGVQNFNGDNSNIQSLAGMQ--FFTNLKE 67
Query: 497 FNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQI 556
++S N+ S ++ L T L++L + N ++ + + S + L + +N L
Sbjct: 68 LHLSHNQIS-DLS-PLKDLTKLEELSVNRNRLK-NL-NGIPSAC-LSRLFLDNNELRD-- 120
Query: 557 PEYLENLSFLEYLNLSYN 574
+ L +L LE L++ N
Sbjct: 121 TDSLIHLKNLEILSIRNN 138
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 44/229 (19%), Positives = 87/229 (37%), Gaps = 21/229 (9%)
Query: 52 VTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFS 111
K +L +++ L LS ++ N ++N + + L+ L L++N S
Sbjct: 21 AVKQNLGKQSVT-DLVS-QKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKELHLSHNQIS 76
Query: 112 GKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLS 171
+ + L + L + RN L + G L L + +N L S+ +L
Sbjct: 77 -DL-SPLKDLTKLEELSVNRNRLK-NLN---GIPSACLSRLFLDNNELRD--TDSLIHLK 128
Query: 172 TLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRF 231
LE +++ N L + LG L L +L+L N + + + + + L +
Sbjct: 129 NLEILSIRNNKL--KSIVMLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKC 184
Query: 232 NGSLPLDIGVSLPKLLGFIVAENNFAGSI-PESLSNASNLVELTLFDNQ 279
+ P+ P+L ++ I P +SN + V+ +
Sbjct: 185 V-NEPVKY---QPELYITNTVKDPDGRWISPYYISNGGSYVDGCVLWEL 229
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 18/86 (20%), Positives = 39/86 (45%), Gaps = 6/86 (6%)
Query: 490 NLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSS 549
L N V N+ + + + +Q ++ S+ + + ++KEL +S
Sbjct: 17 GLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHLSH 72
Query: 550 NNLSGQIPEYLENLSFLEYLNLSYNH 575
N +S + L++L+ LE L+++ N
Sbjct: 73 NQIS-DL-SPLKDLTKLEELSVNRNR 96
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 31/205 (15%), Positives = 67/205 (32%), Gaps = 17/205 (8%)
Query: 116 TNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLER 175
+N + N + ++ + + ++N ++++ A + + L+
Sbjct: 13 FPDPGLANAVKQNLGKQSVTDLVSQK---ELSGVQNFNGDNSNIQS--LAGMQFFTNLKE 67
Query: 176 INVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSL 235
+++ N + + L +L L L++ NR + + + L +FL N +
Sbjct: 68 LHLSHNQI--SDLSPLKDLTKLEELSVNRNRLKNL---NGIPSACLSRLFLDNNELRDTD 122
Query: 236 PLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLE 295
L L L + N L S L L L N+ + LK +
Sbjct: 123 SLI---HLKNLEILSIRNNKL--KSIVMLGFLSKLEVLDLHGNEITNTGGL--TRLKKVN 175
Query: 296 WLNLGSNNLGTGEANDLDFLTLLTN 320
W++L L +
Sbjct: 176 WIDLTGQKCVNEPVKYQPELYITNT 200
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 55/218 (25%), Positives = 90/218 (41%), Gaps = 53/218 (24%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIR-HRNLIKIITIC 745
+G+GSF K ++ AVK+I+ + + + E AL+ H N++K+ +
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ---KEITALKLCEGHPNIVKLHEV- 74
Query: 746 SSIDFKGVDFQAIVYEYMQNGSLEDWLHQ----SEDQQEARSLTLIQRINIIIDVASAIE 801
F +V E + G L + + + SE EA I+ + SA+
Sbjct: 75 ----FHDQLHTFLVMELLNGGELFERIKKKKHFSE--TEAS--------YIMRKLVSAVS 120
Query: 802 YIHHHCQPPVVHGDLKPSNVLL---DQDLVAHLGDFGLAKFL--SSSPLDTAVETPSSSK 856
++H VVH DLKP N+L + +L + DFG A+ + PL T
Sbjct: 121 HMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC------- 170
Query: 857 GIKGTVGYIAPE------YGMGGEASMTGDVYSFGILL 888
T+ Y APE Y D++S G++L
Sbjct: 171 ---FTLHYAAPELLNQNGYDE--SC----DLWSLGVIL 199
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 5e-20
Identities = 58/230 (25%), Positives = 96/230 (41%), Gaps = 39/230 (16%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVIN---LKQKGASNGFVAECQALRNIRH 735
+ F IG+GSFG V + M A+K +N ++ E Q ++ + H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 736 RNLIKIITICSSIDFKGVDFQA-----IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRI 790
L+ + S FQ +V + + G L L Q+ +E ++
Sbjct: 75 PFLVNLW--YS--------FQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETV-----KL 119
Query: 791 NIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVE 850
I ++ A++Y+ + ++H D+KP N+LLD+ H+ DF +A L E
Sbjct: 120 -FICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR-------E 168
Query: 851 TPSSSKGIKGTVGYIAPE---YGMGGEASMTGDVYSFGILLLEMFTRRRP 897
T ++ GT Y+APE G S D +S G+ E+ RRP
Sbjct: 169 TQITTMA--GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 5e-20
Identities = 30/185 (16%), Positives = 63/185 (34%), Gaps = 15/185 (8%)
Query: 393 ELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMAD 452
K L + A + + LT + L++ ++ + + N+ +L + +
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINN 75
Query: 453 IELTGALPPQILSISTLSL--SLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPV 510
I T IS LS L + ++ + L +L +IS + I
Sbjct: 76 IHATN-----YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILT 130
Query: 511 TLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLN 570
++ + + L N I L +L +K L++ + + +E+ L L
Sbjct: 131 KINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLY 187
Query: 571 LSYNH 575
Sbjct: 188 AFSQT 192
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-17
Identities = 35/222 (15%), Positives = 62/222 (27%), Gaps = 63/222 (28%)
Query: 286 IYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANL 345
I + +L ++ L + N+ DL + N +LT
Sbjct: 38 ITEAQMNSLTYITLANINV-----TDLTGIEYAHNIKDLT-------------------- 72
Query: 346 SSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSN 405
I + P I L NL L + +T + L +L LL + +
Sbjct: 73 --------INNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHS 122
Query: 406 FLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILS 465
I T + L + ++ LS N I P L L
Sbjct: 123 AHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKS------------------ 163
Query: 466 ISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGE 507
L++ ++ + +E + L G+
Sbjct: 164 -------LNIQFDGVHDYRGIE--DFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 4e-16
Identities = 27/198 (13%), Positives = 64/198 (32%), Gaps = 35/198 (17%)
Query: 357 NQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLG 416
+ + I + +L + + + +T I N++ L +++ +
Sbjct: 33 SSTANITEA---QMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHATN--YNPIS 85
Query: 417 NLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLS 476
L+ L L + D+ P+L +L L D+S
Sbjct: 86 GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLL-------------------------DIS 120
Query: 477 YNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSL 536
++ ++ ++ L + ++S N +I L L+ L +Q + +
Sbjct: 121 HSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDY--RGI 177
Query: 537 SSLKSIKELDMSSNNLSG 554
+ +L S + G
Sbjct: 178 EDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 4e-12
Identities = 23/218 (10%), Positives = 57/218 (26%), Gaps = 42/218 (19%)
Query: 145 NWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGE 204
+ N + + + +++L I + + + N+ L +
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINV--TDLTGIEYAHNIKDLTINN 75
Query: 205 NRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESL 264
N + + L L + + +L
Sbjct: 76 IH--------ATNYNPISG-------------------LSNLERLRIMGKDVTSDKIPNL 108
Query: 265 SNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTEL 324
S ++L L + + + +L + ++L N T D+ L L L
Sbjct: 109 SGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT----DIMPLKTLPE---L 161
Query: 325 TAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGI 362
++ + + I + + + I G
Sbjct: 162 KSLNIQFDGVHDYRG--IEDFPK-LNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 7e-10
Identities = 20/121 (16%), Positives = 49/121 (40%), Gaps = 5/121 (4%)
Query: 481 SGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLK 540
S T + + +L Y ++ + + +++ L + + + +S L
Sbjct: 33 SSTANITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHATNY--NPISGLS 88
Query: 541 SIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTK-GVFSNKTGISLSGNGK 599
+++ L + +++ L L+ L L++S++ + + TK I LS NG
Sbjct: 89 NLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA 148
Query: 600 V 600
+
Sbjct: 149 I 149
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 9e-10
Identities = 31/184 (16%), Positives = 57/184 (30%), Gaps = 11/184 (5%)
Query: 50 QRVTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNS 109
+ L + + ++ L Y+ LA+ N I ++ L + N
Sbjct: 23 KAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIH 77
Query: 110 FSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGN 169
+ +S SNL ++ + L L L I+ + I
Sbjct: 78 ATN--YNPISGLSNLERLRIMGKDVTSDKIPNLS-GLTSLTLLDISHSAHDDSILTKINT 134
Query: 170 LSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTN 229
L + I++ NG I L L L LN+ + I + L ++ +
Sbjct: 135 LPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQ 191
Query: 230 RFNG 233
G
Sbjct: 192 TIGG 195
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 5e-20
Identities = 55/224 (24%), Positives = 102/224 (45%), Gaps = 34/224 (15%)
Query: 681 FSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIK 740
++ + +IG GSFG VY+ L ++G +VA+K + ++ + E Q +R + H N+++
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 111
Query: 741 II-TICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASA 799
+ SS + K + +V +Y+ ++ ++ + ++ + + +
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK--LYMYQLFRS 168
Query: 800 IEYIHHHCQPPVVHGDLKPSNVLLDQDL-VAHLGDFGLAKFLSSSPLDTAVETPSSSKGI 858
+ YIH + H D+KP N+LLD D V L DFG AK L + +
Sbjct: 169 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---------- 215
Query: 859 KGTVGYI------APEYGMGG-EASMTGDVYSFGILLLEMFTRR 895
YI APE G + + + DV+S G +L E+ +
Sbjct: 216 -----YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 6e-20
Identities = 42/205 (20%), Positives = 78/205 (38%), Gaps = 26/205 (12%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICS 746
+G G+FG V++ G + K IN E + + H LI +
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA-- 116
Query: 747 SIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHH 806
F+ ++ E++ G L D + E ++ + IN + ++++H H
Sbjct: 117 ---FEDKYEMVLILEFLSGGELFDRI-----AAEDYKMSEAEVINYMRQACEGLKHMHEH 168
Query: 807 CQPPVVHGDLKPSNVLLDQDLVAHL--GDFGLAKFLS-SSPLDTAVETPSSSKGIKGTVG 863
+VH D+KP N++ + + + DFGLA L+ + T
Sbjct: 169 ---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT----------ATAE 215
Query: 864 YIAPEYGMGGEASMTGDVYSFGILL 888
+ APE D+++ G+L
Sbjct: 216 FAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 6e-20
Identities = 63/265 (23%), Positives = 104/265 (39%), Gaps = 34/265 (12%)
Query: 664 QQFPMISYAELSKAT-NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVIN---LKQKGA 719
+F + E T N F ++G+G FG V + G M A K + +K++
Sbjct: 168 NRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG 227
Query: 720 SNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQ 779
+ E Q L + R ++++ + ++ D +V M G L+ ++
Sbjct: 228 EAMALNEKQILEKVNSRF---VVSLAYA--YETKDALCLVLTLMNGGDLKFHIYHMGQAG 282
Query: 780 --EARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAH--LGDFG 835
EAR++ I +E +H +V+ DLKP N+LLD H + D G
Sbjct: 283 FPEARAVFYAAEI------CCGLEDLHRER---IVYRDLKPENILLDDH--GHIRISDLG 331
Query: 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRR 895
LA + + KG GTVGY+APE + + D ++ G LL EM +
Sbjct: 332 LAVHVPEG---------QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
Query: 896 RPTDGMFNQGLTLHEFARTALPDKV 920
P + + E R
Sbjct: 383 SPFQQ-RKKKIKREEVERLVKEVPE 406
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 8e-20
Identities = 57/229 (24%), Positives = 102/229 (44%), Gaps = 25/229 (10%)
Query: 675 SKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINL-KQKGASNGF-------VAE 726
S AT+ + IG G++G VYK +G VA+K + + G G VA
Sbjct: 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 727 CQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTL 786
+ L H N+++++ +C++ +V+E++ L +L D+ L
Sbjct: 65 LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL----DKAPPPGLPA 119
Query: 787 IQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLD 846
+++ ++++H +C +VH DLKP N+L+ L DFGLA+ S
Sbjct: 120 ETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS----- 171
Query: 847 TAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRR 895
+ + + T+ Y APE + + D++S G + EMF R+
Sbjct: 172 --YQMALTPVVV--TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 8e-20
Identities = 53/227 (23%), Positives = 93/227 (40%), Gaps = 41/227 (18%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALR--NIRHR 736
+D +G+G++G V K +G ++AVK I + L +I R
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQK-----RLLMDLDISMR 61
Query: 737 NLIKIITICSS---IDFKGVDFQ----AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQR 789
+ F G F+ I E M + SL+ + Q D+ + ++ +
Sbjct: 62 T-------VDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGK 113
Query: 790 INIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSS-PLDTA 848
I + + A+E++H V+H D+KPSNVL++ + DFG++ +L D
Sbjct: 114 I--AVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID 169
Query: 849 VETPSSSKGIKGTVGYIAPE----YGMGGEASMTGDVYSFGILLLEM 891
G Y+APE S+ D++S GI ++E+
Sbjct: 170 A----------GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 206
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 57/227 (25%), Positives = 86/227 (37%), Gaps = 59/227 (25%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVA------ECQALRNIRHRNLIK 740
+G G F V K G A K I ++ +S V+ E LR IRH N+I
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 741 IITICSSIDFKGVDFQAIVYEYMQNGSLEDWL----HQSEDQQEARSLTLIQRINIIIDV 796
+ I F+ ++ E + G L D+L +E EA + +
Sbjct: 73 LHDI-----FENKTDVVLILELVSGGELFDFLAEKESLTE--DEAT--------QFLKQI 117
Query: 797 ASAIEYIHHHCQPPVVHGDLKPSNVLL----DQDLVAHLGDFGLAKFLS-SSPLDTAVET 851
+ Y+H + H DLKP N++L + L DFG+A + +
Sbjct: 118 LDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF-- 172
Query: 852 PSSSKGIKGTVGYIAPE------YGMGGEASMTGDVYSFG----ILL 888
GT ++APE G+ EA D++S G ILL
Sbjct: 173 --------GTPEFVAPEIVNYEPLGL--EA----DMWSIGVITYILL 205
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 55/217 (25%), Positives = 100/217 (46%), Gaps = 27/217 (12%)
Query: 685 NMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIIT 743
+G G++ VYKG G+ VA+K + L + G + + E ++ ++H N++++
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYD 70
Query: 744 ICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYI 803
+ + + +V+E+M N L+ ++ R L L + + +
Sbjct: 71 VIHT---ENKLT--LVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124
Query: 804 HHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDT----AVETPSSSKGIK 859
H + ++H DLKP N+L+++ LGDFGLA+ P++T V
Sbjct: 125 HENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVV---------- 170
Query: 860 GTVGYIAPEYGMGGEASMTG-DVYSFGILLLEMFTRR 895
T+ Y AP+ MG T D++S G +L EM T +
Sbjct: 171 -TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-19
Identities = 55/219 (25%), Positives = 86/219 (39%), Gaps = 47/219 (21%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVA------ECQALRNIRHRNLIK 740
+G G F V K G+ A K I +Q AS V+ E LR + H N+I
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 741 IITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAI 800
+ + ++ ++ E + G L D+L Q E SL+ + + I + +
Sbjct: 80 LHDV-----YENRTDVVLILELVSGGELFDFLAQKE------SLSEEEATSFIKQILDGV 128
Query: 801 EYIHHHCQPPVVHGDLKPSNVLL----DQDLVAHLGDFGLAKFLS-SSPLDTAVETPSSS 855
Y+H + H DLKP N++L L DFGLA +
Sbjct: 129 NYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF------ 179
Query: 856 KGIKGTVGYIAPE------YGMGGEASMTGDVYSFGILL 888
GT ++APE G+ EA D++S G++
Sbjct: 180 ----GTPEFVAPEIVNYEPLGL--EA----DMWSIGVIT 208
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 55/240 (22%), Positives = 96/240 (40%), Gaps = 37/240 (15%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGAS-NGFVAECQ-ALRNIRHR 736
D IG+G++G V K +G ++AVK I + + +R+
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 737 NLIKIITICSSIDFKGVDFQA----IVYEYMQNGSLEDWLHQSEDQQEAR-SLTLIQRIN 791
+++ F G F+ I E M + S + + + ++ +
Sbjct: 82 YIVQ---------FYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGK-- 129
Query: 792 IIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVET 851
I + A+ ++ + + ++H D+KPSN+LLD+ L DFG++ L S T
Sbjct: 130 ITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTR--- 184
Query: 852 PSSSKGIKGTVGYIAPE----YGMGGEASMTGDVYSFGILLLEMFTRRRP---TDGMFNQ 904
G Y+APE + DV+S GI L E+ T R P + +F+Q
Sbjct: 185 ------DAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ 238
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 50/230 (21%), Positives = 88/230 (38%), Gaps = 47/230 (20%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKV------INLKQKGASNGFVAECQALRN 732
DF ++G+GSF V A+K+ I + E +
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT---RERDVMSR 86
Query: 733 IRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINI 792
+ H +K+ + F+ + Y +NG L L I++I
Sbjct: 87 LDHPFFVKLY--FT---FQDDEKLYFGLSYAKNGEL---------------LKYIRKIGS 126
Query: 793 IID---------VASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSS 843
+ + SA+EY+H ++H DLKP N+LL++D+ + DFG AK LS
Sbjct: 127 FDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 183
Query: 844 PLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT 893
+ GT Y++PE A + D+++ G ++ ++
Sbjct: 184 SKQARANS------FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 227
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-19
Identities = 59/229 (25%), Positives = 96/229 (41%), Gaps = 44/229 (19%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK-GASNGFVAECQALRNIRHRN 737
+ + +G+G++ VYKG +VA+K I L+ + GA + E L++++H N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 738 ---LIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSE---DQQEARSLTLIQRIN 791
L II S+ +V+EY+ L+ +L + + L Q +
Sbjct: 62 IVTLHDIIHTEKSL--------TLVFEYLDK-DLKQYLDDCGNIINMHNVKLF-LFQLL- 110
Query: 792 IIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDT---- 847
+ Y H V+H DLKP N+L+++ L DFGLA+ S P T
Sbjct: 111 ------RGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNE 160
Query: 848 AVETPSSSKGIKGTVGYIAPEYGMGGEASMTG-DVYSFGILLLEMFTRR 895
V T+ Y P+ +G T D++ G + EM T R
Sbjct: 161 VV-----------TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 2e-19
Identities = 61/264 (23%), Positives = 105/264 (39%), Gaps = 29/264 (10%)
Query: 664 QQFPMISYAELSKAT-NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVIN---LKQKGA 719
+F + E + F ++G+G FG V+ + G + A K +N LK++
Sbjct: 169 LRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKG 228
Query: 720 SNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQ 779
G + E + L + R ++ + + F+ +V M G + H +
Sbjct: 229 YQGAMVEKKILAKVHSRFIVSL--AYA---FETKTDLCLVMTIMNGGDI--RYHIYNVDE 281
Query: 780 EARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKF 839
+ + I + S +E++H +++ DLKP NVLLD D + D GLA
Sbjct: 282 DNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAV- 337
Query: 840 LSSSPLDTAVETPSSSKGIK---GTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRR 896
E + K GT G++APE +G E + D ++ G+ L EM R
Sbjct: 338 ----------ELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARG 387
Query: 897 PTDGMFNQGLTLHEFARTALPDKV 920
P + + E + L V
Sbjct: 388 PFRA-RGEKVENKELKQRVLEQAV 410
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-19
Identities = 52/219 (23%), Positives = 92/219 (42%), Gaps = 47/219 (21%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVA------ECQALRNIRHRNLIK 740
+G G F V K G+ A K I ++ +S V+ E L+ I+H N+I
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 741 IITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAI 800
+ + ++ ++ E + G L D+L + E SLT + + + + +
Sbjct: 79 LHEV-----YENKTDVILILELVAGGELFDFLAEKE------SLTEEEATEFLKQILNGV 127
Query: 801 EYIHHHCQPPVVHGDLKPSNVLL-DQDLVAH---LGDFGLAKFLS-SSPLDTAVETPSSS 855
Y+H + H DLKP N++L D+++ + DFGLA + +
Sbjct: 128 YYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF------ 178
Query: 856 KGIKGTVGYIAPE------YGMGGEASMTGDVYSFGILL 888
GT ++APE G+ EA D++S G++
Sbjct: 179 ----GTPEFVAPEIVNYEPLGL--EA----DMWSIGVIT 207
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 54/220 (24%), Positives = 91/220 (41%), Gaps = 41/220 (18%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNI------RHRNLIK 740
IG+GS+G V+K + G +VA+K + + ALR I +H NL+
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESE--DDPVI--KKIALREIRMLKQLKHPNLVN 66
Query: 741 IITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAI 800
++ + K +V+EY + LH+ + Q L++ +I A+
Sbjct: 67 LLEVFRR---KRRLH--LVFEYCDH----TVLHELDRYQRGVPEHLVK--SITWQTLQAV 115
Query: 801 EYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDT----AVETPSSSK 856
+ H H +H D+KP N+L+ + V L DFG A+ L + P D
Sbjct: 116 NFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVA------- 164
Query: 857 GIKGTVGYIAPEYGMGGEASMTG-DVYSFGILLLEMFTRR 895
T Y +PE +G DV++ G + E+ +
Sbjct: 165 ----TRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 3e-19
Identities = 48/217 (22%), Positives = 82/217 (37%), Gaps = 48/217 (22%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNI-RHRNLIKIITIC 745
+G G G V + A+K++ A E + + ++++I+ +
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARR----EVELHWRASQCPHIVRIVDVY 124
Query: 746 SSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQ----QEARSLTLIQRINIIIDVASAIE 801
+ + G IV E + G L + DQ +EA I+ + AI+
Sbjct: 125 EN-LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS--------EIMKSIGEAIQ 175
Query: 802 YIHHHCQPPVVHGDLKPSNVLL---DQDLVAHLGDFGLAKFLSSS-PLDTAVETPSSSKG 857
Y+H + H D+KP N+L + + L DFG AK +S L T
Sbjct: 176 YLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC-------- 224
Query: 858 IKGTVGYIAPE------YGMGGEASMTGDVYSFGILL 888
T Y+APE Y D++S G+++
Sbjct: 225 --YTPYYVAPEVLGPEKYDK--SC----DMWSLGVIM 253
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 3e-19
Identities = 49/193 (25%), Positives = 74/193 (38%), Gaps = 35/193 (18%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVA------ECQALRNIRHRNLIK 740
+G G F V K G+ A K I +Q AS V E LR + H N+I
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 741 IITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAI 800
+ + ++ ++ E + G L D+L Q E SL+ + + I + +
Sbjct: 80 LHDV-----YENRTDVVLILELVSGGELFDFLAQKE------SLSEEEATSFIKQILDGV 128
Query: 801 EYIHHHCQPPVVHGDLKPSNVLL----DQDLVAHLGDFGLAKFLS-SSPLDTAVETPSSS 855
Y+H + H DLKP N++L L DFGLA +
Sbjct: 129 NYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF------ 179
Query: 856 KGIKGTVGYIAPE 868
GT ++APE
Sbjct: 180 ----GTPEFVAPE 188
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 88.3 bits (220), Expect = 3e-19
Identities = 47/222 (21%), Positives = 94/222 (42%), Gaps = 37/222 (16%)
Query: 685 NMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGF----VAECQALRNIRHRNLIK 740
IG+G++G V+K E +VA+K + L G + E L+ ++H+N+++
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDD--DDEGVPSSALREICLLKELKHKNIVR 65
Query: 741 IITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAI 800
+ + S +V+E+ L+ + + +++ + + + +
Sbjct: 66 LHDVLHS---DKKLT--LVFEFCDQ-DLKKYF---DSCNGDLDPEIVK--SFLFQLLKGL 114
Query: 801 EYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDT----AVETPSSSK 856
+ H V+H DLKP N+L++++ L +FGLA+ P+ V
Sbjct: 115 GFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV------- 163
Query: 857 GIKGTVGYIAPEYGMGGEASMTG-DVYSFGILLLEMFTRRRP 897
T+ Y P+ G + T D++S G + E+ RP
Sbjct: 164 ----TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 3e-19
Identities = 61/267 (22%), Positives = 108/267 (40%), Gaps = 24/267 (8%)
Query: 310 NDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRN 369
+ + E L + L+S + I+ + I + GI+
Sbjct: 12 TPIKQIFSDDAFAETIKDNLKKKSVTDAVT--QNELNS-IDQIIANNSDIKSV--QGIQY 66
Query: 370 LVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSN 429
L N+ +L ++ NKLT P + LKNL L+LD N + +SL +L L +L+L N
Sbjct: 67 LPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK--DLSSLKDLKKLKSLSLEHN 122
Query: 430 DLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSL--SLDLSYNLLSGTLPLE 487
+ I L + L L++ + ++T I +S L+ +L L N +S +PL
Sbjct: 123 GIS-DING-LVHLPQLESLYLGNNKIT-----DITVLSRLTKLDTLSLEDNQISDIVPLA 175
Query: 488 VGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDM 547
L L +S N S ++ L+ +L L L + S+L +
Sbjct: 176 --GLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKN 231
Query: 548 SSNNLSGQIPEYLENLSFLEYLNLSYN 574
+ +L PE + + E N+ ++
Sbjct: 232 TDGSLVT--PEIISDDGDYEKPNVKWH 256
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 58/313 (18%), Positives = 113/313 (36%), Gaps = 57/313 (18%)
Query: 262 ESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNC 321
S + ++ L V+ L +++ + ++++ + + L N
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDI-----KSVQGIQYLPN- 69
Query: 322 TELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDN 381
+T + L+ N+ + P +ANL + + + + N++ + + +++L L L ++ N
Sbjct: 70 --VTKLFLNGNKLTDIKP--LANLKN-LGWLFLDENKVKDL--SSLKDLKKLKSLSLEHN 122
Query: 382 KLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGN 441
++ I + L L+ LYL +N + T L LT L L+L N + I P L
Sbjct: 123 GIS-DIN-GLVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS-DIVP-LAG 176
Query: 442 CKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISV 501
L L LS N +S L LKNL +
Sbjct: 177 LTKLQN-------------------------LYLSKNHISDLRALA--GLKNLDVLELFS 209
Query: 502 NRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKEL-DMSSNNLSGQIPEYL 560
+ S + SL + + I + D N+ +PE+
Sbjct: 210 QECLNKPINHQSNLVVPNTVKNTDG--------SLVTPEIISDDGDYEKPNVKWHLPEFT 261
Query: 561 ENLSFLEYLNLSY 573
+SF+ Y ++
Sbjct: 262 NEVSFIFYQPVTI 274
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 4e-18
Identities = 49/229 (21%), Positives = 82/229 (35%), Gaps = 47/229 (20%)
Query: 350 TDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAG 409
++ + I I ++ + +T + EL ++ + +++ +
Sbjct: 5 SETITVPTPIKQIFS--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI-- 58
Query: 410 GIPTSLGNLTLLTNL---ALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSI 466
S+ + L N+ L+ N L I P L N KNL L
Sbjct: 59 ---KSVQGIQYLPNVTKLFLNGNKLT-DIKP-LANLKNLGWL------------------ 95
Query: 467 STLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGN 526
L N + L+ +LK L ++ N S +I L L+ LYL N
Sbjct: 96 -------FLDENKVKDLSSLK--DLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNN 144
Query: 527 SFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNH 575
+ + LS L + L + N +S I L L+ L+ L LS NH
Sbjct: 145 KIT--DITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNH 189
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 8e-15
Identities = 49/242 (20%), Positives = 98/242 (40%), Gaps = 24/242 (9%)
Query: 190 NLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGF 249
+ I NL + + V + ++S++ + + + LP +
Sbjct: 19 SDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQ---YLPNVTKL 73
Query: 250 IVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEA 309
+ N I + L+N NL L L +N+ + +S + LK L+ L+L N +
Sbjct: 74 FLNGNKLT-DI-KPLANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGI----- 124
Query: 310 NDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRN 369
+D++ L + +L ++ L +N+ + ++ L+ + + + NQIS I +
Sbjct: 125 SDINGLV---HLPQLESLYLGNNKITDI--TVLSRLTK-LDTLSLEDNQISDI--VPLAG 176
Query: 370 LVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSN 429
L L L + N ++ + A+ LKNL +L L S NL + + +
Sbjct: 177 LTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDG 234
Query: 430 DL 431
L
Sbjct: 235 SL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 50/314 (15%), Positives = 98/314 (31%), Gaps = 75/314 (23%)
Query: 116 TNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLER 175
+ + I N ++ ++ + ++ + ++ + I L + +
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVTQN---ELNSIDQIIANNSDIKSVQG--IQYLPNVTK 72
Query: 176 INVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSL 235
+ + GN L I L NL+NL L L EN+ + ++SSL++
Sbjct: 73 LFLNGNKL-TDIK-PLANLKNLGWLFLDENK--------VKDLSSLKD------------ 110
Query: 236 PLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLE 295
L KL + N S L + L L L +N+ +++ L L+
Sbjct: 111 -------LKKLKSLSLEHNGI--SDINGLVHLPQLESLYLGNNKIT-DITV-LSRLTKLD 159
Query: 296 WLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIA 355
L+L N + +D+ L LT L ++
Sbjct: 160 TLSLEDNQI-----SDIVPLAGLTKLQNLY----------------------------LS 186
Query: 356 GNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSL 415
N IS + + L NL L + + + L + L P +
Sbjct: 187 KNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEII 242
Query: 416 GNLTLLTNLALSSN 429
+ + +
Sbjct: 243 SDDGDYEKPNVKWH 256
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 42/229 (18%), Positives = 84/229 (36%), Gaps = 18/229 (7%)
Query: 52 VTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFS 111
K +L +++ T + L+ + + +++ + I L + L L N +
Sbjct: 26 TIKDNLKKKSV--TDAVTQNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLT 81
Query: 112 GKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLS 171
I L+ NL N + ++ + KL++L++ N ++ + +L
Sbjct: 82 -DI-KPLANLKNLGWLFLDENKVK-DLSSLKDLK--KLKSLSLEHNGISD--INGLVHLP 134
Query: 172 TLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRF 231
LE + + N + L L L L+L +N+ S IVP + ++ L+N++L N
Sbjct: 135 QLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHI 190
Query: 232 NGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQF 280
+ L L L + SN + D
Sbjct: 191 SDLRALA---GLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 6e-19
Identities = 60/237 (25%), Positives = 96/237 (40%), Gaps = 42/237 (17%)
Query: 675 SKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIR 734
K + F M GQG+FG V G GM VA+K + ++ N + Q L +
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-IQDPRFRNRELQIMQDLAVLH 77
Query: 735 HRNLIKIITICSSIDFKGVD--FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTL----IQ 788
H N++++ + ++ + + +V EY+ + LH+ R + I+
Sbjct: 78 HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP----DT-LHRCCRNYYRRQVAPPPILIK 132
Query: 789 RINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQ---DLVAHLGDFGLAKFLSSSPL 845
+ + +I +H V H D+KP NVL+++ L L DFG AK L SP
Sbjct: 133 V--FLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLK--LCDFGSAKKL--SPS 185
Query: 846 DTAVETPSSSKGIKGTVGYI------APEYGMGGEASMTG-DVYSFGILLLEMFTRR 895
+ V YI APE G + T D++S G + EM
Sbjct: 186 EPNVA-------------YICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 6e-19
Identities = 63/257 (24%), Positives = 110/257 (42%), Gaps = 54/257 (21%)
Query: 647 ARRRRSAHKSSVSQLMDQQFPMISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMM 706
R S V++L + P +++L + IG GSFG VY N +
Sbjct: 32 GGRAGSLKDPDVAELFFKDDPEKLFSDLRE----------IGHGSFGAVYFARDVRNSEV 81
Query: 707 VAVKVINLKQKGASNGF---VAECQALRNIRHRNLIKIITICSSIDFKGVDFQA----IV 759
VA+K ++ K ++ + + E + L+ +RH N I+ ++G + +V
Sbjct: 82 VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ---------YRGCYLREHTAWLV 132
Query: 760 YEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIII-DVASAIEYIHHHCQPPVVHGDLKP 818
EY GS D L + + L ++ I + + Y+H H ++H D+K
Sbjct: 133 MEYCL-GSASDLLEVHK-----KPLQEVE-IAAVTHGALQGLAYLHSH---NMIHRDVKA 182
Query: 819 SNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGY-IAPEYGMGGEASM 877
N+LL + + LGDFG A ++ + ++ V TP Y +APE + +
Sbjct: 183 GNILLSEPGLVKLGDFGSASIMAPA--NSFVGTP-----------YWMAPEVILAMDEGQ 229
Query: 878 TG---DVYSFGILLLEM 891
DV+S GI +E+
Sbjct: 230 YDGKVDVWSLGITCIEL 246
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 7e-19
Identities = 54/232 (23%), Positives = 99/232 (42%), Gaps = 33/232 (14%)
Query: 675 SKATNDFSSSNMIGQGSFGFVYKG-NLGENGMMVAVKVINLKQKGASNGF-------VAE 726
+A + IG+G++G V+K +L G VA+K + ++ G VA
Sbjct: 7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT--GEEGMPLSTIREVAV 64
Query: 727 CQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQN---GSLEDWLHQSEDQQEARS 783
+ L H N++++ +C+ +V+E++ L+ + +
Sbjct: 65 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD 124
Query: 784 LTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSS 843
+ + Q + ++++H H VVH DLKP N+L+ L DFGLA+ S
Sbjct: 125 M-MFQ-------LLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYS-- 171
Query: 844 PLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRR 895
+ +S + T+ Y APE + + D++S G + EMF R+
Sbjct: 172 -----FQMALTSVVV--TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 7e-19
Identities = 49/254 (19%), Positives = 85/254 (33%), Gaps = 40/254 (15%)
Query: 647 ARRRRSAHKSSVSQLMDQQFPMISYAELSKATNDFSS----SNMIGQGSFGFVYKGNLGE 702
R + S+ + + + + +G G+FG V++
Sbjct: 121 IVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERA 180
Query: 703 NGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEY 762
G A K + + E Q + +RH L+ + F+ + ++YE+
Sbjct: 181 TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA-----FEDDNEMVMIYEF 235
Query: 763 MQNGSLEDWL-----HQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLK 817
M G L + + SE EA + + V + ++H + VH DLK
Sbjct: 236 MSGGELFEKVADEHNKMSE--DEA--------VEYMRQVCKGLCHMHEN---NYVHLDLK 282
Query: 818 PSNVLLDQDLVAHL--GDFGLAKFLS-SSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGE 874
P N++ L DFGL L + T + APE G
Sbjct: 283 PENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTA----------EFAAPEVAEGKP 332
Query: 875 ASMTGDVYSFGILL 888
D++S G+L
Sbjct: 333 VGYYTDMWSVGVLS 346
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 8e-19
Identities = 63/225 (28%), Positives = 95/225 (42%), Gaps = 29/225 (12%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVIN---LKQKGASNGFVAECQALRNIRH 735
NDFS +IG+G FG VY + G M A+K ++ +K K + E L +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 736 RNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIID 795
+ I+ + + F D + + + M G L L Q EA I
Sbjct: 249 GDCPFIVCMSYA--FHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEI----- 301
Query: 796 VASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAH--LGDFGLAKFLSSSPLDTAVETPS 853
+E++H+ VV+ DLKP+N+LLD+ H + D GLA S +V
Sbjct: 302 -ILGLEHMHNRF---VVYRDLKPANILLDEH--GHVRISDLGLACDFSKKKPHASV---- 351
Query: 854 SSKGIKGTVGYIAPEYGMGGEA-SMTGDVYSFGILLLEMFTRRRP 897
GT GY+APE G A + D +S G +L ++ P
Sbjct: 352 ------GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 9e-19
Identities = 38/214 (17%), Positives = 80/214 (37%), Gaps = 41/214 (19%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICS 746
+G+G FG V++ + K + + E L RHRN++ +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHES-- 69
Query: 747 SIDFKGVDFQAIVYEYMQNGSLEDWL-----HQSEDQQEARSLTLIQRINIIIDVASAIE 801
F+ ++ +++E++ + + + +E +E ++ + V A++
Sbjct: 70 ---FESMEELVMIFEFISGLDIFERINTSAFELNE--REI--------VSYVHQVCEALQ 116
Query: 802 YIHHHCQPPVVHGDLKPSNVLLDQDLVAHL--GDFGLAKFLS-SSPLDTAVETPSSSKGI 858
++H H + H D++P N++ + + +FG A+ L
Sbjct: 117 FLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--------- 164
Query: 859 KGTVGYIAPEYGMGGEASMTGDVYSFG----ILL 888
Y APE S D++S G +LL
Sbjct: 165 -TAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLL 197
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-18
Identities = 55/220 (25%), Positives = 92/220 (41%), Gaps = 41/220 (18%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNI------RHRNLIK 740
+G+GS+G V K + G +VA+K + A+R I RH NL+
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDD--DKMV--KKIAMREIKLLKQLRHENLVN 88
Query: 741 IITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAI 800
++ +C K + +V+E++ + L E ++Q + + + I
Sbjct: 89 LLEVCKK---KKRWY--LVFEFVDH----TILDDLELFPNGLDYQVVQ--KYLFQIINGI 137
Query: 801 EYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDT----AVETPSSSK 856
+ H H ++H D+KP N+L+ Q V L DFG A+ L ++P +
Sbjct: 138 GFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVA------- 186
Query: 857 GIKGTVGYIAPEYGMGGEA-SMTGDVYSFGILLLEMFTRR 895
T Y APE +G DV++ G L+ EMF
Sbjct: 187 ----TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 2e-18
Identities = 55/244 (22%), Positives = 105/244 (43%), Gaps = 23/244 (9%)
Query: 662 MDQQFPMISYAELSKATNDFSSSNM-IGQGSFGFVYKG--NLGENGMMVAVKVINLKQKG 718
MD F + +E + + F +G+G++G VYK G++ A+K I + G
Sbjct: 3 MDYDFKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI--EGTG 60
Query: 719 ASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQN--GSLEDWLHQSE 776
S E LR ++H N+I + + S + V ++++Y ++ + + S+
Sbjct: 61 ISMSACREIALLRELKHPNVISLQKVFLSHADRKV---WLLFDYAEHDLWHIIKFHRASK 117
Query: 777 DQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAH----LG 832
++ L +++ + I Y+H + V+H DLKP+N+L+ + +
Sbjct: 118 ANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIA 174
Query: 833 DFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTG-DVYSFGILLLEM 891
D G A+ +SPL + T Y APE +G D+++ G + E+
Sbjct: 175 DMGFARLF-NSPLKP--LADLDPVVV--TFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 229
Query: 892 FTRR 895
T
Sbjct: 230 LTSE 233
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 2e-18
Identities = 48/231 (20%), Positives = 88/231 (38%), Gaps = 39/231 (16%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGAS-NGFVAECQAL-RNIRHR 736
ND + +G G+ G V+K + G ++AVK + + + + ++
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 737 NLIKIITICSSIDFKGVDFQA----IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINI 792
+++ G I E M + + E ++ ++
Sbjct: 85 YIVQ---------CFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPER----ILGKM-- 129
Query: 793 IIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSS-PLDTAVET 851
+ + A+ Y+ V+H D+KPSN+LLD+ L DFG++ L D +
Sbjct: 130 TVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA-- 185
Query: 852 PSSSKGIKGTVGYIAPE-----YGMGGEASMTGDVYSFGILLLEMFTRRRP 897
G Y+APE + + DV+S GI L+E+ T + P
Sbjct: 186 --------GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 3e-18
Identities = 60/253 (23%), Positives = 100/253 (39%), Gaps = 59/253 (23%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVIN---LKQKGASNGFVAECQALRNIRH 735
+DF +IG+G+F V + + G + A+K++N + ++G + F E L N
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 736 RNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIID 795
R + ++ + F+ ++ +V EY G L LTL+ + I
Sbjct: 121 RWITQLH--FA---FQDENYLYLVMEYYVGGDL---------------LTLLSKFGERIP 160
Query: 796 ----------VASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAH--LGDFGLAKFLSSS 843
+ AI+ +H VH D+KP N+LLD+ H L DFG L +
Sbjct: 161 AEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRC--GHIRLADFGSCLKLRAD 215
Query: 844 PLDTAVETPSSSKGIKGTVGYIAPE--YGMGGEASMTG-----DVYSFGILLLEMFTRRR 896
S GT Y++PE +GG D ++ G+ EMF +
Sbjct: 216 GTVR-------SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268
Query: 897 P-----TDGMFNQ 904
P T + +
Sbjct: 269 PFYADSTAETYGK 281
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 5e-18
Identities = 51/233 (21%), Positives = 96/233 (41%), Gaps = 47/233 (20%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGF----VAECQALRNIR 734
+ + +G+G++G VYK VA+K I L+ G + E L+ ++
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH--EEEGVPGTAIREVSLLKELQ 91
Query: 735 HRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSE--DQQEARSLTLIQRINI 792
HRN+I++ ++ +++EY +N L+ ++ ++ + +S L Q
Sbjct: 92 HRNIIELKSVIHH---NHRLH--LIFEYAEN-DLKKYMDKNPDVSMRVIKSF-LYQ---- 140
Query: 793 IIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAH-----LGDFGLAKFLSSSPLDT 847
+ + + + H +H DLKP N+LL + +GDFGLA+ P+
Sbjct: 141 ---LINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQ 193
Query: 848 ----AVETPSSSKGIKGTVGYIAPEYGMGGEASMTG-DVYSFGILLLEMFTRR 895
+ T+ Y PE +G T D++S + EM +
Sbjct: 194 FTHEII-----------TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 6e-18
Identities = 57/230 (24%), Positives = 99/230 (43%), Gaps = 47/230 (20%)
Query: 681 FSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINL--KQKGASNGFVAECQALRNIRHRNL 738
+++ +IG GSFG V++ L E+ VA+K + + K E Q +R ++H N+
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNR------ELQIMRIVKHPNV 94
Query: 739 IKII-TICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTL----IQRINII 793
+ + S+ D K F +V EY+ E ++++ T+ I+ +
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEYVP----ET-VYRASRHYAKLKQTMPMLLIK--LYM 147
Query: 794 IDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQD-LVAHLGDFGLAKFLSSSPLDTAVETP 852
+ ++ YIH + H D+KP N+LLD V L DFG AK L + + +
Sbjct: 148 YQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS---- 200
Query: 853 SSSKGIKGTVGYI------APEYGMGG-EASMTGDVYSFGILLLEMFTRR 895
YI APE G + D++S G ++ E+ +
Sbjct: 201 -----------YICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 7e-18
Identities = 58/298 (19%), Positives = 110/298 (36%), Gaps = 56/298 (18%)
Query: 617 LKKRTDFLLKVVVPVTVSGVILSLCLVLFLARRRRSAHKSSVSQLMDQQFPMISYAELSK 676
+K + L V ++ L +++ ++ + + I+ +
Sbjct: 6 FEKMDNLLRDPKSEVNSDCLLDGLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLR 65
Query: 677 AT-NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVIN---LKQKGASNGFVAECQALRN 732
D+ +IG+G+FG V + A+K+++ + ++ S F E +
Sbjct: 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 125
Query: 733 IRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINI 792
++++ + F+ + +V EYM G L + L+ ++
Sbjct: 126 ANSPWVVQLF--YA---FQDDRYLYMVMEYMPGGDL---------------VNLMSNYDV 165
Query: 793 IIDVA--------SAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAH--LGDFGLAKFLSS 842
A A++ IH +H D+KP N+LLD+ H L DFG ++
Sbjct: 166 PEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNK 220
Query: 843 SPLD---TAVETPSSSKGIKGTVGYIAPE--YGMGGEASMTGDV--YSFGILLLEMFT 893
+ TAV TP YI+PE GG+ + +S G+ L EM
Sbjct: 221 EGMVRCDTAVGTPD----------YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 268
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 1e-17
Identities = 57/258 (22%), Positives = 100/258 (38%), Gaps = 53/258 (20%)
Query: 657 SVSQLMDQQFPMISYAELSKAT-NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVIN-- 713
++ + ++ P S + + DF +IG+G+FG V L + A+K++N
Sbjct: 51 NILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKW 110
Query: 714 -LKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWL 772
+ ++ + F E L N + + + + F+ + +V +Y G L
Sbjct: 111 EMLKRAETACFREERDVLVNGDSKWITTLH--YA---FQDDNNLYLVMDYYVGGDL---- 161
Query: 773 HQSEDQQEARSLTLIQRINIIID----------VASAIEYIHHHCQPPVVHGDLKPSNVL 822
LTL+ + + + AI+ +H VH D+KP N+L
Sbjct: 162 -----------LTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNIL 207
Query: 823 LDQDLVAH--LGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTG- 879
+D + H L DFG L D V++ + GT YI+PE E
Sbjct: 208 MDMN--GHIRLADFGSCLKLME---DGTVQSSVAV----GTPDYISPEILQAMEGGKGRY 258
Query: 880 ----DVYSFGILLLEMFT 893
D +S G+ + EM
Sbjct: 259 GPECDWWSLGVCMYEMLY 276
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 2e-17
Identities = 55/246 (22%), Positives = 89/246 (36%), Gaps = 16/246 (6%)
Query: 363 IPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTS-LGNLTLL 421
IP+ + N +EL KL A +L+ + + N + I NL L
Sbjct: 24 IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 81
Query: 422 TNLALS-SNDLQGSIPPS-LGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNL 479
+ + +N+L I P N NL L +++ + LP S + LD+ N+
Sbjct: 82 HEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNI 139
Query: 480 LSGTLPLEV--GNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPS-SL 536
T+ G V ++ N EI + T L +L L N+ +P+
Sbjct: 140 NIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVF 198
Query: 537 SSLKSIKELDMSSNNLSGQIPEY-LENLSFLEYLNLSYNHFEGEVPTKGVFSNKTGISLS 595
LD+S + +P Y LENL L + ++PT SL+
Sbjct: 199 HGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLK---KLPTLEKLVALMEASLT 254
Query: 596 GNGKVC 601
C
Sbjct: 255 YPSHCC 260
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 6e-16
Identities = 43/252 (17%), Positives = 83/252 (32%), Gaps = 15/252 (5%)
Query: 180 GNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDI 239
+ + IP++L RN I L + I + LE + + N + D+
Sbjct: 18 ESKV-TEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADV 74
Query: 240 GVSLPKLLGFIVAENNFAGSIPES-LSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLN 298
+LPKL + + N I N NL L + + + ++ L+
Sbjct: 75 FSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLD 134
Query: 299 LGSNN-LGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGN 357
+ N + T E N L+ E + L+ N + +S N + + N
Sbjct: 135 IQDNINIHTIERNSFVGLS-----FESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNN 188
Query: 358 QISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGN 417
+ + V L + ++ + + LK L+ + +L
Sbjct: 189 NLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLKKLP----TLEK 244
Query: 418 LTLLTNLALSSN 429
L L +L+
Sbjct: 245 LVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 9e-10
Identities = 41/209 (19%), Positives = 67/209 (32%), Gaps = 6/209 (2%)
Query: 114 IPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASI-GNLST 172
IP++L R N I L I + LE + I+ N + A + NL
Sbjct: 24 IPSDLPR--NAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80
Query: 173 LERINVLGNGLWGRIPNN-LGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRF 231
L I + I NL NL L + + + + + N
Sbjct: 81 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 140
Query: 232 NGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIY-FRS 290
++ + V L + N I S N + L EL L DN ++ F
Sbjct: 141 IHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHG 200
Query: 291 LKNLEWLNLGSNNLGTGEANDLDFLTLLT 319
L++ + + + L+ L L
Sbjct: 201 ASGPVILDISRTRIHSLPSYGLENLKKLR 229
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 6e-08
Identities = 47/310 (15%), Positives = 80/310 (25%), Gaps = 75/310 (24%)
Query: 38 CQWTGVTCGHRH---------QRVTKLDLSNRTIGGTLSPYV-GNLSFLRYLNLADNNFH 87
C C + +L + + L + ++ N+
Sbjct: 9 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVL 67
Query: 88 GEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWL 147
I + FS L + N + I E N
Sbjct: 68 EVIE---------------ADVFSN--------LPKLHEIRIEKANNLLYINPEAFQNLP 104
Query: 148 KLENLTIADNHLTGHFPASI-GNLSTLERINVLGNGLWGRIPNNL--GNLRNLILLNLGE 204
L+ L I++ + H P + +++ N I N G ++L L +
Sbjct: 105 NLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNK 163
Query: 205 NRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPE-S 263
N I S FN + L+ + L ++NN +P
Sbjct: 164 NGIQEI-HNSAFNGTQLDELNL-------------------------SDNNNLEELPNDV 197
Query: 264 LSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTE 323
AS V L + + S +LK L + +L L L
Sbjct: 198 FHGASGPVILDISRTRIHSLPSYGLENLKKLRARST----------YNLKKLPTLEKLVA 247
Query: 324 LTAIGLDDNR 333
L L
Sbjct: 248 LMEASLTYPS 257
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 2e-17
Identities = 41/219 (18%), Positives = 80/219 (36%), Gaps = 45/219 (20%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASN--GFVAECQALRNIRHR-NLIKIIT 743
+G+G F V + G A K + +++G + E L + +I +
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 744 ICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYI 803
+ ++ ++ EY G + + ++ I +I + + Y+
Sbjct: 97 V-----YENTSEIILILEYAAGGEIFSLCLPELAE----MVSENDVIRLIKQILEGVYYL 147
Query: 804 HHHCQPPVVHGDLKPSNVLL---DQDLVAHLGDFGLAKFLS-SSPLDTAVETPSSSKGIK 859
H + +VH DLKP N+LL + DFG+++ + + L +
Sbjct: 148 HQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM---------- 194
Query: 860 GTVGYIAPE------YGMGGEASMTGDVYSFG----ILL 888
GT Y+APE D+++ G +LL
Sbjct: 195 GTPEYLAPEILNYDPITT--AT----DMWNIGIIAYMLL 227
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 64/254 (25%), Positives = 112/254 (44%), Gaps = 46/254 (18%)
Query: 650 RRSAHKSSVSQLMDQQFPMISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAV 709
H SS + + Q M Y +L K +G+G++G VYK G +VA+
Sbjct: 2 HHHHHHSSGRENLYFQGLMEKYQKLEK----------VGEGTYGVVYKA-KDSQGRIVAL 50
Query: 710 KVINLKQKGASNGF----VAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQN 765
K I L + G + E L+ + H N++ +I + S + +V+E+M+
Sbjct: 51 KRIRLDAE--DEGIPSTAIREISLLKELHHPNIVSLIDVIHS---ERCLT--LVFEFMEK 103
Query: 766 GSLEDWLHQSE---DQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVL 822
L+ L +++ + + L Q + + + H H ++H DLKP N+L
Sbjct: 104 -DLKKVLDENKTGLQDSQIKIY-LYQ-------LLRGVAHCHQHR---ILHRDLKPQNLL 151
Query: 823 LDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTG-DV 881
++ D L DFGLA+ P+ + + + T+ Y AP+ MG + T D+
Sbjct: 152 INSDGALKLADFGLARAF-GIPV-----RSYTHEVV--TLWYRAPDVLMGSKKYSTSVDI 203
Query: 882 YSFGILLLEMFTRR 895
+S G + EM T +
Sbjct: 204 WSIGCIFAEMITGK 217
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 3e-17
Identities = 29/220 (13%), Positives = 55/220 (25%), Gaps = 60/220 (27%)
Query: 687 IGQGSFGFVYKG---NLGENGMMVAVKVINLKQKGASNG---FVAECQALRNIRHRNLIK 740
G ++ L VA+ ++ + + ++ L I
Sbjct: 39 HGGVPPLQFWQALDTALDR---QVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG--- 92
Query: 741 IITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAI 800
+ + + + +V E+++ GSL++ S A I + +A+A
Sbjct: 93 VARVLDVVHTRAGGL--VVAEWIRGGSLQEVADTSPSPVGA--------IRAMQSLAAAA 142
Query: 801 EYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKG 860
+ H V PS V + D L P
Sbjct: 143 DAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPATM----------PDANPQD------ 183
Query: 861 TVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDG 900
D+ G L + R P
Sbjct: 184 -------------------DIRGIGASLYALLVNRWPLPE 204
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 62/276 (22%), Positives = 97/276 (35%), Gaps = 70/276 (25%)
Query: 259 SIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLL 318
IP++L + L L N R S F S L+ L+L + T E L+
Sbjct: 21 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLS-- 76
Query: 319 TNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGI-RNLVNLVELC 377
L+ + L N + S + G L +L +L
Sbjct: 77 ----HLSTLILTGNP-----------IQS---------------LALGAFSGLSSLQKLV 106
Query: 378 MDDNKLTGTIPH-AIGELKNLQLLYLDSNFLAGGIPTSL------GNLTLLTNLALSSND 430
+ L ++ + IG LK L+ L + N + S NLT L +L LSSN
Sbjct: 107 AVETNLA-SLENFPIGHLKTLKELNVAHNLI-----QSFKLPEYFSNLTNLEHLDLSSNK 160
Query: 431 LQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGN 490
+Q SI + + L ++ L+LSLDLS N ++ +
Sbjct: 161 IQ-SIYC--TDLRVLHQM------------------PLLNLSLDLSLNPMN-FIQPGAFK 198
Query: 491 LKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGN 526
L + N+ TSLQ+++L N
Sbjct: 199 EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 46/222 (20%), Positives = 83/222 (37%), Gaps = 19/222 (8%)
Query: 363 IPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSL-GNLTLL 421
IP + + L + N L ++ LQ+L L + I +L+ L
Sbjct: 22 IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSHL 78
Query: 422 TNLALSSNDLQGSIPPSL-GNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLL 480
+ L L+ N +Q S+ +L +L + L +L + L++++NL+
Sbjct: 79 STLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLI 136
Query: 481 SGTLPLEVG---NLKNLVYFNISVNRFSGEIPV-TLSACTSLQ----QLYLQGNSFSGSI 532
+ L NL NL + ++S N+ I L + L L N + I
Sbjct: 137 Q-SFKLP-EYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FI 192
Query: 533 PSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYN 574
+KEL + +N L + L+ L+ + L N
Sbjct: 193 QPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 7e-12
Identities = 47/229 (20%), Positives = 84/229 (36%), Gaps = 20/229 (8%)
Query: 211 VPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESL-SNASN 269
+P ++ S +N+ L N L S P+L ++ +I + + S+
Sbjct: 22 IPDNLP--FSTKNLDLSFNPL-RHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77
Query: 270 LVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGL 329
L L L N + F L +L+ L NL + E + + L + +
Sbjct: 78 LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENF------PIGHLKTLKELNV 131
Query: 330 DDNRFGGV-LPHSIANLSSTMTDIVIAGNQISGIIPTGI-RNLVNL----VELCMDDNKL 383
N LP +NL++ + + ++ N+I I R L + + L + N +
Sbjct: 132 AHNLIQSFKLPEYFSNLTN-LEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPM 189
Query: 384 TGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQ 432
I + L+ L LD+N L LT L + L +N
Sbjct: 190 N-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 237
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 48/281 (17%), Positives = 81/281 (28%), Gaps = 69/281 (24%)
Query: 38 CQWTGVTC-GHRHQRV--------TKLDLSNRTIGGTLSPYV-GNLSFLRYLNLADNNFH 87
C ++ LDLS + L Y + L+ L+L+
Sbjct: 7 VPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ 65
Query: 88 GEIPHQI-GRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNW 146
I L L L+L N +
Sbjct: 66 -TIEDGAYQSLSHLSTLILTGNPIQ-------------------------SLALGAFSGL 99
Query: 147 LKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNL-GNLRNLILLNLGEN 205
L+ L + +L + N G+L+ L LN+ N
Sbjct: 100 SSLQKLVAVETNLA-------------------------SLENFPIGHLKTLKELNVAHN 134
Query: 206 RFSGIVPPSIF-NISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVA---ENNFAGSIP 261
P F N+++LE++ L +N+ S+ L ++ ++ N I
Sbjct: 135 LIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQ 193
Query: 262 ESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSN 302
L EL L NQ + F L +L+ + L +N
Sbjct: 194 PGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 9e-09
Identities = 34/139 (24%), Positives = 57/139 (41%), Gaps = 12/139 (8%)
Query: 466 ISTLSLSLDLSYNLLSGTLPLEV-GNLKNLVYFNISVNRFSGEIPV-TLSACTSLQQLYL 523
+ + +LDLS+N L L + L ++S I + + L L L
Sbjct: 26 LPFSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLIL 83
Query: 524 QGNSFSGSIPSSL-SSLKSIKELDMSSNNLSGQIPEYL-ENLSFLEYLNLSYNHFEGEVP 581
GN S+ S L S+++L NL+ + + +L L+ LN+++N +
Sbjct: 84 TGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-SFK 140
Query: 582 TKGVFSNKTG---ISLSGN 597
FSN T + LS N
Sbjct: 141 LPEYFSNLTNLEHLDLSSN 159
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-16
Identities = 62/236 (26%), Positives = 104/236 (44%), Gaps = 42/236 (17%)
Query: 673 ELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINL-KQKGASNGF----VAEC 727
++ + + +G+G F VYK +VA+K I L + A +G + E
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 728 QALRNIRHRNLIK---IITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSL 784
+ L+ + H N+I S+I ++V+++M+ LE + +D +
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNI--------SLVFDFMET-DLEVII---KDNSLVLTP 111
Query: 785 TLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSP 844
+ I+ ++ +EY+H H ++H DLKP+N+LLD++ V L DFGLAK S P
Sbjct: 112 SHIK--AYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS-P 165
Query: 845 LDT----AVETPSSSKGIKGTVGYIAPEYGMGGEASMTG-DVYSFGILLLEMFTRR 895
V T Y APE G G D+++ G +L E+ R
Sbjct: 166 NRAYTHQVV-----------TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 52/231 (22%), Positives = 91/231 (39%), Gaps = 44/231 (19%)
Query: 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQA-------- 729
+ + IG G+ G V VA+K + S F + A
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL-------SRPFQNQTHAKRAYRELV 76
Query: 730 -LRNIRHRNLIKIITI----CSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSL 784
++ + H+N+I ++ + S +F+ V IV E M + L Q + L
Sbjct: 77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDV---YIVMELMD----AN-LCQVIQME----L 124
Query: 785 TLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSP 844
+ ++ + I+++H ++H DLKPSN+++ D + DFGLA+ +S
Sbjct: 125 DHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 181
Query: 845 LDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRR 895
+ T T Y APE +G D++S G ++ EM
Sbjct: 182 MMT---------PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 2e-16
Identities = 52/233 (22%), Positives = 99/233 (42%), Gaps = 45/233 (19%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGF--VAECQ-ALRNIR-------HR 736
+G+G++G V+K G +VAVK I + F + Q R I H
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKI-------FDAFQNSTDAQRTFREIMILTELSGHE 69
Query: 737 NLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDV 796
N++ ++ + + + + V +V++YM+ D LH L + + ++ +
Sbjct: 70 NIVNLLNVLRADNDRDV---YLVFDYME----TD-LHAVIRANI---LEPVHKQYVVYQL 118
Query: 797 ASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSK 856
I+Y+H ++H D+KPSN+LL+ + + DFGL++ + T S ++
Sbjct: 119 IKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINE 175
Query: 857 GIKGTVG-------------YIAPEYGMGGEA-SMTGDVYSFGILLLEMFTRR 895
+ Y APE +G + D++S G +L E+ +
Sbjct: 176 NTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 57/225 (25%), Positives = 97/225 (43%), Gaps = 48/225 (21%)
Query: 685 NMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGF----VAECQALRNIRHRNLIK 740
IG+G++G VYK G A+K I L++ G + E L+ ++H N++K
Sbjct: 8 EKIGEGTYGVVYKA-QNNYGETFALKKIRLEK--EDEGIPSTTIREISILKELKHSNIVK 64
Query: 741 IITICSSID--FKGVDFQAIVYEYMQNGSLEDWLHQSE---DQQEARSLTLIQRINIIID 795
+ + + +V+E++ L+ L E + A+S L+Q +
Sbjct: 65 LYDVIHTKKRLV-------LVFEHLDQ-DLKKLLDVCEGGLESVTAKSF-LLQLL----- 110
Query: 796 VASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDT----AVET 851
+ I Y H V+H DLKP N+L++++ + DFGLA+ P+ V
Sbjct: 111 --NGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV-- 162
Query: 852 PSSSKGIKGTVGYIAPEYGMGGEASMTG-DVYSFGILLLEMFTRR 895
T+ Y AP+ MG + T D++S G + EM
Sbjct: 163 ---------TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 3e-16
Identities = 61/234 (26%), Positives = 99/234 (42%), Gaps = 29/234 (12%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVI---NLKQKGASNGFVAECQALRNIRH 735
N+F ++G+G+FG V G A+K++ + K + E + L+N RH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 736 RNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIID 795
L + S F+ D V EY G L L + E R+ R +
Sbjct: 208 PFLTALK--YS---FQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA-----RF-YGAE 256
Query: 796 VASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSS 855
+ SA++Y+H VV+ DLK N++LD+D + DFGL K ++ ++
Sbjct: 257 IVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK--------EGIKDGATM 306
Query: 856 KGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP-----TDGMFNQ 904
K GT Y+APE + D + G+++ EM R P + +F
Sbjct: 307 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 360
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 5e-16
Identities = 60/234 (25%), Positives = 100/234 (42%), Gaps = 39/234 (16%)
Query: 368 RNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALS 427
+ + +E+ D LT +P + K+ +L+L N L +L T LT L L
Sbjct: 7 SKVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 428 SNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLE 487
+L + G L L ++ +L +LP ++ L+ LD+S+N L+ +LPL
Sbjct: 64 RAELT-KLQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALT-VLDVSFNRLT-SLPLG 118
Query: 488 VGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSL-SSLKSIKELD 546
G LQ+LYL+GN ++P L + +++L
Sbjct: 119 A---------------LRG--------LGELQELYLKGNELK-TLPPGLLTPTPKLEKLS 154
Query: 547 MSSNNLSGQIPEYL-ENLSFLEYLNLSYNHFEGEVPTKGVFSNK--TGISLSGN 597
+++NNL+ ++P L L L+ L L N +P KG F + L GN
Sbjct: 155 LANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IP-KGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 5e-16
Identities = 44/193 (22%), Positives = 67/193 (34%), Gaps = 17/193 (8%)
Query: 259 SIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLL 318
++P L + L L +N L LNL L + +
Sbjct: 24 ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDG------- 74
Query: 319 TNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGI-RNLVNLVELC 377
L + L N+ LP L + T + ++ N+++ +P G R L L EL
Sbjct: 75 -TLPVLGTLDLSHNQL-QSLPLLGQTLPAL-TVLDVSFNRLTS-LPLGALRGLGELQELY 130
Query: 378 MDDNKLTGTIPHAI-GELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIP 436
+ N+L T+P + L+ L L +N L L L L L L N L +IP
Sbjct: 131 LKGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIP 188
Query: 437 PSLGNCKNLIELH 449
L
Sbjct: 189 KGFFGSHLLPFAF 201
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 48/215 (22%), Positives = 82/215 (38%), Gaps = 19/215 (8%)
Query: 217 NISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLF 276
++S V +LP D+ L ++EN +L + L +L L
Sbjct: 8 KVASHLEVNCDKRNL-TALPPDLPKDTTILH---LSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 277 DNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGG 336
+ K+ + +L L L+L N L + L LT + + NR
Sbjct: 64 RAELT-KLQV-DGTLPVLGTLDLSHNQLQS-------LPLLGQTLPALTVLDVSFNRLTS 114
Query: 337 VLPHSIANLSSTMTDIVIAGNQISGIIPTGI-RNLVNLVELCMDDNKLTGTIPHAI-GEL 394
+ ++ L + ++ + GN++ +P G+ L +L + +N LT +P + L
Sbjct: 115 LPLGALRGLGE-LQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGL 171
Query: 395 KNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSN 429
+NL L L N L IP LL L N
Sbjct: 172 ENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 48/208 (23%), Positives = 69/208 (33%), Gaps = 20/208 (9%)
Query: 34 STNLCQWTGVTC-GHRHQRV--------TKLDLSNRTIGGTLSPYV-GNLSFLRYLNLAD 83
+ + V C + T L LS + T S + L LNL
Sbjct: 6 VSKVASHLEVNCDKRNLTALPPDLPKDTTILHLSENLLY-TFSLATLMPYTRLTQLNLDR 64
Query: 84 NNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELG 143
++ G L L L L++N +P L + N L +P
Sbjct: 65 AEL-TKLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGAL 120
Query: 144 YNWLKLENLTIADNHLTGHFPASI-GNLSTLERINVLGNGLWGRIPNNL-GNLRNLILLN 201
+L+ L + N L P + LE++++ N L +P L L NL L
Sbjct: 121 RGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLL 178
Query: 202 LGENRFSGIVPPSIFNISSLENVFLPTN 229
L EN I P F L FL N
Sbjct: 179 LQENSLYTI-PKGFFGSHLLPFAFLHGN 205
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 5e-16
Identities = 56/237 (23%), Positives = 92/237 (38%), Gaps = 39/237 (16%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVK------VINLKQKGASNGFVAECQALRN 732
+ F +G GSFG V E+G A+K V+ LKQ + E + L+
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL---NEKRILQA 97
Query: 733 IRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINI 792
+ L+K+ S FK +V EY+ G + L + E + R
Sbjct: 98 VNFPFLVKL--EFS---FKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA-----RF-Y 146
Query: 793 IIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETP 852
+ EY+H +++ DLKP N+L+DQ + DFG AK
Sbjct: 147 AAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----------RVK 192
Query: 853 SSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP-----TDGMFNQ 904
+ + GT +APE + + D ++ G+L+ EM P ++ +
Sbjct: 193 GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 249
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 6e-16
Identities = 68/224 (30%), Positives = 97/224 (43%), Gaps = 37/224 (16%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQ-ALRNI------RHRNLI 739
+G+G++G V G +VA+K I K LR I +H N+I
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDK------PLFALRTLREIKILKHFKHENII 72
Query: 740 KIITIC---SSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDV 796
I I S +F V I+ E MQ D LH+ Q L+ I
Sbjct: 73 TIFNIQRPDSFENFNEV---YIIQELMQ----TD-LHRVISTQM---LSDDHIQYFIYQT 121
Query: 797 ASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSK 856
A++ +H V+H DLKPSN+L++ + + DFGLA+ + S D + T S
Sbjct: 122 LRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS- 177
Query: 857 GIKGTVG---YIAPEYGMGGEASMTG--DVYSFGILLLEMFTRR 895
G+ V Y APE M A + DV+S G +L E+F RR
Sbjct: 178 GMVEFVATRWYRAPEV-MLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 6e-16
Identities = 50/248 (20%), Positives = 92/248 (37%), Gaps = 40/248 (16%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVA-----ECQALRNIRHRNLIKI 741
IG GS+G V + +VA+K I + + E L + H +++K+
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKIL---RVFEDLIDCKRILREIAILNRLNHDHVVKV 117
Query: 742 ITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIE 801
+ I D + D +V E + D + + I+ + + ++ ++
Sbjct: 118 LDIVIPKDVEKFDELYVVLEIADS----D-FKKLFRTPVYLTELHIKTL--LYNLLVGVK 170
Query: 802 YIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGT 861
Y+H ++H DLKP+N L++QD + DFGLA+ + + S +
Sbjct: 171 YVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNL 227
Query: 862 VG-------------------YIAPEYGMGGEASMTG--DVYSFGILLLEMFTRRRPTDG 900
V Y APE + + + T DV+S G + E+ +
Sbjct: 228 VTFPHTKNLKRQLTGHVVTRWYRAPEL-ILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286
Query: 901 MFNQGLTL 908
L
Sbjct: 287 YHADRGPL 294
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 8e-16
Identities = 44/224 (19%), Positives = 85/224 (37%), Gaps = 50/224 (22%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIR-------HRNLI 739
+G+G + V++ N V VK++ V + + R I+ N+I
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKP---------VKKKKIKREIKILENLRGGPNII 94
Query: 740 KII-TICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVAS 798
+ + + +V+E++ N + D I+ + ++
Sbjct: 95 TLADIVKDPVSRTPA----LVFEHVNNTDFKQLYQTLTDYD-------IRF--YMYEILK 141
Query: 799 AIEYIHHHCQPPVVHGDLKPSNVLLDQ---DLVAHLGDFGLAKFLSSSPLDTA-VETPSS 854
A++Y H ++H D+KP NV++D L L D+GLA+F V
Sbjct: 142 ALDYCHSMG---IMHRDVKPHNVMIDHEHRKL--RLIDWGLAEFYHPGQEYNVRV----- 191
Query: 855 SKGIKGTVGYIAPEYGMGGEA-SMTGDVYSFGILLLEMFTRRRP 897
+ + PE + + + D++S G +L M R+ P
Sbjct: 192 -----ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 9e-16
Identities = 51/232 (21%), Positives = 93/232 (40%), Gaps = 46/232 (19%)
Query: 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQA-------- 729
+ + IG G+ G V VA+K + S F + A
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL-------SRPFQNQTHAKRAYRELV 113
Query: 730 -LRNIRHRNLIKIITI----CSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSL 784
++ + H+N+I ++ + + +F+ V +V E M + L Q + L
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDV---YLVMELM-----DANLCQVIQME----L 161
Query: 785 TLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSP 844
+ ++ + I+++H ++H DLKPSN+++ D + DFGLA+ +S
Sbjct: 162 DHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 218
Query: 845 LDTA-VETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRR 895
+ T V T Y APE +G D++S G ++ EM +
Sbjct: 219 MMTPYVVTRY----------YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 46/197 (23%), Positives = 83/197 (42%), Gaps = 15/197 (7%)
Query: 259 SIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLL 318
+IP ++ ++ +L L N+ S F L L L L N L T A L
Sbjct: 30 AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKEL--- 84
Query: 319 TNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGI-RNLVNLVELC 377
L + + DN+ LP + + + ++ + NQ+ +P + +L L L
Sbjct: 85 ---KNLETLWVTDNKL-QALPIGVFDQLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYLS 139
Query: 378 MDDNKLTGTIPH-AIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIP 436
+ N+L ++P +L +L+ L L +N L + LT L L L +N L+ +P
Sbjct: 140 LGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVP 197
Query: 437 P-SLGNCKNLIELHMAD 452
+ + + L L + +
Sbjct: 198 EGAFDSLEKLKMLQLQE 214
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 58/199 (29%), Positives = 84/199 (42%), Gaps = 12/199 (6%)
Query: 380 DNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSL 439
KLT IP I + + L L SN L+ + LT L L L+ N LQ ++P +
Sbjct: 25 SKKLT-AIPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGI 80
Query: 440 -GNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEV-GNLKNLVYF 497
KNL L + D +L ALP + L L N L +LP V +L L Y
Sbjct: 81 FKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYL 138
Query: 498 NISVNRFSGEIPVTL-SACTSLQQLYLQGNSFSGSIPSSL-SSLKSIKELDMSSNNLSGQ 555
++ N +P + TSL++L L N +P L +K L + +N L
Sbjct: 139 SLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRV 196
Query: 556 IPEYLENLSFLEYLNLSYN 574
++L L+ L L N
Sbjct: 197 PEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 48/183 (26%), Positives = 76/183 (41%), Gaps = 13/183 (7%)
Query: 53 TKLDLSNRTIGGTLSPYV-GNLSFLRYLNLADNNFHGEIPHQI-GRLVRLEALVLANNSF 110
KLDL + + +L L+ LR L L DN +P I L LE L + +N
Sbjct: 40 KKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKL 97
Query: 111 SGKIPTNL-SRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASI-G 168
+P + + NL RN L +P + + KL L++ N L P +
Sbjct: 98 Q-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFD 154
Query: 169 NLSTLERINVLGNGLWGRIPNNL-GNLRNLILLNLGENRFSGIVPPSIF-NISSLENVFL 226
L++L+ + + N L R+P L L L L N+ + P F ++ L+ + L
Sbjct: 155 KLTSLKELRLYNNQL-KRVPEGAFDKLTELKTLKLDNNQLKRV-PEGAFDSLEKLKMLQL 212
Query: 227 PTN 229
N
Sbjct: 213 QEN 215
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-15
Identities = 84/499 (16%), Positives = 151/499 (30%), Gaps = 100/499 (20%)
Query: 122 SNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGN 181
++ S + + L AEL + + + + D LT A ++S+
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLT---EARCKDISSA-------- 51
Query: 182 GLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGV 241
L L LNL N + + + + G
Sbjct: 52 ---------LRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAG- 101
Query: 242 SLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGK-VSIYFRSLKN----LEW 296
G + +L L EL L DN + + L + LE
Sbjct: 102 ---------------CGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEK 146
Query: 297 LNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFG--GV--LPHSIANLSSTMTDI 352
L L +L L ++L + + + +N GV L + + + +
Sbjct: 147 LQLEYCSLSAASCEPL--ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEAL 204
Query: 353 VIAGNQIS----GIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGE-----LKNLQLLYLD 403
+ ++ + + + +L EL + NKL + L+ L++
Sbjct: 205 KLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIW 264
Query: 404 SNFL----AGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLG-----NCKNLIELHMADIE 454
+ G + L L L+L+ N+L L L L +
Sbjct: 265 ECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCS 324
Query: 455 LTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSA 514
T + S L+ N + L+ IS NR L
Sbjct: 325 FT--------AACCSHFSSVLAQN-------------RFLLELQISNNRLEDAGVRELCQ 363
Query: 515 -----CTSLQQLYLQGNSFS----GSIPSSLSSLKSIKELDMSSNNLSGQIPEYL----- 560
+ L+ L+L S S+ ++L + S++ELD+S+N L L
Sbjct: 364 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVR 423
Query: 561 ENLSFLEYLNLSYNHFEGE 579
+ LE L L ++ E
Sbjct: 424 QPGCLLEQLVLYDIYWSEE 442
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-10
Identities = 68/400 (17%), Positives = 130/400 (32%), Gaps = 81/400 (20%)
Query: 47 HRHQRVTKLDLSNRTIGGT----LSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVR--- 99
++ KL L N + G LS + L L+ L+L+DN + +
Sbjct: 82 TPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQ 141
Query: 100 --LEALVLANNSFSGK----IPTNLSRCSNLISFNARRNNL----VGEIPAELGYNWLKL 149
LE L L S S + + L + N++ V + L + +L
Sbjct: 142 CRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQL 201
Query: 150 ENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSG 209
E L + +T + +L + + + +L L LG N+
Sbjct: 202 EALKLESCGVT---SDNCRDLCGI-----------------VASKASLRELALGSNKLGD 241
Query: 210 IVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNF----AGSIPESLS 265
+ ++ L L + +L + E G + L
Sbjct: 242 V------GMAELCPGLLHPSSRLRTLWIW--------------ECGITAKGCGDLCRVLR 281
Query: 266 NASNLVELTLFDNQFRGK-VSIYFRSLKN----LEWLNLGSNNLGTGEANDLDFLTLLTN 320
+L EL+L N+ + + +L LE L + S + + ++L
Sbjct: 282 AKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFS--SVLAQ 339
Query: 321 CTELTAIGLDDNRFG--GV--LPHSIANLSSTMTDIVIAGNQISGI----IPTGIRNLVN 372
L + + +NR GV L + S + + +A +S + + +
Sbjct: 340 NRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHS 399
Query: 373 LVELCMDDNKLTGTIPHAIGE-LKN----LQLLYLDSNFL 407
L EL + +N L + E ++ L+ L L +
Sbjct: 400 LRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYW 439
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 8e-08
Identities = 58/419 (13%), Positives = 119/419 (28%), Gaps = 95/419 (22%)
Query: 47 HRHQRVTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLA 106
+ + +L+L + +G V L + ++ L L
Sbjct: 53 RVNPALAELNLRSNELGDVGVHCVLQG-------LQTPSCK------------IQKLSLQ 93
Query: 107 NNSFSGK----IPTNLSRCSNLISFNARRNNL----VGEIPAELGYNWLKLENLTIADNH 158
N +G + + L L + N L + + L +LE L +
Sbjct: 94 NCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCS 153
Query: 159 LTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNI 218
L+ AS L+++ L + L + N +
Sbjct: 154 LS---AASCEPLASV-----------------LRAKPDFKELTVSNNDINE--------- 184
Query: 219 SSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNF----AGSIPESLSNASNLVELT 274
+ + L + S +L + + +++ ++L EL
Sbjct: 185 AGVR-----------VLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELA 233
Query: 275 LFDNQFRGKVSIYF-----RSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGL 329
L N+ L L + + DL +L L + L
Sbjct: 234 LGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDL--CRVLRAKESLKELSL 291
Query: 330 DDNRFG--GV--LPHSIANLSSTMTDIVIAGNQISG----IIPTGIRNLVNLVELCMDDN 381
N G G L ++ + + + + + + L+EL + +N
Sbjct: 292 AGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNN 351
Query: 382 KLTGTIPHAIGEL-----KNLQLLYLDSNFL----AGGIPTSLGNLTLLTNLALSSNDL 431
+L + + L++L+L + + +L L L LS+N L
Sbjct: 352 RLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCL 410
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 3e-04
Identities = 49/310 (15%), Positives = 85/310 (27%), Gaps = 86/310 (27%)
Query: 47 HRHQRVTKLDLSNRTIG----GTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLV---- 98
++ L L + + L V + + LR L L N ++ +
Sbjct: 196 DSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPS 255
Query: 99 -RLEALVLANNSFSGK----IPTNLSRCSNLISFNARRNNL----VGEIPAELGYNWLKL 149
RL L + + K + L +L + N L + L +L
Sbjct: 256 SRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQL 315
Query: 150 ENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSG 209
E+L + T A + S++ L R L+ L + NR
Sbjct: 316 ESLWVKSCSFT---AACCSHFSSV-----------------LAQNRFLLELQISNNRLE- 354
Query: 210 IVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASN 269
D GV + L + + S
Sbjct: 355 ----------------------------DAGV---RELCQGLGQPG------------SV 371
Query: 270 LVELTLFDNQFRGK----VSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELT 325
L L L D ++ + +L L+L +N LG L ++ L
Sbjct: 372 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQL-VESVRQPGCLLE 430
Query: 326 AIGLDDNRFG 335
+ L D +
Sbjct: 431 QLVLYDIYWS 440
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 3e-15
Identities = 64/254 (25%), Positives = 101/254 (39%), Gaps = 73/254 (28%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKV------INLKQKGASNGFVAECQALRN 732
DF +G GSFG V+ NG A+KV + LKQ +N E L
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTN---DERLMLSI 62
Query: 733 IRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINI 792
+ H +I++ + F+ ++ +Y++ G L +L+++
Sbjct: 63 VTHPFIIRMW--GT---FQDAQQIFMIMDYIEGGEL---------------FSLLRKSQR 102
Query: 793 ---------IIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAH--LGDFGLAKFLS 841
+V A+EY+H +++ DLKP N+LLD++ H + DFG AK
Sbjct: 103 FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKN--GHIKITDFGFAK--- 154
Query: 842 SSPLDTAVETPSSSKGIKGTVGYIAPE------YGMGGEASMTGDVYSFGILLLEMFTRR 895
P + + GT YIAPE Y + D +SFGIL+ EM
Sbjct: 155 --------YVPDVTYTLCGTPDYIAPEVVSTKPYN------KSIDWWSFGILIYEMLAGY 200
Query: 896 RP-----TDGMFNQ 904
P T + +
Sbjct: 201 TPFYDSNTMKTYEK 214
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 3e-15
Identities = 58/248 (23%), Positives = 106/248 (42%), Gaps = 56/248 (22%)
Query: 679 NDFSSSNMIGQGSFGFVY---KGNLGENGMMVAVKVI---NLKQKGASNGFVAECQALRN 732
+ F ++GQGSFG V+ K + + + A+KV+ LK + + R+
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDR-----VRTKMERD 78
Query: 733 I----RHRNLIKIITICSSIDFKGVDFQA-----IVYEYMQNGSLEDWLHQSEDQQEARS 783
I H ++K+ + FQ ++ ++++ G L L + E
Sbjct: 79 ILVEVNHPFIVKLH--YA--------FQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV 128
Query: 784 LTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAH--LGDFGLAKFLS 841
+ + ++A A++++H +++ DLKP N+LLD++ H L DFGL+K
Sbjct: 129 -----KFYLA-ELALALDHLHSLG---IIYRDLKPENILLDEE--GHIKLTDFGLSK--- 174
Query: 842 SSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP---- 897
+++ + GTV Y+APE + + D +SFG+L+ EM T P
Sbjct: 175 -----ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK 229
Query: 898 -TDGMFNQ 904
Sbjct: 230 DRKETMTM 237
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 4e-15
Identities = 51/252 (20%), Positives = 90/252 (35%), Gaps = 70/252 (27%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITI-- 744
+G GSFG V + E+G A+K + + + E ++ + H N+IK++
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDHVNIIKLVDYFY 70
Query: 745 -------------------------------CSSIDFKGVDFQAIVYEYMQNGSLEDWLH 773
++ + ++ EY+ + LH
Sbjct: 71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP----DT-LH 125
Query: 774 Q--SEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLD-QDLVAH 830
+ + RS+ + I + A+ +IH + H D+KP N+L++ +D
Sbjct: 126 KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNTLK 182
Query: 831 LGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYI------APEYGMGGEASMTG-DVYS 883
L DFG AK L S A YI APE +G D++S
Sbjct: 183 LCDFGSAKKLIPSEPSVA---------------YICSRFYRAPELMLGATEYTPSIDLWS 227
Query: 884 FGILLLEMFTRR 895
G + E+ +
Sbjct: 228 IGCVFGELILGK 239
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 5e-15
Identities = 52/228 (22%), Positives = 85/228 (37%), Gaps = 45/228 (19%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVIN--LKQKGASNGFVAECQALRNIR---------H 735
I GS+G V G + G+ VA+K + + N R +R H
Sbjct: 30 ISSGSYGAVCAG-VDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 736 RNLIKIITI---CSSIDFKGVDFQAIVYEYMQNGSLEDWLHQ-SEDQQEARSLTLIQRIN 791
N++ + I + +V E M+ D L Q DQ+ ++
Sbjct: 89 PNILGLRDIFVHFEEPAMHKL---YLVTELMRT----D-LAQVIHDQRIV--ISPQHIQY 138
Query: 792 IIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVET 851
+ + + +H + VVH DL P N+LL + + DF LA+ ++ T
Sbjct: 139 FMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKT---- 191
Query: 852 PSSSKGIKGTVG---YIAPEYGMG-GEASMTGDVYSFGILLLEMFTRR 895
V Y APE M + D++S G ++ EMF R+
Sbjct: 192 --------HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 6e-15
Identities = 49/222 (22%), Positives = 87/222 (39%), Gaps = 32/222 (14%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFV--------AECQALRNIRHRNL 738
IG G FG +Y A V+ ++ + F A+ ++ R
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 739 IKIITI-----CSSIDFKGVDFQAIVYEYMQNG-SLEDWLHQSEDQQEARSLTLIQRINI 792
+ + I +FKG ++ +V E + G L+ Q+ + + +
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQN------GTFKKSTVLQL 156
Query: 793 IIDVASAIEYIHHHCQPPVVHGDLKPSNVLL---DQDLVAHLGDFGLAKFLSSSPLDTAV 849
I + +EYIH + VHGD+K +N+LL + D V +L D+GL+ +
Sbjct: 157 GIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQV-YLADYGLSYRYCPN--GNHK 210
Query: 850 ETP-SSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLE 890
+ + KG GT+ + + + G S DV G +L
Sbjct: 211 QYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLR 252
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 7e-15
Identities = 37/160 (23%), Positives = 64/160 (40%), Gaps = 25/160 (15%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQAL-RNIRHRNLIKIITIC 745
+G G G V + A+K++ A E + R + ++++I+ +
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARR----EVELHWRASQCPHIVRIVDVY 80
Query: 746 SSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQ----QEARSLTLIQRINIIIDVASAIE 801
+ + G IV E + G L + DQ +EA I+ + AI+
Sbjct: 81 EN-LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS--------EIMKSIGEAIQ 131
Query: 802 YIHHHCQPPVVHGDLKPSNVLL---DQDLVAHLGDFGLAK 838
Y+H + H D+KP N+L + + L DFG AK
Sbjct: 132 YLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 8e-15
Identities = 42/259 (16%), Positives = 84/259 (32%), Gaps = 40/259 (15%)
Query: 321 CTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDD 380
C + + I +L + + + + I NL N+ + +
Sbjct: 10 CHQEEDFRVTCKDI-----QRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSI 64
Query: 381 NKLTGTIP-HAIGELKNLQLLYLDSNFLAGGIPTS-LGNLTLLTNLALSSNDLQGSIPP- 437
+ + H+ L + + + + I L L LL L + + L+ P
Sbjct: 65 DVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDL 123
Query: 438 -SLGNCKNLIELHMADIELTGALPPQILS-ISTLSLSLDLSYNLLSGTLPLEVGNLKNLV 495
+ + L + D ++P + +L+L L N +
Sbjct: 124 TKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-------------- 169
Query: 496 YFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPS-SLSSLKS-IKELDMSSNNLS 553
++ F+G T L +YL N + I + + S LD+S +++
Sbjct: 170 --SVQGYAFNG---------TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218
Query: 554 GQIPEY-LENLSFLEYLNL 571
+P LE+L L N
Sbjct: 219 -ALPSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 37/263 (14%), Positives = 77/263 (29%), Gaps = 41/263 (15%)
Query: 171 STLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNR 230
E V + RIP+ + + L L E I + N+ ++ +++ +
Sbjct: 11 HQEEDFRVTCKDI-QRIPSLPPSTQTL---KLIETHLRTIPSHAFSNLPNISRIYVSIDV 66
Query: 231 FNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSI-YFR 289
L S N S + + + + + + +
Sbjct: 67 TLQQLE------------------------SHSFYNLSKVTHIEIRNTRNLTYIDPDALK 102
Query: 290 SLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLP-HSIANLSST 348
L L++L + + L LT + + + + DN + +P ++ L +
Sbjct: 103 ELPLLKFLGIFNTGL-----KMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNE 157
Query: 349 MTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAI--GELKNLQLLYLDSN- 405
+ + N + + N L + ++ NK I G LL +
Sbjct: 158 TLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTS 216
Query: 406 --FLAGGIPTSLGNLTLLTNLAL 426
L L L L
Sbjct: 217 VTALPSKGLEHLKELIARNTWTL 239
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 7e-08
Identities = 30/231 (12%), Positives = 72/231 (31%), Gaps = 38/231 (16%)
Query: 120 RCSNLISFNARRNNL--VGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERIN 177
C F ++ + +P + L + + HL + NL + RI
Sbjct: 9 ECHQEEDFRVTCKDIQRIPSLPPST-------QTLKLIETHLRTIPSHAFSNLPNISRIY 61
Query: 178 VLGNGLWGRIP----NNLGNLRNLIL----------------------LNLGENRFSGIV 211
V + ++ NL + ++ + L +
Sbjct: 62 VSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFP 121
Query: 212 PPS-IFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNL 270
+ +++ + + N + S+P++ L + NN S+ N + L
Sbjct: 122 DLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKL 181
Query: 271 VELTLFDNQFRGKVSIY-FRSLKN-LEWLNLGSNNLGTGEANDLDFLTLLT 319
+ L N++ + F + + L++ ++ + L+ L L
Sbjct: 182 DAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKELI 232
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 42/256 (16%), Positives = 81/256 (31%), Gaps = 57/256 (22%)
Query: 52 VTKLDLSNRTIGGTLSPYV-GNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSF 110
L L + T+ + NL + + ++ + L +LE+ +SF
Sbjct: 33 TQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDV----------TLQQLES-----HSF 76
Query: 111 SGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPA--SIG 168
S + R + I + L+ L I + L FP +
Sbjct: 77 YN--------LSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVY 127
Query: 169 NLSTLERINVLGNGLWGRIPNN-LGNLRN-LILLNLGENRFSGIVPPSIFNISSLENVFL 226
+ + + N IP N L N + L L N F+ + FN + L+ V+L
Sbjct: 128 STDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSV-QGYAFNGTKLDAVYL 186
Query: 227 PTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSI 286
N++ + ++ F G S L + ++
Sbjct: 187 NKNKYLTVID----------------KDAFGG-------VYSGPSLLDVSQTSVT---AL 220
Query: 287 YFRSLKNLEWLNLGSN 302
+ L++L+ L +
Sbjct: 221 PSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 28/180 (15%), Positives = 59/180 (32%), Gaps = 13/180 (7%)
Query: 51 RVTKLDLS-NRTIGGTLSPYV-GNLSFLRYLNLADNNFHGEIPHQI-GRLVRLEALVLAN 107
++++ +S + T+ L + NLS + ++ + + I L L+ L + N
Sbjct: 56 NISRIYVSIDVTLQ-QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFN 114
Query: 108 NSFSGKIP--TNLSRCSNLISFNARRNNLVGEIPAELGYNWLK-LENLTIADNHLTGHFP 164
P T + N + IP L + +N T
Sbjct: 115 TGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQ 172
Query: 165 ASIGNLSTLERINVLGNGLWGRIPNNL--GNLRNLILLNLGENRFSGIVPPSIF-NISSL 221
N + L+ + + N I + G LL++ + + + P ++ L
Sbjct: 173 GYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTAL-PSKGLEHLKEL 231
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 1e-14
Identities = 49/219 (22%), Positives = 98/219 (44%), Gaps = 39/219 (17%)
Query: 686 MIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHR---NLIKII 742
+IG+GSFG V K + VA+K++ +++ E + L ++R + N + +I
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE-EIRILEHLRKQDKDNTMNVI 162
Query: 743 TICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEY 802
+ + F+ + +E + +L + + +++ Q SL L+++ + ++
Sbjct: 163 HMLENFTFRN--HICMTFELLSM-NLYELIKKNKFQ--GFSLPLVRKF--AHSILQCLDA 215
Query: 803 IHHHCQPPVVHGDLKPSNVLLDQDLVAH--LGDFGLAKFLSSSPLDTAVETPSSSKGIKG 860
+H + ++H DLKP N+LL Q + + DFG + + + +
Sbjct: 216 LHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH--------QRVYT------ 258
Query: 861 TVGYI------APEYGMGGEASMTGDVYSFGILLLEMFT 893
YI APE +G M D++S G +L E+ T
Sbjct: 259 ---YIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLT 294
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-14
Identities = 62/229 (27%), Positives = 97/229 (42%), Gaps = 36/229 (15%)
Query: 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQ-ALRNI--- 733
+++ + IG+G++G V N + VA+K I+ + CQ LR I
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH------QTYCQRTLREIKIL 79
Query: 734 ---RHRNLIK---IITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLI 787
RH N+I II + K V IV + M+ D L++ Q L+
Sbjct: 80 LRFRHENIIGINDIIRAPTIEQMKDV---YIVQDLME----TD-LYKLLKTQH---LSND 128
Query: 788 QRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDT 847
+ + ++YIH V+H DLKPSN+LL+ + DFGLA+ T
Sbjct: 129 HICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 185
Query: 848 AVETPSSSKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRR 895
T + T Y APE + + + D++S G +L EM + R
Sbjct: 186 GFLTEYVA-----TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-14
Identities = 41/224 (18%), Positives = 84/224 (37%), Gaps = 35/224 (15%)
Query: 686 MIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIR--------HRN 737
+G G F V+ N VA+K++ + E + L+ +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED-EIKLLQRVNDADNTKEDSMG 84
Query: 738 LIKIITICSSIDFKGVDFQ--AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIID 795
I+ + + KG + +V+E + +L + + E + L +++I
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRG--IPLIYVKQI--SKQ 139
Query: 796 VASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAH------LGDFGLAKFLSSSPLDTAV 849
+ ++Y+H C ++H D+KP NVL++ + D G ++ D
Sbjct: 140 LLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLG-----NACWYDEHY 192
Query: 850 ETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT 893
++ Y +PE +G D++S L+ E+ T
Sbjct: 193 TNSIQTRE------YRSPEVLLGAPWGCGADIWSTACLIFELIT 230
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 76.6 bits (188), Expect = 2e-14
Identities = 54/242 (22%), Positives = 92/242 (38%), Gaps = 47/242 (19%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNI----- 733
DF+ ++G+GSFG V + AVK++ K + V + +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILK-KDVVIQDDDVECTMVEKRVLALPG 399
Query: 734 RHRNLIKIITICSSIDFKGVDFQA-----IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQ 788
+ L ++ FQ V EY+ G L + Q +E +
Sbjct: 400 KPPFLTQLH--SC--------FQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA----- 444
Query: 789 RINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAH--LGDFGLAKFLSSSPLD 846
++A + ++ +++ DLK NV+LD + H + DFG+ K
Sbjct: 445 VF-YAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSE--GHIKIADFGMCK-------- 490
Query: 847 TAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP-----TDGM 901
+ ++K GT YIAPE + D ++FG+LL EM + P D +
Sbjct: 491 ENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 550
Query: 902 FN 903
F
Sbjct: 551 FQ 552
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 2e-14
Identities = 49/236 (20%), Positives = 85/236 (36%), Gaps = 51/236 (21%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQA---------LRNIRHRN 737
IG+GS+G+VY VA+K + + F L ++
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKV-------NRMFEDLIDCKRILREITILNRLKSDY 86
Query: 738 LIKIITIC---SSIDFKGVDFQAIVYEYMQNGSLEDWLHQ--SEDQQEARSLTLIQRINI 792
+I++ + + F + IV E + L + LT I
Sbjct: 87 IIRLYDLIIPDDLLKFDEL---YIVLEIA-----DSDLKKLFKTPIF----LTEEHIKTI 134
Query: 793 IIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETP 852
+ ++ +IH + ++H DLKP+N LL+QD + DFGLA+ ++S V
Sbjct: 135 LYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDL 191
Query: 853 SSSKGIKGTVG--------------YIAPEYGMGGEASMTG-DVYSFGILLLEMFT 893
++ Y APE + E D++S G + E+
Sbjct: 192 EENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 3e-14
Identities = 63/240 (26%), Positives = 98/240 (40%), Gaps = 44/240 (18%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVI---NLKQKGASNGFVAECQALRNIRH 735
NDF ++G+G+FG V G A+K++ + K V E + L+N RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 736 RNLIKIITICSSIDFKGVDFQA-----IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRI 790
L + + FQ V EY G L L + E R+ R
Sbjct: 65 PFLTALK--YA--------FQTHDRLCFVMEYANGGELFFHLSRERVFTEERA-----RF 109
Query: 791 NIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAH--LGDFGLAKFLSSSPLDTA 848
++ SA+EY+H VV+ D+K N++LD+D H + DFGL K
Sbjct: 110 -YGAEIVSALEYLHSR---DVVYRDIKLENLMLDKD--GHIKITDFGLCK--------EG 155
Query: 849 VETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP-----TDGMFN 903
+ ++ K GT Y+APE + D + G+++ EM R P + +F
Sbjct: 156 ISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE 215
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 3e-14
Identities = 53/355 (14%), Positives = 107/355 (30%), Gaps = 82/355 (23%)
Query: 264 LSNASNLVELTLFDNQFRGK----VSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLT 319
++ S + +L + + V +++ + L N +GT A L +
Sbjct: 1 MARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWL--SENIA 57
Query: 320 NCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMD 379
+ +L D G V L + + L + +
Sbjct: 58 SKKDLEIAEFSDIFTGRVKDEIPEALRL---------------LLQALLKCPKLHTVRLS 102
Query: 380 DNKLTGTIPHAIGEL----KNLQLLYLDSN--------FLAGGIP-----TSLGNLTLLT 422
DN T + + L+ LYL +N +A + N L
Sbjct: 103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLR 162
Query: 423 NLALSSNDLQG----SIPPSLGNCKNLIELHMA--DIELTGALPPQILSISTLSLSLDLS 476
++ N L+ + + + L + M I G L L+
Sbjct: 163 SIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGI---------EHLLLEGLA 213
Query: 477 YNLLSGTLPLEVGNLKNLVYFNISVNRFSGE----IPVTLSACTSLQQLYLQGNSFSG-- 530
Y + L ++ N F+ + + L + +L++L L S
Sbjct: 214 YC-------------QELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARG 260
Query: 531 --SIPSSLSSL--KSIKELDMSSNNLSGQ----IPEYL-ENLSFLEYLNLSYNHF 576
++ + S L ++ L + N + + + E + L +L L+ N F
Sbjct: 261 AAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 63/331 (19%), Positives = 94/331 (28%), Gaps = 70/331 (21%)
Query: 52 VTKLDLSNRTIGGT----LSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLAN 107
V ++ LS TIG LS + + L +D GR+ L
Sbjct: 34 VKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDI--------FTGRVKDEIPEALRL 85
Query: 108 NSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLK----LENLTIADNHLTGHF 163
+ L +C L + N G E ++L LE+L + +N L
Sbjct: 86 ------LLQALLKCPKLHTVRLSDNAF-GPTAQEPLIDFLSKHTPLEHLYLHNNGLG--- 135
Query: 164 PASIGNLSTLERINVLGNGLWGRIPN-NLGNLRNLILLNLGENRFS--GIVP--PSIFNI 218
+ L N N L + G NR + + +
Sbjct: 136 --PQA-------GAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSH 186
Query: 219 SSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDN 278
L V + N G+ + E L+ L L L DN
Sbjct: 187 RLLHTVKMVQNGIR-----PEGI---------------EHLLLEGLAYCQELKVLDLQDN 226
Query: 279 QFRGKVSIYF----RSLKNLEWLNLGSNNLGTGEANDL-DFLTLLTNCTELTAIGLDDNR 333
F S +S NL L L L A + D + L N L + L N
Sbjct: 227 TFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIG-LQTLRLQYNE 285
Query: 334 FGG----VLPHSIANLSSTMTDIVIAGNQIS 360
L I + + + GN+ S
Sbjct: 286 IELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 75.6 bits (185), Expect = 3e-14
Identities = 42/258 (16%), Positives = 84/258 (32%), Gaps = 19/258 (7%)
Query: 321 CTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDD 380
+L A L+D S +++ L +
Sbjct: 301 LCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCR--DSATDEQLFRCELSV 358
Query: 381 NKLTGTIPHAIGELKNLQLLYLDSNFLA---GGIPTSLGNLTLLTNLALSSNDLQGSIPP 437
K T + + K LQ L ++ + + +L L + L+ P
Sbjct: 359 EKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPM 417
Query: 438 SLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYF 497
+L + + + L L++ L T+ + L + +
Sbjct: 418 RAAYLDDLRSKFLLENSVLKMEYAD-------VRVLHLAHKDL--TVLCHLEQLLLVTHL 468
Query: 498 NISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSG-QI 556
++S NR +P L+A L+ L N+ ++ +++L ++EL + +N L
Sbjct: 469 DLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQSAA 525
Query: 557 PEYLENLSFLEYLNLSYN 574
+ L + L LNL N
Sbjct: 526 IQPLVSCPRLVLLNLQGN 543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 70.2 bits (171), Expect = 2e-12
Identities = 51/305 (16%), Positives = 93/305 (30%), Gaps = 49/305 (16%)
Query: 245 KLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNL 304
L + + + + + + E L ++ + + L L
Sbjct: 303 DLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECW-CRDSATDEQLFRCELSVEKS 361
Query: 305 GTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIP 364
+ + L +C EL + ++ + + L + + +
Sbjct: 362 TVLQ-------SELESCKELQELEPENKWCLLTIILLMRALDPLLYEK----ETLQYFST 410
Query: 365 TGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNL 424
+ + L +K E ++++L+L L + L L L+T+L
Sbjct: 411 LKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHL 468
Query: 425 ALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTL 484
LS N L+ ++PP+L + L L S N L +
Sbjct: 469 DLSHNRLR-ALPPALAALRCLEVL-------------------------QASDNALE-NV 501
Query: 485 PLEVGNLKNLVYFNISVNRFSG-EIPVTLSACTSLQQLYLQGN------SFSGSIPSSLS 537
V NL L + NR L +C L L LQGN + L
Sbjct: 502 D-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 560
Query: 538 SLKSI 542
S+ SI
Sbjct: 561 SVSSI 565
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 67.9 bits (165), Expect = 9e-12
Identities = 32/243 (13%), Positives = 74/243 (30%), Gaps = 12/243 (4%)
Query: 357 NQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLG 416
+Q+ I + + C+ + L L + + L
Sbjct: 311 DQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKSTV-LQSELE 369
Query: 417 NLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLS 476
+ L L + +I + ++ + + E + LD
Sbjct: 370 SCKELQELEPENKWCLLTIILLM----RALDPLLYEKETLQYFSTLKAVDPMRAAYLDDL 425
Query: 477 YNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSL 536
+ + ++ +++ + + L + L L N ++P +L
Sbjct: 426 RSKFLLENSVLKMEYADVRVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPAL 482
Query: 537 SSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEG--EVPTKGVFSNKTGISL 594
++L+ ++ L S N L + + NL L+ L L N + + ++L
Sbjct: 483 AALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNL 540
Query: 595 SGN 597
GN
Sbjct: 541 QGN 543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 63.2 bits (153), Expect = 2e-10
Identities = 52/301 (17%), Positives = 88/301 (29%), Gaps = 58/301 (19%)
Query: 141 ELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILL 200
+ WL ++ L H I S ++ VL + L
Sbjct: 295 RPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRC 354
Query: 201 NLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSI 260
L + S ++ + + L+ L + L ++ + A +
Sbjct: 355 ELSVEK-STVLQSELESCKELQ-----------ELEPENKWCLLTIILLMRALDPLL-YE 401
Query: 261 PESLSNASNLVEL--------TLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDL 312
E+L S L + ++F + S+ ++ L+L +L L
Sbjct: 402 KETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL-----TVL 456
Query: 313 DFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVN 372
L L T L +LS N++ + P + L
Sbjct: 457 CHLEQLLLVTHL-------------------DLS---------HNRLRAL-PPALAALRC 487
Query: 373 LVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAG-GIPTSLGNLTLLTNLALSSNDL 431
L L DN L + + L LQ L L +N L L + L L L N L
Sbjct: 488 LEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 545
Query: 432 Q 432
Sbjct: 546 C 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 51.7 bits (123), Expect = 1e-06
Identities = 40/286 (13%), Positives = 77/286 (26%), Gaps = 59/286 (20%)
Query: 36 NLCQWTGVTCGHRHQRVTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIG 95
L Q T + L L L+ + ++
Sbjct: 312 QLPQHTFRVIWTGSDSQKECVLLKDRPE-CWCRDSATDEQLFRCELSVEKST-VLQSELE 369
Query: 96 RLVRLEALVLANN-------------SFSGKIPTNLSRCSNL-------ISFNARRNNLV 135
L+ L N L S L ++ +
Sbjct: 370 SCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKF 429
Query: 136 GEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLR 195
+ L + + L +A LT + L + +++ N L +P L LR
Sbjct: 430 LLENSVLKMEYADVRVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRL-RALPPALAALR 486
Query: 196 NLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENN 255
L +L +N + N+ + N LP+L ++ N
Sbjct: 487 CLEVLQASDNA--------LENVDGVAN-------------------LPRLQELLLCNNR 519
Query: 256 FAG-SIPESLSNASNLVELTLFDNQ------FRGKVSIYFRSLKNL 294
+ + L + LV L L N + +++ S+ ++
Sbjct: 520 LQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 565
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 50.9 bits (121), Expect = 2e-06
Identities = 31/203 (15%), Positives = 63/203 (31%), Gaps = 10/203 (4%)
Query: 396 NLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIEL 455
+L L+ L + + + L + +E
Sbjct: 303 DLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPE-CWCRDSATDEQLFRCEL-SVEK 360
Query: 456 TGALPPQILSISTL-SLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSA 514
+ L ++ S L L + + LL+ L + L L+Y ++ FS +
Sbjct: 361 STVLQSELESCKELQELEPENKWCLLTIILLMR--ALDPLLYEKETLQYFST---LKAVD 415
Query: 515 CTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYN 574
L + F ++ L ++ +L+ + +LE L + +L+LS+N
Sbjct: 416 PMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHN 473
Query: 575 HFEGEVPTKGVFSNKTGISLSGN 597
P + S N
Sbjct: 474 RLRALPPALAALRCLEVLQASDN 496
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 4e-14
Identities = 50/225 (22%), Positives = 90/225 (40%), Gaps = 37/225 (16%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVA-----ECQALRNIRHRNLIKI 741
+G G G V+ + VA+K I L ++ E + +R + H N++K+
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVL-----TDPQSVKHALREIKIIRRLDHDNIVKV 73
Query: 742 ITI-------CSSIDFKGVDFQAI--VYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINI 792
I + + ++ V EYM+ D L +Q L
Sbjct: 74 FEILGPSGSQLTDDVGSLTELNSVYIVQEYMET----D-LANVLEQGP---LLEEHARLF 125
Query: 793 IIDVASAIEYIHHHCQPPVVHGDLKPSNVLLD-QDLVAHLGDFGLAKFLSSSPLDTAVET 851
+ + ++YIH V+H DLKP+N+ ++ +DLV +GDFGLA+ + +
Sbjct: 126 MYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182
Query: 852 PSSSKGIKGTVGYIAPEYGMGGEA-SMTGDVYSFGILLLEMFTRR 895
T Y +P + + D+++ G + EM T +
Sbjct: 183 EGLV-----TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 4e-14
Identities = 54/232 (23%), Positives = 96/232 (41%), Gaps = 47/232 (20%)
Query: 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQA-------- 729
+ S +G G++G V +G VA+K + S F +E A
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL-------SRPFQSEIFAKRAYRELL 75
Query: 730 -LRNIRHRNLIKIITI----CSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSL 784
L++++H N+I ++ + S +F +V +MQ D L + +
Sbjct: 76 LLKHMQHENVIGLLDVFTPASSLRNFYDF---YLVMPFMQ----TD-LQKIMGLK----F 123
Query: 785 TLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSP 844
+ + ++ + ++YIH VVH DLKP N+ +++D + DFGLA+ +
Sbjct: 124 SEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM 180
Query: 845 LDTAVETPSSSKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRR 895
V T Y APE + + T D++S G ++ EM T +
Sbjct: 181 TGYVV-----------TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.3 bits (181), Expect = 4e-14
Identities = 52/246 (21%), Positives = 96/246 (39%), Gaps = 50/246 (20%)
Query: 679 NDFSSSNMIGQGSFGFVY---KGNLGENGMMVAVKVINLKQKGASNGFVAEC-----QAL 730
F ++G+G +G V+ K G + A+KV+ K N L
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLK-KAMIVRNAKDTAHTKAERNIL 75
Query: 731 RNIRHRNLIKIITICSSIDFKGVDFQA-----IVYEYMQNGSLEDWLHQSEDQQEARSLT 785
++H ++ +I + FQ ++ EY+ G L L + E +
Sbjct: 76 EEVKHPFIVDLI--YA--------FQTGGKLYLILEYLSGGELFMQLEREGIFMEDTA-- 123
Query: 786 LIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAH--LGDFGLAKFLSSS 843
+ +++ A+ ++H +++ DLKP N++L+ H L DFGL K
Sbjct: 124 ---CFYLA-EISMALGHLHQK---GIIYRDLKPENIMLNHQ--GHVKLTDFGLCK----- 169
Query: 844 PLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP-----T 898
++ + + GT+ Y+APE M + D +S G L+ +M T P
Sbjct: 170 ---ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR 226
Query: 899 DGMFNQ 904
++
Sbjct: 227 KKTIDK 232
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 7e-14
Identities = 57/242 (23%), Positives = 97/242 (40%), Gaps = 47/242 (19%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNI----- 733
DF M+G+GSFG V+ + A+K + K + V + +
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALK-KDVVLMDDDVECTMVEKRVLSLAW 75
Query: 734 RHRNLIKIITICSSIDFKGVDFQA-----IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQ 788
H L + C+ FQ V EY+ G L + +R+
Sbjct: 76 EHPFLTHMF--CT--------FQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRA----- 120
Query: 789 RINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAH--LGDFGLAKFLSSSPLD 846
++ ++++H +V+ DLK N+LLD+D H + DFG+ K
Sbjct: 121 TF-YAAEIILGLQFLHSK---GIVYRDLKLDNILLDKD--GHIKIADFGMCK-------- 166
Query: 847 TAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP-----TDGM 901
+ + + GT YIAPE +G + + + D +SFG+LL EM + P + +
Sbjct: 167 ENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL 226
Query: 902 FN 903
F+
Sbjct: 227 FH 228
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 7e-14
Identities = 53/232 (22%), Positives = 93/232 (40%), Gaps = 46/232 (19%)
Query: 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQA-------- 729
+ +G G++G V G G VA+K + F +E A
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL-------YRPFQSELFAKRAYRELR 76
Query: 730 -LRNIRHRNLIKIITI----CSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSL 784
L+++RH N+I ++ + + DF +V +M D L + ++ L
Sbjct: 77 LLKHMRHENVIGLLDVFTPDETLDDFTDF---YLVMPFMG----TD-LGKLMKHEK---L 125
Query: 785 TLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSP 844
+ ++ + + YIH ++H DLKP N+ +++D + DFGLA+ S
Sbjct: 126 GEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM 182
Query: 845 LDTAVETPSSSKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRR 895
V T Y APE + + T D++S G ++ EM T +
Sbjct: 183 TGYVV-----------TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 8e-14
Identities = 55/234 (23%), Positives = 101/234 (43%), Gaps = 49/234 (20%)
Query: 679 NDFSSSNMIGQGSFGFVY---KGNLGENGMMVAVKVINLKQKGASNGFVAEC-QALRNIR 734
+F ++G G++G V+ K + + G + A+KV+ K E + R +
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLK-KATIVQKAKTTEHTRTERQV- 111
Query: 735 HRNLIK------IITICSSIDFKGVDFQA-----IVYEYMQNGSLEDWLHQSEDQQEARS 783
L ++T+ + FQ ++ +Y+ G L L Q E E
Sbjct: 112 ---LEHIRQSPFLVTLHYA-------FQTETKLHLILDYINGGELFTHLSQRERFTEHEV 161
Query: 784 LTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAH--LGDFGLAKFLS 841
+I + ++ A+E++H +++ D+K N+LLD + H L DFGL+K
Sbjct: 162 -----QI-YVGEIVLALEHLHKL---GIIYRDIKLENILLDSN--GHVVLTDFGLSKEFV 210
Query: 842 SSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEA--SMTGDVYSFGILLLEMFT 893
+ + A GT+ Y+AP+ GG++ D +S G+L+ E+ T
Sbjct: 211 ADETERA-------YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT 257
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 1e-13
Identities = 55/232 (23%), Positives = 97/232 (41%), Gaps = 46/232 (19%)
Query: 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQA-------- 729
+ + + +G G++G V + G+ VAVK + S F + A
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-------SRPFQSIIHAKRTYRELR 80
Query: 730 -LRNIRHRNLIKIITI----CSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSL 784
L++++H N+I ++ + S +F V +V M D L+ Q+ L
Sbjct: 81 LLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMG----AD-LNNIVKCQK---L 129
Query: 785 TLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSP 844
T +I + ++YIH ++H DLKPSN+ +++D + DFGLA+ +
Sbjct: 130 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM 186
Query: 845 LDTAVETPSSSKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRR 895
T Y APE + + T D++S G ++ E+ T R
Sbjct: 187 TGYVA-----------TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 50/160 (31%), Positives = 72/160 (45%), Gaps = 11/160 (6%)
Query: 272 ELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDD 331
+L L FR L L WLNL N L T A D L TEL +GL +
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDL------TELGTLGLAN 92
Query: 332 NRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGI-RNLVNLVELCMDDNKLTGTIPH- 389
N+ LP + + + + + + GNQ+ +P+G+ L L EL ++ N+L +IP
Sbjct: 93 NQL-ASLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQ-SIPAG 149
Query: 390 AIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSN 429
A +L NLQ L L +N L + L L + L N
Sbjct: 150 AFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 8e-09
Identities = 43/149 (28%), Positives = 71/149 (47%), Gaps = 22/149 (14%)
Query: 295 EWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVI 354
E L+L S L T L T+LT + LD N+ L + + + + + +
Sbjct: 38 EKLDLQSTGLATLSDATFRGL------TKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGL 90
Query: 355 AGNQISGIIPTGI-RNLVNLVELCMDDNKLTGTIPHAI-GELKNLQLLYLDSNFLAGGIP 412
A NQ++ +P G+ +L L +L + N+L ++P + L L+ L L++N L
Sbjct: 91 ANNQLAS-LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQL----- 143
Query: 413 TSL-----GNLTLLTNLALSSNDLQGSIP 436
S+ LT L L+LS+N LQ S+P
Sbjct: 144 QSIPAGAFDKLTNLQTLSLSTNQLQ-SVP 171
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 43/189 (22%), Positives = 68/189 (35%), Gaps = 35/189 (18%)
Query: 343 ANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAI-GELKNLQLLY 401
+ + + + + ++ + R L L L +D N+L T+ + +L L L
Sbjct: 31 SGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLG 89
Query: 402 LDSNFLA---GGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGA 458
L +N LA G+ LT L L L N L+ S+P G L +L
Sbjct: 90 LANNQLASLPLGVFDH---LTQLDKLYLGGNQLK-SLPS--GVFDRLTKLK--------- 134
Query: 459 LPPQILSISTLSLSLDLSYNLLSGTLPLEV-GNLKNLVYFNISVNRFSGEIPVTLSACTS 517
L L+ N L ++P L NL ++S N+
Sbjct: 135 -------------ELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGK 180
Query: 518 LQQLYLQGN 526
LQ + L GN
Sbjct: 181 LQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 5e-05
Identities = 34/137 (24%), Positives = 55/137 (40%), Gaps = 9/137 (6%)
Query: 466 ISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQG 525
I + LDL L+ L L + N+ N+ T L L L
Sbjct: 33 IPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLAN 92
Query: 526 NSFSGSIPSSL-SSLKSIKELDMSSNNLSGQIPEYL-ENLSFLEYLNLSYNHFEGEVPTK 583
N + S+P + L + +L + N L +P + + L+ L+ L L+ N + +P
Sbjct: 93 NQLA-SLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQ-SIPA- 148
Query: 584 GVF---SNKTGISLSGN 597
G F +N +SLS N
Sbjct: 149 GAFDKLTNLQTLSLSTN 165
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 47/229 (20%), Positives = 82/229 (35%), Gaps = 29/229 (12%)
Query: 687 IGQGSFGFVYKGNL-----GENGMMVAVKVINLKQKGASNGF-----VAECQALRNIRHR 736
IGQG FG +Y ++ + VKV A+ + ++
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 737 NLIKIITICSSIDFKGVDFQAIVYEYM----QNGSLEDWLHQSEDQQEARSLTLIQRINI 792
+K + + D Y +M L+ + A+ + + +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIY-----EANAKRFSRKTVLQL 157
Query: 793 IIDVASAIEYIHHHCQPPVVHGDLKPSNVLL---DQDLVAHLGDFGLAKFLSSSPLDTAV 849
+ + +EYIH H VHGD+K SN+LL + D V +L D+GLA
Sbjct: 158 SLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQV-YLVDYGLAYRYCPE--GVHK 211
Query: 850 ETP-SSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897
+ GT+ + + + G S GD+ G +++ T P
Sbjct: 212 AYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-13
Identities = 67/244 (27%), Positives = 98/244 (40%), Gaps = 49/244 (20%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNL 738
+DF +IG+GSFG V + AVKV+ K+ + RN+ L
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQ-KKAILKKKEEKHIMSERNV----L 92
Query: 739 IK------IITICSSIDFKGVDFQA-----IVYEYMQNGSLEDWLHQSEDQQEARSLTLI 787
+K ++ + S FQ V +Y+ G L L + E R+
Sbjct: 93 LKNVKHPFLVGLHFS-------FQTADKLYFVLDYINGGELFYHLQRERCFLEPRA---- 141
Query: 788 QRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAH--LGDFGLAKFLSSSPL 845
R ++ASA+ Y+H +V+ DLKP N+LLD H L DFGL K
Sbjct: 142 -RF-YAAEIASALGYLHSL---NIVYRDLKPENILLDSQ--GHIVLTDFGLCK------- 187
Query: 846 DTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP-----TDG 900
+E S++ GT Y+APE T D + G +L EM P T
Sbjct: 188 -ENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE 246
Query: 901 MFNQ 904
M++
Sbjct: 247 MYDN 250
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 3e-13
Identities = 54/242 (22%), Positives = 92/242 (38%), Gaps = 47/242 (19%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNI----- 733
DF+ ++G+GSFG V + AVK++ K + V + +
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILK-KDVVIQDDDVECTMVEKRVLALPG 78
Query: 734 RHRNLIKIITICSSIDFKGVDFQA-----IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQ 788
+ L ++ FQ V EY+ G L + Q +E +
Sbjct: 79 KPPFLTQLH--SC--------FQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA----- 123
Query: 789 RINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAH--LGDFGLAKFLSSSPLD 846
++A + ++ +++ DLK NV+LD + H + DFG+ K
Sbjct: 124 VF-YAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSE--GHIKIADFGMCK-------- 169
Query: 847 TAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP-----TDGM 901
+ ++K GT YIAPE + D ++FG+LL EM + P D +
Sbjct: 170 ENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 229
Query: 902 FN 903
F
Sbjct: 230 FQ 231
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 7e-13
Identities = 54/232 (23%), Positives = 95/232 (40%), Gaps = 44/232 (18%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNL 738
DF +IG+GS+ V L + + A+KV+ K+ + + Q +++
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVK-KELVNDDEDIDWVQTEKHV----F 63
Query: 739 IK------IITICSSIDFKGVDFQA-----IVYEYMQNGSLEDWLHQSEDQQEARSLTLI 787
+ ++ + S FQ V EY+ G L + + E +
Sbjct: 64 EQASNHPFLVGLHSC-------FQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA---- 112
Query: 788 QRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAH--LGDFGLAKFLSSSPL 845
R +++ A+ Y+H +++ DLK NVLLD + H L D+G+ K
Sbjct: 113 -RF-YSAEISLALNYLHER---GIIYRDLKLDNVLLDSE--GHIKLTDYGMCK------- 158
Query: 846 DTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897
+ ++ GT YIAPE G + + D ++ G+L+ EM R P
Sbjct: 159 -EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 8e-13
Identities = 62/240 (25%), Positives = 96/240 (40%), Gaps = 43/240 (17%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNI----- 733
++F ++G+GSFG V + E G + AVKV+ K + V + I
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLK-KDVILQDDDVECTMTEKRILSLAR 81
Query: 734 RHRNLIKIITICSSIDFKGVDFQA-----IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQ 788
H L ++ C FQ V E++ G L + +S EAR+
Sbjct: 82 NHPFLTQLF--CC--------FQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARA----- 126
Query: 789 RINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTA 848
R ++ SA+ ++H +++ DLK NVLLD + L DFG+ K
Sbjct: 127 RF-YAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK--------EG 174
Query: 849 VETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP-----TDGMFN 903
+ ++ GT YIAPE D ++ G+LL EM P D +F
Sbjct: 175 ICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFE 234
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 53/232 (22%), Positives = 95/232 (40%), Gaps = 44/232 (18%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNL 738
DF +IG+GS+ V L + + A++V+ K+ + + Q +++
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVK-KELVNDDEDIDWVQTEKHV----F 106
Query: 739 IK------IITICSSIDFKGVDFQA-----IVYEYMQNGSLEDWLHQSEDQQEARSLTLI 787
+ ++ + S FQ V EY+ G L + + E +
Sbjct: 107 EQASNHPFLVGLHSC-------FQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA---- 155
Query: 788 QRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAH--LGDFGLAKFLSSSPL 845
R +++ A+ Y+H +++ DLK NVLLD + H L D+G+ K
Sbjct: 156 -RF-YSAEISLALNYLHER---GIIYRDLKLDNVLLDSE--GHIKLTDYGMCK------- 201
Query: 846 DTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897
+ ++ GT YIAPE G + + D ++ G+L+ EM R P
Sbjct: 202 -EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 40/232 (17%), Positives = 81/232 (34%), Gaps = 49/232 (21%)
Query: 687 IGQGSFGFVYKG--------NLGENGMMVAVKV----------INLKQKGASNGFVAECQ 728
+ + G +Y+ + G ++K+ N Q+ A V + +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 729 ALRNIRHRNLIKIITICSSIDFKGV---DFQAIVYEYMQNG-SLEDWLHQSEDQQEARSL 784
L + + + GV ++ +V + G SL+ L D L
Sbjct: 110 KLYSTPLLAIPTCM-------GFGVHQDKYRFLVLPSL--GRSLQSAL----DVSPKHVL 156
Query: 785 TLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLL---DQDLVAHLGDFGLAKFLS 841
+ + + + A+E++H + VHG++ N+ + DQ V L +G A
Sbjct: 157 SERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQV-TLAGYGFAFRYC 212
Query: 842 SSPLDTAVETP---SSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLE 890
+ S +G + +I+ + G S D+ S G +L+
Sbjct: 213 ----PSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLK 260
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 9e-12
Identities = 43/160 (26%), Positives = 68/160 (42%), Gaps = 26/160 (16%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICS 746
IG G+FG + G VA+K+ +K + E + + L I
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL--EYRFY-----KQLGSGDGIPQ 69
Query: 747 SIDFKGV--DFQAIVYEYMQNG-SLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYI 803
F G + A+V E + G SLED + R+ +L + I I + S +EY+
Sbjct: 70 VYYF-GPCGKYNAMVLELL--GPSLEDLFDLCD-----RTFSLKTVLMIAIQLISRMEYV 121
Query: 804 HHHCQPPVVHGDLKPSNVLLDQDL-----VAHLGDFGLAK 838
H +++ D+KP N L+ + V H+ DF LAK
Sbjct: 122 HSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 51/222 (22%), Positives = 85/222 (38%), Gaps = 28/222 (12%)
Query: 211 VPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNL 270
P F + L ++ + N+ S+ + N+
Sbjct: 13 FPDDAF--AETIKANLKKKSVT-DAVTQNELNSIDQIIA---NNSDIKSVQ-GIQYLPNV 65
Query: 271 VELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLD 330
L L N+ +S + L NL +L L N L + D L T L + L
Sbjct: 66 RYLALGGNKLH-DISA-LKELTNLTYLILTGNQLQSLPNGVFDKL------TNLKELVLV 117
Query: 331 DNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGI-RNLVNLVELCMDDNKLTGTIPH 389
+N+ LP + + + +T + +A NQ+ +P G+ L NL EL + N+L ++P
Sbjct: 118 ENQL-QSLPDGVFDKLTNLTYLNLAHNQLQS-LPKGVFDKLTNLTELDLSYNQLQ-SLPE 174
Query: 390 AI-GELKNLQLLYLDSNFLAGGIP-------TSLGNLTLLTN 423
+ +L L+ L L N L +P TSL + L N
Sbjct: 175 GVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 58/233 (24%), Positives = 82/233 (35%), Gaps = 53/233 (22%)
Query: 322 TELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDN 381
E L + N +++ I+ + I + GI+ L N+ L + N
Sbjct: 19 AETIKANLKKKSVTDAVT---QNELNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGN 73
Query: 382 KLTGTIPHAIG---ELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPS 438
KL I EL NL L L N L LT L L L N LQ
Sbjct: 74 KLH-----DISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ------ 122
Query: 439 LGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEV-GNLKNLVYF 497
+LP + T L+L++N L +LP V L NL
Sbjct: 123 -------------------SLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTEL 162
Query: 498 NISVNRFSGEIPV----TLSACTSLQQLYLQGNSFSGSIPS----SLSSLKSI 542
++S N+ +P L T L+ L L N S+P L+SL+ I
Sbjct: 163 DLSYNQLQ-SLPEGVFDKL---TQLKDLRLYQNQLK-SVPDGVFDRLTSLQYI 210
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 52/214 (24%), Positives = 92/214 (42%), Gaps = 25/214 (11%)
Query: 685 NMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHR---NLIKI 741
++IG+GSFG V K VA+K+I K+ + + E + L + I
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQI-EVRLLELMNKHDTEMKYYI 118
Query: 742 ITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIE 801
+ + F+ +V+E + +L D L + SL L ++ + +A+
Sbjct: 119 VHLKRHFMFRN--HLCLVFEMLSY-NLYDLLRNT--NFRGVSLNLTRK--FAQQMCTALL 171
Query: 802 YIHHHCQPPVVHGDLKPSNVLLDQDLVAH--LGDFGLAKFLSSSPLDTAVETPSSSKGIK 859
++ + ++H DLKP N+LL + + DFG SS L + S+
Sbjct: 172 FLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG-----SSCQLGQRIYQYIQSR--- 222
Query: 860 GTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT 893
Y +PE +G + D++S G +L+EM T
Sbjct: 223 ---FYRSPEVLLGMPYDLAIDMWSLGCILVEMHT 253
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 33/173 (19%), Positives = 58/173 (33%), Gaps = 37/173 (21%)
Query: 259 SIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLL 318
IP +L + E+ L N + F K L ++L +N + + L
Sbjct: 25 EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLR-- 80
Query: 319 TNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGI-RNLVNLVELC 377
L ++ L N ++ +P + L +L L
Sbjct: 81 ----SLNSLVLYGN-----------KITE---------------LPKSLFEGLFSLQLLL 110
Query: 378 MDDNKLTGTIPH-AIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSN 429
++ NK+ + A +L NL LL L N L + L + + L+ N
Sbjct: 111 LNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 4e-09
Identities = 33/154 (21%), Positives = 63/154 (40%), Gaps = 9/154 (5%)
Query: 377 CMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIP 436
C LT IP + E + + L+ N + P + L + LS+N + +
Sbjct: 18 CRG-KGLT-EIPTNLPE--TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELA 72
Query: 437 P-SLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEV-GNLKNL 494
P + ++L L + ++T LP + L L+ N ++ L ++ +L NL
Sbjct: 73 PDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNL 130
Query: 495 VYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSF 528
++ N+ T S ++Q ++L N F
Sbjct: 131 NLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 29/133 (21%), Positives = 53/133 (39%), Gaps = 5/133 (3%)
Query: 150 ENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNL-GNLRNLILLNLGENRFS 208
+ + N + P + L RI++ N + + + LR+L L L N+ +
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQI-SELAPDAFQGLRSLNSLVLYGNKIT 93
Query: 209 GIVPPSIF-NISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNA 267
+ P S+F + SL+ + L N+ N L +D L L + +N + S
Sbjct: 94 EL-PKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPL 151
Query: 268 SNLVELTLFDNQF 280
+ + L N F
Sbjct: 152 RAIQTMHLAQNPF 164
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 64.9 bits (157), Expect = 3e-11
Identities = 32/197 (16%), Positives = 60/197 (30%), Gaps = 39/197 (19%)
Query: 677 ATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNG--------FVAE-- 726
T IG+G FG V++ + VA+K+I ++ NG + E
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 727 -CQALRNIRHRNLIKIITICSSIDF---KGVDFQAIVYEYMQ----NGSLEDWLHQSEDQ 778
+ L + + +G ++ + GS D +D
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135
Query: 779 Q-----------------EARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNV 821
Q + +L +I+ + +++ + H DL NV
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNV 193
Query: 822 LLDQDLVAHLGDFGLAK 838
LL + + L K
Sbjct: 194 LLKKTSLKKLHYTLNGK 210
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 3e-11
Identities = 47/270 (17%), Positives = 89/270 (32%), Gaps = 53/270 (19%)
Query: 686 MIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIR-----HRNLIK 740
+G G F V+ + VA+KV+ + + E + L+++R N
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDPNDPNREM 102
Query: 741 IITICSSIDFKGVD--FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVAS 798
++ + GV+ +V+E + + L W+ +S + L L II V
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNY----QGLPLPCVKKIIQQVLQ 157
Query: 799 AIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGI 858
++Y+H C+ ++H D+KP N+LL + A S + S+
Sbjct: 158 GLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215
Query: 859 KG--------------------------------------TVGYIAPEYGMGGEASMTGD 880
T Y + E +G + D
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPAD 275
Query: 881 VYSFGILLLEMFTRRRPTDGMFNQGLTLHE 910
++S + E+ T + + T E
Sbjct: 276 IWSTACMAFELATGDYLFEPHSGEEYTRDE 305
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 7e-11
Identities = 46/158 (29%), Positives = 71/158 (44%), Gaps = 24/158 (15%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICS 746
IG GSFG +Y G G VA+K+ +K K E + + ++ + I
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI--ESKIYKMMQ-----GGVGIP- 68
Query: 747 SIDFKGV--DFQAIVYEYMQNG-SLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYI 803
+I + G D+ +V E + G SLED + R +L + + + S IEYI
Sbjct: 69 TIRWCGAEGDYNVMVMELL--GPSLEDLFNFCS-----RKFSLKTVLLLADQMISRIEYI 121
Query: 804 HHHCQPPVVHGDLKPSNVLLDQDL---VAHLGDFGLAK 838
H +H D+KP N L+ + ++ DFGLAK
Sbjct: 122 HSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 8e-11
Identities = 36/160 (22%), Positives = 63/160 (39%), Gaps = 26/160 (16%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICS 746
IG+GSFG +++G N VA+K + E + + L I +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD--EYRTY-----KLLAGCTGIPN 70
Query: 747 SIDFKGV--DFQAIVYEYMQNG-SLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYI 803
F G +V + + G SLED L R ++ + + ++ I
Sbjct: 71 VYYF-GQEGLHNVLVIDLL--GPSLEDLLDLCG-----RKFSVKTVAMAAKQMLARVQSI 122
Query: 804 HHHCQPPVVHGDLKPSNVLLDQDL-----VAHLGDFGLAK 838
H +V+ D+KP N L+ + + ++ DFG+ K
Sbjct: 123 HEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 9e-11
Identities = 35/150 (23%), Positives = 62/150 (41%), Gaps = 14/150 (9%)
Query: 259 SIPESLSNASNLVELTLFDNQFRG-KVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTL 317
IPE + EL L +N+F + + F+ L L +N +N + E + +
Sbjct: 25 KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGAS- 81
Query: 318 LTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGI-RNLVNLVEL 376
+ I L NR V L S + +++ N+I+ + L ++ L
Sbjct: 82 -----GVNEILLTSNRLENVQHKMFKGLES-LKTLMLRSNRITCV-GNDSFIGLSSVRLL 134
Query: 377 CMDDNKLTGTIPH-AIGELKNLQLLYLDSN 405
+ DN++T T+ A L +L L L +N
Sbjct: 135 SLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 30/168 (17%), Positives = 57/168 (33%), Gaps = 30/168 (17%)
Query: 363 IPTGIRNLVNLVELCMDDNKLTGTIPHAI-GELKNLQLLYLDSNFLAGGIPTSLGNLTLL 421
IP I EL +++N+ T I +L L+ + +N + + + +
Sbjct: 26 IPEHI--PQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGV 83
Query: 422 TNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLS 481
+ L+SN L+ ++ K L L L L N ++
Sbjct: 84 NEILLTSNRLE-NVQH--KMFKGLESLKT----------------------LMLRSNRIT 118
Query: 482 GTLPLEV-GNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSF 528
+ + L ++ ++ N+ + P SL L L N F
Sbjct: 119 -CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 30/170 (17%), Positives = 61/170 (35%), Gaps = 36/170 (21%)
Query: 410 GIPTSLGNLTLLTNLALSSNDLQGSIPPS--LGNCKNLIELHMADIELTGALPPQILSIS 467
IP L L++N+ + + L +++ ++ ++T + +
Sbjct: 29 HIPQYT------AELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGA 80
Query: 468 TLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNS 527
+ + L+ N L + ++ F G SL+ L L+ N
Sbjct: 81 SGVNEILLTSNRLE-NVQHKM---------------FKG--------LESLKTLMLRSNR 116
Query: 528 FSGSIPS-SLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHF 576
+ + + S L S++ L + N ++ P + L L LNL N F
Sbjct: 117 IT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 30/157 (19%), Positives = 58/157 (36%), Gaps = 17/157 (10%)
Query: 38 CQWTGVTCGHR---------HQRVTKLDLSNRTIGGTLSP--YVGNLSFLRYLNLADNNF 86
C+ T V C ++ Q +L L+N L L LR +N ++N
Sbjct: 11 CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKI 69
Query: 87 HGEIPHQI-GRLVRLEALVLANNSFSGKIPTNL-SRCSNLISFNARRNNLVGEIPAELGY 144
+I + ++L +N + + +L + R N + + +
Sbjct: 70 T-DIEEGAFEGASGVNEILLTSNRLEN-VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFI 126
Query: 145 NWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGN 181
+ L++ DN +T P + L +L +N+L N
Sbjct: 127 GLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 41/203 (20%), Positives = 64/203 (31%), Gaps = 40/203 (19%)
Query: 259 SIPESLSNASNLVELTLFDNQFRG-KVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTL 317
++P+SL S L L N + L NL L L N+L + +
Sbjct: 32 NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPN 89
Query: 318 LTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELC 377
L L +LS N + + +L L L
Sbjct: 90 LR---YL-------------------DLS---------SNHLHTLDEFLFSDLQALEVLL 118
Query: 378 MDDNKLTGTIPHAIGELKNLQLLYLDSN---FLAGGIPTSLGNLTLLTNLALSSNDLQGS 434
+ +N + +A ++ LQ LYL N + L L L LSSN L+
Sbjct: 119 LYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK-K 177
Query: 435 IPPSLGNCKNLIELHMADIELTG 457
+P + + L + L
Sbjct: 178 LPL--TDLQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 48/233 (20%), Positives = 72/233 (30%), Gaps = 70/233 (30%)
Query: 377 CMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIP-TSLGNLTLLTNLALSSNDLQGSI 435
C +L +P ++ LL L N L+ + LT L +L LS N L I
Sbjct: 25 CSK-QQLP-NVPQSL--PSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FI 79
Query: 436 PP-SLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNL 494
+ NL L DLS N L TL
Sbjct: 80 SSEAFVPVPNLRYL-------------------------DLSSNHLH-TLD--------- 104
Query: 495 VYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPS-SLSSLKSIKELDMSSNNLS 553
S +L+ L L N + + + +++L +S N +S
Sbjct: 105 --------------EFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS 149
Query: 554 GQIPE----YLENLSFLEYLNLSYNHFEGEVPTKGVFSN-----KTGISLSGN 597
+ P L L L+LS N + ++P K G+ L N
Sbjct: 150 -RFPVELIKDGNKLPKLMLLDLSSNKLK-KLP-LTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 7e-06
Identities = 37/192 (19%), Positives = 64/192 (33%), Gaps = 37/192 (19%)
Query: 149 LENLTIADNHLTGHFP-ASIGNLSTLERINVLGNGLWGRIPNN-LGNLRNLILLNLGENR 206
L ++ N+L+ + L+ L + + N L I + + NL L+L N
Sbjct: 41 TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHL-NFISSEAFVPVPNLRYLDLSSNH 99
Query: 207 FSGIVPPSIF-NISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLS 265
+ +F ++ +LE + L N V + +
Sbjct: 100 LHTL-DEFLFSDLQALEVLLLYNNHI---------VVVD----------------RNAFE 133
Query: 266 NASNLVELTLFDNQ---FRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCT 322
+ + L +L L NQ F ++ L L L+L SN L DL L
Sbjct: 134 DMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNG 193
Query: 323 ELTAIGLDDNRF 334
+ L +N
Sbjct: 194 ----LYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 32/158 (20%), Positives = 66/158 (41%), Gaps = 11/158 (6%)
Query: 76 LRYLNLADNNFHGEIPHQI--GRLVRLEALVLANNSFSGKIPTN-LSRCSNLISFNARRN 132
L+L+ NN + + RL L +L+L++N + I + NL + N
Sbjct: 41 TALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSN 98
Query: 133 NLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPN--- 189
+L + L + LE L + +NH+ + +++ L+++ + N + R P
Sbjct: 99 HLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQI-SRFPVELI 156
Query: 190 -NLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFL 226
+ L L+LL+L N+ + + + + L
Sbjct: 157 KDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGL 194
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 44/201 (21%), Positives = 78/201 (38%), Gaps = 19/201 (9%)
Query: 694 FVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGV 753
F GNL + + K KGA + + +L + + +S
Sbjct: 108 FCKFGNLSTYLRSKRNEFVPYKTKGAR---FRQGKDYVGAIPVDLKRRLDSITSSQ---- 160
Query: 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEAR-SLTLIQRINIIIDVASAIEYIHHHCQPPVV 812
+ +++ SL D + + + LTL I VA +E++ +
Sbjct: 161 --SSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCI 215
Query: 813 HGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG 872
H DL N+LL + V + DFGLA+ + + + ++APE
Sbjct: 216 HRDLAARNILLSEKNVVKICDFGLARDIYKD------PDYVRKGDARLPLKWMAPETIFD 269
Query: 873 GEASMTGDVYSFGILLLEMFT 893
++ DV+SFG+LL E+F+
Sbjct: 270 RVYTIQSDVWSFGVLLWEIFS 290
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 46/135 (34%), Positives = 66/135 (48%), Gaps = 10/135 (7%)
Query: 272 ELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDD 331
L L DNQ F SL NL+ L LGSN LG D LT +LT + L
Sbjct: 44 ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLT------QLTVLDLGT 97
Query: 332 NRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPH-A 390
N+ VLP ++ + + ++ + N+++ + P GI L +L L +D N+L +IPH A
Sbjct: 98 NQLT-VLPSAVFDRLVHLKELFMCCNKLTEL-PRGIERLTHLTHLALDQNQLK-SIPHGA 154
Query: 391 IGELKNLQLLYLDSN 405
L +L YL N
Sbjct: 155 FDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 5e-09
Identities = 30/119 (25%), Positives = 50/119 (42%), Gaps = 13/119 (10%)
Query: 343 ANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAI-GELKNLQLLY 401
A + + + + NQI+ + P +L+NL EL + N+L +P + L L +L
Sbjct: 36 AGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLD 94
Query: 402 LDSNFLAGGIPTSL-----GNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIEL 455
L +N L T L L L L + N L +P + +L L + +L
Sbjct: 95 LGTNQL-----TVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQL 147
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 34/130 (26%), Positives = 52/130 (40%), Gaps = 4/130 (3%)
Query: 398 QLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSL-GNCKNLIELHMADIELT 456
Q+LYL N + P +L L L L SN L ++P + + L L + +LT
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT 101
Query: 457 GALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACT 516
LP + L + N L+ LP + L +L + + N+ +
Sbjct: 102 -VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLS 159
Query: 517 SLQQLYLQGN 526
SL YL GN
Sbjct: 160 SLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 40/141 (28%), Positives = 59/141 (41%), Gaps = 18/141 (12%)
Query: 466 ISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSA-----CTSLQQ 520
I T + L L N ++ P +L NL + N+ L T L
Sbjct: 38 IPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-----ALPVGVFDSLTQLTV 92
Query: 521 LYLQGNSFSGSIPSSL-SSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGE 579
L L N + +PS++ L +KEL M N L+ +P +E L+ L +L L N +
Sbjct: 93 LDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKS- 149
Query: 580 VPTKGVF---SNKTGISLSGN 597
+P G F S+ T L GN
Sbjct: 150 IP-HGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 34/140 (24%), Positives = 56/140 (40%), Gaps = 6/140 (4%)
Query: 164 PASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFN-ISSLE 222
PA I + + + + N + P +L NL L LG N+ +P +F+ ++ L
Sbjct: 35 PAGI--PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-LPVGVFDSLTQLT 91
Query: 223 NVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRG 282
+ L TN+ LP + L L + N +P + ++L L L NQ +
Sbjct: 92 VLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKS 149
Query: 283 KVSIYFRSLKNLEWLNLGSN 302
F L +L L N
Sbjct: 150 IPHGAFDRLSSLTHAYLFGN 169
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 54/326 (16%), Positives = 103/326 (31%), Gaps = 57/326 (17%)
Query: 265 SNASNLVELTLFDNQFRGKVSIYF-----RSLKNLEWLNLGSNNLGTGEANDLDFLTLLT 319
+ +++ L L N K S N+ LNL N L +++L TL
Sbjct: 48 NTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDEL-VKTLAA 106
Query: 320 NCTELTAIGLDDNRFG--GV--LPHSIANLSSTMTDIVIAGNQISGIIPTGIRNL----- 370
+T + L N F + +NL +++T + + GN + L
Sbjct: 107 IPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLG---IKSSDELIQILA 163
Query: 371 ---VNLVELCMDDNKLTGTIPHAIGEL-----KNLQLLYLDSNFL----AGGIPTSL-GN 417
N+ L + N L + + ++ L L +N L +
Sbjct: 164 AIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSI 223
Query: 418 LTLLTNLALSSNDLQGS----IPPSLGNCKNLIELHMADIELTG-------ALPPQILSI 466
+ +L L N L G + + K+L +++ + AL +I
Sbjct: 224 PNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNI 283
Query: 467 STLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGN 526
+ + +D + + + + + NL + V L + Q N
Sbjct: 284 QKI-ILVDKNGKEIHPSHSIPISNLIRELSGKADVPS--------LLNQCLIFAQKHQTN 334
Query: 527 SFSGSIPSSLSSLKSIKELDMSSNNL 552
+IP L +E + L
Sbjct: 335 IEDLNIPDEL------RESIQTCKPL 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 57/357 (15%), Positives = 112/357 (31%), Gaps = 83/357 (23%)
Query: 257 AGSIPESLSNASNLVELTLFDNQFRGKVSIYF-----RSLKNLEWLNLGSNNLGTGEAND 311
+ + E S + L L N ++ + ++ LNL N+LG +++
Sbjct: 11 SNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDE 70
Query: 312 LDFLTLLTNCTELTAIGLDDNRFGG----VLPHSIANLSSTMTDIVIAGNQISGIIPTGI 367
L L +T++ L N L ++A + T+T + + N S
Sbjct: 71 L-VQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFS---SKSS 126
Query: 368 RNLV--------NLVELCMDDNKLTGTIPHAIGEL-----KNLQLLYLDSNFL----AGG 410
++ L + N L + ++ N+ L L N L
Sbjct: 127 SEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAE 186
Query: 411 IPTSLGNL-TLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTL 469
+ L ++ +T+L LS+N L + L + SI
Sbjct: 187 LAKFLASIPASVTSLDLSANLLGLK------SYAELAYI--------------FSSIPNH 226
Query: 470 SLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFS 529
+SL+L N L G + L + LQ +YL +
Sbjct: 227 VVSLNLCLNCLHGPSLENLKLL--------------------KDSLKHLQTVYLDYDIVK 266
Query: 530 G-------SIPSSLSSLKSIKELDMSSNNLSG----QIPEYLENLSF-LEYLNLSYN 574
++ ++ +++ I +D + + I + LS + +L
Sbjct: 267 NMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQ 323
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 42/230 (18%), Positives = 86/230 (37%), Gaps = 43/230 (18%)
Query: 686 MIGQGSFGFVYKG-NLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHR---NLIKI 741
+G+G+FG V + + VA+K+I K + E L+ I+ + N
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL-EINVLKKIKEKDKENKFLC 84
Query: 742 ITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIE 801
+ + +F G I +E + + ++L ++ Q L ++ + + A+
Sbjct: 85 VLMSDWFNFHG--HMCIAFELL-GKNTFEFLKENNFQ--PYPLPHVRHM--AYQLCHALR 137
Query: 802 YIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAV------------ 849
++H + + H DLKP N+L L + + S +T++
Sbjct: 138 FLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCE-EKSVKNTSIRVADFGSATFDH 193
Query: 850 ETPSSSKGIKGTVGYI------APEYGMGGEASMTGDVYSFGILLLEMFT 893
E ++ + PE + + DV+S G +L E +
Sbjct: 194 EHHTT---------IVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 234
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 59.6 bits (144), Expect = 3e-09
Identities = 43/157 (27%), Positives = 73/157 (46%), Gaps = 22/157 (14%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICS 746
IG GSFG +Y G + VA+K+ N+K K + E + R ++ I
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY--ESKIYRILQGGTGI------P 66
Query: 747 SIDFKGV--DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIH 804
++ + GV D+ +V + + SLED +R L+L + + + + +E++H
Sbjct: 67 NVRWFGVEGDYNVLVMD-LLGPSLEDLF-----NFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 805 HHCQPPVVHGDLKPSNVLLDQDLVAH---LGDFGLAK 838
+H D+KP N L+ A+ + DFGLAK
Sbjct: 121 SKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 5e-09
Identities = 25/101 (24%), Positives = 45/101 (44%), Gaps = 12/101 (11%)
Query: 343 ANLSSTMTDIVIAGNQISGIIPTGI-RNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLY 401
++ T++++ N++ I G+ L +LV+L + N+LTG P+A ++Q L
Sbjct: 25 RDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQ 84
Query: 402 LDSNFLAGGIPTSLGN-----LTLLTNLALSSNDLQGSIPP 437
L N + + N L L L L N + + P
Sbjct: 85 LGENKI-----KEISNKMFLGLHQLKTLNLYDNQIS-CVMP 119
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 6e-06
Identities = 29/137 (21%), Positives = 46/137 (33%), Gaps = 36/137 (26%)
Query: 272 ELTLFDNQFRGKVSI-YFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLD 330
EL L DN+ S F L +L L L N L E N + + + + L
Sbjct: 33 ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGA------SHIQELQLG 86
Query: 331 DNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGI-RNLVNLVELCMDDNKLTGTIPH 389
+N+ + I + L L L + DN+++ +
Sbjct: 87 ENK-----------IKE---------------ISNKMFLGLHQLKTLNLYDNQIS-CVMP 119
Query: 390 -AIGELKNLQLLYLDSN 405
+ L +L L L SN
Sbjct: 120 GSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 28/110 (25%), Positives = 51/110 (46%), Gaps = 4/110 (3%)
Query: 322 TELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGI-RNLVNLVELCMDD 380
T + L+DN G + + + + + NQ++GI ++ EL + +
Sbjct: 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGI-EPNAFEGASHIQELQLGE 87
Query: 381 NKLTGTIPHAI-GELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSN 429
NK+ I + + L L+ L L N ++ +P S +L LT+L L+SN
Sbjct: 88 NKIK-EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 28/104 (26%), Positives = 52/104 (50%), Gaps = 8/104 (7%)
Query: 473 LDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSI 532
L LS N + L ++NL ++ N +I + +L++L++ N + S+
Sbjct: 53 LALSTNNIEKISSLS--GMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SL 108
Query: 533 PSSLSSLKSIKELDMSSNNLS--GQIPEYLENLSFLEYLNLSYN 574
S + L +++ L MS+N ++ G+I + L L LE L L+ N
Sbjct: 109 -SGIEKLVNLRVLYMSNNKITNWGEI-DKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 5e-07
Identities = 20/71 (28%), Positives = 34/71 (47%), Gaps = 3/71 (4%)
Query: 507 EIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFL 566
++ TLS + + L L N+ I SSLS +++++ L + N + +I L
Sbjct: 39 KMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KIENLDAVADTL 95
Query: 567 EYLNLSYNHFE 577
E L +SYN
Sbjct: 96 EELWISYNQIA 106
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 38/204 (18%), Positives = 66/204 (32%), Gaps = 69/204 (33%)
Query: 357 NQISGI--IPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTS 414
I I + + L L + N + I + ++NL++L L N
Sbjct: 32 GMIPPIEKMDATLSTLKACKHLALSTNNIE-KISS-LSGMENLRILSLGRN--------- 80
Query: 415 LGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLD 474
+ + NL ++ L+ L
Sbjct: 81 --LIKKIENLDAVADTLE---------------------------------------ELW 99
Query: 475 LSYNLLSGTLPLEVGNLKNLVYFNISVNRFS--GEIPVTLSACTSLQQLYLQGNSFSGSI 532
+SYN ++ +E L NL +S N+ + GEI L+A L+ L L GN
Sbjct: 100 ISYNQIASLSGIE--KLVNLRVLYMSNNKITNWGEI-DKLAALDKLEDLLLAGNPLYNDY 156
Query: 533 PSS----------LSSLKSIKELD 546
+ + L ++K+LD
Sbjct: 157 KENNATSEYRIEVVKRLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 5e-06
Identities = 39/148 (26%), Positives = 59/148 (39%), Gaps = 39/148 (26%)
Query: 260 IPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLT 319
+ +LS L L N K+S ++NL L+LG N + E
Sbjct: 40 MDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIKKIE----------- 86
Query: 320 NCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMD 379
LD ++ T+ ++ I+ NQI+ + +GI LVNL L M
Sbjct: 87 --------NLD-------------AVADTLEELWISYNQIASL--SGIEKLVNLRVLYMS 123
Query: 380 DNKLT--GTIPHAIGELKNLQLLYLDSN 405
+NK+T G I + L L+ L L N
Sbjct: 124 NNKITNWGEIDK-LAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 20/90 (22%), Positives = 37/90 (41%), Gaps = 18/90 (20%)
Query: 520 QLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGE 579
+L+ + ++LS+LK+ K L +S+NN+ +I L + L L+L N +
Sbjct: 29 ELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-- 83
Query: 580 VPTKGVFSNKTGISLSGNGKVCGGLDELNL 609
+ V L+EL +
Sbjct: 84 -------------KIENLDAVADTLEELWI 100
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 33/132 (25%), Positives = 52/132 (39%), Gaps = 16/132 (12%)
Query: 79 LNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEI 138
L+ ++ + L + L L+ N+ KI ++LS NL + RN + +
Sbjct: 30 LHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLI--KK 84
Query: 139 PAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVL---GNGL--WGRIPNNLGN 193
L LE L I+ N + S+ + L + VL N + WG I + L
Sbjct: 85 IENLDAVADTLEELWISYNQIA-----SLSGIEKLVNLRVLYMSNNKITNWGEI-DKLAA 138
Query: 194 LRNLILLNLGEN 205
L L L L N
Sbjct: 139 LDKLEDLLLAGN 150
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 43/224 (19%), Positives = 83/224 (37%), Gaps = 27/224 (12%)
Query: 686 MIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHR--NLIKIIT 743
+G G+FG V +N AVKV+ +K + + E L+ I++ N I+
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI-EADILKKIQNDDINNNNIVK 100
Query: 744 ICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYI 803
+ +++E + SL + + ++ + I+ I++ A+ Y+
Sbjct: 101 YHGKFMYYD--HMCLIFEPL-GPSLYEIITRN--NYNGFHIEDIKLY--CIEILKALNYL 153
Query: 804 HHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETP--------SSS 855
+ H DLKP N+LLD ++ ++
Sbjct: 154 RKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCAT 210
Query: 856 KGIKGTVGYI------APEYGMGGEASMTGDVYSFGILLLEMFT 893
I APE + ++ D++SFG +L E++T
Sbjct: 211 FKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 3e-08
Identities = 42/230 (18%), Positives = 88/230 (38%), Gaps = 43/230 (18%)
Query: 686 MIGQGSFGFVYKG-NLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHR---NLIKI 741
+G+G+FG V + + G VAVK++ + E Q L ++ + +
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS-EIQVLEHLNTTDPNSTFRC 79
Query: 742 ITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIE 801
+ + + G IV+E + S D++ ++ L I+++ + ++
Sbjct: 80 VQMLEWFEHHG--HICIVFELL-GLSTYDFIKEN--GFLPFRLDHIRKM--AYQICKSVN 132
Query: 802 YIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAV------------ 849
++H + + H DLKP N+L Q + + + + ++ +
Sbjct: 133 FLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRD-ERTLINPDIKVVDFGSATYDD 188
Query: 850 ETPSSSKGIKGTVGYI------APEYGMGGEASMTGDVYSFGILLLEMFT 893
E S+ + APE + S DV+S G +L+E +
Sbjct: 189 EHHST---------LVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYL 229
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 6e-08
Identities = 34/136 (25%), Positives = 60/136 (44%), Gaps = 11/136 (8%)
Query: 272 ELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDD 331
L L N + + F L +L L LG N L + + L T LT + L
Sbjct: 32 YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKL------TSLTYLNLST 85
Query: 332 NRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGI-RNLVNLVELCMDDNKLTGTIPH- 389
N+ LP+ + + + + ++ + NQ+ +P G+ L L +L + N+L ++P
Sbjct: 86 NQL-QSLPNGVFDKLTQLKELALNTNQLQS-LPDGVFDKLTQLKDLRLYQNQLK-SVPDG 142
Query: 390 AIGELKNLQLLYLDSN 405
L +LQ ++L N
Sbjct: 143 VFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 29/101 (28%), Positives = 48/101 (47%), Gaps = 13/101 (12%)
Query: 343 ANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAI-GELKNLQLLY 401
+ + T + + N + + L +L +L + NKL ++P+ + +L +L L
Sbjct: 24 TGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLN 82
Query: 402 LDSNFLAGGIPTSLGN-----LTLLTNLALSSNDLQGSIPP 437
L +N L SL N LT L LAL++N LQ S+P
Sbjct: 83 LSTNQL-----QSLPNGVFDKLTQLKELALNTNQLQ-SLPD 117
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 39/125 (31%), Positives = 51/125 (40%), Gaps = 17/125 (13%)
Query: 363 IPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLA---GGIPTSLGNLT 419
+PTGI L ++ N L EL +L LYL N L G+ L +
Sbjct: 22 VPTGIP--AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTS-- 77
Query: 420 LLTNLALSSNDLQGSIPP----SLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDL 475
LT L LS+N LQ S+P L L EL + +L +LP + T L L
Sbjct: 78 -LTYLNLSTNQLQ-SLPNGVFDKLT---QLKELALNTNQLQ-SLPDGVFDKLTQLKDLRL 131
Query: 476 SYNLL 480
N L
Sbjct: 132 YQNQL 136
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 53.2 bits (127), Expect = 2e-07
Identities = 20/104 (19%), Positives = 35/104 (33%), Gaps = 7/104 (6%)
Query: 502 NRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPS-SLSSLKSIKELDMSSNNLSGQIPEY- 559
+ + L +L +LY++ + L L ++ L + + L +
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDA 75
Query: 560 LENLSFLEYLNLSYNHFEGEVPTKGVFSNK--TGISLSGNGKVC 601
L LNLS+N E + + LSGN C
Sbjct: 76 FHFTPRLSRLNLSFNALE-SLS-WKTVQGLSLQELVLSGNPLHC 117
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 52.8 bits (126), Expect = 3e-07
Identities = 19/91 (20%), Positives = 36/91 (39%), Gaps = 2/91 (2%)
Query: 363 IPTGIRNLVNLVELCMDDNKLTGTIP-HAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLL 421
+ NL EL +++ + + + L L+ L + + L P + L
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 422 TNLALSSNDLQGSIPPSLGNCKNLIELHMAD 452
+ L LS N L+ S+ +L EL ++
Sbjct: 83 SRLNLSFNALE-SLSWKTVQGLSLQELVLSG 112
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 51.7 bits (123), Expect = 7e-07
Identities = 23/95 (24%), Positives = 34/95 (35%), Gaps = 3/95 (3%)
Query: 339 PHSIANLSSTMTDIVIAGNQISGIIPTG-IRNLVNLVELCMDDNKLTGTIPHAIGELKNL 397
H + + T++ I Q + +R L L L + + L P A L
Sbjct: 24 LHHLPGAENL-TELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 398 QLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQ 432
L L N L ++ L+ L L LS N L
Sbjct: 83 SRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 24/104 (23%), Positives = 42/104 (40%), Gaps = 7/104 (6%)
Query: 377 CMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPT-SLGNLTLLTNLALSSNDLQGSI 435
C D L H + +NL LY+++ + L L L NL + + L+ +
Sbjct: 15 CTRDGALD--SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FV 71
Query: 436 PP-SLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYN 478
P + L L+++ L +L + + +L L LS N
Sbjct: 72 APDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQ-ELVLSGN 113
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.8 bits (113), Expect = 1e-05
Identities = 18/88 (20%), Positives = 32/88 (36%), Gaps = 2/88 (2%)
Query: 490 NLKNLVYFNISVNRFSGEIP-VTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMS 548
+NL I + + L L+ L + + P + + L++S
Sbjct: 29 GAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88
Query: 549 SNNLSGQIPEYLENLSFLEYLNLSYNHF 576
N L + ++ LS L+ L LS N
Sbjct: 89 FNALESLSWKTVQGLS-LQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 43.2 bits (101), Expect = 3e-04
Identities = 17/94 (18%), Positives = 25/94 (26%), Gaps = 8/94 (8%)
Query: 242 SLPKLLGFIVAENNFAGSIP-ESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLG 300
L + + L L LT+ + R F L LNL
Sbjct: 29 GAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88
Query: 301 SNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRF 334
N L + + L+ L + L N
Sbjct: 89 FNALESLSWKTVQGLS-------LQELVLSGNPL 115
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 3e-07
Identities = 20/99 (20%), Positives = 42/99 (42%), Gaps = 12/99 (12%)
Query: 343 ANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYL 402
+ +T++ + GNQ + ++P + N +L + + +N+++ + + L L L
Sbjct: 27 KGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLIL 85
Query: 403 DSNFLAGGIPTSL-----GNLTLLTNLALSSNDLQGSIP 436
N L + L L L+L ND+ +P
Sbjct: 86 SYNRL-----RCIPPRTFDGLKSLRLLSLHGNDIS-VVP 118
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 9e-06
Identities = 31/110 (28%), Positives = 60/110 (54%), Gaps = 6/110 (5%)
Query: 322 TELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGI-RNLVNLVELCMDD 380
++T + LD N+F ++P ++N +T I ++ N+IS + N+ L+ L +
Sbjct: 31 RDVTELYLDGNQFT-LVPKELSNYKH-LTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSY 87
Query: 381 NKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPT-SLGNLTLLTNLALSSN 429
N+L P LK+L+LL L N ++ +P + +L+ L++LA+ +N
Sbjct: 88 NRLRCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 30/136 (22%), Positives = 47/136 (34%), Gaps = 36/136 (26%)
Query: 272 ELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDD 331
EL L NQF V + K+L ++L +N + T + T+L + L
Sbjct: 35 ELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNM------TQLLTLILSY 87
Query: 332 NRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGI-RNLVNLVELCMDDNKLTGTIPH- 389
NR L IP L +L L + N ++ +P
Sbjct: 88 NR-----------LRC---------------IPPRTFDGLKSLRLLSLHGNDIS-VVPEG 120
Query: 390 AIGELKNLQLLYLDSN 405
A +L L L + +N
Sbjct: 121 AFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 27/85 (31%), Positives = 43/85 (50%), Gaps = 6/85 (7%)
Query: 516 TSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNH 575
+ +LYL GN F+ +P LS+ K + +D+S+N +S + N++ L L LSYN
Sbjct: 31 RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89
Query: 576 FEGEVPTKGVF---SNKTGISLSGN 597
+P F + +SL GN
Sbjct: 90 LR-CIP-PRTFDGLKSLRLLSLHGN 112
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 4e-07
Identities = 25/88 (28%), Positives = 41/88 (46%), Gaps = 4/88 (4%)
Query: 490 NLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSS 549
++K LV N N G++ L+ L + SI ++L L +K+L++S
Sbjct: 18 DVKELVLDNSRSNE--GKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSD 73
Query: 550 NNLSGQIPEYLENLSFLEYLNLSYNHFE 577
N +SG + E L +LNLS N +
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 4e-06
Identities = 32/158 (20%), Positives = 50/158 (31%), Gaps = 33/158 (20%)
Query: 393 ELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMAD 452
++K L L SN G + L L+ + L S+ N L +L
Sbjct: 18 DVKELVLDNSRSN--EGKLEGLTDEFEELEFLSTINVGLT-----SIANLPKLNKLK--- 67
Query: 453 IELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSG-EIPVT 511
L+LS N +SG L + NL + N+S N+
Sbjct: 68 -------------------KLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEP 108
Query: 512 LSACTSLQQLYLQGNSFSGSI---PSSLSSLKSIKELD 546
L +L+ L L + + L + LD
Sbjct: 109 LKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLD 146
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 1e-05
Identities = 25/116 (21%), Positives = 42/116 (36%), Gaps = 7/116 (6%)
Query: 217 NISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLF 276
S ++ + L +R N + +L SI +L + L +L L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72
Query: 277 DNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDN 332
DN+ G + + NL LNL N + DL + L L ++ L +
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKI-----KDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 4e-05
Identities = 21/114 (18%), Positives = 44/114 (38%), Gaps = 9/114 (7%)
Query: 320 NCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIV---IAGNQISGIIPTGIRNLVNLVEL 376
+++ + LD++R + L+ ++ ++ I + L L +L
Sbjct: 15 TPSDVKELVLDNSRSNEG---KLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKL 69
Query: 377 CMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAG-GIPTSLGNLTLLTNLALSSN 429
+ DN+++G + + NL L L N + L L L +L L +
Sbjct: 70 ELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 5e-05
Identities = 32/143 (22%), Positives = 58/143 (40%), Gaps = 16/143 (11%)
Query: 266 NASNLVELTLFDNQF-RGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTEL 324
S++ EL L +++ GK+ + LE+L+ + L + + L +L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS--------IANLPKLNKL 66
Query: 325 TAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGI-IPTGIRNLVNLVELCMDDN-- 381
+ L DNR G L + +T + ++GN+I + ++ L NL L + +
Sbjct: 67 KKLELSDNRVSGGLEVLAEKCPN-LTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEV 125
Query: 382 -KLTGTIPHAIGELKNLQLLYLD 403
L + L L YLD
Sbjct: 126 TNLNDYRENVFKLLPQLT--YLD 146
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 5e-05
Identities = 25/108 (23%), Positives = 48/108 (44%), Gaps = 4/108 (3%)
Query: 347 STMTDIVIAGNQISGI-IPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSN 405
S + ++V+ ++ + + L L + LT +I + + +L L+ L L N
Sbjct: 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSDN 74
Query: 406 FLAGGIPTSLGNLTLLTNLALSSNDLQG-SIPPSLGNCKNLIELHMAD 452
++GG+ LT+L LS N ++ S L +NL L + +
Sbjct: 75 RVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFN 122
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 5e-07
Identities = 43/325 (13%), Positives = 97/325 (29%), Gaps = 31/325 (9%)
Query: 264 LSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTE 323
++ NL L L K++ + LE L G L+ C E
Sbjct: 207 VTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKE 266
Query: 324 LTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGI-IPTGIRNLVNLVELCMDDNK 382
L + + LP + ++ S +T + ++ + + + L L + D
Sbjct: 267 LRCLSGFWDAVPAYLPA-VYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY- 324
Query: 383 LTGTIPHAIGE----LKNLQLLYLDSNFLAG-------GIPTSLGNLTLLTNLALSSNDL 431
+ + L+ L++ + + G+ + L ++ +
Sbjct: 325 IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQM 384
Query: 432 QGSIPPSLG-NCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGN 490
+ ++ N N+ L I L+ L V +
Sbjct: 385 TNAALITIARNRPNMTRFR--------------LCIIEPKAPDYLTLEPLDIGFGAIVEH 430
Query: 491 LKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSG-SIPSSLSSLKSIKELDMSS 549
K+L ++S + ++ L + S + LS S+++L++
Sbjct: 431 CKDLRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRD 490
Query: 550 NNLSGQ-IPEYLENLSFLEYLNLSY 573
+ + L + L +S
Sbjct: 491 CPFGDKALLANASKLETMRSLWMSS 515
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 5e-07
Identities = 28/116 (24%), Positives = 44/116 (37%), Gaps = 11/116 (9%)
Query: 318 LTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTD---IVIAGNQISGIIPTGIRNLVNLV 374
TN + L + I NL +T+ I + N+I + G L L
Sbjct: 15 YTNAVRDRELDLRGYKI-----PVIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLK 67
Query: 375 ELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAG-GIPTSLGNLTLLTNLALSSN 429
L +++N++ L +L L L +N L G L +L LT L + N
Sbjct: 68 TLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 9e-07
Identities = 17/127 (13%), Positives = 39/127 (30%), Gaps = 7/127 (5%)
Query: 473 LDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSI 532
+ L+ L+ N ++ + I + + N +
Sbjct: 2 VKLTAELIEQAAQYT--NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL 57
Query: 533 PSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFE--GEVPTKGVFSNKT 590
L+ +K L +++N + + L L L L+ N G++ + T
Sbjct: 58 -DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLT 116
Query: 591 GISLSGN 597
+ + N
Sbjct: 117 YLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 19/143 (13%), Positives = 40/143 (27%), Gaps = 18/143 (12%)
Query: 413 TSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSL- 471
N L L + I + +D E+ + L
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--------KLDGFPLL 63
Query: 472 ----SLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVT-LSACTSLQQLYLQGN 526
+L ++ N + L +L ++ N + L++ SL L + N
Sbjct: 64 RRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
Query: 527 ---SFSGSIPSSLSSLKSIKELD 546
+ + + ++ LD
Sbjct: 124 PVTNKKHYRLYVIYKVPQVRVLD 146
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 24/143 (16%), Positives = 53/143 (37%), Gaps = 14/143 (9%)
Query: 262 ESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNC 321
+NA EL L + + +L + ++ N + LD LL
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI-----RKLDGFPLLRRL 66
Query: 322 TELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGI-IPTGIRNLVNLVELCMDD 380
L +++NR + L +T++++ N + + + +L +L LC+
Sbjct: 67 KTLL---VNNNRICRIGEGLDQALPD-LTELILTNNSLVELGDLDPLASLKSLTYLCILR 122
Query: 381 N---KLTGTIPHAIGELKNLQLL 400
N + I ++ +++L
Sbjct: 123 NPVTNKKHYRLYVIYKVPQVRVL 145
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 50.0 bits (118), Expect = 2e-06
Identities = 24/162 (14%), Positives = 59/162 (36%), Gaps = 14/162 (8%)
Query: 432 QGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSL-SLDLSYNLLSGTLPLEVGN 490
Q + P L L L + ++ +L + S L +++ L ++ N
Sbjct: 161 QVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPN 220
Query: 491 LKNLVYFNISVNRFSGEIPVTLSA------CTSLQQLYLQGNSFSGSIPSSLSS---LKS 541
L+ LV + + +L+ L + + L
Sbjct: 221 LEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQ 280
Query: 542 IKELDMSSNNLSG----QIPEYLENLSFLEYLNLSYNHFEGE 579
++ +D+S+ L+ + ++++ + L+++N+ YN+ E
Sbjct: 281 LETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 3e-06
Identities = 27/100 (27%), Positives = 46/100 (46%), Gaps = 13/100 (13%)
Query: 343 ANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAI-GELKNLQLLY 401
+ S+ T + + N++ + L L +L + N++ ++P + +L L +LY
Sbjct: 24 TGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILY 82
Query: 402 LDSNFLAGGIPTSL-----GNLTLLTNLALSSNDLQGSIP 436
L N L SL LT L LAL +N L+ S+P
Sbjct: 83 LHENKL-----QSLPNGVFDKLTQLKELALDTNQLK-SVP 116
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 33/135 (24%), Positives = 52/135 (38%), Gaps = 35/135 (25%)
Query: 273 LTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDN 332
L L N+ + F L L L+L N + + D LT +LT + L +N
Sbjct: 33 LELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLT------KLTILYLHEN 86
Query: 333 RFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGI-RNLVNLVELCMDDNKLTGTIPH-A 390
+ L S +P G+ L L EL +D N+L ++P
Sbjct: 87 K-----------LQS---------------LPNGVFDKLTQLKELALDTNQLK-SVPDGI 119
Query: 391 IGELKNLQLLYLDSN 405
L +LQ ++L +N
Sbjct: 120 FDRLTSLQKIWLHTN 134
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 3e-06
Identities = 29/111 (26%), Positives = 49/111 (44%), Gaps = 4/111 (3%)
Query: 467 STLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGN 526
S+ S +D+ + ++ LV N N G+I + +L+ L L
Sbjct: 2 SSGSSGMDMKRRIHLELRNRTPAAVRELVLDNCKSND--GKIEGLTAEFVNLEFLSLINV 59
Query: 527 SFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFE 577
S+ S+L L +K+L++S N + G + E L L +LNLS N +
Sbjct: 60 GLI-SV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 23/116 (19%), Positives = 41/116 (35%), Gaps = 7/116 (6%)
Query: 217 NISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLF 276
+++ + L + N + L + S+ +L L +L L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELS 79
Query: 277 DNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDN 332
+N+ G + + L NL LNL N L D+ L L L ++ L +
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKL-----KDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 33/143 (23%), Positives = 55/143 (38%), Gaps = 16/143 (11%)
Query: 266 NASNLVELTLFDNQFR-GKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTEL 324
+ + EL L + + GK+ NLE+L+L + L + L L +L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGL-----ISVSNLPKLPKLKKL 76
Query: 325 TAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGI-IPTGIRNLVNLVELCMDDN-- 381
L +NR G L L + +T + ++GN++ I ++ L L L + +
Sbjct: 77 E---LSENRIFGGLDMLAEKLPN-LTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEV 132
Query: 382 -KLTGTIPHAIGELKNLQLLYLD 403
L L L YLD
Sbjct: 133 TNLNDYRESVFKLLPQLT--YLD 153
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 26/109 (23%), Positives = 50/109 (45%), Gaps = 6/109 (5%)
Query: 347 STMTDIVIAGNQISGI-IPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSN 405
+ + ++V+ + + I VNL L + + L ++ + + +L L+ L L N
Sbjct: 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSEN 81
Query: 406 FLAGGIPTSLGNLTLLTNLALSSNDLQ--GSIPPSLGNCKNLIELHMAD 452
+ GG+ L LT+L LS N L+ ++ P L + L L + +
Sbjct: 82 RIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEP-LKKLECLKSLDLFN 129
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 21/114 (18%), Positives = 43/114 (37%), Gaps = 9/114 (7%)
Query: 320 NCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIV---IAGNQISGIIPTGIRNLVNLVEL 376
+ + LD+ + I L++ ++ + + + + + L L +L
Sbjct: 22 TPAAVRELVLDNCKSN---DGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKL 76
Query: 377 CMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAG-GIPTSLGNLTLLTNLALSSN 429
+ +N++ G + +L NL L L N L L L L +L L +
Sbjct: 77 ELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 48.8 bits (116), Expect = 7e-06
Identities = 73/554 (13%), Positives = 165/554 (29%), Gaps = 101/554 (18%)
Query: 47 HRHQRVTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLA 106
R + L L + + N + L +L+++
Sbjct: 70 RRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVT---------EISNNLRQLKSVHFR 120
Query: 107 NNSFSGKIPTNL--SRCSNLISFNARRNNLVGEI-PAELGYNWLKLENLTIADN---HLT 160
S L +R +L + + + + + K++ L + ++
Sbjct: 121 RMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKD 180
Query: 161 GHFPASIG-NLSTLERINVLGNGLWG-------RIPNNLGNLRNLILLNLGENRFSGIVP 212
G + + + ++LE +N I N +L ++ + F +
Sbjct: 181 GKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKV-----GDFEILEL 235
Query: 213 PSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAG--SIPESLSNASNL 270
F ++ F + + ++L ++ G +P A+ +
Sbjct: 236 VGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQI 295
Query: 271 VELTLFDNQFRGKVSIY-FRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGL 329
+L L + + NLE L N +G D L C +L + +
Sbjct: 296 RKLDLLYALLETEDHCTLIQKCPNLEVLET-RNVIG-----DRGLEVLAQYCKQLKRLRI 349
Query: 330 DDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPH 389
+ G + + ++ + ++ + L + + + +T
Sbjct: 350 E----RGADEQGMEDEEGLVSQRGLI--ALA-------QGCQELEYMAVYVSDITNESLE 396
Query: 390 AIGE----LKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNL 445
+IG L + +L+ LD +P G +LL CK L
Sbjct: 397 SIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIG------------------CKKL 438
Query: 446 IELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVG-NLKNLVYFNISVNRF 504
+ L L+ +G N+ + +
Sbjct: 439 -----------------------RRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGE 475
Query: 505 SGE-IPVTLSACTSLQQLYLQGNSFS-GSIPSSLSSLKSIKELDMSSNNLSGQIPEYLE- 561
S E + C +LQ+L ++G FS +I ++++ L S++ L + S + ++
Sbjct: 476 SDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQM 535
Query: 562 --NLSFLEYLNLSY 573
+E +
Sbjct: 536 ARPYWNIELIPSRR 549
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.7 bits (115), Expect = 1e-05
Identities = 64/515 (12%), Positives = 132/515 (25%), Gaps = 161/515 (31%)
Query: 542 IKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNKTGISLSGNGKVC 601
E ++ + + + F++ N + K + S +
Sbjct: 11 TGEHQYQYKDI---LSVFEDA--FVD--NFDCKDVQDM--PKSILSKEE----------- 50
Query: 602 GGLDE-LNLPPCPSRGLKKRTDFLLKVVVPVTVSGVILSLCLVL-----FLARRRRSAHK 655
+D + T L ++ V + VL FL ++ +
Sbjct: 51 --IDHIIMSKD-----AVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQR 103
Query: 656 SSVSQLMDQQFPMISYAE-LSKATND---FSSSNM--------IGQGSFGFVYKGNLGEN 703
Y E + ND F+ N+ + Q N+ +
Sbjct: 104 -------QPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLID 156
Query: 704 GMM------VAVKVIN---LKQKGASNGF---VAECQALRNIRHRNLIKII-TICSSIDF 750
G++ VA+ V ++ K F + C +++++ + ID
Sbjct: 157 GVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCN-----SPETVLEMLQKLLYQIDP 211
Query: 751 KGVDFQAIVYEYMQN-GSLEDWL-HQSEDQQEARSLTLIQRINIIIDVASA--IEYIHHH 806
S++ L + + L L+ +V +A +
Sbjct: 212 NWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCL-LVLL-----NVQNAKAWNAFNLS 265
Query: 807 CQPPVVHGDLKPSNVLLDQ-----DLVAHLGDFG-------LAKFLSSSPLDTAVETPSS 854
C+ + + ++ L L H L K+L P D P
Sbjct: 266 CKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQD----LPRE 321
Query: 855 SKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914
P L + GL + +
Sbjct: 322 VLT-------TNP-------------------RRLSIIAE------SIRDGLATWDNWKH 349
Query: 915 ALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEE-----RLVAV------VETGVVCSM 963
DK+ I++S L L E ++V + T ++ +
Sbjct: 350 VNCDKLTTIIESSL--------------NVLEPAEYRKMFDRLSVFPPSAHIPTILLSLI 395
Query: 964 --ESPTERMEMRDVVAKLCR----ARDTFLGRMRI 992
+ ++ VV KL + + + I
Sbjct: 396 WFDVIKS--DVMVVVNKLHKYSLVEKQPKESTISI 428
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.9 bits (113), Expect = 2e-05
Identities = 72/488 (14%), Positives = 126/488 (25%), Gaps = 191/488 (39%)
Query: 277 DNQFRGKVSIY----FRSLKNLEWL-NLGSNN-------LGTGEANDLDFLTLLTNCTEL 324
DNQ K ++ + L+ L L LG+G+ T +
Sbjct: 122 DNQVFAKYNVSRLQPYLKLRQ--ALLELRPAKNVLIDGVLGSGK-------------TWV 166
Query: 325 TAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELC--MDDNK 382
+ + I L+ N S P + L L +L +D N
Sbjct: 167 ALDVCLSYKVQCKMDFKIFWLN--------LKNCNS---PETV--LEMLQKLLYQIDPNW 213
Query: 383 LTG-----TIPHAIGELKN-LQLLYLDSNFLAGGIPTSLGNL-----------------T 419
+ I I ++ L+ L + L L
Sbjct: 214 TSRSDHSSNIKLRIHSIQAELRRLLKSKPY-----ENCLLVLLNVQNAKAWNAFNLSCKI 268
Query: 420 LLT----NLA----------LSSNDLQGSIPP--SLGNCKNLIELHMADIELTGALPPQI 463
LLT + +S + ++ P ++ D LP ++
Sbjct: 269 LLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQD------LPREV 322
Query: 464 LSISTLSLSL---------------------------DLSYNLLSGTLPLEVGNL-KNLV 495
L+ + LS+ + S N+L P E + L
Sbjct: 323 LTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLE---PAEYRKMFDRLS 379
Query: 496 YFNISVNRFSGEIPV-TLSA-------------CTSLQQLYL---QGNSFSGSIPS-SLS 537
F S + IP LS L + L Q + SIPS L
Sbjct: 380 VFPPSAH-----IPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLE 434
Query: 538 SLKSIKEL--------------------DMSSNNLSGQIPEYL----------ENLSFLE 567
++ D+ L ++ E ++
Sbjct: 435 LKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFR 494
Query: 568 YLNLSYNHFEGEVPTKGVFSNKTGISLSGNGKVCGGLDELNL--------PPCPSRGLKK 619
+ L + E ++ + + +G + L +L P R +
Sbjct: 495 MVFLDFRFLEQKI-------RHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNA 547
Query: 620 RTDFLLKV 627
DFL K+
Sbjct: 548 ILDFLPKI 555
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 28/79 (35%), Positives = 40/79 (50%), Gaps = 13/79 (16%)
Query: 363 IPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSL-----GN 417
+P GI + L +++N++T P L NLQ LY +SN L T++
Sbjct: 27 VPAGI--PTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKL-----TAIPTGVFDK 79
Query: 418 LTLLTNLALSSNDLQGSIP 436
LT LT L L+ N L+ SIP
Sbjct: 80 LTQLTQLDLNDNHLK-SIP 97
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 4e-05
Identities = 29/79 (36%), Positives = 37/79 (46%), Gaps = 13/79 (16%)
Query: 363 IPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSL-----GN 417
+PTGI L + DN++T P L L L LD+N L T L
Sbjct: 24 VPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQL-----TVLPAGVFDK 76
Query: 418 LTLLTNLALSSNDLQGSIP 436
LT LT L+L+ N L+ SIP
Sbjct: 77 LTQLTQLSLNDNQLK-SIP 94
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 8e-05
Identities = 33/211 (15%), Positives = 69/211 (32%), Gaps = 30/211 (14%)
Query: 372 NLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDL 431
++ + + + + + +S + L + L NL+L L
Sbjct: 71 GVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRL 130
Query: 432 QGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNL 491
I +L NL+ L+++ S +L LS +
Sbjct: 131 SDPIVNTLAKNSNLVRLNLSGCS----------GFSEFALQTLLS-------------SC 167
Query: 492 KNLVYFNIS-VNRFS--GEIPVTLSACTSLQQLYLQGNSFS---GSIPSSLSSLKSIKEL 545
L N+S F+ ++ QL L G + + + + ++ L
Sbjct: 168 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 227
Query: 546 DMSS-NNLSGQIPEYLENLSFLEYLNLSYNH 575
D+S L + L++L++L+LS +
Sbjct: 228 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY 258
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 9e-05
Identities = 38/327 (11%), Positives = 92/327 (28%), Gaps = 39/327 (11%)
Query: 254 NNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLD 313
+ L S L++ F +F+ + L +L LNL + + +
Sbjct: 36 KKLGKLGRQVLP-PSELLDHLFFHYEFQNQ-RFSAEVLSSLRQLNLAGVRMTPVKCTVVA 93
Query: 314 FLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIR----- 368
+ L + L + L + ++ + + + N + P +
Sbjct: 94 AV-LGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLG---PEACKDLRDL 149
Query: 369 ---NLVNLVELCMDDNKLTGT----IPHAIGELKNLQLLYLDSNFL----AGGIPTSLGN 417
+ + L + +N LT + + ++ L L L + L
Sbjct: 150 LLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDR 209
Query: 418 LTLLTNLALSSNDLQGS----IPPSLGNCKNLIELHMA--DIELTGALP-PQILSISTLS 470
L L ++ N + + + +L LH+ ++ G + +
Sbjct: 210 NRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGG 269
Query: 471 LSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFS- 529
+ +S + L + S +R + + L L+ + +
Sbjct: 270 ARVVVSLTEGTAVSEYWSVILSEVQRNLNSWDRARVQRHLELL------LRDLEDSRGAT 323
Query: 530 ---GSIPSSLSSLKSIKELDMSSNNLS 553
L ++ L +
Sbjct: 324 LNPWRKAQLLRVEGEVRALLEQLGSSG 350
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 992 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.98 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.97 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.95 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.94 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.93 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.93 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.92 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.92 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.92 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.92 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.92 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.91 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.9 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.9 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.89 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.88 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.88 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.88 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.88 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.88 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.87 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.87 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.87 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.87 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.86 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.86 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.85 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.85 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.85 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.85 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.85 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.84 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.83 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.83 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.83 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.82 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.82 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.82 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.81 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.79 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.79 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.79 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.78 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.78 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.77 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.77 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.76 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.76 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.76 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.75 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.75 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.73 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.73 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.72 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.72 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.72 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.72 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.71 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.71 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.68 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.64 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.63 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.62 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.6 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.6 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.58 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.56 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.56 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.55 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.54 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.53 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.52 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.52 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.5 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.5 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.5 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.5 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.48 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.43 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.41 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.38 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.3 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.24 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.24 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.23 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.2 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.19 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.95 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.93 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.91 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.88 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.83 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.81 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.78 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.74 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.53 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.44 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.37 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.29 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.27 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.26 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.18 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.03 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.01 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.88 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.87 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.66 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.64 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.63 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.56 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.35 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.26 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.23 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.16 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.11 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.96 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.83 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.78 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.7 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.64 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.52 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.38 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.38 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.11 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.7 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.58 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.51 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.82 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-80 Score=759.62 Aligned_cols=603 Identities=29% Similarity=0.466 Sum_probs=468.9
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCCcCCCCCCceEeeEEcCCCCeEEEeeccccccCCc---cC------------
Q 037275 3 VPSNETDRLALLAIGSQLEDDPLGVTSSWNNSTNLCQWTGVTCGHRHQRVTKLDLSNRTIGGT---LS------------ 67 (992)
Q Consensus 3 ~~~~~~~~~~ll~~~~~~~~~~~~~~~~w~~~~~~c~w~gv~c~~~~~~v~~ldl~~~~l~~~---l~------------ 67 (992)
..+.++||+|||+||+++. ||. .+++|+.++|||+|.||+|+ .++|+.|||+++.+.|. +|
T Consensus 7 ~~~~~~~~~all~~k~~~~-~~~-~l~~W~~~~~~C~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l 82 (768)
T 3rgz_A 7 SQSLYREIHQLISFKDVLP-DKN-LLPDWSSNKNPCTFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESL 82 (768)
T ss_dssp -CCHHHHHHHHHHHHTTCS-CTT-SSTTCCTTSCGGGSTTEEEE--TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEE
T ss_pred ccCCHHHHHHHHHHHhhCC-Ccc-cccCCCCCCCCcCCcceEEC--CCcEEEEECCCCCcCCccCccChhHhccCccccc
Confidence 4567899999999999996 777 89999989999999999998 68999999999998876 44
Q ss_pred -----------CCCCCCCcCCeeeccCCCCCccCCc--cccCCCCCCEEEeecccCCCCCCccc-ccCCCCcEeeccccc
Q 037275 68 -----------PYVGNLSFLRYLNLADNNFHGEIPH--QIGRLVRLEALVLANNSFSGKIPTNL-SRCSNLISFNARRNN 133 (992)
Q Consensus 68 -----------~~l~~l~~L~~L~L~~n~l~~~~p~--~~~~l~~L~~L~Ls~n~l~~~~p~~l-~~l~~L~~L~l~~n~ 133 (992)
+.++.+++|++|||++|.+.|.+|. .++.+++|++|+|++|.+++.+|..+ .++++|++|++++|+
T Consensus 83 ~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~ 162 (768)
T 3rgz_A 83 FLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANS 162 (768)
T ss_dssp ECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSC
T ss_pred CCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCc
Confidence 5778888888999999888888888 88888888888888888887777765 677777777777777
Q ss_pred ccccCChhh--c----------------------ccccccccccccccccCCCCCCccccccccceEEecCCcccCCcCC
Q 037275 134 LVGEIPAEL--G----------------------YNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPN 189 (992)
Q Consensus 134 l~~~~p~~~--~----------------------~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~ 189 (992)
+++..|..+ . ..+++|++|+|++|.+++.+|. ++++++|++|++++|.+.+.+|.
T Consensus 163 l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~ 241 (768)
T 3rgz_A 163 ISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSR 241 (768)
T ss_dssp CEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHH
T ss_pred cCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccH
Confidence 775555431 1 2455666666666666665555 77777777777777777767777
Q ss_pred ccCCCCcccEEeccCcccccccCccccccCCCcEEeccCCccCCCCCccccccccccchhhccccccCCCCchhhhcccc
Q 037275 190 NLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASN 269 (992)
Q Consensus 190 ~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~ 269 (992)
.|+++++|++|+|++|++++.+|.. .+++|++|++++|++++.+|..++..+++|++|++++|++.+.+|..|+++++
T Consensus 242 ~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~ 319 (768)
T 3rgz_A 242 AISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSL 319 (768)
T ss_dssp HTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTT
T ss_pred HHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCC
Confidence 7777777777777777777665554 66777777777777777777777766688888888888888888888888888
Q ss_pred Cceeeecccccccccccc-ccccCccceEecCCCCCCCCCCCCchhhh-------------------hccC--CCcceEe
Q 037275 270 LVELTLFDNQFRGKVSIY-FRSLKNLEWLNLGSNNLGTGEANDLDFLT-------------------LLTN--CTELTAI 327 (992)
Q Consensus 270 L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~~~~~~~-------------------~l~~--~~~L~~L 327 (992)
|++|++++|++++.++.. |..+++|++|+|++|+++..-+..+..+. .+.. +++|+.|
T Consensus 320 L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L 399 (768)
T 3rgz_A 320 LESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQEL 399 (768)
T ss_dssp CCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEE
T ss_pred ccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEE
Confidence 888888888888666654 88888888888888887633222222211 1111 4556666
Q ss_pred ecCCCcCCCcCCcccccccccceeEEeeCCccccccCCCccCCCcccEEEccCCcCCCCCCccccCCCCCcEEeccCccc
Q 037275 328 GLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFL 407 (992)
Q Consensus 328 ~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 407 (992)
++++|++.+.+|..+..+. +|+.|++++|++++.+|..+..+++|++|++++|++++.+|..+..+++|++|+|++|++
T Consensus 400 ~L~~n~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l 478 (768)
T 3rgz_A 400 YLQNNGFTGKIPPTLSNCS-ELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDL 478 (768)
T ss_dssp ECCSSEEEEECCGGGGGCT-TCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCC
T ss_pred ECCCCccccccCHHHhcCC-CCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcc
Confidence 6666666666666666654 477777777777777777777777777777777777767777777777777777777777
Q ss_pred cccCCCCCCCccccCceeccCCcccCCCCCCccccccccccccccccccccCchhhhhhcccccccccccccccCcccc-
Q 037275 408 AGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPL- 486 (992)
Q Consensus 408 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~- 486 (992)
++.+|..+.++++|++|+|++|++++.+|.+++.+++|++|++++|++++.+|..+... +.++.|++++|.++|.+|.
T Consensus 479 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l-~~L~~L~Ls~N~l~g~ip~~ 557 (768)
T 3rgz_A 479 TGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDC-RSLIWLDLNTNLFNGTIPAA 557 (768)
T ss_dssp CSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGC-TTCCEEECCSSEEESBCCGG
T ss_pred cCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCC-CCCCEEECCCCccCCcCChH
Confidence 77777777777777777777777777777777777777777777777777666665543 3344667777776665554
Q ss_pred ---------------------------------------------------------------------cccCCCCccEE
Q 037275 487 ---------------------------------------------------------------------EVGNLKNLVYF 497 (992)
Q Consensus 487 ---------------------------------------------------------------------~~~~l~~L~~L 497 (992)
.++.+++|++|
T Consensus 558 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~L 637 (768)
T 3rgz_A 558 MFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFL 637 (768)
T ss_dssp GGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEE
T ss_pred HhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEE
Confidence 34456789999
Q ss_pred eeecccccccCCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcccCCCChhhhhcCCCcceEecCCCcCc
Q 037275 498 NISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFE 577 (992)
Q Consensus 498 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 577 (992)
||++|+++|.+|..|+.+++|+.|+|++|+++|.+|..|+++++|+.|||++|+++|.+|..+..+++|++||+++|+++
T Consensus 638 dLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~ 717 (768)
T 3rgz_A 638 DMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLS 717 (768)
T ss_dssp ECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEE
T ss_pred ECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCccCCcccccccCCCCcCCCCCCCCCCCCCCCCCC
Q 037275 578 GEVPTKGVFSNKTGISLSGNGKVCGGLDELNLPPCPSRGLK 618 (992)
Q Consensus 578 ~~~~~~~~~~~~~~~~l~~N~~~C~~~~~~~~~~~~~~~~~ 618 (992)
|.+|..+.|..+...++.|||++||.|. ++|+.....
T Consensus 718 g~iP~~~~~~~~~~~~~~gN~~Lcg~~l----~~C~~~~~~ 754 (768)
T 3rgz_A 718 GPIPEMGQFETFPPAKFLNNPGLCGYPL----PRCDPSNAD 754 (768)
T ss_dssp EECCSSSSGGGSCGGGGCSCTEEESTTS----CCCCSCC--
T ss_pred ccCCCchhhccCCHHHhcCCchhcCCCC----cCCCCCccC
Confidence 9999999999999999999999999875 478765543
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-62 Score=606.99 Aligned_cols=520 Identities=34% Similarity=0.513 Sum_probs=407.9
Q ss_pred CeEEEeeccccccCCccCC--CCCCCCcCCeeeccCCCCCccCCccc-cCCCCCCEEEeecccCCCCCCcc---------
Q 037275 50 QRVTKLDLSNRTIGGTLSP--YVGNLSFLRYLNLADNNFHGEIPHQI-GRLVRLEALVLANNSFSGKIPTN--------- 117 (992)
Q Consensus 50 ~~v~~ldl~~~~l~~~l~~--~l~~l~~L~~L~L~~n~l~~~~p~~~-~~l~~L~~L~Ls~n~l~~~~p~~--------- 117 (992)
.+++.|||++|.+.|.+|. .++.+++|++|||++|.+.+.+|..+ ..+++|++|+|++|++++..|..
T Consensus 100 ~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~l~~ 179 (768)
T 3rgz_A 100 ASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGE 179 (768)
T ss_dssp TTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHHHHHTTCCTT
T ss_pred CCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChhhhhhccCCC
Confidence 4577888888888887777 78888888888888887776666554 44555555555444444332221
Q ss_pred ----------------cccCCCCcEeecccccccccCChhhcccccccccccccccccCCCCCCccccccccceEEe---
Q 037275 118 ----------------LSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINV--- 178 (992)
Q Consensus 118 ----------------l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l--- 178 (992)
++.+++|++|++++|++++.+|. + .++++|++|+|++|.+++.+|..+.++++|++|++
T Consensus 180 L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l-~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n 257 (768)
T 3rgz_A 180 LKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-L-GDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSN 257 (768)
T ss_dssp CCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-C-TTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSS
T ss_pred CCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-c-ccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCC
Confidence 13445555555555555544444 2 24555555555555555555555555555555554
Q ss_pred -------------------cCCcccCCcCCccCCC-CcccEEeccCcccccccCccccccCCCcEEeccCCccCCCCCcc
Q 037275 179 -------------------LGNGLWGRIPNNLGNL-RNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLD 238 (992)
Q Consensus 179 -------------------~~n~l~~~~~~~l~~l-~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~ 238 (992)
++|.+.+.+|..+..+ ++|++|+|++|++++.+|..+.++++|++|++++|++.|.+|..
T Consensus 258 ~l~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~ 337 (768)
T 3rgz_A 258 QFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMD 337 (768)
T ss_dssp CCEESCCCCCCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHH
T ss_pred cccCccCccccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHH
Confidence 4555544566666554 67777777777777667777777777777777777777677766
Q ss_pred ccccccccchhhccccccCCCCchhhhccc-cCceeeeccccccccccccccc--cCccceEecCCCCCCCCCCCCchhh
Q 037275 239 IGVSLPKLLGFIVAENNFAGSIPESLSNAS-NLVELTLFDNQFRGKVSIYFRS--LKNLEWLNLGSNNLGTGEANDLDFL 315 (992)
Q Consensus 239 ~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~-~L~~L~L~~N~l~~~~~~~~~~--l~~L~~L~L~~N~l~~~~~~~~~~~ 315 (992)
.+..+++|+.|++++|++.+.+|..+..++ +|++|++++|++++..+..+.. +++|++|++++|+++... +
T Consensus 338 ~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~------p 411 (768)
T 3rgz_A 338 TLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKI------P 411 (768)
T ss_dssp HHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEEC------C
T ss_pred HHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCcccccc------C
Confidence 566677777777777777777777777776 7777777777777666666655 677777777777776422 2
Q ss_pred hhccCCCcceEeecCCCcCCCcCCcccccccccceeEEeeCCccccccCCCccCCCcccEEEccCCcCCCCCCccccCCC
Q 037275 316 TLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELK 395 (992)
Q Consensus 316 ~~l~~~~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 395 (992)
..+.++++|+.|++++|++.+.+|..+..+. +|+.|++++|++++.+|..+..+++|++|++++|++++.+|..+..++
T Consensus 412 ~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 490 (768)
T 3rgz_A 412 PTLSNCSELVSLHLSFNYLSGTIPSSLGSLS-KLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCT 490 (768)
T ss_dssp GGGGGCTTCCEEECCSSEEESCCCGGGGGCT-TCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCT
T ss_pred HHHhcCCCCCEEECcCCcccCcccHHHhcCC-CCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCC
Confidence 4578899999999999999999999998886 599999999999999999999999999999999999999999999999
Q ss_pred CCcEEeccCccccccCCCCCCCccccCceeccCCcccCCCCCCccccccccccccccccccccCchhhhhhc--------
Q 037275 396 NLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSIS-------- 467 (992)
Q Consensus 396 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~-------- 467 (992)
+|++|+|++|++++.+|..+..+++|++|+|++|++++.+|..++.+++|+.|++++|+++|.+|..++...
T Consensus 491 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~ 570 (768)
T 3rgz_A 491 NLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFI 570 (768)
T ss_dssp TCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTT
T ss_pred CCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcc
Confidence 999999999999999999999999999999999999999999999999999999999999999998776421
Q ss_pred -------------------------------------------------------------ccccccccccccccCcccc
Q 037275 468 -------------------------------------------------------------TLSLSLDLSYNLLSGTLPL 486 (992)
Q Consensus 468 -------------------------------------------------------------~~~~~L~l~~N~l~~~~~~ 486 (992)
..++.|||++|+++|.+|.
T Consensus 571 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~ 650 (768)
T 3rgz_A 571 AGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPK 650 (768)
T ss_dssp CSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCG
T ss_pred ccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCH
Confidence 3456799999999999999
Q ss_pred cccCCCCccEEeeecccccccCCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcccCCCChhhhhcCCCc
Q 037275 487 EVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFL 566 (992)
Q Consensus 487 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 566 (992)
.++++++|+.|+|++|+++|.+|..|+++++|+.|+|++|+++|.+|..+..+++|++|||++|+|+|.+|.. ..+.++
T Consensus 651 ~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~-~~~~~~ 729 (768)
T 3rgz_A 651 EIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM-GQFETF 729 (768)
T ss_dssp GGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSS-SSGGGS
T ss_pred HHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCc-hhhccC
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999964 345566
Q ss_pred ceEecCCCcCccc
Q 037275 567 EYLNLSYNHFEGE 579 (992)
Q Consensus 567 ~~L~l~~N~l~~~ 579 (992)
....+.+|+.-|-
T Consensus 730 ~~~~~~gN~~Lcg 742 (768)
T 3rgz_A 730 PPAKFLNNPGLCG 742 (768)
T ss_dssp CGGGGCSCTEEES
T ss_pred CHHHhcCCchhcC
Confidence 6677888875543
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-58 Score=566.79 Aligned_cols=564 Identities=20% Similarity=0.191 Sum_probs=444.2
Q ss_pred CceEeeEEcCC---------CCeEEEeeccccccCCccCCCCCCCCcCCeeeccCCCCCccCCccccCCCCCCEEEeecc
Q 037275 38 CQWTGVTCGHR---------HQRVTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANN 108 (992)
Q Consensus 38 c~w~gv~c~~~---------~~~v~~ldl~~~~l~~~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n 108 (992)
|.+..|.|+.. ..+++.|||++|.+.+..+..++.+++|++|+|++|.+++..|..|+.+++|++|+|++|
T Consensus 4 ~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n 83 (680)
T 1ziw_A 4 VSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83 (680)
T ss_dssp CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSS
T ss_pred eECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCC
Confidence 45556677532 346899999999998777778999999999999999999888999999999999999999
Q ss_pred cCCCCCCcccccCCCCcEeecccccccccCChhhcccccccccccccccccCCCCCCccccccccceEEecCCcccCCcC
Q 037275 109 SFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIP 188 (992)
Q Consensus 109 ~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~ 188 (992)
++++..+..|+.+++|++|++++|+++ .+|+..+.++++|++|+|++|.+++..|..++++++|++|++++|.+.+..+
T Consensus 84 ~l~~l~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 162 (680)
T 1ziw_A 84 ELSQLSDKTFAFCTNLTELHLMSNSIQ-KIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKS 162 (680)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCCC-CCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCH
T ss_pred ccCccChhhhccCCCCCEEECCCCccC-ccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCH
Confidence 999433447999999999999999998 5665555589999999999999998889999999999999999999977766
Q ss_pred CccC--CCCcccEEeccCcccccccCcccccc---------------------------CCCcEEeccCCccCCCCCccc
Q 037275 189 NNLG--NLRNLILLNLGENRFSGIVPPSIFNI---------------------------SSLENVFLPTNRFNGSLPLDI 239 (992)
Q Consensus 189 ~~l~--~l~~L~~L~L~~n~l~~~~p~~l~~l---------------------------~~L~~L~l~~N~l~~~~~~~~ 239 (992)
..+. .+++|+.|++++|++++..|..+..+ ++|++|++++|.+.+..|..+
T Consensus 163 ~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~ 242 (680)
T 1ziw_A 163 EELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTF 242 (680)
T ss_dssp HHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTT
T ss_pred HHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHh
Confidence 6654 45899999999999998878777655 456777777777775544433
Q ss_pred ccccc--ccchhhccccccCCCCchhhhccccCceeeeccccccccccccccccCccceEecCCCCCCC-CCCCCchh--
Q 037275 240 GVSLP--KLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGT-GEANDLDF-- 314 (992)
Q Consensus 240 ~~~~~--~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~-- 314 (992)
..++ +|+.|++++|++.+..|..|+.+++|++|++++|++++..+..|..+++|++|++++|.... ++...+..
T Consensus 243 -~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~ 321 (680)
T 1ziw_A 243 -LGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKID 321 (680)
T ss_dssp -GGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEEC
T ss_pred -hccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccC
Confidence 3343 48888888888887777888888888888888888888888888888888888888765431 00000000
Q ss_pred hhhccCCCcceEeecCCCcCCCcCCcccccccccceeEEeeCCccc--cccCCCccCC--CcccEEEccCCcCCCCCCcc
Q 037275 315 LTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQIS--GIIPTGIRNL--VNLVELCMDDNKLTGTIPHA 390 (992)
Q Consensus 315 ~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~--~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~ 390 (992)
...+..+++|+.|++++|++.+..+..+..+. .|++|++++|.+. ......|..+ ++|+.|++++|++++..|.+
T Consensus 322 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~ 400 (680)
T 1ziw_A 322 DFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLI-NLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDA 400 (680)
T ss_dssp TTTTTTCTTCCEEECCSCCBCCCCTTTTTTCT-TCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTT
T ss_pred hhhcccCCCCCEEECCCCccCCCChhHhcccc-CCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhh
Confidence 01466788899999999999988887777765 4888888888743 2333344433 57888888888888888888
Q ss_pred ccCCCCCcEEeccCccccccCC-CCCCCccccCceeccCCcccCCCCCCcccccccccccccccccc--ccCchhhhhhc
Q 037275 391 IGELKNLQLLYLDSNFLAGGIP-TSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELT--GALPPQILSIS 467 (992)
Q Consensus 391 ~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~--~~~p~~~~~~~ 467 (992)
|..+++|+.|+|++|++++.+| ..|.++++|++|++++|++.+..+..|..+++|+.|++++|.+. +.+|..+. ..
T Consensus 401 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~-~l 479 (680)
T 1ziw_A 401 FSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQ-PL 479 (680)
T ss_dssp TTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTT-TC
T ss_pred hhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccc-cC
Confidence 8888899999999998876555 57888888999999999888888888888889999999888886 34555443 34
Q ss_pred ccccccccccccccCcccccccCCCCccEEeeecccccccCC--------cccccccccceeeccCCcccccCCcccccc
Q 037275 468 TLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIP--------VTLSACTSLQQLYLQGNSFSGSIPSSLSSL 539 (992)
Q Consensus 468 ~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--------~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 539 (992)
..++.|++++|++++..+..|..+++|++|+|++|++++..+ ..|.++++|+.|+|++|+|+...+..|.++
T Consensus 480 ~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l 559 (680)
T 1ziw_A 480 RNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDL 559 (680)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred CCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccc
Confidence 556678899999887777778888899999999998886422 237788889999999998885555678888
Q ss_pred CCCCEEECCCcccCCCChhhhhcCCCcceEecCCCcCcccCCCC-C-ccCCcccccccCCCCcCCCCC
Q 037275 540 KSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTK-G-VFSNKTGISLSGNGKVCGGLD 605 (992)
Q Consensus 540 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~-~~~~~~~~~l~~N~~~C~~~~ 605 (992)
++|+.|+|++|+|++..+..|..+++|+.|++++|++++.++.. . .++.++.+++.+|||.|+|..
T Consensus 560 ~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 560 FELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627 (680)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred cCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence 99999999999998777777888889999999999888876642 2 467788888899999988863
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-59 Score=559.15 Aligned_cols=523 Identities=20% Similarity=0.248 Sum_probs=329.8
Q ss_pred CHHHHHHHHHHHhhccCCCCCCC-------CCCcCCCCCCce---EeeEEcCCCCeEEEeeccccccCCccCCCCCCCCc
Q 037275 6 NETDRLALLAIGSQLEDDPLGVT-------SSWNNSTNLCQW---TGVTCGHRHQRVTKLDLSNRTIGGTLSPYVGNLSF 75 (992)
Q Consensus 6 ~~~~~~~ll~~~~~~~~~~~~~~-------~~w~~~~~~c~w---~gv~c~~~~~~v~~ldl~~~~l~~~l~~~l~~l~~ 75 (992)
...|+.||.+|++++..+.+... ++|+.+++||.| .||+|+.. ++|+.|||+++.+.|.+|+.++++++
T Consensus 28 ~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C~~~-~~V~~L~L~~~~l~g~lp~~l~~L~~ 106 (636)
T 4eco_A 28 YIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSN-GRVTGLSLEGFGASGRVPDAIGQLTE 106 (636)
T ss_dssp HHHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGGGTTCCTTEEECTT-CCEEEEECTTSCCEEEECGGGGGCTT
T ss_pred HHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCcccccCCCCeEEcCC-CCEEEEEecCcccCCcCChHHhcCcc
Confidence 34799999999999866655433 389999999999 99999865 89999999999999999999999999
Q ss_pred CCeeeccCCCC------Cc------cCCccccCCCCCCEEEeecccCCCCCCccccc-CCCCcEeecccccccccCChhh
Q 037275 76 LRYLNLADNNF------HG------EIPHQIGRLVRLEALVLANNSFSGKIPTNLSR-CSNLISFNARRNNLVGEIPAEL 142 (992)
Q Consensus 76 L~~L~L~~n~l------~~------~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~-l~~L~~L~l~~n~l~~~~p~~~ 142 (992)
|++|||++|.+ .+ .+|... +..|+ ++++.|.+.+.+|..+.. +..+..+++....+..
T Consensus 107 L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~------ 177 (636)
T 4eco_A 107 LEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKK------ 177 (636)
T ss_dssp CCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCC------
T ss_pred ceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCcccccccc------
Confidence 99999999977 22 455444 56667 888888888777776653 2233333333222210
Q ss_pred ccccccccccccc--ccccCCCCCCccccccccceEEecCCcccCC-----------------cCCccC--CCCcccEEe
Q 037275 143 GYNWLKLENLTIA--DNHLTGHFPASIGNLSTLERINVLGNGLWGR-----------------IPNNLG--NLRNLILLN 201 (992)
Q Consensus 143 ~~~l~~L~~L~L~--~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~-----------------~~~~l~--~l~~L~~L~ 201 (992)
.....++.+.+. +|++++ +|+.++++++|++|+|++|.+.+. +|..++ ++++|++|+
T Consensus 178 -~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~ 255 (636)
T 4eco_A 178 -SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVE 255 (636)
T ss_dssp -CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEE
T ss_pred -ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEE
Confidence 011233333333 467776 777777777777777777777664 777777 777777777
Q ss_pred ccCcccccccCccccccCCCcEEeccCCc-cCC-CCCccccc-----cccccchhhccccccCCCCch--hhhccccCce
Q 037275 202 LGENRFSGIVPPSIFNISSLENVFLPTNR-FNG-SLPLDIGV-----SLPKLLGFIVAENNFAGSIPE--SLSNASNLVE 272 (992)
Q Consensus 202 L~~n~l~~~~p~~l~~l~~L~~L~l~~N~-l~~-~~~~~~~~-----~~~~L~~l~l~~n~l~~~~p~--~l~~l~~L~~ 272 (992)
|++|++.+.+|..++++++|++|++++|+ ++| .+|..++. .+++|+.|++++|+++ .+|. .++++++|++
T Consensus 256 L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~ 334 (636)
T 4eco_A 256 VYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGM 334 (636)
T ss_dssp EECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCE
T ss_pred ecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCE
Confidence 77777777777777777777777777776 665 55554432 1255555555555555 5555 6666666666
Q ss_pred eeeccccccccccccccccCccceEecCCCCCCCCCCCCchhhhhccCCCc-ceEeecCCCcCCCcCCccccccccccee
Q 037275 273 LTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTE-LTAIGLDDNRFGGVLPHSIANLSSTMTD 351 (992)
Q Consensus 273 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~~-L~~L~l~~n~l~~~~~~~~~~l~~~L~~ 351 (992)
|++++|++++.+| .|..+++|++|+|++|+++.++. .+..+++ |+.|++++|++. .+|..+....
T Consensus 335 L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~~lp~-------~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~----- 400 (636)
T 4eco_A 335 LECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPA-------NFCGFTEQVENLSFAHNKLK-YIPNIFDAKS----- 400 (636)
T ss_dssp EECCSCCCEEECC-CCEEEEEESEEECCSSEEEECCT-------TSEEECTTCCEEECCSSCCS-SCCSCCCTTC-----
T ss_pred EeCcCCcCccchh-hhCCCCCCCEEECCCCccccccH-------hhhhhcccCcEEEccCCcCc-ccchhhhhcc-----
Confidence 6666666665555 66666666666666666654332 2344444 555555555554 3343333221
Q ss_pred EEeeCCccccccCCCccCCCcccEEEccCCcCCCCCCcccc-------CCCCCcEEeccCccccccCCCCCCCccccCce
Q 037275 352 IVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIG-------ELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNL 424 (992)
Q Consensus 352 L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 424 (992)
+++|++|++++|++++..|..|. .+++|+.|+|++|++++..+..+..+++|+.|
T Consensus 401 ------------------l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L 462 (636)
T 4eco_A 401 ------------------VSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSI 462 (636)
T ss_dssp ------------------SSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEE
T ss_pred ------------------cCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEE
Confidence 12455555555555544444444 44455555555555552222223334555555
Q ss_pred eccCCcccCCCCCC-cccc-------ccccccccccccccccCchhhhhhcccccccccccccccCccccccc--CCCCc
Q 037275 425 ALSSNDLQGSIPPS-LGNC-------KNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVG--NLKNL 494 (992)
Q Consensus 425 ~L~~N~l~~~~~~~-~~~l-------~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~--~l~~L 494 (992)
+|++|+|+ .+|.. +... ++|+.| +|++|+++ .+|..+. .+++|
T Consensus 463 ~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L-------------------------~Ls~N~l~-~lp~~~~~~~l~~L 515 (636)
T 4eco_A 463 NLMGNMLT-EIPKNSLKDENENFKNTYLLTSI-------------------------DLRFNKLT-KLSDDFRATTLPYL 515 (636)
T ss_dssp ECCSSCCS-BCCSSSSEETTEECTTGGGCCEE-------------------------ECCSSCCC-BCCGGGSTTTCTTC
T ss_pred ECCCCCCC-CcCHHHhccccccccccCCccEE-------------------------ECcCCcCC-ccChhhhhccCCCc
Confidence 55555555 23322 2211 144444 33333333 3444444 56666
Q ss_pred cEEeeecccccccCCcccccccccceeec------cCCcccccCCccccccCCCCEEECCCcccCCCChhhhhcCCCcce
Q 037275 495 VYFNISVNRFSGEIPVTLSACTSLQQLYL------QGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEY 568 (992)
Q Consensus 495 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L------~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 568 (992)
++|+|++|++++ +|..+..+++|+.|+| ++|++.+.+|..+..+++|++|+|++|+| +.+|..+. ++|+.
T Consensus 516 ~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~ 591 (636)
T 4eco_A 516 VGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISV 591 (636)
T ss_dssp CEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCE
T ss_pred CEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCCE
Confidence 666666666664 5666666666666666 67888888999999999999999999999 47777665 78999
Q ss_pred EecCCCcCcccCCCCC---ccCCcccccccCCCCcCCCC
Q 037275 569 LNLSYNHFEGEVPTKG---VFSNKTGISLSGNGKVCGGL 604 (992)
Q Consensus 569 L~l~~N~l~~~~~~~~---~~~~~~~~~l~~N~~~C~~~ 604 (992)
|++++|++.+...... .......+.+..+...|+|+
T Consensus 592 L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~C~ 630 (636)
T 4eco_A 592 LDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQDIRGCD 630 (636)
T ss_dssp EECCSCTTCEEECTTTHHHHHTTCCEEECCTTSEEESCG
T ss_pred EECcCCCCccccHHhcchhhhcccceeecCCccccCCCc
Confidence 9999998886443221 11222333444444555554
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-56 Score=547.62 Aligned_cols=536 Identities=18% Similarity=0.170 Sum_probs=460.2
Q ss_pred EEeeccccccCCccCCCCCCCCcCCeeeccCCCCCccCCccccCCCCCCEEEeecccCCCCCCcccccCCCCcEeecccc
Q 037275 53 TKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRN 132 (992)
Q Consensus 53 ~~ldl~~~~l~~~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n 132 (992)
+.+|.+++++ ..+|..+. +++++|+|++|++++..|..|..+++|++|+|++|++++..|..++++++|++|++++|
T Consensus 7 ~~~~cs~~~L-~~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n 83 (680)
T 1ziw_A 7 EVADCSHLKL-TQVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83 (680)
T ss_dssp SEEECCSSCC-SSCCSCSC--TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSS
T ss_pred CeeECCCCCc-cccccccC--CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCC
Confidence 4689999998 56887765 79999999999999766778999999999999999999888999999999999999999
Q ss_pred cccccCChhhcccccccccccccccccCCCCCCccccccccceEEecCCcccCCcCCccCCCCcccEEeccCcccccccC
Q 037275 133 NLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVP 212 (992)
Q Consensus 133 ~l~~~~p~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p 212 (992)
+++ .+|...+.++++|++|+|++|.+++..|..|+++++|++|++++|.+.+..|..++++++|++|++++|++++..+
T Consensus 84 ~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 162 (680)
T 1ziw_A 84 ELS-QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKS 162 (680)
T ss_dssp CCC-CCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCH
T ss_pred ccC-ccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCH
Confidence 998 7888766689999999999999998777899999999999999999998889999999999999999999997666
Q ss_pred cccc--ccCCCcEEeccCCccCCCCCccccc--------------------------cccccchhhccccccCCCCchhh
Q 037275 213 PSIF--NISSLENVFLPTNRFNGSLPLDIGV--------------------------SLPKLLGFIVAENNFAGSIPESL 264 (992)
Q Consensus 213 ~~l~--~l~~L~~L~l~~N~l~~~~~~~~~~--------------------------~~~~L~~l~l~~n~l~~~~p~~l 264 (992)
..+. .+++|++|++++|++++..|..+.. ..++|+.|++++|.+.+..|..|
T Consensus 163 ~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~ 242 (680)
T 1ziw_A 163 EELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTF 242 (680)
T ss_dssp HHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTT
T ss_pred HHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHh
Confidence 6554 5689999999999998655543221 12567888889999998888889
Q ss_pred hcccc--CceeeeccccccccccccccccCccceEecCCCCCCCCCCCCchhhhhccCCCcceEeecCCCcCCCc-----
Q 037275 265 SNASN--LVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGV----- 337 (992)
Q Consensus 265 ~~l~~--L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~l~~~----- 337 (992)
..++. |++|++++|++++..+..|..+++|++|+|++|+++.+... .+..+++|+.|++++|...+.
T Consensus 243 ~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~------~~~~l~~L~~L~L~~~~~~~~~~~~~ 316 (680)
T 1ziw_A 243 LGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSH------SLHGLFNVRYLNLKRSFTKQSISLAS 316 (680)
T ss_dssp GGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTT------TTTTCTTCCEEECTTCBCCC------
T ss_pred hccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChh------hhcCCCCccEEeccchhhhccccccc
Confidence 88865 99999999999988889999999999999999999876543 467788999999998876642
Q ss_pred CCc----ccccccccceeEEeeCCccccccCCCccCCCcccEEEccCCcCCCC--CCccccCC--CCCcEEeccCccccc
Q 037275 338 LPH----SIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGT--IPHAIGEL--KNLQLLYLDSNFLAG 409 (992)
Q Consensus 338 ~~~----~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~--~~~~~~~l--~~L~~L~L~~N~l~~ 409 (992)
+|. .+..+ .+|++|++++|+++++.+..|.++++|++|++++|.+... .+..|..+ ++|+.|++++|++++
T Consensus 317 lp~i~~~~~~~l-~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~ 395 (680)
T 1ziw_A 317 LPKIDDFSFQWL-KCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISK 395 (680)
T ss_dssp CCEECTTTTTTC-TTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCE
T ss_pred ccccChhhcccC-CCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCe
Confidence 222 34444 4699999999999999999999999999999999986532 23334433 589999999999999
Q ss_pred cCCCCCCCccccCceeccCCcccCCCC-CCccccccccccccccccccccCchhhhhhccccccccccccccc--Ccccc
Q 037275 410 GIPTSLGNLTLLTNLALSSNDLQGSIP-PSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLS--GTLPL 486 (992)
Q Consensus 410 ~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~--~~~~~ 486 (992)
..|..|..+++|+.|++++|++++.+| ..|.++++|++|++++|++++. ++..+...+.++.|++++|.++ +..|.
T Consensus 396 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~~~~~~~~~~L~~L~l~~n~l~~~~~~p~ 474 (680)
T 1ziw_A 396 IESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQL-TRNSFALVPSLQRLMLRRVALKNVDSSPS 474 (680)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEEC-CTTTTTTCTTCCEEECTTSCCBCTTCSSC
T ss_pred EChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCccee-ChhhhhcCcccccchhccccccccccCCc
Confidence 999999999999999999999987665 6899999999999999999854 4445555677889999999997 57889
Q ss_pred cccCCCCccEEeeecccccccCCcccccccccceeeccCCcccccCC--------ccccccCCCCEEECCCcccCCCChh
Q 037275 487 EVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIP--------SSLSSLKSIKELDMSSNNLSGQIPE 558 (992)
Q Consensus 487 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--------~~~~~l~~L~~L~Ls~N~l~~~~p~ 558 (992)
.|..+++|++|+|++|++++..+..|.++++|++|+|++|++++..+ ..|.++++|++|+|++|+|+...+.
T Consensus 475 ~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~ 554 (680)
T 1ziw_A 475 PFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVE 554 (680)
T ss_dssp TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTT
T ss_pred ccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHH
Confidence 99999999999999999998888889999999999999999986532 2378999999999999999966556
Q ss_pred hhhcCCCcceEecCCCcCcccCCCC-CccCCcccccccCCCCc
Q 037275 559 YLENLSFLEYLNLSYNHFEGEVPTK-GVFSNKTGISLSGNGKV 600 (992)
Q Consensus 559 ~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~~~~~~l~~N~~~ 600 (992)
.|..+++|+.|++++|++++.++.. ..++.++.+++.+|...
T Consensus 555 ~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~ 597 (680)
T 1ziw_A 555 VFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLIT 597 (680)
T ss_dssp TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCC
T ss_pred HcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCC
Confidence 7999999999999999999877653 45688999999999653
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-56 Score=536.78 Aligned_cols=495 Identities=19% Similarity=0.140 Sum_probs=255.8
Q ss_pred cCCeeeccCCCCCccCCccccCCCCCCEEEeecccCCCCCCcccccCCCCcEeecccccccccCChhhcccccccccccc
Q 037275 75 FLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTI 154 (992)
Q Consensus 75 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~~L~L 154 (992)
++++|||++|++++..|..|+.+++|++|+|++|++++..|..|+++++|++|++++|++++..|..+. ++++|++|++
T Consensus 34 ~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~-~l~~L~~L~L 112 (606)
T 3t6q_A 34 STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALS-GPKALKHLFF 112 (606)
T ss_dssp TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTS-SCTTCCEEEC
T ss_pred cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhc-ccccccEeec
Confidence 445555555555544455555555555555555555544455555555555555555555533333332 4555555555
Q ss_pred cccccCCCCCCccccccccceEEecCCcccCCcCCccCCCCcccEEeccCcccccccCccccccCCCc--EEeccCCccC
Q 037275 155 ADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLE--NVFLPTNRFN 232 (992)
Q Consensus 155 ~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~--~L~l~~N~l~ 232 (992)
++|.+++..|..++++++|++|++++|.+.+..+..+..+++|++|++++|++++..|..+..+++|+ .|++++|++.
T Consensus 113 ~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~ 192 (606)
T 3t6q_A 113 IQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA 192 (606)
T ss_dssp TTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCC
T ss_pred cccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccC
Confidence 55555544445555555555555555555443323333355555555555555544444555555555 5555555555
Q ss_pred CCCCccccccccccchhhccccc--------------------------cCCCCchhhhccc--cCceeeeccccccccc
Q 037275 233 GSLPLDIGVSLPKLLGFIVAENN--------------------------FAGSIPESLSNAS--NLVELTLFDNQFRGKV 284 (992)
Q Consensus 233 ~~~~~~~~~~~~~L~~l~l~~n~--------------------------l~~~~p~~l~~l~--~L~~L~L~~N~l~~~~ 284 (992)
+..|.. + ....|+.+++++|. .....+..+..+. +|++|++++|.+++..
T Consensus 193 ~~~~~~-~-~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~ 270 (606)
T 3t6q_A 193 GIEPGA-F-DSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNIS 270 (606)
T ss_dssp EECTTT-T-TTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCC
T ss_pred ccChhH-h-hhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccC
Confidence 333222 1 12344444444443 1111122233322 5666666666666666
Q ss_pred cccccccCccceEecCCCCCCCCCCCCchhhhhccCCCcceEeecCCCcCCCcCCcccccccccceeEEeeCCccccccC
Q 037275 285 SIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIP 364 (992)
Q Consensus 285 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~ 364 (992)
+..|..+++|++|++++|+++.++. .+..+++|+.|++++|++.+..|..+..++ +|++|++++|.+.+.+|
T Consensus 271 ~~~~~~l~~L~~L~l~~n~l~~lp~-------~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~n~~~~~~~ 342 (606)
T 3t6q_A 271 SNTFHCFSGLQELDLTATHLSELPS-------GLVGLSTLKKLVLSANKFENLCQISASNFP-SLTHLSIKGNTKRLELG 342 (606)
T ss_dssp TTTTTTCTTCSEEECTTSCCSCCCS-------SCCSCTTCCEEECTTCCCSBGGGGCGGGCT-TCSEEECCSCSSCCBCC
T ss_pred HHHhccccCCCEEeccCCccCCCCh-------hhcccccCCEEECccCCcCcCchhhhhccC-cCCEEECCCCCcccccc
Confidence 6566666666666666666655433 245555666666666666655555555543 36666666665554333
Q ss_pred C-CccCCCcccEEEccCCcCCCCC--CccccCCCCCcEEeccCccccccCCCCCCCccccCceeccCCcccCCCCCC-cc
Q 037275 365 T-GIRNLVNLVELCMDDNKLTGTI--PHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPS-LG 440 (992)
Q Consensus 365 ~-~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-~~ 440 (992)
. .+..+++|++|++++|.+++.. +..+..+++|++|++++|++++..|..|..+++|+.|++++|++++..+.. +.
T Consensus 343 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 422 (606)
T 3t6q_A 343 TGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQ 422 (606)
T ss_dssp SSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTT
T ss_pred hhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhh
Confidence 3 3555666666666666655433 445555666666666666665555555666666666666666665443332 55
Q ss_pred ccccccccccccccccccCchhhhhhcccccccccccccccCc---ccccccCCCCccEEeeecccccccCCcccccccc
Q 037275 441 NCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGT---LPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTS 517 (992)
Q Consensus 441 ~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~---~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 517 (992)
.+++|++|++++|.+++..|..+ ...+.++.|++++|.+++. .+..+..+++|++|+|++|++++..|..|.++++
T Consensus 423 ~l~~L~~L~l~~n~l~~~~~~~~-~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~ 501 (606)
T 3t6q_A 423 NLHLLKVLNLSHSLLDISSEQLF-DGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKM 501 (606)
T ss_dssp TCTTCCEEECTTCCCBTTCTTTT-TTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred CcccCCEEECCCCccCCcCHHHH-hCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccC
Confidence 55666666555555553333222 2233344455555555431 1133445555555555555555444455555555
Q ss_pred cceeeccCCcccccCCccccccCCCCEEECCCcccCCCChhhhhcCCCcceEecCCCcCcccCCC
Q 037275 518 LQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPT 582 (992)
Q Consensus 518 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~ 582 (992)
|++|+|++|++++..|..+.++++| +|+|++|++++.+|..+..+++|+.|++++|+|.|.|+.
T Consensus 502 L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 565 (606)
T 3t6q_A 502 MNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSN 565 (606)
T ss_dssp CCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGGG
T ss_pred CCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCCc
Confidence 5555555555555455555555555 555555555544444455555555555555555554443
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-56 Score=557.01 Aligned_cols=546 Identities=20% Similarity=0.196 Sum_probs=444.7
Q ss_pred CceEeeEEcCCCCeEEEeeccccccCCccCCCCCCCCcCCeeeccCCCCCccC-CccccCCCCCCEEEeecccCCCCCCc
Q 037275 38 CQWTGVTCGHRHQRVTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEI-PHQIGRLVRLEALVLANNSFSGKIPT 116 (992)
Q Consensus 38 c~w~gv~c~~~~~~v~~ldl~~~~l~~~l~~~l~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~Ls~n~l~~~~p~ 116 (992)
|.|..|.+ ...+++.|||++|.+.+..+..++.+++|++|||++|.+.+.+ |..|+++++|++|+|++|++++..|.
T Consensus 14 ~~L~~vP~--lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~ 91 (844)
T 3j0a_A 14 CNLTQVPQ--VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPD 91 (844)
T ss_dssp CCSSCCCS--SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTT
T ss_pred CCCCCCCC--CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHh
Confidence 56777776 5567999999999998888899999999999999999776677 77899999999999999999988899
Q ss_pred ccccCCCCcEeecccccccccCChh-hcccccccccccccccccCCCCC-CccccccccceEEecCCcccCCcCCccCCC
Q 037275 117 NLSRCSNLISFNARRNNLVGEIPAE-LGYNWLKLENLTIADNHLTGHFP-ASIGNLSTLERINVLGNGLWGRIPNNLGNL 194 (992)
Q Consensus 117 ~l~~l~~L~~L~l~~n~l~~~~p~~-~~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l 194 (992)
.|+++++|++|+|++|++++.+|.. .+.++++|++|+|++|.+++..| ..|+++++|++|++++|.+.+..+..+..+
T Consensus 92 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l 171 (844)
T 3j0a_A 92 AFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPL 171 (844)
T ss_dssp SSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHH
T ss_pred HccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccc
Confidence 9999999999999999999777664 45588999999999999987655 578999999999999999988888888888
Q ss_pred --CcccEEeccCcccccccCccccccCC------CcEEeccCCccCCCCCccccccc--cccchhhcc---------ccc
Q 037275 195 --RNLILLNLGENRFSGIVPPSIFNISS------LENVFLPTNRFNGSLPLDIGVSL--PKLLGFIVA---------ENN 255 (992)
Q Consensus 195 --~~L~~L~L~~n~l~~~~p~~l~~l~~------L~~L~l~~N~l~~~~~~~~~~~~--~~L~~l~l~---------~n~ 255 (992)
++|+.|+|++|.+.+..|..+..+.+ |++|++++|.+++.++..+...+ .++..+.+. .++
T Consensus 172 ~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~ 251 (844)
T 3j0a_A 172 QGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHN 251 (844)
T ss_dssp HHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSS
T ss_pred cCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccc
Confidence 89999999999999888887777665 99999999999887776655432 344555544 344
Q ss_pred cCCCCchhhhcc--ccCceeeeccccccccccccccccCccceEecCCCCCCCCCCCCchhhhhccCCCcceEeecCCCc
Q 037275 256 FAGSIPESLSNA--SNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNR 333 (992)
Q Consensus 256 l~~~~p~~l~~l--~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~ 333 (992)
+....+..|..+ ++|++|++++|.+.+..+..|..+++|+.|+|++|+++.+... .+..+++|+.|++++|+
T Consensus 252 l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~------~~~~l~~L~~L~Ls~N~ 325 (844)
T 3j0a_A 252 IKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADE------AFYGLDNLQVLNLSYNL 325 (844)
T ss_dssp STTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTT------TTTTCSSCCEEEEESCC
T ss_pred cCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChH------HhcCCCCCCEEECCCCC
Confidence 444445555554 6899999999999988889999999999999999999876553 46678899999999999
Q ss_pred CCCcCCcccccccccceeEEeeCCccccccCCCccCCCcccEEEccCCcCCCCCCccccCCCCCcEEeccCccccccCCC
Q 037275 334 FGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPT 413 (992)
Q Consensus 334 l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 413 (992)
+.+..|..+..++ +|+.|++++|+++++.+..|..+++|++|+|++|.+++. + .+++|+.|++++|+++ .+|.
T Consensus 326 l~~~~~~~~~~l~-~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i-~----~~~~L~~L~l~~N~l~-~l~~ 398 (844)
T 3j0a_A 326 LGELYSSNFYGLP-KVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI-H----FIPSIPDIFLSGNKLV-TLPK 398 (844)
T ss_dssp CSCCCSCSCSSCT-TCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC-S----SCCSCSEEEEESCCCC-CCCC
T ss_pred CCccCHHHhcCCC-CCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc-c----CCCCcchhccCCCCcc-cccc
Confidence 9988888888776 599999999999988888899999999999999999843 2 3788999999999998 4554
Q ss_pred CCCCccccCceeccCCcccCCCC-CCccccccccccccccccccccCchhhhhhccccccccccccccc-----Cccccc
Q 037275 414 SLGNLTLLTNLALSSNDLQGSIP-PSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLS-----GTLPLE 487 (992)
Q Consensus 414 ~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~-----~~~~~~ 487 (992)
. ..+++.|++++|++++... ..+..+++|+.|++++|++++..+...+.....++.|++++|.++ +..+..
T Consensus 399 ~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~ 475 (844)
T 3j0a_A 399 I---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDV 475 (844)
T ss_dssp C---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSC
T ss_pred c---ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhh
Confidence 3 4578899999999985322 224578899999999999987666555656677888999999987 344566
Q ss_pred ccCCCCccEEeeecccccccCCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcccCCCChhhhhcCCCcc
Q 037275 488 VGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLE 567 (992)
Q Consensus 488 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 567 (992)
|.++++|++|+|++|++++.+|..|.++++|+.|+|++|+|++..+..+. ++|+.|+|++|+|++..|..| .+|+
T Consensus 476 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~---~~L~ 550 (844)
T 3j0a_A 476 FEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVF---VSLS 550 (844)
T ss_dssp SSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCC---SSCC
T ss_pred hcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHh---CCcC
Confidence 88899999999999999988888899999999999999999977777666 899999999999998888765 4788
Q ss_pred eEecCCCcCcccCCCCCccCCcc--cccccCCC--CcCCCCCC
Q 037275 568 YLNLSYNHFEGEVPTKGVFSNKT--GISLSGNG--KVCGGLDE 606 (992)
Q Consensus 568 ~L~l~~N~l~~~~~~~~~~~~~~--~~~l~~N~--~~C~~~~~ 606 (992)
.|++++|++.|.|+..+...++. ...+.|.+ ..|..|..
T Consensus 551 ~l~l~~Np~~C~c~~~~f~~~~~~~~~~~~~~~~~~~C~~p~~ 593 (844)
T 3j0a_A 551 VLDITHNKFICECELSTFINWLNHTNVTIAGPPADIYCVYPDS 593 (844)
T ss_dssp EEEEEEECCCCSSSCCSHHHHHHHTTTTTCCCGGGCCCSSCSS
T ss_pred EEEecCCCcccccccHHHHHHHHhcCcccccccccCccCCchh
Confidence 99999999999988655444332 22233332 46766654
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-56 Score=533.85 Aligned_cols=506 Identities=20% Similarity=0.165 Sum_probs=442.5
Q ss_pred EeeEEcCC---------CCeEEEeeccccccCCccCCCCCCCCcCCeeeccCCCCCccCCccccCCCCCCEEEeecccCC
Q 037275 41 TGVTCGHR---------HQRVTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFS 111 (992)
Q Consensus 41 ~gv~c~~~---------~~~v~~ldl~~~~l~~~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~ 111 (992)
..|.|... ...++.|||++|.+.+..|..++.+++|++|+|++|++.+..|..|+.+++|++|+|++|+++
T Consensus 15 ~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~ 94 (606)
T 3t6q_A 15 KTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLI 94 (606)
T ss_dssp TEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCS
T ss_pred ceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCccc
Confidence 35778643 246899999999998878889999999999999999999888999999999999999999999
Q ss_pred CCCCcccccCCCCcEeecccccccccCChhhcccccccccccccccccCCCCCCccccccccceEEecCCcccCCcCCcc
Q 037275 112 GKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNL 191 (992)
Q Consensus 112 ~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l 191 (992)
+..|..|+.+++|++|++++|++++ ++...+.++++|++|++++|.+++..+..+..+++|++|++++|.+.+..|..|
T Consensus 95 ~~~~~~~~~l~~L~~L~L~~n~i~~-l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 173 (606)
T 3t6q_A 95 FMAETALSGPKALKHLFFIQTGISS-IDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDM 173 (606)
T ss_dssp EECTTTTSSCTTCCEEECTTSCCSC-GGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHH
T ss_pred ccChhhhcccccccEeeccccCccc-CCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhh
Confidence 8889999999999999999999994 433334589999999999999997554555569999999999999988888889
Q ss_pred CCCCccc--EEeccCcccccccCccccccCCCcEEeccCCccC-------------------------CCCCcccccccc
Q 037275 192 GNLRNLI--LLNLGENRFSGIVPPSIFNISSLENVFLPTNRFN-------------------------GSLPLDIGVSLP 244 (992)
Q Consensus 192 ~~l~~L~--~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~-------------------------~~~~~~~~~~~~ 244 (992)
+.+++|+ .|++++|++++..|..+ ...+|++|++++|... ..++...+..+.
T Consensus 174 ~~l~~L~~l~L~l~~n~l~~~~~~~~-~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~ 252 (606)
T 3t6q_A 174 SSLQQATNLSLNLNGNDIAGIEPGAF-DSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLC 252 (606)
T ss_dssp HTTTTCCSEEEECTTCCCCEECTTTT-TTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGG
T ss_pred hhhcccceeEEecCCCccCccChhHh-hhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhh
Confidence 9999999 99999999997666554 4568999999887510 122233333333
Q ss_pred --ccchhhccccccCCCCchhhhccccCceeeeccccccccccccccccCccceEecCCCCCCCCCCCCchhhhhccCCC
Q 037275 245 --KLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCT 322 (992)
Q Consensus 245 --~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~ 322 (992)
+++.+++++|++.+..+..|+.+++|++|++++|+++ ..|..+..+++|++|++++|+++.+.+ ..+..++
T Consensus 253 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~------~~~~~l~ 325 (606)
T 3t6q_A 253 EMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQ------ISASNFP 325 (606)
T ss_dssp GSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGG------GCGGGCT
T ss_pred cCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCch------hhhhccC
Confidence 7899999999999998888999999999999999999 566778999999999999999987543 3467889
Q ss_pred cceEeecCCCcCCCcCCcc-cccccccceeEEeeCCcccccc--CCCccCCCcccEEEccCCcCCCCCCccccCCCCCcE
Q 037275 323 ELTAIGLDDNRFGGVLPHS-IANLSSTMTDIVIAGNQISGII--PTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQL 399 (992)
Q Consensus 323 ~L~~L~l~~n~l~~~~~~~-~~~l~~~L~~L~l~~n~i~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 399 (992)
+|+.|++++|.+.+.+|.. +..+ .+|++|++++|++++.. +..+..+++|++|++++|++.+..|..|..+++|+.
T Consensus 326 ~L~~L~l~~n~~~~~~~~~~~~~l-~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 404 (606)
T 3t6q_A 326 SLTHLSIKGNTKRLELGTGCLENL-ENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLEL 404 (606)
T ss_dssp TCSEEECCSCSSCCBCCSSTTTTC-TTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSE
T ss_pred cCCEEECCCCCcccccchhhhhcc-CcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCe
Confidence 9999999999999877766 5544 56999999999999877 888999999999999999999888999999999999
Q ss_pred EeccCccccccCCC-CCCCccccCceeccCCcccCCCCCCccccccccccccccccccccC-c-hhhhhhcccccccccc
Q 037275 400 LYLDSNFLAGGIPT-SLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGAL-P-PQILSISTLSLSLDLS 476 (992)
Q Consensus 400 L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~-p-~~~~~~~~~~~~L~l~ 476 (992)
|++++|++++..+. .+..+++|++|++++|.+++..|..+..+++|++|++++|++++.. + ...+.....++.|+++
T Consensus 405 L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls 484 (606)
T 3t6q_A 405 LDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLS 484 (606)
T ss_dssp EECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECT
T ss_pred EECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECC
Confidence 99999999977665 4899999999999999999988999999999999999999998632 2 2445666778899999
Q ss_pred cccccCcccccccCCCCccEEeeecccccccCCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcccCCCC
Q 037275 477 YNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQI 556 (992)
Q Consensus 477 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 556 (992)
+|++++..|..|..+++|++|+|++|++++..|..|..++.| .|+|++|++++..|..+..+++|+.|+|++|+++...
T Consensus 485 ~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 563 (606)
T 3t6q_A 485 FCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTC 563 (606)
T ss_dssp TSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSG
T ss_pred CCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccC
Confidence 999998889999999999999999999999999999999999 9999999999988999999999999999999998644
Q ss_pred h
Q 037275 557 P 557 (992)
Q Consensus 557 p 557 (992)
+
T Consensus 564 ~ 564 (606)
T 3t6q_A 564 S 564 (606)
T ss_dssp G
T ss_pred C
Confidence 4
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-55 Score=528.25 Aligned_cols=518 Identities=19% Similarity=0.167 Sum_probs=305.2
Q ss_pred eEEEeeccccccCCccCCCCCCCCcCCeeeccCCCCCccCCccccCCCCCCEEEeecccCCCCCCcccccCCCCcEeecc
Q 037275 51 RVTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNAR 130 (992)
Q Consensus 51 ~v~~ldl~~~~l~~~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~ 130 (992)
+++.|||++|.+.+..+..++.+++|++|+|++|++++..|..|+.+++|++|+|++|++++..|..|+++++|++|+++
T Consensus 33 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~ 112 (606)
T 3vq2_A 33 STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAV 112 (606)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECT
T ss_pred CcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEcc
Confidence 34555555555544444455555555555555555554444445555555555555555554445555555555555555
Q ss_pred cccccccCChhhcccccccccccccccccCC-CCCCccccccccceEEecCCcccCCcCCccCCCCccc----EEeccCc
Q 037275 131 RNNLVGEIPAELGYNWLKLENLTIADNHLTG-HFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLI----LLNLGEN 205 (992)
Q Consensus 131 ~n~l~~~~p~~~~~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~----~L~L~~n 205 (992)
+|+++ .+|...+.++++|++|++++|.+++ .+|..|+++++|++|++++|.+.+..|..|+.+++|+ +|++++|
T Consensus 113 ~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n 191 (606)
T 3vq2_A 113 ETKLA-SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLN 191 (606)
T ss_dssp TSCCC-CSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTC
T ss_pred CCccc-cccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCC
Confidence 55554 2222222345555555555555543 3455555555555555555555444444444444433 4555555
Q ss_pred ccccccCccccccCCCcEEeccCCccCCCCCccccccccccchhhccccccCC------CCchhhhccc--cCceeee-c
Q 037275 206 RFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAG------SIPESLSNAS--NLVELTL-F 276 (992)
Q Consensus 206 ~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~------~~p~~l~~l~--~L~~L~L-~ 276 (992)
.+++..+..+ ...+|++|++++|.+.+.........++.++.+.+..+.+.+ ..+..+..+. .++.+++ .
T Consensus 192 ~l~~~~~~~~-~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~ 270 (606)
T 3vq2_A 192 PIDFIQDQAF-QGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTY 270 (606)
T ss_dssp CCCEECTTTT-TTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECC
T ss_pred CcceeCcccc-cCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccc
Confidence 5553222222 222455555555544432222222333333333332222211 1111111111 2334444 5
Q ss_pred cccccccccccccccCccceEecCCCCCCCCCCCCchhhhhccCCCcceEeecCCCcCCCcCCcccccccccceeEEeeC
Q 037275 277 DNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAG 356 (992)
Q Consensus 277 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~ 356 (992)
.|.+.+..+. +..+++|+.|++++|.++.++ .+..+++|+.|++++|.+ +.+| .+ .+ +.|++|++++
T Consensus 271 ~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~l~--------~l~~~~~L~~L~l~~n~l-~~lp-~~-~l-~~L~~L~l~~ 337 (606)
T 3vq2_A 271 TNDFSDDIVK-FHCLANVSAMSLAGVSIKYLE--------DVPKHFKWQSLSIIRCQL-KQFP-TL-DL-PFLKSLTLTM 337 (606)
T ss_dssp CTTCCGGGGS-CGGGTTCSEEEEESCCCCCCC--------CCCTTCCCSEEEEESCCC-SSCC-CC-CC-SSCCEEEEES
T ss_pred cccccccccc-cccCCCCCEEEecCccchhhh--------hccccccCCEEEcccccC-cccc-cC-CC-CccceeeccC
Confidence 6666766666 778888888888888887654 256677888888888888 5666 33 33 4688888888
Q ss_pred CccccccCCCccCCCcccEEEccCCcCCCC--CCccccCCCCCcEEeccCccccccCCCCCCCccccCceeccCCcccCC
Q 037275 357 NQISGIIPTGIRNLVNLVELCMDDNKLTGT--IPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGS 434 (992)
Q Consensus 357 n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 434 (992)
|...+.. .+..+++|++|++++|++++. .|..+..+++|+.|++++|++++ +|..+..+++|+.|++++|++.+.
T Consensus 338 n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~ 414 (606)
T 3vq2_A 338 NKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRV 414 (606)
T ss_dssp CSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEEST
T ss_pred CcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCc
Confidence 8555433 566788888888888888755 37777888888888888888874 557788888888888888888876
Q ss_pred CC-CCccccccccccccccccccccCchhhhhhcccccccccccccccC-cccccccCCCCccEEeeecccccccCCccc
Q 037275 435 IP-PSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSG-TLPLEVGNLKNLVYFNISVNRFSGEIPVTL 512 (992)
Q Consensus 435 ~~-~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 512 (992)
.| ..+..+++|++|++++|++++..|..+. ....++.|++++|.+++ .+|..++.+++|++|+|++|++++..|..|
T Consensus 415 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~-~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~ 493 (606)
T 3vq2_A 415 TEFSAFLSLEKLLYLDISYTNTKIDFDGIFL-GLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVF 493 (606)
T ss_dssp TTTTTTTTCTTCCEEECTTSCCEECCTTTTT-TCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTT
T ss_pred cChhhhhccccCCEEECcCCCCCccchhhhc-CCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhh
Confidence 66 5777888888887777777755544433 33445566777777665 356666667777777777777766666666
Q ss_pred ccccccceeeccCCcccccCCccccccCCCCEEECCCcccCCCChhhhhcCC-CcceEecCCCcCcccCCCCCccCC
Q 037275 513 SACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLS-FLEYLNLSYNHFEGEVPTKGVFSN 588 (992)
Q Consensus 513 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~l~~N~l~~~~~~~~~~~~ 588 (992)
.++++|++|+|++|++++.+|..|.++++|++|+|++|+|+ .+|..+..++ +|++|++++|+|.|.++..+...+
T Consensus 494 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~~~~~~~ 569 (606)
T 3vq2_A 494 DTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEHQKFLQW 569 (606)
T ss_dssp TTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTTHHHHTT
T ss_pred cccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCccHHHHHH
Confidence 66777777777777776666666777777777777777766 4555566665 477777777777766665433333
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-56 Score=539.71 Aligned_cols=490 Identities=19% Similarity=0.249 Sum_probs=325.1
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCCcCCC-----CC--Cce------------EeeEEcCCCCeEEEeeccccccCCc
Q 037275 5 SNETDRLALLAIGSQLEDDPLGVTSSWNNST-----NL--CQW------------TGVTCGHRHQRVTKLDLSNRTIGGT 65 (992)
Q Consensus 5 ~~~~~~~~ll~~~~~~~~~~~~~~~~w~~~~-----~~--c~w------------~gv~c~~~~~~v~~ldl~~~~l~~~ 65 (992)
+..+|++||++||+++. +| +|+.+. +| |.| .||+|+. +++|+.|||+++++.|.
T Consensus 266 ~~~~d~~ALl~~k~~l~-~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~-~~~V~~L~Ls~~~L~G~ 338 (876)
T 4ecn_A 266 EYIKDYKALKAIWEALD-GK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAGFGAKGR 338 (876)
T ss_dssp HHHHHHHHHHHHHHHTT-GG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT-TSCEEEEECTTTCCEEE
T ss_pred cchHHHHHHHHHHHHcC-CC-----CCCcCCCcccccCCccccccccccccccCcCceEecC-CCCEEEEECccCCCCCc
Confidence 34579999999999984 54 786443 55 999 9999986 68999999999999999
Q ss_pred cCCCCCCCCcCCeeec-cCCCCCccCCccccC------------------------------------------------
Q 037275 66 LSPYVGNLSFLRYLNL-ADNNFHGEIPHQIGR------------------------------------------------ 96 (992)
Q Consensus 66 l~~~l~~l~~L~~L~L-~~n~l~~~~p~~~~~------------------------------------------------ 96 (992)
+|+.+++|++|++||| ++|.+.|..|-....
T Consensus 339 ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~ 418 (876)
T 4ecn_A 339 VPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIK 418 (876)
T ss_dssp ECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCC
T ss_pred CchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccc
Confidence 9999999999999999 889888764422111
Q ss_pred ---CCCCCEEEee--cccCCCCCCcccccCCCCcEeecccccccc-cCChhhcccccccccccccccccCCCCCCccc--
Q 037275 97 ---LVRLEALVLA--NNSFSGKIPTNLSRCSNLISFNARRNNLVG-EIPAELGYNWLKLENLTIADNHLTGHFPASIG-- 168 (992)
Q Consensus 97 ---l~~L~~L~Ls--~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~-~~p~~~~~~l~~L~~L~L~~n~l~~~~p~~~~-- 168 (992)
...++.+.++ .|++++ +|..|+++++|+.|+|++|++++ .+|... +..+.|.+++.+|+.++
T Consensus 419 ~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~---------~~~s~n~~~g~iP~~l~f~ 488 (876)
T 4ecn_A 419 KDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDW---------EDANSDYAKQYENEELSWS 488 (876)
T ss_dssp CCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSC---------SCTTSHHHHHHTTSCCCGG
T ss_pred cccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccc---------cccccccccccCChhhhhc
Confidence 1112222222 245554 55555555555555555555554 122111 01111333335888877
Q ss_pred cccccceEEecCCcccCCcCCccCCCCcccEEeccCcc-ccc-ccCccccccC-------CCcEEeccCCccCCCCCc-c
Q 037275 169 NLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENR-FSG-IVPPSIFNIS-------SLENVFLPTNRFNGSLPL-D 238 (992)
Q Consensus 169 ~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~-l~~-~~p~~l~~l~-------~L~~L~l~~N~l~~~~~~-~ 238 (992)
++++|++|+|++|.+.+.+|..|+++++|+.|+|++|+ +++ .+|..++.++ +|++|+|++|+++ .+|. .
T Consensus 489 ~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~ 567 (876)
T 4ecn_A 489 NLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASA 567 (876)
T ss_dssp GCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHH
T ss_pred cCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChh
Confidence 88888888888888888888888888888999998887 887 7787777665 8888888888877 4443 1
Q ss_pred ccccccccchhhccccccCCCCchhhhccccCceeeeccccccccccccccccCccceEecCCCCCCCCCCCCchhhhhc
Q 037275 239 IGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLL 318 (992)
Q Consensus 239 ~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l 318 (992)
.++++++|++|+|++|+++ .+| .|..+++|++|+|++|+++.++. .+
T Consensus 568 ------------------------~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~~lp~-------~l 614 (876)
T 4ecn_A 568 ------------------------SLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIEEIPE-------DF 614 (876)
T ss_dssp ------------------------HHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCSCCCT-------TS
T ss_pred ------------------------hhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccccchH-------HH
Confidence 3444444555555555444 233 44444555555555554443322 13
Q ss_pred cCCCc-ceEeecCCCcCCCcCCccccccc-ccceeEEeeCCccccccCCC---cc--CCCcccEEEccCCcCCCCCCcc-
Q 037275 319 TNCTE-LTAIGLDDNRFGGVLPHSIANLS-STMTDIVIAGNQISGIIPTG---IR--NLVNLVELCMDDNKLTGTIPHA- 390 (992)
Q Consensus 319 ~~~~~-L~~L~l~~n~l~~~~~~~~~~l~-~~L~~L~l~~n~i~~~~~~~---~~--~l~~L~~L~L~~N~l~~~~~~~- 390 (992)
..+++ |+.|++++|++. .+|..+.... .+|+.|++++|++.+.+|.. +. .+++|+.|+|++|+++ .+|..
T Consensus 615 ~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~ 692 (876)
T 4ecn_A 615 CAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTEL 692 (876)
T ss_dssp CEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHH
T ss_pred hhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHH
Confidence 34444 555555555544 3444443332 13555556666555544322 12 2347778888888887 44443
Q ss_pred ccCCCCCcEEeccCccccccCCCCCCC--------ccccCceeccCCcccCCCCCCcc--ccccccccccccccccccCc
Q 037275 391 IGELKNLQLLYLDSNFLAGGIPTSLGN--------LTLLTNLALSSNDLQGSIPPSLG--NCKNLIELHMADIELTGALP 460 (992)
Q Consensus 391 ~~~l~~L~~L~L~~N~l~~~~~~~~~~--------l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~l~~n~l~~~~p 460 (992)
+..+++|+.|+|++|+|+ .+|..+.. +++|+.|+|++|+|+ .+|..+. .+++|+.|++++|
T Consensus 693 ~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N------- 763 (876)
T 4ecn_A 693 FATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYN------- 763 (876)
T ss_dssp HHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSS-------
T ss_pred HccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCC-------
Confidence 447778888888888877 44443332 337888888888888 5677665 7777777744444
Q ss_pred hhhhhhcccccccccccccccCcccccccCCCCccEEeeec------ccccccCCcccccccccceeeccCCcccccCCc
Q 037275 461 PQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISV------NRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPS 534 (992)
Q Consensus 461 ~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~------N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 534 (992)
.+++ +|..+..+++|+.|+|++ |++.+.+|..|..+++|+.|+|++|+| +.+|.
T Consensus 764 ------------------~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~ 823 (876)
T 4ecn_A 764 ------------------CFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDE 823 (876)
T ss_dssp ------------------CCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCS
T ss_pred ------------------CCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCH
Confidence 4443 566666777777777755 777788888888888888888888888 57787
Q ss_pred cccccCCCCEEECCCcccCCCChhhhhcCCCcceEecCCCcCcc
Q 037275 535 SLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEG 578 (992)
Q Consensus 535 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 578 (992)
.+. ++|+.|+|++|++....+..+.....+..+.|.+|++..
T Consensus 824 ~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~~~ 865 (876)
T 4ecn_A 824 KLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQD 865 (876)
T ss_dssp CCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTTSE
T ss_pred hhc--CCCCEEECCCCCCCccChHHccccccchheeecCCCccc
Confidence 765 589999999998887777777776677788888887765
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-54 Score=537.55 Aligned_cols=527 Identities=18% Similarity=0.168 Sum_probs=450.5
Q ss_pred EeeccccccCCccCCCCCCCCcCCeeeccCCCCCccCCccccCCCCCCEEEeecccCCCCC-CcccccCCCCcEeecccc
Q 037275 54 KLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKI-PTNLSRCSNLISFNARRN 132 (992)
Q Consensus 54 ~ldl~~~~l~~~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~-p~~l~~l~~L~~L~l~~n 132 (992)
.+|.+++++ ..+|. ..++|++|||++|.+++..|..|..+++|++|+|++|.+.+.+ |..|+++++|++|+|++|
T Consensus 8 ~~dcs~~~L-~~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N 83 (844)
T 3j0a_A 8 IAFYRFCNL-TQVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSS 83 (844)
T ss_dssp EEEESCCCS-SCCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTC
T ss_pred EEEccCCCC-CCCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCC
Confidence 455566677 45676 5689999999999999888999999999999999999777677 788999999999999999
Q ss_pred cccccCChhhcccccccccccccccccCCCCCCc--cccccccceEEecCCcccCCcC-CccCCCCcccEEeccCccccc
Q 037275 133 NLVGEIPAELGYNWLKLENLTIADNHLTGHFPAS--IGNLSTLERINVLGNGLWGRIP-NNLGNLRNLILLNLGENRFSG 209 (992)
Q Consensus 133 ~l~~~~p~~~~~~l~~L~~L~L~~n~l~~~~p~~--~~~l~~L~~L~l~~n~l~~~~~-~~l~~l~~L~~L~L~~n~l~~ 209 (992)
++.+..|..+. ++++|++|+|++|.+++.+|.. |.++++|++|++++|.+.+..+ ..|+++++|++|+|++|.+++
T Consensus 84 ~l~~~~p~~~~-~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~ 162 (844)
T 3j0a_A 84 KIYFLHPDAFQ-GLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFL 162 (844)
T ss_dssp CCCEECTTSSC-SCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCC
T ss_pred cCcccCHhHcc-CCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCe
Confidence 99966666665 8999999999999999877765 9999999999999999977655 579999999999999999998
Q ss_pred ccCcccccc--CCCcEEeccCCccCCCCCcccccc-----ccccchhhccccccCCCCchhhhcc---ccCceeeec---
Q 037275 210 IVPPSIFNI--SSLENVFLPTNRFNGSLPLDIGVS-----LPKLLGFIVAENNFAGSIPESLSNA---SNLVELTLF--- 276 (992)
Q Consensus 210 ~~p~~l~~l--~~L~~L~l~~N~l~~~~~~~~~~~-----~~~L~~l~l~~n~l~~~~p~~l~~l---~~L~~L~L~--- 276 (992)
..+..+..+ ++|+.|+++.|.+.+..|..+... ...|+.|++++|++.+.+|..+... .++..|.++
T Consensus 163 ~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~ 242 (844)
T 3j0a_A 163 VCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHI 242 (844)
T ss_dssp CCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSC
T ss_pred eCHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceeccccc
Confidence 889999888 899999999999998777654321 1248999999999998888877654 567788776
Q ss_pred ------ccccccccccccccc--CccceEecCCCCCCCCCCCCchhhhhccCCCcceEeecCCCcCCCcCCccccccccc
Q 037275 277 ------DNQFRGKVSIYFRSL--KNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSST 348 (992)
Q Consensus 277 ------~N~l~~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~l~~~ 348 (992)
.|.+.+.....|..+ ++|++|+|++|.+..+... .+..+++|+.|++++|++.+..|..+..+. +
T Consensus 243 ~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~------~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~-~ 315 (844)
T 3j0a_A 243 MGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSR------VFETLKDLKVLNLAYNKINKIADEAFYGLD-N 315 (844)
T ss_dssp CBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSC------CSSSCCCCCEEEEESCCCCEECTTTTTTCS-S
T ss_pred ccccccccccCCCChhhhhccccCCccEEECCCCcccccChh------hhhcCCCCCEEECCCCcCCCCChHHhcCCC-C
Confidence 344444555566665 7899999999999876543 467889999999999999999888888775 6
Q ss_pred ceeEEeeCCccccccCCCccCCCcccEEEccCCcCCCCCCccccCCCCCcEEeccCccccccCCCCCCCccccCceeccC
Q 037275 349 MTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSS 428 (992)
Q Consensus 349 L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 428 (992)
|++|++++|++++..|..|..+++|++|++++|++.+..+..|..+++|+.|+|++|.+++. ..+++|+.|++++
T Consensus 316 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i-----~~~~~L~~L~l~~ 390 (844)
T 3j0a_A 316 LQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI-----HFIPSIPDIFLSG 390 (844)
T ss_dssp CCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC-----SSCCSCSEEEEES
T ss_pred CCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc-----cCCCCcchhccCC
Confidence 99999999999999999999999999999999999988888999999999999999999842 2378899999999
Q ss_pred CcccCCCCCCccccccccccccccccccccCchhhhhhcccccccccccccccCcccc-cccCCCCccEEeeeccccc--
Q 037275 429 NDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPL-EVGNLKNLVYFNISVNRFS-- 505 (992)
Q Consensus 429 N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~-- 505 (992)
|+++ .+|.. ..+++.|++++|++++.-........+.++.|+|++|++++..+. .+..+++|++|+|++|.++
T Consensus 391 N~l~-~l~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~ 466 (844)
T 3j0a_A 391 NKLV-TLPKI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLA 466 (844)
T ss_dssp CCCC-CCCCC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSS
T ss_pred CCcc-ccccc---ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccc
Confidence 9999 45654 467899999999998654444444566788999999999965543 4667899999999999997
Q ss_pred ---ccCCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcccCCCChhhhhcCCCcceEecCCCcCcccCCC
Q 037275 506 ---GEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPT 582 (992)
Q Consensus 506 ---~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~ 582 (992)
+..+..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..+. ++|+.|+|++|++++.+|.
T Consensus 467 ~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~ 544 (844)
T 3j0a_A 467 WETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPD 544 (844)
T ss_dssp CCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSC
T ss_pred cccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChh
Confidence 44556789999999999999999999999999999999999999999987777766 8999999999999998885
Q ss_pred CCccCCcccccccCCCCcCCCCC
Q 037275 583 KGVFSNKTGISLSGNGKVCGGLD 605 (992)
Q Consensus 583 ~~~~~~~~~~~l~~N~~~C~~~~ 605 (992)
.+..+..+++.+|||.|+|+.
T Consensus 545 --~~~~L~~l~l~~Np~~C~c~~ 565 (844)
T 3j0a_A 545 --VFVSLSVLDITHNKFICECEL 565 (844)
T ss_dssp --CCSSCCEEEEEEECCCCSSSC
T ss_pred --HhCCcCEEEecCCCccccccc
Confidence 467899999999999998864
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-55 Score=529.86 Aligned_cols=489 Identities=18% Similarity=0.104 Sum_probs=422.6
Q ss_pred CeEEEeeccccccCCccCCCCCCCCcCCeeeccCCCCCccCCccccCCCCCCEEEeecccCCCCCCcccccCCCCcEeec
Q 037275 50 QRVTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNA 129 (992)
Q Consensus 50 ~~v~~ldl~~~~l~~~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l 129 (992)
.+++.|||++|.+.+..|..++.+++|++|+|++|.+++..|..|+.+++|++|+|++|++++..|..++++++|++|++
T Consensus 56 ~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 135 (606)
T 3vq2_A 56 SELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNV 135 (606)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEEC
T ss_pred ccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeC
Confidence 46899999999998877889999999999999999999877999999999999999999999666688999999999999
Q ss_pred ccccccc-cCChhhcccccccccccccccccCCCCCCccccccccc----eEEecCCcccCCcCCccCCCCcccEEeccC
Q 037275 130 RRNNLVG-EIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLE----RINVLGNGLWGRIPNNLGNLRNLILLNLGE 204 (992)
Q Consensus 130 ~~n~l~~-~~p~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~----~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~ 204 (992)
++|++++ .+|..+. ++++|++|++++|.+++..|..++.+.+|+ +|++++|.+.+..+..+.. .+|+.|++++
T Consensus 136 ~~n~l~~~~lp~~~~-~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~-~~L~~L~L~~ 213 (606)
T 3vq2_A 136 AHNFIHSCKLPAYFS-NLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQG-IKLHELTLRG 213 (606)
T ss_dssp CSSCCCCCCCCGGGG-TCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTT-CEEEEEEEES
T ss_pred CCCcccceechHhHh-hcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCcceeCcccccC-ceeeeeeccC
Confidence 9999986 6788776 899999999999999998899999988876 7999999997655555555 4999999999
Q ss_pred cccc-cccCccccccCCCcEEeccCCccCCC-----CCcccccccc--ccchhhc-cccccCCCCchhhhccccCceeee
Q 037275 205 NRFS-GIVPPSIFNISSLENVFLPTNRFNGS-----LPLDIGVSLP--KLLGFIV-AENNFAGSIPESLSNASNLVELTL 275 (992)
Q Consensus 205 n~l~-~~~p~~l~~l~~L~~L~l~~N~l~~~-----~~~~~~~~~~--~L~~l~l-~~n~l~~~~p~~l~~l~~L~~L~L 275 (992)
|.++ +..|..+.++++|+.+++..+.+.+. ++...+..+. .++.+.+ ..|.+.+.+|. +..+++|+.|++
T Consensus 214 n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l 292 (606)
T 3vq2_A 214 NFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSL 292 (606)
T ss_dssp CCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEE
T ss_pred CccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEe
Confidence 9997 45788899999999999877665532 1112222222 3444555 67788888887 999999999999
Q ss_pred ccccccccccccccccCccceEecCCCCCCCCCCCCchhhhhccCCCcceEeecCCCcCCCcCCcccccccccceeEEee
Q 037275 276 FDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIA 355 (992)
Q Consensus 276 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~ 355 (992)
++|.+.... .+..+++|++|++++|+++.++. + .+++|+.|++++|+..+.. .+..+ ++|++|+++
T Consensus 293 ~~~~~~~l~--~l~~~~~L~~L~l~~n~l~~lp~--------~-~l~~L~~L~l~~n~~~~~~--~~~~l-~~L~~L~ls 358 (606)
T 3vq2_A 293 AGVSIKYLE--DVPKHFKWQSLSIIRCQLKQFPT--------L-DLPFLKSLTLTMNKGSISF--KKVAL-PSLSYLDLS 358 (606)
T ss_dssp ESCCCCCCC--CCCTTCCCSEEEEESCCCSSCCC--------C-CCSSCCEEEEESCSSCEEC--CCCCC-TTCCEEECC
T ss_pred cCccchhhh--hccccccCCEEEcccccCccccc--------C-CCCccceeeccCCcCccch--hhccC-CCCCEEECc
Confidence 999998544 88999999999999999977652 4 7899999999999666544 34444 469999999
Q ss_pred CCcccccc--CCCccCCCcccEEEccCCcCCCCCCccccCCCCCcEEeccCccccccCC-CCCCCccccCceeccCCccc
Q 037275 356 GNQISGII--PTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIP-TSLGNLTLLTNLALSSNDLQ 432 (992)
Q Consensus 356 ~n~i~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~ 432 (992)
+|++++.. |..+..+++|++|++++|.++ .+|..+..+++|+.|++++|++++..| ..+.++++|+.|++++|+++
T Consensus 359 ~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~ 437 (606)
T 3vq2_A 359 RNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTK 437 (606)
T ss_dssp SSCEEEEEECCHHHHCCSCCCEEECCSCSEE-EECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCE
T ss_pred CCccCCCcchhhhhccCCcccEeECCCCccc-cchhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCC
Confidence 99999874 788999999999999999998 466889999999999999999998777 68999999999999999999
Q ss_pred CCCCCCccccccccccccccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeecccccccCCccc
Q 037275 433 GSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTL 512 (992)
Q Consensus 433 ~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 512 (992)
+..|..+..+++|++|++++|++++.+++..+.....++.|++++|.+++..|..|..+++|++|+|++|++++..|..|
T Consensus 438 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 517 (606)
T 3vq2_A 438 IDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHY 517 (606)
T ss_dssp ECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGT
T ss_pred ccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHc
Confidence 98999999999999999999999986545555566777889999999999889999999999999999999999889999
Q ss_pred ccccccceeeccCCcccccCCccccccC-CCCEEECCCcccCCCCh
Q 037275 513 SACTSLQQLYLQGNSFSGSIPSSLSSLK-SIKELDMSSNNLSGQIP 557 (992)
Q Consensus 513 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~p 557 (992)
..+++|+.|+|++|+|+ .+|..+..++ +|++|++++|.+...-+
T Consensus 518 ~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~ 562 (606)
T 3vq2_A 518 NQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICE 562 (606)
T ss_dssp TTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred cCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCc
Confidence 99999999999999999 6777799997 59999999999986444
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=489.97 Aligned_cols=495 Identities=16% Similarity=0.186 Sum_probs=379.3
Q ss_pred CCceEeeEEcCCCCeEEEeeccccccCCccCCCCCCCCcCCeeeccCCCCCccCCccccCCCCCCEEEeecccCCCCCCc
Q 037275 37 LCQWTGVTCGHRHQRVTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPT 116 (992)
Q Consensus 37 ~c~w~gv~c~~~~~~v~~ldl~~~~l~~~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~ 116 (992)
.|.|.|| |+. +++++ ..+|+.+. ++|++|+|++|++++..|..|..+++|++|+|++|++++..|.
T Consensus 3 ~C~~~~~-c~~----------~~~~l-~~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~ 68 (549)
T 2z81_A 3 SCDASGV-CDG----------RSRSF-TSIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGD 68 (549)
T ss_dssp EECTTSE-EEC----------TTSCC-SSCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTT
T ss_pred cCCCCce-EEC----------CCCcc-ccccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChh
Confidence 4999998 843 44555 46777664 7899999999999977788899999999999999999977778
Q ss_pred ccccCCCCcEeecccccccccCChhhcccccccccccccccccCC-CCCCccccccccceEEecCCcccCCcC-CccCCC
Q 037275 117 NLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTG-HFPASIGNLSTLERINVLGNGLWGRIP-NNLGNL 194 (992)
Q Consensus 117 ~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~l~~n~l~~~~~-~~l~~l 194 (992)
.|+.+++|++|++++|+++ .+|...+.++++|++|+|++|.+++ ..|..++++++|++|++++|.+.+.+| ..|.++
T Consensus 69 ~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l 147 (549)
T 2z81_A 69 AFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGL 147 (549)
T ss_dssp TTTTCTTCCEEECTTSCCC-SCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTC
T ss_pred hccccccCCEEECCCCccC-ccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcc
Confidence 8999999999999999998 4555544589999999999999986 357889999999999999998545555 679999
Q ss_pred CcccEEeccCcccccccCccccccCCCcEEeccCCccCCCCCccccccccccchhhccccccCCCC--c-hhhhccccCc
Q 037275 195 RNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSI--P-ESLSNASNLV 271 (992)
Q Consensus 195 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~--p-~~l~~l~~L~ 271 (992)
++|++|++++|++++..|..+..+++|++|+++.|.+. .+|...+..+++|+.|++++|++.+.. | .....+++|+
T Consensus 148 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~ 226 (549)
T 2z81_A 148 TSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMK 226 (549)
T ss_dssp CEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBST-THHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCC
T ss_pred cccCeeeccCCcccccChhhhhccccCceEecccCccc-ccchhhHhhcccccEEEccCCccccccccccchhhhhhccc
Confidence 99999999999999889999999999999999999886 556555556888999999999988742 2 2234578899
Q ss_pred eeeeccccccccccc----cccccCccceEecCCCCCCCCCCCCchhhhhccCCCcceEeecCCCcCCCcCC----cccc
Q 037275 272 ELTLFDNQFRGKVSI----YFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLP----HSIA 343 (992)
Q Consensus 272 ~L~L~~N~l~~~~~~----~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~l~~~~~----~~~~ 343 (992)
+|++++|.+++..+. .+..+.+|+.|++++|.+..+..-.......+..+.+|+.|.+.++.+..... ..+.
T Consensus 227 ~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~ 306 (549)
T 2z81_A 227 KLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVY 306 (549)
T ss_dssp EEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHH
T ss_pred ceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhh
Confidence 999999998865543 34567889999999988766433222223345667778888888877653210 0111
Q ss_pred cccccceeEEeeCCccccccCCCc-cCCCcccEEEccCCcCCCCCC---ccccCCCCCcEEeccCccccccCC--CCCCC
Q 037275 344 NLSSTMTDIVIAGNQISGIIPTGI-RNLVNLVELCMDDNKLTGTIP---HAIGELKNLQLLYLDSNFLAGGIP--TSLGN 417 (992)
Q Consensus 344 ~l~~~L~~L~l~~n~i~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~L~~N~l~~~~~--~~~~~ 417 (992)
....+++.|++++|+++. +|..+ ..+++|++|+|++|++++..| ..++.+++|+.|+|++|++++..+ ..+..
T Consensus 307 ~~~~~L~~L~l~~n~l~~-ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~ 385 (549)
T 2z81_A 307 SLLEKVKRITVENSKVFL-VPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLT 385 (549)
T ss_dssp HHSTTCCEEEEESSCCCC-CCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGG
T ss_pred hhcccceEEEeccCcccc-CCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhc
Confidence 223467778888887763 44443 567788888888888776543 236677778888888888774322 34667
Q ss_pred ccccCceeccCCcccCCCCCCccccccccccccccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEE
Q 037275 418 LTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYF 497 (992)
Q Consensus 418 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L 497 (992)
+++|++|++++|+++ .+|..+..+++|++|++++|+++ .+|..+ .++|++|
T Consensus 386 l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~--------------------------~l~~~~--~~~L~~L 436 (549)
T 2z81_A 386 LKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR--------------------------VVKTCI--PQTLEVL 436 (549)
T ss_dssp CTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS--------------------------CCCTTS--CTTCSEE
T ss_pred CCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcc--------------------------cccchh--cCCceEE
Confidence 777888888888877 56777777777777766666554 222222 2589999
Q ss_pred eeecccccccCCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcccCCCChhhhhcCCCcceEecCCCcCc
Q 037275 498 NISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFE 577 (992)
Q Consensus 498 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 577 (992)
+|++|++++.+ ..+++|++|+|++|+|+ .+|. ...+++|++|+|++|+|++.+|..+..+++|+.|++++|+|.
T Consensus 437 ~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 510 (549)
T 2z81_A 437 DVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510 (549)
T ss_dssp ECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBC
T ss_pred ECCCCChhhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCcc
Confidence 99999998643 57889999999999998 6776 567899999999999999988888999999999999999999
Q ss_pred ccCCCC
Q 037275 578 GEVPTK 583 (992)
Q Consensus 578 ~~~~~~ 583 (992)
|.+|..
T Consensus 511 ~~~~~~ 516 (549)
T 2z81_A 511 CSCPRI 516 (549)
T ss_dssp CCHHHH
T ss_pred CCCccH
Confidence 988853
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=485.98 Aligned_cols=511 Identities=20% Similarity=0.185 Sum_probs=274.5
Q ss_pred EEEeeccccccCCccCCCCCCCCcCCeeeccCCCCCccCCccccCCCCCCEEEeecccCCCCCCcccccCCCCcEeeccc
Q 037275 52 VTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARR 131 (992)
Q Consensus 52 v~~ldl~~~~l~~~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~ 131 (992)
++.|||++|.+.+..+..+..+++|++|||++|++++..|..|+.+++|++|+|++|++++..|..|+.+++|++|++++
T Consensus 30 l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 109 (570)
T 2z63_A 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVE 109 (570)
T ss_dssp CCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTT
T ss_pred ccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccccc
Confidence 44455555544433344444455555555555544433344444455555555555554433334444455555555555
Q ss_pred ccccccCChhhcccccccccccccccccCC-CCCCccccccccceEEecCCcccCCcCCccCCCCcc----cEEeccCcc
Q 037275 132 NNLVGEIPAELGYNWLKLENLTIADNHLTG-HFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNL----ILLNLGENR 206 (992)
Q Consensus 132 n~l~~~~p~~~~~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L----~~L~L~~n~ 206 (992)
|+++ .+|...+.++++|++|++++|.+++ .+|..|+++++|++|++++|.+.+..+..++.+++| +.|++++|.
T Consensus 110 n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~ 188 (570)
T 2z63_A 110 TNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188 (570)
T ss_dssp SCCC-CSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCC
T ss_pred cccc-cCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCC
Confidence 5444 2332222244445555555544443 234444444455555555444444444444444444 444445544
Q ss_pred cccccCccccccCCCcEEeccCCccCCCCCccccccccccchhhccccc------cCCCCchhhhccc--cCceeeeccc
Q 037275 207 FSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENN------FAGSIPESLSNAS--NLVELTLFDN 278 (992)
Q Consensus 207 l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~L~~l~l~~n~------l~~~~p~~l~~l~--~L~~L~L~~N 278 (992)
+++..|..+..+ +|++|++++|.............++.+..+.+..+. +.......+..+. .++.+++++|
T Consensus 189 l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~ 267 (570)
T 2z63_A 189 MNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 267 (570)
T ss_dssp CCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEET
T ss_pred ceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcc
Confidence 444333333332 444444444422211000001111111111111000 0001111111111 2334444444
Q ss_pred -cccccccccccccCccceEecCCCCCCCCCCCCchhhhhccCCCcceEeecCCCcCCCcCCcccccccccceeEEeeCC
Q 037275 279 -QFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGN 357 (992)
Q Consensus 279 -~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n 357 (992)
.+.+..+..|..+++|++|++++|.++.++. .+..+ +|+.|++++|.+. .+|.. ..+.|+.|++++|
T Consensus 268 ~~~~~~~~~~~~~l~~L~~L~l~~~~l~~l~~-------~~~~~-~L~~L~l~~n~~~-~l~~~---~l~~L~~L~l~~n 335 (570)
T 2z63_A 268 DYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD-------FSYNF-GWQHLELVNCKFG-QFPTL---KLKSLKRLTFTSN 335 (570)
T ss_dssp TEEESCSTTTTGGGTTCSEEEEESCEECSCCB-------CCSCC-CCSEEEEESCBCS-SCCBC---BCSSCCEEEEESC
T ss_pred hhhhhhchhhhcCcCcccEEEecCccchhhhh-------hhccC-CccEEeeccCccc-ccCcc---cccccCEEeCcCC
Confidence 4444444555555555555555555544332 12333 4455555555444 22221 1123444555555
Q ss_pred ccccccCCCccCCCcccEEEccCCcCCCCC--CccccCCCCCcEEeccCccccccCCCCCCCccccCceeccCCcccCCC
Q 037275 358 QISGIIPTGIRNLVNLVELCMDDNKLTGTI--PHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSI 435 (992)
Q Consensus 358 ~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 435 (992)
.+.+..+. ..+++|++|++++|++++.. +..+..+++|++|++++|++++..+. +..+++|+.|++++|.+.+..
T Consensus 336 ~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~ 412 (570)
T 2z63_A 336 KGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMS 412 (570)
T ss_dssp BSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCT
T ss_pred cccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCcccccc
Confidence 44443332 34445555555555544322 34444455555555555555433222 444555555555555554433
Q ss_pred C-CCccccccccccccccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeeccccc-ccCCcccc
Q 037275 436 P-PSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFS-GEIPVTLS 513 (992)
Q Consensus 436 ~-~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~ 513 (992)
+ ..+..+++|+ .|++++|.+++..|..+..+++|++|++++|.++ +.+|..+.
T Consensus 413 ~~~~~~~l~~L~-------------------------~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~ 467 (570)
T 2z63_A 413 EFSVFLSLRNLI-------------------------YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT 467 (570)
T ss_dssp TSCTTTTCTTCC-------------------------EEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCT
T ss_pred chhhhhcCCCCC-------------------------EEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhh
Confidence 3 2344444444 4577777777778888999999999999999998 57899999
Q ss_pred cccccceeeccCCcccccCCccccccCCCCEEECCCcccCCCChhhhhcCCCcceEecCCCcCcccCCCCCcc-CCccc-
Q 037275 514 ACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVF-SNKTG- 591 (992)
Q Consensus 514 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-~~~~~- 591 (992)
.+++|++|+|++|++++..|..|..+++|++|+|++|++++..|..|..+++|+.|++++|+++|.+|....+ .|+..
T Consensus 468 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~wl~~~ 547 (570)
T 2z63_A 468 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKN 547 (570)
T ss_dssp TCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTHHHHHHHHHT
T ss_pred cccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcchHHHHHHHHhc
Confidence 9999999999999999988999999999999999999999988888999999999999999999999987655 44432
Q ss_pred -ccccCCCCcCCCCC
Q 037275 592 -ISLSGNGKVCGGLD 605 (992)
Q Consensus 592 -~~l~~N~~~C~~~~ 605 (992)
..+.+.+ .|++|.
T Consensus 548 ~~~~~~~~-~C~~~~ 561 (570)
T 2z63_A 548 SQKEQGSA-KCSGSG 561 (570)
T ss_dssp GGGEESCC-BBTTTC
T ss_pred cccCCCch-hhCCCC
Confidence 3455666 887764
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=442.75 Aligned_cols=265 Identities=24% Similarity=0.419 Sum_probs=210.8
Q ss_pred cCCCCCCccccccceEEEEeEEC-----CCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCc
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLG-----ENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 753 (992)
++|.+.+.||+|+||+||+|++. .+++.||||+++.......++|.+|++++++++|||||+++|+|.+ .
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-----~ 87 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE-----G 87 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----S
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEee-----C
Confidence 46788899999999999999874 3578999999976555566789999999999999999999999753 4
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccc-------hhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCC
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQ-------QEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQD 826 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 826 (992)
+..++|||||++|+|.++++..... .....++|.+++.|+.|||+||+|||++ +||||||||+|||++++
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN 164 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCC
Confidence 5679999999999999999875421 1234699999999999999999999999 99999999999999999
Q ss_pred CcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCC
Q 037275 827 LVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQG 905 (992)
Q Consensus 827 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~ 905 (992)
+.+||+|||+|+....... ........||+.|||||++.+..|+.++|||||||++|||+| |+.||.+....
T Consensus 165 ~~~Ki~DFGla~~~~~~~~------~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~- 237 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDY------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN- 237 (299)
T ss_dssp GCEEECCCSCHHHHTGGGC------EEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-
T ss_pred CcEEECCcccceecCCCCc------eeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-
Confidence 9999999999986643211 111233468999999999999999999999999999999999 99999764221
Q ss_pred ccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 037275 906 LTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDT 985 (992)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 985 (992)
+++.....+.. ...+ ...+.++.+++.+||+.||++|||++||.+.|+++.+.
T Consensus 238 ----------------~~~~~i~~~~~-~~~p----------~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 238 ----------------EVIECITQGRV-LQRP----------RTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp ----------------HHHHHHHHTCC-CCCC----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------------HHHHHHHcCCC-CCCC----------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 11111111111 0011 11234688999999999999999999999999988654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=440.10 Aligned_cols=250 Identities=21% Similarity=0.299 Sum_probs=207.5
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAI 758 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 758 (992)
..|++.++||+|+||+||+|++..+|+.||||+++.......+.+.+|+.+|++++|||||++++++. +.+.+|+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~-----~~~~~~i 148 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDELWV 148 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEEE
Confidence 46999999999999999999999999999999998776666778999999999999999999999964 4567899
Q ss_pred EEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccce
Q 037275 759 VYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAK 838 (992)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 838 (992)
|||||++|+|.+++... .+++.++..++.||+.||+|||++ +||||||||+|||++.+|.+||+|||+|+
T Consensus 149 vmEy~~gg~L~~~l~~~-------~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~ 218 (346)
T 4fih_A 149 VMEFLEGGALTDIVTHT-------RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCA 218 (346)
T ss_dssp EECCCTTEEHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEeCCCCCcHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCce
Confidence 99999999999999753 489999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCCh
Q 037275 839 FLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPD 918 (992)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 918 (992)
.+... .......+||+.|||||++.+..|+.++||||+||++|||++|++||.+....
T Consensus 219 ~~~~~--------~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-------------- 276 (346)
T 4fih_A 219 QVSKE--------VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-------------- 276 (346)
T ss_dssp ECCSS--------SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------------
T ss_pred ecCCC--------CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--------------
Confidence 76532 12234568999999999999999999999999999999999999999753211
Q ss_pred hHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 919 KVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
+.+..... .... . .........++.+++.+||+.||++|||++|+++
T Consensus 277 ---~~~~~i~~-~~~~----~----~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 277 ---KAMKMIRD-NLPP----R----LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp ---HHHHHHHH-SSCC----C----CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---HHHHHHHc-CCCC----C----CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11111110 0000 0 0001122346889999999999999999999976
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-51 Score=438.42 Aligned_cols=264 Identities=27% Similarity=0.400 Sum_probs=203.3
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC--CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK--GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
.++|++.++||+|+||+||+|++. ..||||+++.... ...+.|.+|+.++++++|||||+++|++.. +.
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~------~~ 105 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK------DN 105 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC------Ce
Confidence 357888999999999999999974 2599999874432 234679999999999999999999998642 23
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++|||||++|+|.++++.... .+++.++..|+.|||+||+|||++ +||||||||+|||+++++.+||+|||
T Consensus 106 ~~iVmEy~~gGsL~~~l~~~~~-----~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFG 177 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHVQET-----KFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFG 177 (307)
T ss_dssp CEEEEECCSSCBHHHHHHTSCC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCS
T ss_pred EEEEEEcCCCCCHHHHHhhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeecc
Confidence 6899999999999999976543 499999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccC---CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHH
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG---GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFA 912 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~ 912 (992)
+|+...... .........||+.|||||++.+ +.|+.++|||||||++|||+||+.||.+......
T Consensus 178 la~~~~~~~------~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~------ 245 (307)
T 3omv_A 178 LATVKSRWS------GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ------ 245 (307)
T ss_dssp SCBC------------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH------
T ss_pred CceecccCC------cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH------
Confidence 998764321 1122344579999999999864 4689999999999999999999999976422110
Q ss_pred hhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhh
Q 037275 913 RTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTFL 987 (992)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 987 (992)
+...+ .......... ......+.++.+++.+||+.||++||||+||++.|+.++..+.
T Consensus 246 -------~~~~~----~~~~~~p~~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 246 -------IIFMV----GRGYASPDLS------KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp -------HHHHH----HTTCCCCCST------TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred -------HHHHH----hcCCCCCCcc------cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 00111 0010000000 0011234568899999999999999999999999998876653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-51 Score=442.86 Aligned_cols=265 Identities=26% Similarity=0.420 Sum_probs=205.4
Q ss_pred cCCCCCCccccccceEEEEeEEC-----CCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCc
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLG-----ENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 753 (992)
++|.+.++||+|+||+||+|++. .+++.||||+++.......++|.+|+++|++++|||||+++|+|.+ .
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-----~ 115 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTE-----G 115 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----S
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----C
Confidence 46677889999999999999874 3688999999976555566789999999999999999999999753 4
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccc---------hhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeC
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQ---------QEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLD 824 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~---------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 824 (992)
...++|||||++|+|.++++..... ....+++|.+++.|+.|||+||+|||++ +||||||||+|||++
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVG 192 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEEC
Confidence 5679999999999999999875422 1124699999999999999999999999 999999999999999
Q ss_pred CCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCcc
Q 037275 825 QDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFN 903 (992)
Q Consensus 825 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~ 903 (992)
+++.+||+|||+|+....... ........||+.|||||++.+..|+.++|||||||++|||+| |+.||.+...
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~------~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~ 266 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDY------YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN 266 (329)
T ss_dssp TTTEEEECCCC----------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH
T ss_pred CCCcEEEcccccceeccCCCc------ceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH
Confidence 999999999999987643321 112234569999999999999999999999999999999999 9999976422
Q ss_pred CCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 037275 904 QGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRAR 983 (992)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 983 (992)
. +++.....+. ....+. ..+.++.+++.+||+.||++||||+||++.|+.+.
T Consensus 267 ~-----------------~~~~~i~~g~-~~~~p~----------~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~ 318 (329)
T 4aoj_A 267 T-----------------EAIDCITQGR-ELERPR----------ACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318 (329)
T ss_dssp H-----------------HHHHHHHHTC-CCCCCT----------TCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred H-----------------HHHHHHHcCC-CCCCcc----------cccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence 1 1111111111 011111 12356889999999999999999999999999986
Q ss_pred Hh
Q 037275 984 DT 985 (992)
Q Consensus 984 ~~ 985 (992)
+.
T Consensus 319 ~~ 320 (329)
T 4aoj_A 319 QA 320 (329)
T ss_dssp HS
T ss_pred hC
Confidence 54
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-51 Score=443.83 Aligned_cols=251 Identities=20% Similarity=0.313 Sum_probs=200.6
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC--CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK--GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
++|++.+.||+|+||+||+|++..+|+.||||+++.... ...+.+.+|++++++++|||||++++++. +.+.+
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~-----~~~~~ 98 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFE-----ENGSL 98 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEE-----ECCEE
Confidence 589999999999999999999999999999999975432 23467899999999999999999999954 45678
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
|+|||||++|+|.+++...+. ..+++.+++.|+.||+.||+|||++ +||||||||+|||++.+|.+||+|||+
T Consensus 99 yiVmEy~~gg~L~~~i~~~~~----~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGl 171 (350)
T 4b9d_A 99 YIVMDYCEGGDLFKRINAQKG----VLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGI 171 (350)
T ss_dssp EEEEECCTTCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTE
T ss_pred EEEEeCCCCCcHHHHHHHcCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEccccc
Confidence 999999999999999976542 2578999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhC
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTAL 916 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 916 (992)
|+..... .......+||+.|||||++.+..|+.++||||+||++|||+||+.||.+...
T Consensus 172 a~~~~~~--------~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------------- 230 (350)
T 4b9d_A 172 ARVLNST--------VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM------------- 230 (350)
T ss_dssp ESCCCHH--------HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-------------
T ss_pred ceeecCC--------cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-------------
Confidence 9865421 1112345799999999999999999999999999999999999999976321
Q ss_pred ChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 917 PDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.+++.......+.. . ......++.+++.+||+.||++|||++|+++
T Consensus 231 ----~~~~~~i~~~~~~~-----~------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 231 ----KNLVLKIISGSFPP-----V------SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp ----HHHHHHHHHTCCCC-----C------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----HHHHHHHHcCCCCC-----C------CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11122222111110 0 0112345889999999999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=436.46 Aligned_cols=261 Identities=24% Similarity=0.293 Sum_probs=207.3
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
.+.|++.++||+|+||+||+|++..+|+.||||+++.... ..+|+.++++++|||||++++++. +...+|
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~-----~~~~~~ 126 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVR-----EGPWVN 126 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEE-----ETTEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEE
Confidence 3467888899999999999999999999999999974332 247999999999999999999964 456679
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCC-cEEEeeccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDL-VAHLGDFGL 836 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~ 836 (992)
+|||||++|+|.++++... .+++..+..++.||+.||+|||++ +||||||||+|||++.+| .+||+|||+
T Consensus 127 ivmEy~~gg~L~~~l~~~~------~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGl 197 (336)
T 4g3f_A 127 IFMELLEGGSLGQLIKQMG------CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGH 197 (336)
T ss_dssp EEECCCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTT
T ss_pred EEEeccCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCC
Confidence 9999999999999997643 589999999999999999999999 999999999999999988 699999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhC
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTAL 916 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 916 (992)
|+.+....... ........+||+.|||||++.+..|+.++||||+||++|||+||++||.+..... ..........
T Consensus 198 a~~~~~~~~~~---~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~i~~~~~ 273 (336)
T 4g3f_A 198 ALCLQPDGLGK---SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP-LCLKIASEPP 273 (336)
T ss_dssp CEEC---------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC-CHHHHHHSCC
T ss_pred CeEccCCCccc---ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-HHHHHHcCCC
Confidence 99876432211 1112234579999999999999999999999999999999999999998743332 1211111110
Q ss_pred ChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 037275 917 PDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTF 986 (992)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 986 (992)
+ . ... ......++.+++.+||+.||++|||+.|+++.|.++....
T Consensus 274 ~----------------~---~~~------~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~ 318 (336)
T 4g3f_A 274 P----------------I---REI------PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318 (336)
T ss_dssp G----------------G---GGS------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred C----------------c---hhc------CccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence 0 0 000 0112345889999999999999999999999998887654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=435.13 Aligned_cols=261 Identities=25% Similarity=0.399 Sum_probs=206.3
Q ss_pred CCCCCCccccccceEEEEeEEC-----CCCeEEEEEEeeccC-CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCc
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLG-----ENGMMVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 753 (992)
++++.++||+|+||+||+|++. .+++.||||+++... ....++|.+|+.++++++|||||+++|+|.+ .
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-----~ 101 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK-----D 101 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-----S
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE-----C
Confidence 5667789999999999999963 357899999996443 3345789999999999999999999999754 3
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccc----------hhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQ----------QEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLL 823 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 823 (992)
...++|||||++|+|.+++...... .....+++.++++|+.|||+||+|||++ +||||||||+|||+
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl 178 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLV 178 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEE
Confidence 4569999999999999999764321 1124689999999999999999999999 99999999999999
Q ss_pred CCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCc
Q 037275 824 DQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMF 902 (992)
Q Consensus 824 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~ 902 (992)
++++.+||+|||+|+...... .........||+.|||||++.++.|+.++|||||||++|||+| |+.||.+..
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~------~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~ 252 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAAD------YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 252 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGG------CBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC
T ss_pred CCCCCEEECCcccceeccCCC------ceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999998664321 1122344579999999999999999999999999999999999 899997642
Q ss_pred cCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 037275 903 NQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRA 982 (992)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 982 (992)
.. +++.....+.. . .. ..+.+.++.+++.+||+.||++||||+||++.|+..
T Consensus 253 ~~-----------------~~~~~i~~~~~-~----~~------p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 253 NQ-----------------DVVEMIRNRQV-L----PC------PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HH-----------------HHHHHHHTTCC-C----CC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HH-----------------HHHHHHHcCCC-C----CC------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 21 11111111110 0 01 112345688999999999999999999999998753
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=430.34 Aligned_cols=249 Identities=21% Similarity=0.334 Sum_probs=207.4
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc---CCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK---QKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
++|++.++||+|+||+||+|++..+|+.||||++... .....+.+.+|++++++++|||||++++++ .+.+.
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~ 106 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDEK 106 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCE
Confidence 4799999999999999999999999999999999743 344567899999999999999999999995 45667
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
+|+|||||++|+|.+++.+.. .+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 107 ~yivmEy~~gG~L~~~i~~~~------~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFG 177 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIRKIG------SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFG 177 (311)
T ss_dssp EEEEECCCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcC
Confidence 899999999999999998643 589999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 915 (992)
+|+.+.... ........+||+.|||||++.+..|+.++||||+||++|||+||++||.+...
T Consensus 178 la~~~~~~~------~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------------ 239 (311)
T 4aw0_A 178 TAKVLSPES------KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE------------ 239 (311)
T ss_dssp TCEECCTTT------TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------------
T ss_pred CceecCCCC------CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------------
Confidence 999875432 12233456899999999999999999999999999999999999999976321
Q ss_pred CChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 037275 916 LPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVV 976 (992)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 976 (992)
.++...+....+.. +. ....++.+++.+||+.||++|||++|++
T Consensus 240 -----~~~~~~i~~~~~~~------p~------~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 240 -----GLIFAKIIKLEYDF------PE------KFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp -----HHHHHHHHHTCCCC------CT------TCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred -----HHHHHHHHcCCCCC------Cc------ccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 11222222221110 00 1134578999999999999999999974
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-50 Score=424.89 Aligned_cols=249 Identities=25% Similarity=0.388 Sum_probs=197.5
Q ss_pred CCCCccccccceEEEEeEECCCCeEEEEEEeeccC--CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEE
Q 037275 682 SSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIV 759 (992)
Q Consensus 682 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 759 (992)
++.++||+|+||+||+|.+..+++.||+|++.... ....+.+.+|++++++++|||||++++++... ..+...+++|
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~-~~~~~~~~lv 107 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE-ETTEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeec-cCCCcEEEEE
Confidence 56678999999999999999999999999996443 22346789999999999999999999987542 2335668999
Q ss_pred EEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeccCCCCCeeeC-CCCcEEEeeccc
Q 037275 760 YEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPP--VVHGDLKPSNVLLD-QDLVAHLGDFGL 836 (992)
Q Consensus 760 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~ 836 (992)
||||++|+|.+++.+.. .+++..+..++.||+.||+|||++ + ||||||||+|||++ .++.+||+|||+
T Consensus 108 mEy~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGl 178 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTG
T ss_pred EeCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcC
Confidence 99999999999997643 589999999999999999999998 6 99999999999997 479999999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhC
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTAL 916 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 916 (992)
|+.... ......+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+................
T Consensus 179 a~~~~~----------~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~ 247 (290)
T 3fpq_A 179 ATLKRA----------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK 247 (290)
T ss_dssp GGGCCT----------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC
T ss_pred CEeCCC----------CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCC
Confidence 975432 12234579999999998865 6999999999999999999999999753221110000000000
Q ss_pred ChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 917 PDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
+.. .......++.+++.+||+.||++|||++|+++
T Consensus 248 ~~~--------------------------~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 248 PAS--------------------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CGG--------------------------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCC--------------------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 00011235789999999999999999999975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=441.86 Aligned_cols=251 Identities=21% Similarity=0.299 Sum_probs=208.2
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
.+.|++.++||+|+||+||+|++..+|+.||||++........+.+.+|+.+|++++|||||++++++. ..+.+|
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~-----~~~~~~ 224 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDELW 224 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEE-----ECCEEE
Confidence 357999999999999999999999999999999998776667778999999999999999999999964 456789
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+|||||++|+|.++++.. .+++.++..++.||+.||+|||++ +||||||||+|||++.+|.+||+|||+|
T Consensus 225 iVmEy~~gG~L~~~i~~~-------~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla 294 (423)
T 4fie_A 225 VVMEFLEGGALTDIVTHT-------RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFC 294 (423)
T ss_dssp EEEECCTTEEHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTC
T ss_pred EEEeCCCCCcHHHHHhcc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccc
Confidence 999999999999999743 389999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALP 917 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 917 (992)
+.+... .......+||+.|||||++.+..|+.++||||+||++|||++|++||.+....
T Consensus 295 ~~~~~~--------~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~------------- 353 (423)
T 4fie_A 295 AQVSKE--------VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL------------- 353 (423)
T ss_dssp EECCSS--------CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------------
T ss_pred eECCCC--------CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-------------
Confidence 876532 12234568999999999999999999999999999999999999999753111
Q ss_pred hhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 918 DKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
+.+..+.. .... .. ........++.+++.+||+.||++|||++|+++
T Consensus 354 ----~~~~~i~~-~~~~----~~----~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 354 ----KAMKMIRD-NLPP----RL----KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp ----HHHHHHHH-SCCC----CC----SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----HHHHHHHc-CCCC----CC----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11111110 0000 00 000112345889999999999999999999986
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=465.55 Aligned_cols=510 Identities=20% Similarity=0.169 Sum_probs=388.8
Q ss_pred cccccCCccCCCCCCCCcCCeeeccCCCCCccCCccccCCCCCCEEEeecccCCCCCCcccccCCCCcEeeccccccccc
Q 037275 58 SNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGE 137 (992)
Q Consensus 58 ~~~~l~~~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~ 137 (992)
++.++ ..+|..+. +++++|||++|++++..+..|..+++|++|+|++|++++..|..|+++++|++|++++|+++ .
T Consensus 15 ~~~~l-~~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~-~ 90 (570)
T 2z63_A 15 MELNF-YKIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-S 90 (570)
T ss_dssp CSSCC-SSCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC-E
T ss_pred CCCCc-cccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCC-c
Confidence 33344 45666543 57999999999999777778999999999999999999766788999999999999999998 5
Q ss_pred CChhhcccccccccccccccccCCCCCCccccccccceEEecCCcccC-CcCCccCCCCcccEEeccCcccccccCcccc
Q 037275 138 IPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWG-RIPNNLGNLRNLILLNLGENRFSGIVPPSIF 216 (992)
Q Consensus 138 ~p~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~-~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~ 216 (992)
+|+..+.++++|++|++++|.+++..+..++++++|++|++++|.+.+ .+|..|+++++|++|++++|++++..|..+.
T Consensus 91 ~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 170 (570)
T 2z63_A 91 LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLR 170 (570)
T ss_dssp ECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGH
T ss_pred cCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHcc
Confidence 555555588999999999999996656679999999999999999876 4688899999999999999999977778888
Q ss_pred ccCCC----cEEeccCCccCCCCCccccccccccchhhccccccC-CCCchhhhccccCceeeecccccccccccccccc
Q 037275 217 NISSL----ENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFA-GSIPESLSNASNLVELTLFDNQFRGKVSIYFRSL 291 (992)
Q Consensus 217 ~l~~L----~~L~l~~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~-~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l 291 (992)
.+++| +.|++++|.+.+..| ..+... +|+.+++++|... ..++..+..+++++.+.+..+.+.. .
T Consensus 171 ~l~~L~~~~~~L~l~~n~l~~~~~-~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~--------~ 240 (570)
T 2z63_A 171 VLHQMPLLNLSLDLSLNPMNFIQP-GAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN--------E 240 (570)
T ss_dssp HHHTCTTCCCEEECTTCCCCEECT-TTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCC--------C
T ss_pred chhccchhhhhcccCCCCceecCH-HHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccC--------c
Confidence 88888 888999888874333 333222 5555655555332 1234445555555544443322110 0
Q ss_pred CccceEecCCCCCCCCCCCCchhhhhccCCCcceEeecCCC-cCCCcCCcccccccccceeEEeeCCccccccCCCccCC
Q 037275 292 KNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDN-RFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNL 370 (992)
Q Consensus 292 ~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n-~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l 370 (992)
+.+..++...+.. +..+ .++.++++++ .+.+..|..+..+. +|+.|++++|.++ .+|..+..+
T Consensus 241 ----------~~l~~~~~~~~~~---l~~l-~l~~l~l~~~~~~~~~~~~~~~~l~-~L~~L~l~~~~l~-~l~~~~~~~ 304 (570)
T 2z63_A 241 ----------GNLEKFDKSALEG---LCNL-TIEEFRLAYLDYYLDDIIDLFNCLT-NVSSFSLVSVTIE-RVKDFSYNF 304 (570)
T ss_dssp ----------SSCEECCTTTTGG---GGGS-EEEEEEEEETTEEESCSTTTTGGGT-TCSEEEEESCEEC-SCCBCCSCC
T ss_pred ----------hhhhhcchhhhcc---cccc-chhhhhhhcchhhhhhchhhhcCcC-cccEEEecCccch-hhhhhhccC
Confidence 1111122221211 1111 3566666666 66666666666554 5788888888877 466677777
Q ss_pred CcccEEEccCCcCCCCCCccccCCCCCcEEeccCccccccCCCCCCCccccCceeccCCcccCCC--CCCcccccccccc
Q 037275 371 VNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSI--PPSLGNCKNLIEL 448 (992)
Q Consensus 371 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L 448 (992)
+|++|++++|.+. .+|. ..+++|+.|++++|.+.+..+. ..+++|+.|++++|++++.. |..+..+++|++|
T Consensus 305 -~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L 378 (570)
T 2z63_A 305 -GWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYL 378 (570)
T ss_dssp -CCSEEEEESCBCS-SCCB--CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEE
T ss_pred -CccEEeeccCccc-ccCc--ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEE
Confidence 8888888888887 4554 4677888888888887765554 67788888888888887543 5667778888888
Q ss_pred ccccccccccCchhhhhhcccccccccccccccCccc-ccccCCCCccEEeeecccccccCCcccccccccceeeccCCc
Q 037275 449 HMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLP-LEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNS 527 (992)
Q Consensus 449 ~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~ 527 (992)
++++|.+++. |.. +.....++.|++++|.+++..+ ..+..+++|++|++++|.+++..|..|.++++|++|+|++|+
T Consensus 379 ~l~~n~l~~~-~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 456 (570)
T 2z63_A 379 DLSFNGVITM-SSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNS 456 (570)
T ss_dssp ECCSCSEEEE-EEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCE
T ss_pred ECCCCccccc-ccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCc
Confidence 8888888743 333 4445566778999999887665 578999999999999999999999999999999999999999
Q ss_pred cc-ccCCccccccCCCCEEECCCcccCCCChhhhhcCCCcceEecCCCcCcccCCC-CCccCCcccccccCCCCcCCCCC
Q 037275 528 FS-GSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPT-KGVFSNKTGISLSGNGKVCGGLD 605 (992)
Q Consensus 528 l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~~~~~~l~~N~~~C~~~~ 605 (992)
++ +.+|..+..+++|++|+|++|++++..|..|..+++|++|++++|++++.++. ...++.++.+++.+|++.|.|+.
T Consensus 457 l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 536 (570)
T 2z63_A 457 FQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536 (570)
T ss_dssp EGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred CccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence 98 57899999999999999999999998899999999999999999999998775 35678899999999999998865
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=415.93 Aligned_cols=247 Identities=28% Similarity=0.387 Sum_probs=189.8
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
.++|++.+.||+|+||+||+|++..+|+.||||+++... ......+.+|++++++++|||||++++++ .+.+
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~ 86 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVI-----KSKD 86 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EECC
Confidence 468999999999999999999999999999999996432 33456789999999999999999999995 4456
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
..++||||+ +|+|.+++.+.. .+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+||
T Consensus 87 ~~~ivmEy~-~g~L~~~l~~~~------~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DF 156 (275)
T 3hyh_A 87 EIIMVIEYA-GNELFDYIVQRD------KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADF 156 (275)
T ss_dssp EEEEEEECC-CEEHHHHHHHSC------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCS
T ss_pred EEEEEEeCC-CCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeec
Confidence 789999999 679999997643 589999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCc-CcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEA-SMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 913 (992)
|+|+...... .....+||+.|||||++.+..+ +.++||||+||++|||+||+.||.+... .
T Consensus 157 Gla~~~~~~~---------~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~-----~---- 218 (275)
T 3hyh_A 157 GLSNIMTDGN---------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI-----P---- 218 (275)
T ss_dssp SCC------------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----H----
T ss_pred CCCeecCCCC---------ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH-----H----
Confidence 9998654321 2234579999999999998876 5799999999999999999999975311 1
Q ss_pred hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 914 TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.+........+. .+. ....++.+++.+||+.||++|||++|+++
T Consensus 219 --------~~~~~i~~~~~~--~p~----------~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 219 --------VLFKNISNGVYT--LPK----------FLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp --------HHHHHHHHTCCC--CCT----------TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --------HHHHHHHcCCCC--CCC----------CCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 111111111110 000 11345789999999999999999999986
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-49 Score=424.65 Aligned_cols=285 Identities=23% Similarity=0.296 Sum_probs=206.8
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAI 758 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 758 (992)
++|.+.++||+|+||+||+|++ +|+.||||+++.... .......|+..+.+++|||||+++|+|.+.+ ......++
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~~~l 78 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceEEEE
Confidence 3577889999999999999998 589999999864321 1222344566667889999999999986532 22346799
Q ss_pred EEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEeccCCCCCeeeCCCCcEEEee
Q 037275 759 VYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHH-----CQPPVVHGDLKPSNVLLDQDLVAHLGD 833 (992)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-----~~~~ivH~Dlkp~NIll~~~~~~kl~D 833 (992)
|||||++|+|.++++.. .+++..+.+++.|+++||+|||++ ..++||||||||+|||++.++.+||+|
T Consensus 79 V~Ey~~~gsL~~~l~~~-------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~D 151 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp EEECCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred EecCCCCCcHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEe
Confidence 99999999999999753 489999999999999999999975 245899999999999999999999999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccCC------CcCcccchhhHHHHHHHHHhCCCCCCCCccCCcc
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG------EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLT 907 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~ 907 (992)
||+|+........ ........+||+.|||||++.+. .++.++|||||||++|||+||++||....+....
T Consensus 152 FGla~~~~~~~~~----~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p 227 (303)
T 3hmm_A 152 LGLAVRHDSATDT----IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227 (303)
T ss_dssp CTTCEEEETTTTE----ESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred CCCCccccCCCCc----eeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccccc
Confidence 9999876543211 11122345799999999998754 4788999999999999999999888654333222
Q ss_pred HHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 037275 908 LHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDT 985 (992)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 985 (992)
+....... .....+....... ..+..........+....+.+++.+||+.||++||||.||++.|+++.++
T Consensus 228 ~~~~~~~~--~~~~~~~~~~~~~-----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 228 YYDLVPSD--PSVEEMRKVVCEQ-----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp TTTTSCSS--CCHHHHHHHHTTS-----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred chhccccc--chHHHHHHHHhcc-----cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 21111100 0111111111100 11111112223345667899999999999999999999999999998765
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=470.01 Aligned_cols=514 Identities=18% Similarity=0.164 Sum_probs=345.9
Q ss_pred cCCeeeccCCCCCccCCccccCCCCCCEEEeecccCCCCCCcccccCCCCcEeecccccccccCChhhcccccccccccc
Q 037275 75 FLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTI 154 (992)
Q Consensus 75 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~~L~L 154 (992)
++++|||++|+|++..|.+|.++++|++|+|++|+|++..|..|+++++|++|+|++|+++ .+|...+.++++|++|+|
T Consensus 53 ~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~-~l~~~~f~~L~~L~~L~L 131 (635)
T 4g8a_A 53 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVA 131 (635)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC-EECGGGGTTCTTCCEEEC
T ss_pred CCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCC-CCCHHHhcCCCCCCEEEC
Confidence 4566666666666434445666666666666666666434445666666666666666665 455555556666666666
Q ss_pred cccccCCCCCCccccccccceEEecCCcccC-CcCCccCCCCcccEEeccCcccccccCccccccCCCc----EEeccCC
Q 037275 155 ADNHLTGHFPASIGNLSTLERINVLGNGLWG-RIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLE----NVFLPTN 229 (992)
Q Consensus 155 ~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~-~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~----~L~l~~N 229 (992)
++|++++..+..|+++++|++|++++|.+.+ ..|..++.+++|++|+|++|++++..|..+..+.+++ .++++.|
T Consensus 132 s~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n 211 (635)
T 4g8a_A 132 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 211 (635)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTC
T ss_pred CCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccC
Confidence 6666665444556666666666666666643 2455556666666666666666655555555444332 4555666
Q ss_pred ccCCCCCccccccccccchhhccccccC-------------------------------CCCchhhhccccCceeeeccc
Q 037275 230 RFNGSLPLDIGVSLPKLLGFIVAENNFA-------------------------------GSIPESLSNASNLVELTLFDN 278 (992)
Q Consensus 230 ~l~~~~~~~~~~~~~~L~~l~l~~n~l~-------------------------------~~~p~~l~~l~~L~~L~L~~N 278 (992)
.+. .++...+. ...+..+.+.+|... ......+..+..+..+++..+
T Consensus 212 ~l~-~i~~~~~~-~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~ 289 (635)
T 4g8a_A 212 PMN-FIQPGAFK-EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 289 (635)
T ss_dssp CCC-EECTTTTT-TCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEE
T ss_pred ccc-ccCccccc-chhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhh
Confidence 555 22222221 112233333333222 222233444444444444443
Q ss_pred ccc---ccccccccccCccceEecCCCCCCCCCCCCchhhhhccCCCcceEeecCCCcCCCcCCcccccccccceeEEee
Q 037275 279 QFR---GKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIA 355 (992)
Q Consensus 279 ~l~---~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~ 355 (992)
... ......+..+.+++.+.+.+|.+..+. .+.....|+.|++.+|.+.+..+..+ ..++.+.+.
T Consensus 290 ~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~--------~~~~~~~L~~L~l~~~~~~~~~~~~l----~~L~~l~l~ 357 (635)
T 4g8a_A 290 YLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVK--------DFSYNFGWQHLELVNCKFGQFPTLKL----KSLKRLTFT 357 (635)
T ss_dssp CCCSCEEECTTTTGGGTTCSEEEEESCEEEECG--------GGGSCCCCSEEEEESCEESSCCCCBC----TTCCEEEEE
T ss_pred hhcccccchhhhhhhhccccccccccccccccc--------ccccchhhhhhhcccccccCcCcccc----hhhhhcccc
Confidence 322 122334556667777777777665432 35556778888888888876655433 347778888
Q ss_pred CCccccccCCCccCCCcccEEEccCCcCCC--CCCccccCCCCCcEEeccCccccccCCCCCCCccccCceeccCCcccC
Q 037275 356 GNQISGIIPTGIRNLVNLVELCMDDNKLTG--TIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQG 433 (992)
Q Consensus 356 ~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 433 (992)
+|.+... .....+++|+.|++++|.+.. ..+..+..+.+|+.|+++.|.+. ..+..+..+++|+.++++.|.+..
T Consensus 358 ~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~-~~~~~~~~l~~L~~l~l~~~~~~~ 434 (635)
T 4g8a_A 358 SNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQ 434 (635)
T ss_dssp SCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEE-EECSCCTTCTTCCEEECTTSEEES
T ss_pred cccCCCC--cccccccccccchhhccccccccccccchhhhhhhhhhhccccccc-cccccccccccccchhhhhccccc
Confidence 8887643 334578899999999998853 45667778889999999999887 456678888999999998887765
Q ss_pred CCC-CCccccccccccccccccccccCchhhhhhccccccccccccccc-CcccccccCCCCccEEeeecccccccCCcc
Q 037275 434 SIP-PSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLS-GTLPLEVGNLKNLVYFNISVNRFSGEIPVT 511 (992)
Q Consensus 434 ~~~-~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 511 (992)
..+ ..|..+++++.++++.|.+.+. ++..+.....++.|++++|.+. +..|..|..+++|++|+|++|+|++..|..
T Consensus 435 ~~~~~~~~~l~~l~~l~ls~n~l~~~-~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~ 513 (635)
T 4g8a_A 435 MSEFSVFLSLRNLIYLDISHTHTRVA-FNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA 513 (635)
T ss_dssp TTSSCTTTTCTTCCEEECTTSCCEEC-CTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTT
T ss_pred cccccccccccccccccccccccccc-cccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHH
Confidence 443 4678889999999999998854 4455555666778899998754 457788999999999999999999888999
Q ss_pred cccccccceeeccCCcccccCCccccccCCCCEEECCCcccCCCChhhhhcC-CCcceEecCCCcCcccCCCCCccCCcc
Q 037275 512 LSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENL-SFLEYLNLSYNHFEGEVPTKGVFSNKT 590 (992)
Q Consensus 512 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~l~~N~l~~~~~~~~~~~~~~ 590 (992)
|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+ ++|++|+|++|+|.|.|...+...|++
T Consensus 514 f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~~~~~~wl~ 593 (635)
T 4g8a_A 514 FNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIK 593 (635)
T ss_dssp TTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGGHHHHHHHH
T ss_pred HcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCcHHHHHHHH
Confidence 9999999999999999998888889999999999999999999989989888 689999999999999998655544443
Q ss_pred cc---cccCCCCcCCCCCCC
Q 037275 591 GI---SLSGNGKVCGGLDEL 607 (992)
Q Consensus 591 ~~---~l~~N~~~C~~~~~~ 607 (992)
.. ........|+.|...
T Consensus 594 ~~~~~~~~~~~~~C~~P~~~ 613 (635)
T 4g8a_A 594 DQRQLLVEVERMECATPSDK 613 (635)
T ss_dssp HTTTTBSCGGGCBBCSSTTT
T ss_pred hCCCccCCCCCceeCCchHH
Confidence 21 112234678887654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-49 Score=431.02 Aligned_cols=272 Identities=22% Similarity=0.337 Sum_probs=213.8
Q ss_pred HHHHhcCCCCCCccccccceEEEEeEECCC-----CeEEEEEEeeccCC-CchhHHHHHHHHHHhccC-CcceeEEEEee
Q 037275 674 LSKATNDFSSSNMIGQGSFGFVYKGNLGEN-----GMMVAVKVINLKQK-GASNGFVAECQALRNIRH-RNLIKIITICS 746 (992)
Q Consensus 674 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h-~niv~~~~~~~ 746 (992)
.+...++|++.+.||+|+||+||+|++... ++.||||+++.... ...+.+.+|++++++++| ||||+++|+|.
T Consensus 59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~ 138 (353)
T 4ase_A 59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 138 (353)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEE
Confidence 334567899999999999999999997533 46899999964433 234678999999999965 89999999974
Q ss_pred cccccCcceEEEEEEeccCCCHHHHHhhcccc----------hhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccC
Q 037275 747 SIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQ----------QEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDL 816 (992)
Q Consensus 747 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dl 816 (992)
. .....++|||||++|+|.++++..... .....+++.++..++.|||+||+|||++ +||||||
T Consensus 139 ~----~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDL 211 (353)
T 4ase_A 139 K----PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL 211 (353)
T ss_dssp C----TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred e----cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCcc
Confidence 3 334569999999999999999865431 1124589999999999999999999999 9999999
Q ss_pred CCCCeeeCCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CC
Q 037275 817 KPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RR 895 (992)
Q Consensus 817 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~ 895 (992)
||+|||+++++.+||+|||+|+....+.. ........||+.|||||++.+..|+.++|||||||++|||+| |+
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~------~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~ 285 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPD------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 285 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTT------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCC------ceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCC
Confidence 99999999999999999999987654321 112234568999999999999999999999999999999998 99
Q ss_pred CCCCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 037275 896 RPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDV 975 (992)
Q Consensus 896 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 975 (992)
.||.+..... .+...+. .......+. ....++.+++.+||+.||++|||++||
T Consensus 286 ~Pf~~~~~~~-------------~~~~~i~----~g~~~~~p~----------~~~~~~~~li~~c~~~dP~~RPt~~ei 338 (353)
T 4ase_A 286 SPYPGVKIDE-------------EFCRRLK----EGTRMRAPD----------YTTPEMYQTMLDCWHGEPSQRPTFSEL 338 (353)
T ss_dssp CSSTTCCCSH-------------HHHHHHH----HTCCCCCCT----------TCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCCCCHHH-------------HHHHHHH----cCCCCCCCc----------cCCHHHHHHHHHHcCcChhHCcCHHHH
Confidence 9998643221 1111111 111111111 123458899999999999999999999
Q ss_pred HHHHHHHHHh
Q 037275 976 VAKLCRARDT 985 (992)
Q Consensus 976 l~~L~~~~~~ 985 (992)
++.|+++.+.
T Consensus 339 l~~L~~llq~ 348 (353)
T 4ase_A 339 VEHLGNLLQA 348 (353)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999998764
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=468.98 Aligned_cols=515 Identities=17% Similarity=0.205 Sum_probs=378.3
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCCcCCCCC----CceEe-eEEcCC--CCeEEEeeccccccCCccCCCCCCCCcCC
Q 037275 5 SNETDRLALLAIGSQLEDDPLGVTSSWNNSTNL----CQWTG-VTCGHR--HQRVTKLDLSNRTIGGTLSPYVGNLSFLR 77 (992)
Q Consensus 5 ~~~~~~~~ll~~~~~~~~~~~~~~~~w~~~~~~----c~w~g-v~c~~~--~~~v~~ldl~~~~l~~~l~~~l~~l~~L~ 77 (992)
...++.+.-.|+++-...- .-..|....+. |.|.. ..|..= ...|+. | .-.+++
T Consensus 24 ~~~~~~~d~~aL~~~~~~~---~~~~w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C-~---------------~~~~V~ 84 (636)
T 4eco_A 24 RTAEYIKDYLALKEIWDAL---NGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSL-N---------------SNGRVT 84 (636)
T ss_dssp CCCHHHHHHHHHHHHHHHT---TGGGCCCCC------CCCCCSSCGGGTTCCTTEEE-C---------------TTCCEE
T ss_pred hhhhHHHHHHHHHHHHHHc---CCCCcccCCcCCccCCCCCCCCCcccccCCCCeEE-c---------------CCCCEE
Confidence 3455566777777776432 12578644322 47852 222211 011221 1 014789
Q ss_pred eeeccCCCCCccCCccccCCCCCCEEEeecccC------CC------CCCcccccCCCCcEeecccccccccCChhhccc
Q 037275 78 YLNLADNNFHGEIPHQIGRLVRLEALVLANNSF------SG------KIPTNLSRCSNLISFNARRNNLVGEIPAELGYN 145 (992)
Q Consensus 78 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l------~~------~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~ 145 (992)
.|+|++|++.|.+|++|+.|++|++|+|++|.+ .| .+|... +..|+ ++++.|.+.+.+|..+...
T Consensus 85 ~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~ 161 (636)
T 4eco_A 85 GLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDL 161 (636)
T ss_dssp EEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHH
T ss_pred EEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHH
Confidence 999999999999999999999999999999987 33 445444 55666 8888888888888777655
Q ss_pred ccccccccccccccCCCCCCccccccccceEEe--cCCcccCCcCCccCCCCcccEEeccCcccccc-------------
Q 037275 146 WLKLENLTIADNHLTGHFPASIGNLSTLERINV--LGNGLWGRIPNNLGNLRNLILLNLGENRFSGI------------- 210 (992)
Q Consensus 146 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l--~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~------------- 210 (992)
+.++..+++....+.. .....++.+.+ .+|++.+ +|..|+++++|++|+|++|++++.
T Consensus 162 ~~~l~~~~l~~~~~~~------~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~ 234 (636)
T 4eco_A 162 IKDCINSDPQQKSIKK------SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEY 234 (636)
T ss_dssp HHHHHHHCTTSCCCCC------CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHH
T ss_pred HHHHhhcCcccccccc------ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccch
Confidence 5666666666544432 12223443433 3688888 999999999999999999999985
Q ss_pred ----cCcccc--ccCCCcEEeccCCccCCCCCccccccccccchhhccccccCCCCchhhhccccCceeeecccc-ccc-
Q 037275 211 ----VPPSIF--NISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQ-FRG- 282 (992)
Q Consensus 211 ----~p~~l~--~l~~L~~L~l~~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~-l~~- 282 (992)
+|..++ ++++|++|++++|++.+. +|..|+++++|++|++++|+ +++
T Consensus 235 ~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~-------------------------~p~~l~~l~~L~~L~Ls~n~~l~~~ 289 (636)
T 4eco_A 235 AQQYKTEDLKWDNLKDLTDVEVYNCPNLTK-------------------------LPTFLKALPEMQLINVACNRGISGE 289 (636)
T ss_dssp HHHHTTSCCCGGGCTTCCEEEEECCTTCSS-------------------------CCTTTTTCSSCCEEECTTCTTSCHH
T ss_pred hcccCchhhhhcccCCCCEEEecCCcCCcc-------------------------ChHHHhcCCCCCEEECcCCCCCccc
Confidence 899999 999999999999988754 45566677777777777777 776
Q ss_pred ccccccccc------CccceEecCCCCCCCCCCCCchhhhhccCCCcceEeecCCCcCCCcCCcccccccccceeEEeeC
Q 037275 283 KVSIYFRSL------KNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAG 356 (992)
Q Consensus 283 ~~~~~~~~l------~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~ 356 (992)
..|..+..+ ++|++|+|++|+++.++. ...+.++++|+.|++++|++.|.+| .+..+. +|++|++++
T Consensus 290 ~lp~~~~~L~~~~~l~~L~~L~L~~n~l~~ip~-----~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~-~L~~L~L~~ 362 (636)
T 4eco_A 290 QLKDDWQALADAPVGEKIQIIYIGYNNLKTFPV-----ETSLQKMKKLGMLECLYNQLEGKLP-AFGSEI-KLASLNLAY 362 (636)
T ss_dssp HHHHHHHHHHHSGGGGTCCEEECCSSCCSSCCC-----HHHHTTCTTCCEEECCSCCCEEECC-CCEEEE-EESEEECCS
T ss_pred cchHHHHhhhccccCCCCCEEECCCCcCCccCc-----hhhhccCCCCCEEeCcCCcCccchh-hhCCCC-CCCEEECCC
Confidence 666666665 778888888887775442 0135667777777777777777777 565554 577788888
Q ss_pred CccccccCCCccCCCc-ccEEEccCCcCCCCCCccccCCC--CCcEEeccCccccccCCCCCC-------CccccCceec
Q 037275 357 NQISGIIPTGIRNLVN-LVELCMDDNKLTGTIPHAIGELK--NLQLLYLDSNFLAGGIPTSLG-------NLTLLTNLAL 426 (992)
Q Consensus 357 n~i~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~L~~N~l~~~~~~~~~-------~l~~L~~L~L 426 (992)
|+++ .+|..+..+++ |++|++++|+++ .+|..+..+. +|+.|++++|++++..|..|. .+++|+.|+|
T Consensus 363 N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~L 440 (636)
T 4eco_A 363 NQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINL 440 (636)
T ss_dssp SEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEEC
T ss_pred Cccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEEC
Confidence 8877 66777888888 888888888887 6777776654 788888888888877777777 6777888888
Q ss_pred cCCcccCCCCCCccccccccccccccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeecccccc
Q 037275 427 SSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSG 506 (992)
Q Consensus 427 ~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 506 (992)
++|+++...+..+..+++|++|++++|+++ .+|...+.. .+..+.++++|++|+|++|+++
T Consensus 441 s~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~-----------------~~~~~~~l~~L~~L~Ls~N~l~- 501 (636)
T 4eco_A 441 SNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKD-----------------ENENFKNTYLLTSIDLRFNKLT- 501 (636)
T ss_dssp CSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEE-----------------TTEECTTGGGCCEEECCSSCCC-
T ss_pred cCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhcc-----------------ccccccccCCccEEECcCCcCC-
Confidence 888887433333455777777777776666 444332211 0112334569999999999999
Q ss_pred cCCcccc--cccccceeeccCCcccccCCccccccCCCCEEEC------CCcccCCCChhhhhcCCCcceEecCCCcCcc
Q 037275 507 EIPVTLS--ACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDM------SSNNLSGQIPEYLENLSFLEYLNLSYNHFEG 578 (992)
Q Consensus 507 ~~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L------s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 578 (992)
.+|..+. .+++|+.|+|++|+|++ +|..+.++++|++|+| ++|++.+.+|..+..+++|+.|+|++|++.
T Consensus 502 ~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~- 579 (636)
T 4eco_A 502 KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR- 579 (636)
T ss_dssp BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCCC-
T ss_pred ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcCC-
Confidence 6788886 99999999999999997 8999999999999999 568889999999999999999999999994
Q ss_pred cCCCCCccCCcccccccCCCCcCCCC
Q 037275 579 EVPTKGVFSNKTGISLSGNGKVCGGL 604 (992)
Q Consensus 579 ~~~~~~~~~~~~~~~l~~N~~~C~~~ 604 (992)
.+|.. .++.++.+++++|++.|-..
T Consensus 580 ~ip~~-~~~~L~~L~Ls~N~l~~~~~ 604 (636)
T 4eco_A 580 KVNEK-ITPNISVLDIKDNPNISIDL 604 (636)
T ss_dssp BCCSC-CCTTCCEEECCSCTTCEEEC
T ss_pred ccCHh-HhCcCCEEECcCCCCccccH
Confidence 55543 44889999999999988543
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-48 Score=455.93 Aligned_cols=482 Identities=17% Similarity=0.154 Sum_probs=318.3
Q ss_pred EEeeccccccCCccCCCCCCCCcCCeeeccCCCCCccCCccccCCCCCCEEEeecccCCCCCCcccccCCCCcEeecccc
Q 037275 53 TKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRN 132 (992)
Q Consensus 53 ~~ldl~~~~l~~~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n 132 (992)
+.+|++++++. .+|+.+. ++|++|+|++|++++..|..|..+++|++|+|++|++++..|..|+.+++|++|++++|
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 79 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence 36899999985 6887776 89999999999999766778999999999999999999777889999999999999999
Q ss_pred cccccCChhhcccccccccccccccccCC-CCCCccccccccceEEecCCcccCCcCCccCCCCcc--cEEeccCccc--
Q 037275 133 NLVGEIPAELGYNWLKLENLTIADNHLTG-HFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNL--ILLNLGENRF-- 207 (992)
Q Consensus 133 ~l~~~~p~~~~~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L--~~L~L~~n~l-- 207 (992)
+++ .+|.. .+++|++|+|++|.+++ .+|..|+++++|++|++++|.+.+ ..+..+++| +.|++++|++
T Consensus 80 ~l~-~lp~~---~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~ 152 (520)
T 2z7x_B 80 KLV-KISCH---PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYG 152 (520)
T ss_dssp CCC-EEECC---CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTT
T ss_pred cee-ecCcc---ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccc
Confidence 998 77776 67889999999999886 467888889999999999988855 356677777 8888888888
Q ss_pred ccccCccccccC-CCcEEeccCCccCCCCCccccccccccchhhccccccCCCCchhhhccccCceeeecccc-------
Q 037275 208 SGIVPPSIFNIS-SLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQ------- 279 (992)
Q Consensus 208 ~~~~p~~l~~l~-~L~~L~l~~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~------- 279 (992)
.+..|..+..+. +...+++++|++.+.++... +.++++|+.|++++|.
T Consensus 153 ~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~------------------------~~~l~~L~~L~l~~n~~~~~~~~ 208 (520)
T 2z7x_B 153 EKEDPEGLQDFNTESLHIVFPTNKEFHFILDVS------------------------VKTVANLELSNIKCVLEDNKCSY 208 (520)
T ss_dssp SSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCC------------------------CTTCSEEEECCEEECCSTTTTHH
T ss_pred cccccccccccccceEEEEeccCcchhhhhhhh------------------------hhcccceeeccccccccccccce
Confidence 667777777665 34455666776665555444 4445555555555554
Q ss_pred ccccccccccccCccceEecCCCCCCCCCCCCchhhhhccCCCcceEeecCCCcCCCcCCcccccccccceeEEeeCCcc
Q 037275 280 FRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQI 359 (992)
Q Consensus 280 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i 359 (992)
+.+.++ .|..+++|+.|++++|.++.... ..+......++ |++|++++|++
T Consensus 209 ~~~~~~-~l~~l~~L~~L~l~~~~l~~~~~---~~~~~~~~~~~-------------------------L~~L~l~~n~l 259 (520)
T 2z7x_B 209 FLSILA-KLQTNPKLSNLTLNNIETTWNSF---IRILQLVWHTT-------------------------VWYFSISNVKL 259 (520)
T ss_dssp HHHHHH-GGGGCTTCCEEEEEEEEEEHHHH---HHHHHHHHTSS-------------------------CSEEEEEEEEE
T ss_pred eecchh-hhccccchhhccccccccCHHHH---HHHHHHhhhCc-------------------------ccEEEeecccc
Confidence 443333 45555555555555554432100 00000001123 44444444444
Q ss_pred ccccCCCc-----cCCCcccEEEccCCcCCCCCC-ccccCC---CCCcEEeccCccccccCCCCCCCccccCceeccCCc
Q 037275 360 SGIIPTGI-----RNLVNLVELCMDDNKLTGTIP-HAIGEL---KNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSND 430 (992)
Q Consensus 360 ~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~~-~~~~~l---~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 430 (992)
++.+|..+ ..+++|+.+++++|.+ .+| ..+..+ .+|+.|++++|.+.+.. .+..+++|++|++++|+
T Consensus 260 ~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~ 335 (520)
T 2z7x_B 260 QGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNL 335 (520)
T ss_dssp ESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSC
T ss_pred cCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCc
Confidence 44444444 5555566666666655 223 333333 45666666666554221 12455556666666666
Q ss_pred ccCCCCCCccccccccccccccccccc--cCchhhhhhcccccccccccccccCcccc-cccCCCCccEEeeeccccccc
Q 037275 431 LQGSIPPSLGNCKNLIELHMADIELTG--ALPPQILSISTLSLSLDLSYNLLSGTLPL-EVGNLKNLVYFNISVNRFSGE 507 (992)
Q Consensus 431 l~~~~~~~~~~l~~L~~L~l~~n~l~~--~~p~~~~~~~~~~~~L~l~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~ 507 (992)
+++..|..+..+++|++|++++|++++ .+|.. +.....++.|++++|.+++.+|. .+..+++|++|++++|++++.
T Consensus 336 l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~ 414 (520)
T 2z7x_B 336 LTDTVFENCGHLTELETLILQMNQLKELSKIAEM-TTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDT 414 (520)
T ss_dssp CCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHH-HTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGG
T ss_pred cChhhhhhhccCCCCCEEEccCCccCccccchHH-HhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcc
Confidence 665555556666666666555555553 22222 22233344557777777764554 377888899999999998877
Q ss_pred CCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcccCCCChhhhhcCCCcceEecCCCcCcccCCCCCc-c
Q 037275 508 IPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGV-F 586 (992)
Q Consensus 508 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~ 586 (992)
.|..+. ++|+.|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..+..+++|++|++++|+++|.|+..+. .
T Consensus 415 ~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~~~~~~ 491 (520)
T 2z7x_B 415 IFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLS 491 (520)
T ss_dssp GGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHHHHHHHH
T ss_pred hhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccCCchHHHH
Confidence 776664 68899999999988 7787777889999999999999843334488888899999999999888875433 2
Q ss_pred CCcccc-cccCCCCcCCCCC
Q 037275 587 SNKTGI-SLSGNGKVCGGLD 605 (992)
Q Consensus 587 ~~~~~~-~l~~N~~~C~~~~ 605 (992)
.++... ........|+.|.
T Consensus 492 ~~~~~~~~~~~~~~~C~~p~ 511 (520)
T 2z7x_B 492 RWLNKNSQKEQGSAKCSGSG 511 (520)
T ss_dssp HHHHHTTTTEESCCBBTTTC
T ss_pred HHHHhccccCCCCCCcCCcc
Confidence 222111 1122445677653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=417.62 Aligned_cols=264 Identities=23% Similarity=0.386 Sum_probs=192.7
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC-CchhHHHHHHHHHHhccCCcceeEEEEeecccc------
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIITICSSIDF------ 750 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------ 750 (992)
.++|++.+.||+|+||+||+|+++.+|+.||||+++.... ...+.+.+|++++++++|||||++++++.+.+.
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 4578999999999999999999999999999999975443 234678999999999999999999998765331
Q ss_pred -cCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcE
Q 037275 751 -KGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVA 829 (992)
Q Consensus 751 -~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 829 (992)
....+.|+|||||++|+|.+++...... ...++..++.++.||++||+|||++ +|+||||||+|||++.++.+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~---~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~v 157 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTI---EERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVV 157 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSG---GGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCE
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCC---ChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcE
Confidence 2344579999999999999999865432 2356777899999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCCCCCc----ccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCC
Q 037275 830 HLGDFGLAKFLSSSPLDTAV----ETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQG 905 (992)
Q Consensus 830 kl~Dfg~a~~~~~~~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~ 905 (992)
||+|||+|+........... .........+||+.|||||++.+..|+.++||||+||++|||++ ||....+..
T Consensus 158 Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~ 234 (299)
T 4g31_A 158 KVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERV 234 (299)
T ss_dssp EECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH
T ss_pred EEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHH
Confidence 99999999987654321111 11122345679999999999999999999999999999999996 775421110
Q ss_pred ccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 906 LTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
..+........|. ...+......+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~p~---------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 235 RTLTDVRNLKFPP---------------------------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHHHTTCCCH---------------------------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHhcCCCCC---------------------------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0000000001110 11122344678999999999999999999986
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=457.64 Aligned_cols=486 Identities=18% Similarity=0.223 Sum_probs=325.2
Q ss_pred CCeeeccCCCCCccCCccccCCCCCCEEEeecccCCCCCCcccccCCCCcEeecccccccccCChhhccccccccccccc
Q 037275 76 LRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIA 155 (992)
Q Consensus 76 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~~L~L~ 155 (992)
..+.|+++|+++ .+|..+. ++|++|+|++|++++..|..|+.+++|++|++++|++++..|..+ ..+++|++|+|+
T Consensus 7 ~~~c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~-~~l~~L~~L~Ls 82 (549)
T 2z81_A 7 SGVCDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAF-YSLGSLEHLDLS 82 (549)
T ss_dssp TSEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTT-TTCTTCCEEECT
T ss_pred CceEECCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhc-cccccCCEEECC
Confidence 345688888888 7887664 789999999999987777888888888888888888874333333 467778888888
Q ss_pred ccccCCCCCCccccccccceEEecCCcccC-CcCCccCCCCcccEEeccCcccccccC-ccccccCCCcEEeccCCccCC
Q 037275 156 DNHLTGHFPASIGNLSTLERINVLGNGLWG-RIPNNLGNLRNLILLNLGENRFSGIVP-PSIFNISSLENVFLPTNRFNG 233 (992)
Q Consensus 156 ~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~-~~~~~l~~l~~L~~L~L~~n~l~~~~p-~~l~~l~~L~~L~l~~N~l~~ 233 (992)
+|.+++..|..|+++++|++|++++|.+.+ ..|..++++++|++|++++|++.+.+| ..+.++++|++|++++|++++
T Consensus 83 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~ 162 (549)
T 2z81_A 83 DNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRN 162 (549)
T ss_dssp TSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCE
T ss_pred CCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccc
Confidence 888776666667777778888887777754 345677777777777777777333343 567777777777777777664
Q ss_pred CCCccccccccccchhhccccccCCCCchhhhccccCceeeeccccccccccccccccCccceEecCCCCCCCCCCCCch
Q 037275 234 SLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLD 313 (992)
Q Consensus 234 ~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 313 (992)
. +|..++.+++|++|++++|.+.......+..+++|++|++++|+++..+....
T Consensus 163 ~-------------------------~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~- 216 (549)
T 2z81_A 163 Y-------------------------QSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPL- 216 (549)
T ss_dssp E-------------------------CTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCC-
T ss_pred c-------------------------ChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCcccccccccc-
Confidence 3 34445555555555555555553333333445555555555555554322111
Q ss_pred hhhhccCCCcceEeecCCCcCCCcCCccccc---ccccceeEEeeCCcccccc------CCCccCCCcccEEEccCCcCC
Q 037275 314 FLTLLTNCTELTAIGLDDNRFGGVLPHSIAN---LSSTMTDIVIAGNQISGII------PTGIRNLVNLVELCMDDNKLT 384 (992)
Q Consensus 314 ~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~---l~~~L~~L~l~~n~i~~~~------~~~~~~l~~L~~L~L~~N~l~ 384 (992)
.....+++|+.|++++|.+.+..+..+.. ....++.+++++|.+.+.. ...+..+.+|+.|++.++.+.
T Consensus 217 --~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~ 294 (549)
T 2z81_A 217 --PVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIP 294 (549)
T ss_dssp --SSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCS
T ss_pred --chhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccc
Confidence 11233455555666665555443332221 1124555666666555421 123445566666666666554
Q ss_pred CC-----CCccccCCCCCcEEeccCccccccCCCCC-CCccccCceeccCCcccCCC---CCCccccccccccccccccc
Q 037275 385 GT-----IPHAIGELKNLQLLYLDSNFLAGGIPTSL-GNLTLLTNLALSSNDLQGSI---PPSLGNCKNLIELHMADIEL 455 (992)
Q Consensus 385 ~~-----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~---~~~~~~l~~L~~L~l~~n~l 455 (992)
.. .+..+....+|+.|++++|+++ .+|..+ ..+++|++|++++|++++.. +..++.+++|++|++++|++
T Consensus 295 ~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l 373 (549)
T 2z81_A 295 QFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHL 373 (549)
T ss_dssp CGGGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCC
T ss_pred hhhhcccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcc
Confidence 21 1122233456666777766665 444443 35666667777777666543 23356666677777777766
Q ss_pred cccCc-hhhhhhcccccccccccccccCcccccccCCCCccEEeeecccccccCCcccccccccceeeccCCcccccCCc
Q 037275 456 TGALP-PQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPS 534 (992)
Q Consensus 456 ~~~~p-~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 534 (992)
++..+ ...+.....++.|++++|+++ .+|..+..+++|++|++++|++++ +|..+. ++|++|+|++|+|++.+
T Consensus 374 ~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~-l~~~~~--~~L~~L~Ls~N~l~~~~-- 447 (549)
T 2z81_A 374 RSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV-VKTCIP--QTLEVLDVSNNNLDSFS-- 447 (549)
T ss_dssp CCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSC-CCTTSC--TTCSEEECCSSCCSCCC--
T ss_pred cccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCccc-ccchhc--CCceEEECCCCChhhhc--
Confidence 63221 133444455666788888888 678889999999999999999984 454442 58999999999999643
Q ss_pred cccccCCCCEEECCCcccCCCChhhhhcCCCcceEecCCCcCcccCCC-CCccCCcccccccCCCCcCCCC
Q 037275 535 SLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPT-KGVFSNKTGISLSGNGKVCGGL 604 (992)
Q Consensus 535 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~~~~~~l~~N~~~C~~~ 604 (992)
..+++|++|+|++|+|+ .+|. ...+++|++|+|++|++++.+|. ...++.++.+++.+|+|.|+|+
T Consensus 448 --~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 448 --LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp --CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred --ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence 57899999999999999 6665 46799999999999999998876 4677889999999999999885
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=417.90 Aligned_cols=243 Identities=23% Similarity=0.305 Sum_probs=191.1
Q ss_pred cCCCCCCccccccceEEEEeEEC---CCCeEEEEEEeeccC--CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCc
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLG---ENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 753 (992)
++|++.+.||+|+||+||+|+.. .+++.||||+++... ......+.+|++++++++|||||++++++. +.
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~ 98 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQ-----TE 98 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEE-----ET
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----EC
Confidence 47999999999999999999873 467899999996432 223456889999999999999999999954 45
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGD 833 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 833 (992)
+..|+|||||++|+|.+++.+.. .+++.++..++.|++.||+|||++ +|+||||||+|||++.+|.+||+|
T Consensus 99 ~~~~ivmEy~~gg~L~~~l~~~~------~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~D 169 (304)
T 3ubd_A 99 GKLYLILDFLRGGDLFTRLSKEV------MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTD 169 (304)
T ss_dssp TEEEEEECCCTTCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEES
T ss_pred CEEEEEEEcCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecc
Confidence 67899999999999999998643 589999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 913 (992)
||+|+..... .......+||+.|||||++.+..|+.++||||+||++|||+||+.||.+....
T Consensus 170 FGla~~~~~~--------~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~--------- 232 (304)
T 3ubd_A 170 FGLSKESIDH--------EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK--------- 232 (304)
T ss_dssp SEEEEC-------------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---------
T ss_pred cccceeccCC--------CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH---------
Confidence 9999865432 12233467999999999999999999999999999999999999999763211
Q ss_pred hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCH
Q 037275 914 TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEM 972 (992)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 972 (992)
+.+.......+. .+. ....++.+++.+||+.||++|||+
T Consensus 233 --------~~~~~i~~~~~~--~p~----------~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 233 --------ETMTMILKAKLG--MPQ----------FLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp --------HHHHHHHHCCCC--CCT----------TSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred --------HHHHHHHcCCCC--CCC----------cCCHHHHHHHHHHcccCHHHCCCC
Confidence 111111111110 000 113458899999999999999995
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=461.25 Aligned_cols=470 Identities=19% Similarity=0.217 Sum_probs=367.0
Q ss_pred CcCCeeeccCCCCCccCCccccCCCCCCEEEe-ecccCCCCCCcccccCC-CCc-----Eeec----------ccccccc
Q 037275 74 SFLRYLNLADNNFHGEIPHQIGRLVRLEALVL-ANNSFSGKIPTNLSRCS-NLI-----SFNA----------RRNNLVG 136 (992)
Q Consensus 74 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L-s~n~l~~~~p~~l~~l~-~L~-----~L~l----------~~n~l~~ 136 (992)
.+++.|+|++|++.|.+|++|+.|++|++|+| ++|.++|..|-...... .+. .+.. ...++.+
T Consensus 323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~ 402 (876)
T 4ecn_A 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402 (876)
T ss_dssp SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence 57899999999999999999999999999999 99999877553321110 000 0000 0000000
Q ss_pred cCC----------hhhcccccccccccccc--cccCCCCCCccccccccceEEecCCcccC-----------------Cc
Q 037275 137 EIP----------AELGYNWLKLENLTIAD--NHLTGHFPASIGNLSTLERINVLGNGLWG-----------------RI 187 (992)
Q Consensus 137 ~~p----------~~~~~~l~~L~~L~L~~--n~l~~~~p~~~~~l~~L~~L~l~~n~l~~-----------------~~ 187 (992)
.++ .........++.+.+.. |.+++ +|..|+++++|++|+|++|.+.+ .+
T Consensus 403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~i 481 (876)
T 4ecn_A 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYE 481 (876)
T ss_dssp HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHT
T ss_pred HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccC
Confidence 000 00001234566666655 99997 89999999999999999999987 39
Q ss_pred CCccC--CCCcccEEeccCcccccccCccccccCCCcEEeccCCc-cCC-CCCccccccccccchhhccccccCCCCchh
Q 037275 188 PNNLG--NLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNR-FNG-SLPLDIGVSLPKLLGFIVAENNFAGSIPES 263 (992)
Q Consensus 188 ~~~l~--~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~-l~~-~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~ 263 (992)
|..++ ++++|++|+|++|++.+.+|..|+++++|++|+|++|+ +++ .+|..+.. ++..
T Consensus 482 P~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~------------------L~~~ 543 (876)
T 4ecn_A 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTR------------------LADD 543 (876)
T ss_dssp TSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHH------------------HHHC
T ss_pred ChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHh------------------hhhc
Confidence 99988 99999999999999999999999999999999999998 775 44433220 0112
Q ss_pred hhccccCceeeeccccccccccc--cccccCccceEecCCCCCCCCCCCCchhhhhccCCCcceEeecCCCcCCCcCCcc
Q 037275 264 LSNASNLVELTLFDNQFRGKVSI--YFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHS 341 (992)
Q Consensus 264 l~~l~~L~~L~L~~N~l~~~~~~--~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~l~~~~~~~ 341 (992)
+..+++|++|+|++|+++ .+|. .|.++++|++|+|++|+++.++ .+..+++|+.|++++|++. .+|..
T Consensus 544 ~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~~lp--------~~~~L~~L~~L~Ls~N~l~-~lp~~ 613 (876)
T 4ecn_A 544 EDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVRHLE--------AFGTNVKLTDLKLDYNQIE-EIPED 613 (876)
T ss_dssp TTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCCBCC--------CCCTTSEESEEECCSSCCS-CCCTT
T ss_pred ccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcccch--------hhcCCCcceEEECcCCccc-cchHH
Confidence 334459999999999999 6676 8999999999999999998655 3788899999999999999 88988
Q ss_pred cccccccceeEEeeCCccccccCCCccCCCc--ccEEEccCCcCCCCCCccc---c--CCCCCcEEeccCccccccCCCC
Q 037275 342 IANLSSTMTDIVIAGNQISGIIPTGIRNLVN--LVELCMDDNKLTGTIPHAI---G--ELKNLQLLYLDSNFLAGGIPTS 414 (992)
Q Consensus 342 ~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~--L~~L~L~~N~l~~~~~~~~---~--~l~~L~~L~L~~N~l~~~~~~~ 414 (992)
+..+..+|+.|+|++|+++ .+|..+..+.. |+.|+|++|++.+.+|... . .+++|+.|+|++|+++ .+|..
T Consensus 614 l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~ 691 (876)
T 4ecn_A 614 FCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTE 691 (876)
T ss_dssp SCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHH
T ss_pred HhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHH
Confidence 9888766999999999999 67888887755 9999999999998766432 2 3458999999999999 55554
Q ss_pred -CCCccccCceeccCCcccCCCCCCcccc--------ccccccccccccccccCchhhhhhcccccccccccccccCccc
Q 037275 415 -LGNLTLLTNLALSSNDLQGSIPPSLGNC--------KNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLP 485 (992)
Q Consensus 415 -~~~l~~L~~L~L~~N~l~~~~~~~~~~l--------~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~ 485 (992)
+..+++|+.|+|++|+|+ .+|..+... ++|+.| +|++|+++ .+|
T Consensus 692 ~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L-------------------------~Ls~N~L~-~lp 744 (876)
T 4ecn_A 692 LFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTI-------------------------DLRFNKLT-SLS 744 (876)
T ss_dssp HHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEE-------------------------ECCSSCCC-CCC
T ss_pred HHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEE-------------------------ECCCCCCc-cch
Confidence 458899999999999999 566544332 266666 55555565 677
Q ss_pred cccc--CCCCccEEeeecccccccCCcccccccccceeeccC------CcccccCCccccccCCCCEEECCCcccCCCCh
Q 037275 486 LEVG--NLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQG------NSFSGSIPSSLSSLKSIKELDMSSNNLSGQIP 557 (992)
Q Consensus 486 ~~~~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~------N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p 557 (992)
..+. .+++|+.|+|++|++++ +|..+..+++|+.|+|++ |++.+.+|..|.++++|+.|+|++|+| +.+|
T Consensus 745 ~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip 822 (876)
T 4ecn_A 745 DDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVD 822 (876)
T ss_dssp GGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCC
T ss_pred HHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccC
Confidence 7776 89999999999999997 788999999999999976 888999999999999999999999999 5888
Q ss_pred hhhhcCCCcceEecCCCcCcccCCCCC-ccCCcccccccCCCCcC--CCCC
Q 037275 558 EYLENLSFLEYLNLSYNHFEGEVPTKG-VFSNKTGISLSGNGKVC--GGLD 605 (992)
Q Consensus 558 ~~~~~l~~L~~L~l~~N~l~~~~~~~~-~~~~~~~~~l~~N~~~C--~~~~ 605 (992)
..+. ++|+.|||++|++....+... .........+.+|++.| +|+.
T Consensus 823 ~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~~~I~gC~~ 871 (876)
T 4ecn_A 823 EKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDA 871 (876)
T ss_dssp SCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTTSEEESCGG
T ss_pred Hhhc--CCCCEEECCCCCCCccChHHccccccchheeecCCCccccCCCCC
Confidence 8765 699999999999986544321 11223455667776655 6653
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=454.01 Aligned_cols=508 Identities=19% Similarity=0.172 Sum_probs=397.8
Q ss_pred CCCCCccCCccccCCCCCCEEEeecccCCCCCCcccccCCCCcEeecccccccccCChhhcccccccccccccccccCCC
Q 037275 83 DNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGH 162 (992)
Q Consensus 83 ~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~~L~L~~n~l~~~ 162 (992)
+.+++ .+|..+. +.+++|||++|+|++..|..|+++++|++|||++|+++ .+|+..+.++++|++|+|++|++++.
T Consensus 40 ~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~-~i~~~~f~~L~~L~~L~Ls~N~l~~l 115 (635)
T 4g8a_A 40 ELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSL 115 (635)
T ss_dssp TSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCC-EECTTTTTTCTTCCEEECTTCCCCEE
T ss_pred CCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCC-CcChhHhcCCCCCCEEEccCCcCCCC
Confidence 33444 6676553 47999999999999656678999999999999999998 78887777999999999999999977
Q ss_pred CCCccccccccceEEecCCcccCCcCCccCCCCcccEEeccCcccccc-cCccccccCCCcEEeccCCccCCCCCccccc
Q 037275 163 FPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGI-VPPSIFNISSLENVFLPTNRFNGSLPLDIGV 241 (992)
Q Consensus 163 ~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~-~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~ 241 (992)
.+..|.++++|++|++++|++.+..+..|+++++|++|+|++|++++. .|..+..+++|++|++++|++++..+. .+.
T Consensus 116 ~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~l~ 194 (635)
T 4g8a_A 116 ALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT-DLR 194 (635)
T ss_dssp CGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGG-GGH
T ss_pred CHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccc-ccc
Confidence 677899999999999999999877777899999999999999999853 578889999999999999999854443 333
Q ss_pred cccccc----hhhccccccCCCCchhhhccccCceeeeccccccc-cccccccccCccceEecCCCCCCC------CCCC
Q 037275 242 SLPKLL----GFIVAENNFAGSIPESLSNASNLVELTLFDNQFRG-KVSIYFRSLKNLEWLNLGSNNLGT------GEAN 310 (992)
Q Consensus 242 ~~~~L~----~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~------~~~~ 310 (992)
.+.++. .+.++.|.+....+..+ ....+..+++.+|.... ..+..+..+..++...+..+.... ....
T Consensus 195 ~L~~l~~~~~~~~ls~n~l~~i~~~~~-~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~ 273 (635)
T 4g8a_A 195 VLHQMPLLNLSLDLSLNPMNFIQPGAF-KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKS 273 (635)
T ss_dssp HHHTCTTCCCEEECTTCCCCEECTTTT-TTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTT
T ss_pred chhhhhhhhhhhhcccCcccccCcccc-cchhhhhhhhhcccccccccchhhcCCccccccccccccccccccccccccc
Confidence 344333 46678888886555544 44567888998886652 334456666666665554332211 1111
Q ss_pred Cchh---------------------hhhccCCCcceEeecCCCcCCCcCCcccccccccceeEEeeCCccccccCCCccC
Q 037275 311 DLDF---------------------LTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRN 369 (992)
Q Consensus 311 ~~~~---------------------~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~ 369 (992)
.+.. ...+..+.+++.+.+.++.+....+ +.. ...++.|++.+|.+.+..+. .
T Consensus 274 ~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~--~~~-~~~L~~L~l~~~~~~~~~~~---~ 347 (635)
T 4g8a_A 274 ALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKD--FSY-NFGWQHLELVNCKFGQFPTL---K 347 (635)
T ss_dssp TTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECGG--GGS-CCCCSEEEEESCEESSCCCC---B
T ss_pred ccccccchhhhhhhhhhhcccccchhhhhhhhcccccccccccccccccc--ccc-chhhhhhhcccccccCcCcc---c
Confidence 1110 1112333445555555555543322 111 23477788888887765443 4
Q ss_pred CCcccEEEccCCcCCCCCCccccCCCCCcEEeccCccccc--cCCCCCCCccccCceeccCCcccCCCCCCccccccccc
Q 037275 370 LVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAG--GIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIE 447 (992)
Q Consensus 370 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 447 (992)
+..|+.++++.|.+... ..+..+++|+.|++++|.+.. ..+..+..+.+|+.|+++.|.+.. .+..+..+++|+.
T Consensus 348 l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~-~~~~~~~l~~L~~ 424 (635)
T 4g8a_A 348 LKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVIT-MSSNFLGLEQLEH 424 (635)
T ss_dssp CTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEE-ECSCCTTCTTCCE
T ss_pred chhhhhcccccccCCCC--cccccccccccchhhccccccccccccchhhhhhhhhhhcccccccc-ccccccccccccc
Confidence 56778888888877632 334568899999999998863 345556677889999999999884 5667889999999
Q ss_pred cccccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeecccc-cccCCcccccccccceeeccCC
Q 037275 448 LHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRF-SGEIPVTLSACTSLQQLYLQGN 526 (992)
Q Consensus 448 L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l-~~~~~~~~~~l~~L~~L~L~~N 526 (992)
+++.+|......+...+.....+..+++++|.+++..+..+..++.|++|+|++|.+ .+..|..|..+++|++|+|++|
T Consensus 425 l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N 504 (635)
T 4g8a_A 425 LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 504 (635)
T ss_dssp EECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTS
T ss_pred hhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCC
Confidence 999999998888888888888889999999999999999999999999999999985 4468889999999999999999
Q ss_pred cccccCCccccccCCCCEEECCCcccCCCChhhhhcCCCcceEecCCCcCcccCCCC-Ccc-CCcccccccCCCCcCCCC
Q 037275 527 SFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTK-GVF-SNKTGISLSGNGKVCGGL 604 (992)
Q Consensus 527 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~-~~~~~~~l~~N~~~C~~~ 604 (992)
+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|++++.+|.. ..+ +.++.+++.+|||.|+|.
T Consensus 505 ~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 505 QLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp CCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred ccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence 999999999999999999999999999999999999999999999999999988763 333 678999999999999985
Q ss_pred C
Q 037275 605 D 605 (992)
Q Consensus 605 ~ 605 (992)
.
T Consensus 585 ~ 585 (635)
T 4g8a_A 585 H 585 (635)
T ss_dssp G
T ss_pred c
Confidence 3
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=416.54 Aligned_cols=284 Identities=23% Similarity=0.282 Sum_probs=205.7
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC--CchhHHHHHHHHHHhccCCcceeEEEEeecc-cccCcce
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK--GASNGFVAECQALRNIRHRNLIKIITICSSI-DFKGVDF 755 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~~~ 755 (992)
++|++.++||+|+||+||+|++..+|+.||||+++.... ...+.+.+|+++|++++|||||++++++... .+.+...
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 579999999999999999999999999999999964432 2345688999999999999999999987643 2445678
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.|+|||||+ |+|.+++.... .+++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~------~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFG 203 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQ------PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFG 203 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEeCCC-CCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecc
Confidence 899999995 68999997543 589999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
+|+.+...... ........+||+.|||||++.+. .++.++||||+||++|||++|++||.+....+ .+......
T Consensus 204 la~~~~~~~~~----~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~-~l~~I~~~ 278 (398)
T 4b99_A 204 MARGLCTSPAE----HQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH-QLQLIMMV 278 (398)
T ss_dssp TCBCC-----------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHHH
T ss_pred eeeecccCccc----cccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH-HHHHHHHh
Confidence 99876432211 12233456899999999998875 56899999999999999999999998743221 11111111
Q ss_pred h--CChhHHHHHHhhHhHhhhccCCCCCCccc-cchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 915 A--LPDKVMEIVDSVLLLEVQASNSRSCGDER-LRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 915 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
. .+..............+........+... ........++.+++.+||+.||++||||+|+++
T Consensus 279 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 279 LGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp HCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 1 01110000000000000000000000000 000012346789999999999999999999975
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=434.53 Aligned_cols=462 Identities=17% Similarity=0.154 Sum_probs=307.4
Q ss_pred EEeeccccccCCccCCCCCCCCcCCeeeccCCCCCccCCccccCCCCCCEEEeecccCCCCCCcccccCCCCcEeecccc
Q 037275 53 TKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRN 132 (992)
Q Consensus 53 ~~ldl~~~~l~~~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n 132 (992)
+.+|+++++++ .+|..+. ++|++|+|++|++++..|..|..+++|++|+|++|++++..|..|+.+++|++|++++|
T Consensus 34 ~~l~ls~~~L~-~ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 110 (562)
T 3a79_B 34 SMVDYSNRNLT-HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN 110 (562)
T ss_dssp CEEECTTSCCC-SCCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred cEEEcCCCCCc-cCCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence 78999999996 4887665 89999999999999777789999999999999999999777899999999999999999
Q ss_pred cccccCChhhcccccccccccccccccCC-CCCCccccccccceEEecCCcccCCcCCccCCCCcc--cEEeccCccc--
Q 037275 133 NLVGEIPAELGYNWLKLENLTIADNHLTG-HFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNL--ILLNLGENRF-- 207 (992)
Q Consensus 133 ~l~~~~p~~~~~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L--~~L~L~~n~l-- 207 (992)
+++ .+|.. .+++|++|+|++|.+++ .+|..|+++++|++|++++|.+.+. .+..+++| +.|++++|++
T Consensus 111 ~l~-~lp~~---~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~ 183 (562)
T 3a79_B 111 RLQ-NISCC---PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHI 183 (562)
T ss_dssp CCC-EECSC---CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCC
T ss_pred cCC-ccCcc---ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccc
Confidence 998 78877 68999999999999996 3468899999999999999998653 45555566 9999999999
Q ss_pred ccccCccccccC-CCcEEeccCCccCCCCCccccccccccchhhccccccCCCCchhhhccccCceeeecccc-----cc
Q 037275 208 SGIVPPSIFNIS-SLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQ-----FR 281 (992)
Q Consensus 208 ~~~~p~~l~~l~-~L~~L~l~~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~-----l~ 281 (992)
++..|..+..+. ..-.++++.|.+.+.++... +..+++|+.|++++|+ +.
T Consensus 184 ~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~------------------------~~~l~~L~~L~l~~n~~~~~~l~ 239 (562)
T 3a79_B 184 KGGETESLQIPNTTVLHLVFHPNSLFSVQVNMS------------------------VNALGHLQLSNIKLNDENCQRLM 239 (562)
T ss_dssp CSSSCCEEEECCEEEEEEEECSSSCCCCCCEEE------------------------ESSEEEEEEEEEECCSTTHHHHH
T ss_pred cccCcccccccCcceEEEEecCccchhhhhhhc------------------------ccccceEEEecccccccccchHH
Confidence 777888887765 12255677777765544433 3445555556665553 11
Q ss_pred ccccccccccCccceEecCCCCCCCCCCCCchhhhhccCCCcceEeecCCCcCCCcCCccc-----ccccccceeEEeeC
Q 037275 282 GKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSI-----ANLSSTMTDIVIAG 356 (992)
Q Consensus 282 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~l~~~~~~~~-----~~l~~~L~~L~l~~ 356 (992)
+ ....|..+++|+.|+++++.++... +.........++|++|++++|.+.+.+|..+ ..+ ..|..+++..
T Consensus 240 ~-~~~~l~~l~~L~~L~L~~~~l~~~~---~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L-~~L~~~~~~~ 314 (562)
T 3a79_B 240 T-FLSELTRGPTLLNVTLQHIETTWKC---SVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETAL-KSLMIEHVKN 314 (562)
T ss_dssp H-HHHHHHSCSSCEEEEEEEEEECHHH---HHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSC-CEEEEEEEEE
T ss_pred H-HHHHHhccCcceEEEecCCcCcHHH---HHHHHHhhhcccccEEEEeccEeeccccchhhhcccccc-hheehhhccc
Confidence 1 1123455556666665555443210 1111111122355555555555555555444 111 1233333333
Q ss_pred CccccccC-CCccC---CCcccEEEccCCcCCCCCCccccCCCCCcEEeccCccccccCCCCCCCccccCceeccCCccc
Q 037275 357 NQISGIIP-TGIRN---LVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQ 432 (992)
Q Consensus 357 n~i~~~~~-~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 432 (992)
|.+ .+| ..+.. ..+|++|++++|.+.... ....+++|++|++++|++++..|..+.++++|+.|++++|+++
T Consensus 315 ~~~--~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 390 (562)
T 3a79_B 315 QVF--LFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK 390 (562)
T ss_dssp CCC--SSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCC
T ss_pred cee--ecChhhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcC
Confidence 333 111 11111 134555555555543211 1134555555555555555545555555555555555555555
Q ss_pred CCC--CCCccccccccccccccccccccCchhhhhhcccccccccccccccCcccc-cccCCCCccEEeeecccccccCC
Q 037275 433 GSI--PPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPL-EVGNLKNLVYFNISVNRFSGEIP 509 (992)
Q Consensus 433 ~~~--~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~ 509 (992)
+.. |..|..+++|++| ++++|++++.+|. .+..+++|++|+|++|++++..|
T Consensus 391 ~~~~~~~~~~~l~~L~~L-------------------------~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 445 (562)
T 3a79_B 391 NFFKVALMTKNMSSLETL-------------------------DVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVF 445 (562)
T ss_dssp BTTHHHHTTTTCTTCCEE-------------------------ECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGG
T ss_pred CcccchhhhcCCCCCCEE-------------------------ECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchh
Confidence 321 2334445555444 6666666653443 47788899999999999887666
Q ss_pred cccccccccceeeccCCcccccCCccccccCCCCEEECCCcccCCCChhhhhcCCCcceEecCCCcCcccCCCCCc
Q 037275 510 VTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGV 585 (992)
Q Consensus 510 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~ 585 (992)
..+. ++|++|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..+..+++|++|++++|+|.|.|+..+.
T Consensus 446 ~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~~~~ 518 (562)
T 3a79_B 446 RCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPGIRY 518 (562)
T ss_dssp SSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCCHHHHHH
T ss_pred hhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCCcchHHH
Confidence 6554 68899999999988 6777777889999999999999843333488889999999999999988876444
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=439.40 Aligned_cols=447 Identities=20% Similarity=0.247 Sum_probs=332.6
Q ss_pred CeEEEeeccccccCCccCCCCCCCCcCCeeeccCCCCCccCCccccCCCCCCEEEeecccCCCCCCcccccCCCCcEeec
Q 037275 50 QRVTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNA 129 (992)
Q Consensus 50 ~~v~~ldl~~~~l~~~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l 129 (992)
.+++.|||++|.+.+..|..++.+++|++|+|++|++++..|..|+.+++|++|+|++|+++ .+|.. .+++|++|++
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 97 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDL 97 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEEC
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEec
Confidence 57899999999998777788999999999999999999877999999999999999999999 78877 8999999999
Q ss_pred ccccccc-cCChhhcccccccccccccccccCCCCCCcccccccc--ceEEecCCcc--cCCcCCccCCCC-cccEEecc
Q 037275 130 RRNNLVG-EIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTL--ERINVLGNGL--WGRIPNNLGNLR-NLILLNLG 203 (992)
Q Consensus 130 ~~n~l~~-~~p~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L--~~L~l~~n~l--~~~~~~~l~~l~-~L~~L~L~ 203 (992)
++|++++ .+|..+. ++++|++|++++|.+++ ..+..+++| ++|++++|.+ .+..|..+..+. +...++++
T Consensus 98 ~~N~l~~~~~p~~~~-~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~ 173 (520)
T 2z7x_B 98 SFNAFDALPICKEFG-NMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFP 173 (520)
T ss_dssp CSSCCSSCCCCGGGG-GCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECC
T ss_pred cCCccccccchhhhc-cCCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEEEEec
Confidence 9999996 4677765 89999999999999986 567888888 9999999999 888898888876 45577889
Q ss_pred CcccccccCc-cccccCCCcEEeccCCccCCCCCccccccccccchhhccccccCCCCchhhhccccCceeeeccccccc
Q 037275 204 ENRFSGIVPP-SIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRG 282 (992)
Q Consensus 204 ~n~l~~~~p~-~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~ 282 (992)
+|++.+.++. .+..+++|+.|++++|.-..... .+.+.+| .++.+++|+.|++++|.+++
T Consensus 174 ~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~------------------~~~~~~~-~l~~l~~L~~L~l~~~~l~~ 234 (520)
T 2z7x_B 174 TNKEFHFILDVSVKTVANLELSNIKCVLEDNKCS------------------YFLSILA-KLQTNPKLSNLTLNNIETTW 234 (520)
T ss_dssp SSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTH------------------HHHHHHH-GGGGCTTCCEEEEEEEEEEH
T ss_pred cCcchhhhhhhhhhcccceeeccccccccccccc------------------eeecchh-hhccccchhhccccccccCH
Confidence 9998876554 67789999999999987110000 0111222 45555666666666665553
Q ss_pred ccccccc---ccCccceEecCCCCCC-CCCCCCchhhhhccCCCcceEeecCCCcCCCcCC-ccccccc--ccceeEEee
Q 037275 283 KVSIYFR---SLKNLEWLNLGSNNLG-TGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLP-HSIANLS--STMTDIVIA 355 (992)
Q Consensus 283 ~~~~~~~---~l~~L~~L~L~~N~l~-~~~~~~~~~~~~l~~~~~L~~L~l~~n~l~~~~~-~~~~~l~--~~L~~L~l~ 355 (992)
.....+. ..++|++|++++|+++ .++...+.. ....+++|+.+++++|.+ .+| ..+..+. .+++.|+++
T Consensus 235 ~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~--~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~ 310 (520)
T 2z7x_B 235 NSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDY--SGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVS 310 (520)
T ss_dssp HHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCC--CSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEE
T ss_pred HHHHHHHHHhhhCcccEEEeecccccCccccchhhc--ccccCceeEeccccccce--ecchhhhhcccccCceeEEEcC
Confidence 3222111 1345666666666655 333221100 014555666666666666 333 3333321 237777777
Q ss_pred CCccccccCCCccCCCcccEEEccCCcCCCCCCccccCCCCCcEEeccCccccc--cCCCCCCCccccCceeccCCcccC
Q 037275 356 GNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAG--GIPTSLGNLTLLTNLALSSNDLQG 433 (992)
Q Consensus 356 ~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~ 433 (992)
+|.+.... .+..+++|++|++++|++++..|..+..+++|+.|+|++|++++ .+|..+..+++|++|++++|++++
T Consensus 311 ~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~ 388 (520)
T 2z7x_B 311 GTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSY 388 (520)
T ss_dssp SSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBC
T ss_pred CCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCc
Confidence 77765432 12577788888888888887788888888888888888888875 445667788888888888888886
Q ss_pred CCCC-CccccccccccccccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeecccccccCCccc
Q 037275 434 SIPP-SLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTL 512 (992)
Q Consensus 434 ~~~~-~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 512 (992)
.+|. .+..+++|++|++++ |++++..|..+. ++|++|+|++|+++ .+|..+
T Consensus 389 ~l~~~~~~~l~~L~~L~Ls~-------------------------N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~ 440 (520)
T 2z7x_B 389 DEKKGDCSWTKSLLSLNMSS-------------------------NILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQV 440 (520)
T ss_dssp CGGGCSCCCCTTCCEEECCS-------------------------SCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGG
T ss_pred ccccchhccCccCCEEECcC-------------------------CCCCcchhhhhc--ccCCEEECCCCccc-ccchhh
Confidence 4444 467777777775555 445445555443 79999999999999 788878
Q ss_pred ccccccceeeccCCcccccCCcc-ccccCCCCEEECCCcccCCCCh
Q 037275 513 SACTSLQQLYLQGNSFSGSIPSS-LSSLKSIKELDMSSNNLSGQIP 557 (992)
Q Consensus 513 ~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p 557 (992)
..+++|++|+|++|+|++ +|.. |..+++|++|+|++|++++..+
T Consensus 441 ~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c~c~ 485 (520)
T 2z7x_B 441 VKLEALQELNVASNQLKS-VPDGIFDRLTSLQKIWLHTNPWDCSCP 485 (520)
T ss_dssp GGCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred hcCCCCCEEECCCCcCCc-cCHHHhccCCcccEEECcCCCCcccCC
Confidence 899999999999999995 5554 9999999999999999997544
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=402.97 Aligned_cols=210 Identities=25% Similarity=0.350 Sum_probs=172.2
Q ss_pred HHhcCCCCCCccccccceEEEEeEEC---CCCeEEEEEEeeccCCCchhHHHHHHHHHHhc-cCCcceeEEEEeeccccc
Q 037275 676 KATNDFSSSNMIGQGSFGFVYKGNLG---ENGMMVAVKVINLKQKGASNGFVAECQALRNI-RHRNLIKIITICSSIDFK 751 (992)
Q Consensus 676 ~~~~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 751 (992)
...++|++.++||+|+||+||+|+++ .+++.||+|++... ....++.+|+++++.+ +||||+++++++ .
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~-----~ 90 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCF-----R 90 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEE-----E
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEE-----E
Confidence 44678999999999999999999874 46789999998533 3456788999999998 699999999985 4
Q ss_pred CcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCC-CcEE
Q 037275 752 GVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQD-LVAH 830 (992)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~k 830 (992)
..++.++||||+++|+|.+++. .+++.++..++.|++.||+|||++ ||+||||||+|||++.+ +.+|
T Consensus 91 ~~~~~~lvmE~~~g~~L~~~~~---------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~k 158 (361)
T 4f9c_A 91 KNDHVVIAMPYLEHESFLDILN---------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYA 158 (361)
T ss_dssp ETTEEEEEEECCCCCCHHHHHT---------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEE
T ss_pred ECCEEEEEEeCCCcccHHHHHc---------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEE
Confidence 4567899999999999999984 388999999999999999999999 99999999999999877 7999
Q ss_pred EeecccceecCCCCCCCC--------------------cccCCCCCcccccccccccccccCC-CcCcccchhhHHHHHH
Q 037275 831 LGDFGLAKFLSSSPLDTA--------------------VETPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLL 889 (992)
Q Consensus 831 l~Dfg~a~~~~~~~~~~~--------------------~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ 889 (992)
|+|||+|+.......... ..........+||+.|||||++.+. .|+.++||||+||++|
T Consensus 159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ 238 (361)
T 4f9c_A 159 LVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFL 238 (361)
T ss_dssp ECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHH
T ss_pred ECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHH
Confidence 999999987654321100 0011122345799999999998775 5899999999999999
Q ss_pred HHHhCCCCCCCCccC
Q 037275 890 EMFTRRRPTDGMFNQ 904 (992)
Q Consensus 890 elltg~~pf~~~~~~ 904 (992)
||++|+.||....++
T Consensus 239 ell~G~~Pf~~~~~~ 253 (361)
T 4f9c_A 239 SLLSGRYPFYKASDD 253 (361)
T ss_dssp HHHHTCSSSSCCSSH
T ss_pred HHHHCCCCCCCCCCH
Confidence 999999999764443
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=411.32 Aligned_cols=250 Identities=24% Similarity=0.296 Sum_probs=198.1
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc---CCCchhHHHHH---HHHHHhccCCcceeEEEEeeccccc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK---QKGASNGFVAE---CQALRNIRHRNLIKIITICSSIDFK 751 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E---~~~l~~l~h~niv~~~~~~~~~~~~ 751 (992)
.++|++.++||+|+||+||+|+++.+|+.||||+++.. .........+| +.+++.++|||||++++++ .
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f-----~ 262 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----H 262 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-----E
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE-----E
Confidence 46899999999999999999999999999999999643 12223333444 5666777999999999984 4
Q ss_pred CcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEE
Q 037275 752 GVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHL 831 (992)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 831 (992)
+.+.+|+|||||+||+|.+++.+.. .+++..+..++.||+.||+|||++ +||||||||+|||++.+|.+||
T Consensus 263 ~~~~lylVmEy~~GGdL~~~l~~~~------~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL 333 (689)
T 3v5w_A 263 TPDKLSFILDLMNGGDLHYHLSQHG------VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRI 333 (689)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEE
T ss_pred ECCEEEEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEe
Confidence 5677899999999999999998643 589999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCCCCCcccCCCCCcccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHH
Q 037275 832 GDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHE 910 (992)
Q Consensus 832 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~ 910 (992)
+|||+|+.+.... ....+||+.|||||++.+ ..|+.++||||+||++|||++|++||.+..... ..
T Consensus 334 ~DFGlA~~~~~~~----------~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~--~~- 400 (689)
T 3v5w_A 334 SDLGLACDFSKKK----------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KH- 400 (689)
T ss_dssp CCCTTCEECSSCC----------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC--HH-
T ss_pred cccceeeecCCCC----------CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HH-
Confidence 9999998765321 234579999999999864 579999999999999999999999997632221 11
Q ss_pred HHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 037275 911 FARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERME-----MRDVVA 977 (992)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 977 (992)
.+.......... .+ .....++.+++.+||+.||++|++ ++||++
T Consensus 401 -----------~i~~~i~~~~~~------~p------~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 401 -----------EIDRMTLTMAVE------LP------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp -----------HHHHHHHHCCCC------CC------TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred -----------HHHHhhcCCCCC------CC------ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 111111111100 00 011345789999999999999998 677754
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=415.74 Aligned_cols=253 Identities=21% Similarity=0.315 Sum_probs=206.7
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
.++|++.+.||+|+||+||+|+++.+|+.||+|++........+.+.+|+.+|+.++|||||++++++ .+...++
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-----~~~~~~~ 230 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMV 230 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----ECSSEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEE
Confidence 46899999999999999999999999999999999765555567789999999999999999999995 4566789
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCC--CcEEEeecc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQD--LVAHLGDFG 835 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~Dfg 835 (992)
+|||||++|+|.+++..... .+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||
T Consensus 231 iv~E~~~gg~L~~~i~~~~~-----~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG 302 (573)
T 3uto_A 231 MIYEFMSGGELFEKVADEHN-----KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFG 302 (573)
T ss_dssp EEEECCCCCBHHHHHTCTTS-----CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCS
T ss_pred EEEeecCCCcHHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeecc
Confidence 99999999999999975432 489999999999999999999999 99999999999999854 899999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 915 (992)
+|+.+.... .....+||+.|||||++.+..|+.++||||+||++|||++|++||.+....
T Consensus 303 ~a~~~~~~~---------~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~----------- 362 (573)
T 3uto_A 303 LTAHLDPKQ---------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD----------- 362 (573)
T ss_dssp SCEECCTTS---------EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-----------
T ss_pred ceeEccCCC---------ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-----------
Confidence 999875421 123357999999999999999999999999999999999999999863221
Q ss_pred CChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 916 LPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
+.+.......+.. .. ........++.+++.+||+.||++|||+.|+++
T Consensus 363 ------~~~~~i~~~~~~~------~~--~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 363 ------ETLRNVKSCDWNM------DD--SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp ------HHHHHHHTTCCCC------CS--GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ------HHHHHHHhCCCCC------Cc--ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111111111100 00 000112345789999999999999999999986
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=385.04 Aligned_cols=294 Identities=28% Similarity=0.457 Sum_probs=258.7
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCCcCCCCCCc--eEeeEEcCCC--CeEEEeeccccccCC--ccCCCCCCCCcC
Q 037275 3 VPSNETDRLALLAIGSQLEDDPLGVTSSWNNSTNLCQ--WTGVTCGHRH--QRVTKLDLSNRTIGG--TLSPYVGNLSFL 76 (992)
Q Consensus 3 ~~~~~~~~~~ll~~~~~~~~~~~~~~~~w~~~~~~c~--w~gv~c~~~~--~~v~~ldl~~~~l~~--~l~~~l~~l~~L 76 (992)
+.|.++|++||++||+++. ||. .+++|+.+++||. |.||+|+..+ ++|+.|||+++.+.+ .+|+.++.+++|
T Consensus 1 ~~c~~~~~~aL~~~k~~~~-~~~-~l~~W~~~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L 78 (313)
T 1ogq_A 1 ELCNPQDKQALLQIKKDLG-NPT-TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL 78 (313)
T ss_dssp CCSCHHHHHHHHHHHHHTT-CCG-GGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred CCCCHHHHHHHHHHHHhcC-Ccc-cccCCCCCCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCC
Confidence 4699999999999999984 665 7899988899998 9999998655 799999999999999 899999999999
Q ss_pred CeeeccC-CCCCccCCccccCCCCCCEEEeecccCCCCCCcccccCCCCcEeecccccccccCChhhccccccccccccc
Q 037275 77 RYLNLAD-NNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIA 155 (992)
Q Consensus 77 ~~L~L~~-n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~~L~L~ 155 (992)
++|+|++ |.+.+.+|..|+.+++|++|+|++|++++.+|..++.+++|++|++++|++++.+|..+. .+++|++|+|+
T Consensus 79 ~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~L~ 157 (313)
T 1ogq_A 79 NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSIS-SLPNLVGITFD 157 (313)
T ss_dssp SEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGG-GCTTCCEEECC
T ss_pred CeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHh-cCCCCCeEECc
Confidence 9999995 999999999999999999999999999999999999999999999999999988998876 79999999999
Q ss_pred ccccCCCCCCcccccc-ccceEEecCCcccCCcCCccCCCCcccEEeccCcccccccCccccccCCCcEEeccCCccCCC
Q 037275 156 DNHLTGHFPASIGNLS-TLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGS 234 (992)
Q Consensus 156 ~n~l~~~~p~~~~~l~-~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~ 234 (992)
+|.+++.+|..++.++ +|++|++++|.+.+.+|..+..+. |+.|+|++|++++..|..+..+++|++|++++|++++.
T Consensus 158 ~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 236 (313)
T 1ogq_A 158 GNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFD 236 (313)
T ss_dssp SSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCB
T ss_pred CCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeee
Confidence 9999999999999998 999999999999989999999987 99999999999998999999999999999999999866
Q ss_pred CCccccccccccchhhccccccCCCCchhhhccccCceeeeccccccccccccccccCccceEecCCCC
Q 037275 235 LPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNN 303 (992)
Q Consensus 235 ~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 303 (992)
+|. +..+++|++|++++|++++.+|..+..+++|++|+|++|++++.+|.. ..+++|+.|++++|+
T Consensus 237 ~~~--~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 237 LGK--VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNK 302 (313)
T ss_dssp GGG--CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSS
T ss_pred cCc--ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCC
Confidence 554 345667777777777777677777777777777777777777666654 566666666666665
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=410.59 Aligned_cols=444 Identities=19% Similarity=0.211 Sum_probs=338.3
Q ss_pred CeEEEeeccccccCCccCCCCCCCCcCCeeeccCCCCCccCCccccCCCCCCEEEeecccCCCCCCcccccCCCCcEeec
Q 037275 50 QRVTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNA 129 (992)
Q Consensus 50 ~~v~~ldl~~~~l~~~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l 129 (992)
..++.|||++|.+.+..+..++.+++|++|+|++|++++..|+.|..+++|++|+|++|+++ .+|.. .+++|++|++
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 128 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDL 128 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEEC
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEEC
Confidence 46899999999998777789999999999999999999878999999999999999999999 78877 8999999999
Q ss_pred ccccccc-cCChhhcccccccccccccccccCCCCCCcccccccc--ceEEecCCcc--cCCcCCccCCCC--cccEEec
Q 037275 130 RRNNLVG-EIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTL--ERINVLGNGL--WGRIPNNLGNLR--NLILLNL 202 (992)
Q Consensus 130 ~~n~l~~-~~p~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L--~~L~l~~n~l--~~~~~~~l~~l~--~L~~L~L 202 (992)
++|++++ .+|..+. ++++|++|++++|.+++ ..+..+++| ++|++++|.+ .+..|..|..+. .| .+++
T Consensus 129 s~N~l~~l~~p~~~~-~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l-~l~l 203 (562)
T 3a79_B 129 SFNDFDVLPVCKEFG-NLTKLTFLGLSAAKFRQ---LDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVL-HLVF 203 (562)
T ss_dssp CSSCCSBCCCCGGGG-GCTTCCEEEEECSBCCT---TTTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEE-EEEE
T ss_pred CCCCccccCchHhhc-ccCcccEEecCCCcccc---CchhhhhhceeeEEEeecccccccccCcccccccCcceE-EEEe
Confidence 9999985 3445554 89999999999999986 356666666 9999999999 888888888765 33 6688
Q ss_pred cCcccccccCc-cccccCCCcEEeccCCccCCCCCccccccccccchhhccccccCCCCchhhhccccCceeeecccccc
Q 037275 203 GENRFSGIVPP-SIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFR 281 (992)
Q Consensus 203 ~~n~l~~~~p~-~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~ 281 (992)
++|.+.+.++. .+..+++|+.|++++|+..-. .+. .....+..+++|+.|+++++.+.
T Consensus 204 ~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~--------------------~l~-~~~~~l~~l~~L~~L~L~~~~l~ 262 (562)
T 3a79_B 204 HPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQ--------------------RLM-TFLSELTRGPTLLNVTLQHIETT 262 (562)
T ss_dssp CSSSCCCCCCEEEESSEEEEEEEEEECCSTTHH--------------------HHH-HHHHHHHSCSSCEEEEEEEEEEC
T ss_pred cCccchhhhhhhcccccceEEEecccccccccc--------------------hHH-HHHHHHhccCcceEEEecCCcCc
Confidence 99998876654 466789999999999852200 000 11224555566666666665554
Q ss_pred cccccc---ccccCccceEecCCCCCC-CCCCCCchhhhhccCCCcceEeecCCCcCCCcCC-cccccc--cccceeEEe
Q 037275 282 GKVSIY---FRSLKNLEWLNLGSNNLG-TGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLP-HSIANL--SSTMTDIVI 354 (992)
Q Consensus 282 ~~~~~~---~~~l~~L~~L~L~~N~l~-~~~~~~~~~~~~l~~~~~L~~L~l~~n~l~~~~~-~~~~~l--~~~L~~L~l 354 (992)
+..... .....+|++|++++|+++ .++...+.. ...+++.|+.++++.|.+ .+| ..+..+ ..++++|++
T Consensus 263 ~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~--~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~l 338 (562)
T 3a79_B 263 WKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTY--SETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNIKMLSI 338 (562)
T ss_dssp HHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCC--CSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCCSEEEE
T ss_pred HHHHHHHHHhhhcccccEEEEeccEeeccccchhhhc--ccccchheehhhccccee--ecChhhhhhhhccCcceEEEc
Confidence 321111 112236667777776665 333322111 124556666666666665 333 222222 124888899
Q ss_pred eCCccccccCCCccCCCcccEEEccCCcCCCCCCccccCCCCCcEEeccCcccccc--CCCCCCCccccCceeccCCccc
Q 037275 355 AGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGG--IPTSLGNLTLLTNLALSSNDLQ 432 (992)
Q Consensus 355 ~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~L~~N~l~ 432 (992)
++|.+.... ....+++|++|++++|++++..|..+..+++|+.|+|++|++++. .|..|.++++|+.|++++|+++
T Consensus 339 ~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~ 416 (562)
T 3a79_B 339 SDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLN 416 (562)
T ss_dssp ESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCB
T ss_pred cCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCC
Confidence 999876432 126889999999999999988999999999999999999999963 3567999999999999999999
Q ss_pred CCCCC-CccccccccccccccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeecccccccCCcc
Q 037275 433 GSIPP-SLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVT 511 (992)
Q Consensus 433 ~~~~~-~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 511 (992)
+.+|. .+..+++|++|++++|+++ +..|..+. ++|++|+|++|+++ .+|..
T Consensus 417 ~~~~~~~~~~l~~L~~L~l~~n~l~-------------------------~~~~~~l~--~~L~~L~L~~N~l~-~ip~~ 468 (562)
T 3a79_B 417 SHAYDRTCAWAESILVLNLSSNMLT-------------------------GSVFRCLP--PKVKVLDLHNNRIM-SIPKD 468 (562)
T ss_dssp SCCSSCCCCCCTTCCEEECCSSCCC-------------------------GGGGSSCC--TTCSEEECCSSCCC-CCCTT
T ss_pred CccChhhhcCcccCCEEECCCCCCC-------------------------cchhhhhc--CcCCEEECCCCcCc-ccChh
Confidence 84554 5888899998866555544 34444443 69999999999999 67777
Q ss_pred cccccccceeeccCCcccccCCcc-ccccCCCCEEECCCcccCCCCh
Q 037275 512 LSACTSLQQLYLQGNSFSGSIPSS-LSSLKSIKELDMSSNNLSGQIP 557 (992)
Q Consensus 512 ~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p 557 (992)
+..+++|++|+|++|+|++ +|.. |..+++|+.|+|++|.+.+..+
T Consensus 469 ~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c~c~ 514 (562)
T 3a79_B 469 VTHLQALQELNVASNQLKS-VPDGVFDRLTSLQYIWLHDNPWDCTCP 514 (562)
T ss_dssp TTSSCCCSEEECCSSCCCC-CCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred hcCCCCCCEEECCCCCCCC-CCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence 7799999999999999995 5555 9999999999999999997555
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=394.47 Aligned_cols=403 Identities=18% Similarity=0.205 Sum_probs=223.3
Q ss_pred CCCCCceEe--eEEcCCCCeEEEeeccccccCCccCCCCCCCCcCCeeeccCCCCCccCCccccCCCCCCEEEeecccCC
Q 037275 34 STNLCQWTG--VTCGHRHQRVTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFS 111 (992)
Q Consensus 34 ~~~~c~w~g--v~c~~~~~~v~~ldl~~~~l~~~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~ 111 (992)
+...|.|.+ |.|+.. ++ ..+|. + .++|++|||++|++++..|..|+.+++|++|+|++|.+.
T Consensus 4 ~~~~c~~~~~~~~c~~~------------~l-~~lp~-l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~ 67 (455)
T 3v47_A 4 GTSECSVIGYNAICINR------------GL-HQVPE-L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPG 67 (455)
T ss_dssp ---CCEEETTEEECCSS------------CC-SSCCC-C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTT
T ss_pred ccceeEEEccccCcCCC------------Cc-ccCCC-C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCccc
Confidence 345677776 666432 33 34554 2 267788888888887666777777788888888777776
Q ss_pred CCC-CcccccCCCCcEeecccccccccCChhhcccccccccccccccccCCCCCCccccccccceEEecCCcccCCcCCc
Q 037275 112 GKI-PTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNN 190 (992)
Q Consensus 112 ~~~-p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~ 190 (992)
+.+ |..|+.+++|++|++++|+++ +..|..|+++++|++|++++|.+.+..|..
T Consensus 68 ~~i~~~~~~~l~~L~~L~Ls~n~l~-------------------------~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 122 (455)
T 3v47_A 68 LVIRNNTFRGLSSLIILKLDYNQFL-------------------------QLETGAFNGLANLEVLTLTQCNLDGAVLSG 122 (455)
T ss_dssp CEECTTTTTTCTTCCEEECTTCTTC-------------------------EECTTTTTTCTTCCEEECTTSCCBTHHHHS
T ss_pred ceECcccccccccCCEEeCCCCccC-------------------------ccChhhccCcccCCEEeCCCCCCCccccCc
Confidence 444 344555555555555555554 333444444555555555555554333322
Q ss_pred --cCCCCcccEEeccCcccccccCcc-ccccCCCcEEeccCCccCCCCCccccccccccchhhccccccCCCCchhhhcc
Q 037275 191 --LGNLRNLILLNLGENRFSGIVPPS-IFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNA 267 (992)
Q Consensus 191 --l~~l~~L~~L~L~~n~l~~~~p~~-l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l 267 (992)
|.++++|++|+|++|++++..|.. +.++++|++|++++|++.+..| ..+..+
T Consensus 123 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-------------------------~~l~~l 177 (455)
T 3v47_A 123 NFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICE-------------------------EDLLNF 177 (455)
T ss_dssp STTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCT-------------------------TTSGGG
T ss_pred ccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccCh-------------------------hhhhcc
Confidence 455555555555555555443433 4444444444444444432211 111111
Q ss_pred --ccCceeeeccccccccccccccccCccceEecCCCCCCCCCCCCchhhhhccCCCcceEeecCCCcCCCcCCcccccc
Q 037275 268 --SNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANL 345 (992)
Q Consensus 268 --~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~l 345 (992)
.+|+.|++++|.+.+..+..+. ......+..+++|+.|++++|++.+..|..+...
T Consensus 178 ~~~~L~~L~l~~n~l~~~~~~~~~----------------------~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~ 235 (455)
T 3v47_A 178 QGKHFTLLRLSSITLQDMNEYWLG----------------------WEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDA 235 (455)
T ss_dssp TTCEEEEEECTTCBCTTCSTTCTT----------------------HHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHH
T ss_pred ccccccccccccCcccccchhhcc----------------------ccccccccccceeeeEecCCCcccccchhhhhcc
Confidence 2333333333333322211110 0000111122333333333333333333222221
Q ss_pred cccceeEEeeCCccccccCCCccCCCcccEEEccCCcCCCCCCccccCCCCCcEEeccCccccccCCCCCCC--ccccCc
Q 037275 346 SSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGN--LTLLTN 423 (992)
Q Consensus 346 ~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~--l~~L~~ 423 (992)
. ..++|+.|++++|.+.+.. +..+.+.+..+..+.. .++|+.
T Consensus 236 ~----------------------~~~~L~~L~l~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~L~~ 279 (455)
T 3v47_A 236 I----------------------AGTKIQSLILSNSYNMGSS--------------FGHTNFKDPDNFTFKGLEASGVKT 279 (455)
T ss_dssp T----------------------TTCCEEEEECTTCTTTSCC--------------TTCCSSCCCCTTTTGGGTTSCCCE
T ss_pred c----------------------cccceeeEeeccccccccc--------------cchhhhccCcccccccccccCceE
Confidence 0 0133444444444333210 0111111111122222 235556
Q ss_pred eeccCCcccCCCCCCccccccccccccccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeeccc
Q 037275 424 LALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNR 503 (992)
Q Consensus 424 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 503 (992)
|++++|.+++..|..|..+++|++|+++ +|.+++..|..|..+++|++|+|++|+
T Consensus 280 L~l~~n~l~~~~~~~~~~l~~L~~L~Ls-------------------------~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 334 (455)
T 3v47_A 280 CDLSKSKIFALLKSVFSHFTDLEQLTLA-------------------------QNEINKIDDNAFWGLTHLLKLNLSQNF 334 (455)
T ss_dssp EECCSSCCCEECTTTTTTCTTCCEEECT-------------------------TSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred EEecCccccccchhhcccCCCCCEEECC-------------------------CCcccccChhHhcCcccCCEEECCCCc
Confidence 6666666665555556666666555333 333333445566677788888888888
Q ss_pred ccccCCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcccCCCChhhhhcCCCcceEecCCCcCcccCCCC
Q 037275 504 FSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTK 583 (992)
Q Consensus 504 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~ 583 (992)
+++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|++|++++|+|+|.+|..
T Consensus 335 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 414 (455)
T 3v47_A 335 LGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 414 (455)
T ss_dssp CCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred cCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCcc
Confidence 88777888888999999999999999888999999999999999999999877778899999999999999999999865
Q ss_pred Cc
Q 037275 584 GV 585 (992)
Q Consensus 584 ~~ 585 (992)
..
T Consensus 415 ~~ 416 (455)
T 3v47_A 415 DY 416 (455)
T ss_dssp HH
T ss_pred hH
Confidence 43
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=394.04 Aligned_cols=422 Identities=23% Similarity=0.279 Sum_probs=190.2
Q ss_pred CCCCCCCcCCeeeccCCCCCccCCccccCCCCCCEEEeecccCCCCCCcccccCCCCcEeecccccccccCChhhccccc
Q 037275 68 PYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWL 147 (992)
Q Consensus 68 ~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~ 147 (992)
|.-...++|++|++++|++ |.+|++|+.+++|++|++++|+++|.+|.+++.+++|+.++++.|.. .
T Consensus 5 p~~~~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~------------~ 71 (454)
T 1jl5_A 5 PRNVSNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD------------R 71 (454)
T ss_dssp ------------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH------------H
T ss_pred ccccccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc------------c
Confidence 3334567788888888888 58888888888888888888888888888888877776665555432 2
Q ss_pred ccccccccccccCCCCCCccccccccceEEecCCcccCCcCCccCCCCcccEEeccCcccccccCccccccCCCcEEecc
Q 037275 148 KLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLP 227 (992)
Q Consensus 148 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~ 227 (992)
++++|++++|.+++ +|.. .++|++|++++|.+.+ +|.. +++|++|++++|++++ +|.. .++|++|+++
T Consensus 72 ~l~~L~l~~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~ 139 (454)
T 1jl5_A 72 QAHELELNNLGLSS-LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVS 139 (454)
T ss_dssp TCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECC
T ss_pred CCCEEEecCCcccc-CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECc
Confidence 45566666666653 3332 2456666666666643 4432 2455666666666553 2221 1455555555
Q ss_pred CCccCCCCCccccccccccchhhccccccCCCCchhhhccccCceeeeccccccccccccccccCccceEecCCCCCCCC
Q 037275 228 TNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTG 307 (992)
Q Consensus 228 ~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 307 (992)
+|++++ + | .++++++|++|++++|++++. |.. ..+|++|++++|+++.+
T Consensus 140 ~n~l~~-l-------------------------p-~~~~l~~L~~L~l~~N~l~~l-p~~---~~~L~~L~L~~n~l~~l 188 (454)
T 1jl5_A 140 NNQLEK-L-------------------------P-ELQNSSFLKIIDVDNNSLKKL-PDL---PPSLEFIAAGNNQLEEL 188 (454)
T ss_dssp SSCCSS-C-------------------------C-CCTTCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCSSC
T ss_pred CCCCCC-C-------------------------c-ccCCCCCCCEEECCCCcCccc-CCC---cccccEEECcCCcCCcC
Confidence 555542 2 2 244444444444444444432 111 12455555555554443
Q ss_pred CCCCchhhhhccCCCcceEeecCCCcCCCcCCcccccccccceeEEeeCCccccccCCCccCCCcccEEEccCCcCCCCC
Q 037275 308 EANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTI 387 (992)
Q Consensus 308 ~~~~~~~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 387 (992)
+ .+..+++|+.|++++|++.+ +|.. ..+|++|++++|+++ .+| .+..+++|++|++++|++++ +
T Consensus 189 ~--------~~~~l~~L~~L~l~~N~l~~-l~~~----~~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l 252 (454)
T 1jl5_A 189 P--------ELQNLPFLTAIYADNNSLKK-LPDL----PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-L 252 (454)
T ss_dssp C--------CCTTCTTCCEEECCSSCCSS-CCCC----CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-C
T ss_pred c--------cccCCCCCCEEECCCCcCCc-CCCC----cCcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-c
Confidence 2 13444455555555555543 2211 124666666666666 344 36777777777777777764 3
Q ss_pred CccccCCCCCcEEeccCccccccCCCCCCCccccCceeccCCcccCCCCCCccccccccccccccccccccCchhhhhhc
Q 037275 388 PHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSIS 467 (992)
Q Consensus 388 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~ 467 (992)
|.. +++|+.|++++|++++ +|.. .++|+.|++++|++++ +|.. .++|+.|++++|++++ ++ ...
T Consensus 253 ~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~-l~~~---~~~L~~L~l~~N~l~~-i~----~~~ 316 (454)
T 1jl5_A 253 PDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSG-LSEL---PPNLYYLNASSNEIRS-LC----DLP 316 (454)
T ss_dssp CSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSE-ESCC---CTTCCEEECCSSCCSE-EC----CCC
T ss_pred ccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCc-ccCc---CCcCCEEECcCCcCCc-cc----CCc
Confidence 432 3667777777777774 4433 2567777777777774 2211 1466666666666653 11 111
Q ss_pred ccccccccccccccCcccccccCCCCccEEeeecccccccCCcccccccccceeeccCCcccc--cCCccccccCCCCEE
Q 037275 468 TLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSG--SIPSSLSSLKSIKEL 545 (992)
Q Consensus 468 ~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L 545 (992)
..++.|++++|++++ +|.. +++|++|++++|++++ +|. .+++|++|++++|++++ .+|..+..+
T Consensus 317 ~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~-lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L------ 382 (454)
T 1jl5_A 317 PSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAE-VPE---LPQNLKQLHVEYNPLREFPDIPESVEDL------ 382 (454)
T ss_dssp TTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSSCCCCCTTCCEE------
T ss_pred CcCCEEECCCCcccc-cccc---CCcCCEEECCCCcccc-ccc---hhhhccEEECCCCCCCcCCCChHHHHhh------
Confidence 234445555555553 3332 3566666666666663 343 34566666666666665 444444332
Q ss_pred ECCCcccCCCChhhhhcCCCcceEecCCCcCcc--cCCCCCccCCcccccccCCCCcC
Q 037275 546 DMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEG--EVPTKGVFSNKTGISLSGNGKVC 601 (992)
Q Consensus 546 ~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~--~~~~~~~~~~~~~~~l~~N~~~C 601 (992)
+.|++.+.+|.. +++|++|++++|++++ .+| +.+..+.+.+|...|
T Consensus 383 --~~n~~~~~i~~~---~~~L~~L~ls~N~l~~~~~iP-----~sl~~L~~~~~~~~~ 430 (454)
T 1jl5_A 383 --RMNSHLAEVPEL---PQNLKQLHVETNPLREFPDIP-----ESVEDLRMNSERVVD 430 (454)
T ss_dssp --ECCC----------------------------------------------------
T ss_pred --hhcccccccccc---cCcCCEEECCCCcCCccccch-----hhHhheeCcCcccCC
Confidence 234444444442 3788899999999887 333 235556666665544
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=370.33 Aligned_cols=251 Identities=22% Similarity=0.302 Sum_probs=206.6
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
.++|++.++||+|+||+||+|.+..+++.||||++........+.+.+|+.++++++||||+++++++.. ....+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~ 93 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELW 93 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEE-----CCEEE
Confidence 4689999999999999999999988999999999987766677889999999999999999999998643 45679
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||+++|+|.+++... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 94 lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~ 163 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC 163 (297)
T ss_dssp EEEECCTTCBHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEECCCCCCHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCc
Confidence 999999999999999753 388999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALP 917 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 917 (992)
....... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.....
T Consensus 164 ~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------------ 223 (297)
T 3fxz_A 164 AQITPEQ--------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------------ 223 (297)
T ss_dssp EECCSTT--------CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------------
T ss_pred eecCCcc--------cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH------------
Confidence 8765422 12234569999999999999999999999999999999999999997532110
Q ss_pred hhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 918 DKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
............ ..........+.+++.+||+.||++|||++|+++
T Consensus 224 -----~~~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 224 -----ALYLIATNGTPE---------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp -----HHHHHHHHCSCC---------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----HHHHHHhCCCCC---------CCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 000000000000 0001122345889999999999999999999986
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=393.60 Aligned_cols=397 Identities=17% Similarity=0.158 Sum_probs=256.1
Q ss_pred CCcCCCCCCceEeeEEcC-CCCeEEEeeccccccCCccCCCCCCCCcCCeeeccCCCCCccC-CccccCCCCCCEEEeec
Q 037275 30 SWNNSTNLCQWTGVTCGH-RHQRVTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEI-PHQIGRLVRLEALVLAN 107 (992)
Q Consensus 30 ~w~~~~~~c~w~gv~c~~-~~~~v~~ldl~~~~l~~~l~~~l~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~Ls~ 107 (992)
.|....-.|.+.|++.-. ...+++.|||++|.+.+..|..++.+++|++|+|++|.+.+.+ |..|..+++|++|+|++
T Consensus 9 ~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~ 88 (455)
T 3v47_A 9 SVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88 (455)
T ss_dssp EEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTT
T ss_pred EEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCC
Confidence 443333447776665422 3457999999999998888999999999999999999998666 56799999999999999
Q ss_pred ccCCCCCCcccccCCCCcEeecccccccccCChh-hcccccccccccccccccCCCCCCc-cccccccceEEecCCcccC
Q 037275 108 NSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAE-LGYNWLKLENLTIADNHLTGHFPAS-IGNLSTLERINVLGNGLWG 185 (992)
Q Consensus 108 n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~-~~~~l~~L~~L~L~~n~l~~~~p~~-~~~l~~L~~L~l~~n~l~~ 185 (992)
|++++..|..|+++++|++|++++|++++.+|.. .+..+++|++|+|++|.+++..|.. +.++++|++|++++|.+.+
T Consensus 89 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~ 168 (455)
T 3v47_A 89 NQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKS 168 (455)
T ss_dssp CTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSC
T ss_pred CccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccc
Confidence 9999888999999999999999999988654443 2234555666666666555544444 4555555555555555544
Q ss_pred CcCCccCCCCcccEEeccCcccccccCccccccCCCcEEeccCCccCCCCCccccccccccchhhccccccCCCCchhhh
Q 037275 186 RIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLS 265 (992)
Q Consensus 186 ~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~ 265 (992)
..|..+..+. ..+|+.|++++|.+.+..+..+. ......+.
T Consensus 169 ~~~~~l~~l~----------------------~~~L~~L~l~~n~l~~~~~~~~~-----------------~~~~~~~~ 209 (455)
T 3v47_A 169 ICEEDLLNFQ----------------------GKHFTLLRLSSITLQDMNEYWLG-----------------WEKCGNPF 209 (455)
T ss_dssp CCTTTSGGGT----------------------TCEEEEEECTTCBCTTCSTTCTT-----------------HHHHCCTT
T ss_pred cChhhhhccc----------------------cccccccccccCcccccchhhcc-----------------cccccccc
Confidence 4444444330 03445555555544421111100 00111233
Q ss_pred ccccCceeeecccccccccccccccc---CccceEecCCCCCCCCCCCCchhhhhccCCCcceEeecCCCcCCCcCCccc
Q 037275 266 NASNLVELTLFDNQFRGKVSIYFRSL---KNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSI 342 (992)
Q Consensus 266 ~l~~L~~L~L~~N~l~~~~~~~~~~l---~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~l~~~~~~~~ 342 (992)
.+++|++|++++|++++..+..+..+ .+|+.|++++|.+..... ..+
T Consensus 210 ~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~--------------------~~~---------- 259 (455)
T 3v47_A 210 KNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSF--------------------GHT---------- 259 (455)
T ss_dssp TTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCT--------------------TCC----------
T ss_pred ccceeeeEecCCCcccccchhhhhccccccceeeEeecccccccccc--------------------chh----------
Confidence 45677777777777776666665544 566666666665432110 001
Q ss_pred ccccccceeEEeeCCccccccCCCccCCCcccEEEccCCcCCCCCCccccCCCCCcEEeccCccccccCCCCCCCccccC
Q 037275 343 ANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLT 422 (992)
Q Consensus 343 ~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 422 (992)
.+.+..+..+..+ ..++|+.|++++|++++..|..|..+++|+
T Consensus 260 ---------------~~~~~~~~~~~~~----------------------~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 302 (455)
T 3v47_A 260 ---------------NFKDPDNFTFKGL----------------------EASGVKTCDLSKSKIFALLKSVFSHFTDLE 302 (455)
T ss_dssp ---------------SSCCCCTTTTGGG----------------------TTSCCCEEECCSSCCCEECTTTTTTCTTCC
T ss_pred ---------------hhccCcccccccc----------------------cccCceEEEecCccccccchhhcccCCCCC
Confidence 1111111111111 123455555555555555555555555555
Q ss_pred ceeccCCcccCCCCCCccccccccccccccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeecc
Q 037275 423 NLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVN 502 (992)
Q Consensus 423 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N 502 (992)
+|+|++|++++..|..|..+++|++|+++ +|.+++..|..|..+++|++|+|++|
T Consensus 303 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls-------------------------~N~l~~~~~~~~~~l~~L~~L~Ls~N 357 (455)
T 3v47_A 303 QLTLAQNEINKIDDNAFWGLTHLLKLNLS-------------------------QNFLGSIDSRMFENLDKLEVLDLSYN 357 (455)
T ss_dssp EEECTTSCCCEECTTTTTTCTTCCEEECC-------------------------SSCCCEECGGGGTTCTTCCEEECCSS
T ss_pred EEECCCCcccccChhHhcCcccCCEEECC-------------------------CCccCCcChhHhcCcccCCEEECCCC
Confidence 55555555555555556566666555333 33333344566777888888888888
Q ss_pred cccccCCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcccCCCCh
Q 037275 503 RFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIP 557 (992)
Q Consensus 503 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p 557 (992)
++++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|++++..|
T Consensus 358 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 358 HIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred cccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 8888888889999999999999999997777778899999999999999998776
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=373.02 Aligned_cols=273 Identities=22% Similarity=0.371 Sum_probs=215.6
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
.++|++.++||+|+||+||+|++..+++.||+|++........+.+.+|++++++++||||+++++++.+ ....+
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~ 83 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK-----DKRLN 83 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec-----CCeeE
Confidence 3578899999999999999999998999999999865555566789999999999999999999999653 45679
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||+++|+|.+++..... .+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 155 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSMDS-----QYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLA 155 (310)
T ss_dssp EEEECCTTCBHHHHHHHCCT-----TSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTC
T ss_pred EEEEecCCCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccc
Confidence 99999999999999986433 489999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCc------ccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHH
Q 037275 838 KFLSSSPLDTAV------ETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEF 911 (992)
Q Consensus 838 ~~~~~~~~~~~~------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~ 911 (992)
+........... ..........||+.|+|||++.+..++.++|||||||++|||++|..||..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~--- 232 (310)
T 3s95_A 156 RLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF--- 232 (310)
T ss_dssp EECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS---
T ss_pred eecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH---
Confidence 876543321110 00111124579999999999999999999999999999999999999987643321111
Q ss_pred HhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhhc
Q 037275 912 ARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTFLGR 989 (992)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 989 (992)
........+... ...+ ...+.+++.+||+.||++|||++|+++.|+++++.+.+.
T Consensus 233 -----~~~~~~~~~~~~--------~~~~----------~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~~ 287 (310)
T 3s95_A 233 -----GLNVRGFLDRYC--------PPNC----------PPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGH 287 (310)
T ss_dssp -----SBCHHHHHHHTC--------CTTC----------CTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHC
T ss_pred -----hhhhhccccccC--------CCCC----------CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccCc
Confidence 001111111100 0111 234889999999999999999999999999998876543
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=371.96 Aligned_cols=288 Identities=32% Similarity=0.481 Sum_probs=224.0
Q ss_pred ccHHHHHHHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecc
Q 037275 669 ISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSI 748 (992)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 748 (992)
+++.++...+++|++.+.||+|+||+||+|++. +++.||||++........+.+.+|+.+++.++||||+++++++.
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-- 105 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD-- 105 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECC--
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc--
Confidence 334455667889999999999999999999975 78999999987666666788999999999999999999999964
Q ss_pred cccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCc
Q 037275 749 DFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLV 828 (992)
Q Consensus 749 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 828 (992)
.....++||||+++|+|.+++...... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.
T Consensus 106 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~ 177 (321)
T 2qkw_B 106 ---ERNEMILIYKYMENGNLKRHLYGSDLP--TMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFV 177 (321)
T ss_dssp ---CTTCCEEEEECCTTCBTGGGSSSSCCC--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCC
T ss_pred ---CCCeEEEEEEcCCCCcHHHHHhccCCC--ccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCC
Confidence 345669999999999999998754321 23589999999999999999999999 9999999999999999999
Q ss_pred EEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCC-cc
Q 037275 829 AHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQG-LT 907 (992)
Q Consensus 829 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~-~~ 907 (992)
+||+|||+++...... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.+..... ..
T Consensus 178 ~kl~Dfg~~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~ 251 (321)
T 2qkw_B 178 PKITDFGISKKGTELD------QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVN 251 (321)
T ss_dssp EEECCCTTCEECSSSS------CCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCC
T ss_pred EEEeeccccccccccc------ccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHH
Confidence 9999999998654321 1112233468999999999988899999999999999999999999998653322 11
Q ss_pred HHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 037275 908 LHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTF 986 (992)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 986 (992)
...+...... ..... .............+....+.+++.+||+.||++|||++|+++.|+.+.+..
T Consensus 252 ~~~~~~~~~~-----------~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 252 LAEWAVESHN-----------NGQLE--QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp HHHHTHHHHT-----------TTCCC--SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHHHhhhccc-----------cccHH--HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 2221111000 00000 000000111223566788999999999999999999999999999987643
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=371.40 Aligned_cols=285 Identities=23% Similarity=0.338 Sum_probs=215.1
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
.++|++.++||+|+||+||+|++. ++.||||++.... .......+|+.++++++||||+++++++..... .....+
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~~~~~ 98 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS-VDVDLW 98 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS-SSEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCC-CCceEE
Confidence 458999999999999999999984 8999999996432 234456678999999999999999999865322 244579
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcC-------CCCeEeccCCCCCeeeCCCCcEE
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHC-------QPPVVHGDLKPSNVLLDQDLVAH 830 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-------~~~ivH~Dlkp~NIll~~~~~~k 830 (992)
+||||+++|+|.++++.. .+++..++.++.|++.||+|||+.. .++|+||||||+||+++.++.+|
T Consensus 99 lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~k 171 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKAN-------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC 171 (322)
T ss_dssp EEEECCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEE
T ss_pred EEEecCCCCCHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEE
Confidence 999999999999999753 3899999999999999999999751 23799999999999999999999
Q ss_pred EeecccceecCCCCCCCCcccCCCCCcccccccccccccccC-----CCcCcccchhhHHHHHHHHHhCCCCCCCCccCC
Q 037275 831 LGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-----GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQG 905 (992)
Q Consensus 831 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~ 905 (992)
|+|||+|+....... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+..+..
T Consensus 172 L~DFg~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~ 245 (322)
T 3soc_A 172 IADFGLALKFEAGKS------AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245 (322)
T ss_dssp ECCCTTCEEECTTSC------CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCC
T ss_pred EccCCcccccccccC------ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchh
Confidence 999999987754321 112233569999999999876 356778999999999999999999998755443
Q ss_pred ccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 037275 906 LTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDT 985 (992)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 985 (992)
...........+ ....+.+.... ...+..............++.+++.+||+.||++|||++||++.|+++.+.
T Consensus 246 ~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 246 MLPFEEEIGQHP-SLEDMQEVVVH-----KKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp CCTTHHHHCSSC-CHHHHHHHHTT-----SCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccchhhhhccCC-chhhhhhhhhc-----ccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 222111111111 11111111111 111111122222334567799999999999999999999999999998764
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=375.31 Aligned_cols=289 Identities=33% Similarity=0.612 Sum_probs=226.7
Q ss_pred cCCCcccHHHHHHHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC-CCchhHHHHHHHHHHhccCCcceeEE
Q 037275 664 QQFPMISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIKII 742 (992)
Q Consensus 664 ~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~ 742 (992)
.+...+++.++....++|++.+.||+|+||+||+|+.. +++.||||++.... ......+.+|+.++++++||||++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 93 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCC
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceE
Confidence 34556889999999999999999999999999999865 78999999986443 22344789999999999999999999
Q ss_pred EEeecccccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCee
Q 037275 743 TICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVL 822 (992)
Q Consensus 743 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIl 822 (992)
+++.. ....++||||+++|+|.+++...... ...+++..++.++.|++.||+|||++..++|+||||||+||+
T Consensus 94 ~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil 166 (326)
T 3uim_A 94 GFCMT-----PTERLLVYPYMANGSVASCLRERPES--QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANIL 166 (326)
T ss_dssp EEECC-----SSCCEEEEECCTTCBHHHHHHCCSTT--CCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEE
T ss_pred EEEec-----CCceEEEEEeccCCCHHHHHHhcccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEE
Confidence 99643 44558999999999999999875432 345899999999999999999999986678999999999999
Q ss_pred eCCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCC-
Q 037275 823 LDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGM- 901 (992)
Q Consensus 823 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~- 901 (992)
++.++.+||+|||+++...... ........||+.|+|||++.+..++.++||||+||++|+|++|+.||...
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 239 (326)
T 3uim_A 167 LDEEFEAVVGDFGLAKLMDYKD-------THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 239 (326)
T ss_dssp ECTTCCEEECCCSSCEECCSSS-------SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHH
T ss_pred ECCCCCEEeccCccccccCccc-------ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccc
Confidence 9999999999999998765321 11223345899999999998889999999999999999999999999642
Q ss_pred --ccCCccHHHHHhhhCChh-HHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 902 --FNQGLTLHEFARTALPDK-VMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 902 --~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
.........+........ .....+ .........+....+.+++.+||+.||++|||++||++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 305 (326)
T 3uim_A 240 LANDDDVMLLDWVKGLLKEKKLEALVD--------------VDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRM 305 (326)
T ss_dssp HTTTSCSBHHHHHTTTTSSCCSTTSSC--------------TTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred cccccchhHHHHHHHHhhchhhhhhcC--------------hhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHH
Confidence 112222333332222111 000000 001112235667889999999999999999999999999
Q ss_pred HHH
Q 037275 979 LCR 981 (992)
Q Consensus 979 L~~ 981 (992)
|++
T Consensus 306 L~~ 308 (326)
T 3uim_A 306 LEG 308 (326)
T ss_dssp HHT
T ss_pred hcC
Confidence 975
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=368.86 Aligned_cols=281 Identities=22% Similarity=0.350 Sum_probs=210.2
Q ss_pred hcCCCCCCccccccceEEEEeE----ECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGN----LGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 753 (992)
.++|++.+.||+|+||+||+|+ ...+++.||||++........+.+.+|+.++++++||||+++++++... +.
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~ 85 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GR 85 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH---HH
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CC
Confidence 4588999999999999999998 4568899999999755555567889999999999999999999987532 23
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGD 833 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 833 (992)
...++||||+++|+|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~D 157 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHKE-----RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGD 157 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC
T ss_pred CceEEEEEeCCCCCHHHHHHhccc-----ccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEcc
Confidence 446899999999999999986543 489999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 913 (992)
||+++....... .........++..|+|||++.+..++.++|||||||++|||++|..||...... ......
T Consensus 158 fg~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~---~~~~~~ 229 (295)
T 3ugc_A 158 FGLTKVLPQDKE-----FFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE---FMRMIG 229 (295)
T ss_dssp CCSCC------------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH---HHHHHC
T ss_pred CcccccccCCcc-----eeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH---HHhhhc
Confidence 999987654321 111222345788899999999999999999999999999999999998652111 111111
Q ss_pred hhC-ChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhh
Q 037275 914 TAL-PDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTFL 987 (992)
Q Consensus 914 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 987 (992)
... .................... ......++.+++.+||+.||++|||++|+++.|+++++.+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~ 294 (295)
T 3ugc_A 230 NDKQGQMIVFHLIELLKNNGRLPR----------PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294 (295)
T ss_dssp TTCCTHHHHHHHHHHHHTTCCCCC----------CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred CccccchhHHHHHHHHhccCcCCC----------CcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence 111 11111111111111110000 11224568999999999999999999999999999988764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=369.08 Aligned_cols=249 Identities=22% Similarity=0.330 Sum_probs=203.6
Q ss_pred HhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC--CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcc
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK--GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
..++|++.+.||+|+||.||+|++..+|+.||||++..... ...+.+.+|+.+++.++||||+++++++. ...
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-----~~~ 87 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE-----TEK 87 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECC
Confidence 35689999999999999999999988999999999975432 23456889999999999999999999964 455
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
..++||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DF 158 (328)
T 3fe3_A 88 TLYLIMEYASGGEVFDYLVAHG------RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADF 158 (328)
T ss_dssp EEEEEECCCTTCBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECST
T ss_pred EEEEEEECCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeec
Confidence 6799999999999999997643 489999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcC-cccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEAS-MTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 913 (992)
|++...... .......||+.|+|||++.+..+. .++||||+||++|+|++|+.||.+...
T Consensus 159 G~a~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---------- 219 (328)
T 3fe3_A 159 GFSNEFTVG---------GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL---------- 219 (328)
T ss_dssp TCCGGGSSS---------CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH----------
T ss_pred cCceecCCC---------CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH----------
Confidence 999765432 122345699999999999888765 799999999999999999999976321
Q ss_pred hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 914 TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.+.......+.+.. + .....++.+++.+||+.||++|||++|+++
T Consensus 220 -------~~~~~~i~~~~~~~------p------~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 220 -------KELRERVLRGKYRI------P------FYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp -------HHHHHHHHHCCCCC------C------TTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred -------HHHHHHHHhCCCCC------C------CCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11111111111100 0 011345789999999999999999999975
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=364.49 Aligned_cols=265 Identities=28% Similarity=0.398 Sum_probs=200.8
Q ss_pred HHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC--CchhHHHHHHHHHHhccCCcceeEEEEeecccccCc
Q 037275 676 KATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK--GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 676 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 753 (992)
...++|++.+.||+|+||+||+|++ +++.||||++..... ...+.+.+|++++++++||||+++++++. ..
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~ 106 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT-----QP 106 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----ST
T ss_pred CChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----EC
Confidence 3456899999999999999999988 588999999864432 23357889999999999999999999964 34
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeccCCCCCeeeCCCCcEEE
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPP--VVHGDLKPSNVLLDQDLVAHL 831 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl 831 (992)
...++||||+++|+|.+++..... ...+++..++.++.|++.||+|||++ + |+||||||+||+++.++.+||
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL 180 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGA---REQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKV 180 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTH---HHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEE
T ss_pred CceEEEEecCCCCcHHHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEE
Confidence 456999999999999999986542 23489999999999999999999999 8 999999999999999999999
Q ss_pred eecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHH
Q 037275 832 GDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEF 911 (992)
Q Consensus 832 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~ 911 (992)
+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....
T Consensus 181 ~Dfg~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~------- 245 (309)
T 3p86_A 181 CDFGLSRLKASTF--------LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA------- 245 (309)
T ss_dssp CCCC-------------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH-------
T ss_pred CCCCCCccccccc--------cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------
Confidence 9999997544321 1223456899999999999999999999999999999999999999753211
Q ss_pred HhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhh
Q 037275 912 ARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTFLG 988 (992)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 988 (992)
+............ .. ......++.+++.+||+.||++|||++|+++.|+++.+...+
T Consensus 246 ----------~~~~~~~~~~~~~----~~------~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p 302 (309)
T 3p86_A 246 ----------QVVAAVGFKCKRL----EI------PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP 302 (309)
T ss_dssp ----------HHHHHHHHSCCCC----CC------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC----
T ss_pred ----------HHHHHHHhcCCCC----CC------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCC
Confidence 0000000000000 00 011234588999999999999999999999999998876544
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=358.65 Aligned_cols=284 Identities=30% Similarity=0.471 Sum_probs=222.9
Q ss_pred CCCcccHHHHHHHhcCCCCC------CccccccceEEEEeEECCCCeEEEEEEeeccC----CCchhHHHHHHHHHHhcc
Q 037275 665 QFPMISYAELSKATNDFSSS------NMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ----KGASNGFVAECQALRNIR 734 (992)
Q Consensus 665 ~~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~ 734 (992)
....+++.++..++++|... ++||+|+||+||+|+. +++.||||++.... ....+.+.+|+.++++++
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 88 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ 88 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence 45678999999999998877 8999999999999997 58899999986432 233567899999999999
Q ss_pred CCcceeEEEEeecccccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 037275 735 HRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHG 814 (992)
Q Consensus 735 h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~ 814 (992)
||||+++++++.. ....++||||+++|+|.+++..... ...+++..++.++.|++.||+|||++ +|+||
T Consensus 89 h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~ 157 (307)
T 2nru_A 89 HENLVELLGFSSD-----GDDLCLVYVYMPNGSLLDRLSCLDG---TPPLSWHMRCKIAQGAANGINFLHEN---HHIHR 157 (307)
T ss_dssp CTTBCCEEEEECS-----SSSCEEEEECCTTCBHHHHHHTGGG---CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECS
T ss_pred CCCeEEEEEEEec-----CCceEEEEEecCCCcHHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecC
Confidence 9999999999643 4456999999999999999975432 24589999999999999999999999 99999
Q ss_pred cCCCCCeeeCCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhC
Q 037275 815 DLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTR 894 (992)
Q Consensus 815 Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg 894 (992)
||||+||+++.++.+||+|||.+........ ........||+.|+|||++.+ .++.++|||||||++|+|++|
T Consensus 158 dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g 230 (307)
T 2nru_A 158 DIKSANILLDEAFTAKISDFGLARASEKFAQ------TVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITG 230 (307)
T ss_dssp CCCGGGEEECTTCCEEECCCTTCEECCSCSS------CEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHC
T ss_pred CCCHHHEEEcCCCcEEEeecccccccccccc------cccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHC
Confidence 9999999999999999999999987653211 111233568999999998765 588999999999999999999
Q ss_pred CCCCCCCccCCccHHHHHhhh--CChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCH
Q 037275 895 RRPTDGMFNQGLTLHEFARTA--LPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEM 972 (992)
Q Consensus 895 ~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 972 (992)
+.||........ ...+.... ....+.+.+++.. ..........+.+++.+||+.||++|||+
T Consensus 231 ~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 294 (307)
T 2nru_A 231 LPAVDEHREPQL-LLDIKEEIEDEEKTIEDYIDKKM---------------NDADSTSVEAMYSVASQCLHEKKNKRPDI 294 (307)
T ss_dssp CCSBCTTBSSSB-TTHHHHHHHTTSCCHHHHSCSSC---------------SCCCHHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred CCCcccCcchHH-HHHHHHHhhhhhhhhhhhccccc---------------cccchHHHHHHHHHHHHHcCCCcccCcCH
Confidence 999987543321 11111110 1111122211100 11224456779999999999999999999
Q ss_pred HHHHHHHHHHHH
Q 037275 973 RDVVAKLCRARD 984 (992)
Q Consensus 973 ~evl~~L~~~~~ 984 (992)
+||++.|+++.+
T Consensus 295 ~~l~~~L~~l~~ 306 (307)
T 2nru_A 295 KKVQQLLQEMTA 306 (307)
T ss_dssp HHHHHHHHHHC-
T ss_pred HHHHHHHHHHhc
Confidence 999999998754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=364.15 Aligned_cols=263 Identities=22% Similarity=0.297 Sum_probs=211.7
Q ss_pred CCcccHHHHHHHhcC----------CCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccC
Q 037275 666 FPMISYAELSKATND----------FSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRH 735 (992)
Q Consensus 666 ~~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 735 (992)
.+.+++++++.+++. |+..++||+|+||.||+|++..+|+.||||++........+.+.+|+.++++++|
T Consensus 22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence 356788888877764 6677899999999999999988999999999987666667789999999999999
Q ss_pred CcceeEEEEeecccccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecc
Q 037275 736 RNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGD 815 (992)
Q Consensus 736 ~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~D 815 (992)
|||+++++++.. ....++||||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+|||
T Consensus 102 ~niv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~-------~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~D 166 (321)
T 2c30_A 102 FNVVEMYKSYLV-----GEELWVLMEFLQGGALTDIVSQV-------RLNEEQIATVCEAVLQALAYLHAQ---GVIHRD 166 (321)
T ss_dssp TTBCCEEEEEEE-----TTEEEEEECCCCSCBHHHHHTTC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred CCcceEEEEEEE-----CCEEEEEEecCCCCCHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCC
Confidence 999999998653 34679999999999999998643 489999999999999999999999 999999
Q ss_pred CCCCCeeeCCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCC
Q 037275 816 LKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRR 895 (992)
Q Consensus 816 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~ 895 (992)
|||+||+++.++.+||+|||++....... .......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 167 lkp~NIll~~~~~~kl~Dfg~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~ 238 (321)
T 2c30_A 167 IKSDSILLTLDGRVKLSDFGFCAQISKDV--------PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238 (321)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECCSSS--------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred CCHHHEEECCCCcEEEeeeeeeeecccCc--------cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 99999999999999999999998765321 1123456999999999999999999999999999999999999
Q ss_pred CCCCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 037275 896 RPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDV 975 (992)
Q Consensus 896 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 975 (992)
.||...... + ....... .. .... .........+.+++.+||+.||++|||++|+
T Consensus 239 ~pf~~~~~~-----~------------~~~~~~~-~~----~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~el 292 (321)
T 2c30_A 239 PPYFSDSPV-----Q------------AMKRLRD-SP----PPKL----KNSHKVSPVLRDFLERMLVRDPQERATAQEL 292 (321)
T ss_dssp CTTTTSCHH-----H------------HHHHHHH-SS----CCCC----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CCCCCCCHH-----H------------HHHHHhc-CC----CCCc----CccccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 999753211 0 0000000 00 0000 0011123458899999999999999999999
Q ss_pred HH
Q 037275 976 VA 977 (992)
Q Consensus 976 l~ 977 (992)
++
T Consensus 293 l~ 294 (321)
T 2c30_A 293 LD 294 (321)
T ss_dssp HT
T ss_pred hc
Confidence 86
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=378.25 Aligned_cols=408 Identities=23% Similarity=0.265 Sum_probs=192.7
Q ss_pred CCeEEEeeccccccCCccCCCCCCCCcCCeeeccCCCCCccCCccccCCCCC-------------CEEEeecccCCCCCC
Q 037275 49 HQRVTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRL-------------EALVLANNSFSGKIP 115 (992)
Q Consensus 49 ~~~v~~ldl~~~~l~~~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-------------~~L~Ls~n~l~~~~p 115 (992)
..+++.++++++.+ |.+|+.++++++|++|++++|.+.|.+|.+++.+++| ++|++++|+++ .+|
T Consensus 10 ~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~-~lp 87 (454)
T 1jl5_A 10 NTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLP 87 (454)
T ss_dssp -------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCS-CCC
T ss_pred cccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccc-cCC
Confidence 35688999999999 9999999999999999999999999999999999987 56666666655 344
Q ss_pred cccccCCCCcEeecccccccccCChhhcccccccccccccccccCCCCCCccccccccceEEecCCcccCCcCCccCCCC
Q 037275 116 TNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLR 195 (992)
Q Consensus 116 ~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~ 195 (992)
.. .++|++|++++|++++ +|.. +++|++|++++|.+++ +|.. .++|++|++++|.+.+ +| .|++++
T Consensus 88 ~~---~~~L~~L~l~~n~l~~-lp~~----~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~ 153 (454)
T 1jl5_A 88 EL---PPHLESLVASCNSLTE-LPEL----PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSS 153 (454)
T ss_dssp SC---CTTCSEEECCSSCCSS-CCCC----CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCT
T ss_pred CC---cCCCCEEEccCCcCCc-cccc----cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCC
Confidence 31 2455555555555553 4432 2345555555555552 2221 1345555555555533 44 355555
Q ss_pred cccEEeccCcccccccCccccccCCCcEEeccCCccCCCCCccccccccccchhhccccccCCCCchhhhccccCceeee
Q 037275 196 NLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTL 275 (992)
Q Consensus 196 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L 275 (992)
+|++|++++|++++ +|..+ .+|++|++++|+++ + +| .++.+++|++|++
T Consensus 154 ~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~-------------------------~-l~-~~~~l~~L~~L~l 202 (454)
T 1jl5_A 154 FLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLE-------------------------E-LP-ELQNLPFLTAIYA 202 (454)
T ss_dssp TCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCS-------------------------S-CC-CCTTCTTCCEEEC
T ss_pred CCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCC-------------------------c-Cc-cccCCCCCCEEEC
Confidence 55555555555543 33322 24444444444444 3 33 3566666666666
Q ss_pred ccccccccccccccccCccceEecCCCCCCCCCCCCchhhhhccCCCcceEeecCCCcCCCcCCcccccccccceeEEee
Q 037275 276 FDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIA 355 (992)
Q Consensus 276 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~ 355 (992)
++|++++.+. . ..+|++|++++|+++.++. +..+++|+.|++++|++.+ +|.. ...|+.|+++
T Consensus 203 ~~N~l~~l~~-~---~~~L~~L~l~~n~l~~lp~--------~~~l~~L~~L~l~~N~l~~-l~~~----~~~L~~L~l~ 265 (454)
T 1jl5_A 203 DNNSLKKLPD-L---PLSLESIVAGNNILEELPE--------LQNLPFLTTIYADNNLLKT-LPDL----PPSLEALNVR 265 (454)
T ss_dssp CSSCCSSCCC-C---CTTCCEEECCSSCCSSCCC--------CTTCTTCCEEECCSSCCSS-CCSC----CTTCCEEECC
T ss_pred CCCcCCcCCC-C---cCcccEEECcCCcCCcccc--------cCCCCCCCEEECCCCcCCc-cccc----ccccCEEECC
Confidence 6666664222 1 1466666666666654431 4456666666666666664 2221 2346666666
Q ss_pred CCccccccCCCccCCCcccEEEccCCcCCCCCCccccCCCCCcEEeccCccccccCCCCCCCccccCceeccCCcccCCC
Q 037275 356 GNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSI 435 (992)
Q Consensus 356 ~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 435 (992)
+|++++ +|.. +++|++|++++|++++. |.. .++|+.|++++|++++ ++.. .++|+.|++++|++++ +
T Consensus 266 ~N~l~~-l~~~---~~~L~~L~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~-i~~~---~~~L~~L~Ls~N~l~~-l 332 (454)
T 1jl5_A 266 DNYLTD-LPEL---PQSLTFLDVSENIFSGL-SEL---PPNLYYLNASSNEIRS-LCDL---PPSLEELNVSNNKLIE-L 332 (454)
T ss_dssp SSCCSC-CCCC---CTTCCEEECCSSCCSEE-SCC---CTTCCEEECCSSCCSE-ECCC---CTTCCEEECCSSCCSC-C
T ss_pred CCcccc-cCcc---cCcCCEEECcCCccCcc-cCc---CCcCCEEECcCCcCCc-ccCC---cCcCCEEECCCCcccc-c
Confidence 666664 3322 25666777777766641 211 1466677777776664 2211 1356667777777664 4
Q ss_pred CCCccccccccccccccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeecccccc--cCCcccc
Q 037275 436 PPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSG--EIPVTLS 513 (992)
Q Consensus 436 ~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~ 513 (992)
|.. +++|+.| ++++|+++ .+|. .+++|++|++++|++++ .+|..+.
T Consensus 333 p~~---~~~L~~L-------------------------~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~ 380 (454)
T 1jl5_A 333 PAL---PPRLERL-------------------------IASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVE 380 (454)
T ss_dssp CCC---CTTCCEE-------------------------ECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCC
T ss_pred ccc---CCcCCEE-------------------------ECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHH
Confidence 433 3455555 55555555 4454 46889999999999987 5665554
Q ss_pred cccccceeeccCCcccccCCccccccCCCCEEECCCcccCC--CChhhhhcCCCcceEecCCCcCcccCCC
Q 037275 514 ACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSG--QIPEYLENLSFLEYLNLSYNHFEGEVPT 582 (992)
Q Consensus 514 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~l~~N~l~~~~~~ 582 (992)
. |+.|.+.+.+|.. +++|+.|++++|++++ .+|. +|+.|.+.+|.+.+..+.
T Consensus 381 ~--------L~~n~~~~~i~~~---~~~L~~L~ls~N~l~~~~~iP~------sl~~L~~~~~~~~~~~~~ 434 (454)
T 1jl5_A 381 D--------LRMNSHLAEVPEL---PQNLKQLHVETNPLREFPDIPE------SVEDLRMNSERVVDPYEF 434 (454)
T ss_dssp E--------EECCC---------------------------------------------------------
T ss_pred h--------hhhcccccccccc---cCcCCEEECCCCcCCccccchh------hHhheeCcCcccCCcccc
Confidence 3 3457777777763 5789999999999986 5554 466777888888876553
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=364.09 Aligned_cols=273 Identities=19% Similarity=0.258 Sum_probs=212.7
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC-CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
++|++.++||+|+||+||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++++.. ......+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~~~~ 85 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE---TTTRHKV 85 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC---TTTCCEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeec---CCCceEE
Confidence 57899999999999999999999899999999997433 3345678899999999999999999998753 2344679
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeee----CCCCcEEEee
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLL----DQDLVAHLGD 833 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~D 833 (992)
+||||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|
T Consensus 86 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~D 159 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSN---AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTD 159 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGG---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECC
T ss_pred EEEeCCCCCCHHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEcc
Confidence 99999999999999986543 23489999999999999999999999 99999999999999 7888999999
Q ss_pred cccceecCCCCCCCCcccCCCCCccccccccccccccc--------CCCcCcccchhhHHHHHHHHHhCCCCCCCCccCC
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGM--------GGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQG 905 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~ 905 (992)
||+++...... ......||+.|+|||++. +..++.++|||||||++|||++|+.||.......
T Consensus 160 fg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 230 (319)
T 4euu_A 160 FGAARELEDDE---------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR 230 (319)
T ss_dssp CTTCEECCTTC---------CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGG
T ss_pred CCCceecCCCC---------ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccc
Confidence 99998765432 122346899999999876 5788999999999999999999999997543322
Q ss_pred ccHHHHHhhhCChhHHHHHHhhHhHhhhc-------------cCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCH
Q 037275 906 LTLHEFARTALPDKVMEIVDSVLLLEVQA-------------SNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEM 972 (992)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 972 (992)
.... .+.......... ......+............+.+++.+||+.||++|||+
T Consensus 231 ~~~~-------------~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~ 297 (319)
T 4euu_A 231 RNKE-------------VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF 297 (319)
T ss_dssp GCHH-------------HHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCH
T ss_pred hhHH-------------HHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccH
Confidence 1111 111111111000 00001111112235567789999999999999999999
Q ss_pred HHHHHHHHHH
Q 037275 973 RDVVAKLCRA 982 (992)
Q Consensus 973 ~evl~~L~~~ 982 (992)
+|+++...+.
T Consensus 298 ~ell~h~~d~ 307 (319)
T 4euu_A 298 DQFFAETSDI 307 (319)
T ss_dssp HHHHHHHHHH
T ss_pred HHhhhccHHH
Confidence 9999887754
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=367.71 Aligned_cols=252 Identities=22% Similarity=0.323 Sum_probs=203.3
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCC------chhHHHHHHHHHHhccCCcceeEEEEeeccccc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKG------ASNGFVAECQALRNIRHRNLIKIITICSSIDFK 751 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 751 (992)
.++|++.+.||+|+||+||+|++..+|+.||+|+++..... ..+.+.+|+.++++++||||+++++++.
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~----- 85 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYE----- 85 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEE-----
Confidence 45799999999999999999999999999999999754322 3467899999999999999999999954
Q ss_pred CcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCC----
Q 037275 752 GVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDL---- 827 (992)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---- 827 (992)
.....++||||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~ 156 (361)
T 2yab_A 86 NRTDVVLILELVSGGELFDFLAQKE------SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIP 156 (361)
T ss_dssp CSSEEEEEEECCCSCBHHHHHTTCS------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSC
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCcc
Confidence 4567799999999999999997543 589999999999999999999999 999999999999998877
Q ss_pred cEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCcc
Q 037275 828 VAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLT 907 (992)
Q Consensus 828 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~ 907 (992)
.+||+|||++....... ......||+.|+|||++.+..++.++||||+||++|+|++|..||.+....
T Consensus 157 ~vkl~DFG~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~--- 224 (361)
T 2yab_A 157 HIKLIDFGLAHEIEDGV---------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--- 224 (361)
T ss_dssp CEEECCCSSCEECCTTC---------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---
T ss_pred CEEEEecCCceEcCCCC---------ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---
Confidence 79999999998765421 123356999999999999999999999999999999999999999763211
Q ss_pred HHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 908 LHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
+ .........+.. . ..........+.+++.+||..||++|||+.|+++
T Consensus 225 --~------------~~~~i~~~~~~~------~--~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 225 --E------------TLANITAVSYDF------D--EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp --H------------HHHHHHTTCCCC------C--HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --H------------HHHHHHhcCCCC------C--chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 111111000000 0 0000112345889999999999999999999985
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=357.60 Aligned_cols=268 Identities=22% Similarity=0.386 Sum_probs=206.6
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHh--ccCCcceeEEEEeecccccCcce
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRN--IRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
.++|++.+.||+|+||+||+|++ +++.||||++... ....+.+|.+++.. ++||||+++++++... ......
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~-~~~~~~ 80 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTS-RHSSTQ 80 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEE-ETTEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccc-cCCCce
Confidence 46899999999999999999998 6899999998533 34556677777776 7999999999987542 234566
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEeccCCCCCeeeCCCC
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIH--------HHCQPPVVHGDLKPSNVLLDQDL 827 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH--------~~~~~~ivH~Dlkp~NIll~~~~ 827 (992)
.++||||+++|+|.++++.. .+++..++.++.|++.||+||| +. +|+||||||+||+++.++
T Consensus 81 ~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~ 150 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQLT-------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNG 150 (301)
T ss_dssp EEEEECCCTTCBHHHHHTTC-------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTS
T ss_pred eEEehhhccCCCHHHHHhhc-------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCC
Confidence 79999999999999999643 4899999999999999999999 77 999999999999999999
Q ss_pred cEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCC------CcCcccchhhHHHHHHHHHhC-------
Q 037275 828 VAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG------EASMTGDVYSFGILLLEMFTR------- 894 (992)
Q Consensus 828 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~il~elltg------- 894 (992)
.+||+|||+|+........ .........||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 151 ~~kl~Dfg~a~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~ 226 (301)
T 3q4u_A 151 QCCIADLGLAVMHSQSTNQ----LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV 226 (301)
T ss_dssp CEEECCCTTCEEEETTTTE----EECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CEEEeeCCCeeeccccccc----ccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccc
Confidence 9999999999876543211 11112334799999999998876 566799999999999999999
Q ss_pred ---CCCCCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCC
Q 037275 895 ---RRPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERME 971 (992)
Q Consensus 895 ---~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 971 (992)
+.||................... ...+..............++.+++.+||+.||++|||
T Consensus 227 ~~~~~pf~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps 289 (301)
T 3q4u_A 227 EDYKPPFYDVVPNDPSFEDMRKVVCV-----------------DQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLT 289 (301)
T ss_dssp CCCCCTTTTTSCSSCCHHHHHHHHTT-----------------SCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCC
T ss_pred ccccccccccCCCCcchhhhhHHHhc-----------------cCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCC
Confidence 77776543333222222111100 0001111111122345678999999999999999999
Q ss_pred HHHHHHHHHHH
Q 037275 972 MRDVVAKLCRA 982 (992)
Q Consensus 972 ~~evl~~L~~~ 982 (992)
++||++.|+++
T Consensus 290 ~~~i~~~L~~i 300 (301)
T 3q4u_A 290 ALRIKKTLTKI 300 (301)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHhcc
Confidence 99999999875
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=371.28 Aligned_cols=267 Identities=22% Similarity=0.384 Sum_probs=210.2
Q ss_pred hcCCCCCCccccccceEEEEeEEC-------CCCeEEEEEEeeccCC-CchhHHHHHHHHHHhc-cCCcceeEEEEeecc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLG-------ENGMMVAVKVINLKQK-GASNGFVAECQALRNI-RHRNLIKIITICSSI 748 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 748 (992)
.++|++.+.||+|+||+||+|++. .++..||||+++.... ...+.+.+|+.+++++ +||||+++++++.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~-- 157 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT-- 157 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC--
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc--
Confidence 468899999999999999999863 3567899999964432 2346789999999999 8999999999964
Q ss_pred cccCcceEEEEEEeccCCCHHHHHhhcccch----------hhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCC
Q 037275 749 DFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQ----------EARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKP 818 (992)
Q Consensus 749 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp 818 (992)
.....++||||+++|+|.+++....... ....+++.+++.++.||+.||+|||++ +|+||||||
T Consensus 158 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp 231 (370)
T 2psq_A 158 ---QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA 231 (370)
T ss_dssp ---SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCG
T ss_pred ---cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccch
Confidence 3445699999999999999998754210 123589999999999999999999999 999999999
Q ss_pred CCeeeCCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCC
Q 037275 819 SNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRP 897 (992)
Q Consensus 819 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p 897 (992)
+||+++.++.+||+|||+++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |+.|
T Consensus 232 ~NIll~~~~~~kl~DFG~a~~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p 305 (370)
T 2psq_A 232 RNVLVTENNVMKIADFGLARDINNIDYY------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305 (370)
T ss_dssp GGEEECTTCCEEECCCSSCEETTCCCTT------CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred hhEEECCCCCEEEccccCCcccCcccce------ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCC
Confidence 9999999999999999999876543211 11223457889999999999999999999999999999999 9999
Q ss_pred CCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 898 TDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 898 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
|.+..... ....+.. ...... ......++.+++.+||+.||++|||+.|+++
T Consensus 306 ~~~~~~~~--------------~~~~~~~----~~~~~~----------~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 357 (370)
T 2psq_A 306 YPGIPVEE--------------LFKLLKE----GHRMDK----------PANCTNELYMMMRDCWHAVPSQRPTFKQLVE 357 (370)
T ss_dssp STTCCGGG--------------HHHHHHT----TCCCCC----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHH--------------HHHHHhc----CCCCCC----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 97642211 1111100 000000 0112345889999999999999999999999
Q ss_pred HHHHHHHhh
Q 037275 978 KLCRARDTF 986 (992)
Q Consensus 978 ~L~~~~~~~ 986 (992)
.|+++....
T Consensus 358 ~L~~il~~~ 366 (370)
T 2psq_A 358 DLDRILTLT 366 (370)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHh
Confidence 999987643
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=362.20 Aligned_cols=249 Identities=26% Similarity=0.335 Sum_probs=203.7
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc---CCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK---QKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
.++|++.+.||+|+||+||+|+...+|+.||+|+++.. .......+.+|+.+++.++||||+++++++. ...
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-----~~~ 78 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-----THD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE-----CSS
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEE-----eCC
Confidence 35899999999999999999999989999999999743 3445677899999999999999999999854 455
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
..++||||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 79 ~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DF 149 (337)
T 1o6l_A 79 RLCFVMEYANGGELFFHLSRER------VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDF 149 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeec
Confidence 7799999999999999997543 589999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
|+++..... ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+....
T Consensus 150 G~a~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---------- 211 (337)
T 1o6l_A 150 GLCKEGISD--------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---------- 211 (337)
T ss_dssp TTCBCSCCT--------TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH----------
T ss_pred cchhhcccC--------CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH----------
Confidence 999854321 11233457999999999999999999999999999999999999999753111
Q ss_pred hCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 037275 915 ALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERM-----EMRDVVA 977 (992)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 977 (992)
............ .+ .....++.+++.+||+.||++|| +++||++
T Consensus 212 -------~~~~~i~~~~~~------~p------~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 212 -------RLFELILMEEIR------FP------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -------HHHHHHHHCCCC------CC------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -------HHHHHHHcCCCC------CC------CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 111111111100 00 01134588999999999999999 8999875
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=374.01 Aligned_cols=261 Identities=27% Similarity=0.397 Sum_probs=208.6
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC-CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
.++|++.+.||+|+||.||+|++..+++.||||+++.... .....+.+|++++++++||||+++++++.. ....
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~~ 187 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-----KQPI 187 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS-----SSSC
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec-----CCCc
Confidence 4578899999999999999999988899999999864322 233568899999999999999999999643 3456
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
++||||+++|+|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 188 ~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~ 259 (377)
T 3cbl_A 188 YIVMELVQGGDFLTFLRTEGA-----RLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGM 259 (377)
T ss_dssp EEEEECCTTCBHHHHHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred EEEEEcCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCC
Confidence 999999999999999986432 489999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhhh
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~ 915 (992)
++....... ........+++.|+|||++.+..++.++|||||||++|||++ |..||.+....
T Consensus 260 s~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~----------- 322 (377)
T 3cbl_A 260 SREEADGVY------AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ----------- 322 (377)
T ss_dssp CEECTTSEE------ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH-----------
T ss_pred ceecCCCce------eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----------
Confidence 986543211 111122346788999999998899999999999999999998 99999764221
Q ss_pred CChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 037275 916 LPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDT 985 (992)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 985 (992)
...+.+.. ....... ...+.++.+++.+||+.||++|||++||++.|+++.+.
T Consensus 323 ---~~~~~~~~----~~~~~~~----------~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 323 ---QTREFVEK----GGRLPCP----------ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp ---HHHHHHHT----TCCCCCC----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---HHHHHHHc----CCCCCCC----------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 01111111 0000000 11234588999999999999999999999999998764
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=364.61 Aligned_cols=263 Identities=26% Similarity=0.398 Sum_probs=206.5
Q ss_pred hcCCCCCCccccccceEEEEeEECCC---CeEEEEEEeeccC-CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGEN---GMMVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 753 (992)
.++|++.+.||+|+||+||+|++..+ +..||||+++... ....+.+.+|+.++++++||||+++++++. ..
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~ 122 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVT-----RG 122 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----GG
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----eC
Confidence 35788899999999999999999744 4569999997442 233467899999999999999999999964 34
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGD 833 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 833 (992)
...++||||+++|+|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~D 194 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTHDG-----QFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSD 194 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTTTT-----CSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred CccEEEeeCCCCCcHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECC
Confidence 556999999999999999975432 489999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHH
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFA 912 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~ 912 (992)
||+++........ ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+....
T Consensus 195 fg~a~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-------- 261 (325)
T 3kul_A 195 FGLSRVLEDDPDA-----AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR-------- 261 (325)
T ss_dssp CSSCEECC----C-----CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--------
T ss_pred CCcccccccCccc-----eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH--------
Confidence 9999877543211 111223346788999999998999999999999999999999 99999753221
Q ss_pred hhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 037275 913 RTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTF 986 (992)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 986 (992)
+........ .... ........+.+++.+||+.||++|||+.||++.|+++.+..
T Consensus 262 ---------~~~~~~~~~-~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 262 ---------DVISSVEEG-YRLP----------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp ---------HHHHHHHTT-CCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred ---------HHHHHHHcC-CCCC----------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 111111100 0000 00112346889999999999999999999999999987654
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=367.08 Aligned_cols=296 Identities=22% Similarity=0.318 Sum_probs=211.8
Q ss_pred HhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHH--HHhccCCcceeEEEEeecccccCcc
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQA--LRNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
..++|++.+.||+|+||+||+|+. +++.||||++.... ...+..|.++ +..++||||+++++++......+..
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 356899999999999999999988 68999999996432 3344445444 4458999999999877665566677
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcC------CCCeEeccCCCCCeeeCCCCc
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHC------QPPVVHGDLKPSNVLLDQDLV 828 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~------~~~ivH~Dlkp~NIll~~~~~ 828 (992)
.+++||||+++|+|.+++.... .++..++.++.|++.||+|||+.. .++|+||||||+||+++.++.
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 158 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSLHT-------SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT 158 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHCC-------BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC
T ss_pred eEEEEEecCCCCcHHHHHhhcc-------cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc
Confidence 7899999999999999997543 588899999999999999999862 238999999999999999999
Q ss_pred EEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccC-------CCcCcccchhhHHHHHHHHHhCCCCCCCC
Q 037275 829 AHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-------GEASMTGDVYSFGILLLEMFTRRRPTDGM 901 (992)
Q Consensus 829 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~elltg~~pf~~~ 901 (992)
+||+|||+++.+...................||+.|+|||++.+ ..++.++|||||||++|||++|..||...
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 238 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238 (336)
T ss_dssp EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence 99999999988765432222112223344579999999999877 46778999999999999999997776443
Q ss_pred ccCCccHHHHHhhh-CChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 037275 902 FNQGLTLHEFARTA-LPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLC 980 (992)
Q Consensus 902 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 980 (992)
.........+.... ......+. ...... .......+...........++.+++.+||+.||++|||++|+++.|+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~ 314 (336)
T 3g2f_A 239 ESVPEYQMAFQTEVGNHPTFEDM-QVLVSR---EKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMA 314 (336)
T ss_dssp SCCCCCCCTTHHHHCSSCCHHHH-HHHHTT---SCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred cchhHHHHhhhcccCCCchHHHH-Hhhhcc---cccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHH
Confidence 22211111111111 11111111 111100 01111112222223345667999999999999999999999999999
Q ss_pred HHHHhhhh
Q 037275 981 RARDTFLG 988 (992)
Q Consensus 981 ~~~~~~~~ 988 (992)
++.+.+..
T Consensus 315 ~ll~~~~~ 322 (336)
T 3g2f_A 315 ELMMIWER 322 (336)
T ss_dssp HHHHCCCC
T ss_pred HHHHHHHh
Confidence 99887654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=375.19 Aligned_cols=263 Identities=21% Similarity=0.237 Sum_probs=207.0
Q ss_pred HHHHHHHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc---CCCchhHHHHHHHHHHhccCCcceeEEEEeec
Q 037275 671 YAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK---QKGASNGFVAECQALRNIRHRNLIKIITICSS 747 (992)
Q Consensus 671 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 747 (992)
+.++....++|++.++||+|+||+||+|++..+++.||+|+++.. .......+.+|+.+++.++||||+++++++.
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~- 144 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ- 144 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE-
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-
Confidence 445555678999999999999999999999989999999999642 2333455889999999999999999999864
Q ss_pred ccccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCC
Q 037275 748 IDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDL 827 (992)
Q Consensus 748 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 827 (992)
+....++||||+++|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++
T Consensus 145 ----~~~~~~lV~Ey~~gg~L~~~l~~~~~-----~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g 212 (437)
T 4aw2_A 145 ----DDNNLYLVMDYYVGGDLLTLLSKFED-----RLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNG 212 (437)
T ss_dssp ----CSSEEEEEECCCTTCBHHHHHHTTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTS
T ss_pred ----eCCEEEEEEecCCCCcHHHHHHHccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCC
Confidence 45667999999999999999986432 489999999999999999999999 999999999999999999
Q ss_pred cEEEeecccceecCCCCCCCCcccCCCCCccccccccccccccc-----CCCcCcccchhhHHHHHHHHHhCCCCCCCCc
Q 037275 828 VAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGM-----GGEASMTGDVYSFGILLLEMFTRRRPTDGMF 902 (992)
Q Consensus 828 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 902 (992)
.+||+|||+|+...... .......+||+.|+|||++. ...++.++|||||||++|||++|+.||.+..
T Consensus 213 ~vkL~DFGla~~~~~~~-------~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~ 285 (437)
T 4aw2_A 213 HIRLADFGSCLKLMEDG-------TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES 285 (437)
T ss_dssp CEEECCCTTCEECCTTS-------CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred CEEEcchhhhhhcccCC-------CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999998764321 11123357999999999986 5679999999999999999999999997632
Q ss_pred cCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCC--CCCHHHHHH
Q 037275 903 NQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTE--RMEMRDVVA 977 (992)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~ 977 (992)
.. +....+.........+... .....++.+++.+||..+|++ ||+++|+++
T Consensus 286 ~~-----------------~~~~~i~~~~~~~~~p~~~-------~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 286 LV-----------------ETYGKIMNHKERFQFPTQV-------TDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HH-----------------HHHHHHHTHHHHCCCCSSC-------CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred hh-----------------HHHHhhhhccccccCCccc-------ccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 11 1111111111100000000 011345789999999998888 999999875
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=365.14 Aligned_cols=254 Identities=22% Similarity=0.296 Sum_probs=202.1
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC-CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
.++|++.+.||+|+||+||+|++..+++.||||++..... ...+.+.+|+.+++.++||||+++++++. .....
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~ 80 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQ 80 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEe-----cCCeE
Confidence 4689999999999999999999998999999999964432 23466889999999999999999999864 45567
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
++||||+++|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~ 151 (323)
T 3tki_A 81 YLFLEYCSGGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGL 151 (323)
T ss_dssp EEEEECCTTEEGGGGSBTTT------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEEEcCCCCcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeec
Confidence 99999999999999986543 489999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccCCCc-CcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEA-SMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 915 (992)
++.+.... .........||+.|+|||++.+..+ +.++||||+||++|+|++|+.||............+....
T Consensus 152 a~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 225 (323)
T 3tki_A 152 ATVFRYNN------RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 225 (323)
T ss_dssp CEECEETT------EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTC
T ss_pred cceeccCC------cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccc
Confidence 98654321 1122234579999999999988775 7789999999999999999999986543322222221111
Q ss_pred CChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 916 LPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
... .........+.+++.+||+.||++|||++|+++
T Consensus 226 ~~~--------------------------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 226 TYL--------------------------NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp TTS--------------------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccC--------------------------CccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 000 000112345789999999999999999999975
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=362.09 Aligned_cols=252 Identities=18% Similarity=0.285 Sum_probs=203.6
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
.++|++.+.||+|+||+||+|++..+++.||+|++... ......+.+|+.+++.++||||+++++++. +....+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~~ 77 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFE-----SMEELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEE-----ETTEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEe-----cCCEEE
Confidence 46899999999999999999999999999999998643 334566889999999999999999999964 345679
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCC--CCcEEEeecc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQ--DLVAHLGDFG 835 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfg 835 (992)
+||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++. ++.+||+|||
T Consensus 78 lv~e~~~g~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg 149 (321)
T 1tki_A 78 MIFEFISGLDIFERINTSA-----FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFG 149 (321)
T ss_dssp EEECCCCCCBHHHHHTSSS-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred EEEEeCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECC
Confidence 9999999999999997543 2489999999999999999999999 9999999999999987 7899999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 915 (992)
+++...... ......||+.|+|||++.+..++.++||||+||++|+|++|..||.+....
T Consensus 150 ~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----------- 209 (321)
T 1tki_A 150 QARQLKPGD---------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ----------- 209 (321)
T ss_dssp TCEECCTTC---------EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-----------
T ss_pred CCeECCCCC---------ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH-----------
Confidence 998765321 122346899999999999988999999999999999999999999763221
Q ss_pred CChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 916 LPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
+.........+.. ..........++.+++.+||..||++|||+.|+++
T Consensus 210 ------~~~~~i~~~~~~~--------~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 210 ------QIIENIMNAEYTF--------DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp ------HHHHHHHHTCCCC--------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ------HHHHHHHcCCCCC--------ChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111111110000 00000112346889999999999999999999987
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=360.84 Aligned_cols=269 Identities=20% Similarity=0.255 Sum_probs=210.7
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhc-cCCcceeEEEEeecccccCcceEE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNI-RHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
++|++.+.||+|+||+||+|++..+++.||||++.... ....+.+|+.+++++ +||||+++++++.. ....+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-----~~~~~ 81 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPC-----GKYNA 81 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEE-----TTEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEec-----CCccE
Confidence 57899999999999999999998899999999986443 345688999999999 99999999998643 45679
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCc-----EEEe
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLV-----AHLG 832 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~ 832 (992)
+||||+ +++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++. +||+
T Consensus 82 lv~e~~-~~~L~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~ 152 (330)
T 2izr_A 82 MVLELL-GPSLEDLFDLCD-----RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHII 152 (330)
T ss_dssp EEEECC-CCBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEEC
T ss_pred EEEEeC-CCCHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEE
Confidence 999999 999999998643 2589999999999999999999999 9999999999999999887 9999
Q ss_pred ecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHH
Q 037275 833 DFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFA 912 (992)
Q Consensus 833 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~ 912 (992)
|||+++........... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.+..... ..+..
T Consensus 153 DFg~a~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~--~~~~~ 229 (330)
T 2izr_A 153 DFALAKEYIDPETKKHI-PYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT--LKERY 229 (330)
T ss_dssp CCTTCEESBCTTTCCBC-CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS--HHHHH
T ss_pred EcccceeeecCCCCccc-cccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccccc--HHHHH
Confidence 99999976543221111 1112345679999999999999999999999999999999999999998753221 11111
Q ss_pred hhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 037275 913 RTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTF 986 (992)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 986 (992)
........... .+ ......+ ++.+++..||+.||.+||++++|.+.|+++.+..
T Consensus 230 ------------~~i~~~~~~~~------~~-~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 230 ------------QKIGDTKRATP------IE-VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp ------------HHHHHHHHHSC------HH-HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ------------HHHHhhhccCC------HH-HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 10000000000 00 0000012 6899999999999999999999999999887654
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=369.58 Aligned_cols=281 Identities=17% Similarity=0.245 Sum_probs=212.1
Q ss_pred hcCCCCCCccccccceEEEEeEECCC-----CeEEEEEEeeccCCC-----------chhHHHHHHHHHHhccCCcceeE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGEN-----GMMVAVKVINLKQKG-----------ASNGFVAECQALRNIRHRNLIKI 741 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~~ 741 (992)
.++|++.+.||+|+||+||+|.+..+ ++.||||++...... ....+..|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 45899999999999999999998654 578999998643311 11223445556677789999999
Q ss_pred EEEeecccccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCe
Q 037275 742 ITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNV 821 (992)
Q Consensus 742 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NI 821 (992)
++++... ..+..+.++||||+ +++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||
T Consensus 114 ~~~~~~~-~~~~~~~~lv~e~~-g~~L~~~~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Ni 183 (364)
T 3op5_A 114 WGSGLHD-KNGKSYRFMIMDRF-GSDLQKIYEANA-----KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNL 183 (364)
T ss_dssp EEEEEEE-ETTEEEEEEEEECE-EEEHHHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred Eeeeeec-cCCcceEEEEEeCC-CCCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHE
Confidence 9997652 23346679999999 999999998643 2599999999999999999999999 999999999999
Q ss_pred eeC--CCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCC
Q 037275 822 LLD--QDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTD 899 (992)
Q Consensus 822 ll~--~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~ 899 (992)
+++ .++.+||+|||+|+.+......... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 184 ll~~~~~~~~kl~DFG~a~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~ 262 (364)
T 3op5_A 184 LLNYKNPDQVYLVDYGLAYRYCPEGVHKAY-AADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWE 262 (364)
T ss_dssp EEESSCTTCEEECCCTTCEESSGGGCCCCS-SCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEecCCCCeEEEEECCcceecccCCccccc-ccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 998 8899999999999876543221111 1122244569999999999999999999999999999999999999998
Q ss_pred CCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 037275 900 GMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKL 979 (992)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 979 (992)
+.... .................+++..+.. ...+.++.+++..||+.||++||++++|++.|
T Consensus 263 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l 324 (364)
T 3op5_A 263 DNLKD-PKYVRDSKIRYRENIASLMDKCFPA-----------------ANAPGEIAKYMETVKLLDYTEKPLYENLRDIL 324 (364)
T ss_dssp GGTTC-HHHHHHHHHHHHHCHHHHHHHHSCT-----------------TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred ccccC-HHHHHHHHHHhhhhHHHHHHHhccc-----------------ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Confidence 64322 1222222222222333333322100 11134688999999999999999999999999
Q ss_pred HHHHHhhh
Q 037275 980 CRARDTFL 987 (992)
Q Consensus 980 ~~~~~~~~ 987 (992)
+++.+...
T Consensus 325 ~~~~~~~~ 332 (364)
T 3op5_A 325 LQGLKAIG 332 (364)
T ss_dssp HHHHHHTT
T ss_pred HHHHHHcC
Confidence 99887653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=358.82 Aligned_cols=261 Identities=22% Similarity=0.398 Sum_probs=203.7
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCC---chhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKG---ASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
++|++.+.||+|+||.||+|++..+++.||+|++...... ..+.+.+|+.++++++||||+++++++. ....
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-----~~~~ 85 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDE-----EDDC 85 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEE-----CSSE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeee-----eCCe
Confidence 5799999999999999999999989999999998644332 2357889999999999999999999953 4566
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++||||+++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 86 ~~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg 156 (294)
T 4eqm_A 86 YYLVMEYIEGPTLSEYIESHG------PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFG 156 (294)
T ss_dssp EEEEEECCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCS
T ss_pred EEEEEeCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCC
Confidence 799999999999999997643 589999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 915 (992)
+++...... ........||+.|+|||++.+..++.++||||+||++|+|++|+.||.+....... .......
T Consensus 157 ~~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~-~~~~~~~ 228 (294)
T 4eqm_A 157 IAKALSETS-------LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA-IKHIQDS 228 (294)
T ss_dssp SSTTC--------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH-HHHHSSC
T ss_pred Ccccccccc-------ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHhhcc
Confidence 998654321 11223356899999999999999999999999999999999999999763221100 0000000
Q ss_pred CChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHHHHH
Q 037275 916 LPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERM-EMRDVVAKLCRARD 984 (992)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~ 984 (992)
.+..... .....+..+.+++.+||+.||++|| +++++.+.|+++..
T Consensus 229 ~~~~~~~-----------------------~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 229 VPNVTTD-----------------------VRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp CCCHHHH-----------------------SCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred CCCcchh-----------------------cccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 0100000 0011234688999999999999999 89999998887643
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=351.86 Aligned_cols=257 Identities=25% Similarity=0.430 Sum_probs=207.7
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAI 758 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 758 (992)
++|++.+.||+|+||+||+|++. +++.||+|++... ....+.+.+|++++++++||||+++++++. .....++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 82 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAPICL 82 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSEEE
T ss_pred hhceeeheecCCCccEEEEEEec-CCCeEEEEEeccc-ccCHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCceEE
Confidence 57889999999999999999997 6888999999643 334567999999999999999999999964 3455799
Q ss_pred EEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccce
Q 037275 759 VYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAK 838 (992)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 838 (992)
||||+++++|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.++
T Consensus 83 v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 154 (269)
T 4hcu_A 83 VFEFMEHGCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTR 154 (269)
T ss_dssp EEECCTTCBHHHHHHTTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGG
T ss_pred EEEeCCCCcHHHHHHhcCc-----ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccc
Confidence 9999999999999976443 489999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhhhCC
Q 037275 839 FLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFARTALP 917 (992)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 917 (992)
...... ........+|+.|+|||++.+..++.++||||+|+++|+|++ |+.||......
T Consensus 155 ~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~------------- 214 (269)
T 4hcu_A 155 FVLDDQ-------YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------------- 214 (269)
T ss_dssp GBCCHH-------HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------------
T ss_pred cccccc-------cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH-------------
Confidence 654321 112233457889999999998999999999999999999999 99999753211
Q ss_pred hhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 037275 918 DKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDT 985 (992)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 985 (992)
+........ ..... ......++.+++.+||+.||++|||++|+++.|+++.+.
T Consensus 215 ----~~~~~~~~~-~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 215 ----EVVEDISTG-FRLYK----------PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp ----HHHHHHHTT-CCCCC----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ----HHHHHHhcC-ccCCC----------CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 111111000 00000 001134588999999999999999999999999998764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=352.28 Aligned_cols=258 Identities=28% Similarity=0.410 Sum_probs=207.6
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
.++|++.+.||+|+||+||+|++. ++..||+|+++... ...+.+.+|++++++++||||+++++++. .....+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 79 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCS-----KEYPIY 79 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSEE
T ss_pred hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCceE
Confidence 457899999999999999999986 67889999996433 34567899999999999999999999963 445679
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||+++++|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~ 151 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSHGK-----GLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMT 151 (268)
T ss_dssp EEEECCTTCBHHHHHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCE
T ss_pred EEEEccCCCcHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccc
Confidence 99999999999999976542 489999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhhhC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFARTAL 916 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 916 (992)
........ .......+|+.|+|||++.+..++.++||||+|+++|+|++ |+.||......
T Consensus 152 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------------ 212 (268)
T 3sxs_A 152 RYVLDDQY-------VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS------------ 212 (268)
T ss_dssp EECCTTCE-------EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH------------
T ss_pred eecchhhh-------hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH------------
Confidence 87654321 11223456788999999998899999999999999999999 99999753211
Q ss_pred ChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 037275 917 PDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDT 985 (992)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 985 (992)
+.......... .... ......+.+++.+||+.||++|||++|+++.|+++++.
T Consensus 213 -----~~~~~~~~~~~-~~~~----------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 213 -----EVVLKVSQGHR-LYRP----------HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp -----HHHHHHHTTCC-CCCC----------TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred -----HHHHHHHcCCC-CCCC----------CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 00110000000 0000 01134588999999999999999999999999988654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=359.35 Aligned_cols=280 Identities=21% Similarity=0.334 Sum_probs=191.9
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC-CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
.++|++.+.||+|+||+||+|.+..+++.||+|+++... ......+.+|+.++++++||||+++++++. ..+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~ 78 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIH-----TENKL 78 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEEC-----CTTEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEE-----ECCeE
Confidence 458999999999999999999999899999999997543 334567889999999999999999999954 45567
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
++||||++ |+|.+++...........+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 79 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 154 (317)
T 2pmi_A 79 TLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGL 154 (317)
T ss_dssp EEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSS
T ss_pred EEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCcc
Confidence 99999997 69999998654332334589999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 915 (992)
++...... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||.+..... .........
T Consensus 155 ~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~ 225 (317)
T 2pmi_A 155 ARAFGIPV--------NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE-QLKLIFDIM 225 (317)
T ss_dssp CEETTSCC--------CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHH
T ss_pred ceecCCCc--------ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHh
Confidence 98764321 112234689999999998764 68999999999999999999999998643221 111111100
Q ss_pred -C-ChhHHHHHHhhHhHhhhccCCCCCCccc------cchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 916 -L-PDKVMEIVDSVLLLEVQASNSRSCGDER------LRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 916 -~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
. ++......... ..+............ ........++.+++.+||+.||++|||++|+++
T Consensus 226 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 226 GTPNESLWPSVTKL--PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp CSCCTTTCGGGGGC--TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCCChhHhhhhhhh--hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0 00000000000 000000000000000 000012346899999999999999999999975
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=363.29 Aligned_cols=256 Identities=20% Similarity=0.308 Sum_probs=203.0
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC-----CCchhHHHHHHHHHHhccCCcceeEEEEeecccccC
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ-----KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKG 752 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 752 (992)
.++|++.+.||+|+||+||+|++..+++.||||++.... ....+.+.+|+.+++.++||||+++++++. .
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~ 97 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYS-----S 97 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----E
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEE-----e
Confidence 357999999999999999999999899999999986321 224577899999999999999999999864 3
Q ss_pred cceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCc---E
Q 037275 753 VDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLV---A 829 (992)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~ 829 (992)
....++||||+++|+|.+++...... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++. +
T Consensus 98 ~~~~~lv~e~~~g~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~v 172 (351)
T 3c0i_A 98 DGMLYMVFEFMDGADLCFEIVKRADA--GFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPV 172 (351)
T ss_dssp TTEEEEEEECCSSCBHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCE
T ss_pred CCEEEEEEeCCCCCCHHHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcE
Confidence 45679999999999999988754321 23589999999999999999999999 9999999999999987654 9
Q ss_pred EEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHH
Q 037275 830 HLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLH 909 (992)
Q Consensus 830 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~ 909 (992)
||+|||++....... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+...
T Consensus 173 kl~Dfg~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------ 238 (351)
T 3c0i_A 173 KLGGFGVAIQLGESG--------LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE------ 238 (351)
T ss_dssp EECCCTTCEECCTTS--------CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH------
T ss_pred EEecCcceeEecCCC--------eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH------
Confidence 999999998765421 112335699999999999999999999999999999999999999976311
Q ss_pred HHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 910 EFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
+ .........+.. ..........++.+++.+||+.||++|||+.|+++
T Consensus 239 ~------------~~~~i~~~~~~~--------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 239 R------------LFEGIIKGKYKM--------NPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp H------------HHHHHHHTCCCC--------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred H------------HHHHHHcCCCCC--------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 011111000000 00000112346889999999999999999999985
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=372.46 Aligned_cols=276 Identities=21% Similarity=0.341 Sum_probs=214.7
Q ss_pred cHHHHHHHhcCCCCCCccccccceEEEEeE-----ECCCCeEEEEEEeeccCC-CchhHHHHHHHHHHhc-cCCcceeEE
Q 037275 670 SYAELSKATNDFSSSNMIGQGSFGFVYKGN-----LGENGMMVAVKVINLKQK-GASNGFVAECQALRNI-RHRNLIKII 742 (992)
Q Consensus 670 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~-----~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~ 742 (992)
...+.....++|++.+.||+|+||.||+|+ ...+++.||||+++.... ...+.+.+|+++++++ +||||++++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 344555567899999999999999999998 455679999999964332 2345689999999999 799999999
Q ss_pred EEeecccccCcceEEEEEEeccCCCHHHHHhhcccch-------------------------------------------
Q 037275 743 TICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQ------------------------------------------- 779 (992)
Q Consensus 743 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------------------------------------------- 779 (992)
+++.. .....++||||+++|+|.+++.......
T Consensus 93 ~~~~~----~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (359)
T 3vhe_A 93 GACTK----PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV 168 (359)
T ss_dssp EEECS----TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------
T ss_pred eeeec----CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccc
Confidence 99753 2344699999999999999998754210
Q ss_pred -----------------hhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceecCC
Q 037275 780 -----------------EARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSS 842 (992)
Q Consensus 780 -----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 842 (992)
....+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 245 (359)
T 3vhe_A 169 EEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYK 245 (359)
T ss_dssp ---------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTS
T ss_pred cccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecc
Confidence 012289999999999999999999999 999999999999999999999999999986643
Q ss_pred CCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhhhCChhHH
Q 037275 843 SPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFARTALPDKVM 921 (992)
Q Consensus 843 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 921 (992)
... ........||+.|+|||++.+..++.++|||||||++|||++ |+.||.+...... ..
T Consensus 246 ~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-------------~~ 306 (359)
T 3vhe_A 246 DPD------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-------------FC 306 (359)
T ss_dssp CTT------CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-------------HH
T ss_pred ccc------chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH-------------HH
Confidence 221 112234568899999999999999999999999999999998 9999976432211 11
Q ss_pred HHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 037275 922 EIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDT 985 (992)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 985 (992)
..+. ........ .....++.+++.+||+.||++|||++||++.|+++...
T Consensus 307 ~~~~----~~~~~~~~----------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 307 RRLK----EGTRMRAP----------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp HHHH----HTCCCCCC----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHH----cCCCCCCC----------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 1111 00000000 01134588999999999999999999999999998764
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=354.49 Aligned_cols=272 Identities=16% Similarity=0.197 Sum_probs=212.8
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhc-cCCcceeEEEEeecccccCcceE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNI-RHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
.++|++.+.||+|+||+||+|++..+++.||||++... .....+.+|+.+++.+ +|++++++++++. .....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~~~ 81 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ-----EGLHN 81 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEE-----ETTEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecC-----CCcee
Confidence 35799999999999999999999889999999998533 2345688999999999 7999999999853 44567
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCc-----EEE
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLV-----AHL 831 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl 831 (992)
++||||+ +++|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++. +||
T Consensus 82 ~lv~e~~-~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl 152 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDLCGR-----KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYV 152 (298)
T ss_dssp EEEEECC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred EEEEEec-CCCHHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEE
Confidence 9999999 9999999986532 489999999999999999999999 9999999999999987776 999
Q ss_pred eecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHH
Q 037275 832 GDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEF 911 (992)
Q Consensus 832 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~ 911 (992)
+|||+++........... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.+...... .+.
T Consensus 153 ~Dfg~~~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~ 229 (298)
T 1csn_A 153 VDFGMVKFYRDPVTKQHI-PYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN--KQK 229 (298)
T ss_dssp CCCTTCEESBCTTTCCBC-CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH--HHH
T ss_pred EECccccccccccccccc-cccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcccc--HHH
Confidence 999999987654321111 11223456799999999999999999999999999999999999999987432211 110
Q ss_pred HhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhh
Q 037275 912 ARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTFL 987 (992)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 987 (992)
. ..+.......... ........++.+++.+||+.||++|||+++|++.|+++.+...
T Consensus 230 ~--------~~~~~~~~~~~~~-----------~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 230 Y--------ERIGEKKQSTPLR-----------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp H--------HHHHHHHHHSCHH-----------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred H--------HHHHhhccCccHH-----------HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 0 0000000000000 0000123568999999999999999999999999999987654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=357.51 Aligned_cols=275 Identities=23% Similarity=0.333 Sum_probs=200.7
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC--CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
.++|++.++||+|+||+||+|++. +++.||+|++.... ......+.+|++++++++||||+++++++. ....
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~ 93 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIH-----SERC 93 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----CSSC
T ss_pred HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEc-----cCCE
Confidence 468999999999999999999996 68999999986443 223467889999999999999999999954 4556
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++||||+++ +|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 94 ~~lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg 164 (311)
T 3niz_A 94 LTLVFEFMEK-DLKKVLDENKT-----GLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFG 164 (311)
T ss_dssp EEEEEECCSE-EHHHHHHTCTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEcCCCC-CHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCc
Confidence 7999999974 88888876543 489999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
+++...... .......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+....+. .......
T Consensus 165 ~a~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~ 235 (311)
T 3niz_A 165 LARAFGIPV--------RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ-LPKIFSI 235 (311)
T ss_dssp TCEETTSCC--------C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH-HHHHHHH
T ss_pred CceecCCCc--------ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHH
Confidence 998764321 11223468999999999876 5689999999999999999999999987544322 2221111
Q ss_pred h---CChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 915 A---LPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 915 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
. .+..+....+................ ..........++.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 236 LGTPNPREWPQVQELPLWKQRTFQVFEKKP-WSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HCCCCTTTSGGGTTSHHHHSCCCCCCCCCC-HHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HCCCChHHhhhhhccchhhhcccccccCCc-HHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 1 11111100000000000000000000 00000112346889999999999999999999985
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=372.13 Aligned_cols=255 Identities=19% Similarity=0.261 Sum_probs=203.2
Q ss_pred HHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC--CchhHHHHHHHHHHhccCCcceeEEEEeecccccCc
Q 037275 676 KATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK--GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 676 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 753 (992)
...++|++.+.||+|+||+||+|.+..+|+.||+|++..... ...+.+.+|+.++++++||||+++++++. ..
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-----~~ 82 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSIS-----EE 82 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEE-----CS
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEE-----EC
Confidence 345689999999999999999999999999999999975432 23456889999999999999999999854 45
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeC---CCCcEE
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLD---QDLVAH 830 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~k 830 (992)
...++||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++ .++.+|
T Consensus 83 ~~~~lv~E~~~gg~L~~~i~~~~------~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vk 153 (444)
T 3soa_A 83 GHHYLIFDLVTGGELFEDIVARE------YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVK 153 (444)
T ss_dssp SEEEEEECCCBCCBHHHHHHHCS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEE
T ss_pred CEEEEEEEeCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEE
Confidence 66799999999999999998643 489999999999999999999999 999999999999998 567899
Q ss_pred EeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHH
Q 037275 831 LGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHE 910 (992)
Q Consensus 831 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~ 910 (992)
|+|||+|....... .......||+.|+|||++.+..++.++||||+||++|+|++|++||.+....
T Consensus 154 L~DFG~a~~~~~~~--------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~------ 219 (444)
T 3soa_A 154 LADFGLAIEVEGEQ--------QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH------ 219 (444)
T ss_dssp ECCCSSCBCCCTTC--------CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------
T ss_pred EccCceeEEecCCC--------ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH------
Confidence 99999998665321 1223457999999999999999999999999999999999999999753211
Q ss_pred HHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 911 FARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
+.......+.+.... ........++.+++.+||+.||++|||+.|+++
T Consensus 220 -----------~~~~~i~~~~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 220 -----------RLYQQIKAGAYDFPS--------PEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp -----------HHHHHHHHTCCCCCT--------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -----------HHHHHHHhCCCCCCc--------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 111111111111000 000112345889999999999999999999986
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=357.92 Aligned_cols=252 Identities=23% Similarity=0.330 Sum_probs=202.6
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCC------chhHHHHHHHHHHhccCCcceeEEEEeeccccc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKG------ASNGFVAECQALRNIRHRNLIKIITICSSIDFK 751 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 751 (992)
.++|++.+.||+|+||.||+|++..+++.||+|++...... ..+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~----- 84 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE----- 84 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----
Confidence 34689999999999999999999989999999999754321 3567899999999999999999999964
Q ss_pred CcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCC----
Q 037275 752 GVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDL---- 827 (992)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---- 827 (992)
.....++||||+++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~ 155 (326)
T 2y0a_A 85 NKTDVILILELVAGGELFDFLAEKE------SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKP 155 (326)
T ss_dssp CSSEEEEEEECCCSCBHHHHHTTSS------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSC
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhcC------CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCC
Confidence 4556799999999999999997543 589999999999999999999999 999999999999999887
Q ss_pred cEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCcc
Q 037275 828 VAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLT 907 (992)
Q Consensus 828 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~ 907 (992)
.+||+|||+++...... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+..... .
T Consensus 156 ~~kl~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~ 225 (326)
T 2y0a_A 156 RIKIIDFGLAHKIDFGN---------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-T 225 (326)
T ss_dssp CEEECCCTTCEECCTTS---------CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-H
T ss_pred CEEEEECCCCeECCCCC---------ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-H
Confidence 89999999998765321 1223468999999999998999999999999999999999999997632110 0
Q ss_pred HHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 908 LHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
............ ..........+.+++.+||+.||++|||+.|+++
T Consensus 226 ~~~~~~~~~~~~------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 226 LANVSAVNYEFE------------------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HHHHHHTCCCCC------------------------HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHhcCCCcC------------------------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000000000000 0000112345789999999999999999999986
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=365.33 Aligned_cols=250 Identities=24% Similarity=0.304 Sum_probs=198.6
Q ss_pred HhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc---CCCchhHHHHHHHHHHhc-cCCcceeEEEEeecccccC
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK---QKGASNGFVAECQALRNI-RHRNLIKIITICSSIDFKG 752 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 752 (992)
..++|++.++||+|+||+||+|++..+++.||||+++.. .......+.+|..+++.+ +||||+++++++. .
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~-----~ 95 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQ-----T 95 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----C
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEE-----e
Confidence 356899999999999999999999989999999999743 233456688999999988 7999999999853 4
Q ss_pred cceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEe
Q 037275 753 VDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLG 832 (992)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 832 (992)
....++||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 96 ~~~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~ 166 (353)
T 3txo_A 96 PDRLFFVMEFVNGGDLMFHIQKSR------RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLA 166 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEEC
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEc
Confidence 556799999999999999997643 489999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHH
Q 037275 833 DFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFA 912 (992)
Q Consensus 833 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~ 912 (992)
|||+|+..... .......+||+.|+|||++.+..++.++||||+||++|||++|+.||.+....
T Consensus 167 DFG~a~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-------- 230 (353)
T 3txo_A 167 DFGMCKEGICN--------GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED-------- 230 (353)
T ss_dssp CCTTCBCSCC-----------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------
T ss_pred cccceeecccC--------CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH--------
Confidence 99999753321 12233457999999999999889999999999999999999999999763211
Q ss_pred hhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCH------HHHHH
Q 037275 913 RTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEM------RDVVA 977 (992)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~ 977 (992)
+........... .+ .....++.+++.+||+.||++||++ +|+++
T Consensus 231 ---------~~~~~i~~~~~~------~p------~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 231 ---------DLFEAILNDEVV------YP------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ---------HHHHHHHHCCCC------CC------TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ---------HHHHHHHcCCCC------CC------CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 111111111110 00 0113457899999999999999998 66654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=363.92 Aligned_cols=253 Identities=22% Similarity=0.283 Sum_probs=198.1
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhc-cCCcceeEEEEeecccccCc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNI-RHRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 753 (992)
.++|++.++||+|+||+||+|++..+++.||+|+++... ......+.+|..+++++ +||||+++++++. ..
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~-----~~ 125 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-----TE 125 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEE-----CS
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEE-----EC
Confidence 468999999999999999999999999999999997542 33345688999999887 8999999999854 45
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGD 833 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 833 (992)
...++||||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 126 ~~~~lV~E~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~D 196 (396)
T 4dc2_A 126 SRLFFVIEYVNGGDLMFHMQRQR------KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTD 196 (396)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECC
T ss_pred CEEEEEEEcCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEee
Confidence 67799999999999999997643 589999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 913 (992)
||+|+.... ........+||+.|+|||++.+..++.++||||+||++|||++|+.||..........
T Consensus 197 FGla~~~~~--------~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~----- 263 (396)
T 4dc2_A 197 YGMCKEGLR--------PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD----- 263 (396)
T ss_dssp CTTCBCCCC--------TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC----------
T ss_pred cceeeeccc--------CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccc-----
Confidence 999985322 1122344679999999999999999999999999999999999999997532211100
Q ss_pred hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCH
Q 037275 914 TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEM 972 (992)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 972 (992)
......+.......... .+ .....++.+++.+||+.||++||++
T Consensus 264 ---~~~~~~~~~~i~~~~~~------~p------~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 264 ---QNTEDYLFQVILEKQIR------IP------RSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp ----CCHHHHHHHHHHCCCC------CC------TTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ---hhhHHHHHHHHhccccC------CC------CcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 00000111111111110 00 0123457899999999999999996
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=362.98 Aligned_cols=273 Identities=22% Similarity=0.374 Sum_probs=197.2
Q ss_pred HhcCCCCCCccccccceEEEEeEECCCCe---EEEEEEeecc--CCCchhHHHHHHHHHHhccCCcceeEEEEeeccccc
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLGENGM---MVAVKVINLK--QKGASNGFVAECQALRNIRHRNLIKIITICSSIDFK 751 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 751 (992)
..++|++.+.||+|+||+||+|++..++. .||||+++.. .....+.+.+|++++++++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 34589999999999999999999876654 8999999654 334457789999999999999999999997653322
Q ss_pred C-cceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEE
Q 037275 752 G-VDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAH 830 (992)
Q Consensus 752 ~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 830 (992)
+ ....++||||+++|+|.+++...........+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEE
Confidence 1 123489999999999999998665433334689999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHH
Q 037275 831 LGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLH 909 (992)
Q Consensus 831 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~ 909 (992)
|+|||+++....... ........+++.|+|||++.+..++.++|||||||++|||++ |+.||.+..... ..
T Consensus 178 l~Dfg~a~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~ 249 (323)
T 3qup_A 178 VADFGLSRKIYSGDY------YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE--IY 249 (323)
T ss_dssp ECCCCC-----------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HH
T ss_pred Eeecccccccccccc------ccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH--HH
Confidence 999999987654321 111223456889999999999999999999999999999999 999997643221 00
Q ss_pred HHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 037275 910 EFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTF 986 (992)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 986 (992)
........ .. .......++.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus 250 ---------------~~~~~~~~-~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 250 ---------------NYLIGGNR-LK----------QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp ---------------HHHHTTCC-CC----------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred ---------------HHHhcCCC-CC----------CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 00000000 00 00112345889999999999999999999999999987643
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=367.21 Aligned_cols=262 Identities=27% Similarity=0.463 Sum_probs=196.5
Q ss_pred hcCCCCCCccccccceEEEEeEEC---CCCeEEEEEEeeccC-CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLG---ENGMMVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 753 (992)
.++|++.+.||+|+||.||+|++. .++..||||+++... ....+.+.+|+.++++++||||+++++++.. .
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~ 118 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK-----S 118 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----S
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----C
Confidence 357999999999999999999875 457789999996543 2334678999999999999999999999643 4
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGD 833 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 833 (992)
...++||||+++|+|.+++..... .+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~D 190 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKHDA-----QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSD 190 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTT-----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECC
T ss_pred CceEEEEeCCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECc
Confidence 456999999999999999976532 489999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHH
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFA 912 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~ 912 (992)
||+++....... .........+++.|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 191 fg~a~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~-------- 257 (373)
T 2qol_A 191 FGLGRVLEDDPE-----AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ-------- 257 (373)
T ss_dssp C---------------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH--------
T ss_pred CccccccccCCc-----cceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--------
Confidence 999987654321 1111122345788999999999999999999999999999998 99999753211
Q ss_pred hhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 037275 913 RTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDT 985 (992)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 985 (992)
.....+.. ...... ......++.+++.+||+.||++|||+.||++.|+++.+.
T Consensus 258 ------~~~~~i~~----~~~~~~----------~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 258 ------DVIKAVDE----GYRLPP----------PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp ------HHHHHHHT----TEECCC----------CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ------HHHHHHHc----CCCCCC----------CccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 01111110 000000 011235688999999999999999999999999998764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=353.73 Aligned_cols=252 Identities=21% Similarity=0.316 Sum_probs=195.8
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC--------------------------CchhHHHHHHHHHH
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK--------------------------GASNGFVAECQALR 731 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~ 731 (992)
.++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 4689999999999999999999998999999999864321 12356889999999
Q ss_pred hccCCcceeEEEEeecccccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 037275 732 NIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPV 811 (992)
Q Consensus 732 ~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i 811 (992)
+++||||+++++++.. ......++||||+++++|.+++.. ..+++..++.++.|++.||+|||++ +|
T Consensus 92 ~l~h~~iv~~~~~~~~---~~~~~~~lv~e~~~~~~l~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i 158 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDD---PNEDHLYMVFELVNQGPVMEVPTL-------KPLSEDQARFYFQDLIKGIEYLHYQ---KI 158 (298)
T ss_dssp TCCCTTBCCEEEEEEC---SSSSEEEEEEECCTTCBSCCSSCS-------SCCCHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hCCCCCCCeEEEEEEc---CCCCEEEEEEecCCCCcHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---Ce
Confidence 9999999999999754 234577999999999999886532 2589999999999999999999999 99
Q ss_pred EeccCCCCCeeeCCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCC---cCcccchhhHHHHH
Q 037275 812 VHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGE---ASMTGDVYSFGILL 888 (992)
Q Consensus 812 vH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~il 888 (992)
+||||||+||+++.++.+||+|||+++...... .......||+.|+|||++.+.. ++.++|||||||++
T Consensus 159 vH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l 230 (298)
T 2zv2_A 159 IHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD--------ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230 (298)
T ss_dssp ECCCCCGGGEEECTTSCEEECCCTTCEECSSSS--------CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHH
T ss_pred eccCCCHHHEEECCCCCEEEecCCCcccccccc--------ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHH
Confidence 999999999999999999999999998765321 1122346899999999987765 47889999999999
Q ss_pred HHHHhCCCCCCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCC
Q 037275 889 LEMFTRRRPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTE 968 (992)
Q Consensus 889 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 968 (992)
|+|++|+.||.+... . ............ .+. ......++.+++.+||+.||++
T Consensus 231 ~~l~~g~~pf~~~~~-----~------------~~~~~~~~~~~~------~~~----~~~~~~~l~~li~~~l~~dp~~ 283 (298)
T 2zv2_A 231 YCFVFGQCPFMDERI-----M------------CLHSKIKSQALE------FPD----QPDIAEDLKDLITRMLDKNPES 283 (298)
T ss_dssp HHHHHSSCSSCCSSH-----H------------HHHHHHHHCCCC------CCS----SSCCCHHHHHHHHHHTCSCTTT
T ss_pred HHHHHCCCCCCCccH-----H------------HHHHHHhcccCC------CCC----ccccCHHHHHHHHHHhhcChhh
Confidence 999999999975311 0 011111100000 000 0112345889999999999999
Q ss_pred CCCHHHHHH
Q 037275 969 RMEMRDVVA 977 (992)
Q Consensus 969 RPs~~evl~ 977 (992)
|||++|+++
T Consensus 284 R~s~~e~l~ 292 (298)
T 2zv2_A 284 RIVVPEIKL 292 (298)
T ss_dssp SCCHHHHTT
T ss_pred CCCHHHHhc
Confidence 999999975
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=354.74 Aligned_cols=274 Identities=18% Similarity=0.283 Sum_probs=200.0
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC--CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK--GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
++|++.++||+|+||+||+|++..+++.||+|++..... .....+.+|+.++++++||||+++++++. .....
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEE-----eCCEE
Confidence 578999999999999999999998999999999975433 23467889999999999999999999964 34567
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
++||||+++ ++.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.
T Consensus 77 ~lv~e~~~~-~l~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~ 147 (292)
T 3o0g_A 77 TLVFEFCDQ-DLKKYFDSCN-----GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGL 147 (292)
T ss_dssp EEEEECCSE-EHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEecCCC-CHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeccc
Confidence 999999975 6666665433 2489999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccCCC-cCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGE-ASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 915 (992)
++...... .......||+.|+|||++.+.. ++.++||||+||++|||++|..||....+............
T Consensus 148 ~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~ 219 (292)
T 3o0g_A 148 ARAFGIPV--------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL 219 (292)
T ss_dssp CEECCSCC--------SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHH
T ss_pred ceecCCcc--------ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHh
Confidence 98764321 1223346899999999987765 89999999999999999998888644322211122211111
Q ss_pred CC---hhHHHHHHhhHhHhhhccCC-CCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 916 LP---DKVMEIVDSVLLLEVQASNS-RSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 916 ~~---~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.. ..+... .. ...+..... ...............++.+++.+||+.||++|||++|+++
T Consensus 220 ~~~~~~~~~~~-~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 220 GTPTEEQWPSM-TK--LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCTTTCTTG-GG--STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCChhhhhhh-cc--cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00 000000 00 000000000 0000000001123456789999999999999999999985
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=350.31 Aligned_cols=273 Identities=21% Similarity=0.268 Sum_probs=210.6
Q ss_pred HhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
..++|++.+.||+|+||+||+|++..+++.||||++.... ....+.+|+.+++.++|++++..++++. ......
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~----~~~~~~ 80 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDYN 80 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEE----EETTEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeec----CCCCce
Confidence 3568999999999999999999998899999999875432 3345889999999999998888887764 345567
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeee---CCCCcEEEee
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLL---DQDLVAHLGD 833 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~D 833 (992)
++||||+ +++|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||++ +.++.+||+|
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~D 151 (296)
T 4hgt_A 81 VMVMELL-GPSLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIID 151 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECC
T ss_pred EEEEEcc-CCCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEec
Confidence 9999999 9999999985432 489999999999999999999999 99999999999999 7889999999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCc--cHHHH
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGL--TLHEF 911 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~--~~~~~ 911 (992)
||.++........... .........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+...... .....
T Consensus 152 fg~a~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 230 (296)
T 4hgt_A 152 FGLAKKYRDARTHQHI-PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 230 (296)
T ss_dssp CTTCEECBCTTTCCBC-CCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHH
T ss_pred CccceeccCcccCccC-CCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhh
Confidence 9999987654321111 11223456799999999999999999999999999999999999999987533221 11111
Q ss_pred HhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhh
Q 037275 912 ARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTFLG 988 (992)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 988 (992)
.....+...... ......++.+++.+||+.||++|||++||++.|+++..+...
T Consensus 231 ~~~~~~~~~~~~-----------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~ 284 (296)
T 4hgt_A 231 SEKKMSTPIEVL-----------------------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp HHHHHHSCHHHH-----------------------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred hcccccchhhhh-----------------------hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence 111000000000 001134689999999999999999999999999999876543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=358.52 Aligned_cols=279 Identities=23% Similarity=0.318 Sum_probs=204.3
Q ss_pred HhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC-----CchhHHHHHHHHHHhcc---CCcceeEEEEeecc
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK-----GASNGFVAECQALRNIR---HRNLIKIITICSSI 748 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~ 748 (992)
..++|++.++||+|+||+||+|++..+++.||||++..... .....+.+|+.++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 35689999999999999999999988999999999974331 22356778888887775 99999999998765
Q ss_pred cccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCc
Q 037275 749 DFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLV 828 (992)
Q Consensus 749 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 828 (992)
........++||||+. |+|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~ 158 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP----PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGT 158 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCT----TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCC
Confidence 5444556899999996 699999986543 2489999999999999999999999 9999999999999999999
Q ss_pred EEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccH
Q 037275 829 AHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTL 908 (992)
Q Consensus 829 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~ 908 (992)
+||+|||.++..... .......||+.|+|||++.+..++.++||||+||++|||++|++||.+..... ..
T Consensus 159 ~kl~Dfg~a~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~ 228 (308)
T 3g33_A 159 VKLADFGLARIYSYQ---------MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QL 228 (308)
T ss_dssp EEECSCSCTTTSTTC---------CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH-HH
T ss_pred EEEeeCccccccCCC---------cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HH
Confidence 999999999865432 12234568999999999999999999999999999999999999997643221 11
Q ss_pred HHHHhhh-CCh--hHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 909 HEFARTA-LPD--KVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 909 ~~~~~~~-~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
....... .+. .+..... .....+.. ...........+...++.+++.+||+.||++|||+.|+++
T Consensus 229 ~~i~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 229 GKIFDLIGLPPEDDWPRDVS-LPRGAFPP---RGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHHHHHHCCCCTTTSCSSCS-SCGGGSCC---CCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHhCCCChhhccchhh-ccccccCC---CCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 1111100 000 0000000 00000000 0000000000122456889999999999999999999985
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=362.71 Aligned_cols=254 Identities=20% Similarity=0.306 Sum_probs=203.3
Q ss_pred HhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC--CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcc
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK--GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.++++++||||+++++++. ...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~ 101 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EES 101 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCC
Confidence 45689999999999999999999998999999999975432 23456889999999999999999999864 455
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCC---cEEE
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDL---VAHL 831 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl 831 (992)
..++||||+++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++ .+||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl 172 (362)
T 2bdw_A 102 FHYLVFDLVTGGELFEDIVARE------FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKL 172 (362)
T ss_dssp EEEEEECCCCSCBHHHHHTTCS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEE
T ss_pred EEEEEEecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEE
Confidence 6799999999999999997543 489999999999999999999999 999999999999997654 5999
Q ss_pred eecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHH
Q 037275 832 GDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEF 911 (992)
Q Consensus 832 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~ 911 (992)
+|||++....... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+....
T Consensus 173 ~DfG~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~------- 236 (362)
T 2bdw_A 173 ADFGLAIEVNDSE---------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH------- 236 (362)
T ss_dssp CCCTTCBCCTTCC---------SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------
T ss_pred eecCcceEecCCc---------ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-------
Confidence 9999998665321 123356999999999999999999999999999999999999999753211
Q ss_pred HhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 912 ARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
+.........+.. + .........++.+++.+||+.||++|||+.|+++.
T Consensus 237 ----------~~~~~i~~~~~~~------~--~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 237 ----------RLYAQIKAGAYDY------P--SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp ----------HHHHHHHHTCCCC------C--TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ----------HHHHHHHhCCCCC------C--cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1111111111100 0 00011123458899999999999999999999864
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=352.19 Aligned_cols=254 Identities=24% Similarity=0.400 Sum_probs=201.5
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCc-------hhHHHHHHHHHHhccCCcceeEEEEeecccc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGA-------SNGFVAECQALRNIRHRNLIKIITICSSIDF 750 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 750 (992)
.++|++.+.||+|+||+||+|++..+++.||+|++....... .+.+.+|+.++++++||||+++++++.+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 95 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP-- 95 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT--
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC--
Confidence 358999999999999999999999899999999986443222 16789999999999999999999986432
Q ss_pred cCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeccCCCCCeeeCCCCc
Q 037275 751 KGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPP--VVHGDLKPSNVLLDQDLV 828 (992)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~ 828 (992)
. ++||||+++|+|.+++..... .+++..++.++.|++.||+|||++ + |+||||||+||+++.++.
T Consensus 96 ---~--~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~ 162 (287)
T 4f0f_A 96 ---P--RMVMEFVPCGDLYHRLLDKAH-----PIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDE 162 (287)
T ss_dssp ---T--EEEEECCTTCBHHHHHHCTTS-----CCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCT
T ss_pred ---C--eEEEEecCCCCHHHHHhcccC-----CccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCC
Confidence 1 699999999999999875432 589999999999999999999999 8 999999999999988776
Q ss_pred -----EEEeecccceecCCCCCCCCcccCCCCCcccccccccccccc--cCCCcCcccchhhHHHHHHHHHhCCCCCCCC
Q 037275 829 -----AHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYG--MGGEASMTGDVYSFGILLLEMFTRRRPTDGM 901 (992)
Q Consensus 829 -----~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 901 (992)
+||+|||+++.... ......||+.|+|||++ ....++.++||||+||++|||++|+.||...
T Consensus 163 ~~~~~~kl~Dfg~~~~~~~-----------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 231 (287)
T 4f0f_A 163 NAPVCAKVADFGLSQQSVH-----------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY 231 (287)
T ss_dssp TCSCCEEECCCTTCBCCSS-----------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CCceeEEeCCCCccccccc-----------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 99999999974332 12234689999999998 3456789999999999999999999999764
Q ss_pred ccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 037275 902 FNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCR 981 (992)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 981 (992)
........... ........ . ......++.+++.+||+.||++|||++|+++.|++
T Consensus 232 ~~~~~~~~~~~---------------~~~~~~~~----~------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 232 SYGKIKFINMI---------------REEGLRPT----I------PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp CCCHHHHHHHH---------------HHSCCCCC----C------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred cccHHHHHHHH---------------hccCCCCC----C------CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 33211111110 00000000 0 01123468899999999999999999999999986
Q ss_pred H
Q 037275 982 A 982 (992)
Q Consensus 982 ~ 982 (992)
+
T Consensus 287 l 287 (287)
T 4f0f_A 287 L 287 (287)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=358.54 Aligned_cols=247 Identities=26% Similarity=0.359 Sum_probs=200.2
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc---CCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK---QKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
.++|++.+.||+|+||+||+|++..+++.||+|++... .......+.+|+.+++.++||||+++++++. ...
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-----~~~ 82 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT-----TPT 82 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCC
Confidence 46899999999999999999999989999999998643 2334567899999999999999999999964 345
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
..++||||+ +|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 83 ~~~lv~E~~-~g~l~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DF 152 (336)
T 3h4j_B 83 DIVMVIEYA-GGELFDYIVEKK------RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADF 152 (336)
T ss_dssp EEEEEECCC-CEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCS
T ss_pred EEEEEEECC-CCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEe
Confidence 679999999 789999987543 489999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCc-CcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEA-SMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 913 (992)
|++...... .......||+.|+|||++.+..+ ++++||||+||++|+|++|+.||.+....... .
T Consensus 153 G~s~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~-~---- 218 (336)
T 3h4j_B 153 GLSNIMTDG---------NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF-K---- 218 (336)
T ss_dssp SCTBTTTTS---------BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB-C----
T ss_pred ccceeccCC---------cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH-H----
Confidence 999865432 12233469999999999988876 68999999999999999999999764222100 0
Q ss_pred hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 914 TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
... ... ...+ .....++.+++.+||+.||++|||++|+++
T Consensus 219 -~i~-----------~~~------~~~p------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 219 -KVN-----------SCV------YVMP------DFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp -CCC-----------SSC------CCCC------TTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred -HHH-----------cCC------CCCc------ccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 000 000 0000 011345789999999999999999999975
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=349.28 Aligned_cols=272 Identities=22% Similarity=0.273 Sum_probs=213.0
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
.++|++.+.||+|+||+||+|++..+++.||||++.... ....+.+|+.+++.++|++++..++++.. .....+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~~ 81 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNV 81 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccC----CCCceE
Confidence 468999999999999999999998899999999986433 34568899999999999988877776532 445679
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeee---CCCCcEEEeec
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLL---DQDLVAHLGDF 834 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Df 834 (992)
+||||+ +++|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||++ +.++.+||+||
T Consensus 82 lv~e~~-~~~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Df 152 (296)
T 3uzp_A 82 MVMELL-GPSLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDF 152 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCC
T ss_pred EEEEec-CCCHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeC
Confidence 999999 8999999975432 489999999999999999999999 99999999999999 48889999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCC--ccHHHHH
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQG--LTLHEFA 912 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~--~~~~~~~ 912 (992)
|.+............ .........||+.|+|||++.+..++.++|||||||++|||++|+.||.+..... .......
T Consensus 153 g~~~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 231 (296)
T 3uzp_A 153 GLAKKYRDARTHQHI-PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS 231 (296)
T ss_dssp TTCEECBCTTTCCBC-CCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH
T ss_pred CCccccccccccccc-ccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhc
Confidence 999887654321111 1122345679999999999999999999999999999999999999998743221 1111111
Q ss_pred hhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhh
Q 037275 913 RTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTFLG 988 (992)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 988 (992)
....+..... . ......++.+++.+||+.||++|||++||++.|+++......
T Consensus 232 ~~~~~~~~~~-----~------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 232 EKKMSTPIEV-----L------------------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp HHHHHSCHHH-----H------------------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred ccccCCchHH-----H------------------HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 1100000000 0 001134589999999999999999999999999999876543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=368.62 Aligned_cols=287 Identities=18% Similarity=0.171 Sum_probs=206.1
Q ss_pred hcCCCCCCccccc--cceEEEEeEECCCCeEEEEEEeeccCC--CchhHHHHHHHHHHhccCCcceeEEEEeecccccCc
Q 037275 678 TNDFSSSNMIGQG--SFGFVYKGNLGENGMMVAVKVINLKQK--GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 678 ~~~~~~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 753 (992)
.++|++.++||+| +||+||+|++..+++.||||+++.... ...+.+.+|+.+++.++||||+++++++. ..
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~ 98 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFI-----AD 98 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ET
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEE-----EC
Confidence 4589999999999 999999999998999999999975432 23466788999999999999999999964 34
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGD 833 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 833 (992)
...++||||+++|+|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~d 171 (389)
T 3gni_B 99 NELWVVTSFMAYGSAKDLICTHFM----DGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSG 171 (389)
T ss_dssp TEEEEEEECCTTCBHHHHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECC
T ss_pred CEEEEEEEccCCCCHHHHHhhhcc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcc
Confidence 567999999999999999986532 2589999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccC--CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHH
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG--GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEF 911 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~ 911 (992)
||.+............ .........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+...... ....
T Consensus 172 fg~~~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~ 249 (389)
T 3gni_B 172 LRSNLSMISHGQRQRV-VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM-LLEK 249 (389)
T ss_dssp GGGCEECEETTEECSC-BCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH-HHHC
T ss_pred cccceeeccccccccc-cccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHH
Confidence 9998765432211111 1122334578999999999887 5799999999999999999999999987433322 1111
Q ss_pred HhhhCChhHHH-------H---HHh-----hHhHhhhc---cCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHH
Q 037275 912 ARTALPDKVME-------I---VDS-----VLLLEVQA---SNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMR 973 (992)
Q Consensus 912 ~~~~~~~~~~~-------~---~~~-----~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 973 (992)
.....+..... . ... ........ ..................++.+++.+||+.||++|||++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ 329 (389)
T 3gni_B 250 LNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAS 329 (389)
T ss_dssp --------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHH
T ss_pred hcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHH
Confidence 11111100000 0 000 00000000 000000000001122345689999999999999999999
Q ss_pred HHHHH
Q 037275 974 DVVAK 978 (992)
Q Consensus 974 evl~~ 978 (992)
|+++.
T Consensus 330 ell~h 334 (389)
T 3gni_B 330 TLLNH 334 (389)
T ss_dssp HHTTS
T ss_pred HHhcC
Confidence 99853
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=370.94 Aligned_cols=288 Identities=19% Similarity=0.236 Sum_probs=215.3
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC-CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
.++|++.++||+|+||+||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++++.. .+....
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~---~~~~~~ 84 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE---TTTRHK 84 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC---TTTCCE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeecc---CCCCee
Confidence 357899999999999999999999899999999997433 3345678899999999999999999998753 234467
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeee----CCCCcEEEe
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLL----DQDLVAHLG 832 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~ 832 (992)
++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~ 158 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSN---AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLT 158 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGG---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEEC
T ss_pred EEEEecCCCCCHHHHHHhhhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEe
Confidence 999999999999999986542 22489999999999999999999999 99999999999999 778889999
Q ss_pred ecccceecCCCCCCCCcccCCCCCcccccccccccccccC--------CCcCcccchhhHHHHHHHHHhCCCCCCCCccC
Q 037275 833 DFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG--------GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQ 904 (992)
Q Consensus 833 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~elltg~~pf~~~~~~ 904 (992)
|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 159 DFG~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~ 229 (396)
T 4eut_A 159 DFGAARELEDDE---------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229 (396)
T ss_dssp CGGGCEECCCGG---------GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCT
T ss_pred cCCCceEccCCC---------ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcc
Confidence 999998765321 1223468999999998765 56788999999999999999999999764333
Q ss_pred CccHHHHHhh--hCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 037275 905 GLTLHEFART--ALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRA 982 (992)
Q Consensus 905 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 982 (992)
.......... ..+......+....... .......+............+.+++.+||+.||++|||++|+++.++++
T Consensus 230 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 230 RRNKEVMYKIITGKPSGAISGVQKAENGP--IDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (396)
T ss_dssp TTCHHHHHHHHHSCCTTCCEEEECSTTCC--EEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred cchHHHHHHHhcCCCcccchhheeccCCC--cccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence 2221111110 00000000000000000 0000011111122355677889999999999999999999999999887
Q ss_pred HHh
Q 037275 983 RDT 985 (992)
Q Consensus 983 ~~~ 985 (992)
.+.
T Consensus 308 l~~ 310 (396)
T 4eut_A 308 LHR 310 (396)
T ss_dssp HTC
T ss_pred hhc
Confidence 654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=362.24 Aligned_cols=250 Identities=24% Similarity=0.339 Sum_probs=201.1
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc---CCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK---QKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
.++|++.+.||+|+||.||+|++..+++.||+|++... .......+.+|+.+++.++||||+++++++. ...
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-----~~~ 88 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ-----DEE 88 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----eCC
Confidence 35799999999999999999999999999999999643 2345577889999999999999999999854 455
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
..++||||+.+|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DF 159 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQNV------HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDF 159 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred EEEEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEecc
Confidence 6799999999999999997643 489999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccC---CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHH
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG---GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEF 911 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~ 911 (992)
|+|+..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ..+
T Consensus 160 G~a~~~~~~---------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~--~~~- 227 (384)
T 4fr4_A 160 NIAAMLPRE---------TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS--SKE- 227 (384)
T ss_dssp TTCEECCTT---------CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC--HHH-
T ss_pred ceeeeccCC---------CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc--HHH-
Confidence 999876532 12234579999999999864 458999999999999999999999997532221 111
Q ss_pred HhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCC-HHHHH
Q 037275 912 ARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERME-MRDVV 976 (992)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl 976 (992)
.......... ..+ .....++.+++.+||+.||++||+ +++++
T Consensus 228 -----------~~~~~~~~~~------~~p------~~~s~~~~~li~~lL~~dP~~R~s~~~~l~ 270 (384)
T 4fr4_A 228 -----------IVHTFETTVV------TYP------SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ 270 (384)
T ss_dssp -----------HHHHHHHCCC------CCC------TTSCHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred -----------HHHHHhhccc------CCC------CcCCHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence 1111100000 000 011345889999999999999999 66654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=366.56 Aligned_cols=259 Identities=19% Similarity=0.229 Sum_probs=206.0
Q ss_pred HHHHHHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc---CCCchhHHHHHHHHHHhccCCcceeEEEEeecc
Q 037275 672 AELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK---QKGASNGFVAECQALRNIRHRNLIKIITICSSI 748 (992)
Q Consensus 672 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 748 (992)
.++....++|++.++||+|+||+||+|++..+++.||+|+++.. .......+.+|+.+++.++||||+++++++.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-- 139 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ-- 139 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE--
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE--
Confidence 44555678999999999999999999999999999999999642 2334456889999999999999999999854
Q ss_pred cccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCc
Q 037275 749 DFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLV 828 (992)
Q Consensus 749 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 828 (992)
+....++||||+++|+|.++++.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.
T Consensus 140 ---~~~~~~lV~E~~~gg~L~~~l~~~-------~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ 206 (410)
T 3v8s_A 140 ---DDRYLYMVMEYMPGGDLVNLMSNY-------DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGH 206 (410)
T ss_dssp ---CSSEEEEEECCCTTEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSC
T ss_pred ---ECCEEEEEEeCCCCCcHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCC
Confidence 456779999999999999999743 388999999999999999999999 9999999999999999999
Q ss_pred EEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCC----cCcccchhhHHHHHHHHHhCCCCCCCCccC
Q 037275 829 AHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGE----ASMTGDVYSFGILLLEMFTRRRPTDGMFNQ 904 (992)
Q Consensus 829 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~il~elltg~~pf~~~~~~ 904 (992)
+||+|||+|+...... .......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+....
T Consensus 207 ikL~DFG~a~~~~~~~-------~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~ 279 (410)
T 3v8s_A 207 LKLADFGTCMKMNKEG-------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 279 (410)
T ss_dssp EEECCCTTCEECCTTS-------EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred EEEeccceeEeeccCC-------cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh
Confidence 9999999998765421 11123457999999999987655 889999999999999999999999753211
Q ss_pred CccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCC--CCCHHHHHH
Q 037275 905 GLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTE--RMEMRDVVA 977 (992)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~ 977 (992)
+....+.........+.. .....++.+++.+||..+|++ ||+++||++
T Consensus 280 -----------------~~~~~i~~~~~~~~~p~~--------~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 280 -----------------GTYSKIMNHKNSLTFPDD--------NDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp -----------------HHHHHHHTHHHHCCCCTT--------CCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred -----------------hHHHHHHhccccccCCCc--------ccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 111111111111000000 011345889999999999998 999999975
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=349.20 Aligned_cols=258 Identities=25% Similarity=0.423 Sum_probs=205.1
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
.++|++.+.||+|+||+||+|++. ++..||+|+++.. ....+.+.+|++++++++||||+++++++. .....+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 95 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCT-----KQRPIF 95 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSEE
T ss_pred HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCC-CCCHHHHHHHHHHHhcCCCCCEeeEEEEEe-----cCCCeE
Confidence 457899999999999999999987 7889999999743 334577899999999999999999999963 445679
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||+++|+|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+
T Consensus 96 lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~ 167 (283)
T 3gen_A 96 IITEYMANGCLLNYLREMRH-----RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLS 167 (283)
T ss_dssp EEECCCTTCBHHHHHHCGGG-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGG
T ss_pred EEEeccCCCcHHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccc
Confidence 99999999999999976432 489999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhhhC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFARTAL 916 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 916 (992)
+...... ........+|+.|+|||++.+..++.++||||+|+++|+|++ |+.||......
T Consensus 168 ~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~------------ 228 (283)
T 3gen_A 168 RYVLDDE-------YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS------------ 228 (283)
T ss_dssp GGBCCHH-------HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------------
T ss_pred ccccccc-------cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh------------
Confidence 8654321 111223457889999999998899999999999999999998 99999753211
Q ss_pred ChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 037275 917 PDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDT 985 (992)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 985 (992)
+....... ....... ......+.+++.+||+.||++|||++|+++.|+++.++
T Consensus 229 -----~~~~~~~~-~~~~~~~----------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 229 -----ETAEHIAQ-GLRLYRP----------HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp -----HHHHHHHT-TCCCCCC----------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----HHHHHHhc-ccCCCCC----------CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 00110000 0000000 01124588999999999999999999999999998764
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=358.27 Aligned_cols=265 Identities=25% Similarity=0.367 Sum_probs=202.5
Q ss_pred HhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC-CCchhHHHHHHHHHHhccCCcceeEEEEeecccc-----
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIKIITICSSIDF----- 750 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----- 750 (992)
..++|++.+.||+|+||.||+|++..+++.||||+++... ....+.+.+|+.++++++||||+++++++.+...
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 3567999999999999999999999899999999997543 3345778999999999999999999998754321
Q ss_pred -----------------------------------------------cCcceEEEEEEeccCCCHHHHHhhcccchhhcc
Q 037275 751 -----------------------------------------------KGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARS 783 (992)
Q Consensus 751 -----------------------------------------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~ 783 (992)
....+.++||||+++|+|.+++...... ..
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~---~~ 160 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL---ED 160 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG---GG
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc---cc
Confidence 1223479999999999999999876532 34
Q ss_pred cCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceecCCCCCCCCc----ccCCCCCccc
Q 037275 784 LTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAV----ETPSSSKGIK 859 (992)
Q Consensus 784 l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~----~~~~~~~~~~ 859 (992)
.++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++........... ..........
T Consensus 161 ~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T 3qd2_B 161 REHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV 237 (332)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC
T ss_pred hhhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccC
Confidence 67778999999999999999999 9999999999999999999999999999987654211110 0012234457
Q ss_pred ccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCC
Q 037275 860 GTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRS 939 (992)
Q Consensus 860 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (992)
||+.|+|||++.+..++.++||||+||++|||++|..|+... . ..........
T Consensus 238 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-------~------------~~~~~~~~~~-------- 290 (332)
T 3qd2_B 238 GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-------V------------RIITDVRNLK-------- 290 (332)
T ss_dssp -CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-------H------------HHHHHHHTTC--------
T ss_pred CCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-------H------------HHHHHhhccC--------
Confidence 999999999999999999999999999999999987764210 0 0000000000
Q ss_pred CCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 940 CGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 940 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
..........++.+++.+||+.||++|||++|+++
T Consensus 291 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 291 ---FPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp ---CCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred ---CCcccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 00011223445789999999999999999999985
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=364.79 Aligned_cols=253 Identities=19% Similarity=0.267 Sum_probs=204.0
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
.++|++.+.||+|+||+||+|.+..+++.||+|++..........+.+|+.+++.++||||+++++++. .....+
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~~~ 124 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE-----DKYEMV 124 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-----CSSEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEE-----eCCEEE
Confidence 458999999999999999999999899999999997554445567899999999999999999999964 456679
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCC--CCcEEEeecc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQ--DLVAHLGDFG 835 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfg 835 (992)
+||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++. ++.+||+|||
T Consensus 125 lv~E~~~gg~L~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG 196 (387)
T 1kob_A 125 LILEFLSGGELFDRIAAED-----YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFG 196 (387)
T ss_dssp EEEECCCCCBHHHHTTCTT-----CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred EEEEcCCCCcHHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecc
Confidence 9999999999999997543 2489999999999999999999999 9999999999999974 4789999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 915 (992)
+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....
T Consensus 197 ~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~----------- 256 (387)
T 1kob_A 197 LATKLNPDE---------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL----------- 256 (387)
T ss_dssp TCEECCTTS---------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-----------
T ss_pred cceecCCCc---------ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH-----------
Confidence 998765321 112346899999999999999999999999999999999999999763211
Q ss_pred CChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 916 LPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
+.+.......... .. ........++.+++.+||+.||++|||+.|+++
T Consensus 257 ------~~~~~i~~~~~~~--~~------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 257 ------ETLQNVKRCDWEF--DE------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp ------HHHHHHHHCCCCC--CS------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ------HHHHHHHhCCCCC--Cc------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 0111111100000 00 000112345889999999999999999999986
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=367.01 Aligned_cols=267 Identities=23% Similarity=0.364 Sum_probs=206.8
Q ss_pred hcCCCCCCccccccceEEEEeEE-----CCCCeEEEEEEeeccC-CCchhHHHHHHHHHHhccCCcceeEEEEeeccccc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNL-----GENGMMVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIKIITICSSIDFK 751 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 751 (992)
.++|++.++||+|+||+||+|+. ..+++.||||+++... ......+.+|+.++++++||||+++++++..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~---- 145 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ---- 145 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec----
Confidence 35789999999999999999994 4467899999986332 2334568899999999999999999999643
Q ss_pred CcceEEEEEEeccCCCHHHHHhhcccc-hhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCC---
Q 037275 752 GVDFQAIVYEYMQNGSLEDWLHQSEDQ-QEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDL--- 827 (992)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~--- 827 (992)
....++||||+++|+|.+++...... .....+++.+++.++.|++.||+|||++ +|+||||||+||+++.++
T Consensus 146 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~ 221 (367)
T 3l9p_A 146 -SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGR 221 (367)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTC
T ss_pred -CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCc
Confidence 44559999999999999999876432 1223589999999999999999999999 999999999999999555
Q ss_pred cEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCc
Q 037275 828 VAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGL 906 (992)
Q Consensus 828 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~ 906 (992)
.+||+|||+|+...... .........||+.|+|||++.+..++.++|||||||++|||++ |..||.+....
T Consensus 222 ~~kL~DFG~a~~~~~~~------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~-- 293 (367)
T 3l9p_A 222 VAKIGDFGMARDIYRAG------YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-- 293 (367)
T ss_dssp CEEECCCHHHHHHHHHS------SCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--
T ss_pred eEEECCCcccccccccc------ccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--
Confidence 59999999998653221 1112233467899999999999999999999999999999998 99999763211
Q ss_pred cHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 037275 907 TLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTF 986 (992)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 986 (992)
+......... ..... ......+.+++.+||+.||++|||++||++.|+.+.+..
T Consensus 294 ---------------~~~~~i~~~~-~~~~~----------~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 294 ---------------EVLEFVTSGG-RMDPP----------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp ---------------HHHHHHHTTC-CCCCC----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred ---------------HHHHHHHcCC-CCCCC----------ccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 1111111000 00000 112345889999999999999999999999999887643
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=369.60 Aligned_cols=255 Identities=30% Similarity=0.392 Sum_probs=206.4
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
.++|++.++||+|+||.||+|++. ++.||||+++... ..+.+.+|+.++++++||||+++++++.. .....+
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~~ 263 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLY 263 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEEC----TTSCEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEc----CCCceE
Confidence 457888999999999999999984 7899999996433 56789999999999999999999998753 334579
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||+++|+|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 264 iv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a 336 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLT 336 (450)
T ss_dssp EEEECCTTCBHHHHHHHHCT----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEecCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCc
Confidence 99999999999999986542 2478999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhhhC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFARTAL 916 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 916 (992)
+..... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||.+....+ ...
T Consensus 337 ~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~------ 397 (450)
T 1k9a_A 337 KEASST-----------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVP------ 397 (450)
T ss_dssp EECC-----------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--HHH------
T ss_pred cccccc-----------ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH------
Confidence 854321 111246889999999999999999999999999999998 999998643221 111
Q ss_pred ChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 037275 917 PDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTF 986 (992)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 986 (992)
.+. ..+..... .....++.+++.+||+.||++|||+.|+++.|+++....
T Consensus 398 ------~i~----~~~~~~~p----------~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~ 447 (450)
T 1k9a_A 398 ------RVE----KGYKMDAP----------DGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE 447 (450)
T ss_dssp ------HHH----TTCCCCCC----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred ------HHH----cCCCCCCC----------CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhh
Confidence 110 00000001 112356889999999999999999999999999987654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=360.65 Aligned_cols=251 Identities=24% Similarity=0.350 Sum_probs=201.9
Q ss_pred HHHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhc-cCCcceeEEEEeecccc
Q 037275 675 SKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNI-RHRNLIKIITICSSIDF 750 (992)
Q Consensus 675 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 750 (992)
....++|++.++||+|+||+||+|++..+++.||+|+++... ......+..|..+++.+ +||||+++++++.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~---- 88 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ---- 88 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE----
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEE----
Confidence 445678999999999999999999999999999999997432 34556788899999887 9999999999854
Q ss_pred cCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEE
Q 037275 751 KGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAH 830 (992)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 830 (992)
+....++||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+|
T Consensus 89 -~~~~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vk 158 (345)
T 1xjd_A 89 -TKENLFFVMEYLNGGDLMYHIQSCH------KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIK 158 (345)
T ss_dssp -CSSEEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEE
T ss_pred -eCCEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEE
Confidence 4566799999999999999997643 489999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHH
Q 037275 831 LGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHE 910 (992)
Q Consensus 831 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~ 910 (992)
|+|||+|+..... ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+....
T Consensus 159 L~DFG~a~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------ 224 (345)
T 1xjd_A 159 IADFGMCKENMLG--------DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE------ 224 (345)
T ss_dssp ECCCTTCBCCCCT--------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------
T ss_pred EeEChhhhhcccC--------CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH------
Confidence 9999999754321 11234457999999999999999999999999999999999999999753211
Q ss_pred HHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 037275 911 FARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMR-DVV 976 (992)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl 976 (992)
+.......... . .+ .....++.+++.+||+.||++||++. ||+
T Consensus 225 -----------~~~~~i~~~~~--~----~p------~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 225 -----------ELFHSIRMDNP--F----YP------RWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp -----------HHHHHHHHCCC--C----CC------TTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -----------HHHHHHHhCCC--C----CC------cccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 11111111110 0 00 01134588999999999999999997 654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=352.87 Aligned_cols=246 Identities=25% Similarity=0.317 Sum_probs=202.3
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc---CCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK---QKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
.++|++.+.||+|+||+||+|+...+|+.||+|+++.. .....+.+.+|+.+++.++||||+++++++. +..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~~~ 79 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ-----DAQ 79 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE-----CSS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEE-----eCC
Confidence 45799999999999999999999989999999999743 2344567889999999999999999999854 456
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
..++||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 80 ~~~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Df 150 (318)
T 1fot_A 80 QIFMIMDYIEGGELFSLLRKSQ------RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDF 150 (318)
T ss_dssp EEEEEECCCCSCBHHHHHHHTS------SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEEeCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeec
Confidence 7799999999999999997643 489999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
|+++..... .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+....
T Consensus 151 g~a~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---------- 209 (318)
T 1fot_A 151 GFAKYVPDV-----------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM---------- 209 (318)
T ss_dssp SSCEECSSC-----------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH----------
T ss_pred CcceecCCc-----------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH----------
Confidence 999865431 12346899999999999999999999999999999999999999753211
Q ss_pred hCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 037275 915 ALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERM-----EMRDVVA 977 (992)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 977 (992)
+........... .+ .....++.+++.+||+.||++|| +++|+++
T Consensus 210 -------~~~~~i~~~~~~------~p------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 210 -------KTYEKILNAELR------FP------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp -------HHHHHHHHCCCC------CC------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -------HHHHHHHhCCCC------CC------CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 111111111100 00 01134588999999999999999 8888874
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=376.03 Aligned_cols=205 Identities=23% Similarity=0.361 Sum_probs=160.2
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC--CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK--GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
++|++.++||+|+||+||+|++..+++.||||++..... ...+.+.+|+.++++++||||+++++++...........
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 689999999999999999999998999999999864322 234678899999999999999999999876655666788
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
++||||+ +|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 133 ~lv~e~~-~~~L~~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGl 202 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRTPV------YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGL 202 (458)
T ss_dssp EEEECCC-SEEHHHHHHSSC------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEecc-ccchhhhcccCC------CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeeccccc
Confidence 9999998 579999997543 589999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCCCc-------------------ccCCCCCcccccccccccccc-cCCCcCcccchhhHHHHHHHHHh
Q 037275 837 AKFLSSSPLDTAV-------------------ETPSSSKGIKGTVGYIAPEYG-MGGEASMTGDVYSFGILLLEMFT 893 (992)
Q Consensus 837 a~~~~~~~~~~~~-------------------~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~ellt 893 (992)
|+........... .........+||+.|+|||++ .+..++.++|||||||++|||++
T Consensus 203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 9876532211000 001123456789999999976 56679999999999999999999
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=359.74 Aligned_cols=259 Identities=23% Similarity=0.400 Sum_probs=200.5
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeE----EEEEEeecc-CCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCc
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMM----VAVKVINLK-QKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 753 (992)
++|++.++||+|+||+||+|++..+++. ||+|.++.. .....+.+.+|+.++++++||||+++++++...
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----- 89 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----- 89 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-----
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----
Confidence 4789999999999999999998767665 577777533 234557899999999999999999999997542
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGD 833 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 833 (992)
..++|+||+++|+|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 90 -~~~~v~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~D 160 (327)
T 3poz_A 90 -TVQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITD 160 (327)
T ss_dssp -SEEEEEECCTTCBHHHHHHHSTT-----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECC
T ss_pred -CeEEEEEecCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEcc
Confidence 25799999999999999986543 489999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHH
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFA 912 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~ 912 (992)
||+|+....... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.....
T Consensus 161 fg~a~~~~~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------- 227 (327)
T 3poz_A 161 FGLAKLLGAEEK------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE------- 227 (327)
T ss_dssp TTHHHHHTTTCC-------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------
T ss_pred CcceeEccCCcc------cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH-------
Confidence 999987654321 112223457889999999999999999999999999999999 999997642221
Q ss_pred hhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 037275 913 RTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDT 985 (992)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 985 (992)
....+... .... .......++.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 228 -------~~~~~~~~----~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 228 -------ISSILEKG----ERLP----------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -------HHHHHHTT----CCCC----------CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred -------HHHHHHcC----CCCC----------CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 11111110 0000 0011234588999999999999999999999999988754
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=360.54 Aligned_cols=254 Identities=22% Similarity=0.290 Sum_probs=193.4
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
.++|++.+.||+|+||+||+|++..+++.||||++.... ...+.+.+|+.+++.++||||+++++++. .....+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~~~ 92 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVIL-----TPTHLA 92 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEe-----eCCEEE
Confidence 458999999999999999999999999999999996433 34467889999999999999999999964 445679
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCc--EEEeecc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLV--AHLGDFG 835 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg 835 (992)
+||||+++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++. +||+|||
T Consensus 93 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg 163 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAG------RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFG 163 (361)
T ss_dssp EEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCC
T ss_pred EEEEeCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecC
Confidence 9999999999999997543 489999999999999999999999 9999999999999987765 9999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcc-cchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMT-GDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
+|+..... .......||+.|+|||++.+..++.+ +||||+||++|+|++|+.||.+...... .
T Consensus 164 ~a~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~------ 227 (361)
T 3uc3_A 164 YSKSSVLH---------SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD-Y------ 227 (361)
T ss_dssp CC------------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC-H------
T ss_pred cccccccc---------CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH-H------
Confidence 99743221 12233469999999999988877655 8999999999999999999986433221 1
Q ss_pred hCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 915 ALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
...+.......+.. +.. .....++.+++.+||+.||++|||+.|+++.
T Consensus 228 ------~~~~~~~~~~~~~~------~~~----~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 228 ------RKTIQRILSVKYSI------PDD----IRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp ------HHHHHHHHTTCCCC------CTT----SCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ------HHHHHHHhcCCCCC------CCc----CCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 11111111111100 000 0113457899999999999999999999864
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=358.74 Aligned_cols=280 Identities=21% Similarity=0.271 Sum_probs=212.2
Q ss_pred cCCCCCCccccccceEEEEeE----ECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcc
Q 037275 679 NDFSSSNMIGQGSFGFVYKGN----LGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
++|++.+.||+|+||.||+|+ ...+++.||||++........+.+.+|++++++++||||+++++++.. .+..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~ 99 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG---PGRQ 99 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC---SSSC
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEec---CCCc
Confidence 578999999999999999999 456889999999976555556778999999999999999999998653 3456
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
..++||||+++++|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Df 171 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQRHRA-----RLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADF 171 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCG
T ss_pred eEEEEEeecCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEccc
Confidence 67999999999999999986543 489999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
|.++....... .........||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ...+...
T Consensus 172 g~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~--~~~~~~~ 244 (327)
T 3lxl_A 172 GLAKLLPLDKD-----YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF--LRMMGCE 244 (327)
T ss_dssp GGCEECCTTCS-----EEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH--HHHCC--
T ss_pred ccceecccCCc-----cceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchh--hhhcccc
Confidence 99987654321 1112233458889999999998899999999999999999999999986521110 0000000
Q ss_pred hCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhh
Q 037275 915 ALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTFL 987 (992)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 987 (992)
.............. ...... ........+.+++.+||+.||++|||++|+++.|+++.....
T Consensus 245 ~~~~~~~~~~~~~~-~~~~~~----------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 245 RDVPALSRLLELLE-EGQRLP----------APPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp --CCHHHHHHHHHH-TTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred cccccHHHHHHHhh-cccCCC----------CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 00111111111111 110000 011224568999999999999999999999999998876543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=352.80 Aligned_cols=275 Identities=23% Similarity=0.366 Sum_probs=207.9
Q ss_pred cCCCCCCccccccceEEEEeE----ECCCCeEEEEEEeeccC-CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCc
Q 037275 679 NDFSSSNMIGQGSFGFVYKGN----LGENGMMVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 753 (992)
.+|++.+.||+|+||.||+|+ ...+++.||+|+++... ....+.+.+|+.++++++||||+++++++.. .+.
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 97 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE---DGG 97 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC------
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEec---CCC
Confidence 468899999999999999999 45689999999997443 3345778999999999999999999999754 233
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGD 833 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 833 (992)
...++||||+++|+|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~D 169 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPKNKN-----KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGD 169 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHHHTT-----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECC
T ss_pred ceEEEEEEeCCCCcHHHHHHhccc-----cCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECc
Confidence 557899999999999999975442 489999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 913 (992)
||.+........ .........||..|+|||++.+..++.++||||+||++|+|++|+.|+..... .......
T Consensus 170 fg~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~ 241 (302)
T 4e5w_A 170 FGLTKAIETDKE-----YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA---LFLKMIG 241 (302)
T ss_dssp CTTCEECCTTCC-----EEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH---HHHHHHC
T ss_pred ccccccccCCCc-----ceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh---HHhhccC
Confidence 999987754321 11222344688899999999999999999999999999999999998643110 0001111
Q ss_pred hhCChh-HHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 037275 914 TALPDK-VMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRAR 983 (992)
Q Consensus 914 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 983 (992)
...... ....... ....... .. ......++.+++.+||+.||++|||++|+++.|+++.
T Consensus 242 ~~~~~~~~~~~~~~-~~~~~~~----~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 242 PTHGQMTVTRLVNT-LKEGKRL----PC------PPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp SCCGGGHHHHHHHH-HHTTCCC----CC------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CcccccCHHHHHHH-HhccCCC----CC------CCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 111111 1111111 1111100 00 0122356899999999999999999999999999875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=356.37 Aligned_cols=259 Identities=23% Similarity=0.363 Sum_probs=203.0
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeE----EEEEEeeccC-CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCc
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMM----VAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 753 (992)
++|++.++||+|+||+||+|++..+++. ||+|++.... ......+.+|+.++++++||||+++++++. .
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~ 86 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP------G 86 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC------B
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc------C
Confidence 4788999999999999999999777765 7777764332 334456789999999999999999999863 2
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGD 833 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 833 (992)
...++||||+++|+|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~D 158 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQHRG-----ALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVAD 158 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHSSGG-----GSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECS
T ss_pred CccEEEEEeCCCCCHHHHHHHccc-----cCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECC
Confidence 346899999999999999986532 488999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHH
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFA 912 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~ 912 (992)
||+++....... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+....
T Consensus 159 fg~a~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------- 224 (325)
T 3kex_A 159 FGVADLLPPDDK------QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA-------- 224 (325)
T ss_dssp CSGGGGSCCCTT------CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT--------
T ss_pred CCcccccCcccc------cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH--------
Confidence 999987654321 112233467889999999998999999999999999999999 99999864221
Q ss_pred hhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 037275 913 RTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDT 985 (992)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 985 (992)
.....+.. . ........ ...++.+++.+||+.||++|||+.|+++.|+++...
T Consensus 225 ------~~~~~~~~---~-~~~~~~~~----------~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 225 ------EVPDLLEK---G-ERLAQPQI----------CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp ------HHHHHHHT---T-CBCCCCTT----------BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred ------HHHHHHHc---C-CCCCCCCc----------CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11111110 0 00000011 122478899999999999999999999999987643
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=356.76 Aligned_cols=269 Identities=22% Similarity=0.389 Sum_probs=212.0
Q ss_pred hcCCCCCCccccccceEEEEeEE-----CCCCeEEEEEEeeccCC-CchhHHHHHHHHHHhc-cCCcceeEEEEeecccc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNL-----GENGMMVAVKVINLKQK-GASNGFVAECQALRNI-RHRNLIKIITICSSIDF 750 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 750 (992)
.++|++.+.||+|+||+||+|++ ..+++.||||+++.... ...+.+.+|+.+++++ +||||+++++++..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--- 98 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI--- 98 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec---
Confidence 46899999999999999999985 45678999999974433 2346789999999999 99999999999643
Q ss_pred cCcceEEEEEEeccCCCHHHHHhhcccc------------hhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCC
Q 037275 751 KGVDFQAIVYEYMQNGSLEDWLHQSEDQ------------QEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKP 818 (992)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp 818 (992)
....++||||+++|+|.+++...... .....+++..++.++.|++.||+|||++ +|+||||||
T Consensus 99 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp 173 (313)
T 1t46_A 99 --GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAA 173 (313)
T ss_dssp --SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred --CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCcc
Confidence 44569999999999999999865421 1123589999999999999999999999 999999999
Q ss_pred CCeeeCCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCC
Q 037275 819 SNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRP 897 (992)
Q Consensus 819 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p 897 (992)
+||+++.++.+||+|||.++....... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.|
T Consensus 174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p 247 (313)
T 1t46_A 174 RNILLTHGRITKICDFGLARDIKNDSN------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247 (313)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTT------SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred ceEEEcCCCCEEEcccccccccccccc------ceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999987654321 111223457889999999988899999999999999999999 9999
Q ss_pred CCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 898 TDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 898 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
|.+..... .....+.. ...... ......++.+++.+||+.||++|||+.|+++
T Consensus 248 ~~~~~~~~-------------~~~~~~~~----~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 300 (313)
T 1t46_A 248 YPGMPVDS-------------KFYKMIKE----GFRMLS----------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (313)
T ss_dssp STTCCSSH-------------HHHHHHHH----TCCCCC----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCcccchh-------------HHHHHhcc----CCCCCC----------cccCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 97643221 11111111 000000 0112345889999999999999999999999
Q ss_pred HHHHHHHhhh
Q 037275 978 KLCRARDTFL 987 (992)
Q Consensus 978 ~L~~~~~~~~ 987 (992)
.|+++.+...
T Consensus 301 ~L~~~~~~~~ 310 (313)
T 1t46_A 301 LIEKQISEST 310 (313)
T ss_dssp HHHHHHHHTC
T ss_pred HHHHHHHHhh
Confidence 9999887654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=372.86 Aligned_cols=278 Identities=18% Similarity=0.222 Sum_probs=200.8
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc--CCCchhHHHHHHHHHHhccCCcceeEEEEeecccc-cCcc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK--QKGASNGFVAECQALRNIRHRNLIKIITICSSIDF-KGVD 754 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 754 (992)
.++|++.++||+|+||+||+|.+..+++.||||++... .....+.+.+|+.+++.++||||+++++++..... ....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 46899999999999999999999999999999999643 23345678899999999999999999999765332 3446
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
..++||||+++ ++.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~--------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DF 208 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 208 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred eEEEEEeCCCC-CHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEE
Confidence 77999999976 56666642 388999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
|+|+..... .......||+.|+|||++.+..|+.++||||+||++|||++|+.||.+....+ .+......
T Consensus 209 G~a~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~-~~~~i~~~ 278 (464)
T 3ttj_A 209 GLARTAGTS---------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQ 278 (464)
T ss_dssp CCC-----C---------CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHH
T ss_pred EeeeecCCC---------cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHh
Confidence 999865432 12234578999999999999999999999999999999999999998743211 11111111
Q ss_pred hC-C-hhHHHHHHhhHhHhhhccCCC------------CCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 915 AL-P-DKVMEIVDSVLLLEVQASNSR------------SCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 915 ~~-~-~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.. + ......+.............. ..............++.+++.+||+.||++|||++|+++
T Consensus 279 lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 279 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 10 0 000000000000000000000 000011111223567899999999999999999999986
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=355.34 Aligned_cols=277 Identities=21% Similarity=0.323 Sum_probs=199.3
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCC--chhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKG--ASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
.++|++.+.||+|+||+||+|++..+|+.||+|++...... ..+.+.+|+.++++++||||+++++++. ....
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~ 76 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFR-----RKRR 76 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheee-----cCCe
Confidence 35899999999999999999999989999999998644332 2456789999999999999999999964 3456
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++||||+++++|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 77 ~~lv~e~~~~~~l~~~~~~~~------~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg 147 (311)
T 4agu_A 77 LHLVFEYCDHTVLHELDRYQR------GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFG 147 (311)
T ss_dssp EEEEEECCSEEHHHHHHHTSS------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEEeCCCchHHHHHhhhc------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCC
Confidence 799999999999999887543 489999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
.+....... .......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+....+. .......
T Consensus 148 ~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~ 218 (311)
T 4agu_A 148 FARLLTGPS--------DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ-LYLIRKT 218 (311)
T ss_dssp TCEECC--------------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHH
T ss_pred CchhccCcc--------cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHH
Confidence 998765321 11223468999999999876 5789999999999999999999999986432211 1111111
Q ss_pred --hCChhHHHHHHhh-HhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 915 --ALPDKVMEIVDSV-LLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 915 --~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
............. ..........................+.+++.+||+.||++|||++|+++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 219 LGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp HCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred hcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 1111111111110 00000000000000000001123456889999999999999999999985
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=355.84 Aligned_cols=275 Identities=24% Similarity=0.410 Sum_probs=203.7
Q ss_pred HHhcCCCCCCccccccceEEEEeEECC---CCeEEEEEEeeccCC--CchhHHHHHHHHHHhccCCcceeEEEEeecccc
Q 037275 676 KATNDFSSSNMIGQGSFGFVYKGNLGE---NGMMVAVKVINLKQK--GASNGFVAECQALRNIRHRNLIKIITICSSIDF 750 (992)
Q Consensus 676 ~~~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 750 (992)
...++|.+.+.||+|+||.||+|.... +++.||+|+++.... ...+.+.+|+.++++++||||+++++++.....
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 345678899999999999999998754 456899999875432 234668999999999999999999999876544
Q ss_pred cCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEE
Q 037275 751 KGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAH 830 (992)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 830 (992)
.+....++||||+++|+|.+++...........+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEE
Confidence 44456799999999999999997554333345699999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHH
Q 037275 831 LGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLH 909 (992)
Q Consensus 831 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~ 909 (992)
|+|||+++....... ........+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+..... ..
T Consensus 188 l~Dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~ 259 (313)
T 3brb_A 188 VADFGLSKKIYSGDY------YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE--MY 259 (313)
T ss_dssp ECSCSCC----------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HH
T ss_pred EeecCcceecccccc------cCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH--HH
Confidence 999999987643221 111223457889999999999999999999999999999999 889987642221 00
Q ss_pred HHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhh
Q 037275 910 EFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTFL 987 (992)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 987 (992)
........ .. ........+.+++.+||+.||++|||+.|+++.|+++.+.+.
T Consensus 260 ---------------~~~~~~~~-~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 260 ---------------DYLLHGHR-LK----------QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp ---------------HHHHTTCC-CC----------CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred ---------------HHHHcCCC-CC----------CCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 00000000 00 001123468899999999999999999999999999987653
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=362.06 Aligned_cols=248 Identities=22% Similarity=0.297 Sum_probs=195.4
Q ss_pred CCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEEEEe
Q 037275 683 SSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEY 762 (992)
Q Consensus 683 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 762 (992)
..+.||+|+||.||+|++..+|+.||+|+++.......+.+.+|++++++++||||+++++++. .....++||||
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~~lv~E~ 167 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE-----SKNDIVLVMEY 167 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEEEEEEEC
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCEEEEEEeC
Confidence 3568999999999999999899999999997655555678999999999999999999999964 34567999999
Q ss_pred ccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeee--CCCCcEEEeecccceec
Q 037275 763 MQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLL--DQDLVAHLGDFGLAKFL 840 (992)
Q Consensus 763 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll--~~~~~~kl~Dfg~a~~~ 840 (992)
+++|+|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++..
T Consensus 168 ~~~~~L~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~ 239 (373)
T 2x4f_A 168 VDGGELFDRIIDESY-----NLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239 (373)
T ss_dssp CTTCEEHHHHHHTGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEEC
T ss_pred CCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceec
Confidence 999999999875432 489999999999999999999999 99999999999999 67789999999999876
Q ss_pred CCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCChhH
Q 037275 841 SSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKV 920 (992)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 920 (992)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....
T Consensus 240 ~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---------------- 294 (373)
T 2x4f_A 240 KPRE---------KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA---------------- 294 (373)
T ss_dssp CTTC---------BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH----------------
T ss_pred CCcc---------ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH----------------
Confidence 5322 122346899999999999999999999999999999999999999764221
Q ss_pred HHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 921 MEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
+.+.......... . .........++.+++.+||+.||++|||++|+++
T Consensus 295 -~~~~~i~~~~~~~------~--~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 295 -ETLNNILACRWDL------E--DEEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp -HHHHHHHHTCCCS------C--SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -HHHHHHHhccCCC------C--hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1111111110000 0 0000112356889999999999999999999987
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=358.94 Aligned_cols=271 Identities=21% Similarity=0.357 Sum_probs=206.9
Q ss_pred HhcCCCCCCccccccceEEEEeEE-----CCCCeEEEEEEeeccC-CCchhHHHHHHHHHHhc-cCCcceeEEEEeeccc
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNL-----GENGMMVAVKVINLKQ-KGASNGFVAECQALRNI-RHRNLIKIITICSSID 749 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 749 (992)
..++|++.+.||+|+||+||+|++ ..+++.||||++.... ....+.+.+|+.+++++ +||||+++++++..
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-- 120 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL-- 120 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee--
Confidence 356899999999999999999997 3456789999996432 33457789999999999 89999999999643
Q ss_pred ccCcceEEEEEEeccCCCHHHHHhhcccc-----------------hhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 037275 750 FKGVDFQAIVYEYMQNGSLEDWLHQSEDQ-----------------QEARSLTLIQRINIIIDVASAIEYIHHHCQPPVV 812 (992)
Q Consensus 750 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iv 812 (992)
....++||||+++|+|.+++...... .....+++..++.++.|++.||+|||++ +|+
T Consensus 121 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iv 194 (344)
T 1rjb_A 121 ---SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCV 194 (344)
T ss_dssp ---SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred ---CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 44569999999999999999865421 0113489999999999999999999999 999
Q ss_pred eccCCCCCeeeCCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHH
Q 037275 813 HGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMF 892 (992)
Q Consensus 813 H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 892 (992)
||||||+||+++.++.+||+|||++........ ........||+.|+|||++.+..++.++|||||||++|||+
T Consensus 195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 268 (344)
T 1rjb_A 195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSN------YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 268 (344)
T ss_dssp ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTT------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHT
T ss_pred cCCCChhhEEEcCCCcEEeCCCccCcccccCcc------ceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHH
Confidence 999999999999999999999999986643221 11123345788999999998889999999999999999999
Q ss_pred h-CCCCCCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCC
Q 037275 893 T-RRRPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERME 971 (992)
Q Consensus 893 t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 971 (992)
| |..||.+..... . ....+.. ....... .....++.+++.+||+.||++|||
T Consensus 269 t~g~~p~~~~~~~~-~------------~~~~~~~----~~~~~~~----------~~~~~~l~~li~~~l~~dp~~Rps 321 (344)
T 1rjb_A 269 SLGVNPYPGIPVDA-N------------FYKLIQN----GFKMDQP----------FYATEEIYIIMQSCWAFDSRKRPS 321 (344)
T ss_dssp TTSCCSSTTCCCSH-H------------HHHHHHT----TCCCCCC----------TTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred cCCCCCcccCCcHH-H------------HHHHHhc----CCCCCCC----------CCCCHHHHHHHHHHcCCCchhCcC
Confidence 8 999997643221 1 1111110 0000000 111345889999999999999999
Q ss_pred HHHHHHHHHHHHHhhhh
Q 037275 972 MRDVVAKLCRARDTFLG 988 (992)
Q Consensus 972 ~~evl~~L~~~~~~~~~ 988 (992)
+.|+++.|+.+.+....
T Consensus 322 ~~~l~~~l~~~~~~~~~ 338 (344)
T 1rjb_A 322 FPNLTSFLGCQLADAEE 338 (344)
T ss_dssp HHHHHHHHHHHC-----
T ss_pred HHHHHHHHHHHHHHHHH
Confidence 99999999998766543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=355.40 Aligned_cols=253 Identities=22% Similarity=0.281 Sum_probs=198.1
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC---CchhHHHHHHHHHHhc-cCCcceeEEEEeecccccCc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK---GASNGFVAECQALRNI-RHRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 753 (992)
.++|++.+.||+|+||.||+|++..+++.||+|+++.... ...+.+.+|..+++++ +||||+++++++. ..
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~-----~~ 82 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-----TE 82 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CS
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEE-----eC
Confidence 3578999999999999999999999999999999975432 2345678899999988 8999999999853 45
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGD 833 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 833 (992)
...++||||+++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 83 ~~~~lv~e~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~D 153 (345)
T 3a8x_A 83 SRLFFVIEYVNGGDLMFHMQRQR------KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTD 153 (345)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEe
Confidence 67799999999999999997543 489999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 913 (992)
||+++..... ........||+.|+|||++.+..++.++||||+||++|||++|+.||...........
T Consensus 154 FG~a~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---- 221 (345)
T 3a8x_A 154 YGMCKEGLRP--------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ---- 221 (345)
T ss_dssp GGGCBCSCCT--------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC----------
T ss_pred ccccccccCC--------CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccc----
Confidence 9999853321 1123345799999999999999999999999999999999999999975322110000
Q ss_pred hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCH
Q 037275 914 TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEM 972 (992)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 972 (992)
............... ..+ .....++.+++.+||+.||++||++
T Consensus 222 ----~~~~~~~~~i~~~~~------~~p------~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 222 ----NTEDYLFQVILEKQI------RIP------RSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp -----CHHHHHHHHHHCCC------CCC------TTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ----ccHHHHHHHHHcCCC------CCC------CCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 000011111111110 000 0123458899999999999999996
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=352.87 Aligned_cols=272 Identities=22% Similarity=0.322 Sum_probs=196.7
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC--CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
++|++.+.||+|+||+||+|++ .+++.||+|++.... ......+.+|+.++++++||||+++++++. .....
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 75 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH-----TKKRL 75 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE-----CSSCE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEc-----cCCeE
Confidence 5789999999999999999999 478999999986443 223467889999999999999999999964 34567
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
++||||+++ +|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 76 ~lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 146 (288)
T 1ob3_A 76 VLVFEHLDQ-DLKKLLDVCEG-----GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGL 146 (288)
T ss_dssp EEEEECCSE-EHHHHHHTSTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred EEEEEecCC-CHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECcc
Confidence 999999975 99999876432 489999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 915 (992)
++...... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||.+....+ .........
T Consensus 147 ~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~ 217 (288)
T 1ob3_A 147 ARAFGIPV--------RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRIL 217 (288)
T ss_dssp HHHHCC-----------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHH
T ss_pred ccccCccc--------cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHH
Confidence 98664321 112234689999999998764 58999999999999999999999998643221 111111100
Q ss_pred C---ChhHHHHHHhhHhHhhhccCCCCC-CccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 916 L---PDKVMEIVDSVLLLEVQASNSRSC-GDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 916 ~---~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
. ...+... .. ...+........ ............++.+++.+||+.||++|||++|+++
T Consensus 218 ~~~~~~~~~~~-~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 218 GTPNSKNWPNV-TE--LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCCCTTTSTTG-GG--STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCChhhchhh-hc--ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 0000000 00 000000000000 0000000112356789999999999999999999975
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=360.86 Aligned_cols=251 Identities=22% Similarity=0.292 Sum_probs=187.3
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
.++|++.+.||+|+||+||+|++..+++.||||+++... ..+.+.+|++++++++||||+++++++. .....+
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~ 124 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFE-----TPTEIS 124 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEE-----CSSEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEe-----cCCeEE
Confidence 467999999999999999999999899999999996432 3456889999999999999999999964 345679
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCC---CCcEEEeec
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQ---DLVAHLGDF 834 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Df 834 (992)
+||||+++|+|.+++.... .+++.+++.++.|++.||+|||+. +|+||||||+||+++. ++.+||+||
T Consensus 125 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Df 195 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVEKG------YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADF 195 (349)
T ss_dssp EEECCCCSCBHHHHHTTCS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCC
T ss_pred EEEEeCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccC
Confidence 9999999999999997543 489999999999999999999999 9999999999999975 889999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
|+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..........
T Consensus 196 g~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~---- 262 (349)
T 2w4o_A 196 GLSKIVEHQV---------LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRR---- 262 (349)
T ss_dssp C-------------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHH----
T ss_pred ccccccCccc---------ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHH----
Confidence 9998654321 122346899999999999999999999999999999999999999753221111111
Q ss_pred hCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 915 ALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
........ . .....+...++.+++.+||+.||++|||+.|+++
T Consensus 263 ------------i~~~~~~~--~------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 263 ------------ILNCEYYF--I------SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp ------------HHTTCCCC--C------TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ------------HHhCCCcc--C------CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11000000 0 0000112346889999999999999999999986
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=363.83 Aligned_cols=272 Identities=23% Similarity=0.403 Sum_probs=209.8
Q ss_pred HHhcCCCCCCccccccceEEEEeEEC-----CCCeEEEEEEeeccCC-CchhHHHHHHHHHHhccCCcceeEEEEeeccc
Q 037275 676 KATNDFSSSNMIGQGSFGFVYKGNLG-----ENGMMVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIITICSSID 749 (992)
Q Consensus 676 ~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 749 (992)
...++|++.+.||+|+||.||+|++. .+++.||||+++.... ...+.+.+|+.++++++||||+++++++..
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-- 121 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV-- 121 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc--
Confidence 34678999999999999999999986 3458999999974432 234678999999999999999999999643
Q ss_pred ccCcceEEEEEEeccCCCHHHHHhhcccch------------------hhcccCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 037275 750 FKGVDFQAIVYEYMQNGSLEDWLHQSEDQQ------------------EARSLTLIQRINIIIDVASAIEYIHHHCQPPV 811 (992)
Q Consensus 750 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i 811 (992)
....++||||+++|+|.+++....... ....+++.+++.++.|++.||+|||++ +|
T Consensus 122 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~i 195 (343)
T 1luf_A 122 ---GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF 195 (343)
T ss_dssp ---SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred ---CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 455699999999999999998753210 124689999999999999999999999 99
Q ss_pred EeccCCCCCeeeCCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHH
Q 037275 812 VHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEM 891 (992)
Q Consensus 812 vH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 891 (992)
+||||||+||+++.++.+||+|||+++....... ........+|+.|+|||++.+..++.++|||||||++|||
T Consensus 196 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el 269 (343)
T 1luf_A 196 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADY------YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 269 (343)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGC------BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred ecCCCCcceEEECCCCeEEEeecCCCcccccCcc------ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHH
Confidence 9999999999999999999999999986643211 1122334578999999999988999999999999999999
Q ss_pred Hh-CCCCCCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCC
Q 037275 892 FT-RRRPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERM 970 (992)
Q Consensus 892 lt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 970 (992)
++ |+.||.+.... +.......... ...+ ......+.+++.+||+.||++||
T Consensus 270 ~t~g~~p~~~~~~~-----------------~~~~~~~~~~~-----~~~~------~~~~~~l~~li~~~l~~~p~~Rp 321 (343)
T 1luf_A 270 FSYGLQPYYGMAHE-----------------EVIYYVRDGNI-----LACP------ENCPLELYNLMRLCWSKLPADRP 321 (343)
T ss_dssp HTTTCCTTTTSCHH-----------------HHHHHHHTTCC-----CCCC------TTCCHHHHHHHHHHTCSSGGGSC
T ss_pred HhcCCCcCCCCChH-----------------HHHHHHhCCCc-----CCCC------CCCCHHHHHHHHHHcccCcccCC
Confidence 99 99999753211 11111110000 0000 11234588999999999999999
Q ss_pred CHHHHHHHHHHHHHhhhhc
Q 037275 971 EMRDVVAKLCRARDTFLGR 989 (992)
Q Consensus 971 s~~evl~~L~~~~~~~~~~ 989 (992)
|+.|+++.|+++.+.+.+.
T Consensus 322 s~~~~~~~L~~~~~~~~~~ 340 (343)
T 1luf_A 322 SFCSIHRILQRMCERAEGT 340 (343)
T ss_dssp CHHHHHHHHHHTTC-----
T ss_pred CHHHHHHHHHHHHhhhhhh
Confidence 9999999999998776543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=363.46 Aligned_cols=210 Identities=26% Similarity=0.337 Sum_probs=179.6
Q ss_pred CcccHHHHHHHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhcc-----CCcceeE
Q 037275 667 PMISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIR-----HRNLIKI 741 (992)
Q Consensus 667 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~~ 741 (992)
..+++.+-....++|++.++||+|+||+||+|++..+++.||||+++. .......+..|+.+++.+. ||||+++
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 344555555567799999999999999999999998999999999863 2233456788999999996 9999999
Q ss_pred EEEeecccccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCe
Q 037275 742 ITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNV 821 (992)
Q Consensus 742 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NI 821 (992)
++++.. ....++||||+ +++|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+||
T Consensus 102 ~~~~~~-----~~~~~lv~e~~-~~~L~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NI 168 (360)
T 3llt_A 102 HGKFMY-----YDHMCLIFEPL-GPSLYEIITRNNY----NGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENI 168 (360)
T ss_dssp EEEEEE-----TTEEEEEECCC-CCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred cceeeE-----CCeeEEEEcCC-CCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccE
Confidence 998653 45679999999 8999999986542 2589999999999999999999999 999999999999
Q ss_pred eeCC-------------------------CCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcC
Q 037275 822 LLDQ-------------------------DLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEAS 876 (992)
Q Consensus 822 ll~~-------------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 876 (992)
+++. ++.+||+|||+|+..... .....||+.|+|||++.+..++
T Consensus 169 ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~ 237 (360)
T 3llt_A 169 LLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----------HGSIINTRQYRAPEVILNLGWD 237 (360)
T ss_dssp EESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----------CCSCCSCGGGCCHHHHTTCCCC
T ss_pred EEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----------CcCccCcccccCcHHHcCCCCC
Confidence 9975 789999999999864421 1234689999999999999999
Q ss_pred cccchhhHHHHHHHHHhCCCCCCCC
Q 037275 877 MTGDVYSFGILLLEMFTRRRPTDGM 901 (992)
Q Consensus 877 ~~~DiwSlG~il~elltg~~pf~~~ 901 (992)
.++||||+||++|||++|+.||.+.
T Consensus 238 ~~~DiwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 238 VSSDMWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp TTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CccchHHHHHHHHHHHHCCCCCCCC
Confidence 9999999999999999999999864
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=361.24 Aligned_cols=272 Identities=19% Similarity=0.259 Sum_probs=202.3
Q ss_pred cCCCCCCccccccceEEEEeEECC---CCeEEEEEEeeccCCC-----------chhHHHHHHHHHHhccCCcceeEEEE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGE---NGMMVAVKVINLKQKG-----------ASNGFVAECQALRNIRHRNLIKIITI 744 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~~~~~ 744 (992)
++|++.+.||+|+||+||+|++.. ++..||+|++...... ....+.+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 579999999999999999999976 7889999998644321 12346678888999999999999998
Q ss_pred eecccccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeC
Q 037275 745 CSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLD 824 (992)
Q Consensus 745 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 824 (992)
+... +.+....++||||+ +++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++
T Consensus 117 ~~~~-~~~~~~~~lv~e~~-~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~ 185 (345)
T 2v62_A 117 GLTE-FKGRSYRFMVMERL-GIDLQKISGQNG------TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLG 185 (345)
T ss_dssp EEEE-SSSCEEEEEEEECE-EEEHHHHCBGGG------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE
T ss_pred cccc-cCCCcEEEEEEecc-CCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEc
Confidence 7652 24467789999999 999999997543 589999999999999999999999 999999999999998
Q ss_pred CCC--cEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCc
Q 037275 825 QDL--VAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMF 902 (992)
Q Consensus 825 ~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 902 (992)
.++ .+||+|||+|+.+......... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 186 ~~~~~~~kL~Dfg~a~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 264 (345)
T 2v62_A 186 YKNPDQVYLADYGLSYRYCPNGNHKQY-QENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNL 264 (345)
T ss_dssp SSSTTSEEECCCTTCEESSGGGCCCCC-CCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGT
T ss_pred cCCCCcEEEEeCCCceecccccccccc-hhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 887 9999999999876532211110 1111234579999999999999999999999999999999999999996532
Q ss_pred cCCccHHHHHh---hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 037275 903 NQGLTLHEFAR---TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKL 979 (992)
Q Consensus 903 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 979 (992)
........... ...+....... .......++.+++.+||+.||++|||++||++.|
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L 323 (345)
T 2v62_A 265 KDPVAVQTAKTNLLDELPQSVLKWA---------------------PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKIL 323 (345)
T ss_dssp TCHHHHHHHHHHHHHTTTHHHHHHS---------------------CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred cccHHHHHHHHhhcccccHHHHhhc---------------------cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHH
Confidence 22111111111 01111110000 0001234689999999999999999999999999
Q ss_pred HHHH
Q 037275 980 CRAR 983 (992)
Q Consensus 980 ~~~~ 983 (992)
+++.
T Consensus 324 ~~~~ 327 (345)
T 2v62_A 324 NPHG 327 (345)
T ss_dssp CTTC
T ss_pred hccC
Confidence 8753
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=356.00 Aligned_cols=246 Identities=21% Similarity=0.256 Sum_probs=202.7
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc---CCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK---QKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
.++|++.+.||+|+||.||+|++..+|+.||+|++... .....+.+.+|+.+++.++||||+++++++. +..
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~ 114 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK-----DNS 114 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----cCC
Confidence 35899999999999999999999989999999999643 2344567889999999999999999999854 456
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
..++||||+++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 115 ~~~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DF 185 (350)
T 1rdq_E 115 NLYMVMEYVAGGEMFSHLRRIG------RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDF 185 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred EEEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEccc
Confidence 7799999999999999998643 489999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
|+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+....
T Consensus 186 g~a~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---------- 244 (350)
T 1rdq_E 186 GFAKRVKGR-----------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI---------- 244 (350)
T ss_dssp TTCEECSSC-----------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------
T ss_pred ccceeccCC-----------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH----------
Confidence 999875432 12346999999999999999999999999999999999999999753111
Q ss_pred hCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 037275 915 ALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERME-----MRDVVA 977 (992)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 977 (992)
+........... .+ .....++.+++.+||+.||++||+ ++||++
T Consensus 245 -------~~~~~i~~~~~~------~p------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 245 -------QIYEKIVSGKVR------FP------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -------HHHHHHHHCCCC------CC------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -------HHHHHHHcCCCC------CC------CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 111111111100 00 011345889999999999999998 888764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=360.44 Aligned_cols=267 Identities=23% Similarity=0.356 Sum_probs=210.1
Q ss_pred hcCCCCCCccccccceEEEEeEECC-------CCeEEEEEEeeccCC-CchhHHHHHHHHHHhc-cCCcceeEEEEeecc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGE-------NGMMVAVKVINLKQK-GASNGFVAECQALRNI-RHRNLIKIITICSSI 748 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 748 (992)
.++|.+.++||+|+||+||+|++.. .+..||||+++.... .....+.+|+++++++ +||||+++++++..
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~- 146 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ- 146 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc-
Confidence 4588999999999999999999742 346899999964432 2346789999999999 99999999999643
Q ss_pred cccCcceEEEEEEeccCCCHHHHHhhcccc----------hhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCC
Q 037275 749 DFKGVDFQAIVYEYMQNGSLEDWLHQSEDQ----------QEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKP 818 (992)
Q Consensus 749 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp 818 (992)
....++||||+++|+|.+++...... .....+++..++.++.|++.||+|||++ +|+||||||
T Consensus 147 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp 219 (382)
T 3tt0_A 147 ----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAA 219 (382)
T ss_dssp ----SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCG
T ss_pred ----CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCc
Confidence 44569999999999999999875421 1123589999999999999999999999 999999999
Q ss_pred CCeeeCCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCC
Q 037275 819 SNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRP 897 (992)
Q Consensus 819 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p 897 (992)
+||+++.++.+||+|||+|+....... ........+|+.|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 220 ~NIll~~~~~~kL~DFG~a~~~~~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p 293 (382)
T 3tt0_A 220 RNVLVTEDNVMKIADFGLARDIHHIDY------YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293 (382)
T ss_dssp GGEEECTTCCEEECSCSCCCCSSCCCT------TCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ceEEEcCCCcEEEcccCcccccccccc------cccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999987654321 112233457889999999999999999999999999999999 9999
Q ss_pred CCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 898 TDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 898 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
|.+.... ++....... ...... .....++.+++.+||+.||++|||++||++
T Consensus 294 ~~~~~~~-----------------~~~~~~~~~-~~~~~~----------~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 345 (382)
T 3tt0_A 294 YPGVPVE-----------------ELFKLLKEG-HRMDKP----------SNCTNELYMMMRDCWHAVPSQRPTFKQLVE 345 (382)
T ss_dssp STTCCHH-----------------HHHHHHHTT-CCCCCC----------SSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHH-----------------HHHHHHHcC-CCCCCC----------ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9753211 111111100 000000 112345889999999999999999999999
Q ss_pred HHHHHHHhh
Q 037275 978 KLCRARDTF 986 (992)
Q Consensus 978 ~L~~~~~~~ 986 (992)
.|+++.+..
T Consensus 346 ~L~~~~~~~ 354 (382)
T 3tt0_A 346 DLDRIVALT 354 (382)
T ss_dssp HHHHHHHHS
T ss_pred HHHHHHHHH
Confidence 999997654
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=350.97 Aligned_cols=275 Identities=20% Similarity=0.257 Sum_probs=200.1
Q ss_pred hcCCCCC-CccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhc-cCCcceeEEEEeecccccCcce
Q 037275 678 TNDFSSS-NMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNI-RHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 678 ~~~~~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 755 (992)
.++|++. ++||+|+||+||+|++..+++.||||++..........+.+|+++++++ +||||+++++++. ....
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~-----~~~~ 85 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFE-----EEDR 85 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEe-----eCCE
Confidence 3468775 7899999999999999889999999999766666677899999999985 7999999999964 3456
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCc---EEEe
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLV---AHLG 832 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~ 832 (992)
.++||||+++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++. +||+
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~ 156 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHKRR------HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKIC 156 (316)
T ss_dssp EEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEEC
T ss_pred EEEEEEcCCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEE
Confidence 799999999999999997643 589999999999999999999999 9999999999999988775 9999
Q ss_pred ecccceecCCCCCCCCcccCCCCCcccccccccccccccC-----CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCcc
Q 037275 833 DFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-----GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLT 907 (992)
Q Consensus 833 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~ 907 (992)
|||++............ .........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+..
T Consensus 157 Dfg~~~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 235 (316)
T 2ac3_A 157 DFDLGSGIKLNGDCSPI-STPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCG 235 (316)
T ss_dssp CTTCCC--------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSC
T ss_pred EccCccccccCCccccc-cccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccc
Confidence 99999865432111100 1112233469999999999875 56889999999999999999999999875433211
Q ss_pred HHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 908 LHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.... ...+.....+......... ..+. ........++.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~--~~~~~~~~~~~~~i~~~~~------~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 236 WDRG--EACPACQNMLFESIQEGKY------EFPD--KDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp C------CCHHHHHHHHHHHHHCCC------CCCH--HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cccc--ccchhHHHHHHHHHhccCc------ccCc--hhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 1100 0000001111111111100 0000 000112356889999999999999999999986
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=356.87 Aligned_cols=250 Identities=24% Similarity=0.306 Sum_probs=201.6
Q ss_pred HhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc---CCCchhHHHHHHHHHHhc-cCCcceeEEEEeecccccC
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK---QKGASNGFVAECQALRNI-RHRNLIKIITICSSIDFKG 752 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 752 (992)
..++|++.++||+|+||+||+|++..+++.||+|+++.. .....+.+.+|..++..+ +||+|+++++++ ..
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~ 92 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QT 92 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE-----EC
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE-----Ec
Confidence 356899999999999999999999988999999999743 234556788999999988 899999999985 34
Q ss_pred cceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEe
Q 037275 753 VDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLG 832 (992)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 832 (992)
....++||||+++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 93 ~~~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~ 163 (353)
T 2i0e_A 93 MDRLYFVMEYVNGGDLMYHIQQVG------RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIA 163 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEEC
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEE
Confidence 567799999999999999997543 489999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHH
Q 037275 833 DFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFA 912 (992)
Q Consensus 833 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~ 912 (992)
|||+|+..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.+....
T Consensus 164 DFG~a~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-------- 227 (353)
T 2i0e_A 164 DFGMCKENIWD--------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-------- 227 (353)
T ss_dssp CCTTCBCCCCT--------TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------
T ss_pred eCCcccccccC--------CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH--------
Confidence 99999854321 11233457999999999999999999999999999999999999999753211
Q ss_pred hhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 037275 913 RTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERME-----MRDVVA 977 (992)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 977 (992)
++.......... .+ .....++.+++.+||+.||++||+ ++||++
T Consensus 228 ---------~~~~~i~~~~~~------~p------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 228 ---------ELFQSIMEHNVA------YP------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp ---------HHHHHHHHCCCC------CC------TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred ---------HHHHHHHhCCCC------CC------CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 111111111110 00 012345889999999999999996 466654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=350.53 Aligned_cols=261 Identities=22% Similarity=0.324 Sum_probs=197.2
Q ss_pred hcCCCCCCccccccceEEEEeEECC---CCeEEEEEEeeccCC-CchhHHHHHHHHHHhccCCcceeEEEEeecccccCc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGE---NGMMVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 753 (992)
.++|++.+.||+|+||.||+|.+.. .+..||+|+++.... ...+.+.+|+.++++++||||+++++++. .
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~ 87 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------E 87 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC------S
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc------c
Confidence 4588999999999999999999854 356799999864332 23467899999999999999999999863 2
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGD 833 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 833 (992)
...++||||+++|+|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~D 159 (281)
T 1mp8_A 88 NPVWIIMELCTLGELRSFLQVRKY-----SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGD 159 (281)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTT-----TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC
T ss_pred CccEEEEecCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECc
Confidence 345899999999999999975432 489999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHH
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFA 912 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~ 912 (992)
||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+ ....
T Consensus 160 fg~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~--~~~~- 229 (281)
T 1mp8_A 160 FGLSRYMEDSTY-------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGR- 229 (281)
T ss_dssp --------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHH-
T ss_pred cccccccCcccc-------cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH--HHHH-
Confidence 999987654221 11122346789999999988899999999999999999997 999997643221 1000
Q ss_pred hhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhh
Q 037275 913 RTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTFL 987 (992)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 987 (992)
+ ..... .. ........+.+++.+||+.||++|||+.|+++.|+++.+...
T Consensus 230 -----------i---~~~~~-~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 279 (281)
T 1mp8_A 230 -----------I---ENGER-LP----------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 279 (281)
T ss_dssp -----------H---HTTCC-CC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred -----------H---HcCCC-CC----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhc
Confidence 0 00000 00 001123458899999999999999999999999999877643
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=363.51 Aligned_cols=263 Identities=23% Similarity=0.269 Sum_probs=205.1
Q ss_pred cHHHHHHHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhccCCcceeEEEEee
Q 037275 670 SYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNIRHRNLIKIITICS 746 (992)
Q Consensus 670 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 746 (992)
.+.+.....++|++.++||+|+||+||+|+...+|+.||+|+++... ......+.+|..++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34455556789999999999999999999999899999999996422 233456889999999999999999999854
Q ss_pred cccccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCC
Q 037275 747 SIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQD 826 (992)
Q Consensus 747 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 826 (992)
+....++||||+++|+|.+++..... .+++..+..++.||+.||+|||++ +|+||||||+||+++.+
T Consensus 132 -----~~~~~~lVmE~~~gg~L~~~l~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~ 198 (412)
T 2vd5_A 132 -----DENYLYLVMEYYVGGDLLTLLSKFGE-----RIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRC 198 (412)
T ss_dssp -----CSSEEEEEECCCCSCBHHHHHHHHSS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT
T ss_pred -----eCCEEEEEEcCCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCC
Confidence 45677999999999999999986432 489999999999999999999999 99999999999999999
Q ss_pred CcEEEeecccceecCCCCCCCCcccCCCCCccccccccccccccc-------CCCcCcccchhhHHHHHHHHHhCCCCCC
Q 037275 827 LVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGM-------GGEASMTGDVYSFGILLLEMFTRRRPTD 899 (992)
Q Consensus 827 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwSlG~il~elltg~~pf~ 899 (992)
+.+||+|||+|+....... ......+||+.|+|||++. +..++.++|||||||++|||++|+.||.
T Consensus 199 g~vkL~DFGla~~~~~~~~-------~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~ 271 (412)
T 2vd5_A 199 GHIRLADFGSCLKLRADGT-------VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFY 271 (412)
T ss_dssp SCEEECCCTTCEECCTTSC-------EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred CCEEEeechhheeccCCCc-------cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCC
Confidence 9999999999987653211 1122357999999999987 4578999999999999999999999997
Q ss_pred CCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCC---CCHHHHH
Q 037275 900 GMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTER---MEMRDVV 976 (992)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~evl 976 (992)
+.... +....+........... .......++.+++.+||. +|++| |+++|++
T Consensus 272 ~~~~~-----------------~~~~~i~~~~~~~~~p~-------~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~ 326 (412)
T 2vd5_A 272 ADSTA-----------------ETYGKIVHYKEHLSLPL-------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFR 326 (412)
T ss_dssp CSSHH-----------------HHHHHHHTHHHHCCCC-----------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHH
T ss_pred CCCHH-----------------HHHHHHHhcccCcCCCc-------cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHh
Confidence 63211 11111111000000000 001123468899999999 99998 5898886
Q ss_pred H
Q 037275 977 A 977 (992)
Q Consensus 977 ~ 977 (992)
+
T Consensus 327 ~ 327 (412)
T 2vd5_A 327 T 327 (412)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=375.96 Aligned_cols=258 Identities=24% Similarity=0.445 Sum_probs=209.2
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
..+|++.++||+|+||.||+|++..++..||||+++.. ....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-----~~~~~ 292 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPFY 292 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSCE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc-ccchHHHHHHHHHHHhcCCCCEeeEEEEEec-----CCcEE
Confidence 34688899999999999999999888999999999643 3356789999999999999999999999743 34569
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||+++|+|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 293 lv~E~~~~g~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a 365 (495)
T 1opk_A 293 IITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLS 365 (495)
T ss_dssp EEEECCTTCBHHHHHHHSCT----TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred EEEEccCCCCHHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccc
Confidence 99999999999999986432 2589999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhhhC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFARTAL 916 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 916 (992)
+....... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||.+....
T Consensus 366 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~------------ 426 (495)
T 1opk_A 366 RLMTGDTY-------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------------ 426 (495)
T ss_dssp ECCTTCCE-------ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG------------
T ss_pred eeccCCce-------eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH------------
Confidence 87653321 11223456789999999998999999999999999999999 99999764321
Q ss_pred ChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 037275 917 PDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRAR 983 (992)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 983 (992)
...+.+.. ....... .....++.+++.+||+.||++|||+.||++.|+.+.
T Consensus 427 --~~~~~~~~----~~~~~~~----------~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 427 --QVYELLEK----DYRMERP----------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp --GHHHHHHT----TCCCCCC----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred --HHHHHHHc----CCCCCCC----------CCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 11111111 1100000 112346889999999999999999999999998764
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=343.65 Aligned_cols=252 Identities=21% Similarity=0.234 Sum_probs=204.0
Q ss_pred HhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
..++|++.+.||+|+||+||+|++..++..||+|++........+.+.+|++++++++||||+++++++. .....
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~ 81 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE-----DNTDI 81 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCeE
Confidence 3457999999999999999999999899999999998766667788999999999999999999999964 45567
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeee---CCCCcEEEee
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLL---DQDLVAHLGD 833 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~D 833 (992)
++||||+++++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||++ +.++.+||+|
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~D 152 (277)
T 3f3z_A 82 YLVMELCTGGELFERVVHKR------VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLID 152 (277)
T ss_dssp EEEEECCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred EEEEeccCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEe
Confidence 99999999999999987643 489999999999999999999999 99999999999999 7889999999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 913 (992)
||.+....... ......||+.|+|||++.+. ++.++||||+|+++|+|++|+.||....... .......
T Consensus 153 fg~~~~~~~~~---------~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~ 221 (277)
T 3f3z_A 153 FGLAARFKPGK---------MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE-VMLKIRE 221 (277)
T ss_dssp CTTCEECCTTS---------CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHH
T ss_pred cccceeccCcc---------chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHh
Confidence 99998765322 22334689999999987654 8999999999999999999999997632210 0000000
Q ss_pred hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 914 TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
...... ..........+.+++.+||+.||++|||+.|+++
T Consensus 222 ~~~~~~------------------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 222 GTFTFP------------------------EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp CCCCCC------------------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCCCC------------------------chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000 0000012356889999999999999999999985
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=373.09 Aligned_cols=262 Identities=26% Similarity=0.428 Sum_probs=209.7
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
.++|++.+.||+|+||+||+|++. ++..||||+++... ...+.+.+|+.++++++||||+++++++. ....+
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~------~~~~~ 258 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT------KEPIY 258 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSSCE
T ss_pred hHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe------CCccE
Confidence 457888999999999999999996 57889999997433 45678999999999999999999999863 23468
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||+++|+|.++++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 259 lv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a 331 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSDEG----SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLA 331 (454)
T ss_dssp EEECCCTTCBHHHHHHSHHH----HTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGG
T ss_pred EEEeecCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCc
Confidence 99999999999999986532 2588999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhhhC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFARTAL 916 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 916 (992)
+...... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+....
T Consensus 332 ~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~------------ 392 (454)
T 1qcf_A 332 RVIEDNE-------YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP------------ 392 (454)
T ss_dssp GGBCCHH-------HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------------
T ss_pred eEcCCCc-------eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH------------
Confidence 8764321 111123346889999999998899999999999999999999 99999763211
Q ss_pred ChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhhc
Q 037275 917 PDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTFLGR 989 (992)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 989 (992)
++..... ........ .....++.+++.+||+.||++|||+++|++.|+++......+
T Consensus 393 -----~~~~~i~-~~~~~~~~----------~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~~ 449 (454)
T 1qcf_A 393 -----EVIRALE-RGYRMPRP----------ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQ 449 (454)
T ss_dssp -----HHHHHHH-HTCCCCCC----------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCCS
T ss_pred -----HHHHHHH-cCCCCCCC----------CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhccccc
Confidence 1111111 11110001 112356889999999999999999999999999886654443
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=355.28 Aligned_cols=281 Identities=22% Similarity=0.359 Sum_probs=213.3
Q ss_pred hcCCCCCCccccccceEEEEeEE----CCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNL----GENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 753 (992)
.++|++.+.||+|+||.||+|++ ..+++.||||++........+.+.+|++++++++||||+++++++.. .+.
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~ 116 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AGR 116 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC------
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe---cCC
Confidence 45688999999999999999984 55799999999976655566789999999999999999999998753 223
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGD 833 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 833 (992)
...++||||+++++|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~D 188 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQKHKE-----RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGD 188 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHHSTT-----SSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECC
T ss_pred CceEEEEECCCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEec
Confidence 456899999999999999986542 489999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 913 (992)
||++......... ........++..|+|||++.+..++.++|||||||++|||++|..||...... ......
T Consensus 189 fg~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~---~~~~~~ 260 (326)
T 2w1i_A 189 FGLTKVLPQDKEY-----YKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE---FMRMIG 260 (326)
T ss_dssp CTTCEECCSSCSE-----EECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH---HHHHHC
T ss_pred Ccchhhccccccc-----cccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH---HHHhhc
Confidence 9999876543211 11122335778899999998888999999999999999999999987642110 111111
Q ss_pred hhCC-hhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhh
Q 037275 914 TALP-DKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTFL 987 (992)
Q Consensus 914 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 987 (992)
.... ......+........... .......++.+++.+||+.||++|||+.||++.|+++++.+.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~ 325 (326)
T 2w1i_A 261 NDKQGQMIVFHLIELLKNNGRLP----------RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325 (326)
T ss_dssp TTCCTHHHHHHHHHHHHTTCCCC----------CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred cccchhhhHHHHHHHhhcCCCCC----------CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 1111 001101111111100000 011223568999999999999999999999999999998765
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=356.48 Aligned_cols=266 Identities=22% Similarity=0.362 Sum_probs=198.2
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCc---hhHHHHHHHHHHhccCCcceeEEEEeecccccCcc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGA---SNGFVAECQALRNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
.++|++.+.||+|+||.||+|++..+++.||||+++...... ...+.+|+.++++++||||+++++++.... ....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~~ 89 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP 89 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TTEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-CCCc
Confidence 458999999999999999999998899999999997543222 356889999999999999999999875432 2234
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
..++||||+++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Df 160 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDF 160 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCC
T ss_pred ccEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeec
Confidence 5699999999999999997543 589999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
|+++....... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.+..............
T Consensus 161 g~a~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~ 235 (311)
T 3ork_A 161 GIARAIADSGN-----SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRED 235 (311)
T ss_dssp SCC-----------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC
T ss_pred cCccccccccc-----ccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC
Confidence 99987654221 1122234568999999999999999999999999999999999999997632211000000000
Q ss_pred hCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHH-HHHHHHH
Q 037275 915 ALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVV-AKLCRAR 983 (992)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl-~~L~~~~ 983 (992)
..+. .........++.+++.+||+.||++||++.+++ +.+.+..
T Consensus 236 ~~~~-------------------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 236 PIPP-------------------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp CCCH-------------------------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCCc-------------------------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 0000 000011234588999999999999999766654 4555443
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=354.93 Aligned_cols=266 Identities=22% Similarity=0.357 Sum_probs=209.8
Q ss_pred hcCCCCCCccccccceEEEEeEE-----CCCCeEEEEEEeeccC-CCchhHHHHHHHHHHhccCCcceeEEEEeeccccc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNL-----GENGMMVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIKIITICSSIDFK 751 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 751 (992)
.++|.+.+.||+|+||.||+|++ ..+++.||||+++... ....+.+.+|+.++++++||||+++++++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~----- 96 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS----- 96 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe-----
Confidence 56889999999999999999987 3456899999996433 233467889999999999999999999964
Q ss_pred CcceEEEEEEeccCCCHHHHHhhcccch------------------hhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 037275 752 GVDFQAIVYEYMQNGSLEDWLHQSEDQQ------------------EARSLTLIQRINIIIDVASAIEYIHHHCQPPVVH 813 (992)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH 813 (992)
.....++||||+++|+|.+++....... ....+++.+++.++.|++.||+|||++ +|+|
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH 173 (314)
T 2ivs_A 97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVH 173 (314)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcc
Confidence 3445699999999999999998754310 123589999999999999999999999 9999
Q ss_pred ccCCCCCeeeCCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh
Q 037275 814 GDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT 893 (992)
Q Consensus 814 ~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt 893 (992)
|||||+||+++.++.+||+|||+++....... ........+|+.|+|||++.+..++.++||||+||++|||++
T Consensus 174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t 247 (314)
T 2ivs_A 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDS------YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247 (314)
T ss_dssp CCCSGGGEEEETTTEEEECCCTTCEECTTTSC------EECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred cccchheEEEcCCCCEEEcccccccccccccc------ceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHh
Confidence 99999999999999999999999987654321 111223457889999999998899999999999999999999
Q ss_pred -CCCCCCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCH
Q 037275 894 -RRRPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEM 972 (992)
Q Consensus 894 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 972 (992)
|+.||.+.... .....+.. ...... .......+.+++.+||+.||++|||+
T Consensus 248 ~g~~p~~~~~~~--------------~~~~~~~~----~~~~~~----------~~~~~~~~~~li~~~l~~dp~~Rps~ 299 (314)
T 2ivs_A 248 LGGNPYPGIPPE--------------RLFNLLKT----GHRMER----------PDNCSEEMYRLMLQCWKQEPDKRPVF 299 (314)
T ss_dssp TSCCSSTTCCGG--------------GHHHHHHT----TCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCCCCCCCCHH--------------HHHHHhhc----CCcCCC----------CccCCHHHHHHHHHHccCChhhCcCH
Confidence 99999764321 11111110 000000 01123458899999999999999999
Q ss_pred HHHHHHHHHHHHh
Q 037275 973 RDVVAKLCRARDT 985 (992)
Q Consensus 973 ~evl~~L~~~~~~ 985 (992)
.|+++.|+++.+.
T Consensus 300 ~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 300 ADISKDLEKMMVK 312 (314)
T ss_dssp HHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHhh
Confidence 9999999998764
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=345.84 Aligned_cols=254 Identities=24% Similarity=0.380 Sum_probs=191.5
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC----CchhHHHHHHHHHHhccCCcceeEEEEeecccccCc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK----GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 753 (992)
.++|++.++||+|+||.||+|++ .++.||||+++.... ...+.+.+|+++++.++||||+++++++.. .
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 78 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK-----E 78 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC-----C
T ss_pred hhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-----C
Confidence 35789999999999999999998 488999999864322 234678999999999999999999999643 4
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCC--------
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQ-------- 825 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-------- 825 (992)
...++||||+++++|.+++... .+++..++.++.|++.||+|||++...+|+||||||+||+++.
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~ 151 (271)
T 3dtc_A 79 PNLCLVMEFARGGPLNRVLSGK-------RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLS 151 (271)
T ss_dssp --CEEEEECCTTEEHHHHHTSS-------CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCS
T ss_pred CceEEEEEcCCCCCHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccccccc
Confidence 4569999999999999998632 4899999999999999999999991112999999999999986
Q ss_pred CCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCC
Q 037275 826 DLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQG 905 (992)
Q Consensus 826 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~ 905 (992)
++.+||+|||.+....... .....||+.|+|||++.+..++.++||||+|+++|+|++|+.||.+.....
T Consensus 152 ~~~~kl~Dfg~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 221 (271)
T 3dtc_A 152 NKILKITDFGLAREWHRTT----------KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA 221 (271)
T ss_dssp SCCEEECCCCC-----------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH
T ss_pred CcceEEccCCccccccccc----------ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 7789999999998654321 123458999999999998899999999999999999999999997632110
Q ss_pred ccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 037275 906 LTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRA 982 (992)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 982 (992)
............ . ........+.+++.+||+.||++|||+.|+++.|+++
T Consensus 222 -----------------~~~~~~~~~~~~----~------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 222 -----------------VAYGVAMNKLAL----P------IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp -----------------HHHHHHTSCCCC----C------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred -----------------HHHhhhcCCCCC----C------CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 000000000000 0 0011234588999999999999999999999999764
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=351.68 Aligned_cols=257 Identities=26% Similarity=0.425 Sum_probs=198.1
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAI 758 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 758 (992)
++|++.+.||+|+||+||+|++ .++.||||++. .....+.+.+|+.++++++||||+++++++.+ ..++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-------~~~l 76 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIVKLYGACLN-------PVCL 76 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECS--STTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT-------TTEE
T ss_pred hHeeeeeEeecCCCceEEEEEE--CCeeEEEEEec--ChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-------CcEE
Confidence 5788999999999999999998 47899999985 33456778999999999999999999998642 2489
Q ss_pred EEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCc-EEEeecccc
Q 037275 759 VYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLV-AHLGDFGLA 837 (992)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-~kl~Dfg~a 837 (992)
||||+++|+|.+++..... ...+++..++.++.|+++||+|||+....+|+||||||+||+++.++. +||+|||++
T Consensus 77 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~ 153 (307)
T 2eva_A 77 VMEYAEGGSLYNVLHGAEP---LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA 153 (307)
T ss_dssp EEECCTTCBHHHHHHCSSS---EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-
T ss_pred EEEcCCCCCHHHHHhccCC---CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccc
Confidence 9999999999999986542 234788999999999999999999931128999999999999988886 799999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALP 917 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 917 (992)
...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 154 ~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---------- 212 (307)
T 2eva_A 154 CDIQTH-----------MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR---------- 212 (307)
T ss_dssp ----------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH----------
T ss_pred cccccc-----------cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH----------
Confidence 754321 12235899999999999999999999999999999999999999754222100
Q ss_pred hhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 037275 918 DKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTF 986 (992)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 986 (992)
.......... ... .......+.+++.+||+.||++|||++|+++.|+++.+.+
T Consensus 213 -----~~~~~~~~~~-~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 213 -----IMWAVHNGTR-PPL----------IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp -----HHHHHHTTCC-CCC----------BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred -----HHHHHhcCCC-CCc----------ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 0000000000 000 0112345889999999999999999999999999987654
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=349.09 Aligned_cols=262 Identities=24% Similarity=0.434 Sum_probs=212.2
Q ss_pred HhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
..++|++.+.||+|+||+||+|.+..+++.||+|++.. .....+.+.+|+.++++++||||+++++++. .....
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~ 84 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPF 84 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECS-CSTHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCCE
Confidence 45688999999999999999999998899999999863 3345677899999999999999999999964 44567
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
++||||+++++|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.
T Consensus 85 ~~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~ 157 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGL 157 (288)
T ss_dssp EEEEECCTTEEHHHHHHHCCT----TTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCG
T ss_pred EEEEEcCCCCcHHHHHHhccc----CCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCcc
Confidence 999999999999999986543 3589999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhhh
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~ 915 (992)
+....... ........+|+.|+|||++.+..++.++||||+|+++|+|++ |..||.+....
T Consensus 158 ~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~----------- 219 (288)
T 3kfa_A 158 SRLMTGDT-------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----------- 219 (288)
T ss_dssp GGTSCSSS-------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-----------
T ss_pred ceeccCCc-------cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----------
Confidence 98665322 111223457889999999998899999999999999999999 99999763221
Q ss_pred CChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 037275 916 LPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTF 986 (992)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 986 (992)
...+.+.. ....... ......+.+++.+||+.||++|||++|+++.|+++....
T Consensus 220 ---~~~~~~~~----~~~~~~~----------~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 220 ---QVYELLEK----DYRMERP----------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp ---GHHHHHHT----TCCCCCC----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---HHHHHHhc----cCCCCCC----------CCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 11111111 0000000 112345889999999999999999999999999887653
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=369.68 Aligned_cols=331 Identities=22% Similarity=0.240 Sum_probs=238.5
Q ss_pred ccceEEecCCcccCCcCCccCCCCcccEEeccCcccccccCccccccCCCcEEeccCCccCCCCCccccccccccchhhc
Q 037275 172 TLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIV 251 (992)
Q Consensus 172 ~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~L~~l~l 251 (992)
+|++|+|++|.+.+..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++
T Consensus 33 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~------------------ 94 (477)
T 2id5_A 33 ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKL------------------ 94 (477)
T ss_dssp TCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCS------------------
T ss_pred CCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCc------------------
Confidence 45555555555544445555555555555555555555445555555555555555555441
Q ss_pred cccccCCCCchhhhccccCceeeeccccccccccccccccCccceEecCCCCCCCCCCCCchhhhhccCCCcceEeecCC
Q 037275 252 AENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDD 331 (992)
Q Consensus 252 ~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~~L~~L~l~~ 331 (992)
..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|.+
T Consensus 95 -------~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l--------------------------- 140 (477)
T 2id5_A 95 -------IPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDL--------------------------- 140 (477)
T ss_dssp -------CCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTC---------------------------
T ss_pred -------cCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCcc---------------------------
Confidence 1122344455555555555555555454555555555544444443
Q ss_pred CcCCCcCCcccccccccceeEEeeCCccccccCCCccCCCcccEEEccCCcCCCCCCccccCCCCCcEEeccCccccccC
Q 037275 332 NRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGI 411 (992)
Q Consensus 332 n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 411 (992)
+++.+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|++.+..
T Consensus 141 ----------------------------~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~ 192 (477)
T 2id5_A 141 ----------------------------VYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIR 192 (477)
T ss_dssp ----------------------------CEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEEC
T ss_pred ----------------------------ceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeC
Confidence 3344556677778888888888887666667888888888888888888777
Q ss_pred CCCCCCccccCceeccCCcccCCCCCCccccccccccccccccccccCchhhhhhcccccccccccccccCcccccccCC
Q 037275 412 PTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNL 491 (992)
Q Consensus 412 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l 491 (992)
+..|..+++|+.|++++|.+.+.+|.......+|++| ++++|.+++..+..+..+
T Consensus 193 ~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L-------------------------~l~~n~l~~~~~~~~~~l 247 (477)
T 2id5_A 193 DYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSL-------------------------SITHCNLTAVPYLAVRHL 247 (477)
T ss_dssp TTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEE-------------------------EEESSCCCSCCHHHHTTC
T ss_pred hhhcccCcccceeeCCCCccccccCcccccCccccEE-------------------------ECcCCcccccCHHHhcCc
Confidence 7788888888888888887766666665555566666 445555554444568889
Q ss_pred CCccEEeeecccccccCCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcccCCCChhhhhcCCCcceEec
Q 037275 492 KNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNL 571 (992)
Q Consensus 492 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 571 (992)
++|++|+|++|.+++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|+|++..+..|..+++|+.|++
T Consensus 248 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 327 (477)
T 2id5_A 248 VYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLIL 327 (477)
T ss_dssp TTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEEC
T ss_pred cccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEc
Confidence 99999999999999888888999999999999999999999999999999999999999999888888999999999999
Q ss_pred CCCcCcccCCCCCccCCcccccccCCCCcCCCCCCC
Q 037275 572 SYNHFEGEVPTKGVFSNKTGISLSGNGKVCGGLDEL 607 (992)
Q Consensus 572 ~~N~l~~~~~~~~~~~~~~~~~l~~N~~~C~~~~~~ 607 (992)
++|+|.|.|+..+.+.+.....+.++...|++|..+
T Consensus 328 ~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p~~~ 363 (477)
T 2id5_A 328 DSNPLACDCRLLWVFRRRWRLNFNRQQPTCATPEFV 363 (477)
T ss_dssp CSSCEECSGGGHHHHTTTTSSCCTTCCCBEEESGGG
T ss_pred cCCCccCccchHhHHhhhhccccCccCceeCCchHH
Confidence 999999999877666666667788999999887643
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=367.42 Aligned_cols=212 Identities=24% Similarity=0.332 Sum_probs=172.0
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC--CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK--GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
.++|++.++||+|+||+||+|++..+++.||||++..... ...+.+.+|+.++++++||||+++++++..........
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 3589999999999999999999999999999999964322 23467889999999999999999999987655555567
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++||||++ |+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~------~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFG 174 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPI------FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFG 174 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEecCC-cCHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCC
Confidence 899999996 59999997543 489999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcc--------------cCCCCCcccccccccccccc-cCCCcCcccchhhHHHHHHHHHhCCCCCC
Q 037275 836 LAKFLSSSPLDTAVE--------------TPSSSKGIKGTVGYIAPEYG-MGGEASMTGDVYSFGILLLEMFTRRRPTD 899 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~--------------~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~elltg~~pf~ 899 (992)
+|+............ ........+||+.|+|||++ .+..++.++||||+||++|||++|..||.
T Consensus 175 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 175 LARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp TCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred CcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 999875432110000 00123456799999999985 56679999999999999999998655554
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=352.22 Aligned_cols=261 Identities=28% Similarity=0.427 Sum_probs=193.9
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC--CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK--GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
.++|++.++||+|+||+||+|++. ..||+|+++.... ...+.+.+|+.++++++||||+++++++. ...
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~------~~~ 93 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST------APQ 93 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSS
T ss_pred ccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc------CCc
Confidence 458999999999999999999874 3599999965433 23467899999999999999999999742 234
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++||||+++++|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg 165 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHASET-----KFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFG 165 (289)
T ss_dssp CEEEEECCCEEEHHHHHTTC--------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC
T ss_pred cEEEEEecCCCcHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccce
Confidence 5899999999999999975543 489999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCccccccccccccccc---CCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHH
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGM---GGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFA 912 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~ 912 (992)
+++...... .........||+.|+|||++. +..++.++|||||||++|+|++|+.||........
T Consensus 166 ~~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------ 233 (289)
T 3og7_A 166 LATEKSRWS------GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------ 233 (289)
T ss_dssp ------------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH------
T ss_pred ecccccccc------ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH------
Confidence 998654321 111223356899999999886 56788899999999999999999999976432211
Q ss_pred hhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 037275 913 RTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARD 984 (992)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 984 (992)
....+.. ..... ... ........++.+++.+||+.||++|||++|+++.|+++.+
T Consensus 234 -------~~~~~~~---~~~~~-~~~------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 234 -------IIEMVGR---GSLSP-DLS------KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp -------HHHHHHH---TSCCC-CTT------SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred -------HHHHhcc---cccCc-chh------hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 1111110 00000 000 0011223568999999999999999999999999998753
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=353.24 Aligned_cols=251 Identities=22% Similarity=0.264 Sum_probs=179.2
Q ss_pred CCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhcc-CCcceeEEEEeecccccCcceEEEEEEe
Q 037275 684 SNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIR-HRNLIKIITICSSIDFKGVDFQAIVYEY 762 (992)
Q Consensus 684 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~ 762 (992)
.+.||+|+||+||+|++..+++.||||++... ....+.+|+.+++.+. ||||+++++++. +....++||||
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~-----~~~~~~lv~e~ 87 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFH-----DQLHTFLVMEL 87 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSSEEEEEECC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEE-----cCCEEEEEEEc
Confidence 47899999999999999989999999998633 3466789999999997 999999999964 45567999999
Q ss_pred ccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCC---cEEEeeccccee
Q 037275 763 MQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDL---VAHLGDFGLAKF 839 (992)
Q Consensus 763 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~Dfg~a~~ 839 (992)
+++|+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++ .+||+|||+++.
T Consensus 88 ~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~ 158 (325)
T 3kn6_A 88 LNGGELFERIKKKK------HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158 (325)
T ss_dssp CCSCBHHHHHHHCS------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred cCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence 99999999998643 589999999999999999999999 999999999999997766 899999999986
Q ss_pred cCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCChh
Q 037275 840 LSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDK 919 (992)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 919 (992)
..... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+...... ...
T Consensus 159 ~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----------~~~ 220 (325)
T 3kn6_A 159 KPPDN--------QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT----------CTS 220 (325)
T ss_dssp CCC------------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-----------------CCC
T ss_pred cCCCC--------CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc----------ccc
Confidence 54321 122334689999999999999999999999999999999999999986432110 001
Q ss_pred HHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 920 VMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
..+.......+.+. ...........++.+++.+||+.||++|||++|+++
T Consensus 221 ~~~~~~~i~~~~~~--------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 221 AVEIMKKIKKGDFS--------FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HHHHHHHHTTTCCC--------CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred HHHHHHHHHcCCCC--------CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 11122211111110 000011123456889999999999999999999873
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=349.09 Aligned_cols=252 Identities=23% Similarity=0.320 Sum_probs=202.8
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCC------chhHHHHHHHHHHhccCCcceeEEEEeeccccc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKG------ASNGFVAECQALRNIRHRNLIKIITICSSIDFK 751 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 751 (992)
.++|++.+.||+|+||.||+|++..+|+.||+|++...... ..+.+.+|+.++++++||||+++++++.
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----- 85 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE----- 85 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEe-----
Confidence 45799999999999999999999989999999999754322 3567899999999999999999999964
Q ss_pred CcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCC----
Q 037275 752 GVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDL---- 827 (992)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---- 827 (992)
.....++||||+++++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~ 156 (321)
T 2a2a_A 86 NRTDVVLILELVSGGELFDFLAQKE------SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIP 156 (321)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHTCS------CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSC
T ss_pred cCCEEEEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcC
Confidence 4456799999999999999997543 488999999999999999999999 999999999999999888
Q ss_pred cEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCcc
Q 037275 828 VAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLT 907 (992)
Q Consensus 828 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~ 907 (992)
.+||+|||.+....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..... .
T Consensus 157 ~~kl~Dfg~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~ 226 (321)
T 2a2a_A 157 HIKLIDFGLAHEIEDGV---------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-T 226 (321)
T ss_dssp CEEECCCTTCEECCTTC---------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-H
T ss_pred CEEEccCccceecCccc---------cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH-H
Confidence 79999999998765421 1223468999999999999999999999999999999999999997632110 0
Q ss_pred HHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 908 LHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
........... ... ........+.+++.+||+.||++|||+.|+++
T Consensus 227 ~~~i~~~~~~~-~~~-----------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 227 LANITSVSYDF-DEE-----------------------FFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp HHHHHTTCCCC-CHH-----------------------HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred HHHHHhccccc-Chh-----------------------hhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00000000000 000 00112345889999999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=362.35 Aligned_cols=281 Identities=21% Similarity=0.245 Sum_probs=200.5
Q ss_pred HHHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccc----
Q 037275 675 SKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDF---- 750 (992)
Q Consensus 675 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---- 750 (992)
....++|++.++||+|+||+||+|++..+|+.||||++..... ...+|+++++.++||||+++++++.....
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 3456789999999999999999999998999999999864322 22379999999999999999999754322
Q ss_pred -----------------------------cCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHH
Q 037275 751 -----------------------------KGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIE 801 (992)
Q Consensus 751 -----------------------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~ 801 (992)
.+..+.++||||++ |+|.+.+...... ...+++..++.++.|+++||+
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~--~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRS--GRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHH
Confidence 34456789999997 5888888753321 346899999999999999999
Q ss_pred HHHhcCCCCeEeccCCCCCeeeC-CCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCC-CcCccc
Q 037275 802 YIHHHCQPPVVHGDLKPSNVLLD-QDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-EASMTG 879 (992)
Q Consensus 802 ~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~ 879 (992)
|||++ +|+||||||+||+++ .++.+||+|||.|+...... ......||+.|+|||++.+. .++.++
T Consensus 156 ~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~~ 223 (383)
T 3eb0_A 156 FIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---------PSVAYICSRFYRAPELMLGATEYTPSI 223 (383)
T ss_dssp HHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---------CCCCCCCCSSCCCHHHHTTCSSCCTHH
T ss_pred HHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---------CCcCcccCCCccCHHHhcCCCCCCcch
Confidence 99999 999999999999997 68899999999998764322 12334689999999988775 589999
Q ss_pred chhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCcc---ccchHHHHHHHHH
Q 037275 880 DVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDE---RLRTEERLVAVVE 956 (992)
Q Consensus 880 DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~ 956 (992)
||||+||++|||++|+.||.+....+ .+..............+... ...+........... .........++.+
T Consensus 224 DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~g~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (383)
T 3eb0_A 224 DLWSIGCVFGELILGKPLFSGETSID-QLVRIIQIMGTPTKEQMIRM--NPHYTEVRFPTLKAKDWRKILPEGTPSLAID 300 (383)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHHHH--CTTC--CCCCCCCCCCHHHHSCTTCCHHHHH
T ss_pred hhhhHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHHHh--CcccccccCCccCcccHHhhCCCCCCHHHHH
Confidence 99999999999999999998743221 12222221111111111100 000000000000000 0001113456899
Q ss_pred HHhhccCCCCCCCCCHHHHHH
Q 037275 957 TGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 957 li~~cl~~dP~~RPs~~evl~ 977 (992)
++.+||+.||++|||+.|+++
T Consensus 301 li~~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 301 LLEQILRYEPDLRINPYEAMA 321 (383)
T ss_dssp HHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHccCChhhCCCHHHHhc
Confidence 999999999999999999984
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=344.06 Aligned_cols=255 Identities=23% Similarity=0.358 Sum_probs=202.8
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC--CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK--GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
.++|++.+.||+|+||+||+|++ .++.||||+++.... ...+.+.+|+.++++++||||+++++++... ....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~ 83 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP---PAPH 83 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT---TSSS
T ss_pred HHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC---CCCC
Confidence 35899999999999999999999 488999999975432 2345789999999999999999999997542 2356
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeccCCCCCeeeCCCCcEEEee
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPP--VVHGDLKPSNVLLDQDLVAHLGD 833 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~D 833 (992)
.++||||+++|+|.+++..... ..+++..++.++.|++.||+|||++ + |+||||||+||+++.++.++|+|
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~ 156 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEGTN----FVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISM 156 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSCSS----CCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEG
T ss_pred eEeeecccCCCcHHHHHhhccc----CCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEe
Confidence 6999999999999999986542 2589999999999999999999998 7 99999999999999999999999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCc---ccchhhHHHHHHHHHhCCCCCCCCccCCccHHH
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASM---TGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHE 910 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~ 910 (992)
||++..... ....||+.|+|||++.+..++. ++|||||||++|||++|+.||.+.....
T Consensus 157 ~~~~~~~~~-------------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----- 218 (271)
T 3kmu_A 157 ADVKFSFQS-------------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME----- 218 (271)
T ss_dssp GGSCCTTSC-------------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH-----
T ss_pred ccceeeecc-------------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH-----
Confidence 998754221 2235899999999988765554 7999999999999999999997532210
Q ss_pred HHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 037275 911 FARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARD 984 (992)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 984 (992)
............ ..+ .....++.+++.+||+.||++|||++|+++.|+++.+
T Consensus 219 ------------~~~~~~~~~~~~----~~~------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 219 ------------IGMKVALEGLRP----TIP------PGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp ------------HHHHHHHSCCCC----CCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ------------HHHHHHhcCCCC----CCC------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 001111000000 000 1123458899999999999999999999999998754
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=342.33 Aligned_cols=258 Identities=25% Similarity=0.421 Sum_probs=207.4
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
.++|++.+.||+|+||.||+|++. +++.||+|++.... ...+.+.+|++++++++||||+++++++.. ....+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 79 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPIC 79 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SSSCE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcc-----CCCeE
Confidence 357889999999999999999996 68899999997443 345678999999999999999999999643 44569
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||+++++|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+
T Consensus 80 lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~ 151 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMT 151 (267)
T ss_dssp EEECCCTTCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGG
T ss_pred EEEeCCCCCcHHHHHhhCcc-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccc
Confidence 99999999999999976532 489999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhhhC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFARTAL 916 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 916 (992)
....... ........+++.|+|||++.+..++.++||||+|+++|+|++ |+.||......
T Consensus 152 ~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------------ 212 (267)
T 3t9t_A 152 RFVLDDQ-------YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------------ 212 (267)
T ss_dssp GGBCCHH-------HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------------
T ss_pred ccccccc-------ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH------------
Confidence 8654321 111223457889999999988899999999999999999999 89998753211
Q ss_pred ChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 037275 917 PDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDT 985 (992)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 985 (992)
+........ ...... ......+.+++.+||+.||++|||++|+++.|+++.++
T Consensus 213 -----~~~~~i~~~-~~~~~~----------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 213 -----EVVEDISTG-FRLYKP----------RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp -----HHHHHHHTT-CCCCCC----------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -----HHHHHHhcC-CcCCCC----------ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 111111000 000000 01134588999999999999999999999999998764
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=342.24 Aligned_cols=263 Identities=26% Similarity=0.450 Sum_probs=208.7
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
.++|++.+.||+|+||.||+|++. ++..||+|++... ....+.+.+|++++++++||||+++++++.. ...+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~ 83 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ------EPIY 83 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCC-cccHHHHHHHHHHHHhCCCcCcceEEEEEcC------CCcE
Confidence 457899999999999999999986 6788999998643 3346789999999999999999999998642 2358
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||+++++|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+||++++++.+||+|||.+
T Consensus 84 ~v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 156 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLA 156 (279)
T ss_dssp EEEECCTTCBHHHHTTSHHH----HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEecCCCCCHHHHHhcCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCccc
Confidence 99999999999999975432 2589999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhhhC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFARTAL 916 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 916 (992)
........ .......+++.|+|||++.+..++.++||||||+++|||++ |+.||.+.... +
T Consensus 157 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-----~------ 218 (279)
T 1qpc_A 157 RLIEDNEY-------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-----E------ 218 (279)
T ss_dssp EECSSSCE-------ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----H------
T ss_pred ccccCccc-------ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH-----H------
Confidence 87654321 11223456889999999988899999999999999999999 99999753211 0
Q ss_pred ChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhhcc
Q 037275 917 PDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTFLGRM 990 (992)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~ 990 (992)
....... ...... ......++.+++.+||+.||++|||++++++.|+++.....++.
T Consensus 219 ------~~~~~~~-~~~~~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 275 (279)
T 1qpc_A 219 ------VIQNLER-GYRMVR----------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQY 275 (279)
T ss_dssp ------HHHHHHT-TCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC----
T ss_pred ------HHHHHhc-ccCCCC----------cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCCC
Confidence 1111000 000000 01123468899999999999999999999999999988766554
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=348.54 Aligned_cols=267 Identities=24% Similarity=0.343 Sum_probs=200.6
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
.++|++.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.++++++||||+++++++.. ..
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~ 105 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----DN 105 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TT
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----CC
Confidence 457999999999999999999998899999999997432 2234668899999999999999999999653 44
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
..++||||+++|+|.+++...... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Df 180 (310)
T 2wqm_A 106 ELNIVLELADAGDLSRMIKHFKKQ--KRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDL 180 (310)
T ss_dssp EEEEEEECCCSCBHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred cEEEEEecCCCCCHHHHHHHhccc--ccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEec
Confidence 679999999999999999764321 34589999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
|++....... .......|++.|+|||++.+..++.++||||||+++|+|++|+.||.+..... .
T Consensus 181 g~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~----- 244 (310)
T 2wqm_A 181 GLGRFFSSKT--------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL---Y----- 244 (310)
T ss_dssp --------------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH---H-----
T ss_pred cceeeecCCC--------ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH---H-----
Confidence 9998654321 11223468999999999999999999999999999999999999997532111 0
Q ss_pred hCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhh
Q 037275 915 ALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTFL 987 (992)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 987 (992)
............. . .......++.+++.+||+.||++|||++||++.|+++.+...
T Consensus 245 -------~~~~~~~~~~~~~-----~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 245 -------SLCKKIEQCDYPP-----L-----PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp -------HHHHHHHTTCSCC-----C-----CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred -------HHHHHhhcccCCC-----C-----cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 1111111000000 0 001123458899999999999999999999999999987654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=350.12 Aligned_cols=268 Identities=25% Similarity=0.395 Sum_probs=206.7
Q ss_pred hcCCCCCCccccccceEEEEeEECCC---CeEEEEEEeeccCC-CchhHHHHHHHHHHhccCCcceeEEEEeecccccCc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGEN---GMMVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 753 (992)
..+|++.++||+|+||+||+|++..+ ...||+|.+..... ...+.+.+|+.++++++||||+++++++.. ..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~ 99 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----SE 99 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC----SS
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc----CC
Confidence 45688899999999999999997533 34689998864332 334678999999999999999999998643 34
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGD 833 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 833 (992)
...++||||+++|+|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 100 ~~~~~v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~D 171 (298)
T 3f66_A 100 GSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVAD 171 (298)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECS
T ss_pred CceEEEEeCCCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECc
Confidence 556899999999999999975432 489999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHH
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFA 912 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~ 912 (992)
||.++........ .........+|+.|+|||.+.+..++.++||||+|+++|+|++ |.+||.+..... ......
T Consensus 172 fg~a~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~-~~~~~~ 246 (298)
T 3f66_A 172 FGLARDMYDKEYY----SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-ITVYLL 246 (298)
T ss_dssp CGGGCCCSCGGGC----BC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT-HHHHHH
T ss_pred ccccccccccchh----ccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH-HHHHHh
Confidence 9999876543211 1122334567889999999999999999999999999999999 566665432221 111110
Q ss_pred hhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhhc
Q 037275 913 RTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTFLGR 989 (992)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 989 (992)
... . ... .......+.+++.+||+.||++|||++|+++.|+++.+.+.++
T Consensus 247 ~~~----------------~-~~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~~ 296 (298)
T 3f66_A 247 QGR----------------R-LLQ----------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 296 (298)
T ss_dssp TTC----------------C-CCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCCS
T ss_pred cCC----------------C-CCC----------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccC
Confidence 000 0 000 0011245889999999999999999999999999999887664
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=352.80 Aligned_cols=253 Identities=19% Similarity=0.357 Sum_probs=200.7
Q ss_pred hcCCCCCCccccccceEEEEeEECCCC-------eEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENG-------MMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDF 750 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 750 (992)
.++|++.+.||+|+||+||+|++..++ ..||+|++........+.+.+|+.++++++||||+++++++..
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--- 83 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVC--- 83 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC---
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe---
Confidence 357889999999999999999987665 5799999976666667889999999999999999999999643
Q ss_pred cCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCc--
Q 037275 751 KGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLV-- 828 (992)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-- 828 (992)
....++||||+++|+|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.
T Consensus 84 --~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~ 153 (289)
T 4fvq_A 84 --GDENILVQEFVKFGSLDTYLKKNKN-----CINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRK 153 (289)
T ss_dssp --TTCCEEEEECCTTCBHHHHHHHTGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGG
T ss_pred --CCCCEEEEECCCCCCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCccc
Confidence 3455899999999999999986543 389999999999999999999999 9999999999999998886
Q ss_pred ------EEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCCC
Q 037275 829 ------AHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRRRPTDGM 901 (992)
Q Consensus 829 ------~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~ 901 (992)
+||+|||.+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|..|+...
T Consensus 154 ~~~~~~~kl~Dfg~~~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~ 221 (289)
T 4fvq_A 154 TGNPPFIKLSDPGISITVLP------------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA 221 (289)
T ss_dssp GTBCCEEEECCCCSCTTTSC------------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred ccccceeeeccCcccccccC------------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccc
Confidence 99999999864432 122357889999999887 67899999999999999999955444321
Q ss_pred ccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 037275 902 FNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCR 981 (992)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 981 (992)
.+.. . ...... .. ....... ..++.+++.+||+.||++|||++|+++.|++
T Consensus 222 ~~~~----~---------~~~~~~----~~--~~~~~~~----------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 272 (289)
T 4fvq_A 222 LDSQ----R---------KLQFYE----DR--HQLPAPK----------AAELANLINNCMDYEPDHRPSFRAIIRDLNS 272 (289)
T ss_dssp SCHH----H---------HHHHHH----TT--CCCCCCS----------SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHT
T ss_pred cchH----H---------HHHHhh----cc--CCCCCCC----------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 1110 0 000000 00 0000001 2247889999999999999999999999998
Q ss_pred HHH
Q 037275 982 ARD 984 (992)
Q Consensus 982 ~~~ 984 (992)
+..
T Consensus 273 l~~ 275 (289)
T 4fvq_A 273 LFT 275 (289)
T ss_dssp CC-
T ss_pred hcC
Confidence 754
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=349.38 Aligned_cols=245 Identities=24% Similarity=0.303 Sum_probs=191.1
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCC--chhHHHHHHHHHHhc-cCCcceeEEEEeecccccCcce
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKG--ASNGFVAECQALRNI-RHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 755 (992)
++|++.++||+|+||+||+|++..+++.||||++...... .......|+..+.++ +||||+++++++. ....
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~-----~~~~ 131 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE-----EGGI 131 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE-----eCCE
Confidence 5799999999999999999999989999999998643322 223445566665555 8999999999964 3456
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++||||+ +++|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG 202 (311)
T 3p1a_A 132 LYLQTELC-GPSLQQHCEAWGA-----SLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFG 202 (311)
T ss_dssp EEEEEECC-CCBHHHHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCT
T ss_pred EEEEEecc-CCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccce
Confidence 79999999 7799999876542 599999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 915 (992)
++....... ......||+.|+|||++.+ .++.++|||||||++|||++|..|+.+.. .........
T Consensus 203 ~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----~~~~~~~~~ 268 (311)
T 3p1a_A 203 LLVELGTAG---------AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----GWQQLRQGY 268 (311)
T ss_dssp TCEECC---------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----HHHHHTTTC
T ss_pred eeeecccCC---------CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----HHHHHhccC
Confidence 998765321 1223458999999998876 78999999999999999999977664310 111111111
Q ss_pred CChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 916 LPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.+... ......++.+++.+||+.||++|||++|+++
T Consensus 269 ~~~~~--------------------------~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 269 LPPEF--------------------------TAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp CCHHH--------------------------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCccc--------------------------ccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 11000 0112345899999999999999999999985
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=359.16 Aligned_cols=258 Identities=20% Similarity=0.271 Sum_probs=194.6
Q ss_pred hcCCCCC-CccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHh-ccCCcceeEEEEeecccccCcce
Q 037275 678 TNDFSSS-NMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRN-IRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 678 ~~~~~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
.++|.+. ++||+|+||+||+|.+..+++.||||+++. ...+.+|+.++.+ .+||||+++++++... +.+...
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~-~~~~~~ 133 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC 133 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeec-ccCCcE
Confidence 3466666 689999999999999999999999999852 3457788888754 5899999999987531 234567
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCC---CCcEEEe
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQ---DLVAHLG 832 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~ 832 (992)
.++||||+++|+|.+++..... ..+++..+..++.||+.||+|||++ +|+||||||+||+++. ++.+||+
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~ 206 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGD----QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT 206 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC-------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEEC
T ss_pred EEEEEEeCCCCcHHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEE
Confidence 8999999999999999986532 2589999999999999999999999 9999999999999987 7899999
Q ss_pred ecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHH
Q 037275 833 DFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFA 912 (992)
Q Consensus 833 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~ 912 (992)
|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.......
T Consensus 207 DFG~a~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~----- 272 (400)
T 1nxk_A 207 DFGFAKETTSH---------NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----- 272 (400)
T ss_dssp CCTTCEECC--------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC-----
T ss_pred ecccccccCCC---------CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc-----
Confidence 99999865432 1123456899999999999999999999999999999999999999764332110
Q ss_pred hhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 913 RTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
...... .....+.... ........++.+++.+||+.||++|||++|+++.
T Consensus 273 -----~~~~~~---i~~~~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 273 -----PGMKTR---IRMGQYEFPN--------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp -----CSHHHH---HHHTCCCCCT--------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -----HHHHHH---HHcCcccCCC--------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000000 0001110000 0001123458899999999999999999999874
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=357.48 Aligned_cols=277 Identities=21% Similarity=0.257 Sum_probs=198.3
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC--CchhHHHHHHHHHHhccCCcceeEEEEeeccc-ccCcc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK--GASNGFVAECQALRNIRHRNLIKIITICSSID-FKGVD 754 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~ 754 (992)
.++|++.+.||+|+||.||+|.+..+|+.||||++..... ...+.+.+|+.+++.++||||+++++++.... .....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 3579999999999999999999998999999999854322 23456889999999999999999999976532 12234
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
..++||||+ +++|.+++... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~-------~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Df 172 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE-------KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDF 172 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred eEEEEEecC-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEee
Confidence 569999999 88999999752 489999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 913 (992)
|+++..... .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+ .+.....
T Consensus 173 g~a~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~l~~i~~ 240 (367)
T 1cm8_A 173 GLARQADSE-----------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-QLKEIMK 240 (367)
T ss_dssp TTCEECCSS-----------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHH
T ss_pred ecccccccc-----------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH
Confidence 999875421 223468999999999877 679999999999999999999999998643221 1111111
Q ss_pred hh--CChhHHHHHHhhHhHhhhccCCCCCC-ccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 914 TA--LPDKVMEIVDSVLLLEVQASNSRSCG-DERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 914 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.. .+......+.......+......... .-..........+.+++.+||+.||++|||++|+++
T Consensus 241 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 241 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 11 11111111100000000000000000 000001122456889999999999999999999986
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=350.91 Aligned_cols=276 Identities=25% Similarity=0.374 Sum_probs=208.9
Q ss_pred CCCCCccccccceEEEEeEE----CCCCeEEEEEEeeccCC-CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 681 FSSSNMIGQGSFGFVYKGNL----GENGMMVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
|++.++||+|+||+||+|.+ ..+++.||||+++.... ...+.+.+|++++++++||||+++++++.. .+...
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~~ 109 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCED---AGAAS 109 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---TTTTE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEec---CCCce
Confidence 48999999999999987754 45789999999975432 234668999999999999999999999754 23456
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++||||+++|+|.+++... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg 179 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRH-------SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFG 179 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGG
T ss_pred EEEEEecccCCcHHHHHhhC-------CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcc
Confidence 79999999999999999753 389999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 915 (992)
.+........ .........+|+.|+|||++.+..++.++||||+||++|+|++|+.||...... ... ...
T Consensus 180 ~a~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~---~~~--~~~ 249 (318)
T 3lxp_A 180 LAKAVPEGHE-----YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTK---FLE--LIG 249 (318)
T ss_dssp GCEECCTTCS-----EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH---HHH--HHC
T ss_pred cccccccccc-----ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchh---hhh--hhc
Confidence 9987754321 111223345788999999999989999999999999999999999998652111 000 001
Q ss_pred CChhHHHH--HHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhhc
Q 037275 916 LPDKVMEI--VDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTFLGR 989 (992)
Q Consensus 916 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 989 (992)
........ +........... .......++.+++.+||+.||++|||++|+++.|+++.+++.++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 315 (318)
T 3lxp_A 250 IAQGQMTVLRLTELLERGERLP----------RPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ 315 (318)
T ss_dssp SCCHHHHHHHHHHHHHTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred ccccchhHHHHHHHHhcccCCC----------CCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence 11111110 111110000000 01122356899999999999999999999999999999887654
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=342.68 Aligned_cols=252 Identities=21% Similarity=0.314 Sum_probs=202.0
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC--CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK--GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.++++++||||+++++++. ....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 79 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EESF 79 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE-----cCCE
Confidence 4689999999999999999999998999999999975432 23466889999999999999999999964 4456
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCc---EEEe
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLV---AHLG 832 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~ 832 (992)
.++||||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++. +||+
T Consensus 80 ~~~v~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~ 150 (284)
T 3kk8_A 80 HYLVFDLVTGGELFEDIVARE------FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLA 150 (284)
T ss_dssp EEEEECCCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEEC
T ss_pred EEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEe
Confidence 699999999999999987543 589999999999999999999999 9999999999999976655 9999
Q ss_pred ecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHH
Q 037275 833 DFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFA 912 (992)
Q Consensus 833 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~ 912 (992)
|||.+....... ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||.+....
T Consensus 151 Dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-------- 213 (284)
T 3kk8_A 151 DFGLAIEVNDSE---------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-------- 213 (284)
T ss_dssp CCTTCEECCSSC---------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------
T ss_pred eceeeEEcccCc---------cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh--------
Confidence 999998765321 123356899999999999999999999999999999999999999753211
Q ss_pred hhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 913 RTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.............. .........++.+++.+||+.||++|||++|+++
T Consensus 214 ---------~~~~~~~~~~~~~~--------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 214 ---------RLYAQIKAGAYDYP--------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp ---------HHHHHHHHTCCCCC--------TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---------HHHHHHHhccccCC--------chhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 11111111110000 0000112345889999999999999999999986
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=359.54 Aligned_cols=212 Identities=23% Similarity=0.377 Sum_probs=167.1
Q ss_pred HHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc--CCCchhHHHHHHHHHHhcc-CCcceeEEEEeecccccC
Q 037275 676 KATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK--QKGASNGFVAECQALRNIR-HRNLIKIITICSSIDFKG 752 (992)
Q Consensus 676 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 752 (992)
...++|++.+.||+|+||+||+|.+..+|+.||||++... .......+.+|+.+++++. ||||+++++++.. .+
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~---~~ 82 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRA---DN 82 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC---TT
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEec---CC
Confidence 3467899999999999999999999999999999998533 2233456789999999997 9999999999753 23
Q ss_pred cceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEe
Q 037275 753 VDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLG 832 (992)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 832 (992)
....++||||++ |+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 83 ~~~~~lv~e~~~-~~L~~~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~ 151 (388)
T 3oz6_A 83 DRDVYLVFDYME-TDLHAVIRAN-------ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVA 151 (388)
T ss_dssp SSCEEEEEECCS-EEHHHHHHHT-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEEC
T ss_pred CCEEEEEecccC-cCHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEec
Confidence 456799999997 5999998753 488999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCCCCC-------------cccCCCCCcccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCC
Q 037275 833 DFGLAKFLSSSPLDTA-------------VETPSSSKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRRRPT 898 (992)
Q Consensus 833 Dfg~a~~~~~~~~~~~-------------~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf 898 (992)
|||+|+.......... ..........+||+.|+|||++.+ ..++.++||||+||++|||++|++||
T Consensus 152 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf 231 (388)
T 3oz6_A 152 DFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF 231 (388)
T ss_dssp CCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred CCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCC
Confidence 9999987643211100 001122344679999999999876 67899999999999999999999999
Q ss_pred CCC
Q 037275 899 DGM 901 (992)
Q Consensus 899 ~~~ 901 (992)
.+.
T Consensus 232 ~~~ 234 (388)
T 3oz6_A 232 PGS 234 (388)
T ss_dssp CCS
T ss_pred CCC
Confidence 874
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=356.13 Aligned_cols=283 Identities=22% Similarity=0.240 Sum_probs=207.9
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC-CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
.++|++.++||+|+||.||+|.+..+++.||||++..... .....+.+|++++++++||||+++++++...........
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 4589999999999999999999998999999999964332 233678899999999999999999999876555556678
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
++||||++ |+|.+++... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.
T Consensus 106 ~iv~e~~~-~~L~~~l~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 174 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ-------HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGL 174 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEcccC-cCHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcc
Confidence 99999996 5999998643 489999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 915 (992)
++....... .........||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+....+ .+.......
T Consensus 175 a~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~ 248 (364)
T 3qyz_A 175 ARVADPDHD-----HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-QLNHILGIL 248 (364)
T ss_dssp CEECCGGGC-----BCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG-HHHHHHHHH
T ss_pred eEecCCCCC-----ccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH-HHHHHHHHh
Confidence 987653211 1112234579999999998654 458999999999999999999999998743322 122221111
Q ss_pred C--ChhHHHHHHhhHhHhhhccCCCCCCcc-ccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 916 L--PDKVMEIVDSVLLLEVQASNSRSCGDE-RLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 916 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
. +..............+........... .........++.+++.+||+.||++|||++|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 249 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp CSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1 111000000000000000000000000 0000112356889999999999999999999985
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=367.04 Aligned_cols=248 Identities=26% Similarity=0.369 Sum_probs=202.3
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc---CCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK---QKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
.++|.+.+.||+|+||.||+|++..+|+.||||++... .......+.+|+.+++.++||||+++++++. ...
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~-----~~~ 89 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS-----TPS 89 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECC
Confidence 35799999999999999999999989999999999643 2234567899999999999999999999964 345
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
..++||||+++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DF 160 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICKNG------RLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADF 160 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTSSS------SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred EEEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEec
Confidence 6799999999999999997543 489999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCc-CcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEA-SMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 913 (992)
|++....... ......||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.+....
T Consensus 161 G~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~--------- 222 (476)
T 2y94_A 161 GLSNMMSDGE---------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP--------- 222 (476)
T ss_dssp SSCEECCTTC---------CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH---------
T ss_pred cchhhccccc---------cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH---------
Confidence 9998765321 1223469999999999988765 68999999999999999999999753211
Q ss_pred hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 914 TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
........+.+. .+ .....++.+++.+||+.||++|||++|+++
T Consensus 223 --------~~~~~i~~~~~~------~p------~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 223 --------TLFKKICDGIFY------TP------QYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp --------HHHHHHHTTCCC------CC------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --------HHHHHHhcCCcC------CC------ccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 111111111100 00 011245889999999999999999999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=351.28 Aligned_cols=253 Identities=23% Similarity=0.295 Sum_probs=198.6
Q ss_pred HhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhc-cCCcceeEEEEeecccccCcce
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNI-RHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 755 (992)
..++|++.+.||+|+||+||+|.+..+++.||||++..... ...+|++++.++ +||||+++++++. +...
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~-----~~~~ 90 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYD-----DGKY 90 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEE-----CSSE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEE-----cCCE
Confidence 35679999999999999999999999999999999964432 235788888888 7999999999953 4567
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCC----CcEEE
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQD----LVAHL 831 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl 831 (992)
.++||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||++..+ +.+||
T Consensus 91 ~~lv~E~~~gg~L~~~i~~~~------~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl 161 (342)
T 2qr7_A 91 VYVVTELMKGGELLDKILRQK------FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRI 161 (342)
T ss_dssp EEEEECCCCSCBHHHHHHTCT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEE
T ss_pred EEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEE
Confidence 799999999999999997643 489999999999999999999999 99999999999998443 35999
Q ss_pred eecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHH
Q 037275 832 GDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEF 911 (992)
Q Consensus 832 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~ 911 (992)
+|||+++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.... .
T Consensus 162 ~Dfg~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~---- 227 (342)
T 2qr7_A 162 CDFGFAKQLRAEN--------GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD--T---- 227 (342)
T ss_dssp CCCTTCEECBCTT--------CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS--C----
T ss_pred EECCCcccCcCCC--------CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC--C----
Confidence 9999998765321 1223356899999999998888999999999999999999999999763221 1
Q ss_pred HhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 912 ARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
..++......+.+..... .......++.+++.+||+.||++|||+.|+++
T Consensus 228 --------~~~~~~~i~~~~~~~~~~--------~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 228 --------PEEILARIGSGKFSLSGG--------YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp --------HHHHHHHHHHCCCCCCST--------TTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --------HHHHHHHHccCCcccCcc--------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111121111111110000 00112345889999999999999999999986
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=345.56 Aligned_cols=253 Identities=24% Similarity=0.335 Sum_probs=197.2
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC-CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
++|++.++||+|+||+||+|++..+++.||+|++.... ....+.+.+|++++++++||||+++++++. .....+
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~ 96 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFE-----DYHNMY 96 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhee-----cCCeEE
Confidence 57899999999999999999999899999999997543 334678899999999999999999999964 445679
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeee---CCCCcEEEeec
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLL---DQDLVAHLGDF 834 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Df 834 (992)
+||||+++|+|.+++...... ...+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+||
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Df 171 (285)
T 3is5_A 97 IVMETCEGGELLERIVSAQAR--GKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDF 171 (285)
T ss_dssp EEECCCSCCBHHHHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCC
T ss_pred EEEEeCCCCcHHHHHHhhhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEee
Confidence 999999999999999764321 34689999999999999999999999 99999999999999 45678999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
|++....... ......||+.|+|||++. +.++.++||||+||++|||++|+.||.+.... +
T Consensus 172 g~a~~~~~~~---------~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~-----~---- 232 (285)
T 3is5_A 172 GLAELFKSDE---------HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE-----E---- 232 (285)
T ss_dssp CCCCC-------------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----H----
T ss_pred ecceecCCcc---------cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH-----H----
Confidence 9998654321 123346899999999875 56899999999999999999999999763211 0
Q ss_pred hCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 915 ALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.......... ...... .....++.+++.+||+.||++|||++|+++
T Consensus 233 --------~~~~~~~~~~-----~~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 233 --------VQQKATYKEP-----NYAVEC----RPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp --------HHHHHHHCCC-----CCCC------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred --------HHhhhccCCc-----cccccc----CcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000000000 000000 001345789999999999999999999985
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=353.88 Aligned_cols=271 Identities=22% Similarity=0.356 Sum_probs=211.1
Q ss_pred HHhcCCCCCCccccccceEEEEeEECCCC-----eEEEEEEeeccCC-CchhHHHHHHHHHHhc-cCCcceeEEEEeecc
Q 037275 676 KATNDFSSSNMIGQGSFGFVYKGNLGENG-----MMVAVKVINLKQK-GASNGFVAECQALRNI-RHRNLIKIITICSSI 748 (992)
Q Consensus 676 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 748 (992)
...++|++.+.||+|+||+||+|.+..++ ..||+|++..... ...+.+.+|+.+++++ +||||+++++++..
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 121 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH- 121 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec-
Confidence 34568999999999999999999986555 3799999864432 2346789999999999 89999999999643
Q ss_pred cccCcceEEEEEEeccCCCHHHHHhhcccch--------hhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCC
Q 037275 749 DFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQ--------EARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSN 820 (992)
Q Consensus 749 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~N 820 (992)
....++||||+++|+|.+++....... ....+++..++.++.|++.||+|||++ +|+||||||+|
T Consensus 122 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~N 194 (333)
T 2i1m_A 122 ----GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARN 194 (333)
T ss_dssp ----SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred ----CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccce
Confidence 445699999999999999998654210 023579999999999999999999999 99999999999
Q ss_pred eeeCCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCC
Q 037275 821 VLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTD 899 (992)
Q Consensus 821 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~ 899 (992)
|+++.++.+||+|||+++....... ........+|+.|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 195 Il~~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 268 (333)
T 2i1m_A 195 VLLTNGHVAKIGDFGLARDIMNDSN------YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYP 268 (333)
T ss_dssp CEEEGGGEEEBCCCGGGCCGGGCTT------SEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred EEECCCCeEEECccccccccccccc------eeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCc
Confidence 9999999999999999986543221 111223457889999999988899999999999999999999 999997
Q ss_pred CCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 037275 900 GMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKL 979 (992)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 979 (992)
+..... .....+.. ........ .....+.+++.+||+.||++|||+.||++.|
T Consensus 269 ~~~~~~-------------~~~~~~~~----~~~~~~~~----------~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L 321 (333)
T 2i1m_A 269 GILVNS-------------KFYKLVKD----GYQMAQPA----------FAPKNIYSIMQACWALEPTHRPTFQQICSFL 321 (333)
T ss_dssp TCCSSH-------------HHHHHHHH----TCCCCCCT----------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccchhH-------------HHHHHHhc----CCCCCCCC----------CCCHHHHHHHHHHhccChhhCcCHHHHHHHH
Confidence 643221 11111111 11000000 1134588999999999999999999999999
Q ss_pred HHHHHhhh
Q 037275 980 CRARDTFL 987 (992)
Q Consensus 980 ~~~~~~~~ 987 (992)
+++.....
T Consensus 322 ~~~~~~~~ 329 (333)
T 2i1m_A 322 QEQAQEDR 329 (333)
T ss_dssp HHHHHHHH
T ss_pred HHHHHhhh
Confidence 99876543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=346.29 Aligned_cols=258 Identities=21% Similarity=0.352 Sum_probs=207.2
Q ss_pred HhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccc------
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDF------ 750 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------ 750 (992)
..++|++.+.||+|+||.||+|++..+++.||+|++.... ..+.+|++++++++||||+++++++....+
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3457999999999999999999998899999999996432 456789999999999999999998754222
Q ss_pred -----cCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCC
Q 037275 751 -----KGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQ 825 (992)
Q Consensus 751 -----~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 825 (992)
......++||||+++|+|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~ 157 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG----EKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVD 157 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcC
Confidence 224567999999999999999986532 3689999999999999999999999 9999999999999999
Q ss_pred CCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCC
Q 037275 826 DLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQG 905 (992)
Q Consensus 826 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~ 905 (992)
++.+||+|||.+....... ......|++.|+|||++.+..++.++||||||+++|+|++|..|+...
T Consensus 158 ~~~~kl~Dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---- 224 (284)
T 2a19_B 158 TKQVKIGDFGLVTSLKNDG---------KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET---- 224 (284)
T ss_dssp TTEEEECCCTTCEESSCCS---------CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH----
T ss_pred CCCEEECcchhheeccccc---------cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH----
Confidence 9999999999998765422 122345899999999999999999999999999999999999886321
Q ss_pred ccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 037275 906 LTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDT 985 (992)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 985 (992)
. ........... . ......+.+++.+||+.||++|||+.|+++.|..+.+.
T Consensus 225 ---~------------~~~~~~~~~~~--------~------~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 225 ---S------------KFFTDLRDGII--------S------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp ---H------------HHHHHHHTTCC--------C------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred ---H------------HHHHHhhcccc--------c------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 0 00000000000 0 01123478999999999999999999999999988765
Q ss_pred hh
Q 037275 986 FL 987 (992)
Q Consensus 986 ~~ 987 (992)
..
T Consensus 276 ~~ 277 (284)
T 2a19_B 276 PE 277 (284)
T ss_dssp --
T ss_pred CC
Confidence 44
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=354.61 Aligned_cols=260 Identities=22% Similarity=0.394 Sum_probs=200.2
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEE----EEEEeecc-CCCchhHHHHHHHHHHhccCCcceeEEEEeecccccC
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMV----AVKVINLK-QKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKG 752 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~v----avK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 752 (992)
.++|++.++||+|+||+||+|++..+++.| |+|.+... .....+.+.+|+.++++++||||+++++++...
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~---- 89 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS---- 89 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS----
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC----
Confidence 357999999999999999999997777654 66666432 334567899999999999999999999997532
Q ss_pred cceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEe
Q 037275 753 VDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLG 832 (992)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 832 (992)
..++|+||+.+|+|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 90 --~~~~v~~~~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~ 159 (327)
T 3lzb_A 90 --TVQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKIT 159 (327)
T ss_dssp --SEEEEECCCSSCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEEC
T ss_pred --CceEEEEecCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEc
Confidence 25899999999999999986543 489999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHH
Q 037275 833 DFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEF 911 (992)
Q Consensus 833 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~ 911 (992)
|||+++....... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.....
T Consensus 160 DfG~a~~~~~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~------ 227 (327)
T 3lzb_A 160 DFGLAKLLGAEEK------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE------ 227 (327)
T ss_dssp CTTC----------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG------
T ss_pred cCcceeEccCccc------cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH------
Confidence 9999987653321 112223457889999999999999999999999999999999 999997643221
Q ss_pred HhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 037275 912 ARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDT 985 (992)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 985 (992)
....+.. ...... ......++.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 228 --------~~~~~~~----~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 228 --------ISSILEK----GERLPQ----------PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp --------HHHHHHT----TCCCCC----------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred --------HHHHHHc----CCCCCC----------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 1111111 000000 011234588999999999999999999999999998754
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=353.90 Aligned_cols=245 Identities=23% Similarity=0.340 Sum_probs=201.4
Q ss_pred HHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC--------CchhHHHHHHHHHHhccCCcceeEEEEeec
Q 037275 676 KATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK--------GASNGFVAECQALRNIRHRNLIKIITICSS 747 (992)
Q Consensus 676 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 747 (992)
...++|++.+.||+|+||+||+|++..+++.||||+++.... .....+.+|+.++++++||||+++++++.
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~- 99 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE- 99 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE-
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 345689999999999999999999999999999999975431 13346788999999999999999999964
Q ss_pred ccccCcceEEEEEEeccCC-CHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCC
Q 037275 748 IDFKGVDFQAIVYEYMQNG-SLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQD 826 (992)
Q Consensus 748 ~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 826 (992)
.....++||||+.+| +|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.+
T Consensus 100 ----~~~~~~lv~e~~~~g~~l~~~~~~~~------~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~ 166 (335)
T 3dls_A 100 ----NQGFFQLVMEKHGSGLDLFAFIDRHP------RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAED 166 (335)
T ss_dssp ----CSSEEEEEEECCTTSCBHHHHHHTCC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT
T ss_pred ----eCCEEEEEEEeCCCCccHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCC
Confidence 455679999999777 9999997653 489999999999999999999999 99999999999999999
Q ss_pred CcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCc-CcccchhhHHHHHHHHHhCCCCCCCCccCC
Q 037275 827 LVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEA-SMTGDVYSFGILLLEMFTRRRPTDGMFNQG 905 (992)
Q Consensus 827 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~ 905 (992)
+.+||+|||+++...... ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......
T Consensus 167 ~~~kL~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~- 236 (335)
T 3dls_A 167 FTIKLIDFGSAAYLERGK---------LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET- 236 (335)
T ss_dssp SCEEECCCTTCEECCTTC---------CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-
T ss_pred CcEEEeecccceECCCCC---------ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-
Confidence 999999999998765422 1223468999999999988876 78999999999999999999999752110
Q ss_pred ccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 906 LTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
...... .. .....++.+++.+||+.||++|||++|+++.
T Consensus 237 ------~~~~~~------------------~~----------~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 ------VEAAIH------------------PP----------YLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ------TTTCCC------------------CS----------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ------HhhccC------------------CC----------cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 00 0012458899999999999999999999874
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=352.34 Aligned_cols=277 Identities=19% Similarity=0.239 Sum_probs=210.2
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
.++|++.+.||+|+||.||+|++..+++.||||++........+.+.+|+.++++++||||+++++++... .......+
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~~~~~ 106 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRE-RGAKHEAW 106 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEE-ETTEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEec-cCCCceeE
Confidence 45799999999999999999999889999999998765555667889999999999999999999987532 12345779
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||+++|+|.+++...... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDK--GNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred EEEEeCCCCcHHHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 999999999999999864321 34689999999999999999999999 9999999999999999999999999998
Q ss_pred eecCCCCCCCCc-ccCCCCCcccccccccccccccCCC---cCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh
Q 037275 838 KFLSSSPLDTAV-ETPSSSKGIKGTVGYIAPEYGMGGE---ASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 838 ~~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 913 (992)
............ ..........||+.|+|||++.+.. ++.++|||||||++|||++|+.||..............
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~- 260 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV- 260 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH-
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh-
Confidence 765321100000 0000012234799999999987653 78899999999999999999999864322211111111
Q ss_pred hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 037275 914 TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTF 986 (992)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 986 (992)
.. .... + .......++.+++.+||+.||++|||++|+++.|+++....
T Consensus 261 -----------~~----~~~~------~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 308 (317)
T 2buj_A 261 -----------QN----QLSI------P----QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA 308 (317)
T ss_dssp -----------HC----C--C------C----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred -----------hc----cCCC------C----ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence 00 0000 0 00112345889999999999999999999999999876543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=354.91 Aligned_cols=267 Identities=21% Similarity=0.262 Sum_probs=202.0
Q ss_pred HHHHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc-----CCCchhHHHHHHHHHHhccCCcceeEEEEeecc
Q 037275 674 LSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK-----QKGASNGFVAECQALRNIRHRNLIKIITICSSI 748 (992)
Q Consensus 674 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 748 (992)
+....++|++.+.||+|+||+||+|++..+++.||+|++... .....+.+.+|+.++++++||||+++++++.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-- 98 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE-- 98 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE--
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc--
Confidence 345566899999999999999999999999999999998643 2345678899999999999999999999964
Q ss_pred cccCcceEEEEEEeccCCCHHHHHhhcccch----------------------------------hhcccCHHHHHHHHH
Q 037275 749 DFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQ----------------------------------EARSLTLIQRINIII 794 (992)
Q Consensus 749 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----------------------------------~~~~l~~~~~~~i~~ 794 (992)
.....++||||+++|+|.+++....... ....+++..++.++.
T Consensus 99 ---~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 175 (345)
T 3hko_A 99 ---DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMR 175 (345)
T ss_dssp ---CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHH
T ss_pred ---cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHH
Confidence 4556799999999999999996321110 012356788899999
Q ss_pred HHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCC--cEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccC
Q 037275 795 DVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDL--VAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG 872 (992)
Q Consensus 795 qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 872 (992)
|++.||+|||++ +|+||||||+||+++.++ .+||+|||+++.+...... .........||+.|+|||++.+
T Consensus 176 qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~ 248 (345)
T 3hko_A 176 QIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNG----EYYGMTTKAGTPYFVAPEVLNT 248 (345)
T ss_dssp HHHHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC------------CCCGGGCCHHHHTC
T ss_pred HHHHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCcc----ccccccccCCCccccCchhhcc
Confidence 999999999999 999999999999998776 8999999999876432111 1112234568999999999865
Q ss_pred --CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHH
Q 037275 873 --GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEER 950 (992)
Q Consensus 873 --~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 950 (992)
..++.++|||||||++|||++|+.||.+....+ . ...+... ... .........
T Consensus 249 ~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~------------~~~~~~~----~~~--------~~~~~~~~~ 303 (345)
T 3hko_A 249 TNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDAD-T------------ISQVLNK----KLC--------FENPNYNVL 303 (345)
T ss_dssp SSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-H------------HHHHHHC----CCC--------TTSGGGGGS
T ss_pred CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHH-H------------HHHHHhc----ccc--------cCCcccccC
Confidence 678999999999999999999999997642211 0 0111110 000 000011112
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 951 LVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 951 ~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
..++.+++.+||+.||++|||+.|+++
T Consensus 304 ~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 304 SPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp CHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 346889999999999999999999986
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=350.47 Aligned_cols=249 Identities=21% Similarity=0.304 Sum_probs=191.1
Q ss_pred hcCCCCCCccccccceEEEEeEEC---CCCeEEEEEEeeccC----CCchhHHHHHHHHHHhccCCcceeEEEEeecccc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLG---ENGMMVAVKVINLKQ----KGASNGFVAECQALRNIRHRNLIKIITICSSIDF 750 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 750 (992)
.++|++.++||+|+||.||+|+.. .+++.||+|+++... ......+.+|+.+++.++||||+++++++.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~---- 91 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ---- 91 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE----
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE----
Confidence 458999999999999999999984 588999999996432 233456788999999999999999999864
Q ss_pred cCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEE
Q 037275 751 KGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAH 830 (992)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 830 (992)
.....++||||+++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+|
T Consensus 92 -~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~k 161 (327)
T 3a62_A 92 -TGGKLYLILEYLSGGELFMQLEREG------IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVK 161 (327)
T ss_dssp -CSSCEEEEEECCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEE
T ss_pred -cCCEEEEEEeCCCCCcHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEE
Confidence 3556799999999999999997543 488999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHH
Q 037275 831 LGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHE 910 (992)
Q Consensus 831 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~ 910 (992)
|+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.+....
T Consensus 162 l~Dfg~~~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------ 227 (327)
T 3a62_A 162 LTDFGLCKESIHD--------GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK------ 227 (327)
T ss_dssp ECCCSCC------------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------
T ss_pred EEeCCcccccccC--------CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH------
Confidence 9999999754321 11223456899999999999999999999999999999999999999763211
Q ss_pred HHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 037275 911 FARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERM-----EMRDVVA 977 (992)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 977 (992)
+........... .+ .....++.+++.+||+.||++|| +++|+++
T Consensus 228 -----------~~~~~i~~~~~~------~p------~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 228 -----------KTIDKILKCKLN------LP------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp -----------HHHHHHHHTCCC------CC------TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred -----------HHHHHHHhCCCC------CC------CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 111111111100 00 01134588999999999999999 7778765
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=360.27 Aligned_cols=267 Identities=25% Similarity=0.412 Sum_probs=198.7
Q ss_pred CCCCCCccccccceEEEEeEECCC---CeEEEEEEeeccC-CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGEN---GMMVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
.|++.++||+|+||+||+|++..+ +..||+|.++... ....+.+.+|+.++++++||||+++++++.. ....
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~----~~~~ 165 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----SEGS 165 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECC----CSSC
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEc----CCCC
Confidence 466778999999999999997432 3468999986433 3345778999999999999999999998643 3345
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++||||+++|+|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG 237 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFG 237 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCTTC-----CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-
T ss_pred eEEEEECCCCCCHHHHHhhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecc
Confidence 6899999999999999976432 478999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhh
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~ 914 (992)
+++........ .........+|+.|+|||++.+..++.++|||||||++|||++ |.+||.+....+ .......
T Consensus 238 ~a~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~--~~~~~~~ 311 (373)
T 3c1x_A 238 LARDMYDKEFD----SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYLLQ 311 (373)
T ss_dssp ------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC--HHHHHHT
T ss_pred ccccccccccc----cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH--HHHHHHc
Confidence 99866433211 1112233457889999999999999999999999999999999 777886543221 1111100
Q ss_pred hCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhhcc
Q 037275 915 ALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTFLGRM 990 (992)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~ 990 (992)
.. ..... ......+.+++.+||+.||++|||++|+++.|+++.+.+.+..
T Consensus 312 ---------------~~-~~~~p----------~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~ 361 (373)
T 3c1x_A 312 ---------------GR-RLLQP----------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 361 (373)
T ss_dssp ---------------TC-CCCCC----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred ---------------CC-CCCCC----------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccccc
Confidence 00 00000 1123458899999999999999999999999999998876543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=354.44 Aligned_cols=277 Identities=21% Similarity=0.339 Sum_probs=214.3
Q ss_pred HHHHHHHhcCCCCCCccccccceEEEEeEE-----CCCCeEEEEEEeeccCC-CchhHHHHHHHHHHhc-cCCcceeEEE
Q 037275 671 YAELSKATNDFSSSNMIGQGSFGFVYKGNL-----GENGMMVAVKVINLKQK-GASNGFVAECQALRNI-RHRNLIKIIT 743 (992)
Q Consensus 671 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~ 743 (992)
..+.....++|++.+.||+|+||+||+|++ ..+++.||||+++.... ...+.+.+|+.+++++ +||||+++++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 344445567999999999999999999985 34678999999964432 2345788999999999 7999999999
Q ss_pred EeecccccCcceEEEEEEeccCCCHHHHHhhcccch----------hhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 037275 744 ICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQ----------EARSLTLIQRINIIIDVASAIEYIHHHCQPPVVH 813 (992)
Q Consensus 744 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH 813 (992)
++.. .....++||||+++|+|.+++....... ....+++..++.++.|++.||+|||++ +|+|
T Consensus 99 ~~~~----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H 171 (316)
T 2xir_A 99 ACTK----PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIH 171 (316)
T ss_dssp EECC----TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred EEec----CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccc
Confidence 9743 2345699999999999999998654310 012378999999999999999999999 9999
Q ss_pred ccCCCCCeeeCCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh
Q 037275 814 GDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT 893 (992)
Q Consensus 814 ~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt 893 (992)
|||||+||+++.++.+||+|||.++....... ........||+.|+|||++.+..++.++|||||||++|||++
T Consensus 172 ~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t 245 (316)
T 2xir_A 172 RDLAARNILLSEKNVVKICDFGLARDIYKDPD------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245 (316)
T ss_dssp SCCSGGGEEECGGGCEEECCCGGGSCTTTCTT------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred ccCccceEEECCCCCEEECCCccccccccCcc------ceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHh
Confidence 99999999999999999999999986643221 111233457889999999999999999999999999999998
Q ss_pred -CCCCCCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCH
Q 037275 894 -RRRPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEM 972 (992)
Q Consensus 894 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 972 (992)
|+.||.+...... ....+.. ....... .....++.+++.+||+.||++|||+
T Consensus 246 ~g~~p~~~~~~~~~-------------~~~~~~~----~~~~~~~----------~~~~~~l~~li~~~l~~dp~~Rps~ 298 (316)
T 2xir_A 246 LGASPYPGVKIDEE-------------FCRRLKE----GTRMRAP----------DYTTPEMYQTMLDCWHGEPSQRPTF 298 (316)
T ss_dssp TSCCSSTTCCCSHH-------------HHHHHHH----TCCCCCC----------TTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCCCCcccchhHH-------------HHHHhcc----CccCCCC----------CCCCHHHHHHHHHHcCCChhhCcCH
Confidence 9999976432211 1111100 0000000 0113458899999999999999999
Q ss_pred HHHHHHHHHHHHhhh
Q 037275 973 RDVVAKLCRARDTFL 987 (992)
Q Consensus 973 ~evl~~L~~~~~~~~ 987 (992)
.|+++.|+++.....
T Consensus 299 ~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 299 SELVEHLGNLLQANA 313 (316)
T ss_dssp HHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHHhhhc
Confidence 999999999886543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=358.52 Aligned_cols=251 Identities=27% Similarity=0.315 Sum_probs=192.7
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHH-HHhccCCcceeEEEEeecccccCc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQA-LRNIRHRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~~ 753 (992)
.++|++.++||+|+||+||+|++..+++.||+|+++... ......+.+|..+ ++.++||||+++++++. ..
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~-----~~ 111 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ-----TA 111 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEE-----CS
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEE-----eC
Confidence 357999999999999999999999999999999997543 2233456677776 56789999999999854 45
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGD 833 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 833 (992)
...++||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 112 ~~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~D 182 (373)
T 2r5t_A 112 DKLYFVLDYINGGELFYHLQRER------CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTD 182 (373)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECC
T ss_pred CEEEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEee
Confidence 67799999999999999997643 488999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 913 (992)
||+++..... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+....
T Consensus 183 FG~a~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--------- 245 (373)
T 2r5t_A 183 FGLCKENIEH--------NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--------- 245 (373)
T ss_dssp CCBCGGGBCC--------CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH---------
T ss_pred CccccccccC--------CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH---------
Confidence 9999854321 12234457999999999999999999999999999999999999999753211
Q ss_pred hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 037275 914 TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKL 979 (992)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 979 (992)
+........... .. ......+.+++.+||+.||++||++.+.++.+
T Consensus 246 --------~~~~~i~~~~~~------~~------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i 291 (373)
T 2r5t_A 246 --------EMYDNILNKPLQ------LK------PNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 291 (373)
T ss_dssp --------HHHHHHHHSCCC------CC------SSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred --------HHHHHHHhcccC------CC------CCCCHHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence 111111111100 00 01134578999999999999999986544443
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=368.29 Aligned_cols=262 Identities=29% Similarity=0.474 Sum_probs=204.3
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
.++|++.++||+|+||+||+|.+. .+..||||+++... ...+.+.+|+.++++++||||+++++++.. ...+
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~~~ 254 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY 254 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred hhHceeeeeecCCCCeEEEEEEEC-CCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC------CceE
Confidence 357888999999999999999997 46789999997443 345789999999999999999999998643 3458
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||+++|+|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 255 iv~e~~~~gsL~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a 327 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGET----GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLA 327 (452)
T ss_dssp EEECCCTTCBHHHHHSHHH----HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred EEehhhcCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccc
Confidence 9999999999999997543 23589999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhhhC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFARTAL 916 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 916 (992)
+....... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||.+....
T Consensus 328 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~------------ 388 (452)
T 1fmk_A 328 RLIEDNEY-------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------------ 388 (452)
T ss_dssp C---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------------
T ss_pred eecCCCce-------ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH------------
Confidence 87653221 11223347889999999998899999999999999999999 99999764221
Q ss_pred ChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhhc
Q 037275 917 PDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTFLGR 989 (992)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 989 (992)
+...... ........ ......+.+++.+||+.||++|||+++|++.|+++.....++
T Consensus 389 -----~~~~~i~-~~~~~~~~----------~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~ 445 (452)
T 1fmk_A 389 -----EVLDQVE-RGYRMPCP----------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 445 (452)
T ss_dssp -----HHHHHHH-TTCCCCCC----------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCC
T ss_pred -----HHHHHHH-cCCCCCCC----------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCcc
Confidence 1111111 00000000 122346889999999999999999999999999887655444
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=362.61 Aligned_cols=254 Identities=22% Similarity=0.307 Sum_probs=193.7
Q ss_pred HHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC--------CCchhHHHHHHHHHHhccCCcceeEEEEeec
Q 037275 676 KATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--------KGASNGFVAECQALRNIRHRNLIKIITICSS 747 (992)
Q Consensus 676 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 747 (992)
...++|.+.+.||+|+||+||+|.+..+++.||||++.... ......+.+|+.++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 34678999999999999999999999999999999996432 1223457899999999999999999998532
Q ss_pred ccccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCC
Q 037275 748 IDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDL 827 (992)
Q Consensus 748 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 827 (992)
...++||||+++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++
T Consensus 212 ------~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~ 276 (419)
T 3i6u_A 212 ------EDYYIVLELMEGGELFDKVVGNK------RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQE 276 (419)
T ss_dssp ------SEEEEEEECCTTCBGGGGTSSSC------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSS
T ss_pred ------CceEEEEEcCCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCC
Confidence 23589999999999999886543 589999999999999999999999 999999999999996544
Q ss_pred ---cEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccC---CCcCcccchhhHHHHHHHHHhCCCCCCCC
Q 037275 828 ---VAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG---GEASMTGDVYSFGILLLEMFTRRRPTDGM 901 (992)
Q Consensus 828 ---~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~pf~~~ 901 (992)
.+||+|||+|+..... .......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||...
T Consensus 277 ~~~~~kl~DFG~a~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~ 347 (419)
T 3i6u_A 277 EDCLIKITDFGHSKILGET---------SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH 347 (419)
T ss_dssp SSCCEEECCSSTTTSCC--------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred CcceEEEeecccceecCCC---------ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 5999999999876432 12233568999999999853 57888999999999999999999999864
Q ss_pred ccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 902 FNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
................. ..... ......+.+++.+||+.||++|||++|+++
T Consensus 348 ~~~~~~~~~i~~~~~~~-~~~~~-----------------------~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 348 RTQVSLKDQITSGKYNF-IPEVW-----------------------AEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp SSSCCHHHHHHTTCCCC-CHHHH-----------------------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cchHHHHHHHhcCCCCC-Cchhh-----------------------cccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 33322222211111110 00000 012345889999999999999999999986
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=356.43 Aligned_cols=275 Identities=21% Similarity=0.307 Sum_probs=195.3
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC-CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
++|++.+.||+|+||+||+|++..+++.||+|++..... .....+.+|+.++++++||||+++++++. .....+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 76 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-----TEKSLT 76 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEE-----CSSCEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEe-----eCCEEE
Confidence 578999999999999999999998999999999864432 22234567999999999999999999964 345679
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||++ |+|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 77 lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a 147 (324)
T 3mtl_A 77 LVFEYLD-KDLKQYLDDCGN-----IINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLA 147 (324)
T ss_dssp EEEECCS-EEHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEE
T ss_pred EEecccc-cCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCccc
Confidence 9999997 599999876543 489999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh--
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART-- 914 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~-- 914 (992)
+...... .......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+....+ ........
T Consensus 148 ~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~ 218 (324)
T 3mtl_A 148 RAKSIPT--------KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE-QLHFIFRILG 218 (324)
T ss_dssp ECC--------------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHC
T ss_pred ccccCCc--------cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhC
Confidence 8654321 11223468999999999876 568999999999999999999999998643221 11111111
Q ss_pred -hCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 915 -ALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 915 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
..+..+...........+.... ...............++.+++.+||+.||++|||++|+++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 219 TPTEETWPGILSNEEFKTYNYPK-YRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp CCCTTTSTTGGGCHHHHHTCCCC-CCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCChHhchhhhcchhhccccccc-ccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0011111111100000000000 0000000001112356789999999999999999999986
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=357.83 Aligned_cols=280 Identities=21% Similarity=0.330 Sum_probs=193.6
Q ss_pred HHHHHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC--CchhHHHHHHHHHHhccCCcceeEEEEeecccc
Q 037275 673 ELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK--GASNGFVAECQALRNIRHRNLIKIITICSSIDF 750 (992)
Q Consensus 673 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 750 (992)
......++|++.++||+|+||+||+|++..+++.||||+++.... .....+.+|+.++++++||||+++++++.
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~---- 103 (329)
T 3gbz_A 28 PSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIH---- 103 (329)
T ss_dssp ----CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEE----
T ss_pred CcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEe----
Confidence 344567799999999999999999999999999999999964432 22456789999999999999999999964
Q ss_pred cCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeee-----CC
Q 037275 751 KGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLL-----DQ 825 (992)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll-----~~ 825 (992)
.....++||||++ |+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||++ +.
T Consensus 104 -~~~~~~lv~e~~~-~~L~~~~~~~~------~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~ 172 (329)
T 3gbz_A 104 -HNHRLHLIFEYAE-NDLKKYMDKNP------DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASE 172 (329)
T ss_dssp -ETTEEEEEEECCS-EEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----
T ss_pred -cCCEEEEEEecCC-CCHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCc
Confidence 3456799999997 59999997654 489999999999999999999999 99999999999999 45
Q ss_pred CCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCCCccC
Q 037275 826 DLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRRRPTDGMFNQ 904 (992)
Q Consensus 826 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~ 904 (992)
++.+||+|||+++...... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||.+....
T Consensus 173 ~~~~kl~Dfg~a~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 244 (329)
T 3gbz_A 173 TPVLKIGDFGLARAFGIPI--------RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI 244 (329)
T ss_dssp CCEEEECCTTHHHHHC-------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred cceEEECcCCCccccCCcc--------cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH
Confidence 5669999999998764321 112334679999999998875 4899999999999999999999999764322
Q ss_pred CccHHHHHhhhCChh-HHHHHHhhHhHhhhccCC--CCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 905 GLTLHEFARTALPDK-VMEIVDSVLLLEVQASNS--RSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 905 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
+...........+.. ....... ......... ...............++.+++.+||+.||++|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 245 DQLFKIFEVLGLPDDTTWPGVTA--LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp HHHHHHHHHHCCCCTTTSTTGGG--STTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHhCCCchhhhhhhhh--hhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 111111000001100 0000000 000000000 0000000000012356889999999999999999999975
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=342.60 Aligned_cols=254 Identities=22% Similarity=0.295 Sum_probs=203.7
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC-CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++. .....
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 80 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQ 80 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEE-----cCCEE
Confidence 467999999999999999999999899999999997443 334577899999999999999999999864 34566
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
++||||+++++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~ 151 (276)
T 2yex_A 81 YLFLEYCSGGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGL 151 (276)
T ss_dssp EEEEECCTTEEGGGGSBTTT------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEEEecCCCcHHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCC
Confidence 99999999999999986432 489999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccCCCc-CcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEA-SMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 915 (992)
+....... .........|++.|+|||++.+..+ +.++||||||+++|||++|+.||............+....
T Consensus 152 ~~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 225 (276)
T 2yex_A 152 ATVFRYNN------RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 225 (276)
T ss_dssp CEECEETT------EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTC
T ss_pred ccccCCCc------chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcc
Confidence 98654321 1112234568999999999887765 7789999999999999999999987543322222211110
Q ss_pred CChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 916 LPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
... .........+.+++.+||+.||++|||++|+++
T Consensus 226 ~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 226 TYL--------------------------NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp TTS--------------------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccc--------------------------CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 000 000112345789999999999999999999975
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=345.09 Aligned_cols=260 Identities=20% Similarity=0.356 Sum_probs=203.4
Q ss_pred hcCCCCCCccccccceEEEEeEECC---CCeEEEEEEeeccC-CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGE---NGMMVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 753 (992)
.++|++.+.||+|+||+||+|++.. ++..||+|++.... ....+.+.+|+.++++++||||+++++++..
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------ 84 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE------ 84 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS------
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC------
Confidence 4689999999999999999998642 34579999986442 2345678999999999999999999998642
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGD 833 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 833 (992)
...++||||+++++|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 85 ~~~~~v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~D 156 (281)
T 3cc6_A 85 EPTWIIMELYPYGELGHYLERNKN-----SLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGD 156 (281)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHTT-----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECC
T ss_pred CCCEEEEecCCCCCHHHHHHhccc-----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCc
Confidence 234899999999999999976432 489999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHH
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFA 912 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~ 912 (992)
||.+........ .......+++.|+|||++.+..++.++|||||||++|||++ |+.||....... ..
T Consensus 157 fg~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~--~~--- 224 (281)
T 3cc6_A 157 FGLSRYIEDEDY-------YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD--VI--- 224 (281)
T ss_dssp CCGGGCC----------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG--HH---
T ss_pred cCCCcccccccc-------cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH--HH---
Confidence 999987654221 11223457889999999988899999999999999999998 999997532221 11
Q ss_pred hhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 037275 913 RTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTF 986 (992)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 986 (992)
..+.. ... .... ......+.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus 225 ---------~~~~~---~~~-~~~~----------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 275 (281)
T 3cc6_A 225 ---------GVLEK---GDR-LPKP----------DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275 (281)
T ss_dssp ---------HHHHH---TCC-CCCC----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---------HHHhc---CCC-CCCC----------CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence 11100 000 0000 012345889999999999999999999999999987643
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=346.26 Aligned_cols=268 Identities=24% Similarity=0.372 Sum_probs=206.5
Q ss_pred CCCCCCccccccceEEEEeEECCCC---eEEEEEEeeccCC-CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENG---MMVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
.|+..++||+|+||+||+|++..++ ..||+|++..... ...+.+.+|+.++++++||||+++++++.. ....
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~ 97 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLP----PEGL 97 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC----SSSC
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEec----CCCC
Confidence 4666789999999999999975443 4799999864332 234678899999999999999999999743 2334
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++||||+.+|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 98 ~~~v~e~~~~~~L~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg 169 (298)
T 3pls_A 98 PHVLLPYMCHGDLLQFIRSPQ-----RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFG 169 (298)
T ss_dssp CEEEECCCTTCBHHHHHHCTT-----CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTT
T ss_pred cEEEEecccCCCHHHHHhccc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCC
Confidence 489999999999999997643 2488999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 915 (992)
.++........ .........+++.|+|||.+.+..++.++|||||||++|+|++|..|+....+.. ...
T Consensus 170 ~~~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~-~~~------ 238 (298)
T 3pls_A 170 LARDILDREYY----SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF-DLT------ 238 (298)
T ss_dssp SSCTTTTGGGG----CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG-GHH------
T ss_pred CcccccCCccc----ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH-HHH------
Confidence 99865432211 1222334568899999999999999999999999999999999655543322211 111
Q ss_pred CChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhhcc
Q 037275 916 LPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTFLGRM 990 (992)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~ 990 (992)
..+... ..... .......+.+++.+||+.||++|||++|+++.|+++.+.+.+..
T Consensus 239 ------~~~~~~----~~~~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~ 293 (298)
T 3pls_A 239 ------HFLAQG----RRLPQ----------PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH 293 (298)
T ss_dssp ------HHHHTT----CCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCC
T ss_pred ------HHhhcC----CCCCC----------CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccc
Confidence 111100 00000 01113458899999999999999999999999999998876543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=350.00 Aligned_cols=267 Identities=22% Similarity=0.373 Sum_probs=207.8
Q ss_pred hcCCCCCCccccccceEEEEeEEC-------CCCeEEEEEEeeccCC-CchhHHHHHHHHHHhc-cCCcceeEEEEeecc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLG-------ENGMMVAVKVINLKQK-GASNGFVAECQALRNI-RHRNLIKIITICSSI 748 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 748 (992)
.++|++.+.||+|+||+||+|++. .+++.||||+++.... .....+.+|+.+++++ +||||+++++++..
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~- 112 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 112 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc-
Confidence 468999999999999999999975 3567899999964432 2346788999999999 89999999999643
Q ss_pred cccCcceEEEEEEeccCCCHHHHHhhcccch----------hhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCC
Q 037275 749 DFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQ----------EARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKP 818 (992)
Q Consensus 749 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp 818 (992)
....++||||+++|+|.+++....... ....+++..++.++.|++.||+|||++ +|+||||||
T Consensus 113 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp 185 (334)
T 2pvf_A 113 ----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA 185 (334)
T ss_dssp ----SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSG
T ss_pred ----CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCcc
Confidence 445699999999999999998654210 123489999999999999999999999 999999999
Q ss_pred CCeeeCCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCC
Q 037275 819 SNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRP 897 (992)
Q Consensus 819 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p 897 (992)
+||+++.++.+||+|||+++....... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.|
T Consensus 186 ~NIll~~~~~~kL~Dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p 259 (334)
T 2pvf_A 186 RNVLVTENNVMKIADFGLARDINNIDY------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259 (334)
T ss_dssp GGEEECTTCCEEECCCTTCEECTTTSS------EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ceEEEcCCCCEEEcccccccccccccc------ccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999987654321 111223357889999999988899999999999999999999 9999
Q ss_pred CCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 898 TDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 898 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
|.+.... + +....... ...... .....++.+++.+||+.||++|||+.|+++
T Consensus 260 ~~~~~~~-----~------------~~~~~~~~-~~~~~~----------~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 311 (334)
T 2pvf_A 260 YPGIPVE-----E------------LFKLLKEG-HRMDKP----------ANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311 (334)
T ss_dssp STTCCHH-----H------------HHHHHHHT-CCCCCC----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCcCCHH-----H------------HHHHHhcC-CCCCCC----------ccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 9753211 1 11111000 000000 112345889999999999999999999999
Q ss_pred HHHHHHHhh
Q 037275 978 KLCRARDTF 986 (992)
Q Consensus 978 ~L~~~~~~~ 986 (992)
.|+++....
T Consensus 312 ~L~~l~~~~ 320 (334)
T 2pvf_A 312 DLDRILTLT 320 (334)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHhcc
Confidence 999987654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=350.46 Aligned_cols=272 Identities=19% Similarity=0.260 Sum_probs=204.3
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhcc-CCcceeEEEEeecccccCcceEE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIR-HRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
++|++.++||+|+||+||+|++..+++.||||+++. ...+.+.+|+.++++++ ||||+++++++.. ......+
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~---~~~~~~~ 109 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKD---PVSRTPA 109 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCCEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeecc---CCCCceE
Confidence 579999999999999999999988999999999863 34577899999999997 9999999999754 2245679
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCC-cEEEeeccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDL-VAHLGDFGL 836 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~ 836 (992)
+||||+++++|.+++. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++ .+||+|||+
T Consensus 110 lv~e~~~~~~l~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~ 177 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQ---------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGL 177 (330)
T ss_dssp EEEECCCCCCHHHHGG---------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEeccCchhHHHHHH---------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCC
Confidence 9999999999999985 378889999999999999999999 999999999999999777 899999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 915 (992)
|+...... ......|++.|+|||++.+ ..++.++||||+||++|+|++|+.||.........+.......
T Consensus 178 a~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~ 248 (330)
T 3nsz_A 178 AEFYHPGQ---------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 248 (330)
T ss_dssp CEECCTTC---------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHH
T ss_pred ceEcCCCC---------ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhc
Confidence 98765322 1223468999999999877 6789999999999999999999999965433322222222222
Q ss_pred CChhHHHHHHhhHhH---hhh---ccCCCCCCc---cccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 916 LPDKVMEIVDSVLLL---EVQ---ASNSRSCGD---ERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 916 ~~~~~~~~~~~~~~~---~~~---~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
......+.++..... ... ......... ..........++.+++.+||+.||++|||++|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 249 GTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp CHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 222222222211000 000 000000000 00001113456899999999999999999999986
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=352.60 Aligned_cols=247 Identities=26% Similarity=0.358 Sum_probs=196.8
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCC---chhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKG---ASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
+.|+..+.||+|+||+||+|++..+++.||||++...... ..+.+.+|++++++++||||+++++++.. ...
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~ 128 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHT 128 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CCe
Confidence 4588899999999999999999889999999999754332 23568899999999999999999999643 456
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++||||+. |++.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 129 ~~lv~e~~~-g~l~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG 199 (348)
T 1u5q_A 129 AWLVMEYCL-GSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG 199 (348)
T ss_dssp EEEEEECCS-EEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCT
T ss_pred EEEEEecCC-CCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeecc
Confidence 799999996 68888886543 2589999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCccccccccccccccc---CCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHH
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGM---GGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFA 912 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~ 912 (992)
++...... ....||+.|+|||++. +..++.++|||||||++|||++|+.||.+....
T Consensus 200 ~a~~~~~~------------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~-------- 259 (348)
T 1u5q_A 200 SASIMAPA------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------- 259 (348)
T ss_dssp TCBSSSSB------------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------
T ss_pred CceecCCC------------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--------
Confidence 99765321 2346899999999874 567899999999999999999999998753211
Q ss_pred hhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 913 RTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
..+.......... . ........+.+++.+||+.||++|||++|+++.
T Consensus 260 ---------~~~~~~~~~~~~~-----~-----~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 260 ---------SALYHIAQNESPA-----L-----QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp ---------HHHHHHHHSCCCC-----C-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ---------HHHHHHHhcCCCC-----C-----CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0000011000000 0 001113457899999999999999999999753
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=358.67 Aligned_cols=273 Identities=14% Similarity=0.173 Sum_probs=206.5
Q ss_pred cCCCCCCccccccceEEEEeEECC--------CCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCccee----------
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGE--------NGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIK---------- 740 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------- 740 (992)
++|++.+.||+|+||+||+|++.. .++.||+|++... ..+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 589999999999999999999986 4889999998633 46889999999999999998
Q ss_pred -----EEEEeecccccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecc
Q 037275 741 -----IITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGD 815 (992)
Q Consensus 741 -----~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~D 815 (992)
+++++. ......++||||+ +++|.+++..... ..+++..++.++.|++.||+|||++ +|+|||
T Consensus 117 ~~i~~~~~~~~----~~~~~~~lv~e~~-~~~L~~~l~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~D 184 (352)
T 2jii_A 117 LAIPTCMGFGV----HQDKYRFLVLPSL-GRSLQSALDVSPK----HVLSERSVLQVACRLLDALEFLHEN---EYVHGN 184 (352)
T ss_dssp CSCCCCCEEEE----ETTTEEEEEEECC-CEEHHHHHHHSGG----GCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSC
T ss_pred cCccchhhccc----cCCcEEEEEecCC-CcCHHHHHHhCCc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCC
Confidence 444432 2356779999999 9999999986532 3699999999999999999999999 999999
Q ss_pred CCCCCeeeCCCC--cEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh
Q 037275 816 LKPSNVLLDQDL--VAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT 893 (992)
Q Consensus 816 lkp~NIll~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt 893 (992)
|||+||+++.++ .+||+|||+++........... .........||+.|+|||++.+..++.++|||||||++|||++
T Consensus 185 ikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 263 (352)
T 2jii_A 185 VTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAY-VEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLY 263 (352)
T ss_dssp CCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCC-CTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred CCHHHEEEcCCCCceEEEecCcceeeccCCCccccc-cccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHh
Confidence 999999999998 9999999999876543211111 1122234579999999999999999999999999999999999
Q ss_pred CCCCCCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHH
Q 037275 894 RRRPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMR 973 (992)
Q Consensus 894 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 973 (992)
|+.||.......... ........ ... ......+.. ......++.+++.+||+.||++|||++
T Consensus 264 g~~pf~~~~~~~~~~------------~~~~~~~~-~~~-~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ 325 (352)
T 2jii_A 264 GFLPWTNCLPNTEDI------------MKQKQKFV-DKP-GPFVGPCGH----WIRPSETLQKYLKVVMALTYEEKPPYA 325 (352)
T ss_dssp SCCTTGGGTTCHHHH------------HHHHHHHH-HSC-CCEECTTSC----EECCCHHHHHHHHHHHTCCTTCCCCHH
T ss_pred CCCCcccCCcCHHHH------------HHHHHhcc-CCh-hhhhhhccc----cCCCcHHHHHHHHHHHhCChhhCCCHH
Confidence 999997643221111 11110000 000 000000000 001135689999999999999999999
Q ss_pred HHHHHHHHHHHhhh
Q 037275 974 DVVAKLCRARDTFL 987 (992)
Q Consensus 974 evl~~L~~~~~~~~ 987 (992)
||++.|+++.+...
T Consensus 326 ~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 326 MLRNNLEALLQDLR 339 (352)
T ss_dssp HHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHhcC
Confidence 99999999987653
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=343.91 Aligned_cols=251 Identities=25% Similarity=0.379 Sum_probs=199.1
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC--CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
.|++.+.||+|+||+||+|.+..++..||+|++.... ....+.+.+|+.++++++||||+++++++... ..+....+
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~~~~ 105 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCIV 105 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE-SSSCEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccc-cCCCceEE
Confidence 4778889999999999999999999999999987443 23346789999999999999999999987542 23456789
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeccCCCCCeeeC-CCCcEEEeec
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPP--VVHGDLKPSNVLLD-QDLVAHLGDF 834 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~kl~Df 834 (992)
+||||+++|+|.+++.... .+++..++.++.|++.||+|||+. + |+||||||+||+++ .++.+||+||
T Consensus 106 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Df 176 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDL 176 (290)
T ss_dssp EEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred EEEEecCCCCHHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeC
Confidence 9999999999999997543 589999999999999999999999 7 99999999999997 7899999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
|++...... ......||+.|+|||++. +.++.++||||+||++|+|++|+.||................
T Consensus 177 g~~~~~~~~----------~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 245 (290)
T 1t4h_A 177 GLATLKRAS----------FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG 245 (290)
T ss_dssp TGGGGCCTT----------SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT
T ss_pred CCccccccc----------ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhcc
Confidence 999754322 122346899999999876 458999999999999999999999997532221111110000
Q ss_pred hCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 915 ALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
..+. ........++.+++.+||+.||++|||++|+++
T Consensus 246 ~~~~--------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 246 VKPA--------------------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CCCG--------------------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCcc--------------------------ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 0000 000011245889999999999999999999985
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=369.42 Aligned_cols=254 Identities=25% Similarity=0.347 Sum_probs=204.7
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc---CCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK---QKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
.++|++.++||+|+||.||+|++..+|+.||+|++... .......+.+|+.++++++||||+++++++. ...
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-----~~~ 257 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE-----TKD 257 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEe-----eCC
Confidence 45799999999999999999999989999999999643 2344567889999999999999999999854 456
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
..++||||+++|+|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~~----~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DF 330 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMGQ----AGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDL 330 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEEEcCCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEec
Confidence 77999999999999999976542 2489999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
|+|+...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+...... ...
T Consensus 331 Gla~~~~~~~---------~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~-~~~---- 396 (576)
T 2acx_A 331 GLAVHVPEGQ---------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-REE---- 396 (576)
T ss_dssp TTCEECCTTC---------CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC-HHH----
T ss_pred ccceecccCc---------cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh-HHH----
Confidence 9998765321 12234799999999999999999999999999999999999999986432211 111
Q ss_pred hCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 037275 915 ALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERM-----EMRDVVA 977 (992)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 977 (992)
+...+ .. .... .+ .....++.+++.+||+.||++|| +++||++
T Consensus 397 -----i~~~i---~~--~~~~----~p------~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 397 -----VERLV---KE--VPEE----YS------ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp -----HHHHH---HH--CCCC----CC------TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred -----HHHHh---hc--cccc----CC------ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 11111 00 0000 00 11234588999999999999999 7888875
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=359.75 Aligned_cols=272 Identities=21% Similarity=0.267 Sum_probs=208.1
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
.++|++.++||+|+||.||+|++..+++.||||++.... ....+.+|+++++.++|++.+..+.++. ......+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~----~~~~~~~ 79 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFG----VEGDYNV 79 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEE----EETTEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEE----eeCCEEE
Confidence 368999999999999999999998899999999986443 2345889999999998755554444432 2345669
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeee---CCCCcEEEeec
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLL---DQDLVAHLGDF 834 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Df 834 (992)
+||||+ +++|.+++..... .+++..++.|+.||+.||+|||++ +|+||||||+|||+ +.++.+||+||
T Consensus 80 lvme~~-g~sL~~ll~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DF 150 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFCSR-----KLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDF 150 (483)
T ss_dssp EEEECC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCC
T ss_pred EEEECC-CCCHHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeC
Confidence 999999 9999999985432 489999999999999999999999 99999999999999 58899999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
|+++.+......... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.+...... .+...
T Consensus 151 Gla~~~~~~~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~--~~~~~- 226 (483)
T 3sv0_A 151 GLAKKYRDTSTHQHI-PYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK--KQKYE- 226 (483)
T ss_dssp TTCEECBCTTTCCBC-CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSH--HHHHH-
T ss_pred CcceeccCCcccccc-ccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhH--HHHHH-
Confidence 999987653321111 11223356799999999999999999999999999999999999999987533211 11110
Q ss_pred hCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 037275 915 ALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTF 986 (992)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 986 (992)
.+........... .......++.+++..||+.||++||++++|++.|+++....
T Consensus 227 -------~i~~~~~~~~~~~-----------l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 227 -------KISEKKVATSIEA-----------LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp -------HHHHHHHHSCHHH-----------HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -------HHhhccccccHHH-----------HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 0111000000000 00011346899999999999999999999999999987644
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=346.69 Aligned_cols=282 Identities=22% Similarity=0.318 Sum_probs=214.2
Q ss_pred cHHHHHHHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHh--ccCCcceeEEEEeec
Q 037275 670 SYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRN--IRHRNLIKIITICSS 747 (992)
Q Consensus 670 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~ 747 (992)
+...-....++|++.+.||+|+||+||+|++ +++.||||++... ....+.+|+++++. ++||||+++++++..
T Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred ceeecccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 3333445567899999999999999999998 5899999998533 34567889999888 789999999999754
Q ss_pred ccccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEeccCCCC
Q 037275 748 IDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIH--------HHCQPPVVHGDLKPS 819 (992)
Q Consensus 748 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH--------~~~~~~ivH~Dlkp~ 819 (992)
.. ......++||||+++|+|.+++... .+++..++.++.|++.||+||| +. +|+||||||+
T Consensus 108 ~~-~~~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~ 176 (342)
T 1b6c_B 108 DN-GTWTQLWLVSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSK 176 (342)
T ss_dssp CC-SSCCCEEEEECCCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGG
T ss_pred cC-CccceeEEEEeecCCCcHHHHHhcc-------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHH
Confidence 32 1123679999999999999999753 4899999999999999999999 77 9999999999
Q ss_pred CeeeCCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCC------CcCcccchhhHHHHHHHHHh
Q 037275 820 NVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG------EASMTGDVYSFGILLLEMFT 893 (992)
Q Consensus 820 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~il~ellt 893 (992)
||+++.++.+||+|||++.......... ........||+.|+|||++.+. .++.++|||||||++|||++
T Consensus 177 NIll~~~~~~kL~Dfg~~~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~t 252 (342)
T 1b6c_B 177 NILVKKNGTCCIADLGLAVRHDSATDTI----DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR 252 (342)
T ss_dssp GEEECTTSCEEECCCTTCEEEETTTTEE----EECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HEEECCCCCEEEEECCCceecccccccc----ccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHh
Confidence 9999999999999999998765432110 0122345699999999998765 34478999999999999999
Q ss_pred C----------CCCCCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccC
Q 037275 894 R----------RRPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSM 963 (992)
Q Consensus 894 g----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 963 (992)
| +.||............+...... . ..+..........+....+.+++.+||+
T Consensus 253 g~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~------------~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~ 315 (342)
T 1b6c_B 253 RCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCE------------Q-----KLRPNIPNRWQSCEALRVMAKIMRECWY 315 (342)
T ss_dssp TBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTT------------S-----CCCCCCCGGGGTSHHHHHHHHHHHHHCC
T ss_pred ccCcCCcccccccCccccCcCcccHHHHHHHHHH------------H-----HhCCCCcccccchhHHHHHHHHHHHHhc
Confidence 9 67776543332222222111100 0 0011111112234566789999999999
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhhh
Q 037275 964 ESPTERMEMRDVVAKLCRARDTFLG 988 (992)
Q Consensus 964 ~dP~~RPs~~evl~~L~~~~~~~~~ 988 (992)
.||++|||+.||++.|+++.++..-
T Consensus 316 ~dp~~Rps~~~i~~~L~~i~~~~~~ 340 (342)
T 1b6c_B 316 ANGAARLTALRIKKTLSQLSQQEGI 340 (342)
T ss_dssp SSGGGSCCHHHHHHHHHHHHHTTC-
T ss_pred cChhhCCCHHHHHHHHHHHHHHhcC
Confidence 9999999999999999999876543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=341.11 Aligned_cols=251 Identities=23% Similarity=0.415 Sum_probs=183.2
Q ss_pred HhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCc
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 753 (992)
..++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.++++++||||+++++++. ..
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 83 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE-----DS 83 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEE-----CS
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEc-----cC
Confidence 3568999999999999999999998899999999996432 234567899999999999999999999964 34
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGD 833 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 833 (992)
...++||||+++++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~d 155 (278)
T 3cok_A 84 NYVYLVLEMCHNGEMNRYLKNRV-----KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIAD 155 (278)
T ss_dssp SEEEEEEECCTTEEHHHHHHTCS-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECC
T ss_pred CeEEEEEecCCCCcHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEe
Confidence 56799999999999999998643 2589999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 913 (992)
||.+....... .......||+.|+|||++.+..++.++||||+|+++|||++|+.||........ ...
T Consensus 156 fg~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~--- 223 (278)
T 3cok_A 156 FGLATQLKMPH--------EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-LNK--- 223 (278)
T ss_dssp CTTCEECC------------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------
T ss_pred ecceeeccCCC--------CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-HHH---
Confidence 99998764321 111234689999999999988999999999999999999999999976422210 000
Q ss_pred hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 914 TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
. ....+ ..+ .....++.+++.+||+.||++|||++|+++
T Consensus 224 -~------------~~~~~------~~~------~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 224 -V------------VLADY------EMP------SFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp -C------------CSSCC------CCC------TTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -H------------hhccc------CCc------cccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 0 00000 000 011345789999999999999999999986
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=343.15 Aligned_cols=282 Identities=22% Similarity=0.339 Sum_probs=207.6
Q ss_pred HHHHHHHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhc--cCCcceeEEEEeecc
Q 037275 671 YAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNI--RHRNLIKIITICSSI 748 (992)
Q Consensus 671 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~ 748 (992)
........++|++.+.||+|+||.||+|++. ++.||||++... ......+|.+++... +||||+++++++...
T Consensus 29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 103 (337)
T 3mdy_A 29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKG 103 (337)
T ss_dssp HHHHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred cccccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence 3334445678999999999999999999984 899999998533 234455666666555 899999999987653
Q ss_pred cccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEeccCCCCCeee
Q 037275 749 DFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHC-----QPPVVHGDLKPSNVLL 823 (992)
Q Consensus 749 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-----~~~ivH~Dlkp~NIll 823 (992)
. ......++||||+++|+|.++++.. .+++..++.++.|++.||+|||++. .++|+||||||+||++
T Consensus 104 ~-~~~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill 175 (337)
T 3mdy_A 104 T-GSWTQLYLITDYHENGSLYDYLKST-------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV 175 (337)
T ss_dssp C-GGGCEEEEEECCCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE
T ss_pred C-CCCCceEEEEeccCCCcHHHHhhcc-------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE
Confidence 2 2235679999999999999999643 4899999999999999999999761 3389999999999999
Q ss_pred CCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcc------cchhhHHHHHHHHHhC---
Q 037275 824 DQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMT------GDVYSFGILLLEMFTR--- 894 (992)
Q Consensus 824 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~------~DiwSlG~il~elltg--- 894 (992)
+.++.+||+|||+++......... ........||+.|+|||++.+..++.+ +|||||||++|||++|
T Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~ 251 (337)
T 3mdy_A 176 KKNGTCCIADLGLAVKFISDTNEV----DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVS 251 (337)
T ss_dssp CTTSCEEECCCTTCEECC-------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCB
T ss_pred CCCCCEEEEeCCCceeeccccccc----cCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCc
Confidence 999999999999998765432111 111234569999999999887766655 9999999999999999
Q ss_pred -------CCCCCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCC
Q 037275 895 -------RRPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPT 967 (992)
Q Consensus 895 -------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 967 (992)
+.||................ . .....+..........+...++.+++.+||+.||+
T Consensus 252 ~~~~~~~~~p~~~~~~~~~~~~~~~~~---------~--------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~ 314 (337)
T 3mdy_A 252 GGIVEEYQLPYHDLVPSDPSYEDMREI---------V--------CIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPA 314 (337)
T ss_dssp TTBCCCCCCTTTTTSCSSCCHHHHHHH---------H--------TTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGG
T ss_pred ccccccccccHhhhcCCCCchhhhHHH---------H--------hhhccCccccccchhhHHHHHHHHHHHHhhhhChh
Confidence 44544432222211111110 0 00011111112222346677899999999999999
Q ss_pred CCCCHHHHHHHHHHHHHhh
Q 037275 968 ERMEMRDVVAKLCRARDTF 986 (992)
Q Consensus 968 ~RPs~~evl~~L~~~~~~~ 986 (992)
+|||++||++.|+++.+..
T Consensus 315 ~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 315 SRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp GSCCHHHHHHHHHHHHHTT
T ss_pred hCCCHHHHHHHHHHHHhhc
Confidence 9999999999999998764
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=368.37 Aligned_cols=249 Identities=24% Similarity=0.316 Sum_probs=193.0
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc---CCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK---QKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
.++|++.++||+|+||.||+|++..+|+.||||+++.. .......+.+|+.+++.++||||+++++++. ...
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~-----~~~ 221 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ-----THD 221 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEE-----ETT
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEe-----eCC
Confidence 46799999999999999999999999999999999743 3334566788999999999999999999964 345
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCCCCCeeeCCCCcEEEee
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHH-HCQPPVVHGDLKPSNVLLDQDLVAHLGD 833 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~D 833 (992)
..++||||+++|+|.+++.... .+++..+..++.|++.||+|||+ + +|+||||||+||+++.++.+||+|
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~D 292 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSRER------VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITD 292 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECC
T ss_pred EEEEEEeeCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEcc
Confidence 6799999999999999997543 58999999999999999999998 7 999999999999999999999999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 913 (992)
||+|+..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.+....
T Consensus 293 FG~a~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--------- 355 (446)
T 4ejn_A 293 FGLCKEGIKD--------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------- 355 (446)
T ss_dssp CCCCCTTCC-------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---------
T ss_pred CCCceeccCC--------CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---------
Confidence 9999753321 11223457999999999999999999999999999999999999999753211
Q ss_pred hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 037275 914 TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERM-----EMRDVVA 977 (992)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 977 (992)
............ .+ .....++.+++.+||+.||++|| |++|+++
T Consensus 356 --------~~~~~i~~~~~~------~p------~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 356 --------KLFELILMEEIR------FP------RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp --------HHHHHHHHCCCC------CC------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --------HHHHHHHhCCCC------CC------ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 111111111110 00 01134588999999999999999 9999975
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=350.95 Aligned_cols=263 Identities=25% Similarity=0.425 Sum_probs=199.4
Q ss_pred cCCCCCCccccccceEEEEeEECCC----CeEEEEEEeeccCC-CchhHHHHHHHHHHhccCCcceeEEEEeecccccCc
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGEN----GMMVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 753 (992)
.+|++.+.||+|+||+||+|.+..+ +..||||+++.... .....+.+|+.++++++||||+++++++. ..
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~ 118 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS-----KY 118 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SS
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe-----cC
Confidence 3567789999999999999987543 34699999964432 23456889999999999999999999964 34
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGD 833 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 833 (992)
...++||||+++|+|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~D 190 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREKDG-----EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSD 190 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTT-----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECC
T ss_pred CCcEEEEeCCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECC
Confidence 567999999999999999976432 489999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHH
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFA 912 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~ 912 (992)
||.++........ ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+....
T Consensus 191 fg~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-------- 257 (333)
T 1mqb_A 191 FGLSRVLEDDPEA-----TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-------- 257 (333)
T ss_dssp CCC----------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------
T ss_pred CCcchhhcccccc-----ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH--------
Confidence 9999876543211 111222346789999999999999999999999999999999 99999653211
Q ss_pred hhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhh
Q 037275 913 RTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTFL 987 (992)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 987 (992)
+........ .... ........+.+++.+||+.||++||++.|+++.|+++.+...
T Consensus 258 ---------~~~~~~~~~-~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 258 ---------EVMKAINDG-FRLP----------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp ---------HHHHHHHTT-CCCC----------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred ---------HHHHHHHCC-CcCC----------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 111111000 0000 001123458899999999999999999999999999876543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=341.65 Aligned_cols=248 Identities=23% Similarity=0.371 Sum_probs=199.5
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
.++|++.+.||+|+||+||+|++..+++.||+|++.... ......+.+|+.++++++||||+++++++. ...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 82 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----DAT 82 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe-----cCC
Confidence 468999999999999999999999999999999986432 233567889999999999999999999964 345
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
..++||||+++|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~------~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Df 153 (279)
T 3fdn_A 83 RVYLILEYAPLGTVYRELQKLS------KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADF 153 (279)
T ss_dssp EEEEEECCCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSC
T ss_pred EEEEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEec
Confidence 6799999999999999997643 489999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
|++...... ......|++.|+|||++.+..++.++||||+|+++|+|++|+.||......
T Consensus 154 g~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---------- 213 (279)
T 3fdn_A 154 GWSVHAPSS----------RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ---------- 213 (279)
T ss_dssp CEESCC------------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH----------
T ss_pred cccccCCcc----------cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH----------
Confidence 998654322 122346899999999999999999999999999999999999999753211
Q ss_pred hCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 915 ALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
+.......... . .+ ......+.+++.+||+.||++|||++|+++.
T Consensus 214 -------~~~~~~~~~~~--~----~~------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 214 -------ETYKRISRVEF--T----FP------DFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp -------HHHHHHHHTCC--C----CC------TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred -------HHHHHHHhCCC--C----CC------CcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 01111100000 0 00 0113457899999999999999999999864
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=342.61 Aligned_cols=265 Identities=21% Similarity=0.354 Sum_probs=208.7
Q ss_pred cCCCCCC-ccccccceEEEEeEEC--CCCeEEEEEEeeccCC-CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcc
Q 037275 679 NDFSSSN-MIGQGSFGFVYKGNLG--ENGMMVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 679 ~~~~~~~-~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
++|.+.+ .||+|+||.||+|.+. .++..||||+++.... ...+.+.+|++++++++||||+++++++. ..
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~ 82 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ------AE 82 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE------SS
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec------CC
Confidence 4566666 9999999999999863 4678899999975432 34567899999999999999999999963 23
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
..++||||+++++|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Df 154 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKRE-----EIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDF 154 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTT-----TSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCC
T ss_pred CcEEEEEeCCCCCHHHHHHhCCc-----cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcc
Confidence 46999999999999999975432 489999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 913 (992)
|++........ .........+|+.|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 155 g~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--------- 220 (287)
T 1u59_A 155 GLSKALGADDS-----YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--------- 220 (287)
T ss_dssp TTCEECTTCSC-----EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---------
T ss_pred cceeeeccCcc-----eeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---------
Confidence 99987754321 1111223357899999999988889999999999999999998 99999763221
Q ss_pred hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhhcc
Q 037275 914 TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTFLGRM 990 (992)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~ 990 (992)
.....+.. ... . .. ......++.+++.+||+.||++|||+.|+++.|+++..+.....
T Consensus 221 -----~~~~~i~~---~~~-~----~~------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 278 (287)
T 1u59_A 221 -----EVMAFIEQ---GKR-M----EC------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 278 (287)
T ss_dssp -----HHHHHHHT---TCC-C----CC------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred -----HHHHHHhc---CCc-C----CC------CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcc
Confidence 01111110 000 0 00 01123468899999999999999999999999999988776543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=341.66 Aligned_cols=255 Identities=30% Similarity=0.393 Sum_probs=199.3
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
.++|++.+.||+|+||+||+|++ +|+.||||+++.. ...+.+.+|+.++++++||||+++++++.. .....+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~~ 91 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLY 91 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECC----C--CCE
T ss_pred hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEc----CCCceE
Confidence 46899999999999999999998 4889999998633 355778999999999999999999998643 334569
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||+++|+|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 92 lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~ 164 (278)
T 1byg_A 92 IVTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLT 164 (278)
T ss_dssp EEECCCTTEEHHHHHHHHHH----HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred EEEecCCCCCHHHHHHhccc----ccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccc
Confidence 99999999999999976532 2488999999999999999999999 9999999999999999999999999998
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhhhC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFARTAL 916 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 916 (992)
....... ....+++.|+|||++.+..++.++||||||+++|||++ |+.||....... ..
T Consensus 165 ~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~~------- 224 (278)
T 1byg_A 165 KEASSTQ-----------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VV------- 224 (278)
T ss_dssp ----------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--HH-------
T ss_pred ccccccc-----------cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--HH-------
Confidence 7544221 12246889999999988899999999999999999998 999997532210 00
Q ss_pred ChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 037275 917 PDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTF 986 (992)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 986 (992)
..+.. ...... .......+.+++.+||+.||++|||+.|+++.|++++...
T Consensus 225 -----~~~~~----~~~~~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 225 -----PRVEK----GYKMDA----------PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp -----HHHTT----TCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -----HHHhc----CCCCCC----------cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 00000 000000 0112346889999999999999999999999999997654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=348.75 Aligned_cols=265 Identities=20% Similarity=0.258 Sum_probs=198.1
Q ss_pred HHHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCC---chhHHHHHHHHHHhccCCcceeEEEEeeccccc
Q 037275 675 SKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKG---ASNGFVAECQALRNIRHRNLIKIITICSSIDFK 751 (992)
Q Consensus 675 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 751 (992)
....++|++.+.||+|+||.||+|++..+++.||+|++...... ..+.+.+|+.++++++||||+++++++..
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~---- 105 (309)
T 2h34_A 30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI---- 105 (309)
T ss_dssp ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE----
T ss_pred CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee----
Confidence 34467899999999999999999999889999999999644322 23678899999999999999999999643
Q ss_pred CcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEE
Q 037275 752 GVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHL 831 (992)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 831 (992)
....++||||+++++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||
T Consensus 106 -~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl 175 (309)
T 2h34_A 106 -DGQLYVDMRLINGVDLAAMLRRQG------PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYL 175 (309)
T ss_dssp -TTEEEEEEECCCCEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEE
T ss_pred -CCeEEEEEEecCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEE
Confidence 456799999999999999997543 489999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHH
Q 037275 832 GDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEF 911 (992)
Q Consensus 832 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~ 911 (992)
+|||++....... ........|++.|+|||++.+..++.++||||||+++|||++|+.||.+.... .....
T Consensus 176 ~Dfg~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~ 246 (309)
T 2h34_A 176 VDFGIASATTDEK-------LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAH 246 (309)
T ss_dssp CSCCC-----------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHH
T ss_pred ecCccCccccccc-------cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHH
Confidence 9999997654321 11122346899999999999999999999999999999999999999753211 00000
Q ss_pred HhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHHHHHhh
Q 037275 912 ARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERM-EMRDVVAKLCRARDTF 986 (992)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~~~ 986 (992)
.....+. ..........++.+++.+||+.||++|| |++++++.|+++.+..
T Consensus 247 ~~~~~~~------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 247 INQAIPR------------------------PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp HHSCCCC------------------------GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred hccCCCC------------------------ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 0000000 0000011234588999999999999999 9999999998876543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=338.64 Aligned_cols=257 Identities=23% Similarity=0.320 Sum_probs=202.1
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC------CchhHHHHHHHHHHhccCCcceeEEEEeecccccC
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK------GASNGFVAECQALRNIRHRNLIKIITICSSIDFKG 752 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 752 (992)
++|++.+.||+|+||.||+|++..+++.||+|+++.... ...+.+.+|+.++++++||||+++++++. .
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~ 79 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFE-----N 79 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheec-----C
Confidence 478999999999999999999998999999999874432 13567899999999999999999999964 3
Q ss_pred cceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCC----c
Q 037275 753 VDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDL----V 828 (992)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~ 828 (992)
....++||||+++++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++ .
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~ 150 (283)
T 3bhy_A 80 KTDVVLILELVSGGELFDFLAEKE------SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPR 150 (283)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCC
T ss_pred CCeEEEEEeecCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCc
Confidence 456799999999999999997533 589999999999999999999999 999999999999998877 8
Q ss_pred EEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccH
Q 037275 829 AHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTL 908 (992)
Q Consensus 829 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~ 908 (992)
+||+|||.+....... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||.+..... ..
T Consensus 151 ~kl~dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~ 220 (283)
T 3bhy_A 151 IKLIDFGIAHKIEAGN---------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE-TL 220 (283)
T ss_dssp EEECCCTTCEECC-----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HH
T ss_pred eEEEecccceeccCCC---------cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH-HH
Confidence 9999999998764321 1223458999999999999999999999999999999999999997632110 00
Q ss_pred HHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHHHH
Q 037275 909 HEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA--KLCRAR 983 (992)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~ 983 (992)
.......... . ..........+.+++.+||+.||++|||+.|+++ .++.++
T Consensus 221 ~~~~~~~~~~-~-----------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 221 TNISAVNYDF-D-----------------------EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp HHHHTTCCCC-C-----------------------HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred HHhHhcccCC-c-----------------------chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 0000000000 0 0000112345889999999999999999999997 344443
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=349.33 Aligned_cols=271 Identities=20% Similarity=0.261 Sum_probs=195.2
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhcc-CCcceeEEEEeeccc---ccCc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIR-HRNLIKIITICSSID---FKGV 753 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~---~~~~ 753 (992)
..+|++.++||+|+||.||+|++..+++.||||++........+.+.+|+.+++++. ||||+++++++.... ....
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 357999999999999999999999899999999987665555677899999999996 999999999975322 2445
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeccCCCCCeeeCCCCcEEE
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPP--VVHGDLKPSNVLLDQDLVAHL 831 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl 831 (992)
...++||||+. |+|.+++..... ...+++..++.++.|++.||+|||++ + |+||||||+||+++.++.+||
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl 179 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMES---RGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKL 179 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHT---TCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEB
T ss_pred ceEEEEEEecC-CCHHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEE
Confidence 66899999995 799999876432 23589999999999999999999999 8 999999999999999999999
Q ss_pred eecccceecCCCCCCCCcc----cCCCCCcccccccccccccc---cCCCcCcccchhhHHHHHHHHHhCCCCCCCCccC
Q 037275 832 GDFGLAKFLSSSPLDTAVE----TPSSSKGIKGTVGYIAPEYG---MGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQ 904 (992)
Q Consensus 832 ~Dfg~a~~~~~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~ 904 (992)
+|||+++............ .........||+.|+|||++ .+..++.++|||||||++|+|++|+.||......
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~ 259 (337)
T 3ll6_A 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL 259 (337)
T ss_dssp CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence 9999998765432111000 00111234689999999998 5667899999999999999999999999653211
Q ss_pred CccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 037275 905 GLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARD 984 (992)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 984 (992)
. .... ......... ....+.+++.+||+.||++|||++|+++.|+++..
T Consensus 260 ~-----------------~~~~----~~~~~~~~~----------~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 260 R-----------------IVNG----KYSIPPHDT----------QYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp ---------------------------CCCCTTCC----------SSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H-----------------hhcC----cccCCcccc----------cchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0 0000 000000000 11237789999999999999999999999999876
Q ss_pred hh
Q 037275 985 TF 986 (992)
Q Consensus 985 ~~ 986 (992)
..
T Consensus 309 ~~ 310 (337)
T 3ll6_A 309 AR 310 (337)
T ss_dssp HT
T ss_pred cc
Confidence 54
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=359.52 Aligned_cols=200 Identities=23% Similarity=0.311 Sum_probs=171.9
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhc------cCCcceeEEEEeeccccc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNI------RHRNLIKIITICSSIDFK 751 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~~~~~~ 751 (992)
..+|++.++||+|+||+||+|.+..+++.||||+++.. ......+.+|+.+++.+ +|+||+++++++..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~---- 170 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF---- 170 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE----
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc----
Confidence 45799999999999999999999989999999999632 22345678899888887 57799999998643
Q ss_pred CcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCc--E
Q 037275 752 GVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLV--A 829 (992)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~ 829 (992)
....++||||+. ++|.+++..... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++. +
T Consensus 171 -~~~~~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~v 241 (429)
T 3kvw_A 171 -RNHICMTFELLS-MNLYELIKKNKF----QGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGI 241 (429)
T ss_dssp -TTEEEEEECCCC-CBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCE
T ss_pred -CCeEEEEEeccC-CCHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcce
Confidence 456799999995 699999986543 2589999999999999999999999 9999999999999999987 9
Q ss_pred EEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCc
Q 037275 830 HLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMF 902 (992)
Q Consensus 830 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 902 (992)
||+|||+|+..... .....||+.|+|||++.+..++.++|||||||++|||++|++||.+..
T Consensus 242 kL~DFG~a~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 242 KVIDFGSSCYEHQR-----------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp EECCCTTCEETTCC-----------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEeecccceecCCc-----------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 99999999765432 123468999999999999999999999999999999999999998753
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=350.83 Aligned_cols=276 Identities=23% Similarity=0.333 Sum_probs=195.3
Q ss_pred HHHHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC-----CchhHHHHHHHHHHhccCCcceeEEEEeecc
Q 037275 674 LSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK-----GASNGFVAECQALRNIRHRNLIKIITICSSI 748 (992)
Q Consensus 674 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 748 (992)
+....++|++.+.||+|+||.||+|++..+|+.||||++..... ...+.+.+|+.++++++||||+++++++.
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-- 82 (346)
T 1ua2_A 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG-- 82 (346)
T ss_dssp --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEe--
Confidence 34456789999999999999999999988999999999964322 12356889999999999999999999964
Q ss_pred cccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCc
Q 037275 749 DFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLV 828 (992)
Q Consensus 749 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 828 (992)
.....++||||+++ +|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.
T Consensus 83 ---~~~~~~lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~ 150 (346)
T 1ua2_A 83 ---HKSNISLVFDFMET-DLEVIIKDNSL-----VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGV 150 (346)
T ss_dssp ---CTTCCEEEEECCSE-EHHHHHTTCCS-----SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCC
T ss_pred ---eCCceEEEEEcCCC-CHHHHHHhcCc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCC
Confidence 34556999999976 89998876432 488889999999999999999999 9999999999999999999
Q ss_pred EEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCCCccCCcc
Q 037275 829 AHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLT 907 (992)
Q Consensus 829 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~ 907 (992)
+||+|||+++...... .......||+.|+|||++.+. .++.++|||||||++|||++|.+||.+..... .
T Consensus 151 ~kl~Dfg~a~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~-~ 221 (346)
T 1ua2_A 151 LKLADFGLAKSFGSPN--------RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-Q 221 (346)
T ss_dssp EEECCCGGGSTTTSCC--------CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-H
T ss_pred EEEEecccceeccCCc--------ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-H
Confidence 9999999998654321 122334689999999998764 58899999999999999999999987642211 1
Q ss_pred HHHHHhhh-CC--hhHHHHHHhhHhHhhhccCCCCCCccc--cchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 908 LHEFARTA-LP--DKVMEIVDSVLLLEVQASNSRSCGDER--LRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 908 ~~~~~~~~-~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
+....... .+ +.+.+... ..++ .......... ........++.+++.+||+.||++|||++|+++
T Consensus 222 ~~~i~~~~~~~~~~~~~~~~~---~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 222 LTRIFETLGTPTEEQWPDMCS---LPDY--VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp HHHHHHHHCCCCTTTSSSTTS---STTC--CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred HHHHHHHcCCCChhhhhhhcc---Cccc--ccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 11111100 00 00000000 0000 0000000000 000122356899999999999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=352.70 Aligned_cols=278 Identities=22% Similarity=0.347 Sum_probs=200.8
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCc--hhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGA--SNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
.++|++.+.||+|+||.||+|++..+++.||||++....... .+.+.+|+.++++++||||+++++++. ....
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~ 98 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK-----KKKR 98 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee-----cCCE
Confidence 458999999999999999999999899999999986443322 355789999999999999999999964 3456
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++||||+++++|.++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 99 ~~lv~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg 169 (331)
T 4aaa_A 99 WYLVFEFVDHTILDDLELFPN------GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFG 169 (331)
T ss_dssp EEEEEECCSEEHHHHHHHSTT------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCT
T ss_pred EEEEEecCCcchHHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCC
Confidence 799999999999988866433 489999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
.++...... .......||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+...... .......
T Consensus 170 ~~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~ 240 (331)
T 4aaa_A 170 FARTLAAPG--------EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ-LYHIMMC 240 (331)
T ss_dssp TC--------------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHH
T ss_pred CceeecCCc--------cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHH
Confidence 998654321 112234689999999998775 789999999999999999999999986433211 1111111
Q ss_pred --hCChhHHHHHHhhHh-HhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 915 --ALPDKVMEIVDSVLL-LEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 915 --~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
............... ........................+.+++.+||+.||++|||++|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 241 LGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp HCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 111111111111100 0000000000000000011234668999999999999999999999863
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=343.32 Aligned_cols=264 Identities=25% Similarity=0.356 Sum_probs=206.0
Q ss_pred HhcCCCCCC-ccccccceEEEEeEE--CCCCeEEEEEEeeccCC--CchhHHHHHHHHHHhccCCcceeEEEEeeccccc
Q 037275 677 ATNDFSSSN-MIGQGSFGFVYKGNL--GENGMMVAVKVINLKQK--GASNGFVAECQALRNIRHRNLIKIITICSSIDFK 751 (992)
Q Consensus 677 ~~~~~~~~~-~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 751 (992)
..++|++.+ .||+|+||+||+|.+ ..+++.||||+++.... ...+.+.+|+.+++.++||||+++++++.
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----- 88 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE----- 88 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC-----
Confidence 345788888 999999999999954 55678999999974432 23567899999999999999999999862
Q ss_pred CcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEE
Q 037275 752 GVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHL 831 (992)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 831 (992)
....++||||+++++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||
T Consensus 89 -~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl 158 (291)
T 1xbb_A 89 -AESWMLVMEMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKI 158 (291)
T ss_dssp -SSSEEEEEECCTTEEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEE
T ss_pred -CCCcEEEEEeCCCCCHHHHHHhCc------CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEE
Confidence 234689999999999999997643 489999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHH
Q 037275 832 GDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHE 910 (992)
Q Consensus 832 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~ 910 (992)
+|||++......... ........+++.|+|||++.+..++.++||||||+++|+|++ |+.||.+.... +
T Consensus 159 ~Dfg~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~ 228 (291)
T 1xbb_A 159 SDFGLSKALRADENY-----YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-----E 228 (291)
T ss_dssp CCCTTCEECCTTCSE-----EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----H
T ss_pred ccCCcceeeccCCCc-----ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH-----H
Confidence 999999876543211 111122346789999999988889999999999999999999 99999763211 0
Q ss_pred HHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhh
Q 037275 911 FARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTFLG 988 (992)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 988 (992)
....+.. ... ...+ ......+.+++.+||+.||++|||+.|+++.|+++.....+
T Consensus 229 ---------~~~~~~~---~~~-----~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 283 (291)
T 1xbb_A 229 ---------VTAMLEK---GER-----MGCP------AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 283 (291)
T ss_dssp ---------HHHHHHT---TCC-----CCCC------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHH
T ss_pred ---------HHHHHHc---CCC-----CCCC------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhh
Confidence 1111110 000 0000 11234688999999999999999999999999998876654
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=348.33 Aligned_cols=259 Identities=22% Similarity=0.366 Sum_probs=203.8
Q ss_pred HHHHHHHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCC--------chhHHHHHHHHHHhc-cCCcceeE
Q 037275 671 YAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKG--------ASNGFVAECQALRNI-RHRNLIKI 741 (992)
Q Consensus 671 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l-~h~niv~~ 741 (992)
+.......++|++.+.||+|+||.||+|++..+|+.||||+++..... ..+.+.+|+.+++++ +||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 334455667899999999999999999999888999999999754321 134678899999999 79999999
Q ss_pred EEEeecccccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCe
Q 037275 742 ITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNV 821 (992)
Q Consensus 742 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NI 821 (992)
++++. .....++||||+++++|.+++.... .+++..+..++.|++.||+|||+. ||+||||||+||
T Consensus 166 ~~~~~-----~~~~~~lv~e~~~g~~L~~~l~~~~------~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NI 231 (365)
T 2y7j_A 166 IDSYE-----SSSFMFLVFDLMRKGELFDYLTEKV------ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENI 231 (365)
T ss_dssp EEEEE-----BSSEEEEEECCCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred EEEEe-----eCCEEEEEEEeCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHE
Confidence 99864 3456799999999999999997542 589999999999999999999999 999999999999
Q ss_pred eeCCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccC------CCcCcccchhhHHHHHHHHHhCC
Q 037275 822 LLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG------GEASMTGDVYSFGILLLEMFTRR 895 (992)
Q Consensus 822 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwSlG~il~elltg~ 895 (992)
+++.++.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+
T Consensus 232 l~~~~~~ikl~DfG~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~ 302 (365)
T 2y7j_A 232 LLDDNMQIRLSDFGFSCHLEPGE---------KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGS 302 (365)
T ss_dssp EECTTCCEEECCCTTCEECCTTC---------CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSS
T ss_pred EECCCCCEEEEecCcccccCCCc---------ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCC
Confidence 99999999999999998765321 1233568999999998753 36889999999999999999999
Q ss_pred CCCCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 037275 896 RPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDV 975 (992)
Q Consensus 896 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 975 (992)
.||...... . .........+.. ...........+.+++.+||+.||++|||++|+
T Consensus 303 ~pf~~~~~~-----~------------~~~~i~~~~~~~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~el 357 (365)
T 2y7j_A 303 PPFWHRRQI-----L------------MLRMIMEGQYQF--------SSPEWDDRSSTVKDLISRLLQVDPEARLTAEQA 357 (365)
T ss_dssp CSSCCSSHH-----H------------HHHHHHHTCCCC--------CHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CCCCCCCHH-----H------------HHHHHHhCCCCC--------CCcccccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 999753111 0 000000000000 000000123458899999999999999999999
Q ss_pred HH
Q 037275 976 VA 977 (992)
Q Consensus 976 l~ 977 (992)
++
T Consensus 358 l~ 359 (365)
T 2y7j_A 358 LQ 359 (365)
T ss_dssp HH
T ss_pred hc
Confidence 86
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=354.39 Aligned_cols=252 Identities=25% Similarity=0.372 Sum_probs=191.4
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCC--chhHHHHHHHHHHhccC--CcceeEEEEeecccccCc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKG--ASNGFVAECQALRNIRH--RNLIKIITICSSIDFKGV 753 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~ 753 (992)
.++|++.+.||+|+||+||+|.+. +++.||||++...... ..+.+.+|+.++++++| |||+++++++. ..
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-----~~ 81 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TD 81 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CS
T ss_pred cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe-----eC
Confidence 357899999999999999999985 7899999999754332 33678999999999976 99999999964 44
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGD 833 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 833 (992)
...++|||+ .+|+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++ ++.+||+|
T Consensus 82 ~~~~lv~e~-~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~D 150 (343)
T 3dbq_A 82 QYIYMVMEC-GNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLID 150 (343)
T ss_dssp SEEEEEECC-CSEEHHHHHHHSC------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECC
T ss_pred CEEEEEEeC-CCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEee
Confidence 567999995 5889999998643 589999999999999999999999 999999999999996 67899999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccC-----------CCcCcccchhhHHHHHHHHHhCCCCCCCCc
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-----------GEASMTGDVYSFGILLLEMFTRRRPTDGMF 902 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwSlG~il~elltg~~pf~~~~ 902 (992)
||+++...... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 151 FG~a~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 224 (343)
T 3dbq_A 151 FGIANQMQPDT------TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 224 (343)
T ss_dssp CSSSCCC------------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred cccccccCccc------ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh
Confidence 99998765322 1112234569999999999864 678999999999999999999999997532
Q ss_pred cCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 903 NQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
+.... ....++. .... ..+. ....++.+++.+||+.||++|||+.|+++.
T Consensus 225 ~~~~~------------~~~~~~~----~~~~----~~~~------~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 225 NQISK------------LHAIIDP----NHEI----EFPD------IPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp SHHHH------------HHHHHCT----TSCC----CCCC------CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hHHHH------------HHHHhcC----Cccc----CCcc------cCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 21100 1111110 0000 0000 012357899999999999999999999864
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=345.33 Aligned_cols=251 Identities=22% Similarity=0.294 Sum_probs=199.6
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
.++|++.+.||+|+||+||+|++..+|+.||+|+++.........+.+|+.++++++||||+++++++. .....+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 82 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE-----STTHYY 82 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcc-----cCCEEE
Confidence 457999999999999999999999899999999997555445567899999999999999999999864 445679
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeee---CCCCcEEEeec
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLL---DQDLVAHLGDF 834 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Df 834 (992)
+||||+++++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||++ +.++.+||+||
T Consensus 83 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Df 153 (304)
T 2jam_A 83 LVMQLVSGGELFDRILERG------VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDF 153 (304)
T ss_dssp EEECCCCSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSC
T ss_pred EEEEcCCCccHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccC
Confidence 9999999999999997543 489999999999999999999999 99999999999999 78899999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
|.+...... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||......
T Consensus 154 g~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---------- 213 (304)
T 2jam_A 154 GLSKMEQNG----------IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES---------- 213 (304)
T ss_dssp STTCCCCCB----------TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH----------
T ss_pred CcceecCCC----------ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH----------
Confidence 998754321 122345899999999999999999999999999999999999999753211
Q ss_pred hCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 915 ALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
+.........+.. . .........++.+++.+||+.||++|||++|+++
T Consensus 214 -------~~~~~i~~~~~~~--~------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 214 -------KLFEKIKEGYYEF--E------SPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp -------HHHHHHHHCCCCC--C------TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred -------HHHHHHHcCCCCC--C------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111111110000 0 0000112346889999999999999999999986
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=356.15 Aligned_cols=359 Identities=19% Similarity=0.205 Sum_probs=177.1
Q ss_pred cCCCCCCCCcCCeeeccCCCCCccCCccccCCCCCCEEEeecccCCCCCCcccccCCCCcEeecccccccccCChhhccc
Q 037275 66 LSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYN 145 (992)
Q Consensus 66 l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~ 145 (992)
.+..++++++|++|+|++|.+++ +| .++.+++|++|+|++|++++ +| ++.+++|++|++++|++++ +|
T Consensus 34 ~~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~-~~------ 101 (457)
T 3bz5_A 34 DTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTN-LD------ 101 (457)
T ss_dssp SEEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC-CC------
T ss_pred cccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCce-ee------
Confidence 33455566666666666666663 44 46666666666666666663 33 5556666666666655552 22
Q ss_pred ccccccccccccccCCCCCCccccccccceEEecCCcccCCcCCccCCCCcccEEeccCcccccccCccccccCCCcEEe
Q 037275 146 WLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVF 225 (992)
Q Consensus 146 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 225 (992)
++++++|++|++++|++.+ +| ++.+++|++|++++|++++. + +..+++|++|+
T Consensus 102 ---------------------~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~ 154 (457)
T 3bz5_A 102 ---------------------VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELD 154 (457)
T ss_dssp ---------------------CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEE
T ss_pred ---------------------cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEE
Confidence 4444445555555554433 22 44555555555555555532 2 44455555555
Q ss_pred ccCCccCCCCCccccccccccchhhccccccCCCCchhhhccccCceeeeccccccccccccccccCccceEecCCCCCC
Q 037275 226 LPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLG 305 (992)
Q Consensus 226 l~~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 305 (992)
+++|+..+.+ .++.+++|++|++++|++++.. +..+++|+.|++++|+++
T Consensus 155 l~~n~~~~~~---------------------------~~~~l~~L~~L~ls~n~l~~l~---l~~l~~L~~L~l~~N~l~ 204 (457)
T 3bz5_A 155 CHLNKKITKL---------------------------DVTPQTQLTTLDCSFNKITELD---VSQNKLLNRLNCDTNNIT 204 (457)
T ss_dssp CTTCSCCCCC---------------------------CCTTCTTCCEEECCSSCCCCCC---CTTCTTCCEEECCSSCCS
T ss_pred CCCCCccccc---------------------------ccccCCcCCEEECCCCccceec---cccCCCCCEEECcCCcCC
Confidence 5555332211 1223344444444444444321 444444555555555444
Q ss_pred CCCCCCchhhhhccCCCcceEeecCCCcCCCcCCcccccccccceeEEeeCCccccccCCCccCCCcccEEEccCCcCCC
Q 037275 306 TGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTG 385 (992)
Q Consensus 306 ~~~~~~~~~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~ 385 (992)
.++ +..+++|+.|++++|++.+ +| +..+ ++|+.|++++|++++.. +..+++|+.|++++|
T Consensus 205 ~~~---------l~~l~~L~~L~Ls~N~l~~-ip--~~~l-~~L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n---- 264 (457)
T 3bz5_A 205 KLD---------LNQNIQLTFLDCSSNKLTE-ID--VTPL-TQLTYFDCSVNPLTELD---VSTLSKLTTLHCIQT---- 264 (457)
T ss_dssp CCC---------CTTCTTCSEEECCSSCCSC-CC--CTTC-TTCSEEECCSSCCSCCC---CTTCTTCCEEECTTC----
T ss_pred eec---------cccCCCCCEEECcCCcccc-cC--cccc-CCCCEEEeeCCcCCCcC---HHHCCCCCEEeccCC----
Confidence 321 2233333444433333332 11 1111 11233333333333221 122334444444433
Q ss_pred CCCccccCCCCCcEEeccCccccccCCCCCCCccccCceeccCCcccCCCCCCccccccccccccccccccccCchhhhh
Q 037275 386 TIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILS 465 (992)
Q Consensus 386 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~ 465 (992)
+|+.|++++|.+.+.+| +..+++|+.|++++|.+.+.+|. ...+|+.|
T Consensus 265 ----------~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~---~~~~L~~L----------------- 312 (457)
T 3bz5_A 265 ----------DLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDC---QAAGITEL----------------- 312 (457)
T ss_dssp ----------CCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEEC---TTCCCSCC-----------------
T ss_pred ----------CCCEEECCCCccCCccc--ccccccCCEEECCCCcccceecc---CCCcceEe-----------------
Confidence 23334444444443333 23444455555555544433332 11222222
Q ss_pred hcccccccccccccccCcccccccCCCCccEEeeecccccccCCcccccccccceeeccCCcccccCCccccccCCCCEE
Q 037275 466 ISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKEL 545 (992)
Q Consensus 466 ~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 545 (992)
+++ .+++|++|++++|++++. + ++.+++|+.|++++|+|++ ++.|..|
T Consensus 313 --------~l~-------------~~~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~--------l~~L~~L 360 (457)
T 3bz5_A 313 --------DLS-------------QNPKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD--------FSSVGKI 360 (457)
T ss_dssp --------CCT-------------TCTTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB--------CTTGGGS
T ss_pred --------chh-------------hcccCCEEECCCCccccc-c--cccCCcCcEEECCCCCCCC--------ccccccc
Confidence 222 335677777777777763 2 6777777777777777764 2455666
Q ss_pred ECCCcccCCCChhhhhcCCCcceEecCCCcCcccCCC
Q 037275 546 DMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPT 582 (992)
Q Consensus 546 ~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~ 582 (992)
++++|+++|. ..+..|+.+++++|+++|.+|.
T Consensus 361 ~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~ 392 (457)
T 3bz5_A 361 PALNNNFEAE-----GQTITMPKETLTNNSLTIAVSP 392 (457)
T ss_dssp SGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCT
T ss_pred cccCCcEEec-----ceeeecCccccccCcEEEEcCh
Confidence 7777777754 3455677777777777777664
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=356.40 Aligned_cols=274 Identities=22% Similarity=0.363 Sum_probs=211.6
Q ss_pred HHHHHhcCCCCCCccccccceEEEEeEEC-----CCCeEEEEEEeeccCC-CchhHHHHHHHHHHhccCCcceeEEEEee
Q 037275 673 ELSKATNDFSSSNMIGQGSFGFVYKGNLG-----ENGMMVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIITICS 746 (992)
Q Consensus 673 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 746 (992)
+.....++|++.+.||+|+||.||+|++. .+++.||+|++..... .....+.+|+.++++++||||+++++++.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 34445678999999999999999999875 3578899999864332 23456889999999999999999999964
Q ss_pred cccccCcceEEEEEEeccCCCHHHHHhhcccch----hhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCee
Q 037275 747 SIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQ----EARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVL 822 (992)
Q Consensus 747 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIl 822 (992)
. ....++||||+++|+|.+++....... ....+++..++.++.|++.||+|||++ +|+||||||+||+
T Consensus 99 ~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIl 170 (322)
T 1p4o_A 99 Q-----GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCM 170 (322)
T ss_dssp S-----SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEE
T ss_pred c-----CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEE
Confidence 3 445699999999999999998654211 113568999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCC
Q 037275 823 LDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGM 901 (992)
Q Consensus 823 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~ 901 (992)
++.++.+||+|||+++....... ........+|+.|+|||++.+..++.++||||+||++|+|++ |+.||.+.
T Consensus 171 i~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 244 (322)
T 1p4o_A 171 VAEDFTVKIGDFGMTRDIYETDY------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 244 (322)
T ss_dssp ECTTCCEEECCTTCCCGGGGGGC------EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred EcCCCeEEECcCccccccccccc------cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC
Confidence 99999999999999986543211 111223357889999999998899999999999999999999 89998753
Q ss_pred ccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 037275 902 FNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCR 981 (992)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 981 (992)
... + ........... .. .......+.+++.+||+.||++|||+.|+++.|++
T Consensus 245 ~~~-----~------------~~~~~~~~~~~-----~~------~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~ 296 (322)
T 1p4o_A 245 SNE-----Q------------VLRFVMEGGLL-----DK------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 296 (322)
T ss_dssp CHH-----H------------HHHHHHTTCCC-----CC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGG
T ss_pred CHH-----H------------HHHHHHcCCcC-----CC------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 211 1 11111100000 00 01123458899999999999999999999999998
Q ss_pred HHHhhhh
Q 037275 982 ARDTFLG 988 (992)
Q Consensus 982 ~~~~~~~ 988 (992)
+.+....
T Consensus 297 ~~~~~~~ 303 (322)
T 1p4o_A 297 EMEPGFR 303 (322)
T ss_dssp GSCTTHH
T ss_pred hhccCCc
Confidence 7665443
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=350.88 Aligned_cols=288 Identities=19% Similarity=0.239 Sum_probs=205.2
Q ss_pred cHHHHHHHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCc-----------hhHHHHHHHHHHhccCCcc
Q 037275 670 SYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGA-----------SNGFVAECQALRNIRHRNL 738 (992)
Q Consensus 670 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~ni 738 (992)
...++....++|++.+.||+|+||.||+|.+. +++.||||++....... .+.+.+|+.++++++||||
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 35677888999999999999999999999986 59999999986432211 2678999999999999999
Q ss_pred eeEEEEeecccccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCC
Q 037275 739 IKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKP 818 (992)
Q Consensus 739 v~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp 818 (992)
+++++++...+.......++||||++ |+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp 162 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR-----IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHP 162 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCG
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCCh
Confidence 99999986655455667899999997 68988887543 2589999999999999999999999 999999999
Q ss_pred CCeeeCCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCC
Q 037275 819 SNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRRRP 897 (992)
Q Consensus 819 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p 897 (992)
+||+++.++.+||+|||.++..... .......||+.|+|||++.+ ..++.++||||+||++|+|++|+.|
T Consensus 163 ~NIl~~~~~~~kl~Dfg~~~~~~~~---------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p 233 (362)
T 3pg1_A 163 GNILLADNNDITICDFNLAREDTAD---------ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKAL 233 (362)
T ss_dssp GGEEECTTCCEEECCTTC------------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred HHEEEcCCCCEEEEecCcccccccc---------cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCC
Confidence 9999999999999999999754322 12233468999999998877 6789999999999999999999999
Q ss_pred CCCCccCCccHHHHHhhhCChhHHHHH--HhhHhHhhhccCCCCCCccc--cchHHHHHHHHHHHhhccCCCCCCCCCHH
Q 037275 898 TDGMFNQGLTLHEFARTALPDKVMEIV--DSVLLLEVQASNSRSCGDER--LRTEERLVAVVETGVVCSMESPTERMEMR 973 (992)
Q Consensus 898 f~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 973 (992)
|.+..... .................. .......+............ .........+.+++.+||+.||++|||++
T Consensus 234 f~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 312 (362)
T 3pg1_A 234 FRGSTFYN-QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTE 312 (362)
T ss_dssp CCCSSHHH-HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCCHHH-HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHH
Confidence 98643211 111111111111111110 00000000000000000000 00112245688999999999999999999
Q ss_pred HHHH
Q 037275 974 DVVA 977 (992)
Q Consensus 974 evl~ 977 (992)
|+++
T Consensus 313 ell~ 316 (362)
T 3pg1_A 313 QALR 316 (362)
T ss_dssp HHHT
T ss_pred HHHc
Confidence 9985
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=349.16 Aligned_cols=282 Identities=23% Similarity=0.355 Sum_probs=204.2
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC--CchhHHHHHHHHHHhccCCcceeEEEEeecccc---cC
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK--GASNGFVAECQALRNIRHRNLIKIITICSSIDF---KG 752 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~ 752 (992)
.++|++.++||+|+||+||+|++..+|+.||||++..... .....+.+|+.+++.++||||+++++++..... ..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 4689999999999999999999998999999999864432 234578899999999999999999999865321 11
Q ss_pred cceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEe
Q 037275 753 VDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLG 832 (992)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 832 (992)
....++||||+++ ++.+.+..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~ 166 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLV-----KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLA 166 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred CceEEEEEeccCC-CHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEc
Confidence 4567999999975 88888765432 489999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCCCCCcccCCCCCcccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHH
Q 037275 833 DFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEF 911 (992)
Q Consensus 833 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~ 911 (992)
|||+|+.+...... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+..... .....
T Consensus 167 Dfg~a~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i 241 (351)
T 3mi9_A 167 DFGLARAFSLAKNS----QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-QLALI 241 (351)
T ss_dssp CCTTCEECCCCSSS----SCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHH
T ss_pred cchhcccccccccc----cccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHH
Confidence 99999876532211 1222334568999999998876 468999999999999999999999998643221 11111
Q ss_pred Hhh--hCChhHHHHHHhhHhHhhhccCCCCCCccccchHH------HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 912 ART--ALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEE------RLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 912 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
... ..+.......+... .+. .............+ ....+.+++.+||+.||++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~--~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 242 SQLCGSITPEVWPNVDNYE--LYE--KLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp HHHHCCCCTTTSTTGGGCG--GGT--SSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHhCCCChhhccccccch--hhc--ccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 110 01111000000000 000 00000000001111 1345889999999999999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=363.24 Aligned_cols=260 Identities=15% Similarity=0.162 Sum_probs=193.8
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc---CCCchhHHHHHHH---HHHhccCCcceeEE-------EE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK---QKGASNGFVAECQ---ALRNIRHRNLIKII-------TI 744 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~---~l~~l~h~niv~~~-------~~ 744 (992)
.++|++.+.||+|+||+||+|++..+|+.||||++... .....+.+.+|+. ++++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788899999999999999999888999999999743 3344577899994 55555899999998 44
Q ss_pred eecccc-------cCcc-----eEEEEEEeccCCCHHHHHhhcccchh-hcccCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 037275 745 CSSIDF-------KGVD-----FQAIVYEYMQNGSLEDWLHQSEDQQE-ARSLTLIQRINIIIDVASAIEYIHHHCQPPV 811 (992)
Q Consensus 745 ~~~~~~-------~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i 811 (992)
+..... .+.. ..++||||+ +|+|.+++.......+ ...+++..++.++.|++.||+|||++ +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 332110 0111 368999999 6899999986542211 23455688999999999999999999 99
Q ss_pred EeccCCCCCeeeCCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCC-----------CcCcccc
Q 037275 812 VHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-----------EASMTGD 880 (992)
Q Consensus 812 vH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~D 880 (992)
+||||||+||+++.++.+||+|||+|+.... ......| +.|+|||++.+. .++.++|
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~D 295 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFD 295 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----------cccCCCC-cCccChhhhcccccccccccccccCChhhh
Confidence 9999999999999999999999999985332 1123457 999999999887 8999999
Q ss_pred hhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhh
Q 037275 881 VYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVV 960 (992)
Q Consensus 881 iwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 960 (992)
||||||++|||++|+.||.+........ .... ... ....++.+++.+
T Consensus 296 vwSlG~il~elltg~~Pf~~~~~~~~~~-----------------~~~~------~~~----------~~~~~~~~li~~ 342 (377)
T 3byv_A 296 AWALGLVIYWIWCADLPITKDAALGGSE-----------------WIFR------SCK----------NIPQPVRALLEG 342 (377)
T ss_dssp HHHHHHHHHHHHHSSCCC------CCSG-----------------GGGS------SCC----------CCCHHHHHHHHH
T ss_pred HHHHHHHHHHHHHCCCCCcccccccchh-----------------hhhh------hcc----------CCCHHHHHHHHH
Confidence 9999999999999999997643221100 0000 000 112458899999
Q ss_pred ccCCCCCCCCCHHHHHH--HHHHHHHhh
Q 037275 961 CSMESPTERMEMRDVVA--KLCRARDTF 986 (992)
Q Consensus 961 cl~~dP~~RPs~~evl~--~L~~~~~~~ 986 (992)
||+.||++|||+.|+++ .++++.+..
T Consensus 343 ~L~~dp~~Rpt~~e~l~hp~f~~~~~~~ 370 (377)
T 3byv_A 343 FLRYPKEDRLLPLQAMETPEYEQLRTEL 370 (377)
T ss_dssp HTCSSGGGCCCHHHHHTSHHHHHHHHHH
T ss_pred HcCCCchhCCCHHHHhhChHHHHHHHHH
Confidence 99999999999999986 455554443
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=341.81 Aligned_cols=253 Identities=23% Similarity=0.340 Sum_probs=196.7
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEE
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIV 759 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 759 (992)
+|....+||+|+||.||+|++..+++.||||++........+.+.+|+.+++.++||||+++++++.. ....++|
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv 97 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE-----NGFIKIF 97 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe-----CCcEEEE
Confidence 45555699999999999999988999999999986666667789999999999999999999999643 4567999
Q ss_pred EEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCC-CCcEEEeecccce
Q 037275 760 YEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQ-DLVAHLGDFGLAK 838 (992)
Q Consensus 760 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~ 838 (992)
|||+++++|.+++..... ...+++..++.++.|++.||+|||++ +|+||||||+||+++. ++.+||+|||.+.
T Consensus 98 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~ 171 (295)
T 2clq_A 98 MEQVPGGSLSALLRSKWG---PLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSK 171 (295)
T ss_dssp EECCSEEEHHHHHHHTTC---CCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCE
T ss_pred EEeCCCCCHHHHHHhhcc---CCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeeccccc
Confidence 999999999999986532 23467889999999999999999999 9999999999999987 8999999999998
Q ss_pred ecCCCCCCCCcccCCCCCcccccccccccccccCCC--cCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhC
Q 037275 839 FLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGE--ASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTAL 916 (992)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 916 (992)
...... .......|++.|+|||++.+.. ++.++||||||+++|+|++|+.||........
T Consensus 172 ~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---------- 233 (295)
T 2clq_A 172 RLAGIN--------PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA---------- 233 (295)
T ss_dssp ESCC-------------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH----------
T ss_pred ccCCCC--------CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH----------
Confidence 764321 1122346899999999987653 78999999999999999999999964321100
Q ss_pred ChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 917 PDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
....... .... .... .....++.+++.+||+.||++|||++|+++
T Consensus 234 -----~~~~~~~-~~~~----~~~~------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 234 -----AMFKVGM-FKVH----PEIP------ESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp -----HHHHHHH-HCCC----CCCC------TTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred -----HHHhhcc-cccc----cccc------ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000000 0000 0000 112345889999999999999999999975
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=359.87 Aligned_cols=277 Identities=22% Similarity=0.287 Sum_probs=198.7
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccc-cCcceEE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDF-KGVDFQA 757 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~ 757 (992)
.+|++.++||+|+||+||+|++..+|+.||||++..... ...+|++++++++||||+++++++..... .+..+.+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 368899999999999999999998999999999864322 23479999999999999999998754322 3345567
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCC-CcEEEeeccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQD-LVAHLGDFGL 836 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~ 836 (992)
+||||+++ ++.+.+..... ....+++..++.++.||++||+|||++ +|+||||||+|||++.+ +.+||+|||+
T Consensus 130 lv~e~~~~-~l~~~~~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSR--AKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred eehhcccc-cHHHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchh
Confidence 99999975 77776654321 134689999999999999999999999 99999999999999965 5789999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 915 (992)
++...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.... ..+.+.....
T Consensus 204 a~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~-~~l~~i~~~l 273 (420)
T 1j1b_A 204 AKQLVRGE---------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVL 273 (420)
T ss_dssp CEECCTTC---------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHH
T ss_pred hhhcccCC---------CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHh
Confidence 98764321 12234689999999998765 7999999999999999999999999874322 1122222211
Q ss_pred CChhHHHHHHhhHhHhhhccCCCCCCccc---cchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 916 LPDKVMEIVDSVLLLEVQASNSRSCGDER---LRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
....... +... ...+............ ........++.+++.+||+.||++|||+.|+++
T Consensus 274 g~p~~~~-~~~~-~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 274 GTPTREQ-IREM-NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp CSCCHHH-HHHH-CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCHHH-HHhh-ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 1111011 1000 0000000000000000 000112356899999999999999999999985
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=363.77 Aligned_cols=252 Identities=27% Similarity=0.337 Sum_probs=201.0
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc--CCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK--QKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
.++|++.++||+|+||+||+|++..+++.||||++... .......+.+|+.++++++||||+++++++. ....
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~ 95 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----DSSS 95 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEE-----cCCE
Confidence 45799999999999999999999989999999998643 2345677899999999999999999999964 4566
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeC---CCCcEEEe
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLD---QDLVAHLG 832 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~ 832 (992)
.++||||+++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++ .++.+||+
T Consensus 96 ~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~ 166 (486)
T 3mwu_A 96 FYIVGELYTGGELFDEIIKRK------RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKII 166 (486)
T ss_dssp EEEEECCCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEEC
T ss_pred EEEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEE
Confidence 799999999999999987643 489999999999999999999999 999999999999995 55689999
Q ss_pred ecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHH
Q 037275 833 DFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFA 912 (992)
Q Consensus 833 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~ 912 (992)
|||+|+...... ......||+.|+|||++.+ .++.++||||+||++|+|++|++||.+....
T Consensus 167 Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------- 228 (486)
T 3mwu_A 167 DFGLSTCFQQNT---------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY-------- 228 (486)
T ss_dssp SCSCTTTBCCC-------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------
T ss_pred ECCcCeECCCCC---------ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------
Confidence 999998654321 1233469999999999875 5899999999999999999999999763211
Q ss_pred hhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 913 RTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
+.+.......+.. ..........++.+++.+||+.||++|||+.|+++.
T Consensus 229 ---------~~~~~i~~~~~~~--------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 229 ---------DILKRVETGKYAF--------DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp ---------HHHHHHHHTCCCS--------CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred ---------HHHHHHHhCCCCC--------CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1111111111100 000111223458899999999999999999999873
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=363.88 Aligned_cols=256 Identities=24% Similarity=0.366 Sum_probs=204.1
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc---CCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK---QKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
.++|++.++||+|+||+||+|++..+|+.||+|++... .......+.+|+.++++++||||+++++++. ...
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-----~~~ 258 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFE-----TKT 258 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-----eCC
Confidence 36789999999999999999999989999999999643 2334567889999999999999999999853 456
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
..++||||+++|+|.+++...... ...+++..++.++.||+.||+|||++ +|+||||||+||+++.+|.+||+||
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DF 333 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVDED--NPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDL 333 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSSTT--SCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEEEeccCCCHHHHHHHhhcc--cccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeec
Confidence 679999999999999999765321 23589999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
|+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..... ...+
T Consensus 334 Gla~~~~~~~--------~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~-~~~~---- 400 (543)
T 3c4z_A 334 GLAVELKAGQ--------TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKE---- 400 (543)
T ss_dssp TTCEECCTTC--------CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC-CHHH----
T ss_pred ceeeeccCCC--------cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch-hHHH----
Confidence 9998765321 11233579999999999999999999999999999999999999998643221 1111
Q ss_pred hCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCH-----HHHH
Q 037275 915 ALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEM-----RDVV 976 (992)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl 976 (992)
+......... ..+ ......+.+++.+||+.||++||++ +||+
T Consensus 401 --------~~~~i~~~~~------~~p------~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~ 447 (543)
T 3c4z_A 401 --------LKQRVLEQAV------TYP------DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLR 447 (543)
T ss_dssp --------HHHHHHHCCC------CCC------TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHH
T ss_pred --------HHHHHhhccc------CCC------cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHH
Confidence 1111111000 000 1123458899999999999999975 5665
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=346.80 Aligned_cols=264 Identities=25% Similarity=0.395 Sum_probs=205.2
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEE--EEEEeecc-CCCchhHHHHHHHHHHhc-cCCcceeEEEEeecccccCcc
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMV--AVKVINLK-QKGASNGFVAECQALRNI-RHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~v--avK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 754 (992)
++|++.+.||+|+||.||+|++..++..+ |+|.++.. .....+.+.+|+++++++ +||||+++++++. ...
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-----~~~ 99 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRG 99 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE-----ETT
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeee-----eCC
Confidence 58999999999999999999998788755 99988643 234456789999999999 8999999999964 345
Q ss_pred eEEEEEEeccCCCHHHHHhhcccc----------hhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeC
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQ----------QEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLD 824 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 824 (992)
..++||||+++|+|.+++...... .....+++..++.++.|++.||+|||++ +|+||||||+||+++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~ 176 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG 176 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEc
Confidence 679999999999999999865411 1123689999999999999999999999 999999999999999
Q ss_pred CCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCcc
Q 037275 825 QDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFN 903 (992)
Q Consensus 825 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~ 903 (992)
.++.+||+|||+++..... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||.+...
T Consensus 177 ~~~~~kL~Dfg~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~ 247 (327)
T 1fvr_A 177 ENYVAKIADFGLSRGQEVY---------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 247 (327)
T ss_dssp GGGCEEECCTTCEESSCEE---------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred CCCeEEEcccCcCcccccc---------ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH
Confidence 9999999999999743211 11222346889999999988889999999999999999998 9999976321
Q ss_pred CCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 037275 904 QGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRAR 983 (992)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 983 (992)
. + ....... ...... ......++.+++.+||+.||++|||++|+++.|+++.
T Consensus 248 ~-----~------------~~~~~~~-~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 299 (327)
T 1fvr_A 248 A-----E------------LYEKLPQ-GYRLEK----------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 299 (327)
T ss_dssp H-----H------------HHHHGGG-TCCCCC----------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H-----H------------HHHHhhc-CCCCCC----------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1 1 1111100 000000 0112345889999999999999999999999999987
Q ss_pred Hhhh
Q 037275 984 DTFL 987 (992)
Q Consensus 984 ~~~~ 987 (992)
+...
T Consensus 300 ~~~~ 303 (327)
T 1fvr_A 300 EERK 303 (327)
T ss_dssp HSSS
T ss_pred Hhhc
Confidence 7543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=365.28 Aligned_cols=252 Identities=23% Similarity=0.316 Sum_probs=197.4
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC--CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
.++|++.++||+|+||+||+|++..+++.||+|++.... ......+.+|+.+++.++||||+++++++. ....
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~ 110 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE-----DKRN 110 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCCE
Confidence 347999999999999999999999999999999997443 334577899999999999999999999964 4556
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCC---CcEEEe
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQD---LVAHLG 832 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~ 832 (992)
.++||||+++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.. +.+||+
T Consensus 111 ~~lv~e~~~~g~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~ 181 (494)
T 3lij_A 111 YYLVMECYKGGELFDEIIHRM------KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIV 181 (494)
T ss_dssp EEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred EEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEE
Confidence 799999999999999987543 489999999999999999999999 99999999999999764 569999
Q ss_pred ecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHH
Q 037275 833 DFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFA 912 (992)
Q Consensus 833 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~ 912 (992)
|||+|+...... ......||+.|+|||++. +.++.++||||+||++|+|++|++||.+....
T Consensus 182 DfG~a~~~~~~~---------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------- 243 (494)
T 3lij_A 182 DFGLSAVFENQK---------KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ-------- 243 (494)
T ss_dssp CCTTCEECBTTB---------CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------
T ss_pred ECCCCeECCCCc---------cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--------
Confidence 999998765321 223356999999999876 56999999999999999999999999763221
Q ss_pred hhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 913 RTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
++........+... ..........+.+++.+||+.||++|||+.|+++.
T Consensus 244 ---------~~~~~i~~~~~~~~--------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 244 ---------EILRKVEKGKYTFD--------SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp ---------HHHHHHHHTCCCCC--------SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ---------HHHHHHHhCCCCCC--------chhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 11111111111000 00011123458899999999999999999999853
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=350.79 Aligned_cols=278 Identities=18% Similarity=0.198 Sum_probs=196.8
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC--CchhHHHHHHHHHHhccCCcceeEEEEeeccc-ccCcc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK--GASNGFVAECQALRNIRHRNLIKIITICSSID-FKGVD 754 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~ 754 (992)
.++|++.+.||+|+||+||+|.+..+++.||||++..... ...+.+.+|+.+++.++||||+++++++.... .....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 3589999999999999999999998999999999974322 23456889999999999999999999976432 23345
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
..++||||+++ +|.+++.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df 171 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 171 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCC
T ss_pred ceEEEEEcCCC-CHHHHHhh--------ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEe
Confidence 77999999964 78888752 378999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
|+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+..... .+......
T Consensus 172 g~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~ 241 (371)
T 2xrw_A 172 GLARTAGTSF---------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQ 241 (371)
T ss_dssp CC-------------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHC-
T ss_pred eccccccccc---------ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHH
Confidence 9998654321 1233568999999999999999999999999999999999999998643211 11111110
Q ss_pred hC--ChhHHHHHHhhHhHhhhccCC------------CCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 915 AL--PDKVMEIVDSVLLLEVQASNS------------RSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 915 ~~--~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.. .......+.+........... ...+...........++.+++.+||+.||++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 242 LGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 00 000000000000000000000 0000111112234567899999999999999999999986
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=344.24 Aligned_cols=259 Identities=23% Similarity=0.315 Sum_probs=203.8
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC--CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK--GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
.++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+.+|+.++++++||||+++++++.. .....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~~ 81 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNTT 81 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---GGGTE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEec---CCCce
Confidence 4689999999999999999999998999999999975432 234668999999999999999999998643 23456
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCC-----eEeccCCCCCeeeCCCCcEE
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPP-----VVHGDLKPSNVLLDQDLVAH 830 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~-----ivH~Dlkp~NIll~~~~~~k 830 (992)
.++||||+++|+|.+++...... ...+++..++.++.|++.||+|||+. + |+||||||+||+++.++.+|
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~k 156 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKE--RQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVK 156 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEE
T ss_pred EEEEEeCCCCCCHHHHHHhhccc--CCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEE
Confidence 79999999999999999865421 33589999999999999999999999 7 99999999999999999999
Q ss_pred EeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHH
Q 037275 831 LGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHE 910 (992)
Q Consensus 831 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~ 910 (992)
|+|||.++...... .......|++.|+|||++.+..++.++||||||+++|+|++|+.||......
T Consensus 157 l~dfg~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------ 222 (279)
T 2w5a_A 157 LGDFGLARILNHDT--------SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK------ 222 (279)
T ss_dssp ECCCCHHHHC---C--------HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------
T ss_pred EecCchheeecccc--------ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH------
Confidence 99999998654321 1112345899999999999989999999999999999999999999763211
Q ss_pred HHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 037275 911 FARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLC 980 (992)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 980 (992)
+........... ... .....++.+++.+||+.||++|||++||++.+.
T Consensus 223 -----------~~~~~i~~~~~~-----~~~------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 223 -----------ELAGKIREGKFR-----RIP------YRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp -----------HHHHHHHHTCCC-----CCC------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred -----------HHHHHHhhcccc-----cCC------cccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 111111111000 000 112345889999999999999999999997653
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=348.22 Aligned_cols=264 Identities=22% Similarity=0.321 Sum_probs=200.9
Q ss_pred HHHHHHHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhc-cCCcceeEEEEeeccc
Q 037275 671 YAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNI-RHRNLIKIITICSSID 749 (992)
Q Consensus 671 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 749 (992)
+.++....++|++.+.||+|+||.||+|++..+++.||||++.... .....+.+|+.+++++ +||||+++++++....
T Consensus 16 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred chhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 3344456778999999999999999999998899999999997443 3457789999999999 8999999999976532
Q ss_pred cc-CcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCc
Q 037275 750 FK-GVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLV 828 (992)
Q Consensus 750 ~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 828 (992)
.. .....++||||+++|+|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~ 167 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNTKG----NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAE 167 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHSGG----GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCC
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhccc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCC
Confidence 21 14677999999999999999986542 3589999999999999999999999 9999999999999999999
Q ss_pred EEEeecccceecCCCCCCCCcccCCCCCccccccccccccccc-----CCCcCcccchhhHHHHHHHHHhCCCCCCCCcc
Q 037275 829 AHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGM-----GGEASMTGDVYSFGILLLEMFTRRRPTDGMFN 903 (992)
Q Consensus 829 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 903 (992)
+||+|||++....... .......|++.|+|||++. +..++.++|||||||++|+|++|+.||.+...
T Consensus 168 ~kl~Dfg~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 239 (326)
T 2x7f_A 168 VKLVDFGVSAQLDRTV--------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP 239 (326)
T ss_dssp EEECCCTTTC---------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred EEEeeCcCceecCcCc--------cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH
Confidence 9999999998654321 1123346899999999986 56789999999999999999999999965321
Q ss_pred CCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 904 QGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
. . .......... .. . ........+.+++.+||+.||++|||++|+++
T Consensus 240 ~-----~------------~~~~~~~~~~----~~-~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 240 M-----R------------ALFLIPRNPA----PR-L-----KSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp H-----H------------HHHHHHHSCC----CC-C-----SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred H-----H------------HHHHhhcCcc----cc-C-----CccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1 0 0000000000 00 0 00111345889999999999999999999987
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=356.26 Aligned_cols=251 Identities=24% Similarity=0.372 Sum_probs=191.6
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC--CchhHHHHHHHHHHhcc--CCcceeEEEEeecccccCcc
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK--GASNGFVAECQALRNIR--HRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~ 754 (992)
.+|++.+.||+|+||+||+|.+. +++.||||++..... ...+.+.+|+.++++++ ||||+++++++.. ..
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~-----~~ 129 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-----DQ 129 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SS
T ss_pred CceEEEEEEccCCCeEEEEEEcC-CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec-----CC
Confidence 45999999999999999999987 489999999975432 23467899999999996 5999999998643 44
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
..++||| +.+++|.+++.... .+++.+++.++.||+.||+|||++ +|+||||||+||+++ ++.+||+||
T Consensus 130 ~~~lv~E-~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DF 198 (390)
T 2zmd_A 130 YIYMVME-CGNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDF 198 (390)
T ss_dssp EEEEEEE-CCSEEHHHHHHHCS------SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCC
T ss_pred EEEEEEe-cCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEec
Confidence 5799999 56889999998643 478899999999999999999999 999999999999995 589999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccC-----------CCcCcccchhhHHHHHHHHHhCCCCCCCCcc
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-----------GEASMTGDVYSFGILLLEMFTRRRPTDGMFN 903 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 903 (992)
|+++.+.... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....+
T Consensus 199 G~a~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~ 272 (390)
T 2zmd_A 199 GIANQMQPDT------TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 272 (390)
T ss_dssp SSSCCC---------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred CccccccCCC------ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH
Confidence 9998764321 1111234569999999999865 3688999999999999999999999975322
Q ss_pred CCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 904 QGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
.... +..+++. ..... .+. ....++.+++.+||+.||++|||+.|+++.
T Consensus 273 ~~~~------------~~~~~~~----~~~~~----~~~------~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 273 QISK------------LHAIIDP----NHEIE----FPD------IPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HHHH------------HHHHHCT----TSCCC----CCC------CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHH------------HHHHhCc----cccCC----CCc------cchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 1000 1111111 00000 000 012458899999999999999999999853
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=355.02 Aligned_cols=200 Identities=29% Similarity=0.425 Sum_probs=173.8
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC-CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
.++|++.+.||+|+||+||+|++..+++.||+|++..... ...+.+.+|+.++++++||||+++++++.. ....
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 106 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEI 106 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE-----TTEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE-----CCEE
Confidence 3579999999999999999999998999999999975432 234678999999999999999999998643 4567
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHH-HCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
++||||+++|+|.+++.... .+++..+..++.|++.||+|||+ + +|+||||||+||+++.++.+||+|||
T Consensus 107 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 177 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFG 177 (360)
T ss_dssp EEEECCCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCC
T ss_pred EEEEECCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHhC---CEEcCCccHHHEEECCCCCEEEEECC
Confidence 99999999999999997643 48999999999999999999998 5 79999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCC
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGM 901 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 901 (992)
++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 178 ~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 178 VSGQLIDS----------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp CCHHHHHH----------C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred CCcccccc----------cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 98754321 122346899999999999999999999999999999999999999763
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=348.57 Aligned_cols=265 Identities=18% Similarity=0.252 Sum_probs=205.0
Q ss_pred CcccHHHHHHHhcCCCCC-CccccccceEEEEeEECCCCeEEEEEEeeccC--CCchhHHHHHHHHHHhc-cCCcceeEE
Q 037275 667 PMISYAELSKATNDFSSS-NMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNI-RHRNLIKII 742 (992)
Q Consensus 667 ~~~~~~~~~~~~~~~~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~ 742 (992)
+.+.+.......++|.+. +.||+|+||+||+|++..+++.||+|++.... ......+.+|+.+++.+ +||||++++
T Consensus 16 ~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~ 95 (327)
T 3lm5_A 16 ENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95 (327)
T ss_dssp CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred hhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence 344445555666788887 89999999999999999899999999997443 23356789999999999 569999999
Q ss_pred EEeecccccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCee
Q 037275 743 TICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVL 822 (992)
Q Consensus 743 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIl 822 (992)
+++. .....++||||+++|+|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+||+
T Consensus 96 ~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl 163 (327)
T 3lm5_A 96 EVYE-----NTSEIILILEYAAGGEIFSLCLPELA----EMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNIL 163 (327)
T ss_dssp EEEE-----CSSEEEEEEECCTTEEGGGGGSSCC-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred EEEE-----eCCeEEEEEEecCCCcHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEE
Confidence 9964 45567999999999999999865432 3589999999999999999999999 9999999999999
Q ss_pred eCC---CCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCC
Q 037275 823 LDQ---DLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTD 899 (992)
Q Consensus 823 l~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~ 899 (992)
++. ++.+||+|||+++...... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.
T Consensus 164 ~~~~~~~~~~kL~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 234 (327)
T 3lm5_A 164 LSSIYPLGDIKIVDFGMSRKIGHAC---------ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFV 234 (327)
T ss_dssp ESCBTTBCCEEECCGGGCEEC------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred EecCCCCCcEEEeeCccccccCCcc---------ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 988 7899999999998765321 1223468999999999999999999999999999999999999997
Q ss_pred CCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 900 GMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
+..... ............ . ..........+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~-----------------~~~~i~~~~~~~--~------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 235 GEDNQE-----------------TYLNISQVNVDY--S------EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp CSSHHH-----------------HHHHHHHTCCCC--C------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCCchH-----------------HHHHHHhccccc--C------chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 632210 000000000000 0 0000112345889999999999999999999975
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=336.76 Aligned_cols=247 Identities=21% Similarity=0.348 Sum_probs=202.2
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc---CCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK---QKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
.++|++.+.||+|+||.||+|++..+++.||+|++... .......+.+|++++++++||||+++++++. ...
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 87 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH-----DRK 87 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE-----cCC
Confidence 45899999999999999999999989999999998643 2334567899999999999999999999964 345
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
..++||||+++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Df 158 (284)
T 2vgo_A 88 RIYLMLEFAPRGELYKELQKHG------RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADF 158 (284)
T ss_dssp EEEEEECCCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCC
T ss_pred EEEEEEEeCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecc
Confidence 6799999999999999997643 489999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
|.+...... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||...... +
T Consensus 159 g~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~---- 219 (284)
T 2vgo_A 159 GWSVHAPSL----------RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT-----E---- 219 (284)
T ss_dssp TTCEECSSS----------CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-----H----
T ss_pred cccccCccc----------ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh-----H----
Confidence 999765431 122346899999999999999999999999999999999999999753211 0
Q ss_pred hCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 915 ALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.......... . .+ .....++.+++.+||+.||++|||++|+++
T Consensus 220 --------~~~~~~~~~~--~----~~------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 220 --------THRRIVNVDL--K----FP------PFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp --------HHHHHHTTCC--C----CC------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --------HHHHHhcccc--C----CC------CcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 0011100000 0 00 011345789999999999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=356.15 Aligned_cols=277 Identities=21% Similarity=0.267 Sum_probs=186.4
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC--CchhHHHHHHHHHHhccCCcceeEEEEeeccc-ccCcc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK--GASNGFVAECQALRNIRHRNLIKIITICSSID-FKGVD 754 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~ 754 (992)
.++|++.+.||+|+||.||+|.+..+|+.||||++..... ...+.+.+|+.+++.++||||+++++++.... .....
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 3589999999999999999999999999999999864322 23467889999999999999999999975431 22345
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
..++||||+ +++|.+++... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DF 176 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQ-------KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDF 176 (367)
T ss_dssp CCEEEEECC-CEECC-----C-------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-
T ss_pred eEEEEeccc-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeec
Confidence 679999999 78999998642 489999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 913 (992)
|+++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+ .+.....
T Consensus 177 G~a~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~l~~i~~ 244 (367)
T 2fst_X 177 GLARHTADE-----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILR 244 (367)
T ss_dssp -------------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHH
T ss_pred ccccccccc-----------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH
Confidence 999864321 223468999999999877 678999999999999999999999998743211 1111111
Q ss_pred hh-CC-hhHHHHHHhhHhHhhhccCCCCCCcc-ccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 914 TA-LP-DKVMEIVDSVLLLEVQASNSRSCGDE-RLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 914 ~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.. .+ ......+.......+........... ..........+.+++.+||+.||++|||++|+++
T Consensus 245 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 245 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 11 01 00000000000000000000000000 0000112356889999999999999999999985
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=340.03 Aligned_cols=250 Identities=21% Similarity=0.299 Sum_probs=202.8
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.++++++||||+++++++. ...
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~ 88 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----DND 88 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeec-----cCC
Confidence 457999999999999999999999899999999986543 223466889999999999999999999964 345
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
..++||||+++++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 89 ~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df 159 (294)
T 2rku_A 89 FVFVVLELCRRRSLLELHKRRK------ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDF 159 (294)
T ss_dssp EEEEEEECCTTCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred EEEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEec
Confidence 6799999999999999987543 589999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
|.+....... .......||+.|+|||++.+..++.++||||+|+++|+|++|+.||...... +
T Consensus 160 g~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~---- 222 (294)
T 2rku_A 160 GLATKVEYDG--------ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-----E---- 222 (294)
T ss_dssp TTCEECCSTT--------CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----H----
T ss_pred cCceecccCc--------cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----H----
Confidence 9998764321 1122346899999999999989999999999999999999999999753211 0
Q ss_pred hCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 915 ALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
.......... ..+ ......+.+++.+||+.||++|||++|+++.
T Consensus 223 --------~~~~~~~~~~------~~~------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 223 --------TYLRIKKNEY------SIP------KHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp --------HHHHHHTTCC------CCC------TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred --------HHHHHhhccC------CCc------cccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0000000000 000 0112457899999999999999999999863
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=342.97 Aligned_cols=253 Identities=23% Similarity=0.336 Sum_probs=197.8
Q ss_pred HHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 676 KATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 676 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
...++|++.+.||+|+||.||+|.+..+|+.||+|++... .....+.+|+.++++++||||+++++++.. ...
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 98 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFK-----NTD 98 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCE
Confidence 3456899999999999999999999988999999999643 345678999999999999999999998643 456
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++||||+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 99 ~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg 170 (314)
T 3com_A 99 LWIVMEYCGAGSVSDIIRLRN-----KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFG 170 (314)
T ss_dssp EEEEEECCTTEEHHHHHHHHT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCT
T ss_pred EEEEeecCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecc
Confidence 799999999999999997433 2589999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 915 (992)
.+....... .......|++.|+|||++.+..++.++||||||+++|+|++|+.||...... ..
T Consensus 171 ~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~----- 233 (314)
T 3com_A 171 VAGQLTDTM--------AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM----RA----- 233 (314)
T ss_dssp TCEECBTTB--------SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH----HH-----
T ss_pred cchhhhhhc--------cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH----HH-----
Confidence 998765321 1223346899999999999999999999999999999999999999753211 00
Q ss_pred CChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 916 LPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
..... ... .... .........+.+++.+||+.||++|||+.|+++
T Consensus 234 --------~~~~~-~~~----~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 234 --------IFMIP-TNP----PPTF----RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp --------HHHHH-HSC----CCCC----SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred --------HHHHh-cCC----Cccc----CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 00000 000 0000 000112345889999999999999999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=354.37 Aligned_cols=276 Identities=21% Similarity=0.270 Sum_probs=194.9
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccc-cCcceEE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDF-KGVDFQA 757 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~ 757 (992)
.+|++.++||+|+||+||+|++..+++ ||+|.+..... ...+|+++++.++||||+++++++..... .+..+.+
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 478999999999999999999975554 88887753322 12379999999999999999999865432 3445578
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeC-CCCcEEEeeccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLD-QDLVAHLGDFGL 836 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~ 836 (992)
+||||+++ ++...+..... ....+++..++.++.|+++||+|||++ +|+||||||+||+++ .++.+||+|||+
T Consensus 115 lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~ 188 (394)
T 4e7w_A 115 LVLEYVPE-TVYRASRHYAK--LKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGS 188 (394)
T ss_dssp EEEECCSE-EHHHHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEeeccCc-cHHHHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence 99999976 44444432211 123689999999999999999999999 999999999999998 799999999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 915 (992)
|+...... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||.+....+ .+.......
T Consensus 189 a~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~l~~i~~~~ 258 (394)
T 4e7w_A 189 AKILIAGE---------PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID-QLVEIIKVL 258 (394)
T ss_dssp CEECCTTC---------CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHH
T ss_pred cccccCCC---------CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHh
Confidence 98764322 12234689999999998765 58999999999999999999999998743221 122222211
Q ss_pred CChhHHHHHHhhHhHhhhccCCCCCCc---cccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 916 LPDKVMEIVDSVLLLEVQASNSRSCGD---ERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.......+ ... ...+.......... ..........++.+++.+||+.||++|||+.|+++
T Consensus 259 g~p~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 259 GTPSREQI-KTM-NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp CCCCHHHH-HHH-CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCCHHHH-Hhh-ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 11111100 000 00110000000000 00000113456899999999999999999999986
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=351.54 Aligned_cols=360 Identities=19% Similarity=0.193 Sum_probs=243.6
Q ss_pred CCCCccCCccccCCCCCCEEEeecccCCCCCCcccccCCCCcEeecccccccccCChhhcccccccccccccccccCCCC
Q 037275 84 NNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHF 163 (992)
Q Consensus 84 n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~~L~L~~n~l~~~~ 163 (992)
....+..+..++.+++|++|+|++|.+++ +| .++.+++|++|++++|++ ++ +
T Consensus 28 ~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l-------------------------~~-~ 79 (457)
T 3bz5_A 28 FEMQATDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNI-------------------------TT-L 79 (457)
T ss_dssp TTCCTTSEEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCC-------------------------SC-C
T ss_pred cCcCcccccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcC-------------------------Ce-E
Confidence 33444455566777777777777777763 44 455555555555555554 43 2
Q ss_pred CCccccccccceEEecCCcccCCcCCccCCCCcccEEeccCcccccccCccccccCCCcEEeccCCccCCCCCccccccc
Q 037275 164 PASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSL 243 (992)
Q Consensus 164 p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~ 243 (992)
| ++.+++|++|++++|.+.+. + ++++++|++|++++|++++ +| +..+++|++|++++|++++
T Consensus 80 ~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~---------- 141 (457)
T 3bz5_A 80 D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTE---------- 141 (457)
T ss_dssp C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSC----------
T ss_pred c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCccce----------
Confidence 3 67788999999999999664 4 8999999999999999996 44 8999999999999998873
Q ss_pred cccchhhccccccCCCCchhhhccccCceeeeccccccccccccccccCccceEecCCCCCCCCCCCCchhhhhccCCCc
Q 037275 244 PKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTE 323 (992)
Q Consensus 244 ~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~~ 323 (992)
++ ++.+++|++|++++|+..+.. .+..+++|++|++++|+++.++ +..+++
T Consensus 142 ----------------l~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~l~---------l~~l~~ 192 (457)
T 3bz5_A 142 ----------------ID--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITELD---------VSQNKL 192 (457)
T ss_dssp ----------------CC--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCCCC---------CTTCTT
T ss_pred ----------------ec--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccceec---------cccCCC
Confidence 11 556789999999999654444 5888999999999999998754 455677
Q ss_pred ceEeecCCCcCCCcCCcccccccccceeEEeeCCccccccCCCccCCCcccEEEccCCcCCCCCCccccCCCCCcEEecc
Q 037275 324 LTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLD 403 (992)
Q Consensus 324 L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 403 (992)
|+.|++++|++++. .++.+++|++|++++|++++ +| +..+++|+.|+++
T Consensus 193 L~~L~l~~N~l~~~----------------------------~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~ 241 (457)
T 3bz5_A 193 LNRLNCDTNNITKL----------------------------DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCS 241 (457)
T ss_dssp CCEEECCSSCCSCC----------------------------CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECC
T ss_pred CCEEECcCCcCCee----------------------------ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEee
Confidence 77777777777643 13444555555555555554 23 4455555555555
Q ss_pred CccccccCCCCCCCccccCceeccCCcccCCCCCCccccccccccccccccccccCchhhhhhcccccccccccccccCc
Q 037275 404 SNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGT 483 (992)
Q Consensus 404 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~ 483 (992)
+|++++.. +..+++|+.|++++|+ |+.|++++|.+.+.+|. .....++.|++++|.+.+.
T Consensus 242 ~N~l~~~~---~~~l~~L~~L~l~~n~--------------L~~L~l~~n~~~~~~~~---~~l~~L~~L~Ls~n~~l~~ 301 (457)
T 3bz5_A 242 VNPLTELD---VSTLSKLTTLHCIQTD--------------LLEIDLTHNTQLIYFQA---EGCRKIKELDVTHNTQLYL 301 (457)
T ss_dssp SSCCSCCC---CTTCTTCCEEECTTCC--------------CSCCCCTTCTTCCEEEC---TTCTTCCCCCCTTCTTCCE
T ss_pred CCcCCCcC---HHHCCCCCEEeccCCC--------------CCEEECCCCccCCcccc---cccccCCEEECCCCcccce
Confidence 55555432 2233444444444332 22333444443333331 1122333446666666656
Q ss_pred ccccccCCCCccEEeeecccccccCCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcccCCCChhhhhcC
Q 037275 484 LPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENL 563 (992)
Q Consensus 484 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 563 (992)
+|. ...+|+.|++++| ++|++|++++|+|++. + ++++++|+.|++++|+|++ +
T Consensus 302 l~~---~~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~--------l 354 (457)
T 3bz5_A 302 LDC---QAAGITELDLSQN-------------PKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD--------F 354 (457)
T ss_dssp EEC---TTCCCSCCCCTTC-------------TTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB--------C
T ss_pred ecc---CCCcceEechhhc-------------ccCCEEECCCCccccc-c--cccCCcCcEEECCCCCCCC--------c
Confidence 653 3456666666655 6899999999999974 3 9999999999999999996 3
Q ss_pred CCcceEecCCCcCcccCCCCCccCCcccccccCCCCc
Q 037275 564 SFLEYLNLSYNHFEGEVPTKGVFSNKTGISLSGNGKV 600 (992)
Q Consensus 564 ~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~l~~N~~~ 600 (992)
+.|..|++++|.++|.. .+..+..+.+..|...
T Consensus 355 ~~L~~L~l~~n~l~g~~----~~~~l~~l~l~~N~l~ 387 (457)
T 3bz5_A 355 SSVGKIPALNNNFEAEG----QTITMPKETLTNNSLT 387 (457)
T ss_dssp TTGGGSSGGGTSEEEEE----EEEECCCBCCBTTBEE
T ss_pred cccccccccCCcEEecc----eeeecCccccccCcEE
Confidence 56788899999999872 3445666777777543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=362.97 Aligned_cols=252 Identities=23% Similarity=0.312 Sum_probs=199.0
Q ss_pred HhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC-------------CchhHHHHHHHHHHhccCCcceeEEE
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK-------------GASNGFVAECQALRNIRHRNLIKIIT 743 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~~~~ 743 (992)
..++|++.++||+|+||+||+|++..+++.||+|++..... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 35689999999999999999999998999999999964321 23467899999999999999999999
Q ss_pred EeecccccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeee
Q 037275 744 ICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLL 823 (992)
Q Consensus 744 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 823 (992)
++. +....++||||+++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||++
T Consensus 114 ~~~-----~~~~~~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~ 179 (504)
T 3q5i_A 114 VFE-----DKKYFYLVTEFYEGGELFEQIINRH------KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILL 179 (504)
T ss_dssp EEE-----CSSEEEEEEECCTTCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred EEE-----cCCEEEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEE
Confidence 964 4566799999999999999997543 589999999999999999999999 99999999999999
Q ss_pred CCCC---cEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCC
Q 037275 824 DQDL---VAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDG 900 (992)
Q Consensus 824 ~~~~---~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 900 (992)
+.++ .+||+|||+|....... ......||+.|+|||++. +.++.++||||+||++|+|++|+.||.+
T Consensus 180 ~~~~~~~~~kl~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~ 249 (504)
T 3q5i_A 180 ENKNSLLNIKIVDFGLSSFFSKDY---------KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGG 249 (504)
T ss_dssp SSTTCCSSEEECCCTTCEECCTTS---------CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ecCCCCccEEEEECCCCEEcCCCC---------ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 8776 69999999998765321 223346999999999876 4699999999999999999999999986
Q ss_pred CccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 901 MFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.... +++.......+.. ..........++.+++.+||+.||.+|||++|+++
T Consensus 250 ~~~~-----------------~~~~~i~~~~~~~--------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 250 QNDQ-----------------DIIKKVEKGKYYF--------DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp SSHH-----------------HHHHHHHHCCCCC--------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCHH-----------------HHHHHHHcCCCCC--------CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 3221 1111111110000 00000112345889999999999999999999985
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=352.76 Aligned_cols=191 Identities=25% Similarity=0.378 Sum_probs=105.8
Q ss_pred CCCcCCeeeccCCCCCccCCccccCCCCCCEEEeecccCCCCCCcccccCCCCcEeecccccccccCChhhccccccccc
Q 037275 72 NLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLEN 151 (992)
Q Consensus 72 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~~ 151 (992)
.+++|+.|++++|.+. .+|. +..+++|++|+|++|.++ .+|. ++.+++|++|++++|++++ ++. +.++++|++
T Consensus 44 ~l~~l~~L~l~~~~i~-~l~~-~~~l~~L~~L~Ls~n~l~-~~~~-~~~l~~L~~L~l~~n~l~~-~~~--~~~l~~L~~ 116 (466)
T 1o6v_A 44 DLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLT-DITP-LKNLTKLVDILMNNNQIAD-ITP--LANLTNLTG 116 (466)
T ss_dssp HHHTCCEEECCSSCCC-CCTT-GGGCTTCCEEECCSSCCC-CCGG-GTTCTTCCEEECCSSCCCC-CGG--GTTCTTCCE
T ss_pred HhccccEEecCCCCCc-cCcc-hhhhcCCCEEECCCCccC-Cchh-hhccccCCEEECCCCcccc-Chh--hcCCCCCCE
Confidence 3566777777777776 4553 666777777777777776 3443 6666777777776666663 332 235556666
Q ss_pred ccccccccCCCCCCccccccccceEEecCCcccCCcCCccCCCCcccEEeccCcccccccCccccccCCCcEEeccCCcc
Q 037275 152 LTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRF 231 (992)
Q Consensus 152 L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l 231 (992)
|++++|.+++. |. +.++++|++|++++|.+.+ ++ .+..+++|++|+++ |.+.+. ..+.++++|++|++++|.+
T Consensus 117 L~L~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~-~~~~~~--~~~~~l~~L~~L~l~~n~l 189 (466)
T 1o6v_A 117 LTLFNNQITDI-DP-LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFG-NQVTDL--KPLANLTTLERLDISSNKV 189 (466)
T ss_dssp EECCSSCCCCC-GG-GTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEE-ESCCCC--GGGTTCTTCCEEECCSSCC
T ss_pred EECCCCCCCCC-hH-HcCCCCCCEEECCCCccCC-Ch-hhccCCcccEeecC-CcccCc--hhhccCCCCCEEECcCCcC
Confidence 66666665533 22 5556666666666665533 22 35555666666654 333322 1255555555555555554
Q ss_pred CCCCCccccccccccchhhccccccCCCCchhhhccccCceeeeccccccccccccccccCccceEecCCCCCC
Q 037275 232 NGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLG 305 (992)
Q Consensus 232 ~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 305 (992)
.+ + ..+..+++|++|++++|++++..+ +..+++|++|++++|+++
T Consensus 190 ~~--------------------------~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~ 234 (466)
T 1o6v_A 190 SD--------------------------I-SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLK 234 (466)
T ss_dssp CC--------------------------C-GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCC
T ss_pred CC--------------------------C-hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcc
Confidence 41 1 124445555555555555554433 444555555555555544
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=346.89 Aligned_cols=249 Identities=21% Similarity=0.297 Sum_probs=202.6
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
.++|.+.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++. ...
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~ 114 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----DND 114 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----cCC
Confidence 457999999999999999999999899999999987442 223467889999999999999999999964 345
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
..++||||+++++|.+++.... .+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 115 ~~~lv~e~~~~~~L~~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Df 185 (335)
T 2owb_A 115 FVFVVLELCRRRSLLELHKRRK------ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDF 185 (335)
T ss_dssp EEEEEECCCTTCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCC
T ss_pred eEEEEEecCCCCCHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeec
Confidence 6799999999999999987543 589999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
|++....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... +
T Consensus 186 g~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~---- 248 (335)
T 2owb_A 186 GLATKVEYDG--------ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-----E---- 248 (335)
T ss_dssp TTCEECCSTT--------CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----H----
T ss_pred cCceecccCc--------ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH-----H----
Confidence 9998764321 1123346899999999999999999999999999999999999999753211 0
Q ss_pred hCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 915 ALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
........... .. ......+.+++.+||+.||++|||++|+++
T Consensus 249 --------~~~~~~~~~~~------~~------~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 249 --------TYLRIKKNEYS------IP------KHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp --------HHHHHHHTCCC------CC------TTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred --------HHHHHhcCCCC------CC------ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01111100000 00 011245788999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=338.17 Aligned_cols=250 Identities=24% Similarity=0.342 Sum_probs=203.4
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC-CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
.+.|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.++++++||||+++++++.. ....
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 95 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----DTKL 95 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----CCeE
Confidence 356899999999999999999998899999999997543 3445788999999999999999999998643 4567
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
++||||+++++|.+++... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.
T Consensus 96 ~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~ 165 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLEPG-------PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGV 165 (303)
T ss_dssp EEEEECCTTEEHHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEeCCCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeeccc
Confidence 9999999999999998642 489999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhC
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTAL 916 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 916 (992)
+....... .......|++.|+|||++.+..++.++||||||+++|+|++|+.||...... .
T Consensus 166 ~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~------ 226 (303)
T 3a7i_A 166 AGQLTDTQ--------IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM-----K------ 226 (303)
T ss_dssp CEECBTTB--------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----H------
T ss_pred ceecCccc--------cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH-----H------
Confidence 98765421 1123356899999999999999999999999999999999999998753211 0
Q ss_pred ChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 917 PDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
....+. ... ..... ......+.+++.+||+.||++|||+.|+++.
T Consensus 227 ---~~~~~~---~~~-----~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 227 ---VLFLIP---KNN-----PPTLE------GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp ---HHHHHH---HSC-----CCCCC------SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred ---HHHHhh---cCC-----CCCCc------cccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000000 000 00000 0113458899999999999999999999874
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=353.08 Aligned_cols=259 Identities=16% Similarity=0.131 Sum_probs=201.8
Q ss_pred HhcCCCCCCccccccceEEEEeE-----ECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhcc---CCcceeEEEEeecc
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGN-----LGENGMMVAVKVINLKQKGASNGFVAECQALRNIR---HRNLIKIITICSSI 748 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~ 748 (992)
..++|++.++||+|+||+||+|. ...+++.||||+++.. ...++.+|+++++.++ |+||+++++++..
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~- 138 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF- 138 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC-
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec-
Confidence 35679999999999999999994 5568899999998533 4566788888888886 9999999999643
Q ss_pred cccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCC---
Q 037275 749 DFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQ--- 825 (992)
Q Consensus 749 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~--- 825 (992)
.+..++||||+++|+|.+++...... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.
T Consensus 139 ----~~~~~lv~e~~~~g~L~~~l~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~ 210 (365)
T 3e7e_A 139 ----QNGSVLVGELYSYGTLLNAINLYKNT-PEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFL 210 (365)
T ss_dssp ----SSCEEEEECCCCSCBHHHHHHHHHTS-TTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGT
T ss_pred ----CCCcEEEEeccCCCcHHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEeccccc
Confidence 44569999999999999999864321 124599999999999999999999999 9999999999999998
Q ss_pred --------CCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCC
Q 037275 826 --------DLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897 (992)
Q Consensus 826 --------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p 897 (992)
++.+||+|||+|+.+.... .........||+.|+|||++.+..++.++|||||||++|||+||+.|
T Consensus 211 ~~~~~~~~~~~~kl~DFG~a~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 284 (365)
T 3e7e_A 211 EQDDEDDLSAGLALIDLGQSIDMKLFP------KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284 (365)
T ss_dssp CC------CTTEEECCCTTCEEGGGSC------TTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCC
T ss_pred CccccccccCCEEEeeCchhhhhhccC------CCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCc
Confidence 8999999999998654221 11122345699999999999999999999999999999999999999
Q ss_pred CCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCC-CCHHHHH
Q 037275 898 TDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTER-MEMRDVV 976 (992)
Q Consensus 898 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~evl 976 (992)
|............ .. +.. . ....+.+++..|+..+|.+| |+++++.
T Consensus 285 f~~~~~~~~~~~~----~~---------------------~~~-----~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~ 331 (365)
T 3e7e_A 285 KVKNEGGECKPEG----LF---------------------RRL-----P---HLDMWNEFFHVMLNIPDCHHLPSLDLLR 331 (365)
T ss_dssp CEEEETTEEEECS----CC---------------------TTC-----S---SHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred cccCCCCceeech----hc---------------------ccc-----C---cHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence 8653221110000 00 000 0 12346678888999999998 6788888
Q ss_pred HHHHHHHHhh
Q 037275 977 AKLCRARDTF 986 (992)
Q Consensus 977 ~~L~~~~~~~ 986 (992)
+.|++.....
T Consensus 332 ~~l~~~l~~~ 341 (365)
T 3e7e_A 332 QKLKKVFQQH 341 (365)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHh
Confidence 8888776553
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=346.68 Aligned_cols=266 Identities=23% Similarity=0.368 Sum_probs=201.8
Q ss_pred hcCCCCCCccccccceEEEEeE-----ECCCCeEEEEEEeeccC-CCchhHHHHHHHHHHhccCCcceeEEEEeeccccc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGN-----LGENGMMVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIKIITICSSIDFK 751 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~-----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 751 (992)
.++|++.+.||+|+||.||+|+ ...+++.||||++.... ......+.+|+.++++++||||+++++++..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---- 104 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ---- 104 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC----
Confidence 4589999999999999999999 44577899999996332 2344678899999999999999999999643
Q ss_pred CcceEEEEEEeccCCCHHHHHhhcccc-hhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCC---CC
Q 037275 752 GVDFQAIVYEYMQNGSLEDWLHQSEDQ-QEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQ---DL 827 (992)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~ 827 (992)
....++||||+++|+|.+++...... .....+++..++.++.|++.||+|||++ +|+||||||+||+++. +.
T Consensus 105 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~ 180 (327)
T 2yfx_A 105 -SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGR 180 (327)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTC
T ss_pred -CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcc
Confidence 44559999999999999999876432 1123589999999999999999999999 9999999999999984 44
Q ss_pred cEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCc
Q 037275 828 VAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGL 906 (992)
Q Consensus 828 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~ 906 (992)
.+||+|||++........ ........||+.|+|||++.+..++.++|||||||++|+|++ |+.||......
T Consensus 181 ~~kl~Dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-- 252 (327)
T 2yfx_A 181 VAKIGDFGMARDIYRASY------YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-- 252 (327)
T ss_dssp CEEECCCHHHHHHHC------------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--
T ss_pred eEEECccccccccccccc------cccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH--
Confidence 699999999986543221 111233457899999999988899999999999999999998 99998753211
Q ss_pred cHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 037275 907 TLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDT 985 (992)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 985 (992)
+.......... .... ......+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 253 ---------------~~~~~~~~~~~-~~~~----------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 253 ---------------EVLEFVTSGGR-MDPP----------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp ---------------HHHHHHHTTCC-CCCC----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ---------------HHHHHHhcCCC-CCCC----------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 11111110000 0000 11234588999999999999999999999999988654
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=343.63 Aligned_cols=253 Identities=22% Similarity=0.293 Sum_probs=196.6
Q ss_pred HhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC--------CCchhHHHHHHHHHHhccCCcceeEEEEeecc
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--------KGASNGFVAECQALRNIRHRNLIKIITICSSI 748 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 748 (992)
..++|++.+.||+|+||.||+|++..+++.||||++.... ......+.+|++++++++||||+++++++..
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 86 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 86 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC-
Confidence 3467999999999999999999999899999999986432 1223458899999999999999999998643
Q ss_pred cccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCc
Q 037275 749 DFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLV 828 (992)
Q Consensus 749 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 828 (992)
. ..++||||+++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.
T Consensus 87 ----~-~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~ 152 (322)
T 2ycf_A 87 ----E-DYYIVLELMEGGELFDKVVGNK------RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEE 152 (322)
T ss_dssp ----S-SEEEEEECCTTEETHHHHSTTC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSS
T ss_pred ----C-ceEEEEecCCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCC
Confidence 2 2699999999999999987543 589999999999999999999999 9999999999999987664
Q ss_pred ---EEEeecccceecCCCCCCCCcccCCCCCccccccccccccccc---CCCcCcccchhhHHHHHHHHHhCCCCCCCCc
Q 037275 829 ---AHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGM---GGEASMTGDVYSFGILLLEMFTRRRPTDGMF 902 (992)
Q Consensus 829 ---~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 902 (992)
+||+|||+++...... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||....
T Consensus 153 ~~~~kl~Dfg~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 223 (322)
T 2ycf_A 153 DCLIKITDFGHSKILGETS---------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 223 (322)
T ss_dssp SCCEEECCCTTCEECCCCH---------HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTT
T ss_pred CCeEEEccCccceeccccc---------ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 9999999998764321 112345899999999863 5678999999999999999999999998643
Q ss_pred cCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 903 NQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
................ .... ......++.+++.+||+.||++|||++|+++
T Consensus 224 ~~~~~~~~~~~~~~~~-~~~~-----------------------~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 224 TQVSLKDQITSGKYNF-IPEV-----------------------WAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp CSSCHHHHHHHTCCCC-CHHH-----------------------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hHHHHHHHHHhCcccc-Cchh-----------------------hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 3322111111111100 0000 0012345889999999999999999999985
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=370.64 Aligned_cols=262 Identities=29% Similarity=0.470 Sum_probs=208.4
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
.++|++.++||+|+||.||+|++. .+..||||+++... ...+.+.+|++++++++||||+++++++.. ...+
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~~~ 337 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY 337 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred hhhhhhheecccCCCeEEEEEEEC-CCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee------ccce
Confidence 457888999999999999999997 46789999997443 345789999999999999999999998643 3468
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||+++|+|.+++.... ...+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 338 lv~e~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a 410 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGET----GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLA 410 (535)
T ss_dssp EEECCCTTEEHHHHHSHHH----HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTST
T ss_pred EeeehhcCCcHHHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccc
Confidence 9999999999999997543 23589999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhhhC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFARTAL 916 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 916 (992)
+...... ........++..|+|||++.+..++.++|||||||++|||++ |+.||.+....
T Consensus 411 ~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~------------ 471 (535)
T 2h8h_A 411 RLIEDNE-------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------------ 471 (535)
T ss_dssp TTCCCHH-------HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH------------
T ss_pred eecCCCc-------eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------------
Confidence 8654321 111223346889999999998899999999999999999999 99999764221
Q ss_pred ChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhhc
Q 037275 917 PDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTFLGR 989 (992)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 989 (992)
++.+... ..+..... ......+.+++.+||+.||++|||+++|++.|+++......+
T Consensus 472 -----~~~~~i~-~~~~~~~~----------~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~ 528 (535)
T 2h8h_A 472 -----EVLDQVE-RGYRMPCP----------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 528 (535)
T ss_dssp -----HHHHHHH-TTCCCCCC----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSCS
T ss_pred -----HHHHHHH-cCCCCCCC----------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCcc
Confidence 1111111 00000000 112345889999999999999999999999999876654443
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=345.81 Aligned_cols=253 Identities=22% Similarity=0.318 Sum_probs=197.7
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
.++|++.+.||+|+||.||+|++..+++.||+|++........+.+.+|+.++++++||||+++++++.. ....+
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 92 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYH-----DGKLW 92 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----C-CEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeee-----CCeEE
Confidence 4589999999999999999999998999999999976666677889999999999999999999999643 45679
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||+++++|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 93 lv~e~~~~~~l~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 164 (302)
T 2j7t_A 93 IMIEFCPGGAVDAIMLELDR-----GLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVS 164 (302)
T ss_dssp EEEECCTTEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHH
T ss_pred EEEEeCCCCcHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCC
Confidence 99999999999999876432 489999999999999999999999 9999999999999999999999999987
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccc-----cCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHH
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYG-----MGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFA 912 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~ 912 (992)
..... .........||+.|+|||++ .+..++.++|||||||++|+|++|+.||......
T Consensus 165 ~~~~~--------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------- 228 (302)
T 2j7t_A 165 AKNLK--------TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-------- 228 (302)
T ss_dssp HHHHH--------HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------
T ss_pred ccccc--------cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH--------
Confidence 54321 11112234689999999987 4667899999999999999999999999753211
Q ss_pred hhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 913 RTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
............ . .........++.+++.+||+.||++|||+.|+++
T Consensus 229 ---------~~~~~~~~~~~~-----~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 229 ---------RVLLKIAKSDPP-----T----LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp ---------HHHHHHHHSCCC-----C----CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ---------HHHHHHhccCCc-----c----cCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 000000000000 0 0001112345889999999999999999999975
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=366.13 Aligned_cols=251 Identities=28% Similarity=0.382 Sum_probs=202.3
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
.++|++.++||+|+||+||+|++..+++.||||++.... ......+.+|+.++++++||||+++++++. ...
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~ 99 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE-----DKG 99 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----eCC
Confidence 357999999999999999999999999999999996442 345677899999999999999999999964 456
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeee---CCCCcEEE
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLL---DQDLVAHL 831 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl 831 (992)
..++||||+.+|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||++ +.++.+||
T Consensus 100 ~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl 170 (484)
T 3nyv_A 100 YFYLVGEVYTGGELFDEIISRK------RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRI 170 (484)
T ss_dssp EEEEEECCCCSCBHHHHHHTCS------CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEE
T ss_pred EEEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEE
Confidence 6799999999999999997643 489999999999999999999999 99999999999999 56789999
Q ss_pred eecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHH
Q 037275 832 GDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEF 911 (992)
Q Consensus 832 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~ 911 (992)
+|||+|+...... ......||+.|+|||++.+ .++.++||||+||++|+|++|++||.+....
T Consensus 171 ~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------- 233 (484)
T 3nyv_A 171 IDFGLSTHFEASK---------KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY------- 233 (484)
T ss_dssp CCTTHHHHBCCCC---------SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------
T ss_pred EeeeeeEEccccc---------ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH-------
Confidence 9999998765321 1233468999999999876 6899999999999999999999999763211
Q ss_pred HhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 912 ARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
+.+.......+.. ...........+.+++.+||+.||++|||+.|+++
T Consensus 234 ----------~~~~~i~~~~~~~--------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 234 ----------DILKKVEKGKYTF--------ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp ----------HHHHHHHHCCCCC--------CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----------HHHHHHHcCCCCC--------CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 1111111111100 00011122345889999999999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=345.04 Aligned_cols=279 Identities=20% Similarity=0.292 Sum_probs=198.3
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeeccc--------
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSID-------- 749 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-------- 749 (992)
.++|++.+.||+|+||.||+|++..+++.||+|++........+.+.+|+.++++++||||+++++++....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 358999999999999999999999889999999997665555678899999999999999999999875321
Q ss_pred -ccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeC-CCC
Q 037275 750 -FKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLD-QDL 827 (992)
Q Consensus 750 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~ 827 (992)
.......++||||++ |+|.+++... .+++..++.++.|++.||+|||++ +|+||||||+||+++ +++
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 158 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQG-------PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDL 158 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTC-------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTT
T ss_pred cccccCceeEEeeccC-CCHHHHhhcC-------CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCC
Confidence 234567899999997 6999998642 488999999999999999999999 999999999999997 567
Q ss_pred cEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCc
Q 037275 828 VAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGL 906 (992)
Q Consensus 828 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~ 906 (992)
.+||+|||.++....... .........++..|+|||++.+ ..++.++|||||||++|||++|+.||.+.....
T Consensus 159 ~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~- 232 (320)
T 2i6l_A 159 VLKIGDFGLARIMDPHYS-----HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE- 232 (320)
T ss_dssp EEEECCCTTCBCC-------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-
T ss_pred eEEEccCccccccCCCcc-----cccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH-
Confidence 999999999987643211 1112233457899999998765 678999999999999999999999998643211
Q ss_pred cHHHHHhhhC--Chh-HHHHHHh---hHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 907 TLHEFARTAL--PDK-VMEIVDS---VLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 907 ~~~~~~~~~~--~~~-~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.......... ... ..+.... ........ .. ............++.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 233 QMQLILESIPVVHEEDRQELLSVIPVYIRNDMTE--PH--KPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTS--CC--CCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHhcCCCchhhhhhhhhcCcccccccccC--CC--CChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 1111111110 000 1111100 00000000 00 0000000112456899999999999999999999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=347.41 Aligned_cols=289 Identities=24% Similarity=0.270 Sum_probs=196.8
Q ss_pred HHHHHHHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccc
Q 037275 671 YAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDF 750 (992)
Q Consensus 671 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 750 (992)
..+.....++|++.+.||+|+||+||+|++..+++.||||++... ........+|+..++.++||||+++++++.....
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp SHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 345667788999999999999999999999989999999998643 3344567788888999999999999999865332
Q ss_pred --cCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHH--hcCCCCeEeccCCCCCeeeCC-
Q 037275 751 --KGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIH--HHCQPPVVHGDLKPSNVLLDQ- 825 (992)
Q Consensus 751 --~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH--~~~~~~ivH~Dlkp~NIll~~- 825 (992)
....+.++||||+++ ++.+.+..... ....+++..+..++.|++.||+||| ++ +|+||||||+||+++.
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~ 167 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYR--RQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEA 167 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETT
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCC
Confidence 233457899999975 66655543221 1335889999999999999999999 88 9999999999999996
Q ss_pred CCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCCCccC
Q 037275 826 DLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRRRPTDGMFNQ 904 (992)
Q Consensus 826 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~ 904 (992)
++.+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+....
T Consensus 168 ~~~~kl~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~ 238 (360)
T 3e3p_A 168 DGTLKLCDFGSAKKLSPSE---------PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA 238 (360)
T ss_dssp TTEEEECCCTTCBCCCTTS---------CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CCcEEEeeCCCceecCCCC---------CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH
Confidence 8999999999998765322 12234689999999998665 4899999999999999999999999874322
Q ss_pred CccHHHHHhhhC--ChhHHHHHHhhHhHhhhccCCCCCCcc---ccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 905 GLTLHEFARTAL--PDKVMEIVDSVLLLEVQASNSRSCGDE---RLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 905 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
..+....+... +.......++... ............. .........++.+++.+||+.||++|||+.|+++
T Consensus 239 -~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 239 -GQLHEIVRVLGCPSREVLRKLNPSHT-DVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp -HHHHHHHHHHCCCCHHHHHHHCTTCC-CGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -HHHHHHHHHcCCCCHHHHHhcccchh-hccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 11222222111 1111111111000 0000000000000 0000113467899999999999999999999985
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=334.45 Aligned_cols=249 Identities=27% Similarity=0.375 Sum_probs=194.3
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc---CCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK---QKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
.++|++.+.||+|+||.||+|++..+++.||||++... .....+.+.+|+.+++.++||||+++++++. ...
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 84 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS-----TPT 84 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEe-----cCC
Confidence 35899999999999999999999889999999999643 2344567899999999999999999999864 345
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
..++||||+++++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~df 155 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICKHG------RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADF 155 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCC
T ss_pred eEEEEEeccCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeec
Confidence 6799999999999999997643 489999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCc-CcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEA-SMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 913 (992)
|.+....... ......|++.|+|||++.+..+ +.++||||+|+++|+|++|+.||......
T Consensus 156 g~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------- 217 (276)
T 2h6d_A 156 GLSNMMSDGE---------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP--------- 217 (276)
T ss_dssp CGGGCCCC----------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH---------
T ss_pred ccccccCCCc---------ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH---------
Confidence 9998654321 1123458999999999888765 68999999999999999999999753111
Q ss_pred hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 914 TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
........... ..+ ......+.+++.+||+.||++|||++|+++.
T Consensus 218 --------~~~~~~~~~~~------~~~------~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 218 --------TLFKKIRGGVF------YIP------EYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp --------HHHHHHHHCCC------CCC------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --------HHHHHhhcCcc------cCc------hhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11111110000 000 0113458899999999999999999999873
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=350.39 Aligned_cols=347 Identities=29% Similarity=0.409 Sum_probs=208.7
Q ss_pred cccccccccccccCCCCCCccccccccceEEecCCcccCCcCCccCCCCcccEEeccCcccccccCccccccCCCcEEec
Q 037275 147 LKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFL 226 (992)
Q Consensus 147 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l 226 (992)
++|+.|++++|.++ .+| .+..+++|++|++++|.+.+..+ +.++++|++|++++|++++..+ +.++++|++|++
T Consensus 46 ~~l~~L~l~~~~i~-~l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L 119 (466)
T 1o6v_A 46 DQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTL 119 (466)
T ss_dssp HTCCEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred ccccEEecCCCCCc-cCc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEEC
Confidence 34444444444444 233 24445555555555555533222 5555555555555555553222 555555555555
Q ss_pred cCCccCCCCCccccccccccchhhccccccCCCCchhhhccccCceeeeccccccccccccccccCccceEecCCCCCCC
Q 037275 227 PTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGT 306 (992)
Q Consensus 227 ~~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 306 (992)
++|++++. +. +..+++|++|++++|.+.+ ++ .++.+++|++|+++ |.+.+..+ +..+++|++|++++|.++.
T Consensus 120 ~~n~l~~~-~~--~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~-~~~~~~~~--~~~l~~L~~L~l~~n~l~~ 191 (466)
T 1o6v_A 120 FNNQITDI-DP--LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVSD 191 (466)
T ss_dssp CSSCCCCC-GG--GTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEE-ESCCCCGG--GTTCTTCCEEECCSSCCCC
T ss_pred CCCCCCCC-hH--HcCCCCCCEEECCCCccCC-Ch-hhccCCcccEeecC-CcccCchh--hccCCCCCEEECcCCcCCC
Confidence 55544421 10 1112222222222222221 11 24445555555553 33332221 4555555555555555443
Q ss_pred CCCCCchhhhhccCCCcceEeecCCCcCCCcCCcccccccccceeEEeeCCccccccCCCccCCCcccEEEccCCcCCCC
Q 037275 307 GEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGT 386 (992)
Q Consensus 307 ~~~~~~~~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~ 386 (992)
++ .+..+++ |++|++++|++++..| ++.+++|++|++++|++++.
T Consensus 192 ~~--------~l~~l~~-------------------------L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~ 236 (466)
T 1o6v_A 192 IS--------VLAKLTN-------------------------LESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI 236 (466)
T ss_dssp CG--------GGGGCTT-------------------------CSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC
T ss_pred Ch--------hhccCCC-------------------------CCEEEecCCccccccc--ccccCCCCEEECCCCCcccc
Confidence 21 1333333 4555555555554443 55667777888888777643
Q ss_pred CCccccCCCCCcEEeccCccccccCCCCCCCccccCceeccCCcccCCCCCCccccccccccccccccccccCchhhhhh
Q 037275 387 IPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSI 466 (992)
Q Consensus 387 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~ 466 (992)
..+..+++|+.|++++|++++..+ +..+++|+.|++++|++++..+ +..+++|+.|++++|+++
T Consensus 237 --~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~---------- 300 (466)
T 1o6v_A 237 --GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLE---------- 300 (466)
T ss_dssp --GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCS----------
T ss_pred --hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCccc----------
Confidence 356777788888888888775544 6777788888888888875433 667777777755555443
Q ss_pred cccccccccccccccCcccccccCCCCccEEeeecccccccCCcccccccccceeeccCCcccccCCccccccCCCCEEE
Q 037275 467 STLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELD 546 (992)
Q Consensus 467 ~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 546 (992)
+..+ +..+++|++|+|++|++++..| +..+++|++|++++|++++. ..+..+++|+.|+
T Consensus 301 ---------------~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~ 359 (466)
T 1o6v_A 301 ---------------DISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLS 359 (466)
T ss_dssp ---------------CCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEE
T ss_pred ---------------Cchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEe
Confidence 3322 6788899999999999987665 78889999999999999865 4788999999999
Q ss_pred CCCcccCCCChhhhhcCCCcceEecCCCcCcccCC
Q 037275 547 MSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVP 581 (992)
Q Consensus 547 Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~ 581 (992)
+++|++++..| +..+++|+.|++++|++++.+.
T Consensus 360 l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~~p~ 392 (466)
T 1o6v_A 360 AGHNQISDLTP--LANLTRITQLGLNDQAWTNAPV 392 (466)
T ss_dssp CCSSCCCBCGG--GTTCTTCCEEECCCEEEECCCB
T ss_pred CCCCccCccch--hhcCCCCCEEeccCCcccCCch
Confidence 99999998776 8889999999999999988543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=372.33 Aligned_cols=256 Identities=21% Similarity=0.341 Sum_probs=200.1
Q ss_pred ccccccceEEEEeEEC--CCCeEEEEEEeeccC-CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEEEEe
Q 037275 686 MIGQGSFGFVYKGNLG--ENGMMVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEY 762 (992)
Q Consensus 686 ~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 762 (992)
.||+|+||+||+|.+. .++..||||+++... ....+.+.+|++++++++||||+++++++.. ...++||||
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~------~~~~lv~E~ 416 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------EALMLVMEM 416 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES------SSEEEEEEC
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc------CCeEEEEEe
Confidence 7999999999999874 356789999997543 3356789999999999999999999999743 246999999
Q ss_pred ccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceecCC
Q 037275 763 MQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSS 842 (992)
Q Consensus 763 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 842 (992)
+++|+|.+++..... .+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+|+....
T Consensus 417 ~~~g~L~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 417 AGGGPLHKFLVGKRE-----EIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp CTTCBHHHHHTTCTT-----TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred CCCCcHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 999999999975432 489999999999999999999999 999999999999999999999999999986643
Q ss_pred CCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhhhCChhHH
Q 037275 843 SPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFARTALPDKVM 921 (992)
Q Consensus 843 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 921 (992)
.... ........+++.|+|||++.+..++.++|||||||++|||++ |+.||.+.... ...
T Consensus 489 ~~~~-----~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--------------~~~ 549 (613)
T 2ozo_A 489 DDSY-----YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--------------EVM 549 (613)
T ss_dssp ------------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH--------------HHH
T ss_pred CCce-----eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH--------------HHH
Confidence 2110 111122345789999999998999999999999999999998 99999864321 011
Q ss_pred HHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhh
Q 037275 922 EIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTFLG 988 (992)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 988 (992)
..+.. ....... .....++.+++.+||+.||++|||+.+|++.|+.+..+...
T Consensus 550 ~~i~~----~~~~~~p----------~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~ 602 (613)
T 2ozo_A 550 AFIEQ----GKRMECP----------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602 (613)
T ss_dssp HHHHT----TCCCCCC----------TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred HHHHc----CCCCCCC----------CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence 11110 0000000 11235689999999999999999999999999998776544
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=349.47 Aligned_cols=280 Identities=24% Similarity=0.308 Sum_probs=204.2
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC-CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
.++|++.+.||+|+||+||+|++..+|+.||||++..... .....+.+|+.++++++||||+++++++....+......
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 4589999999999999999999998999999999964332 234567899999999999999999999876555666788
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
++||||+. |+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 90 ~lv~e~~~-~~L~~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ-------MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGL 158 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEeccC-ccHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccc
Confidence 99999996 5999998752 489999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCCCc--ccCCCCCcccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh
Q 037275 837 AKFLSSSPLDTAV--ETPSSSKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 837 a~~~~~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 913 (992)
++........... ..........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+...... ......
T Consensus 159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~ 237 (353)
T 2b9h_A 159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ-LLLIFG 237 (353)
T ss_dssp CEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHH
T ss_pred ccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHH
Confidence 9877543211110 01112234578999999998764 6789999999999999999999999986432111 111000
Q ss_pred h-hCC-----------hhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 914 T-ALP-----------DKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 914 ~-~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
. ..+ ....+..... . ..... ...........++.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~-----~--~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 238 IIGTPHSDNDLRCIESPRAREYIKSL-----P--MYPAA-PLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHCCCCSTTTTTTCCCHHHHHHHHTS-----C--CCCCC-CHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhCCCchhccccccccchhhHHhhcc-----c--CCCCc-chhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0 000 0000110000 0 00000 000000122456889999999999999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=370.64 Aligned_cols=255 Identities=25% Similarity=0.370 Sum_probs=199.4
Q ss_pred CccccccceEEEEeEE--CCCCeEEEEEEeeccCC--CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEEE
Q 037275 685 NMIGQGSFGFVYKGNL--GENGMMVAVKVINLKQK--GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVY 760 (992)
Q Consensus 685 ~~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 760 (992)
++||+|+||+||+|.+ ..+++.||||+++.... ...+.+.+|++++++++||||+++++++.. ...++||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~~~~lv~ 448 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM 448 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES------SSEEEEE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------CCEEEEE
Confidence 4799999999999955 45678999999975432 335789999999999999999999998742 2368999
Q ss_pred EeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceec
Q 037275 761 EYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFL 840 (992)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 840 (992)
||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+|+.+
T Consensus 449 E~~~~g~L~~~l~~~~------~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 519 (635)
T 4fl3_A 449 EMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL 519 (635)
T ss_dssp ECCTTEEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHT
T ss_pred EccCCCCHHHHHhhCC------CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCcccc
Confidence 9999999999997543 589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhhhCChh
Q 037275 841 SSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFARTALPDK 919 (992)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 919 (992)
...... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.... .
T Consensus 520 ~~~~~~-----~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--------------~ 580 (635)
T 4fl3_A 520 RADENY-----YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--------------E 580 (635)
T ss_dssp TC------------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------------H
T ss_pred ccCccc-----cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------------H
Confidence 543211 111222346789999999999999999999999999999998 99999764221 0
Q ss_pred HHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhh
Q 037275 920 VMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTFL 987 (992)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 987 (992)
....+.. .... ..+ .....++.+++.+||+.||++|||+++|++.|+++..++.
T Consensus 581 ~~~~i~~----~~~~----~~p------~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l~ 634 (635)
T 4fl3_A 581 VTAMLEK----GERM----GCP------AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 634 (635)
T ss_dssp HHHHHHT----TCCC----CCC------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHC
T ss_pred HHHHHHc----CCCC----CCC------CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhc
Confidence 1111111 0000 000 1123568999999999999999999999999999877653
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=337.80 Aligned_cols=248 Identities=21% Similarity=0.280 Sum_probs=196.7
Q ss_pred HhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC--CCchhHHHHHHHHHHhc-cCCcceeEEEEeecccccCc
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNI-RHRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 753 (992)
..++|++.+.||+|+||+||+|++..+++.||+|++.... ......+.+|+..+..+ +||||+++++++.+ .
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~-----~ 83 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE-----D 83 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE-----T
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec-----C
Confidence 3568999999999999999999999899999999997542 23456788999999999 99999999999643 4
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCC-------
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQD------- 826 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~------- 826 (992)
...++||||+++|+|.+++...... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.+
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~ 158 (289)
T 1x8b_A 84 DHMLIQNEYCNGGSLADAISENYRI--MSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAAS 158 (289)
T ss_dssp TEEEEEEECCTTCBHHHHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC---------
T ss_pred CeEEEEEEecCCCcHHHHHHhhccc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccc
Confidence 5679999999999999999865421 23589999999999999999999999 99999999999999844
Q ss_pred ------------CcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCC-CcCcccchhhHHHHHHHHHh
Q 037275 827 ------------LVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFT 893 (992)
Q Consensus 827 ------------~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt 893 (992)
..+||+|||.+...... ....||+.|+|||++.+. .++.++|||||||++|+|++
T Consensus 159 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (289)
T 1x8b_A 159 EEGDEDDWASNKVMFKIGDLGHVTRISSP------------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAG 226 (289)
T ss_dssp -----------CCCEEECCCTTCEETTCS------------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTT
T ss_pred cccccccccCCceEEEEcccccccccCCc------------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhc
Confidence 48999999999876432 122489999999998776 56789999999999999999
Q ss_pred CCCCCCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHH
Q 037275 894 RRRPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMR 973 (992)
Q Consensus 894 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 973 (992)
|.+|+... ........... ...+ .....++.+++.+||+.||++|||+.
T Consensus 227 ~~~~~~~~----~~~~~~~~~~~---------------------~~~~------~~~~~~~~~li~~~l~~dp~~Rps~~ 275 (289)
T 1x8b_A 227 AEPLPRNG----DQWHEIRQGRL---------------------PRIP------QVLSQEFTELLKVMIHPDPERRPSAM 275 (289)
T ss_dssp CCCCCSSS----HHHHHHHTTCC---------------------CCCS------SCCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCCcch----hHHHHHHcCCC---------------------CCCC------cccCHHHHHHHHHHhCCCcccCCCHH
Confidence 99876431 01111100000 0000 01134588999999999999999999
Q ss_pred HHHH
Q 037275 974 DVVA 977 (992)
Q Consensus 974 evl~ 977 (992)
|+++
T Consensus 276 ~ll~ 279 (289)
T 1x8b_A 276 ALVK 279 (289)
T ss_dssp HHHT
T ss_pred HHhh
Confidence 9975
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=336.13 Aligned_cols=256 Identities=20% Similarity=0.325 Sum_probs=199.5
Q ss_pred HhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC----CCchhHHHHHHHHHHhccCCcceeEEEEeecccccC
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ----KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKG 752 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 752 (992)
..++|++.+.||+|+||.||+|.+..+++.||+|+++... ......+.+|+.++++++||||+++++++.. .+
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~ 79 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYN---EE 79 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC---C-
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEc---CC
Confidence 3578999999999999999999999899999999996432 3445778999999999999999999998643 33
Q ss_pred cceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEe
Q 037275 753 VDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLG 832 (992)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 832 (992)
....++||||++++ +.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 80 ~~~~~lv~e~~~~~-l~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~ 151 (305)
T 2wtk_C 80 KQKMYMVMEYCVCG-MQEMLDSVPE----KRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKIS 151 (305)
T ss_dssp --CEEEEEECCSEE-HHHHHHHSTT----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred CCeEEEEehhccCC-HHHHHHhCcc----cccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEee
Confidence 45679999999876 8787765432 3589999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCCCCCcccCCCCCcccccccccccccccCCC--cCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHH
Q 037275 833 DFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGE--ASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHE 910 (992)
Q Consensus 833 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~ 910 (992)
|||.+........ ........||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+... .
T Consensus 152 dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~- 219 (305)
T 2wtk_C 152 ALGVAEALHPFAA------DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI-----Y- 219 (305)
T ss_dssp CCTTCEECCTTCS------SCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH-----H-
T ss_pred ccccccccCcccc------ccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH-----H-
Confidence 9999987653221 11122345899999999987643 47899999999999999999999975311 1
Q ss_pred HHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 911 FARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
+........... .. ......+.+++.+||+.||++|||++|+++.
T Consensus 220 -----------~~~~~i~~~~~~------~~------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 220 -----------KLFENIGKGSYA------IP------GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp -----------HHHHHHHHCCCC------CC------SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -----------HHHHHHhcCCCC------CC------CccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111111111000 00 0123458899999999999999999999863
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=353.14 Aligned_cols=260 Identities=11% Similarity=0.016 Sum_probs=182.3
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC---CchhHHHHHHHHHHhc--cCCcceeEEE-------Ee
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK---GASNGFVAECQALRNI--RHRNLIKIIT-------IC 745 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~h~niv~~~~-------~~ 745 (992)
..+|++.+.||+|+||+||+|++..+++.||||++..... ...+.+.+|+.+++.+ +||||++++. ++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 3458899999999999999999998999999999976543 2345677886555555 5999888653 32
Q ss_pred ecccc------------cCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHH------HHHHHHHHHHHHHHHhcC
Q 037275 746 SSIDF------------KGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQR------INIIIDVASAIEYIHHHC 807 (992)
Q Consensus 746 ~~~~~------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~------~~i~~qi~~~L~~LH~~~ 807 (992)
..... ......++||||++ |+|.+++..... .+++..+ +.++.|++.||+|||++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-----~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~- 213 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-----VYVFRGDEGILALHILTAQLIRLAANLQSK- 213 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-----SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT-
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-----ccchhhhhhhhhHHHHHHHHHHHHHHHHHC-
Confidence 21110 01145799999998 899999987532 2455555 77889999999999999
Q ss_pred CCCeEeccCCCCCeeeCCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccC--CCcCcccchhhHH
Q 037275 808 QPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG--GEASMTGDVYSFG 885 (992)
Q Consensus 808 ~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG 885 (992)
+|+||||||+||+++.++.+||+|||+|+..... .....+|+.|+|||++.+ ..++.++||||||
T Consensus 214 --~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG 280 (371)
T 3q60_A 214 --GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----------GPASSVPVTYAPREFLNASTATFTHALNAWQLG 280 (371)
T ss_dssp --TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----------EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHH
T ss_pred --CCccCcCCHHHEEECCCCCEEEEecceeeecCCC-----------ccCccCCcCCcChhhccCCCCCcCccccHHHHH
Confidence 9999999999999999999999999999865421 112346799999999987 6799999999999
Q ss_pred HHHHHHHhCCCCCCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCC
Q 037275 886 ILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMES 965 (992)
Q Consensus 886 ~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 965 (992)
|++|||++|+.||.+........ +...... .. ..... ...........+.+++.+||+.|
T Consensus 281 ~il~elltg~~Pf~~~~~~~~~~--~~~~~~~-------------~~---~~~~~--~~~~~~~~~~~~~~li~~~L~~d 340 (371)
T 3q60_A 281 LSIYRVWCLFLPFGLVTPGIKGS--WKRPSLR-------------VP---GTDSL--AFGSCTPLPDFVKTLIGRFLNFD 340 (371)
T ss_dssp HHHHHHHHSSCSTTBCCTTCTTC--CCBCCTT-------------SC---CCCSC--CCTTSSCCCHHHHHHHHHHTCSS
T ss_pred HHHHHHHhCCCCCCCcCcccccc--hhhhhhh-------------hc---ccccc--chhhccCCCHHHHHHHHHHcCCC
Confidence 99999999999998753221100 0000000 00 00000 00000112346889999999999
Q ss_pred CCCCCCHHHHHH
Q 037275 966 PTERMEMRDVVA 977 (992)
Q Consensus 966 P~~RPs~~evl~ 977 (992)
|++|||+.|+++
T Consensus 341 P~~Rpt~~e~l~ 352 (371)
T 3q60_A 341 RRRRLLPLEAME 352 (371)
T ss_dssp TTTCCCHHHHTT
T ss_pred hhhCCCHHHHhc
Confidence 999999999974
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=371.73 Aligned_cols=250 Identities=24% Similarity=0.307 Sum_probs=203.1
Q ss_pred HhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc---CCCchhHHHHHHHHHHhc-cCCcceeEEEEeecccccC
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK---QKGASNGFVAECQALRNI-RHRNLIKIITICSSIDFKG 752 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 752 (992)
..++|++.++||+|+||+||+|++..+++.||||+++.. .....+.+..|..++..+ +||+|+++++++ .+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~-----~~ 413 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QT 413 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC-----BC
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE-----Ee
Confidence 456899999999999999999999999999999999743 344556788999999988 799999999984 45
Q ss_pred cceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEe
Q 037275 753 VDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLG 832 (992)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 832 (992)
....++||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 414 ~~~~~lV~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~ 484 (674)
T 3pfq_A 414 MDRLYFVMEYVNGGDLMYHIQQVG------RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIA 484 (674)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEEC
T ss_pred CCEEEEEEeCcCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEe
Confidence 667899999999999999998643 489999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHH
Q 037275 833 DFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFA 912 (992)
Q Consensus 833 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~ 912 (992)
|||+|+..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.+....
T Consensus 485 DFGla~~~~~~--------~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~-------- 548 (674)
T 3pfq_A 485 DFGMCKENIWD--------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-------- 548 (674)
T ss_dssp CCTTCEECCCT--------TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------
T ss_pred ecceeeccccC--------CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH--------
Confidence 99999864322 12234467999999999999999999999999999999999999999763211
Q ss_pred hhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 037275 913 RTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEM-----RDVVA 977 (992)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 977 (992)
++...+...... .+ .....++.+++.+||+.||++||++ +||++
T Consensus 549 ---------~~~~~i~~~~~~------~p------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 549 ---------ELFQSIMEHNVA------YP------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ---------HHHHHHHSSCCC------CC------TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ---------HHHHHHHhCCCC------CC------ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 111111111110 00 0123458899999999999999998 56553
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=350.78 Aligned_cols=278 Identities=18% Similarity=0.253 Sum_probs=204.2
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhcc--------CCcceeEEEEeeccc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIR--------HRNLIKIITICSSID 749 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~~~~~~~~~~ 749 (992)
.++|++.++||+|+||+||+|++..+++.||||+++.. ....+.+.+|+.+++.++ ||||+++++++....
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 36899999999999999999999989999999999632 234567889999999995 788999999875321
Q ss_pred ccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCC--
Q 037275 750 FKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDL-- 827 (992)
Q Consensus 750 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-- 827 (992)
......++||||+ ++++.+++..... ..+++..++.++.||+.||+|||++. +|+||||||+|||++.++
T Consensus 115 -~~~~~~~lv~e~~-~~~l~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~ 186 (397)
T 1wak_A 115 -VNGTHICMVFEVL-GHHLLKWIIKSNY----QGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQY 186 (397)
T ss_dssp -TTEEEEEEEECCC-CCBHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHH
T ss_pred -CCCceEEEEEecc-CccHHHHHHhccc----CCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchh
Confidence 2456789999999 6677777665432 25899999999999999999999853 799999999999999775
Q ss_pred -----------------------------------------------cEEEeecccceecCCCCCCCCcccCCCCCcccc
Q 037275 828 -----------------------------------------------VAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKG 860 (992)
Q Consensus 828 -----------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~g 860 (992)
.+||+|||.|+..... .....|
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----------~~~~~g 255 (397)
T 1wak_A 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----------FTEDIQ 255 (397)
T ss_dssp HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----------SCSCCS
T ss_pred hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----------CccCCC
Confidence 7999999999876432 123468
Q ss_pred cccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHH-----HHHhh--hCChhHHHHHHhhHhHhhh
Q 037275 861 TVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLH-----EFART--ALPDKVMEIVDSVLLLEVQ 933 (992)
Q Consensus 861 t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~-----~~~~~--~~~~~~~~~~~~~~~~~~~ 933 (992)
|+.|+|||++.+..++.++|||||||++|||++|+.||.+......... ..... ..+.... ........+-
T Consensus 256 t~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~--~~~~~~~~~~ 333 (397)
T 1wak_A 256 TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLI--VAGKYSKEFF 333 (397)
T ss_dssp CGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHH--HHCTTGGGTB
T ss_pred CCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHh--hccccccccc
Confidence 9999999999999999999999999999999999999987543322111 11110 0111110 0000000000
Q ss_pred cc--CCCCCCc------------cccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 934 AS--NSRSCGD------------ERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 934 ~~--~~~~~~~------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.. ....... ......+....+.+++.+||+.||++|||++|+++
T Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 334 TKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred CCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00 0000000 00112455678999999999999999999999985
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=339.72 Aligned_cols=262 Identities=27% Similarity=0.375 Sum_probs=195.8
Q ss_pred hcCCCCCCccccccceEEEEeEECC-CC--eEEEEEEeeccC---CCchhHHHHHHHHHHhccCCcceeEEEEeeccccc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGE-NG--MMVAVKVINLKQ---KGASNGFVAECQALRNIRHRNLIKIITICSSIDFK 751 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 751 (992)
.++|++.+.||+|+||+||+|++.. ++ ..||||+++... ....+.+.+|+.++++++||||+++++++...
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 93 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--- 93 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC---
Confidence 3579999999999999999998632 33 369999986432 33456789999999999999999999996532
Q ss_pred CcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEE
Q 037275 752 GVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHL 831 (992)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 831 (992)
..++||||+++|+|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||
T Consensus 94 ---~~~~v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl 162 (291)
T 1u46_A 94 ---PMKMVTELAPLGSLLDRLRKHQG-----HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKI 162 (291)
T ss_dssp ---SCEEEEECCTTCBHHHHHHHHGG-----GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEE
T ss_pred ---CceeeEecccCCCHHHHHHhccC-----CcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEE
Confidence 25899999999999999986532 489999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHH
Q 037275 832 GDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHE 910 (992)
Q Consensus 832 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~ 910 (992)
+|||++........ .........+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.+....
T Consensus 163 ~Dfg~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------ 231 (291)
T 1u46_A 163 GDFGLMRALPQNDD-----HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------ 231 (291)
T ss_dssp CCCTTCEECCC-CC-----EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------
T ss_pred cccccccccccccc-----chhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH------
Confidence 99999987654321 1111223457889999999988889999999999999999999 99999753211
Q ss_pred HHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 037275 911 FARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDT 985 (992)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 985 (992)
+............ . .......++.+++.+||+.||++|||+.|+++.|+++...
T Consensus 232 -----------~~~~~~~~~~~~~------~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 232 -----------QILHKIDKEGERL------P----RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp -----------HHHHHHHTSCCCC------C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred -----------HHHHHHHccCCCC------C----CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 1111111000000 0 0011235689999999999999999999999999887543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=335.44 Aligned_cols=254 Identities=22% Similarity=0.308 Sum_probs=201.4
Q ss_pred HHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC---------CchhHHHHHHHHHHhcc-CCcceeEEEEe
Q 037275 676 KATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK---------GASNGFVAECQALRNIR-HRNLIKIITIC 745 (992)
Q Consensus 676 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~~~~~~ 745 (992)
...++|++.+.||+|+||.||+|++..+++.||||+++.... ...+.+.+|+.+++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 446789999999999999999999998999999999975431 12356789999999995 99999999996
Q ss_pred ecccccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCC
Q 037275 746 SSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQ 825 (992)
Q Consensus 746 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 825 (992)
. .....++||||+++++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.
T Consensus 94 ~-----~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~ 159 (298)
T 1phk_A 94 E-----TNTFFFLVFDLMKKGELFDYLTEKV------TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDD 159 (298)
T ss_dssp E-----CSSEEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECT
T ss_pred c-----cCCeEEEEEeccCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcC
Confidence 3 4566799999999999999997543 589999999999999999999999 9999999999999999
Q ss_pred CCcEEEeecccceecCCCCCCCCcccCCCCCccccccccccccccc------CCCcCcccchhhHHHHHHHHHhCCCCCC
Q 037275 826 DLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGM------GGEASMTGDVYSFGILLLEMFTRRRPTD 899 (992)
Q Consensus 826 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwSlG~il~elltg~~pf~ 899 (992)
++.+||+|||.+....... ......|++.|+|||++. ...++.++||||||+++|+|++|+.||.
T Consensus 160 ~~~~kl~dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 230 (298)
T 1phk_A 160 DMNIKLTDFGFSCQLDPGE---------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW 230 (298)
T ss_dssp TCCEEECCCTTCEECCTTC---------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCcEEEecccchhhcCCCc---------ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCc
Confidence 9999999999998765321 122346899999999875 4568899999999999999999999997
Q ss_pred CCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 900 GMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
..... ............. . ..........+.+++.+||+.||++|||++|+++
T Consensus 231 ~~~~~-----------------~~~~~~~~~~~~~-----~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 231 HRKQM-----------------LMLRMIMSGNYQF-----G---SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp CSSHH-----------------HHHHHHHHTCCCC-----C---TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CccHH-----------------HHHHHHhcCCccc-----C---cccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 53211 0111111110000 0 0001122456889999999999999999999975
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=349.09 Aligned_cols=203 Identities=25% Similarity=0.330 Sum_probs=170.1
Q ss_pred HHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhcc-CC-----cceeEEEEeeccc
Q 037275 676 KATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIR-HR-----NLIKIITICSSID 749 (992)
Q Consensus 676 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~~~~~~~~~~ 749 (992)
...++|++.++||+|+||+||+|++..+++.||||+++.. ......+.+|+.+++.++ |+ +|+++.+++..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~-- 127 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF-- 127 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE--
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc--
Confidence 3467899999999999999999999989999999999632 223456778999988885 44 49999998643
Q ss_pred ccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeC--CCC
Q 037275 750 FKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLD--QDL 827 (992)
Q Consensus 750 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~ 827 (992)
....++||||++ |+|.+++..... ..+++..+..++.|++.||+|||++ ..+|+||||||+||+++ .++
T Consensus 128 ---~~~~~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~ 198 (382)
T 2vx3_A 128 ---RNHLCLVFEMLS-YNLYDLLRNTNF----RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRS 198 (382)
T ss_dssp ---TTEEEEEEECCC-CBHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSC
T ss_pred ---CCceEEEEecCC-CCHHHHHhhcCc----CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCC
Confidence 456799999995 599999986542 2589999999999999999999953 12899999999999994 477
Q ss_pred cEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCC
Q 037275 828 VAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGM 901 (992)
Q Consensus 828 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 901 (992)
.+||+|||+|+..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 199 ~~kL~DFG~a~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 199 AIKIVDFGSSCQLGQR-----------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp CEEECCCTTCEETTCC-----------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cEEEEeccCceecccc-----------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 8999999999876432 12346899999999999999999999999999999999999999864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=341.57 Aligned_cols=280 Identities=22% Similarity=0.356 Sum_probs=204.6
Q ss_pred HHhcCCCCCCccccccceEEEEeEEC-CCCeEEEEEEeeccC--CCchhHHHHHHHHHHhc---cCCcceeEEEEeeccc
Q 037275 676 KATNDFSSSNMIGQGSFGFVYKGNLG-ENGMMVAVKVINLKQ--KGASNGFVAECQALRNI---RHRNLIKIITICSSID 749 (992)
Q Consensus 676 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~ 749 (992)
...++|++.+.||+|+||+||+|++. .+++.||+|+++... ......+.+|+.+++.+ +||||+++++++....
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 34578999999999999999999994 678999999986443 22344677888888777 8999999999986444
Q ss_pred ccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcE
Q 037275 750 FKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVA 829 (992)
Q Consensus 750 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 829 (992)
.......++||||++ |+|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~ 159 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQI 159 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCT----TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCE
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhccc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCE
Confidence 445677899999997 699999986542 2489999999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHH
Q 037275 830 HLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLH 909 (992)
Q Consensus 830 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~ 909 (992)
||+|||.++..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..... ...
T Consensus 160 kl~Dfg~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~ 229 (326)
T 1blx_A 160 KLADFGLARIYSFQ---------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLG 229 (326)
T ss_dssp EECSCCSCCCCCGG---------GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHH
T ss_pred EEecCcccccccCC---------CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH-HHH
Confidence 99999999765421 11233568999999999999999999999999999999999999998643211 011
Q ss_pred HHHhhh-CCh--hHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 910 EFARTA-LPD--KVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 910 ~~~~~~-~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
...... .+. .+...... ...... .................+.+++.+||+.||++|||+.|+++
T Consensus 230 ~i~~~~~~~~~~~~~~~~~~-~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 230 KILDVIGLPGEEDWPRDVAL-PRQAFH---SKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp HHHHHHCCCCGGGSCTTCSS-CGGGSC---CCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHcCCCCcccCcccccc-chhhhc---ccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 111000 000 00000000 000000 00000000000122456889999999999999999999985
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=340.00 Aligned_cols=255 Identities=22% Similarity=0.284 Sum_probs=185.2
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCC--chhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKG--ASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
.++|++.+.||+|+||+||+|++..+++.||+|+++..... ..+.+.++...++.++||||+++++++. ....
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----~~~~ 80 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF-----REGD 80 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSS
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee-----ccCC
Confidence 46899999999999999999999989999999999644221 1233445555678889999999999964 3456
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++||||++ |+|.+++...... ...+++..++.++.|++.||+|||++. +|+||||||+||+++.++.+||+|||
T Consensus 81 ~~lv~e~~~-~~l~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T 3fme_A 81 VWICMELMD-TSLDKFYKQVIDK--GQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFG 155 (290)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-
T ss_pred EEEEEehhc-cchHHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecC
Confidence 799999997 5998888754321 346999999999999999999999852 89999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccc----cCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHH
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYG----MGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEF 911 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~ 911 (992)
.++...... ......||+.|+|||++ .+..++.++||||+||++|+|++|+.||.............
T Consensus 156 ~~~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 226 (290)
T 3fme_A 156 ISGYLVDDV---------AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV 226 (290)
T ss_dssp -----------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHH
T ss_pred Ccccccccc---------cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHH
Confidence 998664321 11223589999999995 56678999999999999999999999997532211111111
Q ss_pred HhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 912 ARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.. ... .. . .......++.+++.+||+.||++|||++|+++
T Consensus 227 ------------~~----~~~----~~-~-----~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 227 ------------VE----EPS----PQ-L-----PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ------------HH----SCC----CC-C-----CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ------------hc----cCC----CC-c-----ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 00 000 00 0 00112345889999999999999999999987
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=345.13 Aligned_cols=272 Identities=22% Similarity=0.312 Sum_probs=184.5
Q ss_pred HHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC-CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcc
Q 037275 676 KATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 676 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
...++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.++++++||||+++++++.. ..
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 86 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVV-----KD 86 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEES-----SS
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEee-----cC
Confidence 34568999999999999999999998889999999986433 3345678899999999999999999998643 34
Q ss_pred eEEEEEEeccCCCHHHHHhhcccch--hhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEe
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQ--EARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLG 832 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 832 (992)
..++||||+++++|.+++....... ....+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~ 163 (303)
T 2vwi_A 87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIA 163 (303)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEEC
T ss_pred CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEE
Confidence 5799999999999999997532211 123589999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCCCCCcccCCCCCcccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHH
Q 037275 833 DFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEF 911 (992)
Q Consensus 833 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~ 911 (992)
|||.+.......... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ....
T Consensus 164 dfg~~~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~ 239 (303)
T 2vwi_A 164 DFGVSAFLATGGDIT---RNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV-LMLT 239 (303)
T ss_dssp CCHHHHHCC------------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-HHHH
T ss_pred eccchheeccCCCcc---chhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH-HHHH
Confidence 999998664321100 1112234568999999999876 5689999999999999999999999976432211 0000
Q ss_pred HhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 912 ARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.....+....... ..........++.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 240 LQNDPPSLETGVQ------------------DKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp HTSSCCCTTC-----------------------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hccCCCccccccc------------------cchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0000000000000 00000112345889999999999999999999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=340.31 Aligned_cols=274 Identities=19% Similarity=0.264 Sum_probs=202.0
Q ss_pred hcCCCCCCccccccceEEEEeEE-CCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCc------ceeEEEEeecccc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNL-GENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRN------LIKIITICSSIDF 750 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~~ 750 (992)
.++|++.+.||+|+||+||+|.+ ..+++.||||+++.. ....+.+.+|+++++.++|++ ++++++++.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~---- 87 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE---- 87 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE----
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc----
Confidence 35899999999999999999998 557899999998632 234567889999999997665 999999864
Q ss_pred cCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCC-----
Q 037275 751 KGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQ----- 825 (992)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~----- 825 (992)
.....++||||+ +++|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.
T Consensus 88 -~~~~~~lv~e~~-~~~l~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~ 158 (339)
T 1z57_A 88 -HHGHICIVFELL-GLSTYDFIKENGF----LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTE 158 (339)
T ss_dssp -ETTEEEEEEECC-CCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEE
T ss_pred -cCCcEEEEEcCC-CCCHHHHHHhcCC----CCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEecccccc
Confidence 345679999999 8899999976542 2588999999999999999999999 9999999999999987
Q ss_pred --------------CCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHH
Q 037275 826 --------------DLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEM 891 (992)
Q Consensus 826 --------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 891 (992)
++.+||+|||.++..... .....||+.|+|||++.+..++.++|||||||++|||
T Consensus 159 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el 227 (339)
T 1z57_A 159 AYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEY 227 (339)
T ss_dssp EEC----CEEEEESCCCEEECCCSSCEETTSC-----------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHH
T ss_pred ccCCccccccccccCCCceEeeCcccccCccc-----------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHH
Confidence 668999999999864321 1234689999999999999999999999999999999
Q ss_pred HhCCCCCCCCccCCccHHHHHh--hhCChhHHHHHHhhHh--------------HhhhccCCCCCCccccchHHHHHHHH
Q 037275 892 FTRRRPTDGMFNQGLTLHEFAR--TALPDKVMEIVDSVLL--------------LEVQASNSRSCGDERLRTEERLVAVV 955 (992)
Q Consensus 892 ltg~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~l~ 955 (992)
++|+.||......+ ....... ...+............ .......................++.
T Consensus 228 ~~g~~pf~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 306 (339)
T 1z57_A 228 YLGFTVFPTHDSKE-HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLF 306 (339)
T ss_dssp HHSSCSCCCSCHHH-HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHH
T ss_pred HhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHH
Confidence 99999998643221 1111111 1112111110000000 00000000000000111234467799
Q ss_pred HHHhhccCCCCCCCCCHHHHHH
Q 037275 956 ETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 956 ~li~~cl~~dP~~RPs~~evl~ 977 (992)
+++.+||+.||++|||++|+++
T Consensus 307 ~li~~~L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 307 DLIQKMLEYDPAKRITLREALK 328 (339)
T ss_dssp HHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHhCcCcccccCHHHHhc
Confidence 9999999999999999999975
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=346.65 Aligned_cols=255 Identities=23% Similarity=0.317 Sum_probs=198.8
Q ss_pred hcCCCCCCccccccceEEEEeEEC---CCCeEEEEEEeeccC----CCchhHHHHHHHHHHhc-cCCcceeEEEEeeccc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLG---ENGMMVAVKVINLKQ----KGASNGFVAECQALRNI-RHRNLIKIITICSSID 749 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 749 (992)
.++|++.++||+|+||+||+|+.. .+++.||||+++... ....+.+.+|+++++++ +||||+++++++.
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--- 129 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ--- 129 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE---
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe---
Confidence 358999999999999999999984 478999999986332 23445677899999999 6999999999864
Q ss_pred ccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcE
Q 037275 750 FKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVA 829 (992)
Q Consensus 750 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 829 (992)
.....++||||+++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+
T Consensus 130 --~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~ 198 (355)
T 1vzo_A 130 --TETKLHLILDYINGGELFTHLSQRE------RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHV 198 (355)
T ss_dssp --ETTEEEEEECCCCSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCE
T ss_pred --eCceEEEEeecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcE
Confidence 3456799999999999999997543 489999999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCC--CcCcccchhhHHHHHHHHHhCCCCCCCCccCCcc
Q 037275 830 HLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG--EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLT 907 (992)
Q Consensus 830 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~ 907 (992)
||+|||+++...... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||........
T Consensus 199 kl~DfG~a~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~- 270 (355)
T 1vzo_A 199 VLTDFGLSKEFVADE-------TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS- 270 (355)
T ss_dssp EESCSSEEEECCGGG-------GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-
T ss_pred EEeeCCCCeecccCC-------CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch-
Confidence 999999998654321 1122345699999999998863 578899999999999999999999975432211
Q ss_pred HHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 037275 908 LHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERM-----EMRDVVAK 978 (992)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 978 (992)
... +......... ..+ .+....+.+++.+||+.||++|| |++|+++.
T Consensus 271 ~~~------------~~~~~~~~~~------~~~------~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 271 QAE------------ISRRILKSEP------PYP------QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp HHH------------HHHHHHHCCC------CCC------TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred HHH------------HHHHHhccCC------CCC------cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 111 1111110000 000 11234578999999999999999 99999864
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=347.56 Aligned_cols=276 Identities=19% Similarity=0.259 Sum_probs=197.9
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCC--chhHHHHHHHHHHhccCCcceeEEEEeecccc-cCcc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKG--ASNGFVAECQALRNIRHRNLIKIITICSSIDF-KGVD 754 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 754 (992)
.++|.+.+.||+|+||+||+|.+..+|+.||||++...... ....+.+|+.+++.++||||+++++++..... ....
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 35889999999999999999999999999999999644322 24678899999999999999999999764332 1222
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
..++||||+. ++|.+++.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Df 188 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM--------EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDF 188 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECST
T ss_pred eEEEEEcccc-ccHHHHhhc--------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEec
Confidence 3489999996 688888742 389999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 913 (992)
|.++..... .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+....+ .+.....
T Consensus 189 g~a~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~ 256 (371)
T 4exu_A 189 GLARHADAE-----------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILK 256 (371)
T ss_dssp TCC-------------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHH
T ss_pred CcccccccC-----------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHH
Confidence 999855321 223468999999999877 689999999999999999999999998643221 1111111
Q ss_pred hh-CC-hhHHHHHHhhHhHhhhccCCCCCCcc-ccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 914 TA-LP-DKVMEIVDSVLLLEVQASNSRSCGDE-RLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 914 ~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.. .+ ......+.......+........... ..........+.+++.+||+.||++|||++|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 257 VTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 11 11 11100000000000000000000000 0000112456899999999999999999999985
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=348.50 Aligned_cols=210 Identities=22% Similarity=0.341 Sum_probs=158.6
Q ss_pred cCCCC-CCccccccceEEEEeEEC--CCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 679 NDFSS-SNMIGQGSFGFVYKGNLG--ENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 679 ~~~~~-~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
+.|++ .++||+|+||+||+|++. .+++.||||++... .....+.+|+.++++++||||+++++++.. .....
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~~~ 94 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLS---HADRK 94 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEE---TTTTE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEec---CCCCe
Confidence 34665 568999999999999965 46889999998533 334578899999999999999999999743 33567
Q ss_pred EEEEEEeccCCCHHHHHhhcccc---hhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeee----CCCCc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQ---QEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLL----DQDLV 828 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~ 828 (992)
.++||||++ |+|.+++...... .....+++..++.++.||+.||+|||++ +|+||||||+||++ +.++.
T Consensus 95 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 95 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTC
T ss_pred EEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCc
Confidence 799999996 5898888754321 1123489999999999999999999999 99999999999999 67889
Q ss_pred EEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCCCc
Q 037275 829 AHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRRRPTDGMF 902 (992)
Q Consensus 829 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~ 902 (992)
+||+|||+|+....... .........||+.|+|||++.+. .++.++||||+||++|||++|++||.+..
T Consensus 171 ~kl~Dfg~a~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLK-----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp EEECCTTCCC---------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred EEEEECCCceecCCCCc-----ccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 99999999987653211 11223345789999999998874 58999999999999999999999997643
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=329.62 Aligned_cols=254 Identities=26% Similarity=0.323 Sum_probs=201.2
Q ss_pred HHHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC--CCchhHHHHHHHHHHhccCCcceeEEEEeecccccC
Q 037275 675 SKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKG 752 (992)
Q Consensus 675 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 752 (992)
....++|++.+.||+|+||.||+|++..+++.||+|++.... ......+.+|+.++++++||||+++++++. .
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~ 92 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----D 92 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----C
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEe-----C
Confidence 344568999999999999999999998899999999996443 345677899999999999999999999964 3
Q ss_pred cceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCC---CcE
Q 037275 753 VDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQD---LVA 829 (992)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~ 829 (992)
....++||||+++++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.+ +.+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~ 163 (287)
T 2wei_A 93 SSSFYIVGELYTGGELFDEIIKRK------RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDI 163 (287)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCE
T ss_pred CCeEEEEEEccCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccE
Confidence 456799999999999999987543 489999999999999999999999 99999999999999754 479
Q ss_pred EEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHH
Q 037275 830 HLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLH 909 (992)
Q Consensus 830 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~ 909 (992)
||+|||.+....... ......|++.|+|||++.+ .++.++||||||+++|+|++|+.||.+....
T Consensus 164 kL~Dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----- 228 (287)
T 2wei_A 164 KIIDFGLSTCFQQNT---------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY----- 228 (287)
T ss_dssp EECSTTGGGTBCCCS---------SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----
T ss_pred EEeccCcceeecCCC---------ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH-----
Confidence 999999998654321 1223458999999998765 4899999999999999999999999763211
Q ss_pred HHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 910 EFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
+............ ..........++.+++.+||+.||++|||+.|+++
T Consensus 229 ------------~~~~~~~~~~~~~--------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 229 ------------DILKRVETGKYAF--------DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp ------------HHHHHHHHCCCCC--------CSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------HHHHHHHcCCCCC--------CchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0111111110000 00000112345889999999999999999999987
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=353.22 Aligned_cols=329 Identities=19% Similarity=0.161 Sum_probs=203.8
Q ss_pred ccccccccccccCCCCCCccccccccceEEecCCcccCCcCCccCCCCcccEEeccCcccccccCccccccCCCcEEecc
Q 037275 148 KLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLP 227 (992)
Q Consensus 148 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~ 227 (992)
++++|+|++|++++..|..|.++++|++|+|++|.+.+..|..|.++++|++|+|++|++++..+..|.++++|++|+|+
T Consensus 33 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 112 (477)
T 2id5_A 33 ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDIS 112 (477)
T ss_dssp TCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECT
T ss_pred CCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECC
Confidence 45666666666665556667777777777777777766667777777777777777777775444556677777777777
Q ss_pred CCccCCCCCccccccccccchhhccccccCCCCchhhhccccCceeeeccccccccccccccccCccceEecCCCCCCCC
Q 037275 228 TNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTG 307 (992)
Q Consensus 228 ~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 307 (992)
+|++.+ ..|..|..+++|++|++++|.+++..+..|..+++|++|+|++|+++.+
T Consensus 113 ~n~i~~-------------------------~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 167 (477)
T 2id5_A 113 ENKIVI-------------------------LLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSI 167 (477)
T ss_dssp TSCCCE-------------------------ECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSC
T ss_pred CCcccc-------------------------CChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCccc
Confidence 776652 2344566677777777777777777777777777777777777766543
Q ss_pred CCCCchhhhhccCCCcceEeecCCCcCCCcCCcccccccccceeEEeeCCccccccCCCccCCCcccEEEccCCcCCCCC
Q 037275 308 EANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTI 387 (992)
Q Consensus 308 ~~~~~~~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 387 (992)
+. ..|.++++|+.|+|++|.+.+..
T Consensus 168 ~~-------------------------------------------------------~~l~~l~~L~~L~l~~n~i~~~~ 192 (477)
T 2id5_A 168 PT-------------------------------------------------------EALSHLHGLIVLRLRHLNINAIR 192 (477)
T ss_dssp CH-------------------------------------------------------HHHTTCTTCCEEEEESCCCCEEC
T ss_pred Ch-------------------------------------------------------hHhcccCCCcEEeCCCCcCcEeC
Confidence 21 11223334444444444444333
Q ss_pred CccccCCCCCcEEeccCccccccCCCCCCCccccCceeccCCcccCCCCCCccccccccccccccccccccCchhhhhhc
Q 037275 388 PHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSIS 467 (992)
Q Consensus 388 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~ 467 (992)
+..|..+++|+.|++++|.+.+.+|.......+|+.|+|++|++++..+..|..+++|+.|++
T Consensus 193 ~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L----------------- 255 (477)
T 2id5_A 193 DYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNL----------------- 255 (477)
T ss_dssp TTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEEC-----------------
T ss_pred hhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeEC-----------------
Confidence 334444444444444444444344444444445555555555555333334555555555533
Q ss_pred ccccccccccccccCcccccccCCCCccEEeeecccccccCCcccccccccceeeccCCcccccCCccccccCCCCEEEC
Q 037275 468 TLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDM 547 (992)
Q Consensus 468 ~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 547 (992)
++|.+++..+..|..+++|++|+|++|++++..|..|.++++|+.|+|++|+|++..+..|..+++|++|+|
T Consensus 256 --------s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 327 (477)
T 2id5_A 256 --------SYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLIL 327 (477)
T ss_dssp --------CSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEEC
T ss_pred --------CCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEc
Confidence 333333334445666777777777788777777778888888888888888888766677788888888888
Q ss_pred CCcccCCCChhhhhcCCCcceEecCCCcCcccCCC
Q 037275 548 SSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPT 582 (992)
Q Consensus 548 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~ 582 (992)
++|.+... ....+-...+..+++.++...|..|.
T Consensus 328 ~~N~l~c~-c~~~~~~~~~~~~~~~~~~~~C~~p~ 361 (477)
T 2id5_A 328 DSNPLACD-CRLLWVFRRRWRLNFNRQQPTCATPE 361 (477)
T ss_dssp CSSCEECS-GGGHHHHTTTTSSCCTTCCCBEEESG
T ss_pred cCCCccCc-cchHhHHhhhhccccCccCceeCCch
Confidence 88888743 22222233445566777777776664
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=335.21 Aligned_cols=265 Identities=23% Similarity=0.334 Sum_probs=194.6
Q ss_pred HhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeeccc-------
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSID------- 749 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------- 749 (992)
..++|++.+.||+|+||.||+|++..+++.||||++... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 346799999999999999999999889999999999632 234567889999999999999999999875421
Q ss_pred -ccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCc
Q 037275 750 -FKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLV 828 (992)
Q Consensus 750 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 828 (992)
.......++||||+++|+|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~ 154 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENL-----NQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRN 154 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCG-----GGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhcccc-----ccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCC
Confidence 1335678999999999999999986432 478899999999999999999999 9999999999999999999
Q ss_pred EEEeecccceecCCCCCCCC------cccCCCCCcccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCCC
Q 037275 829 AHLGDFGLAKFLSSSPLDTA------VETPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRRRPTDGM 901 (992)
Q Consensus 829 ~kl~Dfg~a~~~~~~~~~~~------~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~ 901 (992)
+||+|||.+........... ...........||+.|+|||++.+. .++.++||||+||++|||++ ||...
T Consensus 155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~ 231 (303)
T 1zy4_A 155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG 231 (303)
T ss_dssp EEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred EEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc
Confidence 99999999987653211000 0001122345689999999998764 68999999999999999998 54321
Q ss_pred ccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 902 FNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.+. ............ ..... ........+.+++.+||+.||++|||++|+++
T Consensus 232 ~~~----------------~~~~~~~~~~~~--~~~~~------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 232 MER----------------VNILKKLRSVSI--EFPPD------FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHH----------------HHHHHHHHSTTC--CCCTT------CCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhH----------------HHHHHhcccccc--ccCcc------ccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 100 011111100000 00000 01122345789999999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-37 Score=337.69 Aligned_cols=257 Identities=21% Similarity=0.289 Sum_probs=175.2
Q ss_pred hcCCCCCC-ccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 678 TNDFSSSN-MIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 678 ~~~~~~~~-~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
.++|++.+ +||+|+||+||+|++..+++.||||++... .....+....++.++||||+++++++.... .+....
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~ 101 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMH-HGKRCL 101 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhcc-CCCceE
Confidence 45888854 699999999999999989999999998532 122223333466779999999999975422 235567
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCC---CCcEEEee
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQ---DLVAHLGD 833 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~D 833 (992)
++||||+++|+|.+++..... ..+++.+++.++.|++.||+|||++ +|+||||||+||+++. ++.+||+|
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~----~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~D 174 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGD----QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTD 174 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-C----CCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred EEEEeccCCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEec
Confidence 999999999999999986542 2589999999999999999999999 9999999999999976 45699999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 913 (992)
||+++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........
T Consensus 175 fg~~~~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---- 240 (336)
T 3fhr_A 175 FGFAKETTQNA----------LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG---- 240 (336)
T ss_dssp CTTCEEC--------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------
T ss_pred cccceeccccc----------cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh----
Confidence 99998654321 1234589999999999888999999999999999999999999976432211000
Q ss_pred hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 914 TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
............. .........++.+++.+||+.||++|||++|+++
T Consensus 241 ---------~~~~~~~~~~~~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 241 ---------MKRRIRLGQYGFP--------NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp -------------------CCC--------TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ---------HHHhhhccccccC--------chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000000000000 0000112345889999999999999999999987
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=361.29 Aligned_cols=177 Identities=13% Similarity=0.100 Sum_probs=104.5
Q ss_pred CCCCCCCCCcCCCCCCc----eEeeEEcCCCCeEEEeeccccccCCccCCCCCCCCcCCeeeccCCCCCccCCccccCCC
Q 037275 23 DPLGVTSSWNNSTNLCQ----WTGVTCGHRHQRVTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLV 98 (992)
Q Consensus 23 ~~~~~~~~w~~~~~~c~----w~gv~c~~~~~~v~~ldl~~~~l~~~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~ 98 (992)
+....+++|..+.+||. |.++.|+ .+ ++-..... .....-..+.+++.|++++|.+....+..+..++
T Consensus 4 ~~~~~l~~~~~~~~C~~~~~~~~c~~~~---~~---i~~~~~~~--~~~~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~ 75 (597)
T 3oja_B 4 QQRYNVKPRQPEYKCIDSNLQYDCVFYD---VH---IDMQTQDV--YFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFR 75 (597)
T ss_dssp -------CCCSEECCCCC--CCSEEECS---CE---ECSSCCCC--EESCSSGGGCCCSEEEESSCEESEECTHHHHHCC
T ss_pred cccccccCCCCCCcCcccCcCceeEecC---ce---eccccccc--ccCcccccCCCceEEEeeCCCCCCcCHHHHccCC
Confidence 34445689998888884 5555443 11 11111111 1111122467778888888888743344567788
Q ss_pred CCCEEEeecccCCCCCCcccccCCCCcEeecccccccccCChhhcccccccccccccccccCCCCCCccccccccceEEe
Q 037275 99 RLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINV 178 (992)
Q Consensus 99 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l 178 (992)
+|++|+|++|.+++..|..|+.+++|++|+|++|.++ +..|..|+++++|++|+|
T Consensus 76 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-------------------------~~~~~~~~~l~~L~~L~L 130 (597)
T 3oja_B 76 QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-------------------------YLPPHVFQNVPLLTVLVL 130 (597)
T ss_dssp CCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC-------------------------CCCTTTTTTCTTCCEEEC
T ss_pred CCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCC-------------------------CCCHHHHcCCCCCCEEEe
Confidence 8888888888887655566666666666666666555 344445556666666666
Q ss_pred cCCcccCCcCCccCCCCcccEEeccCcccccccCccccccCCCcEEeccCCccC
Q 037275 179 LGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFN 232 (992)
Q Consensus 179 ~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~ 232 (992)
++|.+.+..+..|+++++|++|+|++|.+++..|..|..+++|++|++++|.++
T Consensus 131 ~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 184 (597)
T 3oja_B 131 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT 184 (597)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCS
T ss_pred eCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCC
Confidence 666664444444566667777777777776666666666677777776666665
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=339.76 Aligned_cols=263 Identities=21% Similarity=0.284 Sum_probs=196.0
Q ss_pred HhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC--CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcc
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
..++|++.+.||+|+||.||+|++.. .||+|+++... ....+.+.+|+.++++++||||+++++++.. ..
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~ 102 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS-----PP 102 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC-----SS
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec-----CC
Confidence 35689999999999999999999853 49999986432 2334567889999999999999999999653 44
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
..++||||+++++|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||+++ ++.+||+||
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Df 173 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAKI-----VLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDF 173 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSCC-----CCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCC
T ss_pred ceEEEeecccCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeec
Confidence 57999999999999999976432 488999999999999999999999 999999999999998 679999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccC---------CCcCcccchhhHHHHHHHHHhCCCCCCCCccCC
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG---------GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQG 905 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~ 905 (992)
|+++......... .........|++.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 174 g~~~~~~~~~~~~---~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~- 249 (319)
T 2y4i_B 174 GLFSISGVLQAGR---REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE- 249 (319)
T ss_dssp SCCC-------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH-
T ss_pred CCccccccccccc---cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-
Confidence 9987654221110 1122233468999999998864 35788999999999999999999999753211
Q ss_pred ccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 037275 906 LTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDT 985 (992)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 985 (992)
................. ....++.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 250 ----------------~~~~~~~~~~~~~~~~~----------~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 250 ----------------AIIWQMGTGMKPNLSQI----------GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp ----------------HHHHHHHTTCCCCCCCS----------SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred ----------------HHHHHhccCCCCCCCcC----------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 01111100000000000 1123488999999999999999999999999988765
Q ss_pred h
Q 037275 986 F 986 (992)
Q Consensus 986 ~ 986 (992)
.
T Consensus 304 ~ 304 (319)
T 2y4i_B 304 N 304 (319)
T ss_dssp -
T ss_pred h
Confidence 3
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-37 Score=365.38 Aligned_cols=259 Identities=23% Similarity=0.355 Sum_probs=203.2
Q ss_pred hcCCCCCCccccccceEEEEeEECC---CCeEEEEEEeeccCC-CchhHHHHHHHHHHhccCCcceeEEEEeecccccCc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGE---NGMMVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 753 (992)
.++|++.+.||+|+||+||+|.+.. .+..||+|+++.... ...+.+.+|+.++++++||||+++++++.+
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------ 462 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------ 462 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS------
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec------
Confidence 4678899999999999999999853 356899999864332 234678999999999999999999998632
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGD 833 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 833 (992)
+..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~D 534 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVRK-----FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGD 534 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTT-----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC
T ss_pred CceEEEEEcCCCCcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEe
Confidence 34589999999999999997543 2489999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHH
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFA 912 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~ 912 (992)
||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+....
T Consensus 535 FG~a~~~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-------- 599 (656)
T 2j0j_A 535 FGLSRYMEDSTY-------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-------- 599 (656)
T ss_dssp CCCCCSCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------
T ss_pred cCCCeecCCCcc-------eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH--------
Confidence 999987643221 11122346789999999988899999999999999999997 99999763211
Q ss_pred hhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 037275 913 RTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDT 985 (992)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 985 (992)
+.......... .... ......+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 600 ---------~~~~~i~~~~~-~~~~----------~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 600 ---------DVIGRIENGER-LPMP----------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp ---------HHHHHHHHTCC-CCCC----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------HHHHHHHcCCC-CCCC----------ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 01111110000 0000 11234688999999999999999999999999998765
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=344.09 Aligned_cols=265 Identities=22% Similarity=0.317 Sum_probs=199.6
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCc---h--------------hHHHHHHHHHHhccCCccee
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGA---S--------------NGFVAECQALRNIRHRNLIK 740 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~--------------~~~~~E~~~l~~l~h~niv~ 740 (992)
.++|++.+.||+|+||.||+|++ +++.||||++....... . +.+.+|+.++++++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 45899999999999999999999 89999999996432111 1 78999999999999999999
Q ss_pred EEEEeecccccCcceEEEEEEeccCCCHHHH------HhhcccchhhcccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEe
Q 037275 741 IITICSSIDFKGVDFQAIVYEYMQNGSLEDW------LHQSEDQQEARSLTLIQRINIIIDVASAIEYIHH-HCQPPVVH 813 (992)
Q Consensus 741 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH 813 (992)
+++++.. .+..++||||+++|+|.++ +.... ...+++..++.++.|++.||+|||+ + +|+|
T Consensus 108 ~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H 175 (348)
T 2pml_X 108 CEGIITN-----YDEVYIIYEYMENDSILKFDEYFFVLDKNY----TCFIPIQVIKCIIKSVLNSFSYIHNEK---NICH 175 (348)
T ss_dssp CSEEEES-----SSEEEEEEECCTTCBSSEESSSEESSCSSS----CCCCCHHHHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred EEEEEee-----CCeEEEEEeccCCCcHHHHHHHhhhhhhcc----ccCCCHHHHHHHHHHHHHHHHHHhccC---CEee
Confidence 9999643 4567999999999999998 44321 2468999999999999999999999 8 9999
Q ss_pred ccCCCCCeeeCCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCC-CcCc-ccchhhHHHHHHHH
Q 037275 814 GDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-EASM-TGDVYSFGILLLEM 891 (992)
Q Consensus 814 ~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DiwSlG~il~el 891 (992)
|||||+||+++.++.+||+|||.+...... ......|++.|+|||++.+. .++. ++|||||||++|||
T Consensus 176 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l 245 (348)
T 2pml_X 176 RDVKPSNILMDKNGRVKLSDFGESEYMVDK----------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVM 245 (348)
T ss_dssp CCCCGGGEEECTTSCEEECCCTTCEECBTT----------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHH
T ss_pred cCCChHhEEEcCCCcEEEeccccccccccc----------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHH
Confidence 999999999999999999999999876432 12234689999999999887 6666 99999999999999
Q ss_pred HhCCCCCCCCccCCccHHHHHhhhC--ChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCC
Q 037275 892 FTRRRPTDGMFNQGLTLHEFARTAL--PDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTER 969 (992)
Q Consensus 892 ltg~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 969 (992)
++|+.||.................. +.......... ..............++.+++.+||+.||++|
T Consensus 246 ~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 314 (348)
T 2pml_X 246 FYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPL-----------TNKKSTCSNNFLSNEDIDFLKLFLRKNPAER 314 (348)
T ss_dssp HHSSCSSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTT-----------CC--------CCCHHHHHHHHHHCCSSGGGS
T ss_pred HhCCCCCCCCCcHHHHHHHHhccCcCCccchhhhhccc-----------cccccccchhhcCHHHHHHHHHHccCChhhC
Confidence 9999999864332111111110000 00000000000 0000000001224568899999999999999
Q ss_pred CCHHHHHH
Q 037275 970 MEMRDVVA 977 (992)
Q Consensus 970 Ps~~evl~ 977 (992)
||++|+++
T Consensus 315 ps~~e~l~ 322 (348)
T 2pml_X 315 ITSEDALK 322 (348)
T ss_dssp CCHHHHHT
T ss_pred CCHHHHhc
Confidence 99999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=337.20 Aligned_cols=274 Identities=18% Similarity=0.249 Sum_probs=199.6
Q ss_pred hcCCCCCCccccccceEEEEeEECCCC-eEEEEEEeeccCCCchhHHHHHHHHHHhccCCc------ceeEEEEeecccc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENG-MMVAVKVINLKQKGASNGFVAECQALRNIRHRN------LIKIITICSSIDF 750 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~~ 750 (992)
.++|++.+.||+|+||+||+|.+..++ +.||+|+++.. ....+.+.+|+.++++++|++ ++.+.+++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~---- 92 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN---- 92 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE----
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee----
Confidence 358999999999999999999997666 79999998632 234567888999999998766 888888753
Q ss_pred cCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeee-------
Q 037275 751 KGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLL------- 823 (992)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll------- 823 (992)
.....++||||+ ++++.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+||++
T Consensus 93 -~~~~~~lv~e~~-~~~l~~~l~~~~~----~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~ 163 (355)
T 2eu9_A 93 -FHGHMCIAFELL-GKNTFEFLKENNF----QPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFET 163 (355)
T ss_dssp -ETTEEEEEEECC-CCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEE
T ss_pred -eCCeEEEEEecc-CCChHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccc
Confidence 345679999999 6788887765432 2589999999999999999999999 99999999999999
Q ss_pred ------------CCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHH
Q 037275 824 ------------DQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEM 891 (992)
Q Consensus 824 ------------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 891 (992)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||
T Consensus 164 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el 232 (355)
T 2eu9_A 164 LYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----------HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEY 232 (355)
T ss_dssp EECCC-CCCEEEESCCCEEECCCTTCEETTSC-----------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred cccccccccccccCCCcEEEeecCcccccccc-----------ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHH
Confidence 56789999999999864322 1234689999999999999999999999999999999
Q ss_pred HhCCCCCCCCccCCccHHHHH--hhhCChhHHHHHHhhHh--------------HhhhccCCCCCCccccchHHHHHHHH
Q 037275 892 FTRRRPTDGMFNQGLTLHEFA--RTALPDKVMEIVDSVLL--------------LEVQASNSRSCGDERLRTEERLVAVV 955 (992)
Q Consensus 892 ltg~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~l~ 955 (992)
++|+.||....... ...... ....|............ ..+....................++.
T Consensus 233 ~~g~~pf~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 311 (355)
T 2eu9_A 233 YRGFTLFQTHENRE-HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLF 311 (355)
T ss_dssp HHSSCSCCCSSHHH-HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHH
T ss_pred HhCCCCCCCCCHHH-HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHH
Confidence 99999998643221 111111 11122211110000000 00000000000000111223456789
Q ss_pred HHHhhccCCCCCCCCCHHHHHH
Q 037275 956 ETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 956 ~li~~cl~~dP~~RPs~~evl~ 977 (992)
+++.+||+.||++|||++|+++
T Consensus 312 ~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 312 DLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp HHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHhcCChhhCcCHHHHhc
Confidence 9999999999999999999974
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=340.45 Aligned_cols=275 Identities=19% Similarity=0.246 Sum_probs=196.9
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCC--chhHHHHHHHHHHhccCCcceeEEEEeecccc-cCcce
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKG--ASNGFVAECQALRNIRHRNLIKIITICSSIDF-KGVDF 755 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 755 (992)
++|.+.+.||+|+||.||+|++..+|+.||||++...... ..+.+.+|+.+++.++||||+++++++..... .....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 5789999999999999999999989999999998643322 24568899999999999999999999754321 11234
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++||||++ |+|.+++.. .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 104 ~~lv~e~~~-~~l~~~~~~--------~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg 171 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMGL--------KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFG 171 (353)
T ss_dssp CEEEEECCS-EEGGGTTTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTT
T ss_pred EEEEecccc-CCHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecc
Confidence 589999997 588877642 389999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
.++..... .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+....+ .+......
T Consensus 172 ~~~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~i~~~ 239 (353)
T 3coi_A 172 LARHADAE-----------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKV 239 (353)
T ss_dssp CTTC-------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH-HHHHHHHH
T ss_pred cccCCCCC-----------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHH
Confidence 99754321 123468999999999877 678999999999999999999999997643211 11111111
Q ss_pred h-C-ChhHHHHHHhhHhHhhhccCCCC-CCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 915 A-L-PDKVMEIVDSVLLLEVQASNSRS-CGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 915 ~-~-~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
. . +......+.......+....... ...-.........++.+++.+||+.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 240 TGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 0 11110000000000000000000 00000001123456899999999999999999999985
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=341.61 Aligned_cols=278 Identities=18% Similarity=0.259 Sum_probs=200.7
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhcc-----------CCcceeEEEEee
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIR-----------HRNLIKIITICS 746 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~ 746 (992)
.++|++.+.||+|+||+||+|++..+++.||||++.. .......+.+|+.++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 3589999999999999999999988999999999863 2233466789999999886 899999999876
Q ss_pred cccccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeC--
Q 037275 747 SIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLD-- 824 (992)
Q Consensus 747 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~-- 824 (992)
... ......++||||+ +++|.+++..... ..+++..++.++.||+.||+|||++. +|+||||||+||+++
T Consensus 97 ~~~-~~~~~~~lv~e~~-~~~L~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~ 168 (373)
T 1q8y_A 97 HKG-PNGVHVVMVFEVL-GENLLALIKKYEH----RGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIV 168 (373)
T ss_dssp EEE-TTEEEEEEEECCC-CEEHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEE
T ss_pred ccC-CCCceEEEEEecC-CCCHHHHHHHhhc----cCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEecc
Confidence 432 2344779999999 8899999986542 25899999999999999999999953 799999999999994
Q ss_pred ----CCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCC
Q 037275 825 ----QDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDG 900 (992)
Q Consensus 825 ----~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 900 (992)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+
T Consensus 169 ~~~~~~~~~kl~Dfg~a~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 237 (373)
T 1q8y_A 169 DSPENLIQIKIADLGNACWYDEH-----------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 237 (373)
T ss_dssp ETTTTEEEEEECCCTTCEETTBC-----------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred CCCcCcceEEEcccccccccCCC-----------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 4458999999999876432 1223689999999999999999999999999999999999999986
Q ss_pred CccCCc-----cHHHHHhh--hCChhHHHHHHhhHhHhh-hcc-CCCCCCc------------cccchHHHHHHHHHHHh
Q 037275 901 MFNQGL-----TLHEFART--ALPDKVMEIVDSVLLLEV-QAS-NSRSCGD------------ERLRTEERLVAVVETGV 959 (992)
Q Consensus 901 ~~~~~~-----~~~~~~~~--~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~------------~~~~~~~~~~~l~~li~ 959 (992)
...... ........ ..|.....- ......+ ... ....... ..........++.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 315 (373)
T 1q8y_A 238 DEGHSYTKDDDHIAQIIELLGELPSYLLRN--GKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 315 (373)
T ss_dssp -------CHHHHHHHHHHHHCSCCHHHHHH--CTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHG
T ss_pred CcccccCChHHHHHHHHHhcCCCCHHHHhc--cchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHH
Confidence 432211 11111110 011111000 0000000 000 0000000 00112355678999999
Q ss_pred hccCCCCCCCCCHHHHHH
Q 037275 960 VCSMESPTERMEMRDVVA 977 (992)
Q Consensus 960 ~cl~~dP~~RPs~~evl~ 977 (992)
+||+.||++|||++|+++
T Consensus 316 ~~L~~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 316 PMLQLDPRKRADAGGLVN 333 (373)
T ss_dssp GGGCSSTTTCBCHHHHHT
T ss_pred HHhccCccccCCHHHHhh
Confidence 999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=333.70 Aligned_cols=243 Identities=21% Similarity=0.296 Sum_probs=197.2
Q ss_pred HHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCC------chhHHHHHHHHHHhcc--CCcceeEEEEeec
Q 037275 676 KATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKG------ASNGFVAECQALRNIR--HRNLIKIITICSS 747 (992)
Q Consensus 676 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~~~~~~~~ 747 (992)
...++|++.+.||+|+||.||+|++..+++.||||++...... ....+.+|+.++++++ ||||+++++++.
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~- 118 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE- 118 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE-
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe-
Confidence 3456899999999999999999999989999999999754322 2355778999999996 599999999964
Q ss_pred ccccCcceEEEEEEeccC-CCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeC-C
Q 037275 748 IDFKGVDFQAIVYEYMQN-GSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLD-Q 825 (992)
Q Consensus 748 ~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~ 825 (992)
.....++||||+.+ ++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++ +
T Consensus 119 ----~~~~~~lv~e~~~~~~~L~~~l~~~~------~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~ 185 (320)
T 3a99_A 119 ----RPDSFVLILERPEPVQDLFDFITERG------ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLN 185 (320)
T ss_dssp ----CSSEEEEEEECCSSEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETT
T ss_pred ----cCCcEEEEEEcCCCCccHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCC
Confidence 34567999999976 89999997643 589999999999999999999999 999999999999998 7
Q ss_pred CCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCc-CcccchhhHHHHHHHHHhCCCCCCCCccC
Q 037275 826 DLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEA-SMTGDVYSFGILLLEMFTRRRPTDGMFNQ 904 (992)
Q Consensus 826 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~ 904 (992)
++.+||+|||+++...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||....
T Consensus 186 ~~~~kL~Dfg~~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-- 253 (320)
T 3a99_A 186 RGELKLIDFGSGALLKDTV----------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-- 253 (320)
T ss_dssp TTEEEECCCTTCEECCSSC----------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--
T ss_pred CCCEEEeeCcccccccccc----------ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--
Confidence 8999999999998765321 123458999999999877665 688999999999999999999996421
Q ss_pred CccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 905 GLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
...... . ... .....++.+++.+||+.||++|||++|+++
T Consensus 254 -----~~~~~~----------------~--~~~----------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 254 -----EIIRGQ----------------V--FFR----------QRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp -----HHHHCC----------------C--CCS----------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----hhhccc----------------c--ccc----------ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000 0 000 011345889999999999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=332.68 Aligned_cols=256 Identities=24% Similarity=0.361 Sum_probs=192.4
Q ss_pred HHHHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC--CchhHHHHHHHHHHhcc--CCcceeEEEEeeccc
Q 037275 674 LSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK--GASNGFVAECQALRNIR--HRNLIKIITICSSID 749 (992)
Q Consensus 674 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~ 749 (992)
+....++|++.+.||+|+||.||+|.+. +++.||||++..... ...+.+.+|+.++++++ ||||+++++++.
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~--- 98 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI--- 98 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE---
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee---
Confidence 3344568999999999999999999986 689999999975432 23467899999999997 599999999864
Q ss_pred ccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcE
Q 037275 750 FKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVA 829 (992)
Q Consensus 750 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 829 (992)
.....++||| +.+++|.+++.... .+++..++.++.|+++||+|||++ +|+||||||+||+++ ++.+
T Consensus 99 --~~~~~~lv~e-~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~-~~~~ 165 (313)
T 3cek_A 99 --TDQYIYMVME-CGNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGML 165 (313)
T ss_dssp --CSSEEEEEEC-CCSEEHHHHHHHCS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEE
T ss_pred --cCCEEEEEEe-cCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEE-CCeE
Confidence 3456799999 55889999998643 589999999999999999999999 999999999999996 4899
Q ss_pred EEeecccceecCCCCCCCCcccCCCCCcccccccccccccccC-----------CCcCcccchhhHHHHHHHHHhCCCCC
Q 037275 830 HLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-----------GEASMTGDVYSFGILLLEMFTRRRPT 898 (992)
Q Consensus 830 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwSlG~il~elltg~~pf 898 (992)
||+|||++........ ........|++.|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus 166 kL~Dfg~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf 239 (313)
T 3cek_A 166 KLIDFGIANQMQPDTT------SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 239 (313)
T ss_dssp EECCCSSSCC--------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred EEeeccccccccCccc------cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCch
Confidence 9999999987643221 111223468999999999865 46888999999999999999999999
Q ss_pred CCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 899 DGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
......... .....+. .... .... ....++.+++.+||+.||++|||++|+++.
T Consensus 240 ~~~~~~~~~------------~~~~~~~----~~~~----~~~~------~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 240 QQIINQISK------------LHAIIDP----NHEI----EFPD------IPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp TTCCSHHHH------------HHHHHCT----TSCC----CCCC------CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhHHHHHHH------------HHHHHhc----cccc----CCcc------cchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 753221100 1111110 0000 0000 012458899999999999999999999863
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=331.15 Aligned_cols=246 Identities=24% Similarity=0.350 Sum_probs=191.0
Q ss_pred HHHHHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC------CchhHHHHHHHHHHhc----cCCcceeEE
Q 037275 673 ELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK------GASNGFVAECQALRNI----RHRNLIKII 742 (992)
Q Consensus 673 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~h~niv~~~ 742 (992)
+.....++|++.+.||+|+||.||+|++..+++.||||+++.... .....+.+|+.+++++ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 344556789999999999999999999988999999999964432 1234466799999999 899999999
Q ss_pred EEeecccccCcceEEEEEEe-ccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCe
Q 037275 743 TICSSIDFKGVDFQAIVYEY-MQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNV 821 (992)
Q Consensus 743 ~~~~~~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NI 821 (992)
+++. .....++|||| +.+++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||
T Consensus 105 ~~~~-----~~~~~~~v~e~~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Ni 170 (312)
T 2iwi_A 105 DWFE-----TQEGFMLVLERPLPAQDLFDYITEKG------PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENI 170 (312)
T ss_dssp EEC----------CEEEEECCSSEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGE
T ss_pred EEEe-----cCCeEEEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhE
Confidence 9854 34456899999 78999999997643 489999999999999999999999 999999999999
Q ss_pred eeC-CCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCc-CcccchhhHHHHHHHHHhCCCCCC
Q 037275 822 LLD-QDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEA-SMTGDVYSFGILLLEMFTRRRPTD 899 (992)
Q Consensus 822 ll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~ 899 (992)
+++ .++.+||+|||.++...... .....|++.|+|||++.+..+ +.++||||+||++|||++|+.||.
T Consensus 171 l~~~~~~~~kl~dfg~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 240 (312)
T 2iwi_A 171 LIDLRRGCAKLIDFGSGALLHDEP----------YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE 240 (312)
T ss_dssp EEETTTTEEEECCCSSCEECCSSC----------BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred EEeCCCCeEEEEEcchhhhcccCc----------ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCC
Confidence 998 88999999999998765422 123458999999999877666 458999999999999999999996
Q ss_pred CCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 900 GMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
... + .... .. . .. .....++.+++.+||+.||++|||++|+++
T Consensus 241 ~~~-------~------------~~~~----~~--~----~~------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 241 RDQ-------E------------ILEA----EL--H----FP------AHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp SHH-------H------------HHHT----CC--C----CC------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ChH-------H------------Hhhh----cc--C----Cc------ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 420 0 0000 00 0 00 011345789999999999999999999986
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=355.01 Aligned_cols=286 Identities=22% Similarity=0.274 Sum_probs=204.1
Q ss_pred HhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC-CCchhHHHHHHHHHHhccCCcceeEEEEeeccc-ccCcc
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIKIITICSSID-FKGVD 754 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~ 754 (992)
..++|++.++||+|+||+||+|.+..+|+.||||+++... ....+.+.+|++++++++||||+++++++.... +....
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 3478999999999999999999998899999999986432 233467899999999999999999999875422 23356
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCc---EEE
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLV---AHL 831 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl 831 (992)
..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++. +||
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~---~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL 165 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFEN---CCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKI 165 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSC---TTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEE
T ss_pred eEEEEEEeCCCCCHHHHHHhccc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEE
Confidence 67999999999999999986542 23488889999999999999999999 9999999999999987764 999
Q ss_pred eecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHH
Q 037275 832 GDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEF 911 (992)
Q Consensus 832 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~ 911 (992)
+|||.+....... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+... ...|
T Consensus 166 ~DFG~a~~~~~~~---------~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~----~~~~ 232 (676)
T 3qa8_A 166 IDLGYAKELDQGE---------LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ----PVQW 232 (676)
T ss_dssp CSCCCCCBTTSCC---------CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH----HHHS
T ss_pred ccccccccccccc---------ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc----hhhh
Confidence 9999998765322 12335689999999999999999999999999999999999999975311 1111
Q ss_pred HhhhCChhHHHH-HHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHH-----HHHHHHHHH
Q 037275 912 ARTALPDKVMEI-VDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRD-----VVAKLCRAR 983 (992)
Q Consensus 912 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e-----vl~~L~~~~ 983 (992)
............ ......+... .....+............+.+++.+||..||++|||++| ..+.++.+.
T Consensus 233 ~~~i~~~~~~~~~~~~~l~g~~~--~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL 308 (676)
T 3qa8_A 233 HGKVREKSNEHIVVYDDLTGAVK--FSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL 308 (676)
T ss_dssp STTCC------CCSCCCCSSSCC--CCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred hhhhhcccchhhhhhhhhccccc--cccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence 111000000000 0000000000 000011111112234567899999999999999999988 445555544
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=332.41 Aligned_cols=349 Identities=17% Similarity=0.155 Sum_probs=217.2
Q ss_pred CCCCcCCCCCCc-eEeeEEcCCCCeEEEeeccccccCCccCCCCCCCCcCCeeeccCCCCCccCCc-cccCCCCCCEEEe
Q 037275 28 TSSWNNSTNLCQ-WTGVTCGHRHQRVTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPH-QIGRLVRLEALVL 105 (992)
Q Consensus 28 ~~~w~~~~~~c~-w~gv~c~~~~~~v~~ldl~~~~l~~~l~~~l~~l~~L~~L~L~~n~l~~~~p~-~~~~l~~L~~L~L 105 (992)
+++|..+.+||. |.++.|.....++ ............-..+.++++|++++|.++ .+|. .+..+++|++|+|
T Consensus 3 ~~~~~~~~~C~~~~~~~~c~~~~~~i-----~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~-~l~~~~~~~l~~L~~L~L 76 (390)
T 3o6n_A 3 VKPRQPEYKCIDSNLQYDCVFYDVHI-----DMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNL 76 (390)
T ss_dssp ----CCEECBCC------EEEESCEE-----CSSCCCCEESCSSGGGCCCSEEEEESCEES-EECTHHHHHCCCCSEEEC
T ss_pred cCCCCCccceehhhhhhccceeeeee-----ecccccccccccccccCCceEEEecCCchh-hCChhHhcccccCcEEEC
Confidence 578988888885 5555553222222 211111122223345788999999999998 5555 4688999999999
Q ss_pred ecccCCCCCCcccccCCCCcEeecccccccccCChhhcccccccccccccccccCCCCCCccccccccceEEecCCcccC
Q 037275 106 ANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWG 185 (992)
Q Consensus 106 s~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~ 185 (992)
++|++++..|..++.+++|++|++++|+++ .+|+..+.++++|++|+|++|.++...+..|.++++|++|++++|.+.+
T Consensus 77 ~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~ 155 (390)
T 3o6n_A 77 NDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLER 155 (390)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCB
T ss_pred CCCcccccChhhccCCCCcCEEECCCCCCC-cCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCc
Confidence 999998666678888999999999988888 4444444477888888888888884433445778888888888888877
Q ss_pred CcCCccCCCCcccEEeccCcccccccCccccccCCCcEEeccCCccCCCCCccccccccccchhhccccccCCCCchhhh
Q 037275 186 RIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLS 265 (992)
Q Consensus 186 ~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~ 265 (992)
..|..|.++++|++|++++|++++. .+..+++|++|++++|.+++ +.
T Consensus 156 ~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~------------------------------~~ 202 (390)
T 3o6n_A 156 IEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLST------------------------------LA 202 (390)
T ss_dssp CCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSE------------------------------EE
T ss_pred cChhhccCCCCCCEEECCCCcCCcc---ccccccccceeecccccccc------------------------------cC
Confidence 6677788888888888888887743 35566777777777776651 11
Q ss_pred ccccCceeeeccccccccccccccccCccceEecCCCCCCCCCCCCchhhhhccCCCcceEeecCCCcCCCcCCcccccc
Q 037275 266 NASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANL 345 (992)
Q Consensus 266 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~l 345 (992)
...+|++|++++|+++...... .++|++|++++|+++.. ..+..+++|+.|++++|++.+
T Consensus 203 ~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~n~l~~~--------~~l~~l~~L~~L~Ls~n~l~~--------- 262 (390)
T 3o6n_A 203 IPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTDT--------AWLLNYPGLVEVDLSYNELEK--------- 262 (390)
T ss_dssp CCSSCSEEECCSSCCCEEECCC---CSSCCEEECCSSCCCCC--------GGGGGCTTCSEEECCSSCCCE---------
T ss_pred CCCcceEEECCCCeeeeccccc---cccccEEECCCCCCccc--------HHHcCCCCccEEECCCCcCCC---------
Confidence 2246777777777776543322 35677777777776543 124445555555555555544
Q ss_pred cccceeEEeeCCccccccCCCccCCCcccEEEccCCcCCCCCCccccCCCCCcEEeccCccccccCCCCCCCccccCcee
Q 037275 346 SSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLA 425 (992)
Q Consensus 346 ~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 425 (992)
..|..|..+++|++|+|++|++++ +|..+..+++|++|+|++|+++ .+|..+..+++|+.|+
T Consensus 263 ----------------~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~ 324 (390)
T 3o6n_A 263 ----------------IMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLY 324 (390)
T ss_dssp ----------------EESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEE
T ss_pred ----------------cChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEE
Confidence 444455555555555555555552 3444455555666666666555 3444455555666666
Q ss_pred ccCCcccCCCCCCccccccccccccccccccc
Q 037275 426 LSSNDLQGSIPPSLGNCKNLIELHMADIELTG 457 (992)
Q Consensus 426 L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 457 (992)
|++|+|++. + +..+++|+.|++++|++.+
T Consensus 325 L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~ 353 (390)
T 3o6n_A 325 LDHNSIVTL-K--LSTHHTLKNLTLSHNDWDC 353 (390)
T ss_dssp CCSSCCCCC-C--CCTTCCCSEEECCSSCEEH
T ss_pred CCCCcccee-C--chhhccCCEEEcCCCCccc
Confidence 666665532 2 4455566666666666653
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=333.52 Aligned_cols=259 Identities=21% Similarity=0.249 Sum_probs=176.6
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC-CchhHHHHHHH-HHHhccCCcceeEEEEeecccccCcce
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK-GASNGFVAECQ-ALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
.++|++.+.||+|+||.||+|.+..+|+.||||+++.... .....+..|+. +++.++||||+++++++.. .+.
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~-----~~~ 95 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR-----EGD 95 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC-----SSE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe-----CCc
Confidence 3588999999999999999999998999999999975432 22344556665 6777899999999999643 456
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++||||+++ +|.+++...... ....+++..+..++.|++.||+|||+.. +|+||||||+||+++.++.+||+|||
T Consensus 96 ~~lv~e~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg 171 (327)
T 3aln_A 96 CWICMELMST-SFDKFYKYVYSV-LDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFG 171 (327)
T ss_dssp EEEEECCCSE-EHHHHHHHHHHT-TCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCS
T ss_pred eEEEEeecCC-ChHHHHHHHHhh-hcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCC
Confidence 7999999975 888888643211 1235899999999999999999999852 79999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccc----cCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHH
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYG----MGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEF 911 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~ 911 (992)
+++...... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||.+........
T Consensus 172 ~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--- 239 (327)
T 3aln_A 172 ISGQLVDSI---------AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQL--- 239 (327)
T ss_dssp SSCC---------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------
T ss_pred Cceeccccc---------ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHH---
Confidence 998654321 11223589999999998 45678999999999999999999999997532111000
Q ss_pred HhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 912 ARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
........ ..... .........+.+++.+||+.||++|||+.|+++
T Consensus 240 -------------~~~~~~~~-----~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 240 -------------TQVVKGDP-----PQLSN--SEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp -------------CCCCCSCC-----CCCCC--CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -------------HHHhcCCC-----CCCCC--cccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 00000000 00000 000112345889999999999999999999976
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-36 Score=328.94 Aligned_cols=252 Identities=21% Similarity=0.260 Sum_probs=177.8
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCc--hhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGA--SNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
.++|++.+.||+|+||.||+|++..+|+.||||++....... .+.+.++..+++.++||||+++++++. ....
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~-----~~~~ 98 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI-----TNTD 98 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSSE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEe-----cCCc
Confidence 457899999999999999999999899999999997543221 233445556788889999999999964 3456
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHH-HCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
.++||||+ ++.+..+..... ..+++..++.++.|++.||+|||+ + +|+||||||+||+++.++.+||+||
T Consensus 99 ~~lv~e~~-~~~~~~l~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~df 169 (318)
T 2dyl_A 99 VFIAMELM-GTCAEKLKKRMQ-----GPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDF 169 (318)
T ss_dssp EEEEECCC-SEEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEecc-CCcHHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEEC
Confidence 79999999 556666554322 258999999999999999999998 6 8999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCccccccccccccccc-----CCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHH
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGM-----GGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLH 909 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~ 909 (992)
|.+....... ......|++.|+|||++. +..++.++|||||||++|||++|+.||.......
T Consensus 170 g~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---- 236 (318)
T 2dyl_A 170 GISGRLVDDK---------AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF---- 236 (318)
T ss_dssp TTC-----------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH----
T ss_pred CCchhccCCc---------cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH----
Confidence 9997654321 122345899999999984 4578899999999999999999999997532211
Q ss_pred HHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 910 EFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
+.+......... ..+. ......++.+++.+||+.||++|||++|+++
T Consensus 237 ------------~~~~~~~~~~~~-----~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 237 ------------EVLTKVLQEEPP-----LLPG----HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp ------------HHHHHHHHSCCC-----CCCS----SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ------------HHHHHHhccCCC-----CCCc----cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 111111111000 0000 0012345889999999999999999999986
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=327.13 Aligned_cols=274 Identities=18% Similarity=0.217 Sum_probs=220.3
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCC----cCCCCCCceEeeEEc--------CCCCeEEEeeccccccCCccCCCCC
Q 037275 4 PSNETDRLALLAIGSQLEDDPLGVTSSW----NNSTNLCQWTGVTCG--------HRHQRVTKLDLSNRTIGGTLSPYVG 71 (992)
Q Consensus 4 ~~~~~~~~~ll~~~~~~~~~~~~~~~~w----~~~~~~c~w~gv~c~--------~~~~~v~~ldl~~~~l~~~l~~~l~ 71 (992)
.+.++|++||++||+++..||.+++++| +.+.++|.|.||+|+ ....+|+.|||+++.+. .+|+.++
T Consensus 23 ~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~ 101 (328)
T 4fcg_A 23 TALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAF 101 (328)
T ss_dssp CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGG
T ss_pred ccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhhh
Confidence 3567899999999999988999999999 567889999999995 23467999999999995 8999999
Q ss_pred CCCcCCeeeccCCCCCccCCccccCCCCCCEEEeecccCCCCCCcccccCCCCcEeecccccccccCChhhcc-------
Q 037275 72 NLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGY------- 144 (992)
Q Consensus 72 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~------- 144 (992)
.+++|++|+|++|.++ .+|..++.+++|++|+|++|+++ .+|..++.+++|++|++++|++.+.+|..+..
T Consensus 102 ~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~ 179 (328)
T 4fcg_A 102 RLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEH 179 (328)
T ss_dssp GGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCE
T ss_pred hCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhh
Confidence 9999999999999999 89999999999999999999999 89999999999999999999999999987752
Q ss_pred -cccccccccccccccCCCCCCccccccccceEEecCCcccCCcCCccCCCCcccEEeccCcccccccCccccccCCCcE
Q 037275 145 -NWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLEN 223 (992)
Q Consensus 145 -~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~ 223 (992)
++++|++|+|++|.++ .+|..++++++|++|++++|.+. .+|..++.+++|++|+|++|++.+.+|..+..+++|++
T Consensus 180 ~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~ 257 (328)
T 4fcg_A 180 QGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKR 257 (328)
T ss_dssp EESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCE
T ss_pred ccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCE
Confidence 4677777777777777 66777777777777777777774 35556777777777777777777677777777777777
Q ss_pred EeccCCccCCCCCccccccccccchhhccccccCCCCchhhhccccCceeeeccccccccccccccccCccceEecCCCC
Q 037275 224 VFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNN 303 (992)
Q Consensus 224 L~l~~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 303 (992)
|+|++|.+.+ .+|..+.++++|++|+|++|.+.+.+|..+..+++|+.+++..|.
T Consensus 258 L~L~~n~~~~-------------------------~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~ 312 (328)
T 4fcg_A 258 LILKDCSNLL-------------------------TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHL 312 (328)
T ss_dssp EECTTCTTCC-------------------------BCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGG
T ss_pred EECCCCCchh-------------------------hcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHH
Confidence 7777666654 455566667777777777777777777777777777777777666
Q ss_pred CCCC
Q 037275 304 LGTG 307 (992)
Q Consensus 304 l~~~ 307 (992)
+..+
T Consensus 313 ~~~l 316 (328)
T 4fcg_A 313 QAQL 316 (328)
T ss_dssp SCC-
T ss_pred HHHH
Confidence 5443
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=338.96 Aligned_cols=257 Identities=22% Similarity=0.274 Sum_probs=182.9
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhc-cCCcceeEEEEeecccccCcceEEE
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNI-RHRNLIKIITICSSIDFKGVDFQAI 758 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~l 758 (992)
.|...++||+|+||+||.+.. .+|+.||||++... ..+.+.+|+.+++++ +||||+++++++ ......++
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~-~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~-----~~~~~~~l 86 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGS-FQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSE-----TTDRFLYI 86 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEE-SSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEE
T ss_pred eeeccCeEeeCCCeEEEEEEE-ECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCeEEE
Confidence 345568899999999987654 47999999998643 245678999999887 899999999985 34566799
Q ss_pred EEEeccCCCHHHHHhhcccchhh-cccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCC-----------
Q 037275 759 VYEYMQNGSLEDWLHQSEDQQEA-RSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQD----------- 826 (992)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----------- 826 (992)
||||+. |+|.+++......... ...++..++.++.||+.||+|||++ +|+||||||+||+++.+
T Consensus 87 v~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~ 162 (434)
T 2rio_A 87 ALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGA 162 (434)
T ss_dssp EECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCC
T ss_pred EEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCC
Confidence 999995 6999999865432111 1123445678999999999999999 99999999999999654
Q ss_pred --CcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccC-------CCcCcccchhhHHHHHHHHHh-CCC
Q 037275 827 --LVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-------GEASMTGDVYSFGILLLEMFT-RRR 896 (992)
Q Consensus 827 --~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~ellt-g~~ 896 (992)
+.+||+|||+|+......... ........||+.|+|||++.+ ..++.++|||||||++|||++ |+.
T Consensus 163 ~~~~~kL~DFG~a~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~ 238 (434)
T 2rio_A 163 ENLRILISDFGLCKKLDSGQSSF----RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238 (434)
T ss_dssp CSCEEEECCCTTCEECCC------------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCC
T ss_pred CceEEEEcccccceecCCCCccc----eeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCC
Confidence 489999999999775432110 111234569999999999865 578999999999999999999 999
Q ss_pred CCCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 037275 897 PTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVV 976 (992)
Q Consensus 897 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 976 (992)
||.+..... .. +.. ...... ............++.+++.+||+.||++|||+.||+
T Consensus 239 Pf~~~~~~~---~~------------i~~----~~~~~~-----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil 294 (434)
T 2rio_A 239 PFGDKYSRE---SN------------IIR----GIFSLD-----EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVL 294 (434)
T ss_dssp TTCSTTTHH---HH------------HHH----TCCCCC-----CCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCchhhH---HH------------Hhc----CCCCcc-----cccccccccchHHHHHHHHHHhhCChhhCCCHHHHH
Confidence 997532110 01 110 000000 001111234456789999999999999999999998
Q ss_pred H
Q 037275 977 A 977 (992)
Q Consensus 977 ~ 977 (992)
+
T Consensus 295 ~ 295 (434)
T 2rio_A 295 R 295 (434)
T ss_dssp T
T ss_pred h
Confidence 5
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-35 Score=331.78 Aligned_cols=174 Identities=22% Similarity=0.222 Sum_probs=115.8
Q ss_pred CCcEEeccCccccccCCCCCCCccccCceeccCCcccCCCCCCccccccccccccccccccccCchhhhhhccccccccc
Q 037275 396 NLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDL 475 (992)
Q Consensus 396 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l 475 (992)
+|+.|++++|+++.. |.. ..++|+.|++++|.+++. ..+..+++|++| ++
T Consensus 206 ~L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L-------------------------~L 255 (390)
T 3o6n_A 206 AVEELDASHNSINVV-RGP--VNVELTILKLQHNNLTDT--AWLLNYPGLVEV-------------------------DL 255 (390)
T ss_dssp SCSEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCCCC--GGGGGCTTCSEE-------------------------EC
T ss_pred cceEEECCCCeeeec-ccc--ccccccEEECCCCCCccc--HHHcCCCCccEE-------------------------EC
Confidence 444445555544422 211 124556666666666532 345555666555 34
Q ss_pred ccccccCcccccccCCCCccEEeeecccccccCCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcccCCC
Q 037275 476 SYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQ 555 (992)
Q Consensus 476 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 555 (992)
++|.+++..|..|..+++|++|+|++|++++ +|..+..+++|++|+|++|+++ .+|..+..+++|++|+|++|+|++.
T Consensus 256 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~ 333 (390)
T 3o6n_A 256 SYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL 333 (390)
T ss_dssp CSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC
T ss_pred CCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCcccee
Confidence 4444444556667777788888888888874 4556677788888888888887 5677788888888888988888854
Q ss_pred ChhhhhcCCCcceEecCCCcCcccCCCCCccCCcccccccCCCCcCCCCC
Q 037275 556 IPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNKTGISLSGNGKVCGGLD 605 (992)
Q Consensus 556 ~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~l~~N~~~C~~~~ 605 (992)
| +..+++|+.|++++|+|.|.+.. ..+..+....+.+++..|.++.
T Consensus 334 -~--~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~c~~~~ 379 (390)
T 3o6n_A 334 -K--LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKIDY 379 (390)
T ss_dssp -C--CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCSCCCTTC
T ss_pred -C--chhhccCCEEEcCCCCccchhHH-HHHHHHHhhcccccCceecccc
Confidence 3 66788899999999999886543 3445566667788888887644
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=317.15 Aligned_cols=232 Identities=13% Similarity=0.080 Sum_probs=182.0
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCC---chhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKG---ASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
++|++.+.||+|+||.||+|++..+++.||||++...... ..+.+.+|+.++++++||||+++++++.. .+.
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~~~ 105 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT-----RAG 105 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE-----CCc
Confidence 5799999999999999999999988999999999754332 23678999999999999999999999643 456
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++||||+++++|.++++.. ....++.+++.|++.||+|||++ +|+||||||+||+++.++.+||+++|
T Consensus 106 ~~lv~e~~~g~~L~~~l~~~--------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~ 174 (286)
T 3uqc_A 106 GLVVAEWIRGGSLQEVADTS--------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA 174 (286)
T ss_dssp EEEEEECCCEEEHHHHHTTC--------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC
T ss_pred EEEEEEecCCCCHHHHHhcC--------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc
Confidence 79999999999999999542 34456888999999999999999 99999999999999999999998543
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHH--HHHh
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLH--EFAR 913 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~--~~~~ 913 (992)
|++ .++.++|||||||++|||++|+.||.+......... ....
T Consensus 175 ----------------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~ 219 (286)
T 3uqc_A 175 ----------------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTA 219 (286)
T ss_dssp ----------------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTT
T ss_pred ----------------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhc
Confidence 333 267899999999999999999999987543221100 0000
Q ss_pred hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 037275 914 TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTF 986 (992)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 986 (992)
...+ ..... ......++.+++.+||+.||++| |+.|+++.|+++....
T Consensus 220 ~~~~-~~~~~-----------------------~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 220 GQPI-EPADI-----------------------DRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp SCBC-CHHHH-----------------------CTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred cCCC-Chhhc-----------------------ccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 0000 00000 01123458899999999999999 9999999999986543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=335.05 Aligned_cols=250 Identities=24% Similarity=0.326 Sum_probs=180.9
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhc-cCCcceeEEEEeecccccCcceEE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNI-RHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
.+|++.++||+|+||+||.... .+++.||||++.... ...+.+|+.+++.+ +||||+++++++. +....+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~-~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~-----~~~~~~ 94 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGM-FDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEK-----DRQFQY 94 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEE-SSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEE-----ETTEEE
T ss_pred EEEecCCeeecCcCEEEEEEEE-eCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEe-----cCCEEE
Confidence 4688889999999998654333 378999999985432 23456899999999 7999999999854 445679
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCC-----CCcEEEe
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQ-----DLVAHLG 832 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~ 832 (992)
+||||+. |+|.+++..... ...+..++.++.||+.||+|||++ +|+||||||+||+++. ...+||+
T Consensus 95 lv~E~~~-g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~ 165 (432)
T 3p23_A 95 IAIELCA-ATLQEYVEQKDF-----AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMIS 165 (432)
T ss_dssp EEEECCS-EEHHHHHHSSSC-----CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEEC
T ss_pred EEEECCC-CCHHHHHHhcCC-----CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEe
Confidence 9999996 599999986543 244455678999999999999999 9999999999999953 2368899
Q ss_pred ecccceecCCCCCCCCcccCCCCCccccccccccccccc---CCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccH
Q 037275 833 DFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGM---GGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTL 908 (992)
Q Consensus 833 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~ 908 (992)
|||+|+....... .........||+.|+|||++. ...++.++||||+||++|||++ |..||...... .
T Consensus 166 DFG~a~~~~~~~~-----~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~---~ 237 (432)
T 3p23_A 166 DFGLCKKLAVGRH-----SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR---Q 237 (432)
T ss_dssp CTTEEECC-----------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH---H
T ss_pred cccceeeccCCCc-----ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH---H
Confidence 9999987653211 112233456999999999987 4567889999999999999999 99998542111 0
Q ss_pred HHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 909 HEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.... . ... .... ..........+.+++.+||+.||++|||++||++
T Consensus 238 ~~~~-----------~-----~~~----~~~~---~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 238 ANIL-----------L-----GAC----SLDC---LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp HHHH-----------T-----TCC----CCTT---SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHH-----------h-----ccC----Cccc---cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0000 0 000 0000 0011123445789999999999999999999984
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-35 Score=331.32 Aligned_cols=251 Identities=18% Similarity=0.186 Sum_probs=182.9
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC---CchhHHHHHHHHHHhccC-Ccc---------ee----
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK---GASNGFVAECQALRNIRH-RNL---------IK---- 740 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~ni---------v~---- 740 (992)
...|...++||+|+||+||+|++..+|+.||||+++.... ...+.+.+|+.+++.++| ++. +.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 3457778899999999999999998999999999873322 235778999999999976 211 11
Q ss_pred --------EEEEeecccccCcceEEEEEEeccCCCHHHHHhhccc-chhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 037275 741 --------IITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSED-QQEARSLTLIQRINIIIDVASAIEYIHHHCQPPV 811 (992)
Q Consensus 741 --------~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i 811 (992)
+..++...........+++|+++ +++|.+++..... ......+++..++.++.|++.||+|||++ +|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence 11111110011123457777766 6799999963321 11123588899999999999999999999 99
Q ss_pred EeccCCCCCeeeCCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccc----------cCCCcCcccch
Q 037275 812 VHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYG----------MGGEASMTGDV 881 (992)
Q Consensus 812 vH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Di 881 (992)
+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++||
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~Dv 300 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDT 300 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc-----------cccCCC-CceeCchhhhccccccccccCcCCCchhhH
Confidence 99999999999999999999999999865421 223457 999999998 55678899999
Q ss_pred hhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhc
Q 037275 882 YSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVC 961 (992)
Q Consensus 882 wSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 961 (992)
|||||++|||++|+.||......... ..... .+. ....++.+++.+|
T Consensus 301 wSlGvil~elltg~~Pf~~~~~~~~~-----------------~~~~~---------~~~-------~~~~~~~~li~~~ 347 (413)
T 3dzo_A 301 WTLGLAIYWIWCADLPNTDDAALGGS-----------------EWIFR---------SCK-------NIPQPVRALLEGF 347 (413)
T ss_dssp HHHHHHHHHHHHSSCCCCTTGGGSCS-----------------GGGGS---------SCC-------CCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHCCCCCCCcchhhhH-----------------HHHHh---------hcc-------cCCHHHHHHHHHH
Confidence 99999999999999999764322110 00000 000 0124588999999
Q ss_pred cCCCCCCCCCHHHHHH
Q 037275 962 SMESPTERMEMRDVVA 977 (992)
Q Consensus 962 l~~dP~~RPs~~evl~ 977 (992)
|+.||++|||+.|+++
T Consensus 348 l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 348 LRYPKEDRLLPLQAME 363 (413)
T ss_dssp TCSSGGGSCCHHHHTT
T ss_pred ccCChhhCcCHHHHHh
Confidence 9999999999988854
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=317.60 Aligned_cols=256 Identities=30% Similarity=0.514 Sum_probs=228.7
Q ss_pred cceeEEeeCCcccc--ccCCCccCCCcccEEEccC-CcCCCCCCccccCCCCCcEEeccCccccccCCCCCCCccccCce
Q 037275 348 TMTDIVIAGNQISG--IIPTGIRNLVNLVELCMDD-NKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNL 424 (992)
Q Consensus 348 ~L~~L~l~~n~i~~--~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 424 (992)
+++.|++++|++++ .+|..|.++++|++|+|++ |.+.+.+|..|..+++|++|+|++|++++.+|..|.++++|++|
T Consensus 51 ~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L 130 (313)
T 1ogq_A 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred eEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEE
Confidence 57778888888887 7788888888888888884 88888888888888888888888888888888888888888888
Q ss_pred eccCCcccCCCCCCccccccccccccccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeecccc
Q 037275 425 ALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRF 504 (992)
Q Consensus 425 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 504 (992)
+|++|.+++.+|..|..+++|++|++++|++++.+|..+......++.|++++|.+++..|..+..++ |++|+|++|++
T Consensus 131 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l 209 (313)
T 1ogq_A 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNML 209 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEE
T ss_pred eCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcc
Confidence 88888888888888888888888888888888888888877776777889999999999999999997 99999999999
Q ss_pred cccCCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcccCCCChhhhhcCCCcceEecCCCcCcccCCCCC
Q 037275 505 SGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKG 584 (992)
Q Consensus 505 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~ 584 (992)
++.+|..|..+++|+.|+|++|++++.+|. +..+++|++|+|++|+|++.+|..+..+++|++|++++|++++.+|...
T Consensus 210 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~ 288 (313)
T 1ogq_A 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG 288 (313)
T ss_dssp EECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCST
T ss_pred cCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCc
Confidence 999999999999999999999999976665 8899999999999999999999999999999999999999999999888
Q ss_pred ccCCcccccccCCCCcCCCCC
Q 037275 585 VFSNKTGISLSGNGKVCGGLD 605 (992)
Q Consensus 585 ~~~~~~~~~l~~N~~~C~~~~ 605 (992)
.++.++.+++.+|++.|+.|.
T Consensus 289 ~l~~L~~l~l~~N~~lc~~p~ 309 (313)
T 1ogq_A 289 NLQRFDVSAYANNKCLCGSPL 309 (313)
T ss_dssp TGGGSCGGGTCSSSEEESTTS
T ss_pred cccccChHHhcCCCCccCCCC
Confidence 899999999999999999866
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=351.79 Aligned_cols=248 Identities=24% Similarity=0.347 Sum_probs=196.7
Q ss_pred cCCCCCCccccccceEEEEeEECC-CCeEEEEEEeeccCC-CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGE-NGMMVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
++|++.++||+|+||+||+|.+.. +++.||||++..... .....+.+|+.++++++||||+++++++...+..+....
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 689999999999999999999965 689999999864322 334568899999999999999999999876544334446
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
++||||+++++|.+++.. .+++.+++.++.||+.||+|||++ +|+||||||+||+++.+ .+||+|||+
T Consensus 160 ~lv~E~~~g~~L~~~~~~--------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~ 227 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ--------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGA 227 (681)
T ss_dssp EEEEECCCCEECC----C--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred EEEEEeCCCCcHHHHHhC--------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEeccc
Confidence 999999999999987753 489999999999999999999999 99999999999999875 999999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhC
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTAL 916 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 916 (992)
++..... ....||+.|+|||++.+. ++.++|||||||++|+|++|.+||.+......
T Consensus 228 a~~~~~~------------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~---------- 284 (681)
T 2pzi_A 228 VSRINSF------------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL---------- 284 (681)
T ss_dssp CEETTCC------------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC----------
T ss_pred chhcccC------------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc----------
Confidence 9875432 234689999999988765 48899999999999999999998875322211
Q ss_pred ChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHHHHHhh
Q 037275 917 PDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERM-EMRDVVAKLCRARDTF 986 (992)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~~~ 986 (992)
+... ........+.+++.+||+.||++|| +++++.+.|..+.+..
T Consensus 285 ~~~~-------------------------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~ 330 (681)
T 2pzi_A 285 PEDD-------------------------PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREV 330 (681)
T ss_dssp CTTC-------------------------HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHHH
T ss_pred cccc-------------------------cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHHh
Confidence 0000 0011124578999999999999999 5666777777665443
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=311.45 Aligned_cols=236 Identities=20% Similarity=0.287 Sum_probs=180.5
Q ss_pred hcCCCCC-CccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHH-HhccCCcceeEEEEeecccccCcce
Q 037275 678 TNDFSSS-NMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQAL-RNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 678 ~~~~~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
.++|.+. ++||+|+||.||+|.+..+++.||+|+++. ...+.+|+.++ +..+||||+++++++... ..+...
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~-~~~~~~ 89 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC 89 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhh-cCCCce
Confidence 3567776 789999999999999998999999999852 34577899888 556999999999987542 234567
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCC---CCcEEEe
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQ---DLVAHLG 832 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~ 832 (992)
.++||||+++|+|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+||+++. ++.+||+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~ 162 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRGD----QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT 162 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred EEEEEeecCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEe
Confidence 7999999999999999987542 2589999999999999999999999 9999999999999998 7899999
Q ss_pred ecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHH
Q 037275 833 DFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFA 912 (992)
Q Consensus 833 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~ 912 (992)
|||++.... +..++.++||||+||++|||++|+.||.+........ ..
T Consensus 163 Dfg~a~~~~------------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~--~~ 210 (299)
T 3m2w_A 163 DFGFAKETT------------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP--GM 210 (299)
T ss_dssp CCTTCEECT------------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C--CS
T ss_pred ccccccccc------------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH--HH
Confidence 999987432 2346779999999999999999999997632211000 00
Q ss_pred hhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 913 RTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
...... . ..............++.+++.+||+.||++|||++|+++
T Consensus 211 ~~~~~~-----------~--------~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 211 KTRIRM-----------G--------QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp CCSSCT-----------T--------CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHhh-----------c--------cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 000000 0 000000000112456889999999999999999999986
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-32 Score=306.03 Aligned_cols=307 Identities=25% Similarity=0.409 Sum_probs=182.6
Q ss_pred cccccccceEEecCCcccCCcCCccCCCCcccEEeccCcccccccCccccccCCCcEEeccCCccCCCCCcccccccccc
Q 037275 167 IGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKL 246 (992)
Q Consensus 167 ~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~L 246 (992)
+..+++|++|++++|.+. .++ .+..+++|++|++++|++++ ++. +..+++|++|++++|.+++
T Consensus 40 ~~~l~~L~~L~l~~~~i~-~~~-~~~~~~~L~~L~l~~n~i~~-~~~-~~~l~~L~~L~L~~n~i~~------------- 102 (347)
T 4fmz_A 40 QEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQITD-ISP-LSNLVKLTNLYIGTNKITD------------- 102 (347)
T ss_dssp HHHHTTCSEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-------------
T ss_pred chhcccccEEEEeCCccc-cch-hhhhcCCccEEEccCCcccc-chh-hhcCCcCCEEEccCCcccC-------------
Confidence 345556666666666653 233 25556666666666666653 232 5666666666666665541
Q ss_pred chhhccccccCCCCchhhhccccCceeeeccccccccccccccccCccceEecCCCCCCCCCCCCchhhhhccCCCcceE
Q 037275 247 LGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTA 326 (992)
Q Consensus 247 ~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~~L~~ 326 (992)
+| .+..+++|++|++++|++++..+ +..+++|++|++++|..... +..+..+++|+.
T Consensus 103 -------------~~-~~~~l~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~-------~~~~~~l~~L~~ 159 (347)
T 4fmz_A 103 -------------IS-ALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSD-------LSPLSNMTGLNY 159 (347)
T ss_dssp -------------CG-GGTTCTTCSEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCC-------CGGGTTCTTCCE
T ss_pred -------------ch-HHcCCCcCCEEECcCCcccCchh--hccCCceeEEECCCCCCccc-------ccchhhCCCCcE
Confidence 11 34455556666666666554333 55566666666666533221 112344444444
Q ss_pred eecCCCcCCCcCCcccccccccceeEEeeCCccccccCCCccCCCcccEEEccCCcCCCCCCccccCCCCCcEEeccCcc
Q 037275 327 IGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNF 406 (992)
Q Consensus 327 L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 406 (992)
|++++|.+.+. .+ +..+++|++|++++|.+.+..+ +..+++|+.|++++|+
T Consensus 160 L~l~~~~~~~~-------------------------~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~ 210 (347)
T 4fmz_A 160 LTVTESKVKDV-------------------------TP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQ 210 (347)
T ss_dssp EECCSSCCCCC-------------------------GG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSC
T ss_pred EEecCCCcCCc-------------------------hh--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCC
Confidence 44444443321 11 4455566666666666653322 5566666666666666
Q ss_pred ccccCCCCCCCccccCceeccCCcccCCCCCCccccccccccccccccccccCchhhhhhcccccccccccccccCcccc
Q 037275 407 LAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPL 486 (992)
Q Consensus 407 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~ 486 (992)
+++..+ +..+++|++|++++|++++..+ +..+++|++|++++|.++ + + .
T Consensus 211 l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~-------------------------~-~-~ 259 (347)
T 4fmz_A 211 ITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQIS-------------------------D-I-N 259 (347)
T ss_dssp CCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-------------------------C-C-G
T ss_pred CCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccC-------------------------C-C-h
Confidence 664333 5566666666666666664322 566666666644444443 1 1 2
Q ss_pred cccCCCCccEEeeecccccccCCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcccCCCChhhhhcCCCc
Q 037275 487 EVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFL 566 (992)
Q Consensus 487 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 566 (992)
.+..+++|++|++++|++++. ..+..+++|+.|++++|++++..|..+..+++|++|+|++|++++..| +..+++|
T Consensus 260 ~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L 335 (347)
T 4fmz_A 260 AVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKM 335 (347)
T ss_dssp GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTC
T ss_pred hHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhcc
Confidence 456677788888888888753 357778888888888888887777778888888888888888886555 7778888
Q ss_pred ceEecCCCcCc
Q 037275 567 EYLNLSYNHFE 577 (992)
Q Consensus 567 ~~L~l~~N~l~ 577 (992)
++|++++|+++
T Consensus 336 ~~L~l~~N~i~ 346 (347)
T 4fmz_A 336 DSADFANQVIK 346 (347)
T ss_dssp SEESSSCC---
T ss_pred ceeehhhhccc
Confidence 88888888775
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-33 Score=331.69 Aligned_cols=334 Identities=18% Similarity=0.182 Sum_probs=194.8
Q ss_pred ccccchhhccccccCCCCchhhhccccCceeeeccccccccccccccccCccceEecCCCCCCCCCCCCchhhhhccCCC
Q 037275 243 LPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCT 322 (992)
Q Consensus 243 ~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~ 322 (992)
+.+++.+.+.+|.+....+..+..+++|++|+|++|.+++.++..|..+++|++|+|++|.++.+++. .+.+++
T Consensus 50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~------~~~~l~ 123 (597)
T 3oja_B 50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPH------VFQNVP 123 (597)
T ss_dssp GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTT------TTTTCT
T ss_pred CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHH------HHcCCC
Confidence 45666777777777766555667777777777777777777777777777777777777777765543 345666
Q ss_pred cceEeecCCCcCCCcCCcccccccccceeEEeeCCccccccCCCccCCCcccEEEccCCcCCCCCCccccCCCCCcEEec
Q 037275 323 ELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYL 402 (992)
Q Consensus 323 ~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 402 (992)
+|+.|+|++|.+.+..+..+..+. +|++|+|++|.+++..|..|..+++|++|+|++|.+++.. +..+++|+.|++
T Consensus 124 ~L~~L~L~~n~l~~l~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l 199 (597)
T 3oja_B 124 LLTVLVLERNDLSSLPRGIFHNTP-KLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANV 199 (597)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCT-TCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEEC
T ss_pred CCCEEEeeCCCCCCCCHHHhccCC-CCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhc
Confidence 777777777777654444444443 4666777777766666666666667777777777666432 344566666677
Q ss_pred cCccccccCCCCCCCccccCceeccCCcccCCCCCCccccccccccccccccccccCchhhhhhcccccccccccccccC
Q 037275 403 DSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSG 482 (992)
Q Consensus 403 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~ 482 (992)
++|.+++. ...++|+.|++++|.++.. +..+ .++|+.|++++|.+++. ..+...+.+..|+|++|.+++
T Consensus 200 ~~n~l~~l-----~~~~~L~~L~ls~n~l~~~-~~~~--~~~L~~L~L~~n~l~~~---~~l~~l~~L~~L~Ls~N~l~~ 268 (597)
T 3oja_B 200 SYNLLSTL-----AIPIAVEELDASHNSINVV-RGPV--NVELTILKLQHNNLTDT---AWLLNYPGLVEVDLSYNELEK 268 (597)
T ss_dssp CSSCCSEE-----ECCTTCSEEECCSSCCCEE-ECSC--CSCCCEEECCSSCCCCC---GGGGGCTTCSEEECCSSCCCE
T ss_pred ccCccccc-----cCCchhheeeccCCccccc-cccc--CCCCCEEECCCCCCCCC---hhhccCCCCCEEECCCCccCC
Confidence 66666532 1223566666666666632 2222 24566666666666532 223333444455555555555
Q ss_pred cccccccCCCCccEEeeecccccccCCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcccCCCChhhhhc
Q 037275 483 TLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLEN 562 (992)
Q Consensus 483 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 562 (992)
..|..|+.+++|++|+|++|.+++ +|..+..+++|+.|+|++|.|+ .+|..+..+++|+.|+|++|+|++. | +..
T Consensus 269 ~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~-~--~~~ 343 (597)
T 3oja_B 269 IMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LST 343 (597)
T ss_dssp EESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCT
T ss_pred CCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCc-C--hhh
Confidence 555555555555555555555553 3444445555555555555555 3455555555555555555555533 1 344
Q ss_pred CCCcceEecCCCcCcccCCCCCccCCcccccccCCCCcCCC
Q 037275 563 LSFLEYLNLSYNHFEGEVPTKGVFSNKTGISLSGNGKVCGG 603 (992)
Q Consensus 563 l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~l~~N~~~C~~ 603 (992)
+++|+.|++++|+|.|.+.. ..+..+....+.+++..|+.
T Consensus 344 ~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~C~~ 383 (597)
T 3oja_B 344 HHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKI 383 (597)
T ss_dssp TCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCCCCCT
T ss_pred cCCCCEEEeeCCCCCChhHH-HHHHHHhhhccccccccCCc
Confidence 45555555555555554322 12333333444555555554
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-32 Score=304.74 Aligned_cols=306 Identities=24% Similarity=0.371 Sum_probs=166.0
Q ss_pred CCCCCcCCeeeccCCCCCccCCccccCCCCCCEEEeecccCCCCCCcccccCCCCcEeecccccccccCChhhccccccc
Q 037275 70 VGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKL 149 (992)
Q Consensus 70 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L 149 (992)
+..+++|++|++++|.+. .+|. +..+++|++|+|++|+++ .+|. +..+++|++|++++|.++ .+|. +..+++|
T Consensus 40 ~~~l~~L~~L~l~~~~i~-~~~~-~~~~~~L~~L~l~~n~i~-~~~~-~~~l~~L~~L~L~~n~i~-~~~~--~~~l~~L 112 (347)
T 4fmz_A 40 QEELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNLNGNQIT-DISP-LSNLVKLTNLYIGTNKIT-DISA--LQNLTNL 112 (347)
T ss_dssp HHHHTTCSEEECCSSCCC-CCTT-GGGCTTCCEEECCSSCCC-CCGG-GTTCTTCCEEECCSSCCC-CCGG--GTTCTTC
T ss_pred chhcccccEEEEeCCccc-cchh-hhhcCCccEEEccCCccc-cchh-hhcCCcCCEEEccCCccc-CchH--HcCCCcC
Confidence 346677777777777776 4554 777777777877777777 4444 777777777777777776 3432 3356677
Q ss_pred ccccccccccCCCCCCccccccccceEEecCCcccCCcCCccCCCCcccEEeccCcccccccCccccccCCCcEEeccCC
Q 037275 150 ENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTN 229 (992)
Q Consensus 150 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N 229 (992)
++|++++|.+++. |. +..+++|++|++++|.....++ .+..+++|++|++++|.+.+..+ +..+++|++|++++|
T Consensus 113 ~~L~l~~n~i~~~-~~-~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n 187 (347)
T 4fmz_A 113 RELYLNEDNISDI-SP-LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYN 187 (347)
T ss_dssp SEEECTTSCCCCC-GG-GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTS
T ss_pred CEEECcCCcccCc-hh-hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCC
Confidence 7777777777643 33 6677777777777775534333 36777777777777777764322 666777777777777
Q ss_pred ccCCCCCccccccccccchhhccccccCCCCchhhhccccCceeeeccccccccccccccccCccceEecCCCCCCCCCC
Q 037275 230 RFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEA 309 (992)
Q Consensus 230 ~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 309 (992)
.+.+ + +. +..+++|++|++++|.+++..+ +..+++|++|++++|+++.++.
T Consensus 188 ~l~~-~-------------------------~~-~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~ 238 (347)
T 4fmz_A 188 QIED-I-------------------------SP-LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP 238 (347)
T ss_dssp CCCC-C-------------------------GG-GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG
T ss_pred cccc-c-------------------------cc-ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc
Confidence 6652 1 11 4445555555555555554333 4555555555555555544221
Q ss_pred CCchhhhhccCCCcceEeecCCCcCCCcCCcccccccccceeEEeeCCccccccCCCccCCCcccEEEccCCcCCCCCCc
Q 037275 310 NDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPH 389 (992)
Q Consensus 310 ~~~~~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 389 (992)
+..+++|+.|++++|.+.+. ..+..+ ++|++|++++|++++. ..+..+++|++|++++|++++..+.
T Consensus 239 --------~~~l~~L~~L~l~~n~l~~~--~~~~~l-~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~ 305 (347)
T 4fmz_A 239 --------LANLSQLTWLEIGTNQISDI--NAVKDL-TKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDME 305 (347)
T ss_dssp --------GTTCTTCCEEECCSSCCCCC--GGGTTC-TTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHH
T ss_pred --------hhcCCCCCEEECCCCccCCC--hhHhcC-CCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChh
Confidence 33444444444444444421 111111 1233333333333322 1234444444444444444444444
Q ss_pred cccCCCCCcEEeccCccccccCCCCCCCccccCceeccCCcc
Q 037275 390 AIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDL 431 (992)
Q Consensus 390 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 431 (992)
.+..+++|+.|++++|++++..| +..+++|+.|++++|+|
T Consensus 306 ~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i 345 (347)
T 4fmz_A 306 VIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVI 345 (347)
T ss_dssp HHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC--
T ss_pred HhhccccCCEEEccCCccccccC--hhhhhccceeehhhhcc
Confidence 44444444444444444443333 44444444444444444
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-33 Score=308.94 Aligned_cols=247 Identities=16% Similarity=0.155 Sum_probs=185.6
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC--------CchhHHHHHHHHHHhcc---------CCccee
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK--------GASNGFVAECQALRNIR---------HRNLIK 740 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---------h~niv~ 740 (992)
.++|++.++||+|+||+||+|++ +|+.||||+++.... ...+.+.+|+.+++.++ ||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 45789999999999999999998 689999999975432 23377899999999986 888888
Q ss_pred EEEEeeccc-------------------------ccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHH
Q 037275 741 IITICSSID-------------------------FKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIID 795 (992)
Q Consensus 741 ~~~~~~~~~-------------------------~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~q 795 (992)
+.+++.... +.+....++||||+++|++.+.+.+ ..+++..++.++.|
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-------~~~~~~~~~~i~~q 169 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-------KLSSLATAKSILHQ 169 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-------TCCCHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-------cCCCHHHHHHHHHH
Confidence 877643110 1135778999999999977666643 24799999999999
Q ss_pred HHHHHHHHH-hcCCCCeEeccCCCCCeeeCCCC--------------------cEEEeecccceecCCCCCCCCcccCCC
Q 037275 796 VASAIEYIH-HHCQPPVVHGDLKPSNVLLDQDL--------------------VAHLGDFGLAKFLSSSPLDTAVETPSS 854 (992)
Q Consensus 796 i~~~L~~LH-~~~~~~ivH~Dlkp~NIll~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 854 (992)
|+.||+||| ++ +|+||||||+|||++.++ .+||+|||+|+.....
T Consensus 170 i~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----------- 235 (336)
T 2vuw_A 170 LTASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----------- 235 (336)
T ss_dssp HHHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----------
T ss_pred HHHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----------
Confidence 999999999 89 999999999999999887 9999999999876431
Q ss_pred CCcccccccccccccccCCCcCcccchhhHHHH-HHHHHhCCCCCCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhh
Q 037275 855 SKGIKGTVGYIAPEYGMGGEASMTGDVYSFGIL-LLEMFTRRRPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQ 933 (992)
Q Consensus 855 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~i-l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 933 (992)
...||+.|+|||++.+.. +.++||||+|++ .+++++|..||... .|. ....+..... .
T Consensus 236 --~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~--------~~~--------~~~~~~~~~~-~- 294 (336)
T 2vuw_A 236 --IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV--------LWL--------HYLTDKMLKQ-M- 294 (336)
T ss_dssp --EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH--------HHH--------HHHHHHHHHT-C-
T ss_pred --cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch--------hhh--------hHHHHhhhhh-h-
Confidence 236899999999988766 889999998777 77888899987431 000 0011111100 0
Q ss_pred ccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 037275 934 ASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVV 976 (992)
Q Consensus 934 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 976 (992)
................++.+++.+||+.| ||+|++
T Consensus 295 ---~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 295 ---TFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp ---CCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred ---ccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 00000111122345678999999999976 999987
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.98 E-value=6.2e-32 Score=298.93 Aligned_cols=290 Identities=23% Similarity=0.319 Sum_probs=143.8
Q ss_pred ccccccccccccCCCCCCccccccccceEEecCCcccCCcCCccCCCCcccEEeccCcccccccCccccccCCCcEEecc
Q 037275 148 KLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLP 227 (992)
Q Consensus 148 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~ 227 (992)
+++.++++++.++ .+|..+. ++|++|++++|.+.+..|..|.++++|++|+|++|++++..|..|.++++|++|+++
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 110 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence 3445555555554 4444442 455666666666654445556666666666666666665555556666666666666
Q ss_pred CCccCCCCCccccccccccchhhccccccCCCCchhhhccccCceeeeccccccccccccccccCccceEecCCCCCCCC
Q 037275 228 TNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTG 307 (992)
Q Consensus 228 ~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 307 (992)
+|+++ .+| ..+. ++|++|++++|++++..+..|..+++|++|++++|.++..
T Consensus 111 ~n~l~-~l~-------------------------~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~ 162 (332)
T 2ft3_A 111 KNHLV-EIP-------------------------PNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENS 162 (332)
T ss_dssp SSCCC-SCC-------------------------SSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGG
T ss_pred CCcCC-ccC-------------------------cccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccC
Confidence 66554 222 1111 3555555555555544444455555555555555544220
Q ss_pred CCCCchhhhhccCCCcceEeecCCCcCCCcCCcccccccccceeEEeeCCccccccCCCccCCCcccEEEccCCcCCCCC
Q 037275 308 EANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTI 387 (992)
Q Consensus 308 ~~~~~~~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 387 (992)
+..+..+..+ +|++|++++|++++ +
T Consensus 163 -----------------------------------------------------~~~~~~~~~l-~L~~L~l~~n~l~~-l 187 (332)
T 2ft3_A 163 -----------------------------------------------------GFEPGAFDGL-KLNYLRISEAKLTG-I 187 (332)
T ss_dssp -----------------------------------------------------GSCTTSSCSC-CCSCCBCCSSBCSS-C
T ss_pred -----------------------------------------------------CCCcccccCC-ccCEEECcCCCCCc-c
Confidence 0122233333 44455555555442 2
Q ss_pred CccccCCCCCcEEeccCccccccCCCCCCCccccCceeccCCcccCCCCCCccccccccccccccccccccCchhhhhhc
Q 037275 388 PHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSIS 467 (992)
Q Consensus 388 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~ 467 (992)
|..+. ++|+.|++++|++++..+..|..+++|+.|+|++|++++..+..
T Consensus 188 ~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~----------------------------- 236 (332)
T 2ft3_A 188 PKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGS----------------------------- 236 (332)
T ss_dssp CSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTG-----------------------------
T ss_pred Ccccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhH-----------------------------
Confidence 22221 34444444444444433344444444444444444444333333
Q ss_pred ccccccccccccccCcccccccCCCCccEEeeecccccccCCcccccccccceeeccCCcccccCCccccc------cCC
Q 037275 468 TLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSS------LKS 541 (992)
Q Consensus 468 ~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~------l~~ 541 (992)
+..+++|++|+|++|+++ .+|..+..+++|+.|++++|+|++..+..|.. .++
T Consensus 237 --------------------~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~ 295 (332)
T 2ft3_A 237 --------------------LSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAY 295 (332)
T ss_dssp --------------------GGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCC
T ss_pred --------------------hhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHcccccccccccc
Confidence 344444555555555554 34444555555555555555555444444433 245
Q ss_pred CCEEECCCcccC--CCChhhhhcCCCcceEecCCCc
Q 037275 542 IKELDMSSNNLS--GQIPEYLENLSFLEYLNLSYNH 575 (992)
Q Consensus 542 L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~l~~N~ 575 (992)
|+.|++++|.+. +..|..|..+++|+.+++++|+
T Consensus 296 l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 296 YNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp BSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred ccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 666666666665 4556666666667777766663
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=294.21 Aligned_cols=125 Identities=25% Similarity=0.375 Sum_probs=67.7
Q ss_pred cccccccccccCCCCCCccccccccceEEecCCcccCCcCCccCCCCcccEEeccCcccccccCccccccCCCcEEeccC
Q 037275 149 LENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPT 228 (992)
Q Consensus 149 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~ 228 (992)
+++++++++.++ .+|..+. ++|++|++++|.+.+..+..|.++++|++|+|++|++++..|..|..+++|++|++++
T Consensus 33 l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 109 (330)
T 1xku_A 33 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 109 (330)
T ss_dssp TTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCC
Confidence 444444444444 3444332 3555666666666544444566666666666666666655566666666666666666
Q ss_pred CccCCCCCccccccccccchhhccccccCCCCchhhhccccCceeeeccccccccccccccccCccceEecCCCCC
Q 037275 229 NRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNL 304 (992)
Q Consensus 229 N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 304 (992)
|+++ .+|. .+. ++|++|++++|++++..+..|..+++|++|++++|.+
T Consensus 110 n~l~-~l~~-------------------------~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 157 (330)
T 1xku_A 110 NQLK-ELPE-------------------------KMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPL 157 (330)
T ss_dssp SCCS-BCCS-------------------------SCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCC
T ss_pred CcCC-ccCh-------------------------hhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcC
Confidence 6555 2222 111 3555555555555555555555555555555555554
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-31 Score=292.21 Aligned_cols=292 Identities=23% Similarity=0.234 Sum_probs=181.4
Q ss_pred EEeeccccccCCccCCCCCCCCcCCeeeccCCCCCccCCccccCCCCCCEEEeecccCCCCCCcccccCCCCcEeecccc
Q 037275 53 TKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRN 132 (992)
Q Consensus 53 ~~ldl~~~~l~~~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n 132 (992)
+.++++++.+ ..+|..+. ++|++|+|++|++++..|..|..+++|++|+|++|++++..|..++.+++|++|++++|
T Consensus 36 ~~l~~~~~~l-~~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 112 (332)
T 2ft3_A 36 RVVQCSDLGL-KAVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN 112 (332)
T ss_dssp TEEECCSSCC-SSCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSS
T ss_pred CEEECCCCCc-cccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCC
Confidence 4456666666 35666553 57788888888887655667888888888888888887666777777888888888877
Q ss_pred cccccCChhhcccccccccccccccccCCCCCCccccccccceEEecCCccc--CCcCCccCCCCcccEEeccCcccccc
Q 037275 133 NLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLW--GRIPNNLGNLRNLILLNLGENRFSGI 210 (992)
Q Consensus 133 ~l~~~~p~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~--~~~~~~l~~l~~L~~L~L~~n~l~~~ 210 (992)
+++ .+|..++ ++|++|++++|.+++..+..|.++++|++|++++|.+. +..|..+..+ +|+.|++++|++++
T Consensus 113 ~l~-~l~~~~~---~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~- 186 (332)
T 2ft3_A 113 HLV-EIPPNLP---SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG- 186 (332)
T ss_dssp CCC-SCCSSCC---TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-
T ss_pred cCC-ccCcccc---ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-
Confidence 777 6666554 56667777777766544445666666666666666663 2455555555 66666666666663
Q ss_pred cCccccccCCCcEEeccCCccCCCCCccccccccccchhhccccccCCCCchhhhccccCceeeeccccccccccccccc
Q 037275 211 VPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRS 290 (992)
Q Consensus 211 ~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~ 290 (992)
+|..+. ++|++|++++|+++ +..+..+..+++|++|++++|++++..+..|..
T Consensus 187 l~~~~~--~~L~~L~l~~n~i~-------------------------~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~ 239 (332)
T 2ft3_A 187 IPKDLP--ETLNELHLDHNKIQ-------------------------AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSF 239 (332)
T ss_dssp CCSSSC--SSCSCCBCCSSCCC-------------------------CCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGG
T ss_pred cCcccc--CCCCEEECCCCcCC-------------------------ccCHHHhcCCCCCCEEECCCCcCCcCChhHhhC
Confidence 444333 45555555555544 444555666666777777777776666666666
Q ss_pred cCccceEecCCCCCCCCCCCCchhhhhccCCCcceEeecCCCcCCCcCCcccccccccceeEEeeCCccccccCCCccCC
Q 037275 291 LKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNL 370 (992)
Q Consensus 291 l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l 370 (992)
+++|++|+|++|+++.++. .+..+++|+.|++++|++++..+..+..... -...
T Consensus 240 l~~L~~L~L~~N~l~~lp~-------~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~-------------------~~~~ 293 (332)
T 2ft3_A 240 LPTLRELHLDNNKLSRVPA-------GLPDLKLLQVVYLHTNNITKVGVNDFCPVGF-------------------GVKR 293 (332)
T ss_dssp CTTCCEEECCSSCCCBCCT-------TGGGCTTCCEEECCSSCCCBCCTTSSSCSSC-------------------CSSS
T ss_pred CCCCCEEECCCCcCeecCh-------hhhcCccCCEEECCCCCCCccChhHcccccc-------------------cccc
Confidence 6777777777776665443 2444555555555555555443333332110 0113
Q ss_pred CcccEEEccCCcCC--CCCCccccCCCCCcEEeccCcc
Q 037275 371 VNLVELCMDDNKLT--GTIPHAIGELKNLQLLYLDSNF 406 (992)
Q Consensus 371 ~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~L~~N~ 406 (992)
.+|+.|++++|.+. +..|..|..+++|+.+++++|+
T Consensus 294 ~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 294 AYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp CCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred ccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 45677777777765 4566677777777777777764
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.4e-31 Score=289.69 Aligned_cols=193 Identities=21% Similarity=0.299 Sum_probs=114.3
Q ss_pred eeccccccCCccCCCCCCCCcCCeeeccCCCCCccCCccccCCCCCCEEEeecccCCCCCCcccccCCCCcEeecccccc
Q 037275 55 LDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNL 134 (992)
Q Consensus 55 ldl~~~~l~~~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n~l 134 (992)
++++++.+ ..+|..+. ++|++|+|++|++++..+..|+.+++|++|+|++|++++..|..++.+++|++|++++|++
T Consensus 36 l~~~~~~l-~~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l 112 (330)
T 1xku_A 36 VQCSDLGL-EKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 112 (330)
T ss_dssp EECTTSCC-CSCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCC
T ss_pred EEecCCCc-cccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcC
Confidence 44444444 34555443 5777888888888755555777788888888888888766677777777777777777776
Q ss_pred cccCChhhcccccccccccccccccCCCCCCccccccccceEEecCCcccCCcCCccCCCCcccEEeccCccccc--ccC
Q 037275 135 VGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSG--IVP 212 (992)
Q Consensus 135 ~~~~p~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~--~~p 212 (992)
+ .+|..++ ++|++|++++|.+.+..+..|.++++|++|++++|+++. ..+
T Consensus 113 ~-~l~~~~~---------------------------~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 164 (330)
T 1xku_A 113 K-ELPEKMP---------------------------KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIEN 164 (330)
T ss_dssp S-BCCSSCC---------------------------TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCT
T ss_pred C-ccChhhc---------------------------ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcCh
Confidence 6 4444332 345555555555544444445555556666666665542 445
Q ss_pred ccccccCCCcEEeccCCccCCCCCccccccccccchhhccccccCCCCchhhhccccCceeeeccccccccccccccccC
Q 037275 213 PSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLK 292 (992)
Q Consensus 213 ~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 292 (992)
..+..+++|++|++++|+++ .+|. .+. ++|++|++++|++++..+..|..++
T Consensus 165 ~~~~~l~~L~~L~l~~n~l~-~l~~-------------------------~~~--~~L~~L~l~~n~l~~~~~~~~~~l~ 216 (330)
T 1xku_A 165 GAFQGMKKLSYIRIADTNIT-TIPQ-------------------------GLP--PSLTELHLDGNKITKVDAASLKGLN 216 (330)
T ss_dssp TGGGGCTTCCEEECCSSCCC-SCCS-------------------------SCC--TTCSEEECTTSCCCEECTGGGTTCT
T ss_pred hhccCCCCcCEEECCCCccc-cCCc-------------------------ccc--ccCCEEECCCCcCCccCHHHhcCCC
Confidence 55666666666666666655 1221 111 4556666666666655555555555
Q ss_pred ccceEecCCCCCCC
Q 037275 293 NLEWLNLGSNNLGT 306 (992)
Q Consensus 293 ~L~~L~L~~N~l~~ 306 (992)
+|++|+|++|.++.
T Consensus 217 ~L~~L~Ls~n~l~~ 230 (330)
T 1xku_A 217 NLAKLGLSFNSISA 230 (330)
T ss_dssp TCCEEECCSSCCCE
T ss_pred CCCEEECCCCcCce
Confidence 55555555555443
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-35 Score=340.53 Aligned_cols=358 Identities=16% Similarity=0.148 Sum_probs=247.3
Q ss_pred CcCCeeeccCCCCCccCCcc-ccCCCCCCEEEeecccCCC----CCCcccccCCCCcEeecccccccccCChhhccccc-
Q 037275 74 SFLRYLNLADNNFHGEIPHQ-IGRLVRLEALVLANNSFSG----KIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWL- 147 (992)
Q Consensus 74 ~~L~~L~L~~n~l~~~~p~~-~~~l~~L~~L~Ls~n~l~~----~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~- 147 (992)
++|++|||++|+++...... +..+++|++|+|++|++++ .+|..+..+++|++|++++|.+.+..+..++..+.
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 45677777777776433222 5667777777777777763 34556666777777777777776555555555555
Q ss_pred ---ccccccccccccCC----CCCCccccccccceEEecCCcccCCcCCcc-----CCCCcccEEeccCcccccc----c
Q 037275 148 ---KLENLTIADNHLTG----HFPASIGNLSTLERINVLGNGLWGRIPNNL-----GNLRNLILLNLGENRFSGI----V 211 (992)
Q Consensus 148 ---~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l-----~~l~~L~~L~L~~n~l~~~----~ 211 (992)
+|++|+|++|.++. .+|..+..+++|++|++++|.+.+..+..+ ...++|++|+|++|++++. +
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l 162 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 162 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHH
Confidence 57888888887773 457777788888888888888754333332 2245788888888888753 3
Q ss_pred CccccccCCCcEEeccCCccCCCCCccccc----cccccchhhccccccCCC----CchhhhccccCceeeecccccccc
Q 037275 212 PPSIFNISSLENVFLPTNRFNGSLPLDIGV----SLPKLLGFIVAENNFAGS----IPESLSNASNLVELTLFDNQFRGK 283 (992)
Q Consensus 212 p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~----~~~~L~~l~l~~n~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~ 283 (992)
+..+..+++|++|++++|.+.+..+..+.. ..++|+.|++++|++++. ++..+..+++|++|++++|++++.
T Consensus 163 ~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~ 242 (461)
T 1z7x_W 163 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 242 (461)
T ss_dssp HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHH
T ss_pred HHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChH
Confidence 555666788888888888876433322222 244788888888887764 577788889999999999998865
Q ss_pred cc-----ccccccCccceEecCCCCCCCCCCCCchhhhhccCCCcceEeecCCCcCCCcCCcccccc----cccceeEEe
Q 037275 284 VS-----IYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANL----SSTMTDIVI 354 (992)
Q Consensus 284 ~~-----~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~l----~~~L~~L~l 354 (992)
.. ..+..+++|++|+|++|.++..+.. .....+..+++|+.|++++|.+.+..+..+... ..+|++|++
T Consensus 243 ~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~--~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L 320 (461)
T 1z7x_W 243 GMAELCPGLLHPSSRLRTLWIWECGITAKGCG--DLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWV 320 (461)
T ss_dssp HHHHHHHHHTSTTCCCCEEECTTSCCCHHHHH--HHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEEC
T ss_pred HHHHHHHHHhcCCCCceEEECcCCCCCHHHHH--HHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEc
Confidence 43 2333578999999999988753221 123456678889999999998876555444432 246888888
Q ss_pred eCCccccc----cCCCccCCCcccEEEccCCcCCCCCCccccC-----CCCCcEEeccCccccc----cCCCCCCCcccc
Q 037275 355 AGNQISGI----IPTGIRNLVNLVELCMDDNKLTGTIPHAIGE-----LKNLQLLYLDSNFLAG----GIPTSLGNLTLL 421 (992)
Q Consensus 355 ~~n~i~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-----l~~L~~L~L~~N~l~~----~~~~~~~~l~~L 421 (992)
++|.+++. ++..+..+++|++|+|++|.+++..+..+.. .++|++|+|++|++++ .+|..+..+++|
T Consensus 321 ~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L 400 (461)
T 1z7x_W 321 KSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSL 400 (461)
T ss_dssp TTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCC
T ss_pred CCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCc
Confidence 88888765 4555666788888888888877544444432 5678888888888875 566667777888
Q ss_pred CceeccCCcccC
Q 037275 422 TNLALSSNDLQG 433 (992)
Q Consensus 422 ~~L~L~~N~l~~ 433 (992)
++|++++|++++
T Consensus 401 ~~L~l~~N~i~~ 412 (461)
T 1z7x_W 401 RELDLSNNCLGD 412 (461)
T ss_dssp CEEECCSSSCCH
T ss_pred cEEECCCCCCCH
Confidence 888888888774
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-34 Score=336.32 Aligned_cols=365 Identities=20% Similarity=0.191 Sum_probs=202.1
Q ss_pred cccccccccccccCCCCCCc-cccccccceEEecCCcccC----CcCCccCCCCcccEEeccCcccccccCcccc-ccC-
Q 037275 147 LKLENLTIADNHLTGHFPAS-IGNLSTLERINVLGNGLWG----RIPNNLGNLRNLILLNLGENRFSGIVPPSIF-NIS- 219 (992)
Q Consensus 147 ~~L~~L~L~~n~l~~~~p~~-~~~l~~L~~L~l~~n~l~~----~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~-~l~- 219 (992)
++|++|+|++|.++...... +..+++|++|++++|.+.. .++..+..+++|++|+|++|++++..+..+. .++
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 46778888888877543332 6677788888888887743 3456667777788888888877654343333 233
Q ss_pred ---CCcEEeccCCccCCCCCccccccccccchhhccccccCCCCchhhhccccCceeeeccccccccccccccc-----c
Q 037275 220 ---SLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRS-----L 291 (992)
Q Consensus 220 ---~L~~L~l~~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~-----l 291 (992)
+|++|++++|+++..-. ..++..+..+++|++|+|++|.+++..+..+.. .
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~---------------------~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~ 141 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGC---------------------GVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQ 141 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGH---------------------HHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTT
T ss_pred CCCceeEEEccCCCCCHHHH---------------------HHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCC
Confidence 57777777776652100 134667777888888888888887555544332 4
Q ss_pred CccceEecCCCCCCCCCCCCchhhhhccCCCcceEeecCCCcCCCcCCcccccccccceeEEeeCCccccccCCCccCCC
Q 037275 292 KNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLV 371 (992)
Q Consensus 292 ~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~ 371 (992)
++|++|+|++|+++..... .....+..+++|+.|++++|.+.+..+..+..... ...+
T Consensus 142 ~~L~~L~L~~n~l~~~~~~--~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~--------------------~~~~ 199 (461)
T 1z7x_W 142 CRLEKLQLEYCSLSAASCE--PLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLK--------------------DSPC 199 (461)
T ss_dssp CCCCEEECTTSCCBGGGHH--HHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHH--------------------HSCC
T ss_pred CcceEEECCCCCCCHHHHH--HHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHh--------------------cCCC
Confidence 5688888888877653321 12234555667777777777665443332221100 0133
Q ss_pred cccEEEccCCcCCCC----CCccccCCCCCcEEeccCccccccC-----CCCCCCccccCceeccCCcccCC----CCCC
Q 037275 372 NLVELCMDDNKLTGT----IPHAIGELKNLQLLYLDSNFLAGGI-----PTSLGNLTLLTNLALSSNDLQGS----IPPS 438 (992)
Q Consensus 372 ~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~-----~~~~~~l~~L~~L~L~~N~l~~~----~~~~ 438 (992)
+|++|++++|.+++. ++..+..+++|+.|++++|++++.. +..+..+++|+.|++++|.++.. ++..
T Consensus 200 ~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 279 (461)
T 1z7x_W 200 QLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRV 279 (461)
T ss_dssp CCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHH
T ss_pred CceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHH
Confidence 555555555555532 3444555556666666666554321 12222355666666666666532 3444
Q ss_pred ccccccccccccccccccccCchhhhhh----cccccccccccccccCc----ccccccCCCCccEEeeecccccccCCc
Q 037275 439 LGNCKNLIELHMADIELTGALPPQILSI----STLSLSLDLSYNLLSGT----LPLEVGNLKNLVYFNISVNRFSGEIPV 510 (992)
Q Consensus 439 ~~~l~~L~~L~l~~n~l~~~~p~~~~~~----~~~~~~L~l~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 510 (992)
+..+++|++|++++|.++...+..+... ...++.|++++|.+++. ++..+..+++|++|+|++|++++..+.
T Consensus 280 l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~ 359 (461)
T 1z7x_W 280 LRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVR 359 (461)
T ss_dssp HHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHH
T ss_pred HhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHH
Confidence 5555666666666655543222222211 11333344444444432 334445556666666666666544333
Q ss_pred cccc-----ccccceeeccCCcccc----cCCccccccCCCCEEECCCcccCC
Q 037275 511 TLSA-----CTSLQQLYLQGNSFSG----SIPSSLSSLKSIKELDMSSNNLSG 554 (992)
Q Consensus 511 ~~~~-----l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~ 554 (992)
.+.. .++|++|+|++|++++ .+|..+..+++|++|+|++|++++
T Consensus 360 ~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~ 412 (461)
T 1z7x_W 360 ELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 412 (461)
T ss_dssp HHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred HHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCH
Confidence 3332 3456666666666654 455555555666666666666553
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=283.40 Aligned_cols=288 Identities=17% Similarity=0.192 Sum_probs=223.8
Q ss_pred CCCcCCCCCCceEeeEEcCCCCeEEEeeccccccCCccCCCCCCCCcCCeeeccCCCCCccCCccccCCCCCCEEEeecc
Q 037275 29 SSWNNSTNLCQWTGVTCGHRHQRVTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANN 108 (992)
Q Consensus 29 ~~w~~~~~~c~w~gv~c~~~~~~v~~ldl~~~~l~~~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n 108 (992)
+.|.....+|.|.|+ |+ .+++.+ ..+|..+. ++|++|+|++|++++..+..|..+++|++|+|++|
T Consensus 21 ~~~~~~~~~C~~~~~-c~----------~~~~~l-~~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n 86 (353)
T 2z80_A 21 ESSNQASLSCDRNGI-CK----------GSSGSL-NSIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSN 86 (353)
T ss_dssp ------CCEECTTSE-EE----------CCSTTC-SSCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTS
T ss_pred cCCCccCCCCCCCeE-ee----------CCCCCc-cccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCC
Confidence 456566677999887 63 455566 46777655 58999999999999655558999999999999999
Q ss_pred cCCCCCCcccccCCCCcEeecccccccccCChhhcccccccccccccccccCCCCCC--ccccccccceEEecCCc-ccC
Q 037275 109 SFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPA--SIGNLSTLERINVLGNG-LWG 185 (992)
Q Consensus 109 ~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~~L~L~~n~l~~~~p~--~~~~l~~L~~L~l~~n~-l~~ 185 (992)
++++..|..|+.+++|++|++++|+++ .+|...+.++++|++|+|++|.+++ +|. .+.++++|++|++++|. +.+
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~-l~~~~~~~~l~~L~~L~l~~n~~~~~ 164 (353)
T 2z80_A 87 GINTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKT-LGETSLFSHLTKLQILRVGNMDTFTK 164 (353)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCS-SCCHHHHTTCTTCSEEECTTCCCSS-SCSSCSCTTCTTCCEEEEEESSSCCE
T ss_pred ccCccCHhhcCCCCCCCEEECCCCcCC-cCCHhHhCCCccCCEEECCCCCCcc-cCchhhhccCCCCcEEECCCCccccc
Confidence 999777788999999999999999998 6787766688999999999999994 554 78899999999999994 656
Q ss_pred CcCCccCCCCcccEEeccCcccccccCccccccCCCcEEeccCCccCCCCCccccccccccchhhccccccCCCCchhhh
Q 037275 186 RIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLS 265 (992)
Q Consensus 186 ~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~ 265 (992)
..+..|.++++|++|++++|++++..|..+..+++|++|++++|++. .+|...+..+++|+.|++++|++.+..+..+.
T Consensus 165 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~-~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~ 243 (353)
T 2z80_A 165 IQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELS 243 (353)
T ss_dssp ECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCST-THHHHHHHHTTTEEEEEEESCBCTTCCCC---
T ss_pred cCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccc-cchhhhhhhcccccEEECCCCccccccccccc
Confidence 66778999999999999999999888999999999999999999986 56665555678888888888888776555433
Q ss_pred ---ccccCceeeeccccccc----cccccccccCccceEecCCCCCCCCCCCCchhhhhccCCCcceEeecCCCcCCCcC
Q 037275 266 ---NASNLVELTLFDNQFRG----KVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVL 338 (992)
Q Consensus 266 ---~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~l~~~~ 338 (992)
....++.++|++|.+.+ ..+..+..+++|++|+|++|+++.++.. .+..+++|+.|++++|++.+..
T Consensus 244 ~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~------~~~~l~~L~~L~L~~N~~~~~~ 317 (353)
T 2z80_A 244 TGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDG------IFDRLTSLQKIWLHTNPWDCSC 317 (353)
T ss_dssp ---CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTT------TTTTCTTCCEEECCSSCBCCCH
T ss_pred cccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHH------HHhcCCCCCEEEeeCCCccCcC
Confidence 35567777777777764 2456677888888888888888876653 2456677788888888777654
Q ss_pred C
Q 037275 339 P 339 (992)
Q Consensus 339 ~ 339 (992)
|
T Consensus 318 ~ 318 (353)
T 2z80_A 318 P 318 (353)
T ss_dssp H
T ss_pred C
Confidence 3
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-29 Score=288.74 Aligned_cols=258 Identities=19% Similarity=0.179 Sum_probs=180.3
Q ss_pred cceeEEeeCCccccccCCCccCCCcccEEEccCCcCCCCCCccccCCCCCcEEeccCccccccCCCCCCCccccCceecc
Q 037275 348 TMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALS 427 (992)
Q Consensus 348 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 427 (992)
.++.|+|++|+|+++.+..|.++++|++|+|++|++++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|+
T Consensus 65 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 144 (440)
T 3zyj_A 65 NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLR 144 (440)
T ss_dssp TCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECC
T ss_pred CCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCC
Confidence 34555555555555555555556666666666666555555555556666666666666654444455556666666666
Q ss_pred CCcccCCCCCCccccccccccccccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeeccccccc
Q 037275 428 SNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGE 507 (992)
Q Consensus 428 ~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 507 (992)
+|+|+...+..|..+++|++|++++|+..+.++...+.....++.|++++|.++ .+| .+..+++|++|+|++|++++.
T Consensus 145 ~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~ 222 (440)
T 3zyj_A 145 NNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAI 222 (440)
T ss_dssp SCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEE
T ss_pred CCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCcc
Confidence 666655445555556666666666544444555555555555556677777776 444 478899999999999999998
Q ss_pred CCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcccCCCChhhhhcCCCcceEecCCCcCcccCCCCCccC
Q 037275 508 IPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFS 587 (992)
Q Consensus 508 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~ 587 (992)
.|..|.++++|+.|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+|.|.|...+...
T Consensus 223 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~l~~l~~ 302 (440)
T 3zyj_A 223 RPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNCDILWLSW 302 (440)
T ss_dssp CTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSSTTHHHHH
T ss_pred ChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCCCCchHHHH
Confidence 89999999999999999999999999999999999999999999998888889999999999999999999998654433
Q ss_pred Cccccccc--CCCCcCCCCCCC
Q 037275 588 NKTGISLS--GNGKVCGGLDEL 607 (992)
Q Consensus 588 ~~~~~~l~--~N~~~C~~~~~~ 607 (992)
+++..... .....|..|...
T Consensus 303 ~~~~~~~~~~~~~~~C~~P~~l 324 (440)
T 3zyj_A 303 WIKDMAPSNTACCARCNTPPNL 324 (440)
T ss_dssp HHHTTSCSSCSCCCBEEESTTT
T ss_pred HHHhccccCCccccCCCChhHh
Confidence 43332211 123457666543
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.7e-30 Score=279.27 Aligned_cols=215 Identities=20% Similarity=0.212 Sum_probs=162.6
Q ss_pred ccCCCcccEEEccCCcCCCCCCccccCCCCCcEEeccCccccccCC-CCCCCccccCceeccCCcccCCCCCCccccccc
Q 037275 367 IRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIP-TSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNL 445 (992)
Q Consensus 367 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 445 (992)
+..+++|++|+|++|.+. .+|..+..+++|++|++++|++++..+ ..+..+++|++|++++|.+++..+..|..+++|
T Consensus 74 ~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 152 (306)
T 2z66_A 74 DFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL 152 (306)
T ss_dssp HHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTC
T ss_pred cccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCC
Confidence 344566777777777776 456667777777777777777775444 467777788888888888777777777777777
Q ss_pred cccccccccccccCchhhhhhcccccccccccccccC-cccccccCCCCccEEeeecccccccCCcccccccccceeecc
Q 037275 446 IELHMADIELTGALPPQILSISTLSLSLDLSYNLLSG-TLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQ 524 (992)
Q Consensus 446 ~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 524 (992)
++|++++|.++ + ..|..+..+++|++|+|++|++++..|..|..+++|++|+|+
T Consensus 153 ~~L~l~~n~l~-------------------------~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 207 (306)
T 2z66_A 153 EVLKMAGNSFQ-------------------------ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMS 207 (306)
T ss_dssp CEEECTTCEEG-------------------------GGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECT
T ss_pred CEEECCCCccc-------------------------cccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECC
Confidence 77755555443 2 356677788888999999999888778888888999999999
Q ss_pred CCcccccCCccccccCCCCEEECCCcccCCCChhhhhcCC-CcceEecCCCcCcccCCCCCccCC---cccccccCCCCc
Q 037275 525 GNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLS-FLEYLNLSYNHFEGEVPTKGVFSN---KTGISLSGNGKV 600 (992)
Q Consensus 525 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~l~~N~l~~~~~~~~~~~~---~~~~~l~~N~~~ 600 (992)
+|++++..+..+..+++|++|+|++|++++..|..+..++ +|++|++++|+|+|.++..+...+ .+.+....+...
T Consensus 208 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~ 287 (306)
T 2z66_A 208 HNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERME 287 (306)
T ss_dssp TSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCB
T ss_pred CCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccc
Confidence 9999877777888899999999999999988888888884 899999999999988775433333 334555677788
Q ss_pred CCCCCCC
Q 037275 601 CGGLDEL 607 (992)
Q Consensus 601 C~~~~~~ 607 (992)
|..|...
T Consensus 288 C~~p~~~ 294 (306)
T 2z66_A 288 CATPSDK 294 (306)
T ss_dssp EEESGGG
T ss_pred cCCchhh
Confidence 8877643
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=5e-31 Score=290.01 Aligned_cols=289 Identities=18% Similarity=0.240 Sum_probs=214.3
Q ss_pred HHHHHHHhhccCCCCCCCCCCcC--CCCCCceEeeEEcCCCCeEEEeeccccccCCccCCCC--CCCCcCCeeeccCCCC
Q 037275 11 LALLAIGSQLEDDPLGVTSSWNN--STNLCQWTGVTCGHRHQRVTKLDLSNRTIGGTLSPYV--GNLSFLRYLNLADNNF 86 (992)
Q Consensus 11 ~~ll~~~~~~~~~~~~~~~~w~~--~~~~c~w~gv~c~~~~~~v~~ldl~~~~l~~~l~~~l--~~l~~L~~L~L~~n~l 86 (992)
++..+-+++-..|+..++..|+. ..++|.|.++-|.............+... ..++..+ ....+++.|+|++|++
T Consensus 15 ~~~~~~~~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~-~~~~~~l~~~~~~~l~~L~L~~n~l 93 (328)
T 4fcg_A 15 ENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRAL-KATADLLEDATQPGRVALELRSVPL 93 (328)
T ss_dssp --CCCC--CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHH-HHHHHHHHHHTSTTCCEEEEESSCC
T ss_pred cceeeeccccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcch-hhhHHHHhcccccceeEEEccCCCc
Confidence 34444444444566667788864 46889999888843221111111111111 0111111 2357899999999999
Q ss_pred CccCCccccCCCCCCEEEeecccCCCCCCcccccCCCCcEeecccccccccCChhhcccccccccccccccccCCCCCCc
Q 037275 87 HGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPAS 166 (992)
Q Consensus 87 ~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~~L~L~~n~l~~~~p~~ 166 (992)
+ .+|..++.+++|++|+|++|+++ .+|..++.+++|++|++++|+++ .+|..+. .+++|++|+|++|.+.+.+|..
T Consensus 94 ~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~-~l~~L~~L~L~~n~~~~~~p~~ 169 (328)
T 4fcg_A 94 P-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIA-SLNRLRELSIRACPELTELPEP 169 (328)
T ss_dssp S-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGG-GCTTCCEEEEEEETTCCCCCSC
T ss_pred h-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHh-cCcCCCEEECCCCCCccccChh
Confidence 9 89999999999999999999999 99999999999999999999998 8888766 7889999999998888888888
Q ss_pred ccc---------ccccceEEecCCcccCCcCCccCCCCcccEEeccCcccccccCccccccCCCcEEeccCCccCCCCCc
Q 037275 167 IGN---------LSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPL 237 (992)
Q Consensus 167 ~~~---------l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~ 237 (992)
+.. +++|++|++++|.+. .+|..++++++|++|+|++|++++ +|..+..+++|++|++++|.+.
T Consensus 170 ~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~----- 242 (328)
T 4fcg_A 170 LASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTAL----- 242 (328)
T ss_dssp SEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTC-----
T ss_pred HhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcch-----
Confidence 765 667777777777764 666667777777777777777763 5556666666666666666554
Q ss_pred cccccccccchhhccccccCCCCchhhhccccCceeeeccccccccccccccccCccceEecCCCCCCCCCCCCchhhhh
Q 037275 238 DIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTL 317 (992)
Q Consensus 238 ~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~ 317 (992)
+.+|..++.+++|++|+|++|.+.+..|..+..+++|++|+|++|++... .+..
T Consensus 243 --------------------~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~------iP~~ 296 (328)
T 4fcg_A 243 --------------------RNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSR------LPSL 296 (328)
T ss_dssp --------------------CBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCC------CCGG
T ss_pred --------------------hhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhh------ccHH
Confidence 45667788899999999999999999999999999999999999887552 2346
Q ss_pred ccCCCcceEeecCCCcCCCc
Q 037275 318 LTNCTELTAIGLDDNRFGGV 337 (992)
Q Consensus 318 l~~~~~L~~L~l~~n~l~~~ 337 (992)
+.++++|+.+++..+.+...
T Consensus 297 l~~L~~L~~l~l~~~~~~~l 316 (328)
T 4fcg_A 297 IAQLPANCIILVPPHLQAQL 316 (328)
T ss_dssp GGGSCTTCEEECCGGGSCC-
T ss_pred HhhccCceEEeCCHHHHHHH
Confidence 88899999999998877643
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.5e-29 Score=270.47 Aligned_cols=236 Identities=25% Similarity=0.242 Sum_probs=206.1
Q ss_pred ccceeEEeeCCccccccCCCccCCCcccEEEccCCcCCCCCCccccCCCCCcEEeccCcc-ccccCCCCCCCccccCcee
Q 037275 347 STMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNF-LAGGIPTSLGNLTLLTNLA 425 (992)
Q Consensus 347 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~ 425 (992)
.++++|++++|+++++.+..|..+++|++|+|++|.+++..|..|..+++|++|+|++|+ ++...+..|..+++|++|+
T Consensus 32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~ 111 (285)
T 1ozn_A 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (285)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEE
Confidence 457788888888888777888999999999999999988778889999999999999997 8767688899999999999
Q ss_pred ccCCcccCCCCCCccccccccccccccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeeccccc
Q 037275 426 LSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFS 505 (992)
Q Consensus 426 L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 505 (992)
+++|++++..|..|..+++|++|++++| .+++..+..|..+++|++|+|++|+++
T Consensus 112 l~~n~l~~~~~~~~~~l~~L~~L~l~~n-------------------------~l~~~~~~~~~~l~~L~~L~l~~n~l~ 166 (285)
T 1ozn_A 112 LDRCGLQELGPGLFRGLAALQYLYLQDN-------------------------ALQALPDDTFRDLGNLTHLFLHGNRIS 166 (285)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSS-------------------------CCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred CCCCcCCEECHhHhhCCcCCCEEECCCC-------------------------cccccCHhHhccCCCccEEECCCCccc
Confidence 9999999877888888888888855554 444445556888999999999999999
Q ss_pred ccCCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcccCCCChhhhhcCCCcceEecCCCcCcccCCCCCc
Q 037275 506 GEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGV 585 (992)
Q Consensus 506 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~ 585 (992)
+..+..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|+|++..+..+..+++|++|++++|+|.|.++..+.
T Consensus 167 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~~~ 246 (285)
T 1ozn_A 167 SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPL 246 (285)
T ss_dssp EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHH
T ss_pred ccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcHHH
Confidence 87777899999999999999999998899999999999999999999988888899999999999999999999988777
Q ss_pred cCCcccccccCCCCcCCCCCCC
Q 037275 586 FSNKTGISLSGNGKVCGGLDEL 607 (992)
Q Consensus 586 ~~~~~~~~l~~N~~~C~~~~~~ 607 (992)
+.++.......+...|..|...
T Consensus 247 ~~~l~~~~~~~~~~~c~~p~~l 268 (285)
T 1ozn_A 247 WAWLQKFRGSSSEVPCSLPQRL 268 (285)
T ss_dssp HHHHHHCCSEECCCBEEESGGG
T ss_pred HHHHHhcccccCccccCCchHh
Confidence 7778888888889999887643
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.8e-29 Score=288.89 Aligned_cols=239 Identities=20% Similarity=0.205 Sum_probs=172.9
Q ss_pred cceeEEeeCCccccccCCCccCCCcccEEEccCCcCCCCCCccccCCCCCcEEeccCccccccCCCCCCCccccCceecc
Q 037275 348 TMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALS 427 (992)
Q Consensus 348 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 427 (992)
.++.|+|++|+|+++.+..|.++++|++|+|++|++++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|+
T Consensus 76 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 155 (452)
T 3zyi_A 76 NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLR 155 (452)
T ss_dssp TCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECC
T ss_pred CccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECC
Confidence 45555555555555555555566666666666666655555555566666666666666654444555556666666666
Q ss_pred CCcccCCCCCCccccccccccccccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeeccccccc
Q 037275 428 SNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGE 507 (992)
Q Consensus 428 ~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 507 (992)
+|+|+...+..|..+++|+.|++++|...+.++...+.....++.|+|++|++++. | .+..+++|++|+|++|++++.
T Consensus 156 ~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~ 233 (452)
T 3zyi_A 156 NNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-P-NLTPLVGLEELEMSGNHFPEI 233 (452)
T ss_dssp SCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-C-CCTTCTTCCEEECTTSCCSEE
T ss_pred CCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-c-cccccccccEEECcCCcCccc
Confidence 66665544445556666666666654444455555555555555667777777643 3 578899999999999999999
Q ss_pred CCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcccCCCChhhhhcCCCcceEecCCCcCcccCCCCCccC
Q 037275 508 IPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFS 587 (992)
Q Consensus 508 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~ 587 (992)
.|..|.++++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|+|.|.|...+...
T Consensus 234 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~~~~l~~ 313 (452)
T 3zyi_A 234 RPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCDILWLAW 313 (452)
T ss_dssp CGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTTTHHHHH
T ss_pred CcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCCCchHHHH
Confidence 99999999999999999999999999999999999999999999998888889999999999999999999998654333
Q ss_pred C
Q 037275 588 N 588 (992)
Q Consensus 588 ~ 588 (992)
+
T Consensus 314 ~ 314 (452)
T 3zyi_A 314 W 314 (452)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.1e-29 Score=278.82 Aligned_cols=191 Identities=18% Similarity=0.215 Sum_probs=129.5
Q ss_pred ccCCCcccEEEccCCcCCCCCC-ccccCCCCCcEEeccCc-cccccCCCCCCCccccCceeccCCcccCCCCCCcccccc
Q 037275 367 IRNLVNLVELCMDDNKLTGTIP-HAIGELKNLQLLYLDSN-FLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKN 444 (992)
Q Consensus 367 ~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 444 (992)
|.++++|++|++++|++++..+ ..|..+++|++|++++| .+++..+..|.++++|++|++++|++++..|..+..+++
T Consensus 120 ~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~ 199 (353)
T 2z80_A 120 FKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQN 199 (353)
T ss_dssp HTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSE
T ss_pred hCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhcccc
Confidence 4556667777777777664333 36667777777777777 466555667777777777777777777666777777777
Q ss_pred ccccccccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeecccccccCCcccc---ccccccee
Q 037275 445 LIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLS---ACTSLQQL 521 (992)
Q Consensus 445 L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~---~l~~L~~L 521 (992)
|++|++++|+++ . ..+..+..+++|++|++++|.+++..+..+. ....++.+
T Consensus 200 L~~L~l~~n~l~-~------------------------~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l 254 (353)
T 2z80_A 200 VSHLILHMKQHI-L------------------------LLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKF 254 (353)
T ss_dssp EEEEEEECSCST-T------------------------HHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEE
T ss_pred CCeecCCCCccc-c------------------------chhhhhhhcccccEEECCCCccccccccccccccccchhhcc
Confidence 777755555543 1 1122233466777777777777655444332 24556667
Q ss_pred eccCCcccc----cCCccccccCCCCEEECCCcccCCCChhhhhcCCCcceEecCCCcCcccCCC
Q 037275 522 YLQGNSFSG----SIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPT 582 (992)
Q Consensus 522 ~L~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~ 582 (992)
+|++|.+++ .+|..+..+++|++|+|++|+|++..+..|..+++|++|++++|++.|.+|.
T Consensus 255 ~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~~ 319 (353)
T 2z80_A 255 TFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 319 (353)
T ss_dssp EEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred ccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCCC
Confidence 777776664 4677788899999999999999844444468899999999999999998874
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.1e-29 Score=293.09 Aligned_cols=294 Identities=24% Similarity=0.309 Sum_probs=159.1
Q ss_pred CCCCCCCcCCCCCCceEeeEEc------CCCCeEEEeeccccccCCccCCCCCCCCcCCeeeccCCCCCccCCccccCCC
Q 037275 25 LGVTSSWNNSTNLCQWTGVTCG------HRHQRVTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLV 98 (992)
Q Consensus 25 ~~~~~~w~~~~~~c~w~gv~c~------~~~~~v~~ldl~~~~l~~~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~ 98 (992)
....+.|..+++||.|.|..|. -....++.|+++++++. .+|..+. ++|++|+|++|+++ .+|. .++
T Consensus 9 ~~~w~~W~~~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~ 81 (622)
T 3g06_A 9 DAVWSAWRRAAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPP 81 (622)
T ss_dssp -CHHHHHHHTCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCT
T ss_pred HHHHHHHHhcCCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCC
Confidence 3445778888899999775321 11123566777777664 5666554 56666777766666 4555 456
Q ss_pred CCCEEEeecccCCCCCCcccccCCCCcEeecccccccccCChhhcccccccccccccccccCCCCCCccccccccceEEe
Q 037275 99 RLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINV 178 (992)
Q Consensus 99 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l 178 (992)
+|++|+|++|+|+ .+|. .+++|++|++++|+++ .+|. .+++|++|++
T Consensus 82 ~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~l~~----------------------------~l~~L~~L~L 128 (622)
T 3g06_A 82 ELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLT-HLPA----------------------------LPSGLCKLWI 128 (622)
T ss_dssp TCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCC-CCCC----------------------------CCTTCCEEEC
T ss_pred CCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCC-CCCC----------------------------CCCCcCEEEC
Confidence 6666666666666 4554 4555666666666555 3333 2344455555
Q ss_pred cCCcccCCcCCccCCCCcccEEeccCcccccccCccccccCCCcEEeccCCccCCCCCccccccccccchhhccccccCC
Q 037275 179 LGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAG 258 (992)
Q Consensus 179 ~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~ 258 (992)
++|++. .+|.. +++|++|+|++|++++ +|. .+++|+.|++++|++++
T Consensus 129 ~~N~l~-~lp~~---l~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~~------------------------- 175 (622)
T 3g06_A 129 FGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPA---LPSELCKLWAYNNQLTS------------------------- 175 (622)
T ss_dssp CSSCCS-CCCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-------------------------
T ss_pred CCCCCC-cCCCC---CCCCCEEECcCCcCCC-cCC---ccCCCCEEECCCCCCCC-------------------------
Confidence 555542 23332 2455555555555553 232 12345555555555541
Q ss_pred CCchhhhccccCceeeeccccccccccccccccCccceEecCCCCCCCCCCCCchhhhhccCCCcceEeecCCCcCCCcC
Q 037275 259 SIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVL 338 (992)
Q Consensus 259 ~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~l~~~~ 338 (992)
+| ..+++|++|++++|+|++.+. .+++|+.|++++|.++.++.. +++|
T Consensus 176 -l~---~~~~~L~~L~Ls~N~l~~l~~----~~~~L~~L~L~~N~l~~l~~~----------~~~L-------------- 223 (622)
T 3g06_A 176 -LP---MLPSGLQELSVSDNQLASLPT----LPSELYKLWAYNNRLTSLPAL----------PSGL-------------- 223 (622)
T ss_dssp -CC---CCCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSSCCCC----------CTTC--------------
T ss_pred -Cc---ccCCCCcEEECCCCCCCCCCC----ccchhhEEECcCCcccccCCC----------CCCC--------------
Confidence 11 113445555555555553222 124555556665555543310 1223
Q ss_pred CcccccccccceeEEeeCCccccccCCCccCCCcccEEEccCCcCCCCCCccccCCCCCcEEeccCccccccCCCCCCCc
Q 037275 339 PHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNL 418 (992)
Q Consensus 339 ~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 418 (992)
+.|++++|+|++ +| ..+++|+.|+|++|+|+ .+|. .+++|+.|+|++|+|+ .+|..|.++
T Consensus 224 -----------~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l 283 (622)
T 3g06_A 224 -----------KELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHL 283 (622)
T ss_dssp -----------CEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGS
T ss_pred -----------CEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhc
Confidence 333333333332 22 23356667777777666 3443 4566777777777777 556667777
Q ss_pred cccCceeccCCcccCCCCCCccccc
Q 037275 419 TLLTNLALSSNDLQGSIPPSLGNCK 443 (992)
Q Consensus 419 ~~L~~L~L~~N~l~~~~~~~~~~l~ 443 (992)
++|+.|+|++|++++..|..+..++
T Consensus 284 ~~L~~L~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 284 SSETTVNLEGNPLSERTLQALREIT 308 (622)
T ss_dssp CTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred cccCEEEecCCCCCCcCHHHHHhcc
Confidence 7777777777777765555554443
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-31 Score=321.45 Aligned_cols=189 Identities=14% Similarity=0.152 Sum_probs=129.3
Q ss_pred CCCCceEeeEEcCCCCeEEEeeccccccCCccCCCCCCCCcCCeeeccCCCCC---ccCCcccc------------CCCC
Q 037275 35 TNLCQWTGVTCGHRHQRVTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFH---GEIPHQIG------------RLVR 99 (992)
Q Consensus 35 ~~~c~w~gv~c~~~~~~v~~ldl~~~~l~~~l~~~l~~l~~L~~L~L~~n~l~---~~~p~~~~------------~l~~ 99 (992)
.-|++|.++.+... . .+.+..+ .....+..+..+++|++|+|+++... +.+|..++ .+++
T Consensus 39 ~vck~W~~~~~~~~-~---~l~~~~~-~~~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~ 113 (592)
T 3ogk_B 39 LVCRRWFKIDSETR-E---HVTMALC-YTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQ 113 (592)
T ss_dssp TSCHHHHHHHHHHC-C---EEEESCG-GGSCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTT
T ss_pred HHhHHHHHhhhccc-c---EEEEeec-cccChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCC
Confidence 34558999865321 1 2222222 22334445677888999999875321 24444333 7889
Q ss_pred CCEEEeecccCCCCCCcccccC--CCCcEeeccccc-ccccCChhhcccccccccccccccccCCC----CCCccccccc
Q 037275 100 LEALVLANNSFSGKIPTNLSRC--SNLISFNARRNN-LVGEIPAELGYNWLKLENLTIADNHLTGH----FPASIGNLST 172 (992)
Q Consensus 100 L~~L~Ls~n~l~~~~p~~l~~l--~~L~~L~l~~n~-l~~~~p~~~~~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~ 172 (992)
|++|+|++|.+++..+..++.. .+|++|++++|. ++......+...+++|++|+|++|.+++. ++..+.++++
T Consensus 114 L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~ 193 (592)
T 3ogk_B 114 LKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTS 193 (592)
T ss_dssp CCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCC
T ss_pred CCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCC
Confidence 9999999998887667777664 459999999887 32222223334678899999999988765 3334567788
Q ss_pred cceEEecCCccc----CCcCCccCCCCcccEEeccCcccccccCccccccCCCcEEeccCC
Q 037275 173 LERINVLGNGLW----GRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTN 229 (992)
Q Consensus 173 L~~L~l~~n~l~----~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N 229 (992)
|++|++++|.+. +.++..+.++++|+.|+|++|.+.+ +|..+..+++|++|+++.+
T Consensus 194 L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~ 253 (592)
T 3ogk_B 194 LEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSL 253 (592)
T ss_dssp CCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBC
T ss_pred ccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhccccc
Confidence 999999988885 3344556677889999999888885 6777888888988888753
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.8e-30 Score=279.03 Aligned_cols=268 Identities=19% Similarity=0.170 Sum_probs=161.4
Q ss_pred CCCCcCCCCCCceEeeEEcCCCCeEEEeeccccccCCccCCCCCCCCcCCeeeccCCCCC-ccCCcccc-------CCCC
Q 037275 28 TSSWNNSTNLCQWTGVTCGHRHQRVTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFH-GEIPHQIG-------RLVR 99 (992)
Q Consensus 28 ~~~w~~~~~~c~w~gv~c~~~~~~v~~ldl~~~~l~~~l~~~l~~l~~L~~L~L~~n~l~-~~~p~~~~-------~l~~ 99 (992)
..+|.....|+.|..+.+......++.++++++.+ .+|+.+... |++|+|++|++. +.+|..+. .+++
T Consensus 21 ~~~~~~~~~c~~~~~~~~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~ 96 (312)
T 1wwl_A 21 KPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISG 96 (312)
T ss_dssp SCCGGGGGGSSSCSEEEEEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSC
T ss_pred ccchHHHhhhhccccEEEEccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCC
Confidence 35676555666665544332344567777777777 666655544 777777777773 45666555 6777
Q ss_pred CCEEEeecccCCCCCCccc--ccCCCCcEeecccccccccCChhhcccc-----cccccccccccccCCCCCCccccccc
Q 037275 100 LEALVLANNSFSGKIPTNL--SRCSNLISFNARRNNLVGEIPAELGYNW-----LKLENLTIADNHLTGHFPASIGNLST 172 (992)
Q Consensus 100 L~~L~Ls~n~l~~~~p~~l--~~l~~L~~L~l~~n~l~~~~p~~~~~~l-----~~L~~L~L~~n~l~~~~p~~~~~l~~ 172 (992)
|++|+|++|++++.+|..+ +.+++|++|++++|++++. |..+. .+ ++|++|+|++|++++..|..|+++++
T Consensus 97 L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~-~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~ 174 (312)
T 1wwl_A 97 LQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLA-ELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPA 174 (312)
T ss_dssp CCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHH-HHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSS
T ss_pred ccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHH-HHHHhhcCCCcEEEeeCCCCccchHHHhccCCC
Confidence 7777777777777777765 6777777777777777744 54443 34 66777777777777666667777777
Q ss_pred cceEEecCCcccCC--cCCcc--CCCCcccEEeccCccccc--ccC-ccccccCCCcEEeccCCccCCCCCccccccccc
Q 037275 173 LERINVLGNGLWGR--IPNNL--GNLRNLILLNLGENRFSG--IVP-PSIFNISSLENVFLPTNRFNGSLPLDIGVSLPK 245 (992)
Q Consensus 173 L~~L~l~~n~l~~~--~~~~l--~~l~~L~~L~L~~n~l~~--~~p-~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~ 245 (992)
|++|++++|++.+. .|..+ ..+++|++|+|++|++++ .++ ..+..+++|++|++++|++++..|...+.
T Consensus 175 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~---- 250 (312)
T 1wwl_A 175 LSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCD---- 250 (312)
T ss_dssp CCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCC----
T ss_pred CCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhh----
Confidence 77777777776443 23333 666777777777777662 112 22345567777777777666544433333
Q ss_pred cchhhccccccCCCCchhhhccccCceeeeccccccccccccccccCccceEecCCCCCCCCCCCCchhhhhccCCCcce
Q 037275 246 LLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELT 325 (992)
Q Consensus 246 L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~~L~ 325 (992)
.+++|++|+|++|+|+ .+|..+. ++|++|+|++|+++.++. +..+++|+
T Consensus 251 --------------------~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~p~--------~~~l~~L~ 299 (312)
T 1wwl_A 251 --------------------WPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRNPS--------PDELPQVG 299 (312)
T ss_dssp --------------------CCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSCCC--------TTTSCEEE
T ss_pred --------------------hcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCChh--------HhhCCCCC
Confidence 3455555555555555 2233332 455555555555554321 34445555
Q ss_pred EeecCCCcCCC
Q 037275 326 AIGLDDNRFGG 336 (992)
Q Consensus 326 ~L~l~~n~l~~ 336 (992)
.|++++|++++
T Consensus 300 ~L~L~~N~l~~ 310 (312)
T 1wwl_A 300 NLSLKGNPFLD 310 (312)
T ss_dssp EEECTTCTTTC
T ss_pred EEeccCCCCCC
Confidence 55555555553
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-28 Score=267.83 Aligned_cols=248 Identities=19% Similarity=0.229 Sum_probs=166.5
Q ss_pred CceEeeEEcCCCCeEEEeeccccccCCccCCCCCCCCcCCeeeccCCCCCccCCc-cccCCCCCCEEEeecccCCC--CC
Q 037275 38 CQWTGVTCGHRHQRVTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPH-QIGRLVRLEALVLANNSFSG--KI 114 (992)
Q Consensus 38 c~w~gv~c~~~~~~v~~ldl~~~~l~~~l~~~l~~l~~L~~L~L~~n~l~~~~p~-~~~~l~~L~~L~Ls~n~l~~--~~ 114 (992)
|.|.+|+|+... + ..+|..+. ++|++|+|++|+++ .+|. .|..+++|++|+|++|+++. ..
T Consensus 7 C~~~~l~c~~~~------------l-~~ip~~~~--~~l~~L~L~~n~l~-~i~~~~~~~l~~L~~L~L~~n~l~~~~~~ 70 (306)
T 2z66_A 7 CSGTEIRCNSKG------------L-TSVPTGIP--SSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCC 70 (306)
T ss_dssp EETTEEECCSSC------------C-SSCCSCCC--TTCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCEEEEE
T ss_pred eCCCEEEcCCCC------------c-ccCCCCCC--CCCCEEECCCCccC-ccCHhHhhccccCCEEECCCCccCcccCc
Confidence 789999996532 2 34555432 57888888888888 5554 46788888888888888872 23
Q ss_pred CcccccCCCCcEeecccccccccCChhhcccccccccccccccccCCCCC-CccccccccceEEecCCcccCCcCCccCC
Q 037275 115 PTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFP-ASIGNLSTLERINVLGNGLWGRIPNNLGN 193 (992)
Q Consensus 115 p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~l~~n~l~~~~~~~l~~ 193 (992)
|..+..+++|++|++++|.++ .+|..+. .+++|++|++++|.+++..+ ..+..+++|++|++++|.+.+..+..|..
T Consensus 71 ~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~-~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 148 (306)
T 2z66_A 71 SQSDFGTTSLKYLDLSFNGVI-TMSSNFL-GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG 148 (306)
T ss_dssp EHHHHSCSCCCEEECCSCSEE-EEEEEEE-TCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTT
T ss_pred ccccccccccCEEECCCCccc-cChhhcC-CCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhccc
Confidence 667777888888888888887 5666644 67888888888888885544 57788888888888888887777777888
Q ss_pred CCcccEEeccCccccc-ccCccccccCCCcEEeccCCccCCCCCccccccccccchhhccccccCCCCchhhhccccCce
Q 037275 194 LRNLILLNLGENRFSG-IVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVE 272 (992)
Q Consensus 194 l~~L~~L~L~~n~l~~-~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~ 272 (992)
+++|++|+|++|++++ ..|..+..+++|++|++++|++++..| ..+..+++|+.|++++|++++..+..+..+++|++
T Consensus 149 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 227 (306)
T 2z66_A 149 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP-TAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQV 227 (306)
T ss_dssp CTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECT-TTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCE
T ss_pred CcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCH-HHhcCCCCCCEEECCCCccCccChhhccCcccCCE
Confidence 8888888888888875 567788888888888888887773222 22223344444444444444333334444455555
Q ss_pred eeeccccccccccccccccC-ccceEecCCCCC
Q 037275 273 LTLFDNQFRGKVSIYFRSLK-NLEWLNLGSNNL 304 (992)
Q Consensus 273 L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l 304 (992)
|++++|++++..+..+..++ +|++|+|++|.+
T Consensus 228 L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~ 260 (306)
T 2z66_A 228 LDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 260 (306)
T ss_dssp EECTTSCCCBCSSSSCCCCCTTCCEEECTTCCE
T ss_pred eECCCCCCcccCHHHHHhhhccCCEEEccCCCe
Confidence 55555555544444444442 445555544444
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-30 Score=310.92 Aligned_cols=427 Identities=14% Similarity=0.076 Sum_probs=214.4
Q ss_pred cCCccccCCCCCCEEEeecccC---CCCCCcccc------------cCCCCcEeecccccccccCChhhcccccc-cccc
Q 037275 89 EIPHQIGRLVRLEALVLANNSF---SGKIPTNLS------------RCSNLISFNARRNNLVGEIPAELGYNWLK-LENL 152 (992)
Q Consensus 89 ~~p~~~~~l~~L~~L~Ls~n~l---~~~~p~~l~------------~l~~L~~L~l~~n~l~~~~p~~~~~~l~~-L~~L 152 (992)
.++..+..+++|++|+|+++.. .+.+|..++ .+++|++|+|++|.+++..+..+...+++ |++|
T Consensus 64 ~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L 143 (592)
T 3ogk_B 64 TPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETL 143 (592)
T ss_dssp CHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEE
T ss_pred ChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEE
Confidence 3445566788899999987643 134443333 67778888888777766555555433344 7777
Q ss_pred ccccccc-CC-CCCCccccccccceEEecCCcccCC----cCCccCCCCcccEEeccCcccc----cccCccccccCCCc
Q 037275 153 TIADNHL-TG-HFPASIGNLSTLERINVLGNGLWGR----IPNNLGNLRNLILLNLGENRFS----GIVPPSIFNISSLE 222 (992)
Q Consensus 153 ~L~~n~l-~~-~~p~~~~~l~~L~~L~l~~n~l~~~----~~~~l~~l~~L~~L~L~~n~l~----~~~p~~l~~l~~L~ 222 (992)
+|++|.- +. .++....++++|++|+|++|.+.+. ++..+..+++|++|+|++|.++ +.++..+.++++|+
T Consensus 144 ~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~ 223 (592)
T 3ogk_B 144 KLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLV 223 (592)
T ss_dssp EEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCC
T ss_pred ECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCc
Confidence 7777651 11 1122223566777777777766444 2333445666777777777665 23344445666677
Q ss_pred EEeccCCccCCCCCccccccccccchhhccccccCCCCchhhhccccCceeeecccccc---ccccccccccCccceEec
Q 037275 223 NVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFR---GKVSIYFRSLKNLEWLNL 299 (992)
Q Consensus 223 ~L~l~~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~---~~~~~~~~~l~~L~~L~L 299 (992)
+|++++|.+.+ +|..+..+++|++|+++.+... ......+..+++|+.|++
T Consensus 224 ~L~L~~~~~~~--------------------------l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l 277 (592)
T 3ogk_B 224 SVKVGDFEILE--------------------------LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGL 277 (592)
T ss_dssp EEECSSCBGGG--------------------------GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEE
T ss_pred EEeccCccHHH--------------------------HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCc
Confidence 77776666552 3334444455555555432211 112223344444555544
Q ss_pred CCCCCCCCCCCCchhhhhccCCCcceEeecCCCcCCCcCCcccccccccceeEEeeCCccccccCCCccCCCcccEEEcc
Q 037275 300 GSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMD 379 (992)
Q Consensus 300 ~~N~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~ 379 (992)
+++.... ....+..+++|+.|++++|.+.+.....+..-.++|++|+++++...+.++..+..+++|++|+++
T Consensus 278 ~~~~~~~-------l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~ 350 (592)
T 3ogk_B 278 SYMGPNE-------MPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIE 350 (592)
T ss_dssp TTCCTTT-------GGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEE
T ss_pred cccchhH-------HHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEee
Confidence 4432211 112233444455555555544332221111122345555555222222222223445666666666
Q ss_pred C-----------CcCCCCC-CccccCCCCCcEEeccCccccccCCCCCCC-ccccCceecc----CCcccCC-----CCC
Q 037275 380 D-----------NKLTGTI-PHAIGELKNLQLLYLDSNFLAGGIPTSLGN-LTLLTNLALS----SNDLQGS-----IPP 437 (992)
Q Consensus 380 ~-----------N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-l~~L~~L~L~----~N~l~~~-----~~~ 437 (992)
+ |.+++.. +..+..+++|+.|+++.|++++..+..+.. +++|+.|+++ .|.+++. ++.
T Consensus 351 ~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~ 430 (592)
T 3ogk_B 351 RGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRS 430 (592)
T ss_dssp CCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHH
T ss_pred cCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHH
Confidence 2 3443221 122334566666666666666544444433 5566666664 4555532 112
Q ss_pred CccccccccccccccccccccCchhhhhhcccccccccccccccCccccccc-CCCCccEEeeecccccc-cCCcccccc
Q 037275 438 SLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVG-NLKNLVYFNISVNRFSG-EIPVTLSAC 515 (992)
Q Consensus 438 ~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~-~~~~~~~~l 515 (992)
.+.++++|+.|+++.|. |.+++..+..+. .+++|++|+|++|++++ .++..+.++
T Consensus 431 ~~~~~~~L~~L~L~~~~-----------------------~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~ 487 (592)
T 3ogk_B 431 LLIGCKKLRRFAFYLRQ-----------------------GGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGC 487 (592)
T ss_dssp HHHHCTTCCEEEEECCG-----------------------GGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCC
T ss_pred HHHhCCCCCEEEEecCC-----------------------CCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcC
Confidence 24456666666554322 112222222222 25566666666666654 233344556
Q ss_pred cccceeeccCCccccc-CCccccccCCCCEEECCCcccCCCChhhh-hcCCCcceEec
Q 037275 516 TSLQQLYLQGNSFSGS-IPSSLSSLKSIKELDMSSNNLSGQIPEYL-ENLSFLEYLNL 571 (992)
Q Consensus 516 ~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~l 571 (992)
++|++|+|++|.|++. ++..+..+++|++|+|++|++++.....+ ..++.+....+
T Consensus 488 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~ 545 (592)
T 3ogk_B 488 PNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELI 545 (592)
T ss_dssp TTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEEE
T ss_pred cccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEEe
Confidence 6666666666666533 23333456666666666666664432222 23454444433
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-27 Score=274.42 Aligned_cols=251 Identities=22% Similarity=0.236 Sum_probs=222.2
Q ss_pred ceeEEeeCCccccccCCCccCCCcccEEEccCCcCCCCCCccccCCCCCcEEeccCccccccCCCCCCCccccCceeccC
Q 037275 349 MTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSS 428 (992)
Q Consensus 349 L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 428 (992)
...++.+++.++. +|..+. +++++|+|++|++++..+..|..+++|+.|+|++|+|++..+..|.++++|++|+|++
T Consensus 56 ~~~v~c~~~~l~~-iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~ 132 (452)
T 3zyi_A 56 FSKVVCTRRGLSE-VPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFD 132 (452)
T ss_dssp SCEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CcEEEECCCCcCc-cCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCC
Confidence 4556677777774 555444 6899999999999988899999999999999999999988889999999999999999
Q ss_pred CcccCCCCCCccccccccccccccccccccCchhhhhhccccccccccc-ccccCcccccccCCCCccEEeeeccccccc
Q 037275 429 NDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSY-NLLSGTLPLEVGNLKNLVYFNISVNRFSGE 507 (992)
Q Consensus 429 N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 507 (992)
|+|++..+..|..+++|++|++++|+++ .+|...+.....++.|++++ |.+....+..|.++++|++|+|++|++++.
T Consensus 133 n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~ 211 (452)
T 3zyi_A 133 NWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM 211 (452)
T ss_dssp SCCSBCCTTTSSSCTTCCEEECCSCCCC-EECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC
T ss_pred CcCCccChhhhcccCCCCEEECCCCCcc-eeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc
Confidence 9999877788999999999999999998 67777777778888999999 455544445799999999999999999954
Q ss_pred CCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcccCCCChhhhhcCCCcceEecCCCcCcccCCCC-Ccc
Q 037275 508 IPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTK-GVF 586 (992)
Q Consensus 508 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~ 586 (992)
| .+..+++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|++++.++.. ..+
T Consensus 212 -~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 289 (452)
T 3zyi_A 212 -P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPL 289 (452)
T ss_dssp -C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTC
T ss_pred -c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccc
Confidence 4 5889999999999999999999999999999999999999999999999999999999999999999877653 457
Q ss_pred CCcccccccCCCCcCCCCC
Q 037275 587 SNKTGISLSGNGKVCGGLD 605 (992)
Q Consensus 587 ~~~~~~~l~~N~~~C~~~~ 605 (992)
+.++.+++.+|||.|+|..
T Consensus 290 ~~L~~L~L~~Np~~CdC~~ 308 (452)
T 3zyi_A 290 RYLVELHLHHNPWNCDCDI 308 (452)
T ss_dssp TTCCEEECCSSCEECSTTT
T ss_pred cCCCEEEccCCCcCCCCCc
Confidence 8899999999999999854
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-27 Score=273.84 Aligned_cols=252 Identities=22% Similarity=0.247 Sum_probs=222.2
Q ss_pred cceeEEeeCCccccccCCCccCCCcccEEEccCCcCCCCCCccccCCCCCcEEeccCccccccCCCCCCCccccCceecc
Q 037275 348 TMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALS 427 (992)
Q Consensus 348 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 427 (992)
....++..+++++ .+|..+. ++++.|+|++|++++..+..|..+++|++|+|++|+|++..+..|.++++|++|+|+
T Consensus 44 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~ 120 (440)
T 3zyj_A 44 QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF 120 (440)
T ss_dssp TSCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECC
T ss_pred CCCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECC
Confidence 3456777777777 4555554 689999999999998888999999999999999999998888899999999999999
Q ss_pred CCcccCCCCCCccccccccccccccccccccCchhhhhhcccccccccccc-cccCcccccccCCCCccEEeeecccccc
Q 037275 428 SNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYN-LLSGTLPLEVGNLKNLVYFNISVNRFSG 506 (992)
Q Consensus 428 ~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 506 (992)
+|+|++..+..|..+++|++|++++|+++ .+|...+.....++.|++++| .+....+..|.++++|++|+|++|+++
T Consensus 121 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~- 198 (440)
T 3zyj_A 121 DNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR- 198 (440)
T ss_dssp SSCCSSCCTTTSCSCSSCCEEECCSCCCC-EECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-
T ss_pred CCcCCeeCHhHhhccccCceeeCCCCccc-ccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-
Confidence 99999777778999999999999999998 566767777778889999995 455444457999999999999999999
Q ss_pred cCCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcccCCCChhhhhcCCCcceEecCCCcCcccCCCC-Cc
Q 037275 507 EIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTK-GV 585 (992)
Q Consensus 507 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~ 585 (992)
.+| .+..+++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|++++.++.. ..
T Consensus 199 ~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 277 (440)
T 3zyj_A 199 EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTP 277 (440)
T ss_dssp SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSS
T ss_pred ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhcc
Confidence 455 4889999999999999999988999999999999999999999999999999999999999999999877653 55
Q ss_pred cCCcccccccCCCCcCCCCC
Q 037275 586 FSNKTGISLSGNGKVCGGLD 605 (992)
Q Consensus 586 ~~~~~~~~l~~N~~~C~~~~ 605 (992)
++.++.+++.+|||.|+|..
T Consensus 278 l~~L~~L~L~~Np~~CdC~l 297 (440)
T 3zyj_A 278 LHHLERIHLHHNPWNCNCDI 297 (440)
T ss_dssp CTTCCEEECCSSCEECSSTT
T ss_pred ccCCCEEEcCCCCccCCCCc
Confidence 78899999999999999853
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.4e-29 Score=287.74 Aligned_cols=243 Identities=15% Similarity=0.117 Sum_probs=133.6
Q ss_pred cceEeecCCCcCCCcCCcccccccccceeEEeeCCccccccCCCccCCCcccEEEccCCcCCCCCCccccCCCCCcEEec
Q 037275 323 ELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYL 402 (992)
Q Consensus 323 ~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 402 (992)
+|+.|+|++|.+.+..|..+..+. +|++|+|++|.+++.+| |..+++|++|+|++|.+++.. ..++|+.|++
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~-----~~~~L~~L~L 106 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFT-KLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIETLHA 106 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCT-TCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEE-----ECTTCCEEEC
T ss_pred CccEEEeeCCcCCCCCHHHHhCCC-CCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCC-----CCCCcCEEEC
Confidence 444444444444444444444432 35555555555554444 566666666666666665322 1256666666
Q ss_pred cCccccccCCCCCCCccccCceeccCCcccCCCCCCccccccccccccccccccccCchhhhhhcccccccccccccccC
Q 037275 403 DSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSG 482 (992)
Q Consensus 403 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~ 482 (992)
++|.|++..+.. +++|+.|+|++|.|++..|..|+.+++|+.|+++ +|.+++
T Consensus 107 ~~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls-------------------------~N~l~~ 158 (487)
T 3oja_A 107 ANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLK-------------------------LNEIDT 158 (487)
T ss_dssp CSSCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECT-------------------------TSCCCE
T ss_pred cCCcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECC-------------------------CCCCCC
Confidence 666666544432 3556666666666666556566666666666444 444444
Q ss_pred ccccccc-CCCCccEEeeecccccccCCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcccCCCChhhhh
Q 037275 483 TLPLEVG-NLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLE 561 (992)
Q Consensus 483 ~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 561 (992)
..|..+. .+++|++|+|++|.|++..+ +..+++|+.|+|++|+|++ +|..+..+++|+.|+|++|+|++ +|..+.
T Consensus 159 ~~~~~l~~~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~ 234 (487)
T 3oja_A 159 VNFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALR 234 (487)
T ss_dssp EEGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTCC
T ss_pred cChHHHhhhCCcccEEecCCCccccccc--cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcc-cchhhc
Confidence 4444443 56666666666666664422 2345666666666666664 33336666666666666666663 455566
Q ss_pred cCCCcceEecCCCcCcccCC--CCCccCCccccccc-------CCCCcCCCCC
Q 037275 562 NLSFLEYLNLSYNHFEGEVP--TKGVFSNKTGISLS-------GNGKVCGGLD 605 (992)
Q Consensus 562 ~l~~L~~L~l~~N~l~~~~~--~~~~~~~~~~~~l~-------~N~~~C~~~~ 605 (992)
.+++|+.|++++|++.|... ....++.+..+.+. +|++.|.++.
T Consensus 235 ~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~~~~~~~~~~~~~c~~~~ 287 (487)
T 3oja_A 235 FSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPT 287 (487)
T ss_dssp CCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHHHHHHHTSSSSCCCSSTT
T ss_pred cCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEeccccccccCCCcccccCCc
Confidence 66666666666666663221 11223333333333 6777776643
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=9.6e-29 Score=270.34 Aligned_cols=255 Identities=18% Similarity=0.182 Sum_probs=205.0
Q ss_pred CCCCCCcCCeeeccCCCCCccCCccccCCCCCCEEEeecccC-CCCCCcccc-------cCCCCcEeecccccccccCCh
Q 037275 69 YVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSF-SGKIPTNLS-------RCSNLISFNARRNNLVGEIPA 140 (992)
Q Consensus 69 ~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l-~~~~p~~l~-------~l~~L~~L~l~~n~l~~~~p~ 140 (992)
..+..++|++|++++|.+ .+|..+... |++|+|++|++ .+.+|..+. .+++|++|++++|++++.+|.
T Consensus 38 ~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 113 (312)
T 1wwl_A 38 LYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPP 113 (312)
T ss_dssp EEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCC
T ss_pred EEccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHH
Confidence 345677889999999999 688877665 88899999998 456777766 788999999999999888888
Q ss_pred hhc-ccccccccccccccccCCCCCCccccc-----cccceEEecCCcccCCcCCccCCCCcccEEeccCcccccc--cC
Q 037275 141 ELG-YNWLKLENLTIADNHLTGHFPASIGNL-----STLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGI--VP 212 (992)
Q Consensus 141 ~~~-~~l~~L~~L~L~~n~l~~~~p~~~~~l-----~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~--~p 212 (992)
.++ ..+++|++|+|++|++++. |..++.+ ++|++|++++|++.+..|..|+++++|++|+|++|++.+. .|
T Consensus 114 ~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 192 (312)
T 1wwl_A 114 PLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLI 192 (312)
T ss_dssp CSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHH
T ss_pred HHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHH
Confidence 764 5788899999999999876 8888877 8899999999998777778888899999999999987754 23
Q ss_pred ccc--cccCCCcEEeccCCccCCCCCccccccccccchhhccccccCCCCchhhhccccCceeeecccccccccc-cccc
Q 037275 213 PSI--FNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVS-IYFR 289 (992)
Q Consensus 213 ~~l--~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~-~~~~ 289 (992)
..+ ..+++|++|++++|++++ ++. .....+..+++|++|+|++|++++..+ ..+.
T Consensus 193 ~~~~~~~l~~L~~L~L~~N~l~~-~~~---------------------~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 250 (312)
T 1wwl_A 193 SALCPLKFPTLQVLALRNAGMET-PSG---------------------VCSALAAARVQLQGLDLSHNSLRDAAGAPSCD 250 (312)
T ss_dssp HHSCTTSCTTCCEEECTTSCCCC-HHH---------------------HHHHHHHTTCCCSEEECTTSCCCSSCCCSCCC
T ss_pred HHHHhccCCCCCEEECCCCcCcc-hHH---------------------HHHHHHhcCCCCCEEECCCCcCCcccchhhhh
Confidence 344 778888888888888762 110 112345678999999999999998774 5677
Q ss_pred ccCccceEecCCCCCCCCCCCCchhhhhccCCCcceEeecCCCcCCCcCCcccccccccceeEEeeCCccccc
Q 037275 290 SLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGI 362 (992)
Q Consensus 290 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~ 362 (992)
.+++|++|+|++|+++.++.. +. ++|+.|++++|++++. |. +..+ ++|++|++++|++++.
T Consensus 251 ~l~~L~~L~Ls~N~l~~ip~~-------~~--~~L~~L~Ls~N~l~~~-p~-~~~l-~~L~~L~L~~N~l~~~ 311 (312)
T 1wwl_A 251 WPSQLNSLNLSFTGLKQVPKG-------LP--AKLSVLDLSYNRLDRN-PS-PDEL-PQVGNLSLKGNPFLDS 311 (312)
T ss_dssp CCTTCCEEECTTSCCSSCCSS-------CC--SEEEEEECCSSCCCSC-CC-TTTS-CEEEEEECTTCTTTCC
T ss_pred hcCCCCEEECCCCccChhhhh-------cc--CCceEEECCCCCCCCC-hh-HhhC-CCCCEEeccCCCCCCC
Confidence 789999999999999977653 22 7899999999999987 55 6665 4699999999999853
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-26 Score=273.02 Aligned_cols=268 Identities=21% Similarity=0.300 Sum_probs=201.5
Q ss_pred cCCeeeccCCCCCccCCccccCCCCCCEEEeecccCCCCCCcccccCCCCcEeecccccccccCChhhcccccccccccc
Q 037275 75 FLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTI 154 (992)
Q Consensus 75 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~~L~L 154 (992)
.+++|++++|+++ .+|..+. ++|++|+|++|+|+ .+|. .+++|++|+|+
T Consensus 41 ~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls------------------------ 89 (622)
T 3g06_A 41 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVS------------------------ 89 (622)
T ss_dssp CCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEEC------------------------
T ss_pred CCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcC------------------------
Confidence 4678888888887 7777665 67888888888777 5554 34445555554
Q ss_pred cccccCCCCCCccccccccceEEecCCcccCCcCCccCCCCcccEEeccCcccccccCccccccCCCcEEeccCCccCCC
Q 037275 155 ADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGS 234 (992)
Q Consensus 155 ~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~ 234 (992)
+|+++ .+|. .+++|++|++++|.+.+ +|. .+++|+.|++++|++++ +|.. +++|++|++++|++++
T Consensus 90 -~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~- 155 (622)
T 3g06_A 90 -GNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS- 155 (622)
T ss_dssp -SCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-
T ss_pred -CCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC-
Confidence 44444 3444 56788899999998854 555 56889999999999995 6654 4789999999998872
Q ss_pred CCccccccccccchhhccccccCCCCchhhhccccCceeeeccccccccccccccccCccceEecCCCCCCCCCCCCchh
Q 037275 235 LPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDF 314 (992)
Q Consensus 235 ~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 314 (992)
+|. ...+|+.|++++|+|++.+ ..+++|+.|+|++|+++.++..
T Consensus 156 -------------------------l~~---~~~~L~~L~L~~N~l~~l~----~~~~~L~~L~Ls~N~l~~l~~~---- 199 (622)
T 3g06_A 156 -------------------------LPA---LPSELCKLWAYNNQLTSLP----MLPSGLQELSVSDNQLASLPTL---- 199 (622)
T ss_dssp -------------------------CCC---CCTTCCEEECCSSCCSCCC----CCCTTCCEEECCSSCCSCCCCC----
T ss_pred -------------------------cCC---ccCCCCEEECCCCCCCCCc----ccCCCCcEEECCCCCCCCCCCc----
Confidence 222 1357899999999999654 4568899999999988765431
Q ss_pred hhhccCCCcceEeecCCCcCCCcCCcccccccccceeEEeeCCccccccCCCccCCCcccEEEccCCcCCCCCCccccCC
Q 037275 315 LTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGEL 394 (992)
Q Consensus 315 ~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 394 (992)
.++ |+.|++++|.++. +|. .+++|+.|+|++|++++ +| ..+
T Consensus 200 ------~~~-------------------------L~~L~L~~N~l~~-l~~---~~~~L~~L~Ls~N~L~~-lp---~~l 240 (622)
T 3g06_A 200 ------PSE-------------------------LYKLWAYNNRLTS-LPA---LPSGLKELIVSGNRLTS-LP---VLP 240 (622)
T ss_dssp ------CTT-------------------------CCEEECCSSCCSS-CCC---CCTTCCEEECCSSCCSC-CC---CCC
T ss_pred ------cch-------------------------hhEEECcCCcccc-cCC---CCCCCCEEEccCCccCc-CC---CCC
Confidence 133 5555555555553 332 24789999999999995 55 456
Q ss_pred CCCcEEeccCccccccCCCCCCCccccCceeccCCcccCCCCCCccccccccccccccccccccCchhhhhhc
Q 037275 395 KNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSIS 467 (992)
Q Consensus 395 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~ 467 (992)
++|+.|+|++|+|+ .+|. .+++|+.|+|++|+|+ .+|..+..+++|+.|++++|.+++..|..+..+.
T Consensus 241 ~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 241 SELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT 308 (622)
T ss_dssp TTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred CcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence 89999999999999 5555 5788999999999999 6788999999999999999999988887766554
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.3e-28 Score=287.16 Aligned_cols=186 Identities=15% Similarity=0.046 Sum_probs=130.1
Q ss_pred ccccccceEEEEeEECCCCeEEEEEEeeccCC----------CchhHHHHHHHHHHhc-cCCcceeEEEEeecccccCcc
Q 037275 686 MIGQGSFGFVYKGNLGENGMMVAVKVINLKQK----------GASNGFVAECQALRNI-RHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 686 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 754 (992)
..+.|++|.+..++....|+.||+|++..... ...+++.+|+++|+++ .|+||+++++++ ++..
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----ed~~ 315 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG-----ENAQ 315 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE-----ECSS
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----EECC
Confidence 45667777777777666788999999964321 2235689999999999 799999999994 5667
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
..||||||++|++|.+++.... +++.. +|+.||+.||+|+|++ |||||||||+|||++++|.+||+||
T Consensus 316 ~~yLVMEyv~G~~L~d~i~~~~------~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DF 383 (569)
T 4azs_A 316 SGWLVMEKLPGRLLSDMLAAGE------EIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDF 383 (569)
T ss_dssp EEEEEEECCCSEEHHHHHHTTC------CCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEEecCCCCcHHHHHHhCC------CCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeec
Confidence 7899999999999999998654 35554 4789999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCC
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p 897 (992)
|+|+..... .......+||+.|||||++.+ .+..++|+||+|++++++.++..|
T Consensus 384 GlAr~~~~~--------~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 384 GSIVTTPQD--------CSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp TTEESCC-----------CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred ccCeeCCCC--------CccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 999866432 122344679999999999875 467789999999998888766544
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-26 Score=249.62 Aligned_cols=196 Identities=22% Similarity=0.229 Sum_probs=148.0
Q ss_pred ccCCCccCCCcccEEEccCCc-CCCCCCccccCCCCCcEEeccCccccccCCCCCCCccccCceeccCCcccCCCCCCcc
Q 037275 362 IIPTGIRNLVNLVELCMDDNK-LTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLG 440 (992)
Q Consensus 362 ~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 440 (992)
+.|..|..+++|++|++++|. +....|..|..+++|++|++++|++++..+..|.++++|++|++++|++++..+..|.
T Consensus 71 ~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 150 (285)
T 1ozn_A 71 IDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFR 150 (285)
T ss_dssp ECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred eCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhc
Confidence 445566677777778887776 6656677777788888888888888777677777888888888888888866666677
Q ss_pred ccccccccccccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeecccccccCCcccccccccce
Q 037275 441 NCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQ 520 (992)
Q Consensus 441 ~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 520 (992)
.+++|++|++++|++ ++..+..|..+++|++|+|++|++++..|..|..+++|+.
T Consensus 151 ~l~~L~~L~l~~n~l-------------------------~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 205 (285)
T 1ozn_A 151 DLGNLTHLFLHGNRI-------------------------SSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMT 205 (285)
T ss_dssp TCTTCCEEECCSSCC-------------------------CEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCE
T ss_pred cCCCccEEECCCCcc-------------------------cccCHHHhcCccccCEEECCCCcccccCHhHccCcccccE
Confidence 788887775544444 3333445777888999999999998888888999999999
Q ss_pred eeccCCcccccCCccccccCCCCEEECCCcccCCCChhhhhcCCCcceEecCCCcCcccCCCC
Q 037275 521 LYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTK 583 (992)
Q Consensus 521 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~ 583 (992)
|+|++|+|++..+..+..+++|++|+|++|++....+ ...-...++.+..+.|.+.|..|..
T Consensus 206 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~-~~~~~~~l~~~~~~~~~~~c~~p~~ 267 (285)
T 1ozn_A 206 LYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQR 267 (285)
T ss_dssp EECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG-GHHHHHHHHHCCSEECCCBEEESGG
T ss_pred eeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCC-cHHHHHHHHhcccccCccccCCchH
Confidence 9999999997766778899999999999999975333 2222345666778888998887763
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-27 Score=262.33 Aligned_cols=250 Identities=16% Similarity=0.178 Sum_probs=170.4
Q ss_pred hhhhccccCceeeeccccccccccccccccCccceEecCCCCCCCCCCCCchhhhhccCCCcceEeecCCCcCCCcCCcc
Q 037275 262 ESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHS 341 (992)
Q Consensus 262 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~l~~~~~~~ 341 (992)
..+..+++|++|+|++|++++..+..|..+++|++|+|++|+++.+. .+..+++|+
T Consensus 28 ~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~--------~~~~l~~L~---------------- 83 (317)
T 3o53_A 28 SLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETL--------DLESLSTLR---------------- 83 (317)
T ss_dssp HHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEE--------EETTCTTCC----------------
T ss_pred HHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcch--------hhhhcCCCC----------------
Confidence 33444556666666666666666666666666666666666654311 123333333
Q ss_pred cccccccceeEEeeCCccccccCCCccCCCcccEEEccCCcCCCCCCccccCCCCCcEEeccCccccccCCCCCCCcccc
Q 037275 342 IANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLL 421 (992)
Q Consensus 342 ~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 421 (992)
+|++++|++++.. ..++|++|++++|++++..+. .+++|+.|++++|++++..+..+..+++|
T Consensus 84 ---------~L~Ls~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L 146 (317)
T 3o53_A 84 ---------TLDLNNNYVQELL-----VGPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRV 146 (317)
T ss_dssp ---------EEECCSSEEEEEE-----ECTTCCEEECCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSE
T ss_pred ---------EEECcCCcccccc-----CCCCcCEEECCCCccCCcCcc---ccCCCCEEECCCCCCCCccchhhhccCCC
Confidence 3333333333222 225777777877777754333 35677888888888876666677777778
Q ss_pred CceeccCCcccCCCCCCcc-ccccccccccccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeee
Q 037275 422 TNLALSSNDLQGSIPPSLG-NCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNIS 500 (992)
Q Consensus 422 ~~L~L~~N~l~~~~~~~~~-~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls 500 (992)
++|+|++|++++..+..+. .+++|++|++++|+++ +. + ....+++|++|+|+
T Consensus 147 ~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~-------------------------~~-~-~~~~l~~L~~L~Ls 199 (317)
T 3o53_A 147 QYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-------------------------DV-K-GQVVFAKLKTLDLS 199 (317)
T ss_dssp EEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCC-------------------------EE-E-CCCCCTTCCEEECC
T ss_pred CEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCc-------------------------cc-c-cccccccCCEEECC
Confidence 8888888877765555553 5667776655555544 22 2 22348899999999
Q ss_pred cccccccCCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcccC-CCChhhhhcCCCcceEecCC-CcCcc
Q 037275 501 VNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLS-GQIPEYLENLSFLEYLNLSY-NHFEG 578 (992)
Q Consensus 501 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~l~~-N~l~~ 578 (992)
+|++++ +|..+..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+++ +.+|..+..+++|+.|++++ +.+.+
T Consensus 200 ~N~l~~-l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~ 277 (317)
T 3o53_A 200 SNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTG 277 (317)
T ss_dssp SSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHS
T ss_pred CCcCCc-chhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccC
Confidence 999985 4555889999999999999998 57888999999999999999998 78888899999999999984 45555
Q ss_pred cCC
Q 037275 579 EVP 581 (992)
Q Consensus 579 ~~~ 581 (992)
..+
T Consensus 278 ~~~ 280 (317)
T 3o53_A 278 QNE 280 (317)
T ss_dssp SSS
T ss_pred Cch
Confidence 443
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-27 Score=260.82 Aligned_cols=257 Identities=17% Similarity=0.147 Sum_probs=158.3
Q ss_pred ccEEeccCcccccccCccccccCCCcEEeccCCccCCCCCccccccccccchhhccccccCCCCchhhhccccCceeeec
Q 037275 197 LILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLF 276 (992)
Q Consensus 197 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~ 276 (992)
++.++++.+.+....+..+..+++|++|++++|+++ +..|..|+.+++|++|+|+
T Consensus 12 l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~-------------------------~~~~~~~~~l~~L~~L~Ls 66 (317)
T 3o53_A 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-------------------------QISAADLAPFTKLELLNLS 66 (317)
T ss_dssp EEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCC-------------------------CCCHHHHTTCTTCCEEECT
T ss_pred eeEeeccccchhhhHHHHhccCCCCCEEECcCCccC-------------------------cCCHHHhhCCCcCCEEECC
Confidence 455666777666444444445556666666666655 3556778888999999999
Q ss_pred cccccccccccccccCccceEecCCCCCCCCCCCCchhhhhccCCCcceEeecCCCcCCCcCCcccccccccceeEEeeC
Q 037275 277 DNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAG 356 (992)
Q Consensus 277 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~ 356 (992)
+|++++..+ |..+++|++|+|++|+++.++ ..++|+.|++++|++.+..+..+ .+|++|++++
T Consensus 67 ~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~-----------~~~~L~~L~l~~n~l~~~~~~~~----~~L~~L~l~~ 129 (317)
T 3o53_A 67 SNVLYETLD--LESLSTLRTLDLNNNYVQELL-----------VGPSIETLHAANNNISRVSCSRG----QGKKNIYLAN 129 (317)
T ss_dssp TSCCEEEEE--ETTCTTCCEEECCSSEEEEEE-----------ECTTCCEEECCSSCCSEEEECCC----SSCEEEECCS
T ss_pred CCcCCcchh--hhhcCCCCEEECcCCcccccc-----------CCCCcCEEECCCCccCCcCcccc----CCCCEEECCC
Confidence 999987665 888999999999999876532 33677777777777775544332 2466666666
Q ss_pred CccccccCCCccCCCcccEEEccCCcCCCCCCcccc-CCCCCcEEeccCccccccCCCCCCCccccCceeccCCcccCCC
Q 037275 357 NQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIG-ELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSI 435 (992)
Q Consensus 357 n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 435 (992)
|++++..+..+..+++|++|+|++|++++..+..+. .+++|++|+|++|+|++. +. ...+++|++|+|++|+|++ +
T Consensus 130 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~-l 206 (317)
T 3o53_A 130 NKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAF-M 206 (317)
T ss_dssp SCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCE-E
T ss_pred CCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCCc-c
Confidence 666666666666666666666666666655555443 466666666666666643 21 2235566666666666653 3
Q ss_pred CCCccccccccccccccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeeccccc-ccCCccccc
Q 037275 436 PPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFS-GEIPVTLSA 514 (992)
Q Consensus 436 ~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~ 514 (992)
|..+..+++|++|++++|++ + .+|..+..+++|++|++++|.++ +.+|..+..
T Consensus 207 ~~~~~~l~~L~~L~L~~N~l-------------------------~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~ 260 (317)
T 3o53_A 207 GPEFQSAAGVTWISLRNNKL-------------------------V-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSK 260 (317)
T ss_dssp CGGGGGGTTCSEEECTTSCC-------------------------C-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHT
T ss_pred hhhhcccCcccEEECcCCcc-------------------------c-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhc
Confidence 33355555555553333332 2 33444555555556666665555 445555555
Q ss_pred ccccceeecc
Q 037275 515 CTSLQQLYLQ 524 (992)
Q Consensus 515 l~~L~~L~L~ 524 (992)
+++|+.|+++
T Consensus 261 ~~~L~~l~l~ 270 (317)
T 3o53_A 261 NQRVQTVAKQ 270 (317)
T ss_dssp CHHHHHHHHH
T ss_pred cccceEEECC
Confidence 5555555555
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-29 Score=303.98 Aligned_cols=459 Identities=16% Similarity=0.156 Sum_probs=267.9
Q ss_pred CCCceEeeEEcCCCCeEEEeeccccccCCccCCCCCCCCcCCeeeccCCCCCc---cCCc------------cccCCCCC
Q 037275 36 NLCQWTGVTCGHRHQRVTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHG---EIPH------------QIGRLVRL 100 (992)
Q Consensus 36 ~~c~w~gv~c~~~~~~v~~ldl~~~~l~~~l~~~l~~l~~L~~L~L~~n~l~~---~~p~------------~~~~l~~L 100 (992)
-|++|.++.. .....++++.... ......+..+++|+.|+|+++.... ..|. ....+++|
T Consensus 33 vck~W~~~~~----~~~~~l~~~~~~~-~~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L 107 (594)
T 2p1m_B 33 VCKSWYEIER----WCRRKVFIGNCYA-VSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWL 107 (594)
T ss_dssp SCHHHHHHHH----HHCCEEEESSTTS-SCHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTC
T ss_pred HHHHHHHhhh----hhceEEeeccccc-cCHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCC
Confidence 3558988822 1223455554321 1112245678889999999875321 1221 13467889
Q ss_pred CEEEeecccCCCCCCcccc-cCCCCcEeecccc-cccccCChhhcccccccccccccccccCCCCCCccc----cccccc
Q 037275 101 EALVLANNSFSGKIPTNLS-RCSNLISFNARRN-NLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIG----NLSTLE 174 (992)
Q Consensus 101 ~~L~Ls~n~l~~~~p~~l~-~l~~L~~L~l~~n-~l~~~~p~~~~~~l~~L~~L~L~~n~l~~~~p~~~~----~l~~L~ 174 (992)
++|+|++|.+++..+..+. .+++|++|++++| .+++.....+..++++|++|+|++|.+++..+..+. .+++|+
T Consensus 108 ~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~ 187 (594)
T 2p1m_B 108 EEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLV 187 (594)
T ss_dssp CEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCC
T ss_pred CeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCc
Confidence 9999999998877677775 6889999999988 555433444555788899999998887765544443 566888
Q ss_pred eEEecCCc--cc-CCcCCccCCCCcccEEeccCc-ccccccCccccccCCCcEEeccCCccCCCCCccccccccccchhh
Q 037275 175 RINVLGNG--LW-GRIPNNLGNLRNLILLNLGEN-RFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFI 250 (992)
Q Consensus 175 ~L~l~~n~--l~-~~~~~~l~~l~~L~~L~L~~n-~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~L~~l~ 250 (992)
+|++++|. +. ..++..+.++++|++|+|++| .+.+ +|..+..+++|++|+++.+...
T Consensus 188 ~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~------------------ 248 (594)
T 2p1m_B 188 SLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAE------------------ 248 (594)
T ss_dssp EEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCC------------------
T ss_pred EEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCc------------------
Confidence 88888876 21 111122244578888888887 4443 6777777888888887655321
Q ss_pred ccccccCCCCchhhhccccCcee-eeccccccccccccccccCccceEecCCCCCCCCCCCCchhhhhccCCCcceEeec
Q 037275 251 VAENNFAGSIPESLSNASNLVEL-TLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGL 329 (992)
Q Consensus 251 l~~n~l~~~~p~~l~~l~~L~~L-~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~~L~~L~l 329 (992)
+..|.+.+ ++..+.++++|+.| .+.+... ...+..+..+++|++|+|++|.++.. .....+..+++|+.|++
T Consensus 249 ~~~~~~~~-l~~~l~~~~~L~~Ls~~~~~~~-~~l~~~~~~~~~L~~L~L~~~~l~~~-----~l~~~~~~~~~L~~L~l 321 (594)
T 2p1m_B 249 VRPDVYSG-LSVALSGCKELRCLSGFWDAVP-AYLPAVYSVCSRLTTLNLSYATVQSY-----DLVKLLCQCPKLQRLWV 321 (594)
T ss_dssp CCHHHHHH-HHHHHHTCTTCCEEECCBTCCG-GGGGGGHHHHTTCCEEECTTCCCCHH-----HHHHHHTTCTTCCEEEE
T ss_pred cchhhHHH-HHHHHhcCCCcccccCCcccch-hhHHHHHHhhCCCCEEEccCCCCCHH-----HHHHHHhcCCCcCEEeC
Confidence 12223332 34467777788877 4443332 23444455677888888888775421 12223445666666666
Q ss_pred CCCcCCCcCCcccccccccceeEEeeCCccccccCCCccCCCcccEEEccC---------CcCCCCCCcccc-CCCCCcE
Q 037275 330 DDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDD---------NKLTGTIPHAIG-ELKNLQL 399 (992)
Q Consensus 330 ~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~---------N~l~~~~~~~~~-~l~~L~~ 399 (992)
++| +.......+ ...+++|++|++++ +.+++.....+. .+++|+.
T Consensus 322 ~~~-~~~~~l~~l------------------------~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~ 376 (594)
T 2p1m_B 322 LDY-IEDAGLEVL------------------------ASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLES 376 (594)
T ss_dssp EGG-GHHHHHHHH------------------------HHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCE
T ss_pred cCc-cCHHHHHHH------------------------HHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHH
Confidence 655 221111111 12345555565522 333322112222 3566666
Q ss_pred EeccCccccccCCCCCC-CccccCceecc--C----CcccCCC-----CCCccccccccccccccccccccCchhhhhhc
Q 037275 400 LYLDSNFLAGGIPTSLG-NLTLLTNLALS--S----NDLQGSI-----PPSLGNCKNLIELHMADIELTGALPPQILSIS 467 (992)
Q Consensus 400 L~L~~N~l~~~~~~~~~-~l~~L~~L~L~--~----N~l~~~~-----~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~ 467 (992)
|+++.|++++..+..+. .+++|+.|+++ + |.++... +..+..+++|+.|++++
T Consensus 377 L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~--------------- 441 (594)
T 2p1m_B 377 VLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG--------------- 441 (594)
T ss_dssp EEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS---------------
T ss_pred HHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC---------------
Confidence 66666666544333333 35666666666 2 3343110 01134445555554433
Q ss_pred ccccccccccccccCcccccccC-CCCccEEeeecccccccCCccc-ccccccceeeccCCcccccCCc-cccccCCCCE
Q 037275 468 TLSLSLDLSYNLLSGTLPLEVGN-LKNLVYFNISVNRFSGEIPVTL-SACTSLQQLYLQGNSFSGSIPS-SLSSLKSIKE 544 (992)
Q Consensus 468 ~~~~~L~l~~N~l~~~~~~~~~~-l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~ 544 (992)
.+++..+..+.. +++|++|+|++|.+++..+..+ .++++|++|+|++|.+++.... ....+++|++
T Consensus 442 -----------~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~ 510 (594)
T 2p1m_B 442 -----------LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRS 510 (594)
T ss_dssp -----------SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSE
T ss_pred -----------cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCE
Confidence 233233333333 6788888888888875544444 5678888888888888654433 3445788888
Q ss_pred EECCCcccCCCChhhh-hcCCCcceEecCCCcC
Q 037275 545 LDMSSNNLSGQIPEYL-ENLSFLEYLNLSYNHF 576 (992)
Q Consensus 545 L~Ls~N~l~~~~p~~~-~~l~~L~~L~l~~N~l 576 (992)
|+|++|+++......+ ..++.|+...+..+.-
T Consensus 511 L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~~ 543 (594)
T 2p1m_B 511 LWMSSCSVSFGACKLLGQKMPKLNVEVIDERGA 543 (594)
T ss_dssp EEEESSCCBHHHHHHHHHHCTTEEEEEECSSSC
T ss_pred EeeeCCCCCHHHHHHHHHhCCCCEEEEecCCCc
Confidence 8888888854333444 4567777766665543
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-25 Score=241.71 Aligned_cols=213 Identities=20% Similarity=0.214 Sum_probs=185.8
Q ss_pred ccceeEEeeCCccccccCCCccCCCcccEEEccCCcCCCCCCccccCCCCCcEEeccCccccccCCCCCCCccccCceec
Q 037275 347 STMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLAL 426 (992)
Q Consensus 347 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 426 (992)
..+++|++++|++++..+..|.++++|++|++++|++++..+..|..+++|++|+|++|++++..+..|.++++|++|++
T Consensus 28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence 46888889999998888888999999999999999999777788999999999999999999888888999999999999
Q ss_pred cCCcccCCCCCCccccccccccccccccccccCchhhhhhcccccccccccccccC-cccccccCCCCccEEeeeccccc
Q 037275 427 SSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSG-TLPLEVGNLKNLVYFNISVNRFS 505 (992)
Q Consensus 427 ~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~ 505 (992)
++|++++..+..+..+++|++|++++|+++ + .+|..+..+++|++|+|++|+++
T Consensus 108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-------------------------~~~l~~~~~~l~~L~~L~Ls~N~l~ 162 (276)
T 2z62_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQ-------------------------SFKLPEYFSNLTNLEHLDLSSNKIQ 162 (276)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCC-------------------------CCCCCGGGGGCTTCCEEECCSSCCC
T ss_pred CCCCccccCchhcccCCCCCEEECcCCccc-------------------------eecCchhhccCCCCCEEECCCCCCC
Confidence 999999877778899999998866655554 3 25788899999999999999999
Q ss_pred ccCCcccccccccc----eeeccCCcccccCCccccccCCCCEEECCCcccCCCChhhhhcCCCcceEecCCCcCcccCC
Q 037275 506 GEIPVTLSACTSLQ----QLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVP 581 (992)
Q Consensus 506 ~~~~~~~~~l~~L~----~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~ 581 (992)
+..+..|..+.+|+ .|++++|++++..+..+.. .+|++|+|++|+|++..+..|..+++|+.|++++|+|.|.++
T Consensus 163 ~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 163 SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp EECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred cCCHHHhhhhhhccccceeeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence 88888898888888 8999999999766655554 589999999999998777788999999999999999999998
Q ss_pred CCCc
Q 037275 582 TKGV 585 (992)
Q Consensus 582 ~~~~ 585 (992)
....
T Consensus 242 ~l~~ 245 (276)
T 2z62_A 242 RIDY 245 (276)
T ss_dssp TTHH
T ss_pred chHH
Confidence 6543
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.5e-26 Score=265.19 Aligned_cols=224 Identities=23% Similarity=0.265 Sum_probs=174.3
Q ss_pred cCCCcccEEEccCCcCCCCCCccccCCCCCcEEeccCccccccCCCCCCCccccCceeccCCcccCCCCCCccccccccc
Q 037275 368 RNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIE 447 (992)
Q Consensus 368 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 447 (992)
..+++|++|+|++|.+++..|..|..+++|++|+|++|.+++..| |..+++|++|+|++|.|++.. ..++|+.
T Consensus 31 ~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~-----~~~~L~~ 103 (487)
T 3oja_A 31 QSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIET 103 (487)
T ss_dssp TTGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEE-----ECTTCCE
T ss_pred ccCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCC-----CCCCcCE
Confidence 344467777777777766666667777777777777777665444 666677777777777766422 2266677
Q ss_pred cccccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeecccccccCCcccc-cccccceeeccCC
Q 037275 448 LHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLS-ACTSLQQLYLQGN 526 (992)
Q Consensus 448 L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~L~~N 526 (992)
|++++|.+++..+.. .+.+..|+|++|.+++..|..++.+++|++|+|++|.+++.+|..+. .+++|+.|+|++|
T Consensus 104 L~L~~N~l~~~~~~~----l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N 179 (487)
T 3oja_A 104 LHAANNNISRVSCSR----GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179 (487)
T ss_dssp EECCSSCCCCEEECC----CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTS
T ss_pred EECcCCcCCCCCccc----cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCC
Confidence 777777766444332 23456678888999888888999999999999999999998888886 7999999999999
Q ss_pred cccccCCccccccCCCCEEECCCcccCCCChhhhhcCCCcceEecCCCcCcccCCCCCccCCcccccccCCCCcCCCCC
Q 037275 527 SFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNKTGISLSGNGKVCGGLD 605 (992)
Q Consensus 527 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~l~~N~~~C~~~~ 605 (992)
.|++..+ +..+++|++|+|++|+|++..| .+..+++|+.|+|++|.+++.++....++.+..+++.+|++.|++++
T Consensus 180 ~l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~lp~~l~~l~~L~~L~l~~N~l~c~~~~ 255 (487)
T 3oja_A 180 FIYDVKG--QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTLR 255 (487)
T ss_dssp CCCEEEC--CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCBCHHHHH
T ss_pred ccccccc--cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcccchhhccCCCCCEEEcCCCCCcCcchH
Confidence 9997633 4469999999999999997544 59999999999999999999877777788999999999999997643
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.7e-25 Score=236.54 Aligned_cols=217 Identities=19% Similarity=0.276 Sum_probs=171.9
Q ss_pred CCCCceEeeEEcCCCCeEEEeeccccccCCccCCCCCCCCcCCeeeccCCCCCccCCccccCCCCCCEEEeecccCCCCC
Q 037275 35 TNLCQWTGVTCGHRHQRVTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKI 114 (992)
Q Consensus 35 ~~~c~w~gv~c~~~~~~v~~ldl~~~~l~~~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~ 114 (992)
.++|.|.|+.|.-. ..++.+|++++.+. .+|..+. ++|++|+|++|++++..+..|..+++|++|+|++|++++..
T Consensus 2 ~~~C~~~~~~C~c~-~~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~ 77 (270)
T 2o6q_A 2 EALCKKDGGVCSCN-NNKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLP 77 (270)
T ss_dssp CCCBGGGTCSBEEE-TTTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCC
T ss_pred CccCCCCCCCCEeC-CCCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeC
Confidence 47899999988532 23567999999985 5777664 68999999999999655668999999999999999998443
Q ss_pred CcccccCCCCcEeecccccccccCChhhcccccccccccccccccCCCCCCccccccccceEEecCCcccCCcCCccCCC
Q 037275 115 PTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNL 194 (992)
Q Consensus 115 p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l 194 (992)
+..+..+++|++|++++|+++ .+|...+..+++|++|+|++|.+++..|..|.++++|++|++++|.+.+..+..|..+
T Consensus 78 ~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l 156 (270)
T 2o6q_A 78 AGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKL 156 (270)
T ss_dssp TTTTSSCTTCCEEECCSSCCC-CCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred hhhhcCCCCCCEEECCCCcCC-cCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCC
Confidence 445688999999999999988 6776666678889999999998887777778888888888888888876666668888
Q ss_pred CcccEEeccCcccccccCccccccCCCcEEeccCCccCCCCCccccccccccchhhccccccCCCCchhhhccccCceee
Q 037275 195 RNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELT 274 (992)
Q Consensus 195 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~ 274 (992)
++|+.|+|++|++++..+..|..+++|++|++++|++++ +| +..|..+++|++|+
T Consensus 157 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~------------------------~~~~~~l~~L~~L~ 211 (270)
T 2o6q_A 157 TSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKR-VP------------------------EGAFDSLEKLKMLQ 211 (270)
T ss_dssp TTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSC-CC------------------------TTTTTTCTTCCEEE
T ss_pred cccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCc-CC------------------------HHHhccccCCCEEE
Confidence 888888888888887666668888888888888887762 22 33456667777777
Q ss_pred ecccccc
Q 037275 275 LFDNQFR 281 (992)
Q Consensus 275 L~~N~l~ 281 (992)
|++|.+.
T Consensus 212 l~~N~~~ 218 (270)
T 2o6q_A 212 LQENPWD 218 (270)
T ss_dssp CCSSCBC
T ss_pred ecCCCee
Confidence 7777765
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-24 Score=231.32 Aligned_cols=206 Identities=24% Similarity=0.308 Sum_probs=160.1
Q ss_pred ceeEEeeCCccccccCCCccCCCcccEEEccCCcCCCCCCccccCCCCCcEEeccCccccccCCCCCCCccccCceeccC
Q 037275 349 MTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSS 428 (992)
Q Consensus 349 L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 428 (992)
.+.+++++++++. +|..+. +++++|+|++|++++..+..|..+++|++|+|++|+++...+..|..+++|++|+|++
T Consensus 18 ~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~ 94 (270)
T 2o6q_A 18 KNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTD 94 (270)
T ss_dssp TTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCS
T ss_pred CCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCC
Confidence 4556666666663 444333 4677888888888766666777788888888888888766566667788888888888
Q ss_pred CcccCCCCCCccccccccccccccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeecccccccC
Q 037275 429 NDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEI 508 (992)
Q Consensus 429 N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 508 (992)
|++++..+..|..+++|++|++++ |.+++..+..|..+++|++|+|++|++++..
T Consensus 95 n~l~~~~~~~~~~l~~L~~L~l~~-------------------------n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~ 149 (270)
T 2o6q_A 95 NKLQALPIGVFDQLVNLAELRLDR-------------------------NQLKSLPPRVFDSLTKLTYLSLGYNELQSLP 149 (270)
T ss_dssp SCCCCCCTTTTTTCSSCCEEECCS-------------------------SCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred CcCCcCCHhHcccccCCCEEECCC-------------------------CccCeeCHHHhCcCcCCCEEECCCCcCCccC
Confidence 888766666677777777774444 4444455566778889999999999998777
Q ss_pred CcccccccccceeeccCCcccccCCccccccCCCCEEECCCcccCCCChhhhhcCCCcceEecCCCcCcccCCC
Q 037275 509 PVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPT 582 (992)
Q Consensus 509 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~ 582 (992)
+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|++++|+|.|.++.
T Consensus 150 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 223 (270)
T 2o6q_A 150 KGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCNG 223 (270)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSSS
T ss_pred HhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCcc
Confidence 77788999999999999999977777889999999999999999977777788899999999999999988864
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.92 E-value=5.6e-25 Score=236.98 Aligned_cols=202 Identities=22% Similarity=0.240 Sum_probs=119.8
Q ss_pred cceeEEeeCCccccccCCCccCCCcccEEEccCCcCCCCCCccccCCCCCcEEeccCccccccCCCCCCCccccCceecc
Q 037275 348 TMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALS 427 (992)
Q Consensus 348 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 427 (992)
+++++++++|+++. +|..+. ++++.|+|++|++++..+..|..+++|+.|+|++|+|++..+. ..+++|++|+|+
T Consensus 11 ~l~~l~~~~~~l~~-ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~~L~Ls 85 (290)
T 1p9a_G 11 SHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLGTLDLS 85 (290)
T ss_dssp TCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCCEEECC
T ss_pred CccEEECCCCCCCc-CCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCCEEECC
Confidence 35666666666663 333332 4566666666666655556666666666666666666643222 556666666666
Q ss_pred CCcccCCCCCCccccccccccccccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeeccccccc
Q 037275 428 SNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGE 507 (992)
Q Consensus 428 ~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 507 (992)
+|+|+ .+|..+..+++|++| ++++|++++..+..|..+++|++|+|++|++++.
T Consensus 86 ~N~l~-~l~~~~~~l~~L~~L-------------------------~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~ 139 (290)
T 1p9a_G 86 HNQLQ-SLPLLGQTLPALTVL-------------------------DVSFNRLTSLPLGALRGLGELQELYLKGNELKTL 139 (290)
T ss_dssp SSCCS-SCCCCTTTCTTCCEE-------------------------ECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCC
T ss_pred CCcCC-cCchhhccCCCCCEE-------------------------ECCCCcCcccCHHHHcCCCCCCEEECCCCCCCcc
Confidence 66666 455555555555555 3333333333445566666666666666666655
Q ss_pred CCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcccCCCChhhhhcCCCcceEecCCCcCcccCC
Q 037275 508 IPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVP 581 (992)
Q Consensus 508 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~ 581 (992)
.+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+.+|+.|+|++|+|.|.|.
T Consensus 140 ~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c~ 212 (290)
T 1p9a_G 140 PPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCE 212 (290)
T ss_dssp CTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred ChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCcCc
Confidence 5555666666666666666666544455566666666666666666 455555555666666666666666553
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-24 Score=234.23 Aligned_cols=224 Identities=21% Similarity=0.185 Sum_probs=189.0
Q ss_pred EeeCCccccccCCCccCCCcccEEEccCCcCCCCCCccccCCCCCcEEeccCccccccCCCCCCCccccCceeccCCccc
Q 037275 353 VIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQ 432 (992)
Q Consensus 353 ~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 432 (992)
+..+.+++ .+|..+. ++|++|++++|++++..+..|..+++|++|+|++|++++..+..|.++++|++|++++|+++
T Consensus 13 ~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 89 (276)
T 2z62_A 13 QCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89 (276)
T ss_dssp ECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC
T ss_pred EecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccC
Confidence 33444444 3455443 57999999999999777779999999999999999999888888999999999999999999
Q ss_pred CCCCCCccccccccccccccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeeccccccc-CCcc
Q 037275 433 GSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGE-IPVT 511 (992)
Q Consensus 433 ~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~ 511 (992)
+..+..|..+++|++|++++|++ ++..+..+..+++|++|++++|++++. +|..
T Consensus 90 ~~~~~~~~~l~~L~~L~l~~n~l-------------------------~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~ 144 (276)
T 2z62_A 90 SLALGAFSGLSSLQKLVAVETNL-------------------------ASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144 (276)
T ss_dssp EECTTTTTTCTTCCEEECTTSCC-------------------------CCSTTCCCTTCTTCCEEECCSSCCCCCCCCGG
T ss_pred ccChhhhcCCccccEEECCCCCc-------------------------cccCchhcccCCCCCEEECcCCccceecCchh
Confidence 88888899999999885555554 444455688999999999999999874 5899
Q ss_pred cccccccceeeccCCcccccCCccccccCCCC----EEECCCcccCCCChhhhhcCCCcceEecCCCcCcccCCCC-Ccc
Q 037275 512 LSACTSLQQLYLQGNSFSGSIPSSLSSLKSIK----ELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTK-GVF 586 (992)
Q Consensus 512 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~----~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~ 586 (992)
|..+++|+.|+|++|++++..+..|..+++|+ .|++++|++++..+..+. ..+|+.|++++|.+++.++.. ..+
T Consensus 145 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l 223 (276)
T 2z62_A 145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRL 223 (276)
T ss_dssp GGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTC
T ss_pred hccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccC-CCcccEEECCCCceeecCHhHhccc
Confidence 99999999999999999988888899888888 999999999976665554 458999999999999877653 567
Q ss_pred CCcccccccCCCCcCCCCC
Q 037275 587 SNKTGISLSGNGKVCGGLD 605 (992)
Q Consensus 587 ~~~~~~~l~~N~~~C~~~~ 605 (992)
+.++.+++.+|++.|+|+.
T Consensus 224 ~~L~~L~l~~N~~~c~c~~ 242 (276)
T 2z62_A 224 TSLQKIWLHTNPWDCSCPR 242 (276)
T ss_dssp CSCCEEECCSSCBCCCTTT
T ss_pred ccccEEEccCCcccccCCc
Confidence 8899999999999998864
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=8.1e-28 Score=289.06 Aligned_cols=90 Identities=13% Similarity=0.090 Sum_probs=70.0
Q ss_pred cccCCCCccEEeeecccccccCCccccc-ccccceeeccCCcccccCCccc-cccCCCCEEECCCcccCCCChh-hhhcC
Q 037275 487 EVGNLKNLVYFNISVNRFSGEIPVTLSA-CTSLQQLYLQGNSFSGSIPSSL-SSLKSIKELDMSSNNLSGQIPE-YLENL 563 (992)
Q Consensus 487 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~p~-~~~~l 563 (992)
.+..+++|+.|+|++ .+++..+..+.. +++|+.|+|++|.+++..+..+ .++++|++|+|++|.+++.... ....+
T Consensus 427 l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l 505 (594)
T 2p1m_B 427 IVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKL 505 (594)
T ss_dssp HHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGG
T ss_pred HHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhC
Confidence 366788999999987 676655555655 7889999999999876555555 6689999999999999654443 34568
Q ss_pred CCcceEecCCCcCc
Q 037275 564 SFLEYLNLSYNHFE 577 (992)
Q Consensus 564 ~~L~~L~l~~N~l~ 577 (992)
++|++|++++|+++
T Consensus 506 ~~L~~L~l~~~~~~ 519 (594)
T 2p1m_B 506 ETMRSLWMSSCSVS 519 (594)
T ss_dssp GGSSEEEEESSCCB
T ss_pred CCCCEEeeeCCCCC
Confidence 99999999999884
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.91 E-value=5.3e-24 Score=229.38 Aligned_cols=206 Identities=26% Similarity=0.278 Sum_probs=116.1
Q ss_pred ccCCCcccEEEccCCcCCCCCCccccCCCCCcEEeccCccccccCCCCCCCccccCceeccCCcccCCCCCCcccccccc
Q 037275 367 IRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLI 446 (992)
Q Consensus 367 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 446 (992)
++++++++++++++|.++ .+|..+. ++++.|+|++|+|++..+..|..+++|+.|+|++|.|++..+ . ..+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~-~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV-D-GTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC-C-SCCTTCC
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC-C-CCCCcCC
Confidence 344555666666666665 3343332 456666666666665555556666666666666666653222 1 4455555
Q ss_pred ccccccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeecccccccCCcccccccccceeeccCC
Q 037275 447 ELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGN 526 (992)
Q Consensus 447 ~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 526 (992)
+|++++|++ + .+|..+..+++|++|+|++|++++..+..|.++++|++|+|++|
T Consensus 81 ~L~Ls~N~l-------------------------~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N 134 (290)
T 1p9a_G 81 TLDLSHNQL-------------------------Q-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGN 134 (290)
T ss_dssp EEECCSSCC-------------------------S-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTS
T ss_pred EEECCCCcC-------------------------C-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCC
Confidence 553333332 2 34445555666666666666666555555666666666666666
Q ss_pred cccccCCccccccCCCCEEECCCcccCCCChhhhhcCCCcceEecCCCcCcccCCCCCccCCcccccccCCCCcCCC
Q 037275 527 SFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNKTGISLSGNGKVCGG 603 (992)
Q Consensus 527 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~l~~N~~~C~~ 603 (992)
+|++..+..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|+++..++.......++.+.+.+|||.|+|
T Consensus 135 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C~c 211 (290)
T 1p9a_G 135 ELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNC 211 (290)
T ss_dssp CCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred CCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccCcC
Confidence 66655555556666666666666666654445555566666666666666654444444445555666666666655
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.5e-24 Score=253.31 Aligned_cols=193 Identities=18% Similarity=0.172 Sum_probs=141.4
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCC--------chhHHHHHHHHHHhccCCcceeEEEEeeccccc
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKG--------ASNGFVAECQALRNIRHRNLIKIITICSSIDFK 751 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 751 (992)
.+...++||+|+||+||+|+. .++.+|+|+....... ..+++.+|++++++++||||+++..++..
T Consensus 337 ~~~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~---- 410 (540)
T 3en9_A 337 RKIPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD---- 410 (540)
T ss_dssp -----------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE----
T ss_pred cCCCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe----
Confidence 334567999999999999965 5788999986433221 12457899999999999999944443322
Q ss_pred CcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEE
Q 037275 752 GVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHL 831 (992)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 831 (992)
....++||||+++++|.+++.. +..++.|+++||+|||++ +|+||||||+||+++. .+||
T Consensus 411 -~~~~~lVmE~~~ggsL~~~l~~--------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL 470 (540)
T 3en9_A 411 -LDNKRIMMSYINGKLAKDVIED--------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYI 470 (540)
T ss_dssp -TTTTEEEEECCCSEEHHHHSTT--------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEE
T ss_pred -CCccEEEEECCCCCCHHHHHHH--------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEE
Confidence 2234999999999999999874 457899999999999999 9999999999999998 9999
Q ss_pred eecccceecCCCCCCCCcccCCCCCcccccccccccccccC--CCcCcccchhhHHHHHHHHHhCCCCCC
Q 037275 832 GDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG--GEASMTGDVYSFGILLLEMFTRRRPTD 899 (992)
Q Consensus 832 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~pf~ 899 (992)
+|||+|+......... ...........||+.|||||++.. ..|+..+|+||.++-..+-+.++.+|.
T Consensus 471 ~DFGla~~~~~~~~~~-~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 471 IDFGLGKISNLDEDKA-VDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CCCTTCEECCCHHHHH-HHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred EECccCEECCCccccc-cchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 9999999765321000 000001234579999999999887 568888999999999999888877763
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.4e-23 Score=221.50 Aligned_cols=193 Identities=18% Similarity=0.232 Sum_probs=168.8
Q ss_pred CCCCceEeeEEcCCCCeEEEeeccccccCCccCCCCCCCCcCCeeeccCCCCCccCCccccCCCCCCEEEeecccCCCCC
Q 037275 35 TNLCQWTGVTCGHRHQRVTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKI 114 (992)
Q Consensus 35 ~~~c~w~gv~c~~~~~~v~~ldl~~~~l~~~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~ 114 (992)
++||.|.|++|... .+.+|++++.+ ..+|..+. ++|+.|+|++|++++..|..|..+++|++|+|++|++++..
T Consensus 2 ~~Cp~~~gC~C~~~---~~~l~~~~~~l-~~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 75 (251)
T 3m19_A 2 KTCETVTGCTCNEG---KKEVDCQGKSL-DSVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLS 75 (251)
T ss_dssp --CHHHHSSEEEGG---GTEEECTTCCC-SSCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCC
T ss_pred ccCCCCCceEcCCC---CeEEecCCCCc-cccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccC
Confidence 46899999999543 34689999998 57787765 68999999999999878888999999999999999999877
Q ss_pred CcccccCCCCcEeecccccccccCChhhcccccccccccccccccCCCCCCccccccccceEEecCCcccCCcCCccCCC
Q 037275 115 PTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNL 194 (992)
Q Consensus 115 p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l 194 (992)
|..+..+++|++|++++|+++ .+|...+..+++|++|+|++|.+++..+..|.++++|++|+|++|++.+..+..|..+
T Consensus 76 ~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 154 (251)
T 3m19_A 76 AGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKL 154 (251)
T ss_dssp TTTTTTCTTCCEEECTTSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred HhHhccCCcCCEEECCCCccc-ccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcC
Confidence 888999999999999999998 6777766789999999999999997777778999999999999999977777789999
Q ss_pred CcccEEeccCcccccccCccccccCCCcEEeccCCccCCC
Q 037275 195 RNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGS 234 (992)
Q Consensus 195 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~ 234 (992)
++|++|+|++|++++..+..+..+++|++|++++|.+.+.
T Consensus 155 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 155 TNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp TTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred cCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 9999999999999977777889999999999999998754
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.90 E-value=6.9e-24 Score=226.78 Aligned_cols=181 Identities=25% Similarity=0.243 Sum_probs=115.7
Q ss_pred cCCCcccEEEccCCcCCCCCCccccCCCCCcEEeccCccccccCCCCCCCccccCceeccCCcccCCCCCCccccccccc
Q 037275 368 RNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIE 447 (992)
Q Consensus 368 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 447 (992)
..+++|++|++++|.+++. ..+..+++|++|+|++|++++..+..|..+++|++|++++|++++..+..|..+++|++
T Consensus 60 ~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 137 (272)
T 3rfs_A 60 QYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTY 137 (272)
T ss_dssp GGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCE
T ss_pred ccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCE
Confidence 3444555555555555431 24555555555555555555555555555666666666666666555555555666655
Q ss_pred cccccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeecccccccCCcccccccccceeeccCCc
Q 037275 448 LHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNS 527 (992)
Q Consensus 448 L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~ 527 (992)
|++++| .+++..+..+..+++|++|++++|++++..+..|..+++|+.|+|++|+
T Consensus 138 L~L~~n-------------------------~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 192 (272)
T 3rfs_A 138 LNLAHN-------------------------QLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQ 192 (272)
T ss_dssp EECCSS-------------------------CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EECCCC-------------------------ccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCc
Confidence 533333 3333334445666777777777777776666667777888888888888
Q ss_pred ccccCCccccccCCCCEEECCCcccCCCChhhhhcCCCcceEecCCCcCcccCCC
Q 037275 528 FSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPT 582 (992)
Q Consensus 528 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~ 582 (992)
+++..+..|..+++|++|+|++|.+.+. +++|++|+++.|.++|.+|.
T Consensus 193 l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~ 240 (272)
T 3rfs_A 193 LKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRN 240 (272)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBC
T ss_pred CCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccC
Confidence 8877777778888888888888877643 44678888888888887775
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.3e-22 Score=216.93 Aligned_cols=202 Identities=19% Similarity=0.230 Sum_probs=158.7
Q ss_pred ccccchhhccccccCCCCchhhhccccCceeeeccccccccccccccccCccceEecCCCCCCCCCCCCchhhhhccCCC
Q 037275 243 LPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCT 322 (992)
Q Consensus 243 ~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~ 322 (992)
+.++..+.+..+.+... ..+..+++|+.|++++|.++.. ..+..+++|++|+|++|.++.+ ..+..++
T Consensus 18 ~~~l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~~--------~~l~~l~ 85 (272)
T 3rfs_A 18 FAETIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHDI--------SALKELT 85 (272)
T ss_dssp HHHHHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCCC--------GGGTTCT
T ss_pred HHHHHHHHhcCcccccc--cccccccceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCCc--------hhhcCCC
Confidence 34555566666665544 2356788899999999988743 3478888999999999988763 2467788
Q ss_pred cceEeecCCCcCCCcCCcccccccccceeEEeeCCccccccCCCccCCCcccEEEccCCcCCCCCCccccCCCCCcEEec
Q 037275 323 ELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYL 402 (992)
Q Consensus 323 ~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 402 (992)
+|+.|++++|++.+..+..+..+. +|++|++++|++++..+..|..+++|++|++++|++++..+..|..+++|+.|++
T Consensus 86 ~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 164 (272)
T 3rfs_A 86 NLTYLILTGNQLQSLPNGVFDKLT-NLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDL 164 (272)
T ss_dssp TCCEEECTTSCCCCCCTTTTTTCT-TCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCEEECCCCccCccChhHhcCCc-CCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEEC
Confidence 888888888888877666666654 5888888888888887778888888899999888888777777888888899999
Q ss_pred cCccccccCCCCCCCccccCceeccCCcccCCCCCCccccccccccccccccccc
Q 037275 403 DSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTG 457 (992)
Q Consensus 403 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 457 (992)
++|++++..+..|..+++|+.|++++|++++..+..+..+++|+.|++++|.+.+
T Consensus 165 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 219 (272)
T 3rfs_A 165 SYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC 219 (272)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccc
Confidence 9888887777778888888889998888888777778888888888777666553
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.88 E-value=2.7e-22 Score=211.65 Aligned_cols=181 Identities=23% Similarity=0.224 Sum_probs=126.4
Q ss_pred cccEEEccCCcCCCCCCccccCCCCCcEEeccCccccccCCCCCCCccccCceeccCCcccCCCCCCccccccccccccc
Q 037275 372 NLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMA 451 (992)
Q Consensus 372 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 451 (992)
+.++++++++.++ .+|..+. ++|+.|+|++|++++..+..|.++++|++|+|++|.|++..+..|..+++|++|+++
T Consensus 15 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 91 (251)
T 3m19_A 15 GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA 91 (251)
T ss_dssp GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence 3455666666665 4444433 456666666666666666666666666666666666666566666666666666333
Q ss_pred cccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeecccccccCCcccccccccceeeccCCccccc
Q 037275 452 DIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGS 531 (992)
Q Consensus 452 ~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 531 (992)
+ |++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|+|++.
T Consensus 92 ~-------------------------n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 146 (251)
T 3m19_A 92 N-------------------------NQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSI 146 (251)
T ss_dssp T-------------------------SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred C-------------------------CcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCcc
Confidence 3 333334445566777788888888888766666677888888888888888876
Q ss_pred CCccccccCCCCEEECCCcccCCCChhhhhcCCCcceEecCCCcCcccC
Q 037275 532 IPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEV 580 (992)
Q Consensus 532 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 580 (992)
.+..|..+++|++|+|++|+|++..+..|..+++|++|++++|+|+|.+
T Consensus 147 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~ 195 (251)
T 3m19_A 147 PAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCSR 195 (251)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTTS
T ss_pred CHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCCc
Confidence 6667888888888888888888777777888888888888888888763
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=4.8e-23 Score=224.92 Aligned_cols=200 Identities=18% Similarity=0.211 Sum_probs=148.5
Q ss_pred cceeEEeeCCccccccCCCc--cCCCcccEEEccCCcCCCCCC----ccccCCCCCcEEeccCccccccCCCCCCCcccc
Q 037275 348 TMTDIVIAGNQISGIIPTGI--RNLVNLVELCMDDNKLTGTIP----HAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLL 421 (992)
Q Consensus 348 ~L~~L~l~~n~i~~~~~~~~--~~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 421 (992)
+|++|++++|++++..|..+ ..+++|++|+|++|++++..+ ..+..+++|++|+|++|++++..+..|..+++|
T Consensus 92 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L 171 (310)
T 4glp_A 92 RLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPAL 171 (310)
T ss_dssp CCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTC
T ss_pred ceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCC
Confidence 37777777777777777777 778888888888888876544 344567788888888888887777788888888
Q ss_pred CceeccCCcccCC--C--CCCccccccccccccccccccccCchhhhhhcccccccccccccccCcccc----cccCCCC
Q 037275 422 TNLALSSNDLQGS--I--PPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPL----EVGNLKN 493 (992)
Q Consensus 422 ~~L~L~~N~l~~~--~--~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~----~~~~l~~ 493 (992)
++|+|++|++.+. + +..+..+++|++|++++|+++ .++. .++.+++
T Consensus 172 ~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~--------------------------~l~~~~~~l~~~l~~ 225 (310)
T 4glp_A 172 TSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME--------------------------TPTGVCAALAAAGVQ 225 (310)
T ss_dssp CEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC--------------------------CHHHHHHHHHHHTCC
T ss_pred CEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC--------------------------chHHHHHHHHhcCCC
Confidence 8888888887531 1 233467777877766666554 1222 2467788
Q ss_pred ccEEeeecccccccCCcccccc---cccceeeccCCcccccCCccccccCCCCEEECCCcccCCCChhhhhcCCCcceEe
Q 037275 494 LVYFNISVNRFSGEIPVTLSAC---TSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLN 570 (992)
Q Consensus 494 L~~L~Ls~N~l~~~~~~~~~~l---~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 570 (992)
|++|+|++|++++..|..+..+ ++|++|+|++|+|+ .+|..+. ++|++|+|++|+|++. |. +..+++|+.|+
T Consensus 226 L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~ 300 (310)
T 4glp_A 226 PHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLT 300 (310)
T ss_dssp CSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEE
T ss_pred CCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEE
Confidence 8888888888887767777666 58888888888888 5676664 7888888888888854 33 67788888888
Q ss_pred cCCCcCcc
Q 037275 571 LSYNHFEG 578 (992)
Q Consensus 571 l~~N~l~~ 578 (992)
+++|+|+.
T Consensus 301 L~~N~l~~ 308 (310)
T 4glp_A 301 LDGNPFLV 308 (310)
T ss_dssp CSSTTTSC
T ss_pred CcCCCCCC
Confidence 88888863
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.88 E-value=2.9e-24 Score=240.05 Aligned_cols=86 Identities=15% Similarity=0.051 Sum_probs=56.0
Q ss_pred eeeccCCCCCccCCccccCCCCCCEEEeecccCCCCCC----cccccCC-CCcEeecccccccccCChhhccc----ccc
Q 037275 78 YLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIP----TNLSRCS-NLISFNARRNNLVGEIPAELGYN----WLK 148 (992)
Q Consensus 78 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p----~~l~~l~-~L~~L~l~~n~l~~~~p~~~~~~----l~~ 148 (992)
+++|++|+++|.+|..+...++|++|+|++|++++..+ ..+..++ +|++|++++|++++..+..+... .++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 46788888888778777777778888888888875554 5566666 77777777777775555444321 144
Q ss_pred cccccccccccCCCC
Q 037275 149 LENLTIADNHLTGHF 163 (992)
Q Consensus 149 L~~L~L~~n~l~~~~ 163 (992)
|++|+|++|.+++..
T Consensus 82 L~~L~Ls~n~l~~~~ 96 (362)
T 3goz_A 82 VTSLNLSGNFLSYKS 96 (362)
T ss_dssp CCEEECCSSCGGGSC
T ss_pred ccEEECcCCcCChHH
Confidence 555555555544333
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.88 E-value=2.7e-24 Score=240.41 Aligned_cols=268 Identities=18% Similarity=0.164 Sum_probs=196.3
Q ss_pred eeccccccCCccCCCCCCCCcCCeeeccCCCCCccCC----ccccCCC-CCCEEEeecccCCCCCCcccccC-----CCC
Q 037275 55 LDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIP----HQIGRLV-RLEALVLANNSFSGKIPTNLSRC-----SNL 124 (992)
Q Consensus 55 ldl~~~~l~~~l~~~l~~l~~L~~L~L~~n~l~~~~p----~~~~~l~-~L~~L~Ls~n~l~~~~p~~l~~l-----~~L 124 (992)
.+|+.+.+.+.+|..+...++|++|||++|.+++..+ ..+..++ +|++|+|++|++++..+..+..+ ++|
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L 82 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence 5788899999999888888889999999999996665 7788898 99999999999998878888876 999
Q ss_pred cEeecccccccccCChhhccc---c-cccccccccccccCCCCCCcccc-----ccccceEEecCCcccCC----cCCcc
Q 037275 125 ISFNARRNNLVGEIPAELGYN---W-LKLENLTIADNHLTGHFPASIGN-----LSTLERINVLGNGLWGR----IPNNL 191 (992)
Q Consensus 125 ~~L~l~~n~l~~~~p~~~~~~---l-~~L~~L~L~~n~l~~~~p~~~~~-----l~~L~~L~l~~n~l~~~----~~~~l 191 (992)
++|++++|++++..+..++.. + ++|++|+|++|.+++..+..+.. .++|++|++++|.+.+. ++..+
T Consensus 83 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l 162 (362)
T 3goz_A 83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQIL 162 (362)
T ss_dssp CEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHH
T ss_pred cEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHH
Confidence 999999999997777655432 2 78999999999998766655443 36899999999988643 33334
Q ss_pred CCCC-cccEEeccCcccccccCccccc----c-CCCcEEeccCCccCCCCCccccccccccchhhccccccCCCCchhhh
Q 037275 192 GNLR-NLILLNLGENRFSGIVPPSIFN----I-SSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLS 265 (992)
Q Consensus 192 ~~l~-~L~~L~L~~n~l~~~~p~~l~~----l-~~L~~L~l~~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~ 265 (992)
..++ +|++|+|++|++++..+..+.. + ++|++|+|++|.+.+.... .++..+.
T Consensus 163 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~---------------------~l~~~l~ 221 (362)
T 3goz_A 163 AAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYA---------------------ELAYIFS 221 (362)
T ss_dssp HTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHH---------------------HHHHHHH
T ss_pred hcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHH---------------------HHHHHHh
Confidence 5554 8999999999888665554443 3 5888888888887732111 2344555
Q ss_pred cc-ccCceeeecccccccccc----ccccccCccceEecCCCCCCCCCCCCch-hhhhccCCCcceEeecCCCcCCCcCC
Q 037275 266 NA-SNLVELTLFDNQFRGKVS----IYFRSLKNLEWLNLGSNNLGTGEANDLD-FLTLLTNCTELTAIGLDDNRFGGVLP 339 (992)
Q Consensus 266 ~l-~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~~~~l~~~~~L~~L~l~~n~l~~~~~ 339 (992)
.+ ++|++|+|++|.+++..+ ..+..+++|++|+|++|.+..+....+. ....+..+++|+.|++++|++....+
T Consensus 222 ~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~ 301 (362)
T 3goz_A 222 SIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHS 301 (362)
T ss_dssp HSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGC
T ss_pred cCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcch
Confidence 53 478888888888776544 3345667788888888876555543222 22345667777788888887776544
Q ss_pred cccc
Q 037275 340 HSIA 343 (992)
Q Consensus 340 ~~~~ 343 (992)
..+.
T Consensus 302 ~~~~ 305 (362)
T 3goz_A 302 IPIS 305 (362)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 4433
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.7e-22 Score=211.64 Aligned_cols=200 Identities=18% Similarity=0.213 Sum_probs=135.1
Q ss_pred ccceeEEeeCCccccccCCCccCCCcccEEEccCCc-CCCCCCccccCCCCCcEEeccC-ccccccCCCCCCCccccCce
Q 037275 347 STMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNK-LTGTIPHAIGELKNLQLLYLDS-NFLAGGIPTSLGNLTLLTNL 424 (992)
Q Consensus 347 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L 424 (992)
..+++|++++|+++++.+..|.++++|++|++++|+ ++++.+..|..+++|++|++++ |++++..+..|.++++|++|
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence 357777888888877777777788888888888886 7756666777788888888887 77776666677777778888
Q ss_pred eccCCcccCCCCCCccccccccccccccccccccCchhhhhhcccccccccccc-cccCcccccccCCCCcc-EEeeecc
Q 037275 425 ALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYN-LLSGTLPLEVGNLKNLV-YFNISVN 502 (992)
Q Consensus 425 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N-~l~~~~~~~~~~l~~L~-~L~Ls~N 502 (992)
++++|++++ +|. |..+++|+.| ..|++++| .+++..+..|..+++|+ +|++++|
T Consensus 111 ~l~~n~l~~-lp~-~~~l~~L~~L----------------------~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n 166 (239)
T 2xwt_C 111 GIFNTGLKM-FPD-LTKVYSTDIF----------------------FILEITDNPYMTSIPVNAFQGLCNETLTLKLYNN 166 (239)
T ss_dssp EEEEECCCS-CCC-CTTCCBCCSE----------------------EEEEEESCTTCCEECTTTTTTTBSSEEEEECCSC
T ss_pred eCCCCCCcc-ccc-cccccccccc----------------------cEEECCCCcchhhcCcccccchhcceeEEEcCCC
Confidence 888887774 554 6666666511 12244455 45444445566777777 7777777
Q ss_pred cccccCCcccccccccceeeccCCc-ccccCCcccccc-CCCCEEECCCcccCCCChhhhhcCCCcceEecCCC
Q 037275 503 RFSGEIPVTLSACTSLQQLYLQGNS-FSGSIPSSLSSL-KSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYN 574 (992)
Q Consensus 503 ~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 574 (992)
+++.+.+..|.. ++|+.|+|++|+ +++..+..|.++ ++|+.|+|++|+|++. |.. .+++|+.|+++++
T Consensus 167 ~l~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l-~~~--~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 167 GFTSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTAL-PSK--GLEHLKELIARNT 236 (239)
T ss_dssp CCCEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCC-CCT--TCTTCSEEECTTC
T ss_pred CCcccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccC-Chh--HhccCceeeccCc
Confidence 777444444444 677777777774 776556667777 7777777777777643 332 4566777777655
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.87 E-value=2.4e-24 Score=238.75 Aligned_cols=273 Identities=18% Similarity=0.202 Sum_probs=141.1
Q ss_pred CCCCCceEeeEEcCCCCeEEEeeccccccCCccCCCCCCC--CcCCeeeccCCCCCccCCccccCCCCCCEEEeecccCC
Q 037275 34 STNLCQWTGVTCGHRHQRVTKLDLSNRTIGGTLSPYVGNL--SFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFS 111 (992)
Q Consensus 34 ~~~~c~w~gv~c~~~~~~v~~ldl~~~~l~~~l~~~l~~l--~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~ 111 (992)
+.-|.+|.++.|+. ..++.+|++++.+. +..+..+ ++++.|++++|.+.+..|. +..+++|++|+|++|.++
T Consensus 33 ~~vc~~W~~~~~~~--~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~ 106 (336)
T 2ast_B 33 SGVCKRWYRLASDE--SLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIE 106 (336)
T ss_dssp TSSCHHHHHHHTCS--TTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEEC
T ss_pred HHHHHHHHHHhcCc--hhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcC
Confidence 44556899998853 34567777777654 3445555 6677777777777654443 556677777777777666
Q ss_pred CC-CCcccccCCCCcEeecccccccccCChhhccccccccccccccc-ccCCCCCCccccccccceEEecCCcccCCcCC
Q 037275 112 GK-IPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADN-HLTGHFPASIGNLSTLERINVLGNGLWGRIPN 189 (992)
Q Consensus 112 ~~-~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~~L~L~~n-~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~ 189 (992)
+. +|..+..+++|++|++++|++++..|..+. .+++|++|+|++| .+++. .++.
T Consensus 107 ~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~-~~~~L~~L~L~~~~~l~~~-----------------------~l~~ 162 (336)
T 2ast_B 107 VSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLA-KNSNLVRLNLSGCSGFSEF-----------------------ALQT 162 (336)
T ss_dssp HHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHT-TCTTCSEEECTTCBSCCHH-----------------------HHHH
T ss_pred HHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHh-cCCCCCEEECCCCCCCCHH-----------------------HHHH
Confidence 44 555666666666666666665544444443 3455555555554 33321 1333
Q ss_pred ccCCCCcccEEeccCc-ccccc-cCccccccC-CCcEEeccCCc--cCCCCCccccccccccchhhccccccCCCCchhh
Q 037275 190 NLGNLRNLILLNLGEN-RFSGI-VPPSIFNIS-SLENVFLPTNR--FNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESL 264 (992)
Q Consensus 190 ~l~~l~~L~~L~L~~n-~l~~~-~p~~l~~l~-~L~~L~l~~N~--l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l 264 (992)
.+.++++|++|+|++| .+++. ++..+..++ +|++|++++|. ++. +.+|..+
T Consensus 163 ~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~------------------------~~l~~~~ 218 (336)
T 2ast_B 163 LLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQK------------------------SDLSTLV 218 (336)
T ss_dssp HHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCH------------------------HHHHHHH
T ss_pred HHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCH------------------------HHHHHHH
Confidence 3444555555555555 55432 344445555 55555555552 210 0123333
Q ss_pred hccccCceeeecccc-ccccccccccccCccceEecCCCCCCCCCCCCchhhhhccCCCcceEeecCCCcCCCcCCcccc
Q 037275 265 SNASNLVELTLFDNQ-FRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIA 343 (992)
Q Consensus 265 ~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~ 343 (992)
..+++|++|++++|. +++..+..+..+++|++|+|++|. .+.. ..+..+..+++|+.|++++| +. ...+.
T Consensus 219 ~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~--~~~~---~~~~~l~~~~~L~~L~l~~~-i~---~~~~~ 289 (336)
T 2ast_B 219 RRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY--DIIP---ETLLELGEIPTLKTLQVFGI-VP---DGTLQ 289 (336)
T ss_dssp HHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCT--TCCG---GGGGGGGGCTTCCEEECTTS-SC---TTCHH
T ss_pred hhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCC--CCCH---HHHHHHhcCCCCCEEeccCc-cC---HHHHH
Confidence 444455555555554 443444444445555555555553 1111 11123344555555555555 21 11233
Q ss_pred cccccceeEEeeCCccccccCCCccC
Q 037275 344 NLSSTMTDIVIAGNQISGIIPTGIRN 369 (992)
Q Consensus 344 ~l~~~L~~L~l~~n~i~~~~~~~~~~ 369 (992)
.+...+..|++++|++++..|..+++
T Consensus 290 ~l~~~l~~L~l~~n~l~~~~~~~~~~ 315 (336)
T 2ast_B 290 LLKEALPHLQINCSHFTTIARPTIGN 315 (336)
T ss_dssp HHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred HHHhhCcceEEecccCccccCCcccc
Confidence 33334555666666666666655553
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.3e-22 Score=221.63 Aligned_cols=226 Identities=17% Similarity=0.132 Sum_probs=146.2
Q ss_pred cCCeeeccCCCCCcc-CCc--cccCCCCCCEEEeecccCCCCCCccc--ccCCCCcEeecccccccccCC----hhhccc
Q 037275 75 FLRYLNLADNNFHGE-IPH--QIGRLVRLEALVLANNSFSGKIPTNL--SRCSNLISFNARRNNLVGEIP----AELGYN 145 (992)
Q Consensus 75 ~L~~L~L~~n~l~~~-~p~--~~~~l~~L~~L~Ls~n~l~~~~p~~l--~~l~~L~~L~l~~n~l~~~~p----~~~~~~ 145 (992)
.++.|.+.++.+... +.. .+..+++|++|+|++|++++..|..+ +.+++|++|++++|++++..+ ..+. .
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~-~ 143 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQW-L 143 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTT-B
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhh-h
Confidence 467788888777632 111 12345679999999999988888887 888899999999998886555 2223 5
Q ss_pred ccccccccccccccCCCCCCccccccccceEEecCCcccCC--c--CCccCCCCcccEEeccCcccccccCc----cccc
Q 037275 146 WLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGR--I--PNNLGNLRNLILLNLGENRFSGIVPP----SIFN 217 (992)
Q Consensus 146 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~--~--~~~l~~l~~L~~L~L~~n~l~~~~p~----~l~~ 217 (992)
+++|++|+|++|.+++..|..++++++|++|++++|++.+. + +..++.+++|++|+|++|+++. ++. .+..
T Consensus 144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~ 222 (310)
T 4glp_A 144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAA 222 (310)
T ss_dssp CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHH
T ss_pred ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhc
Confidence 77888888888888877777888888888888888886442 2 2234677888888888888862 232 2456
Q ss_pred cCCCcEEeccCCccCCCCCccccccccccchhhccccccCCCCchhhhccccCceeeeccccccccccccccccCccceE
Q 037275 218 ISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWL 297 (992)
Q Consensus 218 l~~L~~L~l~~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 297 (992)
+++|++|+|++|++.+..|..++... .+++|++|+|++|+|+.. |..+. ++|++|
T Consensus 223 l~~L~~L~Ls~N~l~~~~p~~~~~~~----------------------~~~~L~~L~Ls~N~l~~l-p~~~~--~~L~~L 277 (310)
T 4glp_A 223 GVQPHSLDLSHNSLRATVNPSAPRCM----------------------WSSALNSLNLSFAGLEQV-PKGLP--AKLRVL 277 (310)
T ss_dssp TCCCSSEECTTSCCCCCCCSCCSSCC----------------------CCTTCCCEECCSSCCCSC-CSCCC--SCCSCE
T ss_pred CCCCCEEECCCCCCCccchhhHHhcc----------------------CcCcCCEEECCCCCCCch-hhhhc--CCCCEE
Confidence 77888888888877755454332211 113555555555555532 32222 455555
Q ss_pred ecCCCCCCCCCCCCchhhhhccCCCcceEeecCCCcCC
Q 037275 298 NLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFG 335 (992)
Q Consensus 298 ~L~~N~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~l~ 335 (992)
+|++|+++.++. +..+++|+.|++++|+++
T Consensus 278 ~Ls~N~l~~~~~--------~~~l~~L~~L~L~~N~l~ 307 (310)
T 4glp_A 278 DLSSNRLNRAPQ--------PDELPEVDNLTLDGNPFL 307 (310)
T ss_dssp ECCSCCCCSCCC--------TTSCCCCSCEECSSTTTS
T ss_pred ECCCCcCCCCch--------hhhCCCccEEECcCCCCC
Confidence 555555554321 234455556666666554
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.1e-22 Score=210.99 Aligned_cols=206 Identities=16% Similarity=0.159 Sum_probs=172.7
Q ss_pred cccccCCCccCCCcccEEEccCCcCCCCCCccccCCCCCcEEeccCcc-ccccCCCCCCCccccCceeccC-CcccCCCC
Q 037275 359 ISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNF-LAGGIPTSLGNLTLLTNLALSS-NDLQGSIP 436 (992)
Q Consensus 359 i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~ 436 (992)
++ .+|. +. .+|++|++++|++++..+..|..+++|++|++++|+ +++..+..|.++++|++|++++ |++++..+
T Consensus 23 l~-~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~ 98 (239)
T 2xwt_C 23 IQ-RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDP 98 (239)
T ss_dssp CS-SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECT
T ss_pred cc-ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCH
Confidence 44 3455 43 389999999999997777799999999999999997 8877777899999999999998 99997777
Q ss_pred CCccccccccccccccccccccCchhhhhhcccccccccccccccCcccccccCCCCcc---EEeeecc-cccccCCccc
Q 037275 437 PSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLV---YFNISVN-RFSGEIPVTL 512 (992)
Q Consensus 437 ~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~---~L~Ls~N-~l~~~~~~~~ 512 (992)
..|..+++|++|++++|+++ .+|. |..+++|+ +|++++| ++++..+..|
T Consensus 99 ~~f~~l~~L~~L~l~~n~l~--------------------------~lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~ 151 (239)
T 2xwt_C 99 DALKELPLLKFLGIFNTGLK--------------------------MFPD-LTKVYSTDIFFILEITDNPYMTSIPVNAF 151 (239)
T ss_dssp TSEECCTTCCEEEEEEECCC--------------------------SCCC-CTTCCBCCSEEEEEEESCTTCCEECTTTT
T ss_pred HHhCCCCCCCEEeCCCCCCc--------------------------cccc-cccccccccccEEECCCCcchhhcCcccc
Confidence 88999999999866666555 2444 66777777 9999999 9998888889
Q ss_pred ccccccc-eeeccCCcccccCCccccccCCCCEEECCCcc-cCCCChhhhhcC-CCcceEecCCCcCcccCCCCCccCCc
Q 037275 513 SACTSLQ-QLYLQGNSFSGSIPSSLSSLKSIKELDMSSNN-LSGQIPEYLENL-SFLEYLNLSYNHFEGEVPTKGVFSNK 589 (992)
Q Consensus 513 ~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l-~~L~~L~l~~N~l~~~~~~~~~~~~~ 589 (992)
.++++|+ +|++++|+++...+..|.. ++|++|+|++|+ +++..+..|..+ ++|+.|++++|++++.++. .++.+
T Consensus 152 ~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~--~~~~L 228 (239)
T 2xwt_C 152 QGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK--GLEHL 228 (239)
T ss_dssp TTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT--TCTTC
T ss_pred cchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh--HhccC
Confidence 9999999 9999999999544445555 899999999995 997778889999 9999999999999976654 68888
Q ss_pred ccccccCCC
Q 037275 590 TGISLSGNG 598 (992)
Q Consensus 590 ~~~~l~~N~ 598 (992)
+.+.+.++.
T Consensus 229 ~~L~l~~~~ 237 (239)
T 2xwt_C 229 KELIARNTW 237 (239)
T ss_dssp SEEECTTC-
T ss_pred ceeeccCcc
Confidence 888887653
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.87 E-value=2.7e-24 Score=243.00 Aligned_cols=258 Identities=18% Similarity=0.250 Sum_probs=176.3
Q ss_pred CCchhhhccccCceeeecccccccccccc----ccccCccceEecCCCCCCCCCCCCchhhhhccCCCcceEeecCCCcC
Q 037275 259 SIPESLSNASNLVELTLFDNQFRGKVSIY----FRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRF 334 (992)
Q Consensus 259 ~~p~~l~~l~~L~~L~L~~N~l~~~~~~~----~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~l 334 (992)
.++..+..+++|++|+|++|.+++..+.. |..+++|++|+|++|.+.. +
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~---------------------------l 75 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGR---------------------------V 75 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTS---------------------------C
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCc---------------------------c
Confidence 45667888888888888888888664433 5567777777777765543 2
Q ss_pred CCcCCcccccccccceeEEeeCCccccccCCCccCCCcccEEEccCCcCCC----CCCccccCCCCCcEEeccCcccccc
Q 037275 335 GGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTG----TIPHAIGELKNLQLLYLDSNFLAGG 410 (992)
Q Consensus 335 ~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~ 410 (992)
.+.+|..+..+ ...+..+++|++|+|++|.+++ .++..+..+++|++|+|++|.+++.
T Consensus 76 ~~~~~~~~~~l------------------~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~ 137 (386)
T 2ca6_A 76 KDEIPEALRLL------------------LQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQ 137 (386)
T ss_dssp GGGSHHHHHHH------------------HHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHH
T ss_pred ccchhHHHHHH------------------HHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHH
Confidence 22333332211 1234566777788888887775 3566677777888888888877643
Q ss_pred CCCCCC----Cc---------cccCceeccCCccc-CCCC---CCccccccccccccccccccccCchhhhhhccccccc
Q 037275 411 IPTSLG----NL---------TLLTNLALSSNDLQ-GSIP---PSLGNCKNLIELHMADIELTGALPPQILSISTLSLSL 473 (992)
Q Consensus 411 ~~~~~~----~l---------~~L~~L~L~~N~l~-~~~~---~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L 473 (992)
.+..+. .+ ++|++|+|++|+++ ..++ ..+..+++|+.|++++|+++..
T Consensus 138 ~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~--------------- 202 (386)
T 2ca6_A 138 AGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE--------------- 202 (386)
T ss_dssp HHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHH---------------
T ss_pred HHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHh---------------
Confidence 332222 23 67777788777776 2233 2455666677666555554410
Q ss_pred ccccccccCcccccccCCCCccEEeeeccccc----ccCCcccccccccceeeccCCccccc----CCccc--cccCCCC
Q 037275 474 DLSYNLLSGTLPLEVGNLKNLVYFNISVNRFS----GEIPVTLSACTSLQQLYLQGNSFSGS----IPSSL--SSLKSIK 543 (992)
Q Consensus 474 ~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~----~~~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~--~~l~~L~ 543 (992)
.+....+..+..+++|++|+|++|.++ +.+|..+..+++|+.|+|++|+|++. ++..+ +.+++|+
T Consensus 203 -----g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~ 277 (386)
T 2ca6_A 203 -----GIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQ 277 (386)
T ss_dssp -----HHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCC
T ss_pred -----HHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeE
Confidence 000023346778889999999999986 56778888899999999999999865 45666 3489999
Q ss_pred EEECCCcccCC----CChhhh-hcCCCcceEecCCCcCcccCC
Q 037275 544 ELDMSSNNLSG----QIPEYL-ENLSFLEYLNLSYNHFEGEVP 581 (992)
Q Consensus 544 ~L~Ls~N~l~~----~~p~~~-~~l~~L~~L~l~~N~l~~~~~ 581 (992)
+|+|++|+|++ .+|..+ .++++|++|++++|++++..+
T Consensus 278 ~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 278 TLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp EEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred EEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 99999999986 477777 668999999999999886543
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.86 E-value=2.6e-22 Score=233.97 Aligned_cols=208 Identities=21% Similarity=0.282 Sum_probs=139.0
Q ss_pred CCCCcCCCCCC-----ceEee-EEcCCCCeEEEeeccccccCCccCCCCCCCCcCCeeeccCCCCCccCCccccCCCCCC
Q 037275 28 TSSWNNSTNLC-----QWTGV-TCGHRHQRVTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLE 101 (992)
Q Consensus 28 ~~~w~~~~~~c-----~w~gv-~c~~~~~~v~~ldl~~~~l~~~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~ 101 (992)
+.+|..+.++| .|.|+ +|.. .+++.|||+++.+.+ +|+.+. ++|++|+|++|+++ .+| ..+++|+
T Consensus 33 l~~W~~~~~~~~~~~~~~~~l~~C~~--~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~ 103 (571)
T 3cvr_A 33 WDKWEKQALPGENRNEAVSLLKECLI--NQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLE 103 (571)
T ss_dssp HHHHHTTCCTTCCHHHHHHHHHHHHH--TTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCC
T ss_pred HHHHhccCCccccccchhhhcccccc--CCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCC
Confidence 45677677788 79999 7853 358888898888865 777663 78888888888888 677 4578888
Q ss_pred EEEeecccCCCCCCcccccCCCCcEeecccccccccCChhhcccccccccccccccccCCCCCCccccccccceEEecCC
Q 037275 102 ALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGN 181 (992)
Q Consensus 102 ~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n 181 (992)
+|+|++|+|++ +|. +.. +|++|++++|++++ +|. .+++|++|+|++|.+++ +|. .+++|++|+|++|
T Consensus 104 ~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~----~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N 170 (571)
T 3cvr_A 104 YLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE----LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNN 170 (571)
T ss_dssp EEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC----CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSS
T ss_pred EEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC----cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCC
Confidence 88888888884 777 554 78888888887774 665 35667777777777764 554 4566666666666
Q ss_pred cccCCcCCccCCCCcccEEeccCcccccccCccccccCCC-------cEEeccCCccCCCCCccccccccccchhhcccc
Q 037275 182 GLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSL-------ENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAEN 254 (992)
Q Consensus 182 ~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L-------~~L~l~~N~l~~~~~~~~~~~~~~L~~l~l~~n 254 (992)
.+.+ +|. |. ++|+.|+|++|+|+ .+|. +.. +| +.|+|++|+|+
T Consensus 171 ~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~---------------------- 220 (571)
T 3cvr_A 171 QLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT---------------------- 220 (571)
T ss_dssp CCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC----------------------
T ss_pred CCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce----------------------
Confidence 6644 555 44 66666666666666 4454 333 44 44555444444
Q ss_pred ccCCCCchhhhccccCceeeecccccccccccccccc
Q 037275 255 NFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSL 291 (992)
Q Consensus 255 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l 291 (992)
.+|..+..+++|++|+|++|.+++..|..|..+
T Consensus 221 ----~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l 253 (571)
T 3cvr_A 221 ----HIPENILSLDPTCTIILEDNPLSSRIRESLSQQ 253 (571)
T ss_dssp ----CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHH
T ss_pred ----ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHh
Confidence 345555556666666666666666665555443
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.86 E-value=9.8e-23 Score=225.76 Aligned_cols=254 Identities=18% Similarity=0.245 Sum_probs=179.4
Q ss_pred CCEEEeecccCCCCCCcccccC--CCCcEeecccccccccCChhhcccccccccccccccccCCC-CCCccccccccceE
Q 037275 100 LEALVLANNSFSGKIPTNLSRC--SNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGH-FPASIGNLSTLERI 176 (992)
Q Consensus 100 L~~L~Ls~n~l~~~~p~~l~~l--~~L~~L~l~~n~l~~~~p~~~~~~l~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L 176 (992)
++.|++++|.+. |..+..+ ++++.|++++|.+.+..+. ++ .+++|++|+|++|.+++. +|..+..+++|++|
T Consensus 49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~-~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L 123 (336)
T 2ast_B 49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HF-SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL 123 (336)
T ss_dssp SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CC-CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hc-cCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence 344444444443 2333333 4444555555444433332 22 355566666666665543 56667778888888
Q ss_pred EecCCcccCCcCCccCCCCcccEEeccCc-ccccc-cCccccccCCCcEEeccCC-ccCCCCCccccccccccchhhccc
Q 037275 177 NVLGNGLWGRIPNNLGNLRNLILLNLGEN-RFSGI-VPPSIFNISSLENVFLPTN-RFNGSLPLDIGVSLPKLLGFIVAE 253 (992)
Q Consensus 177 ~l~~n~l~~~~~~~l~~l~~L~~L~L~~n-~l~~~-~p~~l~~l~~L~~L~l~~N-~l~~~~~~~~~~~~~~L~~l~l~~ 253 (992)
++++|.+.+..+..++.+++|++|+|++| .+++. ++..+..+++|++|++++| .+++.
T Consensus 124 ~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~------------------- 184 (336)
T 2ast_B 124 SLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEK------------------- 184 (336)
T ss_dssp ECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHH-------------------
T ss_pred eCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChH-------------------
Confidence 88888887778888899999999999999 68753 6777889999999999999 77621
Q ss_pred cccCCCCchhhhccc-cCceeeeccc--ccc-ccccccccccCccceEecCCCC-CCCCCCCCchhhhhccCCCcceEee
Q 037275 254 NNFAGSIPESLSNAS-NLVELTLFDN--QFR-GKVSIYFRSLKNLEWLNLGSNN-LGTGEANDLDFLTLLTNCTELTAIG 328 (992)
Q Consensus 254 n~l~~~~p~~l~~l~-~L~~L~L~~N--~l~-~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~~~~l~~~~~L~~L~ 328 (992)
.++..+..++ +|++|++++| .++ +..+..+..+++|++|+|++|. ++.. .+..+..+++|+.|+
T Consensus 185 -----~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~------~~~~l~~l~~L~~L~ 253 (336)
T 2ast_B 185 -----HVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKND------CFQEFFQLNYLQHLS 253 (336)
T ss_dssp -----HHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGG------GGGGGGGCTTCCEEE
T ss_pred -----HHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHH------HHHHHhCCCCCCEee
Confidence 1355678889 9999999999 455 4556778899999999999998 5542 344677889999999
Q ss_pred cCCCc-CCCcCCcccccccccceeEEeeCCccccccCCCccCC-CcccEEEccCCcCCCCCCccccC
Q 037275 329 LDDNR-FGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNL-VNLVELCMDDNKLTGTIPHAIGE 393 (992)
Q Consensus 329 l~~n~-l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~ 393 (992)
+++|. +.......+..+ ++|+.|++++| ++ ...+..+ ..+..|++++|++++..|..++.
T Consensus 254 l~~~~~~~~~~~~~l~~~-~~L~~L~l~~~-i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~~~~~ 315 (336)
T 2ast_B 254 LSRCYDIIPETLLELGEI-PTLKTLQVFGI-VP---DGTLQLLKEALPHLQINCSHFTTIARPTIGN 315 (336)
T ss_dssp CTTCTTCCGGGGGGGGGC-TTCCEEECTTS-SC---TTCHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred CCCCCCCCHHHHHHHhcC-CCCCEEeccCc-cC---HHHHHHHHhhCcceEEecccCccccCCcccc
Confidence 99996 332222245554 46999999999 33 3345555 34888889999999999988775
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=6.1e-22 Score=211.62 Aligned_cols=162 Identities=18% Similarity=0.128 Sum_probs=123.9
Q ss_pred HHHHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC------------------CchhHHHHHHHHHHhccC
Q 037275 674 LSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK------------------GASNGFVAECQALRNIRH 735 (992)
Q Consensus 674 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h 735 (992)
+......|++.+.||+|+||.||+|.+ .+|+.||+|+++.... .....+.+|+.++++++|
T Consensus 85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~ 163 (282)
T 1zar_A 85 LVRSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG 163 (282)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT
T ss_pred HHhCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC
Confidence 334445677779999999999999999 6899999999963321 123568899999999985
Q ss_pred CcceeEEEEeecccccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecc
Q 037275 736 RNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGD 815 (992)
Q Consensus 736 ~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~D 815 (992)
+++..+++. +..++||||+++|+|.+ +.. .....++.|++.||+|||++ +|+|||
T Consensus 164 ~~v~~~~~~---------~~~~lvmE~~~g~~L~~-l~~------------~~~~~i~~qi~~~l~~lH~~---giiHrD 218 (282)
T 1zar_A 164 LAVPKVYAW---------EGNAVLMELIDAKELYR-VRV------------ENPDEVLDMILEEVAKFYHR---GIVHGD 218 (282)
T ss_dssp SSSCCEEEE---------ETTEEEEECCCCEEGGG-CCC------------SCHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred CCcCeEEec---------cceEEEEEecCCCcHHH-cch------------hhHHHHHHHHHHHHHHHHHC---CCEeCC
Confidence 444443321 23489999999999988 421 12346999999999999999 999999
Q ss_pred CCCCCeeeCCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccC----------CCcCcccchhh
Q 037275 816 LKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG----------GEASMTGDVYS 883 (992)
Q Consensus 816 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~DiwS 883 (992)
|||+||+++ ++.+||+|||+|+. +..|+|||++.. ..|...+|+|.
T Consensus 219 lkp~NILl~-~~~vkl~DFG~a~~---------------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 219 LSQYNVLVS-EEGIWIIDFPQSVE---------------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp CSTTSEEEE-TTEEEECCCTTCEE---------------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred CCHHHEEEE-CCcEEEEECCCCeE---------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 999999999 99999999999973 345789998653 34555566654
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.85 E-value=2.5e-21 Score=210.68 Aligned_cols=191 Identities=27% Similarity=0.402 Sum_probs=135.5
Q ss_pred ceeEEeeCCccccccCCCccCCCcccEEEccCCcCCCCCCccccCCCCCcEEeccCccccccCCCCCCCccccCceeccC
Q 037275 349 MTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSS 428 (992)
Q Consensus 349 L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 428 (992)
|++|++++|.++.. + .+..+++|++|+|++|++++..+ +..+++|++|+|++|++++. + .+..+++|+.|++++
T Consensus 43 L~~L~l~~~~i~~l-~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~l~~ 116 (308)
T 1h6u_A 43 ITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV-S-AIAGLQSIKTLDLTS 116 (308)
T ss_dssp CCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC-G-GGTTCTTCCEEECTT
T ss_pred cCEEEeeCCCccCc-h-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc-h-hhcCCCCCCEEECCC
Confidence 44455555555432 2 46677778888888887774433 77777888888888887743 2 577777888888888
Q ss_pred CcccCCCCCCccccccccccccccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeecccccccC
Q 037275 429 NDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEI 508 (992)
Q Consensus 429 N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 508 (992)
|++++ ++ .+..+++|++|++++|+++ +..+ +..+++|++|+|++|++++..
T Consensus 117 n~l~~-~~-~l~~l~~L~~L~l~~n~l~-------------------------~~~~--l~~l~~L~~L~l~~n~l~~~~ 167 (308)
T 1h6u_A 117 TQITD-VT-PLAGLSNLQVLYLDLNQIT-------------------------NISP--LAGLTNLQYLSIGNAQVSDLT 167 (308)
T ss_dssp SCCCC-CG-GGTTCTTCCEEECCSSCCC-------------------------CCGG--GGGCTTCCEEECCSSCCCCCG
T ss_pred CCCCC-ch-hhcCCCCCCEEECCCCccC-------------------------cCcc--ccCCCCccEEEccCCcCCCCh
Confidence 88775 33 2677777777755555444 2222 667788888888888888544
Q ss_pred CcccccccccceeeccCCcccccCCccccccCCCCEEECCCcccCCCChhhhhcCCCcceEecCCCcCcccC
Q 037275 509 PVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEV 580 (992)
Q Consensus 509 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 580 (992)
+ +..+++|+.|+|++|++++..+ +..+++|++|+|++|++++..| +..+++|+.|++++|++++.+
T Consensus 168 ~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~~~ 233 (308)
T 1h6u_A 168 P--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQP 233 (308)
T ss_dssp G--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEECCC
T ss_pred h--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeecCC
Confidence 3 7888888888888888885433 7888888888888888885543 778888888888888887643
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.85 E-value=2.7e-21 Score=214.74 Aligned_cols=242 Identities=19% Similarity=0.159 Sum_probs=149.5
Q ss_pred CceEeeEEcCCCCeEEEeeccccccCCccCCCCCCCCcCCeeeccCCCCCccCC-ccccCCCCCCEEEeecccCCCCCCc
Q 037275 38 CQWTGVTCGHRHQRVTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIP-HQIGRLVRLEALVLANNSFSGKIPT 116 (992)
Q Consensus 38 c~w~gv~c~~~~~~v~~ldl~~~~l~~~l~~~l~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~Ls~n~l~~~~p~ 116 (992)
|.|..|.|+. +++ ..+|..+ .+++++|+|++|+|+ .+| ..|.++++|++|+|++|++.+.+|.
T Consensus 9 C~~~~v~C~~------------~~L-t~iP~~l--~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~ 72 (350)
T 4ay9_X 9 CSNRVFLCQE------------SKV-TEIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEA 72 (350)
T ss_dssp EETTEEEEES------------TTC-CSCCTTC--CTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECT
T ss_pred eeCCEEEecC------------CCC-CccCcCc--CCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccCh
Confidence 6777777743 334 3566655 357888888888888 455 4678888888888888887656654
Q ss_pred -ccccCCCCcE-eecccccccccCChhhcccccccccccccccccCCCCCCccccccccceEEecC-CcccCCcCCccCC
Q 037275 117 -NLSRCSNLIS-FNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLG-NGLWGRIPNNLGN 193 (992)
Q Consensus 117 -~l~~l~~L~~-L~l~~n~l~~~~p~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~-n~l~~~~~~~l~~ 193 (992)
.|.++++|+. +.++.|+++ .+|+..+..+++|++|++++|+++...+..+....++..|++.+ |.+....+..|..
T Consensus 73 ~~f~~L~~l~~~l~~~~N~l~-~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~ 151 (350)
T 4ay9_X 73 DVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVG 151 (350)
T ss_dssp TSBCSCTTCCEEEEEEETTCC-EECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTT
T ss_pred hHhhcchhhhhhhcccCCccc-ccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhh
Confidence 4567777664 445556666 55555555666777777777777655555555566666666654 3453333344555
Q ss_pred CC-cccEEeccCcccccccCccccccCCCcEEeccC-CccCCCCCccccccccccchhhccccccCCCCchhhhccccCc
Q 037275 194 LR-NLILLNLGENRFSGIVPPSIFNISSLENVFLPT-NRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLV 271 (992)
Q Consensus 194 l~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~-N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~ 271 (992)
+. .++.|+|++|+|+ .+|...+...+|++|++++ |.++ .+| +..|..+++|+
T Consensus 152 ~~~~l~~L~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n~l~-~i~------------------------~~~f~~l~~L~ 205 (350)
T 4ay9_X 152 LSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELP------------------------NDVFHGASGPV 205 (350)
T ss_dssp SBSSCEEEECCSSCCC-EECTTSSTTEEEEEEECTTCTTCC-CCC------------------------TTTTTTEECCS
T ss_pred cchhhhhhcccccccc-CCChhhccccchhHHhhccCCccc-CCC------------------------HHHhccCcccc
Confidence 43 4666666666666 3444444445566666553 2232 222 34567777888
Q ss_pred eeeeccccccccccccccccCccceEecCCCCCCCCCCCCchhhhhccCCCcceEeecCCC
Q 037275 272 ELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDN 332 (992)
Q Consensus 272 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n 332 (992)
+|+|++|+|+..++..|.++++|+.+++ ++++.++ .+.++++|+.++++++
T Consensus 206 ~LdLs~N~l~~lp~~~~~~L~~L~~l~~--~~l~~lP--------~l~~l~~L~~l~l~~~ 256 (350)
T 4ay9_X 206 ILDISRTRIHSLPSYGLENLKKLRARST--YNLKKLP--------TLEKLVALMEASLTYP 256 (350)
T ss_dssp EEECTTSCCCCCCSSSCTTCCEEECTTC--TTCCCCC--------CTTTCCSCCEEECSCH
T ss_pred hhhcCCCCcCccChhhhccchHhhhccC--CCcCcCC--------CchhCcChhhCcCCCC
Confidence 8888888888766666665555554443 3344433 3566777788877653
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.85 E-value=2.7e-21 Score=210.34 Aligned_cols=148 Identities=20% Similarity=0.324 Sum_probs=72.8
Q ss_pred CCCcCCeeeccCCCCCccCCccccCCCCCCEEEeecccCCCCCCcccccCCCCcEeecccccccccCChhhccccccccc
Q 037275 72 NLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLEN 151 (992)
Q Consensus 72 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~~ 151 (992)
.+++|++|++++|.++ .+| .+..+++|++|+|++|+++ .+|. +..+++|++|++++|+++ .++ .+ ..+++|++
T Consensus 39 ~l~~L~~L~l~~~~i~-~l~-~~~~l~~L~~L~L~~n~i~-~~~~-~~~l~~L~~L~L~~n~l~-~~~-~~-~~l~~L~~ 111 (308)
T 1h6u_A 39 DLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQIT-DLAP-LKNLTKITELELSGNPLK-NVS-AI-AGLQSIKT 111 (308)
T ss_dssp HHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCC-CCGG-GTTCCSCCEEECCSCCCS-CCG-GG-TTCTTCCE
T ss_pred HcCCcCEEEeeCCCcc-Cch-hhhccCCCCEEEccCCcCC-CChh-HccCCCCCEEEccCCcCC-Cch-hh-cCCCCCCE
Confidence 4556666666666665 344 4566666666666666665 3333 556666666666666555 222 12 23444555
Q ss_pred ccccccccCCCCCCccccccccceEEecCCcccCCcCCccCCCCcccEEeccCcccccccCccccccCCCcEEeccCCcc
Q 037275 152 LTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRF 231 (992)
Q Consensus 152 L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l 231 (992)
|++++|.+++ +| .+..+++|++|++++|.+.+..+ +..+++|+.|+|++|++++. +. +..+++|++|++++|++
T Consensus 112 L~l~~n~l~~-~~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l 185 (308)
T 1h6u_A 112 LDLTSTQITD-VT-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDL-TP-LANLSKLTTLKADDNKI 185 (308)
T ss_dssp EECTTSCCCC-CG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCC
T ss_pred EECCCCCCCC-ch-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCC-hh-hcCCCCCCEEECCCCcc
Confidence 5555555443 22 14444444444444444432221 44444444444444444421 21 44444444444444444
Q ss_pred C
Q 037275 232 N 232 (992)
Q Consensus 232 ~ 232 (992)
+
T Consensus 186 ~ 186 (308)
T 1h6u_A 186 S 186 (308)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.85 E-value=6.4e-23 Score=231.68 Aligned_cols=166 Identities=20% Similarity=0.238 Sum_probs=85.8
Q ss_pred cCCCCCCCCcCCeeeccCCCCCcc----CCccccCCCCCCEEEeecc---cCCCCCCccc-------ccCCCCcEeeccc
Q 037275 66 LSPYVGNLSFLRYLNLADNNFHGE----IPHQIGRLVRLEALVLANN---SFSGKIPTNL-------SRCSNLISFNARR 131 (992)
Q Consensus 66 l~~~l~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~Ls~n---~l~~~~p~~l-------~~l~~L~~L~l~~ 131 (992)
++..+..+++|++|+|++|.+.+. ++..+..+++|++|+|++| ++++.+|..+ ..+++|++|+|++
T Consensus 24 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~ 103 (386)
T 2ca6_A 24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 103 (386)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred HHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCC
Confidence 444445555555555555555543 2233445555555555553 3333444433 4555555566655
Q ss_pred ccccc----cCChhhcccccccccccccccccCCCCCCccc----cc---------cccceEEecCCccc-CCcC---Cc
Q 037275 132 NNLVG----EIPAELGYNWLKLENLTIADNHLTGHFPASIG----NL---------STLERINVLGNGLW-GRIP---NN 190 (992)
Q Consensus 132 n~l~~----~~p~~~~~~l~~L~~L~L~~n~l~~~~p~~~~----~l---------~~L~~L~l~~n~l~-~~~~---~~ 190 (992)
|.+.+ .+|..+. .+++|++|+|++|.+++..+..+. .+ ++|++|++++|++. +.++ ..
T Consensus 104 n~l~~~~~~~l~~~l~-~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 182 (386)
T 2ca6_A 104 NAFGPTAQEPLIDFLS-KHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT 182 (386)
T ss_dssp CCCCTTTHHHHHHHHH-HCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHH
T ss_pred CcCCHHHHHHHHHHHH-hCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHH
Confidence 55554 2333332 455555666665555433222222 22 56666666666664 2233 34
Q ss_pred cCCCCcccEEeccCcccc--c---ccCccccccCCCcEEeccCCccC
Q 037275 191 LGNLRNLILLNLGENRFS--G---IVPPSIFNISSLENVFLPTNRFN 232 (992)
Q Consensus 191 l~~l~~L~~L~L~~n~l~--~---~~p~~l~~l~~L~~L~l~~N~l~ 232 (992)
+..+++|++|+|++|+++ + ..|..+..+++|++|+|++|.++
T Consensus 183 l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~ 229 (386)
T 2ca6_A 183 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT 229 (386)
T ss_dssp HHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCH
T ss_pred HHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCC
Confidence 555566666666666665 2 23335566666666666666653
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.85 E-value=6.9e-21 Score=211.48 Aligned_cols=241 Identities=19% Similarity=0.182 Sum_probs=182.7
Q ss_pred CeeeccCCCCCccCCccccCCCCCCEEEeecccCCCCCC-cccccCCCCcEeecccccccccCChhhccccccccc-ccc
Q 037275 77 RYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIP-TNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLEN-LTI 154 (992)
Q Consensus 77 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p-~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~~-L~L 154 (992)
++++.++++++ ++|..+ .+++++|+|++|+|+ .+| ..|.++++|++|+|++|++.+.+|...+.+++++++ +.+
T Consensus 12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~ 87 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 87 (350)
T ss_dssp TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEE
T ss_pred CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcc
Confidence 56788999999 888877 368999999999998 565 468999999999999999987888888878887664 666
Q ss_pred cccccCCCCCCccccccccceEEecCCcccCCcCCccCCCCcccEEeccC-cccccccCccccccC-CCcEEeccCCccC
Q 037275 155 ADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGE-NRFSGIVPPSIFNIS-SLENVFLPTNRFN 232 (992)
Q Consensus 155 ~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~-n~l~~~~p~~l~~l~-~L~~L~l~~N~l~ 232 (992)
++|+++...|..|.++++|++|++++|++....+..+....++..|++.+ |++....+..|..+. .++.|++++|+|+
T Consensus 88 ~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~ 167 (350)
T 4ay9_X 88 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 167 (350)
T ss_dssp EETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred cCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc
Confidence 77888877788888899999999999988766666677777788888865 567755455666654 5777888888776
Q ss_pred CCCCccccccccccchhhccccccCCCCchhhhccccCceeeec-cccccccccccccccCccceEecCCCCCCCCCCCC
Q 037275 233 GSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLF-DNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEAND 311 (992)
Q Consensus 233 ~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~-~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 311 (992)
.+|.......+|++|+++ +|.++.+++..|..+++|++|+|++|+|+.++...
T Consensus 168 --------------------------~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~ 221 (350)
T 4ay9_X 168 --------------------------EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYG 221 (350)
T ss_dssp --------------------------EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSS
T ss_pred --------------------------CCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhh
Confidence 233344456789999997 48888888889999999999999999999988643
Q ss_pred chhhhhccCCCcceEeecCCCcCCCcCCcccccccccceeEEeeCCc
Q 037275 312 LDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQ 358 (992)
Q Consensus 312 ~~~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~ 358 (992)
+.++++|+.+++ .--..+| .+..+. +|+.+++.++.
T Consensus 222 ------~~~L~~L~~l~~---~~l~~lP-~l~~l~-~L~~l~l~~~~ 257 (350)
T 4ay9_X 222 ------LENLKKLRARST---YNLKKLP-TLEKLV-ALMEASLTYPS 257 (350)
T ss_dssp ------CTTCCEEECTTC---TTCCCCC-CTTTCC-SCCEEECSCHH
T ss_pred ------hccchHhhhccC---CCcCcCC-CchhCc-ChhhCcCCCCc
Confidence 344444544443 3333455 344543 58888887653
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.84 E-value=2.3e-21 Score=199.59 Aligned_cols=125 Identities=18% Similarity=0.178 Sum_probs=95.7
Q ss_pred cccccccCCCCccEEeeecccccccCCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcccCCCChhhhhc
Q 037275 483 TLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLEN 562 (992)
Q Consensus 483 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 562 (992)
..|..|.++++|++|+|++|+|+...+..|.++++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|..
T Consensus 71 ~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 150 (220)
T 2v9t_B 71 LAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSP 150 (220)
T ss_dssp ECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTT
T ss_pred cCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhC
Confidence 44555666777777788888887666666788888888888888888888888999999999999999999887788889
Q ss_pred CCCcceEecCCCcCcccCCCCCccCCcccccccCCCCcCCCCCCC
Q 037275 563 LSFLEYLNLSYNHFEGEVPTKGVFSNKTGISLSGNGKVCGGLDEL 607 (992)
Q Consensus 563 l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~l~~N~~~C~~~~~~ 607 (992)
+++|++|+|++|+|.|.+...+...++....+......|..|..+
T Consensus 151 l~~L~~L~L~~N~~~c~c~l~~l~~~l~~~~~~~~~~~C~~P~~l 195 (220)
T 2v9t_B 151 LRAIQTMHLAQNPFICDCHLKWLADYLHTNPIETSGARCTSPRRL 195 (220)
T ss_dssp CTTCCEEECCSSCEECSGGGHHHHHHHHHCCCBCSCCBEEESGGG
T ss_pred CCCCCEEEeCCCCcCCCCccHHHHHHHHhCCCCccCCCcCCchHH
Confidence 999999999999999988754443333333344455677776543
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=3.7e-21 Score=198.00 Aligned_cols=130 Identities=17% Similarity=0.119 Sum_probs=101.0
Q ss_pred cccccCcccccccCCCCccEEeeecccccccCCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcccCCCC
Q 037275 477 YNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQI 556 (992)
Q Consensus 477 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 556 (992)
+|++++..+..|..+++|++|+|++|++++..+..|.++++|++|+|++|+|++..|..|..+++|++|+|++|+|++..
T Consensus 66 ~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 145 (220)
T 2v70_A 66 NNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVA 145 (220)
T ss_dssp SSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBC
T ss_pred CCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEEC
Confidence 33333344456677788888888888888777888888999999999999999888899999999999999999999888
Q ss_pred hhhhhcCCCcceEecCCCcCcccCCCCCccCCcccccccCCCCcCCCCCC
Q 037275 557 PEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNKTGISLSGNGKVCGGLDE 606 (992)
Q Consensus 557 p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~l~~N~~~C~~~~~ 606 (992)
|..|..+++|++|++++|+|.|.++..+...++....+......|+.|..
T Consensus 146 ~~~~~~l~~L~~L~L~~N~l~c~c~l~~l~~~~~~~~~~~~~~~C~~P~~ 195 (220)
T 2v70_A 146 PGAFDTLHSLSTLNLLANPFNCNCYLAWLGEWLRKKRIVTGNPRCQKPYF 195 (220)
T ss_dssp TTTTTTCTTCCEEECCSCCEECSGGGHHHHHHHHHSCCBCCCCEEEESGG
T ss_pred HHHhcCCCCCCEEEecCcCCcCCCchHHHHHHHHhcCccccCCccCCChH
Confidence 99999999999999999999998886554444433333233346877653
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.83 E-value=1.3e-21 Score=237.29 Aligned_cols=240 Identities=17% Similarity=0.140 Sum_probs=97.3
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCCc-CCCCCCceEeeEEcCCCCeEEEeeccccccCCccCCCCCCCCcCCeeeccC
Q 037275 5 SNETDRLALLAIGSQLEDDPLGVTSSWN-NSTNLCQWTGVTCGHRHQRVTKLDLSNRTIGGTLSPYVGNLSFLRYLNLAD 83 (992)
Q Consensus 5 ~~~~~~~~ll~~~~~~~~~~~~~~~~w~-~~~~~c~w~gv~c~~~~~~v~~ldl~~~~l~~~l~~~l~~l~~L~~L~L~~ 83 (992)
-.+.++++|+++..+........-..|. ..+..+.|.+++++. .+++.++|.++.+.. .+..+ |+.++|+.
T Consensus 129 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~--~~~~~l~L~~n~~~~-~~~~~-----l~~l~Ls~ 200 (727)
T 4b8c_D 129 LVDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVST--PLTPKIELFANGKDE-ANQAL-----LQHKKLSQ 200 (727)
T ss_dssp ---CCCHHHHHHHHHHHHHHTTC---------------------------------------------------------
T ss_pred ccccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecC--CccceEEeeCCCCCc-chhhH-----hhcCccCc
Confidence 4567899999999987655555667774 455567999999854 679999999988854 33333 44455555
Q ss_pred CCCCccCCccccCCCCCCEEEeecccCCCCCCcccccCCCCcEeecccccccccCChhhcccccccccccccccccCCCC
Q 037275 84 NNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHF 163 (992)
Q Consensus 84 n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~~L~L~~n~l~~~~ 163 (992)
|.+.+ ++++.|++. ..|..+..+++|+.|+|++|.+. .+|..++ .+++|++|+|++|.|+ .+
T Consensus 201 ~~i~~--------------~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~-~l~~L~~L~Ls~N~l~-~l 262 (727)
T 4b8c_D 201 YSIDE--------------DDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIF-KYDFLTRLYLNGNSLT-EL 262 (727)
T ss_dssp ------------------------------------CCCCCCEEECTTSCCS-CCCGGGG-GCCSCSCCBCTTSCCS-CC
T ss_pred ccccC--------------cccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhc-CCCCCCEEEeeCCcCc-cc
Confidence 55442 223334333 33444444444555555554444 4444444 4555555555555555 55
Q ss_pred CCccccccccceEEecCCcccCCcCCccCCCCcccEEeccCcccccccCccccccCCCcEEeccCCccCCCCCccccccc
Q 037275 164 PASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSL 243 (992)
Q Consensus 164 p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~ 243 (992)
|..|+++++|++|+|++|.|. .+|..|+++++|++|+|++|.|+ .+|..|+.+++|++|+|++|.+++.+|..+....
T Consensus 263 p~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~ 340 (727)
T 4b8c_D 263 PAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKS 340 (727)
T ss_dssp CGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHH
T ss_pred ChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcc
Confidence 666666666666666666664 55666666666666666666665 4565666666666666666666655554443322
Q ss_pred cccchhhccccccCCCCchhhhccccCceeeeccc
Q 037275 244 PKLLGFIVAENNFAGSIPESLSNASNLVELTLFDN 278 (992)
Q Consensus 244 ~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N 278 (992)
..+..+++.+|.+++.+|.. |..|+++.|
T Consensus 341 ~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n 369 (727)
T 4b8c_D 341 VTGLIFYLRDNRPEIPLPHE------RRFIEINTD 369 (727)
T ss_dssp HHHHHHHHHHCCCCCCCCCC---------------
T ss_pred hhhhHHhhccCcccCcCccc------cceeEeecc
Confidence 33345667777777777753 445566666
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.83 E-value=1.1e-20 Score=193.07 Aligned_cols=181 Identities=18% Similarity=0.227 Sum_probs=147.6
Q ss_pred CCceEeeEEcCCCCeEEEeeccccccCCccCCCCCCCCcCCeeeccCCCCCccCCccccCCCCCCEEEeecccCCCCCCc
Q 037275 37 LCQWTGVTCGHRHQRVTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPT 116 (992)
Q Consensus 37 ~c~w~gv~c~~~~~~v~~ldl~~~~l~~~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~ 116 (992)
.|.|.+|.|+... + ..+|..+ .++|++|+|++|++++..+..|..+++|++|+|++|++++..+.
T Consensus 6 ~C~~~~v~c~~~~------------l-~~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 70 (208)
T 2o6s_A 6 SCSGTTVECYSQG------------R-TSVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNG 70 (208)
T ss_dssp EEETTEEECCSSC------------C-SSCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTT
T ss_pred EECCCEEEecCCC------------c-cCCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChh
Confidence 3799999996542 2 2344433 45889999999999965566688999999999999999855455
Q ss_pred ccccCCCCcEeecccccccccCChhhcccccccccccccccccCCCCCCccccccccceEEecCCcccCCcCCccCCCCc
Q 037275 117 NLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRN 196 (992)
Q Consensus 117 ~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~ 196 (992)
.+..+++|++|++++|+++ .+|...+..+++|++|+|++|.+++..+..+.++++|++|++++|.+.+..+..|..+++
T Consensus 71 ~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~ 149 (208)
T 2o6s_A 71 VFNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTS 149 (208)
T ss_dssp TTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTT
T ss_pred hcCCCCCcCEEECCCCcCC-ccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCC
Confidence 6788999999999999998 667666668899999999999999776777889999999999999997766667889999
Q ss_pred ccEEeccCcccccccCccccccCCCcEEeccCCccCCCCCcccc
Q 037275 197 LILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIG 240 (992)
Q Consensus 197 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~ 240 (992)
|++|+|++|.+.+ .+++|++|+++.|+++|.+|..++
T Consensus 150 L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~ 186 (208)
T 2o6s_A 150 LQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAG 186 (208)
T ss_dssp CCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTS
T ss_pred ccEEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCc
Confidence 9999999998764 456889999999999999987665
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.82 E-value=1e-19 Score=185.89 Aligned_cols=181 Identities=17% Similarity=0.189 Sum_probs=156.6
Q ss_pred CeeeccCCCCCccCCccccCCCCCCEEEeecccCCCCCCcccccCCCCcEeecccccccccCChhhcccccccccccccc
Q 037275 77 RYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIAD 156 (992)
Q Consensus 77 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~~L~L~~ 156 (992)
+.++.+++.++ .+|..+ .++|++|+|++|++++..+..++.+++|++|++++|+++ .+|...+..+++|++|+|++
T Consensus 10 ~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls~ 85 (208)
T 2o6s_A 10 TTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLST 85 (208)
T ss_dssp TEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC-CCCTTTTTTCTTCCEEECCS
T ss_pred CEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccC-ccChhhcCCCCCcCEEECCC
Confidence 57888999998 778655 468999999999999655667899999999999999998 77777777899999999999
Q ss_pred cccCCCCCCccccccccceEEecCCcccCCcCCccCCCCcccEEeccCcccccccCccccccCCCcEEeccCCccCCCCC
Q 037275 157 NHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLP 236 (992)
Q Consensus 157 n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~ 236 (992)
|.+++..+..|.++++|++|++++|++.+..+..|..+++|++|+|++|++++..+..+..+++|++|++++|.+.+.
T Consensus 86 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-- 163 (208)
T 2o6s_A 86 NQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-- 163 (208)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCC--
T ss_pred CcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecC--
Confidence 999977777789999999999999999877777789999999999999999976666789999999999999988753
Q ss_pred ccccccccccchhhccccccCCCCchhhhcccc
Q 037275 237 LDIGVSLPKLLGFIVAENNFAGSIPESLSNASN 269 (992)
Q Consensus 237 ~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~ 269 (992)
.++++.|.+..|+++|.+|..++.++.
T Consensus 164 ------~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 164 ------CPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp ------TTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred ------CCCHHHHHHHHHhCCceeeccCccccC
Confidence 457888888888888888888776654
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.82 E-value=5.8e-20 Score=190.46 Aligned_cols=163 Identities=21% Similarity=0.252 Sum_probs=111.9
Q ss_pred CCCcCCCCCCceEeeEEcCCCCeEEEeeccccccCCccCCCCCCCCcCCeeeccCCCCCccCCccccCCCCCCEEEeecc
Q 037275 29 SSWNNSTNLCQWTGVTCGHRHQRVTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANN 108 (992)
Q Consensus 29 ~~w~~~~~~c~w~gv~c~~~~~~v~~ldl~~~~l~~~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n 108 (992)
.-|..+++.|+|.+|.|+... + +.+|..+. ++|++|+|++|++++..|..|..+++|++|+|++|
T Consensus 10 ~~~~~~~~~Cs~~~v~c~~~~------------l-~~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N 74 (229)
T 3e6j_A 10 SAACPSQCSCSGTTVDCRSKR------------H-ASVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSN 74 (229)
T ss_dssp -CCCCTTCEEETTEEECTTSC------------C-SSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred hccCCCCCEEeCCEeEccCCC------------c-CccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCC
Confidence 344468889999999996432 3 45666554 88999999999999777888889999999999999
Q ss_pred cCCCCCCcccccCCCCcEeecccccccccCChhhcccccccccccccccccCCCCCCccccccccceEEecCCcccCCcC
Q 037275 109 SFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIP 188 (992)
Q Consensus 109 ~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~ 188 (992)
+|++..+..|..+++|++|+|++|+++ .+|...+..+++|++|+|++|+++ .+|..+..+++|++|+|++|++.+..+
T Consensus 75 ~l~~i~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~ 152 (229)
T 3e6j_A 75 QLGALPVGVFDSLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPH 152 (229)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCT
T ss_pred CCCCcChhhcccCCCcCEEECCCCcCC-ccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCH
Confidence 997433455677888888888877776 555554445666666666666666 556666666666666666666644444
Q ss_pred CccCCCCcccEEeccCcccc
Q 037275 189 NNLGNLRNLILLNLGENRFS 208 (992)
Q Consensus 189 ~~l~~l~~L~~L~L~~n~l~ 208 (992)
..|..+++|+.|+|++|.+.
T Consensus 153 ~~~~~l~~L~~L~l~~N~~~ 172 (229)
T 3e6j_A 153 GAFDRLSSLTHAYLFGNPWD 172 (229)
T ss_dssp TTTTTCTTCCEEECTTSCBC
T ss_pred HHHhCCCCCCEEEeeCCCcc
Confidence 45555555555555555555
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.82 E-value=3.7e-20 Score=215.78 Aligned_cols=190 Identities=24% Similarity=0.337 Sum_probs=123.7
Q ss_pred CcceEeecCCCcCCCcCCcccccccccceeEEeeCCccccccCCCccCCCcccEEEccCCcCCCCCCccccCCCCCcEEe
Q 037275 322 TELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLY 401 (992)
Q Consensus 322 ~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 401 (992)
.+|+.|++++|++++ +|..+. ++|++|+|++|+|+. +| ..+++|++|+|++|+|++ +|. +.. +|+.|+
T Consensus 59 ~~L~~L~Ls~n~L~~-lp~~l~---~~L~~L~Ls~N~l~~-ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~ 126 (571)
T 3cvr_A 59 NQFSELQLNRLNLSS-LPDNLP---PQITVLEITQNALIS-LP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLD 126 (571)
T ss_dssp TTCSEEECCSSCCSC-CCSCCC---TTCSEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEE
T ss_pred CCccEEEeCCCCCCc-cCHhHc---CCCCEEECcCCCCcc-cc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEE
Confidence 367777777777775 454432 456677777777663 34 335666677777776664 444 443 666677
Q ss_pred ccCccccccCCCCCCCccccCceeccCCcccCCCCCCccccccccccccccccccccCchhhhhhccccccccccccccc
Q 037275 402 LDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLS 481 (992)
Q Consensus 402 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~ 481 (992)
|++|+|++ +|. .+++|+.|+|++|+|++ +|. .+++|+.| +|++|+++
T Consensus 127 Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L-------------------------~Ls~N~L~ 173 (571)
T 3cvr_A 127 VDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVL-------------------------SVRNNQLT 173 (571)
T ss_dssp CCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEE-------------------------ECCSSCCS
T ss_pred CCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEE-------------------------ECCCCCCC
Confidence 77766664 444 45666666666666664 443 34555555 44455554
Q ss_pred CcccccccCCCCccEEeeecccccccCCccccccccc-------ceeeccCCcccccCCccccccCCCCEEECCCcccCC
Q 037275 482 GTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSL-------QQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSG 554 (992)
Q Consensus 482 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L-------~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 554 (992)
+ +|. |. ++|++|+|++|+|+ .+|. |.. +| +.|+|++|+|+ .+|..+..+++|+.|+|++|+|++
T Consensus 174 ~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~ 244 (571)
T 3cvr_A 174 F-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSS 244 (571)
T ss_dssp C-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCH
T ss_pred C-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCC
Confidence 3 444 44 77888888888887 4555 554 66 88888888888 577777778888888888888888
Q ss_pred CChhhhhcCCC
Q 037275 555 QIPEYLENLSF 565 (992)
Q Consensus 555 ~~p~~~~~l~~ 565 (992)
.+|..+..+..
T Consensus 245 ~~p~~l~~l~~ 255 (571)
T 3cvr_A 245 RIRESLSQQTA 255 (571)
T ss_dssp HHHHHHHHHHH
T ss_pred cCHHHHHHhhc
Confidence 88887776543
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.81 E-value=4.7e-20 Score=205.62 Aligned_cols=181 Identities=24% Similarity=0.176 Sum_probs=133.6
Q ss_pred cEEEccCCcCCCCCCccccCCCCCcEEeccCccccccCCCCCC-CccccCceeccCCcccCCCCCCcccccccccccccc
Q 037275 374 VELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLG-NLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMAD 452 (992)
Q Consensus 374 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 452 (992)
+.+++++|.++ .+|..+. ..++.|+|++|+|++..+..|. .+++|+.|+|++|+|++..+..|..+++|++|+|++
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 45666666666 3454433 3467777777777766666666 777777777777777766666677777777764444
Q ss_pred ccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeecccccccCCcccccccccceeeccCCcccccC
Q 037275 453 IELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSI 532 (992)
Q Consensus 453 n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 532 (992)
| +|++..+..|..+++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..
T Consensus 98 N-------------------------~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~ 152 (361)
T 2xot_A 98 N-------------------------HLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFP 152 (361)
T ss_dssp S-------------------------CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCC
T ss_pred C-------------------------cCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeC
Confidence 3 343344456777888888888888888877888888999999999999998644
Q ss_pred Cccc---cccCCCCEEECCCcccCCCChhhhhcCCC--cceEecCCCcCcccCCC
Q 037275 533 PSSL---SSLKSIKELDMSSNNLSGQIPEYLENLSF--LEYLNLSYNHFEGEVPT 582 (992)
Q Consensus 533 ~~~~---~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~--L~~L~l~~N~l~~~~~~ 582 (992)
+..| ..+++|+.|+|++|+|++..+..+..++. |+.|+|++|+|.|.|..
T Consensus 153 ~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~C~l 207 (361)
T 2xot_A 153 VELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDCKL 207 (361)
T ss_dssp GGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEECCHHH
T ss_pred HHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccCCcCc
Confidence 4445 57899999999999999877788988887 48899999999998864
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1.1e-21 Score=230.41 Aligned_cols=221 Identities=20% Similarity=0.191 Sum_probs=134.9
Q ss_pred ceEeeEEcCCCCeEEEeeccccccCCcc-------------------------CC---CCCCCCcCCeeeccCCCCCccC
Q 037275 39 QWTGVTCGHRHQRVTKLDLSNRTIGGTL-------------------------SP---YVGNLSFLRYLNLADNNFHGEI 90 (992)
Q Consensus 39 ~w~gv~c~~~~~~v~~ldl~~~~l~~~l-------------------------~~---~l~~l~~L~~L~L~~n~l~~~~ 90 (992)
.|.++.|+....+|-.++++.-.+.-.. +. .+...++|+.|+|++|+++ .+
T Consensus 286 ~W~~~~~~~~~~~vw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~L~~L~Ls~n~L~-~L 364 (567)
T 1dce_A 286 EWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST-VL 364 (567)
T ss_dssp CCBCTTSSCCSEEEEEEECCGGGTSTTSSEEEEEEEETTTTEEEEEEEETTCSEEEEECCSTTTTSSSCCCCHHHHH-HH
T ss_pred eeccCCcccccceeEEeecCccccccccccceEEEeeccCCCCccccccCCCchhhhcccccCccceeccCChhhHH-hh
Confidence 5777777666666777776654332110 00 1356677777777777776 67
Q ss_pred CccccCCCCCCEEEeeccc-------------CCCCCCcccccCCCCcEee-cccccccccCChhhcccccccccccccc
Q 037275 91 PHQIGRLVRLEALVLANNS-------------FSGKIPTNLSRCSNLISFN-ARRNNLVGEIPAELGYNWLKLENLTIAD 156 (992)
Q Consensus 91 p~~~~~l~~L~~L~Ls~n~-------------l~~~~p~~l~~l~~L~~L~-l~~n~l~~~~p~~~~~~l~~L~~L~L~~ 156 (992)
|++++.+++|++|++++|. +.+.+|..++.+++|+.|+ ++.|.+. .|+.+.+++
T Consensus 365 p~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~------------~L~~l~l~~ 432 (567)
T 1dce_A 365 QSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD------------DLRSKFLLE 432 (567)
T ss_dssp HHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH------------HHHHHHHHH
T ss_pred HHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc------------hhhhhhhhc
Confidence 7777777777777776654 4445556666666666666 4544332 345555566
Q ss_pred cccCCCCCCccccccccceEEecCCcccCCcCCccCCCCcccEEeccCcccccccCccccccCCCcEEeccCCccCCCCC
Q 037275 157 NHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLP 236 (992)
Q Consensus 157 n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~ 236 (992)
|.++...+ ..|+.|+|++|.+.+ +|. |+.+++|+.|+|++|+|+ .+|..++.+++|++|+|++|++++
T Consensus 433 n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~--- 500 (567)
T 1dce_A 433 NSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN--- 500 (567)
T ss_dssp HHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC---
T ss_pred ccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC---
Confidence 66553211 136777777777744 555 777777777777777777 567777777777777777777662
Q ss_pred ccccccccccchhhccccccCCCCchhhhccccCceeeeccccccccc-cccccccCccceEecCCCCCCCCC
Q 037275 237 LDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKV-SIYFRSLKNLEWLNLGSNNLGTGE 308 (992)
Q Consensus 237 ~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~ 308 (992)
+| .++.+++|++|+|++|+|++.. |..|..+++|++|+|++|+++.++
T Consensus 501 -----------------------lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 549 (567)
T 1dce_A 501 -----------------------VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEE 549 (567)
T ss_dssp -----------------------CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSS
T ss_pred -----------------------Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCc
Confidence 23 4555555666666666665554 555555566666666665555443
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.4e-19 Score=201.83 Aligned_cols=179 Identities=23% Similarity=0.232 Sum_probs=148.0
Q ss_pred cEEeccCccccccCCCCCCCccccCceeccCCcccCCCCCCcc-ccccccccccccccccccCchhhhhhcccccccccc
Q 037275 398 QLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLG-NCKNLIELHMADIELTGALPPQILSISTLSLSLDLS 476 (992)
Q Consensus 398 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~ 476 (992)
+.+++++|+++ .+|..+. +.++.|+|++|+|++..+..|. .+++|+.|++++
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~------------------------ 73 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSH------------------------ 73 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCS------------------------
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCC------------------------
Confidence 68999999998 5666554 3588999999999987777787 888888885554
Q ss_pred cccccCcccccccCCCCccEEeeecccccccCCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcccCCCC
Q 037275 477 YNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQI 556 (992)
Q Consensus 477 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 556 (992)
|+|++..+..|..+++|++|+|++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..
T Consensus 74 -N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~ 152 (361)
T 2xot_A 74 -NHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFP 152 (361)
T ss_dssp -SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCC
T ss_pred -CcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeC
Confidence 5555455667899999999999999999888888999999999999999999888999999999999999999999766
Q ss_pred hhhh---hcCCCcceEecCCCcCcccCCC-CCccCC--cccccccCCCCcCCCC
Q 037275 557 PEYL---ENLSFLEYLNLSYNHFEGEVPT-KGVFSN--KTGISLSGNGKVCGGL 604 (992)
Q Consensus 557 p~~~---~~l~~L~~L~l~~N~l~~~~~~-~~~~~~--~~~~~l~~N~~~C~~~ 604 (992)
+..| ..+++|+.|+|++|+|+..++. ...++. +..+.+.+|||.|+|.
T Consensus 153 ~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~C~ 206 (361)
T 2xot_A 153 VELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDCK 206 (361)
T ss_dssp GGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEECCHH
T ss_pred HHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccCCcC
Confidence 6666 6799999999999999975542 122333 3678999999999884
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.79 E-value=6.6e-19 Score=182.50 Aligned_cols=95 Identities=18% Similarity=0.267 Sum_probs=76.0
Q ss_pred ccccCCCCccEEeeecccccccCCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcccCCCChhhhhcCCC
Q 037275 486 LEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSF 565 (992)
Q Consensus 486 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 565 (992)
..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..|..+++
T Consensus 82 ~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 160 (229)
T 3e6j_A 82 GVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSS 160 (229)
T ss_dssp TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTT
T ss_pred hhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCC
Confidence 34556677777777777777666667778888888888888888 67788888888888888888888777677888888
Q ss_pred cceEecCCCcCcccCC
Q 037275 566 LEYLNLSYNHFEGEVP 581 (992)
Q Consensus 566 L~~L~l~~N~l~~~~~ 581 (992)
|+.|++++|+|.|.++
T Consensus 161 L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 161 LTHAYLFGNPWDCECR 176 (229)
T ss_dssp CCEEECTTSCBCTTBG
T ss_pred CCEEEeeCCCccCCcc
Confidence 8888888888888876
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.78 E-value=2.6e-19 Score=192.87 Aligned_cols=186 Identities=24% Similarity=0.336 Sum_probs=137.5
Q ss_pred EeeCCccccccCCCccCCCcccEEEccCCcCCCCCCccccCCCCCcEEeccCccccccCCCCCCCccccCceeccCCccc
Q 037275 353 VIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQ 432 (992)
Q Consensus 353 ~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 432 (992)
.+..+.+++.. .+..+++|+.|++++|.+... + .+..+++|+.|+|++|++++..+ +..+++|+.|++++|+++
T Consensus 30 ~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~ 103 (291)
T 1h6t_A 30 NLKKKSVTDAV--TQNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK 103 (291)
T ss_dssp HTTCSCTTSEE--CHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred HhcCCCccccc--chhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCC
Confidence 34444444322 235677788888888888743 3 47778888888888888875444 778888888888888887
Q ss_pred CCCCCCccccccccccccccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeecccccccCCccc
Q 037275 433 GSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTL 512 (992)
Q Consensus 433 ~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 512 (992)
+ ++ .+..+++|++|++++|+++ + + ..+..+++|++|++++|++++. ..+
T Consensus 104 ~-~~-~l~~l~~L~~L~L~~n~i~-------------------------~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l 152 (291)
T 1h6t_A 104 D-LS-SLKDLKKLKSLSLEHNGIS-------------------------D-I-NGLVHLPQLESLYLGNNKITDI--TVL 152 (291)
T ss_dssp C-GG-GGTTCTTCCEEECTTSCCC-------------------------C-C-GGGGGCTTCCEEECCSSCCCCC--GGG
T ss_pred C-Ch-hhccCCCCCEEECCCCcCC-------------------------C-C-hhhcCCCCCCEEEccCCcCCcc--hhh
Confidence 4 33 3777777777755555544 2 1 3466788888999999988864 578
Q ss_pred ccccccceeeccCCcccccCCccccccCCCCEEECCCcccCCCChhhhhcCCCcceEecCCCcCccc
Q 037275 513 SACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGE 579 (992)
Q Consensus 513 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 579 (992)
..+++|+.|+|++|+|++..+ +..+++|+.|+|++|+|++ +| .+..+++|+.|++++|++...
T Consensus 153 ~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~~~ 215 (291)
T 1h6t_A 153 SRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLNK 215 (291)
T ss_dssp GGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEECC
T ss_pred ccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCcccCC
Confidence 888899999999999886544 8888999999999999985 44 488889999999999988763
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.78 E-value=5.9e-19 Score=190.09 Aligned_cols=174 Identities=24% Similarity=0.356 Sum_probs=96.9
Q ss_pred CCCCcCCeeeccCCCCCccCCccccCCCCCCEEEeecccCCCCCCcccccCCCCcEeecccccccccCChhhcccccccc
Q 037275 71 GNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLE 150 (992)
Q Consensus 71 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~ 150 (992)
..+++|++|++++|.+. .+|. +..+++|++|+|++|++++ ++. ++.+++|++|++++|+++ .+|. + ..+++|+
T Consensus 43 ~~l~~L~~L~l~~~~i~-~~~~-~~~l~~L~~L~L~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~-~~~~-l-~~l~~L~ 115 (291)
T 1h6t_A 43 NELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLTD-IKP-LANLKNLGWLFLDENKVK-DLSS-L-KDLKKLK 115 (291)
T ss_dssp HHHHTCCEEECTTSCCC-CCTT-GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC-CGGG-G-TTCTTCC
T ss_pred hhcCcccEEEccCCCcc-cChh-HhcCCCCCEEEccCCccCC-Ccc-cccCCCCCEEECCCCcCC-CChh-h-ccCCCCC
Confidence 35666666666666666 3443 6666666666666666663 333 666666666666666665 2332 2 2455555
Q ss_pred cccccccccCCCCCCccccccccceEEecCCcccCCcCCccCCCCcccEEeccCcccccccCccccccCCCcEEeccCCc
Q 037275 151 NLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNR 230 (992)
Q Consensus 151 ~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~ 230 (992)
+|+|++|.+++. +.+..+++|++|++++|.+.+. ..+..+++|++|+|++|++++..| +..+++|++|++++|+
T Consensus 116 ~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~ 189 (291)
T 1h6t_A 116 SLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNH 189 (291)
T ss_dssp EEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred EEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCc
Confidence 555555555532 3455555555555555555332 345555555555555555553322 5555555555555555
Q ss_pred cCCCCCccccccccccchhhccccccCCCCchhhhccccCceeeeccccccccc
Q 037275 231 FNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKV 284 (992)
Q Consensus 231 l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 284 (992)
++ .+| .+..+++|+.|++++|+++..+
T Consensus 190 i~--------------------------~l~-~l~~l~~L~~L~l~~n~i~~~~ 216 (291)
T 1h6t_A 190 IS--------------------------DLR-ALAGLKNLDVLELFSQECLNKP 216 (291)
T ss_dssp CC--------------------------BCG-GGTTCTTCSEEEEEEEEEECCC
T ss_pred CC--------------------------CCh-hhccCCCCCEEECcCCcccCCc
Confidence 44 122 2556667777777777666433
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.77 E-value=1e-18 Score=179.67 Aligned_cols=153 Identities=16% Similarity=0.197 Sum_probs=108.0
Q ss_pred cEEEccCCcCCCCCCccccCCCCCcEEeccCccccccCCCCCCCccccCceeccCCcccCCCCCCccccccccccccccc
Q 037275 374 VELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADI 453 (992)
Q Consensus 374 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n 453 (992)
+.+++++|.++ .+|..+. ++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..|..|..+++|++|++++|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 45566666665 3444333 46677777777776655566667777777777777777666667777777766644433
Q ss_pred cccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeecccccccCCcccccccccceeeccCCcccccCC
Q 037275 454 ELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIP 533 (992)
Q Consensus 454 ~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 533 (992)
+ +++..+..|..+++|++|+|++|++++..|..|..+++|+.|+|++|+|++..+
T Consensus 91 ~-------------------------l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 145 (220)
T 2v9t_B 91 K-------------------------ITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAK 145 (220)
T ss_dssp C-------------------------CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred c-------------------------CCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECH
Confidence 3 332333446677888888888888887778888888888888888888887777
Q ss_pred ccccccCCCCEEECCCcccCC
Q 037275 534 SSLSSLKSIKELDMSSNNLSG 554 (992)
Q Consensus 534 ~~~~~l~~L~~L~Ls~N~l~~ 554 (992)
..|..+++|++|+|++|.+..
T Consensus 146 ~~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 146 GTFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp TTTTTCTTCCEEECCSSCEEC
T ss_pred HHHhCCCCCCEEEeCCCCcCC
Confidence 778888889999999998863
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.77 E-value=1e-18 Score=179.79 Aligned_cols=156 Identities=19% Similarity=0.201 Sum_probs=118.3
Q ss_pred cEEEccCCcCCCCCCccccCCCCCcEEeccCccccccCC-CCCCCccccCceeccCCcccCCCCCCcccccccccccccc
Q 037275 374 VELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIP-TSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMAD 452 (992)
Q Consensus 374 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 452 (992)
+.+++++|.++ .+|..+. ..++.|+|++|+|++..+ ..|..+++|+.|+|++|+|++..+..|..+++|++|
T Consensus 14 ~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L---- 86 (220)
T 2v70_A 14 TTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEI---- 86 (220)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEE----
T ss_pred CEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEE----
Confidence 46667777766 3454443 345677777777775543 346777777777777777776666677777777776
Q ss_pred ccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeecccccccCCcccccccccceeeccCCcccccC
Q 037275 453 IELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSI 532 (992)
Q Consensus 453 n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 532 (992)
+|++|.+++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..
T Consensus 87 ---------------------~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 145 (220)
T 2v70_A 87 ---------------------LLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVA 145 (220)
T ss_dssp ---------------------ECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBC
T ss_pred ---------------------ECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEEC
Confidence 44444444455666788889999999999999888889999999999999999999888
Q ss_pred CccccccCCCCEEECCCcccCCCCh
Q 037275 533 PSSLSSLKSIKELDMSSNNLSGQIP 557 (992)
Q Consensus 533 ~~~~~~l~~L~~L~Ls~N~l~~~~p 557 (992)
|..|..+++|+.|+|++|.+....+
T Consensus 146 ~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 146 PGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp TTTTTTCTTCCEEECCSCCEECSGG
T ss_pred HHHhcCCCCCCEEEecCcCCcCCCc
Confidence 9999999999999999999986544
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.76 E-value=4.1e-19 Score=178.53 Aligned_cols=120 Identities=25% Similarity=0.359 Sum_probs=83.8
Q ss_pred ccCCCCccEEeeecccccccCCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcccCCCChhhhhcCCCcc
Q 037275 488 VGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLE 567 (992)
Q Consensus 488 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 567 (992)
|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..|..|..+++|+
T Consensus 50 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 129 (192)
T 1w8a_A 50 FGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLT 129 (192)
T ss_dssp GGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCC
T ss_pred cccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCC
Confidence 56667777777777777766677777777777777777777766666677777777777777777777777777777777
Q ss_pred eEecCCCcCcccCCCCCccCCcccccccCCCCcCCCCCCC
Q 037275 568 YLNLSYNHFEGEVPTKGVFSNKTGISLSGNGKVCGGLDEL 607 (992)
Q Consensus 568 ~L~l~~N~l~~~~~~~~~~~~~~~~~l~~N~~~C~~~~~~ 607 (992)
+|+|++|+|.|.++..+...+++...+.++...|+.|..+
T Consensus 130 ~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P~~l 169 (192)
T 1w8a_A 130 SLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKV 169 (192)
T ss_dssp EEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSSTTT
T ss_pred EEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCChHH
Confidence 7777777777777654444444444556666677666543
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.76 E-value=1.8e-18 Score=204.12 Aligned_cols=177 Identities=23% Similarity=0.341 Sum_probs=82.5
Q ss_pred CCCCcCCeeeccCCCCCccCCccccCCCCCCEEEeecccCCCCCCcccccCCCCcEeecccccccccCChhhcccccccc
Q 037275 71 GNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLE 150 (992)
Q Consensus 71 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~ 150 (992)
..+.+|+.|+|++|.+. .+| .+..+++|++|+|++|++++ +|. +..+++|+.|+|++|++. .+|
T Consensus 40 ~~L~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~-~~~-l~~l~~L~~L~Ls~N~l~-~l~----------- 103 (605)
T 1m9s_A 40 NELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTD-IKP-LTNLKNLGWLFLDENKIK-DLS----------- 103 (605)
T ss_dssp HHHTTCCCCBCTTCCCC-CCT-TGGGCTTCCEEECTTSCCCC-CGG-GGGCTTCCEEECCSSCCC-CCT-----------
T ss_pred hcCCCCCEEECcCCCCC-CCh-HHccCCCCCEEEeeCCCCCC-Chh-hccCCCCCEEECcCCCCC-CCh-----------
Confidence 34455555555555554 333 35555555555555555552 222 445555555555555444 222
Q ss_pred cccccccccCCCCCCccccccccceEEecCCcccCCcCCccCCCCcccEEeccCcccccccCccccccCCCcEEeccCCc
Q 037275 151 NLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNR 230 (992)
Q Consensus 151 ~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~ 230 (992)
.+..+++|++|+|++|.+.+ + +.+..+++|+.|+|++|++++. ..+..+++|+.|+|++|+
T Consensus 104 ---------------~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~ 164 (605)
T 1m9s_A 104 ---------------SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQ 164 (605)
T ss_dssp ---------------TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSC
T ss_pred ---------------hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCc
Confidence 44555555555555555532 2 2355555555555555555532 345555555555555555
Q ss_pred cCCCCCccccccccccchhhccccccCCCCchhhhccccCceeeecccccccccccc
Q 037275 231 FNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIY 287 (992)
Q Consensus 231 l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~ 287 (992)
+.+..| +..+++|+.|++++|++.+. ..+..+++|+.|+|++|.+.+.+...
T Consensus 165 l~~~~~---l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p~~~ 216 (605)
T 1m9s_A 165 ISDIVP---LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINH 216 (605)
T ss_dssp CCCCGG---GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCCCCC
T ss_pred CCCchh---hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCcccc
Confidence 542211 11222222222222222221 13555566666666666665444333
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.76 E-value=2.8e-18 Score=202.47 Aligned_cols=202 Identities=23% Similarity=0.311 Sum_probs=127.5
Q ss_pred ccccceEEecCCcccCCcCCccCCCCcccEEeccCcccccccCccccccCCCcEEeccCCccCCCCCccccccccccchh
Q 037275 170 LSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGF 249 (992)
Q Consensus 170 l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~L~~l 249 (992)
+..+..+.+..+.+....+ +..+.+|+.|++++|.++. +| .+..+++|+.|+|++|++.+
T Consensus 20 l~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~---------------- 79 (605)
T 1m9s_A 20 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTD---------------- 79 (605)
T ss_dssp HHHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCC----------------
T ss_pred HHHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCC----------------
Confidence 4455566666666644332 4566777777777777763 33 46677777777777776652
Q ss_pred hccccccCCCCchhhhccccCceeeeccccccccccccccccCccceEecCCCCCCCCCCCCchhhhhccCCCcceEeec
Q 037275 250 IVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGL 329 (992)
Q Consensus 250 ~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~~L~~L~l 329 (992)
++. +..+++|+.|+|++|+|++.. .+..+++|++|+|++|+++.+ ..+..+++|+.|+|
T Consensus 80 ----------~~~-l~~l~~L~~L~Ls~N~l~~l~--~l~~l~~L~~L~Ls~N~l~~l--------~~l~~l~~L~~L~L 138 (605)
T 1m9s_A 80 ----------IKP-LTNLKNLGWLFLDENKIKDLS--SLKDLKKLKSLSLEHNGISDI--------NGLVHLPQLESLYL 138 (605)
T ss_dssp ----------CGG-GGGCTTCCEEECCSSCCCCCT--TSTTCTTCCEEECTTSCCCCC--------GGGGGCTTCSEEEC
T ss_pred ----------Chh-hccCCCCCEEECcCCCCCCCh--hhccCCCCCEEEecCCCCCCC--------ccccCCCccCEEEC
Confidence 222 667777888888888877532 577777777777777777653 22555566666666
Q ss_pred CCCcCCCcCCcccccccccceeEEeeCCccccccCCCccCCCcccEEEccCCcCCCCCCccccCCCCCcEEeccCccccc
Q 037275 330 DDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAG 409 (992)
Q Consensus 330 ~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 409 (992)
++|++.+ . ..+..+++|+.|+|++|++.+..| +..+++|+.|+|++|+|++
T Consensus 139 s~N~l~~-------------------------l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~ 189 (605)
T 1m9s_A 139 GNNKITD-------------------------I--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD 189 (605)
T ss_dssp CSSCCCC-------------------------C--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB
T ss_pred CCCccCC-------------------------c--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCC
Confidence 6665553 2 345566677777777777765444 6667777777777777764
Q ss_pred cCCCCCCCccccCceeccCCcccCCCCCCccccc
Q 037275 410 GIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCK 443 (992)
Q Consensus 410 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 443 (992)
. ..+..+++|+.|+|++|++.+.....+..+.
T Consensus 190 l--~~l~~l~~L~~L~L~~N~l~~~p~~~~~~l~ 221 (605)
T 1m9s_A 190 L--RALAGLKNLDVLELFSQECLNKPINHQSNLV 221 (605)
T ss_dssp C--GGGTTCTTCSEEECCSEEEECCCCCCCSSCE
T ss_pred C--hHHccCCCCCEEEccCCcCcCCcccccccEE
Confidence 3 2466677777777777777654333333333
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=2.5e-18 Score=181.49 Aligned_cols=137 Identities=18% Similarity=0.191 Sum_probs=106.5
Q ss_pred CCCCCccccccceEEEEeEECCCCeE--EEEEEeeccCCC------------------------chhHHHHHHHHHHhcc
Q 037275 681 FSSSNMIGQGSFGFVYKGNLGENGMM--VAVKVINLKQKG------------------------ASNGFVAECQALRNIR 734 (992)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 734 (992)
|++.+.||+|+||.||+|.+..+|+. ||||+++..... ....+.+|+.+++++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 66789999999999999998668888 999997533111 0125789999999998
Q ss_pred CCcc--eeEEEEeecccccCcceEEEEEEeccC-C----CHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHH-hc
Q 037275 735 HRNL--IKIITICSSIDFKGVDFQAIVYEYMQN-G----SLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIH-HH 806 (992)
Q Consensus 735 h~ni--v~~~~~~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH-~~ 806 (992)
|+++ ..++++ ...++||||+.+ | +|.++... .++..+..++.|++.||+||| +.
T Consensus 129 ~~~i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~ 190 (258)
T 1zth_A 129 EAGVSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELGRE---------LKELDVEGIFNDVVENVKRLYQEA 190 (258)
T ss_dssp HTTCCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHGGG---------GGGSCHHHHHHHHHHHHHHHHHTS
T ss_pred hCCCCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHhhc---------cChHHHHHHHHHHHHHHHHHHHHC
Confidence 8864 444432 123899999942 4 67766432 223456789999999999999 88
Q ss_pred CCCCeEeccCCCCCeeeCCCCcEEEeecccceec
Q 037275 807 CQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFL 840 (992)
Q Consensus 807 ~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 840 (992)
+|+||||||+|||++. .++|+|||+|...
T Consensus 191 ---givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 191 ---ELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp ---CEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred ---CEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9999999999999988 9999999999754
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=1.2e-20 Score=221.37 Aligned_cols=192 Identities=19% Similarity=0.174 Sum_probs=141.8
Q ss_pred CCCcccEEEccCCcCCCCCCccccCCCCCcEEeccCcc-------------ccccCCCCCCCccccCcee-ccCCcccCC
Q 037275 369 NLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNF-------------LAGGIPTSLGNLTLLTNLA-LSSNDLQGS 434 (992)
Q Consensus 369 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-------------l~~~~~~~~~~l~~L~~L~-L~~N~l~~~ 434 (992)
..++|+.|+|++|+++ .+|..++.+++|+.|++++|. +.+..|..+.++++|+.|+ ++.|.+
T Consensus 347 ~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~--- 422 (567)
T 1dce_A 347 TDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYL--- 422 (567)
T ss_dssp TTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHH---
T ss_pred cCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhccc---
Confidence 3455555566666555 455555555556655555443 2334444455555555555 444433
Q ss_pred CCCCccccccccccccccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeecccccccCCccccc
Q 037275 435 IPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSA 514 (992)
Q Consensus 435 ~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 514 (992)
.+|..+.+.+|.++. +|. ..++.|+|++|.+++ +|. ++.+++|+.|+|++|+|+ .+|..|+.
T Consensus 423 --------~~L~~l~l~~n~i~~-l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~ 484 (567)
T 1dce_A 423 --------DDLRSKFLLENSVLK-MEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAA 484 (567)
T ss_dssp --------HHHHHHHHHHHHHHH-HHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGG
T ss_pred --------chhhhhhhhcccccc-cCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhc
Confidence 234455555555552 111 135678999999995 666 999999999999999999 78899999
Q ss_pred ccccceeeccCCcccccCCccccccCCCCEEECCCcccCCCC-hhhhhcCCCcceEecCCCcCcccCCCCC
Q 037275 515 CTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQI-PEYLENLSFLEYLNLSYNHFEGEVPTKG 584 (992)
Q Consensus 515 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~~~~~ 584 (992)
+++|+.|+|++|+|++ +| .|+++++|++|+|++|+|++.. |..+..+++|+.|+|++|++++.++...
T Consensus 485 l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~ 553 (567)
T 1dce_A 485 LRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQE 553 (567)
T ss_dssp CTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTT
T ss_pred CCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHH
Confidence 9999999999999996 67 8999999999999999999887 9999999999999999999999887643
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.73 E-value=2.4e-18 Score=172.73 Aligned_cols=158 Identities=24% Similarity=0.278 Sum_probs=124.2
Q ss_pred CceeccCCcccCCCCCCccccccccccccccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeec
Q 037275 422 TNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISV 501 (992)
Q Consensus 422 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~ 501 (992)
+.+++++|.++ .+|..+. ++|++| ++++|.++ .+|..|..+++|++|+|++
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L-------------------------~L~~n~i~-~ip~~~~~l~~L~~L~Ls~ 63 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTEL-------------------------YLDGNQFT-LVPKELSNYKHLTLIDLSN 63 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEE-------------------------ECCSSCCC-SCCGGGGGCTTCCEEECCS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEE-------------------------ECCCCcCc-hhHHHhhcccCCCEEECCC
Confidence 45677777776 4554332 355555 44444444 5667788899999999999
Q ss_pred ccccccCCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcccCCCChhhhhcCCCcceEecCCCcCcccCC
Q 037275 502 NRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVP 581 (992)
Q Consensus 502 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~ 581 (992)
|+|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|++++|+|.|.+.
T Consensus 64 N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~ 143 (193)
T 2wfh_A 64 NRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCN 143 (193)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred CcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCc
Confidence 99998888899999999999999999998888899999999999999999997777789999999999999999999988
Q ss_pred CCCccCCcccccccCCCCcCCCCCCCC
Q 037275 582 TKGVFSNKTGISLSGNGKVCGGLDELN 608 (992)
Q Consensus 582 ~~~~~~~~~~~~l~~N~~~C~~~~~~~ 608 (992)
..+...++.......+...|+.|..+.
T Consensus 144 l~~l~~~~~~~~~~~~~~~C~~P~~l~ 170 (193)
T 2wfh_A 144 MQWLSDWVKSEYKEPGIARCAGPGEMA 170 (193)
T ss_dssp GHHHHHHHHHSSCCCSCCBEEESGGGT
T ss_pred CHHHHHHHHhccCCCCCcCcCCchHHC
Confidence 655444444433444556888876543
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.73 E-value=1.4e-18 Score=210.60 Aligned_cols=189 Identities=25% Similarity=0.323 Sum_probs=115.5
Q ss_pred EeeCCccccccCCCccCCCcccEEEccCCcCCCCCCccccCCCCCcEEeccCccccccCCCCCCCccccCceeccCCccc
Q 037275 353 VIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQ 432 (992)
Q Consensus 353 ~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 432 (992)
++..|.+. ..+..+..+.+|+.|+|++|.+. .+|..+..+++|++|+|++|+|+ .+|..|.++++|++|+|++|+|+
T Consensus 207 ~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~ 283 (727)
T 4b8c_D 207 DDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT 283 (727)
T ss_dssp ----------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS
T ss_pred ccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC
Confidence 34445554 56777888889999999999988 67777778899999999999998 78888889999999999999998
Q ss_pred CCCCCCccccccccccccccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeecccccccCCccc
Q 037275 433 GSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTL 512 (992)
Q Consensus 433 ~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 512 (992)
.+|..|+.+++|++|+|++|. |+ .+|..|+.+++|++|+|++|.|++.+|..+
T Consensus 284 -~lp~~~~~l~~L~~L~L~~N~-------------------------l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~ 336 (727)
T 4b8c_D 284 -SLPAELGSCFQLKYFYFFDNM-------------------------VT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKIL 336 (727)
T ss_dssp -SCCSSGGGGTTCSEEECCSSC-------------------------CC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHH
T ss_pred -ccChhhcCCCCCCEEECCCCC-------------------------CC-ccChhhhcCCCccEEeCCCCccCCCChHHH
Confidence 678888888888888555444 44 667778899999999999999998888888
Q ss_pred ccccc-cceeeccCCcccccCCccccccCCCCEEECCCc--------ccCCCChhhhhcCCCcceEecCCCcCc
Q 037275 513 SACTS-LQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSN--------NLSGQIPEYLENLSFLEYLNLSYNHFE 577 (992)
Q Consensus 513 ~~l~~-L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N--------~l~~~~p~~~~~l~~L~~L~l~~N~l~ 577 (992)
..+.. +..|+|++|.+++.+|.. |+.|++++| .|.+..+..+..+..+....+++|-+.
T Consensus 337 ~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~ 404 (727)
T 4b8c_D 337 TEKSVTGLIFYLRDNRPEIPLPHE------RRFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLC 404 (727)
T ss_dssp HHHHHHHHHHHHHHCCCCCCCCCC-----------------------------------------------CCC
T ss_pred hhcchhhhHHhhccCcccCcCccc------cceeEeecccccccccCCccccccchhhcccccceeeeeccccc
Confidence 66533 345889999999888764 556667777 444444444555556666666666554
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.72 E-value=2.6e-18 Score=189.02 Aligned_cols=156 Identities=16% Similarity=0.153 Sum_probs=99.6
Q ss_pred CccCCCCCC--CCcCCeeeccCCCCCccCCccccC-CCCCCEEEeecccCCCCCCcccccCCCCcEeecccccccccCCh
Q 037275 64 GTLSPYVGN--LSFLRYLNLADNNFHGEIPHQIGR-LVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPA 140 (992)
Q Consensus 64 ~~l~~~l~~--l~~L~~L~L~~n~l~~~~p~~~~~-l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~ 140 (992)
|.++..+.. +.+++.|.++++ +.+.--..+.. +++|++|||++|++. .....-+.++.+..+.+..| .+|.
T Consensus 13 g~l~~~l~~~~~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~-~~~~~~~~~~~~~~~~~~~~----~I~~ 86 (329)
T 3sb4_A 13 GTLISMMTEEEANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIK-MYSGKAGTYPNGKFYIYMAN----FVPA 86 (329)
T ss_dssp TCGGGGSCHHHHHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEEC-CEEESSSSSGGGCCEEECTT----EECT
T ss_pred CcHHhhccchhhCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeE-EecCcccccccccccccccc----ccCH
Confidence 555555554 778899999864 22111123334 788999999999987 11111122222444555555 5677
Q ss_pred hhccc--------ccccccccccccccCCCCCCccccccccceEEecCCcccCCcCCccCCCCcccEEeccCccc----c
Q 037275 141 ELGYN--------WLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRF----S 208 (992)
Q Consensus 141 ~~~~~--------l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l----~ 208 (992)
..|.+ +++|+.|+|.+ .++...+.+|.++++|++|++.+|.+....+..|.++.++..+.+..+.. .
T Consensus 87 ~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~ 165 (329)
T 3sb4_A 87 YAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKN 165 (329)
T ss_dssp TTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTST
T ss_pred HHhcccccccccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccc
Confidence 77777 88888888888 77756666788888888888888888777777788877777777665322 2
Q ss_pred cccCccccccCCCc-EEec
Q 037275 209 GIVPPSIFNISSLE-NVFL 226 (992)
Q Consensus 209 ~~~p~~l~~l~~L~-~L~l 226 (992)
......|.++..|+ .+.+
T Consensus 166 ~i~~~~f~~~~~L~~~i~~ 184 (329)
T 3sb4_A 166 RWEHFAFIEGEPLETTIQV 184 (329)
T ss_dssp TTTTSCEEESCCCEEEEEE
T ss_pred cccccccccccccceeEEe
Confidence 22344566666666 4443
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.72 E-value=9.1e-18 Score=169.63 Aligned_cols=154 Identities=19% Similarity=0.236 Sum_probs=101.3
Q ss_pred CCCCcCCeeeccCCCCCccCCccccCCCCCCEEEeecccCCCCCCcccccCCCCcEeecccccccccCChhhcccccccc
Q 037275 71 GNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLE 150 (992)
Q Consensus 71 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~ 150 (992)
+.+++|++|++++|.++ .+| .+..+++|++|++++|+++ . +..+..+++|++|++++|++++..|..+. .+++|+
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~-~-~~~l~~l~~L~~L~l~~n~l~~~~~~~l~-~l~~L~ 115 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT-N-YNPISGLSNLERLRIMGKDVTSDKIPNLS-GLTSLT 115 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS-C-CGGGTTCTTCCEEEEECTTCBGGGSCCCT-TCTTCC
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC-c-chhhhcCCCCCEEEeECCccCcccChhhc-CCCCCC
Confidence 45667777777777777 566 5777777777777777554 2 33666777777777777777655555554 566777
Q ss_pred cccccccccCCCCCCccccccccceEEecCCcccCCcCCccCCCCcccEEeccCcccccccCccccccCCCcEEeccCCc
Q 037275 151 NLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNR 230 (992)
Q Consensus 151 ~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~ 230 (992)
+|++++|.+++..|..++.+++|++|++++|...+.+| .+..+++|++|++++|++++ ++ .+..+++|++|++++|+
T Consensus 116 ~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQT 192 (197)
T ss_dssp EEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC-
T ss_pred EEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcc
Confidence 77777777766666667777777777777776224444 56677777777777777764 33 56667777777777776
Q ss_pred cC
Q 037275 231 FN 232 (992)
Q Consensus 231 l~ 232 (992)
+.
T Consensus 193 i~ 194 (197)
T 4ezg_A 193 IG 194 (197)
T ss_dssp --
T ss_pred cC
Confidence 64
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.72 E-value=2.4e-17 Score=166.48 Aligned_cols=154 Identities=19% Similarity=0.257 Sum_probs=94.6
Q ss_pred ccCCCCCCEEEeecccCCCCCCcccccCCCCcEeecccccccccCChhhcccccccccccccccccCCCCCCcccccccc
Q 037275 94 IGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTL 173 (992)
Q Consensus 94 ~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L 173 (992)
...+++|++|++++|+++ .+| .+..+++|++|++++|.++ . +..+..+++|
T Consensus 40 ~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~-~--------------------------~~~l~~l~~L 90 (197)
T 4ezg_A 40 EAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT-N--------------------------YNPISGLSNL 90 (197)
T ss_dssp HHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS-C--------------------------CGGGTTCTTC
T ss_pred hhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC-c--------------------------chhhhcCCCC
Confidence 367778888888888887 666 5777777777777766543 1 2244555666
Q ss_pred ceEEecCCcccCCcCCccCCCCcccEEeccCcccccccCccccccCCCcEEeccCCc-cCCCCCccccccccccchhhcc
Q 037275 174 ERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNR-FNGSLPLDIGVSLPKLLGFIVA 252 (992)
Q Consensus 174 ~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~-l~~~~~~~~~~~~~~L~~l~l~ 252 (992)
++|++++|.+.+..+..|+.+++|++|+|++|++++..|..+..+++|++|++++|+ +.
T Consensus 91 ~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-------------------- 150 (197)
T 4ezg_A 91 ERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-------------------- 150 (197)
T ss_dssp CEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC--------------------
T ss_pred CEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc--------------------
Confidence 666666666655556666666666666666666665556666666666666666665 33
Q ss_pred ccccCCCCchhhhccccCceeeeccccccccccccccccCccceEecCCCCCC
Q 037275 253 ENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLG 305 (992)
Q Consensus 253 ~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 305 (992)
.+| .+..+++|++|++++|++++.. .+..+++|++|++++|+++
T Consensus 151 ------~~~-~l~~l~~L~~L~l~~n~i~~~~--~l~~l~~L~~L~l~~N~i~ 194 (197)
T 4ezg_A 151 ------DIM-PLKTLPELKSLNIQFDGVHDYR--GIEDFPKLNQLYAFSQTIG 194 (197)
T ss_dssp ------CCG-GGGGCSSCCEEECTTBCCCCCT--TGGGCSSCCEEEECBC---
T ss_pred ------ccH-hhcCCCCCCEEECCCCCCcChH--HhccCCCCCEEEeeCcccC
Confidence 122 3455566666666666665432 4555666666666666554
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.72 E-value=1e-17 Score=177.30 Aligned_cols=166 Identities=21% Similarity=0.270 Sum_probs=117.2
Q ss_pred EEEeeccccccCCccCCCCCCCCcCCeeeccCCCCCccCCccccCCCCCCEEEeecccCCCCCCcccccCCCCcEeeccc
Q 037275 52 VTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARR 131 (992)
Q Consensus 52 v~~ldl~~~~l~~~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~ 131 (992)
++.++++++.+.+ ++ .+..+++|++|++++|+++ .+| .+..+++|++|+|++|+++ .+|. ++.+++|++|++++
T Consensus 21 l~~l~l~~~~i~~-~~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~-~~~~-l~~l~~L~~L~L~~ 94 (263)
T 1xeu_A 21 AVKQNLGKQSVTD-LV-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQIS-DLSP-LKDLTKLEELSVNR 94 (263)
T ss_dssp HHHHHHTCSCTTS-EE-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCC-CCGG-GTTCSSCCEEECCS
T ss_pred HHHHHhcCCCccc-cc-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccC-CChh-hccCCCCCEEECCC
Confidence 4456666666633 33 4667778888888888877 566 5777888888888888877 4444 77788888888888
Q ss_pred ccccccCChhhcccccccccccccccccCCCCCCccccccccceEEecCCcccCCcCCccCCCCcccEEeccCccccccc
Q 037275 132 NNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIV 211 (992)
Q Consensus 132 n~l~~~~p~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~ 211 (992)
|+++ .+|.... ++|++|+|++|.+++ + +.+.++++|++|++++|++.+. + .+..+++|+.|+|++|++++.
T Consensus 95 N~l~-~l~~~~~---~~L~~L~L~~N~l~~-~-~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~- 165 (263)
T 1xeu_A 95 NRLK-NLNGIPS---ACLSRLFLDNNELRD-T-DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT- 165 (263)
T ss_dssp SCCS-CCTTCCC---SSCCEEECCSSCCSB-S-GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC-
T ss_pred CccC-CcCcccc---CcccEEEccCCccCC-C-hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch-
Confidence 8777 4554322 677778888887774 3 3577777778888887777543 3 577777777888887777754
Q ss_pred CccccccCCCcEEeccCCccCC
Q 037275 212 PPSIFNISSLENVFLPTNRFNG 233 (992)
Q Consensus 212 p~~l~~l~~L~~L~l~~N~l~~ 233 (992)
..+..+++|++|++++|.+.+
T Consensus 166 -~~l~~l~~L~~L~l~~N~~~~ 186 (263)
T 1xeu_A 166 -GGLTRLKKVNWIDLTGQKCVN 186 (263)
T ss_dssp -TTSTTCCCCCEEEEEEEEEEC
T ss_pred -HHhccCCCCCEEeCCCCcccC
Confidence 567777777777777777763
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.71 E-value=9.3e-18 Score=177.66 Aligned_cols=174 Identities=18% Similarity=0.226 Sum_probs=134.4
Q ss_pred CCCcCCeeeccCCCCCccCCccccCCCCCCEEEeecccCCCCCCcccccCCCCcEeecccccccccCChhhccccccccc
Q 037275 72 NLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLEN 151 (992)
Q Consensus 72 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~~ 151 (992)
.+.++..+++++|.++ .++ .+..+++|++|++++|+++ .+| .++.+++|++|++++|+++ .+|. +..+++|++
T Consensus 17 ~l~~l~~l~l~~~~i~-~~~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~-~~~~--l~~l~~L~~ 89 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVT-DLV-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQIS-DLSP--LKDLTKLEE 89 (263)
T ss_dssp HHHHHHHHHHTCSCTT-SEE-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCC-CCGG--GTTCSSCCE
T ss_pred HHHHHHHHHhcCCCcc-ccc-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccC-CChh--hccCCCCCE
Confidence 5777888999999998 555 5889999999999999998 677 7889999999999999988 4554 447888888
Q ss_pred ccccccccCCCCCCccccccccceEEecCCcccCCcCCccCCCCcccEEeccCcccccccCccccccCCCcEEeccCCcc
Q 037275 152 LTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRF 231 (992)
Q Consensus 152 L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l 231 (992)
|+|++|++++ +|.... ++|++|++++|.+.+ ++ .+..+++|+.|+|++|++++. + .+..+++|++|++++|++
T Consensus 90 L~L~~N~l~~-l~~~~~--~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i 162 (263)
T 1xeu_A 90 LSVNRNRLKN-LNGIPS--ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEI 162 (263)
T ss_dssp EECCSSCCSC-CTTCCC--SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCC
T ss_pred EECCCCccCC-cCcccc--CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcC
Confidence 8888888885 443332 788888888888854 33 578888888888888888753 3 677788888888888777
Q ss_pred CCCCCccccccccccchhhccccccCCCCchhhhccccCceeeeccccccccccc
Q 037275 232 NGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSI 286 (992)
Q Consensus 232 ~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~ 286 (992)
++. ..+..+++|++|++++|.+...+..
T Consensus 163 ~~~---------------------------~~l~~l~~L~~L~l~~N~~~~~~~~ 190 (263)
T 1xeu_A 163 TNT---------------------------GGLTRLKKVNWIDLTGQKCVNEPVK 190 (263)
T ss_dssp CBC---------------------------TTSTTCCCCCEEEEEEEEEECCCEE
T ss_pred cch---------------------------HHhccCCCCCEEeCCCCcccCCccc
Confidence 621 3456677888888888888755443
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.71 E-value=2.8e-17 Score=165.07 Aligned_cols=176 Identities=19% Similarity=0.241 Sum_probs=115.5
Q ss_pred cEEeccCccccccCCCCCCCccccCceeccCCcccCCCCC-CccccccccccccccccccccCchhhhhhcccccccccc
Q 037275 398 QLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPP-SLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLS 476 (992)
Q Consensus 398 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~ 476 (992)
+.+++++|+++ .+|..+.. +|++|++++|+|++..+. .|..+++|++| +|+
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L-------------------------~Ls 62 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKL-------------------------ELK 62 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEE-------------------------ECC
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEE-------------------------ECC
Confidence 34555555554 33433322 455566666665544332 35556666555 444
Q ss_pred cccccCcccccccCCCCccEEeeecccccccCCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcccCCCC
Q 037275 477 YNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQI 556 (992)
Q Consensus 477 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 556 (992)
+|.+++..|..|..+++|++|+|++|+|++..+..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+++..
T Consensus 63 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 142 (192)
T 1w8a_A 63 RNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp SSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred CCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcC
Confidence 44444455666777788888888888888877888888889999999999999888889999999999999999998765
Q ss_pred hh-hhhcCCCcceEecCCCcCcccCCCCCccCCcccccccCCCCcCCCCC
Q 037275 557 PE-YLENLSFLEYLNLSYNHFEGEVPTKGVFSNKTGISLSGNGKVCGGLD 605 (992)
Q Consensus 557 p~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~l~~N~~~C~~~~ 605 (992)
+. ++. ..++...+..+...|..|. .+......++..+...|.++.
T Consensus 143 ~l~~~~--~~l~~~~~~~~~~~C~~P~--~l~~~~l~~l~~~~~~C~~~~ 188 (192)
T 1w8a_A 143 HLAWFA--EWLRKKSLNGGAARCGAPS--KVRDVQIKDLPHSEFKCSSEN 188 (192)
T ss_dssp GGHHHH--HHHHHHCCSGGGCBBCSST--TTTTSBGGGSCTTTCCCCCC-
T ss_pred cchHHH--HHHHHcCCCCCCCCCCCCh--HHcCCChhhCcHhhcCcCCCC
Confidence 52 221 2234445666666665554 345555567778888887654
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.68 E-value=1.7e-17 Score=182.55 Aligned_cols=197 Identities=11% Similarity=0.047 Sum_probs=122.5
Q ss_pred ccccchhhccccccCCCCchhhhccccCceeeeccccccccccccccccCccceEecCCCC----CCCCCCCCchhhhhc
Q 037275 243 LPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNN----LGTGEANDLDFLTLL 318 (992)
Q Consensus 243 ~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~----l~~~~~~~~~~~~~l 318 (992)
+++|+.+.+.+ +++.+-+.+|..+++|+.|++++|.+..+.+..|..+.++..+.+..+. ...+.... +
T Consensus 100 ~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~------f 172 (329)
T 3sb4_A 100 KQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFA------F 172 (329)
T ss_dssp CTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSC------E
T ss_pred cCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccc------c
Confidence 44444444444 3433344556666777777777776666666666666666666554421 11111111 2
Q ss_pred cCCCcce--------------------------EeecCCCcCCCcCCcccccccccceeEEeeCCccccccCCCccCCCc
Q 037275 319 TNCTELT--------------------------AIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVN 372 (992)
Q Consensus 319 ~~~~~L~--------------------------~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~ 372 (992)
.++..|+ .+.+.++ +.......+......|+.++|++|+++.+.+..|.++.+
T Consensus 173 ~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~-l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~ 251 (329)
T 3sb4_A 173 IEGEPLETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGK-LDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKY 251 (329)
T ss_dssp EESCCCEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEEC-CCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTT
T ss_pred ccccccceeEEecCCCcHHHHHhhcccCccccceEEEeee-ecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCC
Confidence 2233333 2222221 110001111112346888888888888777788888888
Q ss_pred ccEEEccCCcCCCCCCccccCCCCCc-EEeccCccccccCCCCCCCccccCceeccCCcccCCCCCCccccccccccc
Q 037275 373 LVELCMDDNKLTGTIPHAIGELKNLQ-LLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELH 449 (992)
Q Consensus 373 L~~L~L~~N~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 449 (992)
|+.|+|.+| ++.+.+.+|.++.+|+ .+++.+ .++.+.+.+|.++++|+.|+++.|.++...+.+|.++++|+.++
T Consensus 252 L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 252 LLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp CCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred CCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence 888888887 6667777888888888 888887 67766778888888888888888888877777888888888774
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=5.1e-16 Score=155.75 Aligned_cols=130 Identities=22% Similarity=0.229 Sum_probs=115.8
Q ss_pred ccccccccccCcccccccCCCCccEEeeecccccccCCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcc
Q 037275 472 SLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNN 551 (992)
Q Consensus 472 ~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 551 (992)
.+++++|.++ .+|..+. ++|++|+|++|+|+ .+|..|.++++|+.|+|++|+|++..+..|.++++|++|+|++|+
T Consensus 14 ~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 14 VVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89 (193)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence 4577888887 5666553 68999999999998 677899999999999999999998888999999999999999999
Q ss_pred cCCCChhhhhcCCCcceEecCCCcCcccCCC-CCccCCcccccccCCCCcCCCCC
Q 037275 552 LSGQIPEYLENLSFLEYLNLSYNHFEGEVPT-KGVFSNKTGISLSGNGKVCGGLD 605 (992)
Q Consensus 552 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~~~~~~l~~N~~~C~~~~ 605 (992)
|++..|..|..+++|++|+|++|+++..++. ...++.++.+++.+|+|.|+|..
T Consensus 90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~l 144 (193)
T 2wfh_A 90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCNM 144 (193)
T ss_dssp CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGGG
T ss_pred cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCcC
Confidence 9998889999999999999999999987764 45678899999999999998853
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.63 E-value=8.2e-16 Score=150.90 Aligned_cols=135 Identities=21% Similarity=0.246 Sum_probs=91.4
Q ss_pred cccCceeccCCccc-CCCCCCccccccccccccccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEE
Q 037275 419 TLLTNLALSSNDLQ-GSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYF 497 (992)
Q Consensus 419 ~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L 497 (992)
++|+.|++++|.++ +.+|..+..+++|++|++++|.++ +. ..+..+++|++|
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~-------------------------~~--~~~~~l~~L~~L 76 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-------------------------SV--SNLPKLPKLKKL 76 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCC-------------------------CC--SSCCCCSSCCEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCC-------------------------Ch--hhhccCCCCCEE
Confidence 34555555555554 344555555555555533333332 12 345567777888
Q ss_pred eeecccccccCCcccccccccceeeccCCcccccC-CccccccCCCCEEECCCcccCCCCh---hhhhcCCCcceEecCC
Q 037275 498 NISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSI-PSSLSSLKSIKELDMSSNNLSGQIP---EYLENLSFLEYLNLSY 573 (992)
Q Consensus 498 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~l~~ 573 (992)
+|++|++++.+|..+..+++|++|+|++|+|++.. +..+..+++|++|+|++|++++..+ ..+..+++|++|++++
T Consensus 77 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~ 156 (168)
T 2ell_A 77 ELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYD 156 (168)
T ss_dssp EEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEE
T ss_pred ECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCC
Confidence 88888887667777777888888888888887532 2678888888888888888886555 4788888888888888
Q ss_pred CcCcccC
Q 037275 574 NHFEGEV 580 (992)
Q Consensus 574 N~l~~~~ 580 (992)
|.+...+
T Consensus 157 n~~~~~~ 163 (168)
T 2ell_A 157 REDQEAP 163 (168)
T ss_dssp TTSCBCC
T ss_pred CChhhcc
Confidence 8876544
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.62 E-value=1.1e-15 Score=150.14 Aligned_cols=134 Identities=19% Similarity=0.205 Sum_probs=84.7
Q ss_pred CCCcCCeeeccCCCCC-ccCCccccCCCCCCEEEeecccCCCCCCcccccCCCCcEeecccccccccCChhhcccccccc
Q 037275 72 NLSFLRYLNLADNNFH-GEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLE 150 (992)
Q Consensus 72 ~l~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~ 150 (992)
..++|++|+|++|+++ +.+|..+..+++|++|+|++|++++. ..++.+++|++|++++|++++.+|..+ ..+++|+
T Consensus 22 ~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~ 98 (168)
T 2ell_A 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLA-EKLPNLT 98 (168)
T ss_dssp CTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHH-HHCTTCC
T ss_pred CcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHH-hhCCCCC
Confidence 3467888888888887 67888788888888888888888743 667777777777777777774444333 2455666
Q ss_pred cccccccccCCCC-CCccccccccceEEecCCcccCCcC---CccCCCCcccEEeccCcccc
Q 037275 151 NLTIADNHLTGHF-PASIGNLSTLERINVLGNGLWGRIP---NNLGNLRNLILLNLGENRFS 208 (992)
Q Consensus 151 ~L~L~~n~l~~~~-p~~~~~l~~L~~L~l~~n~l~~~~~---~~l~~l~~L~~L~L~~n~l~ 208 (992)
+|+|++|.+++.. +..+..+++|++|++++|.+.+..+ ..+..+++|++|++++|.+.
T Consensus 99 ~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 99 HLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp EEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred EEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 6666666665321 1455555555555555555533222 24555555555555555554
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.60 E-value=2e-15 Score=149.53 Aligned_cols=109 Identities=22% Similarity=0.272 Sum_probs=84.2
Q ss_pred ccccccccCcccccccCCCCccEEeeecccccccCCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcccC
Q 037275 474 DLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLS 553 (992)
Q Consensus 474 ~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 553 (992)
++++|++++..+..|..+++|++|++++|++++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|+
T Consensus 34 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 113 (177)
T 2o6r_A 34 ELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLK 113 (177)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred EeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcce
Confidence 44444444444455667778888888888888766677788888888888888888777777888888888888888888
Q ss_pred CCChhhhhcCCCcceEecCCCcCcccCCC
Q 037275 554 GQIPEYLENLSFLEYLNLSYNHFEGEVPT 582 (992)
Q Consensus 554 ~~~p~~~~~l~~L~~L~l~~N~l~~~~~~ 582 (992)
+..+..+..+++|++|++++|+|.|.++.
T Consensus 114 ~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 142 (177)
T 2o6r_A 114 SVPDGIFDRLTSLQKIWLHTNPWDCSCPR 142 (177)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred EeCHHHhcCCcccCEEEecCCCeeccCcc
Confidence 76666678888888888888888887764
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.60 E-value=1.2e-15 Score=146.42 Aligned_cols=128 Identities=23% Similarity=0.321 Sum_probs=85.9
Q ss_pred cccCceeccCCccc-CCCCCCccccccccccccccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEE
Q 037275 419 TLLTNLALSSNDLQ-GSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYF 497 (992)
Q Consensus 419 ~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L 497 (992)
++|+.|++++|.++ +.+|..+..+++|++|++++|.++ +. ..+..+++|++|
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~-------------------------~~--~~~~~l~~L~~L 69 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-------------------------SI--ANLPKLNKLKKL 69 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCC-------------------------CC--TTCCCCTTCCEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCC-------------------------Cc--hhhhcCCCCCEE
Confidence 44555555555555 445555555555555544333333 12 345566777777
Q ss_pred eeecccccccCCcccccccccceeeccCCccccc-CCccccccCCCCEEECCCcccCCCCh---hhhhcCCCcceEecCC
Q 037275 498 NISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGS-IPSSLSSLKSIKELDMSSNNLSGQIP---EYLENLSFLEYLNLSY 573 (992)
Q Consensus 498 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~l~~ 573 (992)
+|++|++++.+|..+..+++|++|++++|++++. .+..+..+++|++|++++|++++..+ ..+..+++|++||+++
T Consensus 70 ~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 70 ELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp ECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred ECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 7777777766777777778888888888888753 34678888888888888888886655 5778888888888764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.58 E-value=4.9e-16 Score=169.18 Aligned_cols=136 Identities=15% Similarity=0.194 Sum_probs=99.3
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC--------------CchhH--------HHHHHHHHHhccCCc
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK--------------GASNG--------FVAECQALRNIRHRN 737 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------------~~~~~--------~~~E~~~l~~l~h~n 737 (992)
-|++.+.||+|+||.||+|.+. +|+.||||+++.... ..... ..+|...+.++.+.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 3889999999999999999985 799999999853210 00111 134666666665444
Q ss_pred ce--eEEEEeecccccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEecc
Q 037275 738 LI--KIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGD 815 (992)
Q Consensus 738 iv--~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~D 815 (992)
+. ..+++ ...++||||+++++|..+.. . .....++.|++.+|.|||+. ||||||
T Consensus 175 v~vp~p~~~---------~~~~LVME~i~G~~L~~l~~----------~--~~~~~l~~qll~~l~~lH~~---gIVHrD 230 (397)
T 4gyi_A 175 FPVPEPIAQ---------SRHTIVMSLVDALPMRQVSS----------V--PDPASLYADLIALILRLAKH---GLIHGD 230 (397)
T ss_dssp CSCCCEEEE---------ETTEEEEECCSCEEGGGCCC----------C--SCHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred CCCCeeeec---------cCceEEEEecCCccHhhhcc----------c--HHHHHHHHHHHHHHHHHHHC---CCcCCC
Confidence 32 22222 11279999999888765432 1 12346789999999999999 999999
Q ss_pred CCCCCeeeCCCC----------cEEEeecccceec
Q 037275 816 LKPSNVLLDQDL----------VAHLGDFGLAKFL 840 (992)
Q Consensus 816 lkp~NIll~~~~----------~~kl~Dfg~a~~~ 840 (992)
|||.|||+++++ .+.|+||+.+...
T Consensus 231 LKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 231 FNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 999999998776 4899999988754
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.56 E-value=3.4e-14 Score=159.20 Aligned_cols=252 Identities=11% Similarity=0.138 Sum_probs=125.7
Q ss_pred hhhhccccCceeeeccccccccccccccccCccceEecCCCCCCCCCCCCchhhhhccCCCcceEeecCCCcCCCcCCcc
Q 037275 262 ESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHS 341 (992)
Q Consensus 262 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~l~~~~~~~ 341 (992)
.+|.+. +|+.+.+..| ++.+...+|.+. +|+.+.+.+ .++.++.. .+.+|++|+.+++++|++.......
T Consensus 130 ~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~------aF~~c~~L~~l~l~~n~l~~I~~~a 199 (401)
T 4fdw_A 130 DAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKED------IFYYCYNLKKADLSKTKITKLPAST 199 (401)
T ss_dssp TTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSS------TTTTCTTCCEEECTTSCCSEECTTT
T ss_pred hhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHH------HhhCcccCCeeecCCCcceEechhh
Confidence 345443 5666666555 555555666653 566666654 45554443 2344555555555555554332222
Q ss_pred cccccccceeEEeeCCccccccCCCccCCCcccEEEccCCcCCCCCCccccCCCCCcEEeccCccccccCCCCCCCcccc
Q 037275 342 IANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLL 421 (992)
Q Consensus 342 ~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 421 (992)
|.. ..|+.+.+.+ +++.+...+|.++++|+.+++..| ++.+...+|.+ .+|+.+.+ .+.++.....+|.++++|
T Consensus 200 F~~--~~L~~l~lp~-~l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L 273 (401)
T 4fdw_A 200 FVY--AGIEEVLLPV-TLKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPEL 273 (401)
T ss_dssp TTT--CCCSEEECCT-TCCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTC
T ss_pred Eee--cccCEEEeCC-chheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCC
Confidence 221 2344444442 244444455555555555555543 33233444444 44555555 233333334444444444
Q ss_pred CceeccCCcccCCCCCCccccccccccccccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeec
Q 037275 422 TNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISV 501 (992)
Q Consensus 422 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~ 501 (992)
+.+++.+|.+. .+.+....+..|.++++|+.++|.
T Consensus 274 ~~l~l~~~~~~--------------------------------------------~~~~~~I~~~aF~~c~~L~~l~l~- 308 (401)
T 4fdw_A 274 AEVTTYGSTFN--------------------------------------------DDPEAMIHPYCLEGCPKLARFEIP- 308 (401)
T ss_dssp CEEEEESSCCC--------------------------------------------CCTTCEECTTTTTTCTTCCEECCC-
T ss_pred CEEEeCCcccc--------------------------------------------CCcccEECHHHhhCCccCCeEEeC-
Confidence 44444444332 011111223345555566666665
Q ss_pred ccccccCCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcccCCCChhhhhcCC-CcceEecCCCcC
Q 037275 502 NRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLS-FLEYLNLSYNHF 576 (992)
Q Consensus 502 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~l~~N~l 576 (992)
|.++.+...+|.+|.+|+.++|..| ++.+...+|.++ +|+.|++++|.+....+..|..++ +++.|++..|.+
T Consensus 309 ~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~ 382 (401)
T 4fdw_A 309 ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESV 382 (401)
T ss_dssp TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGH
T ss_pred CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHH
Confidence 3355455556666666666666444 444555666666 666666666666555555555553 556666665543
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.56 E-value=5.5e-15 Score=141.71 Aligned_cols=128 Identities=25% Similarity=0.326 Sum_probs=92.2
Q ss_pred cccccccccccccC-CCCCCccccccccceEEecCCcccCCcCCccCCCCcccEEeccCcccccccCccccccCCCcEEe
Q 037275 147 LKLENLTIADNHLT-GHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVF 225 (992)
Q Consensus 147 ~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 225 (992)
++|++|++++|.++ +.+|..+..+++|++|++++|.+.+. ..++.+++|++|+|++|++++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 56777777777777 66777777778888888888877554 6677778888888888888765666666777777777
Q ss_pred ccCCccCCCCCccccccccccchhhccccccCCCCchhhhccccCceeeecccccccccc---ccccccCccceEecC
Q 037275 226 LPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVS---IYFRSLKNLEWLNLG 300 (992)
Q Consensus 226 l~~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~L~ 300 (992)
+++|++++ + ..+..++.+++|++|++++|.+++.++ ..+..+++|++|+++
T Consensus 95 ls~N~i~~-~-----------------------~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 95 LSGNKIKD-L-----------------------STIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CTTSCCCS-H-----------------------HHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCCcCCC-h-----------------------HHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 77777662 0 012456777778888888888776665 567777777777765
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.55 E-value=5.2e-14 Score=157.71 Aligned_cols=198 Identities=11% Similarity=0.084 Sum_probs=147.5
Q ss_pred ceeEEeeCCccccccCCCccCCCcccEEEccCCcCCCCCCccccCCCCCcEEeccCccccccCCCCCCCccccCceeccC
Q 037275 349 MTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSS 428 (992)
Q Consensus 349 L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 428 (992)
|+.+.+.+ .++.+....|.++.+|+.++|++|+++.+...+|. ..+|+.+.|..+ ++.+...+|.++++|+.+++..
T Consensus 159 L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~ 235 (401)
T 4fdw_A 159 VQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPE 235 (401)
T ss_dssp CCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCT
T ss_pred ceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCC
Confidence 55555553 55556667777777777777777777755555555 467777777644 6656667777777777777776
Q ss_pred CcccCCCCCCccccccccccccccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeeccccc---
Q 037275 429 NDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFS--- 505 (992)
Q Consensus 429 N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~--- 505 (992)
| ++.....+|.+ .+|+.+.+ .|.++......|.++++|+.+++.+|.+.
T Consensus 236 ~-l~~I~~~aF~~-~~L~~i~l--------------------------p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~ 287 (401)
T 4fdw_A 236 N-VSTIGQEAFRE-SGITTVKL--------------------------PNGVTNIASRAFYYCPELAEVTTYGSTFNDDP 287 (401)
T ss_dssp T-CCEECTTTTTT-CCCSEEEE--------------------------ETTCCEECTTTTTTCTTCCEEEEESSCCCCCT
T ss_pred C-ccCcccccccc-CCccEEEe--------------------------CCCccEEChhHhhCCCCCCEEEeCCccccCCc
Confidence 4 45455556665 56666644 23344355677889999999999998875
Q ss_pred --ccCCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcccCCCChhhhhcCCCcceEecCCCcCcccC
Q 037275 506 --GEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEV 580 (992)
Q Consensus 506 --~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 580 (992)
.+.+..|.+|.+|+.++|. |.++.+...+|.++++|+.++|.+| ++...+.+|.++ +|+.+++++|.+....
T Consensus 288 ~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~ 361 (401)
T 4fdw_A 288 EAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVF 361 (401)
T ss_dssp TCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCC
T ss_pred ccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccc
Confidence 4678899999999999999 4588778899999999999999665 776777899999 9999999999876543
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.54 E-value=2.1e-14 Score=142.17 Aligned_cols=83 Identities=18% Similarity=0.266 Sum_probs=46.8
Q ss_pred CceEeeEEcCCCCeEEEeeccccccCCccCCCCCCCCcCCeeeccCCCCCccCCccccCCCCCCEEEeecccCCCCCCcc
Q 037275 38 CQWTGVTCGHRHQRVTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTN 117 (992)
Q Consensus 38 c~w~gv~c~~~~~~v~~ldl~~~~l~~~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~ 117 (992)
|+|.+|.|+.. ++ ..+|..+ .++|++|++++|++++..+..|..+++|++|+|++|++++..+..
T Consensus 7 C~~~~l~~~~~------------~l-~~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 71 (177)
T 2o6r_A 7 CSGTEIRCNSK------------GL-TSVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGV 71 (177)
T ss_dssp EETTEEECCSS------------CC-SSCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTT
T ss_pred eCCCEEEecCC------------CC-ccCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhH
Confidence 67777777543 23 2344333 256777777777777444445666777777777777766333333
Q ss_pred cccCCCCcEeeccccccc
Q 037275 118 LSRCSNLISFNARRNNLV 135 (992)
Q Consensus 118 l~~l~~L~~L~l~~n~l~ 135 (992)
++.+++|++|++++|+++
T Consensus 72 ~~~l~~L~~L~l~~N~l~ 89 (177)
T 2o6r_A 72 FDKLTKLTILYLHENKLQ 89 (177)
T ss_dssp TTTCTTCCEEECCSSCCC
T ss_pred ccCCCccCEEECCCCCcc
Confidence 445555544444444444
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.53 E-value=2.6e-16 Score=159.07 Aligned_cols=153 Identities=22% Similarity=0.205 Sum_probs=110.2
Q ss_pred CCCcCCeeeccCCCCCccCCc------cccCCCCCCEEEeecccCCCCCCcccccCCCCcEeecccccccccCChhhccc
Q 037275 72 NLSFLRYLNLADNNFHGEIPH------QIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYN 145 (992)
Q Consensus 72 ~l~~L~~L~L~~n~l~~~~p~------~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~ 145 (992)
....++.++++.+.+.|.+|. .+..+++|++|+|++|+++ .+| .++.+++|++|++++|+++ .+|..+. .
T Consensus 16 ~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~-~l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~-~ 91 (198)
T 1ds9_A 16 ERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDA-V 91 (198)
T ss_dssp HTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEES-CCC-CHHHHTTCCEEEEEEEEEC-SCSSHHH-H
T ss_pred hcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCc-ccc-ccccCCCCCEEECCCCCcc-cccchhh-c
Confidence 344555666666666655554 7777888888888888877 466 7777788888888888777 6665443 5
Q ss_pred ccccccccccccccCCCCCCccccccccceEEecCCcccCCcC-CccCCCCcccEEeccCcccccccCcc----------
Q 037275 146 WLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIP-NNLGNLRNLILLNLGENRFSGIVPPS---------- 214 (992)
Q Consensus 146 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~-~~l~~l~~L~~L~L~~n~l~~~~p~~---------- 214 (992)
+++|++|+|++|++++ +| .+.++++|++|++++|.+.+..+ ..+..+++|++|++++|.+++..|..
T Consensus 92 ~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~ 169 (198)
T 1ds9_A 92 ADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEV 169 (198)
T ss_dssp HHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHH
T ss_pred CCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHH
Confidence 6778888888888875 44 67788888888888888854222 46788888888999888887665542
Q ss_pred ccccCCCcEEeccCCccC
Q 037275 215 IFNISSLENVFLPTNRFN 232 (992)
Q Consensus 215 l~~l~~L~~L~l~~N~l~ 232 (992)
+..+++|++|+ +|.++
T Consensus 170 ~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 170 VKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp HHHCSSCSEEC--CGGGT
T ss_pred HHhCCCcEEEC--CcccC
Confidence 77788888876 55554
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.52 E-value=1.7e-14 Score=141.44 Aligned_cols=108 Identities=19% Similarity=0.228 Sum_probs=97.0
Q ss_pred ccccccccccCcccccccCCCCccEEeeecccccccCCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcc
Q 037275 472 SLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNN 551 (992)
Q Consensus 472 ~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 551 (992)
.+++++|.++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+
T Consensus 13 ~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~ 89 (170)
T 3g39_A 13 TVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQ 89 (170)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCc
Confidence 4678888887 5666553 889999999999998889999999999999999999998888888999999999999999
Q ss_pred cCCCChhhhhcCCCcceEecCCCcCcccCCC
Q 037275 552 LSGQIPEYLENLSFLEYLNLSYNHFEGEVPT 582 (992)
Q Consensus 552 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~ 582 (992)
|++..+..|..+++|++|+|++|+|.|.++.
T Consensus 90 l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~~ 120 (170)
T 3g39_A 90 LKSIPRGAFDNLKSLTHIWLLNNPWDCACSD 120 (170)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCBCTTBGG
T ss_pred cCEeCHHHhcCCCCCCEEEeCCCCCCCCchh
Confidence 9987778899999999999999999999874
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.52 E-value=1.6e-16 Score=160.51 Aligned_cols=89 Identities=19% Similarity=0.229 Sum_probs=53.5
Q ss_pred cccccCCCCccEEeeecccccccCCcccccccccceeeccCCcccccCC-ccccccCCCCEEECCCcccCCCChh-----
Q 037275 485 PLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIP-SSLSSLKSIKELDMSSNNLSGQIPE----- 558 (992)
Q Consensus 485 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~----- 558 (992)
|..+..+++|++|+|++|++++ +| .+..+++|+.|+|++|+|++..+ ..+..+++|++|++++|++++..|.
T Consensus 86 ~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~ 163 (198)
T 1ds9_A 86 ENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATS 163 (198)
T ss_dssp SSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHH
T ss_pred cchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchH
Confidence 3334444566666666666664 33 46666666666666666663222 3566667777777777777654443
Q ss_pred -----hhhcCCCcceEecCCCcCc
Q 037275 559 -----YLENLSFLEYLNLSYNHFE 577 (992)
Q Consensus 559 -----~~~~l~~L~~L~l~~N~l~ 577 (992)
.+..+++|++|| +|+++
T Consensus 164 ~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 164 EYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp HHHHHHHHHCSSCSEEC--CGGGT
T ss_pred HHHHHHHHhCCCcEEEC--CcccC
Confidence 266777777776 56554
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.50 E-value=3.3e-13 Score=152.10 Aligned_cols=238 Identities=14% Similarity=0.139 Sum_probs=120.6
Q ss_pred hhhhccccCceeeeccccccccccccccccCccceEecCCCCCCCCCCCCchhhhhccCCCcceEeecCCCcCCCcCCcc
Q 037275 262 ESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHS 341 (992)
Q Consensus 262 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~l~~~~~~~ 341 (992)
.+|.++.+|+.+.+.++. ..+....|.++.+|+.+.+..| ++.++.. .+.++..|+.+.+..+...
T Consensus 156 ~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~------~F~~~~~L~~i~~~~~~~~------ 221 (394)
T 4fs7_A 156 EAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDY------CFAECILLENMEFPNSLYY------ 221 (394)
T ss_dssp TTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTT------TTTTCTTCCBCCCCTTCCE------
T ss_pred hhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCch------hhccccccceeecCCCceE------
Confidence 356666667777666543 3355666666677777666554 4444433 2344445554444332211
Q ss_pred cccccccceeEEeeCCccccccCCCccCCCcccEEEccCCcCCCCCCccccCCCCCcEEeccCccccccCCCCCCCcccc
Q 037275 342 IANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLL 421 (992)
Q Consensus 342 ~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 421 (992)
+...+....+|+.+.+..+. +.+....|.....|+.+.+..+... .....|..+..+
T Consensus 222 ---------------------i~~~~~~~~~l~~i~ip~~~-~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l 278 (394)
T 4fs7_A 222 ---------------------LGDFALSKTGVKNIIIPDSF-TELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGL 278 (394)
T ss_dssp ---------------------ECTTTTTTCCCCEEEECTTC-CEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTC
T ss_pred ---------------------eehhhcccCCCceEEECCCc-eecccccccccccceeEEcCCCcce-eecccccccccc
Confidence 11112222344444443322 2233344455555555555544333 344445555555
Q ss_pred CceeccCCcccCCCCCCccccccccccccccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeec
Q 037275 422 TNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISV 501 (992)
Q Consensus 422 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~ 501 (992)
+.+....+.+. ...|..+.+|+.+.+.++ ++..-...|.++.+|+.++|..
T Consensus 279 ~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~--------------------------i~~I~~~aF~~c~~L~~i~lp~ 329 (394)
T 4fs7_A 279 KKVIYGSVIVP---EKTFYGCSSLTEVKLLDS--------------------------VKFIGEEAFESCTSLVSIDLPY 329 (394)
T ss_dssp CEEEECSSEEC---TTTTTTCTTCCEEEECTT--------------------------CCEECTTTTTTCTTCCEECCCT
T ss_pred ceeccCceeec---cccccccccccccccccc--------------------------cceechhhhcCCCCCCEEEeCC
Confidence 55555444322 234455555555433221 1112233455566666666653
Q ss_pred ccccccCCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcccCCCChhhhhcCCCcceE
Q 037275 502 NRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYL 569 (992)
Q Consensus 502 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 569 (992)
+ ++.+-..+|.++.+|+.+++..| ++.+...+|.++++|+.+++..| ++ .+..+|.++++|+.+
T Consensus 330 ~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~I 393 (394)
T 4fs7_A 330 L-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKWI 393 (394)
T ss_dssp T-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred c-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcEE
Confidence 3 44455566777777777777665 55455667777777777777544 33 334556666666554
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.50 E-value=3.5e-14 Score=139.61 Aligned_cols=108 Identities=19% Similarity=0.277 Sum_probs=95.4
Q ss_pred ccccccccccCcccccccCCCCccEEeeecccccccCCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcc
Q 037275 472 SLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNN 551 (992)
Q Consensus 472 ~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 551 (992)
.+++++|.++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+
T Consensus 16 ~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~ 92 (174)
T 2r9u_A 16 LVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNH 92 (174)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCc
Confidence 4678888886 6676664 889999999999998889999999999999999999997777778999999999999999
Q ss_pred cCCCChhhhhcCCCcceEecCCCcCcccCCC
Q 037275 552 LSGQIPEYLENLSFLEYLNLSYNHFEGEVPT 582 (992)
Q Consensus 552 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~ 582 (992)
|++..+..|..+++|++|+|++|+|.|.++.
T Consensus 93 l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~~ 123 (174)
T 2r9u_A 93 LKSIPRGAFDNLKSLTHIYLYNNPWDCECRD 123 (174)
T ss_dssp CCCCCTTTTTTCTTCSEEECCSSCBCTTBGG
T ss_pred cceeCHHHhccccCCCEEEeCCCCccccccc
Confidence 9977777799999999999999999998864
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.50 E-value=1.4e-14 Score=143.27 Aligned_cols=91 Identities=20% Similarity=0.169 Sum_probs=69.7
Q ss_pred ccccCCCCccEEeeecccccccCCcccccccccceeeccCCcccccCCc--cccccCCCCEEECCCcccCCCChh----h
Q 037275 486 LEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPS--SLSSLKSIKELDMSSNNLSGQIPE----Y 559 (992)
Q Consensus 486 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~--~~~~l~~L~~L~Ls~N~l~~~~p~----~ 559 (992)
..+..+++|++|+|++|++++..+..|..+++|++|+|++|+|+ .+|. .+..+++|+.|+|++|+++ .+|. .
T Consensus 58 ~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~ 135 (176)
T 1a9n_A 58 DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYV 135 (176)
T ss_dssp CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHH
T ss_pred cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHH
Confidence 35667778888888888888665565678888888888888886 4554 7788888888888888887 4555 3
Q ss_pred hhcCCCcceEecCCCcCcc
Q 037275 560 LENLSFLEYLNLSYNHFEG 578 (992)
Q Consensus 560 ~~~l~~L~~L~l~~N~l~~ 578 (992)
+..+++|++||+++|....
T Consensus 136 ~~~l~~L~~Ld~~~n~~~~ 154 (176)
T 1a9n_A 136 IYKVPQVRVLDFQKVKLKE 154 (176)
T ss_dssp HHHCTTCSEETTEECCHHH
T ss_pred HHHCCccceeCCCcCCHHH
Confidence 7888888888888887653
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.50 E-value=1.2e-14 Score=143.64 Aligned_cols=133 Identities=17% Similarity=0.250 Sum_probs=75.0
Q ss_pred CCCCCCcCCeeeccCCCCCccCCccccCCC-CCCEEEeecccCCCCCCcccccCCCCcEeecccccccccCChhhccccc
Q 037275 69 YVGNLSFLRYLNLADNNFHGEIPHQIGRLV-RLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWL 147 (992)
Q Consensus 69 ~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~-~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~ 147 (992)
.+.++.+|+.|+|++|+++ .+|. +..+. +|++|+|++|++++ + ..++.+++|++|++++|+++ .+|+.++..++
T Consensus 14 ~~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~-~-~~l~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~ 88 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRK-L-DGFPLLRRLKTLLVNNNRIC-RIGEGLDQALP 88 (176)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCE-E-CCCCCCSSCCEEECCSSCCC-EECSCHHHHCT
T ss_pred hcCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCc-c-cccccCCCCCEEECCCCccc-ccCcchhhcCC
Confidence 3456677777777777777 4554 44444 77777777777773 3 45666666666666666665 34443333444
Q ss_pred ccccccccccccCCCCCCccccccccceEEecCCcccCCcCC--ccCCCCcccEEeccCcccccccCcc----ccccCCC
Q 037275 148 KLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPN--NLGNLRNLILLNLGENRFSGIVPPS----IFNISSL 221 (992)
Q Consensus 148 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~--~l~~l~~L~~L~L~~n~l~~~~p~~----l~~l~~L 221 (992)
+|++|+|++|.++ .+|. .+..+++|+.|++++|.++ .+|.. +..+++|
T Consensus 89 ~L~~L~L~~N~i~-------------------------~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L 142 (176)
T 1a9n_A 89 DLTELILTNNSLV-------------------------ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQV 142 (176)
T ss_dssp TCCEEECCSCCCC-------------------------CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTC
T ss_pred CCCEEECCCCcCC-------------------------cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCcc
Confidence 4444444444443 3333 4455555555555555555 23432 5555566
Q ss_pred cEEeccCCccC
Q 037275 222 ENVFLPTNRFN 232 (992)
Q Consensus 222 ~~L~l~~N~l~ 232 (992)
++|+++.|.+.
T Consensus 143 ~~Ld~~~n~~~ 153 (176)
T 1a9n_A 143 RVLDFQKVKLK 153 (176)
T ss_dssp SEETTEECCHH
T ss_pred ceeCCCcCCHH
Confidence 66666555543
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.48 E-value=6.9e-13 Score=149.50 Aligned_cols=149 Identities=11% Similarity=0.144 Sum_probs=85.1
Q ss_pred cCCCccCCCcccEEEccCCcCCCCCCccccCCCCCcEEeccCccccccCCCCCCCccccCceeccCCcccCCCCCCcccc
Q 037275 363 IPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNC 442 (992)
Q Consensus 363 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 442 (992)
....|..+.+|+.+.+..+... +....|.....++.+....+.+. ...|..+.+|+.+.+.++ ++.....+|.++
T Consensus 245 ~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c 319 (394)
T 4fs7_A 245 GKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESC 319 (394)
T ss_dssp CSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTC
T ss_pred ccccccccccceeEEcCCCcce-eeccccccccccceeccCceeec---cccccccccccccccccc-cceechhhhcCC
Confidence 3445566666666666655443 45556666666666666555432 345666666666666544 444555566666
Q ss_pred ccccccccccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeecccccccCCcccccccccceee
Q 037275 443 KNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLY 522 (992)
Q Consensus 443 ~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 522 (992)
.+|+.+.+.++ + +..-...|.++.+|+.+++..| ++.+...+|.++.+|+.++
T Consensus 320 ~~L~~i~lp~~-v-------------------------~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ 372 (394)
T 4fs7_A 320 TSLVSIDLPYL-V-------------------------EEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVE 372 (394)
T ss_dssp TTCCEECCCTT-C-------------------------CEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEE
T ss_pred CCCCEEEeCCc-c-------------------------cEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEE
Confidence 66666644321 1 1122345566666666666655 5545566677777777777
Q ss_pred ccCCcccccCCccccccCCCCEE
Q 037275 523 LQGNSFSGSIPSSLSSLKSIKEL 545 (992)
Q Consensus 523 L~~N~l~~~~~~~~~~l~~L~~L 545 (992)
+..+ ++ .+..+|.+.++|+.+
T Consensus 373 lp~~-~~-~~~~~F~~c~~L~~I 393 (394)
T 4fs7_A 373 LPKR-LE-QYRYDFEDTTKFKWI 393 (394)
T ss_dssp EEGG-GG-GGGGGBCTTCEEEEE
T ss_pred ECCC-CE-EhhheecCCCCCcEE
Confidence 7654 22 234556666666543
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.43 E-value=2.6e-13 Score=132.91 Aligned_cols=109 Identities=22% Similarity=0.258 Sum_probs=98.2
Q ss_pred CccEEeeecccccccCCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcccCCCChhhhhcCCCcceEecC
Q 037275 493 NLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLS 572 (992)
Q Consensus 493 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 572 (992)
..+.|++++|.++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|+
T Consensus 10 ~~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~ 86 (170)
T 3g39_A 10 SGTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN 86 (170)
T ss_dssp ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence 3578999999999 4666553 789999999999998889999999999999999999998888889999999999999
Q ss_pred CCcCcccCCC-CCccCCcccccccCCCCcCCCC
Q 037275 573 YNHFEGEVPT-KGVFSNKTGISLSGNGKVCGGL 604 (992)
Q Consensus 573 ~N~l~~~~~~-~~~~~~~~~~~l~~N~~~C~~~ 604 (992)
+|+|++.++. ...++.++.+++.+|++.|.|+
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 87 DNQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred CCccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 9999998775 5678899999999999999875
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.41 E-value=4.7e-13 Score=131.50 Aligned_cols=108 Identities=23% Similarity=0.292 Sum_probs=97.3
Q ss_pred ccEEeeecccccccCCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcccCCCChhhhhcCCCcceEecCC
Q 037275 494 LVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSY 573 (992)
Q Consensus 494 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 573 (992)
-+.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus 14 ~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 14 QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 378999999998 6676664 7999999999999998899999999999999999999987777789999999999999
Q ss_pred CcCcccCCC-CCccCCcccccccCCCCcCCCC
Q 037275 574 NHFEGEVPT-KGVFSNKTGISLSGNGKVCGGL 604 (992)
Q Consensus 574 N~l~~~~~~-~~~~~~~~~~~l~~N~~~C~~~ 604 (992)
|+|++.++. ...++.++.+++.+|++.|.+.
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDCECR 122 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred CccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence 999988775 5668899999999999999874
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.38 E-value=2.4e-13 Score=150.59 Aligned_cols=130 Identities=18% Similarity=0.134 Sum_probs=109.6
Q ss_pred cccccc-cccCcccccccCCCCccEEeeec-ccccccCCcccccccccceeeccCCcccccCCccccccCCCCEEECCCc
Q 037275 473 LDLSYN-LLSGTLPLEVGNLKNLVYFNISV-NRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSN 550 (992)
Q Consensus 473 L~l~~N-~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 550 (992)
++.+++ .++ .+|. +..+++|++|+|++ |+|++..+..|.++++|+.|+|++|+|++..|..|.+|++|+.|+|++|
T Consensus 13 v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 90 (347)
T 2ifg_A 13 LRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (347)
T ss_dssp EECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred EEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence 477777 787 5777 99999999999996 9999888899999999999999999999999999999999999999999
Q ss_pred ccCCCChhhhhcCCCcceEecCCCcCcccCCCCCccCCc--ccccccCCCCcCCCCC
Q 037275 551 NLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNK--TGISLSGNGKVCGGLD 605 (992)
Q Consensus 551 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~--~~~~l~~N~~~C~~~~ 605 (992)
+|++..+..|..++ |+.|+|++|+|.|.|...+...++ ....+..+...|..|.
T Consensus 91 ~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~~ 146 (347)
T 2ifg_A 91 ALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQG 146 (347)
T ss_dssp CCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred ccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCCh
Confidence 99977777777776 999999999999988754332222 2334556778888765
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.30 E-value=3.9e-14 Score=157.18 Aligned_cols=135 Identities=16% Similarity=0.078 Sum_probs=64.6
Q ss_pred CCCCCEEEeecccCCCCCCcccccC-----CCCcEeecccccccccCChhhcccccccccccccccccCCCCCCccc---
Q 037275 97 LVRLEALVLANNSFSGKIPTNLSRC-----SNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIG--- 168 (992)
Q Consensus 97 l~~L~~L~Ls~n~l~~~~p~~l~~l-----~~L~~L~l~~n~l~~~~p~~~~~~l~~L~~L~L~~n~l~~~~p~~~~--- 168 (992)
+++|++|+|++|.++......+... ++|+.|+|++|+++......+...+++|++|+|++|.++......+.
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L 150 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL 150 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence 3556777777777663333333322 56666666666665444444444455566666666665533222221
Q ss_pred --cccccceEEecCCcccC----CcCCccCCCCcccEEeccCcccccc----cCccccccCCCcEEeccCCcc
Q 037275 169 --NLSTLERINVLGNGLWG----RIPNNLGNLRNLILLNLGENRFSGI----VPPSIFNISSLENVFLPTNRF 231 (992)
Q Consensus 169 --~l~~L~~L~l~~n~l~~----~~~~~l~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~l~~N~l 231 (992)
..++|++|+|++|.+.. .++..+..+++|++|+|++|.|++. ++..+...++|++|+|++|.|
T Consensus 151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i 223 (372)
T 3un9_A 151 LHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGA 223 (372)
T ss_dssp HSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCC
T ss_pred HhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCC
Confidence 23445555555555422 1222233444455555555554421 122333344444444444444
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.24 E-value=1.5e-10 Score=130.24 Aligned_cols=42 Identities=12% Similarity=0.328 Sum_probs=17.7
Q ss_pred CcccccccccceeeccCCcccccCCccccccCCCCEEECCCcc
Q 037275 509 PVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNN 551 (992)
Q Consensus 509 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 551 (992)
..+|.++.+|+.+.+..+ ++.+...+|.++++|+.+++.+|.
T Consensus 327 ~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~ 368 (394)
T 4gt6_A 327 DDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSR 368 (394)
T ss_dssp TTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCH
T ss_pred HhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCce
Confidence 334444444444444332 332333444444444444444443
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.24 E-value=3.8e-13 Score=149.24 Aligned_cols=160 Identities=18% Similarity=0.177 Sum_probs=107.2
Q ss_pred CCCCcEEeccCccccccCCCCCCC-----ccccCceeccCCcccCCCCCCc-cccccccccccccccccccCchhhhhhc
Q 037275 394 LKNLQLLYLDSNFLAGGIPTSLGN-----LTLLTNLALSSNDLQGSIPPSL-GNCKNLIELHMADIELTGALPPQILSIS 467 (992)
Q Consensus 394 l~~L~~L~L~~N~l~~~~~~~~~~-----l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~l~~n~l~~~~p~~~~~~~ 467 (992)
+++|+.|+|++|.|+......+.. .++|+.|+|++|.|+......+ ..+++|+.|+|++|.++
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~----------- 139 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLG----------- 139 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCC-----------
T ss_pred HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCC-----------
Confidence 456888888888887433322222 2578888888887763222222 23455666655555544
Q ss_pred ccccccccccccccCcccccc-----cCCCCccEEeeeccccccc----CCcccccccccceeeccCCccccc----CCc
Q 037275 468 TLSLSLDLSYNLLSGTLPLEV-----GNLKNLVYFNISVNRFSGE----IPVTLSACTSLQQLYLQGNSFSGS----IPS 534 (992)
Q Consensus 468 ~~~~~L~l~~N~l~~~~~~~~-----~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~~~ 534 (992)
......+ ...++|++|+|++|.|+.. ++..+..+++|++|+|++|.|++. ++.
T Consensus 140 --------------~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~ 205 (372)
T 3un9_A 140 --------------PEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAA 205 (372)
T ss_dssp --------------HHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHH
T ss_pred --------------HHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHH
Confidence 2222222 2356899999999998742 344456788899999999998753 356
Q ss_pred cccccCCCCEEECCCcccCCC----ChhhhhcCCCcceEecCCCcCcc
Q 037275 535 SLSSLKSIKELDMSSNNLSGQ----IPEYLENLSFLEYLNLSYNHFEG 578 (992)
Q Consensus 535 ~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~ 578 (992)
.+...++|++|+|++|+|++. ++..+...++|++|||++|+++.
T Consensus 206 ~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~ 253 (372)
T 3un9_A 206 QLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSS 253 (372)
T ss_dssp HGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCH
T ss_pred HHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCH
Confidence 677788999999999999753 33445567899999999998864
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.23 E-value=1.6e-11 Score=135.88 Aligned_cols=133 Identities=18% Similarity=0.165 Sum_probs=97.8
Q ss_pred CceeccCC-cccCCCCCCccccccccccccccccccccCchhhhhhccccccccccc-ccccCcccccccCCCCccEEee
Q 037275 422 TNLALSSN-DLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSY-NLLSGTLPLEVGNLKNLVYFNI 499 (992)
Q Consensus 422 ~~L~L~~N-~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~-N~l~~~~~~~~~~l~~L~~L~L 499 (992)
..++++++ +|+ .+|. +..+++|+.| +|++ |.|++..+..|.++++|++|+|
T Consensus 11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L-------------------------~l~~~n~l~~~~~~~~~~l~~L~~L~l 63 (347)
T 2ifg_A 11 SGLRCTRDGALD-SLHH-LPGAENLTEL-------------------------YIENQQHLQHLELRDLRGLGELRNLTI 63 (347)
T ss_dssp SCEECCSSCCCT-TTTT-SCSCSCCSEE-------------------------ECCSCSSCCEECGGGSCSCCCCSEEEC
T ss_pred CEEEcCCCCCCC-ccCC-CCCCCCeeEE-------------------------EccCCCCCCCcChhHhccccCCCEEEC
Confidence 34677776 777 4666 7777777777 4443 5555455677888999999999
Q ss_pred ecccccccCCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcccCCCCh-hhhhcCCCcceEecCCCcCcc
Q 037275 500 SVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIP-EYLENLSFLEYLNLSYNHFEG 578 (992)
Q Consensus 500 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~ 578 (992)
++|+|++.+|..|.++++|+.|+|++|+|++..+..|..++ |+.|+|++|.+...-. .+|..+.......+..+.+.|
T Consensus 64 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C 142 (347)
T 2ifg_A 64 VKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQC 142 (347)
T ss_dssp CSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCC
T ss_pred CCCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCC
Confidence 99999988888999999999999999999976666676666 9999999999973222 334433334445566678888
Q ss_pred cCCC
Q 037275 579 EVPT 582 (992)
Q Consensus 579 ~~~~ 582 (992)
..|.
T Consensus 143 ~~~~ 146 (347)
T 2ifg_A 143 HGQG 146 (347)
T ss_dssp SSSS
T ss_pred CCCh
Confidence 7665
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.20 E-value=4.3e-11 Score=126.71 Aligned_cols=147 Identities=17% Similarity=0.130 Sum_probs=112.7
Q ss_pred HHHHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhcc-CCcceeEEEEeecccccC
Q 037275 674 LSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIR-HRNLIKIITICSSIDFKG 752 (992)
Q Consensus 674 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 752 (992)
+......|++...++.|+.+.||++.. .++.+++|+...........+.+|+.+++.+. +..+.++++++..
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~----- 81 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH----- 81 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-----
T ss_pred HHHHhccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec-----
Confidence 445567888888999999999999986 36889999986432233456889999999994 6778888887543
Q ss_pred cceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcC-------------------------
Q 037275 753 VDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHC------------------------- 807 (992)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~------------------------- 807 (992)
.+..++||||++|.++.+.+.. ......++.+++++++.||+..
T Consensus 82 ~~~~~lv~e~i~G~~l~~~~~~-----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (263)
T 3tm0_A 82 DGWSNLLMSEADGVLCSEEYED-----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDL 150 (263)
T ss_dssp TTEEEEEEECCSSEEHHHHCCT-----------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTC
T ss_pred CCceEEEEEecCCeehhhccCC-----------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccc
Confidence 3456899999999998876321 1123467889999999999810
Q ss_pred -------------------------------CCCeEeccCCCCCeeeCCCCcEEEeecccce
Q 037275 808 -------------------------------QPPVVHGDLKPSNVLLDQDLVAHLGDFGLAK 838 (992)
Q Consensus 808 -------------------------------~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 838 (992)
.+.++|||++|.||+++++..+.|+||+.+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 151 ADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1358999999999999876667799999775
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.19 E-value=1.3e-09 Score=122.61 Aligned_cols=84 Identities=12% Similarity=0.154 Sum_probs=43.2
Q ss_pred ccCCCccCCCcccEEEccCCcCCCCCCccccCCCCCcEEeccCccccccCCCCCCCccccCceeccCCcccCCCCCCccc
Q 037275 362 IIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGN 441 (992)
Q Consensus 362 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 441 (992)
+...+|.++.+|+.+.+..+... +...+|.++.+|+.+.+. +.++.....+|.++++|+.++|..+ ++.....+|.+
T Consensus 256 i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~ 332 (394)
T 4gt6_A 256 IETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAG 332 (394)
T ss_dssp ECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT
T ss_pred cccceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhC
Confidence 44455666666666666554433 445555566666666654 3344344445555555555555433 33333444444
Q ss_pred ccccccc
Q 037275 442 CKNLIEL 448 (992)
Q Consensus 442 l~~L~~L 448 (992)
+.+|+.+
T Consensus 333 C~~L~~i 339 (394)
T 4gt6_A 333 CEQLERI 339 (394)
T ss_dssp CTTCCEE
T ss_pred CCCCCEE
Confidence 4444444
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.95 E-value=5.6e-10 Score=118.01 Aligned_cols=137 Identities=15% Similarity=0.098 Sum_probs=96.8
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCc--ceeEEEEeecccccCcceE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRN--LIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~ 756 (992)
..|.+..+.+.|..+.||++... +|+.+++|+.... ....+.+|+.+++.+.+.+ +.+++++.. ..+..
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~-~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~-----~~~~~ 90 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVT-----EAGRD 90 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECT-TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEE-----CSSCE
T ss_pred CCCceEecccCCCCceEEEEecC-CCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEecc-----CCCCC
Confidence 34554444446667999999763 6778999997533 3356789999999996544 455777643 23446
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcC-----------------------------
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHC----------------------------- 807 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~----------------------------- 807 (992)
++||||++|.++. ... .+ ...++.++++.|+.||+..
T Consensus 91 ~~v~e~i~G~~l~--~~~---------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (264)
T 1nd4_A 91 WLLLGEVPGQDLL--SSH---------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQD 156 (264)
T ss_dssp EEEEECCSSEETT--TSC---------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTT
T ss_pred EEEEEecCCcccC--cCc---------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccch
Confidence 9999999998884 211 11 1246677788888888641
Q ss_pred --------------------------CCCeEeccCCCCCeeeCCCCcEEEeecccce
Q 037275 808 --------------------------QPPVVHGDLKPSNVLLDQDLVAHLGDFGLAK 838 (992)
Q Consensus 808 --------------------------~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 838 (992)
.+.++|||++|.||++++++.+.|+|||.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 157 DLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp SCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1139999999999999877667799999875
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.93 E-value=3.6e-08 Score=110.26 Aligned_cols=163 Identities=14% Similarity=0.113 Sum_probs=83.3
Q ss_pred CCcccEEEccCCcCCCCCCccccCCCCCcEEeccCccccccCCCCCCCccccCceeccCCcccCCCCCCccccccccccc
Q 037275 370 LVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELH 449 (992)
Q Consensus 370 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 449 (992)
...+..+.+..+.-. .....+....+|+.+.+..+ ++.....+|.++..|+.+.+..+ ++.....+|.++.+|+.+.
T Consensus 193 ~~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~ 269 (379)
T 4h09_A 193 AKTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLN 269 (379)
T ss_dssp TCCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEE
T ss_pred cccccccccccceeE-Eeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccc
Confidence 334444444333222 33444555556666665443 33244455556666666666544 4434445555555555553
Q ss_pred cccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeecccccccCCcccccccccceeeccCCccc
Q 037275 450 MADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFS 529 (992)
Q Consensus 450 l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 529 (992)
+..+ ++......|.++.+|+.+.+.++.++.+...+|.++.+|+.+.|..+ ++
T Consensus 270 l~~~--------------------------i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~ 322 (379)
T 4h09_A 270 FYAK--------------------------VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LK 322 (379)
T ss_dssp ECCC--------------------------CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CC
T ss_pred cccc--------------------------ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-cc
Confidence 3221 11122234555666666666666665555566666666666666543 44
Q ss_pred ccCCccccccCCCCEEECCCcccCCCChhhhhcC
Q 037275 530 GSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENL 563 (992)
Q Consensus 530 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 563 (992)
.+...+|.++.+|+.+.+..+ ++.....+|.++
T Consensus 323 ~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c 355 (379)
T 4h09_A 323 TIQVYAFKNCKALSTISYPKS-ITLIESGAFEGS 355 (379)
T ss_dssp EECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTS
T ss_pred EEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCC
Confidence 344556666666666666543 443334445443
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.91 E-value=4.4e-10 Score=123.31 Aligned_cols=180 Identities=12% Similarity=0.138 Sum_probs=98.1
Q ss_pred CeEEEeeccccccCC--------ccCCCCCCCCcCCeeeccCCCCC---------ccCCccccCCCCCCEEEeecccCCC
Q 037275 50 QRVTKLDLSNRTIGG--------TLSPYVGNLSFLRYLNLADNNFH---------GEIPHQIGRLVRLEALVLANNSFSG 112 (992)
Q Consensus 50 ~~v~~ldl~~~~l~~--------~l~~~l~~l~~L~~L~L~~n~l~---------~~~p~~~~~l~~L~~L~Ls~n~l~~ 112 (992)
.+|+.|.+......+ .+.+++..+++|+.|.+.++... +.++..+..+++|+.|.|++|.-.
T Consensus 107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l- 185 (362)
T 2ra8_A 107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL- 185 (362)
T ss_dssp GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-
T ss_pred hhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-
Confidence 356677766554432 13445667888999988765432 234455677888999999887311
Q ss_pred CCCcccccCCCCcEeecccccccccCChhhcc-cccccccccccc--cccCCC-----CCCcc--ccccccceEEecCCc
Q 037275 113 KIPTNLSRCSNLISFNARRNNLVGEIPAELGY-NWLKLENLTIAD--NHLTGH-----FPASI--GNLSTLERINVLGNG 182 (992)
Q Consensus 113 ~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~-~l~~L~~L~L~~--n~l~~~-----~p~~~--~~l~~L~~L~l~~n~ 182 (992)
.+|. + .+++|++|++..|.+.......+.. .+++|++|+|+. |...+. +...+ ..+++|++|+|.+|.
T Consensus 186 ~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~ 263 (362)
T 2ra8_A 186 SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAE 263 (362)
T ss_dssp BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCT
T ss_pred eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCC
Confidence 3343 3 3778888888888776444334432 467777777753 221111 00111 234566666666665
Q ss_pred ccCCcCCcc---CCCCcccEEeccCcccccc----cCccccccCCCcEEeccCCccC
Q 037275 183 LWGRIPNNL---GNLRNLILLNLGENRFSGI----VPPSIFNISSLENVFLPTNRFN 232 (992)
Q Consensus 183 l~~~~~~~l---~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~l~~N~l~ 232 (992)
+....+..+ ..+++|++|+|+.|.+++. ++..+..+++|+.|+|++|.++
T Consensus 264 i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~ 320 (362)
T 2ra8_A 264 EQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320 (362)
T ss_dssp THHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred CchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence 532222111 1345566666666655532 2233344555555555555444
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.88 E-value=7e-10 Score=121.72 Aligned_cols=183 Identities=15% Similarity=0.159 Sum_probs=110.4
Q ss_pred ccCCCcccEEEccCCcCC---------CCCCccccCCCCCcEEeccCcc-ccccCCCCCCCccccCceeccCCcccCCCC
Q 037275 367 IRNLVNLVELCMDDNKLT---------GTIPHAIGELKNLQLLYLDSNF-LAGGIPTSLGNLTLLTNLALSSNDLQGSIP 436 (992)
Q Consensus 367 ~~~l~~L~~L~L~~N~l~---------~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 436 (992)
...+++|+.|.+..+... +.+...+..+++|+.|+|++|. +. ++. + .+++|+.|+|..|.++....
T Consensus 135 ~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l~--l~~-~-~~~~L~~L~L~~~~l~~~~l 210 (362)
T 2ra8_A 135 KEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLS--IGK-K-PRPNLKSLEIISGGLPDSVV 210 (362)
T ss_dssp HHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTCB--CCS-C-BCTTCSEEEEECSBCCHHHH
T ss_pred hhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCce--ecc-c-cCCCCcEEEEecCCCChHHH
Confidence 445667777777554321 1233455667888888888773 32 232 3 36788888888777763322
Q ss_pred CCcc--ccccccccccccc--cccccCchhhhhhcccccccccccccccCcccccc--cCCCCccEEeeecccccccCCc
Q 037275 437 PSLG--NCKNLIELHMADI--ELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEV--GNLKNLVYFNISVNRFSGEIPV 510 (992)
Q Consensus 437 ~~~~--~l~~L~~L~l~~n--~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~--~~l~~L~~L~Ls~N~l~~~~~~ 510 (992)
..+. .+++|+.|.|+.+ ...+. ..+. .+...+ ..+++|++|+|++|.+.+..+.
T Consensus 211 ~~l~~~~lp~L~~L~L~~~~~~~~~~-------------------~~~~-~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~ 270 (362)
T 2ra8_A 211 EDILGSDLPNLEKLVLYVGVEDYGFD-------------------GDMN-VFRPLFSKDRFPNLKWLGIVDAEEQNVVVE 270 (362)
T ss_dssp HHHHHSBCTTCCEEEEECBCGGGTCC-------------------SCGG-GTGGGSCTTTCTTCCEEEEESCTTHHHHHH
T ss_pred HHHHHccCCCCcEEEEeccccccccc-------------------hhHH-HHHHHHhcCCCCCcCEEeCCCCCCchHHHH
Confidence 2232 5677777766421 11100 0000 000111 3578899999999988754333
Q ss_pred ccc---cccccceeeccCCccccc----CCccccccCCCCEEECCCcccCCCChhhhhc-CCCcceEecCCCc
Q 037275 511 TLS---ACTSLQQLYLQGNSFSGS----IPSSLSSLKSIKELDMSSNNLSGQIPEYLEN-LSFLEYLNLSYNH 575 (992)
Q Consensus 511 ~~~---~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~l~~N~ 575 (992)
.+. .+++|+.|+|+.|.|++. ++..+..+++|+.|+|++|.|+...-..+.. + ...+++++|+
T Consensus 271 ~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~al--g~~~~~~~~~ 341 (362)
T 2ra8_A 271 MFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSL--PMKIDVSDSQ 341 (362)
T ss_dssp HHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHHC--CSEEECCSBC
T ss_pred HHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHHc--CCEEEecCCc
Confidence 333 477899999999988863 3444567788999999999887544444443 2 3557888776
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.83 E-value=1.7e-07 Score=104.65 Aligned_cols=147 Identities=14% Similarity=0.121 Sum_probs=83.7
Q ss_pred CCCccCCCcccEEEccCCcCCCCCCccccCCCCCcEEeccCccccccCCCCCCCccccCceeccCCcccCCCCCCccccc
Q 037275 364 PTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCK 443 (992)
Q Consensus 364 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 443 (992)
...+....+|+.+.+..+ +..+...+|.....|+.+.+..+ ++.....+|.++.+|+.+.+..+ +......+|.++.
T Consensus 210 ~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~ 286 (379)
T 4h09_A 210 AYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCS 286 (379)
T ss_dssp TTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCT
T ss_pred ecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceecccccccccc
Confidence 344555556666665443 22244555666666666666554 44344556666666666666543 4434455666666
Q ss_pred cccccccccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeecccccccCCcccccccccceeec
Q 037275 444 NLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYL 523 (992)
Q Consensus 444 ~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 523 (992)
+|+.+.+.++.++ ..-...|.++.+|+.+.|..+ ++.+-..+|.++.+|+.+.+
T Consensus 287 ~L~~i~l~~~~i~-------------------------~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~i 340 (379)
T 4h09_A 287 NLTKVVMDNSAIE-------------------------TLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISY 340 (379)
T ss_dssp TCCEEEECCTTCC-------------------------EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCC
T ss_pred ccccccccccccc-------------------------eehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEE
Confidence 6666644444333 122344556666777766544 54455667777778887777
Q ss_pred cCCcccccCCccccccC
Q 037275 524 QGNSFSGSIPSSLSSLK 540 (992)
Q Consensus 524 ~~N~l~~~~~~~~~~l~ 540 (992)
..+ ++.+...+|.+..
T Consensus 341 p~~-v~~I~~~aF~~c~ 356 (379)
T 4h09_A 341 PKS-ITLIESGAFEGSS 356 (379)
T ss_dssp CTT-CCEECTTTTTTSS
T ss_pred CCc-cCEEchhHhhCCC
Confidence 655 5545566676653
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.81 E-value=7.1e-09 Score=114.99 Aligned_cols=145 Identities=14% Similarity=0.209 Sum_probs=105.6
Q ss_pred CCCccccccceEEEEeEECCCCeEEEEEEee--ccC-CCchhHHHHHHHHHHhcc--CCcceeEEEEeecccccCcceEE
Q 037275 683 SSNMIGQGSFGFVYKGNLGENGMMVAVKVIN--LKQ-KGASNGFVAECQALRNIR--HRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 683 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
.++.++.|.++.||++... +..+++|+.. ... ......+.+|+.+++.+. +..+.++++++.+... .+..+
T Consensus 42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~--~g~~~ 117 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESV--IGRAF 117 (359)
T ss_dssp EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTT--TSSCE
T ss_pred eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCc--cCCeE
Confidence 4567899999999999874 4678888775 322 122356889999999996 4557888888654321 23458
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcC------------------------------
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHC------------------------------ 807 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~------------------------------ 807 (992)
+||||++|..+.+.. ...++..++..++.+++++|+.||+..
T Consensus 118 ~vme~v~G~~l~~~~--------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQS--------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLS 189 (359)
T ss_dssp EEEECCCCBCCCCTT--------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHH
T ss_pred EEEEecCCeecCCCc--------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhc
Confidence 999999987774311 113677888889999999999999731
Q ss_pred -------------------------CCCeEeccCCCCCeeeCCCCc--EEEeeccccee
Q 037275 808 -------------------------QPPVVHGDLKPSNVLLDQDLV--AHLGDFGLAKF 839 (992)
Q Consensus 808 -------------------------~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~ 839 (992)
.+.++|||++|.||+++.++. +.|+||+.+..
T Consensus 190 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 190 ETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999987753 68999998874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.78 E-value=4.3e-09 Score=113.73 Aligned_cols=195 Identities=15% Similarity=0.148 Sum_probs=122.3
Q ss_pred CCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhcc-CCc--ceeEEEEeecccccCcceEEEEE
Q 037275 684 SNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIR-HRN--LIKIITICSSIDFKGVDFQAIVY 760 (992)
Q Consensus 684 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~~~~~~~~~~~~~~~~~~lv~ 760 (992)
++.++.|....||++. ..+++|+.... .....+.+|+++++.+. +.. +.+++.+.... ......++||
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~--~~~~~~~~vm 95 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPS--ETYQMSFAGF 95 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCC--SSCSCSCEEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCC--CCCCcceEEE
Confidence 4678999999999875 34889986422 33567889999999883 332 34555443221 1112347899
Q ss_pred EeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcC---------------------------------
Q 037275 761 EYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHC--------------------------------- 807 (992)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--------------------------------- 807 (992)
|+++|.++.+... ..++..++..++.+++..++.||+..
T Consensus 96 ~~i~G~~l~~~~~--------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (304)
T 3sg8_A 96 TKIKGVPLTPLLL--------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKG 167 (304)
T ss_dssp ECCCCEECCHHHH--------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCH
T ss_pred cccCCeECCcccc--------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCc
Confidence 9999988865432 13677777888888888888888610
Q ss_pred ----------------------CCCeEeccCCCCCeeeCC--CCcEEEeecccceecCCCCCCCCcccCC---CC----C
Q 037275 808 ----------------------QPPVVHGDLKPSNVLLDQ--DLVAHLGDFGLAKFLSSSPLDTAVETPS---SS----K 856 (992)
Q Consensus 808 ----------------------~~~ivH~Dlkp~NIll~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~~---~~----~ 856 (992)
.+.++|+|++|.||++++ +..+.++||+.+..-... .+-...... .. .
T Consensus 168 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-~Dl~~~~~~~~~~~~~~~~ 246 (304)
T 3sg8_A 168 PQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-NDFISLMEDDEEYGMEFVS 246 (304)
T ss_dssp HHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-HHHHTTCCTTTSCCHHHHH
T ss_pred ccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-HHHHHHHhhccccCHHHHH
Confidence 245899999999999988 557889999998754321 000000000 00 0
Q ss_pred cccccccccc-cccccCCCcCcccchhhHHHHHHHHHhCCCCC
Q 037275 857 GIKGTVGYIA-PEYGMGGEASMTGDVYSFGILLLEMFTRRRPT 898 (992)
Q Consensus 857 ~~~gt~~y~a-PE~~~~~~~~~~~DiwSlG~il~elltg~~pf 898 (992)
......++.. |+... ......+.|++|.++|.+.+|+.+|
T Consensus 247 ~~l~~Y~~~~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 247 KILNHYKHKDIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHTCSCHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHcCCCCcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0000001111 22211 1122358999999999999998765
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.74 E-value=5e-10 Score=116.17 Aligned_cols=98 Identities=19% Similarity=0.159 Sum_probs=52.8
Q ss_pred CCceEeeEEcCCCCeEEEeeccc---cccCCccCC-C-----------------------CCCCCcCCe--eeccCCCCC
Q 037275 37 LCQWTGVTCGHRHQRVTKLDLSN---RTIGGTLSP-Y-----------------------VGNLSFLRY--LNLADNNFH 87 (992)
Q Consensus 37 ~c~w~gv~c~~~~~~v~~ldl~~---~~l~~~l~~-~-----------------------l~~l~~L~~--L~L~~n~l~ 87 (992)
.|.|.|+.|+..+.+|..+...+ ..+.+.+++ . +...+.|+. ++++.|...
T Consensus 77 l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~~~ 156 (267)
T 3rw6_A 77 LKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKLIMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRS 156 (267)
T ss_dssp HHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHHHHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTSHH
T ss_pred HHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHHHHHhccchhccccCHHHcCCCcchhhcCccccCCHHH
Confidence 58899999998777886665544 233333321 1 222223333 444444322
Q ss_pred ccCCcc----ccCCCCCCEEEeecccCCC--CCCcccccCCCCcEeeccccccc
Q 037275 88 GEIPHQ----IGRLVRLEALVLANNSFSG--KIPTNLSRCSNLISFNARRNNLV 135 (992)
Q Consensus 88 ~~~p~~----~~~l~~L~~L~Ls~n~l~~--~~p~~l~~l~~L~~L~l~~n~l~ 135 (992)
.++.. ...+++|++|+||+|+|++ .+|..++.+++|+.|+|++|+++
T Consensus 157 -~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~ 209 (267)
T 3rw6_A 157 -CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK 209 (267)
T ss_dssp -HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCC
T ss_pred -HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccC
Confidence 22211 1345666666666666664 34455556666666666666655
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.53 E-value=2.6e-08 Score=103.29 Aligned_cols=80 Identities=25% Similarity=0.387 Sum_probs=50.5
Q ss_pred cCCCCccEEeeecccccc--cCCcccccccccceeeccCCcccccCCccccccC--CCCEEECCCcccCCCCh-------
Q 037275 489 GNLKNLVYFNISVNRFSG--EIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLK--SIKELDMSSNNLSGQIP------- 557 (992)
Q Consensus 489 ~~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~Ls~N~l~~~~p------- 557 (992)
.++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|++|+|++|.+.+.+|
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~ 244 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS 244 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence 456677777777777776 3345566677777777777777654 3344444 67777777777765444
Q ss_pred hhhhcCCCcceEe
Q 037275 558 EYLENLSFLEYLN 570 (992)
Q Consensus 558 ~~~~~l~~L~~L~ 570 (992)
..+..+++|+.||
T Consensus 245 ~il~~~P~L~~LD 257 (267)
T 3rw6_A 245 AIRERFPKLLRLD 257 (267)
T ss_dssp HHHHHCTTCCEES
T ss_pred HHHHHCcccCeEC
Confidence 2355666666664
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.37 E-value=1.5e-08 Score=100.24 Aligned_cols=46 Identities=13% Similarity=0.066 Sum_probs=27.2
Q ss_pred cCCCCCCCCcCCeeeccCC-CCCcc----CCccccCCCCCCEEEeecccCC
Q 037275 66 LSPYVGNLSFLRYLNLADN-NFHGE----IPHQIGRLVRLEALVLANNSFS 111 (992)
Q Consensus 66 l~~~l~~l~~L~~L~L~~n-~l~~~----~p~~~~~l~~L~~L~Ls~n~l~ 111 (992)
+...+...+.|++|+|++| .+... +...+...++|++|+|++|+|.
T Consensus 28 l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~ 78 (185)
T 1io0_A 28 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSN 78 (185)
T ss_dssp HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCC
T ss_pred HHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCC
Confidence 3344556666777777776 66532 3344455566666666666665
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.27 E-value=1.8e-07 Score=92.44 Aligned_cols=93 Identities=23% Similarity=0.266 Sum_probs=69.5
Q ss_pred cccccCCCCccEEeeeccccccc----CCcccccccccceeeccCCccccc----CCccccccCCCCEEEC--CCcccCC
Q 037275 485 PLEVGNLKNLVYFNISVNRFSGE----IPVTLSACTSLQQLYLQGNSFSGS----IPSSLSSLKSIKELDM--SSNNLSG 554 (992)
Q Consensus 485 ~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L--s~N~l~~ 554 (992)
...+...++|++|+|++|.|... +...+...++|++|+|++|.|++. +...+...++|++|+| ++|.|+.
T Consensus 58 ~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~ 137 (185)
T 1io0_A 58 AEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGN 137 (185)
T ss_dssp HHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCH
T ss_pred HHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCH
Confidence 34455677899999999988742 334455567899999999998853 4566777788999999 8899875
Q ss_pred C----ChhhhhcCCCcceEecCCCcCc
Q 037275 555 Q----IPEYLENLSFLEYLNLSYNHFE 577 (992)
Q Consensus 555 ~----~p~~~~~l~~L~~L~l~~N~l~ 577 (992)
. +...+...++|++|+|++|.+.
T Consensus 138 ~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 138 NVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 3 3345566688999999998875
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.26 E-value=3.3e-06 Score=89.29 Aligned_cols=135 Identities=18% Similarity=0.115 Sum_probs=96.7
Q ss_pred ccccccce-EEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhcc-CCcceeEEEEeecccccCcceEEEEEEec
Q 037275 686 MIGQGSFG-FVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIR-HRNLIKIITICSSIDFKGVDFQAIVYEYM 763 (992)
Q Consensus 686 ~lg~G~~g-~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 763 (992)
.+..|..+ .||+......+..+++|+.... ....+.+|...++.+. +--+.++++++.+ .+..++|||++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~-----~~~~~lvme~l 102 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRT-----PDDAWLLTTAI 102 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEE-----TTEEEEEEECC
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEE-----CCeEEEEEEee
Confidence 44555555 7999888767788999986522 3556889999999884 3336677777543 24569999999
Q ss_pred cCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 037275 764 QNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHC------------------------------------ 807 (992)
Q Consensus 764 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~------------------------------------ 807 (992)
+|.++.+...... .....++.+++..|+.||...
T Consensus 103 ~G~~~~~~~~~~~----------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (272)
T 4gkh_A 103 PGKTAFQVLEEYP----------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERN 172 (272)
T ss_dssp CSEEHHHHHHHCG----------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGT
T ss_pred CCccccccccCCH----------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccccc
Confidence 9988887654322 122346667777777777531
Q ss_pred -------------------CCCeEeccCCCCCeeeCCCCcEEEeecccce
Q 037275 808 -------------------QPPVVHGDLKPSNVLLDQDLVAHLGDFGLAK 838 (992)
Q Consensus 808 -------------------~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 838 (992)
.+.++|+|+.+.||+++.++.+-|+||+.+.
T Consensus 173 ~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 173 GWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp TCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred chHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1237999999999999988777899999875
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.18 E-value=7.1e-06 Score=88.19 Aligned_cols=137 Identities=17% Similarity=0.183 Sum_probs=90.3
Q ss_pred CCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCC---cceeEEEEeecccccCcceEEEEE
Q 037275 684 SNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHR---NLIKIITICSSIDFKGVDFQAIVY 760 (992)
Q Consensus 684 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~~~~~~~~~~~~lv~ 760 (992)
++.++.|....||+. +..+++|+.. .......+.+|+++++.+.+. .+.+++.++. ...+..++||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~----~~~g~~~~v~ 92 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK----RSDGNPFVGY 92 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE----CTTSCEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc----cCCCceEEEE
Confidence 456888999999988 3568888852 222346789999999999642 3556666643 1234458999
Q ss_pred EeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhc----------------------------------
Q 037275 761 EYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHH---------------------------------- 806 (992)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---------------------------------- 806 (992)
||++|.++.+.... .++..+...++.++++.|+.||+.
T Consensus 93 e~i~G~~l~~~~~~--------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l 164 (306)
T 3tdw_A 93 RKVQGQILGEDGMA--------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLL 164 (306)
T ss_dssp ECCCSEECHHHHHT--------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGS
T ss_pred eccCCeECchhhhh--------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhccccc
Confidence 99999887663211 123333344444444444444432
Q ss_pred -----------------------CCCCeEeccCCCCCeeeCC---CCc-EEEeeccccee
Q 037275 807 -----------------------CQPPVVHGDLKPSNVLLDQ---DLV-AHLGDFGLAKF 839 (992)
Q Consensus 807 -----------------------~~~~ivH~Dlkp~NIll~~---~~~-~kl~Dfg~a~~ 839 (992)
..+.++|+|++|.||+++. ++. +.|+||+.+..
T Consensus 165 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 165 DESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp CHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred chhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2336799999999999987 455 58999998763
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.01 E-value=1.1e-05 Score=89.21 Aligned_cols=84 Identities=7% Similarity=-0.003 Sum_probs=55.8
Q ss_pred CCcc-ccccceEEEEeEEC--C----CCeEEEEEEeeccC---CCchhHHHHHHHHHHhcc-C--CcceeEEEEeecccc
Q 037275 684 SNMI-GQGSFGFVYKGNLG--E----NGMMVAVKVINLKQ---KGASNGFVAECQALRNIR-H--RNLIKIITICSSIDF 750 (992)
Q Consensus 684 ~~~l-g~G~~g~V~~~~~~--~----~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~~~ 750 (992)
.+.| +.|....+|++... . +++.+++|+..... ......+.+|+.+++.+. + -.+.++++++.+...
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88889999998763 0 16688999875332 112356788999999884 3 356778877543221
Q ss_pred cCcceEEEEEEeccCCCHH
Q 037275 751 KGVDFQAIVYEYMQNGSLE 769 (992)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~ 769 (992)
....++||||++|.++.
T Consensus 105 --~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 --LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp --TSSCEEEEECCCCBCCC
T ss_pred --cCCceEEEEecCCCChh
Confidence 13347999999886654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.88 E-value=3.9e-05 Score=85.93 Aligned_cols=76 Identities=16% Similarity=0.117 Sum_probs=49.2
Q ss_pred CCccccccceEEEEeEECCCCeEEEEEEeeccCC-------CchhHHHHHHHHHHhccC--C-cceeEEEEeecccccCc
Q 037275 684 SNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK-------GASNGFVAECQALRNIRH--R-NLIKIITICSSIDFKGV 753 (992)
Q Consensus 684 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-niv~~~~~~~~~~~~~~ 753 (992)
.+.+|.|.++.||+++...+++.|+||....... ....++..|.++++.+.. | .+.+++.+. .
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d-------~ 107 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-------T 107 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-------T
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc-------C
Confidence 4679999999999997655678899998643211 234567889999988742 3 344555542 1
Q ss_pred ceEEEEEEeccCC
Q 037275 754 DFQAIVYEYMQNG 766 (992)
Q Consensus 754 ~~~~lv~e~~~~g 766 (992)
...++||||+++.
T Consensus 108 ~~~~lvmE~l~g~ 120 (397)
T 2olc_A 108 EMAVTVMEDLSHL 120 (397)
T ss_dssp TTTEEEECCCTTS
T ss_pred CccEEEEEeCCCc
Confidence 1237999999763
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.87 E-value=9.3e-06 Score=74.34 Aligned_cols=87 Identities=18% Similarity=0.213 Sum_probs=61.1
Q ss_pred ceeeccCCccc-ccCCccccccCCCCEEECCCcccCCCChhhhhcCCCcceEecCCCcCcccCCCCCccCCcccc--ccc
Q 037275 519 QQLYLQGNSFS-GSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNKTGI--SLS 595 (992)
Q Consensus 519 ~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~--~l~ 595 (992)
..++.+++.|+ ..+|..+. ++|++|+|++|+|+.+.+..|..+++|+.|+|++|+|.|.+...+...++... ...
T Consensus 11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC~l~~l~~wl~~~~~~~~ 88 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDCRLVPLRAWLAGRPERAP 88 (130)
T ss_dssp TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSGGGHHHHHHHHTSSCSGG
T ss_pred CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccCccHHHHHHHHhCccccc
Confidence 36777777776 24554432 36899999999999777788999999999999999999988765444433221 112
Q ss_pred CCCCcCCCCCCC
Q 037275 596 GNGKVCGGLDEL 607 (992)
Q Consensus 596 ~N~~~C~~~~~~ 607 (992)
.....|..|..+
T Consensus 89 ~~~~~C~~P~~l 100 (130)
T 3rfe_A 89 YRDLRCVAPPAL 100 (130)
T ss_dssp GTTCBCCBSTTT
T ss_pred ccCcEeCcChHH
Confidence 235678776643
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.66 E-value=1.1e-05 Score=77.16 Aligned_cols=84 Identities=18% Similarity=0.109 Sum_probs=57.3
Q ss_pred CCccEEeeecccccccCCcccccccccceeeccCCc-ccccCCcccccc----CCCCEEECCCc-ccCCCChhhhhcCCC
Q 037275 492 KNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNS-FSGSIPSSLSSL----KSIKELDMSSN-NLSGQIPEYLENLSF 565 (992)
Q Consensus 492 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l----~~L~~L~Ls~N-~l~~~~p~~~~~l~~ 565 (992)
.+|+.||++++.++..--..+.++++|+.|+|+++. |++..-..++.+ ++|++|+|++| +|+..--..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 467888888887776555556777888888888874 665433444443 36888888887 476544456677788
Q ss_pred cceEecCCCc
Q 037275 566 LEYLNLSYNH 575 (992)
Q Consensus 566 L~~L~l~~N~ 575 (992)
|++|+|++.+
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 8888887764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.64 E-value=0.0002 Score=76.15 Aligned_cols=77 Identities=14% Similarity=0.182 Sum_probs=56.8
Q ss_pred CCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccC---CcceeEEEEeecccccCcceEE
Q 037275 681 FSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRH---RNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 681 ~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~~~~~~~~~~~~~~~~~~ 757 (992)
...++.+|.|..+.||+++.. +|+.|++|+...........+..|+..|+.+.- --+.+++++.. .+
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~~---------~~ 86 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWDD---------RT 86 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEET---------TE
T ss_pred eEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEeccC---------ce
Confidence 445678899999999999985 789999998764444445668899999998842 23455665421 17
Q ss_pred EEEEeccCCC
Q 037275 758 IVYEYMQNGS 767 (992)
Q Consensus 758 lv~e~~~~gs 767 (992)
+||||++++.
T Consensus 87 lv~e~l~~~~ 96 (288)
T 3f7w_A 87 LAMEWVDERP 96 (288)
T ss_dssp EEEECCCCCC
T ss_pred EEEEeecccC
Confidence 8999998764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00015 Score=79.42 Aligned_cols=148 Identities=16% Similarity=0.160 Sum_probs=80.7
Q ss_pred CccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCC--cceeEEEEeeccc-ccCcceEEEEEE
Q 037275 685 NMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHR--NLIKIITICSSID-FKGVDFQAIVYE 761 (992)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~~~-~~~~~~~~lv~e 761 (992)
+.|+.|..+.||++... +..+++|+... ....+..|+.+++.+... .+.+++....... ....+..++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~--~~~~vlk~~~~----~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTD--SGAVCLKRIHR----PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EECC----CEEEEEEET--TEEEEEEEECS----CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeccccccCcEEEEEeC--CCCEEEEecCC----CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 44666778999999874 44589998863 224455667777766421 2333332100000 012345689999
Q ss_pred eccCCCHH--------------HHHhhcccc---hhh-----cccCHHH-------------------------------
Q 037275 762 YMQNGSLE--------------DWLHQSEDQ---QEA-----RSLTLIQ------------------------------- 788 (992)
Q Consensus 762 ~~~~gsL~--------------~~l~~~~~~---~~~-----~~l~~~~------------------------------- 788 (992)
|++|.++. ..++..... ... ..-.|..
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986542 111111100 000 0011211
Q ss_pred HHHHHHHHHHHHHHHHh----------cCCCCeEeccCCCCCeeeCCCCcEEEeecccce
Q 037275 789 RINIIIDVASAIEYIHH----------HCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAK 838 (992)
Q Consensus 789 ~~~i~~qi~~~L~~LH~----------~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 838 (992)
...+..++..++++|++ ...+.++|||+++.||+++.++.+.|+||+.+.
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 11122234456677763 123489999999999999888899999999775
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.56 E-value=1.7e-05 Score=75.91 Aligned_cols=34 Identities=3% Similarity=0.004 Sum_probs=15.2
Q ss_pred CCCEEEeecccCCCCCCcccccCCCCcEeecccc
Q 037275 99 RLEALVLANNSFSGKIPTNLSRCSNLISFNARRN 132 (992)
Q Consensus 99 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n 132 (992)
+|++|||+++.++..--..+..+++|++|+|++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C 95 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKC 95 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCC
Confidence 3445555554444322233444444444444444
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.35 E-value=0.00062 Score=72.56 Aligned_cols=142 Identities=16% Similarity=0.148 Sum_probs=89.5
Q ss_pred CCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhcc---CCcceeEEEEeecccccCcceEEEE
Q 037275 683 SSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIR---HRNLIKIITICSSIDFKGVDFQAIV 759 (992)
Q Consensus 683 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~~~~~lv 759 (992)
..+.|+.|....+|+... ++..+++|+.... ....+..|.+.|+.+. ...+.++++++.. .+..++|
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-----~g~~~lv 109 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNS-----QGHSFLL 109 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-----SSEEEEE
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec-----CCceEEE
Confidence 346789999999999986 4678889987532 3566889999999884 3567788877532 2456999
Q ss_pred EEeccCCCHH--------H---HHhhccc---ch-------------hhcccCHHHHH---HHHH---------------
Q 037275 760 YEYMQNGSLE--------D---WLHQSED---QQ-------------EARSLTLIQRI---NIII--------------- 794 (992)
Q Consensus 760 ~e~~~~gsL~--------~---~l~~~~~---~~-------------~~~~l~~~~~~---~i~~--------------- 794 (992)
|||+++..+. . .++.... .+ ....-+|.... ++..
T Consensus 110 me~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~ 189 (312)
T 3jr1_A 110 LEALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNI 189 (312)
T ss_dssp EECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCH
T ss_pred EEeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHH
Confidence 9999987541 1 2222211 00 00112344321 1111
Q ss_pred -HHHHH-HHHHHh-cCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 795 -DVASA-IEYIHH-HCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 795 -qi~~~-L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
+++.. ...|.. ..++.++|+|+.+.|++++.++ +.|.|++
T Consensus 190 ~~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 190 DLIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 11111 123322 2256899999999999999887 8899974
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.26 E-value=1.6e-05 Score=77.66 Aligned_cols=122 Identities=14% Similarity=0.106 Sum_probs=76.0
Q ss_pred cCCCCCCCCcCCeeeccCC-CCCc----cCCccccCCCCCCEEEeecccCCC----CCCcccccCCCCcEeecccccccc
Q 037275 66 LSPYVGNLSFLRYLNLADN-NFHG----EIPHQIGRLVRLEALVLANNSFSG----KIPTNLSRCSNLISFNARRNNLVG 136 (992)
Q Consensus 66 l~~~l~~l~~L~~L~L~~n-~l~~----~~p~~~~~l~~L~~L~Ls~n~l~~----~~p~~l~~l~~L~~L~l~~n~l~~ 136 (992)
+...+.+-+.|+.|+|++| ++.. .+.+.+..-+.|++|+|++|+|.. .+-+.+..-+.|++|+|+.|.|..
T Consensus 33 l~~ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~ 112 (197)
T 1pgv_A 33 INRLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTP 112 (197)
T ss_dssp HHHHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCH
T ss_pred HHHHHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCH
Confidence 3444556778899999885 7763 255667777889999999998873 233445566778888888887764
Q ss_pred cCChhhcccccccccccccccccCCCCCCccccccccceEEecCC---cccC----CcCCccCCCCcccEEeccCcccc
Q 037275 137 EIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGN---GLWG----RIPNNLGNLRNLILLNLGENRFS 208 (992)
Q Consensus 137 ~~p~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n---~l~~----~~~~~l~~l~~L~~L~L~~n~l~ 208 (992)
..-..+. +.+..-..|++|+|++| .+.. .+.+.+..-+.|+.|+++.|.+.
T Consensus 113 ~Ga~ala---------------------~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 113 ELLARLL---------------------RSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HHHHHHH---------------------HHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHHHHHH---------------------HHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 4333333 22333345666666543 2211 13344555577888888777654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.23 E-value=0.00071 Score=76.13 Aligned_cols=77 Identities=14% Similarity=0.179 Sum_probs=47.2
Q ss_pred CCeEeccCCCCCeeeCCCCcEEEeecccceecCCCCCCCCcccCCCCCccc--ccccccccccccCC---CcCcccchhh
Q 037275 809 PPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIK--GTVGYIAPEYGMGG---EASMTGDVYS 883 (992)
Q Consensus 809 ~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~---~~~~~~DiwS 883 (992)
+.++|||++|.||+++.++ ++++||+.+..-... .+ ..... -...|.+|+..... ......++.+
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~-----~D----la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG-----FD----IGAYLGNLILAFFAQDGHATQENDRKEYKQWILR 301 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH-----HH----HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH-----HH----HHHHHHHHHHHHHhcccccccccchHHHHHHHHH
Confidence 4899999999999998876 999999988753210 00 00000 01346666654311 1122345567
Q ss_pred HHHHHHHHHhCC
Q 037275 884 FGILLLEMFTRR 895 (992)
Q Consensus 884 lG~il~elltg~ 895 (992)
.+..+|+.+++.
T Consensus 302 ~~~~~~~~y~~~ 313 (420)
T 2pyw_A 302 TIEQTWNLFNKR 313 (420)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHHH
Confidence 788888877754
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.16 E-value=9.7e-05 Score=72.09 Aligned_cols=74 Identities=9% Similarity=0.096 Sum_probs=34.6
Q ss_pred chhhhccccCceeeeccccccccccc----cccccCccceEecCCCCCCCCCC-CCchhhhhccCCCcceEeecCCCcC
Q 037275 261 PESLSNASNLVELTLFDNQFRGKVSI----YFRSLKNLEWLNLGSNNLGTGEA-NDLDFLTLLTNCTELTAIGLDDNRF 334 (992)
Q Consensus 261 p~~l~~l~~L~~L~L~~N~l~~~~~~----~~~~l~~L~~L~L~~N~l~~~~~-~~~~~~~~l~~~~~L~~L~l~~n~l 334 (992)
...+...+.|++|+|+.|.|.+.... .+..-+.|++|+|++|....++. ...+....+...+.|+.|+++.|.+
T Consensus 91 A~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 91 IELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp HHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence 34455556666666666666543332 23334456666666442211111 0111223444555556665555443
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.11 E-value=0.0016 Score=69.54 Aligned_cols=72 Identities=10% Similarity=0.119 Sum_probs=45.2
Q ss_pred CCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcc-eeEEEEeecccccCcceEEEEEE
Q 037275 683 SSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNL-IKIITICSSIDFKGVDFQAIVYE 761 (992)
Q Consensus 683 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv~e 761 (992)
-.+.|+.|....+|++ ..+++|+...... ......+|+.+++.+...++ .+++++..+ .-++|+|
T Consensus 22 ~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~-~~~~r~~E~~~l~~l~~~g~~P~~~~~~~~-------~~~~v~e 87 (301)
T 3dxq_A 22 GPLERLGGLTNLVFRA------GDLCLRIPGKGTE-EYINRANEAVAAREAAKAGVSPEVLHVDPA-------TGVMVTR 87 (301)
T ss_dssp SCEEEESCSSEEEEEE------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECTT-------TCCEEEE
T ss_pred ceeEcCCcccccccee------eeEEEECCCCCcc-ceeCHHHHHHHHHHHHHcCCCCceEEEECC-------CCEEEEe
Confidence 3678999999999999 3588998753321 12234578888888753333 455554211 1268999
Q ss_pred ec-cCCCH
Q 037275 762 YM-QNGSL 768 (992)
Q Consensus 762 ~~-~~gsL 768 (992)
|+ ++.++
T Consensus 88 ~i~~g~~l 95 (301)
T 3dxq_A 88 YIAGAQTM 95 (301)
T ss_dssp CCTTCEEC
T ss_pred ecCCCccC
Confidence 99 65444
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0031 Score=68.04 Aligned_cols=166 Identities=14% Similarity=0.116 Sum_probs=90.4
Q ss_pred cccHHHHHHHhcCCCCC-----CccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcc--ee
Q 037275 668 MISYAELSKATNDFSSS-----NMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNL--IK 740 (992)
Q Consensus 668 ~~~~~~~~~~~~~~~~~-----~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~ 740 (992)
.++.+++......|... +.|+.|....+|++... +| .+++|+.... .....+..|+.+++.+....+ .+
T Consensus 6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~ 81 (322)
T 2ppq_A 6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPL 81 (322)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCc
Confidence 45666777766667652 34667888999999874 33 6889988542 233456778888888853232 33
Q ss_pred EEEEeeccc--ccCcceEEEEEEeccCCCHHH--------------HHhhcccc-hhh-----cccCHHHHHH-------
Q 037275 741 IITICSSID--FKGVDFQAIVYEYMQNGSLED--------------WLHQSEDQ-QEA-----RSLTLIQRIN------- 791 (992)
Q Consensus 741 ~~~~~~~~~--~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~~~-~~~-----~~l~~~~~~~------- 791 (992)
++... +.. ....+..+++|+|++|..+.. .++..... ... ....|...+.
T Consensus 82 ~~~~~-~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~ 160 (322)
T 2ppq_A 82 PLPRK-DGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERAD 160 (322)
T ss_dssp BCCBT-TCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred ccCCC-CCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHH
Confidence 33211 000 001234589999998764311 11111000 000 0001221100
Q ss_pred -----HHHHHHHHHHHHHhc----CCCCeEeccCCCCCeeeCCCCcEEEeecccce
Q 037275 792 -----IIIDVASAIEYIHHH----CQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAK 838 (992)
Q Consensus 792 -----i~~qi~~~L~~LH~~----~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 838 (992)
+...+...++++++. .+.+++|+|+.+.||+++.++.+.++||+.+.
T Consensus 161 ~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 161 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011244556666542 13478999999999999887666899999775
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.83 E-value=0.0068 Score=65.49 Aligned_cols=167 Identities=14% Similarity=0.147 Sum_probs=91.9
Q ss_pred CCcccHHHHHHHhcCCCC-----CCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCc--c
Q 037275 666 FPMISYAELSKATNDFSS-----SNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRN--L 738 (992)
Q Consensus 666 ~~~~~~~~~~~~~~~~~~-----~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--i 738 (992)
+...+.+++......|.+ .+.++ |....||++... +|+.+++|+..... .....+..|..+++.+.... +
T Consensus 8 ~~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~v 84 (328)
T 1zyl_A 8 FQTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDE-DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPV 84 (328)
T ss_dssp CCCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCT-TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSB
T ss_pred CCCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcC-CCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCee
Confidence 455666666666555533 23466 778899998764 56679999986332 24556778999888885322 3
Q ss_pred eeEEEEeeccc--ccCcceEEEEEEeccCCCHH-----HH---------Hhhcccc---hhhcccCHHHH----HH----
Q 037275 739 IKIITICSSID--FKGVDFQAIVYEYMQNGSLE-----DW---------LHQSEDQ---QEARSLTLIQR----IN---- 791 (992)
Q Consensus 739 v~~~~~~~~~~--~~~~~~~~lv~e~~~~gsL~-----~~---------l~~~~~~---~~~~~l~~~~~----~~---- 791 (992)
.+++.. +.. ....+..++||||++|..+. .+ ++..... ......++... ..
T Consensus 85 p~~~~~--~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 162 (328)
T 1zyl_A 85 AAPVAF--NGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFED 162 (328)
T ss_dssp CCCCCB--TTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHT
T ss_pred cceeec--CCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhh
Confidence 344332 111 01134557899999875321 11 1111000 00011121110 00
Q ss_pred -----------HHHHHHHHHHHHHhc----CCCCeEeccCCCCCeeeCCCCcEEEeeccccee
Q 037275 792 -----------IIIDVASAIEYIHHH----CQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKF 839 (992)
Q Consensus 792 -----------i~~qi~~~L~~LH~~----~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 839 (992)
+...+...++.+.+. .+..++|||+++.||+++ + .+.++||+.+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 163 ATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred cCcCCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 111112223333321 233688999999999998 4 899999988753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0067 Score=68.35 Aligned_cols=75 Identities=15% Similarity=0.097 Sum_probs=48.4
Q ss_pred CCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcc-eeEEEEeecccccCcceEEEEEEe
Q 037275 684 SNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNL-IKIITICSSIDFKGVDFQAIVYEY 762 (992)
Q Consensus 684 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv~e~ 762 (992)
.+.|+.|-...+|++.....+..+++|+...... ..-...+|..+++.+...++ .++++++ .+ ..||||
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~-~~idR~~E~~vl~~L~~~gl~P~ll~~~-----~~----G~v~e~ 182 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD-EIINREREKKISCILYNKNIAKKIYVFF-----TN----GRIEEF 182 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CC-SCSCHHHHHHHHHHHTTSSSBCCEEEEE-----TT----EEEEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChh-hhcCHHHHHHHHHHHHhcCCCCCEEEEe-----CC----eEEEEe
Confidence 3568888889999999864358899998743221 11223689999999864444 4666653 11 359999
Q ss_pred ccCCCH
Q 037275 763 MQNGSL 768 (992)
Q Consensus 763 ~~~gsL 768 (992)
++|.++
T Consensus 183 I~G~~l 188 (458)
T 2qg7_A 183 MDGYAL 188 (458)
T ss_dssp CCSEEC
T ss_pred eCCccC
Confidence 987543
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.70 E-value=0.0045 Score=67.81 Aligned_cols=144 Identities=12% Similarity=0.147 Sum_probs=82.8
Q ss_pred CCccccccceEEEEeEECC-------CCeEEEEEEeeccCCCchhHHHHHHHHHHhcc-CCcceeEEEEeecccccCcce
Q 037275 684 SNMIGQGSFGFVYKGNLGE-------NGMMVAVKVINLKQKGASNGFVAECQALRNIR-HRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 684 ~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 755 (992)
++.+..|....+|++.... +++.+++|+.... ........+|..+++.+. +.-..++++++. +
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~-----~--- 125 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFP-----E--- 125 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET-----T---
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcC-----C---
Confidence 3567778888999998742 3578999986432 223456678999998884 322356666532 1
Q ss_pred EEEEEEeccCCCHHH--------------HH---hhcccchhhccc--CHHHHHHHHHHHHH------------------
Q 037275 756 QAIVYEYMQNGSLED--------------WL---HQSEDQQEARSL--TLIQRINIIIDVAS------------------ 798 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~--------------~l---~~~~~~~~~~~l--~~~~~~~i~~qi~~------------------ 798 (992)
.+||||++|.++.. .+ +..... ..... -+.++.++..++..
T Consensus 126 -g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~-~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 203 (379)
T 3feg_A 126 -GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMP-FTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLK 203 (379)
T ss_dssp -EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCS-SCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHH
T ss_pred -ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCC-CCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHH
Confidence 38999998765431 11 111000 01111 23445555544322
Q ss_pred -HHHHHHh----c-CCCCeEeccCCCCCeeeCCC----CcEEEeecccce
Q 037275 799 -AIEYIHH----H-CQPPVVHGDLKPSNVLLDQD----LVAHLGDFGLAK 838 (992)
Q Consensus 799 -~L~~LH~----~-~~~~ivH~Dlkp~NIll~~~----~~~kl~Dfg~a~ 838 (992)
.+..|.+ . ....++|+|+.+.||+++.+ +.+.++||..|.
T Consensus 204 ~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 204 DEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2333322 1 12368999999999999876 789999999876
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.64 E-value=0.014 Score=63.04 Aligned_cols=144 Identities=12% Similarity=0.038 Sum_probs=74.4
Q ss_pred CccccccceE-EEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCC--cceeEEEEeecccccCcceEEEEEE
Q 037275 685 NMIGQGSFGF-VYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHR--NLIKIITICSSIDFKGVDFQAIVYE 761 (992)
Q Consensus 685 ~~lg~G~~g~-V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~~~~~~~~~~~lv~e 761 (992)
+.|+.|.... +|+.... ++..+++|...... ...+..|+.+++.+... .+.+++.+.. .. + ++|||
T Consensus 24 ~~l~gg~s~~~~~r~~~~-~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~----~~-g--~ll~e 92 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSP-TGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEH----AR-G--LLLIE 92 (333)
T ss_dssp CC--------CCEEEECT-TCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEET----TT-T--EEEEC
T ss_pred eECCCCCCCceEEEEEcC-CCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecC----CC-C--EEEEe
Confidence 4566665554 6677642 36677787654321 13455678887777432 3455666521 11 2 68999
Q ss_pred eccCCCHHHHHhhcccc--------------------hhhcccCHHHHH-------H-------------HHHHHHHHHH
Q 037275 762 YMQNGSLEDWLHQSEDQ--------------------QEARSLTLIQRI-------N-------------IIIDVASAIE 801 (992)
Q Consensus 762 ~~~~gsL~~~l~~~~~~--------------------~~~~~l~~~~~~-------~-------------i~~qi~~~L~ 801 (992)
++.+.++.+++...... .....++..... . ....+...++
T Consensus 93 ~l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~ 172 (333)
T 3csv_A 93 DLGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFA 172 (333)
T ss_dssp CCCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHH
T ss_pred eCCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHH
Confidence 99777776655432110 000011111100 0 0011122223
Q ss_pred HHHh---cCCCCeEeccCCCCCeeeCCC----CcEEEeeccccee
Q 037275 802 YIHH---HCQPPVVHGDLKPSNVLLDQD----LVAHLGDFGLAKF 839 (992)
Q Consensus 802 ~LH~---~~~~~ivH~Dlkp~NIll~~~----~~~kl~Dfg~a~~ 839 (992)
.+.+ ...+.++|||+.+.||+++.+ +.+.|+||+.+..
T Consensus 173 ~l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 173 QILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HHHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred HHHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 3311 123479999999999999875 6899999998864
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.52 E-value=0.0026 Score=57.88 Aligned_cols=57 Identities=16% Similarity=0.363 Sum_probs=43.3
Q ss_pred cEEeeeccccc-ccCCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcccC
Q 037275 495 VYFNISVNRFS-GEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLS 553 (992)
Q Consensus 495 ~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 553 (992)
..++.+++.++ ..+|..+. .+|+.|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus 11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 36777888776 23554443 36888999999998777778888999999999999775
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.38 E-value=0.012 Score=66.08 Aligned_cols=73 Identities=23% Similarity=0.268 Sum_probs=49.7
Q ss_pred CCccccccceEEEEeEECC-------CCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcc-eeEEEEeecccccCcce
Q 037275 684 SNMIGQGSFGFVYKGNLGE-------NGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNL-IKIITICSSIDFKGVDF 755 (992)
Q Consensus 684 ~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~ 755 (992)
.+.|+.|....||++.... +++.+++|+.... .....+.+|..+++.+...++ .++++.+. +
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~-----~--- 147 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS-----G--- 147 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET-----T---
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC-----C---
Confidence 3567888889999998752 2578999988421 222566689999998853333 56666532 1
Q ss_pred EEEEEEeccCCC
Q 037275 756 QAIVYEYMQNGS 767 (992)
Q Consensus 756 ~~lv~e~~~~gs 767 (992)
.+|+||++|.+
T Consensus 148 -g~v~e~l~G~~ 158 (429)
T 1nw1_A 148 -GRLEEYIPSRP 158 (429)
T ss_dssp -EEEECCCCEEE
T ss_pred -CEEEEEeCCcc
Confidence 48999998643
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.38 E-value=0.0051 Score=67.75 Aligned_cols=73 Identities=10% Similarity=0.127 Sum_probs=44.2
Q ss_pred CccccccceEEEEeEECC--------CCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCc-ceeEEEEeecccccCcce
Q 037275 685 NMIGQGSFGFVYKGNLGE--------NGMMVAVKVINLKQKGASNGFVAECQALRNIRHRN-LIKIITICSSIDFKGVDF 755 (992)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~~~~ 755 (992)
+.++.|....+|++.... .+..+++|+...... .......|..+++.+...+ +.++++.. . +
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~-----~-~-- 109 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF-----N-G-- 109 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE-----T-T--
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec-----C-C--
Confidence 467788888999998742 126889998753221 1123467888888885334 34666542 1 1
Q ss_pred EEEEEEeccCCC
Q 037275 756 QAIVYEYMQNGS 767 (992)
Q Consensus 756 ~~lv~e~~~~gs 767 (992)
++||||++|.+
T Consensus 110 -~~v~e~i~G~~ 120 (369)
T 3c5i_A 110 -GRIEEWLYGDP 120 (369)
T ss_dssp -EEEEECCCSEE
T ss_pred -cEEEEEecCCc
Confidence 68999998754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.11 E-value=0.042 Score=53.71 Aligned_cols=103 Identities=17% Similarity=0.163 Sum_probs=67.2
Q ss_pred CCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceecCCCCC
Q 037275 766 GSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPL 845 (992)
Q Consensus 766 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 845 (992)
-+|.+.++.... ++++.++|.++.|.+.+|.-+-.... . ..+=+.|..|++..+|.|...+ +.+.
T Consensus 33 vSL~eIL~~~~~-----PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQ-----PINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD------- 97 (229)
T ss_dssp EEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C----------
T ss_pred ccHHHHHHHcCC-----CcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc-------
Confidence 389999987654 69999999999999999877632111 1 1233456889999999988764 2111
Q ss_pred CCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCC
Q 037275 846 DTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897 (992)
Q Consensus 846 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p 897 (992)
.....+.|||... ...+.+.=|||+|+++|..+-=..|
T Consensus 98 -------------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -------------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ----------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -------------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0123467888753 3556788899999999999883333
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.70 E-value=0.014 Score=63.20 Aligned_cols=31 Identities=19% Similarity=0.288 Sum_probs=27.7
Q ss_pred CCeEeccCCCCCeeeCCCCcEEEeeccccee
Q 037275 809 PPVVHGDLKPSNVLLDQDLVAHLGDFGLAKF 839 (992)
Q Consensus 809 ~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 839 (992)
..++|+|+.+.||+++.++.+.++||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4789999999999999888999999987764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.51 E-value=0.12 Score=57.15 Aligned_cols=74 Identities=12% Similarity=0.088 Sum_probs=48.3
Q ss_pred CccccccceEEEEeEECCC-------CeEEEEEEeeccCCCchhHHHHHHHHHHhcc-CCcceeEEEEeecccccCcceE
Q 037275 685 NMIGQGSFGFVYKGNLGEN-------GMMVAVKVINLKQKGASNGFVAECQALRNIR-HRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 685 ~~lg~G~~g~V~~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~ 756 (992)
+.+..|-...+|++..... ++.+++|+..... ...-...+|..+++.+. +.-..++++.+ . +
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~-----~-~--- 145 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF-----P-E--- 145 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE-----T-T---
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc-----C-C---
Confidence 4677788889999987521 5789999874332 22223468888888885 32244555542 1 1
Q ss_pred EEEEEeccCCCH
Q 037275 757 AIVYEYMQNGSL 768 (992)
Q Consensus 757 ~lv~e~~~~gsL 768 (992)
+.||||++|.++
T Consensus 146 ~~I~efI~G~~l 157 (424)
T 3mes_A 146 GRIEEFIDGEPL 157 (424)
T ss_dssp EEEEECCCSEEC
T ss_pred CEEEEEeCCccC
Confidence 789999988653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=90.82 E-value=0.8 Score=50.53 Aligned_cols=29 Identities=28% Similarity=0.456 Sum_probs=24.8
Q ss_pred eEeccCCCCCeee------CCCCcEEEeeccccee
Q 037275 811 VVHGDLKPSNVLL------DQDLVAHLGDFGLAKF 839 (992)
Q Consensus 811 ivH~Dlkp~NIll------~~~~~~kl~Dfg~a~~ 839 (992)
++|+|+.+.||++ +++..++++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567899999998763
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 992 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-58 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-54 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-54 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-52 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-51 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-50 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-50 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-50 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-49 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-49 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-49 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-49 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-48 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-47 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-47 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-47 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-47 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-46 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-46 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-46 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-46 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-46 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-45 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-45 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-44 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-43 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-43 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-43 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-43 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-41 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-41 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-41 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-40 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-40 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-39 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-38 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-38 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-38 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-38 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-38 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-38 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-37 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-37 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-37 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-37 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-36 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-36 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-35 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-35 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-35 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-34 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-33 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-32 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-32 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-31 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-31 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 8e-30 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-29 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-29 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-28 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-27 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-18 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-14 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 7e-07 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-27 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-19 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-19 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-06 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-20 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-08 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-20 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-15 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-14 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-13 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-12 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-12 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-05 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-18 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-11 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 8e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.002 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.004 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 5e-08 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.001 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.002 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.002 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 8e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 8e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.004 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 6e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 6e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 2e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 6e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 4e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 8e-06 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 1e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 7e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 8e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 8e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 8e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.003 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.001 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.002 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.002 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.003 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 3e-58
Identities = 73/306 (23%), Positives = 124/306 (40%), Gaps = 51/306 (16%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASN--GFVAECQALRNIRHR 736
+ IG GSFG VYKG + VAVK++N+ F E LR RH
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 737 NLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDV 796
N++ + ++ AIV ++ + SL LH E +I+ I+I
Sbjct: 65 NILLFMGYSTA------PQLAIVTQWCEGSSLYHHLHIIE-----TKFEMIKLIDIARQT 113
Query: 797 ASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSK 856
A ++Y+H ++H DLK +N+ L +DL +GDFGLA S +
Sbjct: 114 AQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW------SGSHQFE 164
Query: 857 GIKGTVGYIAPEYGMGGEA---SMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913
+ G++ ++APE + S DVY+FGI+L E+ T + P + N+ + R
Sbjct: 165 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR 224
Query: 914 TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMR 973
L + ++ + + + ++ C + ER
Sbjct: 225 GYLSPDLSKVRSNCP--------------------KAMKRLMAE---CLKKKRDERPLFP 261
Query: 974 DVVAKL 979
++A +
Sbjct: 262 QILASI 267
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 4e-54
Identities = 58/236 (24%), Positives = 103/236 (43%), Gaps = 24/236 (10%)
Query: 674 LSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK-QKGASNGFVAECQALRN 732
+ +DF + +G G+ G V+K + +G+++A K+I+L+ + N + E Q L
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 733 IRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINI 792
++ S +I E+M GSL+ L ++ + +
Sbjct: 61 CNSPYIVGFYGAFYS-----DGEISICMEHMDGGSLDQVLKKA------GRIPEQILGKV 109
Query: 793 IIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETP 852
I V + Y+ ++H D+KPSN+L++ L DFG++ L S ++ V
Sbjct: 110 SIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV--- 164
Query: 853 SSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTL 908
GT Y++PE G S+ D++S G+ L+EM R P + L L
Sbjct: 165 -------GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 187 bits (476), Expect = 7e-54
Identities = 75/324 (23%), Positives = 139/324 (42%), Gaps = 58/324 (17%)
Query: 670 SYAELSKATNDFSSS---------NMIGQGSFGFVYKGNL---GENGMMVAVKVINLKQ- 716
++ + ++A +F+ +IG G FG V G+L G+ + VA+K +
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 717 KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSE 776
+ F++E + H N+I + + + I+ E+M+NGSL+ +L Q++
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV-----MIITEFMENGSLDSFLRQND 122
Query: 777 DQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836
Q T+IQ + ++ +A+ ++Y+ VH DL N+L++ +LV + DFGL
Sbjct: 123 GQF-----TVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGL 174
Query: 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTR-R 895
++FL DT+ T +S+ G K + + APE + + DV+S+GI++ E+ +
Sbjct: 175 SRFLED---DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 231
Query: 896 RPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVV 955
RP M NQ V+ ++ L + L
Sbjct: 232 RPYWDMTNQ--------------DVINAIEQDYRLPPPMDCPSALHQLMLD--------- 268
Query: 956 ETGVVCSMESPTERMEMRDVVAKL 979
C + R + +V L
Sbjct: 269 -----CWQKDRNHRPKFGQIVNTL 287
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 6e-52
Identities = 65/304 (21%), Positives = 122/304 (40%), Gaps = 33/304 (10%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICS 746
IG+G FG V++G G VAVK+ + ++ S AE +RH N++ I +
Sbjct: 11 IGKGRFGEVWRGKW--RGEEVAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIAADN 67
Query: 747 SIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHH 806
+ +V +Y ++GSL D+L++ ++T+ I + + AS + ++H
Sbjct: 68 KDNGTWTQL-WLVSDYHEHGSLFDYLNR-------YTVTVEGMIKLALSTASGLAHLHME 119
Query: 807 C-----QPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGT 861
+P + H DLK N+L+ ++ + D GLA S+ + + GT
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDI----APNHRVGT 175
Query: 862 VGYIAPEY------GMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915
Y+APE E+ D+Y+ G++ E+ R + +
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ---LPYYDLV 232
Query: 916 LPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDV 975
D +E + V+ + R R ++ E L + + C + R+ +
Sbjct: 233 PSDPSVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 288
Query: 976 VAKL 979
L
Sbjct: 289 KKTL 292
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 2e-51
Identities = 67/304 (22%), Positives = 120/304 (39%), Gaps = 55/304 (18%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNL 738
+G G FG V+ G VAVK + + + + F+AE ++ ++H+ L
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRL 70
Query: 739 IKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVAS 798
+++ + + + I+ EYM+NGSL D+L + LT+ + +++ +A
Sbjct: 71 VRLYAVVTQ------EPIYIITEYMENGSLVDFLKTPSGIK----LTINKLLDMAAQIAE 120
Query: 799 AIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGI 858
+ +I +H DL+ +N+L+ L + DFGLA+ + + +G
Sbjct: 121 GMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA-------REGA 170
Query: 859 KGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLH---EFARTA 915
K + + APE G ++ DV+SFGILL E+ T R + R
Sbjct: 171 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV 230
Query: 916 LPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDV 975
PD E + ++ L C E P +R +
Sbjct: 231 RPDNCPEELYQLMRL------------------------------CWKERPEDRPTFDYL 260
Query: 976 VAKL 979
+ L
Sbjct: 261 RSVL 264
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 1e-50
Identities = 59/236 (25%), Positives = 99/236 (41%), Gaps = 18/236 (7%)
Query: 675 SKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK--QKGASNGFVAECQALRN 732
S+A D+ IG GS+G K +G ++ K ++ + V+E LR
Sbjct: 1 SRA-EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 59
Query: 733 IRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINI 792
++H N+++ + IV EY + G L + + +++ L + +
Sbjct: 60 LKHPNIVRYYDRIIDRTNTTL---YIVMEYCEGGDLASVITKGTKERQ--YLDEEFVLRV 114
Query: 793 IIDVASAIEYIHHH--CQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVE 850
+ + A++ H V+H DLKP+NV LD LGDFGLA+ L+
Sbjct: 115 MTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN--------H 166
Query: 851 TPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGL 906
S +K GT Y++PE + D++S G LL E+ P + L
Sbjct: 167 DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL 222
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 1e-50
Identities = 58/245 (23%), Positives = 102/245 (41%), Gaps = 22/245 (8%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHRNLIKIITI 744
IG+GSF VYKG E + VA + ++ K F E + L+ ++H N+++
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 745 CSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIH 804
S KG +V E M +G+L+ +L + + + + + + ++++H
Sbjct: 77 WES-TVKGKKCIVLVTELMTSGTLKTYLKRF------KVMKIKVLRSWCRQILKGLQFLH 129
Query: 805 HHCQPPVVHGDLKPSNVLL-DQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVG 863
PP++H DLK N+ + +GD GLA +S + GT
Sbjct: 130 TRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI----------GTPE 178
Query: 864 YIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKVMEI 923
++APE + + DVY+FG+ +LEM T P N P ++
Sbjct: 179 FMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV 237
Query: 924 VDSVL 928
+
Sbjct: 238 AIPEV 242
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 6e-50
Identities = 73/301 (24%), Positives = 125/301 (41%), Gaps = 49/301 (16%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNL 738
+GQG FG V+ G VA+K + + F+ E Q ++ +RH L
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKL 74
Query: 739 IKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVAS 798
+++ + S + IV EYM GSL D+L + + L L Q +++ +AS
Sbjct: 75 VQLYAVVS------EEPIYIVTEYMSKGSLLDFLKG----ETGKYLRLPQLVDMAAQIAS 124
Query: 799 AIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGI 858
+ Y+ VH DL+ +N+L+ ++LV + DFGLA+ + + ++ +G
Sbjct: 125 GMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGA 174
Query: 859 KGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPD 918
K + + APE + G ++ DV+SFGILL E+ T+ R
Sbjct: 175 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-------------NR 221
Query: 919 KVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978
+V++ V+ + S D + C + P ER + A
Sbjct: 222 EVLDQVERGYRMPCPPECPESLHDLMCQ--------------CWRKEPEERPTFEYLQAF 267
Query: 979 L 979
L
Sbjct: 268 L 268
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 1e-49
Identities = 57/311 (18%), Positives = 116/311 (37%), Gaps = 50/311 (16%)
Query: 673 ELSKATNDFSSSNM-IGQGSFGFVYKG--NLGENGMMVAVKVINLK-QKGASNGFVAECQ 728
+L ++ +++ +G G+FG V +G + + + VA+KV+ +K + + E Q
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 729 ALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQ 788
+ + + ++++I +C + +V E G L +L + +
Sbjct: 62 IMHQLDNPYIVRLIGVCQAEAL------MLVMEMAGGGPLHKFLVGKR-----EEIPVSN 110
Query: 789 RINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTA 848
++ V+ ++Y+ VH DL NVLL A + DFGL+K L +
Sbjct: 111 VAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD---- 163
Query: 849 VETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTL 908
++ K + + APE + S DV+S+G+ + E + + + +
Sbjct: 164 -SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK----PYKKMKG 218
Query: 909 HEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTE 968
E K ME L A++ C + +
Sbjct: 219 PEVMAFIEQGKRMECPPECP--------------------PELYALMSD---CWIYKWED 255
Query: 969 RMEMRDVVAKL 979
R + V ++
Sbjct: 256 RPDFLTVEQRM 266
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 174 bits (442), Expect = 3e-49
Identities = 65/318 (20%), Positives = 137/318 (43%), Gaps = 49/318 (15%)
Query: 662 MDQQFPMISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASN 721
MD P +Y + D + + +G G +G VY+G + + VAVK + +
Sbjct: 2 MDPSSP--NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVE 58
Query: 722 GFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEA 781
F+ E ++ I+H NL++++ +C+ I+ E+M G+L D+L + Q+
Sbjct: 59 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFY-----IITEFMTYGNLLDYLRECNRQE-- 111
Query: 782 RSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLS 841
++ + + + ++SA+EY+ +H DL N L+ ++ + + DFGL++ ++
Sbjct: 112 --VSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT 166
Query: 842 SSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGM 901
+T ++ G K + + APE + S+ DV++FG+LL E+ T
Sbjct: 167 G-------DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 219
Query: 902 FNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVC 961
+ +V E+++ +E E++ ++ C
Sbjct: 220 ID-------------LSQVYELLEKDYRMERPEGCP-----------EKVYELMRA---C 252
Query: 962 SMESPTERMEMRDVVAKL 979
+P++R ++
Sbjct: 253 WQWNPSDRPSFAEIHQAF 270
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 5e-49
Identities = 69/309 (22%), Positives = 123/309 (39%), Gaps = 47/309 (15%)
Query: 684 SNMIGQGSFGFVYKGNLGEN---GMMVAVKVIN-LKQKGASNGFVAECQALRNIRHRNLI 739
+ +IG+G FG VY G L +N + AVK +N + G + F+ E +++ H N++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 740 KIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASA 799
++ IC + +V YM++G L +++ E + T+ I + VA
Sbjct: 92 SLLGICLRSEGS----PLVVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKG 142
Query: 800 IEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIK 859
+ VH DL N +LD+ + DFGLA+ + D+ + G K
Sbjct: 143 M---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS----VHNKTGAK 195
Query: 860 GTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDK 919
V ++A E + + DV+SFG+LL E+ TR P + + L +
Sbjct: 196 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITVYLLQGR 251
Query: 920 VMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKL 979
+ + + L V+ C R ++V+++
Sbjct: 252 RLLQPEYC--------------------PDPLYEVMLK---CWHPKAEMRPSFSELVSRI 288
Query: 980 CRARDTFLG 988
TF+G
Sbjct: 289 SAIFSTFIG 297
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 5e-49
Identities = 77/301 (25%), Positives = 115/301 (38%), Gaps = 53/301 (17%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNL 738
+ IG+G FG V G+ G VAVK I K + F+AE + +RH NL
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNL 62
Query: 739 IKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVAS 798
++++ + + IV EYM GSL D+L + L + +DV
Sbjct: 63 VQLLGVI----VEEKGGLYIVTEYMAKGSLVDYLRS----RGRSVLGGDCLLKFSLDVCE 114
Query: 799 AIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGI 858
A+EY+ + VH DL NVL+ +D VA + DFGL K SS+
Sbjct: 115 AMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----------QDTG 160
Query: 859 KGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPD 918
K V + APE + S DV+SFGILL E+++ R + L +
Sbjct: 161 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV----PYPRIPLKDVVPRVEKG 216
Query: 919 KVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978
M+ D + V++ C R + +
Sbjct: 217 YKMDAPDGC--------------------PPAVYEVMKN---CWHLDAAMRPSFLQLREQ 253
Query: 979 L 979
L
Sbjct: 254 L 254
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 6e-48
Identities = 66/306 (21%), Positives = 127/306 (41%), Gaps = 50/306 (16%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNL----GENGMMVAVKVINLKQ-KGASNGFVAECQALRNI 733
+ + +IG G FG VYKG L G+ + VA+K + + F+ E +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 734 RHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINII 793
H N+I++ + S I+ EYM+NG+L+ +L + + + +++Q + ++
Sbjct: 67 SHHNIIRLEGVISKYKPM-----MIITEYMENGALDKFLREKDGE-----FSVLQLVGML 116
Query: 794 IDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPS 853
+A+ + + VH DL N+L++ +LV + DFGL++ L P T
Sbjct: 117 RGIAAGM---KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT-----Y 168
Query: 854 SSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913
++ G K + + APE + + DV+SFGI++ E+ T +
Sbjct: 169 TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS---------- 218
Query: 914 TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMR 973
+VM+ ++ L + ++ C + R +
Sbjct: 219 ---NHEVMKAINDGFRLPTPMDCPSAIYQLMMQ--------------CWQQERARRPKFA 261
Query: 974 DVVAKL 979
D+V+ L
Sbjct: 262 DIVSIL 267
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 1e-47
Identities = 63/301 (20%), Positives = 117/301 (38%), Gaps = 49/301 (16%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNL 738
++ + IG G FG V+ G N VA+K I + + F+ E + + + H L
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKL 62
Query: 739 IKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVAS 798
+++ +C +V+E+M++G L D+L A + + +DV
Sbjct: 63 VQLYGVCLEQAPI-----CLVFEFMEHGCLSDYLRTQRGLFAAE-----TLLGMCLDVCE 112
Query: 799 AIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGI 858
+ + + V+H DL N L+ ++ V + DFG+ +F+ + +SS G
Sbjct: 113 GM---AYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-------DQYTSSTGT 162
Query: 859 KGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPD 918
K V + +PE S DV+SFG+L+ E+F+ + +
Sbjct: 163 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-------------NS 209
Query: 919 KVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978
+V+E + + L S C E P +R ++ +
Sbjct: 210 EVVEDISTGFRLYKPRLASTHVYQIMNH--------------CWKERPEDRPAFSRLLRQ 255
Query: 979 L 979
L
Sbjct: 256 L 256
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 3e-47
Identities = 67/302 (22%), Positives = 113/302 (37%), Gaps = 57/302 (18%)
Query: 685 NMIGQGSFGFVYKGNL--GENGMMVAVKVINLK--QKGASNGFVAECQALRNIRHRNLIK 740
+G G+FG V KG + VAVK++ + + +AE ++ + + +++
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 741 IITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAI 800
+I IC + +V E + G L +L Q+ R + I ++ V+ +
Sbjct: 73 MIGICE------AESWMLVMEMAELGPLNKYLQQN------RHVKDKNIIELVHQVSMGM 120
Query: 801 EYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKG 860
+Y+ VH DL NVLL A + DFGL+K L + + K
Sbjct: 121 KYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE-----NYYKAQTHGKW 172
Query: 861 TVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFNQGLT--LHEFARTALP 917
V + APE + S DV+SFG+L+ E F+ ++P GM +T L + R P
Sbjct: 173 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP 232
Query: 918 DKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977
+ ++ L C R V
Sbjct: 233 AGCPREMYDLMNL------------------------------CWTYDVENRPGFAAVEL 262
Query: 978 KL 979
+L
Sbjct: 263 RL 264
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 6e-47
Identities = 65/301 (21%), Positives = 121/301 (40%), Gaps = 49/301 (16%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNL 738
D + +G G FG V G VA+K+I + + + F+ E + + N+ H L
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKL 61
Query: 739 IKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVAS 798
+++ +C+ I+ EYM NG L ++L + Q + + DV
Sbjct: 62 VQLYGVCTKQRP-----IFIITEYMANGCLLNYLREMR-----HRFQTQQLLEMCKDVCE 111
Query: 799 AIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGI 858
A+EY+ +H DL N L++ V + DFGL++++ +SS G
Sbjct: 112 AMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-------TSSVGS 161
Query: 859 KGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPD 918
K V + PE M + S D+++FG+L+ E+++ + F
Sbjct: 162 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-------------NS 208
Query: 919 KVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978
+ E + L L S E++ ++ + C E ER + +++
Sbjct: 209 ETAEHIAQGLRLYRPHLAS-----------EKVYTIMYS---CWHEKADERPTFKILLSN 254
Query: 979 L 979
+
Sbjct: 255 I 255
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 8e-47
Identities = 56/220 (25%), Positives = 93/220 (42%), Gaps = 26/220 (11%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICS 746
+G G+FG VYK E ++ A KVI+ K + ++ E L + H N++K++
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79
Query: 747 SIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHH 806
+ I+ E+ G+++ + + E R LT Q + A+ Y+H +
Sbjct: 80 Y-----ENNLWILIEFCAGGAVDAVMLELE-----RPLTESQIQVVCKQTLDALNYLHDN 129
Query: 807 CQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIA 866
++H DLK N+L D L DFG++ + T GT ++A
Sbjct: 130 ---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNT--------RTIQRRDSFIGTPYWMA 178
Query: 867 PEYGMGGEASMTG-----DVYSFGILLLEMFTRRRPTDGM 901
PE M + DV+S GI L+EM P +
Sbjct: 179 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL 218
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 1e-46
Identities = 56/254 (22%), Positives = 101/254 (39%), Gaps = 28/254 (11%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVIN---LKQKGASNGFVAECQALRNIRH 735
DF +G+G FG VY ++ ++A+KV+ L++ G + E + ++RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 736 RNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIID 795
N++++ ++ EY G++ L + + I +
Sbjct: 66 PNILRLYGYFHD-----ATRVYLILEYAPLGTVYRELQKL------SKFDEQRTATYITE 114
Query: 796 VASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSS 855
+A+A+ Y H V+H D+KP N+LL + DFG + SS T
Sbjct: 115 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-------- 163
Query: 856 KGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGM-FNQGLTLHEFART 914
+ GT+ Y+ PE G D++S G+L E + P + + +
Sbjct: 164 --LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF 221
Query: 915 ALPDKVMEIVDSVL 928
PD V E ++
Sbjct: 222 TFPDFVTEGARDLI 235
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 1e-46
Identities = 65/328 (19%), Positives = 127/328 (38%), Gaps = 65/328 (19%)
Query: 666 FPMISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNG--- 722
+P++ + ND ++IG+G+FG V K + ++G+ + + +K+ + +
Sbjct: 4 YPVLDW-------NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD 56
Query: 723 FVAECQALRNI-RHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSE----- 776
F E + L + H N+I ++ C + + EY +G+L D+L +S
Sbjct: 57 FAGELEVLCKLGHHPNIINLLGACEHRGYL-----YLAIEYAPHGNLLDFLRKSRVLETD 111
Query: 777 -----DQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHL 831
A +L+ Q ++ DVA + + Q +H DL N+L+ ++ VA +
Sbjct: 112 PAFAIANSTASTLSSQQLLHFAADVARGM---DYLSQKQFIHRDLAARNILVGENYVAKI 168
Query: 832 GDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEM 891
DFGL++ E + V ++A E + DV+S+G+LL E+
Sbjct: 169 ADFGLSRG---------QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 219
Query: 892 FTRRRPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERL 951
+ G+T E +E + ++ +
Sbjct: 220 VSLGGT----PYCGMTCAELYEKLPQGYRLEKPLNC--------------------DDEV 255
Query: 952 VAVVETGVVCSMESPTERMEMRDVVAKL 979
++ C E P ER ++ L
Sbjct: 256 YDLMRQ---CWREKPYERPSFAQILVSL 280
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 2e-46
Identities = 53/253 (20%), Positives = 93/253 (36%), Gaps = 22/253 (8%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ-KGASNGFVAECQALRNIRHRN 737
D+ +G+G++G V VAVK++++K+ E + + H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 738 LIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVA 797
++K + + + EY G L D + + +
Sbjct: 65 VVKFYGHRREGNIQ-----YLFLEYCSGGELFDRIEPD------IGMPEPDAQRFFHQLM 113
Query: 798 SAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKG 857
+ + Y+H + H D+KP N+LLD+ + DFGLA +
Sbjct: 114 AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN------NRERLLNK 164
Query: 858 IKGTVGYIAPEYGMGGE-ASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTAL 916
+ GT+ Y+APE E + DV+S GI+L M P D + ++
Sbjct: 165 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 224
Query: 917 PDKVMEIVDSVLL 929
+ +DS L
Sbjct: 225 YLNPWKKIDSAPL 237
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 166 bits (420), Expect = 3e-46
Identities = 57/334 (17%), Positives = 117/334 (35%), Gaps = 65/334 (19%)
Query: 670 SYAELSKATNDFSSSNMIGQGSFGFVYKGNL-----GENGMMVAVKVINLK-QKGASNGF 723
L N+ IG+G+FG V++ E MVAVK++ + F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 724 VAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQ----- 778
E + + N++K++ +C+ +++EYM G L ++L
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPM-----CLLFEYMAYGDLNEFLRSMSPHTVCSL 118
Query: 779 -------------QEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQ 825
L+ +++ I VA+ + Y+ VH DL N L+ +
Sbjct: 119 SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGE 175
Query: 826 DLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFG 885
++V + DFGL++ + S+ + + + ++ PE + DV+++G
Sbjct: 176 NMVVKIADFGLSRNIYSA------DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYG 229
Query: 886 ILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERL 945
++L E+F+ G+ E ++ ++
Sbjct: 230 VVLWEIFSYGLQ----PYYGMAHEEVIYYVRDGNILACPENC------------------ 267
Query: 946 RTEERLVAVVETGVVCSMESPTERMEMRDVVAKL 979
L ++ C + P +R + L
Sbjct: 268 --PLELYNLMRL---CWSKLPADRPSFCSIHRIL 296
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 166 bits (421), Expect = 3e-46
Identities = 56/235 (23%), Positives = 93/235 (39%), Gaps = 32/235 (13%)
Query: 681 FSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNG---FVAECQALRNIRHRN 737
FS IG GSFG VY N +VA+K ++ K ++ + E + L+ +RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 738 LIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVA 797
I+ +V EY + + + L ++ +
Sbjct: 77 TIQYRGCYLREHTA-----WLVMEYCLGSASDLLEVHK------KPLQEVEIAAVTHGAL 125
Query: 798 SAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKG 857
+ Y+H H ++H D+K N+LL + + LGDFG A + + +
Sbjct: 126 QGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM------------APANS 170
Query: 858 IKGTVGYIAPEYGMG---GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLH 909
GT ++APE + G+ DV+S GI +E+ R+ P M H
Sbjct: 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 225
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 7e-45
Identities = 53/217 (24%), Positives = 89/217 (41%), Gaps = 23/217 (10%)
Query: 685 NMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITI 744
IGQG+ G VY G VA++ +NL+Q+ + E +R ++ N++ +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 745 CSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIH 804
D +V EY+ GSL D + + + Q + + A+E++H
Sbjct: 86 YLVGDEL-----WVVMEYLAGGSLTDVVTE-------TCMDEGQIAAVCRECLQALEFLH 133
Query: 805 HHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGY 864
+ V+H D+K N+LL D L DFG ++ S + GT +
Sbjct: 134 SNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT--------PEQSKRSTMVGTPYW 182
Query: 865 IAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGM 901
+APE D++S GI+ +EM P
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 7e-45
Identities = 58/340 (17%), Positives = 124/340 (36%), Gaps = 66/340 (19%)
Query: 664 QQFPMISYAELSKATNDFSSSNMIGQGSFGFVYKG-----NLGENGMMVAVKVINLK-QK 717
+++ E + + ++G G+FG V + + VAVK++ K
Sbjct: 24 REYEYDLKWEFPR--ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS 81
Query: 718 GASNGFVAECQALRNI-RHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQS- 775
++E + + + H N++ ++ C+ +++EY G L ++L
Sbjct: 82 SEREALMSELKMMTQLGSHENIVNLLGACTLSGP-----IYLIFEYCCYGDLLNYLRSKR 136
Query: 776 ----------------EDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPS 819
E++++ LT + VA +E++ VH DL
Sbjct: 137 EKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR 193
Query: 820 NVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTG 879
NVL+ V + DFGLA+ + S + V ++APE G ++
Sbjct: 194 NVLVTHGKVVKICDFGLARDIMSD------SNYVVRGNARLPVKWMAPESLFEGIYTIKS 247
Query: 880 DVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRS 939
DV+S+GILL E+F+ + + +++ + ++ +
Sbjct: 248 DVWSYGILLWEIFSLGVNP------------YPGIPVDANFYKLIQNGFKMDQPFYAT-- 293
Query: 940 CGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKL 979
E + ++++ C +R ++ + L
Sbjct: 294 ---------EEIYIIMQS---CWAFDSRKRPSFPNLTSFL 321
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 2e-44
Identities = 57/305 (18%), Positives = 120/305 (39%), Gaps = 52/305 (17%)
Query: 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNG-----FVAECQALRNIR 734
+F ++G G+FG VYKG G V + V + + A++ + E + ++
Sbjct: 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 735 HRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIII 794
+ ++ +++ IC + + ++ + M G L D++ + +D ++ +N +
Sbjct: 70 NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQ-----YLLNWCV 118
Query: 795 DVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSS 854
+A + Y+ +VH DL NVL+ + DFGLAK L + E
Sbjct: 119 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE------EKEYH 169
Query: 855 SKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914
++G K + ++A E + + DV+S+G+ + E+ T G+ E
Sbjct: 170 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK----PYDGIPASE---- 221
Query: 915 ALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRD 974
+ I++ L + ++ C M R + R+
Sbjct: 222 -----ISSILEKGERLPQPPICTIDVYMIMVK--------------CWMIDADSRPKFRE 262
Query: 975 VVAKL 979
++ +
Sbjct: 263 LIIEF 267
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 1e-43
Identities = 69/311 (22%), Positives = 109/311 (35%), Gaps = 51/311 (16%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNL---GENGMMVAVKVIN---LKQKGASNGFVAECQALRN 732
D +G GSFG V +G + VAVK + L Q A + F+ E A+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 733 IRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINI 792
+ HRNLI++ + + K +V E GSL D L + + L
Sbjct: 68 LDHRNLIRLYGVVLTPPMK------MVTELAPLGSLLDRLRKHQ-----GHFLLGTLSRY 116
Query: 793 IIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETP 852
+ VA + Y+ +H DL N+LL + +GDFGL + L + +
Sbjct: 117 AVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQND-----DHY 168
Query: 853 SSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFA 912
+ K + APE S D + FG+ L EMFT + N
Sbjct: 169 VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-------- 220
Query: 913 RTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEM 972
+I+ + + C + + V C P +R
Sbjct: 221 --------SQILHKIDKEGERLPRPEDCPQD----------IYNVMVQCWAHKPEDRPTF 262
Query: 973 RDVVAKLCRAR 983
+ L A+
Sbjct: 263 VALRDFLLEAQ 273
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 2e-43
Identities = 56/320 (17%), Positives = 110/320 (34%), Gaps = 59/320 (18%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNL-----GENGMMVAVKVINLKQK-GASNGFVAECQALRN 732
N S +G G+FG V + + M VAVK++ ++E + L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 733 I-RHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSED------------QQ 779
+ H N++ ++ C+ ++ EY G L ++L + D +
Sbjct: 83 LGNHMNIVNLLGACTIGGPT-----LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137
Query: 780 EARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKF 839
+ +L L ++ VA + ++ +H DL N+LL + + DFGLA+
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARD 194
Query: 840 LSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTD 899
+ + + V ++APE + DV+S+GI L E+F+
Sbjct: 195 IKND------SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 248
Query: 900 GMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGV 959
++ + E + +++T
Sbjct: 249 PGMPVDSKFYKMIKEGFRMLSPEHAP-----------------------AEMYDIMKT-- 283
Query: 960 VCSMESPTERMEMRDVVAKL 979
C P +R + +V +
Sbjct: 284 -CWDADPLKRPTFKQIVQLI 302
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 4e-43
Identities = 48/229 (20%), Positives = 89/229 (38%), Gaps = 23/229 (10%)
Query: 676 KATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVIN---LKQKGASNGFVAECQALRN 732
K DF ++G+GSF V A+K++ + ++ E +
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 733 IRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINI 792
+ H +K+ + Y +NG L ++ + S
Sbjct: 65 LDHPFFVKLYFTFQDDEKL-----YFGLSYAKNGELLKYIRKI------GSFDETCTRFY 113
Query: 793 IIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETP 852
++ SA+EY+H ++H DLKP N+LL++D+ + DFG AK LS
Sbjct: 114 TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE------SKQ 164
Query: 853 SSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGM 901
+ + GT Y++PE A + D+++ G ++ ++ P
Sbjct: 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 213
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 158 bits (401), Expect = 4e-43
Identities = 51/254 (20%), Positives = 92/254 (36%), Gaps = 24/254 (9%)
Query: 655 KSSVSQLMDQQFPMISYAELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINL 714
+ V + Q +P + + + +G G+FG V++ G A K +
Sbjct: 2 DNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT 61
Query: 715 KQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQ 774
+ E Q + +RH L+ + + ++YE+M G L + +
Sbjct: 62 PHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM-----VMIYEFMSGGELFEKVA- 115
Query: 775 SEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLL--DQDLVAHLG 832
E ++ + + + V + ++H + VH DLKP N++ + L
Sbjct: 116 ----DEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLI 168
Query: 833 DFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMF 892
DFGL L S K GT + APE G D++S G+L +
Sbjct: 169 DFGLTAHLDPK---------QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILL 219
Query: 893 TRRRPTDGMFNQGL 906
+ P G +
Sbjct: 220 SGLSPFGGENDDET 233
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 1e-41
Identities = 58/311 (18%), Positives = 120/311 (38%), Gaps = 51/311 (16%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNL-----GENGMMVAVKVINLKQ-KGASNGFVAECQALRN 732
+ S +GQGSFG VY+G E VA+K +N F+ E ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 733 IRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQ----SEDQQEARSLTLIQ 788
++++++ + S ++ E M G L+ +L + +L +
Sbjct: 80 FNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134
Query: 789 RINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTA 848
I + ++A + Y++ + VH DL N ++ +D +GDFG+ + + +
Sbjct: 135 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET----- 186
Query: 849 VETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTL 908
+ V +++PE G + DV+SFG++L E+ T QGL+
Sbjct: 187 -DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ----PYQGLSN 241
Query: 909 HEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTE 968
+ R + +++ D+ + L ++ C +P
Sbjct: 242 EQVLRFVMEGGLLDKPDNCP--------------------DMLFELMRM---CWQYNPKM 278
Query: 969 RMEMRDVVAKL 979
R ++++ +
Sbjct: 279 RPSFLEIISSI 289
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 151 bits (383), Expect = 1e-41
Identities = 54/247 (21%), Positives = 98/247 (39%), Gaps = 18/247 (7%)
Query: 675 SKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVIN---LKQKGASNGFVAECQALR 731
S ++ + ++G G V+ VAVKV+ + F E Q
Sbjct: 3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 62
Query: 732 NIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRIN 791
+ H ++ + + G IV EY+ +L D +H +T + I
Sbjct: 63 ALNHPAIVAVYDTGEAETPAG-PLPYIVMEYVDGVTLRDIVHTE------GPMTPKRAIE 115
Query: 792 IIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVET 851
+I D A+ + H + ++H D+KP+N+++ + DFG+A+ ++ S +
Sbjct: 116 VIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSG-----NS 167
Query: 852 PSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEF 911
+ + + GT Y++PE G DVYS G +L E+ T P G +
Sbjct: 168 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 227
Query: 912 ARTALPD 918
+P
Sbjct: 228 REDPIPP 234
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 5e-41
Identities = 61/308 (19%), Positives = 111/308 (36%), Gaps = 58/308 (18%)
Query: 679 NDFSSSNMIGQGSFGFVYKG---NLGENGMMVAVKVI-NLKQKGASNGFVAECQALRNIR 734
IG+G FG V++G + + VA+K N F+ E +R
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 735 HRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIII 794
H +++K+I + + + I+ E G L +L SL L I
Sbjct: 67 HPHIVKLIGVITE------NPVWIIMELCTLGELRSFLQV-----RKYSLDLASLILYAY 115
Query: 795 DVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSS 854
+++A+ + VH D+ NVL+ + LGDFGL++++ S T
Sbjct: 116 QLSTAL---AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-------TYYK 165
Query: 855 SKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFNQGLT--LHEF 911
+ K + ++APE + DV+ FG+ + E+ +P G+ N + +
Sbjct: 166 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG 225
Query: 912 ARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERME 971
R +P + S++ C P+ R
Sbjct: 226 ERLPMPPNCPPTLYSLMTK------------------------------CWAYDPSRRPR 255
Query: 972 MRDVVAKL 979
++ A+L
Sbjct: 256 FTELKAQL 263
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 150 bits (380), Expect = 2e-40
Identities = 44/222 (19%), Positives = 81/222 (36%), Gaps = 24/222 (10%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICS 746
+G G+FG V++ G + K IN E + + H LI +
Sbjct: 37 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 96
Query: 747 SIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHH 806
++ E++ G L D + E ++ + IN + ++++H H
Sbjct: 97 D-----KYEMVLILEFLSGGELFDRIA-----AEDYKMSEAEVINYMRQACEGLKHMHEH 146
Query: 807 CQPPVVHGDLKPSNVLLDQDLVAH--LGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGY 864
+VH D+KP N++ + + + DFGLA L+ K T +
Sbjct: 147 ---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD---------EIVKVTTATAEF 194
Query: 865 IAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGL 906
APE D+++ G+L + + P G +
Sbjct: 195 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET 236
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 149 bits (378), Expect = 5e-40
Identities = 56/235 (23%), Positives = 89/235 (37%), Gaps = 31/235 (13%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNG------FVAECQALRN 732
NDFS +IG+G FG VY + G M A+K ++ K+ G +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 733 IRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINI 792
++ + + D + + + M G L L Q EA
Sbjct: 64 GDCPFIVCMSYAFHT-----PDKLSFILDLMNGGDLHYHLSQHGVFSEA------DMRFY 112
Query: 793 IIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETP 852
++ +E++H+ VV+ DLKP+N+LLD+ + D GLA S
Sbjct: 113 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS----------K 159
Query: 853 SSSKGIKGTVGYIAPEYGMGGEA-SMTGDVYSFGILLLEMFTRRRPTDGMFNQGL 906
GT GY+APE G A + D +S G +L ++ P +
Sbjct: 160 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 214
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 144 bits (365), Expect = 4e-39
Identities = 51/238 (21%), Positives = 93/238 (39%), Gaps = 39/238 (16%)
Query: 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNG---------FVAECQAL 730
++ ++G+G V + AVK+I++ G+ + + E L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 731 RNIR-HRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQR 789
R + H N+I++ + F +V++ M+ G L D+L + +L+ +
Sbjct: 64 RKVSGHPNIIQLKDTYETN-----TFFFLVFDLMKKGELFDYLTEK------VTLSEKET 112
Query: 790 INIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAV 849
I+ + I +H +VH DLKP N+LLD D+ L DFG + L
Sbjct: 113 RKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG------ 163
Query: 850 ETPSSSKGIKGTVGYIAPEYGMGGEASMTG------DVYSFGILLLEMFTRRRPTDGM 901
+ + GT Y+APE D++S G+++ + P
Sbjct: 164 ---EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR 218
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 1e-38
Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 24/225 (10%)
Query: 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLI 739
++ + +IG GSFG VY+ L ++G +VA+K + ++ + E Q +R + H N++
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 76
Query: 740 KIITIC-SSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVAS 798
++ SS + K + +V +Y+ H S +Q +L +I + +
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ---TLPVIYVKLYMYQLFR 133
Query: 799 AIEYIHHHCQPPVVHGDLKPSNVLLDQD-LVAHLGDFGLAKFLS-SSPLDTAVETPSSSK 856
++ YIH + H D+KP N+LLD D V L DFG AK L P + + +
Sbjct: 134 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR---- 186
Query: 857 GIKGTVGYIAPEYGMGGEA-SMTGDVYSFGILLLEMFTRRRPTDG 900
Y APE G + + DV+S G +L E+ + G
Sbjct: 187 ------YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 225
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 4e-38
Identities = 41/222 (18%), Positives = 89/222 (40%), Gaps = 25/222 (11%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICS 746
+G+G FG V++ + K + +K E L RHRN++ +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL-VKKEISILNIARHRNILHLHESFE 71
Query: 747 SIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHH 806
S ++ +++E++ + + ++ S + L + ++ + V A++++H H
Sbjct: 72 S-----MEELVMIFEFISGLDIFERINTSAFE-----LNEREIVSYVHQVCEALQFLHSH 121
Query: 807 CQPPVVHGDLKPSNVLLDQDLVAH--LGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGY 864
+ H D++P N++ + + +FG A+ L + + + Y
Sbjct: 122 ---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG---------DNFRLLFTAPEY 169
Query: 865 IAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGL 906
APE S D++S G L+ + + P NQ +
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI 211
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 142 bits (360), Expect = 4e-38
Identities = 48/230 (20%), Positives = 80/230 (34%), Gaps = 21/230 (9%)
Query: 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ-KGASNGFVAECQALRNIRHR 736
+ + +++G G+F V +VA+K I K +G E L I+H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 737 NLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDV 796
N++ + I S ++ + + G L D + + T +I V
Sbjct: 68 NIVALDDIYES-----GGHLYLIMQLVSGGELFDRIVEK------GFYTERDASRLIFQV 116
Query: 797 ASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSK 856
A++Y+H LD+D + DFGL+K S
Sbjct: 117 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG---------SVLS 167
Query: 857 GIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGL 906
GT GY+APE S D +S G++ + P + L
Sbjct: 168 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL 217
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 7e-38
Identities = 59/320 (18%), Positives = 116/320 (36%), Gaps = 60/320 (18%)
Query: 679 NDFSSSNMIGQGSFGFVYKG-------NLGENGMMVAVKVINLKQ-KGASNGFVAECQAL 730
+ +G+G+FG V + VAVK++ + + ++E + +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 731 RNI-RHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQ----------SEDQQ 779
+ I +H+N+I ++ C+ ++ EY G+L ++L +
Sbjct: 73 KMIGKHKNIINLLGACTQDGPL-----YVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 127
Query: 780 EARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKF 839
L+ ++ VA + + +H DL NVL+ +D V + DFGLA+
Sbjct: 128 PEEQLSSKDLVSCAYQVARGM---EYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 184
Query: 840 LSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTD 899
+ + + + V ++APE + DV+SFG+LL E+FT
Sbjct: 185 IHHI------DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS-- 236
Query: 900 GMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGV 959
G+ + E + M+ + L ++
Sbjct: 237 --PYPGVPVEELFKLLKEGHRMDKPSNCT--------------------NELYMMMRD-- 272
Query: 960 VCSMESPTERMEMRDVVAKL 979
C P++R + +V L
Sbjct: 273 -CWHAVPSQRPTFKQLVEDL 291
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 142 bits (358), Expect = 8e-38
Identities = 52/226 (23%), Positives = 88/226 (38%), Gaps = 28/226 (12%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVIN---LKQKGASNGFVAECQALRNIRH 735
DF +G GSFG V+ NG A+KV+ + + E L + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 736 RNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIID 795
+I++ ++ +Y++ G L L +S+ + +
Sbjct: 64 PFIIRMWGTFQD-----AQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV----- 113
Query: 796 VASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSS 855
+ + +++ DLKP N+LLD++ + DFG AK++ P +
Sbjct: 114 ----CLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV-----------PDVT 158
Query: 856 KGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGM 901
+ GT YIAPE + + D +SFGIL+ EM P
Sbjct: 159 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS 204
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 141 bits (356), Expect = 9e-38
Identities = 55/222 (24%), Positives = 89/222 (40%), Gaps = 19/222 (8%)
Query: 686 MIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITIC 745
IG GSFG +Y G G VA+K+ +K K E + + ++ I I C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVGIPTIRWC 71
Query: 746 SSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHH 805
+ D+ +V E + + + S R +L + + + S IEYIH
Sbjct: 72 GAEG----DYNVMVMELLGPSLEDLFNFCS------RKFSLKTVLLLADQMISRIEYIHS 121
Query: 806 HCQPPVVHGDLKPSNVL---LDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTV 862
+H D+KP N L + + ++ DFGLAK + + + K + GT
Sbjct: 122 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN-KNLTGTA 177
Query: 863 GYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQ 904
Y + +G E S D+ S G +L+ P G+
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 219
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 2e-37
Identities = 56/317 (17%), Positives = 108/317 (34%), Gaps = 54/317 (17%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNL-----GENGMMVAVKVINLKQ-KGASNGFVAECQALRN 732
+ +G+G+FG V + + VAVK++ ++E + L +
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 733 IRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQ----------SEDQQEAR 782
I H + + K ++ E+ + G+L +L + +
Sbjct: 73 IGHHLNVVNLLGAC---TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129
Query: 783 SLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSS 842
LTL I VA +E++ +H DL N+LL + V + DFGLA+ +
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186
Query: 843 SPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMF 902
P + + ++APE ++ DV+SFG+LL E+F+
Sbjct: 187 DP------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP---- 236
Query: 903 NQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCS 962
+ + ++ + + + L C
Sbjct: 237 --------YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD--------------CW 274
Query: 963 MESPTERMEMRDVVAKL 979
P++R ++V L
Sbjct: 275 HGEPSQRPTFSELVEHL 291
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 3e-37
Identities = 53/227 (23%), Positives = 89/227 (39%), Gaps = 26/227 (11%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNG---FVAECQAL-RNIR 734
DF M+G+GSFG V+ + A+K + + + E + L
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 735 HRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIII 794
H L + + + V EY+ G L + L +
Sbjct: 62 HPFLTHMFCTFQTKENL-----FFVMEYLNGGDLMYHIQSC------HKFDLSRATFYAA 110
Query: 795 DVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSS 854
++ ++++H +V+ DLK N+LLD+D + DFG+ K +
Sbjct: 111 EIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--------AK 159
Query: 855 SKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGM 901
+ GT YIAPE +G + + + D +SFG+LL EM + P G
Sbjct: 160 TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ 206
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 6e-37
Identities = 56/244 (22%), Positives = 94/244 (38%), Gaps = 18/244 (7%)
Query: 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVIN-LKQKGASNGFVAECQALRNIRHR 736
+++ + IG+G++G V N + VA+K I+ + + + E + L RH
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 737 NLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDV 796
N+I I I + + + +V M L L + L+ + +
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLM-GADLYKLLKT-------QHLSNDHICYFLYQI 118
Query: 797 ASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSK 856
++YIH V+H DLKPSN+LL+ + DFGLA+ +
Sbjct: 119 LRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-----DHTGFLT 170
Query: 857 GIKGTVGYIAPEYGMGGEASMT-GDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915
T Y APE + + D++S G +L EM + R G H
Sbjct: 171 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 230
Query: 916 LPDK 919
P +
Sbjct: 231 SPSQ 234
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 6e-37
Identities = 54/234 (23%), Positives = 101/234 (43%), Gaps = 23/234 (9%)
Query: 674 LSKATNDFSSSNMIGQGSFGFVYKG-NLGENGMMVAVKVINLK--QKGASNGFVAECQAL 730
L +A + IG+G++G V+K +L G VA+K + ++ ++G + E L
Sbjct: 2 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61
Query: 731 RNI---RHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLI 787
R++ H N++++ +C+ +V+E++ E +
Sbjct: 62 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE-----PGVPTE 116
Query: 788 QRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDT 847
+++ + ++++H H VVH DLKP N+L+ L DFGLA+ S
Sbjct: 117 TIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYS------ 167
Query: 848 AVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGM 901
+ + T+ Y APE + + D++S G + EMF R+ G
Sbjct: 168 ---FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 218
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 2e-36
Identities = 48/232 (20%), Positives = 91/232 (39%), Gaps = 26/232 (11%)
Query: 686 MIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQAL-RNIRHRNLIKIITI 744
++G G G V + A+K++ K E + R + ++++I+ +
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDV 73
Query: 745 CSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIH 804
++ + G IV E + G L + DQ + T + I+ + AI+Y+H
Sbjct: 74 YENL-YAGRKCLLIVMECLDGGELFSRIQDRGDQ----AFTEREASEIMKSIGEAIQYLH 128
Query: 805 HHCQPPVVHGDLKPSNVLLD---QDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGT 861
+ H D+KP N+L + + L DFG AK +S +S T
Sbjct: 129 SIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH---------NSLTTPCYT 176
Query: 862 VGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913
Y+APE + + D++S G+++ + P ++ R
Sbjct: 177 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR 228
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 136 bits (343), Expect = 4e-36
Identities = 40/223 (17%), Positives = 78/223 (34%), Gaps = 21/223 (9%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICS 746
IG+GSFG +++G N VA+K + E + + + I +
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ--LRDEYRTYKLLAGCTGIPNVYYFG 70
Query: 747 SIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHH 806
+V + + + R ++ + + ++ IH
Sbjct: 71 QEG----LHNVLVIDLL------GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 120
Query: 807 CQPPVVHGDLKPSNVLLDQDLVAH-----LGDFGLAKFLSSSPLDTAVETPSSSKGIKGT 861
+V+ D+KP N L+ + + + DFG+ KF P+ K + GT
Sbjct: 121 S---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD-PVTKQHIPYREKKNLSGT 176
Query: 862 VGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQ 904
Y++ +G E S D+ + G + + P G+
Sbjct: 177 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA 219
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 2e-35
Identities = 49/228 (21%), Positives = 88/228 (38%), Gaps = 33/228 (14%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNG------FVAECQALRNIRHRNLIK 740
+G G F V K G+ A K I ++ +S E L+ I+H N+I
Sbjct: 18 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 741 IITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAI 800
+ + + ++ E + G L D+L + E E + +++I +
Sbjct: 78 LHEVYEN-----KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI---------L 123
Query: 801 EYIHHHCQPPVVHGDLKPSNVLLDQD----LVAHLGDFGLAKFLSSSPLDTAVETPSSSK 856
+++ + H DLKP N++L + DFGLA + + K
Sbjct: 124 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---------NEFK 174
Query: 857 GIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQ 904
I GT ++APE + D++S G++ + + P G Q
Sbjct: 175 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 222
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 2e-35
Identities = 51/232 (21%), Positives = 104/232 (44%), Gaps = 19/232 (8%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK--QKGASNGFVAECQALRNIRHR 736
+ + IGQG+FG V+K + G VA+K + ++ ++G + E + L+ ++H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 737 NLIKIITICSSIDFKGVDFQA---IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINII 793
N++ +I IC + + +V+++ ++ + + ++Q +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML--- 126
Query: 794 IDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPS 853
+ +++ + ++H D+K +NVL+ +D V L DFGLA+ S + P+
Sbjct: 127 ------LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS----QPN 176
Query: 854 SSKGIKGTVGYIAPEYGMGGEA-SMTGDVYSFGILLLEMFTRRRPTDGMFNQ 904
T+ Y PE +G D++ G ++ EM+TR G Q
Sbjct: 177 RYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ 228
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 7e-35
Identities = 53/226 (23%), Positives = 92/226 (40%), Gaps = 28/226 (12%)
Query: 685 NMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNG-----FVAECQALRNIRHRNLI 739
+ +G+G F VYK +VA+K I L + + + E + L+ + H N+I
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 740 KIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASA 799
++ ++V+++M+ S + ++
Sbjct: 64 GLLDAFGH-----KSNISLVFDFMETDLEVIIKDNSLVLTPS------HIKAYMLMTLQG 112
Query: 800 IEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIK 859
+EY+H H ++H DLKP+N+LLD++ V L DFGLAK S +
Sbjct: 113 LEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS--------PNRAYTHQV 161
Query: 860 GTVGYIAPEYGMGGEA-SMTGDVYSFGILLLEMFTRRRPTDGMFNQ 904
T Y APE G + D+++ G +L E+ R G +
Sbjct: 162 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL 207
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 4e-34
Identities = 57/231 (24%), Positives = 91/231 (39%), Gaps = 25/231 (10%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNG---FVAECQALRNIRH 735
NDF ++G+G+FG V G A+K++ + A + V E + L+N RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 736 RNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIID 795
L + + D V EY G L L + E R+ I
Sbjct: 65 PFLTALKYAFQT-----HDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEI----- 114
Query: 796 VASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSS 855
+ + + VV+ D+K N++LD+D + DFGL K S ++
Sbjct: 115 ----VSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--------DGATM 162
Query: 856 KGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGL 906
K GT Y+APE + D + G+++ EM R P ++ L
Sbjct: 163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 3e-33
Identities = 60/245 (24%), Positives = 102/245 (41%), Gaps = 24/245 (9%)
Query: 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHRN 737
+F IG+G++G VYK G +VA+K I L +G + + E L+ + H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 738 LIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVA 797
++K++ + + + +V+E++ L + D + L + + +
Sbjct: 63 IVKLLDVIHT-----ENKLYLVFEFL-----HQDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 798 SAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKG 857
+ + H H V+H DLKP N+L++ + L DFGLA+ +
Sbjct: 113 QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV--------PVRTYTH 161
Query: 858 IKGTVGYIAPE-YGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTAL 916
T+ Y APE S D++S G + EM TRR G F
Sbjct: 162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 221
Query: 917 PDKVM 921
PD+V+
Sbjct: 222 PDEVV 226
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 126 bits (317), Expect = 4e-32
Identities = 52/262 (19%), Positives = 94/262 (35%), Gaps = 32/262 (12%)
Query: 647 ARRRRSAHKSSVSQLMDQQFPMISYAELSKAT----NDFSSSNMIGQGSFGFVYKGNLGE 702
A ++ S +S L + + E + F +G GSFG V E
Sbjct: 5 AAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKE 64
Query: 703 NGMMVAVKVINLKQKGASNG---FVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIV 759
+G A+K+++ ++ + E + L+ + L+K+ +V
Sbjct: 65 SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN-----LYMV 119
Query: 760 YEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPS 819
EY+ G + L + + + EY+H +++ DLKP
Sbjct: 120 MEYVAGGEMFSHLRRI------GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 170
Query: 820 NVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTG 879
N+L+DQ + DFG AK + + GT +APE + +
Sbjct: 171 NLLIDQQGYIQVTDFGFAKR-----------VKGRTWTLCGTPEALAPEIILSKGYNKAV 219
Query: 880 DVYSFGILLLEMFTRRRPTDGM 901
D ++ G+L+ EM P
Sbjct: 220 DWWALGVLIYEMAAGYPPFFAD 241
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 4e-32
Identities = 48/253 (18%), Positives = 86/253 (33%), Gaps = 34/253 (13%)
Query: 686 MIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNG------FVAECQALRNIR--HRN 737
++G G FG VY G + + VA+K + + E L+ +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 738 LIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVA 797
+I+++ D ++ E + E +L + V
Sbjct: 71 VIRLLDWFERPDSF-----VLILERPEPVQDLFDFI-----TERGALQEELARSFFWQVL 120
Query: 798 SAIEYIHHHCQPPVVHGDLKPSNVLLDQD-LVAHLGDFGLAKFLSSSPLDTAVETPSSSK 856
A+ + H+ V+H D+K N+L+D + L DFG L +
Sbjct: 121 EAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD------- 170
Query: 857 GIKGTVGYIAPEYGMGGEA-SMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915
GT Y PE+ + V+S GILL +M P + + + F R
Sbjct: 171 ---GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-EEIIRGQVFFRQR 226
Query: 916 LPDKVMEIVDSVL 928
+ + ++ L
Sbjct: 227 VSSECQHLIRWCL 239
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 5e-32
Identities = 41/221 (18%), Positives = 88/221 (39%), Gaps = 23/221 (10%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHR 736
+ IG+G++G V+K E +VA+K + L +G + + E L+ ++H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 737 NLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDV 796
N++++ + S +V+E+ + + + D + + ++
Sbjct: 62 NIVRLHDVLHS-----DKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQL------ 110
Query: 797 ASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSK 856
++ + V+H DLKP N+L++++ L +FGLA+ S
Sbjct: 111 ---LKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI-------PVRCYSA 160
Query: 857 GIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRP 897
+ S + D++S G + E+ RP
Sbjct: 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 123 bits (309), Expect = 3e-31
Identities = 50/250 (20%), Positives = 100/250 (40%), Gaps = 30/250 (12%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIR-HRN 737
+D+ +G+G + V++ N V VK++ +K E + L N+R N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPN 91
Query: 738 LIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVA 797
+I + I + A+V+E++ N + ++LT + ++
Sbjct: 92 IITLADIVKDPVSRTP---ALVFEHVNNTDFKQLY---------QTLTDYDIRFYMYEIL 139
Query: 798 SAIEYIHHHCQPPVVHGDLKPSNVLLD-QDLVAHLGDFGLAKFLSSSPLDTAVETPSSSK 856
A++Y H ++H D+KP NV++D + L D+GLA+F
Sbjct: 140 KALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG---------QEYN 187
Query: 857 GIKGTVGYIAPEYGMGGEA-SMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915
+ + PE + + + D++S G +L M R+ P + L A+
Sbjct: 188 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 247
Query: 916 LPDKVMEIVD 925
+ + + +D
Sbjct: 248 GTEDLYDYID 257
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 7e-31
Identities = 52/242 (21%), Positives = 97/242 (40%), Gaps = 30/242 (12%)
Query: 673 ELSKATNDFSSS----NMIGQGSFGFVYKGNLGENGMMVAVKVIN--LKQKGASNGFVAE 726
E++K + + +G G++G V G G VA+K + + + + E
Sbjct: 8 EVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRE 67
Query: 727 CQALRNIRHRNLIKIITICSSID-FKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLT 785
+ L+++RH N+I ++ + + + +V +M G+ L + L
Sbjct: 68 LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKH------EKLG 119
Query: 786 LIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPL 845
+ ++ + + YIH H DLKP N+ +++D + DFGLA+
Sbjct: 120 EDRIQFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQAD---- 172
Query: 846 DTAVETPSSSKGIKGTVGYIAPEYGMGGE-ASMTGDVYSFGILLLEMFTRRRPTDGMFNQ 904
S G T Y APE + + T D++S G ++ EM T + G +
Sbjct: 173 -------SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL 225
Query: 905 GL 906
Sbjct: 226 DQ 227
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 118 bits (295), Expect = 8e-30
Identities = 53/244 (21%), Positives = 99/244 (40%), Gaps = 26/244 (10%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHR 736
+ IG+G++G VYK G A+K I L++ +G + + E L+ ++H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 737 NLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDV 796
N++K+ + + +V+E++ + L + + ++ +
Sbjct: 61 NIVKLYDVIHTKKRL-----VLVFEHLDQDLKKLLDVCE------GGLESVTAKSFLLQL 109
Query: 797 ASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSK 856
+ I Y H V+H DLKP N+L++++ + DFGLA+
Sbjct: 110 LNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFG--------IPVRKYT 158
Query: 857 GIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915
T+ Y AP+ MG + S T D++S G + EM G+ + F
Sbjct: 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILG 218
Query: 916 LPDK 919
P+
Sbjct: 219 TPNS 222
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (295), Expect = 2e-29
Identities = 52/231 (22%), Positives = 98/231 (42%), Gaps = 29/231 (12%)
Query: 679 NDFSSSNMIGQGSFGFVYKG---NLGENGMMVAVKVIN----LKQKGASNGFVAECQALR 731
+F ++G G++G V+ + + G + A+KV+ +++ + E Q L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 732 NIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRIN 791
+IR + + F+ ++ +Y+ G L L Q E E
Sbjct: 84 HIRQSPFLVTLHYA----FQTETKLHLILDYINGGELFTHLSQRERFTEHE--------- 130
Query: 792 IIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVET 851
+ I V + + H + +++ D+K N+LLD + L DFGL+K + + A +
Sbjct: 131 VQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF 190
Query: 852 PSSSKGIKGTVGYIAPEYGMGGEASMTG--DVYSFGILLLEMFTRRRPTDG 900
GT+ Y+AP+ GG++ D +S G+L+ E+ T P
Sbjct: 191 C-------GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV 234
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 118 bits (297), Expect = 2e-29
Identities = 47/220 (21%), Positives = 84/220 (38%), Gaps = 15/220 (6%)
Query: 687 IGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICS 746
+G G F V+ N VA+K++ K + E + L+ + + K ++ +
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 747 SIDFKGVDF-----QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIE 801
+ K +D V+ M L + L + E R + LI I + ++
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139
Query: 802 YIHHHCQPPVVHGDLKPSNVLLDQ-DLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKG 860
Y+H C ++H D+KP NVL++ D +L +A A
Sbjct: 140 YMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADL------GNACWYDEHYTNSIQ 191
Query: 861 TVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDG 900
T Y +PE +G D++S L+ E+ T +
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 231
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 5e-29
Identities = 52/242 (21%), Positives = 98/242 (40%), Gaps = 28/242 (11%)
Query: 667 PMISYAELSKA----TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNG 722
P EL+K + + + +G G++G V + G+ VAVK ++ + +
Sbjct: 2 PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 61
Query: 723 --FVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQE 780
E + L++++H N+I ++ + + + ++ L + +
Sbjct: 62 KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC------ 115
Query: 781 ARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFL 840
+ LT +I + ++YIH H DLKPSN+ +++D + DFGLA+
Sbjct: 116 -QKLTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHT 171
Query: 841 SSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGE-ASMTGDVYSFGILLLEMFTRRRPTD 899
G T Y APE + + T D++S G ++ E+ T R
Sbjct: 172 DDEM-----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 220
Query: 900 GM 901
G
Sbjct: 221 GT 222
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (287), Expect = 3e-28
Identities = 44/231 (19%), Positives = 90/231 (38%), Gaps = 24/231 (10%)
Query: 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVIN--LKQKGASNGFVAECQALRNIRHR 736
+ + IG G+ G V VA+K ++ + + + E ++ + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 737 NLIKIITICSSID-FKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIID 795
N+I ++ + + + +V E M + + + ++ + ++
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSY---------LLYQ 127
Query: 796 VASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSS 855
+ I+++H +H DLKPSN+++ D + DFGLA+ +S + T
Sbjct: 128 MLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY------ 178
Query: 856 KGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGL 906
T Y APE +G D++S G ++ EM + G
Sbjct: 179 ---VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 112 bits (279), Expect = 1e-27
Identities = 75/310 (24%), Positives = 123/310 (39%), Gaps = 15/310 (4%)
Query: 6 NETDRLALLAIGSQLEDDPLGVTSSWNNSTNLCQ--WTGVTC--GHRHQRVTKLDLSNRT 61
N D+ ALL I L + SSW +T+ C W GV C + RV LDLS
Sbjct: 4 NPQDKQALLQIKKDLGNPT--TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLN 61
Query: 62 IGG--TLSPYVGNLSFLRYLNLADN-NFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNL 118
+ + + NL +L +L + N G IP I +L +L L + + + SG IP L
Sbjct: 62 LPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFL 121
Query: 119 SRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLER-IN 177
S+ L++ + N L G +P + + L +T N ++G P S G+ S L +
Sbjct: 122 SQIKTLVTLDFSYNALSGTLPPSI-SSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMT 180
Query: 178 VLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPL 237
+ N L G+IP NL + + ++ + + L
Sbjct: 181 ISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAF---DL 237
Query: 238 DIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWL 297
L G + N G++P+ L+ L L + N G++ +L+ +
Sbjct: 238 GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVS 296
Query: 298 NLGSNNLGTG 307
+N G
Sbjct: 297 AYANNKCLCG 306
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 84.8 bits (208), Expect = 2e-18
Identities = 73/266 (27%), Positives = 115/266 (43%), Gaps = 9/266 (3%)
Query: 350 TDIVIAGNQISGI--IPTGIRNLVNLVELCMDDN-KLTGTIPHAIGELKNLQLLYLDSNF 406
++ ++G + IP+ + NL L L + L G IP AI +L L LY+
Sbjct: 53 NNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTN 112
Query: 407 LAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSI 466
++G IP L + L L S N L G++PPS+ + NL+ + ++GA+P S
Sbjct: 113 VSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSF 172
Query: 467 STLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGN 526
S L S+ +S N L+G +P NL F L Q
Sbjct: 173 SKLFTSMTISRNRLTGKIPPTFANLNL--AFVDLSRNMLEGDASVLFGSDKNTQKIHLAK 230
Query: 527 SFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVF 586
+ + K++ LD+ +N + G +P+ L L FL LN+S+N+ GE+P G
Sbjct: 231 NSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNL 290
Query: 587 SNKTGISLSGNGKVCGGLDELNLPPC 612
+ + N +CG LP C
Sbjct: 291 QRFDVSAYANNKCLCGS----PLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 72.5 bits (176), Expect = 3e-14
Identities = 66/272 (24%), Positives = 108/272 (39%), Gaps = 15/272 (5%)
Query: 145 NWLKLENLTIADNHLTGHF--PASIGNLSTLERINVLGN-GLWGRIPNNLGNLRNLILLN 201
++ NL ++ +L + P+S+ NL L + + G L G IP + L L L
Sbjct: 48 QTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLY 107
Query: 202 LGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIP 261
+ SG +P + I +L + N +G+LP I SLP L+G N +G+IP
Sbjct: 108 ITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSI-SSLPNLVGITFDGNRISGAIP 166
Query: 262 ESLSNASNLVE-LTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTN 320
+S + S L +T+ N+ GK+ F +L + G
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKI 226
Query: 321 CTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDD 380
++ D + G + +L + N+I G +P G+ L L L +
Sbjct: 227 HLAKNSLAFDLGKVGLSKNLNGLDLRN---------NRIYGTLPQGLTQLKFLHSLNVSF 277
Query: 381 NKLTGTIPHAIGELKNLQLLYLDSNFLAGGIP 412
N L G IP G L+ + +N G P
Sbjct: 278 NNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 68.6 bits (166), Expect = 6e-13
Identities = 55/272 (20%), Positives = 90/272 (33%), Gaps = 21/272 (7%)
Query: 189 NNLGNLRNLILLNLGENRFSGI--VPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKL 246
+ + L+L +P S+ N+ L +++ L +L
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103
Query: 247 LGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGT 306
+ N +G+IP+ LS LV L N G + SL NL + N +
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163
Query: 307 GEANDLDFLTLLTNCTELTAIGL----------------DDNRFGGVLPHSIANLSSTMT 350
+ + L ++ L D +R S+ S T
Sbjct: 164 AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNT 223
Query: 351 DIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGG 410
+ + NL L + +N++ GT+P + +LK L L + N L G
Sbjct: 224 QKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGE 283
Query: 411 IPTSLGNLTLLTNLALSSNDLQGSIPPSLGNC 442
IP GNL A ++N P L C
Sbjct: 284 IP-QGGNLQRFDVSAYANNKCLCGSP--LPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 50.1 bits (118), Expect = 7e-07
Identities = 18/109 (16%), Positives = 37/109 (33%), Gaps = 1/109 (0%)
Query: 31 WNNSTNLCQWTGVTCGHRHQRVTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEI 90
+ + + + + T+ + VG L L+L +N +G +
Sbjct: 201 FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTL 260
Query: 91 PHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIP 139
P + +L L +L ++ N+ G+IP N + P
Sbjct: 261 PQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 113 bits (283), Expect = 2e-27
Identities = 80/388 (20%), Positives = 137/388 (35%), Gaps = 30/388 (7%)
Query: 193 NLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVA 252
L + LG+ + V + ++ + + ++ L L +
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSIDGVE---YLNNLTQINFS 74
Query: 253 ENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDL 312
N P L N + LV++ + +NQ + + L N
Sbjct: 75 NNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132
Query: 313 DFLTLLTNCTELTAIGLDDNRFGGVLPHSIAN------LSSTMTDIVIAGNQISGIIPTG 366
+ L + ++ I L++ T + + +
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISV 192
Query: 367 IRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLAL 426
+ L NL L +N+++ P I NL L L+ N L +L +LT LT+L L
Sbjct: 193 LAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDL 248
Query: 427 SSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPL 486
++N + P L L EL + +++ P L+ T N
Sbjct: 249 ANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNL-----ELNENQLEDIS 301
Query: 487 EVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELD 546
+ NLKNL Y + N S P +S+ T LQ+L+ N S SSL++L +I L
Sbjct: 302 PISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLS 357
Query: 547 MSSNNLSGQIPEYLENLSFLEYLNLSYN 574
N +S P L NL+ + L L+
Sbjct: 358 AGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 89.3 bits (220), Expect = 2e-19
Identities = 77/393 (19%), Positives = 135/393 (34%), Gaps = 42/393 (10%)
Query: 72 NLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARR 131
L+ L N + L ++ L + +NL N
Sbjct: 20 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSN 75
Query: 132 NNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIP--- 188
N L P + N KL ++ + +N + P + T + +
Sbjct: 76 NQLTDITPLK---NLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132
Query: 189 ---------NNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDI 239
N + ++ L L + G + +++L + N + +
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISV 192
Query: 240 GVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNL 299
L L I N + P +NL EL+L NQ + + SL NL L+L
Sbjct: 193 LAKLTNLESLIATNNQISDITPL--GILTNLDELSLNGNQLKDIGT--LASLTNLTDLDL 248
Query: 300 GSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQI 359
+N + L L+ T+LT + L N+ + P L+ + N+
Sbjct: 249 ANNQISN--------LAPLSGLTKLTELKLGANQISNISP-----LAGLTALTNLELNEN 295
Query: 360 SGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLT 419
+ I NL NL L + N ++ P + L LQ L+ +N ++ +SL NLT
Sbjct: 296 QLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLT 351
Query: 420 LLTNLALSSNDLQGSIPPSLGNCKNLIELHMAD 452
+ L+ N + P L N + +L + D
Sbjct: 352 NINWLSAGHNQISDLTP--LANLTRITQLGLND 382
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 88.1 bits (217), Expect = 4e-19
Identities = 80/394 (20%), Positives = 144/394 (36%), Gaps = 68/394 (17%)
Query: 50 QRVTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNS 109
+VT L I ++ V L+ L +N ++N P + L +L +++ NN
Sbjct: 44 DQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ 99
Query: 110 FSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPA---- 165
+ P ++ + + + N L+L + TI+D +
Sbjct: 100 IADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQL 159
Query: 166 ----------SIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSI 215
+ NL+TLER+++ N + L L NL L N+ S I P
Sbjct: 160 SFGNQVTDLKPLANLTTLERLDISSN--KVSDISVLAKLTNLESLIATNNQISDITPL-- 215
Query: 216 FNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTL 275
+++L+ + L N+ +L++ +NL +L L
Sbjct: 216 GILTNLDELSLNGNQLKD---------------------------IGTLASLTNLTDLDL 248
Query: 276 FDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFG 335
+NQ L L L LG+N + ++ LTA+ +
Sbjct: 249 ANNQISN--LAPLSGLTKLTELKLGANQISN-----------ISPLAGLTALTNLELNEN 295
Query: 336 GVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELK 395
+ S + +T + + N IS I P + +L L L +NK++ ++ L
Sbjct: 296 QLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLT 351
Query: 396 NLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSN 429
N+ L N ++ P L NLT +T L L+
Sbjct: 352 NINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 72.7 bits (177), Expect = 5e-14
Identities = 41/192 (21%), Positives = 77/192 (40%), Gaps = 15/192 (7%)
Query: 38 CQWTGVTCGHRHQRVTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRL 97
Q + +T + +L L+ + + +L+ L L+LA+N P + L
Sbjct: 207 NQISDITPLGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGL 262
Query: 98 VRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADN 157
+L L L N S P + L + N N L LT+ N
Sbjct: 263 TKLTELKLGANQISNISP-----LAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFN 317
Query: 158 HLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFN 217
+++ P + +L+ L+R+ N + ++L NL N+ L+ G N+ S + P + N
Sbjct: 318 NISDISP--VSSLTKLQRLFFANNKV--SDVSSLANLTNINWLSAGHNQISDLTP--LAN 371
Query: 218 ISSLENVFLPTN 229
++ + + L
Sbjct: 372 LTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 67.7 bits (164), Expect = 2e-12
Identities = 61/363 (16%), Positives = 118/363 (32%), Gaps = 50/363 (13%)
Query: 265 SNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTEL 324
+ + ++ L VS L + L + +D + L N T++
Sbjct: 19 TALAEKMKTVLGKTNVTDTVSQ--TDLDQVTTLQADRLGI-----KSIDGVEYLNNLTQI 71
Query: 325 TAIGLDDNRFGGVLP-HSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKL 383
+N+ + P ++ L + + + T + L D + L
Sbjct: 72 N---FSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPL 128
Query: 384 TGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSS---------NDLQGS 434
EL + + + + + + L++ + + S
Sbjct: 129 KNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVS 188
Query: 435 IPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNL 494
L NL L + +++ P IL+ L L+ N L + +L NL
Sbjct: 189 DISVLAKLTNLESLIATNNQISDITPLGILTNLD---ELSLNGNQLKD--IGTLASLTNL 243
Query: 495 VYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSS---------------- 538
+++ N+ S P LS T L +L L N S P + +
Sbjct: 244 TDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDIS 301
Query: 539 ----LKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNKTGISL 594
LK++ L + NN+S P + +L+ L+ L + N V + +N +S
Sbjct: 302 PISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD-VSSLANLTNINWLSA 358
Query: 595 SGN 597
N
Sbjct: 359 GHN 361
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 47.3 bits (111), Expect = 6e-06
Identities = 45/257 (17%), Positives = 88/257 (34%), Gaps = 23/257 (8%)
Query: 353 VIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIP 412
+ I+ I L ++ + +T T+ +L + L D +
Sbjct: 6 ITQDTPINQIFTD--TALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--I 59
Query: 413 TSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLS 472
+ L LT + S+N L P L N L+++ M + ++ P L+ T
Sbjct: 60 DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTL 117
Query: 473 LDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSI 532
+ + L N L IS + Q L+ + ++
Sbjct: 118 FNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTL 177
Query: 533 PS------------SLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEV 580
L+ L +++ L ++N +S P L+ L+ L+L+ N + +
Sbjct: 178 ERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKD-I 234
Query: 581 PTKGVFSNKTGISLSGN 597
T +N T + L+ N
Sbjct: 235 GTLASLTNLTDLDLANN 251
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 91.6 bits (226), Expect = 1e-20
Identities = 52/295 (17%), Positives = 89/295 (30%), Gaps = 22/295 (7%)
Query: 38 CQWTGVTCGHRH---------QRVTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHG 88
C V C LDL N I NL L L L +N
Sbjct: 10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69
Query: 89 EIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLK 148
P LV+LE L L+ N L + + L +
Sbjct: 70 ISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV 129
Query: 149 LENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFS 208
L +G + + L I + + IP L +L L+L N+ +
Sbjct: 130 --ELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT 184
Query: 209 GIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNAS 268
+ S+ +++L L + + S + ++ L + NN +P L++
Sbjct: 185 KVDAASLKGLNNLA--KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHK 242
Query: 269 NLVELTLFDNQFRG------KVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTL 317
+ + L +N Y + ++L SN + E F +
Sbjct: 243 YIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCV 297
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 88.2 bits (217), Expect = 1e-19
Identities = 57/286 (19%), Positives = 112/286 (39%), Gaps = 18/286 (6%)
Query: 343 ANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYL 402
+L + + N+I+ I +NL NL L + +NK++ P A L L+ LYL
Sbjct: 27 KDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 86
Query: 403 DSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQ 462
N L L L ++ S+ L N ++EL ++ +G
Sbjct: 87 SKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGL-NQMIVVELGTNPLKSSGIENGA 145
Query: 463 ILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLY 522
+ LS ++ ++ + G +L ++ N+ + +L +L +L
Sbjct: 146 FQGMKKLSYI-RIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLG 201
Query: 523 LQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEG---- 578
L NS S SL++ ++EL +++N L ++P L + +++ + L N+
Sbjct: 202 LSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSN 260
Query: 579 ---EVPTKGVFSNKTGISLSGNGKVCGGLDELNLPPCPSRGLKKRT 621
++ +G+SL N + + P R + R
Sbjct: 261 DFCPPGYNTKKASYSGVSLFSN-----PVQYWEIQPSTFRCVYVRA 301
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 55.4 bits (132), Expect = 1e-08
Identities = 37/189 (19%), Positives = 69/189 (36%), Gaps = 32/189 (16%)
Query: 433 GSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLK 492
G + P C +L + +D+ L +P + + LDL N ++ + NLK
Sbjct: 1 GPVCPFRCQC-HLRVVQCSDLGLE-KVPK---DLPPDTALLDLQNNKITEIKDGDFKNLK 55
Query: 493 NLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSL---------------- 536
NL + N+ S P + L++LYL N +P +
Sbjct: 56 NLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHENEITK 114
Query: 537 --------SSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSN 588
+ + EL + SG + + L Y+ ++ + +P +G+ +
Sbjct: 115 VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIP-QGLPPS 172
Query: 589 KTGISLSGN 597
T + L GN
Sbjct: 173 LTELHLDGN 181
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.6 bits (223), Expect = 2e-20
Identities = 47/257 (18%), Positives = 79/257 (30%), Gaps = 5/257 (1%)
Query: 322 TELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDN 381
I L NR V S + + + + D+
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 382 KLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGN 441
+L P L L L+LD L P L L L L N LQ + +
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151
Query: 442 CKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISV 501
NL L + ++ + +L L N ++ P +L L+ +
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRL-LLHQNRVAHVHPHAFRDLGRLMTLYLFA 210
Query: 502 NRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLE 561
N S L+ +LQ L L N + + +++ SS+ + +P+ L
Sbjct: 211 NNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRLA 269
Query: 562 NLSFLEYLNLSYNHFEG 578
L+ N +G
Sbjct: 270 GRDL---KRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.8 bits (182), Expect = 4e-15
Identities = 53/268 (19%), Positives = 94/268 (35%), Gaps = 11/268 (4%)
Query: 187 IPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKL 246
+P + + L NR S + S +L ++L +N
Sbjct: 26 VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 247 LGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGT 306
+ P + L L L + FR L L++L L N L
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143
Query: 307 GEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTG 366
+ + LT + L NR V + L S + +++ N+++ + P
Sbjct: 144 LPDD------TFRDLGNLTHLFLHGNRISSVPERAFRGLHS-LDRLLLHQNRVAHVHPHA 196
Query: 367 IRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLAL 426
R+L L+ L + N L+ A+ L+ LQ L L+ N + L
Sbjct: 197 FRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRG 255
Query: 427 SSNDLQGSIPPSLGNCKNLIELHMADIE 454
SS+++ S+P L ++L L D++
Sbjct: 256 SSSEVPCSLPQRLAG-RDLKRLAANDLQ 282
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.4 bits (173), Expect = 5e-14
Identities = 43/229 (18%), Positives = 76/229 (33%), Gaps = 2/229 (0%)
Query: 76 LRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLV 135
+ + L N L L L +N + + + L + N +
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93
Query: 136 GEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLR 195
+ + +L L + L P L+ L+ + + N L + +L
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLG 153
Query: 196 NLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENN 255
NL L L NR S + + + SL+ + L NR P L +L+ + NN
Sbjct: 154 NLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP-HAFRDLGRLMTLYLFANN 212
Query: 256 FAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNL 304
+ E+L+ L L L DN + L+ S+ +
Sbjct: 213 LSALPTEALAPLRALQYLRLNDNPWVCDCRARP-LWAWLQKFRGSSSEV 260
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.5 bits (168), Expect = 2e-13
Identities = 59/246 (23%), Positives = 93/246 (37%), Gaps = 4/246 (1%)
Query: 363 IPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLT 422
+P GI + + N+++ + +NL +L+L SN LA + L LL
Sbjct: 26 VPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 423 NLALSSNDLQGSIPP-SLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLS 481
L LS N S+ P + L LH+ L P ++ L L N L
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYL-YLQDNALQ 142
Query: 482 GTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKS 541
+L NL + + NR S SL +L L N + P + L
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 542 IKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNKTGISLSGNGKVC 601
+ L + +NNLS E L L L+YL L+ N + + + +++ S + C
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPC 262
Query: 602 GGLDEL 607
L
Sbjct: 263 SLPQRL 268
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.4 bits (160), Expect = 3e-12
Identities = 43/274 (15%), Positives = 87/274 (31%), Gaps = 16/274 (5%)
Query: 234 SLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNL-VELTLFDNQFRGKVSIYFRSLK 292
++P+ I + ++ + N + S NL + + R + +
Sbjct: 25 AVPVGIPAASQRI---FLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLAL 81
Query: 293 NLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDI 352
+ + L + + L L D L + + + +
Sbjct: 82 LEQLDLSDNAQLRSVDPATFHGLGRLHTLH-------LDRCGLQELGPGLFRGLAALQYL 134
Query: 353 VIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIP 412
+ N + + R+L NL L + N+++ A L +L L L N +A P
Sbjct: 135 YLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP 194
Query: 413 TSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLS 472
+ +L L L L +N+L +L + L L + D + +
Sbjct: 195 HAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC--DCRARPLWAWLQK 252
Query: 473 LDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSG 506
S + + +LP L ++ N G
Sbjct: 253 FRGSSSEVPCSLP---QRLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.0 bits (159), Expect = 3e-12
Identities = 42/256 (16%), Positives = 75/256 (29%), Gaps = 31/256 (12%)
Query: 52 VTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEI--------------------- 90
++ L I + L L L N
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93
Query: 91 ----PHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNW 146
P L RL L L P + L + N L +
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTF-RDL 152
Query: 147 LKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENR 206
L +L + N ++ + L +L+R+ + N + P+ +L L+ L L N
Sbjct: 153 GNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANN 212
Query: 207 FSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSN 266
S + ++ + +L+ + L N + L F + + S+P+ L+
Sbjct: 213 LSALPTEALAPLRALQYLRLNDNPWVCDCRARPL--WAWLQKFRGSSSEVPCSLPQRLAG 270
Query: 267 ASNLVELTLFDNQFRG 282
L L N +G
Sbjct: 271 RD-LKRLA--ANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.2 bits (105), Expect = 2e-05
Identities = 26/128 (20%), Positives = 36/128 (28%), Gaps = 2/128 (1%)
Query: 47 HRHQRVTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLA 106
+T L L I L L L L N PH L RL L L
Sbjct: 150 RDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLF 209
Query: 107 NNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPAS 166
N+ S L+ L N V + A + WL+ + + + P
Sbjct: 210 ANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQ--KFRGSSSEVPCSLPQR 267
Query: 167 IGNLSTLE 174
+
Sbjct: 268 LAGRDLKR 275
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 82.1 bits (202), Expect = 2e-18
Identities = 25/167 (14%), Positives = 50/167 (29%), Gaps = 29/167 (17%)
Query: 685 NMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNG----------FVAECQALRNIR 734
++G+G V+ E VK + F
Sbjct: 6 KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 735 HRNLIKIITICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIII 794
R L K+ + + A++ E + L ++ D+ ++
Sbjct: 65 FRALQKLQGLAV-PKVYAWEGNAVLMELIDAKELYRVRVENPDE-------------VLD 110
Query: 795 DVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLS 841
+ + +H +VHGDL NVL+ + + DF + +
Sbjct: 111 MILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVG 153
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 61.6 bits (148), Expect = 4e-11
Identities = 41/227 (18%), Positives = 80/227 (35%), Gaps = 23/227 (10%)
Query: 359 ISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNL 418
I+ I P L N +++ + +T T+ A +L + L + + L
Sbjct: 9 INVIFP--DPALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTT--IEGVQYL 62
Query: 419 TLLTNLALSSNDLQGSIPPS------LGNCKNLIELHMADIELTGALPPQILSISTLSLS 472
L L L N + P +++ I ++ L+ + ++
Sbjct: 63 NNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDV 122
Query: 473 LDLSYNLLSGTLPLEVGNLKNLVYF-------NISVNRFSGEIPVTLSACTSLQQLYLQG 525
L+ L L++ + N+ +S+ L+ + L L
Sbjct: 123 TPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADD 182
Query: 526 NSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLS 572
N S P L+SL ++ E+ + +N +S P L N S L + L+
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 47.3 bits (111), Expect = 2e-06
Identities = 36/220 (16%), Positives = 76/220 (34%), Gaps = 17/220 (7%)
Query: 193 NLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVA 252
L N I + G++ + V + ++ + + + L L+G +
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTIEGVQ---YLNNLIGLELK 71
Query: 253 ENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDL 312
+N P +EL+ + ++ ++ ++L
Sbjct: 72 DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131
Query: 313 DFLTLLTNC-------TELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPT 365
L L N LT + V + S +T + N+IS I P
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP- 190
Query: 366 GIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSN 405
+ +L NL+E+ + +N+++ P + NL ++ L +N
Sbjct: 191 -LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL-TN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.4 bits (106), Expect = 1e-05
Identities = 30/218 (13%), Positives = 65/218 (29%), Gaps = 15/218 (6%)
Query: 242 SLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGS 301
+L + ++N ++ + ++ + L+ F + + L NL L L
Sbjct: 17 ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTIEGV--QYLNNLIGLELKD 72
Query: 302 NNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISG 361
N + + + + + +AG
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 362 IIPTGIRNLVNLVELCM-------DDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTS 414
++ + + N+ L + + L L L D N ++ P
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190
Query: 415 LGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMAD 452
L +L L + L +N + P L N NL + + +
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.9 bits (97), Expect = 2e-04
Identities = 35/201 (17%), Positives = 65/201 (32%), Gaps = 19/201 (9%)
Query: 394 LKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADI 453
L N + + + + +L +T L+ + +I + NLI L + D
Sbjct: 18 LANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDN 73
Query: 454 ELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNIS------------- 500
++T P + L+ T +S L+ +L I+
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 501 VNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYL 560
+ +I YL + S + L++L + L N +S P L
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--L 191
Query: 561 ENLSFLEYLNLSYNHFEGEVP 581
+L L ++L N P
Sbjct: 192 ASLPNLIEVHLKNNQISDVSP 212
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 6e-04
Identities = 35/235 (14%), Positives = 69/235 (29%), Gaps = 26/235 (11%)
Query: 266 NASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELT 325
+N +++ + V+ L + L+ + ++ + L N L
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGV-----TTIEGVQYLNNLIGLE 69
Query: 326 AIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTG 385
DN+ + P + + +S I ++L + D
Sbjct: 70 L---KDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLA 126
Query: 386 TIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNL 445
+ + +L + S LS + Q S L N L
Sbjct: 127 GLSNLQVLYLDLNQITNISPLAGLTNLQY-----------LSIGNAQVSDLTPLANLSKL 175
Query: 446 IELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNIS 500
L D +++ + S+ L + L N +S PL N NL ++
Sbjct: 176 TTLKADDNKISD--ISPLASLPNLI-EVHLKNNQISDVSPL--ANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 8e-04
Identities = 35/217 (16%), Positives = 70/217 (32%), Gaps = 22/217 (10%)
Query: 320 NCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMD 379
I + + + A+L +T + G ++ I G++ L NL+ L +
Sbjct: 17 ALANAIKIAAGKSNVTDTV--TQADLDG-ITTLSAFGTGVTTI--EGVQYLNNLIGLELK 71
Query: 380 DNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLG--------NLTLLTNLALSSNDL 431
DN++T P L + I ++L
Sbjct: 72 DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131
Query: 432 QGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDL-----SYNLLSGTLPL 486
Q + +++ Q+ ++ L+ L N +S PL
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPL 191
Query: 487 EVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYL 523
+L NL+ ++ N+ S P L+ ++L + L
Sbjct: 192 --ASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.002
Identities = 30/231 (12%), Positives = 63/231 (27%), Gaps = 21/231 (9%)
Query: 72 NLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARR 131
L+ + +N + L + L + + +NLI +
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKD 72
Query: 132 NNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNL 191
N + P + L+ + + + +NL
Sbjct: 73 NQITDLAPLKNLTKI-TELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131
Query: 192 GNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIV 251
L + + +G+ +I + + L L
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTT-----------LKA 180
Query: 252 AENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSN 302
+N + P L++ NL+E+ L +NQ + NL + L +N
Sbjct: 181 DDNKISDISP--LASLPNLIEVHLKNNQISD--VSPLANTSNLFIVTL-TN 226
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.7 bits (143), Expect = 4e-10
Identities = 48/255 (18%), Positives = 77/255 (30%), Gaps = 16/255 (6%)
Query: 363 IPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLT 422
+P + + L + +N L + L L LD G L +L
Sbjct: 25 LPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE--LTKLQVDGTLPVLG 80
Query: 423 NLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSG 482
L LS N LQ + + + LP L L L N L
Sbjct: 81 TLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTS--LPLGALRGLGELQELYLKGNELKT 138
Query: 483 TLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSI 542
P + L +++ N + L+ +L L LQ NS +IP +
Sbjct: 139 LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLL 197
Query: 543 KELDMSSNNLSGQIPEYLENLSFLEYLNLSYNH---FEGEVPTKGVFSNKTGISLSGNGK 599
+ N E L F +L + + ++ V K + SN + + K
Sbjct: 198 PFAFLHGNPWLCN----CEILYFRRWLQDNAENVYVWKQGVDVKAMTSNVASVQCDNSDK 253
Query: 600 VCGGLDELNLPPCPS 614
CP+
Sbjct: 254 FPVYKYPGKG--CPT 266
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.8 bits (138), Expect = 2e-09
Identities = 50/211 (23%), Positives = 77/211 (36%), Gaps = 7/211 (3%)
Query: 391 IGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHM 450
+ ++ + + D L +P L T L LS N L +L L +L++
Sbjct: 6 VSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 451 ADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPV 510
ELT L L + +LPL L L ++S NR +
Sbjct: 63 DRAELTKLQVDGTLP----VLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLG 118
Query: 511 TLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLN 570
L LQ+LYL+GN P L+ +++L +++NNL+ L L L+ L
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 571 LSYNHFEGEVPTKGVFSNKTGISLSGNGKVC 601
L N L GN +C
Sbjct: 179 LQENSLYTIPKGFFGSHLLPFAFLHGNPWLC 209
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.6 bits (135), Expect = 4e-09
Identities = 35/188 (18%), Positives = 53/188 (28%), Gaps = 17/188 (9%)
Query: 259 SIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNN-LGTGEANDLDFLTL 317
++P L + L L +N L LNL L L
Sbjct: 24 ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGT 81
Query: 318 LTNCTELTAIGLDDNRFGGV-------------LPHSIANLSSTMTDIVIAGNQISGIIP 364
L + LP + ++ + GN++ + P
Sbjct: 82 LDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPP 141
Query: 365 TGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNL 424
+ L +L + +N LT + L+NL L L N L IP LL
Sbjct: 142 GLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFA 200
Query: 425 ALSSNDLQ 432
L N
Sbjct: 201 FLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.0 bits (123), Expect = 1e-07
Identities = 39/181 (21%), Positives = 60/181 (33%), Gaps = 5/181 (2%)
Query: 52 VTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFS 111
T L LS + + + L LNL + G L L L L++N
Sbjct: 33 TTILHLSENLLYTFSLATLMPYTRLTQLNL--DRAELTKLQVDGTLPVLGTLDLSHNQLQ 90
Query: 112 GKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLS 171
+ ++ N + +P +L+ L + N L P +
Sbjct: 91 SLPLLG--QTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTP 148
Query: 172 TLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRF 231
LE++++ N L L L NL L L EN +P F L FL N +
Sbjct: 149 KLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
Query: 232 N 232
Sbjct: 208 L 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.8 bits (112), Expect = 2e-06
Identities = 42/216 (19%), Positives = 76/216 (35%), Gaps = 15/216 (6%)
Query: 119 SRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINV 178
S+ ++ + N + NL +P +L + L +++N L A++ + L ++N+
Sbjct: 7 SKVASHLEVNCDKRNLT-ALPPDLPKD---TTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 179 LGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLD 238
+ G L L L+L N+ + + + SLPL
Sbjct: 63 --DRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDV--SFNRLTSLPLG 118
Query: 239 IGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLN 298
L +L + N P L+ L +L+L +N + L+NL+ L
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 299 LGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRF 334
L N+L T L L N +
Sbjct: 179 LQENSLYTIPKG-------FFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.8 bits (112), Expect = 2e-06
Identities = 14/66 (21%), Positives = 23/66 (34%), Gaps = 3/66 (4%)
Query: 511 TLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLN 570
+S S ++ + + ++P L K L +S N L L + L LN
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 571 LSYNHF 576
L
Sbjct: 62 LDRAEL 67
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.9 bits (94), Expect = 5e-04
Identities = 40/242 (16%), Positives = 70/242 (28%), Gaps = 43/242 (17%)
Query: 166 SIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVF 225
+ +++ +N L +P +L ++ +L+L EN ++ + L +
Sbjct: 5 EVSKVASHLEVNCDKRNL-TALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 226 LPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVS 285
L L + +LP L ++ N +
Sbjct: 62 LDRAELT---KLQVDGTLPVLGTLDLSHNQLQSLPLLGQTL---------PALTVLDVSF 109
Query: 286 IYFRSLKNLEWLNLGSNNLGTGEANDLDFLT--LLTNCTELTAIGLDDNRFGGVLPHSIA 343
SL LG + N+L L LLT +L + L +N + +
Sbjct: 110 NRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLN 169
Query: 344 NLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLD 403
L NL L + +N L TIP L +L
Sbjct: 170 GLE-------------------------NLDTLLLQENSLY-TIPKGFFGSHLLPFAFLH 203
Query: 404 SN 405
N
Sbjct: 204 GN 205
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.9 bits (135), Expect = 7e-09
Identities = 15/94 (15%), Positives = 29/94 (30%), Gaps = 10/94 (10%)
Query: 493 NLVYFNISVNRFSGE-IPVTLSACTSLQQLYLQGNSFSG----SIPSSLSSLKSIKELDM 547
++ +I S L Q + L + I S+L ++ EL++
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 548 SSNNLSGQIPEYL-----ENLSFLEYLNLSYNHF 576
SN L + ++ L+L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.4 bits (131), Expect = 2e-08
Identities = 19/76 (25%), Positives = 34/76 (44%), Gaps = 9/76 (11%)
Query: 515 CTSLQQLYLQGNSFSG----SIPSSLSSLKSIKELDMSSNNLSGQIPEYL-----ENLSF 565
+ L+ L+L S S+ ++L + S++ELD+S+N L L +
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427
Query: 566 LEYLNLSYNHFEGEVP 581
LE L L ++ E+
Sbjct: 428 LEQLVLYDIYWSEEME 443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.4 bits (126), Expect = 8e-08
Identities = 14/68 (20%), Positives = 22/68 (32%), Gaps = 5/68 (7%)
Query: 517 SLQQLYLQGNSFSGS-IPSSLSSLKSIKELDMSSNNLSGQ----IPEYLENLSFLEYLNL 571
+Q L +Q S + L L+ + + + L+ I L L LNL
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 572 SYNHFEGE 579
N
Sbjct: 63 RSNELGDV 70
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.0 bits (117), Expect = 9e-07
Identities = 15/83 (18%), Positives = 29/83 (34%), Gaps = 9/83 (10%)
Query: 490 NLKNLVYFNISVNRFSGE----IPVTLSACTSLQQLYLQGNSFSGSIPSSLSS-----LK 540
L ++ S + TL A SL++L L N + L
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 541 SIKELDMSSNNLSGQIPEYLENL 563
+++L + S ++ + L+ L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.6 bits (116), Expect = 1e-06
Identities = 15/77 (19%), Positives = 29/77 (37%), Gaps = 5/77 (6%)
Query: 371 VNLVELCMDDNKLTGT-IPHAIGELKNLQLLYLDSNFL----AGGIPTSLGNLTLLTNLA 425
+++ L + +L+ + L+ Q++ LD L I ++L L L
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 426 LSSNDLQGSIPPSLGNC 442
L SN+L +
Sbjct: 62 LRSNELGDVGVHCVLQG 78
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (111), Expect = 5e-06
Identities = 15/98 (15%), Positives = 28/98 (28%), Gaps = 6/98 (6%)
Query: 468 TLSL-SLDLSYNLLSGTLPLEV-GNLKNLVYFNISVNRFSGE----IPVTLSACTSLQQL 521
+L + SLD+ LS E+ L+ + + I L +L +L
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 522 YLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEY 559
L+ N + + +L
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTG 98
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 2e-05
Identities = 14/88 (15%), Positives = 27/88 (30%), Gaps = 6/88 (6%)
Query: 287 YFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGG----VLPHSI 342
+ L L L ++ + L L L + L +N G L S+
Sbjct: 364 LGQPGSVLRVLWLADCDVSDSSCSSL--AATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 343 ANLSSTMTDIVIAGNQISGIIPTGIRNL 370
+ +V+ S + ++ L
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 3e-05
Identities = 15/78 (19%), Positives = 28/78 (35%), Gaps = 9/78 (11%)
Query: 472 SLDLSYNLLSGT----LPLEVGNLKNLVYFNISVNRFSGEIPVTLSA-----CTSLQQLY 522
L L+ +S + L + +L ++S N + L L+QL
Sbjct: 373 VLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLV 432
Query: 523 LQGNSFSGSIPSSLSSLK 540
L +S + L +L+
Sbjct: 433 LYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 5e-05
Identities = 12/78 (15%), Positives = 24/78 (30%), Gaps = 3/78 (3%)
Query: 269 NLVELTLFDNQFRGK-VSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAI 327
++ L + + + L+ + + L L D+ + L L +
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDI--SSALRVNPALAEL 60
Query: 328 GLDDNRFGGVLPHSIANL 345
L N G V H +
Sbjct: 61 NLRSNELGDVGVHCVLQG 78
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 1e-04
Identities = 16/95 (16%), Positives = 28/95 (29%), Gaps = 5/95 (5%)
Query: 264 LSNASNLVELTLFDNQFRGKVSIY----FRSLKNLEWLNLGSNNLGTGEANDLDFLTLLT 319
S L L L D + +L L+L +N LG L ++
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQL-VESVRQ 423
Query: 320 NCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVI 354
L + L D + + + L + +
Sbjct: 424 PGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRV 458
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 2e-04
Identities = 13/94 (13%), Positives = 27/94 (28%), Gaps = 6/94 (6%)
Query: 76 LRYLNLADNNF-HGEIPHQIGRLVRLEALVLANNSFSGK----IPTNLSRCSNLISFNAR 130
++ L++ + L + + + L + + I + L L N R
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 131 RNNLVGEIPAELGYNWLKLENLTIADNHLTGHFP 164
N L + L+ + I L
Sbjct: 64 SNELGDVGVHCVL-QGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 7e-04
Identities = 14/81 (17%), Positives = 25/81 (30%), Gaps = 9/81 (11%)
Query: 368 RNLVNLVELCMDDNKLTGT----IPHAIGELKNLQLLYLDSNFLAGGIPTSLG-----NL 418
+ L L + D ++ + + + +L+ L L +N L L
Sbjct: 366 QPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPG 425
Query: 419 TLLTNLALSSNDLQGSIPPSL 439
LL L L + L
Sbjct: 426 CLLEQLVLYDIYWSEEMEDRL 446
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 0.001
Identities = 14/92 (15%), Positives = 30/92 (32%), Gaps = 9/92 (9%)
Query: 444 NLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSG----TLPLEVGNLKNLVYFNI 499
++ L + EL+ A ++L + + L L+ + + L N+
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 500 SVNRFSGEIPVTL-----SACTSLQQLYLQGN 526
N + + +Q+L LQ
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.002
Identities = 15/79 (18%), Positives = 24/79 (30%), Gaps = 8/79 (10%)
Query: 100 LEALVLANNSFSGK----IPTNLSRCSNLISFNARRNNLVGEIPAELG----YNWLKLEN 151
L L LA+ S + L +L + N L +L LE
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430
Query: 152 LTIADNHLTGHFPASIGNL 170
L + D + + + L
Sbjct: 431 LVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.002
Identities = 14/92 (15%), Positives = 28/92 (30%), Gaps = 5/92 (5%)
Query: 147 LKLENLTIADNHLT-GHFPASIGNLSTLERINVLGNGL----WGRIPNNLGNLRNLILLN 201
L +++L I L+ + + L + + + GL I + L L LN
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 202 LGENRFSGIVPPSIFNISSLENVFLPTNRFNG 233
L N + + + +
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.002
Identities = 17/92 (18%), Positives = 24/92 (26%), Gaps = 9/92 (9%)
Query: 72 NLSFLRYLNLADNNFHGE----IPHQIGRLVRLEALVLANNSFSGKIPTNLSR-----CS 122
S LR L LAD + + + L L L+NN L
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 123 NLISFNARRNNLVGEIPAELGYNWLKLENLTI 154
L E+ L +L +
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDKPSLRV 458
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.002
Identities = 13/88 (14%), Positives = 27/88 (30%), Gaps = 5/88 (5%)
Query: 52 VTKLDLSNRTIGGT-LSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVR----LEALVLA 106
+ LD+ + + + L + + L D I +R L L L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 107 NNSFSGKIPTNLSRCSNLISFNARRNNL 134
+N + + S ++ +L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSL 91
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (88), Expect = 0.003
Identities = 17/89 (19%), Positives = 33/89 (37%), Gaps = 9/89 (10%)
Query: 395 KNLQLLYLDSNFL----AGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLG-----NCKNL 445
L++L+L + + +L L L LS+N L + L L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 446 IELHMADIELTGALPPQILSISTLSLSLD 474
+L + DI + + ++ ++ SL
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (88), Expect = 0.003
Identities = 8/51 (15%), Positives = 16/51 (31%), Gaps = 4/51 (7%)
Query: 533 PSSLSSLKSIKELDMSSNNLSGQ----IPEYLENLSFLEYLNLSYNHFEGE 579
++ L ++ ++S + L L L+LS N
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA 412
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.004
Identities = 17/85 (20%), Positives = 26/85 (30%), Gaps = 5/85 (5%)
Query: 354 IAGNQISGI-IPTGIRNLVNLVELCMDDNKLTG----TIPHAIGELKNLQLLYLDSNFLA 408
I ++S + L + +DD LT I A+ L L L SN L
Sbjct: 9 IQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELG 68
Query: 409 GGIPTSLGNLTLLTNLALSSNDLQG 433
+ + + LQ
Sbjct: 69 DVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 52.3 bits (124), Expect = 5e-08
Identities = 35/206 (16%), Positives = 65/206 (31%), Gaps = 25/206 (12%)
Query: 359 ISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNL 418
I I ++ + +T + EL ++ + +++ + + L
Sbjct: 14 IKQIFS--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS--VQGIQYL 67
Query: 419 TLLTNLALSSNDLQG---------------SIPPSLGNCKNLIELHMADIELTGALPPQI 463
+T L L+ N L + + L I
Sbjct: 68 PNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDI 127
Query: 464 LSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYL 523
+ L L T + L L ++ N+ S +P L+ T LQ LYL
Sbjct: 128 NGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYL 185
Query: 524 QGNSFSGSIPSSLSSLKSIKELDMSS 549
N S +L+ LK++ L++ S
Sbjct: 186 SKNHISD--LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.8 bits (102), Expect = 4e-05
Identities = 29/207 (14%), Positives = 63/207 (30%), Gaps = 27/207 (13%)
Query: 386 TIPHAIGE------LKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSL 439
T+P I + L + + + L + + +++D++ +
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--I 64
Query: 440 GNCKNLIELHMADIELTGALPPQILSISTLSLS--------------LDLSYNLLSGTLP 485
N+ +L + +LT P L L L
Sbjct: 65 QYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGI 124
Query: 486 LEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKEL 545
++ L +L + +T+ + + ++ I L+ L ++ L
Sbjct: 125 SDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV-PLAGLTKLQNL 183
Query: 546 DMSSNNLSGQIPEYLENLSFLEYLNLS 572
+S N++S L L L+ L L
Sbjct: 184 YLSKNHISD--LRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.1 bits (95), Expect = 3e-04
Identities = 40/208 (19%), Positives = 73/208 (35%), Gaps = 26/208 (12%)
Query: 241 VSLPKLLGFIVAENNFAGSIPESLSNAS-----------NLVELTLFDNQFRGKVSIYFR 289
+++P + I +++ FA +I ++L S ++ ++ ++ + I +
Sbjct: 8 ITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGI--Q 65
Query: 290 SLKNLEWLNLGSN---------NLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPH 340
L N+ L L N NL LD + + L
Sbjct: 66 YLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGIS 125
Query: 341 SIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLL 400
I L + T + L L L ++DN+++ +P + L LQ L
Sbjct: 126 DINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNL 183
Query: 401 YLDSNFLAGGIPTSLGNLTLLTNLALSS 428
YL N ++ +L L L L L S
Sbjct: 184 YLSKNHISD--LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 0.001
Identities = 36/212 (16%), Positives = 70/212 (33%), Gaps = 24/212 (11%)
Query: 193 NLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVA 252
I NL + + V + ++S++ + + + LP + +
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQ---YLPNVTKLFLN 76
Query: 253 ENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDL 312
N P +NL L + + N +
Sbjct: 77 GNKLTDIKPL-----ANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEH-------NGI 124
Query: 313 DFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVN 372
+ L + +L ++ L +N+ + S + + + NQIS I+P + L
Sbjct: 125 SDINGLVHLPQLESLYLGNNKITDITVLSRLT---KLDTLSLEDNQISDIVP--LAGLTK 179
Query: 373 LVELCMDDNKLTGTIPHAIGELKNLQLLYLDS 404
L L + N ++ A+ LKNL +L L S
Sbjct: 180 LQNLYLSKNHISD--LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.002
Identities = 9/63 (14%), Positives = 27/63 (42%), Gaps = 4/63 (6%)
Query: 516 TSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNH 575
+ L+ S + ++ + + L SI ++ +++++ ++ L + L L+ N
Sbjct: 24 AETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNK 79
Query: 576 FEG 578
Sbjct: 80 LTD 82
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 53.7 bits (127), Expect = 5e-08
Identities = 21/96 (21%), Positives = 38/96 (39%), Gaps = 10/96 (10%)
Query: 475 LSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPS 534
N S + +L N+S N+ E+P L++L N + +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPE 321
Query: 535 SLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLN 570
+LK +L + N L + P+ E++ L +N
Sbjct: 322 LPQNLK---QLHVEYNPLR-EFPDIPESVEDL-RMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.1 bits (123), Expect = 2e-07
Identities = 21/83 (25%), Positives = 36/83 (43%), Gaps = 8/83 (9%)
Query: 496 YFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQ 555
+N S EI SL++L + N +P+ L + L S N+L+ +
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRL---ERLIASFNHLA-E 318
Query: 556 IPEYLENLSFLEYLNLSYNHFEG 578
+PE +N L+ L++ YN
Sbjct: 319 VPELPQN---LKQLHVEYNPLRE 338
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.1 bits (110), Expect = 7e-06
Identities = 21/96 (21%), Positives = 33/96 (34%), Gaps = 9/96 (9%)
Query: 377 CMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIP 436
N + I +L+ L + +N L +P L L S N L +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVP 320
Query: 437 PSLGNCKNLIELHMADIELTGALPPQILSISTLSLS 472
NL +LH+ L P S+ L ++
Sbjct: 321 ELPQ---NLKQLHVEYNPLRE-FPDIPESVEDLRMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.8 bits (104), Expect = 3e-05
Identities = 25/91 (27%), Positives = 38/91 (41%), Gaps = 10/91 (10%)
Query: 107 NNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPAS 166
N+ S +I + +L N N L+ E+PA +LE L + NHL P
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP----RLERLIASFNHLA-EVPEL 322
Query: 167 IGNLSTLERINVLGNGLWGRIPNNLGNLRNL 197
NL L +V N L P+ ++ +L
Sbjct: 323 PQNLKQL---HVEYNPL-REFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 40.6 bits (93), Expect = 7e-04
Identities = 19/116 (16%), Positives = 36/116 (31%), Gaps = 12/116 (10%)
Query: 38 CQWTGVTCGHRHQRVTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRL 97
+ + L LN+++N E+P
Sbjct: 248 FLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP-- 304
Query: 98 VRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNL--VGEIPAELGYNWLKLEN 151
RLE L+ + N + ++P NL + N L +IP + L++ +
Sbjct: 305 -RLERLIASFNHLA-EVPELP---QNLKQLHVEYNPLREFPDIPESVED--LRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.8 bits (91), Expect = 0.001
Identities = 16/99 (16%), Positives = 31/99 (31%), Gaps = 16/99 (16%)
Query: 275 LFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRF 334
+ N ++ +LE LN+ +N L + L L + N
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKL----------IELPALPPRLERLIASFNHL 316
Query: 335 GGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNL 373
+P NL + + N + P ++ +L
Sbjct: 317 AE-VPELPQNLKQ----LHVEYNPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.4 bits (90), Expect = 0.002
Identities = 22/76 (28%), Positives = 34/76 (44%), Gaps = 7/76 (9%)
Query: 522 YLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVP 581
N+ S I S S++EL++S+N L ++P LE L S+NH EVP
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVP 320
Query: 582 TKGVFSNKTGISLSGN 597
+ N + + N
Sbjct: 321 --ELPQNLKQLHVEYN 334
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 48.2 bits (114), Expect = 3e-07
Identities = 26/108 (24%), Positives = 46/108 (42%), Gaps = 6/108 (5%)
Query: 473 LDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSI 532
L L++ L T+ + L + + ++S NR P L+A L+ L N+
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALE--N 57
Query: 533 PSSLSSLKSIKELDMSSNNL-SGQIPEYLENLSFLEYLNLSYNHFEGE 579
+++L ++EL + +N L + L + L LNL N E
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.0 bits (111), Expect = 7e-07
Identities = 30/125 (24%), Positives = 49/125 (39%), Gaps = 7/125 (5%)
Query: 398 QLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTG 457
++L+L L + L L L+T+L LS N L+ +PP+L + L L +D L
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALEN 57
Query: 458 ALPPQILSISTLSLSLDLSYNLLSGTLPLE-VGNLKNLVYFNISVNRFSGEIPVTLSACT 516
L L L N L + ++ + + LV N+ N E +
Sbjct: 58 VDGVANLPRLQ---ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAE 114
Query: 517 SLQQL 521
L +
Sbjct: 115 MLPSV 119
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 43.9 bits (103), Expect = 8e-06
Identities = 29/144 (20%), Positives = 44/144 (30%), Gaps = 32/144 (22%)
Query: 424 LALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGT 483
L L+ DL ++ L + L DLS+N L
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHL-------------------------DLSHNRLRAL 35
Query: 484 LPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSF-SGSIPSSLSSLKSI 542
P + L+ L S N V LQ+L L N + L S +
Sbjct: 36 PP-ALAALRCLEVLQASDNALENVDGVA--NLPRLQELLLCNNRLQQSAAIQPLVSCPRL 92
Query: 543 KELDMSSNNLSGQIPEYLENLSFL 566
L++ N+L E L+ +
Sbjct: 93 VLLNLQGNSLCQ-EEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 38.2 bits (88), Expect = 8e-04
Identities = 26/134 (19%), Positives = 42/134 (31%), Gaps = 29/134 (21%)
Query: 77 RYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVG 136
R L+LA + + + +L+ + L L++N P L+ L A N L
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALEN 57
Query: 137 EIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRN 196
N +L+ L + +N L L +
Sbjct: 58 VDG---VANLPRLQELLLCNNRLQQ-----------------------SAAIQPLVSCPR 91
Query: 197 LILLNLGENRFSGI 210
L+LLNL N
Sbjct: 92 LVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 36.2 bits (83), Expect = 0.004
Identities = 20/107 (18%), Positives = 41/107 (38%), Gaps = 5/107 (4%)
Query: 55 LDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKI 114
L L+++ + T+ ++ L + +L+L+ N P + L LE VL + + +
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLE--VLQASDNALEN 57
Query: 115 PTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTG 161
++ L N L + + +L L + N L
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.9 bits (120), Expect = 3e-07
Identities = 35/252 (13%), Positives = 81/252 (32%), Gaps = 11/252 (4%)
Query: 53 TKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSG 112
LDL+ + + ++ + + + + + R++ + L+N+
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLAEH-FSPFRVQHMDLSNSVIEV 60
Query: 113 K-IPTNLSRCSNLISFNARRNNLVGEIPAELGYN-WLKLENLTIADNHLTGHFPASIGNL 170
+ LS+CS L + + L I L N L NL+ + +
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 171 STLERINV------LGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENV 224
S L+ +N+ + + + + L L +N + + +L ++
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180
Query: 225 FLPTNRFNGSLPLDIGVSLPKLLGFIVAE-NNFAGSIPESLSNASNLVELTLFDNQFRGK 283
L + + L L ++ + L L L +F G
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240
Query: 284 VSIYFRSLKNLE 295
+ + +L +L+
Sbjct: 241 LQLLKEALPHLQ 252
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.6 bits (109), Expect = 6e-06
Identities = 39/250 (15%), Positives = 66/250 (26%), Gaps = 7/250 (2%)
Query: 200 LNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNF-AG 258
L+L P + S + R PL S ++ ++ +
Sbjct: 5 LDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVS 61
Query: 259 SIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLG--SNNLGTGEANDLDFLT 316
++ LS S L L+L + + NL LNL S L +
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 121
Query: 317 LLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVEL 376
L + + H ++ Q S + R +
Sbjct: 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 181
Query: 377 CMDDNKLTGTIPHAIGELKNLQLLYL-DSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSI 435
D L +L LQ L L + LG + L L + G++
Sbjct: 182 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTL 241
Query: 436 PPSLGNCKNL 445
+L
Sbjct: 242 QLLKEALPHL 251
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.1 bits (105), Expect = 2e-05
Identities = 29/199 (14%), Positives = 68/199 (34%), Gaps = 10/199 (5%)
Query: 388 PHAIGELKNLQLLYLD-SNFLAGGIPTSLGNLTLLTNLALSSNDLQG-SIPPSLGNCKNL 445
P G L + ++ + + ++ LS++ ++ ++ L C L
Sbjct: 14 PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKL 73
Query: 446 IELHMADIELTGALPPQILSISTL-SLSLDLSYNLLSGTLPLEVGNLKNLVYFNI----- 499
L + + L+ + + S L L+L L + + L N+
Sbjct: 74 QNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFD 133
Query: 500 -SVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSN-NLSGQIP 557
+ + T L + N + + + ++ LD+S + L
Sbjct: 134 FTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCF 193
Query: 558 EYLENLSFLEYLNLSYNHF 576
+ L++L++L+LS +
Sbjct: 194 QEFFQLNYLQHLSLSRCYD 212
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.7 bits (104), Expect = 3e-05
Identities = 38/281 (13%), Positives = 85/281 (30%), Gaps = 44/281 (15%)
Query: 254 NNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLD 313
N + L + ++ + ++ +F + ++ ++L ++ +
Sbjct: 10 KNLHPDVTGRLL-SQGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVI-----EVST 62
Query: 314 FLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSS-TMTDIVIAGNQISGIIPTGIRNLVN 372
+L+ C++L + L+ R + +++A S+ ++ + T + +
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122
Query: 373 LVEL-------------------------------CMDDNKLTGTIPHAIGELKNLQLLY 401
L EL + + + + L
Sbjct: 123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL 182
Query: 402 LDSNFLAGGIPTSLGNLTLLTNLALSS-NDLQGSIPPSLGNCKNLIELHMADIELTGALP 460
DS L L L +L+LS D+ LG L L + I G L
Sbjct: 183 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQ 242
Query: 461 PQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISV 501
+ L ++ + + +GN KN + I
Sbjct: 243 ----LLKEALPHLQINCSHFTTIARPTIGNKKNQEIWGIKC 279
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.6 bits (101), Expect = 6e-05
Identities = 28/231 (12%), Positives = 67/231 (29%), Gaps = 16/231 (6%)
Query: 354 IAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLD---SNFLAGG 410
+ G + + + + ++ + + + ++ ++D S
Sbjct: 7 LTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEH---FSPFRVQHMDLSNSVIEVST 62
Query: 411 IPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLS 470
+ L + L NL+L L I +L NL+ L+++ Q L S
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122
Query: 471 LSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQ--------LY 522
L T + ++ +N + S ++L +
Sbjct: 123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL 182
Query: 523 LQGNSFSGSIPSSLSSLKSIKELDMSS-NNLSGQIPEYLENLSFLEYLNLS 572
L ++ L +S ++ + L + L+ L +
Sbjct: 183 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVF 233
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 47.0 bits (110), Expect = 2e-06
Identities = 37/217 (17%), Positives = 70/217 (32%), Gaps = 19/217 (8%)
Query: 353 VIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIP 412
+ I+ I L ++ + +T T+ +L + L D +
Sbjct: 2 ITQDTPINQIFT--DTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--I 55
Query: 413 TSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLS 472
+ L LT + S+N L P I ++ I L +
Sbjct: 56 DGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFN 115
Query: 473 LDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSI 532
++ L NL L + +++ S +T + +
Sbjct: 116 NQITDIDPLKNLT----NLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTD------- 164
Query: 533 PSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYL 569
L++L +++ LD+SSN +S L L+ LE L
Sbjct: 165 LKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESL 199
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.2 bits (106), Expect = 6e-06
Identities = 26/167 (15%), Positives = 47/167 (28%), Gaps = 33/167 (19%)
Query: 387 IPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLI 446
+ + + + LD L L + L S+ ++ N L+
Sbjct: 12 LKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELL 68
Query: 447 ELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSG 506
L++++ L + V NL N+S N
Sbjct: 69 SLNLSNNRLYRLDD-----------------------MSSIVQKAPNLKILNLSGNELKS 105
Query: 507 EIPVTLSACTSLQQLYLQGNSFSGSIPSS-------LSSLKSIKELD 546
E + L++L+L GNS S + + LD
Sbjct: 106 ERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.5 bits (99), Expect = 4e-05
Identities = 24/143 (16%), Positives = 54/143 (37%), Gaps = 7/143 (4%)
Query: 426 LSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLP 485
L ++ + + + D++ + P L + + L+ ++ + TL
Sbjct: 4 LKPEQVE-QLKLIMSKRYDG-SQQALDLKGLRSDP--DLVAQNIDVVLNRRSSMAA-TLR 58
Query: 486 LEVGNLKNLVYFNISVNRFSG--EIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIK 543
+ N+ L+ N+S NR ++ + +L+ L L GN ++
Sbjct: 59 IIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLE 118
Query: 544 ELDMSSNNLSGQIPEYLENLSFL 566
EL + N+LS + +S +
Sbjct: 119 ELWLDGNSLSDTFRDQSTYISAI 141
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 45.6 bits (106), Expect = 8e-06
Identities = 33/168 (19%), Positives = 62/168 (36%), Gaps = 7/168 (4%)
Query: 114 IPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTL 173
IP ++ + N L L L L + N LTG P + S +
Sbjct: 23 IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80
Query: 174 ERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNG 233
+ + + N + L L LNL +N+ S ++P S +++SL ++ L +N FN
Sbjct: 81 QELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140
Query: 234 SLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFR 281
+ L + + P + ++ L ++F+
Sbjct: 141 NCHLAWFAEWLRKK--SLNGGAARCGAPSKV---RDVQIKDLPHSEFK 183
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 42.1 bits (97), Expect = 1e-04
Identities = 34/180 (18%), Positives = 58/180 (32%), Gaps = 15/180 (8%)
Query: 38 CQWTGVTCGHRH---------QRVTKLDLS-NRTIGGTLSPYVGNLSFLRYLNLADNNFH 87
C+ T V C R T+L L+ N + G L L L L N
Sbjct: 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67
Query: 88 GEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWL 147
G P+ ++ L L N L + N N + +P +
Sbjct: 68 GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFE-HLN 126
Query: 148 KLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRF 207
L +L +A N + L + ++ G P+ +R++ + +L + F
Sbjct: 127 SLTSLNLASNPFNCNCH-LAWFAEWLRKKSLNGGAARCGAPS---KVRDVQIKDLPHSEF 182
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 39.8 bits (91), Expect = 7e-04
Identities = 36/175 (20%), Positives = 66/175 (37%), Gaps = 9/175 (5%)
Query: 379 DDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSL-GNLTLLTNLALSSNDLQGSIPP 437
L IP I + L L+ N L L G L L L L N L G P
Sbjct: 16 TGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPN 72
Query: 438 SLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYF 497
+ ++ EL + + ++ + ++ +L+L N +S +P +L +L
Sbjct: 73 AFEGASHIQELQLGENKIKE-ISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSL 131
Query: 498 NISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNL 552
N++ N F+ + L++ L G + PS + ++ D+ +
Sbjct: 132 NLASNPFNCNCHLA-WFAEWLRKKSLNGGAARCGAPSKVRDVQ---IKDLPHSEF 182
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 43.7 bits (101), Expect = 8e-05
Identities = 16/92 (17%), Positives = 34/92 (36%), Gaps = 8/92 (8%)
Query: 492 KNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSG----SIPSSLSSLKSIKELDM 547
K+L I+ + L S++++ L GN+ + +++S K ++ +
Sbjct: 8 KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 548 SSN---NLSGQIPEYLENLSFLEYLNLSYNHF 576
S + +IPE L L +
Sbjct: 67 SDIFTGRVKDEIPEALRLLLQALLKCPKLHTV 98
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 43.3 bits (100), Expect = 1e-04
Identities = 44/327 (13%), Positives = 97/327 (29%), Gaps = 31/327 (9%)
Query: 147 LKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGL----WGRIPNNLGNLRNLILLNL 202
LKL+ +T D A + +++ I + GN + + N+ + ++L +
Sbjct: 10 LKLDAITTED---EKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 203 GENRFSGI----------VPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVA 252
+ + + ++ L V L N F + + L K
Sbjct: 67 SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 126
Query: 253 ENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDL 312
+ G P++ + + ++ + + + + L GS
Sbjct: 127 YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGR-NRLENGSMKEWAKTFQSH 185
Query: 313 DFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVN 372
L + ++ L + L + S + +++ N
Sbjct: 186 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQ-ELKVLDLQDNTFTHLGSSALAIALKSWPN 244
Query: 373 LVELCMDDNKLTGTIPHAIGE------LKNLQLLYLDSNFLAGGIPTSL-----GNLTLL 421
L EL ++D L+ A+ + LQ L L N + +L + L
Sbjct: 245 LRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDL 304
Query: 422 TNLALSSNDLQGSIPPSLGNCKNLIEL 448
L L+ N + + +
Sbjct: 305 LFLELNGNRF-SEEDDVVDEIREVFST 330
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.9 bits (99), Expect = 1e-04
Identities = 13/68 (19%), Positives = 29/68 (42%), Gaps = 8/68 (11%)
Query: 517 SLQQLYLQGNSFSG----SIPSSLSSLKSIKELDMSSNNLSGQ----IPEYLENLSFLEY 568
S++ L+ ++ + S+ + L S+KE+ +S N + + + E + + LE
Sbjct: 4 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63
Query: 569 LNLSYNHF 576
S
Sbjct: 64 AEFSDIFT 71
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.8 bits (96), Expect = 3e-04
Identities = 39/317 (12%), Positives = 91/317 (28%), Gaps = 36/317 (11%)
Query: 292 KNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTD 351
K+L+ + + + +L + I L N G ++ ++ D
Sbjct: 8 KSLKLDAITTEDEK-------SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKD 60
Query: 352 IV------IAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSN 405
+ I ++ IP +R L+ + C + + + + + +L +
Sbjct: 61 LEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKH 120
Query: 406 FLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILS 465
+ L ++ + ++ N L + L +
Sbjct: 121 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAK 180
Query: 466 ISTLSLSLDLSYNLLSGT------------LPLEVGNLKNLVYFNISVNRFSGEIPVTLS 513
L + +G L + N + S + + L
Sbjct: 181 TFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALK 240
Query: 514 ACTSLQQLYLQGNSFSGSIPSSLS------SLKSIKELDMSSNNLSGQIPEYL-----EN 562
+ +L++L L S +++ ++ L + N + L E
Sbjct: 241 SWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEK 300
Query: 563 LSFLEYLNLSYNHFEGE 579
+ L +L L+ N F E
Sbjct: 301 MPDLLFLELNGNRFSEE 317
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.2 bits (92), Expect = 8e-04
Identities = 49/325 (15%), Positives = 78/325 (24%), Gaps = 26/325 (8%)
Query: 245 KLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGK----VSIYFRSLKNLEWLNLG 300
K L S+ L ++ E+ L N + +S S K+LE
Sbjct: 8 KSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 301 SNNL----GTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAG 356
L L C +L + L DN FG + + S T +
Sbjct: 68 DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLY 127
Query: 357 NQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLG 416
+G+ P + ++ + K P +L S S
Sbjct: 128 LHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLEN-GSMKEWAKTFQSHR 186
Query: 417 NLTLLTNLALSSNDLQGSIPPSLGNCKNLI-----ELHMADIELTGALPPQILSISTLSL 471
L + + G L + L
Sbjct: 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR 246
Query: 472 SLDLSYNLLSGT------LPLEVGNLKNLVYFNISVNRFSGEIPVTLSA-----CTSLQQ 520
L L+ LLS L + N + TL L
Sbjct: 247 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLF 306
Query: 521 LYLQGNSFSGSIPSSLSSLKSIKEL 545
L L GN F + ++ +
Sbjct: 307 LELNGNRF-SEEDDVVDEIREVFST 330
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.4 bits (95), Expect = 2e-04
Identities = 9/58 (15%), Positives = 14/58 (24%)
Query: 515 CTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLS 572
+ N+ LD+S + LENL L +
Sbjct: 176 TQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.9 bits (91), Expect = 8e-04
Identities = 26/218 (11%), Positives = 59/218 (27%), Gaps = 6/218 (2%)
Query: 343 ANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVE--LCMDDNKLTGTIPHAIGELKNLQLL 400
++L ++ ++ I +L + + +D K ++
Sbjct: 25 SDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIR 84
Query: 401 YLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALP 460
+N L P + NL L L +S+ ++ + + L + D +
Sbjct: 85 IEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIE 144
Query: 461 PQILSISTLSL-SLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQ 519
+ L L+ N + + N +
Sbjct: 145 RNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPV 204
Query: 520 QLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIP 557
L + L +LK ++ NL ++P
Sbjct: 205 ILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLP 239
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (90), Expect = 0.001
Identities = 14/63 (22%), Positives = 21/63 (33%), Gaps = 4/63 (6%)
Query: 515 CT-SLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSY 573
C S + Q + + IPS L ++ EL L LE + +S
Sbjct: 6 CHCSNRVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQ 62
Query: 574 NHF 576
N
Sbjct: 63 NDV 65
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (86), Expect = 0.003
Identities = 39/232 (16%), Positives = 78/232 (33%), Gaps = 7/232 (3%)
Query: 77 RYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVG 136
R ++ EIP + R L S +L +N+++
Sbjct: 11 RVFLCQESKVT-EIPSDLPR--NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 67
Query: 137 EIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVL-GNGLWGRIPNNLGNLR 195
I A++ N KL + I + + + ++ G+ + +
Sbjct: 68 VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSL 127
Query: 196 NLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENN 255
+LL++ +N + + F S E+V L N+ + + +L +++NN
Sbjct: 128 QKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNN 187
Query: 256 FAGSIP-ESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGT 306
+P + AS V L + + S +LK L + NL
Sbjct: 188 NLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLKK 237
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.2 bits (87), Expect = 0.001
Identities = 7/65 (10%), Positives = 16/65 (24%), Gaps = 2/65 (3%)
Query: 515 CTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYL-ENLSFLEYLNLSY 573
L + L +++ EL + + + L L L +
Sbjct: 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 574 NHFEG 578
+
Sbjct: 66 SGLRF 70
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (87), Expect = 0.002
Identities = 12/67 (17%), Positives = 25/67 (37%), Gaps = 3/67 (4%)
Query: 515 CTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYN 574
++L L+G I + ++L +D S N + + + L L+ L ++ N
Sbjct: 17 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLLVNNN 73
Query: 575 HFEGEVP 581
Sbjct: 74 RICRIGE 80
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (87), Expect = 0.002
Identities = 20/133 (15%), Positives = 36/133 (27%), Gaps = 6/133 (4%)
Query: 369 NLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSS 428
N V EL + K+ I + L + N + L L L +++
Sbjct: 16 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLLVNN 72
Query: 429 NDLQGSIPPSLGNCKNLIELHMADIELTG---ALPPQILSISTLSLSLDLSYNLLSGTLP 485
N + +L EL + + L P L T L
Sbjct: 73 NRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRL 132
Query: 486 LEVGNLKNLVYFN 498
+ + + +
Sbjct: 133 YVIYKVPQVRVLD 145
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (86), Expect = 0.003
Identities = 7/43 (16%), Positives = 16/43 (37%), Gaps = 1/43 (2%)
Query: 534 SSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHF 576
+ ++ +ELD+ + I L + ++ S N
Sbjct: 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI 53
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 992 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.97 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.93 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.93 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.92 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.91 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.9 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.9 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.85 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.83 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.75 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.75 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.75 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.74 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.74 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.74 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.74 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.72 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.71 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.68 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.68 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.67 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.54 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.49 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.49 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.48 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.46 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.44 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.43 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.41 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.41 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.36 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.36 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.31 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.54 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.44 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.4 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.5 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.46 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.44 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.4 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.01 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.73 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.64 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.35 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.08 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-49 Score=421.10 Aligned_cols=250 Identities=22% Similarity=0.301 Sum_probs=206.4
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAI 758 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 758 (992)
++|++.+.||+|+||+||+|++..+|+.||||+++.......+.+.+|++++++++||||+++++++. ..+..++
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~i 94 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELWV 94 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEE-----ECCEEEE
Confidence 47999999999999999999999999999999998766666788999999999999999999999964 3456799
Q ss_pred EEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccce
Q 037275 759 VYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAK 838 (992)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 838 (992)
||||+++|+|.+++.+. .+++.++..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+|+
T Consensus 95 vmEy~~gg~L~~~~~~~-------~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~ 164 (293)
T d1yhwa1 95 VMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (293)
T ss_dssp EEECCTTCBHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEecCCCcHHHHhhcc-------CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhhe
Confidence 99999999999987643 489999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCCh
Q 037275 839 FLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPD 918 (992)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 918 (992)
.+.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....
T Consensus 165 ~~~~~~--------~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-------------- 222 (293)
T d1yhwa1 165 QITPEQ--------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-------------- 222 (293)
T ss_dssp ECCSTT--------CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------------
T ss_pred eecccc--------ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH--------------
Confidence 765321 1223457999999999999999999999999999999999999999753211
Q ss_pred hHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 919 KVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
+.+.......... . ........++.+++.+||+.||++|||++|+++
T Consensus 223 ---~~~~~~~~~~~~~-----~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 223 ---RALYLIATNGTPE-----L----QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp ---HHHHHHHHHCSCC-----C----SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---HHHHHHHhCCCCC-----C----CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111111110000 0 000112345889999999999999999999975
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=419.87 Aligned_cols=254 Identities=22% Similarity=0.295 Sum_probs=202.7
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC-CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
.++|++.+.||+|+||+||+|++..+|+.||||+++... ....+.+.+|+.++++++||||+++++++. +....
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~-----~~~~~ 78 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQ 78 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeec-----cCcee
Confidence 357999999999999999999999899999999997543 233467899999999999999999999964 35567
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
++||||+++|+|.+++.... .+++.++..++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+
T Consensus 79 ~ivmEy~~gg~L~~~l~~~~------~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~ 149 (271)
T d1nvra_ 79 YLFLEYCSGGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGL 149 (271)
T ss_dssp EEEEECCTTEEGGGGSBTTT------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEeccCCCcHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchh
Confidence 99999999999999986533 589999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccCCCc-CcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEA-SMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 915 (992)
|+...... ........+||+.|||||++.+..+ +.++||||+||++|||++|++||....+............
T Consensus 150 a~~~~~~~------~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~ 223 (271)
T d1nvra_ 150 ATVFRYNN------RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 223 (271)
T ss_dssp CEECEETT------EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTC
T ss_pred heeeccCC------ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC
Confidence 98765322 1122344679999999999988876 5789999999999999999999976543322222111110
Q ss_pred CChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 916 LPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
... ........++.+++.+||+.||++|||++|+++
T Consensus 224 ~~~--------------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 224 TYL--------------------------NPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TTS--------------------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCC--------------------------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000 000111245788999999999999999999964
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-49 Score=419.12 Aligned_cols=262 Identities=28% Similarity=0.415 Sum_probs=202.7
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc--CCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK--QKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
.++|++.++||+|+||+||+|+.. ..||||+++.. .....+.+.+|++++++++|||||+++|++.. ..
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~------~~ 77 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------PQ 77 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec------cE
Confidence 468999999999999999999874 35999999644 23445788999999999999999999998642 34
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++||||+++|+|.+++..... .+++..+..++.||++||+|||++ +||||||||+|||++.++.+||+|||
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFG 149 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIET-----KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFG 149 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSCC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCC
T ss_pred EEEEEecCCCCCHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEcccc
Confidence 5899999999999999976543 489999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccC---CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHH
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG---GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFA 912 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~ 912 (992)
+|+...... .........||+.|||||++.+ ..|+.++|||||||++|||+||+.||.+....... .
T Consensus 150 la~~~~~~~------~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~-~--- 219 (276)
T d1uwha_ 150 LATVKSRWS------GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI-I--- 219 (276)
T ss_dssp CSCC------------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH-H---
T ss_pred ceeeccccC------CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHH-H---
Confidence 998765322 1122334579999999999864 35899999999999999999999999764322110 0
Q ss_pred hhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 037275 913 RTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDT 985 (992)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 985 (992)
..+. ...... .........+.++.+++.+||+.||++||||+||++.|+.+.++
T Consensus 220 ---------~~~~----~~~~~p------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 220 ---------FMVG----RGYLSP------DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp ---------HHHH----HTSCCC------CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ---------HHHh----cCCCCC------cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 1110 000000 00000112245689999999999999999999999999998765
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=410.56 Aligned_cols=246 Identities=23% Similarity=0.370 Sum_probs=204.1
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc---CCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK---QKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
++|++.+.||+|+||+||+|+++.+++.||+|++... .....+.+.+|++++++++||||+++++++. +.+.
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~ 80 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----DATR 80 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE-----ECCE
Confidence 5799999999999999999999999999999998632 3445677899999999999999999999964 4566
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++||||+++|+|.+++.... .+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 81 ~~ivmEy~~~g~L~~~l~~~~------~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG 151 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQKLS------KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG 151 (263)
T ss_dssp EEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred EEEEEeecCCCcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccc
Confidence 799999999999999998643 589999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 915 (992)
+|+..... ......||+.|||||++.+..++.++||||+||++|||++|+.||.+....
T Consensus 152 ~a~~~~~~----------~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~----------- 210 (263)
T d2j4za1 152 WSVHAPSS----------RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ----------- 210 (263)
T ss_dssp SCSCCCCC----------CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-----------
T ss_pred eeeecCCC----------cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH-----------
Confidence 99765432 123356999999999999999999999999999999999999999753211
Q ss_pred CChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 916 LPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
+.........+. .+ .....++.+++.+||+.||++|||++|+++
T Consensus 211 ------~~~~~i~~~~~~------~p------~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 211 ------ETYKRISRVEFT------FP------DFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ------HHHHHHHTTCCC------CC------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------HHHHHHHcCCCC------CC------ccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 111111111110 00 012345889999999999999999999986
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-49 Score=416.38 Aligned_cols=258 Identities=23% Similarity=0.318 Sum_probs=195.1
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC--CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK--GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
++|++.+.||+|+||+||+|++..+|+.||||+++.... ...+.+.+|++++++++||||+++++++.+ .....+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~---~~~~~~ 80 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNTTL 80 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------CE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEe---CCCCEE
Confidence 579999999999999999999999999999999975432 234568899999999999999999998753 234567
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcC--CCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHC--QPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
++||||+++|+|.+++...... ...+++..++.++.|++.||+|||++. ..+|+||||||+|||++.++.+||+||
T Consensus 81 ~ivmEy~~~g~L~~~i~~~~~~--~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DF 158 (269)
T d2java1 81 YIVMEYCEGGDLASVITKGTKE--RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 158 (269)
T ss_dssp EEEEECCTTEEHHHHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCH
T ss_pred EEEEecCCCCcHHHHHHhcccc--CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeec
Confidence 9999999999999999765422 346999999999999999999999971 113999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
|+|+...... .......||+.|||||++.+..++.++|||||||++|||+||+.||.+....
T Consensus 159 G~a~~~~~~~--------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~---------- 220 (269)
T d2java1 159 GLARILNHDT--------SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---------- 220 (269)
T ss_dssp HHHHHC-------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH----------
T ss_pred cceeecccCC--------CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH----------
Confidence 9998765321 1223457999999999999999999999999999999999999999763211
Q ss_pred hCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 915 ALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
++.......... ..+ .....++.+++.+||+.||++|||++|+++
T Consensus 221 -------~~~~~i~~~~~~-----~~~------~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 221 -------ELAGKIREGKFR-----RIP------YRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -------HHHHHHHHTCCC-----CCC------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------HHHHHHHcCCCC-----CCC------cccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 111111111110 000 112345889999999999999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=416.81 Aligned_cols=252 Identities=23% Similarity=0.327 Sum_probs=204.7
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAI 758 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 758 (992)
+.|++.+.||+|+||+||+|++..+++.||||+++.......+.+.+|++++++++|||||++++++. +.+..++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~~~~~l 86 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY-----YENNLWI 86 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCCeEEE
Confidence 46899999999999999999999999999999998766667788999999999999999999999964 3456799
Q ss_pred EEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccce
Q 037275 759 VYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAK 838 (992)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 838 (992)
||||+++|+|.+++.+... .+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+
T Consensus 87 vmEy~~~g~L~~~~~~~~~-----~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~ 158 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLELER-----PLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSA 158 (288)
T ss_dssp EEECCTTEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEecCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhh
Confidence 9999999999999875432 599999999999999999999999 99999999999999999999999999997
Q ss_pred ecCCCCCCCCcccCCCCCccccccccccccccc-----CCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh
Q 037275 839 FLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGM-----GGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 913 (992)
..... ........||+.|+|||++. +..|+.++||||+||++|||+||+.||.+....+ .+..
T Consensus 159 ~~~~~--------~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-~~~~--- 226 (288)
T d2jfla1 159 KNTRT--------IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-VLLK--- 226 (288)
T ss_dssp ECHHH--------HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-HHHH---
T ss_pred ccCCC--------cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-HHHH---
Confidence 65321 11123456999999999874 4568999999999999999999999997642221 1111
Q ss_pred hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 914 TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
....... .. ........++.+++.+||+.||++|||++|+++
T Consensus 227 -------------i~~~~~~-----~~----~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 227 -------------IAKSEPP-----TL----AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp -------------HHHSCCC-----CC----SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -------------HHcCCCC-----CC----CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111000 00 001112346889999999999999999999976
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-48 Score=419.97 Aligned_cols=263 Identities=26% Similarity=0.443 Sum_probs=195.7
Q ss_pred cCCCCCCccccccceEEEEeEECCCCe---EEEEEEeeccC-CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcc
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGM---MVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
++|++.++||+|+||+||+|++..+++ .||||.+.... ....+.+.+|++++++++|||||+++|++.. .+
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-----~~ 100 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK-----ST 100 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----SS
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEee-----CC
Confidence 456677899999999999999875553 68999886433 2344679999999999999999999999643 44
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
..++||||+++|+|.+++..... .+++.++..++.|||+||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~-----~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DF 172 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDG-----QFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDF 172 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTT-----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred EEEEEEEecCCCcceeeeccccC-----CCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCc
Confidence 56999999999999999876543 489999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 913 (992)
|+|+......... .........||+.|||||++.++.++.++|||||||++|||+| |+.||.+....
T Consensus 173 Gla~~~~~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~--------- 240 (299)
T d1jpaa_ 173 GLSRFLEDDTSDP---TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ--------- 240 (299)
T ss_dssp --------------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---------
T ss_pred ccceEccCCCCcc---eeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH---------
Confidence 9998775432111 1122233568999999999999999999999999999999998 89999763221
Q ss_pred hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 037275 914 TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDT 985 (992)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 985 (992)
+++..... ...... ..+...++.+++.+||+.||++||||+||++.|+++.+.
T Consensus 241 --------~~~~~i~~-~~~~~~----------~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 241 --------DVINAIEQ-DYRLPP----------PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp --------HHHHHHHT-TCCCCC----------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred --------HHHHHHHc-CCCCCC----------CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 11111110 000000 112245688999999999999999999999999998754
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=411.59 Aligned_cols=257 Identities=25% Similarity=0.448 Sum_probs=197.4
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAI 758 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 758 (992)
++|++.+.||+|+||+||+|++. +++.||||+++. .....+++.+|++++++++||||++++|+|.. .+..++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-----~~~~~l 77 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPICL 77 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCS-SSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSCEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECC-CcCcHHHHHHHHHHHHhcCCCCcccccceecc-----CCceEE
Confidence 47888999999999999999996 678899999974 33456789999999999999999999999753 345699
Q ss_pred EEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccce
Q 037275 759 VYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAK 838 (992)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 838 (992)
||||+++|+|.+++..... .+++..++.++.|+|.||+|||++ +|+||||||+||++++++.+||+|||+|+
T Consensus 78 v~E~~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~ 149 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTR 149 (263)
T ss_dssp EEECCTTCBHHHHHHTTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---
T ss_pred EEEecCCCcHHHHhhcccc-----CCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchhe
Confidence 9999999999999876543 489999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhC-CCCCCCCccCCccHHHHHhhhCC
Q 037275 839 FLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTR-RRPTDGMFNQGLTLHEFARTALP 917 (992)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg-~~pf~~~~~~~~~~~~~~~~~~~ 917 (992)
....... .......||+.|+|||++.+..++.++|||||||++|||+|+ ++||..... .
T Consensus 150 ~~~~~~~-------~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~-----~-------- 209 (263)
T d1sm2a_ 150 FVLDDQY-------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-----S-------- 209 (263)
T ss_dssp ----------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH-----H--------
T ss_pred eccCCCc-------eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH-----H--------
Confidence 7654321 122335689999999999999999999999999999999995 555543211 1
Q ss_pred hhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 037275 918 DKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDT 985 (992)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 985 (992)
++...... ......+. ....++.+++.+||+.||++||||+||++.|++++++
T Consensus 210 ----~~~~~i~~-~~~~~~p~----------~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 210 ----EVVEDIST-GFRLYKPR----------LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp ----HHHHHHHH-TCCCCCCT----------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----HHHHHHHh-cCCCCCcc----------ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 11111111 00000011 1134588999999999999999999999999998763
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.9e-49 Score=420.92 Aligned_cols=260 Identities=23% Similarity=0.421 Sum_probs=209.4
Q ss_pred HhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 677 ATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 677 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
..++|++.++||+|+||+||+|++..+++.||||+++.. ....+++.+|++++++++|||||+++|++. +.+..
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~ 88 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPF 88 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSC
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEe-----eCCee
Confidence 346889999999999999999999888999999998643 445678999999999999999999999964 34556
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
++||||+++|+|.+++..... ..+++..+..++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+
T Consensus 89 ~iv~E~~~~g~l~~~l~~~~~----~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~ 161 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGL 161 (287)
T ss_dssp EEEEECCTTCBHHHHHHHSCT----TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCC
T ss_pred EEEeecccCcchHHHhhhccc----cchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccc
Confidence 999999999999999976542 3689999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhC
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTAL 916 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 916 (992)
|+...... ........|++.|+|||++.+..|+.++|||||||++|||++|..||....+. .+
T Consensus 162 a~~~~~~~-------~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~----~~------ 224 (287)
T d1opja_ 162 SRLMTGDT-------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----SQ------ 224 (287)
T ss_dssp TTTCCSSS-------SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH----HH------
T ss_pred eeecCCCC-------ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH----HH------
Confidence 98765432 11223345889999999999999999999999999999999977765432211 11
Q ss_pred ChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 037275 917 PDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRAR 983 (992)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 983 (992)
..+.+.. ....... .....++.+++.+||+.||++||||+||++.|+.+.
T Consensus 225 ---~~~~i~~----~~~~~~~----------~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 225 ---VYELLEK----DYRMERP----------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp ---HHHHHHT----TCCCCCC----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ---HHHHHhc----CCCCCCC----------ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1111111 1111011 112346899999999999999999999999998764
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-48 Score=407.06 Aligned_cols=249 Identities=25% Similarity=0.388 Sum_probs=197.6
Q ss_pred CCCCccccccceEEEEeEECCCCeEEEEEEeeccC--CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEE
Q 037275 682 SSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIV 759 (992)
Q Consensus 682 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 759 (992)
++.++||+|+||+||+|++..+++.||+|++.... ....+.+.+|++++++++|||||++++++... ..+...+++|
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~~~~~iv 90 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE-SSSCEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeec-cccCCEEEEE
Confidence 56678999999999999999899999999987543 23346789999999999999999999987542 2345678999
Q ss_pred EEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeccCCCCCeeeC-CCCcEEEeeccc
Q 037275 760 YEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPP--VVHGDLKPSNVLLD-QDLVAHLGDFGL 836 (992)
Q Consensus 760 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~ 836 (992)
|||+++|+|.+++.+.. .+++..+..++.||++||+|||++ + |+||||||+|||++ +++.+||+|||+
T Consensus 91 mE~~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGl 161 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL 161 (270)
T ss_dssp EECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EeCCCCCcHHHHHhccc------cccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCc
Confidence 99999999999997643 589999999999999999999998 6 99999999999996 578999999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhC
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTAL 916 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 916 (992)
|+..... ......||+.|||||++.+ .++.++||||+||++|||++|+.||.+................
T Consensus 162 a~~~~~~----------~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~ 230 (270)
T d1t4ha_ 162 ATLKRAS----------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK 230 (270)
T ss_dssp GGGCCTT----------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC
T ss_pred ceeccCC----------ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCC
Confidence 9754321 2234579999999998865 5999999999999999999999999753222111111100000
Q ss_pred ChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 917 PDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
+.. .......++.+++.+||+.||++|||++|+++
T Consensus 231 ~~~--------------------------~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 231 PAS--------------------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp CGG--------------------------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred Ccc--------------------------cCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 000 00111235789999999999999999999975
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-48 Score=408.57 Aligned_cols=258 Identities=24% Similarity=0.421 Sum_probs=205.2
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
.++|++.++||+|+||+||+|+++ +++.||||+++.. ....+.+.+|++++++++|||||+++|++.+ +..+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~------~~~~ 83 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ------EPIY 83 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc------CCeE
Confidence 457889999999999999999986 6789999999643 3456789999999999999999999998642 2358
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||+++|+|.+++..... ..+++..+++|+.||++||+|||++ +|+||||||+||++++++.+||+|||+|
T Consensus 84 iv~Ey~~~g~L~~~~~~~~~----~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla 156 (272)
T d1qpca_ 84 IITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLA 156 (272)
T ss_dssp EEEECCTTCBHHHHTTSHHH----HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHhhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccce
Confidence 99999999999998875442 3589999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALP 917 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 917 (992)
+...... ........||+.|+|||++.++.++.++|||||||++|||+||..|+...... .
T Consensus 157 ~~~~~~~-------~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~----~-------- 217 (272)
T d1qpca_ 157 RLIEDNE-------YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN----P-------- 217 (272)
T ss_dssp EECSSSC-------EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH----H--------
T ss_pred EEccCCc-------cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH----H--------
Confidence 9875432 11223456899999999999999999999999999999999965554322111 0
Q ss_pred hhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 037275 918 DKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARD 984 (992)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 984 (992)
+++..... ......+ .....++.+++.+||+.||++||||+||++.|+....
T Consensus 218 ----~~~~~i~~-~~~~~~p----------~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 218 ----EVIQNLER-GYRMVRP----------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp ----HHHHHHHT-TCCCCCC----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HHHHHHHh-cCCCCCc----------ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 11111110 0000000 1123458899999999999999999999999987643
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-48 Score=421.16 Aligned_cols=200 Identities=28% Similarity=0.416 Sum_probs=176.7
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC-CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
.++|++.++||+|+||+||+|++..+|+.||+|+++... ......+.+|+.++++++|||||++++++. +....
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-----~~~~~ 79 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI 79 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEE-----CSSEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEE
Confidence 468999999999999999999999999999999997543 333567899999999999999999999964 45567
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHH-HCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
++||||+++|+|.+++.+.. .+++..+..++.|++.||+|||+ + +|+||||||+|||++.++.+||+|||
T Consensus 80 ~iVmEy~~gg~L~~~l~~~~------~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFG 150 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFG 150 (322)
T ss_dssp EEEEECCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCC
T ss_pred EEEEEcCCCCcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCC
Confidence 99999999999999997643 48999999999999999999996 6 89999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCC
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGM 901 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 901 (992)
+|+..... .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.
T Consensus 151 la~~~~~~----------~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 151 VSGQLIDS----------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp CCHHHHHH----------TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred CccccCCC----------ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 99865421 123457999999999999999999999999999999999999999764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-47 Score=397.03 Aligned_cols=253 Identities=25% Similarity=0.431 Sum_probs=207.5
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAI 758 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 758 (992)
++|++.++||+|+||+||+|+++ +++.||||+++... ...+++.+|+.++++++||||++++|+|. .....++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~-----~~~~~~i 76 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT-----KQRPIFI 76 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEEC-----CSSSEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEe-----eCCceEE
Confidence 58999999999999999999996 78899999997543 35678999999999999999999999964 3456799
Q ss_pred EEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccce
Q 037275 759 VYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAK 838 (992)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 838 (992)
||||+++|+|.+++..... .+++..+++++.|+++||+|||++ +|+||||||+||++++++.+||+|||+|+
T Consensus 77 v~Ey~~~g~l~~~~~~~~~-----~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~ 148 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLREMRH-----RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSR 148 (258)
T ss_dssp EEECCTTEEHHHHHHSGGG-----CCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCC
T ss_pred EEEccCCCcHHHhhhcccc-----CCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhhe
Confidence 9999999999999876543 489999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhhhCC
Q 037275 839 FLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFARTALP 917 (992)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 917 (992)
....... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+....
T Consensus 149 ~~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~------------- 208 (258)
T d1k2pa_ 149 YVLDDEY-------TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS------------- 208 (258)
T ss_dssp BCSSSSC-------CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-------------
T ss_pred eccCCCc-------eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH-------------
Confidence 7654321 12234568999999999999999999999999999999998 89999764322
Q ss_pred hhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 037275 918 DKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCR 981 (992)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 981 (992)
++...... ......+ .....++.+++.+||+.||++|||++||++.|.+
T Consensus 209 ----~~~~~i~~-~~~~~~p----------~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 209 ----ETAEHIAQ-GLRLYRP----------HLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp ----HHHHHHHT-TCCCCCC----------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ----HHHHHHHh-CCCCCCc----------ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 11111110 1100000 1123468999999999999999999999998864
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-48 Score=410.64 Aligned_cols=251 Identities=21% Similarity=0.334 Sum_probs=203.1
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc---CCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK---QKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
++|++.+.||+|+||+||+|++..+|+.||||+++.. .....+.+.+|++++++++||||+++++++. +.+.
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~~~ 82 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ-----DDEK 82 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEE-----CSSE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEE-----ECCE
Confidence 4799999999999999999999989999999999643 3445577999999999999999999999853 4567
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++||||+++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||++++++.+||+|||
T Consensus 83 ~~ivmEy~~gg~L~~~~~~~~------~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG 153 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIRKIG------SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFG 153 (288)
T ss_dssp EEEEECCCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEEccCCCCHHHhhhccC------CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccc
Confidence 799999999999999987654 589999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 915 (992)
+|+.+.... .........||+.|+|||++.+..++.++||||+||++|||++|+.||.+....
T Consensus 154 ~a~~~~~~~------~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~----------- 216 (288)
T d1uu3a_ 154 TAKVLSPES------KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY----------- 216 (288)
T ss_dssp TCEECC----------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----------
T ss_pred cceecccCC------cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH-----------
Confidence 999775432 112233457999999999999999999999999999999999999999753111
Q ss_pred CChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 916 LPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
+.........+. .+ .....++.+++.+||+.||++|||++|+++.
T Consensus 217 ------~~~~~i~~~~~~------~p------~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 217 ------LIFQKIIKLEYD------FP------EKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp ------HHHHHHHTTCCC------CC------TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred ------HHHHHHHcCCCC------CC------ccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 111111111110 00 0113457899999999999999999997543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=406.30 Aligned_cols=264 Identities=20% Similarity=0.324 Sum_probs=208.2
Q ss_pred cCCCCCCc-cccccceEEEEeEEC--CCCeEEEEEEeeccCC-CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcc
Q 037275 679 NDFSSSNM-IGQGSFGFVYKGNLG--ENGMMVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 679 ~~~~~~~~-lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
++|.+.+. ||+|+||+||+|.++ .++..||||+++.... ...+++.+|++++++++|||||+++|++.. +
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------~ 81 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------E 81 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES------S
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc------C
Confidence 35566664 999999999999875 3456899999964432 335679999999999999999999998743 2
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
..++||||+++|+|.+++...+. .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~~-----~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DF 153 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKRE-----EIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDF 153 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTT-----TSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCC
T ss_pred eEEEEEEeCCCCcHHHHhhcccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccc
Confidence 36899999999999999865443 489999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 913 (992)
|+|+....... .........||+.|+|||++.++.++.++|||||||++|||+| |+.||.+.... ....
T Consensus 154 Gla~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~--~~~~--- 223 (285)
T d1u59a_ 154 GLSKALGADDS-----YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMA--- 223 (285)
T ss_dssp TTCEECTTCSC-----EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHH---
T ss_pred hhhhccccccc-----ccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH--HHHH---
Confidence 99998764321 1122234568999999999999999999999999999999998 99999764221 1111
Q ss_pred hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhhc
Q 037275 914 TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTFLGR 989 (992)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 989 (992)
.+ ..+ .....+ ...+.++.+++.+||+.||++|||+.+|++.|+....++..+
T Consensus 224 ---------~i---~~~-~~~~~p----------~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~ 276 (285)
T d1u59a_ 224 ---------FI---EQG-KRMECP----------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276 (285)
T ss_dssp ---------HH---HTT-CCCCCC----------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred ---------HH---HcC-CCCCCC----------CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhc
Confidence 11 100 000001 112346889999999999999999999999999887665544
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.7e-47 Score=410.06 Aligned_cols=252 Identities=22% Similarity=0.315 Sum_probs=189.2
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC-CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ-KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
.+.|++.+.||+|+||+||+|++..+|+.||||++.... ......+.+|+.++++++||||+++++++ .+.+..
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~~ 82 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY-----ESGGHL 82 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEE-----ECSSEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEE
Confidence 457999999999999999999999899999999997443 23345678999999999999999999995 445678
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeC---CCCcEEEee
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLD---QDLVAHLGD 833 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~D 833 (992)
++||||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||++. +++.+||+|
T Consensus 83 ~lvmE~~~gg~L~~~l~~~~------~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~D 153 (307)
T d1a06a_ 83 YLIMQLVSGGELFDRIVEKG------FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISD 153 (307)
T ss_dssp EEEECCCCSCBHHHHHHTCS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred EEEEeccCCCcHHHhhhccc------CCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEec
Confidence 99999999999999997543 589999999999999999999999 999999999999994 578999999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 913 (992)
||+|+...... .....+||+.|||||++.+..|+.++||||+||++|||++|++||.+....
T Consensus 154 FG~a~~~~~~~---------~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--------- 215 (307)
T d1a06a_ 154 FGLSKMEDPGS---------VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA--------- 215 (307)
T ss_dssp C---------------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---------
T ss_pred cceeEEccCCC---------eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH---------
Confidence 99998654321 223456999999999999999999999999999999999999999753211
Q ss_pred hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 914 TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
+.............. ........++.+++.+||+.||++|||++|+++
T Consensus 216 --------~~~~~i~~~~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 216 --------KLFEQILKAEYEFDS--------PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp --------HHHHHHHTTCCCCCT--------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --------HHHHHHhccCCCCCC--------ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 111111111111000 000112345889999999999999999999986
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.5e-47 Score=414.10 Aligned_cols=253 Identities=21% Similarity=0.309 Sum_probs=205.8
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
.++|++.+.||+|+||+||+|++..+|+.||||++........+.+.+|+.++++++|||||++++++. +.+..+
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~ 99 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE-----DDNEMV 99 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEE-----ETTEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEE
Confidence 458999999999999999999999899999999997655555677899999999999999999999964 456779
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeC--CCCcEEEeecc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLD--QDLVAHLGDFG 835 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~Dfg 835 (992)
+|||||++|+|.+++..... .+++..+..++.||+.||+|||++ +||||||||+|||++ .++.+||+|||
T Consensus 100 ivmE~~~gg~L~~~l~~~~~-----~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG 171 (350)
T d1koaa2 100 MIYEFMSGGELFEKVADEHN-----KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFG 171 (350)
T ss_dssp EEECCCCSCBHHHHHTCTTS-----CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCT
T ss_pred EEEEcCCCCCHHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecc
Confidence 99999999999999965432 489999999999999999999999 999999999999995 46799999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 915 (992)
+|+.+.... ......||+.|||||++.+..++.++||||+||++|||++|+.||.+....
T Consensus 172 ~a~~~~~~~---------~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~----------- 231 (350)
T d1koaa2 172 LTAHLDPKQ---------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD----------- 231 (350)
T ss_dssp TCEECCTTS---------CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----------
T ss_pred hheeccccc---------ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH-----------
Confidence 998765322 223356899999999999999999999999999999999999999763211
Q ss_pred CChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 916 LPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
+.+.......... . .........++.+++.+||+.||++|||++|+++
T Consensus 232 ------~~~~~i~~~~~~~------~--~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 232 ------ETLRNVKSCDWNM------D--DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp ------HHHHHHHHTCCCS------C--CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ------HHHHHHHhCCCCC------C--cccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111111111100 0 0000112345889999999999999999999986
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-46 Score=405.35 Aligned_cols=246 Identities=24% Similarity=0.328 Sum_probs=198.3
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCC---chhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKG---ASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
..|+..+.||+|+||+||+|++..+++.||||+++..... ..+.+.+|++++++++|||||++++++. +.+.
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~ 89 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-----REHT 89 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEE-----ECCE
Confidence 3589999999999999999999999999999999754432 2356889999999999999999999964 3456
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++|||||++|++..++.... .+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 90 ~~iv~E~~~~g~l~~~~~~~~------~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG 160 (309)
T d1u5ra_ 90 AWLVMEYCLGSASDLLEVHKK------PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG 160 (309)
T ss_dssp EEEEEECCSEEHHHHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCT
T ss_pred EEEEEEecCCCchHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecc
Confidence 799999999999987765432 589999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccC---CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHH
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG---GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFA 912 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~ 912 (992)
+|+.... .....||+.|||||++.+ +.|+.++|||||||++|||++|+.||.+....
T Consensus 161 ~a~~~~~------------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~-------- 220 (309)
T d1u5ra_ 161 SASIMAP------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------- 220 (309)
T ss_dssp TCBSSSS------------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------
T ss_pred cccccCC------------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH--------
Confidence 9985432 123469999999999864 46899999999999999999999999753211
Q ss_pred hhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 913 RTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
+.+........... .......++.+++.+||+.||++||||+|+++
T Consensus 221 ---------~~~~~i~~~~~~~~----------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 221 ---------SALYHIAQNESPAL----------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ---------HHHHHHHHSCCCCC----------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---------HHHHHHHhCCCCCC----------CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 11111111111000 00112345889999999999999999999975
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=410.28 Aligned_cols=262 Identities=22% Similarity=0.372 Sum_probs=203.0
Q ss_pred hcCCCCCCccccccceEEEEeEECCCC-----eEEEEEEeecc-CCCchhHHHHHHHHHHhc-cCCcceeEEEEeecccc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENG-----MMVAVKVINLK-QKGASNGFVAECQALRNI-RHRNLIKIITICSSIDF 750 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 750 (992)
.++|++.++||+|+||+||+|++...+ ..||+|++... .......+.+|+.+++++ +|||||++++++.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~---- 111 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT---- 111 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe----
Confidence 357899999999999999999985443 47999998643 334456789999999998 8999999999964
Q ss_pred cCcceEEEEEEeccCCCHHHHHhhcccc-----------------hhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 037275 751 KGVDFQAIVYEYMQNGSLEDWLHQSEDQ-----------------QEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVH 813 (992)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH 813 (992)
..+..++||||+++|+|.++++..... .....+++..++.++.|+++||+|||++ +|||
T Consensus 112 -~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiH 187 (325)
T d1rjba_ 112 -LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVH 187 (325)
T ss_dssp -SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred -eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceee
Confidence 345569999999999999999865421 1123589999999999999999999999 9999
Q ss_pred ccCCCCCeeeCCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh
Q 037275 814 GDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT 893 (992)
Q Consensus 814 ~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt 893 (992)
|||||+||+++.++.+||+|||+|+....... ........||+.|||||++.++.++.++|||||||++|||+|
T Consensus 188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~------~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt 261 (325)
T d1rjba_ 188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSN------YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 261 (325)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTT------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTT
T ss_pred ccCchhccccccCCeEEEeeccccccccCCCc------eeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHh
Confidence 99999999999999999999999986543221 111234568999999999999999999999999999999998
Q ss_pred -CCCCCCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCH
Q 037275 894 -RRRPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEM 972 (992)
Q Consensus 894 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 972 (992)
|+.||.+..... .+.. ++. .......+. ....++.+++.+||+.||++|||+
T Consensus 262 ~g~~Pf~~~~~~~-~~~~------------~~~----~~~~~~~p~----------~~~~~l~~li~~cl~~dP~~RPt~ 314 (325)
T d1rjba_ 262 LGVNPYPGIPVDA-NFYK------------LIQ----NGFKMDQPF----------YATEEIYIIMQSCWAFDSRKRPSF 314 (325)
T ss_dssp TSCCSSTTCCCSH-HHHH------------HHH----TTCCCCCCT----------TCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCCCCCCCCHHH-HHHH------------HHh----cCCCCCCCC----------cCCHHHHHHHHHHcCCChhHCcCH
Confidence 899998643321 1111 111 111110111 123468999999999999999999
Q ss_pred HHHHHHHH
Q 037275 973 RDVVAKLC 980 (992)
Q Consensus 973 ~evl~~L~ 980 (992)
+||++.|.
T Consensus 315 ~ei~~~L~ 322 (325)
T d1rjba_ 315 PNLTSFLG 322 (325)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHh
Confidence 99999885
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=397.80 Aligned_cols=255 Identities=25% Similarity=0.351 Sum_probs=199.4
Q ss_pred CccccccceEEEEeEEC--CCCeEEEEEEeeccC--CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEEE
Q 037275 685 NMIGQGSFGFVYKGNLG--ENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIVY 760 (992)
Q Consensus 685 ~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 760 (992)
++||+|+||+||+|.+. .+++.||||+++... ....+++.+|++++++++|||||+++|+|.. +..++||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~------~~~~lvm 86 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM 86 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES------SSEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc------CCEEEEE
Confidence 46999999999999864 346789999996432 2334679999999999999999999999742 2358999
Q ss_pred EeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccceec
Q 037275 761 EYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKFL 840 (992)
Q Consensus 761 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 840 (992)
||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+|+..
T Consensus 87 E~~~~g~L~~~l~~~~------~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~ 157 (277)
T d1xbba_ 87 EMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL 157 (277)
T ss_dssp ECCTTEEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EcCCCCcHHHHHhhcc------CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhc
Confidence 9999999999997643 589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhhhCChh
Q 037275 841 SSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFARTALPDK 919 (992)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 919 (992)
..... .........||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.... +
T Consensus 158 ~~~~~-----~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~-----~--------- 218 (277)
T d1xbba_ 158 RADEN-----YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-----E--------- 218 (277)
T ss_dssp CTTCS-----EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----H---------
T ss_pred ccccc-----ccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH-----H---------
Confidence 54321 1122234568999999999999999999999999999999998 89999763211 1
Q ss_pred HHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhh
Q 037275 920 VMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTFL 987 (992)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 987 (992)
+...+. .+ .....+ ...+.++.+++.+||+.||++|||++||++.|+....+..
T Consensus 219 ~~~~i~---~~-~~~~~p----------~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~ 272 (277)
T d1xbba_ 219 VTAMLE---KG-ERMGCP----------AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 272 (277)
T ss_dssp HHHHHH---TT-CCCCCC----------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHH---cC-CCCCCC----------cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhcC
Confidence 111111 00 000001 1123468899999999999999999999999887765443
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-47 Score=402.65 Aligned_cols=262 Identities=26% Similarity=0.445 Sum_probs=197.5
Q ss_pred cCCCCCCccccccceEEEEeEECCCC----eEEEEEEeeccCC-CchhHHHHHHHHHHhccCCcceeEEEEeecccccCc
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENG----MMVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 753 (992)
..|+..++||+|+||+||+|.+..++ ..||||+++.... .....+.+|+.++++++|||||+++|++. ..
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~-----~~ 81 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS-----KY 81 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEe-----cC
Confidence 46778899999999999999986444 5799999864432 23456899999999999999999999964 34
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGD 833 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 833 (992)
...++||||+.+|++.+++..... .+++.++..++.|++.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~~-----~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~D 153 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKDG-----EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSD 153 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTT-----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECC
T ss_pred CceEEEEEecccCcchhhhhcccc-----cccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcc
Confidence 556999999999999998876543 589999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 913 (992)
||+|+....... .........||+.|+|||++.++.++.++|||||||++|||++|..|+...... .+
T Consensus 154 FGla~~~~~~~~-----~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~----~~--- 221 (283)
T d1mqba_ 154 FGLSRVLEDDPE-----ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN----HE--- 221 (283)
T ss_dssp CCC----------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HH---
T ss_pred cchhhcccCCCc-----cceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH----HH---
Confidence 999987654321 112223456899999999999999999999999999999999966655432111 11
Q ss_pred hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 037275 914 TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDT 985 (992)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 985 (992)
+...+.. ...... ....+.++.+++.+||+.||++||||.||++.|+++.+.
T Consensus 222 ------~~~~i~~----~~~~~~----------~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 222 ------VMKAIND----GFRLPT----------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp ------HHHHHHT----TCCCCC----------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ------HHHHHhc----cCCCCC----------chhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 1111111 000000 011235688999999999999999999999999988653
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.1e-46 Score=412.50 Aligned_cols=253 Identities=19% Similarity=0.275 Sum_probs=206.3
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
.++|++.+.||+|+||+||+|++..+|+.||||+++.........+.+|+.++++++|||||++++++ .+....+
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~~~ 102 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEMV 102 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSSEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEE
Confidence 35799999999999999999999989999999999765544556788999999999999999999995 4556789
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeC--CCCcEEEeecc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLD--QDLVAHLGDFG 835 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~Dfg 835 (992)
+|||||++|+|.+++..... .+++.+++.++.||+.||+|||++ ||+||||||+|||++ .++.+||+|||
T Consensus 103 ivmE~~~gg~L~~~~~~~~~-----~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFG 174 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAEDY-----KMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFG 174 (352)
T ss_dssp EEEECCCCCBHHHHTTCTTC-----CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred EEEEcCCCChHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecc
Confidence 99999999999998865432 489999999999999999999999 999999999999997 67899999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 915 (992)
+|+.+.... ......||+.|+|||++.+..++.++||||+||++|||+||+.||.+....
T Consensus 175 la~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~----------- 234 (352)
T d1koba_ 175 LATKLNPDE---------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL----------- 234 (352)
T ss_dssp TCEECCTTS---------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-----------
T ss_pred cceecCCCC---------ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-----------
Confidence 999875432 223346899999999999999999999999999999999999999763221
Q ss_pred CChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 916 LPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
+.+.......... ... .......++.+++.+||+.||++|||++|+++
T Consensus 235 ------~~~~~i~~~~~~~--~~~------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 235 ------ETLQNVKRCDWEF--DED------AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp ------HHHHHHHHCCCCC--CSS------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ------HHHHHHHhCCCCC--Ccc------cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111111111100 000 00112345889999999999999999999986
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-46 Score=399.07 Aligned_cols=251 Identities=23% Similarity=0.329 Sum_probs=203.2
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC------CchhHHHHHHHHHHhccCCcceeEEEEeecccccC
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK------GASNGFVAECQALRNIRHRNLIKIITICSSIDFKG 752 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 752 (992)
++|++.+.||+|+||+||+|++..+|+.||||+++.... ...+.+.+|++++++++|||||++++++ .+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~ 84 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-----EN 84 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EE
Confidence 579999999999999999999998999999999964321 2346789999999999999999999995 44
Q ss_pred cceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCC----c
Q 037275 753 VDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDL----V 828 (992)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~ 828 (992)
....++|||||++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++ .
T Consensus 85 ~~~~~iv~E~~~gg~L~~~i~~~~------~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~ 155 (293)
T d1jksa_ 85 KTDVILILELVAGGELFDFLAEKE------SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPR 155 (293)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCC
T ss_pred CCEEEEEEEcCCCccccchhcccc------ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccc
Confidence 567799999999999999997643 589999999999999999999999 999999999999998876 5
Q ss_pred EEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccH
Q 037275 829 AHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTL 908 (992)
Q Consensus 829 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~ 908 (992)
+|++|||+|+...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+ .+
T Consensus 156 vkl~DfG~a~~~~~~~---------~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~~ 225 (293)
T d1jksa_ 156 IKIIDFGLAHKIDFGN---------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TL 225 (293)
T ss_dssp EEECCCTTCEECTTSC---------BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HH
T ss_pred eEecchhhhhhcCCCc---------cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH-HH
Confidence 9999999998765322 2233468999999999999999999999999999999999999998632210 01
Q ss_pred HHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 909 HEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
........... ..........+.+++.+||+.||++|||++|+++
T Consensus 226 ~~i~~~~~~~~------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 226 ANVSAVNYEFE------------------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HHHHTTCCCCC------------------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHhcCCCCC------------------------chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111000000 0000112345789999999999999999999985
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=401.20 Aligned_cols=249 Identities=26% Similarity=0.337 Sum_probs=205.4
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc---CCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK---QKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
.++|+++++||+|+||+||+|++..+|+.||||+++.. .....+.+.+|+.++++++||||+++++++ .+..
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~ 78 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSS
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee-----cccc
Confidence 45799999999999999999999999999999999743 344567789999999999999999999995 4566
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
..++||||+++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+|||++++|.+||+||
T Consensus 79 ~~~iv~ey~~gg~L~~~~~~~~------~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DF 149 (337)
T d1o6la_ 79 RLCFVMEYANGGELFFHLSRER------VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDF 149 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred ccccceeccCCCchhhhhhccc------CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeec
Confidence 7899999999999999998654 589999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
|+|+..... .......+||+.|+|||++.+..|+.++||||+||++|||++|++||.+....
T Consensus 150 G~a~~~~~~--------~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~---------- 211 (337)
T d1o6la_ 150 GLCKEGISD--------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---------- 211 (337)
T ss_dssp TTCBCSCCT--------TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH----------
T ss_pred ccccccccC--------CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH----------
Confidence 999865432 12233467999999999999999999999999999999999999999863211
Q ss_pred hCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 037275 915 ALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERME-----MRDVVA 977 (992)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 977 (992)
++.......... .+. ....++.+++.+||+.||++||+ ++|+++
T Consensus 212 -------~~~~~i~~~~~~--~p~----------~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 212 -------RLFELILMEEIR--FPR----------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -------HHHHHHHHCCCC--CCT----------TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -------HHHHHHhcCCCC--CCc----------cCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 111111111110 000 11345789999999999999995 788875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.9e-46 Score=396.05 Aligned_cols=267 Identities=22% Similarity=0.333 Sum_probs=205.4
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC---CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK---GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
.++|++.+.||+|+||+||+|++..+|+.||||+++.... .....+.+|+++++.++||||+++++++...+ ....
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~~ 84 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP 84 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSSE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCCc
Confidence 3579999999999999999999998999999999974432 23456899999999999999999999876532 2334
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
..++||||+++|+|.+++.... .+++.+++.++.||+.||+|||++ +|+||||||+||+++.++..+++||
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~------~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~ 155 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDF 155 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCC
T ss_pred eEEEEEECCCCCEehhhhcccC------CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehh
Confidence 5789999999999999987643 589999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
|.+........ .........||+.|+|||++.+..+++++||||+||++|||+||++||.+....
T Consensus 156 ~~~~~~~~~~~-----~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---------- 220 (277)
T d1o6ya_ 156 GIARAIADSGN-----SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV---------- 220 (277)
T ss_dssp TTCEECC---------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH----------
T ss_pred hhhhhhccccc-----cccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH----------
Confidence 99986543221 122334467999999999999999999999999999999999999999763211
Q ss_pred hCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHHHHH
Q 037275 915 ALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERM-EMRDVVAKLCRARD 984 (992)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~ 984 (992)
+............ ..........++.+++.+||+.||++|| ||+|+++.|.++++
T Consensus 221 -------~~~~~~~~~~~~~--------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 221 -------SVAYQHVREDPIP--------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp -------HHHHHHHHCCCCC--------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred -------HHHHHHHhcCCCC--------CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 1111111111000 0000011235688999999999999999 89999999998864
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-46 Score=397.32 Aligned_cols=260 Identities=28% Similarity=0.441 Sum_probs=200.8
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
.++|++.+.||+|+||+||+|++. +++.||||+++.. ....+.+.+|+.++++++|||||+++|++.+ +..+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~-~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~------~~~~ 87 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY 87 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEEC-CCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec------CCeE
Confidence 357999999999999999999997 5577999999643 3456789999999999999999999998642 2358
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||+++|+|..++..... ..+++.+++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|
T Consensus 88 lv~Ey~~~g~l~~~~~~~~~----~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla 160 (285)
T d1fmka3 88 IVTEYMSKGSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLA 160 (285)
T ss_dssp EEECCCTTCBHHHHHSHHHH----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred EEEEecCCCchhhhhhhccc----ccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchh
Confidence 99999999999999876432 2589999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALP 917 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 917 (992)
+....... .......||+.|+|||++.++.++.++|||||||++|||++|..||......
T Consensus 161 ~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~------------- 220 (285)
T d1fmka3 161 RLIEDNEY-------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------------- 220 (285)
T ss_dssp C---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------------
T ss_pred hhccCCCc-------eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-------------
Confidence 87654321 1223356899999999999999999999999999999999966655432111
Q ss_pred hhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 037275 918 DKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTF 986 (992)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 986 (992)
.+++...... ...... .....++.+++.+||+.||++|||+++|++.|++.....
T Consensus 221 ---~~~~~~i~~~-~~~~~~----------~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 221 ---REVLDQVERG-YRMPCP----------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp ---HHHHHHHHTT-CCCCCC----------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred ---HHHHHHHHhc-CCCCCC----------cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 1111111111 000001 112346889999999999999999999999888765443
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-46 Score=389.42 Aligned_cols=253 Identities=30% Similarity=0.394 Sum_probs=197.8
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAI 758 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 758 (992)
++|++.++||+|+||.||+|++ .|+.||||+++. ....+.+.+|++++++++||||++++|+|.+ +...+++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~~~~~l 78 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLYI 78 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCC--CC--HHHHHTHHHHTTCCCTTBCCEEEEECC----C--CCEE
T ss_pred HHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEe----cCCcEEE
Confidence 4688899999999999999999 478999999953 3455779999999999999999999998743 3344699
Q ss_pred EEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccce
Q 037275 759 VYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAK 838 (992)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 838 (992)
||||+++|+|.+++..... ..+++..+++|+.||+.||+|||+. +|+||||||+||+++.++.+|++|||+++
T Consensus 79 v~ey~~~g~L~~~l~~~~~----~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~ 151 (262)
T d1byga_ 79 VTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK 151 (262)
T ss_dssp EECCCTTEEHHHHHHHHHH----HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred EEeccCCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccce
Confidence 9999999999999976532 2589999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHHhhhCC
Q 037275 839 FLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFARTALP 917 (992)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 917 (992)
..... .....+|+.|+|||++.++.++.++|||||||++|||+| |++||...... ........
T Consensus 152 ~~~~~-----------~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~--~~~~~i~~--- 215 (262)
T d1byga_ 152 EASST-----------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEK--- 215 (262)
T ss_dssp ---------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHHHHTT---
T ss_pred ecCCC-----------CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHc---
Confidence 65432 122357889999999999999999999999999999998 78887653222 11111110
Q ss_pred hhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 037275 918 DKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDT 985 (992)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 985 (992)
......+ .....++.+++.+||+.||++||||.||+++|++++..
T Consensus 216 -------------~~~~~~~----------~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 216 -------------GYKMDAP----------DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp -------------TCCCCCC----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------------CCCCCCC----------ccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 0000000 11234588999999999999999999999999998653
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-45 Score=399.00 Aligned_cols=259 Identities=23% Similarity=0.401 Sum_probs=202.4
Q ss_pred cCCCCCCccccccceEEEEeEECCCCe----EEEEEEeecc-CCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCc
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGM----MVAVKVINLK-QKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 753 (992)
.+|++.++||+|+||+||+|++..+|+ +||+|.++.. .....+.+.+|+.++++++|||||+++|+|.+.
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~----- 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----- 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-----
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----
Confidence 369999999999999999999977765 5888887533 334567899999999999999999999997542
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGD 833 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 833 (992)
..+++|||+.+|+|.+++..... .+++..+++++.|||.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 84 -~~~~v~e~~~~~~l~~~~~~~~~-----~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~D 154 (317)
T d1xkka_ 84 -TVQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITD 154 (317)
T ss_dssp -SEEEEEECCTTCBHHHHHHHTSS-----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECC
T ss_pred -CeeEEEEeccCCccccccccccc-----CCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeec
Confidence 34789999999999999876543 589999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHH
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFA 912 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~ 912 (992)
||+|+....... ........||+.|+|||++.++.++.++|||||||++|||+| |++||.+.....
T Consensus 155 FGla~~~~~~~~------~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~------- 221 (317)
T d1xkka_ 155 FGLAKLLGAEEK------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE------- 221 (317)
T ss_dssp CSHHHHTTTTCC--------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG-------
T ss_pred cccceecccccc------cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH-------
Confidence 999987654321 112233468999999999999999999999999999999999 888987643221
Q ss_pred hhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 037275 913 RTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDT 985 (992)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 985 (992)
+...+.. ......+ .....++.+++.+||+.||++|||+.||++.|.++..+
T Consensus 222 -------~~~~i~~----~~~~~~p----------~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 222 -------ISSILEK----GERLPQP----------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp -------HHHHHHH----TCCCCCC----------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -------HHHHHHc----CCCCCCC----------cccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 1111111 0000000 11234588999999999999999999999999887654
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4e-45 Score=394.77 Aligned_cols=245 Identities=26% Similarity=0.327 Sum_probs=203.4
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc---CCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK---QKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
++|++.+.||+|+||+||+|+++.+|+.||||+++.. .....+.+.+|+.++++++||||+++++++. +...
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~ 78 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ-----DAQQ 78 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE-----CSSE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEe-----eCCe
Confidence 5799999999999999999999989999999999643 3445677899999999999999999999954 4567
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++||||+++|++..++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||
T Consensus 79 ~~ivmE~~~gg~l~~~~~~~~------~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG 149 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLRKSQ------RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFG 149 (316)
T ss_dssp EEEEECCCCSCBHHHHHHHTS------SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCS
T ss_pred eeeEeeecCCccccccccccc------cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCc
Confidence 899999999999999988654 478889999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 915 (992)
+|+..... .....||+.|||||++.+..|+.++||||+||++|||++|+.||.+...
T Consensus 150 ~a~~~~~~-----------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~------------ 206 (316)
T d1fota_ 150 FAKYVPDV-----------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------------ 206 (316)
T ss_dssp SCEECSSC-----------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------------
T ss_pred cceEeccc-----------cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH------------
Confidence 99876432 1235799999999999999999999999999999999999999976321
Q ss_pred CChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 037275 916 LPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERM-----EMRDVVA 977 (992)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 977 (992)
.+........... .+ .....++.+++.+||+.||++|| |++|+++
T Consensus 207 -----~~~~~~i~~~~~~------~p------~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 207 -----MKTYEKILNAELR------FP------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp -----HHHHHHHHHCCCC------CC------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -----HHHHHHHHcCCCC------CC------CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 1111111111110 00 01124588999999999999996 8999875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=392.40 Aligned_cols=260 Identities=22% Similarity=0.331 Sum_probs=197.5
Q ss_pred hcCCCCCCccccccceEEEEeEECCC---CeEEEEEEeeccCC-CchhHHHHHHHHHHhccCCcceeEEEEeecccccCc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGEN---GMMVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGV 753 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 753 (992)
.++|++.+.||+|+||+||+|++..+ +..||||+++.... ...+.+.+|+.++++++||||++++|++.+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------ 79 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------ 79 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS------
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence 35789999999999999999998643 45789998864333 234678999999999999999999998632
Q ss_pred ceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 037275 754 DFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGD 833 (992)
Q Consensus 754 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 833 (992)
+..++||||+++|++.+++..... .+++..++.++.||++||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~~-----~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~D 151 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRKY-----SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGD 151 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTT-----TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC
T ss_pred CeEEEEEEeccCCcHHhhhhccCC-----CCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEcc
Confidence 346899999999999998875443 589999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHHH
Q 037275 834 FGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEFA 912 (992)
Q Consensus 834 fg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~ 912 (992)
||+|+...... ........||+.|+|||++.+..++.++|||||||++|||+| |.+||.+....+ ..
T Consensus 152 fG~a~~~~~~~-------~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~--~~--- 219 (273)
T d1mp8a_ 152 FGLSRYMEDST-------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VI--- 219 (273)
T ss_dssp --------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HH---
T ss_pred chhheeccCCc-------ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH--HH---
Confidence 99998765322 112233468999999999999999999999999999999998 899997643221 11
Q ss_pred hhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 037275 913 RTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTF 986 (992)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 986 (992)
.....+.. ...+ .....++.+++.+||+.||++|||++||++.|+++.++-
T Consensus 220 ------------~~i~~~~~-~~~~----------~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 220 ------------GRIENGER-LPMP----------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp ------------HHHHTTCC-CCCC----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ------------HHHHcCCC-CCCC----------CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 11110000 0000 112346899999999999999999999999999987654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-45 Score=392.95 Aligned_cols=285 Identities=23% Similarity=0.308 Sum_probs=207.9
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHH--HHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFV--AECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~--~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
++|...++||+|+||+||+|+. +|+.||||+++... ...+. .|+..+++++||||+++++++.+.+ ......
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~ 76 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQL 76 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEE
Confidence 4677788999999999999998 68999999986332 23333 4455556789999999999987533 233467
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEeccCCCCCeeeCCCCcEEE
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHC-----QPPVVHGDLKPSNVLLDQDLVAHL 831 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~kl 831 (992)
++||||+++|+|.+++++. .+++..+++++.|+|.||+|+|+.. .++||||||||+|||++.++.+||
T Consensus 77 ~lv~Ey~~~g~L~~~l~~~-------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl 149 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 149 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred EEEEecccCCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEE
Confidence 9999999999999999753 4899999999999999999999731 238999999999999999999999
Q ss_pred eecccceecCCCCCCCCcccCCCCCcccccccccccccccCC------CcCcccchhhHHHHHHHHHhCCCCCCCCccCC
Q 037275 832 GDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG------EASMTGDVYSFGILLLEMFTRRRPTDGMFNQG 905 (992)
Q Consensus 832 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~il~elltg~~pf~~~~~~~ 905 (992)
+|||+++........ .........||+.|+|||++.+. .++.++|||||||++|||+||..||.......
T Consensus 150 ~DFGl~~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~ 225 (303)
T d1vjya_ 150 ADLGLAVRHDSATDT----IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 225 (303)
T ss_dssp CCCTTCEEEETTTTE----ECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCC
T ss_pred EecCccccccCCCcc----eeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccc
Confidence 999999877543211 11223346799999999998764 36779999999999999999999886543332
Q ss_pred ccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 037275 906 LTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDT 985 (992)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 985 (992)
.......... .......+.... ...+..........+....+.+++.+||+.||++|||+.||++.|+++.+.
T Consensus 226 ~~~~~~~~~~--~~~~~~~~~~~~-----~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 226 LPYYDLVPSD--PSVEEMRKVVCE-----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CTTTTTSCSS--CCHHHHHHHHTT-----SCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cchhhccccc--chHHHHHHHHhc-----cccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 2211111111 111111111110 111111222333445667799999999999999999999999999998865
Q ss_pred hh
Q 037275 986 FL 987 (992)
Q Consensus 986 ~~ 987 (992)
-.
T Consensus 299 ~~ 300 (303)
T d1vjya_ 299 EG 300 (303)
T ss_dssp HC
T ss_pred cC
Confidence 43
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.9e-45 Score=386.12 Aligned_cols=251 Identities=22% Similarity=0.331 Sum_probs=202.0
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCC---------chhHHHHHHHHHHhcc-CCcceeEEEEeecc
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKG---------ASNGFVAECQALRNIR-HRNLIKIITICSSI 748 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 748 (992)
++|++.+.||+|+||+||+|++..+|+.||||+++..... ..+.+.+|+.++++++ ||||+++++++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~--- 79 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY--- 79 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE---
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec---
Confidence 5899999999999999999999989999999999754322 1235789999999997 99999999995
Q ss_pred cccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCc
Q 037275 749 DFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLV 828 (992)
Q Consensus 749 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 828 (992)
.+.+..++||||+++|+|.++++... .+++.++..++.||++||+|||++ +|+||||||+||+++.++.
T Consensus 80 --~~~~~~~ivmE~~~~g~L~~~l~~~~------~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ 148 (277)
T d1phka_ 80 --ETNTFFFLVFDLMKKGELFDYLTEKV------TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMN 148 (277)
T ss_dssp --ECSSEEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCC
T ss_pred --ccCcceEEEEEcCCCchHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCC
Confidence 45667899999999999999997543 589999999999999999999999 9999999999999999999
Q ss_pred EEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccC------CCcCcccchhhHHHHHHHHHhCCCCCCCCc
Q 037275 829 AHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG------GEASMTGDVYSFGILLLEMFTRRRPTDGMF 902 (992)
Q Consensus 829 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwSlG~il~elltg~~pf~~~~ 902 (992)
+||+|||+|+...... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+..
T Consensus 149 ~kl~DFG~a~~~~~~~---------~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~ 219 (277)
T d1phka_ 149 IKLTDFGFSCQLDPGE---------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 219 (277)
T ss_dssp EEECCCTTCEECCTTC---------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eEEccchheeEccCCC---------ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC
Confidence 9999999998765421 2233569999999998753 357889999999999999999999998632
Q ss_pred cCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 903 NQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.. +.......+.... ..........++.+++.+||+.||++|||++||++
T Consensus 220 ~~-----------------~~~~~i~~~~~~~--------~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 220 QM-----------------LMLRMIMSGNYQF--------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HH-----------------HHHHHHHHTCCCC--------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HH-----------------HHHHHHHhCCCCC--------CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11 1111111111100 00011122356889999999999999999999864
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.8e-46 Score=400.64 Aligned_cols=268 Identities=23% Similarity=0.408 Sum_probs=208.2
Q ss_pred HHHHhcCCCCCCccccccceEEEEeEEC-----CCCeEEEEEEeeccCCC-chhHHHHHHHHHHhccCCcceeEEEEeec
Q 037275 674 LSKATNDFSSSNMIGQGSFGFVYKGNLG-----ENGMMVAVKVINLKQKG-ASNGFVAECQALRNIRHRNLIKIITICSS 747 (992)
Q Consensus 674 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 747 (992)
++...++|++.+.||+|+||+||+|++. .+++.||||+++..... ..+++.+|++++++++||||++++++|..
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 87 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 87 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence 3345678999999999999999999974 35689999998644332 34679999999999999999999999754
Q ss_pred ccccCcceEEEEEEeccCCCHHHHHhhcccc------------------hhhcccCHHHHHHHHHHHHHHHHHHHhcCCC
Q 037275 748 IDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQ------------------QEARSLTLIQRINIIIDVASAIEYIHHHCQP 809 (992)
Q Consensus 748 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~ 809 (992)
....++||||+++|+|.+++...... .....+++..++.++.|++.||+|||++
T Consensus 88 -----~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~--- 159 (301)
T d1lufa_ 88 -----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER--- 159 (301)
T ss_dssp -----SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred -----CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---
Confidence 34569999999999999999754321 1233589999999999999999999999
Q ss_pred CeEeccCCCCCeeeCCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHH
Q 037275 810 PVVHGDLKPSNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLL 889 (992)
Q Consensus 810 ~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 889 (992)
+||||||||+||+++.++.+||+|||+|+...... .........|++.|+|||++.+..++.++|||||||++|
T Consensus 160 ~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ 233 (301)
T d1lufa_ 160 KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD------YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLW 233 (301)
T ss_dssp TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGG------CBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred CeEeeEEcccceEECCCCcEEEccchhheeccCCc------cccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHH
Confidence 99999999999999999999999999998664322 112223456889999999999999999999999999999
Q ss_pred HHHhCC-CCCCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCC
Q 037275 890 EMFTRR-RPTDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTE 968 (992)
Q Consensus 890 elltg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 968 (992)
||++|. +||.+.... ++......+.. ...+ ...+.++.+++.+||+.||++
T Consensus 234 ell~~~~~p~~~~~~~-----------------e~~~~v~~~~~-----~~~p------~~~~~~~~~li~~cl~~~P~~ 285 (301)
T d1lufa_ 234 EIFSYGLQPYYGMAHE-----------------EVIYYVRDGNI-----LACP------ENCPLELYNLMRLCWSKLPAD 285 (301)
T ss_dssp HHHTTTCCTTTTSCHH-----------------HHHHHHHTTCC-----CCCC------TTCCHHHHHHHHHHTCSSGGG
T ss_pred HHHccCCCCCCCCCHH-----------------HHHHHHHcCCC-----CCCC------ccchHHHHHHHHHHcCCChhH
Confidence 999985 567653211 11111111110 0001 112346889999999999999
Q ss_pred CCCHHHHHHHHHHHH
Q 037275 969 RMEMRDVVAKLCRAR 983 (992)
Q Consensus 969 RPs~~evl~~L~~~~ 983 (992)
||||.||++.|+++.
T Consensus 286 RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 286 RPSFCSIHRILQRMC 300 (301)
T ss_dssp SCCHHHHHHHHHHTT
T ss_pred CcCHHHHHHHHHHhc
Confidence 999999999999874
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=389.47 Aligned_cols=258 Identities=26% Similarity=0.372 Sum_probs=195.9
Q ss_pred cCCCCCCccccccceEEEEeEECC-C--CeEEEEEEeecc---CCCchhHHHHHHHHHHhccCCcceeEEEEeecccccC
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGE-N--GMMVAVKVINLK---QKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKG 752 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~-~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 752 (992)
++|++.+.||+|+||+||+|++.. + ...||||+++.. .....+++.+|+.++++++||||++++|++.+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~----- 82 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT----- 82 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----
Confidence 578999999999999999998642 2 347999998643 23335678999999999999999999999743
Q ss_pred cceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEe
Q 037275 753 VDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLG 832 (992)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 832 (992)
...++||||+++|++.+++..... .+++..+..++.|+|.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 83 -~~~~lv~e~~~~~~l~~~~~~~~~-----~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~ 153 (273)
T d1u46a_ 83 -PPMKMVTELAPLGSLLDRLRKHQG-----HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIG 153 (273)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHGG-----GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEEC
T ss_pred -cchheeeeeecCcchhhhhhcccC-----CCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeec
Confidence 234899999999999999876543 499999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCCCCCCccCCccHHHH
Q 037275 833 DFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRPTDGMFNQGLTLHEF 911 (992)
Q Consensus 833 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~ 911 (992)
|||+++....... .........|+..|+|||++.+..++.++|||||||++|||+| |+.||.+....
T Consensus 154 DfGl~~~~~~~~~-----~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~------- 221 (273)
T d1u46a_ 154 DFGLMRALPQNDD-----HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------- 221 (273)
T ss_dssp CCTTCEECCC-CC-----EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------
T ss_pred cchhhhhcccCCC-----cceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH-------
Confidence 9999998754321 1122334467889999999999999999999999999999998 89999763221
Q ss_pred HhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 037275 912 ARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRA 982 (992)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 982 (992)
+.............. ....+.++.+++.+||+.||++||||+||.+.|+++
T Consensus 222 ----------~~~~~i~~~~~~~~~----------~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 222 ----------QILHKIDKEGERLPR----------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ----------HHHHHHHTSCCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----------HHHHHHHhCCCCCCC----------cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 111111111110000 011234588999999999999999999999999876
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-45 Score=394.82 Aligned_cols=268 Identities=22% Similarity=0.360 Sum_probs=199.2
Q ss_pred hcCCCCCCccccccceEEEEeEECC-----CCeEEEEEEeeccCC-CchhHHHHHHHHHHhc-cCCcceeEEEEeecccc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGE-----NGMMVAVKVINLKQK-GASNGFVAECQALRNI-RHRNLIKIITICSSIDF 750 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 750 (992)
.++|++.++||+|+||+||+|++.. +++.||||+++.... ...+.+.+|..++.++ +|+||+.+++++..
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~--- 88 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK--- 88 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc---
Confidence 4689999999999999999999743 457899999864332 3345677888888777 68999999998643
Q ss_pred cCcceEEEEEEeccCCCHHHHHhhcccc----------hhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCC
Q 037275 751 KGVDFQAIVYEYMQNGSLEDWLHQSEDQ----------QEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSN 820 (992)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~N 820 (992)
.....++|||||++|+|.++++..... .....+++.++..++.||++||+|||++ +||||||||+|
T Consensus 89 -~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~N 164 (299)
T d1ywna1 89 -PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARN 164 (299)
T ss_dssp -TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred -CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccc
Confidence 345579999999999999999865431 0123589999999999999999999999 99999999999
Q ss_pred eeeCCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhC-CCCCC
Q 037275 821 VLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTR-RRPTD 899 (992)
Q Consensus 821 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg-~~pf~ 899 (992)
||+++++.+||+|||+|+...... .........||+.|+|||++.+..++.++|||||||++|||+|| .+||.
T Consensus 165 ILl~~~~~~Kl~DFGla~~~~~~~------~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~ 238 (299)
T d1ywna1 165 ILLSEKNVVKICDFGLARDIYKDP------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 238 (299)
T ss_dssp EEECGGGCEEECC------CCSCT------TSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred eeECCCCcEEEccCcchhhccccc------cccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCC
Confidence 999999999999999998765432 12223345799999999999999999999999999999999996 56776
Q ss_pred CCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 037275 900 GMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKL 979 (992)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 979 (992)
+..... .+. ..+. .......+ .....++.+++.+||+.||++||||+||++.|
T Consensus 239 ~~~~~~-~~~------------~~~~----~~~~~~~~----------~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L 291 (299)
T d1ywna1 239 GVKIDE-EFC------------RRLK----EGTRMRAP----------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 291 (299)
T ss_dssp TCCCSH-HHH------------HHHH----HTCCCCCC----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCHHH-HHH------------HHHh----cCCCCCCC----------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 532221 111 1111 11100000 11234588999999999999999999999999
Q ss_pred HHHHHh
Q 037275 980 CRARDT 985 (992)
Q Consensus 980 ~~~~~~ 985 (992)
+++.+.
T Consensus 292 ~~ilq~ 297 (299)
T d1ywna1 292 GNLLQA 297 (299)
T ss_dssp HHHHHH
T ss_pred HHHHhC
Confidence 998653
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=394.55 Aligned_cols=257 Identities=20% Similarity=0.268 Sum_probs=200.7
Q ss_pred hcCCCCCC-ccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhc-cCCcceeEEEEeecccccCcce
Q 037275 678 TNDFSSSN-MIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNI-RHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 678 ~~~~~~~~-~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 755 (992)
.++|++.. +||+|+||+||+|++..+++.||||+++. ...+.+|+.++.++ +||||+++++++.+. ......
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~-~~~~~~ 83 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC 83 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeec-ccCCCE
Confidence 45788875 69999999999999998999999999852 35678899987655 899999999987542 234567
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCC---CCcEEEe
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQ---DLVAHLG 832 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~ 832 (992)
+++|||||++|+|.+++..... ..+++.+++.++.||+.||+|||++ +|+||||||+||+++. ++.+||+
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~----~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~ 156 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGD----QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT 156 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSC----CCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred EEEEEECCCCCcHHHHHHhcCC----CCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccc
Confidence 8999999999999999986432 2589999999999999999999999 9999999999999975 5679999
Q ss_pred ecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHH
Q 037275 833 DFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFA 912 (992)
Q Consensus 833 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~ 912 (992)
|||+|+...... ......||+.|+|||++.+..|+.++||||+||++|+|+||++||.+....... ....
T Consensus 157 DFG~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~-~~~~ 226 (335)
T d2ozaa1 157 DFGFAKETTSHN---------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-PGMK 226 (335)
T ss_dssp CCTTCEECCCCC---------CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------
T ss_pred ccceeeeccCCC---------ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH-HHHH
Confidence 999998765432 223356999999999999999999999999999999999999999764322110 0000
Q ss_pred hhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 913 RTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
. . .....+ .. ..........++.+++.+||+.||++|||+.|+++
T Consensus 227 ~-~-----------i~~~~~------~~--~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 227 T-R-----------IRMGQY------EF--PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp --C-----------CCSCSS------SC--CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred H-H-----------HhcCCC------CC--CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0 0 000000 00 00111223456899999999999999999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-45 Score=392.76 Aligned_cols=263 Identities=25% Similarity=0.415 Sum_probs=205.4
Q ss_pred CCccccccceEEEEeEECCCC---eEEEEEEeecc-CCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEEE
Q 037275 684 SNMIGQGSFGFVYKGNLGENG---MMVAVKVINLK-QKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAIV 759 (992)
Q Consensus 684 ~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 759 (992)
.++||+|+||+||+|++..++ ..||||+++.. .....+++.+|++++++++||||++++|++.+ .....++|
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~~~~~lv 107 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----SEGSPLVV 107 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEE----TTTEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEe----cCCceEEE
Confidence 468999999999999986433 46999998643 33345779999999999999999999999753 33457999
Q ss_pred EEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccccee
Q 037275 760 YEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAKF 839 (992)
Q Consensus 760 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 839 (992)
|||+++|+|.+++..... .+++..+++++.|++.||.|+|+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 108 ~E~~~~g~l~~~~~~~~~-----~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~ 179 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD 179 (311)
T ss_dssp EECCTTCBHHHHHHCTTC-----CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCC
T ss_pred EEEeecCchhhhhccccc-----cchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhh
Confidence 999999999999886543 478889999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhCChh
Q 037275 840 LSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTALPDK 919 (992)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 919 (992)
....... .........||+.|+|||++.+..++.++||||||+++|||+||..||...............
T Consensus 180 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~------ 249 (311)
T d1r0pa_ 180 MYDKEFD----SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ------ 249 (311)
T ss_dssp TTTTTCC----CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHT------
T ss_pred ccccccc----cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHc------
Confidence 7543321 122233457899999999999999999999999999999999988887653222111111110
Q ss_pred HHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhhc
Q 037275 920 VMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTFLGR 989 (992)
Q Consensus 920 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 989 (992)
+ .....+. ....++.+++.+||+.||++||||.||++.|+++..++..+
T Consensus 250 ----------g-~~~~~p~----------~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~ 298 (311)
T d1r0pa_ 250 ----------G-RRLLQPE----------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 298 (311)
T ss_dssp ----------T-CCCCCCT----------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred ----------C-CCCCCcc----------cCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhh
Confidence 0 0000001 11345889999999999999999999999999999876553
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-45 Score=395.48 Aligned_cols=252 Identities=18% Similarity=0.279 Sum_probs=203.2
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
.++|++.+.||+|+||+||+|.+..+++.||||+++... .....+.+|+++++.++||||+++++++. +...+|
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~~~ 77 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFE-----SMEELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEE-----ETTEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCEEE
Confidence 468999999999999999999999999999999996443 33456889999999999999999999853 456789
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCC--CcEEEeecc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQD--LVAHLGDFG 835 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~Dfg 835 (992)
+|||||++|+|.+++..... .+++.+++.++.||+.||+|||++ +|+||||||+||+++.+ ..+||+|||
T Consensus 78 lvmE~~~gg~L~~~i~~~~~-----~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG 149 (321)
T d1tkia_ 78 MIFEFISGLDIFERINTSAF-----ELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFG 149 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred EEEecCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccc
Confidence 99999999999999976432 489999999999999999999999 99999999999999854 489999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 915 (992)
+++...... ......+|+.|+|||...+..++.++||||+||++|+|++|+.||.+....
T Consensus 150 ~~~~~~~~~---------~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~----------- 209 (321)
T d1tkia_ 150 QARQLKPGD---------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ----------- 209 (321)
T ss_dssp TCEECCTTC---------EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-----------
T ss_pred hhhccccCC---------cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH-----------
Confidence 998764321 122346899999999999999999999999999999999999999763221
Q ss_pred CChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 916 LPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
+.+.......+.. . .........++.+++.+||+.||++|||++|+++
T Consensus 210 ------~~~~~i~~~~~~~------~--~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 210 ------QIIENIMNAEYTF------D--EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp ------HHHHHHHHTCCCC------C--HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ------HHHHHHHhCCCCC------C--hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111111111000 0 0000012345789999999999999999999986
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-44 Score=396.28 Aligned_cols=245 Identities=21% Similarity=0.259 Sum_probs=203.1
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc---CCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK---QKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
++|++++.||+|+||+||+|+++.+|+.||||++... .....+.+.+|+.+++.++||||+++++++. ....
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~ 115 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK-----DNSN 115 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccc-----cccc
Confidence 5899999999999999999999999999999998633 3345567899999999999999999999854 4566
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.++||||+.+|+|.+++.... .+++..++.++.||+.||.|||++ +||||||||+|||++.++.+||+|||
T Consensus 116 ~~~v~e~~~~g~l~~~l~~~~------~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG 186 (350)
T d1rdqe_ 116 LYMVMEYVAGGEMFSHLRRIG------RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFG 186 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred cccccccccccchhhhHhhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeece
Confidence 799999999999999997654 489999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 915 (992)
+|+..... .....||+.|||||++.+..++.++||||+||++|||+||+.||.+....
T Consensus 187 ~a~~~~~~-----------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~----------- 244 (350)
T d1rdqe_ 187 FAKRVKGR-----------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI----------- 244 (350)
T ss_dssp TCEECSSC-----------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----------
T ss_pred eeeecccc-----------cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH-----------
Confidence 99876432 12356999999999999999999999999999999999999999753111
Q ss_pred CChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 037275 916 LPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERM-----EMRDVVA 977 (992)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 977 (992)
............ .. .....++.+++.+||+.||++|+ |++|+++
T Consensus 245 ------~~~~~i~~~~~~--~p----------~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 245 ------QIYEKIVSGKVR--FP----------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ------HHHHHHHHCCCC--CC----------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ------HHHHHHhcCCCC--CC----------ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 111111111110 00 01234588999999999999994 8999975
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1e-44 Score=399.26 Aligned_cols=250 Identities=23% Similarity=0.291 Sum_probs=196.6
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC---CCchhHHHH---HHHHHHhccCCcceeEEEEeeccccc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ---KGASNGFVA---ECQALRNIRHRNLIKIITICSSIDFK 751 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~h~niv~~~~~~~~~~~~ 751 (992)
.++|++.++||+|+||+||+|++..+|+.||||++.... ......+.+ |+.+++.++|||||++++++.
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~----- 77 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH----- 77 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE-----
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEE-----
Confidence 358999999999999999999999999999999986321 222233444 466677778999999999854
Q ss_pred CcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEE
Q 037275 752 GVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHL 831 (992)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 831 (992)
..+..++||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +||||||||+|||++.+|.+||
T Consensus 78 ~~~~~~ivmE~~~gg~L~~~l~~~~------~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl 148 (364)
T d1omwa3 78 TPDKLSFILDLMNGGDLHYHLSQHG------VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRI 148 (364)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEE
T ss_pred ECCEEEEEEEecCCCcHHHHHHhcc------cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEE
Confidence 4566799999999999999997653 478999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCCCCCcccCCCCCcccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHH
Q 037275 832 GDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHE 910 (992)
Q Consensus 832 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~ 910 (992)
+|||+|+...... .....||+.|+|||++.+ ..|+.++||||+||++|||+||+.||.+..... ...
T Consensus 149 ~DFGla~~~~~~~----------~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~~ 216 (364)
T d1omwa3 149 SDLGLACDFSKKK----------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHE 216 (364)
T ss_dssp CCCTTCEECSSSC----------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC--HHH
T ss_pred eeeceeeecCCCc----------ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH--HHH
Confidence 9999998765422 233469999999999865 568999999999999999999999998643221 111
Q ss_pred HHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 037275 911 FARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERME-----MRDVVA 977 (992)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 977 (992)
....... .. ...+ .....++.+++.+||+.||++||| |+|+++
T Consensus 217 ~~~~~~~------------~~------~~~~------~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 217 IDRMTLT------------MA------VELP------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp HHHHSSS------------CC------CCCC------SSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred HHHhccc------------CC------CCCC------CCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 1111000 00 0000 011345889999999999999999 688764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-45 Score=392.47 Aligned_cols=248 Identities=25% Similarity=0.368 Sum_probs=200.4
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc---CCCchhHHHHHHHHHH-hccCCcceeEEEEeecccccCcc
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK---QKGASNGFVAECQALR-NIRHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~~~ 754 (992)
++|++.++||+|+||+||+|++..+|+.||||+++.. .....+.+..|..++. .++||||+++++++. +.+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~-----~~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ-----TKE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE-----CSS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEc-----cCC
Confidence 5799999999999999999999999999999999643 2344556677777665 689999999999954 456
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
..++||||+++|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+||
T Consensus 77 ~~yivmEy~~~g~L~~~i~~~~------~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DF 147 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQSCH------KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADF 147 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred ceeEEEeecCCCcHHHHhhccC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceecccc
Confidence 6799999999999999998654 489999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
|+|+..... ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+....
T Consensus 148 G~a~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~---------- 209 (320)
T d1xjda_ 148 GMCKENMLG--------DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---------- 209 (320)
T ss_dssp TTCBCCCCT--------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------
T ss_pred chhhhcccc--------cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH----------
Confidence 999865432 12233457999999999999999999999999999999999999999763211
Q ss_pred hCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHH-HHHH
Q 037275 915 ALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMR-DVVA 977 (992)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 977 (992)
++........+ ..+. ....++.+++.+||+.||++|||+. |+++
T Consensus 210 -------~~~~~i~~~~~--~~p~----------~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 210 -------ELFHSIRMDNP--FYPR----------WLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp -------HHHHHHHHCCC--CCCT----------TSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -------HHHHHHHcCCC--CCCc----------cCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 11111111111 0000 1134588999999999999999995 6753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-45 Score=391.63 Aligned_cols=276 Identities=25% Similarity=0.374 Sum_probs=199.2
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC--CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
++|++++.||+|+||+||+|++..+|+.||||+++... ......+.+|++++++++||||+++++++. +....
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~-----~~~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccc-----cccce
Confidence 58999999999999999999999999999999996443 234577899999999999999999999964 45677
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
++||||+.+ ++.+++.... ...+++..++.++.|++.||+|||++ +||||||||+|||++.++.+||+|||.
T Consensus 77 ~iv~e~~~~-~~~~~~~~~~----~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~ 148 (298)
T d1gz8a_ 77 YLVFEFLHQ-DLKKFMDASA----LTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL 148 (298)
T ss_dssp EEEEECCSE-EHHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTH
T ss_pred eEEEeecCC-chhhhhhhhc----ccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCc
Confidence 999999965 5555554332 22599999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccCCC-cCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGE-ASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 915 (992)
|+...... .......||+.|+|||++.... ++.++||||+||++|+|++|+.||.+....+. +.......
T Consensus 149 a~~~~~~~--------~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~-~~~i~~~~ 219 (298)
T d1gz8a_ 149 ARAFGVPV--------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ-LFRIFRTL 219 (298)
T ss_dssp HHHHCCCS--------BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHH
T ss_pred ceeccCCc--------ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH-HHHHHHhc
Confidence 98765321 2233457999999999877665 57899999999999999999999986432211 11111110
Q ss_pred -CCh-hHHHHHHhhHhHhhhccCCCCCCcc-ccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 916 -LPD-KVMEIVDSVLLLEVQASNSRSCGDE-RLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 916 -~~~-~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
.+. ......... .............. .........++.+++.+||+.||++|||++|+++.
T Consensus 220 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 220 GTPDEVVWPGVTSM--PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CCCCTTTSTTGGGS--TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCchhhccccccc--cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 010 000000000 00000000000000 00001123568899999999999999999999863
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-45 Score=393.55 Aligned_cols=270 Identities=23% Similarity=0.276 Sum_probs=192.6
Q ss_pred CCCccccccceEEEEeEECCCCeEEEEEEeeccCCC-----chhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEE
Q 037275 683 SSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKG-----ASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 683 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
.+++||+|+||+||+|++..+|+.||||+++..... ..+.+.+|+.++++++|||||++++++. ..+..+
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~-----~~~~~~ 76 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG-----HKSNIS 76 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC-----CTTCCE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeec-----cCCcee
Confidence 357899999999999999989999999998643221 2356889999999999999999999964 445679
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGLA 837 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 837 (992)
+||||+.++++..+.... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||.|
T Consensus 77 ivmE~~~~~~~~~~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a 147 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIKDNS------LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLA 147 (299)
T ss_dssp EEEECCSEEHHHHHTTCC------SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred ehhhhhcchHHhhhhhcc------cCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccc
Confidence 999999887777665432 2488899999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTAL 916 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 916 (992)
+...... ......+||+.|+|||++.+. .++.++||||+||++|||++|++||.+..+.+ .+........
T Consensus 148 ~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~l~~i~~~~~ 218 (299)
T d1ua2a_ 148 KSFGSPN--------RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRIFETLG 218 (299)
T ss_dssp STTTSCC--------CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHC
T ss_pred cccCCCc--------ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH-HHHHHHHhcC
Confidence 8654321 122335689999999988654 67999999999999999999999997643221 1111111000
Q ss_pred ChhHHHHHHhhHhHhhhccCCCCCCcc--ccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 917 PDKVMEIVDSVLLLEVQASNSRSCGDE--RLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
........+...... .......... .........++.+++.+||+.||++||||+|+++
T Consensus 219 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 219 TPTEEQWPDMCSLPD--YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCTTTSSSTTSSTT--CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCChhhccchhccch--hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 000000000000000 0000000000 0000112356899999999999999999999975
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=391.63 Aligned_cols=263 Identities=25% Similarity=0.393 Sum_probs=203.7
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeE--EEEEEeecc-CCCchhHHHHHHHHHHhc-cCCcceeEEEEeecccccCcc
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMM--VAVKVINLK-QKGASNGFVAECQALRNI-RHRNLIKIITICSSIDFKGVD 754 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 754 (992)
++|++.++||+|+||+||+|+++.+|.. ||||.++.. .....+.+.+|+++++++ +||||++++|+|.+ .+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-----~~ 84 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----RG 84 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-----TT
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec-----CC
Confidence 5888999999999999999999877764 677777533 334556799999999999 79999999999753 45
Q ss_pred eEEEEEEeccCCCHHHHHhhcccc----------hhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeC
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQ----------QEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLD 824 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 824 (992)
..++||||+++|+|.++++..... .....+++..+++++.|||.||.|+|++ +|+||||||+|||++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~ 161 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG 161 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEc
Confidence 679999999999999999765321 1234689999999999999999999999 999999999999999
Q ss_pred CCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCC-CCCCCCcc
Q 037275 825 QDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRR-RPTDGMFN 903 (992)
Q Consensus 825 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~-~pf~~~~~ 903 (992)
.++.+||+|||+|+..... .......||..|+|||.+.++.++.++|||||||++|||++|. +||.+...
T Consensus 162 ~~~~~kl~DfG~a~~~~~~---------~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~ 232 (309)
T d1fvra_ 162 ENYVAKIADFGLSRGQEVY---------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 232 (309)
T ss_dssp GGGCEEECCTTCEESSCEE---------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred CCCceEEcccccccccccc---------ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH
Confidence 9999999999999865421 1222346899999999999999999999999999999999965 56654211
Q ss_pred CCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 037275 904 QGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRAR 983 (992)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 983 (992)
. ++.+....+ ...... .....++.+++.+||+.||++||||+||++.|+++.
T Consensus 233 ~-----------------~~~~~i~~~-~~~~~~----------~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 233 A-----------------ELYEKLPQG-YRLEKP----------LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp H-----------------HHHHHGGGT-CCCCCC----------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H-----------------HHHHHHHhc-CCCCCC----------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1 111111111 000000 112346889999999999999999999999999987
Q ss_pred Hhh
Q 037275 984 DTF 986 (992)
Q Consensus 984 ~~~ 986 (992)
++.
T Consensus 285 ~~~ 287 (309)
T d1fvra_ 285 EER 287 (309)
T ss_dssp HSS
T ss_pred hcC
Confidence 643
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-44 Score=385.38 Aligned_cols=265 Identities=23% Similarity=0.372 Sum_probs=204.1
Q ss_pred hcCCCCCCccccccceEEEEeEECCCC-------eEEEEEEeeccCC-CchhHHHHHHHHHHhc-cCCcceeEEEEeecc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENG-------MMVAVKVINLKQK-GASNGFVAECQALRNI-RHRNLIKIITICSSI 748 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~-------~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 748 (992)
.++|++.+.||+|+||.||+|+...++ ..||||+++.... ....++.+|...+.++ +|||||+++++|.+
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~- 90 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ- 90 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc-
Confidence 358899999999999999999975433 5799999975443 2346788899999888 89999999999753
Q ss_pred cccCcceEEEEEEeccCCCHHHHHhhcccc----------hhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCC
Q 037275 749 DFKGVDFQAIVYEYMQNGSLEDWLHQSEDQ----------QEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKP 818 (992)
Q Consensus 749 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp 818 (992)
....++||||+++|+|.+++...... .....+++.+++.++.|++.||+|||++ +||||||||
T Consensus 91 ----~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp 163 (299)
T d1fgka_ 91 ----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAA 163 (299)
T ss_dssp ----SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred ----CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecc
Confidence 44569999999999999999865421 1234589999999999999999999999 999999999
Q ss_pred CCeeeCCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCC
Q 037275 819 SNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRP 897 (992)
Q Consensus 819 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p 897 (992)
+|||++.++.+||+|||+++...... .........||+.|+|||++.++.|+.++|||||||++|||++ |.+|
T Consensus 164 ~NiLl~~~~~~kl~dfg~~~~~~~~~------~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p 237 (299)
T d1fgka_ 164 RNVLVTEDNVMKIADFGLARDIHHID------YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 237 (299)
T ss_dssp GGEEECTTCCEEECSTTCCCCGGGCC------TTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred cceeecCCCCeEeccchhhccccccc------cccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCC
Confidence 99999999999999999998765432 1222344568999999999999999999999999999999998 7888
Q ss_pred CCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 898 TDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 898 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
|.+.... .....+. ......... ....++.+++.+||+.||++||||.||++
T Consensus 238 ~~~~~~~--------------~~~~~i~----~~~~~~~p~----------~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 238 YPGVPVE--------------ELFKLLK----EGHRMDKPS----------NCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp STTCCHH--------------HHHHHHH----TTCCCCCCS----------SCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHH--------------HHHHHHH----cCCCCCCCc----------cchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 8653211 0111111 111111111 11345889999999999999999999999
Q ss_pred HHHHHHH
Q 037275 978 KLCRARD 984 (992)
Q Consensus 978 ~L~~~~~ 984 (992)
.|+++.+
T Consensus 290 ~L~~i~a 296 (299)
T d1fgka_ 290 DLDRIVA 296 (299)
T ss_dssp HHHHHHH
T ss_pred HHHHHhh
Confidence 9999865
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-44 Score=389.52 Aligned_cols=281 Identities=21% Similarity=0.313 Sum_probs=203.1
Q ss_pred hcCCCCCCccccccceEEEEeEECCC-CeEEEEEEeeccC--CCchhHHHHHHHHHHhc---cCCcceeEEEEeeccccc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGEN-GMMVAVKVINLKQ--KGASNGFVAECQALRNI---RHRNLIKIITICSSIDFK 751 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~ 751 (992)
.++|+++++||+|+||+||+|++..+ ++.||||+++... ......+.+|+.+++.+ +||||+++++++......
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999999655 6789999986442 23345577888887776 799999999998766566
Q ss_pred CcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEE
Q 037275 752 GVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHL 831 (992)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 831 (992)
.....+++|||++++++........ ..+++..++.++.|++.||+|||++ +||||||||+|||++.++.+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl 157 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPE-----PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKL 157 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCT-----TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred cCceEEEEEEeccCCchhhhhhccC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeee
Confidence 6778899999998877665544332 2589999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHH
Q 037275 832 GDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEF 911 (992)
Q Consensus 832 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~ 911 (992)
+|||.++.... ........||+.|+|||++.+..|+.++||||+||++|||++|++||.+....+ .+...
T Consensus 158 ~dfg~~~~~~~---------~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~i 227 (305)
T d1blxa_ 158 ADFGLARIYSF---------QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKI 227 (305)
T ss_dssp CSCCSCCCCCG---------GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHH
T ss_pred cchhhhhhhcc---------cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH-HHHHH
Confidence 99999875432 122344579999999999999999999999999999999999999998643221 11111
Q ss_pred HhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 912 ARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
...........+........... ..................+.+++.+||+.||++||||+|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 228 LDVIGLPGEEDWPRDVALPRQAF-HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp HHHHCCCCGGGSCTTCSSCGGGS-CCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHhhCCCchhcccccccchhhhh-ccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 11100000000000000000000 000000000001112345788999999999999999999975
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-44 Score=388.43 Aligned_cols=267 Identities=22% Similarity=0.390 Sum_probs=208.9
Q ss_pred hcCCCCCCccccccceEEEEeEE-----CCCCeEEEEEEeeccCC-CchhHHHHHHHHHHhc-cCCcceeEEEEeecccc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNL-----GENGMMVAVKVINLKQK-GASNGFVAECQALRNI-RHRNLIKIITICSSIDF 750 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 750 (992)
.++|++.++||+|+||.||+|++ ..+++.||||+++.... .....+.+|+.+++++ +|||||+++|+|.+
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~--- 98 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI--- 98 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee---
Confidence 35888999999999999999986 24668999999975433 2345689999999999 69999999999754
Q ss_pred cCcceEEEEEEeccCCCHHHHHhhcccc------------hhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCC
Q 037275 751 KGVDFQAIVYEYMQNGSLEDWLHQSEDQ------------QEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKP 818 (992)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp 818 (992)
....++||||+++|+|.++++..... .....+++..+..++.||+.||+|||++ +||||||||
T Consensus 99 --~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp 173 (311)
T d1t46a_ 99 --GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAA 173 (311)
T ss_dssp --SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred --CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccc
Confidence 34569999999999999999865421 1233589999999999999999999999 999999999
Q ss_pred CCeeeCCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHh-CCCC
Q 037275 819 SNVLLDQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFT-RRRP 897 (992)
Q Consensus 819 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p 897 (992)
+||+++.++.+|++|||.++....... ........||+.|+|||++.++.++.++|||||||++|||+| |.+|
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~ 247 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSN------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTT------SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred ccccccccCcccccccchheeccCCCc------ceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCC
Confidence 999999999999999999987654321 122344678999999999999999999999999999999999 5555
Q ss_pred CCCCccCCccHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 898 TDGMFNQGLTLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 898 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
|.... ....+. .++.. ....... .....++.+++.+||+.||++||||+||++
T Consensus 248 ~~~~~-~~~~~~------------~~i~~----~~~~~~~----------~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 248 YPGMP-VDSKFY------------KMIKE----GFRMLSP----------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp STTCC-SSHHHH------------HHHHH----TCCCCCC----------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCC-HHHHHH------------HHHhc----CCCCCCc----------ccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 54432 211111 11111 1100000 112345899999999999999999999999
Q ss_pred HHHHHHHh
Q 037275 978 KLCRARDT 985 (992)
Q Consensus 978 ~L~~~~~~ 985 (992)
+|+++.++
T Consensus 301 ~L~~~i~~ 308 (311)
T d1t46a_ 301 LIEKQISE 308 (311)
T ss_dssp HHHHHHHH
T ss_pred HHHHhhcc
Confidence 99987654
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-44 Score=377.59 Aligned_cols=240 Identities=22% Similarity=0.300 Sum_probs=194.1
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC------CchhHHHHHHHHHHhcc--CCcceeEEEEeecccc
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK------GASNGFVAECQALRNIR--HRNLIKIITICSSIDF 750 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~ 750 (992)
++|++.++||+|+||+||+|++..+|+.||||+++.... ....++.+|+.++++++ ||||+++++++
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~----- 78 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF----- 78 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE-----
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE-----
Confidence 579999999999999999999999999999999974321 12244678999999996 89999999995
Q ss_pred cCcceEEEEEEeccC-CCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCC-CCc
Q 037275 751 KGVDFQAIVYEYMQN-GSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQ-DLV 828 (992)
Q Consensus 751 ~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~ 828 (992)
...+..++||||+.+ +++.+++.... .+++.+++.++.|++.||+|||++ +|+||||||+||+++. ++.
T Consensus 79 ~~~~~~~lv~e~~~~~~~l~~~~~~~~------~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~ 149 (273)
T d1xwsa_ 79 ERPDSFVLILERPEPVQDLFDFITERG------ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGE 149 (273)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTE
T ss_pred eeCCeEEEEEEeccCcchHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCe
Confidence 445677999999976 68888887543 589999999999999999999999 9999999999999985 479
Q ss_pred EEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCc-CcccchhhHHHHHHHHHhCCCCCCCCccCCcc
Q 037275 829 AHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEA-SMTGDVYSFGILLLEMFTRRRPTDGMFNQGLT 907 (992)
Q Consensus 829 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~ 907 (992)
+||+|||+|+...... .....||+.|+|||++.+..+ +.++||||+||++|||++|+.||.+..
T Consensus 150 vkl~DFG~a~~~~~~~----------~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----- 214 (273)
T d1xwsa_ 150 LKLIDFGSGALLKDTV----------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 214 (273)
T ss_dssp EEECCCTTCEECCSSC----------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----
T ss_pred EEECccccceeccccc----------ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----
Confidence 9999999998754321 233569999999999887765 577999999999999999999997521
Q ss_pred HHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 908 LHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
+.... .. .... ....++.+++.+||+.||++|||++|+++
T Consensus 215 --~i~~~----------------~~--~~~~----------~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 215 --EIIRG----------------QV--FFRQ----------RVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp --HHHHC----------------CC--CCSS----------CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --HHhhc----------------cc--CCCC----------CCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 00000 00 0000 01245889999999999999999999976
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-44 Score=386.18 Aligned_cols=269 Identities=21% Similarity=0.365 Sum_probs=209.1
Q ss_pred hcCCCCCCccccccceEEEEeEEC-----CCCeEEEEEEeeccCC-CchhHHHHHHHHHHhccCCcceeEEEEeeccccc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLG-----ENGMMVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIITICSSIDFK 751 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 751 (992)
.++|++.++||+|+||+||+|.+. .+++.||||+++.... .....+.+|+.++++++||||++++|++..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~---- 94 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ---- 94 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS----
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec----
Confidence 368889999999999999999874 2357899999964332 233568999999999999999999999743
Q ss_pred CcceEEEEEEeccCCCHHHHHhhcccch----hhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCC
Q 037275 752 GVDFQAIVYEYMQNGSLEDWLHQSEDQQ----EARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDL 827 (992)
Q Consensus 752 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 827 (992)
....++||||+++|+|.+++....... ....+++..+.+++.|+|+||+|||++ +|+||||||+|||+++++
T Consensus 95 -~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 95 -GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF 170 (308)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTC
T ss_pred -CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCc
Confidence 345699999999999999998654321 123478999999999999999999999 999999999999999999
Q ss_pred cEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCC-CCCCCCccCCc
Q 037275 828 VAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRR-RPTDGMFNQGL 906 (992)
Q Consensus 828 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~-~pf~~~~~~~~ 906 (992)
.+||+|||+|+...... .........||+.|+|||.+.++.++.++|||||||++|||+||. +||.+....
T Consensus 171 ~~Kl~DFGla~~~~~~~------~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~-- 242 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETD------YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-- 242 (308)
T ss_dssp CEEECCTTCCCGGGGGG------CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH--
T ss_pred eEEEeecccceeccCCc------ceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH--
Confidence 99999999998764321 112223346899999999999999999999999999999999984 677543211
Q ss_pred cHHHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 037275 907 TLHEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTF 986 (992)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 986 (992)
+.......+.. .... ......+.+++.+||+.||++|||++||++.|++..+..
T Consensus 243 ---------------~~~~~i~~~~~-~~~p----------~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~ 296 (308)
T d1p4oa_ 243 ---------------QVLRFVMEGGL-LDKP----------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 296 (308)
T ss_dssp ---------------HHHHHHHTTCC-CCCC----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred ---------------HHHHHHHhCCC-CCCc----------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 11111111110 0000 112346899999999999999999999999998876655
Q ss_pred hh
Q 037275 987 LG 988 (992)
Q Consensus 987 ~~ 988 (992)
+.
T Consensus 297 ~~ 298 (308)
T d1p4oa_ 297 FR 298 (308)
T ss_dssp HH
T ss_pred Cc
Confidence 43
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.6e-43 Score=379.51 Aligned_cols=275 Identities=20% Similarity=0.277 Sum_probs=197.3
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccC--CCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQ--KGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
++|++.++||+|+||+||+|+++ +|+.||||+++... ....+.+.+|+.++++++||||+++++++. +....
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH-----TKKRL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE-----CSSCE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecc-----cCCce
Confidence 58999999999999999999996 78999999996442 333578999999999999999999999854 45567
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
+++|||+.++.+..+..... .+++..+..++.||+.||+|||++ +||||||||+|||++.++.+|++|||.
T Consensus 76 ~i~~e~~~~~~~~~~~~~~~------~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~ 146 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDVCEG------GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGL 146 (286)
T ss_dssp EEEEECCSEEHHHHHHTSTT------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred eEEEEeehhhhHHHHHhhcC------CcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEeccccc
Confidence 99999998776666655332 599999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 915 (992)
|....... .......|++.|+|||.+.+. .++.++||||+||++|||++|+.||.+..+.+ .+.......
T Consensus 147 a~~~~~~~--------~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~-~~~~i~~~~ 217 (286)
T d1ob3a_ 147 ARAFGIPV--------RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRIL 217 (286)
T ss_dssp HHHHCC-----------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHH
T ss_pred ceecccCc--------cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH-HHHHHHHhh
Confidence 98765321 122334689999999998764 56899999999999999999999998643221 111111111
Q ss_pred CChhHHHHHHhhHhHhhhccCC-CCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 916 LPDKVMEIVDSVLLLEVQASNS-RSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 916 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.........+............ ................+.+++.+||+.||++||||+|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 218 GTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000000000000000000 0000000001112346889999999999999999999974
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-43 Score=384.47 Aligned_cols=276 Identities=24% Similarity=0.298 Sum_probs=197.4
Q ss_pred CCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccc-cCcceEEE
Q 037275 680 DFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDF-KGVDFQAI 758 (992)
Q Consensus 680 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~l 758 (992)
+|+..++||+|+||+||+|++..+|+.||||++..... ...+|++++++++||||+++++++..... .+..+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 68888999999999999999999999999999964432 23479999999999999999999865332 34566789
Q ss_pred EEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCC-cEEEeecccc
Q 037275 759 VYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDL-VAHLGDFGLA 837 (992)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a 837 (992)
||||++++.+..+..... ....+++.++..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+|
T Consensus 97 v~Ey~~~~~~~~l~~~~~---~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a 170 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSR---AKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA 170 (350)
T ss_dssp EEECCSEEHHHHHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred EEeccCCccHHHHHhhhh---ccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccch
Confidence 999997654443332211 133699999999999999999999999 999999999999999775 8999999999
Q ss_pred eecCCCCCCCCcccCCCCCcccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhhC
Q 037275 838 KFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTAL 916 (992)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 916 (992)
+...... ......||+.|+|||.+.+ ..++.++||||+||++|||++|++||......+ .+........
T Consensus 171 ~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~-~l~~i~~~~g 240 (350)
T d1q5ka_ 171 KQLVRGE---------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVLG 240 (350)
T ss_dssp EECCTTS---------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHHHHC
T ss_pred hhccCCc---------ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH-HHHHHHHHhC
Confidence 8765322 2233468999999998765 578999999999999999999999997643221 1122211111
Q ss_pred ChhHHHHHHhhHhHhhhccCC---CCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 917 PDKVMEIVDSVLLLEVQASNS---RSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.... +.+.... ..+..... ...............++.+++.+||+.||++||||.|+++
T Consensus 241 ~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 241 TPTR-EQIREMN-PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp CCCH-HHHHHHC-C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CChH-Hhhhhhc-cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1110 1111100 00000000 0000001111123456889999999999999999999985
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=382.76 Aligned_cols=284 Identities=21% Similarity=0.210 Sum_probs=201.6
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC-CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK-GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
..+|+++++||+|+||+||+|++..+|+.||||+++.... ...+.+.+|+.+|++++||||+++++++....+.....+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 3579999999999999999999999999999999964432 234578899999999999999999999876555555555
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
+++ +|+.+|+|.+++... .+++..++.++.|++.||+|||++ +||||||||+|||++.++.+||+|||+
T Consensus 87 ~l~-~~~~~g~L~~~l~~~-------~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~ 155 (345)
T d1pmea_ 87 YLV-THLMGADLYKLLKTQ-------HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGL 155 (345)
T ss_dssp EEE-EECCCEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEE-EeecCCchhhhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCc
Confidence 555 556689999999643 489999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccC-CCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMG-GEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 915 (992)
|+....... ........+||+.|+|||++.. ..++.++||||+||++|||++|+.||.+....+..........
T Consensus 156 a~~~~~~~~-----~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~ 230 (345)
T d1pmea_ 156 ARVADPDHD-----HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 230 (345)
T ss_dssp CEECCGGGC-----BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred eeeccCCCc-----cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhcc
Confidence 987654321 1222345679999999999854 4678899999999999999999999976432211111111111
Q ss_pred CChhHHHHHHhh-HhHhhhccCCCCCCccc-cchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 916 LPDKVMEIVDSV-LLLEVQASNSRSCGDER-LRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 916 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.+.......... ................. ........++.+++.+||+.||++||||+|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 231 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp SCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111100000000 00000000000000000 000011245889999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.6e-42 Score=370.73 Aligned_cols=267 Identities=22% Similarity=0.285 Sum_probs=202.8
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceEEE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQAI 758 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 758 (992)
++|++.+.||+|+||+||+|++..+|+.||||++.... ...++..|+++++.++|++++..++.+. ......++
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~----~~~~~~~i 80 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDYNVM 80 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEE----EETTEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEE----ecCCEEEE
Confidence 47999999999999999999999899999999986443 3346789999999998887766666553 34456789
Q ss_pred EEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCC---CCcEEEeecc
Q 037275 759 VYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQ---DLVAHLGDFG 835 (992)
Q Consensus 759 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg 835 (992)
||||+ ++++.+.+..... .+++..+..++.|++.||+|||++ +|+||||||+||+++. +..+||+|||
T Consensus 81 vme~~-~~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG 151 (299)
T d1ckia_ 81 VMELL-GPSLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFG 151 (299)
T ss_dssp EEECC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCS
T ss_pred EEEEc-CCchhhhhhhccC-----CCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccC
Confidence 99999 5677777665432 589999999999999999999999 9999999999999854 4579999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHH--HHHh
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLH--EFAR 913 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~--~~~~ 913 (992)
+|+.+......... .........||+.|+|||++.+..++.++|||||||++|||+||+.||........... ....
T Consensus 152 ~a~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~ 230 (299)
T d1ckia_ 152 LAKKYRDARTHQHI-PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 230 (299)
T ss_dssp SCEECBCTTTCCBC-CCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHH
T ss_pred cceeccccccccce-eccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhc
Confidence 99987654322211 22234456799999999999999999999999999999999999999986433221111 1000
Q ss_pred hhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 037275 914 TALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARD 984 (992)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 984 (992)
...+...... ....+.++.+++..||+.||++||+++++.+.|+.+..
T Consensus 231 ~~~~~~~~~~-----------------------~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 231 KKMSTPIEVL-----------------------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp HHHHSCHHHH-----------------------TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred ccCCCChhHh-----------------------ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 0000000000 00123458899999999999999999999988887654
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-42 Score=379.29 Aligned_cols=278 Identities=20% Similarity=0.246 Sum_probs=198.4
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC--CchhHHHHHHHHHHhccCCcceeEEEEeecccc-cCcc
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK--GASNGFVAECQALRNIRHRNLIKIITICSSIDF-KGVD 754 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 754 (992)
.++|+++++||+|+||+||+|++..+|+.||||+++.... ...+.+.+|+++|++++|||||++++++...+. ....
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 4589999999999999999999998999999999964322 234578899999999999999999999865432 3345
Q ss_pred eEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 037275 755 FQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDF 834 (992)
Q Consensus 755 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 834 (992)
.+++||||+ +++|..+.+.. .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+|++||
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Df 165 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE-------KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDF 165 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred eEEEEEecc-cccHHHHHHhc-------cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccc
Confidence 679999999 66888877542 489999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCCCcccCCCCCcccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHh
Q 037275 835 GLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFAR 913 (992)
Q Consensus 835 g~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 913 (992)
|.|+..... .....||+.|+|||++.+. .++.++||||+||++|||++|++||.+..... .+.....
T Consensus 166 g~a~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~-~~~~~~~ 233 (346)
T d1cm8a_ 166 GLARQADSE-----------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-QLKEIMK 233 (346)
T ss_dssp TTCEECCSS-----------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHH
T ss_pred cceeccCCc-----------cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHH-HHHHHHh
Confidence 999875432 2345689999999998764 56899999999999999999999998643221 1111111
Q ss_pred hh--CChhHHHHHHhhHhHhhhccCCCCCCc-cccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 037275 914 TA--LPDKVMEIVDSVLLLEVQASNSRSCGD-ERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAK 978 (992)
Q Consensus 914 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 978 (992)
.. .+......................... ...........+.+++.+||+.||++||||+|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 234 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 11 111111111110000000000000000 000011123457899999999999999999999863
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-42 Score=377.57 Aligned_cols=286 Identities=22% Similarity=0.330 Sum_probs=198.8
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeecc--CCCchhHHHHHHHHHHhccCCcceeEEEEeecccc---cC
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLK--QKGASNGFVAECQALRNIRHRNLIKIITICSSIDF---KG 752 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~ 752 (992)
.++|+++++||+|+||+||+|++..+|+.||||++... .......+.+|+.++++++||||+++++++..... ..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 46899999999999999999999989999999998643 23345678999999999999999999998765321 23
Q ss_pred cceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEe
Q 037275 753 VDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLG 832 (992)
Q Consensus 753 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 832 (992)
....++||||++++.+..+.... ..+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~------~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~ 159 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVL------VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLA 159 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTT------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEEC
T ss_pred CceEEEEEeccCCCccchhhhcc------cccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEee
Confidence 45679999999887666554332 2488999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCCCCCcccCCCCCcccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHH
Q 037275 833 DFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEF 911 (992)
Q Consensus 833 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~ 911 (992)
|||+|+........ .........||+.|+|||++.+. .+++++||||+||++|||++|+.||.+..+.. .....
T Consensus 160 dfg~~~~~~~~~~~----~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~-~~~~i 234 (318)
T d3blha1 160 DFGLARAFSLAKNS----QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-QLALI 234 (318)
T ss_dssp CCTTCEECCC---------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHH
T ss_pred ecceeeeccccccc----ccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH-HHHHH
Confidence 99999876543211 11223345799999999998765 68999999999999999999999997642211 11111
Q ss_pred Hhhh--CChh-HHHHHHhhHhHhhhccC-CCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 912 ARTA--LPDK-VMEIVDSVLLLEVQASN-SRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 912 ~~~~--~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.... .+.. ................. .................+.+++.+||++||++||||+|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 235 SQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp HHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 1100 0000 00000000000000000 00000000001112345778999999999999999999985
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.9e-41 Score=363.32 Aligned_cols=270 Identities=16% Similarity=0.213 Sum_probs=208.5
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccC-CcceeEEEEeecccccCcceEE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRH-RNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~~ 757 (992)
++|++.++||+|+||+||+|++..+|+.||||+++... ....+.+|+++++.+.| +|++.+++++. .....+
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~~~~ 77 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ-----EGLHNV 77 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEE-----ETTEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEee-----cCCccE
Confidence 57999999999999999999999899999999985432 34557889999999965 89999998853 455669
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCC-----CCcEEEe
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQ-----DLVAHLG 832 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~ 832 (992)
+||||+ +++|.+++..... .+++.++..++.|++.||+|||++ +|+||||||+||+++. ++.+||+
T Consensus 78 ~vme~~-~~~l~~~~~~~~~-----~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~ 148 (293)
T d1csna_ 78 LVIDLL-GPSLEDLLDLCGR-----KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVV 148 (293)
T ss_dssp EEEECC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred EEEEec-CCCHHHHHHhhcc-----chhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEc
Confidence 999999 7899999876543 489999999999999999999999 9999999999999974 5789999
Q ss_pred ecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHH
Q 037275 833 DFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFA 912 (992)
Q Consensus 833 Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~ 912 (992)
|||+|+........... .........||+.|||||++.+..++.++|||||||++|||+||+.||.+....... ...
T Consensus 149 DFG~a~~~~~~~~~~~~-~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~--~~~ 225 (293)
T d1csna_ 149 DFGMVKFYRDPVTKQHI-PYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK--QKY 225 (293)
T ss_dssp CCTTCEESBCTTTCCBC-CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH--HHH
T ss_pred ccceeEEcccCccccce-eecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHH--HHH
Confidence 99999987654322211 223344568999999999999999999999999999999999999999864333211 100
Q ss_pred hhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 037275 913 RTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVAKLCRARDTF 986 (992)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 986 (992)
. .+........... .. ...+.++.+++..|++.+|++||+++.+.+.++++.++.
T Consensus 226 ~--------~i~~~~~~~~~~~-l~----------~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 226 E--------RIGEKKQSTPLRE-LC----------AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp H--------HHHHHHHHSCHHH-HT----------TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred H--------HHHhccCCCChHH-hc----------CCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 0 0000000000000 00 011345888999999999999999999999888876543
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=8.1e-42 Score=372.38 Aligned_cols=292 Identities=28% Similarity=0.460 Sum_probs=247.5
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCCcCCCCCCc--eEeeEEcCCC--CeEEEeeccccccCC--ccCCCCCCCCcCCe
Q 037275 5 SNETDRLALLAIGSQLEDDPLGVTSSWNNSTNLCQ--WTGVTCGHRH--QRVTKLDLSNRTIGG--TLSPYVGNLSFLRY 78 (992)
Q Consensus 5 ~~~~~~~~ll~~~~~~~~~~~~~~~~w~~~~~~c~--w~gv~c~~~~--~~v~~ldl~~~~l~~--~l~~~l~~l~~L~~ 78 (992)
|+++||+|||+||+++++ | ..+++|..++|||. |.||+|+..+ .||+.|||+++.+.| .+|+.++++++|++
T Consensus 3 c~~~e~~aLl~~k~~~~~-~-~~l~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~ 80 (313)
T d1ogqa_ 3 CNPQDKQALLQIKKDLGN-P-TTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNF 80 (313)
T ss_dssp SCHHHHHHHHHHHHHTTC-C-GGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSE
T ss_pred CCHHHHHHHHHHHHHCCC-C-CcCCCCCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccccc
Confidence 899999999999999964 4 36899999999995 9999998654 489999999999988 58899999999999
Q ss_pred eeccC-CCCCccCCccccCCCCCCEEEeecccCCCCCCcccccCCCCcEeecccccccccCChhhccccccccccccccc
Q 037275 79 LNLAD-NNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADN 157 (992)
Q Consensus 79 L~L~~-n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~~L~L~~n 157 (992)
|||++ |++.|.+|++|+++++|++|+|++|++.+..|..+..+.+|+.+++++|++.+.+|..+. .+++|+++++++|
T Consensus 81 L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~-~l~~L~~l~l~~n 159 (313)
T d1ogqa_ 81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSIS-SLPNLVGITFDGN 159 (313)
T ss_dssp EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGG-GCTTCCEEECCSS
T ss_pred cccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhc-cCcccceeecccc
Confidence 99997 899999999999999999999999999988899999999999999999999989998886 8999999999999
Q ss_pred ccCCCCCCcccccccc-ceEEecCCcccCCcCCccCCCCcccEEeccCcccccccCccccccCCCcEEeccCCccCCCCC
Q 037275 158 HLTGHFPASIGNLSTL-ERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLP 236 (992)
Q Consensus 158 ~l~~~~p~~~~~l~~L-~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~ 236 (992)
.+++.+|+.+..+..+ +.+++++|++.+..|..+..+..+ .+++++|.+.+.+|..+..+++|+.+++++|.+.+.+|
T Consensus 160 ~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~ 238 (313)
T d1ogqa_ 160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG 238 (313)
T ss_dssp CCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG
T ss_pred ccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccc
Confidence 9999999999988886 889999999998899888887554 79999999999999999999999999999999986554
Q ss_pred ccccccccccchhhccccccCCCCchhhhccccCceeeeccccccccccccccccCccceEecCCCC
Q 037275 237 LDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNN 303 (992)
Q Consensus 237 ~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 303 (992)
. ...+++++.|++++|+++|.+|..|+++++|++|+|++|+|+|.+|. ++++++|+.+++++|+
T Consensus 239 ~--~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 239 K--VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNK 302 (313)
T ss_dssp G--CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSS
T ss_pred c--cccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCc
Confidence 2 23456666666777777666666666666777777777776665553 4555666666666664
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.2e-41 Score=372.76 Aligned_cols=272 Identities=19% Similarity=0.240 Sum_probs=200.3
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhcc-CCcceeEEEEeecccccCcceEE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIR-HRNLIKIITICSSIDFKGVDFQA 757 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~ 757 (992)
++|+++++||+|+||+||+|++..+|+.||||+++. ...+++.+|+++|+++. ||||+++++++.. ......+
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~---~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~---~~~~~~~ 108 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKD---PVSRTPA 108 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---SCHHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCSEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH---HHHHHHHHHHHHHHhccCCCCCcEEEEEEEe---cCCCcee
Confidence 589999999999999999999999999999999853 23567899999999995 9999999998753 3345679
Q ss_pred EEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCC-cEEEeeccc
Q 037275 758 IVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDL-VAHLGDFGL 836 (992)
Q Consensus 758 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~ 836 (992)
+||||+.+++|..+.+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+
T Consensus 109 ~v~e~~~~~~L~~~~~---------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~ 176 (328)
T d3bqca1 109 LVFEHVNNTDFKQLYQ---------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGL 176 (328)
T ss_dssp EEEECCCSCBGGGTTT---------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGG
T ss_pred EEEeecCCCcHHHHhc---------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeeccccc
Confidence 9999999999876642 489999999999999999999999 999999999999998655 699999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 915 (992)
|+...... ......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||....+............
T Consensus 177 a~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~ 247 (328)
T d3bqca1 177 AEFYHPGQ---------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 247 (328)
T ss_dssp CEECCTTC---------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHH
T ss_pred ceeccCCC---------cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHH
Confidence 98765432 22344689999999997765 479999999999999999999999976433221111111111
Q ss_pred CChhHHHHHHhhHh---HhhhccCC---CCCC---ccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 916 LPDKVMEIVDSVLL---LEVQASNS---RSCG---DERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 916 ~~~~~~~~~~~~~~---~~~~~~~~---~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.............. ..+..... +... ...........++.+++.+||+.||++||||+|+++
T Consensus 248 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 248 GTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111111111000 00000000 0000 000011122356889999999999999999999975
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=367.41 Aligned_cols=275 Identities=17% Similarity=0.244 Sum_probs=203.0
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC--CchhHHHHHHHHHHhccCCcceeEEEEeecccccCcceE
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK--GASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDFQ 756 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 756 (992)
++|+++++||+|+||+||+|++..+++.||||+++.... .....+.+|+.++++++||||+++++++. +....
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~-----~~~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccc-----cccce
Confidence 589999999999999999999999999999999965432 34577899999999999999999999964 45567
Q ss_pred EEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 037275 757 AIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFGL 836 (992)
Q Consensus 757 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 836 (992)
++|+|++.++++..++...+ .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.
T Consensus 77 ~iv~~~~~~~~l~~~~~~~~------~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~ 147 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDSCNG------DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGL 147 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTT------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred eEEeeecccccccccccccc------ccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecch
Confidence 99999999999988876543 478999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCCCcccCCCCCcccccccccccccccCCC-cCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh
Q 037275 837 AKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGE-ASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 837 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 915 (992)
|+...... .......+++.|+|||++.+.. ++.++||||+||++|||++|+.||....+............
T Consensus 148 a~~~~~~~--------~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~ 219 (292)
T d1unla_ 148 ARAFGIPV--------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL 219 (292)
T ss_dssp CEECCSCC--------SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHH
T ss_pred hhcccCCC--------ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhc
Confidence 98765432 1222345788999999887665 68999999999999999999999754332222222211111
Q ss_pred CChh--HHHHHHhhHhHhhhcc-CCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 916 LPDK--VMEIVDSVLLLEVQAS-NSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 916 ~~~~--~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.+.. ........ ...... ..................+.+++.+||+.||++||||+||++
T Consensus 220 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 220 GTPTEEQWPSMTKL--PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCTTTCTTGGGS--TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCCChhhhhhhhhc--ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1100 00000000 000000 000000000011122345789999999999999999999975
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-41 Score=372.02 Aligned_cols=277 Identities=18% Similarity=0.203 Sum_probs=195.9
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCC--CchhHHHHHHHHHHhccCCcceeEEEEeecccc-cCcce
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQK--GASNGFVAECQALRNIRHRNLIKIITICSSIDF-KGVDF 755 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 755 (992)
++|+++++||+|+||+||+|++..+|+.||||+++.... ....++.+|+.++++++||||+++++++..... +...+
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 579999999999999999999999999999999974432 234568899999999999999999999765332 35678
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.|+||||+.++ +.+.+.. .+++..++.++.|++.||+|||+. ||+||||||+|||++.++.+|++|||
T Consensus 97 ~~iv~Ey~~~~-l~~~~~~--------~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~ 164 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_dssp EEEEEECCSEE-HHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred eEEEEeccchH-HHHhhhc--------CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechh
Confidence 89999999765 4444431 488999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhhh
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFARTA 915 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 915 (992)
.++..... .......+|+.|+|||++.+..+++++||||+||++|||++|++||.+..... .........
T Consensus 165 ~~~~~~~~---------~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~-~~~~i~~~~ 234 (355)
T d2b1pa1 165 LARTAGTS---------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQL 234 (355)
T ss_dssp C------------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHH
T ss_pred hhhccccc---------cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHH-HHHHHHHhc
Confidence 98765432 22334568999999999999999999999999999999999999997643211 111111111
Q ss_pred C----------ChhHHHHHHhhHhHh----hhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 916 L----------PDKVMEIVDSVLLLE----VQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 916 ~----------~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
. ............... .....................++.+++.+||+.||++||||+||++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 235 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp CCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0 011111111100000 0000000011112223345677899999999999999999999984
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-41 Score=373.43 Aligned_cols=277 Identities=20% Similarity=0.244 Sum_probs=198.2
Q ss_pred hcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCC--chhHHHHHHHHHHhccCCcceeEEEEeecccccCcce
Q 037275 678 TNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKG--ASNGFVAECQALRNIRHRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 678 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 755 (992)
.++|++.++||+|+||+||+|++..+|+.||||+++..... ..+.+.+|++++++++||||+++++++..........
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 35899999999999999999999999999999999744332 3456889999999999999999999876544333344
Q ss_pred EEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 037275 756 QAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAHLGDFG 835 (992)
Q Consensus 756 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 835 (992)
.+++|+|+.+|+|.+++... .+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+|++|||
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~-------~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg 166 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ-------KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 166 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC-------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC-
T ss_pred eEEEEEeecCCchhhhcccc-------cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccc
Confidence 46667788899999998643 489999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCCCcccCCCCCcccccccccccccccCC-CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccHHHHHhh
Q 037275 836 LAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG-EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTLHEFART 914 (992)
Q Consensus 836 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 914 (992)
.|..... ......|++.|+|||+..+. .++.++||||+||++|+|++|++||.+..... ........
T Consensus 167 ~a~~~~~-----------~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~-~~~~i~~~ 234 (348)
T d2gfsa1 167 LARHTDD-----------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRL 234 (348)
T ss_dssp ---CCTG-----------GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHH
T ss_pred hhcccCc-----------ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHH-HHHHHHHh
Confidence 9975432 12335689999999987665 46889999999999999999999998642221 11111111
Q ss_pred hC--ChhHHHHHHhhHhHhhhccCCCCCCcccc--chHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 037275 915 AL--PDKVMEIVDSVLLLEVQASNSRSCGDERL--RTEERLVAVVETGVVCSMESPTERMEMRDVVA 977 (992)
Q Consensus 915 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 977 (992)
.. +..................... ...... .......++.+++.+||+.||++||||+|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 235 VGTPGAELLKKISSESARNYIQSLTQ-MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HCCCCHHHHTTCCCHHHHHHHTTSCC-CCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCCCChHHhhhccchhhhhhhhhccc-CCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 10 1111100000000000000000 000000 00112345789999999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-41 Score=364.20 Aligned_cols=253 Identities=23% Similarity=0.333 Sum_probs=198.1
Q ss_pred cCCCCCCccccccceEEEEeEE---CCCCeEEEEEEeecc----CCCchhHHHHHHHHHHhccC-CcceeEEEEeecccc
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNL---GENGMMVAVKVINLK----QKGASNGFVAECQALRNIRH-RNLIKIITICSSIDF 750 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~---~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~ 750 (992)
++|++.++||+|+||+||+|+. +.+|+.||||+++.. .....+.+.+|++++++++| |||+++++++.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~---- 99 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ---- 99 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE----
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeec----
Confidence 5799999999999999999987 346899999998533 22345678899999999977 89999999854
Q ss_pred cCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeeeCCCCcEE
Q 037275 751 KGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLLDQDLVAH 830 (992)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 830 (992)
+....++||||+.+|+|.+++.... .+++..+..++.|++.||+|+|+. +|+||||||+||+++.++.+|
T Consensus 100 -~~~~~~~v~e~~~~~~L~~~i~~~~------~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vk 169 (322)
T d1vzoa_ 100 -TETKLHLILDYINGGELFTHLSQRE------RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVV 169 (322)
T ss_dssp -ETTEEEEEECCCCSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEE
T ss_pred -cCCceeeeeecccccHHHHHHHhcc------cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEE
Confidence 4456799999999999999998654 468889999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCCCCCcccCCCCCcccccccccccccccCC--CcCcccchhhHHHHHHHHHhCCCCCCCCccCCccH
Q 037275 831 LGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGG--EASMTGDVYSFGILLLEMFTRRRPTDGMFNQGLTL 908 (992)
Q Consensus 831 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~ 908 (992)
|+|||+|+.+.... ........|++.|+|||.+.+. .++.++||||+||++|||++|+.||.+...... .
T Consensus 170 L~DFG~a~~~~~~~-------~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~-~ 241 (322)
T d1vzoa_ 170 LTDFGLSKEFVADE-------TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-Q 241 (322)
T ss_dssp ESCSSEEEECCGGG-------GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-H
T ss_pred Eeeccchhhhcccc-------cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-H
Confidence 99999998765321 2223345689999999998764 467899999999999999999999987543321 1
Q ss_pred HHHHhhhCChhHHHHHHhhHhHhhhccCCCCCCccccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 037275 909 HEFARTALPDKVMEIVDSVLLLEVQASNSRSCGDERLRTEERLVAVVETGVVCSMESPTERM-----EMRDVVA 977 (992)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 977 (992)
.. +......... ... .....++.+++.+||++||++|| ||+|+++
T Consensus 242 ~~------------i~~~~~~~~~--~~~----------~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 242 AE------------ISRRILKSEP--PYP----------QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp HH------------HHHHHHHCCC--CCC----------TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred HH------------HHHhcccCCC--CCc----------ccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 11 1111000000 000 11235688999999999999999 4788875
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.8e-36 Score=337.03 Aligned_cols=277 Identities=18% Similarity=0.215 Sum_probs=190.8
Q ss_pred cCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhcc-----------CCcceeEEEEeec
Q 037275 679 NDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIR-----------HRNLIKIITICSS 747 (992)
Q Consensus 679 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~~ 747 (992)
++|+++++||+|+||+||+|++..+|+.||||+++.. ....+.+.+|+++++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 3699999999999999999999999999999999633 223456788999988875 5789999988653
Q ss_pred ccccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCCCCCeeeCCC
Q 037275 748 IDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHH-HCQPPVVHGDLKPSNVLLDQD 826 (992)
Q Consensus 748 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~ 826 (992)
.+....+++|+++..+.......... ....+++..+..++.|++.||+|||+ . +|+||||||+|||++.+
T Consensus 92 ---~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~ 162 (362)
T d1q8ya_ 92 ---KGPNGVHVVMVFEVLGENLLALIKKY---EHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIV 162 (362)
T ss_dssp ---EETTEEEEEEEECCCCEEHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEE
T ss_pred ---ccccceeeeeeecccccccccccccc---cccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeecc
Confidence 33345566777665554333322221 12368899999999999999999998 6 89999999999999766
Q ss_pred C------cEEEeecccceecCCCCCCCCcccCCCCCcccccccccccccccCCCcCcccchhhHHHHHHHHHhCCCCCCC
Q 037275 827 L------VAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPEYGMGGEASMTGDVYSFGILLLEMFTRRRPTDG 900 (992)
Q Consensus 827 ~------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 900 (992)
+ .++++|||.|...... .....||+.|+|||++.+..++.++||||+||++++|++|+.||..
T Consensus 163 ~~~~~~~~~kl~dfg~s~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~ 231 (362)
T d1q8ya_ 163 DSPENLIQIKIADLGNACWYDEH-----------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 231 (362)
T ss_dssp ETTTTEEEEEECCCTTCEETTBC-----------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred CcccccceeeEeecccccccccc-----------cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCC
Confidence 5 4999999999865321 1234699999999999999999999999999999999999999976
Q ss_pred CccCCcc-----HHHHHhh--hCChhHHHHHHhhHhHhhhc-cCCCCCCc------------cccchHHHHHHHHHHHhh
Q 037275 901 MFNQGLT-----LHEFART--ALPDKVMEIVDSVLLLEVQA-SNSRSCGD------------ERLRTEERLVAVVETGVV 960 (992)
Q Consensus 901 ~~~~~~~-----~~~~~~~--~~~~~~~~~~~~~~~~~~~~-~~~~~~~~------------~~~~~~~~~~~l~~li~~ 960 (992)
....... ....... ..+.......... ...... ........ ..........++.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~ 310 (362)
T d1q8ya_ 232 DEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYT-RTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 310 (362)
T ss_dssp -------CHHHHHHHHHHHHCSCCHHHHHHCTTH-HHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGG
T ss_pred CccccccchhHHHHHHHHHhCCCCHHHhhccccc-ccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHH
Confidence 4322110 1111111 0111111000000 000000 00000000 011124566789999999
Q ss_pred ccCCCCCCCCCHHHHHH
Q 037275 961 CSMESPTERMEMRDVVA 977 (992)
Q Consensus 961 cl~~dP~~RPs~~evl~ 977 (992)
||++||++||||+|+++
T Consensus 311 mL~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 311 MLQLDPRKRADAGGLVN 327 (362)
T ss_dssp GGCSSTTTCBCHHHHHT
T ss_pred HCCCChhHCcCHHHHhc
Confidence 99999999999999975
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.97 E-value=6.4e-32 Score=293.55 Aligned_cols=260 Identities=30% Similarity=0.520 Sum_probs=238.4
Q ss_pred cceeEEeeCCcccc--ccCCCccCCCcccEEEccC-CcCCCCCCccccCCCCCcEEeccCccccccCCCCCCCccccCce
Q 037275 348 TMTDIVIAGNQISG--IIPTGIRNLVNLVELCMDD-NKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNL 424 (992)
Q Consensus 348 ~L~~L~l~~n~i~~--~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 424 (992)
+++.|+|++|++++ .+|..++++++|++|+|++ |+++|.+|..|+++++|++|+|++|++.+..+..+..+++|+.+
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l 130 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence 47788888888877 4788999999999999986 88998999999999999999999999998888889999999999
Q ss_pred eccCCcccCCCCCCccccccccccccccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeecccc
Q 037275 425 ALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRF 504 (992)
Q Consensus 425 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 504 (992)
++++|.+.+.+|..+..+++|+.+++++|.+.+.+|..+.....+...+++++|++++..|..+..+..+ .+++++|.+
T Consensus 131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~ 209 (313)
T d1ogqa_ 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNML 209 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEE
T ss_pred ccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-ccccccccc
Confidence 9999999999999999999999999999999999999999888888889999999999999999888655 799999999
Q ss_pred cccCCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcccCCCChhhhhcCCCcceEecCCCcCcccCCCCC
Q 037275 505 SGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKG 584 (992)
Q Consensus 505 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~ 584 (992)
.+.+|..+..+++|+.|++++|.+++.+| .+..+++|+.|+|++|+|+|.+|..|.++++|++|+|++|+|+|.+|..+
T Consensus 210 ~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~ 288 (313)
T d1ogqa_ 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG 288 (313)
T ss_dssp EECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCST
T ss_pred ccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcc
Confidence 99999999999999999999999997655 68899999999999999999999999999999999999999999999888
Q ss_pred ccCCcccccccCCCCcCCCCCCCCCCCCC
Q 037275 585 VFSNKTGISLSGNGKVCGGLDELNLPPCP 613 (992)
Q Consensus 585 ~~~~~~~~~l~~N~~~C~~~~~~~~~~~~ 613 (992)
.++.++.+++.||+.+||.|. |+|+
T Consensus 289 ~L~~L~~l~l~~N~~l~g~pl----p~c~ 313 (313)
T d1ogqa_ 289 NLQRFDVSAYANNKCLCGSPL----PACT 313 (313)
T ss_dssp TGGGSCGGGTCSSSEEESTTS----SCCC
T ss_pred cCCCCCHHHhCCCccccCCCC----CCCC
Confidence 889999999999999999876 5663
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=1.1e-27 Score=268.31 Aligned_cols=341 Identities=29% Similarity=0.384 Sum_probs=185.9
Q ss_pred ccccccccccccccCCCCCCccccccccceEEecCCcccCCcCCccCCCCcccEEeccCcccccccCccccccCCCcEEe
Q 037275 146 WLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVF 225 (992)
Q Consensus 146 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 225 (992)
+.+|++|++++|.++. + +++..+++|++|++++|+|.+ +| .++++++|++|++++|++++. + .+..+++|+.|+
T Consensus 43 l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~-l~-~l~~L~~L~~L~L~~n~i~~i-~-~l~~l~~L~~L~ 116 (384)
T d2omza2 43 LDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTD-IT-PLKNLTKLVDILMNNNQIADI-T-PLANLTNLTGLT 116 (384)
T ss_dssp HTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEE
T ss_pred hCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCC-Cc-cccCCcccccccccccccccc-c-cccccccccccc
Confidence 3455555665555552 2 355666666666666666643 22 266666666666666666642 2 255666666666
Q ss_pred ccCCccCCCCCccccccccccchhhccccccCCCCchhhhccccCceeeeccccccccccccccccCccceEecCCCCCC
Q 037275 226 LPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLG 305 (992)
Q Consensus 226 l~~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 305 (992)
+++|.+++..+ ......+..+....|.+.......................+.
T Consensus 117 ~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (384)
T d2omza2 117 LFNNQITDIDP---------------------------LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLK 169 (384)
T ss_dssp CCSSCCCCCGG---------------------------GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCG
T ss_pred ccccccccccc---------------------------ccccccccccccccccccccccccccccccccccccccchhh
Confidence 66665552111 112233444444444443322222222222222111111111
Q ss_pred CCCCCCchhhhhccCCCcceEeecCCCcCCCcCCcccccccccceeEEeeCCccccccCCCccCCCcccEEEccCCcCCC
Q 037275 306 TGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTG 385 (992)
Q Consensus 306 ~~~~~~~~~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~ 385 (992)
.+...+.........|.... ......+ ..+..+++++|.+++..| +..+++|++|++++|+++.
T Consensus 170 -----------~~~~~~~~~~~~~~~~~~~~--~~~~~~l-~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~ 233 (384)
T d2omza2 170 -----------PLANLTTLERLDISSNKVSD--ISVLAKL-TNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD 233 (384)
T ss_dssp -----------GGTTCTTCCEEECCSSCCCC--CGGGGGC-TTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC
T ss_pred -----------hhcccccccccccccccccc--ccccccc-cccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC
Confidence 11112222222222222211 1111111 124444555555544333 2344556666666666653
Q ss_pred CCCccccCCCCCcEEeccCccccccCCCCCCCccccCceeccCCcccCCCCCCccccccccccccccccccccCchhhhh
Q 037275 386 TIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILS 465 (992)
Q Consensus 386 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~ 465 (992)
+ +.+..+++|+.|++++|++++..+ +..+++|+.|++++|++++.. .+..++.++.+
T Consensus 234 -~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l----------------- 290 (384)
T d2omza2 234 -I-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS--PLAGLTALTNL----------------- 290 (384)
T ss_dssp -C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEE-----------------
T ss_pred -c-chhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCC--ccccccccccc-----------------
Confidence 2 245556666666666666654332 555566666666666665322 24444555554
Q ss_pred hcccccccccccccccCcccccccCCCCccEEeeecccccccCCcccccccccceeeccCCcccccCCccccccCCCCEE
Q 037275 466 ISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKEL 545 (992)
Q Consensus 466 ~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 545 (992)
+++.|.+++ ...+..+++++.|++++|++++..+ +..+++|++|++++|+|++ ++ .+.++++|++|
T Consensus 291 --------~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L 356 (384)
T d2omza2 291 --------ELNENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD-VS-SLANLTNINWL 356 (384)
T ss_dssp --------ECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEE
T ss_pred --------ccccccccc--ccccchhcccCeEECCCCCCCCCcc--cccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEE
Confidence 444444442 2346778888899999999886543 7888899999999998884 33 58888999999
Q ss_pred ECCCcccCCCChhhhhcCCCcceEecCCC
Q 037275 546 DMSSNNLSGQIPEYLENLSFLEYLNLSYN 574 (992)
Q Consensus 546 ~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 574 (992)
+|++|+|++..| +.++++|+.|+|++|
T Consensus 357 ~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 357 SAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp ECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred ECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 999999986654 788889999999887
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=1.1e-27 Score=268.31 Aligned_cols=163 Identities=28% Similarity=0.418 Sum_probs=117.6
Q ss_pred ceeEEeeCCccccccCCCccCCCcccEEEccCCcCCCCCCccccCCCCCcEEeccCccccccCCCCCCCccccCceeccC
Q 037275 349 MTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSS 428 (992)
Q Consensus 349 L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 428 (992)
+++|++++|+++.. ..+..+++|+.|++++|++++.. .+..+++|+.|++++|++++.. .+..++.++.++++.
T Consensus 221 L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~ 294 (384)
T d2omza2 221 LDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNE 294 (384)
T ss_dssp CCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCS
T ss_pred CCEEECCCCCCCCc--chhhcccccchhccccCccCCCC--cccccccCCEeeccCcccCCCC--ccccccccccccccc
Confidence 44444444444432 24566778888888888887543 3677888888888888887443 266778888888888
Q ss_pred CcccCCCCCCccccccccccccccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeecccccccC
Q 037275 429 NDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEI 508 (992)
Q Consensus 429 N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 508 (992)
|.+++ ...+..+++++.|+++ +|++++.. .+..+++|++|++++|++++ +
T Consensus 295 n~l~~--~~~~~~~~~l~~L~ls-------------------------~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l 344 (384)
T d2omza2 295 NQLED--ISPISNLKNLTYLTLY-------------------------FNNISDIS--PVSSLTKLQRLFFANNKVSD-V 344 (384)
T ss_dssp SCCSC--CGGGGGCTTCSEEECC-------------------------SSCCSCCG--GGGGCTTCCEEECCSSCCCC-C
T ss_pred ccccc--ccccchhcccCeEECC-------------------------CCCCCCCc--ccccCCCCCEEECCCCCCCC-C
Confidence 88874 2346667777766444 44444332 26778899999999999984 3
Q ss_pred CcccccccccceeeccCCcccccCCccccccCCCCEEECCCc
Q 037275 509 PVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSN 550 (992)
Q Consensus 509 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 550 (992)
+ .+.++++|++|++++|+|++..| +.++++|+.|+|++|
T Consensus 345 ~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 345 S-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp G-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred h-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 3 68899999999999999997654 889999999999988
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=1.5e-26 Score=246.83 Aligned_cols=236 Identities=25% Similarity=0.237 Sum_probs=199.1
Q ss_pred ccceeEEeeCCccccccCCCccCCCcccEEEccCCcCCCCCCccccCCCCCcEEecc-CccccccCCCCCCCccccCcee
Q 037275 347 STMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLD-SNFLAGGIPTSLGNLTLLTNLA 425 (992)
Q Consensus 347 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~-~N~l~~~~~~~~~~l~~L~~L~ 425 (992)
+.+++|+|++|+|+++.+..|.++++|++|++++|++..+.+..+..+..++.++.. .|.++...+..|.++++|++|+
T Consensus 32 ~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~ 111 (284)
T d1ozna_ 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (284)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEe
Confidence 457778888888887777788888888888888888887777777888888887664 5567766677888888888888
Q ss_pred ccCCcccCCCCCCccccccccccccccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeeccccc
Q 037275 426 LSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFS 505 (992)
Q Consensus 426 L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 505 (992)
+++|.+....+..+....+|+.+ ++++|.+++..+..|..+++|+.|++++|+++
T Consensus 112 l~~n~~~~~~~~~~~~~~~L~~l-------------------------~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~ 166 (284)
T d1ozna_ 112 LDRCGLQELGPGLFRGLAALQYL-------------------------YLQDNALQALPDDTFRDLGNLTHLFLHGNRIS 166 (284)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEE-------------------------ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred cCCcccccccccccchhcccchh-------------------------hhccccccccChhHhccccchhhcccccCccc
Confidence 88888876666677777777777 55555555555667888999999999999999
Q ss_pred ccCCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcccCCCChhhhhcCCCcceEecCCCcCcccCCCCCc
Q 037275 506 GEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGV 585 (992)
Q Consensus 506 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~ 585 (992)
+..+..|.++++|++|++++|++++..|..|.++++|++|++++|++++..|..|..+++|++|++++|+|.|.|+..+.
T Consensus 167 ~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~~l 246 (284)
T d1ozna_ 167 SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPL 246 (284)
T ss_dssp EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHH
T ss_pred ccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccchHH
Confidence 98899999999999999999999999999999999999999999999999999999999999999999999999987666
Q ss_pred cCCcccccccCCCCcCCCCCCC
Q 037275 586 FSNKTGISLSGNGKVCGGLDEL 607 (992)
Q Consensus 586 ~~~~~~~~l~~N~~~C~~~~~~ 607 (992)
..+++......+...|..|.++
T Consensus 247 ~~~l~~~~~~~~~~~C~~p~~l 268 (284)
T d1ozna_ 247 WAWLQKFRGSSSEVPCSLPQRL 268 (284)
T ss_dssp HHHHHHCCSEECCCBEEESGGG
T ss_pred HHHHHhCcCCCCceEeCCchHH
Confidence 6777777777788889876654
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.93 E-value=1.3e-25 Score=242.29 Aligned_cols=273 Identities=20% Similarity=0.250 Sum_probs=205.1
Q ss_pred CceEeeEEcCCCCeEEEeeccccccCCccCCCCCCCCcCCeeeccCCCCCccCC-ccccCCCCCCEEEeecccCCCCCCc
Q 037275 38 CQWTGVTCGHRHQRVTKLDLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIP-HQIGRLVRLEALVLANNSFSGKIPT 116 (992)
Q Consensus 38 c~w~gv~c~~~~~~v~~ldl~~~~l~~~l~~~l~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~Ls~n~l~~~~p~ 116 (992)
|.|.+|.|+.. ++ ..+|+.+. +.+++|+|++|+++ .+| .+|..+++|++|++++|.++...|.
T Consensus 10 c~~~~~~C~~~------------~L-~~lP~~l~--~~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~l~~n~~~~i~~~ 73 (305)
T d1xkua_ 10 CHLRVVQCSDL------------GL-EKVPKDLP--PDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPG 73 (305)
T ss_dssp EETTEEECTTS------------CC-CSCCCSCC--TTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCCCBCTT
T ss_pred ecCCEEEecCC------------CC-CccCCCCC--CCCCEEECcCCcCC-CcChhHhhccccccccccccccccccchh
Confidence 78999999653 23 46677663 67999999999998 565 4789999999999999999966678
Q ss_pred ccccCCCCcEeecccccccccCChhhcccccccccccccccccCCCCCCccccccccceEEecCCccc--CCcCCccCCC
Q 037275 117 NLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLW--GRIPNNLGNL 194 (992)
Q Consensus 117 ~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~--~~~~~~l~~l 194 (992)
.|.++++|++|++++|+++ .+|...+ ..++.|++.+|.+.+..+..+.....+..++...|... ...+..+..+
T Consensus 74 ~f~~l~~L~~L~l~~n~l~-~l~~~~~---~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l 149 (305)
T d1xkua_ 74 AFAPLVKLERLYLSKNQLK-ELPEKMP---KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGM 149 (305)
T ss_dssp TTTTCTTCCEEECCSSCCS-BCCSSCC---TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGC
T ss_pred hhhCCCccCEecccCCccC-cCccchh---hhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccc
Confidence 8999999999999999988 6776654 46788888888888665556677777888888877542 3445567778
Q ss_pred CcccEEeccCcccccccCccccccCCCcEEeccCCccCCCCCccccccccccchhhccccccCCCCchhhhccccCceee
Q 037275 195 RNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELT 274 (992)
Q Consensus 195 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~ 274 (992)
++|+.+++++|.++ .+|..+ +++|++|++++|...+..+ ..+..++.++.|.+++|.+.+..+..+..+++|++|+
T Consensus 150 ~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~-~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~ 225 (305)
T d1xkua_ 150 KKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDA-ASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELH 225 (305)
T ss_dssp TTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECT-GGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEE
T ss_pred cccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCCh-hHhhccccccccccccccccccccccccccccceeee
Confidence 88888888888887 455543 4688888888888775433 3445667777777777777777777777778888888
Q ss_pred eccccccccccccccccCccceEecCCCCCCCCCCCCchhhhhccCCCcceEeecCCCcCC
Q 037275 275 LFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFG 335 (992)
Q Consensus 275 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~l~ 335 (992)
|++|+|+.+ |..|..+++|++|+|++|+|+.++...|..+..+....+|+.|+|++|++.
T Consensus 226 L~~N~L~~l-p~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 226 LNNNKLVKV-PGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp CCSSCCSSC-CTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred ccccccccc-ccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCc
Confidence 888887744 557777888888888888888777766665555666666666777666654
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.92 E-value=3.6e-24 Score=230.92 Aligned_cols=267 Identities=17% Similarity=0.263 Sum_probs=168.3
Q ss_pred CCcEeecccccccccCChhhcccccccccccccccccCCCCCCccccccccceEEecCCcccCCcCCccCCCCcccEEec
Q 037275 123 NLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNL 202 (992)
Q Consensus 123 ~L~~L~l~~n~l~~~~p~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L 202 (992)
.++.+|.++++++ ++|..++ +++++|+|++|+++...+.+|.++++|++|++++|.+....|..|.++++|++|++
T Consensus 11 ~~~~~~C~~~~L~-~lP~~l~---~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l 86 (305)
T d1xkua_ 11 HLRVVQCSDLGLE-KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 86 (305)
T ss_dssp ETTEEECTTSCCC-SCCCSCC---TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred cCCEEEecCCCCC-ccCCCCC---CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecc
Confidence 4566777777777 7777664 46777778887777444456777777777777777776666677777777777777
Q ss_pred cCcccccccCccccccCCCcEEeccCCccCCCCCccccccccccchhhccccccCCCCchhhhccccCceeeecccccc-
Q 037275 203 GENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFR- 281 (992)
Q Consensus 203 ~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~- 281 (992)
++|+++ .+|..+. ..++.|++++|.+. +..+..+.....+..++...|...
T Consensus 87 ~~n~l~-~l~~~~~--~~l~~L~~~~n~l~-------------------------~l~~~~~~~~~~~~~l~~~~n~~~~ 138 (305)
T d1xkua_ 87 SKNQLK-ELPEKMP--KTLQELRVHENEIT-------------------------KVRKSVFNGLNQMIVVELGTNPLKS 138 (305)
T ss_dssp CSSCCS-BCCSSCC--TTCCEEECCSSCCC-------------------------BBCHHHHTTCTTCCEEECCSSCCCG
T ss_pred cCCccC-cCccchh--hhhhhhhccccchh-------------------------hhhhhhhhccccccccccccccccc
Confidence 777777 3454332 35666666666554 223334555566666777666543
Q ss_pred -ccccccccccCccceEecCCCCCCCCCCCCchhhhhccCCCcceEeecCCCcCCCcCCcccccccccceeEEeeCCccc
Q 037275 282 -GKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQIS 360 (992)
Q Consensus 282 -~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~ 360 (992)
......|..+++|+.+++++|++..++.. ..++ +++|++++|.++
T Consensus 139 ~~~~~~~~~~l~~L~~l~l~~n~l~~l~~~---------~~~~-------------------------L~~L~l~~n~~~ 184 (305)
T d1xkua_ 139 SGIENGAFQGMKKLSYIRIADTNITTIPQG---------LPPS-------------------------LTELHLDGNKIT 184 (305)
T ss_dssp GGBCTTGGGGCTTCCEEECCSSCCCSCCSS---------CCTT-------------------------CSEEECTTSCCC
T ss_pred cCCCccccccccccCccccccCCccccCcc---------cCCc-------------------------cCEEECCCCcCC
Confidence 33445677777777788777777654432 1223 445555555555
Q ss_pred cccCCCccCCCcccEEEccCCcCCCCCCccccCCCCCcEEeccCccccccCCCCCCCccccCceeccCCcccCCCCCCc-
Q 037275 361 GIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSL- 439 (992)
Q Consensus 361 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~- 439 (992)
+..+..|..++.++.|++++|.+++..+.+|..+++|++|+|++|+|+ .+|.+|..+++|++|+|++|+|+......|
T Consensus 185 ~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~ 263 (305)
T d1xkua_ 185 KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFC 263 (305)
T ss_dssp EECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSS
T ss_pred CCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhcc
Confidence 555556666666666666666666666666666666666666666666 445566666677777777766664333232
Q ss_pred -----ccccccccccccccccc
Q 037275 440 -----GNCKNLIELHMADIELT 456 (992)
Q Consensus 440 -----~~l~~L~~L~l~~n~l~ 456 (992)
..+.+|+.|++.+|++.
T Consensus 264 ~~~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 264 PPGYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp CSSCCTTSCCCSEEECCSSSSC
T ss_pred CcchhcccCCCCEEECCCCcCc
Confidence 34455666666666553
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=2.9e-24 Score=226.14 Aligned_cols=203 Identities=21% Similarity=0.205 Sum_probs=162.0
Q ss_pred ceeEEeeCCccccccCCCccCCCcccEEEccCCcCCCCCCccccCCCCCcEEeccCccccccCCCCCCCccccCceeccC
Q 037275 349 MTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSS 428 (992)
Q Consensus 349 L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 428 (992)
+.+++.++++++. +|..+. +++++|+|++|+|++..+.+|..+++|++|+|++|+|+. ++ .+..+++|++|+|++
T Consensus 12 ~~~v~C~~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~Ls~ 86 (266)
T d1p9ag_ 12 HLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLDLSH 86 (266)
T ss_dssp CCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCEEECCS
T ss_pred CeEEEccCCCCCe-eCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-ccccccccccccccc
Confidence 4567888888885 565553 578889999998886666788888899999999998884 33 356788888999998
Q ss_pred CcccCCCCCCccccccccccccccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeecccccccC
Q 037275 429 NDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEI 508 (992)
Q Consensus 429 N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 508 (992)
|+++ ..+..+..+++|+.|++++| .+.+..+..+..+.++++|++++|.++...
T Consensus 87 N~l~-~~~~~~~~l~~L~~L~l~~~-------------------------~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~ 140 (266)
T d1p9ag_ 87 NQLQ-SLPLLGQTLPALTVLDVSFN-------------------------RLTSLPLGALRGLGELQELYLKGNELKTLP 140 (266)
T ss_dssp SCCS-SCCCCTTTCTTCCEEECCSS-------------------------CCCCCCSSTTTTCTTCCEEECTTSCCCCCC
T ss_pred cccc-cccccccccccccccccccc-------------------------ccceeeccccccccccccccccccccceec
Confidence 8888 45667888888887754444 444455566778888999999999998777
Q ss_pred CcccccccccceeeccCCcccccCCccccccCCCCEEECCCcccCCCChhhhhcCCCcceEecCCCcCcccCCCC
Q 037275 509 PVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGEVPTK 583 (992)
Q Consensus 509 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~ 583 (992)
+..+..+++|+.|++++|+|++..+..|..+++|++|+|++|+|+ .+|+.+..+++|++|+|++|+|.|.|...
T Consensus 141 ~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC~~~ 214 (266)
T d1p9ag_ 141 PGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCEIL 214 (266)
T ss_dssp TTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGGGH
T ss_pred cccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCcchH
Confidence 788888889999999999998877888888999999999999998 67777778888999999999888887643
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=7.4e-24 Score=225.68 Aligned_cols=222 Identities=18% Similarity=0.197 Sum_probs=157.1
Q ss_pred eccccccCCccCCCCCCCCcCCeeeccCCCCCccCCccccCCCCCCEEEeecccCCCCCCcccccCCCCcEeeccccccc
Q 037275 56 DLSNRTIGGTLSPYVGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLV 135 (992)
Q Consensus 56 dl~~~~l~~~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n~l~ 135 (992)
+.+++++ ..+|..+. +.+++|+|++|+|++..+..|..+++|++|++++|++.+..+..+..++.+..++.+.+...
T Consensus 17 ~c~~~~L-~~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~ 93 (284)
T d1ozna_ 17 SCPQQGL-QAVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93 (284)
T ss_dssp ECCSSCC-SSCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTC
T ss_pred EcCCCCC-CccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccccccc
Confidence 3444555 36666554 56899999999998444457889999999999999998666667777888888877655444
Q ss_pred ccCChhhcccccccccccccccccCCCCCCccccccccceEEecCCcccCCcCCccCCCCcccEEeccCcccccccCccc
Q 037275 136 GEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSI 215 (992)
Q Consensus 136 ~~~p~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l 215 (992)
..++...+.++++|++|++++|.+....+..+..+.+|+.+++++|.+.+..+..|..+++|+.|++++|++++..+..|
T Consensus 94 ~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f 173 (284)
T d1ozna_ 94 RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAF 173 (284)
T ss_dssp CCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTT
T ss_pred ccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhh
Confidence 46666555567777777777777765556666667777777777777765555667677777777777777776556666
Q ss_pred cccCCCcEEeccCCccCCCCCccccccccccchhhccccccCCCCchhhhccccCceeeeccccccccccccccccCccc
Q 037275 216 FNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLE 295 (992)
Q Consensus 216 ~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 295 (992)
.++++|+++++++|+++ +..|..|..+++|++|++++|++.+..+..|..+++|+
T Consensus 174 ~~l~~L~~l~l~~N~l~-------------------------~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~ 228 (284)
T d1ozna_ 174 RGLHSLDRLLLHQNRVA-------------------------HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQ 228 (284)
T ss_dssp TTCTTCCEEECCSSCCC-------------------------EECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCC
T ss_pred ccccccchhhhhhcccc-------------------------ccChhHhhhhhhcccccccccccccccccccccccccC
Confidence 66667776666666655 23455667777777777777777777777777777777
Q ss_pred eEecCCCCCC
Q 037275 296 WLNLGSNNLG 305 (992)
Q Consensus 296 ~L~L~~N~l~ 305 (992)
+|+|++|.+.
T Consensus 229 ~L~l~~N~l~ 238 (284)
T d1ozna_ 229 YLRLNDNPWV 238 (284)
T ss_dssp EEECCSSCEE
T ss_pred EEEecCCCCC
Confidence 7777777663
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=1.7e-23 Score=220.14 Aligned_cols=198 Identities=22% Similarity=0.193 Sum_probs=101.1
Q ss_pred cceEeecCCCcCCCcCCcccccccccceeEEeeCCccccccCCCccCCCcccEEEccCCcCCCCCCccccCCCCCcEEec
Q 037275 323 ELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYL 402 (992)
Q Consensus 323 ~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 402 (992)
.+.+++.++++++. +|..+ +..+++|+|++|+|+++.+..|.++++|++|+|++|+|+. ++ .++.+++|++|+|
T Consensus 11 ~~~~v~C~~~~L~~-iP~~l---p~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~L 84 (266)
T d1p9ag_ 11 SHLEVNCDKRNLTA-LPPDL---PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLDL 84 (266)
T ss_dssp TCCEEECTTSCCSS-CCSCC---CTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCEEEC
T ss_pred CCeEEEccCCCCCe-eCcCc---CcCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-ccccccccccccc
Confidence 33444555555542 34332 2345555555555555555555555555555555555542 22 2344555555555
Q ss_pred cCccccccCCCCCCCccccCceeccCCcccCCCCCCccccccccccccccccccccCchhhhhhcccccccccccccccC
Q 037275 403 DSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSG 482 (992)
Q Consensus 403 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~ 482 (992)
++|+++ ..+..+.++++|+.|++++|.+.+..+..+..+.++++|++++| .+++
T Consensus 85 s~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n-------------------------~l~~ 138 (266)
T d1p9ag_ 85 SHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGN-------------------------ELKT 138 (266)
T ss_dssp CSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTS-------------------------CCCC
T ss_pred cccccc-ccccccccccccccccccccccceeecccccccccccccccccc-------------------------ccce
Confidence 555555 33444555555555555555555444444555555554433322 2222
Q ss_pred cccccccCCCCccEEeeecccccccCCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcccC
Q 037275 483 TLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLS 553 (992)
Q Consensus 483 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 553 (992)
..+..+..+++|+.|++++|++++..+..|..+++|++|+|++|+|+ .+|.++..+++|+.|+|++|.+.
T Consensus 139 l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 139 LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp CCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred eccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence 33334445555555555555555555555555555555555555555 45555555555555555555543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=3.8e-22 Score=198.09 Aligned_cols=164 Identities=16% Similarity=0.153 Sum_probs=119.2
Q ss_pred CCCCccccccceEEEEeEECCCCeEEEEEEeeccCCC------------------chhHHHHHHHHHHhccCCcceeEEE
Q 037275 682 SSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKG------------------ASNGFVAECQALRNIRHRNLIKIIT 743 (992)
Q Consensus 682 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~l~h~niv~~~~ 743 (992)
.+.++||+|+||+||+|++. +|+.||||+++..... ......+|...+.++.|++++..++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred hhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 45689999999999999985 7999999987532110 0123456888899999999999887
Q ss_pred EeecccccCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCCeee
Q 037275 744 ICSSIDFKGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHCQPPVVHGDLKPSNVLL 823 (992)
Q Consensus 744 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~NIll 823 (992)
+.. .+++|||++++.+.+ ++......++.|++.|++|||++ +|+||||||+|||+
T Consensus 82 ~~~---------~~lvme~~~~~~~~~-------------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv 136 (191)
T d1zara2 82 WEG---------NAVLMELIDAKELYR-------------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLV 136 (191)
T ss_dssp EET---------TEEEEECCCCEEGGG-------------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEE
T ss_pred ecC---------CEEEEEeeccccccc-------------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheee
Confidence 621 179999998744322 34445567899999999999999 99999999999999
Q ss_pred CCCCcEEEeecccceecCCCCCCCCcccCCCCCcccccccccccc-----cccCCCcCcccchhhHHHHH
Q 037275 824 DQDLVAHLGDFGLAKFLSSSPLDTAVETPSSSKGIKGTVGYIAPE-----YGMGGEASMTGDVYSFGILL 888 (992)
Q Consensus 824 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE-----~~~~~~~~~~~DiwSlG~il 888 (992)
+++ .++|+|||.|....... ...|.... .+..+.|+.++|+||..--+
T Consensus 137 ~~~-~~~liDFG~a~~~~~~~----------------~~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 137 SEE-GIWIIDFPQSVEVGEEG----------------WREILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp ETT-EEEECCCTTCEETTSTT----------------HHHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred eCC-CEEEEECCCcccCCCCC----------------cHHHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 865 58999999998654211 11121110 01246788899999976443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.85 E-value=1.2e-19 Score=199.66 Aligned_cols=252 Identities=25% Similarity=0.331 Sum_probs=139.9
Q ss_pred cccccccccccCCCCCCccccccccceEEecCCcccCCcCCccCCCCcccEEeccCcccccccCccccccCCCcEEeccC
Q 037275 149 LENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPT 228 (992)
Q Consensus 149 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~ 228 (992)
|++|++++|.++ .+|. ++.+++|++|++++|.+.. .+.. ...+..+.+..+... .+..+..++.++.++++.
T Consensus 100 L~~L~L~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~-~~~~---~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~ 171 (353)
T d1jl5a_ 100 LEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKK-LPDL---PPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADN 171 (353)
T ss_dssp CCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCS
T ss_pred cccccccccccc-cccc-hhhhccceeeccccccccc-cccc---cccccchhhcccccc--ccccccccccceeccccc
Confidence 555555555554 3332 3455555555555555522 2221 233444444444433 233444555555666655
Q ss_pred CccCCCCCccccccccccchhhccccccCCCCchhhhccccCceeeeccccccccccccccccCccceEecCCCCCCCCC
Q 037275 229 NRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGE 308 (992)
Q Consensus 229 N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 308 (992)
|.+.. ++... .....+....+.+. .++ .+..++.|+.+++++|...... ....++..+.+.+|.+....
T Consensus 172 n~~~~-~~~~~----~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~~~~----~~~~~l~~~~~~~~~~~~~~ 240 (353)
T d1jl5a_ 172 NSLKK-LPDLP----LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKTLP----DLPPSLEALNVRDNYLTDLP 240 (353)
T ss_dssp SCCSS-CCCCC----TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSSCC----SCCTTCCEEECCSSCCSCCC
T ss_pred ccccc-ccccc----cccccccccccccc-ccc-cccccccccccccccccccccc----cccccccccccccccccccc
Confidence 55542 11110 11111222222222 233 3556788888888888776432 23456777888888776532
Q ss_pred CCCchhhhhccCCCcceEeecCCCcCCCcCCcccccccccceeEEeeCCccccccCCCccCCCcccEEEccCCcCCCCCC
Q 037275 309 ANDLDFLTLLTNCTELTAIGLDDNRFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIP 388 (992)
Q Consensus 309 ~~~~~~~~~l~~~~~L~~L~l~~n~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 388 (992)
. ....++..++..+.+.+ +..+.......++..+.+.+.. ..+++|++|+|++|+|+ .+|
T Consensus 241 ~----------~~~~l~~~~~~~~~~~~-----l~~l~~~~~~~~~~~~~~~~~~----~~~~~L~~L~Ls~N~l~-~lp 300 (353)
T d1jl5a_ 241 E----------LPQSLTFLDVSENIFSG-----LSELPPNLYYLNASSNEIRSLC----DLPPSLEELNVSNNKLI-ELP 300 (353)
T ss_dssp C----------CCTTCCEEECCSSCCSE-----ESCCCTTCCEEECCSSCCSEEC----CCCTTCCEEECCSSCCS-CCC
T ss_pred c----------ccccccccccccccccc-----cccccchhcccccccCcccccc----ccCCCCCEEECCCCccC-ccc
Confidence 2 22345556666555542 2233334556667777766432 33578899999999988 556
Q ss_pred ccccCCCCCcEEeccCccccccCCCCCCCccccCceeccCCcccCCCCCCcccccccccccc
Q 037275 389 HAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHM 450 (992)
Q Consensus 389 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 450 (992)
.. +++|+.|+|++|+|+ .+|.. +++|++|+|++|+|+ .+|.... +|+.|.+
T Consensus 301 ~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~~~~---~L~~L~~ 351 (353)
T d1jl5a_ 301 AL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPDIPE---SVEDLRM 351 (353)
T ss_dssp CC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCCCCT---TCCEEEC
T ss_pred cc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCcccc---ccCeeEC
Confidence 43 578889999999988 55643 457888999999988 5665433 3444433
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.83 E-value=5.8e-19 Score=194.04 Aligned_cols=55 Identities=25% Similarity=0.373 Sum_probs=29.8
Q ss_pred CCCccEEeeecccccccCCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcccC
Q 037275 491 LKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLS 553 (992)
Q Consensus 491 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 553 (992)
+++|++|+|++|+|+ .+|.. +++|+.|+|++|+|+ .+|.. +++|++|+|++|+|+
T Consensus 283 ~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~ 337 (353)
T d1jl5a_ 283 PPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR 337 (353)
T ss_dssp CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS
T ss_pred CCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC
Confidence 455666666666665 34432 345566666666665 34432 345556666666655
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=9.2e-22 Score=225.29 Aligned_cols=62 Identities=13% Similarity=0.078 Sum_probs=34.8
Q ss_pred CCCEEEeecccCCCC-CCcccccCCCCcEeecccccccccCChhhc---ccccccccccccccccC
Q 037275 99 RLEALVLANNSFSGK-IPTNLSRCSNLISFNARRNNLVGEIPAELG---YNWLKLENLTIADNHLT 160 (992)
Q Consensus 99 ~L~~L~Ls~n~l~~~-~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~---~~l~~L~~L~L~~n~l~ 160 (992)
+|++|||+.|++++. +.+-+..+++++.|+|++|+++..-...++ ...++|++|+|++|.++
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~ 68 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELG 68 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCH
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCC
Confidence 467788888887742 133345667777777777766532222211 23445555555555554
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=9.5e-18 Score=173.37 Aligned_cols=221 Identities=18% Similarity=0.136 Sum_probs=112.1
Q ss_pred ceEEecCCcccCCcCCccCCCCcccEEeccCcccccccCccccccCCCcEEeccCCccCCCCCccccccccccchhhccc
Q 037275 174 ERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAE 253 (992)
Q Consensus 174 ~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~L~~l~l~~ 253 (992)
+.++.+++.+ ..+|+.+. +++++|+|++|+|+...+..|.++++|++|++++|.+...++..
T Consensus 11 ~~i~c~~~~l-~~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~--------------- 72 (242)
T d1xwdc1 11 RVFLCQESKV-TEIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEAD--------------- 72 (242)
T ss_dssp SEEEEESCSC-SSCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSS---------------
T ss_pred CEEEEeCCCC-CCcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecc---------------
Confidence 4555555555 34554443 35666666666666433445666666666666666655333322
Q ss_pred cccCCCCchhhhccccCceeeecc-ccccccccccccccCccceEecCCCCCCCCCCCCchhhhhccCCCcceEeecCCC
Q 037275 254 NNFAGSIPESLSNASNLVELTLFD-NQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDFLTLLTNCTELTAIGLDDN 332 (992)
Q Consensus 254 n~l~~~~p~~l~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n 332 (992)
.|..+++++++.+.. |.+....+..|.++++|++|++++|.+...+.. ..+..+..+..+..+++
T Consensus 73 ---------~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~-----~~~~~l~~l~~~~~~n~ 138 (242)
T d1xwdc1 73 ---------VFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDV-----HKIHSLQKVLLDIQDNI 138 (242)
T ss_dssp ---------SEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCC-----TTTCBSSCEEEEEESCT
T ss_pred ---------ccccccccccccccccccccccccccccccccccccccchhhhcccccc-----ccccccccccccccccc
Confidence 334445555555432 445555555556666666666666655543321 12233344444444444
Q ss_pred cCCCcCCcccccccccceeEEeeCCccccccCCCccCCCcccE-EEccCCcCCCCCCccccCCCCCcEEeccCccccccC
Q 037275 333 RFGGVLPHSIANLSSTMTDIVIAGNQISGIIPTGIRNLVNLVE-LCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGI 411 (992)
Q Consensus 333 ~l~~~~~~~~~~l~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~-L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 411 (992)
.+....+..+..+...+..+++++|+++.+.+..+.. .++++ +++++|+++.+.+..|.++++|++|+|++|+|+...
T Consensus 139 ~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~-~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~ 217 (242)
T d1xwdc1 139 NIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNG-TQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLP 217 (242)
T ss_dssp TCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTTTT-CCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCC
T ss_pred ccccccccccccccccceeeecccccccccccccccc-hhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccC
Confidence 4443333444444444555555556555444433332 33333 344555555443444555666666666666665444
Q ss_pred CCCCCCccccCceecc
Q 037275 412 PTSLGNLTLLTNLALS 427 (992)
Q Consensus 412 ~~~~~~l~~L~~L~L~ 427 (992)
+..|.++++|+.+++.
T Consensus 218 ~~~~~~l~~L~~l~~~ 233 (242)
T d1xwdc1 218 SYGLENLKKLRARSTY 233 (242)
T ss_dssp SSSCTTCCEEESSSEE
T ss_pred HHHHcCCcccccCcCC
Confidence 4445555555555543
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.75 E-value=1.9e-18 Score=171.10 Aligned_cols=126 Identities=17% Similarity=0.183 Sum_probs=83.8
Q ss_pred ccccccCcccccccCCCCccEEeeecccccccCCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcccCCC
Q 037275 476 SYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQ 555 (992)
Q Consensus 476 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 555 (992)
++|.+.+..+..|..+++|++|+|++|+|+++.|..|.++++|++|+|++|+|++..++.|..+++|++|+|++|.+...
T Consensus 62 ~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~ 141 (192)
T d1w8aa_ 62 KRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp CSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred cccccccccccccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccc
Confidence 33333334455566667777777777777766777777777788888888888777777777888888888888877643
Q ss_pred ChhhhhcCCCcceEecCCCcCcccCCCCCccCCcccccccCCCCcCCCC
Q 037275 556 IPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNKTGISLSGNGKVCGGL 604 (992)
Q Consensus 556 ~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~l~~N~~~C~~~ 604 (992)
.+ ...-...++.+.+..|.+.|..|. .+..+...++..|...|.++
T Consensus 142 ~~-~~~~~~~l~~~~l~~~~~~c~~p~--~l~~~~l~~L~~n~l~C~~~ 187 (192)
T d1w8aa_ 142 CH-LAWFAEWLRKKSLNGGAARCGAPS--KVRDVQIKDLPHSEFKCSSE 187 (192)
T ss_dssp GG-GHHHHHHHHHHCCSGGGCBBCSST--TTTTSBGGGSCTTTCCCCCC
T ss_pred cc-hHHHhhhhhhhcccCCCeEeCCCh--hhcCCEeeecCHhhCcCCCC
Confidence 22 222223466667777777776554 34555666777787777654
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=4.1e-18 Score=176.17 Aligned_cols=210 Identities=18% Similarity=0.141 Sum_probs=107.8
Q ss_pred cccCCccCCCCCCCCcCCeeeccCCCCCccCC-ccccCCCCCCEEEeecccCCCCCC-cccccCCCCcEeeccc-ccccc
Q 037275 60 RTIGGTLSPYVGNLSFLRYLNLADNNFHGEIP-HQIGRLVRLEALVLANNSFSGKIP-TNLSRCSNLISFNARR-NNLVG 136 (992)
Q Consensus 60 ~~l~~~l~~~l~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~Ls~n~l~~~~p-~~l~~l~~L~~L~l~~-n~l~~ 136 (992)
.++ ..+|+.+. +++++|||++|+++ .+| ..|.++++|++|+|++|.+...+| ..|..++++++|++.. |++.
T Consensus 18 ~~l-~~iP~~l~--~~l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~- 92 (242)
T d1xwdc1 18 SKV-TEIPSDLP--RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL- 92 (242)
T ss_dssp CSC-SSCCSCSC--SCCSEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCC-
T ss_pred CCC-CCcCCCCC--CCCCEEECcCCcCC-ccChhHhhccchhhhhhhccccccceeecccccccccccccccccccccc-
Confidence 344 35665543 56788888888887 444 457778888888888887765443 3566677777776654 3343
Q ss_pred cCChhhcccccccccccccccccCCCCCC-ccccccccceEEecCCcccCCcCCccCCCC-cccEEeccCcccccccCcc
Q 037275 137 EIPAELGYNWLKLENLTIADNHLTGHFPA-SIGNLSTLERINVLGNGLWGRIPNNLGNLR-NLILLNLGENRFSGIVPPS 214 (992)
Q Consensus 137 ~~p~~~~~~l~~L~~L~L~~n~l~~~~p~-~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~-~L~~L~L~~n~l~~~~p~~ 214 (992)
.++...+..+++|++|++++|.++...+. .+..+..|..+...++.+....+..|.+++ .++.|++++|+++. ++..
T Consensus 93 ~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~-i~~~ 171 (242)
T d1xwdc1 93 YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNC 171 (242)
T ss_dssp EECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE-ECTT
T ss_pred ccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccc-cccc
Confidence 44444444555566666655555432111 122333444444444444333333343332 44444555554442 2222
Q ss_pred ccccCCCcEEeccCCccCCCCCccccccccccchhhccccccCCCCchhhhccccCceeeeccccccccccccccccCcc
Q 037275 215 IFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNL 294 (992)
Q Consensus 215 l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 294 (992)
.....+++++. .+.+|+++...+..|.++++|++|+|++|+|+..++..|.++++|
T Consensus 172 ~~~~~~l~~~~------------------------~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L 227 (242)
T d1xwdc1 172 AFNGTQLDELN------------------------LSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKL 227 (242)
T ss_dssp TTTTCCEEEEE------------------------CTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEE
T ss_pred cccchhhhccc------------------------cccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCccc
Confidence 22222222221 122222332223345556666666666666665555555555555
Q ss_pred ceEec
Q 037275 295 EWLNL 299 (992)
Q Consensus 295 ~~L~L 299 (992)
+.|++
T Consensus 228 ~~l~~ 232 (242)
T d1xwdc1 228 RARST 232 (242)
T ss_dssp ESSSE
T ss_pred ccCcC
Confidence 55544
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.74 E-value=6.9e-19 Score=174.35 Aligned_cols=159 Identities=25% Similarity=0.309 Sum_probs=131.6
Q ss_pred cCceeccCCcccCCCCCCccccccccccccccccccccCchhhhhhcccccccccccccccC-cccccccCCCCccEEee
Q 037275 421 LTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSG-TLPLEVGNLKNLVYFNI 499 (992)
Q Consensus 421 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~-~~~~~~~~l~~L~~L~L 499 (992)
.+++++++|+++ .+|..+. +++++| +|++|+|++ ..+..|.++++|++|+|
T Consensus 10 ~~~v~Cs~~~L~-~iP~~lp--~~l~~L-------------------------~Ls~N~i~~~~~~~~f~~l~~L~~L~L 61 (192)
T d1w8aa_ 10 GTTVDCTGRGLK-EIPRDIP--LHTTEL-------------------------LLNDNELGRISSDGLFGRLPHLVKLEL 61 (192)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEE-------------------------ECCSCCCCSBCCSCSGGGCTTCCEEEC
T ss_pred CCEEEEeCCCcC-ccCCCCC--CCCCEE-------------------------EeCCCCCcccccccccCCCceEeeeec
Confidence 346677777776 4554432 345555 555555554 33556789999999999
Q ss_pred ecccccccCCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcccCCCChhhhhcCCCcceEecCCCcCccc
Q 037275 500 SVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSYNHFEGE 579 (992)
Q Consensus 500 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 579 (992)
++|++++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|.+|..+++|++|+|++|++.|.
T Consensus 62 ~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~ 141 (192)
T d1w8aa_ 62 KRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp CSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred cccccccccccccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccc
Confidence 99999999999999999999999999999988899999999999999999999988889999999999999999999998
Q ss_pred CCCCCccCCcccccccCCCCcCCCCCCC
Q 037275 580 VPTKGVFSNKTGISLSGNGKVCGGLDEL 607 (992)
Q Consensus 580 ~~~~~~~~~~~~~~l~~N~~~C~~~~~~ 607 (992)
++..+...+++...+.+|...|+.|..+
T Consensus 142 ~~~~~~~~~l~~~~l~~~~~~c~~p~~l 169 (192)
T d1w8aa_ 142 CHLAWFAEWLRKKSLNGGAARCGAPSKV 169 (192)
T ss_dssp GGGHHHHHHHHHHCCSGGGCBBCSSTTT
T ss_pred cchHHHhhhhhhhcccCCCeEeCCChhh
Confidence 8776656667778888888999887643
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.74 E-value=1.8e-18 Score=176.73 Aligned_cols=188 Identities=27% Similarity=0.337 Sum_probs=107.8
Q ss_pred CCCcccEEEccCCcCCCCCCccccCCCCCcEEeccCccccccCCCCCCCccccCceeccCCcccCCCCCCcccccccccc
Q 037275 369 NLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIEL 448 (992)
Q Consensus 369 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 448 (992)
.+.+|+.|++.+|.++. + +.+..+++|++|++++|++++..| +..+++|+.+++++|.++. ++ .+..+++|+.+
T Consensus 39 ~l~~L~~L~l~~~~i~~-l-~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~-i~-~l~~l~~L~~l 112 (227)
T d1h6ua2 39 DLDGITTLSAFGTGVTT-I-EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTL 112 (227)
T ss_dssp HHHTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEE
T ss_pred HcCCcCEEECCCCCCCc-c-hhHhcCCCCcEeecCCceeecccc--ccccccccccccccccccc-cc-ccccccccccc
Confidence 34444444444444442 2 124444444444444444443222 4444444444444444442 21 24444444444
Q ss_pred ccccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeecccccccCCcccccccccceeeccCCcc
Q 037275 449 HMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSF 528 (992)
Q Consensus 449 ~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l 528 (992)
.++++...+..+ +........+.++.+.+... ..+...++|++|++++|.+++.. .+.++++|++|+|++|++
T Consensus 113 ~l~~~~~~~~~~---~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l 185 (227)
T d1h6ua2 113 DLTSTQITDVTP---LAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKI 185 (227)
T ss_dssp ECTTSCCCCCGG---GTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCC
T ss_pred ccccccccccch---hccccchhhhhchhhhhchh--hhhccccccccccccccccccch--hhcccccceecccCCCcc
Confidence 444444332111 11122223345555555432 23667788889999988887433 378888899999999988
Q ss_pred cccCCccccccCCCCEEECCCcccCCCChhhhhcCCCcceEecCC
Q 037275 529 SGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSY 573 (992)
Q Consensus 529 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 573 (992)
++ ++ .+.++++|++|+|++|+|++. + .+.++++|++|++++
T Consensus 186 ~~-l~-~l~~l~~L~~L~Ls~N~lt~i-~-~l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 186 SD-IS-PLASLPNLIEVHLKNNQISDV-S-PLANTSNLFIVTLTN 226 (227)
T ss_dssp CC-CG-GGGGCTTCCEEECTTSCCCBC-G-GGTTCTTCCEEEEEE
T ss_pred CC-Ch-hhcCCCCCCEEECcCCcCCCC-c-ccccCCCCCEEEeeC
Confidence 85 33 378888999999999998854 3 377888899988874
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=4.5e-21 Score=219.48 Aligned_cols=186 Identities=23% Similarity=0.211 Sum_probs=98.2
Q ss_pred cCCCcccEEEccCCcCCC-----CCCccccCCCCCcEEeccCcccccc----CCCCCCCccccCceeccCCcccCCCCCC
Q 037275 368 RNLVNLVELCMDDNKLTG-----TIPHAIGELKNLQLLYLDSNFLAGG----IPTSLGNLTLLTNLALSSNDLQGSIPPS 438 (992)
Q Consensus 368 ~~l~~L~~L~L~~N~l~~-----~~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 438 (992)
.....++.+++++|++.. .....+.....++.+++++|.+... ....+...+.++.+++++|.++......
T Consensus 223 ~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~ 302 (460)
T d1z7xw1 223 ASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARL 302 (460)
T ss_dssp HHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHH
T ss_pred cccccccccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccch
Confidence 344566677776665531 1122233455666666666665422 1112233455666666666654211111
Q ss_pred c-----cccccccccccccccccccCchhhhhhcccccccccccccccCcc----cccccCCCCccEEeeeccccccc--
Q 037275 439 L-----GNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTL----PLEVGNLKNLVYFNISVNRFSGE-- 507 (992)
Q Consensus 439 ~-----~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~-- 507 (992)
+ .....|+.+++ ++|.++... ...+...++|++|+|++|++++.
T Consensus 303 l~~~l~~~~~~L~~l~l-------------------------~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~ 357 (460)
T d1z7xw1 303 LCETLLEPGCQLESLWV-------------------------KSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGV 357 (460)
T ss_dssp HHHHHTSTTCCCCEEEC-------------------------TTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHH
T ss_pred hhccccccccccccccc-------------------------cccchhhhhhhhcccccccccchhhhheeeecccCccc
Confidence 1 11223444444 444443222 12233455777888888877642
Q ss_pred --CCcccc-cccccceeeccCCccccc----CCccccccCCCCEEECCCcccCCCChhhh----h-cCCCcceEecCCCc
Q 037275 508 --IPVTLS-ACTSLQQLYLQGNSFSGS----IPSSLSSLKSIKELDMSSNNLSGQIPEYL----E-NLSFLEYLNLSYNH 575 (992)
Q Consensus 508 --~~~~~~-~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~----~-~l~~L~~L~l~~N~ 575 (992)
++..+. ..+.|++|+|++|.|++. ++..+...++|++|+|++|+|+......+ . +...|+.|++++|.
T Consensus 358 ~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~ 437 (460)
T d1z7xw1 358 RELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIY 437 (460)
T ss_dssp HHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCC
T ss_pred chhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCC
Confidence 222222 345677888888877642 34445566778888888887764333332 1 23367788888777
Q ss_pred Ccc
Q 037275 576 FEG 578 (992)
Q Consensus 576 l~~ 578 (992)
+..
T Consensus 438 ~~~ 440 (460)
T d1z7xw1 438 WSE 440 (460)
T ss_dssp CCH
T ss_pred CCH
Confidence 764
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.72 E-value=9.5e-18 Score=171.23 Aligned_cols=206 Identities=19% Similarity=0.272 Sum_probs=120.0
Q ss_pred cCCeeeccCCCCCccCCccccCCCCCCEEEeecccCCCCCCcccccCCCCcEeecccccccccCChhhcccccccccccc
Q 037275 75 FLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTI 154 (992)
Q Consensus 75 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~~L~L 154 (992)
.+..++++.+++++.+ .+..+.+|++|++++|+|+ .++ .+..+++|++|++++|++++ +++ +..+++|++|++
T Consensus 20 ~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~ls~n~i~~-~~~--l~~l~~l~~l~~ 92 (227)
T d1h6ua2 20 NAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITD-LAP--LKNLTKITELEL 92 (227)
T ss_dssp HHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG--GTTCCSCCEEEC
T ss_pred HHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCC-cch-hHhcCCCCcEeecCCceeec-ccc--cccccccccccc
Confidence 3344555555555432 3455666666666666666 443 46666666666666666653 221 224556666666
Q ss_pred cccccCCCCCCccccccccceEEecCCcccCCcCCccCCCCcccEEeccCcccccccCccccccCCCcEEeccCCccCCC
Q 037275 155 ADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGS 234 (992)
Q Consensus 155 ~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~ 234 (992)
++|.++. + ..+.++++|+.++++++...+. ..+...+.++.+.++++.+.. ...+..+++|++|++++|.+.+
T Consensus 93 ~~n~~~~-i-~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~--~~~~~~~~~L~~L~l~~n~~~~- 165 (227)
T d1h6ua2 93 SGNPLKN-V-SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITN--ISPLAGLTNLQYLSIGNAQVSD- 165 (227)
T ss_dssp CSCCCSC-C-GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCC--CGGGGGCTTCCEEECCSSCCCC-
T ss_pred ccccccc-c-cccccccccccccccccccccc--chhccccchhhhhchhhhhch--hhhhcccccccccccccccccc-
Confidence 6666552 2 2456667777777776665332 235555667777777766653 2335566667777776666541
Q ss_pred CCccccccccccchhhccccccCCCCchhhhccccCceeeeccccccccccccccccCccceEecCCCCCCCCCCCCchh
Q 037275 235 LPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLGSNNLGTGEANDLDF 314 (992)
Q Consensus 235 ~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 314 (992)
. ..++++++|++|+|++|++++.. .|.++++|++|+|++|+++.++
T Consensus 166 -------------------------~-~~l~~l~~L~~L~Ls~n~l~~l~--~l~~l~~L~~L~Ls~N~lt~i~------ 211 (227)
T d1h6ua2 166 -------------------------L-TPLANLSKLTTLKADDNKISDIS--PLASLPNLIEVHLKNNQISDVS------ 211 (227)
T ss_dssp -------------------------C-GGGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECTTSCCCBCG------
T ss_pred -------------------------c-hhhcccccceecccCCCccCCCh--hhcCCCCCCEEECcCCcCCCCc------
Confidence 1 12555667777777777766432 2666677777777777766543
Q ss_pred hhhccCCCcceEeecC
Q 037275 315 LTLLTNCTELTAIGLD 330 (992)
Q Consensus 315 ~~~l~~~~~L~~L~l~ 330 (992)
.+.++++|+.|+++
T Consensus 212 --~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 212 --PLANTSNLFIVTLT 225 (227)
T ss_dssp --GGTTCTTCCEEEEE
T ss_pred --ccccCCCCCEEEee
Confidence 25566666666654
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.71 E-value=1.4e-17 Score=167.33 Aligned_cols=180 Identities=23% Similarity=0.319 Sum_probs=129.1
Q ss_pred EeeCCccccccCCCccCCCcccEEEccCCcCCCCCCccccCCCCCcEEeccCccccccCCCCCCCccccCceeccCCccc
Q 037275 353 VIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQ 432 (992)
Q Consensus 353 ~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 432 (992)
.+..+.+++.++. ..+.+|++|++++|.++.. + .+..+++|++|+|++|+|++.. .++.+++|+.|++++|+|+
T Consensus 30 ~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~ 103 (210)
T d1h6ta2 30 NLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVK 103 (210)
T ss_dssp HTTCSCTTSEECH--HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred HhCcCccCCccCH--HHhcCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccCcc--ccccCcccccccccccccc
Confidence 3444444443332 3456778888888887743 2 3677888888888888887533 2567788888888888887
Q ss_pred CCCCCCccccccccccccccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeecccccccCCccc
Q 037275 433 GSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTL 512 (992)
Q Consensus 433 ~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 512 (992)
+ +| .+..+++|+.|++.+|.+. .+ ..+..+++|+.+++++|.+++ +..+
T Consensus 104 ~-l~-~l~~l~~L~~L~l~~~~~~--------------------------~~-~~l~~l~~l~~l~~~~n~l~~--~~~~ 152 (210)
T d1h6ta2 104 D-LS-SLKDLKKLKSLSLEHNGIS--------------------------DI-NGLVHLPQLESLYLGNNKITD--ITVL 152 (210)
T ss_dssp C-GG-GGTTCTTCCEEECTTSCCC--------------------------CC-GGGGGCTTCCEEECCSSCCCC--CGGG
T ss_pred c-cc-ccccccccccccccccccc--------------------------cc-ccccccccccccccccccccc--cccc
Confidence 4 34 4777777777766555543 11 246677888888888888874 3457
Q ss_pred ccccccceeeccCCcccccCCccccccCCCCEEECCCcccCCCChhhhhcCCCcceEecCC
Q 037275 513 SACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYLNLSY 573 (992)
Q Consensus 513 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 573 (992)
..+++|+.+++++|++++. + .+.++++|++|+|++|+|++ +| .+..+++|++|+|++
T Consensus 153 ~~l~~L~~l~l~~n~l~~i-~-~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 153 SRLTKLDTLSLEDNQISDI-V-PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp GGCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred ccccccccccccccccccc-c-cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence 7888899999999998853 3 38889999999999999984 44 588899999998874
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.68 E-value=6.6e-17 Score=160.86 Aligned_cols=176 Identities=31% Similarity=0.412 Sum_probs=124.0
Q ss_pred EeeCCccccccCCCccCCCcccEEEccCCcCCCCCCccccCCCCCcEEeccCccccccCCCCCCCccccCceeccCCccc
Q 037275 353 VIAGNQISGIIPTGIRNLVNLVELCMDDNKLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQ 432 (992)
Q Consensus 353 ~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 432 (992)
.++.+++++.++ ...+.++++|++++|.++.. +.+..+++|++|++++|+|++..+ +.++++|+.|++++|.+.
T Consensus 24 ~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~ 97 (199)
T d2omxa2 24 VLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA 97 (199)
T ss_dssp HTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred HhCCCCCCCccC--HHHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCcccccccccccccc
Confidence 344555554332 24567788888888888743 346778888888888888875433 778888888888888877
Q ss_pred CCCCCCccccccccccccccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeecccccccCCccc
Q 037275 433 GSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTL 512 (992)
Q Consensus 433 ~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 512 (992)
. ++ .+.++++|+.|++++|.+. . ...+..+++|+.|++++|++.. + ..+
T Consensus 98 ~-~~-~l~~l~~L~~L~l~~~~~~-------------------------~--~~~~~~l~~L~~L~l~~n~l~~-~-~~l 146 (199)
T d2omxa2 98 D-IT-PLANLTNLTGLTLFNNQIT-------------------------D--IDPLKNLTNLNRLELSSNTISD-I-SAL 146 (199)
T ss_dssp C-CG-GGTTCTTCSEEECCSSCCC-------------------------C--CGGGTTCTTCSEEECCSSCCCC-C-GGG
T ss_pred c-cc-ccccccccccccccccccc-------------------------c--ccccchhhhhHHhhhhhhhhcc-c-ccc
Confidence 3 33 3677777777765555443 1 1235677888888888888873 3 357
Q ss_pred ccccccceeeccCCcccccCCccccccCCCCEEECCCcccCCCChhhhhcCCCcceE
Q 037275 513 SACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYL 569 (992)
Q Consensus 513 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 569 (992)
..+++|++|++++|++++. + .+.++++|++|+|++|+|++ ++ .+..+++|+.|
T Consensus 147 ~~~~~L~~L~l~~n~l~~l-~-~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 147 SGLTSLQQLNFSSNQVTDL-K-PLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp TTCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred cccccccccccccccccCC-c-cccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence 7888888888888888753 2 47888888888888888874 33 47778888765
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.68 E-value=9.2e-17 Score=161.23 Aligned_cols=181 Identities=23% Similarity=0.343 Sum_probs=92.6
Q ss_pred eeeccCCCCCccCCccccCCCCCCEEEeecccCCCCCCcccccCCCCcEeecccccccccCChhhccccccccccccccc
Q 037275 78 YLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADN 157 (992)
Q Consensus 78 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~~L~L~~n 157 (992)
..+++.+.+.+.++. ..+..|++|++++|.++ .++ .+..+++|++|++++|+++ .++. + ..+++|++|++++|
T Consensus 28 ~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~L~~n~i~-~l~~-~-~~l~~L~~L~l~~n 100 (210)
T d1h6ta2 28 KDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLT-DIKP-L-ANLKNLGWLFLDEN 100 (210)
T ss_dssp HHHTTCSCTTSEECH--HHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCC-CCGG-G-TTCTTCCEEECCSS
T ss_pred HHHhCcCccCCccCH--HHhcCccEEECcCCCCC-Cch-hHhhCCCCCEEeCCCcccc-Cccc-c-ccCccccccccccc
Confidence 345555655544442 34566677777777766 333 3566666666666666665 2332 1 24455555555555
Q ss_pred ccCCCCCCccccccccceEEecCCcccCCcCCccCCCCcccEEeccCcccccccCccccccCCCcEEeccCCccCCCCCc
Q 037275 158 HLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFNGSLPL 237 (992)
Q Consensus 158 ~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~ 237 (992)
++++ +| .+.++++|+.|++++|.+.. + ..+..+++|+.+++++|.+++ +..+..+++|+++++++|++++
T Consensus 101 ~i~~-l~-~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~---- 170 (210)
T d1h6ta2 101 KVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISD---- 170 (210)
T ss_dssp CCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCC----
T ss_pred cccc-cc-cccccccccccccccccccc-c-ccccccccccccccccccccc--cccccccccccccccccccccc----
Confidence 5552 22 34555555555555555421 1 234555555555555555542 2234445555555555554431
Q ss_pred cccccccccchhhccccccCCCCchhhhccccCceeeeccccccccccccccccCccceEecC
Q 037275 238 DIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDNQFRGKVSIYFRSLKNLEWLNLG 300 (992)
Q Consensus 238 ~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 300 (992)
++ .++++++|++|+|++|+|++. + .|.++++|++|+|+
T Consensus 171 ----------------------i~-~l~~l~~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 171 ----------------------IV-PLAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELF 208 (210)
T ss_dssp ----------------------CG-GGTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEE
T ss_pred ----------------------cc-cccCCCCCCEEECCCCCCCCC-h-hhcCCCCCCEEEcc
Confidence 11 144455555555555555532 1 35555555555554
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.67 E-value=9.8e-17 Score=159.59 Aligned_cols=143 Identities=22% Similarity=0.336 Sum_probs=71.5
Q ss_pred CeeeccCCCCCccCCccccCCCCCCEEEeecccCCCCCCcccccCCCCcEeecccccccccCChhhcccccccccccccc
Q 037275 77 RYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIAD 156 (992)
Q Consensus 77 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~~L~L~~ 156 (992)
..+.++.+.+++.++ ...+.++++|++++|+++ .++ .++.+++|++|++++|+++ .+++ + .++++|++|++++
T Consensus 21 i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~-~~~~-l-~~l~~L~~L~l~~ 93 (199)
T d2omxa2 21 MKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLT-DITP-L-KNLTKLVDILMNN 93 (199)
T ss_dssp HHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCC-CCGG-G-TTCTTCCEEECCS
T ss_pred HHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCC-Ccc-ccccCCCcCcCcccccccc-Cccc-c-cCCcccccccccc
Confidence 344555555554332 235566666666666665 332 3555666666666665555 2222 1 2444555555555
Q ss_pred cccCCCCCCccccccccceEEecCCcccCCcCCccCCCCcccEEeccCcccccccCccccccCCCcEEeccCCccC
Q 037275 157 NHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPPSIFNISSLENVFLPTNRFN 232 (992)
Q Consensus 157 n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~ 232 (992)
|.+.. ++ .+.++++|++|++++|.+... ..+..+++|+.|++++|++.. + +.+..+++|++|++++|+++
T Consensus 94 n~~~~-~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~ 163 (199)
T d2omxa2 94 NQIAD-IT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVT 163 (199)
T ss_dssp SCCCC-CG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCC
T ss_pred ccccc-cc-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhcc-c-cccccccccccccccccccc
Confidence 54442 22 245555555555555554321 224555555555555555542 1 23445555555555555444
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.54 E-value=4.4e-16 Score=164.14 Aligned_cols=201 Identities=18% Similarity=0.167 Sum_probs=104.0
Q ss_pred CEEEeecccCCCCCCcccccCCCCcEeecccccccccCChhhcccccccccccccccccCCCCCCccccccccceEEecC
Q 037275 101 EALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIGNLSTLERINVLG 180 (992)
Q Consensus 101 ~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~ 180 (992)
..+.++...+. ..........+|++||+++|.++++....++..+++|++|+|++|.+++..+..+..+++|++|++++
T Consensus 26 ~~lrl~~~~~~-~~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~ 104 (284)
T d2astb2 26 IAFRCPRSFMD-QPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG 104 (284)
T ss_dssp SEEECTTCEEC-SCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTT
T ss_pred eEeeccccccc-cchhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccc
Confidence 34444444443 22222334445666666666655444444455566666666666666655555566666677777766
Q ss_pred C-cccCC-cCCccCCCCcccEEeccCc-ccccc-cCccccc-cCCCcEEeccCCc--cCCCCCccccccccccchhhccc
Q 037275 181 N-GLWGR-IPNNLGNLRNLILLNLGEN-RFSGI-VPPSIFN-ISSLENVFLPTNR--FNGSLPLDIGVSLPKLLGFIVAE 253 (992)
Q Consensus 181 n-~l~~~-~~~~l~~l~~L~~L~L~~n-~l~~~-~p~~l~~-l~~L~~L~l~~N~--l~~~~~~~~~~~~~~L~~l~l~~ 253 (992)
+ .+... +.....++++|++|+++++ .++.. +...+.. .++|+.|+++++. ++..
T Consensus 105 c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~------------------- 165 (284)
T d2astb2 105 CSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKS------------------- 165 (284)
T ss_dssp CBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHH-------------------
T ss_pred cccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhcccccccccc-------------------
Confidence 4 33211 1112345567777777764 34321 1222333 3567777776542 2100
Q ss_pred cccCCCCchhhhccccCceeeeccc-cccccccccccccCccceEecCCC-CCCCCCCCCchhhhhccCCCcceEeecCC
Q 037275 254 NNFAGSIPESLSNASNLVELTLFDN-QFRGKVSIYFRSLKNLEWLNLGSN-NLGTGEANDLDFLTLLTNCTELTAIGLDD 331 (992)
Q Consensus 254 n~l~~~~p~~l~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~~~~l~~~~~L~~L~l~~ 331 (992)
.+...+.++++|++|++++| .+++.....+.++++|++|+|+++ .++. ..+..+.++++|+.|++++
T Consensus 166 -----~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~------~~l~~L~~~~~L~~L~l~~ 234 (284)
T d2astb2 166 -----DLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIP------ETLLELGEIPTLKTLQVFG 234 (284)
T ss_dssp -----HHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCG------GGGGGGGGCTTCCEEECTT
T ss_pred -----cccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCCh------HHHHHHhcCCCCCEEeeeC
Confidence 11122344566666666664 355555556666666777777664 3432 1223345566666666665
Q ss_pred C
Q 037275 332 N 332 (992)
Q Consensus 332 n 332 (992)
+
T Consensus 235 ~ 235 (284)
T d2astb2 235 I 235 (284)
T ss_dssp S
T ss_pred C
Confidence 5
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.49 E-value=1.2e-14 Score=138.02 Aligned_cols=128 Identities=20% Similarity=0.125 Sum_probs=83.7
Q ss_pred CCCccccCceeccCCcccCCCCCCccccccccccccccccccccCchhhhhhcccccccccccccccCcccccccCCCCc
Q 037275 415 LGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHMADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNL 494 (992)
Q Consensus 415 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L 494 (992)
|.+..++++|+|++|+|+. ++..+..+++|+.|++++|+|+ .+ +.|..+++|
T Consensus 14 ~~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~--------------------------~l-~~~~~l~~L 65 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR--------------------------KL-DGFPLLRRL 65 (162)
T ss_dssp EECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCC--------------------------EE-CCCCCCSSC
T ss_pred ccCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCC--------------------------cc-CCcccCcch
Confidence 3445556666666666663 4444555566665544444333 22 235667778
Q ss_pred cEEeeecccccccCCcccccccccceeeccCCcccccCC-ccccccCCCCEEECCCcccCCCC---hhhhhcCCCcceEe
Q 037275 495 VYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIP-SSLSSLKSIKELDMSSNNLSGQI---PEYLENLSFLEYLN 570 (992)
Q Consensus 495 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~---p~~~~~l~~L~~L~ 570 (992)
++|++++|+++...+..+..+++|+.|++++|+|+.... ..+..+++|++|++++|.++... +..+..+++|++||
T Consensus 66 ~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 66 KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp CEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred hhhhcccccccCCCccccccccccccceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 888888888876556666778888888888888874321 45778888888888888887432 23577888888876
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.49 E-value=8.5e-15 Score=139.19 Aligned_cols=128 Identities=18% Similarity=0.222 Sum_probs=74.2
Q ss_pred CCCCCcCCeeeccCCCCCccCCccccCCCCCCEEEeecccCCCCCCcccccCCCCcEeecccccccccCChhhccccccc
Q 037275 70 VGNLSFLRYLNLADNNFHGEIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKL 149 (992)
Q Consensus 70 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L 149 (992)
+.+...|+.|||++|+++ .+|..+..+++|++|+|++|+|+ .++ .+..+++|++|++++|+++ .+|..++..+++|
T Consensus 14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~-~l~~~~~~~l~~L 89 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDL 89 (162)
T ss_dssp EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCC-EECSCHHHHCTTC
T ss_pred ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhccccccc-CCCcccccccccc
Confidence 446666777777777777 56665566777777777777776 443 3556666666666666655 4444443344444
Q ss_pred ccccccccccCCCCCCccccccccceEEecCCcccCCcCCccCCCCcccEEeccCcccccccCc----cccccCCCcEEe
Q 037275 150 ENLTIADNHLTGHFPASIGNLSTLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGIVPP----SIFNISSLENVF 225 (992)
Q Consensus 150 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~----~l~~l~~L~~L~ 225 (992)
++|++++|+++. +++ ...+..+++|++|++++|.++. .|. .+..+++|++||
T Consensus 90 ~~L~L~~N~i~~-~~~----------------------l~~l~~l~~L~~L~l~~N~i~~-~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 90 TELILTNNSLVE-LGD----------------------LDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp CEEECCSCCCCC-GGG----------------------GGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEET
T ss_pred ccceeccccccc-ccc----------------------ccccccccccchhhcCCCcccc-ccchHHHHHHHCCCcCeeC
Confidence 444444444442 111 1235555666666666666652 332 456677777665
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.48 E-value=5e-14 Score=127.00 Aligned_cols=105 Identities=25% Similarity=0.298 Sum_probs=90.7
Q ss_pred ccccccccccCcccccccCCCCccEEeeecccccccCCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcc
Q 037275 472 SLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNN 551 (992)
Q Consensus 472 ~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 551 (992)
.|+|++|+++ .++ .+..+++|++|++++|+|+ .+|..|+.+++|+.|++++|+|++ +| .+..+++|++|++++|+
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCc
Confidence 4688899998 444 4899999999999999998 567789999999999999999995 44 59999999999999999
Q ss_pred cCCCCh-hhhhcCCCcceEecCCCcCcccCC
Q 037275 552 LSGQIP-EYLENLSFLEYLNLSYNHFEGEVP 581 (992)
Q Consensus 552 l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~~ 581 (992)
|++... ..+..+++|++|++++|+++....
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~ 107 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 107 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCCcCcc
Confidence 986543 578999999999999999986543
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.46 E-value=8.6e-14 Score=125.39 Aligned_cols=85 Identities=22% Similarity=0.271 Sum_probs=53.5
Q ss_pred cccccccCCCCccEEeeecccccccCCcccccccccceeeccCCcccccC-CccccccCCCCEEECCCcccCCC---Chh
Q 037275 483 TLPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSI-PSSLSSLKSIKELDMSSNNLSGQ---IPE 558 (992)
Q Consensus 483 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~---~p~ 558 (992)
.+|..++.+++|+.|++++|+|++ +| .+..+++|+.|++++|+|+... ...+..+++|+.|++++|+++.. ...
T Consensus 34 ~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~ 111 (124)
T d1dcea3 34 ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQER 111 (124)
T ss_dssp CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTH
T ss_pred cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCccCCCCCchhhcCCCCCCEEECCCCcCCcCccHHHH
Confidence 345556666667777777777763 33 3667777777777777776432 24567777777777777777632 233
Q ss_pred hhhcCCCcceE
Q 037275 559 YLENLSFLEYL 569 (992)
Q Consensus 559 ~~~~l~~L~~L 569 (992)
....+|+|+.|
T Consensus 112 l~~~lp~L~~L 122 (124)
T d1dcea3 112 LAEMLPSVSSI 122 (124)
T ss_dssp HHHHCTTCSEE
T ss_pred HHHHCcCcceE
Confidence 44556666654
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.44 E-value=1.7e-15 Score=164.97 Aligned_cols=93 Identities=17% Similarity=0.273 Sum_probs=63.1
Q ss_pred ccccCCCCccEEeeeccccccc----CCcccccccccceeeccCCcccccCCccc----cc--cCCCCEEECCCcccCCC
Q 037275 486 LEVGNLKNLVYFNISVNRFSGE----IPVTLSACTSLQQLYLQGNSFSGSIPSSL----SS--LKSIKELDMSSNNLSGQ 555 (992)
Q Consensus 486 ~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~----~~--l~~L~~L~Ls~N~l~~~ 555 (992)
..+..+++|+.|+|++|.++.. +...+..+++|++|+|++|.|++.....+ .. .+.|++|+|++|+|+..
T Consensus 209 ~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~ 288 (344)
T d2ca6a1 209 EGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELD 288 (344)
T ss_dssp TTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHH
T ss_pred hhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChH
Confidence 3455677788888888887632 34456677888888888888875422222 22 35688899999988642
Q ss_pred ----Chhhhh-cCCCcceEecCCCcCcc
Q 037275 556 ----IPEYLE-NLSFLEYLNLSYNHFEG 578 (992)
Q Consensus 556 ----~p~~~~-~l~~L~~L~l~~N~l~~ 578 (992)
+...+. ++++|++|+|++|.+..
T Consensus 289 ~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 289 AVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp HHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred HHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 233332 56789999999998864
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.43 E-value=5.3e-14 Score=132.63 Aligned_cols=133 Identities=16% Similarity=0.079 Sum_probs=106.0
Q ss_pred cccccccccCcccccccCCCCccEEeeecc-cccccCCcccccccccceeeccCCcccccCCccccccCCCCEEECCCcc
Q 037275 473 LDLSYNLLSGTLPLEVGNLKNLVYFNISVN-RFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNN 551 (992)
Q Consensus 473 L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 551 (992)
++.+++.+. ..|..+..+++|++|++++| .++.+.+..|.++++|+.|+|++|+|+.+.+.+|..+++|++|+|++|+
T Consensus 13 l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~ 91 (156)
T d2ifga3 13 LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA 91 (156)
T ss_dssp EECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred EEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCC
Confidence 456666666 56778889999999999866 5988888899999999999999999998889999999999999999999
Q ss_pred cCCCChhhhhcCCCcceEecCCCcCcccCCCCCccCCc--ccccccCCCCcCCCCCCC
Q 037275 552 LSGQIPEYLENLSFLEYLNLSYNHFEGEVPTKGVFSNK--TGISLSGNGKVCGGLDEL 607 (992)
Q Consensus 552 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~--~~~~l~~N~~~C~~~~~~ 607 (992)
|+...+..|..+ +|+.|+|++|+|.|.+...+...++ ....+..+...|.+|..+
T Consensus 92 l~~l~~~~~~~~-~l~~L~L~~Np~~C~C~~~~l~~~~~~~~~~~~~~~~~C~~p~~l 148 (156)
T d2ifga3 92 LESLSWKTVQGL-SLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPL 148 (156)
T ss_dssp CSCCCSTTTCSC-CCCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSSCS
T ss_pred CcccChhhhccc-cccccccCCCcccCCchHHHHHHHHHhccCccCcCCcEECcChHH
Confidence 996555666554 7999999999999988654332222 233344566788887654
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.41 E-value=1.5e-14 Score=152.25 Aligned_cols=123 Identities=20% Similarity=0.180 Sum_probs=62.6
Q ss_pred cccccccccCCCCCCcccccc--ccceEEecCCcccCCcCCccCCCCcccEEeccCcccccc-cCccccccCCCcEEecc
Q 037275 151 NLTIADNHLTGHFPASIGNLS--TLERINVLGNGLWGRIPNNLGNLRNLILLNLGENRFSGI-VPPSIFNISSLENVFLP 227 (992)
Q Consensus 151 ~L~L~~n~l~~~~p~~~~~l~--~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~-~p~~l~~l~~L~~L~l~ 227 (992)
.|||+++.+. |+.++.+. .+..+.++...+..... ......+|++|||++|.++.. ++..+..+++|++|+++
T Consensus 4 ~lDLs~~~l~---~~~l~~l~~~~~~~lrl~~~~~~~~~~-~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~ 79 (284)
T d2astb2 4 TLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLE 79 (284)
T ss_dssp EEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCC-SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECT
T ss_pred EEECCCCCCC---chHHHHHHhccceEeeccccccccchh-hhccCCCCCEEECCCCccCHHHHHHHHHhCCCccccccc
Confidence 4566666554 23333222 23344444444422222 223345667777776666532 23334556666666666
Q ss_pred CCccCCCCCccccccccccchhhccccccCCCCchhhhccccCceeeeccc-ccccccc-ccccccCccceEecCCC
Q 037275 228 TNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASNLVELTLFDN-QFRGKVS-IYFRSLKNLEWLNLGSN 302 (992)
Q Consensus 228 ~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N-~l~~~~~-~~~~~l~~L~~L~L~~N 302 (992)
+|.+++ ..+..++.+++|++|+++++ .+++... ..+..+++|++|+++++
T Consensus 80 ~~~l~~-------------------------~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c 131 (284)
T d2astb2 80 GLRLSD-------------------------PIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWC 131 (284)
T ss_dssp TCBCCH-------------------------HHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCC
T ss_pred ccCCCc-------------------------HHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccc
Confidence 665442 23344555666777777663 4543222 22345666777776664
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.41 E-value=8.9e-15 Score=159.29 Aligned_cols=245 Identities=20% Similarity=0.176 Sum_probs=123.0
Q ss_pred CCCCCCcCCeeeccCCCCCcc----CCccccCCCCCCEEEeecccCCC---CCC-------cccccCCCCcEeecccccc
Q 037275 69 YVGNLSFLRYLNLADNNFHGE----IPHQIGRLVRLEALVLANNSFSG---KIP-------TNLSRCSNLISFNARRNNL 134 (992)
Q Consensus 69 ~l~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~Ls~n~l~~---~~p-------~~l~~l~~L~~L~l~~n~l 134 (992)
.+.+...|+.|+|++|.+..+ +...+...++|+.|+++++.... ..| ..+..+++|+.|++++|.+
T Consensus 26 ~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i 105 (344)
T d2ca6a1 26 VLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAF 105 (344)
T ss_dssp HHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCC
T ss_pred HHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccccccc
Confidence 344455555555555555421 22334444555555555543321 011 1123344555555555555
Q ss_pred cccCChhhc---ccccccccccccccccCCCCCC-------------ccccccccceEEecCCcccCC----cCCccCCC
Q 037275 135 VGEIPAELG---YNWLKLENLTIADNHLTGHFPA-------------SIGNLSTLERINVLGNGLWGR----IPNNLGNL 194 (992)
Q Consensus 135 ~~~~p~~~~---~~l~~L~~L~L~~n~l~~~~p~-------------~~~~l~~L~~L~l~~n~l~~~----~~~~l~~l 194 (992)
...-...+. ...++|++|++++|.++..-.. .....+.|+.|.+++|.+... +...+...
T Consensus 106 ~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~ 185 (344)
T d2ca6a1 106 GPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSH 185 (344)
T ss_dssp CTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHC
T ss_pred ccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhh
Confidence 432211111 1234555555555554311000 012345677777777766422 22334455
Q ss_pred CcccEEeccCcccccc-----cCccccccCCCcEEeccCCccCCCCCccccccccccchhhccccccCCCCchhhhcccc
Q 037275 195 RNLILLNLGENRFSGI-----VPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSNASN 269 (992)
Q Consensus 195 ~~L~~L~L~~n~l~~~-----~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~l~~ 269 (992)
+.|+.|+|++|++... +...+..+++|++|+|++|.++..-.. .+...+..+++
T Consensus 186 ~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~---------------------~L~~~l~~~~~ 244 (344)
T d2ca6a1 186 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSS---------------------ALAIALKSWPN 244 (344)
T ss_dssp TTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHH---------------------HHHHHGGGCTT
T ss_pred hhhcccccccccccccccccchhhhhcchhhhcccccccccccccccc---------------------ccccccccccc
Confidence 6777777777777531 234466677788888877776521110 12334555666
Q ss_pred Cceeeeccccccccccccc----c--ccCccceEecCCCCCCCCCCCCchhhhhcc-CCCcceEeecCCCcCCC
Q 037275 270 LVELTLFDNQFRGKVSIYF----R--SLKNLEWLNLGSNNLGTGEANDLDFLTLLT-NCTELTAIGLDDNRFGG 336 (992)
Q Consensus 270 L~~L~L~~N~l~~~~~~~~----~--~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~-~~~~L~~L~l~~n~l~~ 336 (992)
|++|+|++|.|++.....+ . ....|++|++++|+|+...... ....+. ++++|+.|++++|++..
T Consensus 245 L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~--l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 245 LRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRT--LKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp CCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHH--HHHHHHHHCTTCCEEECTTSBSCT
T ss_pred chhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHH--HHHHHHccCCCCCEEECCCCcCCC
Confidence 7777777777664433333 2 2345777777777765422211 122232 45667777777777753
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.36 E-value=3.3e-14 Score=140.09 Aligned_cols=130 Identities=22% Similarity=0.218 Sum_probs=92.1
Q ss_pred cCCccccCCCCCCEEEeecccCCCCCCcccccCCCCcEeecccccccccCChhhcccccccccccccccccCCCCCCccc
Q 037275 89 EIPHQIGRLVRLEALVLANNSFSGKIPTNLSRCSNLISFNARRNNLVGEIPAELGYNWLKLENLTIADNHLTGHFPASIG 168 (992)
Q Consensus 89 ~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~~~~~l~~L~~L~L~~n~l~~~~p~~~~ 168 (992)
.+|.++..+++|++|+|++|+|+ .++ .+..+++|+.|++++|+++ .+|... ..+++|++|++++|.++. + +.+.
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~-~~~~~L~~L~l~~N~i~~-l-~~~~ 112 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLD-AVADTLEELWISYNQIAS-L-SGIE 112 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHH-HHHHHCCEEECSEEECCC-H-HHHH
T ss_pred hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccc-cccccccccccccccccc-c-cccc
Confidence 45667777778888888888777 554 4777778888888888776 565432 245678888888888874 3 3577
Q ss_pred cccccceEEecCCcccCCcC--CccCCCCcccEEeccCcccccccCcc----------ccccCCCcEEe
Q 037275 169 NLSTLERINVLGNGLWGRIP--NNLGNLRNLILLNLGENRFSGIVPPS----------IFNISSLENVF 225 (992)
Q Consensus 169 ~l~~L~~L~l~~n~l~~~~~--~~l~~l~~L~~L~L~~n~l~~~~p~~----------l~~l~~L~~L~ 225 (992)
++++|++|++++|++.. ++ ..|..+++|+.|+|++|.+....+.. +..+++|+.||
T Consensus 113 ~l~~L~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 113 KLVNLRVLYMSNNKITN-WGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp HHHHSSEEEESEEECCC-HHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred ccccccccccccchhcc-ccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 78888888888888843 33 45788888888888888876443332 55677888775
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.36 E-value=6.7e-13 Score=124.95 Aligned_cols=113 Identities=19% Similarity=0.173 Sum_probs=98.9
Q ss_pred CCCccEEeeecccccccCCcccccccccceeeccCC-cccccCCccccccCCCCEEECCCcccCCCChhhhhcCCCcceE
Q 037275 491 LKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGN-SFSGSIPSSLSSLKSIKELDMSSNNLSGQIPEYLENLSFLEYL 569 (992)
Q Consensus 491 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 569 (992)
....+.++.+++.+. ..|..+.++++|++|++++| .|+.+.+.+|.++++|+.|+|++|+|+++.|.+|..+++|++|
T Consensus 7 c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L 85 (156)
T d2ifga3 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRL 85 (156)
T ss_dssp CSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEE
T ss_pred cCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccce
Confidence 345567899999998 67888999999999999876 5987777889999999999999999998888999999999999
Q ss_pred ecCCCcCcccCCCCCccCCcccccccCCCCcCCCC
Q 037275 570 NLSYNHFEGEVPTKGVFSNKTGISLSGNGKVCGGL 604 (992)
Q Consensus 570 ~l~~N~l~~~~~~~~~~~~~~~~~l~~N~~~C~~~ 604 (992)
+|++|+|+..++.......+..+++.+|||.|+|-
T Consensus 86 ~Ls~N~l~~l~~~~~~~~~l~~L~L~~Np~~C~C~ 120 (156)
T d2ifga3 86 NLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCA 120 (156)
T ss_dssp ECCSSCCSCCCSTTTCSCCCCEEECCSSCCCCCGG
T ss_pred eccCCCCcccChhhhccccccccccCCCcccCCch
Confidence 99999999877765445568899999999999873
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.31 E-value=3.6e-14 Score=139.90 Aligned_cols=126 Identities=23% Similarity=0.260 Sum_probs=66.9
Q ss_pred ccEEEccCC--cCCCCCCccccCCCCCcEEeccCccccccCCCCCCCccccCceeccCCcccCCCCCCcccccccccccc
Q 037275 373 LVELCMDDN--KLTGTIPHAIGELKNLQLLYLDSNFLAGGIPTSLGNLTLLTNLALSSNDLQGSIPPSLGNCKNLIELHM 450 (992)
Q Consensus 373 L~~L~L~~N--~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 450 (992)
++.+++.++ .+. .++..+..+++|++|+|++|+|+. ++ .+..+++|+.|+|++|+|+ .+|..+..+++|+.|++
T Consensus 25 ~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l 100 (198)
T d1m9la_ 25 AEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWI 100 (198)
T ss_dssp CSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEEC
T ss_pred cceeeeecccCchh-hhhhHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-ccccccccccccccccc
Confidence 444555443 233 445667777777777777777773 33 3666777777777777776 34433333344444433
Q ss_pred ccccccccCchhhhhhcccccccccccccccCcccccccCCCCccEEeeecccccccCC-cccccccccceeeccCCccc
Q 037275 451 ADIELTGALPPQILSISTLSLSLDLSYNLLSGTLPLEVGNLKNLVYFNISVNRFSGEIP-VTLSACTSLQQLYLQGNSFS 529 (992)
Q Consensus 451 ~~n~l~~~~p~~~~~~~~~~~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~ 529 (992)
++|+++ .+ ..+..+++|++|++++|+++.... ..+..+++|+.|+|++|++.
T Consensus 101 ~~N~i~--------------------------~l-~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 101 SYNQIA--------------------------SL-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp SEEECC--------------------------CH-HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred cccccc--------------------------cc-ccccccccccccccccchhccccccccccCCCccceeecCCCccc
Confidence 333332 11 124445555555555555553211 23445555555555555544
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.54 E-value=8.5e-09 Score=97.06 Aligned_cols=85 Identities=22% Similarity=0.220 Sum_probs=51.5
Q ss_pred ccccCCCCccEEeeecccccccC--CcccccccccceeeccCCcccccCCccccccCCCCEEECCCcccCCCCh------
Q 037275 486 LEVGNLKNLVYFNISVNRFSGEI--PVTLSACTSLQQLYLQGNSFSGSIPSSLSSLKSIKELDMSSNNLSGQIP------ 557 (992)
Q Consensus 486 ~~~~~l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p------ 557 (992)
..+..+++|++|+|++|+|+... +..+..+++|+.|+|++|+|+...+-.+....+|+.|+|++|.++....
T Consensus 59 ~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~ 138 (162)
T d1koha1 59 IIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYI 138 (162)
T ss_dssp HHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHH
T ss_pred HHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHH
Confidence 33445677777777777776432 3445667777777777777774333233344567777777777765433
Q ss_pred -hhhhcCCCcceEe
Q 037275 558 -EYLENLSFLEYLN 570 (992)
Q Consensus 558 -~~~~~l~~L~~L~ 570 (992)
..+..+|+|+.||
T Consensus 139 ~~i~~~~P~L~~LD 152 (162)
T d1koha1 139 SAIRERFPKLLRLD 152 (162)
T ss_dssp HHHHTTSTTCCEET
T ss_pred HHHHHHCCCCCEEC
Confidence 2245567777664
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.44 E-value=3.1e-07 Score=94.17 Aligned_cols=149 Identities=17% Similarity=0.141 Sum_probs=103.7
Q ss_pred HHHHHHhcCCCCCCccccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhcc-CCcceeEEEEeecccc
Q 037275 672 AELSKATNDFSSSNMIGQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIR-HRNLIKIITICSSIDF 750 (992)
Q Consensus 672 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 750 (992)
.|+.+....|+..+..+.++.+.||+... +++.+++|+...........+.+|...++.+. +--+.+++.+..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~---- 80 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER---- 80 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE----
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEe----
Confidence 46667777888777766566679999875 56678889886555555667888999988874 333566666532
Q ss_pred cCcceEEEEEEeccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHhcC-----------------------
Q 037275 751 KGVDFQAIVYEYMQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHHHC----------------------- 807 (992)
Q Consensus 751 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~----------------------- 807 (992)
.++..++||++++|.++.+..... .....++.++++.++.||+..
T Consensus 81 -~~~~~~lv~~~l~G~~~~~~~~~~-----------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (263)
T d1j7la_ 81 -HDGWSNLLMSEADGVLCSEEYEDE-----------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNN 148 (263)
T ss_dssp -ETTEEEEEEECCSSEEHHHHTTTC-----------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHT
T ss_pred -cCCceEEEEEeccccccccccccc-----------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHH
Confidence 234568999999998876654211 112234556666667776431
Q ss_pred ---------------------------------CCCeEeccCCCCCeeeCCCCcEEEeecccce
Q 037275 808 ---------------------------------QPPVVHGDLKPSNVLLDQDLVAHLGDFGLAK 838 (992)
Q Consensus 808 ---------------------------------~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 838 (992)
.+.++|+|+.|.||++++++.+-|.||+.+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 149 DLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1237899999999999987777799999875
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.40 E-value=1.2e-08 Score=96.07 Aligned_cols=77 Identities=27% Similarity=0.339 Sum_probs=50.9
Q ss_pred ccccccccCc--ccccccCCCCccEEeeecccccccCCcccccccccceeeccCCcccccCCcc-------ccccCCCCE
Q 037275 474 DLSYNLLSGT--LPLEVGNLKNLVYFNISVNRFSGEIPVTLSACTSLQQLYLQGNSFSGSIPSS-------LSSLKSIKE 544 (992)
Q Consensus 474 ~l~~N~l~~~--~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-------~~~l~~L~~ 544 (992)
+|++|+|+.. ++..+..+++|+.|+|++|+++...+-.+.+...|+.|++++|++....... +..+|+|+.
T Consensus 71 ~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~ 150 (162)
T d1koha1 71 NLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLR 150 (162)
T ss_dssp CCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCE
T ss_pred eCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCE
Confidence 4444444422 2344667788888888888888554444445567888999999887654432 567889998
Q ss_pred EECCCccc
Q 037275 545 LDMSSNNL 552 (992)
Q Consensus 545 L~Ls~N~l 552 (992)
|| ++.+
T Consensus 151 LD--g~~v 156 (162)
T d1koha1 151 LD--GHEL 156 (162)
T ss_dssp ET--TEEC
T ss_pred EC--cCCC
Confidence 86 5554
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.50 E-value=1.7e-05 Score=74.23 Aligned_cols=72 Identities=10% Similarity=0.083 Sum_probs=40.5
Q ss_pred hhhhccccCceeeecccccccccc----ccccccCccceEecCCCCCCCCCCCC-chhhhhccCCCcceEeecCCCc
Q 037275 262 ESLSNASNLVELTLFDNQFRGKVS----IYFRSLKNLEWLNLGSNNLGTGEAND-LDFLTLLTNCTELTAIGLDDNR 333 (992)
Q Consensus 262 ~~l~~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~~~~l~~~~~L~~L~l~~n~ 333 (992)
..+...+.|++|+|++|.|++... ..+...++|++|+|++|.+..++... ......+...+.|+.|+++.+.
T Consensus 66 ~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 66 ELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred hhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence 345555667777777776664332 23445566777777777665543221 2234455556666666665543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.46 E-value=0.00026 Score=76.06 Aligned_cols=77 Identities=16% Similarity=0.133 Sum_probs=49.3
Q ss_pred CCccccccceEEEEeEECCCCeEEEEEEeecc----C---CCchhHHHHHHHHHHhcc-C--CcceeEEEEeecccccCc
Q 037275 684 SNMIGQGSFGFVYKGNLGENGMMVAVKVINLK----Q---KGASNGFVAECQALRNIR-H--RNLIKIITICSSIDFKGV 753 (992)
Q Consensus 684 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~---~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~~~~~~ 753 (992)
.+.||.|....||++....+++.|+||..... . .....+...|.+.++.+. + ..+.+++.+..
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~------- 103 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT------- 103 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET-------
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcC-------
Confidence 34689999999999998767889999975421 1 123345667888888773 2 34666666522
Q ss_pred ceEEEEEEeccCCC
Q 037275 754 DFQAIVYEYMQNGS 767 (992)
Q Consensus 754 ~~~~lv~e~~~~gs 767 (992)
...++|||++++..
T Consensus 104 ~~~~lvmE~L~~~~ 117 (392)
T d2pula1 104 EMAVTVMEDLSHLK 117 (392)
T ss_dssp TTTEEEECCCTTSE
T ss_pred CCCEEEEeccCCcc
Confidence 12379999997643
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.44 E-value=2.2e-05 Score=73.41 Aligned_cols=89 Identities=18% Similarity=0.181 Sum_probs=56.1
Q ss_pred cccCCCCccEEeeeccccccc----CCcccccccccceeeccCCccccc----CCccccccCCCCEEECCCcccCCC---
Q 037275 487 EVGNLKNLVYFNISVNRFSGE----IPVTLSACTSLQQLYLQGNSFSGS----IPSSLSSLKSIKELDMSSNNLSGQ--- 555 (992)
Q Consensus 487 ~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~--- 555 (992)
.+...+.|++|+|++|.+... +...+...+.|++|+|++|.|+.. +-.++...+.|++|+|++|.+...
T Consensus 39 ~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~ 118 (167)
T d1pgva_ 39 AACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQ 118 (167)
T ss_dssp HHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHH
T ss_pred HHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHH
Confidence 344556778888888877632 223344557788888888887743 233455567788888887765532
Q ss_pred ----ChhhhhcCCCcceEecCCCc
Q 037275 556 ----IPEYLENLSFLEYLNLSYNH 575 (992)
Q Consensus 556 ----~p~~~~~l~~L~~L~l~~N~ 575 (992)
+...+...++|+.|+++.+.
T Consensus 119 ~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 119 VEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHHHHHHHhCCCccEeeCcCCC
Confidence 23444556777777776553
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.40 E-value=0.00012 Score=73.62 Aligned_cols=130 Identities=15% Similarity=0.120 Sum_probs=80.6
Q ss_pred ccccccc-eEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCC--cceeEEEEeecccccCcceEEEEEEe
Q 037275 686 MIGQGSF-GFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHR--NLIKIITICSSIDFKGVDFQAIVYEY 762 (992)
Q Consensus 686 ~lg~G~~-g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~~~~~~~~~~~lv~e~ 762 (992)
.+..|.. +.||+.... .+..+++|..... ....+..|...++.+... .+.+++++.. +.+..++||+|
T Consensus 17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~-----~~~~~~~v~~~ 87 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVT-----EAGRDWLLLGE 87 (255)
T ss_dssp ECSCTTSSCEEEEEECT-TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEE-----CSSCEEEEEEC
T ss_pred EcCCcccCCeEEEEEeC-CCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecc-----cccceEEEEEe
Confidence 3444543 689999874 5667888976433 334577888888887432 3556666543 23456899999
Q ss_pred ccCCCHHHHHhhcccchhhcccCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 037275 763 MQNGSLEDWLHQSEDQQEARSLTLIQRINIIIDVASAIEYIHH------------------------------------- 805 (992)
Q Consensus 763 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~------------------------------------- 805 (992)
++|.++.+.. ... ...+.++++.|+-||+
T Consensus 88 i~G~~~~~~~-----------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (255)
T d1nd4a_ 88 VPGQDLLSSH-----------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 153 (255)
T ss_dssp CSSEETTTSC-----------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred eecccccccc-----------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchh
Confidence 9876542210 000 0112223333333332
Q ss_pred --------------cC----CCCeEeccCCCCCeeeCCCCcEEEeecccce
Q 037275 806 --------------HC----QPPVVHGDLKPSNVLLDQDLVAHLGDFGLAK 838 (992)
Q Consensus 806 --------------~~----~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 838 (992)
.. .+.++|+|+.|.||+++++..+-|+||+.+.
T Consensus 154 ~~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 154 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 11 1247999999999999987777899998775
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.01 E-value=0.00039 Score=72.61 Aligned_cols=72 Identities=11% Similarity=0.076 Sum_probs=46.1
Q ss_pred eEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcc--eeEEEEeecccccCcceEEEEEEeccCC
Q 037275 693 GFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNL--IKIITICSSIDFKGVDFQAIVYEYMQNG 766 (992)
Q Consensus 693 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~~~~~~~~~~lv~e~~~~g 766 (992)
-.||+++.. +|+.|++|+.+.. ....+++..|.+.+..+....+ +..+..............+.++++++|.
T Consensus 36 N~vy~v~~~-dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 36 NRVYQFQDE-DRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SEEEEECCT-TCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred ceeEEEEcC-CCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 589999985 7889999998643 3345678889999888853322 2222211111123345668899998764
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.73 E-value=0.00013 Score=67.98 Aligned_cols=42 Identities=10% Similarity=0.050 Sum_probs=18.3
Q ss_pred cCCCCcccEEeccCcccccc----cCccccccCCCcEEeccCCccC
Q 037275 191 LGNLRNLILLNLGENRFSGI----VPPSIFNISSLENVFLPTNRFN 232 (992)
Q Consensus 191 l~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~l~~N~l~ 232 (992)
+...++|++|+|++|.++.. +...+...++++.+++++|.+.
T Consensus 42 l~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~ 87 (166)
T d1io0a_ 42 LKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 87 (166)
T ss_dssp HTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred HhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence 33445555555555554421 1122233444555554444443
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.64 E-value=0.00022 Score=66.24 Aligned_cols=120 Identities=18% Similarity=0.169 Sum_probs=73.3
Q ss_pred CCCCcccEEeccC-cccccc----cCccccccCCCcEEeccCCccCCCCCccccccccccchhhccccccCCCCchhhhc
Q 037275 192 GNLRNLILLNLGE-NRFSGI----VPPSIFNISSLENVFLPTNRFNGSLPLDIGVSLPKLLGFIVAENNFAGSIPESLSN 266 (992)
Q Consensus 192 ~~l~~L~~L~L~~-n~l~~~----~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~L~~l~l~~n~l~~~~p~~l~~ 266 (992)
.+.++|++|+|++ +.++.. +...+...++|++|++++|.++..... .+...+..
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~---------------------~L~~~l~~ 72 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAF---------------------ALAEMLKV 72 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHH---------------------HHHHHHHH
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHH---------------------HHHHHHhh
Confidence 4557788888876 456522 234455778899999998887621111 22345666
Q ss_pred cccCceeeecccccccccc----ccccccCccceEec--CCCCCCCCCCCCchhhhhccCCCcceEeecCCCcC
Q 037275 267 ASNLVELTLFDNQFRGKVS----IYFRSLKNLEWLNL--GSNNLGTGEANDLDFLTLLTNCTELTAIGLDDNRF 334 (992)
Q Consensus 267 l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~L--~~N~l~~~~~~~~~~~~~l~~~~~L~~L~l~~n~l 334 (992)
.++++.+++++|.+..... ..+...++|+.++| ++|.++..... .....+..++.|+.|+++.+..
T Consensus 73 ~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~--~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 73 NNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEM--EIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp CSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHH--HHHHHHHHCSSCCEEECCCSSH
T ss_pred cccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHH--HHHHHHHhCCCcCEEeCcCCCC
Confidence 7788888888888764432 45566777876554 45666442222 2234455667777777765543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.35 E-value=0.0041 Score=64.24 Aligned_cols=166 Identities=13% Similarity=0.063 Sum_probs=85.1
Q ss_pred ccHHHHHHHhcCCCCCCcc-----ccccceEEEEeEECCCCeEEEEEEeeccCCCchhHHHHHHHHHHhccCCcce--eE
Q 037275 669 ISYAELSKATNDFSSSNMI-----GQGSFGFVYKGNLGENGMMVAVKVINLKQKGASNGFVAECQALRNIRHRNLI--KI 741 (992)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~l-----g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv--~~ 741 (992)
.+.+|++....+|.+.+.. ..|.--+.|+.+.. +..+++|++... ...+++..|++++..+...++. ..
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~--~g~yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES--SCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEEC--CCcEEEEEcCCC--CCHHHHHHHHHHHHhhhhcccccccc
Confidence 4667888888889876544 35656788999874 345899998532 2345566788888887533221 11
Q ss_pred EEEeec-ccccCcceEEEEEEeccCCCHH-----H---------HHhhcccc---------------------hhhcccC
Q 037275 742 ITICSS-IDFKGVDFQAIVYEYMQNGSLE-----D---------WLHQSEDQ---------------------QEARSLT 785 (992)
Q Consensus 742 ~~~~~~-~~~~~~~~~~lv~e~~~~gsL~-----~---------~l~~~~~~---------------------~~~~~l~ 785 (992)
+..... .-..-....+.++.+..+.... . .++..... .......
T Consensus 79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 158 (316)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence 110000 0001123345666666553211 0 00000000 0000001
Q ss_pred HHHHHHHHHHHHHHHHHHHhc-CCCCeEeccCCCCCeeeCCCCcEEEeecccce
Q 037275 786 LIQRINIIIDVASAIEYIHHH-CQPPVVHGDLKPSNVLLDQDLVAHLGDFGLAK 838 (992)
Q Consensus 786 ~~~~~~i~~qi~~~L~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 838 (992)
.......+......+...+.. .+.++||+|+.++||+++.+...-+.||+.+.
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 111112222222222322221 23479999999999999988888899999876
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.08 E-value=0.01 Score=63.22 Aligned_cols=74 Identities=20% Similarity=0.198 Sum_probs=50.3
Q ss_pred CCccccccceEEEEeEECC-------CCeEEEEEEeeccCCCchhHHHHHHHHHHhcc-CCcceeEEEEeecccccCcce
Q 037275 684 SNMIGQGSFGFVYKGNLGE-------NGMMVAVKVINLKQKGASNGFVAECQALRNIR-HRNLIKIITICSSIDFKGVDF 755 (992)
Q Consensus 684 ~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 755 (992)
++.|+.|-.-.+|++.... ..+.|.+++.. . ........+|..+++.+. +.-..++++++..
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~-------- 116 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG-------- 116 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT--------
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC--------
Confidence 3578888889999998752 24567888764 2 223345678999999885 4334577776421
Q ss_pred EEEEEEeccCCCH
Q 037275 756 QAIVYEYMQNGSL 768 (992)
Q Consensus 756 ~~lv~e~~~~gsL 768 (992)
.+||||++|.++
T Consensus 117 -g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 -GRLEEYIPSRPL 128 (395)
T ss_dssp -EEEECCCCEEEC
T ss_pred -ceEEEEeccccC
Confidence 689999987543
|